Citrus Sinensis ID: 036011
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 977 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.967 | 0.935 | 0.393 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.961 | 0.910 | 0.375 | 1e-165 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.970 | 0.924 | 0.384 | 1e-161 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.894 | 0.745 | 0.356 | 1e-138 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.900 | 0.704 | 0.348 | 1e-134 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.917 | 0.785 | 0.355 | 1e-130 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.899 | 0.702 | 0.340 | 1e-128 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.932 | 0.871 | 0.330 | 1e-128 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.954 | 0.841 | 0.319 | 1e-125 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.952 | 0.844 | 0.322 | 1e-122 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 639 bits (1647), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/984 (39%), Positives = 575/984 (58%), Gaps = 39/984 (3%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
TD+ ALL FK+ V++ + V+ ++W+ S P+C W G++CG +++RV L L + L G I
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVIS 83
Query: 68 PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQIL 127
P +GN SFL+SLD+ +N F +P E+GQL RL ++ + N G P + S+L L
Sbjct: 84 PSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNL 143
Query: 128 SLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187
L +N G +P+ L +L+ L + + N + G +P+ +GNL+ L + L++NNL+GEIP
Sbjct: 144 RLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIP 203
Query: 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
S++ L + L L NN SG P+++N+S++ L+ + N SG L P + LPNL
Sbjct: 204 SDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLR--PDLGILLPNL 261
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
F++G N TG+IP +++N S L L ++ N+ +G IP TFGN+ L +L L N L +
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGS 320
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
DS + + FL+SLTNC L TL + N L G LP I N SA L ++G+IP+
Sbjct: 321 DS-SRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY 379
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
+IGNL +L L L N L+G +P+++G+L L+ LSL+ N L G IP + ++ L +
Sbjct: 380 DIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLD 439
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS 487
L+ N G +P L + L EL +G NK + +IP ++ LL +++S NSL GSLP
Sbjct: 440 LSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ 499
Query: 488 NIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLD 547
+I LQ L L L N+LSG +P T+G+ + +L L N F G IP G L G++ +D
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVD 558
Query: 548 LSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTT- 606
LSNN+LSG IP+ + L+ LN+S N LEG++P G F+ S N LCG
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 607 LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGI-------MVAIVIVFISCRK--KIAN 657
Q+ PC + KK S K V+ +S GI M ++ ++++ RK K N
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIG--VSVGITLLLLLFMASVTLIWLRKRKKNKETN 676
Query: 658 KIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKG-TFSDGTSFAIKVFN 716
L L + SY D++ AT+GF+ N++G GSFG+VYK ++ A+KV N
Sbjct: 677 NPTPSTLEVLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLN 734
Query: 717 LQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLY 771
+Q A +SF +ECE L+++RHRNL+K+ ++C + N+FRAL+ E MPNGSL+ WL+
Sbjct: 735 MQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
Query: 772 SDNY--------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823
+ L LLERLNI I VA L+YLH P+ HCDLKPSN+LLD+D+ AH
Sbjct: 795 PEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAH 854
Query: 824 VSDFGLSKL---FDEGD--DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTET 878
VSDFGL++L FDE + ++ TIGY APEYG G S DVYS+G+LL E
Sbjct: 855 VSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEM 914
Query: 879 FTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR-QEHTSSAEMDCLLSVLHLAL 937
FT K+PT+++F G +L + K +LP ++++VD ++L ++CL V + L
Sbjct: 915 FTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGL 974
Query: 938 DCCMESPDQRIYMTDAAVKLKKIK 961
CC ESP R+ + +L I+
Sbjct: 975 RCCEESPMNRLATSIVVKELISIR 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 584 bits (1505), Expect = e-165, Method: Compositional matrix adjust.
Identities = 369/983 (37%), Positives = 540/983 (54%), Gaps = 44/983 (4%)
Query: 8 TDQFALLAFKAHVTD--PQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGT 65
TD ALL FK+ V++ + VLA+ W+ S P C W+G++CG R +RV +LNL L G
Sbjct: 30 TDMQALLEFKSQVSENNKREVLAS-WNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 66 IPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQ 125
I P +GN SFL L+++ N+F + +P ++G+L RL+++++ YN G PS + S+L
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLS 148
Query: 126 ILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGE 185
+ L +N +P+ L +LS+L D N + GN P+ +GNL+SL ++ AYN ++GE
Sbjct: 149 TVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208
Query: 186 IPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLP 245
IP E+ L + + +N+ SG P+++NIS++ ++L N SG +L Y LP
Sbjct: 209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSG--NLRADFGYLLP 266
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
NLR LG N+ TG IP ++ N S L D+S N SG IP +FG LR L L + N
Sbjct: 267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGI-RNNS 325
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
++ ++ F+ ++ NC L L V N L G LP I N S +L + + ++G I
Sbjct: 326 LGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
PH+IGNL SL LSL N L+G +P + G+L LQ + LY N + G IP ++ RL
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
+ LN N G IPQ L L +L + +N+ + +IP + L ++LS+N L+G
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHF 505
Query: 486 PSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES 545
P + L++L+ L S N+LSG +P IG + L + N F+G IP L L++
Sbjct: 506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKN 564
Query: 546 LDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT 605
+D SNNNLSG IP+ L +L L+ LN+S NK EG +P G F+ S N +CG
Sbjct: 565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624
Query: 606 -TLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISC------RKKIANK 658
+Q+ PC + +K K V I ++ I+IV C +K A+
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684
Query: 659 IVKEDLLPLAAW-RRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFN 716
D L + + SY ++ AT F+ NL+G G+FG+V+KG + A+KV N
Sbjct: 685 GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744
Query: 717 LQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLY 771
L A +SF +ECE + +RHRNL+K+ + C + NDFRALV E MP GSL+ WL
Sbjct: 745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804
Query: 772 SDN--------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823
++ L E+LNI I VA ALEYLH PV HCD+KPSNILLD+D+ AH
Sbjct: 805 LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAH 864
Query: 824 VSDFGLSKLFDEGD-----DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTET 878
VSDFGL++L + D + + TIGY APEYG G S + DVYS+G+LL E
Sbjct: 865 VSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEM 924
Query: 879 FTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALD 938
F+ KKPTD+ F G+ +L + K S+ G +N + + L VL + +
Sbjct: 925 FSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDE---------GLRLVLQVGIK 974
Query: 939 CCMESPDQRIYMTDAAVKLKKIK 961
C E P R+ +A +L I+
Sbjct: 975 CSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 568 bits (1465), Expect = e-161, Method: Compositional matrix adjust.
Identities = 378/984 (38%), Positives = 544/984 (55%), Gaps = 36/984 (3%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
TD+ ALL FK+ V++ V+ +W+ S P+C W G+ CG +H+RV ++L + L G +
Sbjct: 39 TDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVS 98
Query: 68 PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQIL 127
P +GN SFL SL+++ N FH +P+E+G L RL+++++ N F G P + S L L
Sbjct: 99 PFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTL 158
Query: 128 SLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187
L +N +P +LS+L N + G P+ +GNL+SL ++ YN ++GEIP
Sbjct: 159 DLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIP 218
Query: 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
+I L+ + + +N +G P I+N+S++ +++ GN SG L P LPNL
Sbjct: 219 GDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLR--PDFGSLLPNL 276
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
++ +G N TGTIP +++N S L LD+ N +G IP +FG L+ L +L L NN L
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
S + + FL +LTNC L L V N L G LP I N S L ++G+IPH
Sbjct: 337 YS-SGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
IGNL SL L L N L G +P ++G L +L+ + LY N L G IP L ++ L +
Sbjct: 396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS 487
L N G IP L S L +LNLG+NK + SIP L L+ +N+S N L G L
Sbjct: 456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQ 515
Query: 488 NIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLD 547
+I L+ L+ LD+S N+LSG IP T+ + L L L N F GPIP G LTGL LD
Sbjct: 516 DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLD 574
Query: 548 LSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT-T 606
LS NNLSG IP+ + L+ LN+S N +G +P G F+ + S N LCG +
Sbjct: 575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634
Query: 607 LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVKED--- 663
LQ+ PC + +S + + + +++ + V C K+ K V+ +
Sbjct: 635 LQLQPCSVELPR--RHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNE 692
Query: 664 ----LLPLAA-WRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNL 717
P+ + + + SY ++ + T GF+ NL+G G+FG+V+KG S + AIKV NL
Sbjct: 693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752
Query: 718 QLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLYS 772
A +SF +ECE L +RHRNL+K+ + C + NDFRALV E MPNG+L+ WL+
Sbjct: 753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812
Query: 773 D--------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824
D + L L RLNI I VA AL YLH P+ HCD+KPSNILLD+D+ AHV
Sbjct: 813 DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHV 872
Query: 825 SDFGLSKLFDEGDDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879
SDFGL++L + D + TIGY APEYG G S DVYS+G++L E F
Sbjct: 873 SDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIF 932
Query: 880 TRKKPTDDMFTGEMSLKKWVKESL-PHGLMEVVDTNLLRQEHTSSAEM-DCLLSVLHLAL 937
T K+PT+ +F ++L + K +L +++ D +LR + M +CL V + +
Sbjct: 933 TGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGV 992
Query: 938 DCCMESPDQRIYMTDAAVKLKKIK 961
C ESP RI M +A KL I+
Sbjct: 993 SCSEESPVNRISMAEAISKLVSIR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1270), Expect = e-138, Method: Compositional matrix adjust.
Identities = 349/980 (35%), Positives = 521/980 (53%), Gaps = 106/980 (10%)
Query: 62 LRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVL 121
L G+IP +G + L LD+S N +P + G L L+ + L N G P+ IG
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 122 SKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNN 181
S L L L +N TG IP L NL +L+ N + +IPS + L+ L ++ L+ N+
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 182 LQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVS 241
L G I EIG L++LE+L L NN +G SI N+ +T++ + N +SG +LP +
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISG--ELPADLG 381
Query: 242 YSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLA 301
L NLR S N LTG IP+SI+N + L LDLS N +G IP FG + L+ +++
Sbjct: 382 L-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMN-LTFISIG 439
Query: 302 NNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKL 361
N+ T + P + NC NL TL+VA N L G L P+IG L+ L
Sbjct: 440 RNHFTGEIP-------DDIFNCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSL 491
Query: 362 TGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421
TG IP EIGNL+ L +L L N G IP + L LQGL +Y N+LEG IP ++ ++
Sbjct: 492 TGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMK 551
Query: 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL------------- 468
L+ + L+ NK SG IP + L SL L+L NKF+ SIP+S SL
Sbjct: 552 LLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLL 611
Query: 469 -------------------------------------EYLLAVNLSSNSLSGSLPSNIQN 491
E + ++LS+N SGS+P ++Q
Sbjct: 612 TGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQA 671
Query: 492 LQVLINLDLSRNQLSGDIPITIGSLKDLV-TLSLASNQFEGPIPQTFGSLTGLESLDLSN 550
+ + LD S+N LSG IP + D++ +L+L+ N F G IPQ+FG++T L SLDLS+
Sbjct: 672 CKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSS 731
Query: 551 NNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVP 610
NNL+GEIP+SL L LK L ++ N L+G +P +G FK N LCG + +
Sbjct: 732 NNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCG-SKKPLK 790
Query: 611 PCRANKTEGSKKASRNFLKYVLPPLISTG-----IMVAIVIVFISCRKKIANKIVKE--- 662
PC K+ S +F K LI G ++V ++++ ++C KK KI
Sbjct: 791 PCTI------KQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSES 844
Query: 663 ---DLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL 719
DL +R ++++ATD FN N++G S +VYKG DGT A+KV NL+
Sbjct: 845 SLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKE 904
Query: 720 DRAF--RSFDSECEVLRNVRHRNLIKIFS-SCCNNDFRALVLELMPNGSLEKWLYSDNYF 776
A + F +E + L ++HRNL+KI + + +ALVL M NG+LE ++
Sbjct: 905 FSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAP 964
Query: 777 L-DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835
+ LLE++++ + +A ++YLH G+ P+VHCDLKP+NILLD D VAHVSDFG +++
Sbjct: 965 IGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGF 1024
Query: 836 GDDSVTQTMTIA---TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPT--DDMFT 890
+D T T A TIGY+APE+ V++K DV+S+G+++ E T+++PT +D +
Sbjct: 1025 REDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDS 1084
Query: 891 GEMSLKKWVKESLPH---GLMEVVDTNL------LRQEHTSSAEMDCLLSVLHLALDCCM 941
+M+L++ V++S+ + G++ V+D L L+QE + + L L L C
Sbjct: 1085 QDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQE-------EAIEDFLKLCLFCTS 1137
Query: 942 ESPDQRIYMTDAAVKLKKIK 961
P+ R M + L K++
Sbjct: 1138 SRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 480 bits (1235), Expect = e-134, Method: Compositional matrix adjust.
Identities = 341/979 (34%), Positives = 493/979 (50%), Gaps = 99/979 (10%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
+++ L+L L+G IP L + L +LD+S NN +P E + +L + L N
Sbjct: 264 QLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHL 323
Query: 111 SGSFPSWIG---------VLSKLQI----------------LSLRNNSFTGPIPNSLFNL 145
SGS P I VLS Q+ L L NNS G IP +LF L
Sbjct: 324 SGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFEL 383
Query: 146 SRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNN 205
L N ++G + I NL++L + L +NNL+G++P EI L+ LE+L L N
Sbjct: 384 VELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENR 443
Query: 206 LSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI 265
SG I I N +++ +I++FGN G ++PP + L L + L +N+L G +P S+
Sbjct: 444 FSGEIPQEIGNCTSLKMIDMFGNHFEG--EIPPSIG-RLKELNLLHLRQNELVGGLPASL 500
Query: 266 TNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325
N +L LDL+ N SG IP +FG L+ L L L NN L + P SL + RN
Sbjct: 501 GNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLP-------DSLISLRN 553
Query: 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL 385
LT + ++ N L G + P+ G S+S +F + IP E+GN ++L L L N L
Sbjct: 554 LTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQL 611
Query: 386 NGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI 445
G IP T+G++ +L L + N L G+IP L ++L I LN N LSGPIP L L
Sbjct: 612 TGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLS 671
Query: 446 SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL--INLD---- 499
L EL L SN+F S+P+ ++ LL ++L NSL+GS+P I NL L +NLD
Sbjct: 672 QLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQF 731
Query: 500 ------------------LSRNQLSGDIPITIGSLKDLVT-LSLASNQFEGPIPQTFGSL 540
LSRN L+G+IP+ IG L+DL + L L+ N F G IP T G+L
Sbjct: 732 SGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTL 791
Query: 541 TGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYA 600
+ LE+LDLS+N L+GE+P S+ + L LNVS N L G++ F + SF N
Sbjct: 792 SKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTG 849
Query: 601 LCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKI- 659
LCG + R+N + A + + L + G+M+ ++ +F R K+
Sbjct: 850 LCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG 909
Query: 660 ------------VKEDLLPL----AAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGT 703
+ PL A+ + DI AT +E ++G G G VYK
Sbjct: 910 HGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 969
Query: 704 FSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND--FRALVLEL 760
+G + A+K + D + +SF E + L +RHR+L+K+ C + L+ E
Sbjct: 970 LENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1029
Query: 761 MPNGSLEKWLYSDN-------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSN 813
M NGS+ WL+ D LD RL I +G+A +EYLHH P+VH D+K SN
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1089
Query: 814 ILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPEYGTEGIVSSKCDVYSY 871
+LLD +M AH+ DFGL+K+ E D+ T + T + GY+APEY + K DVYS
Sbjct: 1090 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1149
Query: 872 GVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP---HGLMEVVDTNLLRQEHTSSAEMDC 928
G++L E T K PTD +F EM + +WV+ L +++D L + E D
Sbjct: 1150 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL---KPLLPFEEDA 1206
Query: 929 LLSVLHLALDCCMESPDQR 947
VL +AL C SP +R
Sbjct: 1207 ACQVLEIALQCTKTSPQER 1225
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1197), Expect = e-130, Method: Compositional matrix adjust.
Identities = 333/937 (35%), Positives = 480/937 (51%), Gaps = 41/937 (4%)
Query: 47 ARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLD 106
++ + + L L++ L G IPP + S L SL + N +P ELG+L L I +
Sbjct: 150 SKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIG 209
Query: 107 YN-EFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSR 165
N E SG PS IG S L +L L S +G +P+SL L +LE +I G IPS
Sbjct: 210 GNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSD 269
Query: 166 IGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINL 225
+GN S LV++ L N+L G IP EIG L LE L L N+L G I I N S + +I+L
Sbjct: 270 LGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDL 329
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
N LSG + P L L F + NK +G+IP +I+N S L L L N SGLI
Sbjct: 330 SLNLLSGSI---PSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLI 386
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
P G L L++ +N L E S L +C +L L ++ N L G +P G
Sbjct: 387 PSELGTLTKLTLFFAWSNQL-------EGSIPPGLADCTDLQALDLSRNSLTGTIPS--G 437
Query: 346 NFS-ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404
F +L L+G IP EIGN SL+ L L N + G IPS +G L+++ L
Sbjct: 438 LFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDF 497
Query: 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSS 464
N L G +P ++ L I L+ N L G +P ++SL L+ L++ +N+FS IP+S
Sbjct: 498 SSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPAS 557
Query: 465 FWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL-VTLS 523
L L + LS N SGS+P+++ L LDL N+LSG+IP +G +++L + L+
Sbjct: 558 LGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALN 617
Query: 524 LASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583
L+SN+ G IP SL L LDLS+N L G++ L + L LN+S+N G +P
Sbjct: 618 LSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPD 676
Query: 584 NGPFKYFAPQSFSWNYALCGPT--TLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIM 641
N F+ +PQ N LC T + + + N ASR + L+ T +
Sbjct: 677 NKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTV 736
Query: 642 VAIV---IVFISCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNEC----NLLGRG 694
V ++ + I R+ I N+ E L W+ T + + + D C N++G+G
Sbjct: 737 VLMILGAVAVIRARRNIDNERDSE-LGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKG 795
Query: 695 SFGSVYKGTFSDGTSFAIK-----VFNLQLDRAFR----SFDSECEVLRNVRHRNLIKIF 745
G VY+ +G A+K + N D + SF +E + L +RH+N+++
Sbjct: 796 CSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFL 855
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C N + R L+ + MPNGSL L+ LD R I++G A L YLHH P+
Sbjct: 856 GCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPI 915
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH D+K +NIL+ D +++DFGL+KL DEGD + GY+APEYG ++
Sbjct: 916 VHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITE 975
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924
K DVYSYGV++ E T K+P D + L WV+++ G +EV+D+ L + A
Sbjct: 976 KSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTL---RSRTEA 1030
Query: 925 EMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
E D ++ VL AL C SPD+R M D A LK+IK
Sbjct: 1031 EADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1185), Expect = e-128, Method: Compositional matrix adjust.
Identities = 332/974 (34%), Positives = 477/974 (48%), Gaps = 95/974 (9%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
++ LNL L+G IP L + L +LD+S NN + E ++ +L F+ L N S
Sbjct: 266 IQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLS 325
Query: 112 GSFP-------------------------SWIGVLSKLQILSLRNNSFTGPIPNSLFNLS 146
GS P + I L++L L NN+ TG IP+SLF L
Sbjct: 326 GSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLV 385
Query: 147 RLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNL 206
L N ++G + S I NL++L L +NNL+G++P EIG L LEI+ L N
Sbjct: 386 ELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRF 445
Query: 207 SGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSIT 266
SG + I N + + I+ +GN+LSG + P L +L L +N+L G IP S+
Sbjct: 446 SGEMPVEIGNCTRLQEIDWYGNRLSGEI---PSSIGRLKDLTRLHLRENELVGNIPASLG 502
Query: 267 NASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNL 326
N ++T +DL+ N SG IP +FG L L + + NN L + P SL N +NL
Sbjct: 503 NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLP-------DSLINLKNL 555
Query: 327 TTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALN 386
T + +SN G + P+ G S+S +F + G+IP E+G +L L L N
Sbjct: 556 TRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFT 613
Query: 387 GTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLIS 446
G IP T G++ +L L + N+L G IP +L ++L I LN N LSG IP L L
Sbjct: 614 GRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPL 673
Query: 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLS 506
L EL L SNKF S+P+ +SL +L + L NSL+GS+P I NLQ L L+L NQLS
Sbjct: 674 LGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLS 733
Query: 507 GDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES-LDLSNNNLSGEIPKSLEALL 565
G +P TIG L L L L+ N G IP G L L+S LDLS NN +G IP ++ L
Sbjct: 734 GPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLP 793
Query: 566 FLKQLNVSHNKLEGEIPAN----------------------GPFKYFAPQSFSWNYALCG 603
L+ L++SHN+L GE+P F + +F N LCG
Sbjct: 794 KLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCG 853
Query: 604 PTTLQVPPCRANKTEGSKKASRNFLKYVLPPLIST----GIMVAIVIVFISCRKKIANKI 659
P N+ + S + V+ IS+ +MV ++I+F + K+
Sbjct: 854 S-----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKV 908
Query: 660 ----------VKEDLLPL----AAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFS 705
PL A + DI AT NE ++G G G VYK
Sbjct: 909 RGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELK 968
Query: 706 DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRALVLELMP 762
+G + A+K + D + +SF+ E + L +RHR+L+K+ C + + L+ E M
Sbjct: 969 NGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMA 1028
Query: 763 NGSLEKWLYSD-----NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817
NGS+ WL+++ L RL I +G+A +EYLH+ P+VH D+K SN+LLD
Sbjct: 1029 NGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLD 1088
Query: 818 EDMVAHVSDFGLSKLFDEGDDSVTQ--TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLL 875
++ AH+ DFGL+K+ D+ T+ TM + GY+APEY + K DVYS G++L
Sbjct: 1089 SNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVL 1148
Query: 876 TETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS--SAEMDCLLSVL 933
E T K PT+ MF E + +WV+ L L+ E S E + VL
Sbjct: 1149 MEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVL 1208
Query: 934 HLALDCCMESPDQR 947
+AL C P +R
Sbjct: 1209 EIALQCTKSYPQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 335/1013 (33%), Positives = 494/1013 (48%), Gaps = 102/1013 (10%)
Query: 12 ALLAFKAHVTDPQSVLA-NNW---SISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
ALL +K+ T+ S ++W + S W G++C + LNL+N G+ GT
Sbjct: 53 ALLKWKSTFTNQTSSSKLSSWVNPNTSSFCTSWYGVACSL--GSIIRLNLTNTGIEGTFE 110
Query: 68 ----PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSK 123
L N +F+ D+S N F + G+ +L + L N+ G P +G LS
Sbjct: 111 DFPFSSLPNLTFV---DLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSN 167
Query: 124 LQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ 183
L L L N G IP+ + L+++ + N++ G IPS GNL+ LVN+ L N+L
Sbjct: 168 LDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLS 227
Query: 184 GEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYS 243
G IPSEIGNL NL L L NNL+G I S N+ +TL+N+F NQLSG ++PP++ +
Sbjct: 228 GSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSG--EIPPEIG-N 284
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
+ L SL NKLTG IP+++ N L L L N +G IP G + + L ++ N
Sbjct: 285 MTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISEN 344
Query: 304 YLTTDSPTA-------EWSFLSS----------LTNCRNLTTLAVASNPLRGILPPVIGN 346
LT P + EW FL + N LT L + +N G LP I
Sbjct: 345 KLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICR 404
Query: 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVG------------ 394
L+N D G +P + + +SLI + N+ +G I G
Sbjct: 405 -GGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSN 463
Query: 395 ------------RLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA 442
+ ++L L N++ G+IP ++ ++ +L+ + L+ N+++G +P+ ++
Sbjct: 464 NNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESIS 523
Query: 443 SLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSR 502
++ + +L L N+ S IPS L L ++LSSN S +P + NL L ++LSR
Sbjct: 524 NINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSR 583
Query: 503 NQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLE 562
N L IP + L L L L+ NQ +G I F SL LE LDLS+NNLSG+IP S +
Sbjct: 584 NDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFK 643
Query: 563 ALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGP--TTLQVPPCRANKTEGS 620
+L L ++VSHN L+G IP N F+ P +F N LCG TT + PC ++ S
Sbjct: 644 DMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKS 703
Query: 621 KKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVK--------EDLLPLAAWRR 672
K RN + Y+L P+I I++++ C +K +I + E L + +
Sbjct: 704 HK-DRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGK 762
Query: 673 TSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAF------RSF 726
Y +I +AT F+ L+G G G VYK + A+K N D + + F
Sbjct: 763 VRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEF 821
Query: 727 DSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF--LDLLERLN 784
+E L +RHRN++K+F C + LV E M GSL K L +D+ LD +R+N
Sbjct: 822 LNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRIN 881
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
++ GVA AL Y+HH S +VH D+ NILL ED A +SDFG +KL DS +
Sbjct: 882 VVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKP--DSSNWSA 939
Query: 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT-------GEMSLKK 897
T GY+APE V+ KCDVYS+GVL E + P D + T +SLK
Sbjct: 940 VAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKS 999
Query: 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950
LP E+ ++E +L +L +AL C P R M
Sbjct: 1000 ISDHRLPEPTPEI------KEE---------VLEILKVALLCLHSDPQARPTM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 351/1098 (31%), Positives = 498/1098 (45%), Gaps = 165/1098 (15%)
Query: 6 LTTDQFALLAFKAHVTDPQSVLANNWSISQPI-CKWVGISCGARHQRVRALNLSNMGLRG 64
L +D ALL+ H T S + +W+ S C W+G+ C R Q V LNLS+ G+ G
Sbjct: 24 LNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECD-RRQFVDTLNLSSYGISG 82
Query: 65 TIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKL 124
P + + L + +S N F +P++LG L I L N F+G+ P +G L L
Sbjct: 83 EFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNL 142
Query: 125 QILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG 184
+ LSL NS GP P SL ++ LE N ++G+IPS IGN+S L + L N G
Sbjct: 143 RNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSG 202
Query: 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSL 244
+PS +GN+ L+ L L NNL G + ++ N+ + +++ N L G + P S
Sbjct: 203 PVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAI---PLDFVSC 259
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
+ SL N+ TG +P + N + L + SG IP FG L L L LA N+
Sbjct: 260 KQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNH 319
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
+ P L C+++ L + N L G +P +G S LQ + Y L+G
Sbjct: 320 FSGRIP-------PELGKCKSMIDLQLQQNQLEGEIPGELGMLS-QLQYLHLYTNNLSGE 371
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN---------------- 408
+P I ++SL L L+ N L+G +P + L+QL L+LY N+
Sbjct: 372 VPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLE 431
Query: 409 --------------------------------LEGSIPYDL--CH-LERL----NGIR-- 427
LEGS+P DL C LERL N +R
Sbjct: 432 VLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGG 491
Query: 428 --------------LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLA 473
L+GN +GPIP L +L ++ + L SN+ S SIP SL L
Sbjct: 492 LPDFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEH 551
Query: 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533
+NLS N L G LPS + N L LD S N L+G IP T+GSL +L LSL N F G I
Sbjct: 552 LNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGI 611
Query: 534 PQTF-----------------------GSLTGLESLDLSNNNLSGEIPKSLEALLFLKQL 570
P + G+L L SL+LS+N L+G++P L L L++L
Sbjct: 612 PTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEEL 671
Query: 571 NVSHNKLEGEI------------------------PANGPFKYFAPQSFSWNYALC---- 602
+VSHN L G + P+ F +P SFS N LC
Sbjct: 672 DVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCP 731
Query: 603 -----GPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKI-- 655
P + + PC G S + ++V ++FI C
Sbjct: 732 ADGLACPESSILRPCNMQSNTGKGGLST----------LGIAMIVLGALLFIICLFLFSA 781
Query: 656 -----ANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSF 710
K V+E + + + AT+ N+ ++G+G+ G++YK T S +
Sbjct: 782 FLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVY 841
Query: 711 AIK--VFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEK 768
A+K VF + S E E + VRHRNLIK+ ++ ++ M NGSL
Sbjct: 842 AVKKLVFT-GIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHD 900
Query: 769 WLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826
L+ N LD R NI +G A L YLH +VH D+KP NILLD D+ H+SD
Sbjct: 901 ILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISD 960
Query: 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
FG++KL D+ S+ TIGYMAPE + S + DVYSYGV+L E TRKK D
Sbjct: 961 FGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALD 1020
Query: 887 DMFTGEMSLKKWVKESLPHG--LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESP 944
F GE + WV+ + ++VD +LL E S+ M+ + L LAL C +
Sbjct: 1021 PSFNGETDIVGWVRSVWTQTGEIQKIVDPSLL-DELIDSSVMEQVTEALSLALRCAEKEV 1079
Query: 945 DQRIYMTDAAVKLKKIKI 962
D+R M D +L + I
Sbjct: 1080 DKRPTMRDVVKQLTRWSI 1097
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 342/1059 (32%), Positives = 500/1059 (47%), Gaps = 128/1059 (12%)
Query: 13 LLAFKAHVTDPQSVLANNWSISQPI-CKWVGISCG--ARHQRVRALNLSNMGLRGTIPPH 69
LL K+ D + L NW+ + + C W G+ C + V +LNLS+M L G + P
Sbjct: 34 LLEIKSKFVDAKQNL-RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPS 92
Query: 70 LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129
+G L LD+S N +P E+G L + L+ N+F G P IG L L+ L +
Sbjct: 93 IGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLII 152
Query: 130 RNN------------------------SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSR 165
NN + +G +P S+ NL RL + + N+I G++PS
Sbjct: 153 YNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSE 212
Query: 166 IGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINL 225
IG SLV + LA N L GE+P EIG L+ L ++L N SG I I N +++ + L
Sbjct: 213 IGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLAL 272
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
+ NQL G + PK L +L L +N L GTIP I N S +D S N+ +G I
Sbjct: 273 YKNQLVGPI---PKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEI 329
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNC------------------RNLT 327
P GN+ L +L L N LT P E S L +L+ R L
Sbjct: 330 PLELGNIEGLELLYLFENQLTGTIP-VELSTLKNLSKLDLSINALTGPIPLGFQYLRGLF 388
Query: 328 TLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG 387
L + N L G +PP +G +S L D L+G IP + ++I+L+L N L+G
Sbjct: 389 MLQLFQNSLSGTIPPKLGWYS-DLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSG 447
Query: 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISL 447
IP+ + + L L L NNL G P +LC + I L N+ G IP+ + + +L
Sbjct: 448 NIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSAL 507
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLD-------- 499
+ L L N F+ +P L L +N+SSN L+G +PS I N ++L LD
Sbjct: 508 QRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSG 567
Query: 500 ----------------LSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
LS N LSG IP+ +G+L L L + N F G IP+ GSLTGL
Sbjct: 568 TLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGL 627
Query: 544 E-SLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN------------------ 584
+ +L+LS N L+GEIP L L+ L+ L +++N L GEIP++
Sbjct: 628 QIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLT 687
Query: 585 GP---FKYFAPQSFSWNYALCGP---TTLQVPPCRANKTEGSKKASRNFLKYVLPPLIST 638
GP + + SF N LCGP +Q P +++ G R+ + +
Sbjct: 688 GPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIG 747
Query: 639 GI--MVAIVIVFISCRKKIANKIVKEDLLP--------LAAWRRTSYLDIQRATDGFNEC 688
G+ M+ +IV++ R +D P ++ D+ ATD F+E
Sbjct: 748 GVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDES 807
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVF--------NLQLDRAFRSFDSECEVLRNVRHRN 740
++GRG+ G+VYK G + A+K N +D +FR +E L N+RHRN
Sbjct: 808 FVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFR---AEILTLGNIRHRN 864
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++K+ C + L+ E MP GSL + L+ + LD +R I +G A L YLHH
Sbjct: 865 IVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDC 924
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
+ H D+K +NILLD+ AHV DFGL+K+ D S + + + GY+APEY
Sbjct: 925 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-PHSKSMSAIAGSYGYIAPEYAYTM 983
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME--VVDTNLLRQ 918
V+ K D+YSYGV+L E T K P + G + WV+ + + V+D L +
Sbjct: 984 KVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSYIRRDALSSGVLDARLTLE 1042
Query: 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957
+ + M L+VL +AL C SP R M + L
Sbjct: 1043 DERIVSHM---LTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 977 | ||||||
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.972 | 0.932 | 0.515 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.972 | 0.910 | 0.512 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.905 | 0.834 | 0.559 | 0.0 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.949 | 0.953 | 0.515 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.967 | 0.867 | 0.476 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.972 | 0.908 | 0.485 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.928 | 0.834 | 0.520 | 0.0 | |
| 359482811 | 1118 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.847 | 0.464 | 0.0 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.919 | 0.453 | 0.488 | 0.0 | |
| 359492792 | 1067 | PREDICTED: probable LRR receptor-like se | 0.968 | 0.886 | 0.470 | 0.0 |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/982 (51%), Positives = 656/982 (66%), Gaps = 32/982 (3%)
Query: 8 TDQFALLAFKAHVT-DPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTI 66
TDQ ALLAFK H+T DPQ++L ++WS C W+G+SC R QRV AL+LS+MGL GTI
Sbjct: 30 TDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGTI 89
Query: 67 PPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF-PSWIGVLSKLQ 125
PP LGN SFL L + N+FH LP+E+G LRRL+ + + N+ S P G L +L+
Sbjct: 90 PPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLE 149
Query: 126 ILSLRNNSFTGPIPNSLFNLSRLEKWDSMFN-------------------------IIDG 160
L N+ TG IP+++FN+S L+ D MFN + G
Sbjct: 150 ELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLLSSNQLSG 209
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTI 220
IPS + L + L YNN G IP E+G L LE+L LG+N LSG + SIFN++++
Sbjct: 210 QIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSL 269
Query: 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280
+ + N LSG +P + S LPNL L N +TG++P + N S+L LDLS+N
Sbjct: 270 RTMQICCNNLSG--SIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNK 327
Query: 281 FSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGIL 340
+G + FGNLR L VL+L +N T + +F++SLTN R L L + NPL G+L
Sbjct: 328 MTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGML 387
Query: 341 PPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQ 400
P +GN S+ L FY Y KL GNIP EIGNL +LIVLSL N+L G IP+TVG L ++Q
Sbjct: 388 PNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQ 447
Query: 401 GLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS 460
L L+ NNL GSIP D+C RL I LN N LSG IP C+ +L SLR L L N SS+
Sbjct: 448 VLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSST 507
Query: 461 IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV 520
IP + WSL+ LL +NL SN L GSLPS + ++ I + LS NQLSG+IP TIGSL++L+
Sbjct: 508 IPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLI 567
Query: 521 TLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580
SL+ N F+G IP+ FG L LE LDLS NNLSGEIPKSLEAL +L+ +VS N L+GE
Sbjct: 568 RFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGE 627
Query: 581 IPANGPFKYFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGI 640
IP GPF F +SF N LCGP+ LQVPPC + SK SR L++ LP + S +
Sbjct: 628 IPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSR-LLRFSLPTVASILL 686
Query: 641 MVAIVIVFISCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVY 700
+VA + + + CR++ + E L A RR SYL++ AT+ F+E NLLG GSFGSVY
Sbjct: 687 VVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVY 746
Query: 701 KGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760
+G DG + A+K+FNLQL RAFRSFD+ECE++RN+RHRNL+KI SC N DF+ALVLE
Sbjct: 747 QGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEY 806
Query: 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM 820
MP GSLEKWLYS NY LD+++R+NIMI VA ALEYLHHG+ +PVVHCDLKPSN+LLDEDM
Sbjct: 807 MPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDM 866
Query: 821 VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
VAHV DFG++KL E ++S QT T+ATIGYMAPEYG +G+VS+K DVYS+G++L E T
Sbjct: 867 VAHVCDFGIAKLLGE-NESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLT 925
Query: 881 RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL-RQEHTSSAEMDCLLSVLHLALDC 939
RK+PTD+MF GEMSLK+ VKESLP ++++VD+N+L R + S + C+ S++ LAL C
Sbjct: 926 RKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQC 985
Query: 940 CMESPDQRIYMTDAAVKLKKIK 961
ESP +R+ M + +LK IK
Sbjct: 986 VNESPGERMAMVEILARLKNIK 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/1019 (51%), Positives = 675/1019 (66%), Gaps = 69/1019 (6%)
Query: 3 VQNLTTDQFALLAFKAHVT-DPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMG 61
V N+ +DQ ALLA K + DP ++LA NWSI+ +C WVG++CGARH RV AL+LS+MG
Sbjct: 28 VTNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARHGRVTALDLSDMG 87
Query: 62 LRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVL 121
L GTIPPHLGN SFL + N FH LP+EL +LRR++ + N FSG PSWIG
Sbjct: 88 LTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIPSWIGSF 147
Query: 122 SKLQILSLRNNSFT---------------------------------------------- 135
++LQ LSL +N FT
Sbjct: 148 TQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALYLN 207
Query: 136 -----GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI 190
GPIP++L +L+ FN +G+I IGNL+ L + L NN G IP EI
Sbjct: 208 SNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTIPDEI 267
Query: 191 GNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVF 250
G+L +LE ++L +N LSG + I+N S +T I L NQLSG+L S +LPNL F
Sbjct: 268 GDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYL----PSSSNLPNLEFF 323
Query: 251 SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSP 310
+ N TG IP S+ NASKL +DL +NSF G IP GNL+ L V + N+LT S
Sbjct: 324 IIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVKSS 383
Query: 311 TAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG 370
++ S SSLT C++L +++NPL G LP +GN S+SL+ +DC +TG IP EIG
Sbjct: 384 SSGLSLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPKEIG 443
Query: 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430
NL SL L L N L GTIP+T+ +L +LQ L L+ N LEGS PY+LC L+ L + L
Sbjct: 444 NLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLEV 503
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ 490
N LSG IP CL ++ SLR L++G NKFSS+IPS+ W L +L +NLSSNSLSGSL +I
Sbjct: 504 NALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDIG 563
Query: 491 NLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSN 550
NL+ + +DLS NQLSG IP +IG LK L+ LSLA N+ EG IPQ FG L+ LDLSN
Sbjct: 564 NLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSN 623
Query: 551 NNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVP 610
NNLSGEIPKSLE L +L NVS N+L+GEIP F + +SF N LCG LQV
Sbjct: 624 NNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQ 683
Query: 611 PCRANKTEGSKKASRNFLKYVLPPLISTGIMV----AIVIVFISCRKKIANKIVKEDLLP 666
PC + +GSK AS+ L+Y L++TG+ + A+ I+FI RK+ N + E LLP
Sbjct: 684 PCETSTHQGSKAASKLALRY---GLMATGLTILAVAAVAIIFIRSRKR--NMRITEGLLP 738
Query: 667 LAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSF 726
LA +R SY ++++ATD FNE NLLGRGSFGSVYKGTFSDG+S A+KVFNLQ++ AF+SF
Sbjct: 739 LATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSF 798
Query: 727 DSECEVLRNVRHRNLIKIFSSC--CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN 784
D ECEVLR +RHRNL+KI +SC N DF+ALVLE MPN SLEKWL S +FL+LLERLN
Sbjct: 799 DVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLN 858
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
IM+ VA A+EYLHHG++ P+VHCDLKPSNILLDE+MVAHV+DFG++KL + + S QT+
Sbjct: 859 IMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGD-EHSFIQTI 917
Query: 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
T+AT+GYMAPEYG+EG+VS+ D+YS+G+LL ETFTRKKPTDDMF E+S+K+WV+ES+P
Sbjct: 918 TLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVP 977
Query: 905 HGLMEVVDTNLLR-QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962
G+ ++ D +LLR +E SA+ DC+LSV+ +AL C + P++R + D L K+
Sbjct: 978 GGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKV 1036
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2398), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/889 (55%), Positives = 621/889 (69%), Gaps = 4/889 (0%)
Query: 74 SFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNS 133
S L L++ N H +P+ L + LR + L+ N F+GS P I L+KL+ L L N+
Sbjct: 163 STLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNN 222
Query: 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNL 193
TG IP + L LEK N ++GNIP IGN + L+ +++ NNL G IP+E+GNL
Sbjct: 223 LTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNL 282
Query: 194 QNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLG 253
L+ L LG NN++G I + FN S + +N+ N LSGHL P LPNL L
Sbjct: 283 HTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHL--PSNTGLGLPNLEELYLE 340
Query: 254 KNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAE 313
KN+L+G IP+SI NASKL LDLS+NSFSG IP GNLR L LNLA N LT+ S +E
Sbjct: 341 KNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSE 400
Query: 314 WSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR 373
SFLSSL+NCR+L L NPLRG LP IGN SASL+ YA+DC++ GNIP IGNL
Sbjct: 401 LSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLS 460
Query: 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433
+LI L L N L G IPS +GRL+ LQ SL N L+G IP ++CHLERL+ + L N
Sbjct: 461 NLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGF 520
Query: 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ 493
SG +P CL+++ SLREL LGSN+F+S IP++FWSL+ LL +NLS NSL+G+LP I NL+
Sbjct: 521 SGSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLK 579
Query: 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
V+ +D S NQLSGDIP +I L++L SL+ N+ +GPIP +FG L LE LDLS N+L
Sbjct: 580 VVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSL 639
Query: 554 SGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPCR 613
SG IPKSLE L+ LK NVS N+L+GEI GPF F+ +SF N ALCGP +QVPPC+
Sbjct: 640 SGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCK 699
Query: 614 ANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVKEDLLPLAAWRRT 673
+ T K R F+ + P I+ I+V + V I R +ED LP A WR+
Sbjct: 700 SISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATWRKI 759
Query: 674 SYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVL 733
SY ++ RAT+GFNE NLLG GS GSVYKGT SDG A+KVF+LQL+ FDSECEVL
Sbjct: 760 SYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVL 819
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
R +RHRNL+KI SSCCN DF+AL+LE +P+GSLEKWLYS NY+LD+L+RLNIMI VA AL
Sbjct: 820 RMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASAL 879
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
EYLHHG + PVVHCDLKPSN+L++EDMVAHVSDFG+S+L EG D+VTQT+T+ATIGYMA
Sbjct: 880 EYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEG-DAVTQTLTLATIGYMA 938
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913
PEYG EGIVS K DVYSYG+ L ETFTRKKPTDDMF GEMSLK WVK+SLP + EV+D
Sbjct: 939 PEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDA 998
Query: 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962
NLL +E A+ DC+ S+L+LAL+C + P +RI M D L+KIK+
Sbjct: 999 NLLIEEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIKL 1047
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/970 (51%), Positives = 649/970 (66%), Gaps = 42/970 (4%)
Query: 3 VQNLTTDQFALLAFKAHVT-DPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMG 61
V N++TDQ ALLA K + DP S+L NWS + +C W+G++CGARH RV ALNLS+MG
Sbjct: 29 VTNISTDQDALLALKVRIVGDPNSLLTTNWSTATSVCTWIGVTCGARHNRVTALNLSHMG 88
Query: 62 LRGTIPPHLGNFSFLM--SLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIG 119
L GTIPPHLGN SFL+ L++ + +P L L +L L N G P IG
Sbjct: 89 LAGTIPPHLGNLSFLVFGCLNMFAVLYIGVIPTSLFNLSKLSIFYLSSNNLQGYIPEAIG 148
Query: 120 VLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY 179
L L++LSL N F+ IP+S+FN+S SL ++ +
Sbjct: 149 NLYSLRLLSLEKNEFSDSIPSSIFNIS------------------------SLEQIDFSN 184
Query: 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK 239
N G IP EIGNL NLE++ LG+N L+G + I+N S + +I+L NQLSGHL
Sbjct: 185 NRFSGIIPDEIGNLANLELINLGVNRLAGVVPSGIYNASKMMVISLSSNQLSGHLPS--S 242
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
+ LPNLR LG N TG IP S++NAS+LT + L NSF G IP GNLR L L
Sbjct: 243 LGLLLPNLRRLFLGGNNFTGPIPISLSNASELTLIALPSNSFFGHIPDELGNLRSLQYLY 302
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359
L N+LT S ++ S +SLT C++L L + NPL G LP +GN S+SL+ AY C
Sbjct: 303 LWGNHLTIKSLSSGLSLFNSLTKCKDLRILYLHDNPLNGTLPISVGNLSSSLEVLSAYRC 362
Query: 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCH 419
+TG IP EIGNL +L +LSL+ N L GTIP+T+G+L +LQ L L N LEG P +LC
Sbjct: 363 GITGTIPIEIGNLSNLTLLSLYENDLRGTIPATIGKLRKLQALLLDHNKLEGVFPPELCD 422
Query: 420 LERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSN 479
L+ L + L N LSG IP CL ++ SLR L++ NKF+S+IPS+ W LE +L VNLS N
Sbjct: 423 LQSLAILSLGVNTLSGSIPSCLGNVDSLRNLSMQMNKFNSTIPSTLWRLENILIVNLSFN 482
Query: 480 SLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGS 539
SLSG+L +I NL+V +DLS NQLSG IP +GSLKDL +LSLA N+FEG IPQ+FG
Sbjct: 483 SLSGALAVDIGNLKVATIIDLSGNQLSGQIPPGLGSLKDLSSLSLADNRFEGSIPQSFGD 542
Query: 540 LTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNY 599
L+ LDLSNN LSGEIPK LE L +L NVS N+L+GEIP G F + QSF N
Sbjct: 543 AISLQFLDLSNNTLSGEIPKYLEILRYLTYFNVSFNELQGEIPNGGAFTNLSAQSFMGNK 602
Query: 600 ALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMV----AIVIVFISCRKKI 655
CG QV PC+ +GSK S+ L+Y L++TG+ + A+VI+FI RK+
Sbjct: 603 GFCGAAKFQVQPCKTRTDQGSKAGSKLALRY---GLMATGLTILAVAAVVIIFIRSRKR- 658
Query: 656 ANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVF 715
N+ E LLPLA R SY ++++ATD FNE NLLG+GSFGSVYKG FSDG S A+KVF
Sbjct: 659 -NRRTTEGLLPLATLERISYRELEQATDKFNEINLLGKGSFGSVYKGIFSDGRSVAVKVF 717
Query: 716 NLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC--CNNDFRALVLELMPNGSLEKWLYSD 773
NLQ + AF+SFD E EVLR +RHRNL+KI +SC N +F+ALVLE MPN SLEKWLYS
Sbjct: 718 NLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFMPNHSLEKWLYSP 777
Query: 774 NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833
N+FL+ L+RLNIM+ VA A+EYLHHG++TP+VHCDLKP+NILLDE+M AHV+DFG++KL
Sbjct: 778 NHFLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDENMAAHVTDFGIAKLL 837
Query: 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893
+ + S +T+T+AT+GYMAPEYG+EG+VS+ DVYS+G+L+ ETFT +KPTDDMF EM
Sbjct: 838 GD-ERSFIRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIETFTSRKPTDDMFNEEM 896
Query: 894 SLKKWVKESLPHGLMEVVDTNLLRQEHTS-SAEMDCLLSVLHLALDCCMESPDQRIYMTD 952
++K+WV+ESL G+ ++ D NLLR E SA+ DC++S++ LAL C + P++R + D
Sbjct: 897 NMKQWVQESLAGGVTQIADPNLLRIEDEHLSAKKDCIISMMQLALQCSADLPEERPNIRD 956
Query: 953 AAVKLKKIKI 962
L IK+
Sbjct: 957 VLSTLNHIKV 966
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2293), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1058 (47%), Positives = 654/1058 (61%), Gaps = 113/1058 (10%)
Query: 8 TDQFALLAFKAHVT-DPQSVLANNWSISQPICKWVGISCGARHQRVRAL----------- 55
TD ALL K H DP ++ NWS + C W G++C RH RV AL
Sbjct: 30 TDLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIV 87
Query: 56 -------------NLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNEL-------- 94
++SN G +P LGN L ++ S N+F +P+ L
Sbjct: 88 PPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQH 147
Query: 95 ----------------------------------------GQLRRLRFISLDYNEFSGSF 114
G L L+ +++ N+ SGSF
Sbjct: 148 LLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSF 207
Query: 115 PSWIGVL-------------------------SKLQILSLRNNSFTGPIPNSLFNLSRLE 149
P I L SKLQ+L+L N G IP+ L+ L
Sbjct: 208 PPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELR 267
Query: 150 KWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP 209
N G+IP IGNL+ L ++L NNL G IP EIGNLQNL+I+ L NNL+G
Sbjct: 268 SLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGS 327
Query: 210 IQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS 269
I ++FNIST+ I + N L G +LP + LPNL LG NKL+G IP+ I+NAS
Sbjct: 328 IPHALFNISTMKWIAMTSNNLLG--NLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNAS 385
Query: 270 KLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
KLT L+L NSF+G IP + G+LR L L L N L++ + E + SSL NC+NL L
Sbjct: 386 KLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYL 445
Query: 330 AVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI 389
++ NPL G LP +GN S SL++F A D + G++ IGNL SL L+L N L G I
Sbjct: 446 WLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRI 505
Query: 390 PSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE 449
P+T+G L+ LQGL L+GN+L+GSIP +LC L L + L GNKLSG IP C ++L SLR
Sbjct: 506 PTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRN 565
Query: 450 LNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDI 509
L L SN+F S+I S+ W+L+ +L VNL+SN L+GSLPS I+NL+ + +++S+NQLSG+I
Sbjct: 566 LFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEI 625
Query: 510 PITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQ 569
PI+IG L+DL L L+ N+ +GPIPQ+ G + LE LDLS+NNLSG IPKSL+ LL+LK
Sbjct: 626 PISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKY 685
Query: 570 LNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPC-----RANKTEGSKKAS 624
NVS N L+GEIP G F F+ QSF N ALCG LQV PC RA +T GSK
Sbjct: 686 FNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIV- 744
Query: 625 RNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDG 684
L+YVLP ++ ++A VI+ ++ A +++D L L RR SY ++Q AT+G
Sbjct: 745 ---LRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNG 801
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
F E N LG GSFGSVYKGT SDGT A KVFNLQL+RAF+SFD+ECEVLRN+RHRNL+KI
Sbjct: 802 FQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKI 861
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+SC +F+ALVLE MPN SLEKWLYSD+YFL+ L+RLNIM+ VA LEYLHHG++ P+
Sbjct: 862 ITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPM 921
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
HCD+KPSN+LL+EDMVA ++DFG+SKL E + SV QTMT+ATIGYMAPEYG+EGIVS
Sbjct: 922 AHCDIKPSNVLLNEDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAPEYGSEGIVSV 980
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR-QEHTSS 923
+ DVYSYGVLL ETFT+KKPTD MFT ++SLK WV++SL + +V+D NLL +E +
Sbjct: 981 RGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLA 1040
Query: 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
A+ DC++S+L LAL C + P RI M L+KIK
Sbjct: 1041 AKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIK 1078
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/1040 (48%), Positives = 646/1040 (62%), Gaps = 90/1040 (8%)
Query: 8 TDQFALLAFKAHVT-DPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTI 66
D+FAL+A KAH+T D Q +LA NWS C W GISC A QRV A+NLSNMGL GTI
Sbjct: 8 VDEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTI 67
Query: 67 PPHLGNFSFLMSLDISKNNFHAYLPNELGQL------------------------RRLRF 102
P +GN SFL+SLD++ N+F +PN +G L R LR
Sbjct: 68 APQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRG 127
Query: 103 ISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNI 162
+SL N+F+G P IG LS L+ L L N TG IP + NLS L N I G I
Sbjct: 128 LSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPI 187
Query: 163 PSRIGNLSSLVNVNLAYN---------------NLQG----------------------- 184
P+ I +SSL + A N NLQG
Sbjct: 188 PAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRELL 247
Query: 185 -----------EIPSEIGNLQNLEILVLGMNNLSGPIQPSI----------FNISTITLI 223
IP EIGNL LE + L N+L G I S FNIS + +
Sbjct: 248 SLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLSFNISKLQTL 307
Query: 224 NLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSG 283
L N LSG LP + LP+L +G N+ +GTIP SI+N SKLT L LS NSF+G
Sbjct: 308 GLVQNHLSG--SLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTG 365
Query: 284 LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPV 343
+P NL L L+LA N LT + + FL+SLTNC+ L L + NPL G LP
Sbjct: 366 NVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGTLPNS 425
Query: 344 IGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLS 403
+GN +L+ F A C+ G IP IGNL +LI L L N L G+IP+T+G+L++LQ LS
Sbjct: 426 LGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALS 485
Query: 404 LYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS 463
+ GN + GSIP DLCHL+ L +RL+ NKLSG IP C L +LREL+L SN + +IP
Sbjct: 486 IVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPM 545
Query: 464 SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523
SFWSL LL +NLSSN L+G+LP + N++ + LDLS+N +SG IP +G L++L+TLS
Sbjct: 546 SFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNLITLS 605
Query: 524 LASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583
L+ N+ +GPIP FG L LESLDLS NNLSG IPK+LEAL++LK LNVS NKL+GEIP
Sbjct: 606 LSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPN 665
Query: 584 NGPFKYFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVA 643
GPF F +SF +N ALCG QV C N S K LKY+L P+ ST +V
Sbjct: 666 GGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVV 725
Query: 644 IVIVFISCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGT 703
++++I R + + LP + S+ + AT+ F E NL+G+GS G VYKG
Sbjct: 726 FIVLWIRRRDNMEIPTPIDSWLP-GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGV 784
Query: 704 FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763
S+G + AIKVFNL+ A RSF+SECEV++ +RHRNL++I + C N DF+ALVL+ MPN
Sbjct: 785 LSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPN 844
Query: 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823
GSLEK LYS YFLDL++RLNIMI VA ALEYLHH S+ VVHCDLKPSN+LLD+DMVAH
Sbjct: 845 GSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAH 904
Query: 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK 883
V+DFG++KL E +S+ QT T++TIGYMAPE+G+ GIVS+K DVYSYG+LL E F RKK
Sbjct: 905 VADFGIAKLLTE-TESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKK 963
Query: 884 PTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA-EMDCLLSVLHLALDCCME 942
P D+MFTG+++LK WV ESL + +++VVD NLLR+E A ++ CL S++ LAL C +
Sbjct: 964 PMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTD 1022
Query: 943 SPDQRIYMTDAAVKLKKIKI 962
SP++RI M DA V+LKK +I
Sbjct: 1023 SPEERIDMKDAVVELKKSRI 1042
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2289), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/940 (52%), Positives = 634/940 (67%), Gaps = 33/940 (3%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
R+++L L N GTIPP +GN S L +L + N+ +P E+G+L ++ + + N+
Sbjct: 147 RLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQL 206
Query: 111 SGSFPSWIGVLSKLQILSLRNNS--------------------------FTGPIPNSLFN 144
G+ PS I +S LQ ++L NS FTGPIP++L
Sbjct: 207 VGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSK 266
Query: 145 LSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMN 204
L+ FN G IP I +L+ L ++LA N+L GE+P EIG+L L +L + N
Sbjct: 267 CGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDN 326
Query: 205 NLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNS 264
+L+G I IFNIS++ +L N LSG +LPP LPNL L N L+G IP+S
Sbjct: 327 SLTGHIPFQIFNISSMVSGSLTRNNLSG--NLPPNFGSYLPNLENLILEINWLSGIIPSS 384
Query: 265 ITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324
I NASKL LD +N +G IPH G+LRFL LNL N L +S E SFL+SLTNC+
Sbjct: 385 IGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCK 444
Query: 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINA 384
L L ++ NPL GILP IGN S SLQ F A CKL GNIP EIGNL +L +LSL N
Sbjct: 445 RLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNND 504
Query: 385 LNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASL 444
L GTIP ++G+L++LQGL L N L+GSIP D+C L L + L N+LSG IP CL L
Sbjct: 505 LTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGEL 564
Query: 445 ISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504
LR L LGSNK +S+IPS+ WSL ++L++++SSN L G LPS++ NL+VL+ +DLSRNQ
Sbjct: 565 TFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQ 624
Query: 505 LSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL 564
LSG+IP IG L+DL +LSLA N+FEGPI +F +L LE +DLS+N L GEIPKSLE L
Sbjct: 625 LSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGL 684
Query: 565 LFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKAS 624
++LK L+VS N L GEIP GPF F+ +SF N ALCG L++PPCR T S S
Sbjct: 685 VYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTG-TRWSTTIS 743
Query: 625 RNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDG 684
LKY+LP ++ST + +A++ V+ CRK+ A + + L A WRR SY +I +AT+G
Sbjct: 744 WLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNG 803
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
F+ NLLGRGS GSVY+GT SDG + AIKVFNLQ + AF+SFD+ECEV+ ++RHRNLIKI
Sbjct: 804 FSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKI 863
Query: 745 FSSCCNN--DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
SSC N+ DF+ALVLE +PNGSLE+WLYS NY LD+L+RLNIMI VALA+EYLHHG ST
Sbjct: 864 VSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCST 923
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
PVVHCDLKPSNILLDED HV DFG++KL E ++S+ +T T+ATIGYMAP+Y + GIV
Sbjct: 924 PVVHCDLKPSNILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAPKYVSNGIV 982
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922
++ DVYSYG++L ETFTR++PTD++F+ EMS+K WV + L + EVVD NLLR E
Sbjct: 983 TTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQ 1042
Query: 923 -SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
A+ C+ +L LA+DC +SP++RI M D LKKIK
Sbjct: 1043 FMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482811|ref|XP_002270207.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1086 (46%), Positives = 659/1086 (60%), Gaps = 138/1086 (12%)
Query: 8 TDQFALLAFKAHVTDP-QSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTI 66
TDQ ALLAFK+ + DP S+L NW+ C WVG+SC R QRV AL L GL+GT+
Sbjct: 32 TDQSALLAFKSDIIDPTHSILGGNWTQETSFCNWVGVSCSRRRQRVTALRLQKRGLKGTL 91
Query: 67 PPHLGNFSFLMSLDISKNNFHAYLPNELGQL------------------------RRLRF 102
P+LGN SF++ LD+S N+F +LP ELG L RRL F
Sbjct: 92 SPYLGNLSFIVLLDLSNNSFGGHLPYELGHLYRLRILILQNNQLEGKIPPSISHCRRLEF 151
Query: 103 ISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNI 162
ISL N SG P +G+L KL L L N+ G IP+SL N+S LE + G+I
Sbjct: 152 ISLASNWLSGGIPEELGILPKLDSLLLGGNNLRGTIPSSLGNISTLELLGLRETGLTGSI 211
Query: 163 PSRIGNLSSLVNV----------------------------------------------- 175
PS I N+SSL+++
Sbjct: 212 PSLIFNISSLLSIILTGNSISGSLSVDICQHSPNIEELLFTDNQLSGQLPSGIHRCRELL 271
Query: 176 --NLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPS-------------------- 213
+L+YN G+IP EIG+L+NLE L LG N+L+GPI S
Sbjct: 272 FASLSYNRFDGQIPEEIGSLRNLEELYLGGNHLTGPIPSSIGNISSLQILFLEDNKIQGS 331
Query: 214 ----------------------------IFNISTITLINLFGNQLSGHLDLPPKVSYSLP 245
IFNIS++ ++++ N LSG +LP LP
Sbjct: 332 IPSTLGNLLNLSYLVLELNELTGAIPQEIFNISSLQILSVVKNNLSG--NLPSTTGLGLP 389
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
NL V L N L+G IP S++N S+LT +D+ N F+G IP + GNL+FL L+L N L
Sbjct: 390 NLMVLFLAGNGLSGKIPPSLSNYSQLTKIDIGNNLFTGPIPPSLGNLKFLQTLSLGENQL 449
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
+ E SF+++LTNCR L + + +NPL GI+P IGN S ++N A+ C+L G+I
Sbjct: 450 KVEPGRPELSFITALTNCRLLEEITMPNNPLGGIIPNSIGNLSNHVRNIVAFGCQLKGHI 509
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
P IG+L++L L L N LNG IPST+GRLE LQ ++++ N LEG IP +LC L L
Sbjct: 510 PSGIGSLKNLGTLELGDNNLNGNIPSTIGRLENLQRMNIFNNELEGPIPEELCGLRDLGE 569
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
+ L NKLSG IP C+ +L L++L L SN +SSIP+ WSL LL +NLS NSL GSL
Sbjct: 570 LSLYNNKLSGSIPHCIGNLSRLQKLFLSSNSLTSSIPTGLWSLGNLLFLNLSFNSLGGSL 629
Query: 486 PSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES 545
PS++ L V+ ++DLS N+L G+IP +G+ + L +L+L+ N F+ IP+T G L LE
Sbjct: 630 PSDMGTLTVIEDIDLSWNKLIGNIPGILGTFESLYSLNLSRNSFQEAIPETLGKLRALEF 689
Query: 546 LDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT 605
+DLS NNLSG IPKS EAL LK LN+S N L GEIP GPF F QSF N ALCG +
Sbjct: 690 MDLSQNNLSGTIPKSFEALSHLKYLNLSFNNLSGEIPNGGPFVNFTAQSFLENKALCGRS 749
Query: 606 TLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRK---KIANKIVKE 662
L V PC N+T+ S K + LKYVLP + + + A+ + + RK +I N +
Sbjct: 750 ILLVSPCPTNRTQES-KTKQVLLKYVLPGIAAVVVFGALYYMLKNYRKGKLRIQNLV--- 805
Query: 663 DLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRA 722
DLLP R SYL++QRAT+ F E NLLG GSFGSVYKG SDGT+ A+KV NL+L+ A
Sbjct: 806 DLLPSIQHRMISYLELQRATNSFCETNLLGVGSFGSVYKGILSDGTTVAVKVLNLRLEGA 865
Query: 723 FRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER 782
F+SFD+EC+VL +RHRNLIK+ SSC N D RALVL+ M NGSLEKWLYS NY L+L +R
Sbjct: 866 FKSFDAECKVLARIRHRNLIKVISSCSNLDVRALVLQYMSNGSLEKWLYSHNYCLNLFQR 925
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842
++IM+ VALALEYLHH S PVVHCDLKPSN+LLD+DMVAHV DFGL+K+ E + VTQ
Sbjct: 926 VSIMLDVALALEYLHHSQSEPVVHCDLKPSNVLLDDDMVAHVGDFGLAKILVE-NKVVTQ 984
Query: 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902
T T+ T+GY+APEYG+EG VS+K DVYSYG++L E FTRKKPTD+MF+ E+SL++WV S
Sbjct: 985 TKTLGTLGYIAPEYGSEGRVSTKGDVYSYGIMLLEIFTRKKPTDEMFSEELSLRQWVNAS 1044
Query: 903 LPHGLMEVVDTNLLRQEHTSSA------EMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956
LP +MEVVD LL E + + + LL+++ L L+C + P++R + D VK
Sbjct: 1045 LPENVMEVVDGGLLSIEDGEAGGDVMATQSNLLLAIMELGLECSRDLPEERKGIKDVVVK 1104
Query: 957 LKKIKI 962
L KIK+
Sbjct: 1105 LNKIKL 1110
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2233), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/1035 (48%), Positives = 642/1035 (62%), Gaps = 137/1035 (13%)
Query: 8 TDQFALLAFKAHVT-DPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTI 66
TDQ +LLA KAH+T DP VLA NWS C+W+G+SC A+ QRV AL+LSN+GLRGTI
Sbjct: 506 TDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTI 565
Query: 67 PPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRF------------------------ 102
PP LGN SFL+SLD+S NNFH +P G L RL+
Sbjct: 566 PPDLGNLSFLVSLDLSSNNFHGPIPPSFGNLNRLQSLFLGNNSFTGTIPPSIGNMSMLET 625
Query: 103 ------------------------ISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPI 138
I+L YN SG+ P I L L+ L LR+NSFT PI
Sbjct: 626 LDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGTIPEEISFLPSLEYLYLRSNSFTSPI 685
Query: 139 PNSLFNLSRLEKWDSMFNIIDGNIP--------------------------SRIGNLSSL 172
P+++F +S L+ D N G++P IGN +SL
Sbjct: 686 PSAIFKISTLKAIDLGKNGFSGSMPLDIMCAHRPSLQLIGLDSNRFTGTIHGGIGNCTSL 745
Query: 173 VNVNLAYNNL-QGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
+ L+ N+L GE+P EIG+L L +L + N+L+G I IFNIS++ +L N LS
Sbjct: 746 RELYLSSNDLTAGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLS 805
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291
G +LPP LPNL L N L+G IP+SI NASKL LD +N +G IPH G+
Sbjct: 806 G--NLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGS 863
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASL 351
LRFL LNL N L +S E SFL+SLTNC+ L L ++ NPL GILP IGN S SL
Sbjct: 864 LRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSL 923
Query: 352 QNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG 411
Q F A CKL GNIP EIGNL +L +LSL N L GTIP ++G+L++LQGL L N L+G
Sbjct: 924 QRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQG 983
Query: 412 SIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471
SIP D+C L L + L N+LSG IP CL L LR L LGSNK +S+IPS+ WSL ++
Sbjct: 984 SIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHI 1043
Query: 472 LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531
L++++SSN L G LPS++ NL+VL+ +DLSRNQLSG+IP IG L+DL +LSLA N+FEG
Sbjct: 1044 LSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEG 1103
Query: 532 PIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFA 591
PI +F +L LE +DLS+N L GEIPKSLE L++LK L+VS N L GEIP GPF F+
Sbjct: 1104 PILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFS 1163
Query: 592 PQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISC 651
+SF N ALC
Sbjct: 1164 AESFMMNKALC------------------------------------------------- 1174
Query: 652 RKKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFA 711
RK+ A + + L A WRR SY +I +AT+GF+ NLLGRGS GSVY+GT SDG + A
Sbjct: 1175 RKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAA 1234
Query: 712 IKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRALVLELMPNGSLEKW 769
IKVFNLQ + AF+SFD+ECEV+ ++RHRNLIKI SSC N+ DF+ALVLE +PNGSLE+W
Sbjct: 1235 IKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERW 1294
Query: 770 LYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGL 829
LYS NY LD+L+RLNIMI VALA+EYLHHG STPVVHCDLKPSNILLDED HV DFG+
Sbjct: 1295 LYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGI 1354
Query: 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMF 889
+KL E ++S+ +T T+ATIGYMAP+Y + GIV++ DVYSYG++L ETFTR++PTD++F
Sbjct: 1355 AKLLRE-EESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIF 1413
Query: 890 TGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHL-ALDCCMESPDQRI 948
+ EMS+K WV + L + EVVD NLLR E + L LHL A + ES Q +
Sbjct: 1414 SEEMSMKNWVWDWLCGSITEVVDANLLRGED------EQFLERLHLGANNLKGESSIQEL 1467
Query: 949 YMTDAAVKLKKIKII 963
+ K+++I+
Sbjct: 1468 SFLTSLTNCKRLRIL 1482
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492792|ref|XP_002278117.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2187), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/1034 (47%), Positives = 642/1034 (62%), Gaps = 88/1034 (8%)
Query: 8 TDQFALLAFKAHVT----DPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLR 63
TDQ ALLAFK+ +T DP L +NW+ C WVG+SC + QRV ALNLS MG +
Sbjct: 35 TDQEALLAFKSQITFKSDDP---LVSNWTTEASFCTWVGVSCSSHRQRVTALNLSFMGFQ 91
Query: 64 GTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYN--------------- 108
GTI P +GN SFL LD+S N+ H LP +G LRRLR I+L N
Sbjct: 92 GTISPCIGNLSFLTVLDLSNNSIHGQLPETVGHLRRLRVINLRSNNLEGKIPSSLSQCRR 151
Query: 109 ---------EFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIID 159
F G+ P I LS L+ L L N TG IP+++FN+S L+ D + N +
Sbjct: 152 LQWLLLRSNRFQGNIPKEIAHLSHLEELDLSENYLTGTIPSTIFNMSTLKYIDLVVNNLS 211
Query: 160 G-------------------------------------------------NIPSRIGNLS 170
G +IP+ IG LS
Sbjct: 212 GGIPTTICHKLPDLEVLYLSVNPLGGPFPASLCNCTSIRSISFNRNGFIGSIPADIGCLS 271
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230
L + LA N L G IP +GNL + L + NNLSG I +IFN+++ I+ GN+L
Sbjct: 272 KLEGLGLAMNRLTGTIPLSLGNLSRMRRLRIAYNNLSGGIPEAIFNLTSAYAISFMGNRL 331
Query: 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290
SG +P S LP L +L N+L G IPNSI+NAS+LT L+LS N +G +P + G
Sbjct: 332 SG--SIPELTSLGLPKLNELNLRDNRLNGKIPNSISNASRLTFLELSNNLLNGPVPMSLG 389
Query: 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSAS 350
+LRFL LNL N L+ D E FLSSLT CR+L L + NP+ G+LP IGN S+S
Sbjct: 390 SLRFLRTLNLQRNQLSNDPSERELHFLSSLTGCRDLINLVIGKNPINGVLPKSIGNLSSS 449
Query: 351 LQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLE 410
L+ F A ++ G++P ++GNL +L+ L L N L GT+PS++G L +LQ L L+ N +E
Sbjct: 450 LELFSADATQIKGSLPIKMGNLSNLLALELAGNDLIGTLPSSLGSLSRLQRLRLFINKIE 509
Query: 411 GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEY 470
G IP +LC+L L + L+ NKLSGPIP C+ +L +++ ++L SN S IP W+L
Sbjct: 510 GPIPDELCNLRYLGELLLHENKLSGPIPTCIGNLSTMQVISLSSNALKS-IPPGMWNLNN 568
Query: 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
L +NLS NS++G LP I+NL++ DLS+NQLSG+IP I +LK L L+L+ N F+
Sbjct: 569 LWFLNLSLNSITGYLPPQIENLKMAETFDLSKNQLSGNIPGKISNLKMLRRLNLSDNAFQ 628
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYF 590
G IP L LESLDLS+N LSG IP+S+E L +LK LN+S N L G++P GPF F
Sbjct: 629 GSIPDGISELASLESLDLSSNKLSGIIPESMEKLRYLKYLNLSLNMLSGKVPTGGPFGNF 688
Query: 591 APQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFIS 650
+SF N LCG + L++ C + S+K + +LKYV P+ S ++VA +I+ I
Sbjct: 689 TDRSFVGNGELCGVSKLKLRACPTDSGPKSRKVTF-WLKYVGLPIASVVVLVAFLIIIIK 747
Query: 651 CR-KKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTS 709
R KK A R Y ++ AT+ F E NLLG GSFGSVYKGT SD T
Sbjct: 748 RRGKKKQEAPSWVQFSDGVAPRLIPYHELLSATNNFCEANLLGVGSFGSVYKGTLSDNTI 807
Query: 710 FAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKW 769
A+K+ +LQ++ A +SFD+ECEVLRNVRHRNL+KI SSC N DFRALVL+ MPNGSLE+
Sbjct: 808 AAVKILDLQVEGALKSFDAECEVLRNVRHRNLVKIISSCSNLDFRALVLQYMPNGSLERM 867
Query: 770 LYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGL 829
LYS NYFLDL +RLNIMI VA A+EYLHHG+S VVHCDLKPSN+LLDE+MVAHV+DFG+
Sbjct: 868 LYSYNYFLDLTQRLNIMIDVATAVEYLHHGYSETVVHCDLKPSNVLLDEEMVAHVNDFGI 927
Query: 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMF 889
+K+F + S+TQT T+ T+GY+APEYG+EG VS+K DVYSYG++L ETFTRKKPT +MF
Sbjct: 928 AKIFAK-YKSMTQTATVGTMGYIAPEYGSEGRVSTKGDVYSYGIMLMETFTRKKPTHEMF 986
Query: 890 TGEMSLKKWVKESLPHGLMEVVDTNLLR--QEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
G +SL++WV S P +MEVVD NLL Q +T+ CLLS++ L L C ++SP+QR
Sbjct: 987 VGGLSLRQWVDSSFPDLIMEVVDANLLARDQNNTNGNLQTCLLSIMGLGLQCSLDSPEQR 1046
Query: 948 IYMTDAAVKLKKIK 961
+ M + V+L KI+
Sbjct: 1047 LDMKEVVVRLSKIR 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 977 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.840 | 0.812 | 0.375 | 7.6e-185 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.839 | 0.812 | 0.366 | 5e-179 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.837 | 0.809 | 0.353 | 2.8e-174 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.915 | 0.872 | 0.393 | 1.2e-150 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.906 | 0.755 | 0.332 | 2.8e-121 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.777 | 0.741 | 0.353 | 2.5e-120 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.785 | 0.743 | 0.355 | 6e-119 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.707 | 0.553 | 0.302 | 5.3e-115 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.765 | 0.726 | 0.303 | 1.8e-112 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.568 | 0.488 | 0.335 | 2.4e-111 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1350 (480.3 bits), Expect = 7.6e-185, Sum P(2) = 7.6e-185
Identities = 321/856 (37%), Positives = 478/856 (55%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
TD+ ALL FK+ V++ + V+ ++W+ S P+C W G++CG +++RV L L + L G I
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVIS 83
Query: 68 PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQIL 127
P +GN SFL+SLD+ +N F +P E+GQL RL ++ + N G P + S+L L
Sbjct: 84 PSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNL 143
Query: 128 SLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187
L +N G +P+ L +L+ L + + N + G +P+ +GNL+ L + L++NNL+GEIP
Sbjct: 144 RLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIP 203
Query: 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
S++ L + L L NN SG P+++N+S++ L+ + N SG L P + LPNL
Sbjct: 204 SDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLR--PDLGILLPNL 261
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
F++G N TG+IP +++N S L L ++ N+ +G IP TFGN+ L +L L N L +
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGS 320
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
DS + + FL+SLTNC L TL + N L G LP I N SA L ++G+IP+
Sbjct: 321 DS-SRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY 379
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
+IGNL +L L L N L+G +P+++G+L L+ LSL+ N L G IP + ++ L +
Sbjct: 380 DIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLD 439
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXXXXXXXXX 487
L+ N G +P L + L EL +G ++
Sbjct: 440 LSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ 499
Query: 488 XIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLEXXX 547
I LQ L L L N+LSG +P T+G+ + +L L N F G IP G L G++
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVD 558
Query: 548 XXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTT- 606
G IP+ + L+ LN+S N LEG++P G F+ S N LCG
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 607 LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGI-------MVAIVIVFISCRKKI--AN 657
Q+ PC + KK S K V+ +S GI M ++ ++++ RKK N
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIG--VSVGITLLLLLFMASVTLIWLRKRKKNKETN 676
Query: 658 KIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFN 716
L L + SY D++ AT+GF+ N++G GSFG+VYK ++ A+KV N
Sbjct: 677 NPTPSTLEVLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLN 734
Query: 717 LQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLY 771
+Q A +SF +ECE L+++RHRNL+K+ ++C + N+FRAL+ E MPNGSL+ WL+
Sbjct: 735 MQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
Query: 772 SDNY--------FLDLLERLNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVA 822
+ L LLERLNI I VA L+YLH H H P+ HCDLKPSN+LLD+D+ A
Sbjct: 795 PEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHE-PIAHCDLKPSNVLLDDDLTA 853
Query: 823 HVSDFGLSKLFDEGDD 838
HVSDFGL++L + D+
Sbjct: 854 HVSDFGLARLLLKFDE 869
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1288 (458.5 bits), Expect = 5.0e-179, Sum P(2) = 5.0e-179
Identities = 309/844 (36%), Positives = 446/844 (52%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
+D+ ALL K+ V++ + + W+ S P+C W + CG +H+RV L+L + L G I
Sbjct: 24 SDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVIS 83
Query: 68 PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQIL 127
P +GN SFL+ LD+S N+F +P E+G L RL+++++ +N G P+ + S+L L
Sbjct: 84 PSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYL 143
Query: 128 SLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187
L +N+ +P+ L +L +L N + G P I NL+SL+ +NL YN+L+GEIP
Sbjct: 144 DLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIP 203
Query: 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
+I L + L L MNN SG P+ +N+S++ + L GN SG+L P LPN+
Sbjct: 204 DDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLK--PDFGNLLPNI 261
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
SL N LTG IP ++ N S L + N +G I FG L L L LANN L +
Sbjct: 262 HELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGS 321
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
S + +FL +LTNC +L L+V+ N L G LP I N S L + G+IPH
Sbjct: 322 YS-FGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPH 380
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
+IGNL L L L N L G +P+++G L L L L+ N G IP + +L +L +
Sbjct: 381 DIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLY 440
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXXXXXXXXX 487
L+ N G +P L + +L +G +
Sbjct: 441 LSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPN 500
Query: 488 XIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLEXXX 547
I LQ L+ L L N LSG +P T+G + + L N F+G IP G L G++
Sbjct: 501 DIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVD 559
Query: 548 XXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTT- 606
G I + E L+ LN+S N EG +P G F+ S N LCG
Sbjct: 560 LSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKE 619
Query: 607 LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKIAN--KIVKEDL 664
L++ PC A + K + + +++ + IV +S KK N KI
Sbjct: 620 LKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAP 679
Query: 665 LPLAAWR-RTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRA 722
L + + SY D++ ATDGF+ N++G GSFG+V+K ++ A+KV N+Q A
Sbjct: 680 FTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGA 739
Query: 723 FRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLYSDNY-- 775
+SF +ECE L+++RHRNL+K+ ++C + N+FRAL+ E MPNGSL+KWL+ +
Sbjct: 740 MKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEE 799
Query: 776 ------FLDLLERLNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828
L LLERLNI I VA L+YLH H H P+ HCDLKPSNILLD+D+ AHVSDFG
Sbjct: 800 IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHE-PIAHCDLKPSNILLDDDLTAHVSDFG 858
Query: 829 LSKL 832
L++L
Sbjct: 859 LARL 862
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 2.8e-174, Sum P(2) = 2.8e-174
Identities = 300/848 (35%), Positives = 457/848 (53%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
TD+ ALL FK+ V++ + + ++W+ S P+C W ++CG +H+RV LNL + L G +
Sbjct: 24 TDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGIVS 83
Query: 68 PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQIL 127
P +GN SFL+SLD+S N F +P E+G L RL + + +N G P+ + S+L L
Sbjct: 84 PSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNL 143
Query: 128 SLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187
L +N +P+ L +L++L D N + G +P +GNL+SL ++ NN++GE+P
Sbjct: 144 DLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVP 203
Query: 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
E+ L + L L MN G P+I+N+S + + LFG+ SG L P LPN+
Sbjct: 204 DELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSG--SLKPDFGNLLPNI 261
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
R +LG+N L G IP +++N S L ++ N +G I FG + L L+L+ N L +
Sbjct: 262 RELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGS 321
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
+ + F+ SLTNC +L L+V L G LP I N S L + G+IP
Sbjct: 322 YT-FGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQ 380
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
+IGNL L L L N L G +P+++G+L +L LSLY N + G IP + +L +L +
Sbjct: 381 DIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILY 440
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXXXXXXXXX 487
L+ N G +P L + +L +G +
Sbjct: 441 LSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPN 500
Query: 488 XIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLEXXX 547
I +LQ L+ L L N+ SG +P T+G+ + L L N F+G IP G L G+
Sbjct: 501 DIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVD 559
Query: 548 XXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTT- 606
G IP+ L+ LN+S N G++P+ G F+ N LCG
Sbjct: 560 LSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKD 619
Query: 607 LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFIS---C--RKKIANKIVK 661
L++ PC A + K S + K + L+S GI + +++V S C RK+ N+
Sbjct: 620 LKLKPCLAQEPPVETKHSSHLKKVAI--LVSIGIALLLLLVIASMVLCWFRKRRKNQQTN 677
Query: 662 EDLLP--LAAWR-RTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNL 717
+L+P L + + SY D++ AT+GF+ N++G GSFG+V+K ++ A+KV N+
Sbjct: 678 -NLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736
Query: 718 QLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLYS 772
Q A +SF +ECE L++ RHRNL+K+ ++C + N+FRAL+ E +PNGS++ WL+
Sbjct: 737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP 796
Query: 773 DNY--------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824
+ L LLERLNI+I VA L+YLH P+ HCDLKPSN+LL++D+ AHV
Sbjct: 797 EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHV 856
Query: 825 SDFGLSKL 832
SDFGL++L
Sbjct: 857 SDFGLARL 864
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1470 (522.5 bits), Expect = 1.2e-150, P = 1.2e-150
Identities = 369/937 (39%), Positives = 502/937 (53%)
Query: 9 DQFALLAFKAHVT--DPQSVLANNWSISQPICKWVGISCGARHQR----VRALNLSNMGL 62
D+ ALL+FK+ + QS+ + N S C WVG+ CG R +R V L L + L
Sbjct: 32 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNL 91
Query: 63 RGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLS 122
G I P LGN SFL LD+ N +P EL +L RL+ + L N GS P+ IG +
Sbjct: 92 SGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACT 151
Query: 123 KLQILSLRNNSFTGPIPNSL-FNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNN 181
KL L L +N G IP + +L L N + G IPS +GNL+SL +L++N
Sbjct: 152 KLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNR 211
Query: 182 LQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVS 241
L G IPS +G L +L + LG NNLSG I SI+N+S++ ++ N+L G + P
Sbjct: 212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMI--PTNAF 269
Query: 242 YSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLA 301
+L L V +G N+ G IP S+ NAS LT + + N FSG+I FG LR L+ L L
Sbjct: 270 KTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLW 329
Query: 302 NNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC-K 360
N T +W F+S LTNC L TL + N L G+LP N S SL +F A + K
Sbjct: 330 RNLFQTREQD-DWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSL-SFLALELNK 387
Query: 361 LTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHL 420
+TG+IP +IGNL L L L N G++PS++GRL+ L L Y NNL GSIP + +L
Sbjct: 388 ITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNL 447
Query: 421 ERLNGIRLNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXX 480
LN + L NK SG IP L++L +L L L ++
Sbjct: 448 TELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKN 507
Query: 481 XXXXXX-XXIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGS 539
I +L+ L+ N+LSG IP T+G + L L L +N G IP G
Sbjct: 508 NLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQ 567
Query: 540 LTGLEXXXXXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNY 599
L GLE G+IP SL + L LN+S N GE+P G F + S N
Sbjct: 568 LKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNA 627
Query: 600 ALCGPTT-LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIV---IVFISCRKKI 655
LCG L +P C E K +F VLP +S +AI+ + I+ K+
Sbjct: 628 KLCGGIPDLHLPRC-CPLLENRK----HFP--VLPISVSLAAALAILSSLYLLITWHKR- 679
Query: 656 ANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVF 715
K + SY + +ATDGF NLLG GSFGSVYKG + A+KV
Sbjct: 680 -TKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVL 738
Query: 716 NLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWL 770
L+ +A +SF +ECE LRN+RHRNL+KI + C + NDF+A+V + MPNGSLE W+
Sbjct: 739 KLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWI 798
Query: 771 Y------SDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824
+ +D L+L R+ I++ VA AL+YLH PVVHCD+K SN+LLD DMVAHV
Sbjct: 799 HPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHV 858
Query: 825 SDFGLSKLFDEGDDSVTQTMT----IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
DFGL+++ +G + Q+ + I TIGY APEYG I S+ D+YSYG+L+ E T
Sbjct: 859 GDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVT 918
Query: 881 RKKPTDDMFTGEMSLKKWVKESLPHG-LMEVVDTNLL 916
K+PTD F ++ L+++V+ L HG + +VVDT L+
Sbjct: 919 GKRPTDSTFRPDLGLRQYVELGL-HGRVTDVVDTKLI 954
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
Identities = 307/922 (33%), Positives = 479/922 (51%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+++L L+ L G IP +GN S L+ L++ N +P ELG L +L+ + + N+ +
Sbjct: 242 LQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLT 301
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSS 171
S PS + L++L L L N GPI + L LE N G P I NL +
Sbjct: 302 SSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRN 361
Query: 172 LVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
L + + +NN+ GE+P+++G L NL L N L+GPI SI N + + L++L NQ++
Sbjct: 362 LTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMT 421
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291
G + P+ + NL S+G+N TG IP+ I N S L L ++ N+ +G + G
Sbjct: 422 GEI---PR-GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGK 477
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASL 351
L+ L +L ++ N LT P + N ++L L + SN G +P + N + L
Sbjct: 478 LQKLRILQVSYNSLTGPIPR-------EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-L 529
Query: 352 QNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG 411
Q Y L G IP E+ +++ L VL L N +G IP+ +LE L LSL GN G
Sbjct: 530 QGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNG 589
Query: 412 SIPYDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLR-ELNLGXXXXXXXXXXXXXXLE 469
SIP L L LN ++ N L+G IP + LASL +++ LN LE
Sbjct: 590 SIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLE 649
Query: 470 YXXXXXXXXXXXXXXXXXXIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV-TLSLASNQ 528
+Q + + LD S+N LSG IP + D++ +L+L+ N
Sbjct: 650 MVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNS 709
Query: 529 FEGPIPQTFGSLTGLEXXXXXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFK 588
F G IPQ+FG++T L GEIP+SL L LK L ++ N L+G +P +G FK
Sbjct: 710 FSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFK 769
Query: 589 YFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVF 648
N LCG + + PC K + S + R + ++ + ++V ++++
Sbjct: 770 NINASDLMGNTDLCG-SKKPLKPCTI-KQKSSHFSKRTRVILIILGSAAALLLVLLLVLI 827
Query: 649 ISCRKKIANKIVK--EDLLP----LAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKG 702
++C KK KI E LP +R ++++ATD FN N++G S +VYKG
Sbjct: 828 LTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKG 887
Query: 703 TFSDGTSFAIKVFNLQLDRAFRS--FDSECEVLRNVRHRNLIKIFSSCCNND-FRALVLE 759
DGT A+KV NL+ A F +E + L ++HRNL+KI + +ALVL
Sbjct: 888 QLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLP 947
Query: 760 LMPNGSLEKWLYSDNYFL-DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE 818
M NG+LE ++ + LLE++++ + +A ++YLH G+ P+VHCDLKP+NILLD
Sbjct: 948 FMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDS 1007
Query: 819 DMVAHVSDFGLSKLFDEGDDSVTQTMTIA---TIGYMAPEYGTEGIVSSKCDVYSYGVLL 875
D VAHVSDFG +++ +D T T A TIGY+APE+ V++K DV+S+G+++
Sbjct: 1008 DRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIM 1067
Query: 876 TETFTRKKPT--DDMFTGEMSLKKWVKESLPHG---LMEVVDTNLLRQEHTSSAEMDCLL 930
E T+++PT +D + +M+L++ V++S+ +G ++ V+D L S + + +
Sbjct: 1068 MELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL-GDSIVSLKQEEAIE 1126
Query: 931 SVLHLALDCCMESPDQRIYMTD 952
L L L C P+ R M +
Sbjct: 1127 DFLKLCLFCTSSRPEDRPDMNE 1148
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
Identities = 276/781 (35%), Positives = 410/781 (52%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIP 67
TD+ ALL FK+ V++ V+ +W+ S P+C W G+ CG +H+RV ++L + L G +
Sbjct: 39 TDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVS 98
Query: 68 PHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQIL 127
P +GN SFL SL+++ N FH +P+E+G L RL+++++ N F G P + S L L
Sbjct: 99 PFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTL 158
Query: 128 SLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187
L +N +P +LS+L N + G P+ +GNL+SL ++ YN ++GEIP
Sbjct: 159 DLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIP 218
Query: 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
+I L+ + + +N +G P I+N+S++ +++ GN SG L P LPNL
Sbjct: 219 GDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSG--TLRPDFGSLLPNL 276
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
++ +G N TGTIP +++N S L LD+ N +G IP +FG L+ L +L L NN L
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
S + + FL +LTNC L L V N L G LP I N S L ++G+IPH
Sbjct: 337 YS-SGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
IGNL SL L L N L G +P ++G L +L+ + LY N L G IP L ++ L +
Sbjct: 396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXXXXXXXXX 487
L N G IP L S L +LNLG L
Sbjct: 456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQ 515
Query: 488 XIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLEXXX 547
I L+ L+ LD+S N+LSG IP T+ + L L L N F GPIP G LTGL
Sbjct: 516 DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLD 574
Query: 548 XXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT-T 606
G IP+ + L+ LN+S N +G +P G F+ + S N LCG +
Sbjct: 575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634
Query: 607 LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVKED--- 663
LQ+ PC R + + +++ +++ + +V++ C K+ K V+ +
Sbjct: 635 LQLQPCSVELPRRHSSV-RKIITICVSAVMAALLLLCLCVVYL-CWYKLRVKSVRANNNE 692
Query: 664 ----LLPLAA-WRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNL 717
P+ + + + SY ++ + T GF+ NL+G G+FG+V+KG S + AIKV NL
Sbjct: 693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752
Query: 718 QLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLYS 772
A +SF +ECE L +RHRNL+K+ + C + NDFRALV E MPNG+L+ WL+
Sbjct: 753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812
Query: 773 D 773
D
Sbjct: 813 D 813
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1171 (417.3 bits), Expect = 6.0e-119, P = 6.0e-119
Identities = 282/793 (35%), Positives = 412/793 (51%)
Query: 8 TDQFALLAFKAHVTD--PQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGT 65
TD ALL FK+ V++ + VLA+ W+ S P C W+G++CG R +RV +LNL L G
Sbjct: 30 TDMQALLEFKSQVSENNKREVLAS-WNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 66 IPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQ 125
I P +GN SFL L+++ N+F + +P ++G+L RL+++++ YN G PS + S+L
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLS 148
Query: 126 ILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGE 185
+ L +N +P+ L +LS+L D N + GN P+ +GNL+SL ++ AYN ++GE
Sbjct: 149 TVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208
Query: 186 IPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLP 245
IP E+ L + + +N+ SG P+++NIS++ ++L N SG+L Y LP
Sbjct: 209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRAD--FGYLLP 266
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
NLR LG N+ TG IP ++ N S L D+S N SG IP +FG LR L L + NN L
Sbjct: 267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL 326
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
+S + F+ ++ NC L L V N L G LP I N S +L + + ++G I
Sbjct: 327 GNNSSSG-LEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
PH+IGNL SL LSL N L+G +P + G+L LQ + LY N + G IP ++ RL
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXXXXXXX 485
+ LN N G IPQ L L +L + +
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHF 505
Query: 486 XXXIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLEX 545
+ L++L+ L S N+LSG +P IG + L + N F+G IP L L+
Sbjct: 506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKN 564
Query: 546 XXXXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT 605
G IP+ L +L L+ LN+S NK EG +P G F+ S N +CG
Sbjct: 565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624
Query: 606 T-LQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAIVIVFISC----RKKIANKIV 660
+Q+ PC + +K K V I ++ I+IV C RKK N
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684
Query: 661 --KEDLLPLAAWR-RTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFN 716
D L + + SY ++ AT F+ NL+G G+FG+V+KG + A+KV N
Sbjct: 685 GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744
Query: 717 LQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRALVLELMPNGSLEKWLY 771
L A +SF +ECE + +RHRNL+K+ + C + NDFRALV E MP GSL+ WL
Sbjct: 745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804
Query: 772 SDNYFLDLLERLN 784
L+ LER+N
Sbjct: 805 -----LEDLERVN 812
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 5.3e-115, Sum P(2) = 5.3e-115
Identities = 222/733 (30%), Positives = 341/733 (46%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNEL-GQLRRLRFISLDYNEF 110
++ L+LS L G IP N S L+ L ++ N+ LP + L + L +
Sbjct: 289 LQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQL 348
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLS 170
SG P + L+ L L NNS G IP +LF L L N ++G + I NL+
Sbjct: 349 SGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLT 408
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230
+L + L +NNL+G++P EI L+ LE+L L N SG I I N +++ +I++FGN
Sbjct: 409 NLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHF 468
Query: 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290
G ++PP + L L + L +N+L G +P S+ N +L LDL+ N SG IP +FG
Sbjct: 469 EG--EIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFG 525
Query: 291 NLRFLSVLNLANNYLTTDSPTAEWSFLS----SLTN----------CRNLTTLA--VASN 334
L+ L L L NN L + P + S + +L++ C + + L+ V +N
Sbjct: 526 FLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNN 585
Query: 335 PLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVG 394
+P +GN S +L +LTG IP +G +R L +L + NAL GTIP +
Sbjct: 586 GFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLV 644
Query: 395 RLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGX 454
++L + L N L G IP L L +L ++L+ N+ +P L + L L+L
Sbjct: 645 LCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDG 704
Query: 455 XXXXXXXXXXXXXLEYXXXXXXXXXXXXXXXXXXIQNLQVLINLDLSRNQLSGDIPITIG 514
L + L L L LSRN L+G+IP+ IG
Sbjct: 705 NSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIG 764
Query: 515 SLKDLVT-LSLASNQFEGPIPQTFGSLTGLEXXXXXXXXXXGEIPKSLEALLFLKQLNVS 573
L+DL + L L+ N F G IP T G+L+ LE GE+P S+ + L LNVS
Sbjct: 765 QLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVS 824
Query: 574 HNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRNFLKYVLP 633
N L G++ F + SF N LCG + R+N + A + +
Sbjct: 825 FNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAIS 882
Query: 634 PLISTGIMVAIVIVFISCR----KKI---------ANKIVKEDLLPL----AAWRRTSYL 676
L + G+M+ ++ +F R KK+ ++ + PL A+ +
Sbjct: 883 ALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942
Query: 677 DIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRN 735
DI AT +E ++G G G VYK +G + A+K + D + +SF E + L
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGR 1002
Query: 736 VRHRNLIKIFSSC 748
+RHR+L+K+ C
Sbjct: 1003 IRHRHLVKLMGYC 1015
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.8e-112, Sum P(2) = 1.8e-112
Identities = 244/804 (30%), Positives = 365/804 (45%)
Query: 8 TDQFALLAFKAHVTDPQSVLA------NNWSISQPI-CKWVGISCGARHQRVRALNLSNM 60
++Q LLAFK+ + DP + L N + S+ + C W G+ C A V L LSNM
Sbjct: 29 SEQEILLAFKSDLFDPSNNLQDWKRPENATTFSELVHCHWTGVHCDANGY-VAKLLLSNM 87
Query: 61 GLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGV 120
L G + + +F L +LD+S N F + LP L L L+ I + N F G+FP +G+
Sbjct: 88 NLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGM 147
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
+ L ++ +N+F+G +P L N + LE D +G++PS NL +L + L+ N
Sbjct: 148 ATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGN 207
Query: 181 NLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKV 240
N G++P IG L +LE ++LG N G I ++ + ++L L+G + P +
Sbjct: 208 NFGGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQI--PSSL 265
Query: 241 SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300
L L L +N+LTG +P + + L LDLS N +G IP G L+ L +LNL
Sbjct: 266 G-QLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNL 324
Query: 301 ANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCK 360
N LT P S + NL L + N L G LP +G ++ L+ K
Sbjct: 325 MRNQLTGIIP-------SKIAELPNLEVLELWQNSLMGSLPVHLGK-NSPLKWLDVSSNK 376
Query: 361 LTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHL 420
L+G+IP + R+L L LF N+ +G IP + L + + N++ GSIP L
Sbjct: 377 LSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDL 436
Query: 421 ERLNGIRLNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXX 480
L + L N L+G IP +A SL +++
Sbjct: 437 PMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSSLSSSIFSSPNLQTFIASHNNF 496
Query: 481 XXXXXXXXIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSL 540
IQ+ L LDLS N SG IP I S + LV+L+L SNQ G IP+ +
Sbjct: 497 AGKIPNQ-IQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGM 555
Query: 541 TGLEXXXXXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYA 600
L G IP L A L+ LNVS NKL+G IP+N F P+ N
Sbjct: 556 HMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNG 615
Query: 601 LCGPTTLQVPPCRANKTEGSK--KASRNFLKY-VLPPLISTGIMVAIVIVFIS-----CR 652
LCG +PPC + +K R + + V ++ T ++VA+ ++F++ R
Sbjct: 616 LCGGV---LPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMFLAGRWIYTR 672
Query: 653 KKIANKIVKEDLL---PLAAWRRTSYLDIQRA--TDG-----FNECNLLGRGSFGSVYKG 702
+ + +E + P W + QR T G E N++G G+ G VYK
Sbjct: 673 WDLYSNFAREYIFCKKPREEWP-WRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKA 731
Query: 703 TFSDGTSFAIKVFNL--------QLDRAFRSFDSECEVLRNV------RHRNLIKIFSSC 748
+ V L ++ + D E ++LR V RHRN++KI
Sbjct: 732 EVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYV 791
Query: 749 CNNDFRALVLELMPNGSLEKWLYS 772
N +V E MPNG+L L+S
Sbjct: 792 HNEREVMMVYEYMPNGNLGTALHS 815
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 2.4e-111, Sum P(2) = 2.4e-111
Identities = 193/575 (33%), Positives = 280/575 (48%)
Query: 12 ALLAFKAHVTDPQSVLANNWSISQPI--CKWVGISCGARHQRVRALNLSNMGLRGTIPPH 69
AL AFK ++ DP L + W S P C W G+ C H RV + L + L G I
Sbjct: 31 ALTAFKLNLHDPLGALTS-WDPSTPAAPCDWRGVGC-TNH-RVTEIRLPRLQLSGRISDR 87
Query: 70 LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129
+ L L + N+F+ +P L RL + L YN SG P + L+ L++ ++
Sbjct: 88 ISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVFLQYNSLSGKLPPAMRNLTSLEVFNV 147
Query: 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE 189
N +G IP L S L+ D N G IPS + NL+ L +NL+YN L GEIP+
Sbjct: 148 AGNRLSGEIPVGL--PSSLQFLDISSNTFSGQIPSGLANLTQLQLLNLSYNQLTGEIPAS 205
Query: 190 IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249
+GNLQ+L+ L L N L G + +I N S++ ++ N++ G + P +LP L V
Sbjct: 206 LGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSASENEIGGVI---PAAYGALPKLEV 262
Query: 250 FSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI-PHTFGNLRF-LSVLNLANNYLTT 307
SL N +GT+P S+ + LT + L FN+FS ++ P T N R L VL+L N ++
Sbjct: 263 LSLSNNNFSGTVPFSLFCNTSLTIVQLGFNAFSDIVRPETTANCRTGLQVLDLQENRISG 322
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
P W LTN +L L V+ N G +PP IGN L+ + LTG IP
Sbjct: 323 RFPL--W-----LTNILSLKNLDVSGNLFSGEIPPDIGNLKR-LEELKLANNSLTGEIPV 374
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427
EI SL VL N+L G IP +G ++ L+ LSL N+ G +P + +L++L +
Sbjct: 375 EIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLN 434
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGXXXXXXXXXXXXXXLEYXXXXXXXXXXXXXXXXX 487
L N L+G P L +L SL EL+L L
Sbjct: 435 LGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPA 494
Query: 488 XIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLEXXX 547
+ NL L LDLS+ +SG++P+ + L ++ ++L N F G +P+ F SL L
Sbjct: 495 SVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVN 554
Query: 548 XXXXXXXGEIPKSLEALLFLKQLNVSHNKLEGEIP 582
GEIP++ L L L++S N + G IP
Sbjct: 555 LSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIP 589
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3932 | 0.9672 | 0.9356 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00025217001 | SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (2202 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 977 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-123 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 398 bits (1023), Expect = e-123
Identities = 312/969 (32%), Positives = 455/969 (46%), Gaps = 98/969 (10%)
Query: 13 LLAFKAHVTDPQSVLANNWSISQPICKWVGISCGA-----------------------RH 49
LL+FK+ + DP L+N W+ S +C W GI+C R
Sbjct: 34 LLSFKSSINDPLKYLSN-WNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSF-LMSLDISKNNFHAYLPNELGQLRRLRFISLDYN 108
++ +NLSN L G IP + S L L++S NNF +P G + L + L N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNN 150
Query: 109 EFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGN 168
SG P+ IG S L++L L N G IPNSL NL+ LE N + G IP +G
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 169 LSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGN 228
+ SL + L YNNL GEIP EIG L +L L L NNL+GPI S+ N+
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK---------- 260
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
NL+ L +NKL+G IP SI + KL LDLS NS SG IP
Sbjct: 261 -----------------NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFS 348
L+ L +L+L +N T P A L+SL L L + SN G +P +G +
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVA----LTSLPR---LQVLQLWSNKFSGEIPKNLGKHN 356
Query: 349 ASLQNFYAYDC---KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405
N D LTG IP + + +L L LF N+L G IP ++G L+ + L
Sbjct: 357 ----NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412
Query: 406 GNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSF 465
N+ G +P + L + + ++ N L G I + SL+ L+L NKF +P SF
Sbjct: 413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472
Query: 466 WSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLA 525
S + L ++LS N SG++P + +L L+ L LS N+LSG+IP + S K LV+L L+
Sbjct: 473 GS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531
Query: 526 SNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANG 585
NQ G IP +F + L LDLS N LSGEIPK+L + L Q+N+SHN L G +P+ G
Sbjct: 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591
Query: 586 PFKYFAPQSFSWNYALCG-PTTLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVAI 644
F + + N LCG TT +PPC+ + K S F +VA
Sbjct: 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----KTPSWWFYITCTLGAFLVLALVAF 647
Query: 645 VIVFISCRKKIANKIVKED----LLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVY 700
VFI R + K V+ + L + + + I E N++ RG G+ Y
Sbjct: 648 GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASY 707
Query: 701 KG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759
KG + +G F +K N ++ S ++ + ++H N++K+ C + L+ E
Sbjct: 708 KGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHE 763
Query: 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED 819
+ +L + L + L R I IG+A AL +LH S VV +L P I++D
Sbjct: 764 YIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819
Query: 820 MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879
H+ L L T T + Y+APE ++ K D+Y +G++L E
Sbjct: 820 DEPHLR-LSLPGLL------CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 880 TRKKPTDDMFTGEMSLKKWVKESLPHGLMEV-VDTNLLRQEHTSSAEMDCLLSVLHLALD 938
T K P D F S+ +W + +++ +D ++ + E+ + V++LAL
Sbjct: 873 TGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI---VEVMNLALH 929
Query: 939 CCMESPDQR 947
C P R
Sbjct: 930 CTATDPTAR 938
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 77/265 (29%), Positives = 112/265 (42%), Gaps = 29/265 (10%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG GSFG+VYK G A+K+ + + ++ E +LR + H N++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
+ D LV+E G L +L E I + + LEYLH S ++H
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 808 DLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE---YGTEGIVSS 864
DLKP NILLDE+ V ++DFGL+K S T T YMAPE G
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNG--YGP 178
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924
K DV+S GV+L E T K P F+GE ++++ L
Sbjct: 179 KVDVWSLGVILYELLTGKPP----FSGE----------NILDQLQLIRRILGPPLEFDEP 224
Query: 925 EMDCLLS-VLHLALDCCMESPDQRI 948
+ L C + P +R
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 67/191 (35%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LG G FG+VY G AIK+ + E E+L+ + H N++K++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+ + LV+E GSL+ L + L E L I++ + LEYL HS ++H D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117
Query: 809 LKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-YGTEGIVSSKC 866
LKP NILLD D ++DFGLSKL + + T YMAPE +G S K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 867 DVYSYGVLLTE 877
D++S GV+L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 73/219 (33%), Positives = 99/219 (45%), Gaps = 11/219 (5%)
Query: 689 NLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRNLIKIFS 746
LG GSFG VY G AIKV + + R E ++L+ ++H N+++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTPVV 805
+ D LV+E G L L L E + + ALEYLH G +V
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSKG----IV 119
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H DLKP NILLDED ++DFGL++ D G+ T + T YMAPE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLGKGYGKA 176
Query: 866 CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
D++S GV+L E T K P KK K P
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 78/265 (29%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-----AIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG VYKG A+K F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C + +V+E M G L +L + L L + L+ + +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL---ESKNF 123
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
+H DL N L+ E++V +SDFGLS+ + DD + I +MAPE EG +S
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQEHTS 922
K DV+S+GVLL E FT ++P M ++E + L Q
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGM--------------SNEEVLEYLKNGYRLPQPPNC 228
Query: 923 SAEMDCLLSVLHLALDCCMESPDQR 947
E+ L L C E P+ R
Sbjct: 229 PPEL------YDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 80/266 (30%), Positives = 120/266 (45%), Gaps = 33/266 (12%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-----AIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG VYKGT A+K ++ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWL-YSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
C + +V+E MP G L +L + L L + L+ + +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
+H DL N L+ E++V +SDFGLS+ + DD I +MAPE EG +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 864 SKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQEHT 921
SK DV+S+GVLL E FT ++P MS + ++E + L +
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYP-----GMSNAE---------VLEYLKKGYRLPKPPN 228
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQR 947
E+ L L C E P+ R
Sbjct: 229 CPPEL------YKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSF----AIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIK 743
LG G+FG VYKG A+K R F E V++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL--------YSDNYFLDLLERLNIMIGVALALEY 795
+ C + LVLE M G L +L + L L + L+ I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
L S VH DL N L+ ED+V +SDFGLS+ + D +T I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 856 YGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
+GI +SK DV+S+GVLL E FT P + E+ +++++
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LEYLRK----------GYR 225
Query: 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958
L + E+ + L L C P+ R ++ +L+
Sbjct: 226 LPKPEYCPDE-------LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 79/264 (29%), Positives = 114/264 (43%), Gaps = 29/264 (10%)
Query: 691 LGRGSFGSVYKGT-----FSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG VYKGT T A+K F E +++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C + +V E MP G L +L L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH DL N L+ E++V +SDFGLS+ E D + I +MAPE +G +S
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQEHTSS 923
K DV+S+GVLL E FT GE P+ M + LL +
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQ----------PYPGMSNEEVLELLEDGYRLP 224
Query: 924 AEMDCLLSVLHLALDCCMESPDQR 947
+C + L L C P+ R
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 689 NLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRA--FRSFDSECEVLRNVRHRNLIKIF 745
LLGRGSFGSVY D G A+K L D + + E +L +++H N+++ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 746 SSCCNNDFRAL--VLELMPNGSLEKWLYSD---------NYFLDLLERLNIMIGVALALE 794
S + + L LE + GSL L Y +LE L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115
Query: 795 YLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
YLH +G +VH D+K +NIL+D D V ++DFG +K + + T +MA
Sbjct: 116 YLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
PE D++S G + E T K P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 7/210 (3%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
F LG G FG V++G + + AIK+ + F E + L+ +RH++LI +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
F+ C + ++ ELM GSL +L S + L + +++ VA + YL +S
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS-- 125
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
+H DL NIL+ ED+V V+DFGL++L +D + + APE + G S
Sbjct: 126 -IHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 864 SKCDVYSYGVLLTETFTRKK-PTDDMFTGE 892
+K DV+S+G+LL E FT + P M E
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 4/192 (2%)
Query: 690 LLGRGSFGSVYKGTFSDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+G+G+FG VYKG T A+K L R F E E+L+ H N++K+ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V+EL+P GSL +L L + + L + + A +EYL S +H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N L+ E+ V +SDFG+S+ + G +V+ + I + APE G +S+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 869 YSYGVLLTETFT 880
+SYG+LL ETF+
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 68/208 (32%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFD---SECEVLRNVRHRNLIKIFS 746
LG+GSFG V G +A+KV + + + +E +L + H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALEYLH-HGHSTPV 804
+ + LVLE P G L L + F + ER + LALEYLH G +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFYAAEIVLALEYLHSLG----I 114
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
++ DLKP NILLD D ++DFGL+K T T T Y+APE
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFCG-TPEYLAPEVLLGKGYGK 172
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGE 892
D +S GVLL E T K P F E
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G+G FG VYK G AIKV L+ +E ++L+ +H N++K + S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVALALEYLHHG 799
D +V+E GSL+ DLL+ N + + LEYLH
Sbjct: 68 KKDELWIVMEFCSGGSLK----------DLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE 859
++H D+K +NILL D + DFGLS + TM + T +MAPE
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM-VGTPYWMAPEVING 171
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKP 884
K D++S G+ E K P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 689 NLLGRGSFGSVYKGT-FSDGTSFAIKVFNL-QLDRAFRSF-DSECEVLRNVRHRNLIKIF 745
+G+GSFG VY SDG + +K +L + R +E ++L+ + H N+IK +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL---ERLNIMIGVALALEYLHHGHST 802
S +V+E G L + + + L+ + + LAL+YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE------Y 856
++H D+KP NI L + + + DFG+SK+ + +T+ + T Y++PE Y
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTV-VGTPYYLSPELCQNKPY 180
Query: 857 GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
+ K D++S G +L E T K P F GE
Sbjct: 181 ------NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 81/233 (34%), Positives = 127/233 (54%), Gaps = 24/233 (10%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN 735
L++Q+ T G ++G G FG+V +G ++ G A+K N++ D ++F E V+
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTK 55
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFL-DLLERLNIMIGVALALE 794
+ H+NL+++ +N +V+ELM G+L +L + L +++ L + VA +E
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YL S +VH DL NIL+ ED VA VSDFGL+++ G D+ + + + AP
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAP 166
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG 906
E SSK DV+SYGVLL E F+ + P +MSLK+ VKE + G
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP-----KMSLKE-VKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 11/192 (5%)
Query: 690 LLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G+G FG V G + G A+K A ++F +E V+ +RH NL+++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 750 NNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+ +V E M GSL +L S + L ++L + V +EYL VH D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N+L+ ED+VA VSDFGL+K + S Q + + APE E S+K DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 869 YSYGVLLTETFT 880
+S+G+LL E ++
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 67/192 (34%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 690 LLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRNLIKIFSSC 748
LLG+G+FG V+KGT D T A+K L + + F SE +L+ H N++K+ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V+EL+P G +L L + + + A + YL S +H D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N L+ E+ V +SDFG+S+ D+G S + I I + APE G SS+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-IKWTAPEALNYGRYSSESDV 177
Query: 869 YSYGVLLTETFT 880
+SYG+LL ETF+
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKIFSSC 748
LG+GS G VYK G +A+K ++ D FR E + LR+ ++K + +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN---------IMIGVALALEYLHHG 799
++VLE M GSL DLL+++ I + L+YLH
Sbjct: 69 YKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPE--- 855
++H D+KPSN+L++ ++DFG+SK+ + D Q T + T+ YM+PE
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSPERIQ 173
Query: 856 ---YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
Y D++S G+ L E K P
Sbjct: 174 GESYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 84/290 (28%), Positives = 123/290 (42%), Gaps = 43/290 (14%)
Query: 691 LGRGSFGSVYKGTFS------DGTSFAIKVF-NLQLDRAFRSFDSECEVLRNVRHRNLIK 743
LG G+FG V+ G D A+K + A + F+ E E+L N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYS---DNYFLD----------LLERLNIMIGVA 790
+ C D +V E M +G L K+L S D FL L + L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
+ YL H VH DL N L+ D+V + DFG+S+ D T+ I
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLME 909
+M PE +++ DV+S+GV+L E FT K+P W S ++E
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYGLS-NEEVIE 235
Query: 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959
+ L Q C V + L C P QRI + D +L+K
Sbjct: 236 CITQGRLLQR-----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 2e-25
Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 26/284 (9%)
Query: 684 GFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRH-R 739
+ LG GSFG VY D A+KV +L + F E ++L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWL--YSDNYFLDLLERLNIMIGVALALEYLH 797
N++K++ + LV+E + GSLE L L E L I+ + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 798 HGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMT----IATIGYM 852
S ++H D+KP NILLD D V + DFGL+KL + + + + T GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 853 APEY---GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909
APE + SS D++S G+ L E T P + K S ++
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-------GEKNSSATSQTLKIIL 228
Query: 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
+ T L + S + L + P R+ +
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 689 NLLGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDR--AFRSFDSECEVLRNVRHRNLIKIF 745
+L+GRG+FG VYKG G AIK +L+ + A +S E ++L+N++H N++K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNI--MIGVALALEYLHHGHSTP 803
S +D ++LE NGSL + + F E L + V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH---EQG 119
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
V+H D+K +NIL +D V ++DFG++ KL D D + + T +MAPE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEMSGA 176
Query: 863 SSKCDVYSYGVLLTETFTRKKP 884
S+ D++S G + E T P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVF---NLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG G FG V+ GT++ T A+K + + +F E ++++ +RH L+++++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
C + +V E M GSL +L S L L + +++ +A + YL S +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
DL NIL+ E++V ++DFGL++L E D+ + I + APE G + K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 867 DVYSYGVLLTETFT 880
DV+S+G+LLTE T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 75/283 (26%), Positives = 116/283 (40%), Gaps = 20/283 (7%)
Query: 689 NLLGRGSFGSVYKGTFS---DGTS--FAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLI 742
LG G FG V + D T A+K N + RS F+ E E+LR + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 743 KIFSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
K + C L++E +P+GSL +L ++L L + ++YL
Sbjct: 70 K-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-QTMTIATIGYMAPEYGT 858
+H DL NIL++ + + +SDFGL+K+ E D + + I + APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD-TNLLR 917
SS DV+S+GV L E FT P+ + + G M V LL+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQ-----SPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+ C V L C P R D + + ++
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 60/192 (31%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRA-FRSFDSECEVLRNVRHRNLIKIFSSCC 749
LG G FG V++G +++ T A+K L+ + F +E ++++ +RH LI++++ C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+ +V ELM GSL ++L L L + +++ VA + YL + +H D
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N+L+ E+ + V+DFGL+++ E D + I + APE S K DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 869 YSYGVLLTETFT 880
+S+G+LLTE T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 689 NLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKI 744
++G+G+FG V D FA+K N Q + R+ +E +L+ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN------IMIGVALALEYLHH 798
+ S + + LV++L+ G L Y L + + + + LALEYLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
S ++H D+KP NILLDE H++DF ++ D++T + + T GYMAPE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTS-GTPGYMAPEVLC 172
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP 884
S D +S GV E K+P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 5/192 (2%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKIFSSC 748
+GRG+FG V+ G +D T A+K L ++ F E +L+ H N++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V+EL+ G +L ++ L + E + ++ A +EYL H +H D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N L+ E V +SDFG+S+ ++G + T M + + APE G SS+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 869 YSYGVLLTETFT 880
+S+G+LL E F+
Sbjct: 180 WSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 691 LGRGSFGSVYKGTF-SDGTS----FAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG+VYKG + +G AIKV + A + E V+ +V H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C ++ L+ +LMP G L ++ + + LN + +A + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH DL N+L+ ++DFGL+KL D + I +MA E I +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 865 KCDVYSYGVLLTETFT-RKKPTDDMFTGEMS 894
K DV+SYGV + E T KP + + E+
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 77/289 (26%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 690 LLGRGSFGSVYKGTFS--DGTSFAIKVFNLQLD----RAFRSFDSECEVLRNVRHRNLIK 743
+LG G FGSV +G S DG+ + V ++LD F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 744 IFSSCCNNDFRA------LVLELMPNGSLEKWLYSDN-----YFLDLLERLNIMIGVALA 792
+ C ++L M +G L +L L L L M+ +AL
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+EYL + +H DL N +L EDM V+DFGLSK GD + + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911
A E + + +SK DV+++GV + E TR + P + E+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI------------------ 224
Query: 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+ LR + DCL + L C P R T L+ I
Sbjct: 225 -YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 43/290 (14%)
Query: 691 LGRGSFGSVYKGTF------SDGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIK 743
LG G+FG VYKG TS AIK + + F E E++ +++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL-----YSDNYF----------LDLLERLNIMIG 788
+ C ++ E + +G L ++L +SD LD + L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+A +EYL H VH DL N L+ E + +SDFGLS+ D Q+ ++
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM 908
+ +M PE G +++ D++S+GV+L E F+ F+ +
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---------------- 233
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958
EV+ ++R DC V L ++C E P +R D +L+
Sbjct: 234 EVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 9e-22
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL-------DRAFRSFDSECEVL-RN 735
F ++G GSF +V +AIK+ + + E EVL R
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLTRL 58
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
H +IK++ + + + VLE PNG L +++ LD + LALEY
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEY 117
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG----- 850
LH S ++H DLKP NILLD+DM ++DFG +K+ D + I
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 851 -------------YMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
Y++PE E D+++ G ++ + T K P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRS---FDSECEVLRNVRHRNLIKIFSS 747
+G G FG V+ G + + AIK + S F E +V+ + H L++++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT----IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
C LV E M +G L +L + L + + V + YL S+ V+H
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHR 124
Query: 808 DLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCD 867
DL N L+ E+ V VSDFG+++ F D + T T + + +PE + SSK D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 868 VYSYGVLLTETFTR-KKPTDDMFTGEM 893
V+S+GVL+ E F+ K P ++ E+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-21
Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 689 NLLGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNL 741
+G G++G V G AIK VF+ +D R R E ++LR++RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 742 IK---IFSSCCNNDFRAL--VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
I I DF + V ELM L K + S D + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAP 854
H + V+H DLKPSNIL++ + + DFGL++ D D+ +T + T Y AP
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP-DEDEKGFLTEYVVTRWYRAP 175
Query: 855 E-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
E Y T+ I D++S G + E TRK
Sbjct: 176 ELLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG+G FG V+ GT++ T AIK + +F E +V++ +RH L+++++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 751 NDFRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
+V E M GSL +L + +L L + +++ +A + Y+ + VH DL
Sbjct: 73 EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +NIL+ E++V V+DFGL++L ++ + + Q I + APE G + K DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 870 SYGVLLTETFTRKK-PTDDMFTGEM 893
S+G+LLTE T+ + P M E+
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 65/192 (33%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC- 749
+G+G FG V G + G A+K ++ D ++F +E V+ +RH NL+++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 750 NNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V E M GSL +L S L L + V A+EYL + VH D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N+L+ ED VA VSDFGL+K + S TQ + + APE E S+K DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 869 YSYGVLLTETFT 880
+S+G+LL E ++
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 36/261 (13%)
Query: 689 NLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743
++G G FG V +G AIK D+ F +E ++ H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL-HHGHST 802
+ + ++ E M NGSL+K+L ++ + + + ++ G+A ++YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
VH DL NIL++ ++V VSDFGLS+ ++ + + T I + APE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 863 SSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKES--LPHGLMEVVDTNLLRQE 919
+S DV+S+G+++ E + ++P DM + + +K V++ LP
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKA-VEDGYRLP--------------- 228
Query: 920 HTSSAEMDCLLSVLH-LALDC 939
MDC S L+ L LDC
Sbjct: 229 ----PPMDC-PSALYQLMLDC 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 691 LGRGSFGSVYKGTF--SDGTSF--AIKVF-NLQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG G+FGSV KG + G A+K + + F E V+ + H ++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
C LV+EL P G L K+L + + + + VA+ + YL H V
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH---FV 117
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-QTMTIATIGYMAPEYGTEGIVSS 864
H DL N+LL A +SDFG+S+ G D T + + APE G SS
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDM 888
K DV+SYGV L E F+ KP +M
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 20/283 (7%)
Query: 690 LLGRGSFGSVYKGTF---SDGTSFAIKVFNLQLDRA--FRSFDSECEVLRNVRHRNLIKI 744
LG+G+FGSV + D T + V LQ A R F+ E E+L++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 745 FSSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
C + R LV+E +P GSL +L LD + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGI 861
VH DL NIL++ + + DFGL+K+ + + + + I + APE TE
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 862 VSSKCDVYSYGVLLTETFT---RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918
S DV+S+GV+L E FT + F M K + + H + LL+
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI------ELLKN 241
Query: 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
A C + + +C P QR ++ A++++ I+
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 75/258 (29%), Positives = 110/258 (42%), Gaps = 25/258 (9%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ G + AIK+ + + F E +V+ + H NL++++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810
+V E M NG L +L L L++ V A+EYL S +H DL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYS 870
N L+ ED V VSDFGL++ + D + T + + PE SSK DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 871 YGVLLTETFTRKK-PTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCL 929
+GVL+ E F+ K P + E V ES+ G L + + E
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSE------VVESVSAGYR-------LYRPKLAPTE---- 229
Query: 930 LSVLHLALDCCMESPDQR 947
V + C E P+ R
Sbjct: 230 --VYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLD-----RAFRSFDSECEVLRNVRHRNLIK 743
LLG GSFGSVY+G D G FA+K +L D A + + E +L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL---NIMIGVALALEYLHHGH 800
+ D + LEL+P GSL K L F + + RL I++G LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDRN 122
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG---YMAPEY- 856
VH D+K +NIL+D + V ++DFG++K V + + G +MAPE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVI 173
Query: 857 GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+G D++S G + E T K P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 71/259 (27%), Positives = 123/259 (47%), Gaps = 27/259 (10%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ GT++ T A+K + SF E ++++ +RH L+++++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 751 NDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
+V E M GSL +L + L L +++ VA + Y+ + +H DL
Sbjct: 73 EPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +NIL+ + +V ++DFGL++L ++ + + Q I + APE G + K DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 870 SYGVLLTETFTRKK-PTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDC 928
S+G+LLTE T+ + P M E V E + G + DC
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNRE------VLEQVERG-------------YRMPCPQDC 228
Query: 929 LLSVLHLALDCCMESPDQR 947
+S+ L L C + P++R
Sbjct: 229 PISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 57/194 (29%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG+G FG V+ GT++ T AIK +F E ++++ +RH L+ +++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 751 NDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
+V E M GSL +L D +L L + +++ +A + Y+ + +H DL
Sbjct: 73 EPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +NIL+ +++V ++DFGL++L ++ + + Q I + APE G + K DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 870 SYGVLLTETFTRKK 883
S+G+LLTE T+ +
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 691 LGRGSFGSVY----KGTFSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIK 743
+ +G++G V+ K T G +AIKV + +E ++L + ++K
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
++ S LV+E +P G L L + + + R + + LALEYLH +G
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG--- 113
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKL------FDEGDDSVTQTMTIATIGYMAPEY 856
++H DLKP NIL+D + ++DFGLSK+ + DD + T Y+APE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 857 GTEGIVSSKCDVYSYGVLLTETFT 880
S D +S G +L E
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNL-QLDRAFRS-FDSECEVLRNVRHRNLIKIFSS 747
+G+GSFG+V K SDG K + + + SE +LR ++H N+++ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 748 CCNNDFRAL--VLELMPNGSLEKWL---YSDNYFLDLLERLNIMIGVALALEYLHHG-HS 801
+ + L V+E G L + + + +++ I+ + LAL H+
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 802 TPVV-HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
V H DLKP+NI LD + + DFGL+K+ D S +T + T YM+PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTY-VGTPYYMSPEQLNHM 185
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP 884
K D++S G L+ E P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 64/217 (29%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 689 NLLGRGSFGSVYKG-TFSDGTSFAIKVFNLQ-LDRA-FRSFDSECEVLRNVRHRNLIK-- 743
N +G G+FG VY G A+K +Q D + E +VL ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 744 ----------IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
IF C+ +LE +G + Y L LLE L
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLE----------GL 112
Query: 794 EYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM--TIATIG 850
YLH HG +VH D+KP+NI LD + V + DFG + ++ + + T
Sbjct: 113 AYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 851 YMAPEYGTEGIVSSK---CDVYSYGVLLTETFTRKKP 884
YMAPE T G D++S G ++ E T K+P
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 689 NLLGRGSFGSVYKGTFSD----GTS---FAIKVFNL-QLDRAFRSFDSECEVLRNVRHRN 740
N LG G+FG VY+GT +D G+ A+K D+ + F E ++ N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNY------FLDLLERLNIMIGVALALE 794
++K+ C N+ + +++ELM G L +L L L E L+I + VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 795 YLHHGHSTPVVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
YL H +H DL N L+ E D V + DFGL++ + D + + +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+MAPE +G +++ DV+S+GVL+ E T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRA-FRSFDSECEVLRNVRHRNLIKIFSSC 748
LG G+ G V K G A+K L+++ A + E ++L ++ + +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 749 CNNDFRALVLELMPNGSLEKWL--YSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
NN ++ +E M GSL+K L +L + I + V L YLH H ++H
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIH 124
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
D+KPSNIL++ + DFG+S + +S+ +T + T YMAPE S K
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTF-VGTSSYMAPERIQGNDYSVKS 180
Query: 867 DVYSYGVLLTETFTRKKP 884
D++S G+ L E T + P
Sbjct: 181 DIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LG GS+GSVYK G AIKV + + + E +L+ ++K + S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVALALEYLHH 798
N +V+E GS D+++ N I+ LEYLH
Sbjct: 68 FKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH- 116
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPEYG 857
S +H D+K NILL+E+ A ++DFG+S +L D T+ I T +MAPE
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTV-IGTPFWMAPEVI 171
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
E ++K D++S G+ E K P D+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 689 NLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQ--------LDR-AFRSFDSECEVLRNVRH 738
LG G++ VYK G AIK L ++ A R E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
N+I + + LV E M LEK + + L + + M+ LEYLH
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH- 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--Y 856
S ++H DLKP+N+L+ D V ++DFGL++ F G + T + T Y APE +
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLF 175
Query: 857 GTEGIVSSKCDVYSYGVLLTETFTRK 882
G D++S G + E R
Sbjct: 176 GAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 8e-20
Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 27/256 (10%)
Query: 690 LLGRGSFGSVYKGTFSDG--TSFAIKVFNL----------QLDRAFRSFDSECEVLR-NV 736
LG G+FG VYK + A+K N+ + D++ SE +++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS----DNYFLDLLERL-NIMIGVAL 791
RH N+++ + + ND +V++L+ L + S F + ER+ NI + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
AL YLH +VH DL P+NI+L ED ++DFGL+K + T + TI Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILY 179
Query: 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP--TDDMFTGEMSLKKWVKESLPHGLME 909
PE K DV+++G +L + T + P + +M + + + V E LP G+
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 910 VVDTNLLRQEHTSSAE 925
T+++ T AE
Sbjct: 240 EDVTDVITSCLTPDAE 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 31/280 (11%)
Query: 690 LLGRGSFGSVYKGTFS----DGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKI 744
++G G FG V +G AIK ++ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ ++ E M NG+L+ +L ++ +++ + ++ G+A ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA---TIGYMAPEYGTEGI 861
VH DL NIL++ ++V VSDFGLS+ ++ T T ++ I + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQEH 920
+S DV+SYG+++ E M GE P+ M D N + Q++
Sbjct: 188 FTSASDVWSYGIVMWEV---------MSYGER----------PYWDMSNQDVINAIEQDY 228
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
MDC ++ L LDC + + R L K+
Sbjct: 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 689 NLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQ-LDRAFRSFD-SECEVLRNVRHRNLIKIF 745
N +G+GSFG V+K +D +A+K +L ++R R E VL + +I+ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHST 802
S + +V+E NG L K L D + R I I + LA H HS
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA-----HLHSK 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
++H D+K N+ LD + D G++KL D++ + T Y++PE +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896
+ K DV++ GV+L E T K P D G + LK
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 684 GFNECNLLGRGSFGSVYK-GTFSDGTSFAIKVFNLQLDRAFRSFDS--ECEVLRNVRHRN 740
F LG+GS+GSVYK SD +A+K +L D+ E +L +V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER---LNIMIGVALALEYLH 797
+I + + + +V+E P G L K + L+ I I + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG---YMAP 854
++H DLK +NILL + + + D G+SK+ + + M IG YMAP
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKV-------LKKNMAKTQIGTPHYMAP 170
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
E S K D++S G LL E T P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 689 NLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFS 746
+ LG G +G VY+G + + A+K L+ D F E V++ ++H NL+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
C ++ E M G+L +L + ++ + L + ++ A+EYL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H DL N L+ E+ + V+DFGLS+L GD I + APE S K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 866 CDVYSYGVLLTETFT 880
DV+++GVLL E T
Sbjct: 186 SDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 76/272 (27%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 691 LGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFR---SFDSECEVLRNVRHRNLIK 743
LG G FG V Y +DGT + V L+ + + + E +L+ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 744 IFSSCCNN---DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
+ CC+ L++E +P GSL +L L+L + L + + YLH H
Sbjct: 71 -YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH 127
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD--SVTQTMTIATIGYMAPEYGT 858
+H DL N+LLD D + + DFGL+K EG + V + Y A E
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--PHGLMEVVD-TNL 915
E S DV+S+GV L E T S K +E + G M VV L
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSK-------QSPPKKFEEMIGPKQGQMTVVRLIEL 236
Query: 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
L + +C V L +C R
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 690 LLGRGSFGSVYKGTFSDGTS----FAIKVF-NLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG GSFG V +G +S A+K + +L F E ++ ++ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL-NIMIGVALALEYLHHGHSTP 803
+ + +V EL P GSL L D L+ L + + +A + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT-IGYMAPEYGTEGIV 862
+H DL NILL D + DFGL + + +D + + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 863 SSKCDVYSYGVLLTETFT 880
S DV+ +GV L E FT
Sbjct: 178 SHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 691 LGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG V+ D A+K + A + F E E+L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYS---DNYFLD-----------LLERLNIMIGVA 790
+ C +V E M +G L ++L S D L L + L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
+ YL H VH DL N L+ + +V + DFG+S+ D T+ I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK 883
+M PE +++ D++S+GV+L E FT K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 73/280 (26%), Positives = 122/280 (43%), Gaps = 33/280 (11%)
Query: 690 LLGRGSFGSVYKGTFS----DGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKI 744
++G G FG V++G + AIK R F SE ++ H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
++ E M NG+L+K+L + + + ++ G+A ++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
VH DL NIL++ ++ VSDFGLS+ L D+ + + T + I + APE +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 864 SKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKES--LPHGLMEVVDTNLLRQEH 920
S DV+S+G+++ E + ++P DM E + K + + LP
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGFRLP---------------- 230
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
A MDC +V L L C + +R D L K+
Sbjct: 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/196 (31%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G G++G VYK + G AIKV L+ F E +L+ RH N++ F S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E GSL+ +Y L L I L+ L + H T +H D+
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IATIGYMAPEYGTE---GI 861
K +NILL ED ++DFG+S +T T+ I T +MAPE G
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQ-------LTATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 862 VSSKCDVYSYGVLLTE 877
KCD+++ G+ E
Sbjct: 181 YDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIK 743
+G G++G VYK G A+K ++ ++ A R E ++L+ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 744 ---IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
I +S +V E M + L L S + M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE----- 855
++H D+K SNIL++ D V ++DFGL++ + +S T + T+ Y PE
Sbjct: 121 ---ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGA 176
Query: 856 --YGTEGIVSSKCDVYSYGVLLTETFTRK 882
YG E D++S G +L E F K
Sbjct: 177 TRYGPE------VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 7/213 (3%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLR 734
L+ + D E +LG+G++G VY S AIK + R + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALE 794
++HRN+++ S N F + +E +P GSL L S L E+ I + LE
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-LE 119
Query: 795 YLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
L + H +VH D+K N+L++ V +SDFG SK G + T+T T T+ YMA
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFT-GTLQYMA 177
Query: 854 PEYGTEGI--VSSKCDVYSYGVLLTETFTRKKP 884
PE +G + D++S G + E T K P
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 7/208 (3%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V G + AIK+ + + F E +V+ + H L++++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810
+V E M NG L +L + L + V + YL S +H DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLA 127
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM-TIATIGYMAPEYGTEGIVSSKCDVY 869
N L+D+ VSDFGLS+ DD T ++ + + + PE SSK DV+
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 870 SYGVLLTETFTRKKPTDDMFTGEMSLKK 897
++GVL+ E ++ K + F +++K
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 678 IQRATDGFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQLDRAFRS-FDSECEV 732
IQR C +G G FG VY+G + ++ + A+K + R F E +
Sbjct: 3 IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA 792
+R H +++K+ N +V+EL P G L +L + Y LDL + ++ A
Sbjct: 61 MRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
L YL S VH D+ N+L+ + DFGLS+ ++ + + I +M
Sbjct: 120 LAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWM 175
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTR-KKP 884
APE +S DV+ +GV + E KP
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 690 LLGRGSFGSVYKG-TFSDGTSFAIKVFNL------QLDRAFRSFDS---ECEVLRNVRHR 739
L+G GSFGSVY G S G A+K L DR D+ E +L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLH 797
N+++ S + D + LE +P GS+ L +NY F + L R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVR-NFVRQILKGLNYLH 123
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-----ATIGYM 852
+ ++H D+K +NIL+D +SDFG+SK E + T+T ++ +M
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWM 179
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
APE + + K D++S G L+ E T K P D
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 51/300 (17%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFNLQLDRA-FRSFDSECEVLRNVRHRNLIK 743
LG G FG V K T + T+ A+K+ + R SE +L+ V H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL-----------------YSDNYFLDLLERLNIM 786
++ +C + L++E GSL +L S L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 787 IGVALA------LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840
++ A ++YL +VH DL N+L+ E +SDFGLS+ E D V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900
++ + +MA E + I +++ DV+S+GVLL E T + + G + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG---NPYPGIAPERLF-- 239
Query: 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
NLL+ + +C + +L L C + PD+R D + +L+K+
Sbjct: 240 -------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 690 LLGRGSFGSVY--KGTFSDGTSFAIKVFNL-QLDRAFR-SFDSECEVLRNVRHRNLIKIF 745
++GRG+FG V+ + +D IK + Q+ + R + +EC+VL+ + H N+I+ +
Sbjct: 7 VVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ + +V+E P G+L +++ N LD L+ + + LAL HH H+ +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---HHVHTKLI 122
Query: 805 VHCDLKPSNILLDE-DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
+H DLK NILLD+ MV + DFG+SK+ + T + T Y++PE +
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYN 179
Query: 864 SKCDVYSYGVLLTETFTRKKPTD 886
K D+++ G +L E + K+ +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 53/191 (27%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ G ++ T AIK Q + +F +E +++ ++H L+++++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 751 NDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
++ E M NGSL +L + L + + +++ +A + ++ + +H DL
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +NIL+ E + ++DFGL++L E ++ + I + APE G + K DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 870 SYGVLLTETFT 880
S+G+LLTE T
Sbjct: 188 SFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 33/280 (11%)
Query: 690 LLGRGSFGSVYKGTFS----DGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKI 744
++G G FG V G AIK ++ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ +V E M NGSL+ +L + +++ + ++ G+A ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGY 127
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
VH DL NIL++ ++V VSDFGLS+ L D+ + + T I + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 864 SKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKES--LPHGLMEVVDTNLLRQEH 920
S DV+SYG+++ E + ++P +M + K ++E LP
Sbjct: 188 SASDVWSYGIVMWEVMSYGERPYWEM--SNQDVIKAIEEGYRLP---------------- 229
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
A MDC ++ L LDC + ++R L K+
Sbjct: 230 ---APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G G+ G VYK T G AIK L+ + E ++++ +H N++ + S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLHHGHSTPVVHC 807
D +V+E M GSL + F+ + E + V LEYLH S V+H
Sbjct: 86 VGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHR 140
Query: 808 DLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPE------YGTEG 860
D+K NILL +D ++DFG + +L E + + T +MAPE YG
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPEVIKRKDYGP-- 195
Query: 861 IVSSKCDVYSYGVLLTE 877
K D++S G++ E
Sbjct: 196 ----KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 49/126 (38%), Positives = 69/126 (54%), Gaps = 4/126 (3%)
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557
L L L G IP I L+ L +++L+ N G IP + GS+T LE LDLS N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 558 PKSLEALLFLKQLNVSHNKLEGEIPA--NGPFKYFAPQSFSWNYALCGPTTLQVPPCRAN 615
P+SL L L+ LN++ N L G +PA G + A +F+ N LCG L C +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPH 540
Query: 616 KTEGSK 621
+ G+K
Sbjct: 541 LSVGAK 546
|
Length = 623 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 691 LGRGSFGSV----YKGTFSDGTSFAIKVFNL-------QLDRAFRSFDSECEVLRNVRHR 739
LG GSFG V +KG+ G +A+K+ + Q++ +E +L+++RH
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVL----NEKRILQSIRHP 61
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG------VALAL 793
L+ ++ S ++ LV+E +P G L L R + V LAL
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLAL 114
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYM 852
EYLH +V+ DLKP N+LLD D ++DFG +K T T+ T Y+
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYL 165
Query: 853 APEYGTEGIVSSK-----CDVYSYGVLLTE 877
APE I+ SK D ++ G+L+ E
Sbjct: 166 APE-----IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 691 LGRGSFGSVYKG---TFSDGTSF---AIK-VFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
LG+GSFG VY+G G AIK V R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYS---DNYF------LDLLERLNIMIGVALALE 794
+ +V+ELM G L+ +L S + L + + + +A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YL + VH DL N ++ ED+ + DFG+++ E D + + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFT 880
E +G+ ++K DV+S+GV+L E T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 39/275 (14%)
Query: 691 LGRGSFGSVYKGTF------SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG V+ D A+K D A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL------------ERLNIMIGVALA 792
+ C D +V E M +G L K+L + L+ + L+I +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+ YL H VH DL N L+ E+++ + DFG+S+ D T+ I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912
PE +++ DV+S GV+L E FT K + W + S + +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVIECITQ 237
Query: 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
+L++ T C V L L C P R
Sbjct: 238 GRVLQRPRT------CPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 61/174 (35%), Positives = 92/174 (52%), Gaps = 22/174 (12%)
Query: 689 NLLGRGSFGSVYKGTF-SDGTSFAIKV-FNLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
N +G G+ G+VYK G +A+KV + D R E E+LR+V H N++K
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
+N ++LE M GSLE +D FL + R I+ G+A YLH H +VH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-QILSGIA----YLHRRH---IVH 191
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM-----TIATIGYMAPE 855
D+KPSN+L++ ++DFG+S++ + QTM ++ TI YM+PE
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRI-------LAQTMDPCNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIK------VFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
LG G FG V S +FA+K + S E E+L H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
++ + + + +++E G L L F + R I V LA EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNRG--- 113
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPEYGTEGIV 862
+++ DLKP N+LLD + + DFG +K G +T T T Y+APE I+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCGTPEYVAPE-----II 164
Query: 863 SSK-----CDVYSYGVLLTETFTRKKPTDDMFTGE 892
+K D +S G+LL E T + P F +
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLD------RAFRSFDSECEVLRNVRHRNLIK 743
+G G++G VYK G AIK L+ + A R E ++L+ + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
+ + LV E M + L K + L + + + L + H HG
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTEG 860
++H DLKP N+L++ + V ++DFGL++ F G T + T Y APE G +G
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 861 IVSSKCDVYSYGVLLTETFTRK 882
S+ D++S G + E +R+
Sbjct: 176 -YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 42/283 (14%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG V+ D A+K A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYS---------------DNYFLDLLERLNIMIGV 789
+ C + D +V E M +G L K+L + L L + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
A + YL H VH DL N L+ +++ + DFG+S+ D T+ I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909
+M PE +++ DV+S+GV+L E FT K + W + S ++E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLS-NTEVIE 236
Query: 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTD 952
+ Q C V + L C P QR+ + +
Sbjct: 237 CIT-----QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 53/194 (27%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ G +++ T A+K + ++F E +++ ++H L+++++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERL-NIMIGVALALEYLHHGHSTPVVHCDL 809
+ ++ E M GSL +L SD LL +L + +A + Y+ + +H DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 129
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +N+L+ E ++ ++DFGL+++ E ++ + I + APE G + K DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 870 SYGVLLTETFTRKK 883
S+G+LL E T K
Sbjct: 189 SFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-17
Identities = 36/93 (38%), Positives = 58/93 (62%)
Query: 473 AVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
+ L + L G +P++I L+ L +++LS N + G+IP ++GS+ L L L+ N F G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL 565
IP++ G LT L L+L+ N+LSG +P +L L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 691 LGRGSFGSVYKGTF---SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRNLIKIFS 746
LG G+FG V KG + AIKV + +++ R E E++ + + ++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
C + LV+E+ G L K+L + + + +M V++ ++YL + VH
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--IGYMAPEYGTEGIVSS 864
DL N+LL A +SDFGLSK DDS + + + + APE SS
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDM 888
+ DV+SYG+ + E F+ +KP M
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSEC--EV--LRNVRHR 739
+ + LG G++G VYK G A+K ++LD S E+ L+ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLH 797
N++K+ LV E L+K+L D L L +IM + L Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-- 855
++H DLKP NIL++ D V ++DFGL++ F G T T + T+ Y APE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEIL 170
Query: 856 -----YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y T + D++S G + E T K
Sbjct: 171 LGSKHYST-AV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 690 LLGRGSFGSVYKG-TFSDGTSFAIKVFNL------QLDRAFRS----FDSECEVLRNVRH 738
L+G+G++G VY + G A+K L + D + SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
N+++ ++ ++ LE +P GS+ L + F + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--Y 856
S ++H DLK N+L+D D + +SDFG+SK D+ D+ ++ +MAPE +
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 857 GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
S+K D++S G ++ E F ++P D
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 6/198 (3%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIK---VFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+GRG F VY+ T DG A+K +F+L +A E ++L+ + H N+IK ++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
S ++ +VLEL G L + + L+ + L H HS V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
D+KP+N+ + V + D GL + F + + T YM+PE E + K
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 867 DVYSYGVLLTETFTRKKP 884
D++S G LL E + P
Sbjct: 188 DIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 689 NLLGRGSFGSVYKGTFS----DGTSFAIKVFNL--------QLDRAFRSFDSECEVLRNV 736
LG G+FG VY+G + D + V L + D F E ++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-----FLMEALIMSKF 66
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWL-----YSDNYF-LDLLERLNIMIGVA 790
H+N++++ R ++LELM G L+ +L + L + + L VA
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847
+YL H +H D+ N LL VA ++DFG+++ +
Sbjct: 127 KGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
I +M PE +GI +SK DV+S+GVLL E F+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-16
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 4/107 (3%)
Query: 40 WVGISCG----ARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELG 95
W G C + L L N GLRG IP + L S+++S N+ +P LG
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 96 QLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSL 142
+ L + L YN F+GS P +G L+ L+IL+L NS +G +P +L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQ------LDRAFRSFDSECEVLRNVRHRNLI 742
+LG+G++G+VY G + G A+K L ++ + E ++L++++H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL------NIMIGVALALEYL 796
+ +C +++ ++ +E +P GS+ L N F L E + I+ GVA YL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVA----YL 118
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG----YM 852
H+ VVH D+K +N++L + + + DFG ++ T + + ++ +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
APE E K D++S G + E T K P M
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDS------ECEVLRNVR 737
F +G+GSFG VYK AIKV +L+ + D E + L R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQQEIQFLSQCR 57
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLE--RLN------IMIGV 789
+ K + S +++E GS LDLL+ +L+ I+ V
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREV 107
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT---- 845
L LEYLH +H D+K +NILL E+ ++DFG+S +T TM+
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSG-------QLTSTMSKRNT 157
Query: 846 -IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ T +MAPE + K D++S G+ E + P D+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 64/259 (24%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ T++ T A+K + +F +E V++ ++H L+K+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKL-HAVVT 71
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERL-NIMIGVALALEYLHHGHSTPVVHCDL 809
+ ++ E M GSL +L SD L +L + +A + ++ + +H DL
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +NIL+ +V ++DFGL+++ E ++ + I + APE G + K DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 870 SYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDC 928
S+G+LL E T + P M E V +L G R + C
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE------VIRALERG---------YRMPRPEN----C 228
Query: 929 LLSVLHLALDCCMESPDQR 947
+ ++ + C P++R
Sbjct: 229 PEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 78/241 (32%), Positives = 117/241 (48%), Gaps = 24/241 (9%)
Query: 690 LLGRGSFGSVY---KGTFSD-GTSFAIKVF---NLQLDRAFRSFDSECEVLRNVRHRNLI 742
+LG+GSFG V+ K T D G +A+KV L++ R+ E ++L V H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALEYLHHGHS 801
K+ + L+L+ + G L L + F + E + + +ALAL++LH S
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH---S 116
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMAPEYGTEG 860
+++ DLKP NILLDE+ ++DFGLSK E D + + T+ YMAPE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP---TDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917
+ D +S+GVL+ E T P D T M LK K +P L + LLR
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQS-LLR 230
Query: 918 Q 918
Sbjct: 231 A 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDS---ECEVLRNVRHRNLIKIFS 746
+G G+ VY + AIK +L ++ S D E + + H N++K ++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 747 SCCNNDFRALVLELMPNGSLE---KWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
S D LV+ + GSL K Y LD ++ V LEYLH +G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQTMTIA-TIGYMAPEYGTEG 860
+H D+K NILL ED ++DFG+S L D GD + T T +MAPE +
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 861 I-VSSKCDVYSYGVLLTETFTRKKP 884
K D++S+G+ E T P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 691 LGRGSFGSVY----KGTFSDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNVRHRN-L 741
LG G++G V+ G G +A+KV +Q + +E +VL VR L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALEYLHHGH 800
+ + + + L+L+ + G L LY +F + + I + LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIAEIVLALDHLHQ-- 123
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY--GT 858
+++ D+K NILLD + ++DFGLSK F ++ + TI YMAPE G
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGG 181
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP 884
G D +S GVL E T P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-------HRNLI 742
LG G+FGSVY G AIK ++ + F S++ EC LR V+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLH-HG 799
K+ ND V E M G+L + L D E + +I+ + L ++H HG
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE---- 855
H DLKP N+L+ V ++DFGL++ E T ++T Y APE
Sbjct: 120 F----FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 856 ---YGTEGIVSSKCDVYSYGVLLTETFT 880
Y SS D+++ G ++ E +T
Sbjct: 173 STSY------SSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 689 NLLGRGSFGSVYKGTFSDG----TSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIK 743
++G+G FG VY GT D A+K N D F E ++++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 744 IFSSCCNNDFRALV-LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ C ++ LV L M +G L ++ S+ + + + + + VA +EYL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQ-TMTIATIGYMAPEYGTEG 860
VH DL N +LDE V+DFGL++ ++D+ SV T + +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP 884
++K DV+S+GVLL E TR P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 689 NLLGRGSFGSVYKGTFS-DGT--SFAIKVFN-LQLDRAFRSFDSECEVLRNV-RHRNLIK 743
+++G G+FG V + DG + AIK+ + R F E EVL + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 744 IFSSCCNNDFRALVLELMPNGSL------EKWLYSDNYF---------LDLLERLNIMIG 788
+ +C N + + +E P G+L + L +D F L + L
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIA 847
VA ++YL +H DL N+L+ E++ + ++DFGLS+ G++ V +TM
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRL 180
Query: 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG 906
+ +MA E + ++K DV+S+GVLL E + P M E+ E LP G
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 234
Query: 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
R E +C V L C + P +R +V+L ++
Sbjct: 235 ---------YRMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 71/261 (27%), Positives = 112/261 (42%), Gaps = 22/261 (8%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIK---VFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+GRG F VY+ T D A+K +F + +A + E ++L+ + H N+IK
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
S ++ +VLEL G L + + L+ + + H HS V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
D+KP+N+ + V + D GL + F + + T YM+PE E + K
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 867 DVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926
D++S G LL E + P + +M+L SL + E D L EH S
Sbjct: 188 DIWSLGCLLYEMAALQSP---FYGDKMNLF-----SLCQKI-EQCDYPPLPTEHYSEKLR 238
Query: 927 DCLLSVLHLALDCCMESPDQR 947
+ L+S+ C PDQR
Sbjct: 239 E-LVSM------CIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 43/290 (14%)
Query: 691 LGRGSFGSVYKGTF-----SDGTSFAIKVF-NLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG +FG +YKG AIK ++ + + F E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWL-----YSD-----------NYFLDLLERLNIMIG 788
++ E + G L ++L +SD LD + L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+A +EYL S VH DL NIL+ E + +SD GLS+ D Q ++
Sbjct: 133 IAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM 908
I +M PE G SS D++S+GV+L E F+ F+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---------------- 233
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958
EV++ ++R+ DC + L +C E P +R D +L+
Sbjct: 234 EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNL-----QLDRAFRSFDSECEVLRNVRHRNLIK 743
LLG+G+FG VY D G A+K + + + + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER---LNIMIGVALALEYLHHGH 800
+ +++ ++ +E MP GS++ L + + + R I+ GV EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV----EYLHSNM 124
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPE---- 855
+VH D+K +NIL D + DFG SK S T + T +M+PE
Sbjct: 125 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 856 --YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
YG K DV+S G + E T K P
Sbjct: 182 EGYG------RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 56/287 (19%)
Query: 690 LLGRGSFGSVYKGTFSD------GTSFAIKVFNLQ-LDRAFRSFDSECEVLRNV-RHRNL 741
LG G+FG V K ++ A+K+ ++ SE E+++ + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWL---------YSDNYFLDLLERL------NIM 786
I + C +V+E +G+L +L S + E L +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
VA +E+L S +H DL N+L+ ED V ++DFGL++ D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK------PTDDMFTGEMSLKKWVK 900
+ +MAPE + + + + DV+S+GVLL E FT P +++F
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----------- 244
Query: 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
LL++ + +C + HL DC E P QR
Sbjct: 245 -------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ G + AIK N + + F E +V+ + H L++++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFL--DLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V E M NG L +L L D+L L++ V +EYL +H D
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS---FIHRD 125
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N L+ V VSDFG+++ + D+ + + + + PE SSK DV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 869 YSYGVLLTETFTRKK 883
+S+GVL+ E FT K
Sbjct: 185 WSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRS----FDSECEVLRNVRHRNLIKIF 745
LG G FGSV +G + D + + V +++ RS F SE ++ H N++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 746 SSCCNNDFR------ALVLELMPNGSLEKWL-YS----DNYFLDLLERLNIMIGVALALE 794
C ++L M +G L +L YS +L + M +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YL S +H DL N +L+E+M V+DFGLSK GD + + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
E + + ++K DV+S+GV + E TR + + G V+ S E+ D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPG-------VENS------EIYD-- 225
Query: 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
LRQ + DCL + L C + +P R +L+K
Sbjct: 226 YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFA---IKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G+G F VYK DG A +++F + +A + E ++L+ + H N+IK +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 747 SCCNNDFRALVLELMPNGSLE---KWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
S N+ +VLEL G L K + + + ALE++H S
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT----IATIGYMAPEYGTE 859
++H D+KP+N+ + V + D GL + F +T + T YM+PE E
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPERIHE 180
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE-MSL 895
+ K D++S G LL E + P F G+ M+L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 689 NLLGRGSFGSVYK------GTFSDGTSFAIKVFNLQLDRAFRSFDSECEVL-RNVRHRNL 741
+++G G+FG V K G D +K + + D R F E EVL + H N+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNI 70
Query: 742 IKIFSSCCNNDFRALVLELMPNGSL------EKWLYSDNYF---------LDLLERLNIM 786
I + +C + + L +E P+G+L + L +D F L + L+
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMT 845
VA ++YL +H DL NIL+ E+ VA ++DFGLS+ G + V +TM
Sbjct: 131 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLP 904
+ +MA E + ++ DV+SYGVLL E + P M E+ E LP
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLP 237
Query: 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
G R E ++C V L C E P +R V L ++
Sbjct: 238 QG---------YRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-15
Identities = 71/222 (31%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 690 LLGRGSFGSV-YKGTFSDGTSFAIKVFNLQ------LDRAFRSFDSECEVLRNVRHRNLI 742
+LG G+ G+V SDG FA+KV +++ +RA +E L N +++
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA----QAEVCCLLNCDFFSIV 94
Query: 743 KIFSSCCNNDFR-------------ALVLELMPNGSLEKWLYS----DNYFLDLLERLNI 785
K C+ DF ALVL+ G L + + S + F + L +
Sbjct: 95 K-----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-L 148
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTM 844
I V LA+ HH HS ++H D+K +NILL + + + DFG SK++ D V +T
Sbjct: 149 FIQVLLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
T Y+APE S K D++S GVLL E T K+P D
Sbjct: 206 C-GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFD-----SECEVLRNVRH 738
+ L+GRG++G+VY+G G A+K+ NL D E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58
Query: 739 ---RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALA 792
N+ K + S +++E GS+ + + ++ + I+ V +A
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVA 113
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
L+Y+H V+H D+K +NIL+ + DFG++ L ++ S ++ + T +M
Sbjct: 114 LKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWM 168
Query: 853 APEYGTEGIV-SSKCDVYSYGVLLTETFTRKKP 884
APE TEG +K D++S G+ + E T P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 687 ECNLLGRGSFGSVYKGTFS------DGTSFAIKVF------NLQLDRAFRSFDSECEVLR 734
E LGRG FG V+ T +K NLQ + F E ++ R
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-----FRRELDMFR 63
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL--------ERLNIM 786
+ H+N++++ C + ++LE G L+++L + + L +++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE-GDDSVTQTMT 845
+AL +++L + VH DL N L+ VS LSK D +
Sbjct: 124 TQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNA 178
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ + ++APE E S+K DV+S+GVL+ E FT
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 63/240 (26%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN--LQLDRAFRSFD-SECEVLRN 735
D F ++GRG+FG V+ K G +A+KV + R + +E ++L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNI--MIGVALAL 793
++K++ S + + LV+E MP G L L + F + R I ++ LAL
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LAL 114
Query: 794 EYLHH-GHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSV---------- 840
+ +H G +H D+KP NIL+D D H+ +DFGL K ++ D
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 841 ------------TQTMTIA--TIG---YMAPE------YGTEGIVSSKCDVYSYGVLLTE 877
Q A T+G Y+APE YG E CD +S GV+L E
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 39/228 (17%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR------AFRSFDSECE 731
+R D F+ +G G++G VYK D G A+K L ++ A R E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58
Query: 732 VLRNVRHRNLIKIFSSCCNN----DFRA------LVLELMPN---GSLEKWL--YSDNYF 776
+LR + HRN++ + + DF+ LV E M + G LE L +S+++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 777 LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836
+++L LE L++ H +H D+K SNILL+ ++DFGL++L+
Sbjct: 119 KSFMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NS 168
Query: 837 DDSVTQTMTIATIGYMAPE--YGTEGIVSSKCDVYSYGVLLTETFTRK 882
++S T + T+ Y PE G E DV+S G +L E FT+K
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 15/236 (6%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSF----AIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIK 743
+LG G+FG+VYKG + +G + AIK+ N +A F E ++ ++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYS--DNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ C + + LV +LMP+G L +++ DN LL LN + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQIAKGMMYLEERR- 129
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
+VH DL N+L+ ++DFGL++L + + I +MA E
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 862 VSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916
+ + DV+SYGV + E T KP D + T E+ E LP + +D ++
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 31/279 (11%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-----DRAFRSFDSE 729
L I + T+ F + +LG G+FG+VYKG + +G I V +L +A + E
Sbjct: 1 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59
Query: 730 CEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGV 789
V+ +V + ++ ++ C + + L+ +LMP G L ++ + LN + +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
A + YL +VH DL N+L+ ++DFGL+KL + I
Sbjct: 119 AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLM 908
+MA E I + + DV+SYGV + E T KP D + E+S E LP +
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 235
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
C + V + + C M D R
Sbjct: 236 -------------------CTIDVYMIMVKCWMIDADSR 255
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 70/310 (22%), Positives = 121/310 (39%), Gaps = 85/310 (27%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQL------DRAFRSFDSECEVLRNVRHRNLIK 743
+G G+ G V+K G + A+K L+ ++A R E + L+ +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 744 IFS-----SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL-ERLNIMIGVALALEYLH 797
+ S LV+E MP+ E + + + M+ L+ +
Sbjct: 64 LLDVFPHGSGF-----VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRML-----LKGVA 113
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-- 855
+ H+ ++H DLKP+N+L+ D V ++DFGL++LF E + + + +AT Y APE
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPELL 172
Query: 856 YG----TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE---------------MSLK 896
YG G+ D+++ G + E P +F GE + +
Sbjct: 173 YGARKYDPGV-----DLWAVGCIFAELL-NGSP---LFPGENDIEQLAIVFRTLGTPNEE 223
Query: 897 KWVK-ESLPHGLMEVVDTNLLRQEH------------TSSAEMDCLLSVLHLALDCCMES 943
W SLP D N + S +D L +L
Sbjct: 224 TWPGLTSLP-------DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVY-------D 269
Query: 944 PDQRIYMTDA 953
P +R+ +A
Sbjct: 270 PSKRLSAAEA 279
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-AIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
LG G+FG VYK + F A K+ ++ + F E ++L +H N++ ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN------IMIGVALALEYLHHGHSTP 803
+ +++E G+L D+ L+L L + + AL +LH S
Sbjct: 73 YENKLWILIEFCDGGAL------DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPEY-GTEGI 861
V+H DLK NILL D ++DFG+S K T I T +MAPE E
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETF 180
Query: 862 VS----SKCDVYSYGVLLTETFTRKKPTDDM 888
K D++S G+ L E + P ++
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 24/271 (8%)
Query: 691 LGRGSFGSVYKGTFS---DGTSFAIKVFNLQLDRA---FRSFDSECEVLRNVRHRNLIKI 744
LG G FG V + D T + V +L+ + E E+LRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK- 70
Query: 745 FSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ C D L++E +P+GSL+++L + ++L ++L + + ++YL S
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---S 127
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF--DEGDDSVTQTMTIATIGYMAPEYGTE 859
VH DL N+L++ + + DFGL+K D+ +V + Y APE +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQ 186
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP-HGLMEVVD-TNLLR 917
DV+S+GV L E T D + M+L ++K P HG M V +L
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYC----DSESSPMTL--FLKMIGPTHGQMTVTRLVRVLE 240
Query: 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948
+ +C V L C P +R
Sbjct: 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 11/199 (5%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
LG+G FG V G +A K + L+ + + +E ++L V R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+ D LV+ LM G L+ +Y+ + + LE+LH +V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
+ DLKP N+LLD+ +SD GL+ G T GYMAPE +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 866 CDVYSYGVLLTETFTRKKP 884
D ++ G L E + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 47/219 (21%)
Query: 689 NLLGRGSFGSVYKGTFS-DGTSFAIKV---FNLQL--DRAFRSFDSECEVLRNVRHRNLI 742
+ +G G++G V T G AIK F Q R R E ++LR +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 743 KIFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVA 790
I F + +V ELM L K + + + YFL + R
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IAT 848
L+Y+H S V+H DLKPSN+LL+ + + DFGL+++ D D T +T +AT
Sbjct: 118 -GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYVAT 172
Query: 849 IGYMAPEYGTEGIVSSK-----CDVYSYGVLLTETFTRK 882
Y APE +++SK D++S G +L E + +
Sbjct: 173 RWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNL--------QLDRAFRSFDSECEVL 733
+ E + LG G+ GSV K + G FA+K Q+ R E E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53
Query: 734 RNVRHRNLIKIFSSCCNNDFR--ALVLELMPNGSLEKWLYSDNYFLDLLER--------- 782
++ + ++K + + + + +E GSL D+ + + +R
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL------DSIYKKVKKRGGRIGEKVL 107
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842
I V L YLH S ++H D+KPSNILL + DFG+S E +S+
Sbjct: 108 GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAG 161
Query: 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTE 877
T T T YMAPE S DV+S G+ L E
Sbjct: 162 TFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 23/241 (9%)
Query: 688 CNLLGRGSFGSVY----KGTFSDG--TSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRN 740
LG+GSFG VY KG D T AIK N R F +E V++ +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYS--------DNYFLDLLERLNIMIG-VAL 791
++++ +++ELM G L+ +L S L+++ M G +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
+ YL+ + VH DL N ++ ED + DFG+++ E D + + +
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911
M+PE +G+ ++ DV+S+GV+L E T + + E L ++V E GL++
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-RFVMEG---GLLDKP 243
Query: 912 D 912
D
Sbjct: 244 D 244
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 683 DGFNECNLLGRGSFGSVY--KGTFSDGTSFAIKVFNL----QLDRAFRSFDSECEVLRNV 736
D +G G+FG V+ + S +A+KV + +L + + +E VL+ V
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRL-KQEQHVHNEKRVLKEV 58
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
H +I++F + + F +++E +P G L +L + F + + ALEYL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYL 117
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMAPE 855
H S +V+ DLKP NILLD++ ++DFG +K +T T+ T Y+APE
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPE 168
Query: 856 YGTEGIVSSK-----CDVYSYGVLLTETFTRKKP 884
++ SK D ++ G+L+ E P
Sbjct: 169 -----VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 58/233 (24%)
Query: 691 LGRGSFGSVYKGTF---SDGTSFAIK----VFN--LQLDRAFRSFDSECEVLRNVR-HRN 740
LG+G++G V S+ + AIK VF+ + RA R E ++LR+ R H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 741 LIKIFSSCCNND--FRALVL--ELMPNGSLEKWLYSD--------NYFLDLLERLNIMIG 788
+ ++ F L L ELM L + + S F+ I+ G
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-----YQILCG 117
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--I 846
L+Y+H S V+H DLKP N+L++ D + DFGL++ F E MT +
Sbjct: 118 ----LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 847 ATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
AT Y APE Y T+ I DV+S G +L E RK +F G+
Sbjct: 171 ATRWYRAPEIMLSFQSY-TKAI-----DVWSVGCILAELLGRKP----VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 48/294 (16%)
Query: 689 NLLGRGSFGSVYKGTFS-DGTSF--AIKVFN-LQLDRAFRSFDSECEVLRNV-RHRNLIK 743
+++G G+FG V K DG AIK R F E EVL + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 744 IFSSCCNNDFRALVLELMPNGSL------EKWLYSDNYF---------LDLLERLNIMIG 788
+ +C + + L +E P+G+L + L +D F L + L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIA 847
VA ++YL +H DL NIL+ E+ VA ++DFGLS+ G + V +TM
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRL 173
Query: 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG 906
+ +MA E + ++ DV+SYGVLL E + P M E+ E LP G
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 227
Query: 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
R E +C V L C E P +R V L ++
Sbjct: 228 ---------YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSF----AIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIK 743
LLG G FG+V+KG + +G S AIK + R F+ + ++ H +++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
+ C + LV +L P GSL + LD LN + +A + YL H
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
+VH +L NILL D + ++DFG++ L D + I +MA E G
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 863 SSKCDVYSYGVLLTETFT 880
+ + DV+SYGV + E +
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 58/288 (20%)
Query: 691 LGRGSFGSVY--------KGTFSDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRN 740
LG G FG V K + T A+K+ ++ SE E+++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL---------YSDNYFLDLLERLNI------ 785
+I + +C + +++E G+L ++L Y N E+L+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
VA +EYL S +H DL N+L+ ED V ++DFGL++ D T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK------PTDDMFTGEMSLKKWV 899
+ +MAPE + I + + DV+S+GVLL E FT P +++F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---------- 252
Query: 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
LL++ H +C + + DC P QR
Sbjct: 253 --------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 691 LGRGSFGSVY--------KGTFSDGTSFAIKVF-NLQLDRAFRSFDSECEVLRNV-RHRN 740
LG G FG V K + + A+K+ + D+ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL---------YS------DNYFLDLLERLNI 785
+I + +C + +++E G+L ++L YS L + ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
VA +EYL S +H DL N+L+ ED V ++DFGL++ D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+S+GVLL E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 39/231 (16%)
Query: 690 LLGRGSFGSVYKGTFSDGTS----FAIKVFNL------QLDRAFRSFDSECEVLRNVRHR 739
+LG+G +G V++ G FA+KV Q D A +E +L V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHP 60
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLD------LLERLNIMIGVALAL 793
++ + + L+LE + G L L + F++ L E ++LAL
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLAL 113
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
E+LH +++ DLKP NILLD ++DFGL K + +VT T TI YMA
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIEYMA 168
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFT---------RKKPTDDMFTGEMSL 895
PE D +S G L+ + T RKK D + G+++L
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLD-------RAFRSFDSECEVLRNVRHRNL 741
LLG+G+FG VY +D G A+K +Q D + + + E ++L+N+ H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 742 IKIFSSCCNNDFRAL--VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
++ + + R L +E MP GS++ L S + L E + + LE + +
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQI-LEGVSYL 122
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY-MAPEYGT 858
HS +VH D+K +NIL D + DFG SK S T ++ Y M+PE +
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP 884
K D++S G + E T K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLD-----RAFRSFDSECEVLRNVRHRNLIK 743
LLGRG+FG VY +D G A+K D + + + E ++L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 744 IFSSCCNNDFRALVL--ELMPNGSLEKWLYSDNYFLDLLER---LNIMIGVALALEYLHH 798
+ + + + L + E MP GS++ L + + + R I+ GV+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----YLH- 123
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK------LFDEGDDSVTQTMTIATIGYM 852
S +VH D+K +NIL D + DFG SK + G SVT T +M
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-----GTPYWM 176
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+PE + K DV+S + E T K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 685 FNECNLLGRGSFGSVY---KGTFSD-GTSFAIKVFN----LQLDRAFRSFDSECEVLRNV 736
F +LG G++G V+ K T D G +A+KV +Q + +E VL +V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 737 RHRNLIKIFSSCCNNDFRA-LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALE 794
R + + + L+L+ + G + LY + F + + + G + LALE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE--DEVRFYSGEIILALE 119
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
+LH +V+ D+K NILLD + ++DFGLSK F + T + TI YMAP
Sbjct: 120 HLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAP 175
Query: 855 EYGTEGIVSSK------CDVYSYGVLLTETFTRKKP 884
E I+ K D +S G+L+ E T P
Sbjct: 176 E-----IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 685 FNECNLLGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVR 737
F + +G G++G VYK G A+K L + A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL--EY 795
H N++K+ + LV E + + L+K F+D + G+ L L Y
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASP----LSGIPLPLIKSY 105
Query: 796 LH---HG----HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
L G HS V+H DLKP N+L++ + ++DFGL++ F G T T + T
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 163
Query: 849 IGYMAPE--YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+ Y APE G + S+ D++S G + E TR+
Sbjct: 164 LWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G G++G VYK + G AIKV L+ F E ++++ +H N++ F S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLD-LLERLNIMIGVALALEYLHHGHSTPVVHCD 808
D + +E GSL+ D Y + L I L+ L++ HS +H D
Sbjct: 77 RRDKLWICMEFCGGGSLQ-----DIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IATIGYMAPEYGT---EG 860
+K +NILL ++ ++DFG+S +T T+ I T +MAPE +G
Sbjct: 132 IKGANILLTDNGHVKLADFGVSA-------QITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ CD+++ G+ E + P D+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 9/206 (4%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSF-AIKVFNLQ-LDRAFRSFDSECEVLRNVRHRNLI 742
F + +G+GSFG V+KG + AIK+ +L+ + E VL +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
K + S +++E + GS L + + D + ++ + L+YLH S
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
+H D+K +N+LL E ++DFG++ D + + + T +MAPE +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDM 888
SK D++S G+ E + P DM
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
+G+GS+G V +DG + IK NL+ R ++ + E ++L ++H N++ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 748 CCNND-FRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLHHGHSTPV 804
D +V+ G L L L L E + + +A+AL+YLH H +
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH---I 123
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
+H DLK N+ L + V D G++++ + D + I T YM+PE + +
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNY 181
Query: 865 KCDVYSYGVLLTETFTRK 882
K DV++ G + E T K
Sbjct: 182 KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 39/233 (16%)
Query: 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDS--------------ECEVL 733
LG G++G V K + G AIK + + D E +++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
++H N++ + DF LV+++M L+K + L + I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS----------KLFDEGDDSVTQT 843
LH +H DL P+NI ++ + ++DFGL+ L + +
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 844 MT--IATIGYMAPE--YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
MT + T+ Y APE G E D++S G + E T K +F GE
Sbjct: 190 MTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKP----LFPGE 237
|
Length = 335 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 59/231 (25%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAF-------RSFDSECEVLRNVRHRNLI 742
+G G++G V + G AIK ++ AF R+ E ++LR+ +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNII 67
Query: 743 ---KIFSSCCNNDFRA--LVLELMPNGSLEKWLYSD--------NYFLDLLERLNIMIGV 789
I DF+ +V++LM + L ++SD YFL L R
Sbjct: 68 AIRDILRPP-GADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IA 847
L+Y+H S V+H DLKPSN+L++ED + DFG+++ MT +A
Sbjct: 119 --GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 848 TIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG 891
T Y APE Y ++ D++S G + E R++ +F G
Sbjct: 174 TRWYRAPELLLSLPEY------TTAIDMWSVGCIFAEMLGRRQ----LFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 691 LGRGSFGSVYKGT-FSDGTS-----FAIKVFNLQLDRAFR-SFDSECEVLRNV-RHRNLI 742
LG G+FG V + T + S A+K+ + R + SE +++ ++ H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHS 801
+ +C ++ E G L +L FL L + L+ VA + +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
+H DL N+LL + + DFGL++ + V + + +MAPE +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 862 VSSKCDVYSYGVLLTETFT 880
+ + DV+SYG+LL E F+
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 690 LLGRGSFGSVYKGTF--SDGTSFAIKVFNLQLDRAFRSFD-----SECEVLRNVRHRNLI 742
+LG+G FGSV + DG+ + V L+ D F S D E ++ H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 743 KIFSSCCNNDFRA------LVLELMPNGSLEKWLY----SDNYF-LDLLERLNIMIGVAL 791
K+ + + ++L M +G L +L + F L L + MI +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
+EYL S +H DL N +L+E+M V+DFGLSK GD + + +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFTR 881
+A E + + ++ DV+++GV + E TR
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 66/222 (29%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 685 FNECNLLGRGSFGSV----YKGTFSDGTSFAIKV----FNLQLDRAFRSFDSE---CEVL 733
F +LGRG FG V YK T G +AIK + D S E E
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEV-ESLMCEKRIFETA 56
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG--VAL 791
+ RH L+ +F+ D V+E G L +++D + E + V L
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL 112
Query: 792 ALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
L+YLH + +V+ DLK N+LLD + ++DFGL K G T T T
Sbjct: 113 GLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFC-GTPE 166
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
++APE TE + D + GVL+ E + P F G+
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 39/87 (44%), Positives = 49/87 (56%)
Query: 401 GLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS 460
GL L L G IP D+ L L I L+GN + G IP L S+ SL L+L N F+ S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 461 IPSSFWSLEYLLAVNLSSNSLSGSLPS 487
IP S L L +NL+ NSLSG +P+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 33/206 (16%)
Query: 693 RGSFGSVYKG-TFSDGTSFAIKVF------------NLQLDRAFRSFDSECEVLRNVRHR 739
+G+FGSVY S G FAIKV N++ +RA E
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP-------- 57
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
+ K++ S + D+ LV+E + G + + L + V L +E LH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLH-- 114
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE 859
++H D+KP N+L+D+ ++DFGLS+ E + T Y+APE
Sbjct: 115 -QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPET-IL 166
Query: 860 GIVSSK-CDVYSYGVLLTETFTRKKP 884
G+ K D +S G ++ E P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-12
Identities = 74/214 (34%), Positives = 107/214 (50%), Gaps = 7/214 (3%)
Query: 370 GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGS--IPYDLCHLERLNGIR 427
NL S+ V L +N + T+ L +L L L + S +L +L L +
Sbjct: 40 SNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLD 99
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS 487
LN N+L I + L L +L L+L +N + P L ++LS N + SLPS
Sbjct: 100 LNLNRLRSNISELLE-LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPS 157
Query: 488 NIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLD 547
++NL L NLDLS N LS D+P + +L +L L L+ N+ +P L+ LE LD
Sbjct: 158 PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD 215
Query: 548 LSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581
LSNN++ E+ SL L L L +S+NKLE
Sbjct: 216 LSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLD-------RAFRSFDSECEVLRNVRHRNL 741
LLG+G+FG VY D G A K +Q D + + + E ++L+N++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 742 IKIFSSCCNNDFRALV--LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
++ + + + L +E MP GS++ L + + + R LE + +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY----TRQILEGMSYL 122
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY-MAPEYGT 858
HS +VH D+K +NIL D + DFG SK S T ++ Y M+PE +
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP 884
K DV+S G + E T K P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 691 LGRGSFGSVYKGTFSD------GTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIK 743
LG+GSFG VY+G D T A+K N R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYS-----DNYFLDLLERLNIMIG----VALALE 794
+ +V+ELM +G L+ +L S +N L MI +A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YL+ + VH DL N ++ D + DFG+++ E D + + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896
E +G+ ++ D++S+GV+L E + + + E LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAF---RSFDSECEVLRNVRHRNLIKIFS 746
+G G FG V G S T + V L++ + F E + R+++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYS----DNYFLDLLERLNIMIGVALALEYLHHGHST 802
C LV+E P G L+ +L S + D + +AL L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-----YG 857
+H DL N LL D+ + D+GLS + D VT + ++APE +G
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 858 TEGIV--SSKCDVYSYGVLLTETF 879
+V + + +V+S GV + E F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-12
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 62/232 (26%)
Query: 691 LGRGSFGSVYKGTFSD---GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVR-HRN 740
LG+G++G V+K D A+K F D R FR E L+ + H N
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPN 68
Query: 741 LIKIFSSCCNNDFRA-------LVLELMP---NGSLEKWLYSDNYFLDLLERLN---IMI 787
++K+ N +A LV E M + + ++LE ++ IM
Sbjct: 69 IVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRA---------NILEDVHKRYIMY 114
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-QTMT- 845
+ AL+Y+H G+ V+H DLKPSNILL+ D ++DFGL++ E +++ +T
Sbjct: 115 QLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 846 -IATIGYMAPEYGTEGIVSSKC-----DVYSYGVLLTETFTRKKPTDDMFTG 891
+AT Y APE ++ S D++S G +L E KP +F G
Sbjct: 172 YVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEML-LGKP---LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 685 FNECNLLGRGSFGSVY---KGTFSD-GTSFAIKVFN----LQLDRAFRSFDSECEVLRNV 736
F +LG G++G V+ K + D G +A+KV +Q + +E +VL ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 737 RHRNLIKIFSSCCNNDFRA-LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALE 794
R + D + L+L+ + G L L F + + + I G + LALE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMA 853
+LH +++ D+K NILLD + ++DFGLSK F E D V + + TI YMA
Sbjct: 120 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE--DEVERAYSFCGTIEYMA 174
Query: 854 PEY--GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
P+ G +G D +S GVL+ E T P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 8/195 (4%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G+G+ G+VY + G AIK NLQ +E V+R +H N++ S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E + GSL + +D + + ALE+LH V+H D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
K NILL D ++DFG + S TM + T +MAPE T K D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 870 SYGVLLTETFTRKKP 884
S G++ E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 72/241 (29%), Positives = 108/241 (44%), Gaps = 50/241 (20%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNL----IKIF 745
LGRG++G V K GT A+K ++ E + R L I +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVN------SQE-------QKRLLMDLDISMR 55
Query: 746 SSCCNND-------FRA----LVLELMPNGSLEKW---LYSDNYFL--DLLERLNIMIGV 789
S C FR + +E+M + SL+K+ +Y + D+L + I + +
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD--DSVTQTMTIA 847
ALEYLH S V+H D+KPSN+L++ + + DFG+S G DSV +T+
Sbjct: 113 VKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAG 165
Query: 848 TIGYMAPEY----GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903
YMAPE + K DV+S G+ + E T + P D T LK+ V+E
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225
Query: 904 P 904
P
Sbjct: 226 P 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 691 LGRGSFGSVYKGTFSDGTS---FAIKVF-NLQLDRAFR-SFDSECEVLRNVRHRNLIKIF 745
LG G+FG+V KG + S A+K+ N D A + E V++ + + ++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLD--LLERLNIMIGVALALEYLHHGHSTP 803
C + LV+EL G L K+L + + + + E ++ V++ ++YL T
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYLEE---TN 115
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--IGYMAPEYGTEGI 861
VH DL N+LL A +SDFGLSK D++ + T + + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 862 VSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMS 894
SSK DV+S+GVL+ E F+ +KP M E++
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 63/223 (28%), Positives = 95/223 (42%), Gaps = 38/223 (17%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIF-- 745
++G G++G VYK G AIK+ ++ D E +LR H N+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 746 ----SSCCNNDFRALVLELMPNGSLEKWLYSD--NYFLDLLERLN------IMIGVALAL 793
+ N+D LV+EL GS+ +D +RL I+ L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVS--DFGLSKLFDEGDDSVTQTMT-IATIG 850
YLH V+H D+K NILL ++ A V DFG+S + D ++ + T I T
Sbjct: 127 AYLHENK---VIHRDIKGQNILLTKN--AEVKLVDFGVSA---QLDSTLGRRNTFIGTPY 178
Query: 851 YMAPE-----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+MAPE + ++ DV+S G+ E K P DM
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 64/291 (21%)
Query: 691 LGRGSFGSVY--------KGTFSDGTSFAIKVF-NLQLDRAFRSFDSECEVLRNV-RHRN 740
LG G FG V K + + A+K+ + ++ SE E+++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL---------YSDNY---------FLDLLER 782
+I + +C + +++E G+L ++L YS + F DL+
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV-- 140
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842
+ VA +EYL S +H DL N+L+ E+ V ++DFGL++ + D
Sbjct: 141 -SCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK------PTDDMFTGEMSLK 896
T + +MAPE + + + + DV+S+GVL+ E FT P +++F
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------- 249
Query: 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
LL++ H +C + + DC P R
Sbjct: 250 -----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 690 LLGRGSFGSV-YKGTFSDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRHRNLIKI 744
LLG+G+FG V + G +A+K+ ++ D + +E VL+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSL 60
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
S D V+E + G L L + F + R + AL+YLH G +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK---I 116
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPEYGTEGIVS 863
V+ DLK N++LD+D ++DFGL K EG D+ T T Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 864 SKCDVYSYGVLLTETFTRKKP 884
D + GV++ E + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 51/225 (22%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFD------SECEVLRN 735
D + + +G G++G V + G AIK +L R F+S E +L++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTYRELRLLKH 70
Query: 736 VRHRN---LIKIFS-SCCNNDFRA--LVLELMP---NGSLEKWLYSDNYFLDLLERLNIM 786
+ H N L+ +F+ + DF+ LV LM N ++ SD++ L+ + I+
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ--IL 128
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT- 845
G L+Y+ HS ++H DLKPSNI ++ED + DFGL++ D+ MT
Sbjct: 129 RG----LKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-------EMTG 174
Query: 846 -IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+AT Y APE Y + D++S G ++ E T K
Sbjct: 175 YVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 691 LGRGSFGSVY--KGTFSDGTSFAIKVFNLQLDRAFRSFDSECEV--LRNVRHRNLIKIFS 746
+G GSFG +Y K SD IK +L S+ EV L ++H N++ F+
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY----------- 795
S N +V+E G DL++R+N GV + +
Sbjct: 67 SFQENGRLFIVMEYCDGG-------------DLMKRINRQRGVLFSEDQILSWFVQISLG 113
Query: 796 LHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMA 853
L H H ++H D+K NI L ++ MVA + DFG+++ + DS+ T + T Y++
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN---DSMELAYTCVGTPYYLS 170
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
PE ++K D++S G +L E T K P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 41/223 (18%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVF------NLQLDRAFRSFDSECEVLRNVRH 738
+G+G+FG V++ + T A+K+ ++Q D F E ++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-----FQREAALMAEFDH 67
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWL--------------------YSDNYF-L 777
N++K+ C L+ E M G L ++L N L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 778 DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837
E+L I VA + YL VH DL N L+ E+MV ++DFGLS+ D
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
I +M PE +++ DV++YGV+L E F+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 64/206 (31%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNL---QLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G GSFG+VY AIK + Q + ++ E L+ +RH N I+ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 747 SCCNNDFRA-LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
C + A LV+E GS L L +E I G L YLH S +
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERI 137
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---GTEGIV 862
H D+K NILL E ++DFG + L + V T +MAPE EG
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQY 191
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDM 888
K DV+S G+ E RK P +M
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 127 LSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEI 186
L L N G IPN + L L+ + N I GNIP +G+++SL ++L+YN+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 187 PSEIGNLQNLEILVLGMNNLSG---------PIQPSIFNIS 218
P +G L +L IL L N+LSG + + FN +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 33/87 (37%), Positives = 49/87 (56%)
Query: 378 LSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPI 437
L L L G IP+ + +L LQ ++L GN++ G+IP L + L + L+ N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 438 PQCLASLISLRELNLGSNKFSSSIPSS 464
P+ L L SLR LNL N S +P++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 691 LGRGSFGS--VYKGTFSDGTSFAIKVFNL-QLD-RAFRSFDSECEVLRNVRHRNLIKIFS 746
LG+G+FG +Y+ T D + K NL +L + R +E +L ++H N+I ++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 747 SCCNNDFRALVLELMPNGSL-EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+++ + +E G+L +K + + L + + A+ Y+H ++
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H D+K NI L + + + DFG+SK+ G + + T YM+PE + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 866 CDVYSYGVLLTETFTRKK 883
D+++ G +L E T K+
Sbjct: 182 SDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 59/230 (25%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRA------FRSFDSECEVLRNVR 737
+ E +G G++G+VYK + G A+K + L R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 738 ---HRNLIKIFSSCCNNDFR-----ALVLELM-----------PNGSLEKWLYSDNYFLD 778
H N++++ C LV E + P L D
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET-----IKD 111
Query: 779 LLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838
L+ + ++ GV ++LH S +VH DLKP NIL+ D ++DFGL++++
Sbjct: 112 LMRQ--LLRGV----DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--- 159
Query: 839 SVTQTMTIATIGYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+ T + T+ Y APE Y T D++S G + E F R+
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYAT------PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 52/219 (23%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+GRG++G V S+ AIK F+ ++D R R E ++LR++ H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 744 IFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDN--------YFLDLLERLNIMIGVA 790
I A +V ELM + L + + S YFL L R
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
L+Y+H S V+H DLKPSN+LL+ + + DFGL++ E D +T+ + T
Sbjct: 120 -GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRW 173
Query: 851 YMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y T DV+S G + E RK
Sbjct: 174 YRAPELLLNCSEYTT------AIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-11
Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 707 GTSFAIKVFNLQLD-----RAFRSFDSECEVLRNVRHRNLIKIFSS-CCNNDFRALVLEL 760
G AIK+ L+ D F E + + H N++ + S V E
Sbjct: 3 GHEVAIKL--LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---D 817
+P +L + L +D L E +M+ V L+ L H+ +VH DLKP NI++
Sbjct: 61 VPGRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--IG---YMAPEYGTEGIVSSKCDVYSYG 872
A V DFG+ L D+ T+T T +G Y APE V+ D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 873 VLLTETFT 880
++ E T
Sbjct: 177 LIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 71/247 (28%), Positives = 104/247 (42%), Gaps = 27/247 (10%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR-AFRSFDS----ECEVLRNVRH 738
F + +LG+G FG V + G +A K L+ R R +S E ++L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
+ ++ + + D LVL +M G L+ +Y N E + A L L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAEILCGLED 117
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
H V+ DLKP NILLD+ +SD GL+ EG+ + + T+GYMAPE
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLN 174
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918
+ D + G L+ E + P F G K+ VK E VD +L
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR---KEKVKR-------EEVDRRVLET 220
Query: 919 EHTSSAE 925
E SA+
Sbjct: 221 EEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 43/290 (14%)
Query: 691 LGRGSFGSVYKGTFSDGT------SFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIK 743
LG FG VYKG + AIK + + R F E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL-----YSD----------NYFLDLLERLNIMIG 788
+ +++ + L ++L +SD L+ + ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+A +E+L H VVH DL N+L+ + + +SD GL + D ++
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM 908
I +M+PE G S D++SYGV+L E F+ L+ + S
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYS----NQ 233
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958
+V++ ++R DC V L L+C E P +R D +L+
Sbjct: 234 DVIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 27/230 (11%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
LG G+FG VYK + G A KV + + + E E+L H ++K+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDL---LERLNIMIGVALALEYLHHGHSTPVVH 806
+ +++E P G++ D L+L L I + LE L + HS ++H
Sbjct: 80 WDGKLWIMIEFCPGGAV------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 807 CDLKPSNILLDEDMVAHVSDFGLS----KLFDEGDDSVTQTMTIATIGYMAPEY-----G 857
DLK N+LL D ++DFG+S K D I T +MAPE
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS------FIGTPYWMAPEVVMCETM 187
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907
+ K D++S G+ L E + P ++ + LK + +S P L
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEPPTL 235
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 690 LLGRGSFGSVYKGTFS-DGTSF----AIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIK 743
+LG G+FG+VYKG + DG + AIKV +A + E V+ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+ C + + LV +LMP G L ++ + + + LN + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
+VH DL N+L+ ++DFGL++L D + I +MA E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 864 SKCDVYSYGVLLTETFT-RKKPTD 886
+ DV+SYGV + E T KP D
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 690 LLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVLRNV-RHR 739
+LG+GSFG V KGT +A+KV L+ D + D EC VL +H
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-H 798
L ++ S D V+E + G L + F + R + L L++LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHER 115
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPEYG 857
G +++ DLK N+LLD + ++DFG+ K EG VT + T Y+APE
Sbjct: 116 G----IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEIL 168
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
+ D ++ GVLL E + P +
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 56/171 (32%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
+G+GSFG V +DG +A+KV L+ +L+NV+H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
S D VL+ + G L L + F + R +A AL YLH S ++
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPE 855
+ DLKP NILLD ++DFGL K EG + S T + T Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G+G+ G+VY + G AIK NLQ +E V+R ++ N++ S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E + GSL +D ++ I L+ L HS V+H D+
Sbjct: 87 VGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDI 141
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
K NILL D ++DFG + S TM + T +MAPE T K D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 870 SYGVLLTETFTRKKP 884
S G++ E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGT--SFAIKVF-------NLQLDRAFRSFDSECEVL 733
+ FN LG GSFG V T+ + AIK F Q+D F SE ++L
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKIL 85
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
+ H + ++ S + + LVLE + G +L + F + + + L
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIF 144
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYM 852
EYL S +V+ DLKP N+LLD+D ++DFG +K+ D T+T T+ T Y+
Sbjct: 145 EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYI 195
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
APE D ++ G+ + E P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 30/217 (13%)
Query: 691 LGRGSFGSVY-------------KGTFSDGTSFAIKVFNLQLD---RAFRSFDSECEVLR 734
LG G FG V+ DG + V L+ D A F E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNI--------- 785
+++ N+I++ C ++D ++ E M NG L ++L NI
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 786 --MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843
+ +A ++YL S VH DL N L+ ++DFG+S+ GD Q
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ I +MA E G ++ DV+++GV L E FT
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS- 747
++GRG FG VY +D G +A+K LD+ R + E L + R ++ + S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKC----LDKK-RIKMKQGETLA-LNERIMLSLVSTG 54
Query: 748 ------CCNNDFR-----ALVLELMPNGSLEKWLYSDNYFLDLLERL---NIMIGVALAL 793
C + F + +L+LM G L L F + R I++G
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG----- 109
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
L H H+ VV+ DLKP+NILLDE +SD GL+ F + ++ T GYMA
Sbjct: 110 --LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 163
Query: 854 PEYGTEGIV-SSKCDVYSYGVLL 875
PE +G+ S D +S G +L
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQ------LDRAFRSFDSECEVLRNVRHRNLI 742
LG G+F S Y+ GT A+K + + E ++ + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
++ + C + L +E M GS+ L F + + +N + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ-- 123
Query: 803 PVVHCDLKPSNILLDED-MVAHVSDFGLS-KLFDEGDDS-VTQTMTIATIGYMAPE---- 855
++H D+K +N+L+D ++DFG + +L +G + Q + TI +MAPE
Sbjct: 124 -IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 856 --YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
YG CDV+S G ++ E T K P
Sbjct: 183 EQYG------RSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 687 ECNLLGRGSFGSVYKGTFSD-GTSFAIK------------VFNLQLDRAFRSFDSECEVL 733
+ +GRG+FG+V K GT A+K + LD RS S+C
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS--SDCP-- 63
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL---NIMIGVA 790
++K + + + +ELM + SL+K Y Y ++L+ + I+ +A
Sbjct: 64 ------YIVKFYGALFREGDCWICMELM-DISLDK-FYKYVY--EVLKSVIPEEILGKIA 113
Query: 791 L----ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMT 845
+ AL YL ++H D+KPSNILLD + + DFG+S +L DS+ +T
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV----DSIAKTRD 167
Query: 846 IATIGYMAPEYGTEGIVSS-------KCDVYSYGVLLTETFTRKKP 884
YMAPE I S + DV+S G+ L E T K P
Sbjct: 168 AGCRPYMAPER----IDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 34/89 (38%), Positives = 51/89 (57%)
Query: 103 ISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNI 162
+ LD G P+ I L LQ ++L NS G IP SL +++ LE D +N +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 163 PSRIGNLSSLVNVNLAYNNLQGEIPSEIG 191
P +G L+SL +NL N+L G +P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 58/288 (20%)
Query: 691 LGRGSFGSVYKG-------TFSDGTS-FAIKVF-NLQLDRAFRSFDSECEVLRNV-RHRN 740
LG G FG V + + D T A+K+ + D+ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYS------DNYF---------LDLLERLNI 785
+I + C +++E G+L ++L + D F L + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
VA +EYL S +H DL N+L+ ED V ++DFGL++ + D +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK------PTDDMFTGEMSLKKWV 899
+ +MAPE + + + + DV+S+G+L+ E FT P +++F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF---------- 246
Query: 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
LLR+ H +C + L +C P QR
Sbjct: 247 --------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQR 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 9/206 (4%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSF-AIKVFNLQ-LDRAFRSFDSECEVLRNVRHRNLI 742
F + +G+GSFG V+KG + AIK+ +L+ + E VL +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
K + S + +++E + GS L LD + I+ + L+YLH S
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
+H D+K +N+LL E ++DFG++ D + + + T +MAPE +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDM 888
SK D++S G+ E + P ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 55/164 (33%), Positives = 76/164 (46%), Gaps = 30/164 (18%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLD-------RAFRSFDSECEVL 733
F + LLG+G G V+ KGT G FA+KV + + R +E E+L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVL----TEQEIL 55
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWL--YSDNYFLDLLERLNIMIGVAL 791
+ H L +++S + LV++ P G L + L + + R V L
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLL 114
Query: 792 ALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKL 832
ALEYLH G +V+ DLKP NILL E H+ SDF LSK
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHES--GHIMLSDFDLSKQ 152
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 690 LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECE-VLRNV-----RHRNLI 742
+LG+GSFG V+ FAIK L+ D D EC V + V H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
++ + + V+E + G L + S + F DL + L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH---SK 115
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMAPEYGTEGI 861
+V+ DLK NILLD D ++DFG+ K GD +T T T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQK 172
Query: 862 VSSKCDVYSYGVLLTETFTRKKP 884
++ D +S+GVLL E + P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI---- 744
++GRG FG VY +D G +A+K + + + E L +L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 745 FSSCCNNDFRA-----LVLELMPNGSLEKWLYSDNYFLDLLERL---NIMIGVALALEYL 796
F C F +L+LM G L L F + R I++G L
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG-------L 110
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY 856
H H+ VV+ DLKP+NILLDE +SD GL+ F + ++ T GYMAPE
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 166
Query: 857 GTEGIV-SSKCDVYSYGVLLTETFTRKKP 884
+G S D +S G +L + P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 690 LLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN------VRHR 739
+LG+GSFG V KGT +AIKV L+ D + D +C + +H
Sbjct: 2 VLGKGSFGKVMLAELKGT---DEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHP 56
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-H 798
L + D V+E + G L + F + R V LAL +LH H
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRH 115
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPEYG 857
G V++ DLK NILLD + ++DFG+ K EG + VT T T Y+APE
Sbjct: 116 G----VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
E D ++ GVL+ E + P DD+F
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFD----SECEVLRNVRHRNLIKIF 745
+G+G+FG V+K A+K + ++ F E ++L+ ++H N++ +
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 746 SSCCN-----NDFRA---LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
C N ++ LV E + L L + N L E +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPE 855
++H D+K +NIL+ +D + ++DFGL++ F +S T + T+ Y PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 856 -------YGTEGIVSSKCDVYSYGVLLTETFTR 881
YG D++ G ++ E +TR
Sbjct: 194 LLLGERDYGP------PIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 40/235 (17%)
Query: 689 NLLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFD---SECEVLRNVRHRNL 741
LG GSFG V +KGT G +AIK + + E +L + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ + S + + +LE + G L L F + + + + LA EYLH S
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH---S 136
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMAPEYGTEG 860
+++ DLKP N+LLD V+DFG +K + +T T+ T Y+APE
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE----- 185
Query: 861 IVSSK-----CDVYSYGVLLTETFTRKKPTDD---------MFTGEMSLKKWVKE 901
++ SK D ++ GVLL E P D + G + W
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 690 LLGRGSFGSVY----KGTFSDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRHRNL 741
LLG+G+FG V K T G +A+K+ ++ D + +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFL 57
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ + +D V+E G L L + F + R + ALEYLH S
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---S 113
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPEYGTEG 860
VV+ D+K N++LD+D ++DFGL K EG D T T Y+APE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP 884
D + GV++ E + P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 8/195 (4%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G+G+ G+VY + G AI+ NLQ +E V+R ++ N++ S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E + GSL +D ++ I L+ L HS V+H D+
Sbjct: 88 VGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
K NILL D ++DFG + ++ + T +MAPE T K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 870 SYGVLLTETFTRKKP 884
S G++ E + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 691 LGRGSFGSVYK-GTFSDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRNLIKIFSSC 748
LG G+ GSV K GT A KV ++ + R E +++ R ++ + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
N + + +E M GSL++ +Y + + I + V L YL++ H ++H D
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRD 129
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
+KPSNIL++ + DFG+S E +S+ T + T YM+PE G + K DV
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTVKSDV 185
Query: 869 YSYGVLLTETFTRKKPTDD 887
+S G+ + E K P
Sbjct: 186 WSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 31/91 (34%), Positives = 48/91 (52%)
Query: 450 LNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDI 509
L L + IP+ L +L ++NLS NS+ G++P ++ ++ L LDLS N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 510 PITIGSLKDLVTLSLASNQFEGPIPQTFGSL 540
P ++G L L L+L N G +P G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 29/70 (41%), Positives = 46/70 (65%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+ ++++NLS +RG IPP LG+ + L LD+S N+F+ +P LGQL LR ++L+ N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 110 FSGSFPSWIG 119
SG P+ +G
Sbjct: 502 LSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSF-AIKVFNLQ-LDRAFRSFDSECEVLRNVRHRNLI 742
F + +G+GSFG VYKG + AIK+ +L+ + E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL-----ERLNIMIGVALALEYLH 797
+ + S +++E + GS LDLL E I + L+ L
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----------LDLLKPGPLEETYIATILREILKGLD 115
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG 857
+ HS +H D+K +N+LL E ++DFG++ D + + + T +MAPE
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ K D++S G+ E + P D+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 690 LLGRGSFGSVY----KGTFSDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRHRNL 741
LLG+G+FG V K T G +A+K+ ++ D + +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 57
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ S +D V+E G L L + F + R + AL+YLH +
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSEKN 116
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPEYGTEG 860
VV+ DLK N++LD+D ++DFGL K EG D T T Y+APE +
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP 884
D + GV++ E + P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 8/195 (4%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G+G+ G+V+ + G AIK NLQ +E V++ +++ N++ S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E + GSL +D ++ I L+ L H+ V+H D+
Sbjct: 87 VGDELFVVMEYLAGGSL-----TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDI 141
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
K N+LL D ++DFG + S TM + T +MAPE T K D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 870 SYGVLLTETFTRKKP 884
S G++ E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR-AFRSFDS----ECEVLRNVRH 738
F + +LG+G FG V + G +A K L+ R R +S E ++L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLH 797
R ++ + + D LVL LM G L+ +Y + + + LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPE 855
+V+ DLKP NILLD+ +SD GL+ EG QT+ + T+GYMAPE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGYMAPE 171
Query: 856 YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+ D ++ G LL E + P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 56/218 (25%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR---------AFRSFDSECEVLRNVRHR 739
L+G GS+G V K + G AIK F L+ A R E +L+ +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL----------NIMIGV 789
NL+ + LV E + D+ LD LE+ + +
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFV-----------DHTVLDDLEKYPNGLDESRVRKYLFQI 109
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
+E+ H S ++H D+KP NIL+ + V + DFG ++ + T +AT
Sbjct: 110 LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATR 164
Query: 850 GYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFT 880
Y APE YG D+++ G L+TE T
Sbjct: 165 WYRAPELLVGDTKYG------RAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 56/226 (24%)
Query: 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVF------NLQLDRAFRSFDSECEVLR 734
T+ + + +G G+FG V G + AIK + R +R E ++L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64
Query: 735 NVRHRNLI---KIFSSCCNNDFRALVLELM--------PNGSLEKWLYSDNYFLDLLERL 783
++RH N+I IF S + + V EL+ + LEK YFL
Sbjct: 65 HLRHENIISLSDIFISPLEDIY--FVTELLGTDLHRLLTSRPLEKQFI--QYFL-----Y 115
Query: 784 NIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843
I+ G L+Y+H S VVH DLKPSNIL++E+ + DFGL+++ D T
Sbjct: 116 QILRG----LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMT 163
Query: 844 MTIATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
++T Y APE Y E D++S G + E K
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-AIKVFNL---QLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G GSFG+VY T S A+K + Q + ++ E + L+ ++H N I+ +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-YK 87
Query: 747 SCCNNDFRA-LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
C + A LV+E GS L L +E I G L YLH S ++
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMI 143
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---GTEGIV 862
H D+K NILL E ++DFG + + V T +MAPE EG
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQY 197
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDM 888
K DV+S G+ E RK P +M
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 690 LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVL-RNVRHRNLIKI 744
++G+GSFG V DG +A+KV ++ + + +E VL +NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
S + VL+ + G L L + F + R +A AL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG-DDSVTQTMTIATIGYMAPEYGTEGIVS 863
V+ DLKP NILLD ++DFGL K EG S T T T Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 864 SKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893
+ D + G +L E P EM
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 57/212 (26%), Positives = 85/212 (40%), Gaps = 43/212 (20%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLD------RAFRSFDSECEVLRNVRHRNLI 742
++G G++G V K G AIK F D A R E +VLR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA-------LEY 795
+ + LV E Y + L+LLE + L+
Sbjct: 64 NLKEAFRRKGRLYLVFE-----------YVERTLLELLEASPGGLPPDAVRSYIWQLLQA 112
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
+ + HS ++H D+KP NIL+ E V + DFG ++ S T +AT Y APE
Sbjct: 113 IAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPE 171
Query: 856 -------YGTEGIVSSKCDVYSYGVLLTETFT 880
YG DV++ G ++ E
Sbjct: 172 LLVGDTNYGKP------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 32/79 (40%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 336 LRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGR 395
LRG +P I LQ+ + GNIP +G++ SL VL L N+ NG+IP ++G+
Sbjct: 430 LRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 396 LEQLQGLSLYGNNLEGSIP 414
L L+ L+L GN+L G +P
Sbjct: 489 LTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 678 IQRATDGFNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNL-----QLDRAFRSFDS 728
+Q + ++ ++GRG+FG V +K S +A+K+ + + D AF F
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAF--FWE 92
Query: 729 ECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN--IM 786
E +++ ++++F + ++ + +V+E MP G L + NY D+ E+
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYT 148
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
V LAL+ +H S ++H D+KP N+LLD+ ++DFG DE V +
Sbjct: 149 AEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVRCDTAV 204
Query: 847 ATIGYMAPEY----GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
T Y++PE G +G +CD +S GV L E P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 691 LGRGSFGSVYKG-TFSDGTSF-AIKVFNLQLDRAFRSFDS--ECEVLRNVR---HRNLIK 743
+G G++G V+K +G F A+K +Q + E VLR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 744 IFSSC-CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL-----------NIMIGVAL 791
+F C + R L L+ + + D L+++ ++M +
Sbjct: 69 LFDVCTVSRTDRETKLTLV-------FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
L++LH S VVH DLKP NIL+ ++DFGL++++ + T + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 175
Query: 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFTRK 882
APE + ++ D++S G + E F RK
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV---- 736
TD + +G+G++G VYK T DG+ A+K+ + D E E N+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75
Query: 737 -RHRNLIKIF-----SSCCNNDFRALVLELMPNGS---LEKWLYSDNYFLDLLERLNIMI 787
H N++K + + LVLEL GS L K L LD I+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847
G L L++LH+ ++H D+K +NILL + + DFG+S + + ++
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVG 190
Query: 848 TIGYMAPEY-----GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
T +MAPE + ++CDV+S G+ E P DM
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRN 735
F+ +L+GRG FG V K T G +A+KV L F+ E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
+ ++ + + D LV+E P G L L N + D + +A +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
+H H VH D+KP N+L+D ++DFG + + V + + T Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAPE 173
Query: 856 Y------GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+G +CD +S GV+ E + P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G G++G VYK G A+K+ L+ F E +++ +H N++ F S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLD-LLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+ + + +E GSL+ D Y + L L I L+ L + HS +H D
Sbjct: 77 SREKLWICMEYCGGGSLQ-----DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IATIGYMAPEYGT---EG 860
+K +NILL ++ ++DFG++ +T T+ I T +MAPE G
Sbjct: 132 IKGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ CD+++ G+ E + P D+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 15/181 (8%)
Query: 720 DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLY-------S 772
D A F E ++L + N+ ++ C + +++E M NG L ++L
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 773 DNYFLDLLER---LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGL 829
L L + +A + YL S VH DL N L+ ++ ++DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT--RKKPTDD 887
S+ D Q I +MA E G ++K DV+++GV L E T R++P +
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 888 M 888
+
Sbjct: 237 L 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 711 AIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKW 769
A+K+ ++ R+ F E +++ ++ N+I++ + C +D ++ E M NG L ++
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 770 L----------YSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED 819
L +D + + + +A ++YL S VH DL N L+ ++
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKN 166
Query: 820 MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879
++DFG+S+ GD Q + I +M+ E G ++ DV+++GV L E
Sbjct: 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
Query: 880 T 880
T
Sbjct: 227 T 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 36/202 (17%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G GS G V T S G A+K +L+ + +E ++R+ +H N+++++SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLE--RLN------IMIGVALALEYLHHGHS 801
D +V+E + G+L D++ R+N + + V AL +LH +
Sbjct: 87 VGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLH---A 133
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE------ 855
V+H D+K +ILL D +SDFG + + + + T +MAPE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLP 191
Query: 856 YGTEGIVSSKCDVYSYGVLLTE 877
YGTE D++S G+++ E
Sbjct: 192 YGTE------VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 677 DIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL----------DRAFRSF 726
D++ + + ++GRG+FG V KV+ ++L D AF F
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK----STRKVYAMKLLSKFEMIKRSDSAF--F 90
Query: 727 DSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN-- 784
E +++ ++++F + ++ + +V+E MP G L + NY D+ E+
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARF 146
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
V LAL+ +H S +H D+KP N+LLD+ ++DFG ++ + V
Sbjct: 147 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDT 202
Query: 845 TIATIGYMAPEY----GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+ T Y++PE G +G +CD +S GV L E P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 61/210 (29%), Positives = 88/210 (41%), Gaps = 19/210 (9%)
Query: 690 LLGRGSFGSVYKGTFSDGTSF-AIKVFNLQLDRAFRSFDSECE-VLRNV-----RHRNLI 742
+LG+GSFG V F AIK L+ D D EC V R V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+F + + V+E + G L + S F D + L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF-DEARARFYAAEIICGLQFLH---KK 115
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
+++ DLK N+LLD+D ++DFG+ K G+ + T Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQKY 173
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
+ D +S+GVLL E + P F GE
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 28/75 (37%), Positives = 50/75 (66%)
Query: 160 GNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNIST 219
G IP+ I L L ++NL+ N+++G IP +G++ +LE+L L N+ +G I S+ +++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 220 ITLINLFGNQLSGHL 234
+ ++NL GN LSG +
Sbjct: 492 LRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
L +L+ +L N + G IP S+ + + L LDLS+NSF+G IP + G L L +LNL N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 304 YLTTDSPTA 312
L+ P A
Sbjct: 501 SLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRS------FDSECEVLRNVRHRNLIKI 744
+G G FG V G G S A +V +L RA + F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA-RVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFL------DLLERLNIMIGVALALEYLHH 798
C + LVLE P G L+ +L S+ + D+L+R+ VA L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQ 118
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
+H DL N L D+ + D+GL+ D +T+ + ++APE
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 859 E-------GIVSSKCDVYSYGVLLTETFT 880
+ K +++S GV + E FT
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 690 LLGRGSFGSVY----KGTFSDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNVRHRNL 741
LLG+G+FG V K T G +A+K+ + D + +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ S +D V+E G L L + F + R + AL YLH S
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---S 113
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
VV+ DLK N++LD+D ++DFGL K + D T T Y+APE +
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 862 VSSKCDVYSYGVLLTETFTRKKP 884
D + GV++ E + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-10
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 418 CHLER------LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471
C + ++G+ L+ L G IP ++ L L+ +NL N +IP S S+ L
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 472 LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSL 516
++LS NS +GS+P ++ L L L+L+ N LSG +P +G
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSEC-----EVLRNVR-HRNLI 742
+LG+GSFG V G +A+KV L+ D + D EC +L R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 743 KIFSSCC--NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
+++ CC D V+E + G L + F + R + AL +LH
Sbjct: 60 QLY--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH--- 113
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
+++ DLK N+LLD + ++DFG+ K + + T + T Y+APE E
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
+ D ++ GVLL E P DD+F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 23/236 (9%)
Query: 688 CNLLGRGSFG----SVYKGTFSDGTSFAIKVFNL--QLDRAFRSFDSECEVLRNVRHRNL 741
L+G+ + K T A+K NL + E R ++H N+
Sbjct: 3 LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL---NIMIGVALALEYLHH 798
+ +S + +V LM GS E L +F + L L I+ V AL+Y+H
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ-----TMTIATIGYMA 853
+H +K S+ILL D +S S + ++ + +++
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 854 PEYGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907
PE + + + K D+YS G+ E P DM +M L+K V+ ++P L
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLL 231
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI----- 744
+G+G+FG VY+ D +A+KV + + A + EV + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 745 --------FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
FS ++D LV + M G L L + F + + I + LALE+L
Sbjct: 55 SPFIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY 856
H +V+ DLKP NILLD + DFGLSK + D+ T T T Y+APE
Sbjct: 113 HKYD---IVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFC-GTTEYLAPEV 167
Query: 857 GTEGIVSSK-CDVYSYGVLLTE 877
+ +K D +S GVL+ E
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFD-----SECEVLRNVRH 738
F +LG+G FG V + G +A K L+ R + +E ++L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLH 797
R ++ + + D LVL LM G L+ +Y+ N D + + LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG 857
+V+ DLKP NILLD+ +SD GL+ EG+ T + T+GYMAPE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVV 173
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKP 884
+ D + G L+ E K P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G GS G V T S G A+K +L+ + +E ++R+ +H N++++++S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E + G+L + ++ + + + V AL LH + V+H D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
K +ILL D +SDFG + + + + T +MAPE + + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 870 SYGVLLTETFTRKKPTDDMFTGEMSLK--KWVKESLP 904
S G+++ E + P + E LK K ++++LP
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 14/202 (6%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
LG+G FG V + G +A K N L+ + + E +L V R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+ LV+ +M G L +Y+ +N + LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPEYGTEGIV 862
+++ DLKP N+LLD D +SD GL+ +G ++T A T G+MAPE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQGEEY 174
Query: 863 SSKCDVYSYGVLLTETFTRKKP 884
D ++ GV L E + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 55/198 (27%)
Query: 692 GRGSFGSVYKG---TFSDGTSFAIKVFNLQLDR-------AFRSFDSECEVLRNVRHRNL 741
GRG++G VYK DG +AIK F ++ A R E +LR ++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNI------------MIGV 789
+ + + +++ +L D DL + + M+
Sbjct: 65 VSLVEVFLEHADKSV------------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 790 AL--ALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDE------GD 837
L L +H+ HS V+H DLKP+NIL+ E V + D GL++LF+
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 838 DSVTQTMTIATIGYMAPE 855
D V + TI Y APE
Sbjct: 173 DPV-----VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 34/84 (40%), Positives = 47/84 (55%)
Query: 361 LTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHL 420
L G IP++I LR L ++L N++ G IP ++G + L+ L L N+ GSIP L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 421 ERLNGIRLNGNKLSGPIPQCLASL 444
L + LNGN LSG +P L
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 74/256 (28%), Positives = 118/256 (46%), Gaps = 11/256 (4%)
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNL-SSLVNVNLAY 179
L L L L N I + L L+ L D N I +IP IG L S+L ++L+
Sbjct: 92 LLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSD 149
Query: 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK 239
N ++ +PS + NL NL+ L L N+LS + + N+S + ++L GN++S DLPP
Sbjct: 150 NKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS---DLPP- 203
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
L L L N + + +S++N L+GL+LS N +P + GNL L L+
Sbjct: 204 EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359
L+NN +++ S + L L N + A+ L +L ++ N +L+
Sbjct: 262 LSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLN 321
Query: 360 KLTGNIPHEIGNLRSL 375
+ N S
Sbjct: 322 SILLNNNILSNGETSS 337
|
Length = 394 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G GS G V T G A+K +L+ + +E ++R+ H N++ +++S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
D +V+E + G+L + ++ + + + V AL YLH + V+H D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE------YGTEGIVS 863
K +ILL D +SDFG + + + + T +MAPE YGTE
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTE---- 198
Query: 864 SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK--KWVKESLPHGLME 909
D++S G+++ E + P + E L+ + ++++LP + +
Sbjct: 199 --VDIWSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 11/209 (5%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVL-RNVRHRNLIKI 744
++G+GSFG V ++ +A+KV + + + SE VL +NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
S D VL+ + G L L + FL+ R +A AL YLH S +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
V+ DLKP NILLD ++DFGL K + + + T + T Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEM 893
D + G +L E P T EM
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
VA +E+L S +H DL NILL E+ V + DFGL++ + D V +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + +++ DV+S+GVLL E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 768 KWLYSDNYF--LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVS 825
K L SD+ L L+ L+ VA +E+L S VH DL N+LL + + +
Sbjct: 223 KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 826 DFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
DFGL++ + V++ T + +MAPE + + ++ DV+SYG+LL E F+
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 17/211 (8%)
Query: 685 FNECNLLGRGSFGSVYKG-TFSDGTSFAIKVFNL---QLDRAFRSFDSECEVLRNVRHRN 740
F++ +G GSFG+VY + AIK + Q + ++ E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
I+ + C + A ++ GS L L +E + G L YLH
Sbjct: 77 TIQ-YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---G 857
S ++H D+K NILL E + + DFG + + + V T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAM 186
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
EG K DV+S G+ E RK P +M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNVRHRNLIKI 744
++G+GSFG V SDG+ +A+KV L+ +L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
S + VL+ + G L L + FL+ R VA A+ YLH S +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMAPEYGTEGIVS 863
++ DLKP NILLD ++DFGL K EG + T T T Y+APE +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 864 SKCDVYSYGVLLTE 877
D + G +L E
Sbjct: 175 RTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 67/241 (27%), Positives = 101/241 (41%), Gaps = 51/241 (21%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSE--CEVLRNVR-----HR-- 739
+G G+ G VYK F G A+K + R+ + E +L ++ H
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-------QMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 740 NLIKIFSSCCNNDFRALV-LELMPNGSLEKWLYSDNYFLDLLERLN----------IMIG 788
++K + D + +ELM L+K LL+R+ + +
Sbjct: 75 YIVKCYG-YFITDSDVFICMELMST-CLDK----------LLKRIQGPIPEDILGKMTVA 122
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIA 847
+ AL YL H V+H D+KPSNILLD + DFG+S +L DS +T +
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV----DSKAKTRSAG 176
Query: 848 TIGYMAPEYGTEGIVSSK----CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903
YMAPE + K DV+S G+ L E T + P + T L K ++E
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236
Query: 904 P 904
P
Sbjct: 237 P 237
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 683 DGFNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNL--QLDRAFRS-FDSECEVLRN 735
D F ++GRG+FG V K T G +A+K+ N L RA + F E +VL N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNT---GQVYAMKILNKWEMLKRAETACFREERDVLVN 57
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
R + + + + + LV++ G L L LL + + +A Y
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDL----------LTLLSKFEDRLPEDMARFY 107
Query: 796 L-------HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
L H VH D+KP N+LLD++ ++DFG S L D +V + + T
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGT 166
Query: 849 IGYMAPE-----------YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
Y++PE YG E CD +S GV + E + P
Sbjct: 167 PDYISPEILQAMEDGKGRYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 63/272 (23%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIF---- 745
LG GS G V+ SD A+K L ++ + E +++R + H N++K++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 746 --SSCCNNDFRAL--------VLELMPNG---SLEKWLYSDNYFLDLLERLNIMIGVALA 792
S D +L V E M LE+ S+ + RL M +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFD-EGDDSVTQTMTIATIG 850
L+Y+H S V+H DLKP+N+ ++ ED+V + DFGL+++ D + + T
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 851 YMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG--EMSLKKWVKE 901
Y +P Y T+ I D+++ G + E T K +F G E+ + + E
Sbjct: 184 YRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILE 233
Query: 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVL 933
S+P ++R+E + + LL+V+
Sbjct: 234 SVP----------VVREE-----DRNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
LG G+FG VYK + G A KV + + + + E ++L + H N++K+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDL---LERLNIMIGVALALEYLHHGHSTPVVH 806
+ +++E G++ D L+L L I + LE L++ H ++H
Sbjct: 73 YENNLWILIEFCAGGAV------DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IATIGYMAPEY----- 856
DLK NIL D ++DFG+S T+T+ I T +MAPE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-------KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 857 GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ K DV+S G+ L E + P ++
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-AIKVFNLQLDRAFRSFDSECEV-----LRNVRHRNLIKI 744
+G G++G+VYK F A+K +Q + + EV L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 745 FSSCC-----------------NNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIM 786
C + D R + ++ P G E DL+ +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-------IKDLMRQF--- 117
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
L++LH + +VH DLKP NIL+ ++DFGL++++ + T +
Sbjct: 118 ---LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVV 168
Query: 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK 882
T+ Y APE + ++ D++S G + E F RK
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 685 FNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDS--ECEVLRNVRHRNL 741
F + N +G G++G VY+ + G A+K + +R S E +L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 742 IK------------IFSSC--CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMI 787
++ IF C D +L L+ MP E + +M+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASL-LDNMPTPFSESQVKC------------LML 115
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847
+ L+YLH ++H DLK SN+LL + ++DFGL++ + G + T +
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVV 170
Query: 848 TIGYMAPE--YGTEGIVSSKCDVYSYGVLLTETFTRK 882
T+ Y APE G ++ D+++ G +L E K
Sbjct: 171 TLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 36/207 (17%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFD-----SECEVLRNVR-HRNLIK 743
+G G+F V K + G +AIK + + F+S + E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 744 ----IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-H 798
+F ALV ELM + +L + + L + M + +L+++H +
Sbjct: 63 LIEVLFDRKTGR--LALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ----TMTIATIGYMAP 854
G + H D+KP NIL+ +D++ ++DFG + + T I+T Y AP
Sbjct: 120 G----IFHRDIKPENILIKDDIL-KLADFGSCR-------GIYSKPPYTEYISTRWYRAP 167
Query: 855 E-YGTEGIVSSKCDVYSYGVLLTETFT 880
E T+G K D+++ G + E +
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 685 FNECNLLGRGSFGSVY-KGTFSDGTSFAIKVFNL---QLDRAFRSFDSECEVLRNVRHRN 740
F + +G GSFG+VY AIK + Q + ++ E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
I+ + C + A ++ GS L L +E I G L YLH
Sbjct: 87 SIE-YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--- 142
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---G 857
S ++H D+K NILL E ++DFG + + + V T +MAPE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAM 196
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
EG K DV+S G+ E RK P +M
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR-AFRSFDS----ECEVLRNVRH 738
F +LG+G FG V + G +A K L+ R R ++ E +L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLH 797
R ++ + + D LVL +M G L+ +Y+ N D + + LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG 857
+V+ DLKP NILLD+ +SD GL+ EG+ T + T+GYMAPE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVI 173
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKP 884
+ D + G L+ E + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 677 DIQRATDGFNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNL-----QLDRAFRSFD 727
++ + F+ ++GRG+FG V +K + +A+K+ + + D AF F
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAF--FW 91
Query: 728 SECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIM- 786
E +++ + ++++ + ++ + +V+E MP G L + NY D+ E+
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFY 147
Query: 787 -IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
V LAL+ +H S +H D+KP N+LLD+ ++DFG D + V
Sbjct: 148 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTA 203
Query: 846 IATIGYMAPEY----GTEGIVSSKCDVYSYGVLLTE 877
+ T Y++PE G +G +CD +S GV L E
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 70/256 (27%), Positives = 108/256 (42%), Gaps = 59/256 (23%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIK 743
+G G++G VYKG G A+K L+ + A R E +L+ ++H N++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH----- 798
+ L+ E + + L+K +LD L + L YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKK-------YLDSL-PKGQYMDAELVKSYLYQILQGI 114
Query: 799 --GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE- 855
HS V+H DLKP N+L+D V ++DFGL++ F G T + T+ Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEV 172
Query: 856 -YGTEGIVSSKCDVYSYGVLLTETFTRK--------------------KPTDDMFTGEMS 894
G+ S+ D++S G + E T+K PT+D++ G S
Sbjct: 173 LLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 895 LK-------KWVKESL 903
L KW K SL
Sbjct: 232 LPDYKNTFPKWKKGSL 247
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
VA +E+L S +H DL NILL E+ V + DFGL++ + D V +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + +++ DV+S+GVLL E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 691 LGRGSFGSVYK-GTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-----RHRNLIKI 744
+G+G++G V+K +G+ A+K+ + D E E N+ H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 745 F-----SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN-IMIGVAL--ALEYL 796
+ N D LVLEL GS+ + FL ER+ +I L AL L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGL 137
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY 856
H H +H D+K +NILL + + DFG+S + + ++ T +MAPE
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEV 195
Query: 857 -----GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ ++CDV+S G+ E P D+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 22/286 (7%)
Query: 216 NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLD 275
++S + ++L LD + +L L L N+L I + + + LT LD
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLL-NLLPLPSLDLNLNRLRSNI-SELLELTNLTSLD 122
Query: 276 LSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNP 335
L N+ + + P L L+L++N + + S L N NL L ++ N
Sbjct: 123 LDNNNITDIPPLIGLLKSNLKELDLSDNKIES--------LPSPLRNLPNLKNLDLSFND 174
Query: 336 LRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGR 395
L LP ++ N ++L N K++ ++P EI L +L L L N++ + S++
Sbjct: 175 LS-DLPKLLSN-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230
Query: 396 LEQLQGLSLYGNNLEGSI--PYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLG 453
L+ L GL L N LE +L +LE L+ L+ N++S L SL +LREL+L
Sbjct: 231 LKNLSGLELSNNKLEDLPESIGNLSNLETLD---LSNNQIS--SISSLGSLTNLRELDLS 285
Query: 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLD 499
N S+++P L LL + L+ +L + ++ + N+
Sbjct: 286 GNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLNNNIL 330
|
Length = 394 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 57/219 (26%), Positives = 85/219 (38%), Gaps = 60/219 (27%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIK 743
+G GS+G V+K + G AIK F D A R E +L+ ++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 744 IFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDNYFLDLLER----------LNIMIG 788
+ FR LV E Y D+ L+ LE+ I+
Sbjct: 65 LIEV-----FRRKRKLHLVFE-----------YCDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
A+ + H +H D+KP NIL+ + + DFG +++ D T +AT
Sbjct: 109 TLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVAT 163
Query: 849 IGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFT 880
Y APE YG DV++ G + E T
Sbjct: 164 RWYRAPELLVGDTQYGP------PVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 691 LGRGSFG-SVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSS 747
+G GSFG ++ + DG + IK N+ + E VL N++H N+++ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 748 CCNNDFRALVLELMPNGSLEKW-------LYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
N +V++ G L K L+ ++ LD + + LAL+ H H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALK---HVH 118
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPEYGTE 859
++H D+K NI L +D + DFG++++ + +V T I T Y++PE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICEN 175
Query: 860 GIVSSKCDVYSYGVLLTETFTRK 882
++K D+++ G +L E T K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAF-RSFDSECEVLRNVRHRNLIKIFSSC 748
LG G+ G+VYK A+KV L + + SE E+L +I + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+ ++ E M GSL+ + + L I + V L YL S ++H D
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW---SLKILHRD 120
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTE-GIVSSK 865
+KPSN+L++ + DFG+S +S+ +T + T YMAPE G + GI S
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY-VGTNAYMAPERISGEQYGIHS-- 174
Query: 866 CDVYSYGVLLTETFTRKKPTDDMFTGEMSL 895
DV+S G+ E + P + + SL
Sbjct: 175 -DVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 691 LGRGSFGSV-YKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+G GS G V G A+K+ +L+ + +E ++R+ +H+N+++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
+ +++E + G+L + L+ + + V AL YLH S V+H D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
K +ILL D +SDFG + D + + T +MAPE + ++ D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 870 SYGVLLTETFTRKKP 884
S G+++ E + P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRN 740
D F + + LG G+ G V+K + G A K+ +L++ A R+ E +VL
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLHH 798
++ + + ++ ++ +E M GSL++ L + E++ + I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 121
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPEYG 857
H ++H D+KPSNIL++ + DFG+S +L D +S + T YM+PE
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERL 174
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKP 884
S + D++S G+ L E + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 62/218 (28%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLI 742
F L+G G++G VYKG G AIKV ++ D E +L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 743 KIFSSCCN------NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
+ + +D LV+E GS+ + N + L+ I L L
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPE 855
H H V+H D+K N+LL E+ + DFG+S D +V + T I T +MAPE
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR---TVGRRNTFIGTPYWMAPE 181
Query: 856 Y-----GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ K D++S G+ E P DM
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 55/219 (25%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIK 743
+G G++G VYK G A+K L+ + A R E +L+ + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDL-LERL-----NIMIGVALALEYLH 797
+ +V E LY FLDL L++ + L YL+
Sbjct: 63 LLD---------VVHS-------ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 798 ---HG----HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
G HS V+H DLKP N+L+D + ++DFGL++ F G T T + T+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLW 164
Query: 851 YMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y S+ D++S G + E R+
Sbjct: 165 YRAPEILLGSRQY------STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 32/231 (13%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFN----LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
+G+G +G V+ D G A+K +L+ R +E ++L + L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV-RHVLTERDILTTTKSEWLVKLL 67
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH-GHSTPV 804
+ ++++ L +E +P G L ++ L M + A++ LH G+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGY---- 122
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTEGIV 862
+H DLKP N L+D ++DFGLSK +SV + + YMAPE G
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKG--Y 175
Query: 863 SSKCDVYSYGVLLTETFTRKKP-----TDDMFTGEMSLKKWVKESL--PHG 906
D +S G +L E P ++ + +LK W KE+L P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVY 222
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGTS-FAIKVFNL--QLDRAFRS-FDSECEVLRNVRH 738
+ F ++GRG+FG V + FA+K+ N L RA + F E +VL N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWL--YSDNYFLDLLERLNIMIGVALALEYL 796
+ + + + + + LV++ G L L + D D+ + + +A++ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVIAIDSV 118
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPE 855
H H VH D+KP NIL+D + ++DFG KL ++G +V ++ + T Y++PE
Sbjct: 119 HQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173
Query: 856 Y-----GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+G +CD +S GV + E + P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRA-FRSFDSECEVLRNVRHRNLIKIFSSC 748
LG+G++GSVYK G + A+K L+LD + F E ++L ++ + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFL-----DLLERLNIMIGVALALEYLHHGHSTP 803
+ +E M GSL+K LY+ D+L R I V L++L H+
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEHN-- 123
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY------G 857
++H D+KP+N+L++ + + DFG+S S+ +T I YMAPE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKT-NIGCQSYMAPERIKSGGPN 179
Query: 858 TEGIVSSKCDVYSYGVLLTE 877
+ + DV+S G+ + E
Sbjct: 180 QNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRA--FRSFDSECEVLRNVRHR 739
D + + LG GS+ +VYKG +G A+KV LQ + F + E +L+ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHA 63
Query: 740 NLIKIFSSCCNNDFRALVLELM-----------PNGSLEKWLYSDNYFLDLLERLNIMIG 788
N++ + + LV E + P G L+ +N L L + L
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLR---- 114
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
L Y+H + ++H DLKP N+L+ + ++DFGL++ + S T + + T
Sbjct: 115 ---GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVT 166
Query: 849 IGYMAPEYGTEGIVSSKC-DVYSYGVLLTE 877
+ Y P+ S C D++ G + E
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDR-----AFRSFDSECEVLRNVRHRNLIKI 744
LG G++ +VYKG + G A+K +L + A R E +++ ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVRL 63
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWL--YSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ LV E M + L+K++ + LD + + + + H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTEG 860
V+H DLKP N+L+++ ++DFGL++ F G T + + T+ Y AP+ G+
Sbjct: 121 -VLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSR- 176
Query: 861 IVSSKCDVYSYGVLLTETFT 880
S+ D++S G ++ E T
Sbjct: 177 TYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 690 LLGRGSFGSVYKG---------------TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLR 734
+LG G FG + +G T G S D+ R F +E L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS----------DKQRRGFLAEALTLG 61
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALE 794
H N++++ + +V E M NG+L+ +L L + + ++ G+A ++
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG-YMA 853
YL VH L +L++ D+V +S F +L ++ +++ TM+ + + A
Sbjct: 122 YLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDM 888
PE SS DV+S+G+++ E + ++P DM
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSF------DSECEVLRNVRHRN---L 741
+G G++GSV F T + V +L R F+S E +L++++H N L
Sbjct: 25 VGSGAYGSVC-AAFDTKTGLRVAV--KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 742 IKIFSSCCN----NDFRALVLELMP---NGSLEKWLYSDNYFLDLLERLNIMIGVALALE 794
+ +F+ + ND LV LM N ++ +D++ L+ ++ L
Sbjct: 82 LDVFTPARSLEEFNDVY-LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI---------LR 131
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
L + HS ++H DLKPSN+ ++ED + DFGL++ D+ T +AT Y AP
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAP 186
Query: 855 EYGTEGI-VSSKCDVYSYGVLLTETFT 880
E + + D++S G ++ E T
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 711 AIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKW 769
A+K+ ++ R+ F E ++L ++ N+I++ C + D ++ E M NG L ++
Sbjct: 50 AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109
Query: 770 LYSDNYFLDLLER-------------------LNIMIGVALALEYLHHGHSTPVVHCDLK 810
L S ++ D E L++ + +A ++YL S VH DL
Sbjct: 110 L-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYS 870
N L+ E++ ++DFG+S+ GD Q + I +MA E G ++ DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 871 YGVLLTE 877
+GV L E
Sbjct: 226 FGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIK----VF-NL-QLDRAFRSFDSECEVLRNVRHRN--- 740
+G G+FG V+ T DG A+K VF NL R FR E ++L +H N
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63
Query: 741 LIKIFSSCCNNDFRAL--VLELMPNGSLEKWLYSDNYFLDLLERL---NIMIGVALALEY 795
+ I + F + V ELM L K + S ++ I+ G L+Y
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKY 118
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
LH ++H D+KP N+L++ + V + DFGL+++ +E D+S T + T Y APE
Sbjct: 119 LHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPE 174
Query: 856 YGTEGI-VSSKCDVYSYGVLLTETFTRK 882
+S D++S G + E R+
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 690 LLGRGSFGSV--YKGTFSDGTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNL 741
++G+GS+G V T + G AIK VF D R R E ++LR +RH ++
Sbjct: 7 VIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDI 61
Query: 742 IKIFS---SCCNNDFRAL--VLELM---------PNGSLEKWLYSDNYFLDLLERLNIMI 787
++I +F+ + V ELM N L + +FL L R
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH--QFFLYQLLR----- 114
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL-FDEGDDSVTQTMTI 846
AL+Y+H + V H DLKP NIL + D + DFGL+++ F++ ++ T +
Sbjct: 115 ----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 847 ATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRK 882
AT Y APE + D++S G + E T K
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 691 LGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFDS-------ECEVLRNVRHR 739
LG+G FG V K T G +A K +LD+ S E E+L V
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACK----KLDKKRLKKKSGEKMALLEKEILEKVNSP 53
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
++ + + + LV+ LM G L+ +Y+ +ER+ I + LH
Sbjct: 54 FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV-IHYSAQITCGILHL- 111
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE 859
HS +V+ D+KP N+LLD+ +SD GL+ +G ++TQ T GYMAPE E
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA--GTNGYMAPEILKE 168
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDD 887
S D ++ G + E + P D
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
VA +E+L S +H DL NILL E+ V + DFGL++ + D V +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 46/114 (40%), Positives = 57/114 (50%), Gaps = 8/114 (7%)
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
ALE LH V++ DLKP NILLD + DFGL KL + DD T T T
Sbjct: 104 CALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFC-GTPE 158
Query: 851 YMAPEYGTEGIVSSKC-DVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903
Y+APE G +K D ++ GVLL E T P D EM +K ++E L
Sbjct: 159 YLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPL 210
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRN 740
D F + LG G+ G V K G A K+ +L++ A R+ E +VL
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL-NIMIGVALALEYLHHG 799
++ + + ++ ++ +E M GSL++ L + E L + I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE--EILGKVSIAVLRGLAYLREK 122
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPEYGT 858
H ++H D+KPSNIL++ + DFG+S +L D +S + T YM+PE
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQ 175
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP 884
S + D++S G+ L E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 47/241 (19%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSF------DSECEVLRNVRHRNLIKI 744
+G G++GSV T KV +L R F+S E +L++++H N+I +
Sbjct: 23 VGSGAYGSVCSAY---DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 745 FS----SCCNNDFRA--LVLELMP---NGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
+ +F LV LM N ++ SD + L+ +L L
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL---------LRG 130
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
L + HS ++H DLKPSN+ ++ED + DFGL++ + DD +T +AT Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTG--YVATRWYRAPE 185
Query: 856 YGTEGI-VSSKCDVYSYGVLLTETFTRKK--PTDDMFTGEMSLKKWVKESLPHGLMEVVD 912
+ + D++S G ++ E K P +D LK+ +MEVV
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKR---------IMEVVG 233
Query: 913 T 913
T
Sbjct: 234 T 234
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-08
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 22/168 (13%)
Query: 728 SECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN--- 784
SE L H ++K F ++D L++E G L K + L E L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR-----LKEHLPFQE 168
Query: 785 -----IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839
+ + LAL+ +H S ++H DLK +NI L + + DFG SK + DS
Sbjct: 169 YEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY---SDS 222
Query: 840 VTQTMTIATIG---YMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
V+ + + G Y+APE S K D++S GV+L E T +P
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 690 LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRN------VRHRNLI 742
+LG+GSFG V G FA+K L+ D D EC ++ + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
++ + + V+E + G L + F DL + L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH---SK 115
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
+++ DLK N++LD D ++DFG+ K GD+ + T Y+APE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKY 173
Query: 863 SSKCDVYSYGVLLTETFTRKKP--TDDMFTGEMSLKKWVKESLPH 905
+ D +S+GVLL E + P DD E L + ++ PH
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESIRVDTPH 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 20/218 (9%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLI 742
F ++G G++G VYKG G AIKV ++ D E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 743 KIF------SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
+ S ++D LV+E GS+ + N + L+ I L L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGL 134
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPE 855
H H+ V+H D+K N+LL E+ + DFG+S D +V + T I T +MAPE
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR---TVGRRNTFIGTPYWMAPE 191
Query: 856 Y-----GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ + D++S G+ E P DM
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 673 TSYLDIQRATDGFNECNLLGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDRA--FRSFDSE 729
TSYL++++ LG GS+ +VYKG + +G A+KV +++ + F + E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-RE 53
Query: 730 CEVLRNVRHRNLIKIFSSCCNNDFRALVLELM-----------PNGSLEKWLYSDNYFLD 778
+L+ ++H N++ + + V E M P G L+ N L
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLF 108
Query: 779 LLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838
+ + L L Y+H H ++H DLKP N+L+ ++DFGL++ +
Sbjct: 109 MFQLLR-------GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIP 156
Query: 839 SVTQTMTIATIGYMAPEY---GTEGIVSSKCDVYSYGVLLTETF 879
S T + + T+ Y P+ T+ SS D++ G + E
Sbjct: 157 SQTYSSEVVTLWYRPPDVLLGATD--YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 716 NLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-DFRALVLELMPNGSLEKWLYSDN 774
N+ + + R F ++ R R L+K C N+ + +L+ P SLE+ + D
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMK----CVNHKNIISLLNVFTPQKSLEE--FQDV 97
Query: 775 YFLDLLERLNIMIGVALALEY-------------LHHGHSTPVVHCDLKPSNILLDEDMV 821
Y + L N+ + + L++ + H HS ++H DLKPSNI++ D
Sbjct: 98 YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157
Query: 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR 881
+ DFGL++ S T + T Y APE D++S G ++ E
Sbjct: 158 LKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 882 KKPTDDMFTGEMSLKKWVK 900
K +F G + +W K
Sbjct: 215 KI----LFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 683 DGFNECNLLGRGSFGSV-YKGTFSDGTSFAIKVF------NLQLDRAFRSFDSECEVLRN 735
D + + +G G++G+V G AIK L RA+R E +L++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 736 VRHRN---LIKIFSSCCN----NDFRALVLELMPN--GSLEKWLYSDNYFLDLLERLN-- 784
++H N L+ +F+ + +DF LV+ M G L K E+L+
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFY-LVMPFMGTDLGKLMK-----------HEKLSED 118
Query: 785 -IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843
I V L+ L + H+ ++H DLKP N+ ++ED + DFGL++ D T
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMT 173
Query: 844 MTIATIGYMAPEYGTEGI-VSSKCDVYSYGVLLTETFTRK 882
+ T Y APE + + D++S G ++ E T K
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 63/232 (27%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIK 743
LG G+FG VYK G A+K + ++ A R E ++L+ ++H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 744 IFS-----SCCNNDFRALVLELMP------NGSLE----KWLYSD--NYFLDLLERLNIM 786
+ + R V + P +G LE K S Y L LLE +N
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN-- 129
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE---------GD 837
YLH H ++H D+K +NIL+D + ++DFGL++ +D G
Sbjct: 130 --------YLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 838 DSVTQTMTIATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+ T + T Y PE Y T D++ G + E FTR+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTA------VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGTS-FAIKVFNL--QLDRAFRS-FDSECEVLRNVRH 738
D F ++GRG+FG V +A+K+ N L RA + F E VL N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
+ + + + + ++ LV++ G L L + F D L +A + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--- 855
H VH D+KP N+LLD + ++DFG S L D +V ++ + T Y++PE
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 856 --------YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
YG E CD +S GV + E + P
Sbjct: 177 AMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 773 DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832
D LD + L+ VA + +L S +H DL NILL + + DFGL++
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD 263
Query: 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ V + + +MAPE + + + DV+SYG+LL E F+
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 3/119 (2%)
Query: 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821
P + L +++ L ++ + VA +E+L S VH DL N+L+ E +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ DFGL++ + +++ T + +MAPE + ++ DV+S+G+LL E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 65/223 (29%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN 740
FN +LG+GSFG V KGT +AIK+ L+ D + D EC + V R
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTM---VEKRV 53
Query: 741 L--------IKIFSSCCNN-DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG--V 789
L + SC D V+E + G L +Y E + +
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEI 110
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
A+ L +L HS +++ DLK N++LD + ++DFG+ K + D VT T
Sbjct: 111 AIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
Y+APE D +++GVLL E + P F GE
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 48/197 (24%), Positives = 75/197 (38%), Gaps = 45/197 (22%)
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++K++ S + D V++ +P G + L F + L R I + A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--- 118
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGL---------SKLFDEGDDSVTQTMT------ 845
+H D+KP NIL+D D ++DFGL SK + +GD +M
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 846 --------------------------IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879
+ T Y+APE + CD +S GV+L E
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 880 TRKKPTDDMFTGEMSLK 896
+ P E LK
Sbjct: 239 VGQPPFLADTPAETQLK 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDS----ECEVLRNVRHRNLIKIFS 746
+G G++G VYK T+ I + ++L++ S E +L+ ++H N++++
Sbjct: 10 IGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 747 SCCNNDFRALVLELMPNGSLEKWL-----YSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ LV E + + L+K + ++ N L I+ G+A HS
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC-------HS 120
Query: 802 TPVVHCDLKPSNILLDEDMVA-HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGT 858
V+H DLKP N+L+D A ++DFGL++ F G T T + T+ Y APE G+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 859 EGIVSSKCDVYSYGVLLTETFTRK 882
S+ D++S G + E +K
Sbjct: 179 RH-YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTS-----FAIKVFN-----LQLDRAFRS 725
+ I R D +LL G+FG ++ G D +K +Q+
Sbjct: 1 IAISR--DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL---- 54
Query: 726 FDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN-GSLEKWLYSDNYF-------L 777
E +L + H+N++ I C + VL N G+L+ +L L
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 778 DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK-LFDE- 835
+ +++ I +A + YLH V+H D+ N ++DE++ ++D LS+ LF
Sbjct: 115 STQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 836 ----GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
GD+ + +MA E SS DV+S+GVLL E T
Sbjct: 172 YHCLGDNENR------PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 84/258 (32%), Positives = 126/258 (48%), Gaps = 14/258 (5%)
Query: 316 FLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH--EIGNLR 373
SSL+ +L L+ + L + +L NI E+ NL
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSE--NLLNLLPLPSLDLNLNRLRSNISELLELTNLT 119
Query: 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433
SL + + I + I L++L L N +E S+P L +L L + L+ N L
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKEL---DLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175
Query: 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ 493
S +P+ L++L +L L+L NK S +P L L ++LS+NS+ L S++ NL+
Sbjct: 176 SD-LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232
Query: 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
L L+LS N+L D+P +IG+L +L TL L++NQ GSLT L LDLS N+L
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSL--GSLTNLRELDLSGNSL 289
Query: 554 SGEIPKSLEALLFLKQLN 571
S +P LL L+ L
Sbjct: 290 SNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVL-RNV--- 736
FN +LG+GSFG V KGT +AIK+ L+ D + D EC ++ + V
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVIIQDDDVECTMVEKRVLAL 56
Query: 737 --RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG--VALA 792
+ L ++ S D V+E + G L +Y E + +A+
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG--DDSVTQTMTIATIG 850
L +LH S +++ DLK N++LD + ++DFG+ K E T+T T
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFC-GTPD 166
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
Y+APE D +++GVLL E + P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 12/146 (8%)
Query: 693 RGSFGSVYKG-TFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV----RHRNLIKIFSS 747
RG+FG VY G ++ +A+KV + D ++ + + R+ + ++ ++ S
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTPVVH 806
+ + LV+E + G ++ L+ YF + + I VALAL+YLH HG ++H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHG----IIH 127
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKL 832
DLKP N+L+ + ++DFGLSK+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 27/199 (13%)
Query: 716 NLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-DFRALVLELMPNGSLEKWLYSDN 774
N+ + + R F ++ R R L+K C N+ + L+ P SLE+ + D
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYRELVLMK----CVNHKNIIGLLNVFTPQKSLEE--FQDV 104
Query: 775 YFLDLLERLNIMIGVALALEY-------------LHHGHSTPVVHCDLKPSNILLDEDMV 821
Y + L N+ + + L++ + H HS ++H DLKPSNI++ D
Sbjct: 105 YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 164
Query: 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR 881
+ DFGL++ S T + T Y APE D++S G ++ E
Sbjct: 165 LKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 882 KKPTDDMFTGEMSLKKWVK 900
+F G + +W K
Sbjct: 222 GV----LFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVLRN 735
FN +LG+GSFG V KGT +AIK+ L+ D + D EC VL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 736 VRHRNLIKIFSSCCNN-DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG--VALA 792
+ SC D V+E + G L +Y E + +++
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVG 113
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
L +LH +++ DLK N++LD + ++DFG+ K + D VT T Y+
Sbjct: 114 LFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYI 168
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
APE D ++YGVLL E + P D
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 721 RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN----DFRA--LVLELMPNGSLEKWLYSDN 774
RA+R +++ V H+N+I + + +F+ LV+ELM + +L + + D
Sbjct: 61 RAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD- 114
Query: 775 YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834
LD ER++ ++ L + H HS ++H DLKPSNI++ D + DFGL++
Sbjct: 115 --LDH-ERMSYLLYQMLC--GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 166
Query: 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS 894
S T + T Y APE D++S G ++ E +F G
Sbjct: 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV----LFPGTDH 222
Query: 895 LKKWVK 900
+ +W K
Sbjct: 223 IDQWNK 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 12/106 (11%)
Query: 796 LHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
+ H H V+H DLKP N+L+D+ + ++D GL + F S T I T+ Y AP
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH--EIVTLWYRAP 180
Query: 855 EY---GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
E T S+ D++S G + E +RK+P +F G+ L++
Sbjct: 181 EVLLGSTH--YSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQ 220
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSF-AIKVF--NLQLDRAFRSFDSECEVLRNVRHRNL 741
F ++G G++G V K + AIK F + + + + E ++LR ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL-------NIMIGVALALE 794
+++ + LV E Y + L+LLE + + + ++
Sbjct: 63 VELKEAFRRRGKLYLVFE-----------YVEKNMLELLEEMPNGVPPEKVRSYIYQLIK 111
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
+H H +VH D+KP N+L+ + V + DFG ++ EG ++ T +AT Y +P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSP 170
Query: 855 EYGTEGIVSSKCDVYSYGVLLTE------TFTRKKPTDDMFT 890
E D++S G +L E F + D +FT
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRN 740
D F + LG G+ G V K G A K+ +L++ A R+ E +VL
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF-LDLLERLNIMIGVALALEYLHHG 799
++ + + ++ ++ +E M GSL++ L ++L + I I V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREK 118
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMAPE--Y 856
H ++H D+KPSNIL++ + DFG+S +L D +S + T YM+PE
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQ 171
Query: 857 GTEGIVSSKCDVYSYGVLLTE 877
GT V S D++S G+ L E
Sbjct: 172 GTHYTVQS--DIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 698 SVYKGTFSDGTSFAIKVF---NLQLDRAFRSFDSECEVLRNVRHRNLIKI---FSSCCNN 751
S+YKG F + I+ F + ++E + LR + N++KI ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 752 DFR-ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810
R +L+LE G L + L + L +L++ I L L+ + P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS---KCD 867
+ L+ E+ + GL K+ S + + Y + + + I S K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLND-IFSEYTIKDD 204
Query: 868 VYSYGVLLTETFTRKKPTDDMFTGE---MSLKKWVKESLP 904
+YS GV+L E FT K P +++ T E + + K LP
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 59/247 (23%)
Query: 683 DGFNECNLLGRGSFGSV-YKGTFSDGTSFAIKVFNLQLDRAFRS-----FDSECEVLRNV 736
+ F+ ++G+G+FG V G +A+K L F+ +E +VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
++ ++ S + + L++E +P G L L + F + + R M LA+E +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAV 117
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-------------KLFDEGD------ 837
H +H D+KP NIL+D +SDFGLS KL +G
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL-QGKSNKNRI 173
Query: 838 --------DSVTQTM-------------------TIATIGYMAPEYGTEGIVSSKCDVYS 870
DS+ TM T+ T Y+APE + +CD +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 871 YGVLLTE 877
G ++ E
Sbjct: 234 LGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 677 DIQRATD-GFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN 735
DI R+ + + N++G GSFG VY+ D TS + + + D ++ + E +++N
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYK--NRELLIMKN 115
Query: 736 VRHRNLIKI----FSSCC----NNDFRALVLELMPNGSLEKWL--YS-DNYFLDLLERLN 784
+ H N+I + ++ C N F +V+E +P ++ K++ Y+ +N+ L L
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSVTQT 843
+ AL Y+H S + H DLKP N+L+D + + DFG +K G SV+
Sbjct: 175 YSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY- 230
Query: 844 MTIATIGYMAPEYGTEGI-VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900
I + Y APE ++ D++S G ++ E +F+G+ S+ + V+
Sbjct: 231 --ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR-----AFRSFDSECEVLRNVRHRNLIKI 744
LG G++ +V+KG A+K L+ + A R E +L+N++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
LV E + + L+++L DN +L+ N+ I + L L + H +
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYL--DNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---GTEGI 861
+H DLKP N+L++E ++DFGL++ + + T + + T+ Y P+ TE
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTE-- 180
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903
S+ D++ G +L E T + MF G VKE L
Sbjct: 181 YSTPIDMWGVGCILYEMATGRP----MFPGST-----VKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 691 LGRGSFGSVYKGTFSDGTSFA---------IKVFNLQLDRAFRSFDSECEVLRNVRHRNL 741
LG+GSFG+VY D + A I V L + ++ + E ++L + H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWL---------YSDNYFLDLLERLNIMIGVALA 792
+K +S D ++ E L+ L S+N + + +++GV
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQLLLGV--- 119
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
H+ H ++H DLK NI L +++ + DFG+S+L D T T T T YM
Sbjct: 120 ----HYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT-TFT-GTPYYM 172
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTE 877
+PE SK D++S G +L E
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 691 LGRGSFGSVYKG-TFSDGTSFAIKVFNLQLD------RAFRSFDSECEVLRNVRHRNLIK 743
+G G++G+V+K A+K L D A R E +L+ ++H+N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
++ ++ LV E + L+K+ S N +D + M + L+ L HS
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL---LKGLAFCHSHN 119
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTEGI 861
V+H DLKP N+L++++ ++DFGL++ F G + + T+ Y P+ +G +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 862 VSSKCDVYSYGVLLTE 877
+S D++S G + E
Sbjct: 178 STS-IDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-07
Identities = 39/120 (32%), Positives = 52/120 (43%), Gaps = 23/120 (19%)
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF-----DEGD 837
L+I + +EY+H S V+H DLKP NILL + D+G + D D
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 838 DSVTQT------MTI-----ATIGYMAPE--YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
V + MTI T YMAPE G S D+Y+ GV+L + T P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA--SESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFD----SECEVLR 734
R+ D + + N + G++G VY+ G A+K L++++ F E +L
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59
Query: 735 NVRHRNLIKI----FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVA 790
++H N++ + S + + +V+E + + L+ + + E +M+ +
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIY--MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
+ +LH ++H DLK SN+LL+ + + DFGL++ + TQ + T+
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ--LVVTLW 171
Query: 851 YMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
Y APE Y T D++S G + E KKP +F G+
Sbjct: 172 YRAPELLLGAKEYST------AIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 34/170 (20%)
Query: 721 RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL 780
RA+R E +L+ V H+N+I + + P SLE+ + D Y + L
Sbjct: 66 RAYR----ELVLLKCVNHKNIISLLNV------------FTPQKSLEE--FQDVYLVMEL 107
Query: 781 ERLNIMIGVALALEY-------------LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827
N+ + + L++ + H HS ++H DLKPSNI++ D + DF
Sbjct: 108 MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 167
Query: 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTE 877
GL++ + T + T Y APE D++S G ++ E
Sbjct: 168 GLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 60/265 (22%), Positives = 100/265 (37%), Gaps = 55/265 (20%)
Query: 685 FNECNLLGRGSFGSVYKGTFSD-GTSFAIKVF---NLQLDRAFRSFDSECEVLRNVRHRN 740
F + LG G+FG V D +A+K ++ L +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
+++++ S + D V++ +P G + L F + L R I + A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGL---------SKLFDEGD----DSVTQTMT-- 845
+H D+KP NIL+D D ++DFGL SK + GD DS+ +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 846 ------------------------------IATIGYMAPEYGTEGIVSSKCDVYSYGVLL 875
+ T Y+APE + CD +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 876 TETFTRKKP--TDDMFTGEMSLKKW 898
E + P +M + W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 41/239 (17%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVF---NLQLDRAFRSFDSECEVLRNVRH 738
+ F ++GRG+FG V D G +A+K+ ++ +E ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
++K+F S + L++E +P G + L + + + I V LA++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG--------------DDSVTQTM 844
+H D+KP N+LLD +SDFGL + D Q M
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 845 -------------------TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
T+ T Y+APE + + CD +S GV++ E P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 41/239 (17%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVF---NLQLDRAFRSFDSECEVLRNVRH 738
D F ++GRG+FG V D G +A+K+ ++ +E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
++K+F S + L++E +P G + L + + + I V LA++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIHQ 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG--------------DDSVTQTM 844
+H D+KP N+LLD +SDFGL + D Q M
Sbjct: 120 ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 845 -------------------TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
T+ T Y+APE + + CD +S GV++ E P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 34/108 (31%), Positives = 58/108 (53%), Gaps = 3/108 (2%)
Query: 773 DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832
D++ LDL + L VA +++L S +H D+ N+LL + VA + DFGL++
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ V + + +MAPE + + + + DV+SYG+LL E F+
Sbjct: 262 IMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 7/162 (4%)
Query: 724 RSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF-LDLLER 782
++ E ++L+ + HR +I + + ++ V +MP + + Y D L L +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842
+ I + AL YLH ++H D+K NI LDE A + DFG + D D+
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
T+ +PE +K D++S G++L E +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 53/249 (21%)
Query: 685 FNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQ--LDR-AFRSFDSECEVLRNVRHRN 740
F + LG G+FG V D +A+K + L+R +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++K++ S + D V++ +P G + L F ++L R I + LA+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGL---------SKLFDEGDDSVTQTMT------ 845
+H D+KP NIL+D D ++DFGL SK + +G +M
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 846 ------------------------------IATIGYMAPEYGTEGIVSSKCDVYSYGVLL 875
+ T Y+APE + CD +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 876 TETFTRKKP 884
E + P
Sbjct: 239 FEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 38/211 (18%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRS--FDS----ECEVLRNVRHRNLI 742
+G G++GSV G AIK +L R F+S F E +L++++H N+I
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77
Query: 743 KIF----SSCCNNDFRALVLELMP--NGSLEKWL---YSDNYFLDLLERLNIMIGVAL-A 792
+ S+ ++F+ L +MP L+K + S+ +++ ++ L
Sbjct: 78 GLLDVFTSAVSGDEFQDFYL-VMPYMQTDLQKIMGHPLSE-------DKVQYLVYQMLCG 129
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
L+Y+H S ++H DLKP N+ ++ED + DFGL++ D T + T Y
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYR 181
Query: 853 APEYGTEGIVSSK-CDVYSYGVLLTETFTRK 882
APE + ++ D++S G ++ E T K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN------VRHRNLIKI 744
+G G FG V T A +V +L +A S + E L+ ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVA-RVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 745 FSSCCNNDFRALVLELMPNGSL------EKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
C LV E G L E+W ++ L LL+R+ I + + H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL-LLQRMACEIAAGVTHMHKHN 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
+H DL N L D+ V D+G+ + D T+ + ++APE
Sbjct: 120 -----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 859 E---GIVSSK----CDVYSYGVLLTETF 879
E G+++++ +V++ GV L E F
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 56/241 (23%)
Query: 683 DGFNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRS-----FDSECEVL 733
D F ++GRG+FG V K T G +A+K L+ +E ++L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT---GHIYAMKK--LRKSEMLEKEQVAHVRAERDIL 55
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
+ ++K++ S + ++ L++E +P G + L + F + R I + LA+
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAI 114
Query: 794 EYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF-----------------DE 835
+ +H G+ +H D+KP N+LLD +SDFGL
Sbjct: 115 DSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 836 GDDSVTQTM-------------------TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLT 876
D +++ M T+ T Y+APE + + +CD +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 877 E 877
E
Sbjct: 231 E 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 45/221 (20%)
Query: 691 LGRGSFGSVYKGTFSDGT---SFAIKVFNLQLDRAFRSFDS--ECEVLRNVRHRNLIKIF 745
+GRG++G VYK DG +A+K Q++ S + E +LR ++H N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVI--- 61
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDL------------------LERLNIMI 787
AL + + + WL D DL L R +
Sbjct: 62 ---------ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQ- 842
+ L+ +H+ H+ V+H DLKP+NIL+ E ++D G ++LF+ +
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 843 TMTIATIGYMAPEYGTEGIVSSKC-DVYSYGVLLTETFTRK 882
+ T Y APE +K D+++ G + E T +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 20/60 (33%), Positives = 28/60 (46%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
NL+ L N+LT + L LDLS N+ + + P F L L L+L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 31/95 (32%), Positives = 43/95 (45%), Gaps = 7/95 (7%)
Query: 251 SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSP 310
L L G IPN I+ L ++LS NS G IP + G++ L VL+L+ N P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 311 TAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
SL +L L + N L G +P +G
Sbjct: 484 -------ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 7/160 (4%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
++ L+LS+ + ++P L N L +LD+S N+ + LP L L L + L N+
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGNKI 198
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLS 170
S P I +LS L+ L L NNS + +SL NL L + N ++P IGNLS
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG-LELSNNKLEDLPESIGNLS 255
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPI 210
+L ++L +N Q S +G+L NL L L N+LS +
Sbjct: 256 NLETLDL--SNNQISSISSLGSLTNLRELDLSGNSLSNAL 293
|
Length = 394 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 48/200 (24%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR-------AFRSFDSECEVLRNVRHRNLIK 743
LG G++ +VYKG S T + + ++L+ A R E +L++++H N++
Sbjct: 14 LGEGTYATVYKGR-SKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+ LV E + + L+++L + + N+ + + L L++ H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---GTEG 860
V+H DLKP N+L++E ++DFGL++ + + T + + T+ Y P+ T+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTD- 181
Query: 861 IVSSKCDVYSYGVLLTETFT 880
S++ D++ G + E T
Sbjct: 182 -YSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 14/201 (6%)
Query: 691 LGRGSFGSVYKG----TFSDGTSFAIKVFNLQLDRAFR----SFDSECEVLRNVRHRNLI 742
LG+G+F ++KG G +V LD++ R SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ C D +V E + GSL+ +L + +++ +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDK 119
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--IGYMAPEYGTEG 860
+ H ++ N+LL + + KL D G I I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 861 -IVSSKCDVYSYGVLLTETFT 880
+S D +S+G L E F+
Sbjct: 180 QNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 7/150 (4%)
Query: 729 ECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG 788
E +L+NV H ++I++ + + +VL + L +L + L + + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+ L YLH ++H D+K NI +++ + D G ++ + T+ T
Sbjct: 166 ILEGLRYLH-AQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTET 878
APE +SK D++S G++L E
Sbjct: 223 ---NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 45/221 (20%)
Query: 691 LGRGSFGSVYKGTFSDGTS---FAIKVFNLQLDRAFRSFDS--ECEVLRNVRHRNLIKIF 745
+GRG++G VYK DG +A+K Q++ S + E +LR ++H N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVI--- 61
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL-------------ERLNIMIGVALA 792
+L + + + WL D DL + + + G+ +
Sbjct: 62 ---------SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 793 LEY-----LHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQ- 842
L Y +H+ H+ V+H DLKP+NIL+ E ++D G ++LF+ +
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 843 TMTIATIGYMAPEYGTEGIVSSKC-DVYSYGVLLTETFTRK 882
+ T Y APE +K D+++ G + E T +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 61/274 (22%), Positives = 100/274 (36%), Gaps = 53/274 (19%)
Query: 261 IPNSITNASKLTGLDLSFN------SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEW 314
+ +++ L L LS N + L L+L++N L D
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 315 SFLSSLTNCRNLTTLAVASNPLRG----ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG 370
S L S + L L + +N L +L + + +L+ +L G +
Sbjct: 103 SLLRSSS----LQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158
Query: 371 NL----RSLIVLSLFINALNGT-IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
R L L+L N + I + +GL C+LE L+
Sbjct: 159 KALRANRDLKELNLANNGIGDAGIRALA------EGLK------------ANCNLEVLD- 199
Query: 426 IRLNGNKL----SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWS-----LEYLLAVNL 476
LN N L + + + LASL SL LNLG N + + ++ S LL ++L
Sbjct: 200 --LNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257
Query: 477 SSNSL----SGSLPSNIQNLQVLINLDLSRNQLS 506
S N + + L + + L+ LDL N+
Sbjct: 258 SCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 6e-05
Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 19/165 (11%)
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
+ N IK++ S L+++ + +G L L + L E I+ + AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126
Query: 798 HGHSTPVVHCDLKPSNILLDEDMV-AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY 856
+ ++H D+K N+L D ++ D+GL K+ G S T+ Y +P
Sbjct: 127 KHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD----GTLDYFSP-- 175
Query: 857 GTEGIVSSKCDV----YSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
E I DV ++ GVL E T K P + E+ L+
Sbjct: 176 --EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218
|
Length = 267 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 29/139 (20%), Positives = 58/139 (41%), Gaps = 18/139 (12%)
Query: 705 SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI--KIFSSCCNNDFRALVLELMP 762
+ + +K+ + A R + E +L+ + + L K+ +S ++ + L++E +
Sbjct: 19 TKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76
Query: 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP---VVHCDLKPSNILLDED 819
+L++ + E I LA E L H P + H DL P NIL+D+
Sbjct: 77 GETLDE----------VSEEEKEDIAEQLA-ELLAKLHQLPLLVLCHGDLHPGNILVDDG 125
Query: 820 MVAHVSDFGLSKLFDEGDD 838
+ + D+ + D
Sbjct: 126 KILGIIDWEYAGYGPPAFD 144
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 68/301 (22%), Positives = 117/301 (38%), Gaps = 66/301 (21%)
Query: 691 LGRGSFGSVYKGTFSDGTS--FAIKVFNLQLDR-----AFRSFDSECEVLRNVRHRNLIK 743
LG GS+ +VYKG S T A+K L+ + A R E +L++++H N++
Sbjct: 13 LGEGSYATVYKG-RSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+ LV E + + L++++ L + + + L Y H
Sbjct: 68 LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--- 123
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV-TQTMT--IATIGYMAP------ 854
V+H DLKP N+L+ E ++DFGL++ SV ++T + + T+ Y P
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARA-----KSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 855 -EYGTEGIVSSKCDVYSYGVLLTETFTRK---------------------KPTDDMFTGE 892
EY S+ D++ G + E T + PT++ + G
Sbjct: 179 TEY------STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTD 952
S ++ S P + + R + E LAL P +RI +
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGE--------ELALKFLQYEPKKRISAAE 284
Query: 953 A 953
A
Sbjct: 285 A 285
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-05
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 8/154 (5%)
Query: 728 SECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLY-SDNYFLDLLERLNIM 786
+E +LR + H ++I++ + N F L+L P + + Y + + + + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
V A++YLH ++H D+K NI ++ + DFG + F ++
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
TI APE D++S G++L E T
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 48/196 (24%), Positives = 97/196 (49%), Gaps = 21/196 (10%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR-------AFRSFDSECEVLRNVRHRNLIK 743
LG G++ +V+KG S T + + ++L+ A R E +L++++H N++
Sbjct: 14 LGEGTYATVFKGR-SKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+ + LV E + + L++ Y D+ +++ N+ I + L L + H
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQ--YMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTEGI 861
V+H DLKP N+L++E ++DFGL++ + + T + + T+ Y P+ G+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSE- 181
Query: 862 VSSKCDVYSYGVLLTE 877
S++ D++ G + E
Sbjct: 182 YSTQIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 21/59 (35%), Positives = 32/59 (54%)
Query: 519 LVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L +L L++N+ F L L+ LDLS NNL+ P++ L L+ L++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 22/67 (32%), Positives = 32/67 (47%), Gaps = 7/67 (10%)
Query: 270 KLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
L LDLS N + + F L L VL+L+ N LT+ SP A + +L +L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEA-------FSGLPSLRSL 53
Query: 330 AVASNPL 336
++ N L
Sbjct: 54 DLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 47/225 (20%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNL-------QLDRAFRSFDSECE 731
+ F L+ G++G+VY K T FA+K N Q+ + F E +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVF----VERD 53
Query: 732 VLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVAL 791
+L + ++ +F S +V+E + G L + + R+ V L
Sbjct: 54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV-L 112
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK---------LFDEGDDSVTQ 842
ALEYLH + +VH DLKP N+L+ ++DFGLSK L++ + T+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 843 TM----TIATIGYMAPE------YGTEGIVSSKCDVYSYGVLLTE 877
T Y+APE YG D ++ G++L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYG------KPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 1e-04
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 36/226 (15%)
Query: 691 LGRGSFGSVYKGTFSDGTSF----AIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G G FG V+ F AI L+ +R E V+R ++H+N+++
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 747 SCCN--NDFRALVLELMPNGSLEKWLYSDNYFLDLLER---LNIMIGVALALEYLHHGHS 801
N N +++E G L + + +E ++I + AL Y H+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 802 TP----VVHCDLKPSNILLDEDM-----------------VAHVSDFGLSKLFDEGDDSV 840
P V+H DLKP NI L + +A + DFGLSK + G +S+
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESM 197
Query: 841 TQTMTIATIGYMAPEYGTEGIVS--SKCDVYSYGVLLTETFTRKKP 884
+ + T Y +PE S K D+++ G ++ E + K P
Sbjct: 198 AHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 691 LGRGSFGSVYKGTFSD---------GTSFAIKVFNLQLDRAFR----SFDSECEVLRNVR 737
LGRG+ +Y G + IKV LD + R +F ++R V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
H++++ ++ C + +V E + G L+ +++ + L + + +A AL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL- 121
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFG-LSKLFDEG--DDSVTQTMTIATIGYMAP 854
+VH ++ NILL + + + G KL D G +++ + I ++AP
Sbjct: 122 --EDKDLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQECVERIPWIAP 177
Query: 855 EYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896
E + +S D +S+G L E + GE+ LK
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 24/59 (40%), Positives = 30/59 (50%)
Query: 495 LINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
L +LDLS N+L+ L +L L L+ N P+ F L L SLDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 13/203 (6%)
Query: 690 LLGRGSFGSVYKGTFSDGTS-FAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIF 745
++GRGS+ V +A+KV +L D +E V + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 746 SSCCNNDFRAL-VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
SC + R V+E + G L + + R ++LAL YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHE---RGI 117
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKL-FDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
++ DLK N+LLD + ++D+G+ K GD T + T Y+APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYG 174
Query: 864 SKCDVYSYGVLLTETFTRKKPTD 886
D ++ GVL+ E + P D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 3e-04
Identities = 15/41 (36%), Positives = 23/41 (56%), Gaps = 1/41 (2%)
Query: 6 LTTDQFALLAFKAHVTDPQSVLANNWSISQP-ICKWVGISC 45
L D+ ALLAFK+ + S ++W+ S C W G++C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 52/203 (25%), Positives = 80/203 (39%), Gaps = 13/203 (6%)
Query: 690 LLGRGSFGSVYKGTFSDGTS-FAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIF 745
++GRGS+ V +A+KV +L D +E V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 746 SSCCNNDFRA-LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
SC R LV+E + G L + + R + +AL +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE---RGI 117
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI-ATIGYMAPEYGTEGIVS 863
++ DLK N+LLD D ++D+G+ K EG T T T Y+APE
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 864 SKCDVYSYGVLLTETFTRKKPTD 886
D ++ GVL+ E + P D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 53/235 (22%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 691 LGRGSFGSVYKGTF---SDG--------TSFAIKVFNLQLDRAFRSFDSECEVLRNVRHR 739
LG+G+F ++YKG SD S +KV R +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
+L+K++ C D +V E + G L+ +L+ + + L +L++ +A AL YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117
Query: 800 HSTPVVHCDLKPSNILLDED-------MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+VH ++ NIL+ +SD G+ ++ V + I ++
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171
Query: 853 APEY--GTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLP 904
APE + ++ D +S+G L E + ++P + + E + LP
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 691 LGRG--SFGSVYKGTFS-DGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIF 745
+GRG + SVY + GT +++ +L+ + ++ +E + RH N++ +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLD-LLERL--NIMIGVALALEYLHHGHST 802
+ + ++ M GS L YF + + E L NI+ G L YLH
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQ---N 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLF---DEGDDSVT----QTMTIATIGYMAPE 855
+H ++K S+IL+ D + +S GLS L+ G + + + + +++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 856 YGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
+ + + K D+YS G+ E T + P DM +M L+K
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG--DDSVTQTMTI 846
++LAL +LH +++ DLK N+LLD + ++D+G+ K EG T T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFC- 157
Query: 847 ATIGYMAPEY--GTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
T Y+APE G + S D ++ GVL+ E + P D
Sbjct: 158 GTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 20/60 (33%), Positives = 32/60 (53%)
Query: 446 SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQL 505
+L+ L+L +N+ + +F L L ++LS N+L+ P L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 685 FNECNLLGRGSFG-SVYKGTFSDGTSFAIKVFNLQLDRAFRSFDS---ECEVLRNVRHRN 740
+N ++G GSFG ++ + +A+K ++L ++ + + E +L ++H N
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMK--EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFL---DLLERLNIMIGVALALEYLH 797
++ S + +V+E G L + + L D + L + + L ++
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCLGVQ--- 114
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPEY 856
H H V+H D+K NI L ++ + DFG ++L T + T Y+ PE
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL---TSPGAYACTYVGTPYYVPPEI 171
Query: 857 GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
++K D++S G +L E T K P
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 34/168 (20%)
Query: 690 LLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
L+G G FG VY K+ NL+ + + E V N+ + I ++
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 746 SSCCNND-------------------FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIM 786
+ N D +R ++LE + + E + L++ NIM
Sbjct: 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK--NIM 132
Query: 787 IGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833
+ LEY+H HG S H D+KP NI++D + ++ D+G++ F
Sbjct: 133 KDMLTTLEYIHEHGIS----HGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 10/62 (16%)
Query: 777 LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836
DLL + ++G LH +VH DL SNI+L + + DFGL + DE
Sbjct: 95 PDLLREVGRLVGK------LHKAG---IVHGDLTTSNIILSGGRI-YFIDFGLGEFSDEV 144
Query: 837 DD 838
+D
Sbjct: 145 ED 146
|
Length = 204 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 51/186 (27%), Positives = 68/186 (36%), Gaps = 44/186 (23%)
Query: 664 LLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAF 723
L PL R S+ D F LG G+FG VYK + + S L +A
Sbjct: 118 LAPLEGLFRPSF-----KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEG--KYVLKKA- 169
Query: 724 RSFDSECEVLRNVRHRNLIKIFSSCCNNDF-RALVLELMPNGSLEKWL------------ 770
+ E+ N R R +SC DF + + E WL
Sbjct: 170 -TEYGAVEIWMNERVR--RACPNSCA--DFVYGFLEPVSSKKEDEYWLVWRYEGESTLAD 224
Query: 771 --------YSDNYFL-----DL---LERLNIMIGVALA--LEYLHHGHSTPVVHCDLKPS 812
Y+ +L DL LER N +I + L L HST +VH D+KP
Sbjct: 225 LMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284
Query: 813 NILLDE 818
NI+ E
Sbjct: 285 NIIFSE 290
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 977 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.16 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-115 Score=1107.68 Aligned_cols=916 Identities=32% Similarity=0.523 Sum_probs=786.1
Q ss_pred hHHHHHHHHHHHHhccCCCCCccCCCCCCCCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCc
Q 036011 6 LTTDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNN 85 (977)
Q Consensus 6 ~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~ 85 (977)
.++|+.||++||+++.+|...+ .+|+.+.|||.|.||+|+. ..+|+.|||++++++|.+|+.++.+++|++|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~-~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYL-SNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccC-CCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 4689999999999998776655 6998888999999999985 4689999999999999999999999999999999999
Q ss_pred ccccCCCCcC-CCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCc
Q 036011 86 FHAYLPNELG-QLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPS 164 (977)
Q Consensus 86 l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~ 164 (977)
+++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++++++|++|++++|.+.+.+|.
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 9988888765 999999999999999988886 5689999999999999999999999999999999999999999999
Q ss_pred cccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCC
Q 036011 165 RIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSL 244 (977)
Q Consensus 165 ~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l 244 (977)
.|+++++|++|+|++|++.+.+|..++++++|+.|+|++|++.+.+|..+.++++|+.|++++|.+++. .+..+..+
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~---~p~~l~~l 259 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP---IPSSLGNL 259 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccc---cChhHhCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999853 35567789
Q ss_pred CCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCC
Q 036011 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324 (977)
Q Consensus 245 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 324 (977)
++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|++++|.+++..+.. +..++
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~-------~~~l~ 332 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA-------LTSLP 332 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChh-------HhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999998866543 78899
Q ss_pred CCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEe
Q 036011 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404 (977)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 404 (977)
+|+.|++++|.+.+.+|..++.. .+|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..++.+++|+.|++
T Consensus 333 ~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 333 RLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 99999999999999999888776 47999999999999999999999999999999999999999999999999999999
Q ss_pred ecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCC
Q 036011 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484 (977)
Q Consensus 405 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 484 (977)
++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++.
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~ 490 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGA 490 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCc
Confidence 9999999999999999999999999999999999999999999999999999999888876 458999999999999999
Q ss_pred CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccc
Q 036011 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL 564 (977)
Q Consensus 485 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 564 (977)
.|..|.++++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..|..+++|+.|||++|+++|.+|..+..+
T Consensus 491 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 570 (968)
T PLN00113 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570 (968)
T ss_pred cChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccCCCcccccCCCCCCCCcCCCCCcccCccccCCC-ccCCCCCCCCCCCCccccccccccccccchhhhhHHHH
Q 036011 565 LFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT-TLQVPPCRANKTEGSKKASRNFLKYVLPPLISTGIMVA 643 (977)
Q Consensus 565 ~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 643 (977)
++|+.|++++|+++|.+|..+++.++...++.||+++||.+ ....++|.... +.. ....+++.++.++.++++
T Consensus 571 ~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-----~~~-~~~~~~~~~~~~~~~~~~ 644 (968)
T PLN00113 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-----KTP-SWWFYITCTLGAFLVLAL 644 (968)
T ss_pred cccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-----ccc-eeeeehhHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999865 33456775321 111 111111111221122222
Q ss_pred HHHHHHHhhhhhhhhhhhcccccchhcc-------CCCHHHHHHhhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEe
Q 036011 644 IVIVFISCRKKIANKIVKEDLLPLAAWR-------RTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVF 715 (977)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~ 715 (977)
++++++.+|++......+.+ .....|. .............|...+.||+|+||.||+|+. .+++.||||++
T Consensus 645 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~ 723 (968)
T PLN00113 645 VAFGFVFIRGRNNLELKRVE-NEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723 (968)
T ss_pred HHHHHHHHHhhhcccccccc-cccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEc
Confidence 22223333332211111000 0000011 001122333345678888999999999999996 47899999998
Q ss_pred eccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHH
Q 036011 716 NLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795 (977)
Q Consensus 716 ~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~ 795 (977)
..... ...+|++.+++++|||||+++++|.+.+..++||||+++|+|.++++. ++|..+.+++.|+|+|++|
T Consensus 724 ~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~y 795 (968)
T PLN00113 724 NDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRF 795 (968)
T ss_pred cCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHH
Confidence 64322 223568899999999999999999999999999999999999999963 7899999999999999999
Q ss_pred HHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHH
Q 036011 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLL 875 (977)
Q Consensus 796 LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 875 (977)
||+.++.+|+|||+||+||+++.++.+++. ||.+...... ....++++|+|||++.+..++.|+|||||||++
T Consensus 796 LH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl 868 (968)
T PLN00113 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLIL 868 (968)
T ss_pred hccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHH
Confidence 998778899999999999999999988875 6655433211 123588999999999999999999999999999
Q ss_pred HHHhcCCCCCCcCCcccccHHHHHHhhCCCc-hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 036011 876 TETFTRKKPTDDMFTGEMSLKKWVKESLPHG-LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAA 954 (977)
Q Consensus 876 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~ 954 (977)
|||+||+.||+..........+|.+...... ....+|+.+...... ..+...++.+++.+||+.+|++||+|.||+
T Consensus 869 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 869 IELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV---NQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred HHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc---cHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 9999999999766556667788877655443 344455544332211 223456788999999999999999999999
Q ss_pred HHHHchhh
Q 036011 955 VKLKKIKI 962 (977)
Q Consensus 955 ~~L~~~~~ 962 (977)
++|+++..
T Consensus 946 ~~L~~~~~ 953 (968)
T PLN00113 946 KTLESASR 953 (968)
T ss_pred HHHHHhhc
Confidence 99998865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-60 Score=603.10 Aligned_cols=513 Identities=36% Similarity=0.562 Sum_probs=481.9
Q ss_pred CcEEEEEcCCCCCCccCCcccc-CcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEe
Q 036011 50 QRVRALNLSNMGLRGTIPPHLG-NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILS 128 (977)
Q Consensus 50 ~~v~~L~l~~~~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 128 (977)
..++.|+|++|.+.|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++.+++|++|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 4689999999999999998866 999999999999999987775 5689999999999999999999999999999999
Q ss_pred ccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCC
Q 036011 129 LRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSG 208 (977)
Q Consensus 129 L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~ 208 (977)
|++|.+++.+|..+.++++|++|++++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|++++|++++
T Consensus 171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 250 (968)
T PLN00113 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250 (968)
T ss_pred CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccc
Q 036011 209 PIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288 (977)
Q Consensus 209 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 288 (977)
.+|..+.++++|+.|+|++|++.+. + +..+..+++|++|+|++|++.+.+|..+.++++|++|++++|.+++..|..
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~--~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~ 327 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGP--I-PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeecc--C-chhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChh
Confidence 9999999999999999999999853 2 445668999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCcc
Q 036011 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHE 368 (977)
Q Consensus 289 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~ 368 (977)
+..+++|+.|++++|.+++..|. .+..+++|+.|++++|.+.+..|..++.. ..++.|++.+|++.+.+|..
T Consensus 328 ~~~l~~L~~L~L~~n~l~~~~p~-------~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~-~~L~~L~l~~n~l~~~~p~~ 399 (968)
T PLN00113 328 LTSLPRLQVLQLWSNKFSGEIPK-------NLGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGEIPKS 399 (968)
T ss_pred HhcCCCCCEEECcCCCCcCcCCh-------HHhCCCCCcEEECCCCeeEeeCChhHhCc-CCCCEEECcCCEecccCCHH
Confidence 99999999999999999876554 37889999999999999999999888765 47999999999999999999
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (977)
+..+++|+.|++++|++++.+|..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+
T Consensus 400 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~ 478 (968)
T PLN00113 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLE 478 (968)
T ss_pred HhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccce
Confidence 9999999999999999999999999999999999999999999999999999999999999999998888866 458999
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
.|++++|++++..|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|+.+++|+.|+|++|+
T Consensus 479 ~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 558 (968)
T PLN00113 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558 (968)
T ss_pred EEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcc
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 577 (977)
+++.+|..+..+++|+.|++++|+++|.+|.. ..+..+....+.+|+.
T Consensus 559 l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 606 (968)
T PLN00113 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNID 606 (968)
T ss_pred ccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCcc
Confidence 99999999999999999999999999999964 4455566677788873
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=436.60 Aligned_cols=290 Identities=44% Similarity=0.696 Sum_probs=251.3
Q ss_pred hccCCCHHHHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeee
Q 036011 669 AWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748 (977)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 748 (977)
..+.+++.++..||++|...++||+|+||.||+|..++|+.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765433145699999999999999999999999
Q ss_pred ecCC-eeEEEEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 749 CNND-FRALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 749 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
.+.+ +.++|||||++|+|.++++.... .++|..|.+||.++|+||+|||+.+...|+||||||+|||+|+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999998776 799999999999999999999998888999999999999999999999999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCC-cccccHHHHHHhhCCC
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMF-TGEMSLKKWVKESLPH 905 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~ 905 (977)
||+|+............. .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... ..+..+..|+...+.+
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999965543111111111 69999999999999999999999999999999999999887644 4556699999888777
Q ss_pred c-hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 906 G-LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 906 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+ +.+++|+.+....... .....++.+++.+|++.+|.+||+|.||+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 5 8899999987422211 1456779999999999999999999999999976664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=375.83 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=208.9
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-eeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-FRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 761 (977)
.+..+.||+|..|+||+++++ +++.+|+|++....+ ...+++.+|++++++.+||+||.+||+|...+ ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445678999999999999986 689999999965543 44577899999999999999999999999988 599999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|++++...+. +++....+|+.+|++||.|||+ +++||||||||+|||+++.|+|||||||.+..+..+ .
T Consensus 161 DgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~ 233 (364)
T KOG0581|consen 161 DGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I 233 (364)
T ss_pred CCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence 99999999987644 9999999999999999999995 478999999999999999999999999999987654 2
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....+||..|||||.+.+..|+.++||||||++++|+.+|+.||........ .+.++++.-....+..
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~------------~~~~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL------------DIFELLCAIVDEPPPR 301 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC------------CHHHHHHHHhcCCCCC
Confidence 3446799999999999999999999999999999999999999876411111 1222222222112211
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.. .+..++..++..|++.||.+||+++|++++
T Consensus 302 lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 366778999999999999999999999765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=392.68 Aligned_cols=253 Identities=30% Similarity=0.466 Sum_probs=209.0
Q ss_pred cCccccCcceEEEEEEEeCCCCEEEEEEeeccchh--hHHHHHHHHHHHHhcCCCCcceEeeeeecCC-eeEEEEeccCC
Q 036011 687 ECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR--AFRSFDSECEVLRNVRHRNLIKIFSSCCNND-FRALVLELMPN 763 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 763 (977)
..+.+|+|+||+||+|.++....||||++...... ..+.|.+|+.++++++|||||+++|+|.+.. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999965445999999765422 2568999999999999999999999999887 78999999999
Q ss_pred CCHHHHhhc-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCceeeCCCC-ceEEeecccccccCCCCCcc
Q 036011 764 GSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTP-VVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 764 gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 840 (977)
|+|.++++. ....+++..+.+++.+||+||+||| +.+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 999999988 3667999999999999999999999 677 99999999999999997 99999999998765432 2
Q ss_pred eeeccccCCcccCccccC--CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 841 TQTMTIATIGYMAPEYGT--EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
..+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+....+ ....+.. ...
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~~~v~~-----------~~~--- 263 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VASAVVV-----------GGL--- 263 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHh-----------cCC---
Confidence 233356999999999999 6699999999999999999999999998765421 1111100 000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....+..+...+..++.+||+.||.+||++.+++..|+.+..
T Consensus 264 --Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 --RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 001111256678899999999999999999999999998765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=376.16 Aligned_cols=279 Identities=27% Similarity=0.385 Sum_probs=216.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
..++|...+.||+|+||+||+|+++ ++..||||.+.+. ..+..+-+..|+.+++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4567999999999999999999975 6899999999877 455667789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC------CceEEeeccccc
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED------MVAHVSDFGLSK 831 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~------~~~kl~Dfgla~ 831 (977)
||||+||+|.+|++.++. +++.....++.|+|.||++|| +++||||||||+|||++.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998764 899999999999999999999 8999999999999999864 568999999999
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH--hhCCCc---
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK--ESLPHG--- 906 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~--- 906 (977)
.+.++. .....+|++-|||||++..+.|+.|+|+||+|+++|++++|+.||+.....+.-. .+.+ ...+..
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-YIKKGNEIVPVLPAE 239 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhccccccCchhhh
Confidence 987543 3345689999999999999999999999999999999999999998644333211 1111 111111
Q ss_pred ----hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCccccccccc
Q 036011 907 ----LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVLVLSRAEI 973 (977)
Q Consensus 907 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~~ 973 (977)
..++.-..+..+... .......+....+..+|.+|+.+.++-......+....+...|.+.
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~------~~~~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKD------RISFEDFFDHPFLAANPQDRADAFELESRTDQVKGSESPSSERAYI 304 (429)
T ss_pred ccCchhhhhhHHHhcCccc------cCchHHhhhhhhcccCcccccCcccccccccccccccCCccccccc
Confidence 111111112111111 1112344566677778888888777766666655444444444443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=391.03 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=214.4
Q ss_pred CCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+..++.||+|.||.||.|.++....||+|.++.. .-..+.|.+|+++|++++|++||+++|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456789999999999999987789999998764 333467899999999999999999999999988999999999999
Q ss_pred CHHHHhhc-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 765 SLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 765 sL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
+|.++++. .+..+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+...... .....
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecC
Confidence 99999997 4557899999999999999999999 8999999999999999999999999999999554433 33333
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
...-++.|.|||.+..+.++.|||||||||+|||++| |+.|+..+...+. .+.++ +....
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------------~~~le-----~GyRl 423 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------------LELLE-----RGYRL 423 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------------HHHHh-----ccCcC
Confidence 3446788999999999999999999999999999999 7888776543221 11111 22223
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+.+..|+..+++++..||..+|++|||++.+...++++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 4445688889999999999999999999999999887763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=368.43 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=206.6
Q ss_pred hhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchh-------hHHHHHHHHHHHHhcCCCCcceEeeeeecCC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR-------AFRSFDSECEVLRNVRHRNLIKIFSSCCNND 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 752 (977)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.... ......+|+++|++++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346688889999999999999984 58999999999765311 1233579999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC---CceEEeeccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED---MVAHVSDFGL 829 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgl 829 (977)
..|+||||++||+|.+.+-..+. +.+..-..+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987665 777777889999999999999 8999999999999999755 7899999999
Q ss_pred ccccCCCCCcceeeccccCCcccCccccCCCC---cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI---VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 830 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
|++.+.. ..+...||||.|.|||++.++. +..|+|+||+||++|-+++|.+||.+.........+..+..+..
T Consensus 326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f- 401 (475)
T KOG0615|consen 326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF- 401 (475)
T ss_pred hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc-
Confidence 9988643 3455679999999999988764 33478999999999999999999987433221111111111111
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+....++..+++.+|+..||++|||++|++++
T Consensus 402 --------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 --------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 123345667778999999999999999999999763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=394.52 Aligned_cols=487 Identities=27% Similarity=0.381 Sum_probs=333.1
Q ss_pred EEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccC
Q 036011 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRN 131 (977)
Q Consensus 52 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 131 (977)
...|++++|.+. .+.+.+.++..|.+|++++|++.. +|.+++.+..+..|+.++|+++ .+|..++.+.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 456777777777 566677777777777777777776 6777777777777777777777 7777777777777777777
Q ss_pred cCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCc
Q 036011 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQ 211 (977)
Q Consensus 132 n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 211 (977)
|.+. .+|++++.+-.|+.|+..+|+|+ ..|..++++.+|..|++.+|+++. .|...-+++.|++||.-.|-++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCC
Confidence 7777 67777777777777777777777 677777777777777777777773 4433333777777777777776 677
Q ss_pred hhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCccc-ccccccceEeecccccccccccccc
Q 036011 212 PSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSFNSFSGLIPHTFG 290 (977)
Q Consensus 212 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~ 290 (977)
+.++.+.+|..|+|..|+|. .+| .|.++..|++|+++.|+|. .+|... .++.+|.+|||..|+++ ..|+.++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~---~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR---FLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred hhhcchhhhHHHHhhhcccc---cCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 77777777777777777776 334 3445667777777777777 555554 47777777777777777 4577777
Q ss_pred cccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccc-ccccccc--ccCcccccCCc
Q 036011 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSA-SLQNFYA--YDCKLTGNIPH 367 (977)
Q Consensus 291 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-~L~~L~l--~~n~l~~~~p~ 367 (977)
.+++|..|++++|.|+..++. ++++ +|+.|.+.+|+++.+-.+.+..-+. -|++|.- ..-.++..
T Consensus 273 lLrsL~rLDlSNN~is~Lp~s--------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s--- 340 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISSLPYS--------LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS--- 340 (565)
T ss_pred HhhhhhhhcccCCccccCCcc--------cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC---
Confidence 777777777777777776654 6777 7777777777776543333322211 1222211 00011000
Q ss_pred cccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccc---cceeeecCCccCCCchhhhcCC
Q 036011 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER---LNGIRLNGNKLSGPIPQCLASL 444 (977)
Q Consensus 368 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l 444 (977)
+.=..+.-............+.+.+.|++++-+++ .+|.+.....+ .+..+++.|++. .+|..+..+
T Consensus 341 --------e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~l 410 (565)
T KOG0472|consen 341 --------EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVEL 410 (565)
T ss_pred --------cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHH
Confidence 00000000000011122334556677777777777 55555444333 667777777777 677766666
Q ss_pred CCCC-eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceec
Q 036011 445 ISLR-ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523 (977)
Q Consensus 445 ~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 523 (977)
..+. .+.+++|.+. .+|..++.+++|+.|+|++|-+. .+|..++.+..|++||+|.|++. .+|..+..+..|+.+-
T Consensus 411 kelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtll 487 (565)
T KOG0472|consen 411 KELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLL 487 (565)
T ss_pred HHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHH
Confidence 6544 3445555554 77777888888888888888777 57777888888888888888887 7787777777777777
Q ss_pred cCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCccc
Q 036011 524 LASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 524 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
.++|++..+.|+.+.+|.+|.+|||.+|.|. .+|+.++++++|++|+++||++.
T Consensus 488 as~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 488 ASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 7778888666666888888888888888887 77888888888888888888887
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=382.69 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=210.6
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.+|...+.||+|+|++||.++. ..|+.||+|++++.. ....+.+.+||++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999997 789999999998753 456778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+|+.++|..+++ +++.+++.+++.+++||+.||.||| +.+|+|||||..|++++++.++||+|||+|..+.....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999998 4456999999999999999999999 89999999999999999999999999999999875432
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....||||-|+|||++....++..+||||+|||+|.|+.|++||+...-. ..+.......+.
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~Ik~~~Y~-------------- 236 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKIKLNEYS-------------- 236 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHHHhcCcc--------------
Confidence 233468999999999999999999999999999999999999999753211 111111111000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+........++|.++++.+|.+|||+++|+.+
T Consensus 237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011233446789999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=348.32 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=205.7
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEee-eeecC-CeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFS-SCCNN-DFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~-~~~~lv 757 (977)
.+|.+.++||+|+||+||++.. .+|..||.|.+.... ....+....|+.++++++|||||++++ .+.++ ...++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3477888999999999999984 589999999887443 455677899999999999999999998 44444 448899
Q ss_pred EeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 758 LELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTP-VVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
||||++|+|.++++. .+..+++..+|+++.|++.||..+|....+| |+||||||.||+++.+|.+|++|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998864 3457999999999999999999999533232 789999999999999999999999999998
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.... ......+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+.. -..+.+- +.++
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~K----I~qg------- 243 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKK----IEQG------- 243 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHH----HHcC-------
Confidence 6532 34445689999999999999999999999999999999999999997641 1111111 1111
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+..+.+ ..-+..++.+++..|+..||+.||+....++.+..
T Consensus 244 ----d~~~~p-~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 ----DYPPLP-DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----CCCCCc-HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111111 13466778999999999999999996666655543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=382.82 Aligned_cols=489 Identities=28% Similarity=0.380 Sum_probs=401.0
Q ss_pred cEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEecc
Q 036011 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLR 130 (977)
Q Consensus 51 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 130 (977)
..++|+++++++. ++|++++.+.+++.|+.++|++.. +|..++.+.+|+.|+.++|.+. ++|+.++.+..|+.|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 4789999999999 899999999999999999999988 9999999999999999999999 999999999999999999
Q ss_pred CcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCC
Q 036011 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPI 210 (977)
Q Consensus 131 ~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 210 (977)
+|+++ ..|.+++++.+|..|++.+|.++...|+.+. ++.|++|+...|.++ .+|..++.|.+|+.|+|.+|+|. .+
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 99999 7899999999999999999999955555555 999999999999998 89999999999999999999998 45
Q ss_pred chhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccc
Q 036011 211 QPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290 (977)
Q Consensus 211 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 290 (977)
| .|.+++.|++|+++.|+|. .+|......++++.+|||++|+++ .+|+.+.-+.+|++||+|+|.|++. |..++
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~---~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sLg 295 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE---MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSLG 295 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH---hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC-Ccccc
Confidence 5 8999999999999999998 577888889999999999999999 7899999999999999999999965 77899
Q ss_pred cccccccccccccccCCCCCCch-hhhhcccccCCC-CceEEecCCCCCCCCCcccccccccccccccccCcccccCCcc
Q 036011 291 NLRFLSVLNLANNYLTTDSPTAE-WSFLSSLTNCRN-LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHE 368 (977)
Q Consensus 291 ~l~~L~~L~L~~N~l~~~~~~~~-~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~ 368 (977)
++ +|+.|.+.+|.+.++-.... ......+..+++ .+.=-++.- .|.-.. .-.........
T Consensus 296 nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s--e~~~e~---------------~~t~~~~~~~~ 357 (565)
T KOG0472|consen 296 NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS--EGGTET---------------AMTLPSESFPD 357 (565)
T ss_pred cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC--cccccc---------------cCCCCCCcccc
Confidence 99 99999999999876421100 000000111111 000000100 110000 00001122234
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCC---CCEEEeecccccCccccccccccccce-eeecCCccCCCchhhhcCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQ---LQGLSLYGNNLEGSIPYDLCHLERLNG-IRLNGNKLSGPIPQCLASL 444 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l 444 (977)
...+.+.+.|+++.-+++ .+|+.....-+ ....+++.|++. ++|..+..+..+.+ +.+++|+++ .+|..+..+
T Consensus 358 ~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l 434 (565)
T KOG0472|consen 358 IYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQL 434 (565)
T ss_pred hhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhh
Confidence 456778899999999999 66766544444 888999999998 89999888887665 455555555 899999999
Q ss_pred CCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceecc
Q 036011 445 ISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSL 524 (977)
Q Consensus 445 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 524 (977)
++|..|+|++|-+. .+|..++.+..|+.|+++.|++. .+|..+..+..|+++-.++|++....|..+.++.+|.+|||
T Consensus 435 ~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 435 QKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred hcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence 99999999999998 78999999999999999999998 78999999999999999999998666666999999999999
Q ss_pred CCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcc
Q 036011 525 ASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577 (977)
Q Consensus 525 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 577 (977)
.+|.+. .+|..+++|++|++|+|++|.+. ..+..+--......|..-++++
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdrI 563 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRDRI 563 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhcccC
Confidence 999999 78999999999999999999998 4444443444445554444443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=339.70 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=205.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hh-HHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RA-FRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
+.|+.+.++|+|+||+||+++.+ +|+.||||+|....+ .. .+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888899999999999999976 699999999975543 23 3446799999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
||+..-| +-+.......+...+.++++|+++|+.|+| +++++||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-- 155 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-- 155 (396)
T ss_pred ecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence 9988444 445555556899999999999999999999 8999999999999999999999999999999887422
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH---hhCCCchhhhcchhh
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK---ESLPHGLMEVVDTNL 915 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 915 (977)
..++..+.|.||.|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+-++ +....+ +..| ....++...-
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~p-rhq~iF~~N~ 233 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIP-RHQSIFSSNP 233 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCH-HHHHHhccCC
Confidence 23455679999999999887 6899999999999999999999998876433221 211111 1111 1112211110
Q ss_pred -------hccccCchHH---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 916 -------LRQEHTSSAE---MDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 916 -------~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.......+.+ .....-+++++.+|++.||++|++.++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0000111111 123345789999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.83 Aligned_cols=243 Identities=29% Similarity=0.349 Sum_probs=201.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.++||+|+||.||.++.+ +++.||+|++++.. ....+....|..++.+++||+||.++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999865 68999999998764 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
+||+.||.|..++++.+. +++..+.-++..|+.||.||| +.||||||+||+|||+|.+|+++|+|||+++..-...
T Consensus 104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999987765 889999999999999999999 8999999999999999999999999999998654322
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. .....+||+.|||||++.+..|+..+|.||+|+++|||++|.+||..... .++........ +..
T Consensus 180 ~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k--------~~~ 244 (357)
T KOG0598|consen 180 D--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGK--------LPL 244 (357)
T ss_pred C--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCc--------CCC
Confidence 1 23347899999999999999999999999999999999999999976422 22222221111 111
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIY 949 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 949 (977)
.+.. ......+++.+.+..+|++|..
T Consensus 245 ~p~~------ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 245 PPGY------LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCcc------CCHHHHHHHHHHhccCHHHhcC
Confidence 1110 1223567888888889999963
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=386.84 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=219.7
Q ss_pred CCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+....+.||+|+||+||+|+.. +.+.||||.++.+.+. ...+|++|++++..++|||||+++|+|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3445678999999999999853 3568999999877655 78899999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCc-------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceE
Q 036011 757 VLELMPNGSLEKWLYSDNY-------------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
|+|||..|+|.+|+..... +++..+.+.||.|||.||+||- ++.+|||||..+|.||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence 9999999999999975321 3788999999999999999999 67799999999999999999999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhh
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 902 (977)
|+|||+++.+...+++.......-+++|||||.+..++||.+||||||||++||+++ |+.||.+....+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--------- 714 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--------- 714 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH---------
Confidence 999999998887776655545567889999999999999999999999999999999 8899887644432
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+..+-+..+ .+.+++|+.+++.++..||+..|++||+++||-..|++...
T Consensus 715 ----Ie~i~~g~l------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 ----IECIRAGQL------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----HHHHHcCCc------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 111111222 33445688899999999999999999999999999988764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.05 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=214.8
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.+.|+..+.||.|..++||+|+. +.++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999985 468999999998764 4446889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||.+|++.++++.. ...+++..+..|.+++++||.||| ++|.+|||||+.||||+++|.|||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999864 235899999999999999999999 89999999999999999999999999999876654432
Q ss_pred c-cee-eccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 839 S-VTQ-TMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 839 ~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
. ... ...+||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+.++.+..-. ...+.......+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-n~pp~~~t~~~~-- 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-NDPPTLLTSGLD-- 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCCCCcccccCC--
Confidence 2 222 44589999999999543 3699999999999999999999999988766555443321 112111111111
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+.....+.+++..|++.||++|||+++++..
T Consensus 259 -------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 -------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 12223445578999999999999999999999753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=366.66 Aligned_cols=372 Identities=27% Similarity=0.276 Sum_probs=264.8
Q ss_pred cceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCC
Q 036011 149 EKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGN 228 (977)
Q Consensus 149 ~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N 228 (977)
+.|++++|.+....+..|.++++|+.+++.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+.+..+..|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 34555666665566666777777777777777777 67766555666777777777777555555555555555555555
Q ss_pred cccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCC
Q 036011 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTD 308 (977)
Q Consensus 229 ~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 308 (977)
.|+ +++.. +|..-.++++|+|++|+|+.+....|..+.+|.+|.|++|+++.+
T Consensus 160 ~is---~i~~~------------------------sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 160 LIS---EIPKP------------------------SFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred hhh---cccCC------------------------CCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 444 23333 333334444444444444444444444444555555555555444
Q ss_pred CCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCC
Q 036011 309 SPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGT 388 (977)
Q Consensus 309 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 388 (977)
++.. |+++++|+.|+|..|.|+-. ---.|..+++|+.|.|..|.|...
T Consensus 213 p~r~-------Fk~L~~L~~LdLnrN~iriv-------------------------e~ltFqgL~Sl~nlklqrN~I~kL 260 (873)
T KOG4194|consen 213 PQRS-------FKRLPKLESLDLNRNRIRIV-------------------------EGLTFQGLPSLQNLKLQRNDISKL 260 (873)
T ss_pred CHHH-------hhhcchhhhhhccccceeee-------------------------hhhhhcCchhhhhhhhhhcCcccc
Confidence 4332 44445555555555544310 012466777777778888888777
Q ss_pred CChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCc
Q 036011 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL 468 (977)
Q Consensus 389 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 468 (977)
..+.|..+.++++|+|+.|+++..-..++.++++|+.|+||+|.|..+.++.+...++|++|+|++|+|+...++.|..+
T Consensus 261 ~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L 340 (873)
T KOG4194|consen 261 DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVL 340 (873)
T ss_pred cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHH
Confidence 77788888888888888888887778888888899999999999888888888888889999999999988888888888
Q ss_pred ccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcch---hhhcccccceeccCCccccccccccccCccccCe
Q 036011 469 EYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPI---TIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES 545 (977)
Q Consensus 469 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 545 (977)
..|+.|+|++|.++..-..+|..+++|+.|||++|.|++.+-+ .|..+++|+.|.|.+|+|..+.-.+|.++.+|+.
T Consensus 341 ~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~ 420 (873)
T KOG4194|consen 341 SQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEH 420 (873)
T ss_pred HHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccce
Confidence 9999999999998877777888899999999999988865543 5777889999999999998666678899999999
Q ss_pred eeccCCccCCCCCcccccccccCccccCCCcccccC
Q 036011 546 LDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 546 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
|||.+|.|...-|++|..+ .|++|.+..-.+-+..
T Consensus 421 LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 421 LDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDC 455 (873)
T ss_pred ecCCCCcceeecccccccc-hhhhhhhcccceEEec
Confidence 9999999988888889888 8888888766555443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=354.13 Aligned_cols=267 Identities=27% Similarity=0.351 Sum_probs=212.0
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 756 (977)
.+.|+.+++||+|.||.||+|+. .+|+.||+|+++.+. +.......+||.+|+++.||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45577788999999999999985 579999999988775 34455678999999999999999999988776 68999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|+|||++ +|.-++...+-.++..++..++.|+++||+|+| ++||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 899888887667999999999999999999999 899999999999999999999999999999998765
Q ss_pred CCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH------------HHHhhC
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK------------WVKESL 903 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~------------~~~~~~ 903 (977)
.. ...+..+.|.||.|||.+.+. .|+.+.|+||.|||+.||++|++.|.+...-+ ++.. |....+
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccC
Confidence 43 346667899999999988775 79999999999999999999999987643222 1222 221112
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+. ...+.+.-.......+.....+...++++..++..||++|.|+.++++.
T Consensus 350 P~--~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PH--ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred Cc--ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 21 0111111000001112223455567899999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=322.82 Aligned_cols=267 Identities=25% Similarity=0.331 Sum_probs=212.0
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|...+++|+|.||.||+|+. ++|+.||||.++... +.......+|++.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999995 579999999998653 2234557899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|++. +|...++.....++..++..++.++.+|++|+| ++.|+|||+||.|+|++++|.+||+|||+|+.+.+....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9965 999999998888999999999999999999999 899999999999999999999999999999999876544
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh------hCCCchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE------SLPHGLMEVVD 912 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 912 (977)
... .+.|.+|.|||.+.| ..|+...||||.|||+.||+.|.+-|.+.. +-+++....+. ..+..+..+-|
T Consensus 158 ~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 QTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCcccccccc
Confidence 333 378999999998776 479999999999999999999887666532 22233332221 11112222222
Q ss_pred hhhhcc-cc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQ-EH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~-~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
-.-... +. .......+....++++.+++.++|.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 211111 10 011112345567999999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=377.46 Aligned_cols=270 Identities=27% Similarity=0.454 Sum_probs=227.3
Q ss_pred CCCHHHHHHhhcCC---------CcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC
Q 036011 672 RTSYLDIQRATDGF---------NECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR 737 (977)
Q Consensus 672 ~~~~~~~~~~~~~~---------~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~ 737 (977)
.++|+|...|...| .+.++||.|.||.||+|+++ ....||||.++... ++...+|..|+.+|.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 44566554444443 45689999999999999975 34679999998664 566788999999999999
Q ss_pred CCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 738 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
||||+++.|+.......++|+|||++|+|+.|++.+.+.+.+.+...+.++||.||.||- +.++|||||.++|||++
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVN 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeec
Confidence 999999999999999999999999999999999999888999999999999999999999 79999999999999999
Q ss_pred CCCceEEeecccccccCCCC-CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 818 EDMVAHVSDFGLSKLFDEGD-DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
.+..+|++|||+++.+..+. .........-+++|.|||.+...++|.+||||||||+|||.++ |..||=++...+.
T Consensus 766 snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-- 843 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-- 843 (996)
T ss_pred cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--
Confidence 99999999999999886543 2223333345678999999999999999999999999999887 8888866543321
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
.. -.++....+.+|||+..+.++++.||++|..+||.+.+++..|+++-..
T Consensus 844 ------------Ik-----aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 ------------IK-----AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ------------HH-----HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 11 1122334677889999999999999999999999999999999887543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.95 Aligned_cols=267 Identities=25% Similarity=0.323 Sum_probs=210.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHH--HHHHHHHHHhcC-CCCcceEeeeeecCC-eeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRS--FDSECEVLRNVR-HRNLIKIFSSCCNND-FRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 755 (977)
..++|..+++||.|.||.||+|+.. +|+.||||.++..... +++ =.+|+..++++. ||||+++.+++.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3567888999999999999999854 7999999998766433 233 358999999998 999999999999888 999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+|||||+. +|.++++.+++.+++..+..|+.||++||+|+| ++|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999964 999999999889999999999999999999999 89999999999999999999999999999998765
Q ss_pred CCCcceeeccccCCcccCcccc-CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--------CCc
Q 036011 836 GDDSVTQTMTIATIGYMAPEYG-TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--------PHG 906 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 906 (977)
.. ..+..+.|.||+|||++ +++.|+.+.|+||+|||++|+.+-++-|.+...-++ +.+. -+.+ +.+
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KI-c~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKI-CEVLGTPDKDSWPEG 237 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHH-HHHhCCCccccchhH
Confidence 43 35567899999999975 567899999999999999999999988876432221 1111 1111 111
Q ss_pred --hhhhcchhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 907 --LMEVVDTNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 907 --~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
+...+.-.+.... ........+..+..+++.+|+.+||.+||||++++++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111110000 00111123556789999999999999999999998763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=347.87 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=203.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC--eeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND--FRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 759 (977)
.+|...+.||+|+||+||++... +|+..|||..........+.+.+|++++++++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999975 49999999987664444677899999999999999999999854444 6889999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccccccCC-CC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFDE-GD 837 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~-~~ 837 (977)
|+++|+|.+++...+..+++..+..+..||++||+||| ++|||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999987656999999999999999999999 899999999999999999 79999999999987764 11
Q ss_pred CcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.........||+.|||||++..+ ....++||||+||++.||+||+.||.+. . ....+........ ..+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~---~~~~~~~~ig~~~----~~P--- 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F---EEAEALLLIGRED----SLP--- 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c---chHHHHHHHhccC----CCC---
Confidence 11223345799999999999854 3445999999999999999999999763 1 1111111100000 000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
..+...+....+++.+|+..+|++||||.+++++-
T Consensus 243 ------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11112445578999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=361.72 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=214.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
-.+++.+.+.||+|.||+||+|+|. ..||||++..+. +...+.|+.|+.++++-+|.||+-+.|||..+.. .+|+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3355667789999999999999984 359999998664 4567889999999999999999999999998887 8999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
.+|+|-+|..+++..+..++......||.|||+|+.||| .++|+|||+|+.||++++++.|||+|||++..-.....
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999988778999999999999999999999 89999999999999999999999999999986544332
Q ss_pred cceeeccccCCcccCccccCC---CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 839 SVTQTMTIATIGYMAPEYGTE---GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.......-|..-|||||++.. .+|++.+||||||+|+|||+||..||.... .+. +.-.+-+..
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dq-------------IifmVGrG~ 609 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQ-------------IIFMVGRGY 609 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhh-------------eEEEecccc
Confidence 333334458889999998764 479999999999999999999999997422 211 111111111
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
... .......+|+.+|.+++..||.+++++||.+.+++.+|+.+.+
T Consensus 610 l~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LMP-DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCc-cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 1112234577789999999999999999999999998888775
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.08 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=209.1
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCe
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 753 (977)
++...+|...+.||+|+|++|++|+.. .++.||||++.+.. +...+.+..|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455678999999999999999999854 69999999987653 33445677899999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+|+||+++|+|.++++..+. +++.....++.+|..||+||| ++|||||||||+|||+|+|+++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999988765 999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCCc---------cee--eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 834 DEGDDS---------VTQ--TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 834 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
.+.... ... ...+||..|.+||++..+..++.+|+|+||||+|+|+.|++||.+... ...
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yli-------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLI-------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHH--------
Confidence 753322 111 336899999999999999999999999999999999999999976321 111
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.++++-.....+. .++...+++.+.+..||.+|+|.+++.++
T Consensus 296 ----FqkI~~l~y~fp~~-------fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ----FQKIQALDYEFPEG-------FPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHHHHhcccCCCC-------CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11222211111111 22345678888888899999999877654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=360.00 Aligned_cols=391 Identities=23% Similarity=0.240 Sum_probs=250.7
Q ss_pred cEEEEEcCCCCCCccCCccccCc--ccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEe
Q 036011 51 RVRALNLSNMGLRGTIPPHLGNF--SFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILS 128 (977)
Q Consensus 51 ~v~~L~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 128 (977)
...-||++++.+...--..+..+ +.-+.||||+|++..+.+..|.++++|+.++|.+|.++ .+|...+...+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 34667888877752111112221 23456888888888877888888888888888888888 8888777777888888
Q ss_pred ccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCC
Q 036011 129 LRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSG 208 (977)
Q Consensus 129 L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~ 208 (977)
|.+|.|+..-.+.+.-++.|+.|||+.|.|+..--.+|..-.++++|+|++|+|+...-..|.++.+|..|.|++|+++.
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 88888886666677777777777777777774444556565667777777777776666667777777777777777774
Q ss_pred CCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccc
Q 036011 209 PIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288 (977)
Q Consensus 209 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 288 (977)
..+..|..+.+|+.|+|..|+|+ .+....|.+|++|+.|.|..|.|...-...|..+.++++|+|+.|+++..-.++
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~ir---ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~ 288 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIR---IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW 288 (873)
T ss_pred cCHHHhhhcchhhhhhcccccee---eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc
Confidence 33334444555555555555554 122334455555555555555555444445555555555555555555555555
Q ss_pred cccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCcc
Q 036011 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHE 368 (977)
Q Consensus 289 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~ 368 (977)
+.+|+.|+.|+|++|.|..+.+ +.
T Consensus 289 lfgLt~L~~L~lS~NaI~rih~--------------------------------------------------------d~ 312 (873)
T KOG4194|consen 289 LFGLTSLEQLDLSYNAIQRIHI--------------------------------------------------------DS 312 (873)
T ss_pred ccccchhhhhccchhhhheeec--------------------------------------------------------ch
Confidence 5555555555555555544332 23
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCch---hhhcCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIP---QCLASLI 445 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~ 445 (977)
+...++|++|+|+.|+|+...+.+|..+..|++|+|++|.|...-...|..+++|+.|||++|.|+..+. ..|.+|+
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~ 392 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLP 392 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccch
Confidence 4445566666666666665666666666666666666666665555566666666666666666654443 3466677
Q ss_pred CCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcC
Q 036011 446 SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSR 502 (977)
Q Consensus 446 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 502 (977)
+|+.|+|.+|+|..+...+|.++.+|+.|||.+|.|..+-|++|..+ .|++|.++.
T Consensus 393 ~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 393 SLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred hhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 77777777777776666667777777777777777776667777766 666666543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=354.13 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=209.2
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
..|..-.+||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..+.||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3466678899999999999984 578999999999887777777899999999999999999999999899999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+||+|.+.+.... +++.++..|.+.+++||+||| .+||+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 9999999987655 899999999999999999999 89999999999999999999999999999998876443 2
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....+|||.|||||+...+.|++|.||||||++++||+-|.+||... ..+..... ....+ .+.+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAlyL-Ia~ng-----~P~lk----- 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYL-IATNG-----TPKLK----- 490 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHHH-HhhcC-----CCCcC-----
Confidence 33457999999999999999999999999999999999999998642 11111000 00000 01111
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+.+++.+|++.||++|++++|++++
T Consensus 491 --~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 --NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 112344567899999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=338.16 Aligned_cols=274 Identities=24% Similarity=0.370 Sum_probs=208.6
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHh--cCCCCcceEeeeeecCC----eeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN--VRHRNLIKIFSSCCNND----FRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 756 (977)
......+++|+|.||.||+|++. ++.||||+++.. ..+.|..|-++++. ++|+||++++++-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44556678999999999999984 599999999854 45678888777775 58999999999875544 7889
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHh------cCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH------GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
|+||.+.|+|.+|+..+- ++|....+|+..+++||+|||+ .|+++|+|||||++||||..|+.+.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999998866 8999999999999999999994 66889999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCC-c-----CcccchhhHhHHHHHHhcCCCCCCcCCccc--ccHHHHHHhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGI-V-----SSKCDVYSYGVLLTETFTRKKPTDDMFTGE--MSLKKWVKES 902 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~ 902 (977)
..+.++.........+||.+|||||++.+.. + -.+.||||+|.|+|||+++..-++....++ ..+..-+..+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9998776655555678999999999987653 2 246999999999999999876553212222 2222222221
Q ss_pred CCC-chhhhcchhhhccc-cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 903 LPH-GLMEVVDTNLLRQE-HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 903 ~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..- .+.+.+...-.+.. ...-.....+..+.+.+..||+.||+.|.|+.=|-+++.++..
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111 12222222111111 0011111234457889999999999999999999999888775
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=319.16 Aligned_cols=200 Identities=30% Similarity=0.401 Sum_probs=181.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
-++|+..+.||.|+||+|..++.+ +|..+|+|++.+.. -+..+....|.++++.+.||+++++++.|.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356888999999999999999976 68999999998764 23455678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||++||.|..++++.++ +++..+.-+|.+|+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999987665 899999999999999999999 899999999999999999999999999999987531
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT 890 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~ 890 (977)
....||||.|+|||++.++.|..++|.|||||++|||+.|.+||.+..+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3346899999999999999999999999999999999999999987543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.28 Aligned_cols=247 Identities=27% Similarity=0.376 Sum_probs=207.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|.+.+.||+|+||+||||+.+ +.+.||+|.+.+.. ++..+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999865 68999999998664 3456678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+.| +|.+++...+. ++++.+..|+.++..||.||| +.+|.|||+||+|||++..+.+|+||||+|+.+... .
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence 9976 99999988765 999999999999999999999 899999999999999999999999999999987653 3
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
...+...|||-|||||...+++|+..+|.||+||++||+++|++||.... -..+.+ ... .++
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~---~I~-------------~d~ 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVK---SIL-------------KDP 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHH---HHh-------------cCC
Confidence 33445679999999999999999999999999999999999999996421 111111 111 111
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .+......+..++...+..||.+|.+..+++.+
T Consensus 217 v~--~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 VK--PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CC--CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 00 011344567889999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=357.32 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=204.0
Q ss_pred hcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC-C
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN-D 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 752 (977)
.++|++.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999974 235789999987543 23446789999999999 899999999988764 4
Q ss_pred eeEEEEeccCCCCHHHHhhcCC----------------------------------------------------------
Q 036011 753 FRALVLELMPNGSLEKWLYSDN---------------------------------------------------------- 774 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 774 (977)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999987532
Q ss_pred ---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcc
Q 036011 775 ---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851 (977)
Q Consensus 775 ---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 851 (977)
..+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23678888999999999999999 789999999999999999999999999999876433222222233467889
Q ss_pred cCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHH
Q 036011 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLL 930 (977)
Q Consensus 852 ~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (977)
+|||++.+..++.++|||||||++|||++ |..||.+....+. ...... .+ ..... +..+..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~----~~-------~~~~~------~~~~~~ 304 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK----DG-------TRMRA------PENATP 304 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh----cC-------CCCCC------CCCCCH
Confidence 99999999999999999999999999997 9999876432211 111110 00 00000 112344
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 931 SVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 931 ~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=379.39 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=215.4
Q ss_pred CCCcCccccCcceEEEEEEEeCC--CC----EEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSD--GT----SFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.-+..+.||+|+||.||+|...+ |. .||||.+++.. .+...+|.+|..+|+.++|||||+++|+|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34556889999999999998653 43 48999887664 4567789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 757 VLELMPNGSLEKWLYSD------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
++|||.+|+|..+++.. ...++..+.+.++.|||+|+.||+ ++.+|||||.++|+|+++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999986 557899999999999999999999 778999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
+.+...+.........-+..|||||.+..+.++.|+|||||||++||++| |..||.+....+. +..|
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~----------- 917 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDV----------- 917 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHH-----------
Confidence 97665555444433345678999999999999999999999999999999 7888876533221 1111
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.... ..+.+..|+.++++++.+||+.+|++||++..+++.+.++..
T Consensus 918 -~~gg------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 918 -LEGG------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -HhCC------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 1111 223344578889999999999999999999999998887764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.31 Aligned_cols=259 Identities=29% Similarity=0.431 Sum_probs=211.4
Q ss_pred cCCCcCccccCcceEEEEEEEeCC--C--CE-EEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD--G--TS-FAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
++-...++||+|+||.||+|++.. + .. ||||....+. .....+|.+|+++|++++|||||+++|++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999998652 2 23 8999987532 56678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++|||+|.||+|.++++..+..++..++..++.++|.||+||| +++++||||.++|+|++.++.+||+|||+++.-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999998877999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHH-HhhCCCchhhhcc
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWV-KESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 912 (977)
. .........-+..|+|||.+..+.|++++|||||||++||+++ |..||.+.... ....++ ...++...
T Consensus 314 ~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~~----- 384 (474)
T KOG0194|consen 314 Q--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMPI----- 384 (474)
T ss_pred c--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCCC-----
Confidence 1 1111112246789999999999999999999999999999999 88898775332 223332 22222111
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCc
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGV 965 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~ 965 (977)
+...+..+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 385 ------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 385 ------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ------------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11234457788889999999999999999999988875433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=349.07 Aligned_cols=257 Identities=25% Similarity=0.306 Sum_probs=207.8
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc----h-hhHHHHHHHHHHHHhcC-CCCcceEeeeeecCC
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL----D-RAFRSFDSECEVLRNVR-HRNLIKIFSSCCNND 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 752 (977)
...+.|.+.+.||+|+||.|+.|... +++.||+|++.... . ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999864 78999999877641 1 23455678999999998 999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeeccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSK 831 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~ 831 (977)
..++||||+.||+|.+++.. ...+.+.++.+++.|++.|++|+| ++||+||||||+||++|.+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999998 555889999999999999999999 8999999999999999999 999999999999
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCC-cC-cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGI-VS-SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
.... ........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++...... +.+
T Consensus 170 ~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~k------------ 234 (370)
T KOG0583|consen 170 ISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRK------------ 234 (370)
T ss_pred ccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHH------------
Confidence 8741 112334467999999999999977 86 789999999999999999999987321111 111
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+....+...... . ..++..++.+|+..+|.+|+++.|++ .-.-++.
T Consensus 235 i~~~~~~~p~~~-----~-S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 235 IRKGEFKIPSYL-----L-SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HhcCCccCCCCc-----C-CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 111111111000 0 34568899999999999999999998 4454543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.74 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=200.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
..++|+.++.||+|+||.||.|+-+ +|..+|+|++++.. ....+....|-.+|....+|.||+++..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5678999999999999999999854 69999999998764 3456678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC-
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE- 835 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~- 835 (977)
||||++||++..++...+. +++..+..++.+++.|++.+| +.|++||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999977664 899999999999999999999 89999999999999999999999999999963321
Q ss_pred ---------------------CCCc----ceee-------------------ccccCCcccCccccCCCCcCcccchhhH
Q 036011 836 ---------------------GDDS----VTQT-------------------MTIATIGYMAPEYGTEGIVSSKCDVYSY 871 (977)
Q Consensus 836 ---------------------~~~~----~~~~-------------------~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 871 (977)
.+.. .... ..+|||.|||||++.++.|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0000 1379999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 036011 872 GVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY 949 (977)
Q Consensus 872 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 949 (977)
|||+|||+.|.+||....+.+ ...+.+..... +. .+....+..+..++|.+|+. ||++|..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~----------l~-----fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQE-TYRKIVNWRET----------LK-----FPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhh----------cc-----CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999997644332 12221111100 00 01111223456889999999 9999997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.44 Aligned_cols=270 Identities=22% Similarity=0.279 Sum_probs=207.8
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhh--HHHHHHHHHHHHhcCCCCcceEeeeeec--CCee
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRA--FRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFR 754 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 754 (977)
+..+.|+.+++|++|+||.||+|+.+ +++.||+|+++.+.+.. --...+||.++.+.+|||||.+-.+... -+..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45567889999999999999999975 78999999998665322 2235789999999999999999998764 4578
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|+|||||++ +|...+...+..+...++..++.|+++|++||| ...|+|||+|++|+|++..|.+||+|||+|+.++
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999999987 999999988878999999999999999999999 7899999999999999999999999999999987
Q ss_pred CCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH------hhCCCch
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK------ESLPHGL 907 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~ 907 (977)
... ...+..+.|.||.|||.+.+. .|+.+.|+||+|||+.|++++++-|.+...-+ ++.+... +.++.++
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCc
Confidence 653 345567799999999987764 69999999999999999999999887643221 2222221 1122222
Q ss_pred hhhcch---hhhccccC-c---hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDT---NLLRQEHT-S---SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~---~~~~~~~~-~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.-.. .+...+.. . .........-++++...+..||.+|.|+.|.+++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 211110 01000000 0 0000022445788888999999999999999765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.57 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=209.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..|+..+.||+|.||.||+|... .++.||+|++..+. ....+++++|+.++.+++++||.++|+.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777889999999999999964 68999999998775 45567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
|.||++.+.++.... +++....-|++++..|+.||| .++.+|||||+.||++..+|.+|++|||.+..........
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999977553 488888899999999999999 8999999999999999999999999999998876543322
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
...+|||.|||||++....|+.|+||||+|++.+||.+|.+|+.+..+.... -.+++... +.+
T Consensus 169 --~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------flIpk~~P----P~L----- 231 (467)
T KOG0201|consen 169 --KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------FLIPKSAP----PRL----- 231 (467)
T ss_pred --ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------EeccCCCC----Ccc-----
Confidence 4567999999999999889999999999999999999999999775442110 00111110 001
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..++...+.+++..|++.+|+.||+|.+++++
T Consensus 232 ----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 ----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11455568899999999999999999999865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.66 Aligned_cols=241 Identities=27% Similarity=0.405 Sum_probs=200.6
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHH
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLE 767 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 767 (977)
++-||.|+.|.||.|+++ ++.||||.++. .-+.+|+-|++++||||+.+.|+|...-.+|+|||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 467999999999999984 78899997642 2245889999999999999999999999999999999999999
Q ss_pred HHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecccc
Q 036011 768 KWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847 (977)
Q Consensus 768 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 847 (977)
++++.... +.......|..+||.||.||| .+.|||||||+-||||+.+..|||+|||-++...... +.-..+|
T Consensus 201 ~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaG 273 (904)
T KOG4721|consen 201 EVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAG 273 (904)
T ss_pred HHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhh
Confidence 99987664 888889999999999999999 8899999999999999999999999999998765431 2223579
Q ss_pred CCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHH
Q 036011 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMD 927 (977)
Q Consensus 848 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (977)
|..|||||++...+.++|+||||||||+|||+||..||.+...... +. -+....+ ..+.+..
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----Iw---------GVGsNsL----~LpvPst 335 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IW---------GVGSNSL----HLPVPST 335 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EE---------eccCCcc----cccCccc
Confidence 9999999999999999999999999999999999999976432211 00 0001111 1122345
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 928 CLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 928 ~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
|++.+.-++++||+.-|..||++++++.+|+-.+
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 7778889999999999999999999999987544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=344.98 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=207.9
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.+-|...+.||+|+.|.|-.|++ .+|+.+|||++.+.. +.....+++|+-+|+.+.||||+++|++|++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35678889999999999999996 479999999998763 23345689999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
.||+++|.|.+++-.++. +++.++.+++.||..|+.|+| ..+|+|||+||+|+|+|..+.+||+|||+|..-.++.
T Consensus 91 lEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999987765 899999999999999999999 6789999999999999999999999999998755443
Q ss_pred CcceeeccccCCcccCccccCCCCcC-cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVS-SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
- -...||+|.|.|||++.|.+|. .++||||.|||+|.|+||+.||++..- ..-. ..+..+.
T Consensus 167 l---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----r~LL-lKV~~G~--------- 228 (786)
T KOG0588|consen 167 L---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----RVLL-LKVQRGV--------- 228 (786)
T ss_pred c---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----HHHH-HHHHcCc---------
Confidence 2 2345899999999999999985 689999999999999999999986321 1111 1111111
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.+.+...+.+..+++.+|+..||++|.|+.||.++-
T Consensus 229 -----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 -----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 112223445567899999999999999999998763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.23 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=200.0
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchh---hHHHHHHHHHHHHhcCCCCcceEeeeeec----CCeeEEEEecc
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR---AFRSFDSECEVLRNVRHRNLIKIFSSCCN----NDFRALVLELM 761 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 761 (977)
..||+|++|.||+|++ +|+.||||++...... ..+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 6899999998765322 25678899999999999999999999876 34678999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|.+++.... .+++.....++.+++.|++|||+ ..+++||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 9999999998754 48899999999999999999993 2478899999999999999999999999998654321
Q ss_pred eeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 842 QTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. .......... .
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~----------~---- 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKNNS----------L---- 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcCCC----------C----
Confidence 12358899999999876 6899999999999999999999999976432111 1111100000 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+.+++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0011245568899999999999999999999999998773
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.56 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=203.0
Q ss_pred cCCCcCccccCcceEEEEEEEeCC-----------------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD-----------------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKI 744 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 744 (977)
++|.+.+.||+|+||.||+|.+++ +..||+|++.... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 3469999987653 3345678999999999999999999
Q ss_pred eeeeecCCeeEEEEeccCCCCHHHHhhcCC------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 036011 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDN------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806 (977)
Q Consensus 745 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 806 (977)
++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.||+.||+||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986432 13678889999999999999999 789999
Q ss_pred CCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc--CCCC
Q 036011 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT--RKKP 884 (977)
Q Consensus 807 ~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p 884 (977)
|||||+||+++.++.+||+|||+++...............++..|+|||+..++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987654332222233446788999999988899999999999999999987 4566
Q ss_pred CCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 885 TDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
|...... ....++............ ... +..++..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGRQVY----LFR------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhcccccc----ccC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6543221 112222111111100000 000 11234568899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=376.83 Aligned_cols=481 Identities=31% Similarity=0.372 Sum_probs=301.9
Q ss_pred EEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCC
Q 036011 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSF 134 (977)
Q Consensus 55 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 134 (977)
+|.+..++. .||..+-.-..++.|+++.|-+-...-+.+.+.-+|+.|||++|+++ .+|..+..+.+|+.|+++.|.+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 566666666 67776666666777777777665422223334445777777777776 7777777777777777777777
Q ss_pred CCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhh
Q 036011 135 TGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSI 214 (977)
Q Consensus 135 ~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l 214 (977)
. .+|.+..++.+|++|.|..|.+. .+|.++..+++|++|++++|++. .+|..+..++.++.+..++|.... .+
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~l 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RL 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hh
Confidence 6 56666777777777777777666 66777777777777777777776 666677777777777777662111 11
Q ss_pred ccccceeEEEccCCcccccccCCCccccCCCCce-EEEecCceeeecCCcccccccccceEeeccccccccccccccccc
Q 036011 215 FNISTITLINLFGNQLSGHLDLPPKVSYSLPNLR-VFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLR 293 (977)
Q Consensus 215 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 293 (977)
.... ++.++|..|.+.+.+ + ....+|+ .|+|++|.+. . ..+..+.+|+.|....|+++... -..+
T Consensus 154 g~~~-ik~~~l~~n~l~~~~--~----~~i~~l~~~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~ 219 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSF--L----IDIYNLTHQLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGP 219 (1081)
T ss_pred cccc-chhhhhhhhhcccch--h----cchhhhheeeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCc
Confidence 2221 555666666555321 1 1122333 3666666665 2 23555666666666666665431 2235
Q ss_pred ccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccc
Q 036011 294 FLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR 373 (977)
Q Consensus 294 ~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~ 373 (977)
+|+.|+.++|.++...+ ...-.+|+.+++++|++++. |++++... +|+.+.+.+|+++ .+|..+...+
T Consensus 220 ~l~~L~a~~n~l~~~~~---------~p~p~nl~~~dis~n~l~~l-p~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~ 287 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDV---------HPVPLNLQYLDISHNNLSNL-PEWIGACA-NLEALNANHNRLV-ALPLRISRIT 287 (1081)
T ss_pred chheeeeccCcceeecc---------ccccccceeeecchhhhhcc-hHHHHhcc-cceEecccchhHH-hhHHHHhhhh
Confidence 66666666666664332 22234566666666666643 35555443 5666666666663 5666666677
Q ss_pred cccEEEeecCccCCCCChhhhccCCCCEEEeecccccCcccc-ccccccc-cceeeecCCccCCCchh-hhcCCCCCCee
Q 036011 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPY-DLCHLER-LNGIRLNGNKLSGPIPQ-CLASLISLREL 450 (977)
Q Consensus 374 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~-L~~L~L~~N~l~~~~p~-~~~~l~~L~~L 450 (977)
+|+.|.+..|.+. -+|....+++.|++|+|..|+|. ..|+ .+..+.. |..|..+.|++. ..|. .=..+..|+.|
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~L 364 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQEL 364 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHH
Confidence 7777777777776 55666666677777777777776 3333 2222322 566666666665 2221 11234457777
Q ss_pred ecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc
Q 036011 451 NLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530 (977)
Q Consensus 451 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 530 (977)
++.+|.++...-..+.+...|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..++.|++|...+|++.
T Consensus 365 ylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 365 YLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred HHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 77777777666666777777777777777777544456677777777777777777 67777777777777777777777
Q ss_pred ccccccccCccccCeeeccCCccCCC-CCcccccccccCccccCCCcc
Q 036011 531 GPIPQTFGSLTGLESLDLSNNNLSGE-IPKSLEALLFLKQLNVSHNKL 577 (977)
Q Consensus 531 ~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l 577 (977)
..| .+.+++.|+.+|||.|+|+.. +|.... .++|++|||+||..
T Consensus 444 -~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 444 -SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTR 488 (1081)
T ss_pred -ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCcc
Confidence 566 677777777777777777743 233222 26777777777763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.66 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=218.5
Q ss_pred CCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
...+.++||+|.||.|..+....+..||||.++..... ...+|.+|+++|.+++||||++++|+|..++..++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 35567899999999999999987899999999877644 45889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 763 NGSLEKWLYSDNYFL-DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~-~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+|+|.+++..+..+. ....-.+|+.|||.||+||. +.++||||+.++|+|+|+++++||+|||+++-+..++....
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999998875433 55667789999999999999 89999999999999999999999999999998877777777
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc--CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT--RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
+...+-+++|||||.+.-++++.++|||+||+++||+++ ...||.+....+ ..+-....+.++-..+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~--------- 764 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQV--------- 764 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcce---------
Confidence 767778899999999999999999999999999999876 678887653322 1121222222221111
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
....+.-|+.++++++.+||+.+.++||+++++...|++.
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1222345788899999999999999999999999888764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=305.32 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=210.7
Q ss_pred HhhcCCCcCccccCcceEEEEEEE-eCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Ce
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DF 753 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 753 (977)
...++|++.+.+|+|||+-||.++ ..+++.||+|++.....+..+...+|++..++++|||+++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 457899999999988877788899999999999999999999987543 35
Q ss_pred eEEEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 754 RALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
.|++++|+..|+|.+.+.. .+..+++.+.++|+.+|++||++||+.. .+++||||||.||++.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999998875 3447999999999999999999999322 34999999999999999999999999999
Q ss_pred cccCCCCCc-------ceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH
Q 036011 831 KLFDEGDDS-------VTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 831 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 900 (977)
+...-.-.. +.......|..|.|||.+. +...++++|||||||++|+|+.|..||+.......++
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl----- 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL----- 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----
Confidence 865422111 1122235889999999765 5568899999999999999999999997543222111
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
...+....+...... .++..+.+++.+|++.||.+||++.+++.+++++.
T Consensus 252 ------aLAv~n~q~s~P~~~-----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ------ALAVQNAQISIPNSS-----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EEeeeccccccCCCC-----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111111111111 14567899999999999999999999999998764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=370.63 Aligned_cols=491 Identities=29% Similarity=0.385 Sum_probs=375.1
Q ss_pred cEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEecc
Q 036011 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLR 130 (977)
Q Consensus 51 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 130 (977)
++.+|||++|.+. ..|..+..+.+|+.|+++.|.|.. .|.+..++.+|++|.|.+|.+. .+|.++..+++|++||+|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhh-Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3778888888876 788888888888888888888877 7788888888888888888887 888888888888888888
Q ss_pred CcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCC
Q 036011 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPI 210 (977)
Q Consensus 131 ~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 210 (977)
+|.+. .+|..+..++.++.+..++|..... ++... .+.++|..|.+.+.++..+..+++ .|+|++|++.
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--- 191 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--- 191 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---
Confidence 88887 7788888888888888888822212 22222 777888888888888877777776 7888888876
Q ss_pred chhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccc
Q 036011 211 QPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290 (977)
Q Consensus 211 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 290 (977)
...+..+.+|+.|....|++... ....++|+.|+.++|.++...+. ..-.+|+++|+++|+++.. |++++
T Consensus 192 ~~dls~~~~l~~l~c~rn~ls~l-------~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~l-p~wi~ 261 (1081)
T KOG0618|consen 192 VLDLSNLANLEVLHCERNQLSEL-------EISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNL-PEWIG 261 (1081)
T ss_pred hhhhhhccchhhhhhhhcccceE-------EecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcc-hHHHH
Confidence 23566677888888888887632 12457788888888888843332 2335788888888888865 58888
Q ss_pred cccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCcccc
Q 036011 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG 370 (977)
Q Consensus 291 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~ 370 (977)
.+.+|+.|...+|+++.++. .+...++|+.|++..|.+. .+|+...
T Consensus 262 ~~~nle~l~~n~N~l~~lp~--------ri~~~~~L~~l~~~~nel~--------------------------yip~~le 307 (1081)
T KOG0618|consen 262 ACANLEALNANHNRLVALPL--------RISRITSLVSLSAAYNELE--------------------------YIPPFLE 307 (1081)
T ss_pred hcccceEecccchhHHhhHH--------HHhhhhhHHHHHhhhhhhh--------------------------hCCCccc
Confidence 88888888888888865443 2455566666666666655 4566677
Q ss_pred ccccccEEEeecCccCCCCChhhhccCC-CCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCe
Q 036011 371 NLRSLIVLSLFINALNGTIPSTVGRLEQ-LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE 449 (977)
Q Consensus 371 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 449 (977)
.++.|+.|+|..|+|....+..|.-+.. |..|+.+.|.+.......-..+..|+.|++.+|.++...-..+.++++|+.
T Consensus 308 ~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKV 387 (1081)
T KOG0618|consen 308 GLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKV 387 (1081)
T ss_pred ccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceee
Confidence 8999999999999999555545555554 788889999988444333445788999999999999887778999999999
Q ss_pred eecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccc
Q 036011 450 LNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF 529 (977)
Q Consensus 450 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 529 (977)
|+|++|++.......+.++..|+.|+||+|+++ .+|+.+..+..|++|...+|+|. ..| .+..+++|+.+|+|.|+|
T Consensus 388 LhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 388 LHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred eeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchh
Confidence 999999999666677889999999999999999 68999999999999999999998 788 899999999999999999
Q ss_pred ccc-ccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCCCCCCcCCCCCcccCccccCCCccC
Q 036011 530 EGP-IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQ 608 (977)
Q Consensus 530 ~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~ 608 (977)
+.. +|... ..++|++|||++|.=.-..-..|..+.++..++++-| ..|++..- .+.+-++.||....+
T Consensus 465 ~~~~l~~~~-p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~----~~~d~~~n------~~~~t~Gv~~~~gqr 533 (1081)
T KOG0618|consen 465 SEVTLPEAL-PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN----NTPDGNVN------AFLWTYGVAGVSGQR 533 (1081)
T ss_pred hhhhhhhhC-CCcccceeeccCCcccccchhhhHHhhhhhheecccC----CCCccccc------eeheeeccchhcccc
Confidence 854 34333 3389999999999843344566777888888888877 34443211 123336677766555
Q ss_pred CCCCC
Q 036011 609 VPPCR 613 (977)
Q Consensus 609 ~~~~~ 613 (977)
-+-|.
T Consensus 534 nk~c~ 538 (1081)
T KOG0618|consen 534 NKVCS 538 (1081)
T ss_pred cchhh
Confidence 55554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=320.72 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=206.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++++. +++.-.+.+|+++|+.++||||+.++++|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35688889999999999999984 689999999998764 34455688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||..+|.|.+|+...+. +++.++..+++||..|+.|+| ++++||||+|.+|||+|.++++||+|||++-.+....
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999987665 999999999999999999999 8999999999999999999999999999999886543
Q ss_pred CcceeeccccCCcccCccccCCCCcC-cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVS-SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
..+..||+|-|.+||++.+.+|. +.+|-||+||++|.++.|..||++.... .+.+ ++-.....
T Consensus 208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--~lvr-----------QIs~GaYr 271 (668)
T KOG0611|consen 208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--RLVR-----------QISRGAYR 271 (668)
T ss_pred ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--HHHH-----------Hhhccccc
Confidence 34457899999999999999885 7899999999999999999999874211 1111 11111111
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+...++ ..--+|++|+..+|++|-|+.||..+
T Consensus 272 EP~~PS--------dA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 EPETPS--------DASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCCCc--------hHHHHHHHHHhcCcccchhHHHHhhh
Confidence 111222 23457889999999999999998665
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=347.16 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=203.8
Q ss_pred cCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
++|++.+.||+|+||+||+|++ ..+..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999973 246689999986443 33456788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC------------------------------------------------------------
Q 036011 755 ALVLELMPNGSLEKWLYSDN------------------------------------------------------------ 774 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 774 (977)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999986432
Q ss_pred --------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 775 --------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 775 --------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
..+++..+.+++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 13678899999999999999999 7899999999999999999999999999998765432222
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...++........ .+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~-----------~~ 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRML-----------SP 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccCC-----------CC
Confidence 2222335678999999999999999999999999999998 888886543221 1222221111000 00
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
...+.++.+++.+||+.+|++||++.|+++.|++.
T Consensus 340 ------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.61 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=205.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||.||+|.++ .+..||+|+++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999753 36789999987653 23346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876556899999999999999999999 7899999999999999999999999999876543221
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. .......++..|+|||...+..++.++|||||||++||+++ |..||.+....+ ..+... ++.
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~----~~~--------- 225 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVE----DGF--------- 225 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHH----CCC---------
Confidence 1 11112235678999999999999999999999999999775 999987542211 111111 100
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
..+.+..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0001123455688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.46 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=201.8
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 755 (977)
..++|..+++||+|.||.|+.+..+ +++.||||++++.. +++.+....|.+++... +||.++.++.+|+..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999976 68899999998774 56677888899999888 5999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+.||++..+.+.+ .+++..+.-++..|+.||+||| ++||||||||.+|||+|.+|.+||+|||+++..-.
T Consensus 446 fvmey~~Ggdm~~~~~~~--~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD--VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEEecc--cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999965554433 4899999999999999999999 89999999999999999999999999999985432
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
....++..+|||.|||||++.+..|+.++|.|||||++|||+.|..||.+....+ .... ++....
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~Fds------------I~~d~~ 585 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDS------------IVNDEV 585 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH------------HhcCCC
Confidence 1224556799999999999999999999999999999999999999998642221 1111 111111
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
. . +..+..+.+.++.+++..+|++|..+
T Consensus 586 ~-----y--P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 R-----Y--PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C-----C--CCcccHHHHHHHHHHhccCcccccCC
Confidence 1 1 11234567889999999999999976
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.24 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=200.1
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--------------hhHHHHHHHHHHHHhcCCCCcceE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--------------RAFRSFDSECEVLRNVRHRNLIKI 744 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l 744 (977)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999964 799999999976531 113578899999999999999999
Q ss_pred eeeeec--CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 745 FSSCCN--NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 745 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
+++..+ .+..|+|+|||..|.+... ......++..+++++++++..||+||| .+||+||||||+|+|++++|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 999876 4688999999999988653 222223899999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCc---ceeeccccCCcccCccccCCCC----cCcccchhhHhHHHHHHhcCCCCCCcCCcccccH
Q 036011 823 HVSDFGLSKLFDEGDDS---VTQTMTIATIGYMAPEYGTEGI----VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSL 895 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 895 (977)
||+|||.+.....+... ......+|||.|+|||...++. .+.+.||||+||++|.++.|+.||.+...-+ .
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-l- 327 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-L- 327 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-H-
Confidence 99999999877433211 1122357999999999877632 3568999999999999999999997642211 1
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
+..++...+.... ..+.-..+.+++.++++.||++|.+..||..+.
T Consensus 328 -----------~~KIvn~pL~fP~-----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 -----------FDKIVNDPLEFPE-----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----------HHHHhcCcccCCC-----cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1122222222211 113344578899999999999999999987664
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=346.01 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=203.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
++|++.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+++++.+ +||||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888999999999999998742 34579999987543 33456688999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC------------------------------------------------------------
Q 036011 755 ALVLELMPNGSLEKWLYSDN------------------------------------------------------------ 774 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 774 (977)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885421
Q ss_pred ---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecc
Q 036011 775 ---------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845 (977)
Q Consensus 775 ---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (977)
..+++..+.+++.||+.||+||| ++||+||||||+||++++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 13678889999999999999999 899999999999999999999999999999866433222122223
Q ss_pred ccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchH
Q 036011 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924 (977)
Q Consensus 846 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (977)
.+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ............ .+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~~-----------~~~---- 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQMS-----------RPD---- 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccCcc-----------CCC----
Confidence 35678999999998999999999999999999997 9999876432211 111111100000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 925 EMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+..+.+++.+||+.+|++||++.++++.|+++-
T Consensus 339 --~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 --FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.83 Aligned_cols=269 Identities=25% Similarity=0.282 Sum_probs=206.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEee--ccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec-----CC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFN--LQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----ND 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 752 (977)
....|..++.||+|+||.|+.|... +|+.||||.+. .......++..+|++.++.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999865 79999999987 3445566788999999999999999999998854 45
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..|+|+|+| +.+|.+.++.+.. ++......+++|+++||.|+| +.+|+|||+||+|++++.+...||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 789999999 5699999987654 889999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCCcceeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc----h
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG----L 907 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 907 (977)
..........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+...-+ .-.-+-+..... +
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~--Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH--QLQLILELLGTPSEEDL 252 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH--HHHHHHHhcCCCCHHHH
Confidence 86543334456778999999999754 5689999999999999999999999887632211 111111111110 1
Q ss_pred hhhcch---hhhc----ccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDT---NLLR----QEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~---~~~~----~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+-.. .... .+. ............++++.+|+..||.+|+|++|++++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111100 0000 000 011111234457899999999999999999999876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.34 Aligned_cols=248 Identities=25% Similarity=0.295 Sum_probs=207.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. ......+.+|+++-+.++||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467999999999999999999965 68889999987653 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 758 LELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
+||..+|++...++.+. ..+++.....++.|+|.|+.|+| .++|+||||||+|+|++.++..|++|||-+..-..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999998543 35899999999999999999999 89999999999999999999999999999876432
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
......+||..|.|||+..+..++.++|+|++|++.||++.|.+||.... ....+.+..+-.+. ++
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~-------~p--- 242 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLK-------FP--- 242 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcccc-------CC---
Confidence 12334579999999999999999999999999999999999999998754 22223332221111 11
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+++.+|+..+|.+|.+..|++++
T Consensus 243 ---------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ---------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1123346789999999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=332.75 Aligned_cols=256 Identities=29% Similarity=0.494 Sum_probs=207.4
Q ss_pred cCCCcCccccCcceEEEEEEEeCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998642 2579999987543 334567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC
Q 036011 756 LVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM 820 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 820 (977)
++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999997542 34788899999999999999999 78999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHH
Q 036011 821 VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 899 (977)
.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 999999999987654333223334457889999999988899999999999999999998 999987643221 11111
Q ss_pred HhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.... . .....+++..+.+++.+||+.+|.+||+++||+++|+++
T Consensus 240 ~~~~-----------~------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 RSRQ-----------L------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HcCC-----------c------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1100 0 001123556789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.50 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=206.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||.||+++.. +|..||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999975 68899999987653 3345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 999999999997654 38899999999999999999994 2469999999999999999999999999997654321
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc-------------
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG------------- 906 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 906 (977)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||......+ +...........
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccc
Confidence 223458999999999999999999999999999999999999996532211 111111100000
Q ss_pred ------------------hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 ------------------LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+..+. +............+..++.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDY-IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHH-HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 000000000011244568999999999999999999999876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.93 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=208.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||+||+|++. +...||||+++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56889999999999999999874 24589999987554 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++......+++..+.+++.|++.|++||| +.+|+||||||+||++++++.+|++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999876666899999999999999999999 7999999999999999999999999999999875322
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.........+++.|+|||...+..++.++||||||+++|||++ |..||......+ ..+........
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~----------- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGYRL----------- 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCC-----------
Confidence 2222222345678999999998999999999999999999998 999986532211 11111110000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
+...+++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=334.55 Aligned_cols=245 Identities=25% Similarity=0.304 Sum_probs=200.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999975 68999999987542 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999997655 4889999999999999999999 8999999999999999999999999999998664321
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
....|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ .....
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~--------~~~~~ 218 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----IYEKILAG--------KLEFP 218 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC--------CcCCC
Confidence 12458999999999999999999999999999999999999997532211 11110000 00000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
......+.+++.+|++.||.+||+ ++|++++
T Consensus 219 -------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 -------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011334688999999999999995 8887665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=338.40 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=206.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT----SFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.+|+..+.||+|+||.||+|++. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999864 333 48999986543 34456788999999999999999999998764 5679
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|+||+++|+|.+++......+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999887666899999999999999999999 899999999999999999999999999999977644
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..........++..|+|||++.+..++.++||||||+++|||++ |..||.+....+ ...+...... .
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~----------~ 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER----------L 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCCC----------C
Confidence 33222222335678999999999999999999999999999998 999987542211 1111111000 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+....+...+.+++.+||+.+|++||++.++++.+.++..
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0001123457899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.94 Aligned_cols=249 Identities=33% Similarity=0.546 Sum_probs=194.6
Q ss_pred cCccccCcceEEEEEEEeC-----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 687 ECNLLGRGSFGSVYKGTFS-----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+.||.|.||.||+|.+. .+..|+||++.... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999976 36789999996543 33478899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|+|.+++... ...+++..+.+|+.||++||+||| +.+++||||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 556899999999999999999999 788999999999999999999999999999877433333
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
...........|+|||.+....++.++||||||+++||+++ |+.||.+....+ ....... ....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~~~-----------~~~~-- 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKLKQ-----------GQRL-- 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHHHT-----------TEET--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc-----------cccc--
Confidence 23333457788999999998899999999999999999999 678876542211 1111110 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.....++..+.+++.+||+.+|++||++++++++|
T Consensus 225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00112345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.72 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=211.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe-eEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF-RALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 757 (977)
.+.|..++++|+|+||.++.++++ +++.||+|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467889999999999999999875 68899999987654 4445578899999999999999999999999888 9999
Q ss_pred EeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 758 LELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|+|++||++.+.+...+ ..+++..+.+++.|++.|+.||| +..|+|||||+.||+++.++.|||+|||+|+...+.
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998765 57899999999999999999999 788999999999999999999999999999998765
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.. .....+||+.||+||.+.+.+|..|+||||+||++|||++-+++|........ ..+. ..
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-i~ki----------------~~ 220 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-ILKI----------------NR 220 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-HHHH----------------hh
Confidence 42 33446799999999999999999999999999999999999999976422211 1111 11
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ..+.+..+...+..++..|++.+|+.||++.+++.+
T Consensus 221 ~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 112223345568889999999999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.80 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=200.3
Q ss_pred CCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.|+..+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377788999999999999986 479999999987543 2223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999998876533 35899999999999999999999 8999999999999999999999999999998754322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...... ...... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~-~~~~~~-------~--- 222 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDR-RVKEDQ-------E--- 222 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHH-Hhhccc-------c---
Confidence 22334689999999999999999999999999999999999999975422111 111110 000000 0
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
.........+.+++.+||+.+|++||+ +++++++
T Consensus 223 ----~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 ----EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000112345789999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.26 Aligned_cols=273 Identities=24% Similarity=0.304 Sum_probs=208.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCC-cceEeeeeecCC-----
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRN-LIKIFSSCCNND----- 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 752 (977)
...|..+++||+|+||+||+|+.+ +|+.||+|+++.+.+ .......+|+.+++.++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 344666788999999999999964 789999999987754 24455789999999999999 999999998776
Q ss_pred -eeEEEEeccCCCCHHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 753 -FRALVLELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 753 -~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
..++|+||++. +|..++.... ...+...+..+++||+.||+||| +++|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 78899999965 9999998765 34777899999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh-hCC--
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE-SLP-- 904 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~-- 904 (977)
+|+.+.-.. ...+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+...- .++.....- ..|
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCc
Confidence 999765332 235566799999999998876 7999999999999999999999888775432 222222111 011
Q ss_pred ---Cchhhhcchhhhcccc--Cc---hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 905 ---HGLMEVVDTNLLRQEH--TS---SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 905 ---~~~~~~~~~~~~~~~~--~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
.+.....+-....... .. ...........+++.+|++.+|.+|.|++.++++ +..+.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1111111111100000 00 1111111357899999999999999999999987 65553
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.06 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=215.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC---CC--CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS---DG--TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+..+..++||.|.||.||+|.+. .| -.||||..+.+. .+..+.|.+|..+|+.++||||++++|+|.+. ..++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34455678999999999999863 23 357889887755 34467899999999999999999999999764 5689
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|||.++-|.|..|++.++..++......++.||+.||+||| +..+|||||.++|||+.+...||++|||+++.+...
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999999989999999999999999999999 899999999999999999999999999999998765
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ..+...-++.|||||.+.-..++.++|||.|||.+||++. |.+||.+....+. +. -
T Consensus 545 ~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------------I~------~ 604 (974)
T KOG4257|consen 545 AYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------------IG------H 604 (974)
T ss_pred chh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------------EE------E
Confidence 543 3334556788999999999999999999999999999877 9999987544322 11 1
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+.....+.+..|+..++.++.+||.++|.+||.+.|+...|+.+..
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 12223345556788999999999999999999999999988876654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=339.86 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=204.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 58999999997653 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997654 4889999999999999999999 89999999999999999999999999999986543
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......||+.|+|||++.+..++.++||||+||++|||++|..||......+. ....... .. ....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~--~~----~~~~----- 219 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYW--KE----TLQR----- 219 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhc--cc----cccC-----
Confidence 12234699999999999999999999999999999999999999975432211 1111000 00 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+........+...+.+++.+|++.+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000001234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.48 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=203.1
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||.||+|+++++..+|+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999888889999987643 2234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.++++.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence 99999999865556899999999999999999999 789999999999999999999999999999865432211 11
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ........... ... +.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~-----~~~------~~- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFR-----LYR------PK- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC-----CCC------CC-
Confidence 22235678999999998899999999999999999999 88998653211 11111111000 000 00
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.....+.+++.+||+.+|++||+++|+++.|
T Consensus 225 -----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.80 Aligned_cols=245 Identities=24% Similarity=0.273 Sum_probs=200.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999975 68999999987542 233466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999997654 3788999999999999999999 8999999999999999999999999999998764322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+ .... .......
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~-~~i~--------~~~~~~p 235 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY-EKIL--------AGRLKFP 235 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH-HHHh--------cCCcCCC
Confidence 1246999999999999999999999999999999999999999653211 111 1000 0000000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
. .+...+.+++.+||+.||.+||+ ++|++.+
T Consensus 236 -~------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 -N------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -C------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 01234678999999999999997 5777644
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.07 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=201.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999865 689999999875432 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++ +|.+++...+..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 975 999998776666889999999999999999999 89999999999999999999999999999976543221
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh--hCCC----------ch
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPH----------GL 907 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~----------~~ 907 (977)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. +...... ..+. .+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhh
Confidence 1223458899999998765 5689999999999999999999999975432211 1111100 0000 00
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+....... .........+..+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCch-HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0001010000000 00001123457899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.03 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=205.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 753 (977)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467889999999999999999853 23479999997543 334567899999999996 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 036011 754 RALVLELMPNGSLEKWLYSDN----------------------------------------------------------- 774 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 774 (977)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886421
Q ss_pred ------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC
Q 036011 775 ------------------------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE 818 (977)
Q Consensus 775 ------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 818 (977)
..+++..+..++.|+++||+||| +.+|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13677888999999999999999 789999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHH
Q 036011 819 DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKK 897 (977)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 897 (977)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence 99999999999987644322222223346788999999999999999999999999999997 8999875432211 111
Q ss_pred HHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
... .+. . ......++..+.+++.+||+.+|++||++.++.+.|+++-
T Consensus 352 ~~~----~~~--------~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIK----SGY--------R-----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHh----cCC--------C-----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111 000 0 0001123456889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.83 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=203.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++.|++.+.||+|.|+.||++.. .+|+.+|+|++.... ....+++.+|+++.+.++||||+++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999975 479999999886543 44678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~ 834 (977)
+|+|.|++|..-+-.+ ...++..+-..++||+++|.|+| .++|||||+||+|+++. ....+|++|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999996444333 34788899999999999999999 89999999999999995 34469999999999887
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
. .......+|||+|||||++...+|+..+|||+.|||+|-++.|+.||.+... +..+.+.....+ +.
T Consensus 165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~y-----d~---- 231 (355)
T KOG0033|consen 165 D---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAY-----DY---- 231 (355)
T ss_pred C---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhcccc-----CC----
Confidence 3 2234557899999999999999999999999999999999999999976321 111122111111 00
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+.+....+...+++++|+..||.+|.|+.|++.+
T Consensus 232 ------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 ------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111222334456788999999999999999998653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.91 Aligned_cols=268 Identities=21% Similarity=0.236 Sum_probs=202.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 68899999987543 2334668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|++++.+..+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 9998877655443 345899999999999999999999 88999999999999999999999999999987643321
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH--hhCCCchhhh--cchhh
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK--ESLPHGLMEV--VDTNL 915 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~ 915 (977)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......+. ...... ...+...... .++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchh
Confidence 122234689999999999988999999999999999999999999976432111 111000 0000000000 00000
Q ss_pred hc---c-c-c-C---chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LR---Q-E-H-T---SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~---~-~-~-~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. . . . . ......+...+.+++.+|++.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0 0 0 0 00011234568999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.67 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=201.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999975 689999999875432 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|++ ++|.+++......++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 995 6888888776566899999999999999999999 8999999999999999999999999999987543221
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh--hCCCc-hhhh-----
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPHG-LMEV----- 910 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~-~~~~----- 910 (977)
.......+++.|+|||++.+ ..++.++||||+||++|||++|..||.+.......+...... ..... +...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12233458999999998765 468899999999999999999999997643322222211110 00000 0000
Q ss_pred cchh-hhc-cccCch---HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTN-LLR-QEHTSS---AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~-~~~-~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.++. ... ...... ........+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 000 000000 000122456789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.26 Aligned_cols=242 Identities=25% Similarity=0.269 Sum_probs=195.9
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999997653 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeec
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (977)
+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999987654 4899999999999999999999 8999999999999999999999999999987543221 12233
Q ss_pred cccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchH
Q 036011 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924 (977)
Q Consensus 845 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (977)
.+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...... .. ....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~---~~--------~~~~------- 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELIL---ME--------EIRF------- 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHH---cC--------CCCC-------
Confidence 469999999999999999999999999999999999999996532111 111110 00 0000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 925 EMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
+......+.+++.+|++.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 011234578899999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.39 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=208.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999742 356789999876666666789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 757 VLELMPNGSLEKWLYSDN------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
||||+++++|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999987543 24899999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhC
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ..........
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCc
Confidence 99999986644332222223346778999999999999999999999999999998 888886543211 1111111000
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. ... ..++..+.+++.+||+.+|.+|||+.|+.+.|+++..
T Consensus 241 ~------------~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 241 L------------QRP------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred C------------CCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 0 000 0123457999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.92 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=204.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT----SFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|++.+.||+|+||+||+|++. +++ .|++|.+.... .....++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46888899999999999999864 444 47778775433 2344678889999999999999999998754 45678
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
++||+++|+|.+++......+++..+..++.||+.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876667899999999999999999999 789999999999999999999999999999876544
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..........++..|+|||+..++.++.++||||||+++||+++ |..||.+....+ ..++.......
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~---------- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGERL---------- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCcC----------
Confidence 33333334457788999999998999999999999999999998 999987543211 12221110000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.. ...+...+.+++.+||..+|++|||+.|+.+.|..+..
T Consensus 231 -~~------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 -AQ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00 01123456789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.16 Aligned_cols=256 Identities=32% Similarity=0.484 Sum_probs=206.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC------CCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|.+.+.||+|+||.||+|+..+ ++.||||++...... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998633 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC-------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc
Q 036011 755 ALVLELMPNGSLEKWLYSDN-------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 821 (977)
++||||+++++|.+++...+ ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997542 24788899999999999999999 789999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHH
Q 036011 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (977)
+||+|||++................+++.|+|||++.++.++.++||||+||++|||++ |..||......+ ......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH
Confidence 99999999986543322222223346788999999999999999999999999999998 999986532211 111111
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.+. ... ....++..+.+++.+||+.+|++||++.||++.|++
T Consensus 239 ----~~~-------~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QGR-------LLQ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cCC-------cCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000 000 001234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=339.68 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=217.9
Q ss_pred CCcCccccCcceEEEEEEEe-CCC----CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 685 FNECNLLGRGSFGSVYKGTF-SDG----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
....++||+|+||+||+|.+ .+| -+||+|++.... .+...++.+|+-+|.+++|||+++++|+|.... ..+|+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34467899999999999986 344 468999876543 455688999999999999999999999998766 77999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
+|++.|+|.++++.++..+..+..+.|..|||+||.||| ++++|||||.++||||.+-..+||.|||+++...+.+.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999998888999999999999999999999 89999999999999999999999999999999988776
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
........-.+.|||=|.+....|+.++|||||||++||++| |..|+++....+. +.+.+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------------------~dlle 914 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------------------PDLLE 914 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------------------hHHHh
Confidence 666666667788999999999999999999999999999999 9999988654432 11222
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.....+.+..|..+++.++.+||..|+..||+++++..++.++.
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 22233444567888999999999999999999999999987765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.03 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=211.4
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
+...+|++.++||+|+||.||+|+..+++.+|+|++..........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567889999999999999999988899999999987766566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++|+|.+++.... ..+++..+..++.|++.|++||| +.||+||||+|+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999997643 35899999999999999999999 78999999999999999999999999999987643221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. .....++..|+|||...++.++.++||||||+++|+|++ |+.||......+ ...........
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~------------ 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITAGYRM------------ 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHhCCcC------------
Confidence 1 122346778999999988899999999999999999998 899986543211 11111110000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
+.+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.97 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=198.7
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 78999999876443 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 846 (977)
.+++......+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+|++|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999776656899999999999999999999 8899999999999999999999999999987654322111111122
Q ss_pred cCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHH
Q 036011 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925 (977)
Q Consensus 847 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (977)
.+..|+|||.+.++.++.++||||+|+++|||++ |..||....... .........+. ...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~-----------------~~~ 218 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRL-----------------PCP 218 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCC-----------------CCc
Confidence 3567999999999999999999999999999998 888886532211 11111100000 001
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 926 MDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 926 ~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
..++..+.+++.+|++.+|++||++.++.++|++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1234467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.17 Aligned_cols=255 Identities=22% Similarity=0.415 Sum_probs=206.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788999999999999999998888899999876542 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.++++.. ....++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999999764 345889999999999999999999 789999999999999999999999999999876532211
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||+..++.++.++||||+||++|+|++ |..||......+ ...+.......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYRM-------------- 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCC--------------
Confidence 1122335678999999998899999999999999999998 999986532211 11111111000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
+....++..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00011334578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.50 Aligned_cols=267 Identities=24% Similarity=0.336 Sum_probs=199.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-----eeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-----FRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 756 (977)
-.|+..+++|+|+||.||+|+.. +++.||||+...+.+ .-.+|+++|+.++|||||++..+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34677889999999999999965 579999998754422 2246999999999999999999885432 2347
Q ss_pred EEeccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeecccccc
Q 036011 757 VLELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKL 832 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~ 832 (977)
|||||+. +|.++++.. +..++...+.-+..||.+||+||| +.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 999888742 345888899999999999999999 7999999999999999965 9999999999999
Q ss_pred cCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC-C-Cc-h-
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-P-HG-L- 907 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~- 907 (977)
...+..... ...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.. +..++...++-.= | .. +
T Consensus 176 L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHh
Confidence 987766543 3478889999987764 79999999999999999999999988733 3333444332110 0 00 0
Q ss_pred ------hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 908 ------MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 908 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
.+...+.+...............+.++++.++++++|.+|.++.|++++ ++.++
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 0111111111111011112345567999999999999999999999754 34444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=335.84 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=199.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC--CCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD--GTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|.+.+.||+|+||.||+|+.+. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3569999999999999999998543 4689999987542 2345668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999997655 4899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. ....||+.|+|||++.+..++.++||||+||++|||++|..||....... .... +..+ ...
T Consensus 185 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~-----i~~~-------~~~ 246 (340)
T PTZ00426 185 T-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQK-----ILEG-------IIY 246 (340)
T ss_pred c-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHH-----HhcC-------CCC
Confidence 1 23469999999999998889999999999999999999999997532210 0111 0000 000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
.. . .....+.+++.+|++.+|++|+ +++|++++
T Consensus 247 ~p-~------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FP-K------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC-C------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 0 1123467899999999999995 78887665
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=350.86 Aligned_cols=250 Identities=23% Similarity=0.246 Sum_probs=202.9
Q ss_pred CCCcCccccCcceEEEEEEEeC-C-CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-D-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 3 6789999876665555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 762 PNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 762 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
++|+|.++++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888642 335889999999999999999999 78999999999999999999999999999987654332
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......+||++|+|||++.+..++.++||||+||++|||++|+.||...... .......... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~--------~--- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLYGK--------Y--- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC--------C---
Confidence 22233456999999999999999999999999999999999999998653211 1111110000 0
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
. +.+..+...+.+++.+||+.+|++||++.+++.
T Consensus 289 -~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -D--PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -C--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 000122345789999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=332.53 Aligned_cols=200 Identities=25% Similarity=0.352 Sum_probs=175.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999975 68899999987653 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++.... .+++.....++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999999997654 48899999999999999999994 2479999999999999999999999999997653321
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12345899999999999989999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=328.53 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=208.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++.+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778889999999999999742 356789999876655556779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc
Q 036011 757 VLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 821 (977)
||||+++++|.+++.... ..+++..++.++.||+.|++||| +++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997532 24789999999999999999999 889999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHH
Q 036011 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (977)
+||+|||++................++..|+|||+..+..++.++||||||+++|||+| |+.||......+ ..+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence 99999999986654332222233456788999999999999999999999999999999 999986543221 111110
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+ ..... ...++..+.+++.+||+.+|++||++++|++.|+++..
T Consensus 240 ----~~-------~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 ----QG-------RVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----CC-------CCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 00 00000 01134467899999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.84 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=203.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||+||.|+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777789999887442 234678999999999999999999999999889999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.+++......+++..++.++.||+.||+||| +.+++|+||||+||++++++.+||+|||.++....... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 99999999876556899999999999999999999 88999999999999999999999999999986643321 111
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....++..|+|||+..+..++.++||||||+++|||++ |..||......+ ........... ....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~-----------~~~~- 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRL-----------YRPH- 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCC-----------CCCC-
Confidence 12235678999999988889999999999999999998 999986533211 11111000000 0000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.....+.+++.+||+.+|++||++.++++.++
T Consensus 225 -----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 -----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12346789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.01 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=203.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
.+++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999753 35679999986433 2345668899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 754 RALVLELMPNGSLEKWLYSDN---------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
.++||||+++|+|.+++.... ...++..+..++.|+++|++||| +.+++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999987532 13578889999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhC
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...... ...++..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~--- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVM--- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---
Confidence 99999986644332222222346788999999998999999999999999999999 68888653221 1111111
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
..... ... ..++..+.+++.+|++.+|++||++.|+++.|++
T Consensus 236 ~~~~~--------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLL--------DKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcC--------CCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00000 000 1123457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=325.75 Aligned_cols=271 Identities=27% Similarity=0.418 Sum_probs=206.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC-----CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-----DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 755 (977)
..|++.+.||+|+||.||+|..+ +++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999742 588999999877666667789999999999999999999998754 34678
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999776556899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCccee-eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC--Cchhhhcc
Q 036011 836 GDDSVTQ-TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP--HGLMEVVD 912 (977)
Q Consensus 836 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 912 (977)
....... ....++..|+|||+..+..++.++||||+|+++|||++|..|+...... ..+....... .....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 3322111 1122445699999999889999999999999999999998775432110 0000000000 00000000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
........+....+...+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 --LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred --HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000001111234456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=299.20 Aligned_cols=249 Identities=29% Similarity=0.395 Sum_probs=206.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
..|+..+.+|.|..++|-++..+ +|+.+|+|++.... ....+.-.+|+.+++++ .||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45677789999999999988764 68999999987543 12345567899999999 5999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++|+|.|+.|.|.+++.+.-. +++....+|++|+.+|++||| ...|||||+||+|||+|++.++||+|||+|+.
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999987553 899999999999999999999 89999999999999999999999999999999
Q ss_pred cCCCCCcceeeccccCCcccCccccC------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc-cHHHHHHhhCCC
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGT------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM-SLKKWVKESLPH 905 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 905 (977)
+.++.. -...||||+|+|||.+. ...|+..+|.|+.||+||.++.|.+||-.. .++ .+.-.+
T Consensus 173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~Im------ 241 (411)
T KOG0599|consen 173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMIM------ 241 (411)
T ss_pred cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHHH------
Confidence 887653 34568999999999764 345888999999999999999999998431 110 011111
Q ss_pred chhhhcchhhhcc-ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQ-EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.++ ...++++.+......+++.+|++.||++|.|++|++++
T Consensus 242 ----------eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 242 ----------EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----------hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111 13356677778888999999999999999999999764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=330.59 Aligned_cols=239 Identities=26% Similarity=0.265 Sum_probs=193.2
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 58899999987542 33446678899999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 846 (977)
.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence 99997654 4899999999999999999999 89999999999999999999999999999986432221 223356
Q ss_pred cCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 847 gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .+......... ... +.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~--------~~~-------~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP--------LRF-------PD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC--------CCC-------CC
Confidence 99999999999999999999999999999999999999975321 11111111110 000 01
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 036011 927 DCLLSVLHLALDCCMESPDQRIY---MTDAAV 955 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs---~~ev~~ 955 (977)
.....+.+++.+||+.+|.+||+ +.|++.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 12345788999999999999985 555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.60 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=208.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999965 78999999875422 334456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 2335788999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ......+++.|+|||...+..++.++||||+|+++|||++|+.||....... ..+......... +
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~-- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCDY-----P-- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcCCC-----C--
Confidence 221 1122358889999999988889999999999999999999999986432221 111111000000 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..........+.+++.+||+.+|++||++.+|++.+++++
T Consensus 227 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011133456889999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=321.52 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=205.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999998778899999987543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999997654 45899999999999999999999 789999999999999999999999999999877532211
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
.......+..|+|||+..+..++.++||||||+++|||++ |+.||......+ ....+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYRM-------------- 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC--------------
Confidence 1111223457999999999999999999999999999999 999986542211 11111110000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+....+...+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0001234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.19 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=203.3
Q ss_pred cCCCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|++.+.||+|+||+||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 246789999987443 3344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC
Q 036011 757 VLELMPNGSLEKWLYSDN----------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM 820 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 820 (977)
||||+++++|.+++.... ..+++.....++.|++.||+||| +++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999985321 24788899999999999999999 78999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHH
Q 036011 821 VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 899 (977)
.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||..... ....+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999987654332222233346778999999988899999999999999999998 8888865321 1111111
Q ss_pred HhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
..... .. .+..+...+.+++.+||+.+|++||++.++.++|.+
T Consensus 240 ~~~~~-----------~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQL-----------LP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCc-----------CC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11000 00 011234467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=310.63 Aligned_cols=266 Identities=25% Similarity=0.394 Sum_probs=208.5
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHh--cCCCCcceEeeeeecCC----eeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN--VRHRNLIKIFSSCCNND----FRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 756 (977)
.+....+.||+|.||.||+|++ .|+.||||+|.... .+.+.+|.++++. ++|+||+.+++.-..+. +.+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4567789999999999999999 58999999997443 3456667777765 59999999999865443 6789
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-----HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
|++|.+.|||.||+.... ++....++++..+|.||++|| .+.++.|+|||||++||||..++.+.|+|+|+|.
T Consensus 287 vTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999999998744 899999999999999999999 3567889999999999999999999999999998
Q ss_pred ccCCCCCc--ceeeccccCCcccCccccCCCC----c--CcccchhhHhHHHHHHhcC----------CCCCCcCCcccc
Q 036011 832 LFDEGDDS--VTQTMTIATIGYMAPEYGTEGI----V--SSKCDVYSYGVLLTETFTR----------KKPTDDMFTGEM 893 (977)
Q Consensus 832 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~il~elltg----------~~p~~~~~~~~~ 893 (977)
........ ......+||.+|||||++.... + -..+||||||.|+||+..+ +.||.+..+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 77654322 2344578999999999976532 1 2359999999999999874 477777666665
Q ss_pred cHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 894 SLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+.++..+-.-.+++. ..........++...|.++++.||..+|..|.|+--+.+.+.++..
T Consensus 445 s~eeMrkVVCv~~~R--------P~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLR--------PNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhcceeecccC--------CCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 555533222222111 1112222334567789999999999999999999999999988873
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=331.95 Aligned_cols=242 Identities=24% Similarity=0.275 Sum_probs=195.4
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999864 68999999997653 234456778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeec
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (977)
+|..++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 9998887654 4899999999999999999999 88999999999999999999999999999875432211 2223
Q ss_pred cccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchH
Q 036011 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924 (977)
Q Consensus 845 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (977)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ ....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~~------------~~~~------- 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME------------EIRF------- 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhcC------------CCCC-------
Confidence 469999999999999999999999999999999999999986532211 11111000 0000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 925 EMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
+..+...+.+++.+|++.+|++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 011234578899999999999998 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=331.37 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=203.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeec-CCe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN-NDF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~~ 753 (977)
++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+.+++++ +||||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57889999999999999999642 35789999987543 23345678899999999 89999999998865 456
Q ss_pred eEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 036011 754 RALVLELMPNGSLEKWLYSDN----------------------------------------------------------- 774 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 774 (977)
.+++|||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999986421
Q ss_pred -ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccC
Q 036011 775 -YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853 (977)
Q Consensus 775 -~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 853 (977)
..+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 14789999999999999999999 88999999999999999999999999999987654332222233446778999
Q ss_pred ccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHH
Q 036011 854 PEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSV 932 (977)
Q Consensus 854 PE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 932 (977)
||++.+..++.++||||+||++|||++ |..||.+....+ .+.......... .. +......+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-----------~~------~~~~~~~~ 305 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM-----------RA------PEYATPEI 305 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC-----------CC------CccCCHHH
Confidence 999999999999999999999999998 999986532221 111111110000 00 01123457
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 933 LHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 933 ~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+++.+||+.+|++||++.|++++|+++-
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.17 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=212.1
Q ss_pred cCCCcCccccCcceEEEEEEEeCC-CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.+.....+||-|.||.||.|.|+. .-.||||.++.+ .-..++|.+|+.+|+.++|||+|+++|+|..+...|+|+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345566899999999999999874 567999998755 445689999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
..|+|.+|++.-.+ ..+....+.++.||+.||+||. .+.+|||||.++|.|+.++..||++|||+++++..+.+..
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 99999999986443 4677788899999999999999 7889999999999999999999999999999987543322
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++.|.|||-+....++.|+|||+|||++||+.| |..||.+.... + .+.++...+
T Consensus 423 -HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----q---------VY~LLEkgy---- 483 (1157)
T KOG4278|consen 423 -HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q---------VYGLLEKGY---- 483 (1157)
T ss_pred -ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----H---------HHHHHhccc----
Confidence 223346788999999999999999999999999999998 77887664221 1 122222222
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.-..+..|+++++++++.||+++|.+||+++|+-+.++.+-
T Consensus 484 -RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 -RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22333458889999999999999999999999999998765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=320.43 Aligned_cols=251 Identities=28% Similarity=0.376 Sum_probs=202.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.+|++.+.||+|+||.||+|+++++..+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578889999999999999998777889999986432 223568889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+++|.+++......+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||+++........ ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence 99999999876556899999999999999999999 789999999999999999999999999999865432211 11
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....++..|+|||...+..++.++||||||+++||+++ |+.||......+ .......... .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~--------~-------- 220 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGYR--------L-------- 220 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCCc--------C--------
Confidence 11224457999999999999999999999999999999 788886532211 1111111000 0
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.....++..+.+++.+||+.+|++||++.|+++.|
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00011345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.19 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=204.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.+|++.+.||+|+||.||+|..+ .++.||+|++..+ ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778889999999999999865 5889999998754 333567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++++|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 9999999987543 35899999999999999999999 789999999999999999999999999999876543211
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||...+..++.++|||||||++|||++ |..||...... +..... ... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~-~~~--------~~~~- 225 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELL-EKG--------YRME- 225 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH-HCC--------CCCC-
Confidence 1111234668999999999999999999999999999998 88998653211 111110 000 0000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
....++..+.+++.+||+.+|++||++.++.++|+.+
T Consensus 226 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=323.44 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=205.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGT----SFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
.++|+..++||+|+||+||+|++. +|+ .||+|++.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356888999999999999999853 444 48999986543 33456788999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+++||+++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876666899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
...........+++.|+|||...+..++.++|||||||++|||++ |..||..... .....+.......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcC---------
Confidence 332222222335678999999998899999999999999999998 8888865322 1122222111000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+....+...+.+++.+||+.+|++||++.|+++.++++..
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 --------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0011234467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.62 Aligned_cols=242 Identities=24% Similarity=0.290 Sum_probs=196.0
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999865 68999999997653 234566788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeec
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (977)
+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999887654 4899999999999999999999 8999999999999999999999999999987543221 12233
Q ss_pred cccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchH
Q 036011 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924 (977)
Q Consensus 845 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (977)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ..+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~------~~~--------- 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED------IKF--------- 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC------ccC---------
Confidence 46999999999999999999999999999999999999999653211 1111110000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 925 EMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
+......+.+++.+|++.+|++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 011234578899999999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.95 Aligned_cols=368 Identities=26% Similarity=0.417 Sum_probs=196.4
Q ss_pred ccCcccccEeeccCCccc-ccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcc
Q 036011 70 LGNFSFLMSLDISKNNFH-AYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRL 148 (977)
Q Consensus 70 l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 148 (977)
.|-|+..+-+|+++|.++ +..|.....++++++|.|...++. .+|..++.|.+|++|.+++|+++ .+...+..|+.|
T Consensus 3 tgVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 3 TGVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred ccccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 345666777777777777 457777788888888888888887 78888888888888888888877 455555556666
Q ss_pred cceecccccccc-ccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccC
Q 036011 149 EKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFG 227 (977)
Q Consensus 149 ~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~ 227 (977)
+.+++..|+++. -+|..|-.+..|..|+||+|+++ +.|..+..-+++-.|+||+|+|.
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-------------------- 139 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-------------------- 139 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc--------------------
Confidence 665555555542 23444445555555555555555 45544444444444444444444
Q ss_pred CcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCC
Q 036011 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307 (977)
Q Consensus 228 N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 307 (977)
.+|..++.+|..|-.||||+|++. .+|..+..+..|++|+|++|.+...--..+-.|
T Consensus 140 -------tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsm--------------- 196 (1255)
T KOG0444|consen 140 -------TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSM--------------- 196 (1255)
T ss_pred -------cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccc---------------
Confidence 345445555555555566666655 455555556666666666665543211112222
Q ss_pred CCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCC
Q 036011 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG 387 (977)
Q Consensus 308 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 387 (977)
++|++|.+++-+-+ ...+|.++..+.+|..++++.|.+.
T Consensus 197 ----------------tsL~vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp- 235 (1255)
T KOG0444|consen 197 ----------------TSLSVLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVDLSENNLP- 235 (1255)
T ss_pred ----------------hhhhhhhcccccch------------------------hhcCCCchhhhhhhhhccccccCCC-
Confidence 23333333322211 0123444444455555555555444
Q ss_pred CCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccC
Q 036011 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWS 467 (977)
Q Consensus 388 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 467 (977)
.+|..+..+++|+.|+||+|+|+ ..... .+.-.+|+.|+||+|+++ .+|.+++.
T Consensus 236 ~vPecly~l~~LrrLNLS~N~it-eL~~~------------------------~~~W~~lEtLNlSrNQLt-~LP~avcK 289 (1255)
T KOG0444|consen 236 IVPECLYKLRNLRRLNLSGNKIT-ELNMT------------------------EGEWENLETLNLSRNQLT-VLPDAVCK 289 (1255)
T ss_pred cchHHHhhhhhhheeccCcCcee-eeecc------------------------HHHHhhhhhhccccchhc-cchHHHhh
Confidence 44444444444444444444444 11111 222223333333333333 33333333
Q ss_pred cccCceEEccCCCCC-CCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCee
Q 036011 468 LEYLLAVNLSSNSLS-GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESL 546 (977)
Q Consensus 468 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 546 (977)
+++|+.|.+.+|+++ ..+|..++.|.+|+.+..++|.+. .+|..++.+.+|+.|.|++|++- .+|+.+.-|+.|+.|
T Consensus 290 L~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vL 367 (1255)
T KOG0444|consen 290 LTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVL 367 (1255)
T ss_pred hHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCccee
Confidence 333333333333332 124555555666666666666665 55566666666666666666655 455555555555555
Q ss_pred eccCCc
Q 036011 547 DLSNNN 552 (977)
Q Consensus 547 ~Ls~N~ 552 (977)
||..|.
T Consensus 368 DlreNp 373 (1255)
T KOG0444|consen 368 DLRENP 373 (1255)
T ss_pred eccCCc
Confidence 655554
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.62 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=204.0
Q ss_pred CCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEE
Q 036011 685 FNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRAL 756 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 756 (977)
|...+.||+|+||+||.+.. .+++.||+|++..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 3578999999876532 3456788999999999999999999988653 46789
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++.... +++..+..++.|+++|++||| +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus 86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999997654 899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCcce-eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC-Cchhhhcchh
Q 036011 837 DDSVT-QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP-HGLMEVVDTN 914 (977)
Q Consensus 837 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 914 (977)
..... .....++..|+|||...+..++.++||||||+++|||++|+.||............+...... ....+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 22111 112235667999999988899999999999999999999999986533211111111000000 0011111111
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.. .+....++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 241 ~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MR-----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CC-----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 10 0011234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=348.98 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=205.1
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC--
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-- 752 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 752 (977)
.....++|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+..+..++|+||+++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445678999999999999999999854 79999999987543 344567889999999999999999988765432
Q ss_pred ------eeEEEEeccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceE
Q 036011 753 ------FRALVLELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 753 ------~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 367999999999999998753 235889999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHh
Confidence 9999999876543222223345699999999999999999999999999999999999999965321 11111111
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... . +.+..+...+.+++.+||+.+|.+||++.+++++
T Consensus 259 ~~~~------------~--~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY------------D--PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC------------C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1000 0 0011234567899999999999999999999764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=338.65 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=196.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.|+.++.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 68999999997543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999987655 3889999999999999999999 899999999999999999999999999998643211000
Q ss_pred ---------------------------------------------ceeeccccCCcccCccccCCCCcCcccchhhHhHH
Q 036011 840 ---------------------------------------------VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVL 874 (977)
Q Consensus 840 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 874 (977)
......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00112469999999999998999999999999999
Q ss_pred HHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHH--hhcCCCCCCCCHHH
Q 036011 875 LTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALD--CCMESPDQRIYMTD 952 (977)
Q Consensus 875 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPs~~e 952 (977)
+|||++|..||......+.. ..... ... ..... ....+...+.+++.+ |+..+|..||++.|
T Consensus 238 l~elltG~~Pf~~~~~~~~~-~~i~~---~~~-------~~~~~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ-LKVIN---WEN-------TLHIP-----PQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH-HHHHc---ccc-------ccCCC-----CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999764322111 11000 000 00000 000122345667766 55667777999999
Q ss_pred HHHH
Q 036011 953 AAVK 956 (977)
Q Consensus 953 v~~~ 956 (977)
++++
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.27 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=204.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.+|...+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777889999999999999642 466899999876666667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 757 VLELMPNGSLEKWLYSDN--------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999987643 24789999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |..||......+. .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IECIT- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HHHHH-
Confidence 9999999976543322111222335678999999999999999999999999999998 8888865322111 11000
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
...... ....++..+.+++.+||+.+|.+||++.|+.+.|++
T Consensus 239 ----------~~~~~~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 ----------QGRELE------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----------cCccCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000000 001234557899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=337.68 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=204.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 69999999997553 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC-
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD- 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 837 (977)
||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 34899999999999999999999 7999999999999999999999999999998765432
Q ss_pred --------------------------CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc
Q 036011 838 --------------------------DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG 891 (977)
Q Consensus 838 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~ 891 (977)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001122346999999999999999999999999999999999999999764321
Q ss_pred cccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 036011 892 EMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-MTDAAVK 956 (977)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~ev~~~ 956 (977)
+ .+..-.... ..+..... ..+...+.+++.+|++ +|.+||+ +.|++++
T Consensus 237 ~----~~~~i~~~~-------~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E----TYNKIINWK-------ESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HHHHHhccC-------CcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 111100000 00000000 0134457889999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=341.53 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=207.9
Q ss_pred cCCCcCccccCcceEEEEEEEeCCC-CEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeee-eec------CCe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDG-TSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSS-CCN------NDF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~~~ 753 (977)
.++++.+.|.+|||+.||.|+...+ ..||+|++-...+...+...+||++|++|+ |||||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4466778999999999999997655 999999988777777888999999999997 9999999993 221 246
Q ss_pred eEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
+++.||||.||.|.+++..+- ..+++.++++|+.++++|+++||.. +.+|+|||||-+|||++.++..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 789999999999999998542 2499999999999999999999953 46799999999999999999999999999975
Q ss_pred cCCCCCc-ceee------ccccCCcccCcccc---CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 833 FDEGDDS-VTQT------MTIATIGYMAPEYG---TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 833 ~~~~~~~-~~~~------~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
....... .... ...-|+.|+|||++ .+..+++|+|||++||++|-|+....||++...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------ 263 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------ 263 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence 4332211 0000 12468999999975 577899999999999999999999999976311
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..|++..+.... ...+...|.++|..||+++|.+||++-+|+..+.++..
T Consensus 264 -----laIlng~Y~~P~-----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 -----LAILNGNYSFPP-----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----eeEEeccccCCC-----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 223333332222 13466779999999999999999999999999988773
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=327.14 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=206.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
..++|+..+.||+|+||.||+|... ....+|+|++.... ......+.+|+++++++ +||||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467888999999999999999864 23689999987543 34456688999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcC---------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 753 FRALVLELMPNGSLEKWLYSD---------------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
..+++|||+++|+|.++++.. ...+++..++.++.|++.|++||| +.+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 999999999999999998642 235889999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHH
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLK 896 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 896 (977)
.++.+||+|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||......+ ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence 999999999999987654332222222335678999999988999999999999999999998 888886532211 11
Q ss_pred HHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
+...... .. .....+...+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 245 ~~~~~~~------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGY------------RM-----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCC------------cC-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1110000 00 000122446789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.95 Aligned_cols=266 Identities=23% Similarity=0.275 Sum_probs=197.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----CeeE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DFRA 755 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 755 (977)
+|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 68999999987432 23345688999999999999999999987543 2479
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+. ++|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68999887654 3899999999999999999999 88999999999999999999999999999986533
Q ss_pred CCC-cceeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc----hh
Q 036011 836 GDD-SVTQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG----LM 908 (977)
Q Consensus 836 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 908 (977)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+....... ..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHHH
Confidence 221 112233569999999998865 678999999999999999999999996532211 111111110000 00
Q ss_pred hhcch-------hhhcccc-C-chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDT-------NLLRQEH-T-SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~-------~~~~~~~-~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+... .+..... . ..........+.+++.+||+.+|++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0000000 0 00001123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=334.47 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=193.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+|+..+.||+|+||+||+|+.. +++.||||++..... .....+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566788999999999999865 689999999865433 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|.+.. ..++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.+..... .
T Consensus 155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 999986532 2567788899999999999999 78999999999999999999999999999987643221 1
Q ss_pred eeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 842 QTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ...........
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~----------- 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMS----------- 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhcc-----------
Confidence 223469999999998743 334568999999999999999999997322111 11111000000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ......+...+.+++.+||+.+|++||++.|++++
T Consensus 292 -~~--~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -QP--PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CC--CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00011234568899999999999999999999886
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=325.39 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=202.1
Q ss_pred CCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 257899999875543 334668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC---------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc
Q 036011 757 VLELMPNGSLEKWLYSD---------------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 821 (977)
++||+++++|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998532 124788889999999999999999 789999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHH
Q 036011 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (977)
+||+|||+++...............+++.|+|||++.++.++.++||||+||++|||++ |..||.+.... .+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 99999999887644332222233346788999999988889999999999999999998 77887653221 1111
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
........ ....+++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 238 ~i~~~~~~--------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVL--------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcC--------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111000 0011345567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=332.38 Aligned_cols=263 Identities=19% Similarity=0.208 Sum_probs=199.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999864 68999999743 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+. ++|..++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 95 68888886654 4889999999999999999999 78999999999999999999999999999976432211 1
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc------cccHHHHHHhh------CCCc--
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG------EMSLKKWVKES------LPHG-- 906 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~------~~~~~~~~~~~------~~~~-- 906 (977)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+....... ++..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 222346999999999999999999999999999999999999887542211 11111111110 0000
Q ss_pred --hhhhc---chhhhccccCc---hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 --LMEVV---DTNLLRQEHTS---SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 --~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... .......+... ......+..+.+++.+|++.||.+|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000001111 1112345678899999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=335.00 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=202.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|.+.+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 689999999986532 34456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877556899999999999999999999 89999999999999999999999999999987654332
Q ss_pred cceeeccccCCcccCccccC------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGT------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||......+ .........
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~------ 225 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQ------ 225 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCC------
Confidence 2 223346899999999876 4568899999999999999999999996532211 111110000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... +........+.+++.+|++ +|.+||++.+++++
T Consensus 226 -~~~~~----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 -RFLKF----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -CccCC----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00000 0001123457789999998 99999999998764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.52 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=202.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467889999999999999999875 35678999886543 3334568999999999999999999999999899
Q ss_pred eEEEEeccCCCCHHHHhhcCC------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceEE
Q 036011 754 RALVLELMPNGSLEKWLYSDN------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAHV 824 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl 824 (977)
.++||||+++++|.+++.... ..+++..+.+++.||+.|++||| +.+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997643 24889999999999999999999 78999999999999998654 6999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhC
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~--- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVT--- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH---
Confidence 99999987643222111112234568999999998999999999999999999997 999987533221 111110
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
... .. ..+..++..+.+++.+|++.+|++||++.+|+++|.
T Consensus 236 ~~~-------~~-------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGG-------RL-------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC-------cC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 00 001123456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.38 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=193.8
Q ss_pred ccccCcceEEEEEEEe----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 689 NLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+.||+|+||.||+++. ..++.||||++.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 358899999987542 22335578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++|+|.+++...+ .+.+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999999997655 3788889999999999999999 78999999999999999999999999999875432221
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~--------~~~~~~~-- 220 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKIL--------KGKLNLP-- 220 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHH--------cCCCCCC--
Confidence 122346999999999999989999999999999999999999999753221 1111110 0000000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
..+...+.+++.+|++.+|++|| ++.+++++
T Consensus 221 -----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 221 -----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01234578999999999999999 77777653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.65 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=207.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888999999999999999741 34579999987543 34456789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 752 DFRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
...++||||+++|+|.+++.... ..+++..+..++.||++||+||| +.||+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999997642 24788899999999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
++++.+||+|||+++...............+++.|+|||+..+..++.++||||||+++||+++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987754332222223346678999999998899999999999999999998 7788754321
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
.++.... .... . ......++..+.+++.+||+.+|.+||++.|+++.|+++...
T Consensus 246 ~~~~~~~-~~~~------~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLL-KEGH------R-------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHH-HcCC------c-------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111110 0000 0 000112345688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.47 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=202.3
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||+|+||.||+++.+ +|+.||+|++..... .....+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 699999999864321 2234456799999999999999999999999999999999999999
Q ss_pred HHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecc
Q 036011 767 EKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845 (977)
Q Consensus 767 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (977)
.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 98886543 35889999999999999999999 8999999999999999999999999999998765322 22234
Q ss_pred ccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHH
Q 036011 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925 (977)
Q Consensus 846 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (977)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... ............. ..... .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~--------~~~~~------~ 219 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLED--------EVKFE------H 219 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcc--------ccccc------c
Confidence 6899999999999889999999999999999999999998653221 1111111111110 00000 0
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCcccccc
Q 036011 926 MDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVLVLSR 970 (977)
Q Consensus 926 ~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~ 970 (977)
..+...+.+++.+|++.+|++||+++|+++.+..-..+....+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 123445789999999999999999988887776666654444433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.42 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=203.9
Q ss_pred CCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+|++.+.||+|+||.||+|+.. ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578999887554 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 036011 757 VLELMPNGSLEKWLYSDN-----------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSN 813 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 813 (977)
||||+.+|+|.+++.... ..+++..++.++.|++.|++||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999986421 24788999999999999999999 7899999999999
Q ss_pred eeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCccc
Q 036011 814 ILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGE 892 (977)
Q Consensus 814 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 892 (977)
|++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986643332222223346778999999988899999999999999999998 99998653211
Q ss_pred ccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+..+..... ... ....+...+.+++.+|++.+|++||+++|+++.|+++-
T Consensus 237 -~~~~~~~~~~------------~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 -RLFNLLKTGY------------RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHHHhCCC------------CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111111100 000 01123346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.05 Aligned_cols=265 Identities=25% Similarity=0.335 Sum_probs=195.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC--CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhc---CCCCcceEeeeeec-----
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS--DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV---RHRNLIKIFSSCCN----- 750 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 750 (977)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 47889999987543 22234566777777766 69999999998852
Q ss_pred CCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccc
Q 036011 751 NDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGL 829 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 829 (977)
....++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 446789999996 69999887543 35899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CC--Cc
Q 036011 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LP--HG 906 (977)
Q Consensus 830 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~--~~ 906 (977)
++...... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+....... .+ ..
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence 98764331 2233468999999999988899999999999999999999999997643221 111111110 00 00
Q ss_pred hhh---hcchhhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 907 LME---VVDTNLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 907 ~~~---~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
+.. .....+....... ....+....+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000000 000123445679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=319.21 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=201.1
Q ss_pred CCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe-----
Q 036011 685 FNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF----- 753 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 753 (977)
|.+.+.||+|+||.||+|.... +..||+|++..+. ....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 4789999987543 3345678999999999999999999998865543
Q ss_pred -eEEEEeccCCCCHHHHhhcC-----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 754 -RALVLELMPNGSLEKWLYSD-----NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 754 -~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
.++||||+++|+|..++... ...+++.....++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999888542 225899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
|+++.+.............++..|+|||++.+..++.++||||+||++|||++ |..||.+.... ...++.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~- 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRL- 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC-
Confidence 99987654432222222345678999999988999999999999999999999 88888653221 111211110000
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
..+..+...+.+++.+||+.+|.+||++.|+++.|+++
T Consensus 235 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 ----------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=349.56 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=203.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.++||+|+||.||+|+.. +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999965 68999999987542 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 759 ELMPNGSLEKWLYSD----------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 759 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
||++||+|.+++... ....++..+++++.||++||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 123567788999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCc----------------ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc
Q 036011 829 LSKLFDEGDDS----------------VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892 (977)
Q Consensus 829 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 892 (977)
+++........ ......+||+.|+|||+..+..++.++||||+||++|||+||+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876211100 00112469999999999999999999999999999999999999996532211
Q ss_pred ccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHchh
Q 036011 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-YMTDAAVKLKKIK 961 (977)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~ev~~~L~~~~ 961 (977)
.... .... ++. ......+.+..+.+++.+|++.+|++|| +++++.+.|+...
T Consensus 239 i~~~----~~i~-------~P~------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISYR----DVIL-------SPI------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhh----hhcc-------Chh------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1100 0000 000 0000113345678899999999999996 6677777776654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=336.92 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=199.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999975 68999999997542 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997655 4899999999999999999999 88999999999999999999999999999876532211
Q ss_pred cc------------------------------------eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCC
Q 036011 839 SV------------------------------------TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK 882 (977)
Q Consensus 839 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 882 (977)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 001235999999999999999999999999999999999999
Q ss_pred CCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 036011 883 KPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY---MTDAAVK 956 (977)
Q Consensus 883 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~ev~~~ 956 (977)
.||......+. ....... .. .+.... .......+.+++.+|+. +|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~~~~-~~~i~~~--~~--------~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQET-YRKIINW--KE--------TLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHH-HHHHHcC--CC--------ccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99975432111 1110000 00 000000 00123346788888886 9999998 8888664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.72 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=205.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CC---CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DG---TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.+|.+.+.||+|+||.||+|+.. ++ ..||||++.... ......|..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999864 33 369999987553 34457799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++......+++..++.++.|++.|++||| +.|++||||||+||+++.++.+|++|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876666899999999999999999999 7899999999999999999999999999998765432
Q ss_pred Ccceeeccc---cCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 838 DSVTQTMTI---ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 838 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
......... .+..|+|||+..+..++.++||||+||++||+++ |..||...... ....++.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~--------- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR--------- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence 221111111 2457999999999999999999999999999886 99998653221 12222211100
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.+...+++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000112345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.84 Aligned_cols=252 Identities=26% Similarity=0.307 Sum_probs=211.8
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 755 (977)
....|++.+.||+|.||.||+++.+ +|+.+|+|++.+... ...+.+.+|+++|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3466888899999999999999976 499999999987653 23468899999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC----CceEEeeccccc
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED----MVAHVSDFGLSK 831 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~ 831 (977)
+|||++.||.|.+.+... . +++.++..++.|++.+++||| +.||+|||+||+|+|+... +.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999998877 3 899999999999999999999 8999999999999999633 579999999999
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
+... .......+||+.|+|||++....|+.++||||+||++|.|++|..||.+....+... . +.
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~------------i~ 251 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A------------IL 251 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H------------HH
Confidence 8876 234455789999999999999999999999999999999999999997653322211 1 11
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+ ....+.+.+......+++..|+..||.+|+|+.+++++
T Consensus 252 ~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 11223344556667899999999999999999999985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.50 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=204.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
+.|+.++.||.|.-|+||.++.+ .+..+|+|++.+.. .....+.+.|-++|+.+.||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34667789999999999999976 46899999998775 344556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC-
Q 036011 759 ELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG- 836 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~- 836 (977)
|||+||+|....+.+. ..+++..+.-++..|.-||+||| -.|||+|||||+||||.++|++.|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999888654 47899999999999999999999 899999999999999999999999999998643210
Q ss_pred ------C------------------------C-c----------------------ceeeccccCCcccCccccCCCCcC
Q 036011 837 ------D------------------------D-S----------------------VTQTMTIATIGYMAPEYGTEGIVS 863 (977)
Q Consensus 837 ------~------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 863 (977)
. . . ......+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0 001113699999999999999999
Q ss_pred cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCC
Q 036011 864 SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMES 943 (977)
Q Consensus 864 ~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~ 943 (977)
.++|+|+|||++|||+.|..||.+....+ .+.. ++.+.+.. +..........++|++.+.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~N------------Iv~~~l~F-----p~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRN------------IVGQPLKF-----PEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHH------------HhcCCCcC-----CCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999998754332 2222 22222211 111133445788999999999
Q ss_pred CCCCCC----HHHHHHH
Q 036011 944 PDQRIY----MTDAAVK 956 (977)
Q Consensus 944 P~~RPs----~~ev~~~ 956 (977)
|.+|.. +.||.++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 7777553
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.34 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=204.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
++|.+.+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999752 23579999987543 34456788899999999 7999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 753 FRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
..++||||+++|+|.+++.... ..+++..+.+++.|++.||+||| +.|++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997642 24788999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHH
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLK 896 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 896 (977)
.++.+||+|||.++...............+++.|+|||+..+..++.++||||+||++|||++ |..||..... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----E 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H
Confidence 999999999999986643222111222234568999999998999999999999999999998 8888754321 1
Q ss_pred HHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...... ... .. ......+...+.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 250 ~~~~~~-~~~--------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLL-KEG--------HR-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHH-HcC--------CC-----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111110 000 00 00011234467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=327.08 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=193.0
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHH---HhcCCCCcceEeeeeecCCeeEEE
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVL---RNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677889999999999999865 68999999997543 22345566676655 466799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|..++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999888653 4899999999999999999999 8999999999999999999999999999987543221
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... .....
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~------------~~~~~ 220 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVN------------DEVRY 220 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh------------CCCCC
Confidence 12233569999999999999999999999999999999999999997532211 1111100 00000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAV 955 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~ 955 (977)
+..+...+.+++.+|++.||.+|| ++.++++
T Consensus 221 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 -------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011234578899999999999999 4556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.82 Aligned_cols=252 Identities=24% Similarity=0.275 Sum_probs=197.8
Q ss_pred CCCcCccccCcceEEEEEEEe----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 684 GFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
+|++.+.||+|+||+||+++. .+++.||+|++.+.. ....+.+.+|+++++++ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 358899999987542 23345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999987654 3899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ........... ++
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~~ 228 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------DP 228 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------CC
Confidence 33222 12234699999999998765 478999999999999999999999964322111 11111110000 00
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
.+ .......+.+++.+|++.||++|| ++++++++
T Consensus 229 ~~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PF---------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC---------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 001234567899999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.50 Aligned_cols=254 Identities=27% Similarity=0.475 Sum_probs=197.4
Q ss_pred CCcCccccCcceEEEEEEEeCC-CC--EEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------Ce
Q 036011 685 FNECNLLGRGSFGSVYKGTFSD-GT--SFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------DF 753 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 753 (977)
|.+.+.||+|+||.||+|+..+ ++ .||+|.++... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466889999999999998754 33 68999886542 34457789999999999999999999987432 24
Q ss_pred eEEEEeccCCCCHHHHhhcC-----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 754 RALVLELMPNGSLEKWLYSD-----NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
.+++|||+++|+|.+++... ...+++.....++.|++.||+||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887421 234789999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
+++.+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ...+... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~----~~- 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLR----QG- 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH----cC-
Confidence 9987654332222223346778999999999999999999999999999999 78888653221 1111111 00
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
..... ...+...+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 ------~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 ------NRLKQ------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------CCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 012344578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.92 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=201.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCC---------------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD---------------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFS 746 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~ 746 (977)
++|++.+.||+|+||.||+++..+ ...||+|+++... ......+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 2358999987553 334567899999999999999999999
Q ss_pred eeecCCeeEEEEeccCCCCHHHHhhcCC-----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcee
Q 036011 747 SCCNNDFRALVLELMPNGSLEKWLYSDN-----------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNIL 815 (977)
Q Consensus 747 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 815 (977)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986532 13688899999999999999999 789999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc--CCCCCCcCCcccc
Q 036011 816 LDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT--RKKPTDDMFTGEM 893 (977)
Q Consensus 816 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~ 893 (977)
+++++.+||+|||++................++..|+|||+..++.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999986644332222223345778999999988899999999999999999998 556665432211
Q ss_pred cHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 894 SLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
..... .......... ..... ...++..+.+++.+||+.+|++||++++|++.|++
T Consensus 241 ~~~~~-~~~~~~~~~~----~~~~~------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENT-GEFFRNQGRQ----IYLSQ------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHH-HHhhhhcccc----ccCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111 1100000000 00000 00123468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=332.78 Aligned_cols=202 Identities=25% Similarity=0.390 Sum_probs=176.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++.+++||+|+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 68999999997543 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999997654 4899999999999999999999 89999999999999999999999999999976532110
Q ss_pred c---------------------------------ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCC
Q 036011 839 S---------------------------------VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPT 885 (977)
Q Consensus 839 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 885 (977)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346999999999999999999999999999999999999999
Q ss_pred CcC
Q 036011 886 DDM 888 (977)
Q Consensus 886 ~~~ 888 (977)
.+.
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.55 Aligned_cols=247 Identities=30% Similarity=0.477 Sum_probs=199.6
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHH
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLE 767 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 767 (977)
++||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875543 33456889999999999999999999999999999999999999999
Q ss_pred HHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecccc
Q 036011 768 KWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847 (977)
Q Consensus 768 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 847 (977)
+++......+++..+..++.|++.||.|+| +.+++||||||+||+++.++.+|++|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 999776666899999999999999999999 889999999999999999999999999999765432211 1111234
Q ss_pred CCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 848 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
++.|+|||+..++.++.++||||||+++||+++ |..||....... .......... .. ...
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~--------~~---------~~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYR--------MS---------CPQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCC--------CC---------CCC
Confidence 677999999998899999999999999999998 999986542211 1111111000 00 001
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.++..+.+++.+|++.+|++||++.|++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.92 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=205.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CC---CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DG---TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+..|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999864 33 379999987553 34456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999876666899999999999999999999 7899999999999999999999999999998765432
Q ss_pred Cccee-eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 838 DSVTQ-TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 838 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..... .....++.|+|||+..+..++.++|||||||++||+++ |+.||...... ++..... .. .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~-~~--------~ 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAIN-DG--------F 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHh-cC--------C
Confidence 21111 11223567999999988899999999999999999997 99998653221 1111110 00 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
..+...+++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.05 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=203.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.++||+|+||+||+|+..+...||+|++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 356899999999999999999987777899999875322 33578999999999999999999998754 5578999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 9999999997643 35789999999999999999999 789999999999999999999999999999876543321
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||+..+..++.++||||+|+++||++| |..||......+. ... .....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~-----~~~~~------------ 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQ-----VERGY------------ 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHH-----HhcCC------------
Confidence 1122346678999999988899999999999999999999 7888865432211 000 00000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
......+++..+.+++.+|++.+|++||+++++++.|+..
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0000113455688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.20 Aligned_cols=370 Identities=28% Similarity=0.432 Sum_probs=273.1
Q ss_pred CCEEeCcCccCC-CCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeee
Q 036011 100 LRFISLDYNEFS-GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLA 178 (977)
Q Consensus 100 L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~ 178 (977)
.+-.|+++|.++ +.+|..+..+++++.|.|...++. .+|+.++.+.+|++|.++
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-------------------------~vPeEL~~lqkLEHLs~~ 63 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-------------------------QVPEELSRLQKLEHLSMA 63 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-------------------------hChHHHHHHhhhhhhhhh
Confidence 344555555555 345555555555555555555544 455666666666666666
Q ss_pred cccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceee
Q 036011 179 YNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLT 258 (977)
Q Consensus 179 ~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 258 (977)
+|++. .+-..++.|+.|+.+.+..|++... .+|+++| .+..|++||||+|+++
T Consensus 64 HN~L~-~vhGELs~Lp~LRsv~~R~N~LKns-------------------------GiP~diF-~l~dLt~lDLShNqL~ 116 (1255)
T KOG0444|consen 64 HNQLI-SVHGELSDLPRLRSVIVRDNNLKNS-------------------------GIPTDIF-RLKDLTILDLSHNQLR 116 (1255)
T ss_pred hhhhH-hhhhhhccchhhHHHhhhccccccC-------------------------CCCchhc-ccccceeeecchhhhh
Confidence 66666 4555666677777777777766521 3444444 4556666666666666
Q ss_pred ecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCC
Q 036011 259 GTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338 (977)
Q Consensus 259 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 338 (977)
.+|..+....++-.|+||+|+|..++...|-++..|-.|+||+|++..+||. +..+.+|++|+|++|++..
T Consensus 117 -EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ--------~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 117 -EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQ--------IRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred -hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHH--------HHHHhhhhhhhcCCChhhH
Confidence 5677777777777778888877766666677777777777777777776654 5666667777777776541
Q ss_pred CCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeeccccc-Ccccccc
Q 036011 339 ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLE-GSIPYDL 417 (977)
Q Consensus 339 ~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~ 417 (977)
. --..+..+++|+.|.+++.+-+ .-+|..+
T Consensus 188 f-------------------------------------------------QLrQLPsmtsL~vLhms~TqRTl~N~Ptsl 218 (1255)
T KOG0444|consen 188 F-------------------------------------------------QLRQLPSMTSLSVLHMSNTQRTLDNIPTSL 218 (1255)
T ss_pred H-------------------------------------------------HHhcCccchhhhhhhcccccchhhcCCCch
Confidence 1 0011122344555555554422 2467777
Q ss_pred ccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCe
Q 036011 418 CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLIN 497 (977)
Q Consensus 418 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 497 (977)
..+.+|..+|+|.|.+. ++|+++..+++|+.|+||+|+|+ .+.-......+|++|+||.|+++ .+|++++.|++|+.
T Consensus 219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 78888888888888887 89999999999999999999999 55556677789999999999999 79999999999999
Q ss_pred eeCcCCcCCC-CcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCc
Q 036011 498 LDLSRNQLSG-DIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNK 576 (977)
Q Consensus 498 L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 576 (977)
|++.+|+++- -+|..++.+.+|+.+..++|.+. ..|+.++.+..|+.|.|++|++. .+|+.+.-|+.|+.||+..|+
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 9999999863 47999999999999999999999 89999999999999999999998 889999999999999999998
Q ss_pred ccccCCCC
Q 036011 577 LEGEIPAN 584 (977)
Q Consensus 577 l~~~~p~~ 584 (977)
=--.+|+.
T Consensus 374 nLVMPPKP 381 (1255)
T KOG0444|consen 374 NLVMPPKP 381 (1255)
T ss_pred CccCCCCc
Confidence 76666643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.82 Aligned_cols=240 Identities=24% Similarity=0.309 Sum_probs=189.8
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 58899999997653 22334456677777654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999987654 4899999999999999999999 7899999999999999999999999999998653322 1223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .... +.... +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~-i~~~~---------~~~-------- 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDS-ILNDR---------PHF-------- 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHcCC---------CCC--------
Confidence 3569999999999999999999999999999999999999997532211 0111 00000 000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMT-DAA 954 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-ev~ 954 (977)
+..+...+.+++.+||+.+|++||++. ++.
T Consensus 216 -~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 -PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011233467899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.72 Aligned_cols=242 Identities=25% Similarity=0.268 Sum_probs=194.8
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 78999999997643 233456778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
+|.+++.... .+++..+..++.||+.||+||| + .||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887654 4899999999999999999999 5 7999999999999999999999999999875432221 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~--------~~~p----- 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEE--------IRFP----- 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCC--------CCCC-----
Confidence 346999999999999999999999999999999999999999653211 1111100000 0000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
......+.+++.+|++.||++|+ ++.+++++
T Consensus 217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 --RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01234578899999999999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.67 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=208.4
Q ss_pred CcCccccCcceEEEEEEEeC--CCC--EEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 686 NECNLLGRGSFGSVYKGTFS--DGT--SFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
...++||+|.||.|++|.|. .|+ .||||.++.+... ..++|.+|+.+|-+|+|||++++||+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999985 344 5799999876543 67899999999999999999999999987 667799999
Q ss_pred cCCCCHHHHhhc-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
++.|+|.+.++. ....+-......++.|||.||.||. ++++||||+.++|+++-....|||+|||+.+-+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999988 4446888899999999999999999 899999999999999999999999999999988766555
Q ss_pred cee-eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 840 VTQ-TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 840 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
+.+ ......+.|+|||.+....++.++|||+|||++|||+| |..||.+..... +.+.+|
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------------IL~~iD----- 329 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------------ILKNID----- 329 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------HHHhcc-----
Confidence 443 33456778999999999999999999999999999999 678876532211 122222
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+.+..+.+..|++++++++..||.+.|++|||+.++.+.+-.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 112233445678899999999999999999999999865533
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=326.17 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=191.1
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999998643 23345677899888877 799999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99998886654 4899999999999999999999 88999999999999999999999999999875432211 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc---cccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG---EMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+........ ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------~~~~--- 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------QIRI--- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-------CCCC---
Confidence 346899999999999999999999999999999999999999642211 111122222111111 0000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
+......+.+++.+|++.||++||++
T Consensus 225 ----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 01123456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.95 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=208.9
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCC-----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeec-CCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSD-----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-NDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 753 (977)
..++|.+.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999999765 7889999886443 3445678899999999999999999998766 567
Q ss_pred eEEEEeccCCCCHHHHhhcCC-------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 754 RALVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 889999999999999987532 34889999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCC
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
||+++.+.............++..|+|||++.+..++.++||||+|+++||+++ |+.||..... ..+..+.......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCC
Confidence 999987654332222222346678999999998899999999999999999999 9999865322 1222222211100
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.....++..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 239 -----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011234467899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.67 Aligned_cols=236 Identities=23% Similarity=0.304 Sum_probs=190.2
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.+ +++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999975 68999999987542 23445677888888877 699999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99999887654 4899999999999999999999 8999999999999999999999999999987543221 1223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~--------~~~~~----- 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAILND--------EVVYP----- 216 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHhcC--------CCCCC-----
Confidence 3469999999999999999999999999999999999999997532211 11111100 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
......+.+++.+|++.||++||++
T Consensus 217 --~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 --TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0123456889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.78 Aligned_cols=258 Identities=26% Similarity=0.350 Sum_probs=207.4
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|+. .+++.||||.+.... .....++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 479999999876432 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
||+++++|.+++.. ....+++..++.++.|++.|++||| +.|++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864 2335899999999999999999999 89999999999999999999999999999887643
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ......++..|+|||+..+..++.++||||+|+++|+|++|..||...........+... ....+..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 228 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QCDYPPL 228 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh--------cCCCCCC
Confidence 321 122345889999999999889999999999999999999999998643222111111100 0000000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01124456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.17 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=204.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24589999876443 2334567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 754 RALVLELMPNGSLEKWLYSDN---------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
.++||||+++|+|.+++.... ...++..+..++.|++.||+||| +++|+||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 23467788999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhC
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
+|||+++...............++..|+|||...++.++.++|||||||++|||++ |..||...... ++.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH
Confidence 99999986644332222222345678999999998999999999999999999998 78888653221 1111111
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
... ..... ..+...+.+++.+|++.+|++|||+.++++.+++..
T Consensus 236 ~~~--------~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGG--------YLDQP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCC--------CCCCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 100 00000 112346889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=325.62 Aligned_cols=241 Identities=24% Similarity=0.284 Sum_probs=193.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCC-CCcceEeeeeecCCeeEEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRH-RNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 758 (977)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999865 57899999997643 2345667889999999976 56888999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++..... +++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999999876543 789999999999999999999 78999999999999999999999999999875322111
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+.. .....
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~-----------~~~~~- 220 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIME-----------HNVSY- 220 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHc-----------CCCCC-
Confidence 2233569999999999999999999999999999999999999997542211 1111100 00000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
+......+.+++.+|++.+|.+|++.
T Consensus 221 ------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 ------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00123457889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.48 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=196.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999864 78999999986542 233466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997654 4889999999999999999999 89999999999999999999999999999964321100
Q ss_pred c------------c---------------------------------eeeccccCCcccCccccCCCCcCcccchhhHhH
Q 036011 839 S------------V---------------------------------TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGV 873 (977)
Q Consensus 839 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 873 (977)
. . .....+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001236999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCC---CCH
Q 036011 874 LLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR---IYM 950 (977)
Q Consensus 874 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~ 950 (977)
++|||++|..||......+ .+...... ... +... ........+.+++.+|+. +|.+| +++
T Consensus 237 il~elltG~~Pf~~~~~~~-~~~~i~~~--~~~--------~~~p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE-TYRKIINW--RET--------LYFP-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH-HHHHHHcc--CCc--------cCCC-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 9999999999996532211 11111100 000 0000 000123346788899997 66665 599
Q ss_pred HHHHHH
Q 036011 951 TDAAVK 956 (977)
Q Consensus 951 ~ev~~~ 956 (977)
.|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.26 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=195.4
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
++||+|+||.||+|+.. +++.||||+++... ....+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999865 68999999998643 23345678899999998 799999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999887654 4899999999999999999999 8999999999999999999999999999987532211 1223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc---cccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG---EMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+..... .....++........ .... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-p- 225 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------QIRI-P- 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------CCCC-C-
Confidence 346999999999999999999999999999999999999999643211 111222222111111 0000 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCC------HHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIY------MTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~ev~~~ 956 (977)
..+...+.+++.+|++.+|.+||+ +.|++++
T Consensus 226 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 226 -----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 112345788999999999999997 5666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.70 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=201.9
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5699999999999999999996 478999999987655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++.... .+++..+..++.|++.|++||| +.+|+|||++|+||+++.++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 9999999987554 4899999999999999999999 78999999999999999999999999999987643221 1
Q ss_pred eeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 842 QTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....+++.|+|||.+. ...++.++||||+||++|||++|+.||......+. ...+...... .+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-------~~~~--- 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQ-------PPKL--- 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCC-------CCCC---
Confidence 12345888999999874 44578899999999999999999999864321110 0000000000 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.........+.+++.+||+.+|++||+++++++++
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 ----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00112234678999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.05 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=206.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999863 23479999987543 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876666899999999999999999999 7899999999999999999999999999998765432
Q ss_pred Ccce-eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 838 DSVT-QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 838 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.... .....++..|+|||++.++.++.++||||||+++||+++ |..||.+....+ ...+......
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~~----------- 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGYR----------- 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCCc-----------
Confidence 2111 111224568999999998899999999999999999886 999986542211 1111111100
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.+....++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.52 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=204.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||.||+|+.. ++..||+|++..... .....+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999863 468899999875542 3456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC---------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 036011 755 ALVLELMPNGSLEKWLYSDN---------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSN 813 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 813 (977)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997432 13678889999999999999999 7899999999999
Q ss_pred eeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCccc
Q 036011 814 ILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGE 892 (977)
Q Consensus 814 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 892 (977)
|++++++.++|+|||++..+..............+..|+|||...+..++.++|||||||++|||++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999886543322222222335678999999998899999999999999999998 88888653221
Q ss_pred ccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
++....... ..... ...++..+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ----~~~~~~~~~--------~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ----EVIYYVRDG--------NVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHHHhcC--------CCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111000 00000 01234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.59 Aligned_cols=242 Identities=24% Similarity=0.284 Sum_probs=193.4
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 58899999997653 23345677888988876 799999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 99999887654 4889999999999999999999 78999999999999999999999999999876432221 223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ...... .. .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~----~~--------~~~~p----- 216 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESIL----HD--------DVLYP----- 216 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHH----cC--------CCCCC-----
Confidence 3468999999999999999999999999999999999999997542211 111110 00 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCC-------CHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRI-------YMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~ev~~~ 956 (977)
..+...+.+++.+|++.+|++|| ++.+++++
T Consensus 217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01234578899999999999999 67777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.07 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=196.8
Q ss_pred cccCcceEEEEEEEeC---CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 690 LLGRGSFGSVYKGTFS---DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 356799999875543 334678999999999999999999998864 56789999999999
Q ss_pred HHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce-eec
Q 036011 766 LEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-QTM 844 (977)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 844 (977)
|.+++......+++..+.+++.|++.||+||| +.|++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999876667899999999999999999999 78999999999999999999999999999986544322111 111
Q ss_pred cccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 845 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
..+++.|+|||+.....++.++||||||+++||+++ |..||......+ ....+..... . .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------------~-----~ 218 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR------------L-----D 218 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC------------C-----C
Confidence 234578999999988889999999999999999996 999987643221 1111110000 0 0
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.+..+...+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0112345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.73 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=204.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|++|.||+|+.+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778889999999999999875 68999999987542 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++++|.+++... ...+++..++.++.|++.||+||| +.|++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999875 446899999999999999999999 78999999999999999999999999999987654322
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......|++.|+|||+..+..++.++||||||+++|||++|+.||...... ........ + ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~----~-------~~---- 218 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIR----G-------VF---- 218 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc----C-------CC----
Confidence 122345889999999999999999999999999999999999998654311 11111100 0 00
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. .....+...+.+++.+||+.+|++||++.++++.
T Consensus 219 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 P--PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred C--CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0 0011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=319.05 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=204.6
Q ss_pred cCCCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--Cee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 754 (977)
..|.+.+.||+|+||.||.++. .++..||+|.++... ....+.+.+|+++++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3477889999999999999974 257899999987553 33456789999999999999999999998775 567
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999776556899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCc----------ccccHHHHHHhhC
Q 036011 835 EGDDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT----------GEMSLKKWVKESL 903 (977)
Q Consensus 835 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~----------~~~~~~~~~~~~~ 903 (977)
...... ......++..|+|||+..+..++.++||||+|+++|||++++.|+..... .+.....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-- 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH--
Confidence 433211 11223467789999999888999999999999999999998876533211 01111111100
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.... ...+....+...+.+++.+|++.+|++||+++++++.++++
T Consensus 239 -------~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -------LEEG-----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -------HHcC-----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 00011112455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.71 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=205.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
++|.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56889999999999999999741 35579999987543 33456789999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 755 ALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
++||||+++|+|.++++.... .+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.+|++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999999976433 4799999999999999999999 789999999999999999999999999999866
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.............++..|+|||++.++.++.++||||+||++|||++ |..||......+. ..+.......
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-------- 262 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYR-------- 262 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHcCCc--------
Confidence 43322112222346778999999999999999999999999999998 9999875432211 1111111000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
... .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 263 ----~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ----MAQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 001134578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.86 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=195.7
Q ss_pred cccCcceEEEEEEEeC---CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 690 LLGRGSFGSVYKGTFS---DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
.||+|+||.||+|.++ ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 57899999986543 2345678999999999999999999998854 5678999999999
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce-ee
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-QT 843 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 843 (977)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 4899999999999999999999 78999999999999999999999999999987654332211 11
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
...++..|+|||......++.++||||||+++|||++ |..||...... ...+.+.... .. .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~---~~---------~---- 218 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE---RM---------E---- 218 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC---CC---------C----
Confidence 2234578999999988889999999999999999998 99998754221 1111111100 00 0
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.+..++..+.+++.+||+.+|++||++++|++.|++
T Consensus 219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 001234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.23 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=200.6
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
..++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567999999999999999999875 68999999987532 2233457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999987643 788889999999999999999 889999999999999999999999999999876432
Q ss_pred CCcceeeccccCCcccCccccCCC----CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEG----IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ......... ..
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~---~~------ 264 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDH---KN------ 264 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcC---CC------
Confidence 21 122335699999999987653 4889999999999999999999999753221 111111100 00
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQ--RIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~ev~~~ 956 (977)
.+. .+....+...+.+++.+|++.+|.+ ||++.|++++
T Consensus 265 -~~~-----~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -SLT-----FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -cCC-----CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0001112345778999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.02 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=202.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++||+|+++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888999999999999999988888999999875432 3457899999999999999999999875 456789999999
Q ss_pred CCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 763 NGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 763 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||.+..+...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 999999997643 35899999999999999999999 789999999999999999999999999999876543221 1
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....++..|+|||+..+..++.++||||||+++|||++ |..||.+....+ ...+.......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~--------------- 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGYRM--------------- 222 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC---------------
Confidence 112235678999999988899999999999999999999 888886532211 11111110000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+.+.+.+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011234458899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.33 Aligned_cols=201 Identities=24% Similarity=0.346 Sum_probs=173.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.|+.+++||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 68899999987543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC-
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD- 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 838 (977)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999987654 4788999999999999999999 88999999999999999999999999999754321000
Q ss_pred --------------------------------------------cceeeccccCCcccCccccCCCCcCcccchhhHhHH
Q 036011 839 --------------------------------------------SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVL 874 (977)
Q Consensus 839 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 874 (977)
.......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcC
Q 036011 875 LTETFTRKKPTDDM 888 (977)
Q Consensus 875 l~elltg~~p~~~~ 888 (977)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=332.49 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=203.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 753 (977)
.++|.+.+.||+|+||.||+|++. .++.||||++.... ....+.+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 34689999997553 233457889999999997 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 036011 754 RALVLELMPNGSLEKWLYSDN----------------------------------------------------------- 774 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 774 (977)
.++||||+++|+|.++++..+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986432
Q ss_pred --------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 775 --------------------------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 775 --------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
..+++.....++.|++.||+||| +.+++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 13567788899999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
++++.+|++|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..||......+. .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H
Confidence 9999999999999986543222112222346788999999998899999999999999999998 8889865432211 1
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..... .+. ... .+..+...+.+++.+||+.+|.+||+++|+++.|+++-
T Consensus 352 ~~~~~----~~~--------~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIK----RGY--------RMA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHH----cCC--------CCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11010 000 000 00123456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.31 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=208.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|++|+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 79999999886432 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
||+++|+|.+++... ...+++..+..++.++++|++||| +.||+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 335789999999999999999999 89999999999999999999999999999886543
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ......+++.|+|||...+..++.++||||+|+++|+|++|+.||..... ...+...... .+.
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~~-------- 224 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE-KCD-------- 224 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhh-cCC--------
Confidence 221 11223588899999999888999999999999999999999999864321 1212111100 000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
... .........+.+++.+||+.+|++||++.++++.++++.
T Consensus 225 ---~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 ---YPP-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CCC-CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 001133456789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.74 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=196.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.+|++++.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999865 68999999987542 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999997654 4788899999999999999999 89999999999999999999999999999853321000
Q ss_pred -----------------------------------------cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHH
Q 036011 839 -----------------------------------------SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTE 877 (977)
Q Consensus 839 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 877 (977)
.......+||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112469999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC---CHHHHH
Q 036011 878 TFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI---YMTDAA 954 (977)
Q Consensus 878 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~ev~ 954 (977)
|++|+.||......+... .... .... ..... ...+...+.+++.+|+ .+|.+|+ ++.|++
T Consensus 237 ll~G~~Pf~~~~~~~~~~-~i~~--~~~~--------~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 237 MLVGQPPFLADTPAETQL-KVIN--WETT--------LHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhhCCCCCCCCCHHHHHH-HHhc--cCcc--------ccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999997643221100 0000 0000 00000 0012234566777765 4999999 888887
Q ss_pred HH
Q 036011 955 VK 956 (977)
Q Consensus 955 ~~ 956 (977)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=314.29 Aligned_cols=248 Identities=33% Similarity=0.525 Sum_probs=204.0
Q ss_pred ccccCcceEEEEEEEeCC----CCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+... +..||+|++...... ..+.+.+|++.++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 889999998866543 367889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcC--------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 764 GSLEKWLYSD--------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 764 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
++|.+++... ...+++..++.++.|+++|++||| +.+++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 356899999999999999999999 89999999999999999999999999999988765
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
...........+++.|+|||...+..++.++||||+|+++|||++ |..||...... ...+.... + .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~----~-------~ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK----G-------Y 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc----C-------C
Confidence 432223334457889999999988899999999999999999999 68998764221 11111111 0 0
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.. .....++..+.+++.+||+.+|++||++.|++++|+
T Consensus 225 ~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RL------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 001122456889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.70 Aligned_cols=253 Identities=24% Similarity=0.425 Sum_probs=204.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.++||+|+||.||+|..++++.||+|++..... ....+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467889999999999999999988899999999875432 3467889999999999999999999874 45689999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
.+++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.++++|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 9999999987543 35899999999999999999999 889999999999999999999999999999876532211
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||+..+..++.++||||||+++||+++ |+.||.+....+ ..+........
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRM-------------- 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCCC--------------
Confidence 1122346678999999998899999999999999999999 999997543221 11111110000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+.....+..+.+++.+|++.+|++||+++++...|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001123458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=317.02 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=193.7
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||+|+||+||+++.. +++.||+|++..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 689999999875432 2345678899999999999999999999999999999999999999
Q ss_pred HHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 767 EKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 767 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 2335899999999999999999999 88999999999999999999999999999987654322 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............ .. .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~--------~~-------~ 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND--------SV-------T 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc--------CC-------C
Confidence 3468999999999999999999999999999999999999997532211 111111111000 00 0
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
.+..+...+.+++.+|++.+|++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0112344578999999999999999 56666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.93 Aligned_cols=245 Identities=27% Similarity=0.339 Sum_probs=202.3
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
|.-++-||.|+||.||-|+.. +.+.||||.+.... ...+.++.+|++.+++++|||++.+-|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444567999999999999964 68899999986443 45678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
| -|+-.|++.-...++-+.++..|..+.++||+||| +.+.||||||+.|||+++.|.||++|||.|.+..+..
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--- 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--- 180 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence 9 46999999888888999999999999999999999 8999999999999999999999999999999876543
Q ss_pred eeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 841 TQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
..+|||.|||||++. .+.|+-|+||||+|++..|+.-+++|...+..... +...+.... +.+
T Consensus 181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIAQNes---------PtL-- 245 (948)
T KOG0577|consen 181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES---------PTL-- 245 (948)
T ss_pred ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHHhcCC---------CCC--
Confidence 357999999999864 57899999999999999999999999876533211 111111000 111
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.... -...+.+++..|++.-|.+|||..+++++-
T Consensus 246 ---qs~e---WS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 ---QSNE---WSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---CCch---hHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1122 244578899999999999999999987763
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=319.62 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=205.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC-----------------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcce
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD-----------------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 743 (977)
.++|++.+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999987642 2468999987654 344677899999999999999999
Q ss_pred EeeeeecCCeeEEEEeccCCCCHHHHhhcCC----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCc
Q 036011 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDN----------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSN 813 (977)
Q Consensus 744 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 813 (977)
+++++..++..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999987644 25899999999999999999999 7899999999999
Q ss_pred eeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc--CCCCCCcCCcc
Q 036011 814 ILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT--RKKPTDDMFTG 891 (977)
Q Consensus 814 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~ 891 (977)
|+++.++.++|+|||+++...............+++.|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986644332222333456788999999988889999999999999999998 66777543221
Q ss_pred cccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 892 EMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+ ................ ... ....++..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 241 ~--~~~~~~~~~~~~~~~~----~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q--VIENAGHFFRDDGRQI----YLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H--HHHHHHhccccccccc----cCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1111111110000000 000 001123468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=321.02 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=200.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC--EEEEEEeecc-chhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT--SFAIKVFNLQ-LDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999875 333 4788887643 234456789999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 758 LELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999996532 24788999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||......+ ....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence 99999998643211 11111223567999999998899999999999999999997 999986543211 1111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...+ .... .+..+...+.+++.+||+.+|.+||+++++++.|+++..
T Consensus 231 -~~~~--------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 -LPQG--------YRME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HhcC--------CCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111 0000 011234467899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=325.41 Aligned_cols=237 Identities=27% Similarity=0.308 Sum_probs=187.7
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHH-HHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECE-VLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.. +|+.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 689999999875431 22234444444 56789999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999987654 4889999999999999999999 8899999999999999999999999999987543221 1223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~--------~~~~~~---- 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNK--------PLRLKP---- 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcC--------CCCCCC----
Confidence 346999999999999999999999999999999999999999653211 111111110 000000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMT 951 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 951 (977)
.....+.+++.+|++.+|.+||++.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 ---NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=318.88 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=204.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357889999999999999999864 6899999998876655567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++... .+++.++..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 9999999998654 3789999999999999999999 78999999999999999999999999999886543221
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......+++.|+|||...+..++.++|||||||++|+|++|+.||....... .+... ....... .
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~-~~~~~~~-----~----- 236 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLI-ATNGTPE-----L----- 236 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHH-hcCCCCC-----C-----
Confidence 1223458899999999998889999999999999999999999996532211 11100 0000000 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.........+.+++.+||+.+|++||++.|+++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011233457889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.68 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=204.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
++|.+.+.||+|+||.||+|+.. ....||+|++.... ......+.+|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999742 24579999987543 34456788999999999 6999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 753 FRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
..++||||+++|+|.+++.... ..+++..+.+++.|++.||+||| +.|++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 9999999999999999996532 24788999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHH
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLK 896 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 896 (977)
+++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..||......+ ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 999999999999987653322221222234567999999998999999999999999999999 888886532211 11
Q ss_pred HHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..... . ... .....++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 247 ~~~~~----~-------~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 KLLRE----G-------HRM------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHc----C-------CCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11110 0 000 0011234467899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=318.07 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=200.0
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
+|++.++||+|+||+||++... +++.||||++..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 689999999875432 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998886543 35899999999999999999999 78999999999999999999999999999987643221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+ ...+....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~-~~~~~~~~----------- 221 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEV-ERRVKEDQ----------- 221 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHH-HHHhhhcc-----------
Confidence 2234689999999999999999999999999999999999999975321 1111111 11110000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
. .........+.+++.+||+.||++|| ++.+++++
T Consensus 222 -~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -E--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -c--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 00112344578999999999999999 77788554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=325.05 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=201.1
Q ss_pred cCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC-Ce
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN-DF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 753 (977)
++|++.+.||+|+||+||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999973 247899999987543 33456688999999999 689999999988654 46
Q ss_pred eEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 036011 754 RALVLELMPNGSLEKWLYSDN----------------------------------------------------------- 774 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 774 (977)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986432
Q ss_pred -------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecccc
Q 036011 775 -------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847 (977)
Q Consensus 775 -------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 847 (977)
..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 13678888999999999999999 89999999999999999999999999999987643322222222335
Q ss_pred CCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 848 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
++.|+|||+..+..++.++||||||+++|||++ |..||......+. ...... .+. ....+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~----~~~-------~~~~~~------ 305 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLK----EGT-------RMRAPD------ 305 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHh----ccC-------CCCCCC------
Confidence 678999999988999999999999999999997 8889865322211 111110 000 000000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.....+.+++.+||+.+|++||++.|++++|+.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12235789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.11 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=204.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888999999999999999864 24689999986543 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEe
Q 036011 755 ALVLELMPNGSLEKWLYSDN---------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVS 825 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 825 (977)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999987532 23678899999999999999999 8899999999999999999999999
Q ss_pred ecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCC
Q 036011 826 DFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLP 904 (977)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (977)
|||+++...............++..|+|||...++.++.++|||||||++||+++ |..||.+.... ...++....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~-- 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDG-- 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcC--
Confidence 9999986654332222233456789999999988889999999999999999998 88888653221 111211100
Q ss_pred CchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
. ....+ ..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 238 -~--------~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 -G--------HLDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -C--------CCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 00000 1124567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.58 Aligned_cols=238 Identities=27% Similarity=0.312 Sum_probs=192.0
Q ss_pred ccccCcceEEEEEEEe----CCCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 689 NLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3589999999976532 234457789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 999999987654 4899999999999999999999 88999999999999999999999999999986543221 22
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ........ ....
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~i~~~--------~~~~----- 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----TMTMILKA--------KLGM----- 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----HHHHHHcC--------CCCC-----
Confidence 23468999999999998889999999999999999999999997532211 11110000 0000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTD 952 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 952 (977)
+......+.+++.+||+.||++||++.+
T Consensus 218 --p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 --PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0112345678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.29 Aligned_cols=241 Identities=26% Similarity=0.327 Sum_probs=191.3
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.. +++.||||+++... ......+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999975 58899999997653 23345566788888764 899999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 99999987643 4889999999999999999999 88999999999999999999999999999875432221 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..+.+.... +.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~~~---------~~~--~----- 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRMDN---------PCY--P----- 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCC---------CCC--C-----
Confidence 3468999999999999999999999999999999999999997532211 111111000 000 0
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMT-DAAV 955 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-ev~~ 955 (977)
..+...+.+++.+|++.+|++||++. ++.+
T Consensus 217 --~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 --RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01233467899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.62 Aligned_cols=249 Identities=31% Similarity=0.501 Sum_probs=200.7
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHH
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLE 767 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 767 (977)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 5567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecccc
Q 036011 768 KWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847 (977)
Q Consensus 768 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 847 (977)
+++......+++..+..++.++++|++||| +.+++||||+|+||+++.++.+||+|||.+................+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776556889999999999999999999 78999999999999999999999999999986543221111112234
Q ss_pred CCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 848 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
+..|+|||...++.++.++||||+|+++|||+| |..||...... ........... . ....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~----------~-------~~~~ 218 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYR----------M-------PAPQ 218 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCC----------C-------CCCc
Confidence 567999999988899999999999999999999 78887653221 11111111000 0 0011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.++..+.+++.+|++.+|.+||++.|+++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 234468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=324.05 Aligned_cols=241 Identities=24% Similarity=0.282 Sum_probs=193.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 758 (977)
+|++.+.||+|+||+||+|+.. +++.||+|++.... ......+..|.+++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999865 57899999987653 22334566788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++..... +++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999999999876543 889999999999999999999 7899999999999999999999999999997543221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+.. .....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~i~~-----------~~~~~- 220 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIME-----------HNVAY- 220 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHHHHh-----------CCCCC-
Confidence 12233569999999999999999999999999999999999999997542211 1111110 00000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
+.....++.+++.+|++.+|++|++.
T Consensus 221 ------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 ------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01123456889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=317.35 Aligned_cols=272 Identities=25% Similarity=0.374 Sum_probs=209.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-----CCCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeec--CCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-----DGTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 754 (977)
+.|+..+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999853 3789999999766543 46789999999999999999999999877 5578
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.++++|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999877666899999999999999999999 7899999999999999999999999999998776
Q ss_pred CCCCcce-eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 835 EGDDSVT-QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 835 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
....... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... +...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence 3322211 11223556799999998889999999999999999999999998653222110 0000000000000000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+.. ....+....++..+.+++.+||+.+|++||++.|++++|+++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKE-GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHc-CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0000 0001111234467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=331.22 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=198.8
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
...++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999975 68899999987532 223455789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|+|.+++.... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999997653 788999999999999999999 88999999999999999999999999999987643
Q ss_pred CCCcceeeccccCCcccCccccCCC----CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEG----IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ......... ..
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~---~~----- 264 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDH---KN----- 264 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhC---Cc-----
Confidence 221 122345699999999988654 3789999999999999999999999753221 111111100 00
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQ--RIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~ev~~~ 956 (977)
.+. .+........+.+++.+|++.++.+ ||++.|++++
T Consensus 265 --~~~-----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 --SLN-----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --ccC-----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0001122344667888888755543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=322.73 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=194.5
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.. +++.||||+++... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999998653 23445677888999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999887654 4899999999999999999999 89999999999999999999999999999875322211 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
..+|++.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~~~--------~~~~------ 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILED--------EVRY------ 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHHcC--------CCCC------
Confidence 346899999999999999999999999999999999999999653211 111110000 0000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYM-----TDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~ev~~~ 956 (977)
+..+...+.+++.+||+.||.+||++ .+++++
T Consensus 216 -~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 -PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 01123457899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.06 Aligned_cols=245 Identities=27% Similarity=0.311 Sum_probs=190.5
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHH-HHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSEC-EVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 67889999987543 12223334444 456788999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++..... +++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 999999976543 778888899999999999999 89999999999999999999999999999975432211 223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..+.. ... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i---~~~--------~~~~~----- 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNI---LNK--------PLQLK----- 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHHH---HhC--------CcCCC-----
Confidence 3469999999999999999999999999999999999999997532211 11111 000 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.+....+.+++.+|++.+|.+||++.+.+..+.+
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 217 --PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 0123457889999999999999998765544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=311.55 Aligned_cols=250 Identities=28% Similarity=0.366 Sum_probs=205.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCC-CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
++|+..+.||+|+||.||+|+..+ ++.||+|.+..... .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999764 89999999875533 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++......+++..+..++.|++.|++||| +.+++|||++|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999876667899999999999999999999 78999999999999999999999999999987654321 2
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... . ..... ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~-----~~~~~-----------~~~ 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-M-----IPNKP-----------PPT 218 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-h-----hccCC-----------CCC
Confidence 223457889999999999899999999999999999999999987532221100 0 00000 000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+...+.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00111234567899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=321.76 Aligned_cols=267 Identities=18% Similarity=0.261 Sum_probs=201.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|.+.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67899999999999999999865 688999999875432 2334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++ +|.+++...+..+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 975 888888776666899999999999999999999 89999999999999999999999999999976543221
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh--hCCCc-hhhhcc----
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPHG-LMEVVD---- 912 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~---- 912 (977)
......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+. .....+. ..... +..+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999998765 5689999999999999999999999976432211 1111100 00000 000000
Q ss_pred --hhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 --TNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 --~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....... ............+.+++.+|++.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 0000111234457899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.79 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=201.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-----------------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-----------------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKI 744 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 744 (977)
++|++.+.||+|+||.||+++.. ++..||+|++.... ......+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 24468999987553 3345678999999999999999999
Q ss_pred eeeeecCCeeEEEEeccCCCCHHHHhhcCC----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCce
Q 036011 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDN----------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNI 814 (977)
Q Consensus 745 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NI 814 (977)
++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999987542 13677889999999999999999 78999999999999
Q ss_pred eeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc--CCCCCCcCCccc
Q 036011 815 LLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT--RKKPTDDMFTGE 892 (977)
Q Consensus 815 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~ 892 (977)
++++++.++|+|||+++.+.............+++.|+|||+..++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986644332222222345678999999888889999999999999999998 667775432211
Q ss_pred ccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
. .......+..... .... +....++..+.+++.+||+.+|.+||++.|+++.|++
T Consensus 242 ~--~~~~~~~~~~~~~----~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V--IENTGEFFRDQGR----QVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHhhccc----cccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1100000000000 0000 0011234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=325.28 Aligned_cols=243 Identities=26% Similarity=0.324 Sum_probs=190.4
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHH-HHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECE-VLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999864 68999999987542 223344555554 56778999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|..++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 99998887654 4899999999999999999999 89999999999999999999999999999875432211 223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... ......+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~~~~--------~~~~~~~---- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDNILH--------KPLVLRP---- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHHHHc--------CCccCCC----
Confidence 3469999999999999999999999999999999999999996532111 1111110 0110011
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.....+.+++.+|++.+|.+||++.+.++.+
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1233467899999999999999886544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.72 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=205.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999874 88999999976644 4577899999999999999999999999899999999999
Q ss_pred CCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999999976542 5899999999999999999999 89999999999999999999999999999987632211
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
....+..|+|||+..++.++.++||||+|+++||+++ |..||......+ ...........
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYRM-------------- 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCCCC--------------
Confidence 2235678999999988899999999999999999997 999986532211 11111110000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.....++..+.+++.+|+..+|++||++.|++++|+++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 ---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00112345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.99 Aligned_cols=264 Identities=22% Similarity=0.292 Sum_probs=203.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999865 68889999987553 33445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++...+ .+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99999999997654 48899999999999999999994 2589999999999999999999999999987653321
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc--------------
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG-------------- 906 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 906 (977)
.....++..|+|||+..+..++.++||||||+++|||++|+.||..... .....+........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCCC
Confidence 1234688999999999888899999999999999999999999864321 11222111110000
Q ss_pred -------hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 -------LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+..+... ...........+...+.+++.+|++.+|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIV-NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHh-cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 0000000011234568899999999999999999999877
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=312.27 Aligned_cols=239 Identities=21% Similarity=0.337 Sum_probs=190.6
Q ss_pred ccccCcceEEEEEEEeCC-------------CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 689 NLLGRGSFGSVYKGTFSD-------------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
+.||+|+||.||+|+... ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887665555667899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc-------eEEeecc
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV-------AHVSDFG 828 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-------~kl~Dfg 828 (977)
+||||+++|+|..++......+++..+..++.||++|++||| +.+|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998876666899999999999999999999 899999999999999986654 8999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHh-cCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETF-TRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||......+. .. . ...
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~-~----~~~ 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ER-F----YEG 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HH-H----Hhc
Confidence 98755322 2234788899999886 567899999999999999998 57887754321110 00 0 000
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.... .. .....+.+++.+||+.||.+||++.++++.+
T Consensus 225 ~~~~----------~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCML----------VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CccC----------CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 00 1124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.94 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=201.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999864 68999999987542 1234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999987654 3788999999999999999999 789999999999999999999999999999865432
Q ss_pred CCcce-eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVT-QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..... .....++..|+|||+..+..++.++||||+|+++||+++|+.||......+ ........... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~-----~-- 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPTN-----P-- 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HHHHHhccCCC-----C--
Confidence 21111 123457889999999999899999999999999999999999986532211 10000000000 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+..+...+.+++.+||+.+|.+||++.|++++
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011233457889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=311.80 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=200.5
Q ss_pred ccccCcceEEEEEEEeCC--C--CEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFSD--G--TSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|++|.||+|.+.+ + ..||||++..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987655 566789999999999999999999999988 888999999999
Q ss_pred CCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce-
Q 036011 764 GSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT- 841 (977)
Q Consensus 764 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 841 (977)
|+|.+++.... ..+++...+.++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++..+........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765 46899999999999999999999 88999999999999999999999999999987754332211
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....++..|+|||+..+..++.++||||+||++|||++ |..||......+ ....... . ... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~-~-~~~--------~----- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK-E-GER--------L----- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh-c-CCc--------C-----
Confidence 122357788999999999999999999999999999998 999986542221 1111110 0 000 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
......+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.86 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=206.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC----EEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT----SFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|++.+.||+|+||+||+|..+ +|+ .||+|++..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888899999999999999864 333 689998876543 345678899999999999999999999987 78899
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||.++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999887666899999999999999999999 799999999999999999999999999999877643
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..........++..|+|||......++.++|+||||+++||+++ |+.||......+ ..+.+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~----------- 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEKGER----------- 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhCCCC-----------
Confidence 33222222234678999999988899999999999999999999 999987542211 1111111000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
... +..+...+.+++.+||..+|.+||++.++++.|+++..
T Consensus 230 ~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 LPQ------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 01123357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=314.26 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=205.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998643 3478999887654 3455679999999999999999999998875 456899
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++......+++..+..++.+++.|++||| +.+++||||||+||+++.++.+|++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876656899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. .......++..|+|||......++.++||||+|+++||+++ |..||......+ ...+...... .
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~----------~- 227 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGER----------L- 227 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCc----------C-
Confidence 1 11222235568999999988889999999999999999986 999987643221 1111111000 0
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.....++..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0011234568899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.71 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=201.0
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999975 5788999998766556667889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
++|..++......+++..+..++.|+++||+||| +.|++||||||+||+++.++.+|++|||++........ ...
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccc
Confidence 9999988765556899999999999999999999 78999999999999999999999999999876543211 222
Q ss_pred ccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 844 MTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
...+++.|+|||++. +..++.++||||+||++|||++|+.||......+ ..........+ ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~--- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP---------TL--- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC---------CC---
Confidence 345889999999873 4567889999999999999999999986532211 11111110000 00
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+..+...+.+++.+||+.+|.+||++.+++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011223457899999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.88 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=201.9
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|.+.+.||+|++|.||+|...++..+|+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4588889999999999999998777789999876432 23467889999999999999999999875 456789999999
Q ss_pred CCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 763 NGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 763 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+|+|.++++... ..+++..+..++.|++.||+||| +.|++||||||+||++++++.++|+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 999999997643 35789999999999999999999 789999999999999999999999999999876433211 1
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....++..|+|||+..+..++.++||||+|+++|||++ |..||.+....+ ...+.......
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~--------------- 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM--------------- 222 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC---------------
Confidence 112236678999999998999999999999999999999 889987543221 11111111100
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
....+.+..+.+++.+||+.+|++||+++++++.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=320.71 Aligned_cols=240 Identities=23% Similarity=0.312 Sum_probs=190.9
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+.. +|+.||+|+++... ......+..|.+++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 68999999997653 23345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 99999987654 4889999999999999999999 78999999999999999999999999999875322211 223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+...... +.+ +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~---------~~~---~---- 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDT---------PHY---P---- 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---------CCC---C----
Confidence 356999999999999999999999999999999999999999653221 1111111000 000 0
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMT-DAA 954 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-ev~ 954 (977)
..+..++.+++.+|++.||++||++. ++.
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 --RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01234567899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.91 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=202.7
Q ss_pred cccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHH
Q 036011 690 LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEK 768 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 768 (977)
++|+|.||+||.|++. +...+|||-++....+..+.+.+|+..-++++|.|||+++|.+.+.++.-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 466789999987777777889999999999999999999999999999999999999999999
Q ss_pred HhhcCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEeecccccccCCCCCcceeecc
Q 036011 769 WLYSDNYFL--DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMT 845 (977)
Q Consensus 769 ~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (977)
.++..-+++ .+.+.--+.+||++||.||| ...|||||||-+||||+ -.|.+||+|||-++.+..-. ......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 999876666 67788889999999999999 77899999999999996 68999999999998875432 223345
Q ss_pred ccCCcccCccccCCC--CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 846 IATIGYMAPEYGTEG--IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 846 ~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
.||..|||||++..+ .|+.++|||||||++.||.||++||......+... +.-++. .... +
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVGmy--------KvHP--~ 799 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVGMY--------KVHP--P 799 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhcce--------ecCC--C
Confidence 699999999999866 48999999999999999999999997754332111 111111 1111 1
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.+...+...++.+|+.+||.+||+++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 233456677899999999999999999999763
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.94 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=204.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCC----EEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGT----SFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
.++|+..+.||+|+||.||+|++. +|+ .||+|++..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999864 444 578888765432 3344688999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+++||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999876666899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
...........++..|+|||++.+..++.++||||||+++||+++ |+.||.+... ....++......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---------- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER---------- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC----------
Confidence 332222223346778999999999999999999999999999997 8899865422 112222211100
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.. ....+...+.+++.+||..+|++||+++++++.++++..
T Consensus 230 ~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 LP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 001123457889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.95 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=206.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999864 57899999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999999999876556899999999999999999999 78999999999999999999999999999987643221 1
Q ss_pred eeccccCCcccCccccCCC---CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 842 QTMTIATIGYMAPEYGTEG---IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....++..|+|||...+. .++.++||||+|+++|||++|+.||......+. ........+.. .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~-------~----- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPP-------P----- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCC-------c-----
Confidence 2234588899999998776 889999999999999999999999875432211 11110000000 0
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
...........+.+++.+||+.+|.+||++.+++.
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00111233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=312.41 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=206.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346799999999999999999998888899999987543 2346789999999999999999999999988999999999
Q ss_pred cCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++++|.+++.... ..+++..+..++.+++.|++||| +.+++||||||+||++++++.+|++|||.+.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999997654 35899999999999999999999 789999999999999999999999999999876532211
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......++..|+|||...+..++.++||||+|+++||+++ |+.||...... ..... .......
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~-~~~~~~~------------- 223 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ-VERGYRM------------- 223 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HHcCCCC-------------
Confidence 1112235568999999998899999999999999999998 99998653221 11111 1110000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+...+.+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001123457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.04 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=199.7
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeee-cCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC-NNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 761 (977)
++|.+.+.||+|+||.||+|... |+.||+|.+.... ..+.+.+|+.++++++|+|++++++++. +.+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999874 7889999986432 3467889999999999999999999764 456789999999
Q ss_pred CCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++++|.+++..... .+++..+..++.|++.||+||| +.|++||||||+||++++++.+|++|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC--
Confidence 99999999976543 4789999999999999999999 88999999999999999999999999999876543221
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
...++..|+|||+..+..++.++||||+||++|||++ |+.||...... ....+.......
T Consensus 158 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~-------------- 218 (256)
T cd05082 158 ---TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM-------------- 218 (256)
T ss_pred ---CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCC--------------
Confidence 1235568999999998899999999999999999997 89888643111 111111110000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00012345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.25 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=202.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999975 58999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|..++......+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence 999999888765556899999999999999999999 7899999999999999999999999999987643321 11
Q ss_pred eeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 842 QTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.....+++.|+|||++. ...++.++|||||||++|||++|..||...... ....++.... .+...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~---------~~~~~ 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE---------PPTLS 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCC---------CccCC
Confidence 22345888999999874 345788999999999999999999998653211 1111111000 00000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+...+.+++.+||+.+|++||++.|++++
T Consensus 237 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 -------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011223457889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.86 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=202.2
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
+.+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344566666778999999999999854 6788999998876666677899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDNYFL--DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~ 834 (977)
+||+++++|.+++......+ ++..+..++.||+.|++||| +.+|+||||||+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999998654434 78889999999999999999 789999999999999986 6799999999997664
Q ss_pred CCCCcceeeccccCCcccCccccCCCC--cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.... ......+++.|+|||+..+.. ++.++||||+|+++|+|++|+.||........ ..|......
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~-------- 228 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFK-------- 228 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhc--------
Confidence 3221 122235889999999886543 78999999999999999999999865322111 111100000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... ..+..+...+.+++.+||+.+|.+|||+.|++++
T Consensus 229 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -----IHP--EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----cCC--CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 0011234457899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.35 Aligned_cols=239 Identities=21% Similarity=0.284 Sum_probs=189.6
Q ss_pred cccCcceEEEEEEEeCC-------------------------CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceE
Q 036011 690 LLGRGSFGSVYKGTFSD-------------------------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 744 (977)
+||+|+||.||+|.... ...||+|++.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999876655556678899999999999999999
Q ss_pred eeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC----
Q 036011 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---- 820 (977)
Q Consensus 745 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---- 820 (977)
++++.+....++||||+++|+|..++......+++..+..++.|+++||+||| +.+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999776666899999999999999999999 78999999999999997543
Q ss_pred ---ceEEeecccccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHh-cCCCCCCcCCcccccH
Q 036011 821 ---VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETF-TRKKPTDDMFTGEMSL 895 (977)
Q Consensus 821 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~ 895 (977)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 4899999988644321 12347788999998865 56899999999999999985 6899886543221 1
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
..+.... .... . .....+.+++.+||+.+|++||++.++++.|.
T Consensus 231 ~~~~~~~------------~~~~-~------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYEKK------------HRLP-E------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHhc------------cCCC-C------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111100 0000 0 01234789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=320.22 Aligned_cols=254 Identities=31% Similarity=0.483 Sum_probs=199.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC--EEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT--SFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||.||+|+++ ++. .+|+|.+.... ......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999864 454 45777765432 33456788999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 758 LELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999997532 24789999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||++...... .......++..|+|||+..+..++.++|||||||++|||+| |..||......+ ..+.
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~--- 235 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK--- 235 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHH---
Confidence 99999998643211 11111234667999999988889999999999999999998 999986532211 1111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+.... . .. ...+...+.+++.+||+.+|++||++.++++.++++.
T Consensus 236 -~~~~~~------~-~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 236 -LPQGYR------L-EK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred -HhcCCc------C-CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111100 0 00 0112345789999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=300.87 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=208.2
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
|.++++||+|+||.||+|.++ .|+.+|||..+.+ .+.+++.+|+.+|.+++.|++|++||.|......++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556788999999999999876 6999999997754 4567899999999999999999999999888999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+..++++.++..+++.++..|.+.-+.||+||| ...-+|||||+.|||++.+|.+|++|||.|..+.... ....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhC
Confidence 9999999999889999999999999999999999 5667999999999999999999999999998775432 2234
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
.+.|||.|||||++..-.|+.++||||+|++..||..|++||.+..+.... + .+|. ..+....
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---F---MIPT-----------~PPPTF~ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---F---MIPT-----------KPPPTFK 250 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---E---eccC-----------CCCCCCC
Confidence 467999999999999989999999999999999999999999875432110 0 0010 0111112
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+..-...+.+++++|+-..|++|-|+-+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 233445678899999999999999999888765
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.59 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=198.3
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|+..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 478999999987653 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|..+. .+++..+..++.|++.||+||| +.||+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997652 3678889999999999999999 8999999999999999999999999999998654321
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc--HHHHHHhhCCCchhhhcchhhhcc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS--LKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....++..|+|||++.+..++.++||||+|+++|+|++|+.||......+.. ...+....... ..+..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--- 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL--- 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC---
Confidence 22346899999999999999999999999999999999999999753322111 00111000000 00000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+.+++.+|++.+|++||++.|++++
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001123357899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=332.20 Aligned_cols=265 Identities=18% Similarity=0.193 Sum_probs=200.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+|.+.+.||+|+||.||+|+.. .++.||||... ...+.+|++++++++||||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 58899999643 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+. ++|.+++......+++..+..++.|+++||+||| +.||+||||||+|||++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 7899888766556999999999999999999999 7899999999999999999999999999998764332222
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc------cccHHHHHHhhCC--Cchhh---
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG------EMSLKKWVKESLP--HGLME--- 909 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~--- 909 (977)
......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ...+.+.+..... ..+..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 222346999999999999999999999999999999999988765432111 1112222211100 00000
Q ss_pred --hcc---hhh---hccccCchHHH---HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 --VVD---TNL---LRQEHTSSAEM---DCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 --~~~---~~~---~~~~~~~~~~~---~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.. ... .........+. .....+.+++.+|++.||.+|||+.|++++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000 00000000010 122357889999999999999999999875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.55 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=207.9
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeecc--chhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 756 (977)
.....|+++++||+||.+.||++...+.+.||+|++... .....+.|..|+..|.+++ |.+||++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345679999999999999999999888888988876533 2456778999999999995 9999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||= ..+|..+++++....+...+..+..|+++|+.+.| ++||||.||||.|+|+- .|.+||+|||.|..+...
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99986 45999999988775554588899999999999999 89999999999999984 579999999999998877
Q ss_pred CCcceeeccccCCcccCccccCCCC-----------cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGI-----------VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
.........+||+.||+||.+.... .+.++||||+|||+|+|+.|+.||..... .|.+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK----- 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK----- 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH-----
Confidence 6666666678999999999765322 56789999999999999999999975321 1221
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+..+.++.-..+....+... .+++++..|+..||.+||+..|++++
T Consensus 582 -l~aI~~P~~~Iefp~~~~~~----~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -LHAITDPNHEIEFPDIPEND----ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHhhcCCCccccccCCCCch----HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 34444553322222222211 27899999999999999999999875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.47 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=198.5
Q ss_pred ccccCcceEEEEEEEeC-C---CCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-D---GTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
++||+|+||.||+|++. . +..||+|.+..... ...+.+.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 36899999876543 34567899999999999999999999876 4567899999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce-e
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-Q 842 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 842 (977)
|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998765 5899999999999999999999 78999999999999999999999999999987654332211 1
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....++..|+|||...+..++.++||||||+++||+++ |..||..... .....+.......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~---------------- 217 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL---------------- 217 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC----------------
Confidence 11224567999999999999999999999999999998 9999865422 1222222111000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.....++..+.+++.+||+.+|++||++.++.+.|+++.
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001123346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.46 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=204.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56888999999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++......+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~ 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--K 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--c
Confidence 999999999876666899999999999999999999 78999999999999999999999999999876543221 2
Q ss_pred eeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 842 QTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.....+++.|+|||++. ...++.++||||+|+++|||++|+.||......+ ....+..... +.+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~~ 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEP---------PTLD 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCC---------CCcC
Confidence 22345889999999864 4457889999999999999999999987542211 1111110000 0000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+..+...+.+++.+||+.+|++||++.+++++
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011233457889999999999999999999775
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.76 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=191.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--------C
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--------D 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 752 (977)
.++|.+.++||+|+||+||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999874 68999999885432 2345799999999999999998876432 2
Q ss_pred eeEEEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecc
Q 036011 753 FRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFG 828 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg 828 (977)
..++||||+++ ++.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46689999975 77776653 3345899999999999999999999 89999999999999999665 79999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CCC
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LPH 905 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~ 905 (977)
+|+.+...... ....||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+....+ .+....... ...
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 99876543221 22458999999998765 468999999999999999999999997643221 111111110 000
Q ss_pred chhhhcchhhhc---cccCch-----HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLR---QEHTSS-----AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~---~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+.... ...... .+...+.++.+++.+||+.+|.+|||+.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000000 000000 001123468899999999999999999999754
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.22 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=202.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.+|++.+.||+|+||.||+|.+.+++.+|+|++.... .....+.+|++++++++||+|+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999998778899999886442 223568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence 99999999876666899999999999999999999 789999999999999999999999999999865432211 11
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....++.+|+|||+..++.++.++||||+|+++|||++ |..||......+ ..+... .+. ....+ .
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----~~~-~~~~~------~- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETIN----AGF-RLYKP------R- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHh----CCC-CCCCC------C-
Confidence 22235678999999998899999999999999999998 899986532211 111110 000 00000 0
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.....+.+++.+||+.+|++||++.|++++|.
T Consensus 225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 01345789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.45 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=201.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
++|.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999864 68999999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++...+ .+++.....++.|++.|++||| +.|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999987655 4899999999999999999999 7899999999999999999999999999987654321 12
Q ss_pred eeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 842 QTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....|+..|+|||++. ...++.++||||+||++|||++|..||........ ........... +...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~-------~~~~-- 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQP-------PKLK-- 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCC-------Cccc--
Confidence 22346899999999874 45688999999999999999999999865322111 00000000000 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+...+.+++.+|++.+|++||++++++++
T Consensus 233 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 -----DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -----ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000123457889999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.79 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=201.8
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+|++.+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999865 68999999986543 345567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++... ...+++.....++.|++.||+||| +.+|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999988653 335789999999999999999999 89999999999999999999999999999986643221
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......+++.|+|||+..+..++.++||||+|+++|+|++|..||...... .............
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~----------- 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQGSYKP----------- 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcCCCCC-----------
Confidence 122345888999999999889999999999999999999999999653211 1111100000000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+..+...+.+++.+||+.+|++||++.|++.+
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.95 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=190.5
Q ss_pred ccccCcceEEEEEEEeCC---CCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 689 NLLGRGSFGSVYKGTFSD---GTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 46799998865542 33456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCC----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 765 SLEKWLYSDN----YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 765 sL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 24567788899999999999999 8899999999999999999999999999997654332222
Q ss_pred eeeccccCCcccCccccCCC-------CcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 841 TQTMTIATIGYMAPEYGTEG-------IVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
......++..|+|||++.+. .++.++||||||+++|||++ |..||......+. ..+. .........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---~~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---VREQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---hhcccCCCCC
Confidence 22234577889999987542 35789999999999999996 9999965432221 1110 0000001111
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
+.+. ......+.+++..|| .+|++|||++||.+.|+
T Consensus 233 ~~~~---------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK---------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC---------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1110 012234677889999 58999999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.68 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=194.0
Q ss_pred ccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeee-cCCeeEEEEeccC
Q 036011 689 NLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCC-NNDFRALVLELMP 762 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 762 (977)
+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24579999875432 344567889999999999999999999775 4556789999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc--c
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS--V 840 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~ 840 (977)
+|+|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876555788888999999999999999 789999999999999999999999999999765432111 1
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCC-CCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK-KPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||+..+..++.++||||||+++|||++|. +||..... .....+... . ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~---~--------~~~--- 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQ---G--------RRL--- 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhc---C--------CCC---
Confidence 111234567899999998889999999999999999999964 55543211 111111110 0 000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.....++..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 222 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000112345789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.22 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=196.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 68999999987532 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999875556899999999999999999999 89999999999999999999999999999976543322
Q ss_pred cceeeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC-Cchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP-HGLMEVVD 912 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 912 (977)
.......||+.|+|||++.. +.++.++||||+||++|||++|+.||......+ ....... .....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~--- 228 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKEHFQ--- 228 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCccc---
Confidence 12223469999999998863 457889999999999999999999996532211 1111100 00000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcC--CCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCME--SPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~P~~RPs~~ev~~~ 956 (977)
+ .. ........+.+++.+|+.. ++..||++.+++++
T Consensus 229 --~--~~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 --F--PP----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --C--CC----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00 0011234467777777654 33448899988776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.27 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=204.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
.+|++.+.||+|+||.||+|+.. .+..||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 12368999887543 33456789999999999 7999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 753 FRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
..+++|||+++|+|.+++.... ..+++..+..++.|+++||+||| +.|++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999987532 24788999999999999999999 79999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHH
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLK 896 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 896 (977)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence 999999999999987654322222222335567999999999999999999999999999998 8888865321 1
Q ss_pred HHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
++.......... .....+...+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 244 ~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 ELFKLLKEGHRM--------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHcCCCC--------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 211111000000 0011233467899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=327.92 Aligned_cols=258 Identities=20% Similarity=0.291 Sum_probs=199.8
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND 752 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 752 (977)
++....++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445688999999999999999999975 68899999986532 233455788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+++|+|.+++.... ++...+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999999987654 788889999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCCC----CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEG----IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM 908 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (977)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+... ....
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~---~~~~ 266 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNH---KNSL 266 (371)
T ss_pred cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcC---CCcc
Confidence 653221 122345699999999998654 3789999999999999999999999753221 111111100 0000
Q ss_pred hhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 036011 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQ--RIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~ev~~~ 956 (977)
.+ +...+....+.+++.+|++..+.+ ||++.|++++
T Consensus 267 -----~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 -----TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -----cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 001123345678889999844433 7788888775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.80 Aligned_cols=265 Identities=20% Similarity=0.193 Sum_probs=200.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC---CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
..+|.+.+.||+|+||.||++... .++.||||.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999753 3678999987643 24568999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|++. ++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9995 6888888443 45899999999999999999999 78999999999999999999999999999987655433
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc--ccHHHHHHhh------CCCc-hh-
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE--MSLKKWVKES------LPHG-LM- 908 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~------~~~~-~~- 908 (977)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ..+....+.. ++.. ..
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 333334569999999999999999999999999999999999999996643221 1111111110 0000 00
Q ss_pred --hhcc---hhhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 --EVVD---TNLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 --~~~~---~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+. .......... .........+.+++.+|++.+|++||++.|++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0000000000 0001123456789999999999999999999876
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.15 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=204.1
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.+|+..+.||.|+||+||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 478999999987665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++... .+++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence 999999998754 3899999999999999999999 899999999999999999999999999998866543221
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
.....++..|+|||...+..++.++|||||||++|++++|+.||........ ... ....... .+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~-~~~~~~~--------~~------ 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IATNGTP--------EL------ 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHhcCCc--------cc------
Confidence 1223588899999999988999999999999999999999999865432111 111 1000000 00
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.+|++||++.+++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0011233457889999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.99 Aligned_cols=251 Identities=23% Similarity=0.281 Sum_probs=204.4
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999996 47999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++.... +++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 99999999986543 789999999999999999999 78999999999999999999999999999986644322
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......+++.|+|||...+..++.++||||+||++|++++|..||............+ ..+. +
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-----~~~~-----~------- 233 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----TNGT-----P------- 233 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-----cCCC-----C-------
Confidence 1223458889999999999899999999999999999999999996532211100000 0000 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011233457789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.73 Aligned_cols=242 Identities=22% Similarity=0.288 Sum_probs=191.5
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 68899999998653 23445688899999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 99999887654 4899999999999999999999 88999999999999999999999999999875322111 223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc-cccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG-EMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
..+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+........ .. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~-----~~ 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PI-----RI 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------CC-----CC
Confidence 356999999999999999999999999999999999999999643221 111112211111100 00 00
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
+......+.+++.+|++.||++||++
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 01123446789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.17 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=200.7
Q ss_pred CCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
+|...+.||+|+||+||+|...+++.+|||.+.... .+....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999886432 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997654 3789999999999999999999 7899999999999999999999999999998653211
Q ss_pred C----cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 838 D----SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 838 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
. ........++..|+|||+..+..++.++||||+|+++|+|++|+.||......+. ...... .... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~---~~~~----~~ 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGA---HRGL----MP 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhh---ccCC----CC
Confidence 1 1111234588999999999998999999999999999999999999965322111 000000 0000 00
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.+ ...+...+.+++.+||+.+|++||++.|+++
T Consensus 229 ~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RL---------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC---------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0112345789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.56 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=204.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|.+.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678899999999999999999878888999988754 3335678899999999999999999999887 7789999999
Q ss_pred CCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++... ....++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 999999999764 335788999999999999999999 789999999999999999999999999999866432211
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......++..|+|||++.++.++.++|+||||+++|++++ |+.||...... ....+.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~-------------- 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM-------------- 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC--------------
Confidence 1122335678999999998899999999999999999999 89998653221 112222111100
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.61 Aligned_cols=237 Identities=25% Similarity=0.288 Sum_probs=186.5
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHH-HHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSEC-EVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68999999987543 12233444554 467889999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|..++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99998887544 4788899999999999999999 7899999999999999999999999999987542221 1223
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~--------~~~~~~---- 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHK--------PLQLPG---- 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcC--------CCCCCC----
Confidence 34689999999999999999999999999999999999999965321 1111111110 000000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMT 951 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 951 (977)
.....+.+++.+|++.+|.+||++.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 ---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123468899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.56 Aligned_cols=247 Identities=32% Similarity=0.504 Sum_probs=194.1
Q ss_pred ccccCcceEEEEEEEeC-CCC--EEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGT--SFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+.+ ++. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 343 46888876433 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 764 GSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 764 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 24788999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
++...... ........+..|+|||+.....++.++||||||+++|||++ |..||......+ .... .+.+.
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~-~~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK-LPQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHH-HhCCC
Confidence 98632211 11111234567999999988899999999999999999997 999986532211 1111 01100
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.. .....+...+.+++.+||+.+|.+||++.|+++.|+++
T Consensus 229 ------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 ------RL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ------CC-------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 00011234578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.93 Aligned_cols=241 Identities=24% Similarity=0.293 Sum_probs=192.7
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 758 (977)
+|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999865 68999999987653 233456778888988885 678888999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999987654 3899999999999999999999 8899999999999999999999999999987543221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+.+.. . ....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~---~--------~~~~- 220 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIME---H--------NVSY- 220 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---C--------CCCC-
Confidence 12223458999999999999999999999999999999999999997642211 1111110 0 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
+..+...+.+++.+|++.+|.+|++.
T Consensus 221 ------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 ------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01123456889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.83 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=199.2
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhH--HHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAF--RSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
|++.+.||+|+||+||+++.. +++.||+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999976 567899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++... ..+++..+..++.|+++||++|| +.+|+|+||||+||+++.++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cccc
Confidence 999999999833 34899999999999999999999 78999999999999999999999999999986521 2223
Q ss_pred eeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....++..|+|||+.. +..++.++||||+|+++|+|++|..||....... ............ ......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~~~--------~~~~~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKILKRP--------LPSSSQ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHHHTH--------HHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhccccc--------cccccc
Confidence 34456899999999998 8899999999999999999999999997641111 111111000000 000000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. .......+.+++.+|++.+|++||++.+++++
T Consensus 225 ~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 Q---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp S---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011568999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=315.72 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=201.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999865 68899999987543 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++ ++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 97 5999988776666899999999999999999999 89999999999999999999999999999976543221
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC----Cchhhhcchhh
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP----HGLMEVVDTNL 915 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 915 (977)
......+++.|+|||+..+ ..++.++||||+||++|||++|+.||......+ .. ..+..... ..+........
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QL-HFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHcCCCChhhchhhhcccc
Confidence 1222357889999998765 458889999999999999999999997543211 11 11111110 00111111000
Q ss_pred hcc---cc---C--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQ---EH---T--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~---~~---~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... +. . ......+...+.+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 00 0 00011234457899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=328.01 Aligned_cols=202 Identities=25% Similarity=0.394 Sum_probs=175.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++..++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68999999997542 234566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997654 3899999999999999999999 89999999999999999999999999999875532110
Q ss_pred c---------------------------------ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCC
Q 036011 839 S---------------------------------VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPT 885 (977)
Q Consensus 839 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 885 (977)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011246999999999999999999999999999999999999999
Q ss_pred CcC
Q 036011 886 DDM 888 (977)
Q Consensus 886 ~~~ 888 (977)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.02 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=208.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.+-|...+.||+|.|++|-.|++- .|+.||||++.+..- -....+.+|++.|+.++|||||++|++.......|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356888889999999999999854 899999999987652 23445778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~ 837 (977)
|.-++|+|.+|+-.+...+.+.-..+++.||..|+.|+|+.| +||||+||+||.+- .-|-||+.|||++-.+.++.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999888878999999999999999999999554 99999999999874 67899999999999887765
Q ss_pred CcceeeccccCCcccCccccCCCCcC-cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVS-SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. -+..+|+..|-|||++.+..|+ +++||||+|||+|-+++|+.||....+.+. +.-++|-...
T Consensus 174 k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKYt 237 (864)
T KOG4717|consen 174 K---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKYT 237 (864)
T ss_pred h---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhccccc
Confidence 3 3446899999999999999887 689999999999999999999987544432 2223332221
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .....+..++|..|+..||.+|.+..|++..
T Consensus 238 vP-------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 238 VP-------SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred Cc-------hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 11 1234456889999999999999999988643
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.68 Aligned_cols=193 Identities=23% Similarity=0.283 Sum_probs=167.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999975 5789999975432 23569999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+. ++|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 995 6898888776667999999999999999999999 7899999999999999999999999999997543221
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCC
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~ 886 (977)
......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1223458999999999999999999999999999999999766553
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=324.55 Aligned_cols=265 Identities=24% Similarity=0.314 Sum_probs=198.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-----eeE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-----FRA 755 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 755 (977)
+|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 79999999986532 234467889999999999999999999998766 789
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+. ++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 58888876544 4899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc-hhhh---
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG-LMEV--- 910 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~--- 910 (977)
... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+.... ...... ..+.
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~-~~~g~~~~~~~~~~ 232 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLIT-DLLGTPSLEAMRSA 232 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-HHcCCCCHHHHHHh
Confidence 321 122334588999999988764 57999999999999999999999997643211 111110 000000 0000
Q ss_pred ---cchhhhccccCch-------HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 ---VDTNLLRQEHTSS-------AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ---~~~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+.......+ ........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.12 Aligned_cols=249 Identities=29% Similarity=0.487 Sum_probs=197.5
Q ss_pred ccccCcceEEEEEEEeCC-------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 689 NLLGRGSFGSVYKGTFSD-------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999876543 24456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-----ceEEeeccc
Q 036011 761 MPNGSLEKWLYSD------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-----VAHVSDFGL 829 (977)
Q Consensus 761 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~Dfgl 829 (977)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998752 234788999999999999999999 78999999999999999887 899999999
Q ss_pred ccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchh
Q 036011 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLM 908 (977)
Q Consensus 830 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (977)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||...... ....+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~---~~-- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTA---GG-- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhc---CC--
Confidence 986644332222223346788999999999999999999999999999998 99998643221 11111110 00
Q ss_pred hhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.. .....++..+.+++.+||+.+|.+||+++++.+.|++
T Consensus 231 -----~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -----RL-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----cc-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0011234567899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.37 Aligned_cols=240 Identities=22% Similarity=0.335 Sum_probs=190.6
Q ss_pred ccccCcceEEEEEEEeCC--------CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 689 NLLGRGSFGSVYKGTFSD--------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+.||+|+||.||+|.... ...||+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 335888888765555567789999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc--------eEEeecccccc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV--------AHVSDFGLSKL 832 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Dfgla~~ 832 (977)
+++|+|.+++...+..+++..+..++.||+.||+||| +.+|+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876666899999999999999999999 899999999999999987765 69999999875
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCC-CCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRK-KPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
.... ....+++.|+|||++.+ ..++.++||||||+++|||++|. .||....... .......
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~--------- 220 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED--------- 220 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc---------
Confidence 5432 12347889999999876 45899999999999999999995 5543321111 0000000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
... ... ....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---~~~---~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---RHQ---LPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---ccc---CCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000 11235789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.01 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=203.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999975 58899999987553 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++|+|.+++... .+++.....++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 9999999998754 3788999999999999999999 78999999999999999999999999999976643321
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......++..|+|||++.+..++.++||||||+++|||++|..||........ ... .... .
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~-~~~~--------~----- 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFL-IPKN--------N----- 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhh-hhcC--------C-----
Confidence 22234578899999999988999999999999999999999999875432211 000 0000 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......++..+.+++.+||+.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001112345668899999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.69 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=204.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999865 68999999887543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++...+ .+++.....++.+++.|+.|||+ ..+++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999999987654 48999999999999999999994 3589999999999999999999999999987543221
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....|+..|+|||++.+..++.++|||||||++|++++|+.||......+... ..+..+.+......... .
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~-~ 230 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGILDLLQQIVQEP-P 230 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHHHHHHHHHhhcc-C
Confidence 123468999999999988899999999999999999999999997643321100 00000111111100000 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
......+++..+.+++.+|++.+|++||++.|++++.
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0011112455688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=323.19 Aligned_cols=260 Identities=23% Similarity=0.252 Sum_probs=196.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-----
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND----- 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 752 (977)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 68999999986542 334566789999999999999999999886443
Q ss_pred -eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 753 -FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 753 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
..++||||+++ ++.+.+.. .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999975 56666543 3788899999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH--hhCCCch--
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK--ESLPHGL-- 907 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~-- 907 (977)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..|.. .......
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI----DQWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCcHH
Confidence 653321 122346899999999999999999999999999999999999999754211 11110 0000000
Q ss_pred ------------------------hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 ------------------------MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+....... +............+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIF--PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhcccccc--ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 00000001123457899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.39 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=203.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 68999999987654 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||+++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 9999999999765 4899999999999999999999 78999999999999999999999999999987754321
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......+++.|+|||+..+..++.++||||||+++|||+||+.||......+. .. ...... .+.+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~-~~~~~~----~~~~~---- 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LF-LIPKNN----PPSLE---- 219 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HH-HhhhcC----CCCCc----
Confidence 22234588899999999988899999999999999999999999865322111 00 000000 00000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+...+.+++.+||..+|++||++++++++
T Consensus 220 ----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 ----GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00134457889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.07 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=198.8
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC------
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN------ 751 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 751 (977)
.+++.|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677889999999999999999865 68899999987553 3345688899999998 699999999998653
Q ss_pred CeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
...++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+|||++|+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46789999999999999988643 35889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
........ ......|++.|+|||++. +..++.++||||+||++|||++|+.||.+..... .+... ...
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~-~~~ 231 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLI-PRN 231 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHH-hcC
Confidence 86543221 222345889999999875 3468889999999999999999999986532211 11100 000
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. .+.. ....+...+.+++.+||+.+|.+|||+.|++++
T Consensus 232 ~-----~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 P-----APRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C-----CCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 0000 001123457899999999999999999999753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=317.52 Aligned_cols=271 Identities=21% Similarity=0.275 Sum_probs=198.7
Q ss_pred cCccccCc--ceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 687 ECNLLGRG--SFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 687 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.++||+| +|++||+++.+ +|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999864 78999999987653 234456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998654 234899999999999999999999 7899999999999999999999999998765432111100
Q ss_pred -----eeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchh-----
Q 036011 841 -----TQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM----- 908 (977)
Q Consensus 841 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 908 (977)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||.......... .......+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccccccchh
Confidence 1112346778999999876 468999999999999999999999997643322111 111111110000
Q ss_pred --h--------hcchhhhc------------cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 909 --E--------VVDTNLLR------------QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 909 --~--------~~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
+ ..+..... .....+....+...+.+++.+||+.||++|||++|++++ +++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0 00000000 000001112344568899999999999999999999874 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.19 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=200.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566778999999999999864 58899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++... .+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++++|||++........ .
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence 999999998653 4789999999999999999999 78999999999999999999999999999986643221 1
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
.....++..|+|||+..+..++.++||||||+++|||++|+.||........ ..+. .... .+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~----~~~~----~~~~------ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLI----PKNS----PPTL------ 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhh----hcCC----CCCC------
Confidence 2223578899999999998999999999999999999999999865322111 1110 0000 0000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+...+.+++.+||+.+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11234457899999999999999999999885
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.68 Aligned_cols=250 Identities=23% Similarity=0.281 Sum_probs=197.9
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
|+..+.||+|+||+||+|... +++.||+|++.... ......+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 68999999986543 22234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999998886543 35899999999999999999999 8999999999999999999999999999997654322
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......|+..|+|||++.+..++.++|+||+|+++|||++|..||....... ....+... ...... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~-~~~~~~-----~~---- 224 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRR-VLETEE-----VY---- 224 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-hhcccc-----cc----
Confidence 1123468999999999998999999999999999999999999997532211 11111111 111000 00
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
.......+.+++.+|++.+|++||+ +.+++++
T Consensus 225 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 -----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112334678999999999999999 5566553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=319.65 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=196.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.++||+|+||+||+++.+ .++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999975 57889999986532 223345888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999875556899999999999999999999 89999999999999999999999999999976543221
Q ss_pred cceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 839 SVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... +......... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~-~----- 225 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHK-E----- 225 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HHHHHHhCCC-c-----
Confidence 2223356999999999875 356889999999999999999999999653211 1111110000 0
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCC--CCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPD--QRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~--~RPs~~ev~~~ 956 (977)
..... .....+...+.+++.+|+..++. .|+++.|++++
T Consensus 226 ~~~~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQFP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 00012234567788887755444 47899999776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=305.50 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=203.8
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|+||.||.++.. +++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999854 68999999987543 44556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999775 345899999999999999999999 78999999999999999999999999999987644331
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......+++.|+|||+..+..++.++||||+|+++|||++|..||...... +........... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~--------~-- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQGNYT--------P-- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCCC--------C--
Confidence 223346899999999998888999999999999999999999998653221 111111111000 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+...+.+++.+||+.+|++||++.|++++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 001234467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.48 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=194.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhc---CCCCcceEeeeeec-----CC
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNV---RHRNLIKIFSSCCN-----ND 752 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 752 (977)
+|++.+.||+|+||+||+|+.. +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 689999999875432 2223456677777665 69999999998864 34
Q ss_pred eeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 48988887643 34899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CCC--chh
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LPH--GLM 908 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 908 (977)
...... ......++..|+|||++.+..++.++||||+||++|||++|++||...... ..+.+..... .+. .+.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 764322 122345889999999999889999999999999999999999998653222 1122211110 000 000
Q ss_pred hhc---chhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVV---DTNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~---~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... ......... ......++...+.+++.+|++.||++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000000 000011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=305.72 Aligned_cols=238 Identities=22% Similarity=0.378 Sum_probs=190.4
Q ss_pred ccccCcceEEEEEEEeCCCC-----------EEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 689 NLLGRGSFGSVYKGTFSDGT-----------SFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
+.||+|+||.||+|...+.. .|++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 5788877654333 6788999999999999999999999888 778999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-------ceEEeecccc
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-------VAHVSDFGLS 830 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~Dfgla 830 (977)
|||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876656899999999999999999999 89999999999999999887 7999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCC--CcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEG--IVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
..... .....++..|+|||++.+. .++.++||||+|+++||+++ |..||...... ....+... .
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~--~--- 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD--Q--- 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc--C---
Confidence 86543 1123467789999998876 78999999999999999999 46776553211 11111110 0
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.... ... ...+.+++.+||..+|++||++.|+++.|+
T Consensus 223 ------~~~~--~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ------HRLP--MPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------CCCC--CCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 000 145789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=306.45 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=188.7
Q ss_pred cccCcceEEEEEEEeCC---CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 690 LLGRGSFGSVYKGTFSD---GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|++.++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4578888876443 2334568899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCc----cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 766 LEKWLYSDNY----FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 766 L~~~l~~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
|.+++..... ..++.....++.||+.|++||| +.+|+||||||+||++++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 2467788899999999999999 78999999999999999999999999999876543322222
Q ss_pred eeccccCCcccCccccC-------CCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 842 QTMTIATIGYMAPEYGT-------EGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.....+++.|+|||+.. ...++.++||||+||++|||++ |..||......+ .+...... .......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~----~~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVRE----QDIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhc----cCccCCCC
Confidence 23334677899999864 3457889999999999999999 777876532211 11111111 10011111
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.+ ...+...+.+++..|| .+|++||+++||++.|.
T Consensus 234 ~~---------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QL---------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cc---------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 10 1123344667888898 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.94 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=197.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|.+.+.||+|+||+||+++.. +++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 68899999987532 233455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875556899999999999999999999 89999999999999999999999999999987654322
Q ss_pred cceeeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 839 SVTQTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.......||+.|+|||++.+ +.++.++||||+||++|||++|+.||......+ ....... ...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~---~~~------- 225 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMN---HEE------- 225 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHc---CCC-------
Confidence 12233469999999998865 568899999999999999999999996532211 1111100 000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQ--RIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~ev~~~ 956 (977)
.+... ....+....+.+++.+|+...+.+ |+++++++++
T Consensus 226 ~~~~p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQFP----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCC----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000 000112345678888888765544 4678887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=332.28 Aligned_cols=285 Identities=21% Similarity=0.226 Sum_probs=203.4
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC------CCcceEeeeeec
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH------RNLIKIFSSCCN 750 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~ 750 (977)
+...+++|++.++||+|+||+||+|... .++.||||+++... .....+..|+++++.++| ++++.+++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999864 68899999986432 223445667777777754 458888888876
Q ss_pred C-CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCCC--------
Q 036011 751 N-DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDEDM-------- 820 (977)
Q Consensus 751 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~~-------- 820 (977)
. ...++|||++ +++|.+++...+ .+++..+..|+.||+.||+||| + .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 778988887654 4899999999999999999999 5 5999999999999998765
Q ss_pred --------ceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc
Q 036011 821 --------VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892 (977)
Q Consensus 821 --------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 892 (977)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864322 1233569999999999999999999999999999999999999997643211
Q ss_pred ccHHHHHH--hhCCCchh---------hhcc----------hhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 036011 893 MSLKKWVK--ESLPHGLM---------EVVD----------TNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIY 949 (977)
Q Consensus 893 ~~~~~~~~--~~~~~~~~---------~~~~----------~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 949 (977)
.+..... ..++..+. ++.+ +....... ...........+.+++.+|++.||++|||
T Consensus 353 -~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 353 -HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred -HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1111000 00110000 0000 00000000 00000011245779999999999999999
Q ss_pred HHHHHHH--HH----chhhcCcccccccccc
Q 036011 950 MTDAAVK--LK----KIKIIGVLVLSRAEIG 974 (977)
Q Consensus 950 ~~ev~~~--L~----~~~~~~~~~~~~~~~~ 974 (977)
++|++++ +. +.+..+.|+..|+.|-
T Consensus 432 a~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~ 462 (467)
T PTZ00284 432 ARQMTTHPYVLKYYPECRQHPNYPDNRSMLR 462 (467)
T ss_pred HHHHhcCccccccCCccccCCCCCCccccCC
Confidence 9999863 33 3555677777666654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.22 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=198.6
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.|+..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999865 68999999987543 1223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999999886533 35899999999999999999999 89999999999999999999999999999976543221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ....+ .... .... ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~-~~~~----~~~--- 224 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLV-KEVQ----EEY--- 224 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhh-hhhh----hhc---
Confidence 123468999999999999999999999999999999999999997532211 00110 0000 0000 000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~ 955 (977)
...+...+.+++.+||+.+|++||| +.|+++
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0112345789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=307.61 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=199.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---------hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---------RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777889999999999999864 689999998865421 123568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997654 4789999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCc----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 834 DEGDDS----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 834 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
...... .......|+..|+|||...+..++.++||||+|+++|+|++|+.||....... ..... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~----~--- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI-GE----N--- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH-hc----c---
Confidence 532111 11112347889999999998899999999999999999999999997532111 00000 00 0
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
..+.+ +......+.+++.+||+.+|.+||++.|+++
T Consensus 228 -~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -ASPEI---------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CCCcC---------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 1123456789999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=309.77 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=202.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 689999999865432 233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++++|..+..... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999998888775543 4899999999999999999999 79999999999999999999999999999987654332
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH---hhCCCchhhhcchh-
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK---ESLPHGLMEVVDTN- 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~- 914 (977)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+. ...+.. ...+ ...+..+..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~ 232 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIP-RHQQIFSTNQ 232 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCh-HHhhhccccc
Confidence 1222357889999998766 5688999999999999999999999976433221 111111 0000 000000000
Q ss_pred ----hh-ccc----cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 ----LL-RQE----HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ----~~-~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ... .......+....+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000 0000011234568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.63 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=205.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788889999999999999976 68999999987664 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++++|.+++......++.....+++.|++.|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999999876556899999999999999999999 7 89999999999999999999999999998765432111
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
...++..|+|||+..+..++.++||||+|+++|+|++|+.||.....................
T Consensus 158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 220 (265)
T cd06605 158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------------- 220 (265)
T ss_pred ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-------------
Confidence 145888999999999999999999999999999999999998764322222222211111100
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+...+.+++.+||..+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000001144567899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.21 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=200.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... +.....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999975 78999999887543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSD--NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
+++++|.+++... ...+++..+..++.|+++|++|||+ +.+|+||||||+||+++.++.+||+|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764 2258999999999999999999994 3589999999999999999999999999997654321
Q ss_pred cceeeccccCCcccCccccCCCC------cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGI------VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.....+++.|+|||.+.+.. ++.++||||+||++|+|++|+.||....... ..... ..+.+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~--------~~~~~ 224 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQL--------SAIVD 224 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHH--------HHHhh
Confidence 12235888999999875543 5889999999999999999999996532111 00000 00000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .. ....++...+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~----~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 225 GD----PP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cC----CC--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00 00 0011244567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.85 Aligned_cols=195 Identities=24% Similarity=0.307 Sum_probs=160.4
Q ss_pred CccccCcceEEEEEEEeC---CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCeeEEEEeccC
Q 036011 688 CNLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRALVLELMP 762 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 762 (977)
.++||+|+||+||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46889999986442 23457789999999999999999998854 456789999985
Q ss_pred CCCHHHHhhcC--------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee----CCCCceEEeecccc
Q 036011 763 NGSLEKWLYSD--------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLS 830 (977)
Q Consensus 763 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla 830 (977)
++|.+++... ...+++..+..++.||+.||+||| +.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888877532 124788999999999999999999 8999999999999999 46679999999999
Q ss_pred cccCCCCCc-ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 831 KLFDEGDDS-VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 831 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
+.+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543211 12234568999999998876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.52 Aligned_cols=246 Identities=32% Similarity=0.510 Sum_probs=198.0
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588889999999999999975 67889999986543 345788999999999999999999998754 4689999999
Q ss_pred CCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 763 NGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 763 ~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+++|.+++..... .+++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 9999999976543 5789999999999999999999 7999999999999999999999999999987643221
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....+..|+|||++.++.++.++||||+|+++|||++ |+.||......+ ...... .+ .....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----~~--------~~~~~- 218 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVE----KG--------YRMEP- 218 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh----CC--------CCCCC-
Confidence 11234567999999988899999999999999999997 899986542211 111111 00 00000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
...++..+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 ----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.19 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=198.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 68999999986543 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
++ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988886533 45899999999999999999999 78999999999999999999999999999976543221
Q ss_pred cceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CC----Cchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LP----HGLMEVV 911 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~----~~~~~~~ 911 (977)
......+++.|+|||++.+. .++.++||||+|+++|||+||+.||........ ........ .. .......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 12233578899999987654 578999999999999999999999875322111 11100000 00 0000000
Q ss_pred chhhh--c--cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 DTNLL--R--QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~--~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.... . ..........+..++.+++.+|++.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0 000000011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=304.34 Aligned_cols=250 Identities=31% Similarity=0.525 Sum_probs=201.5
Q ss_pred CCcCccccCcceEEEEEEEeCC-----CCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 685 FNECNLLGRGSFGSVYKGTFSD-----GTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
+++.+.||+|+||.||+++..+ +..||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 488999998765433 5678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYF-LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
||+++++|.+++...... +++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999875544 899999999999999999999 8899999999999999999999999999998776542
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
..... ...+++.|+|||...+..++.++||||+|+++|+|++ |..||..... ....+...... ..
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~-----------~~ 223 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY-----------RL 223 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC-----------CC
Confidence 22111 2237789999999988889999999999999999998 7788765211 11111111000 00
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.. ...++..+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 011345688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=321.17 Aligned_cols=265 Identities=21% Similarity=0.222 Sum_probs=197.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------ 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 751 (977)
..++|++.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 68999999987543 23446678899999999999999999988643
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 356899999965 67666643 3788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--------
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-------- 903 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 903 (977)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .........
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 654322 12234689999999999999999999999999999999999999975322111 110000000
Q ss_pred --CCchhhhcc----------hhhhccc---cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 --PHGLMEVVD----------TNLLRQE---HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 --~~~~~~~~~----------~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+ +...... ............+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000000 0000011123457899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=308.47 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=203.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
++|++.+.||+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999864 3567999988755433 4577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC--------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 756 LVLELMPNGSLEKWLYSDN--------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997644 14899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
|++....... ........++..|+|||.+.+..++.++||||+|+++|++++ |..||.+..... ....... ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~---~~ 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQA---GK 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHc---CC
Confidence 9987543322 112223346778999999988889999999999999999999 778886532211 1111110 00
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.. .. ....++..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 236 ~~--------~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 236 LE--------LP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cC--------CC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 00 001133467899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.48 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=200.1
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec-CCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-NDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 759 (977)
+|++.+.||+|++|.||+++.+ +++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5888999999999999999865 57899999987543 3445678899999999999999999998764 446789999
Q ss_pred ccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++++|.+++... ...+++..+..++.+++.|++||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999764 335899999999999999999999 78999999999999999999999999999987643221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......+++.|+|||+..+..++.++||||+|+++|++++|+.||..... ..+..........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~---------- 220 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLP---------- 220 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCC----------
Confidence 12234588999999999999999999999999999999999999864321 1111111000000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.........+.+++.+|++.+|++||++.+++++
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011234467899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=307.88 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=198.6
Q ss_pred CCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 685 FNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
|.+.+.||+|+||.||+|... .++.||||++..+. ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36889999987543 334567889999999999999999999886532
Q ss_pred eeEEEEeccCCCCHHHHhhcC-----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 753 FRALVLELMPNGSLEKWLYSD-----NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
..++++||+.+|+|.+++... ...+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 124788999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
|.++...............+++.|++||...+..++.++||||+|+++|||++ |+.||..... .....+.... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~--~~ 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG--NR 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC--Cc
Confidence 99987654332222223345678999999998899999999999999999999 8888765322 1111111110 00
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
. .. ...+...+.+++.+||+.+|++||++.|+++.|+++
T Consensus 234 --------~-~~------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 --------L-KQ------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------C-CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 012344688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=322.12 Aligned_cols=263 Identities=21% Similarity=0.221 Sum_probs=197.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------ 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 751 (977)
..++|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 68899999987542 33446678899999999999999999987543
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
...++||||+++ +|.+++.. .+++..+..++.|+++||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357899999965 77777643 3788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc---hh
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG---LM 908 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 908 (977)
...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... ..... ..
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~ 249 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE-QLGTPCPEFM 249 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCCCCHHHH
Confidence 654322 2223468999999999999999999999999999999999999997542211 1111111 00000 00
Q ss_pred hhcch----------------------hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDT----------------------NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+.+ ..... ............+.+++.+|++.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFP-ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCcccccc-ccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 00000 0000001123457899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=318.43 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=197.2
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN----- 751 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 751 (977)
...++|.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 688999999875432 2345677899999999999999999987543
Q ss_pred -CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 752 -DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 752 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
...++++|++ +++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3568999988 78999888654 3899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--CCc-
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--PHG- 906 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~- 906 (977)
+..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+..+....- ...
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 865432 123458999999999876 57899999999999999999999999653221 11112111100 000
Q ss_pred hhhhcc---hhhhcc-cc-CchH----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 LMEVVD---TNLLRQ-EH-TSSA----EMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ~~~~~~---~~~~~~-~~-~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+.. ...... .. .... .......+.+++.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 00 0000 00112346799999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.03 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=199.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 689999999875432 2235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++ ++|.+++......+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 96 5888888765556899999999999999999999 78999999999999999999999999999986543221
Q ss_pred eeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC-C-----chhhhcch
Q 036011 841 TQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP-H-----GLMEVVDT 913 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~ 913 (977)
......+++.|+|||++.+. .++.++||||+||++|||+||+.|+......+..+....+..-. . ......+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234578899999987664 47899999999999999999999865433222211111110000 0 00000000
Q ss_pred hhhccccCc----hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTS----SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......... .........+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000 0011234567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=341.04 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=197.6
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCe
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDF 753 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 753 (977)
....++|.+++.||+|+||+||+|+.. .++.||+|++.... ......+..|+.++++++|||||+++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999975 57889999987542 3345678899999999999999999998854 456
Q ss_pred eEEEEeccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeCCCCCCceeeCC--------
Q 036011 754 RALVLELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGH----STPVVHCDLKPSNILLDE-------- 818 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~dlk~~NIll~~-------- 818 (977)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998753 235899999999999999999999422 156999999999999964
Q ss_pred ---------CCceEEeecccccccCCCCCcceeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 819 ---------DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 819 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998664322 1223469999999998854 4589999999999999999999999964
Q ss_pred CCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 888 MFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
... ........ ... +.+. .......+.+++..||+.+|.+||++.|+++
T Consensus 246 ~~~----~~qli~~l-k~~------p~lp--------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANN----FSQLISEL-KRG------PDLP--------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCc----HHHHHHHH-hcC------CCCC--------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 321 11111110 000 0000 0012345789999999999999999999984
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.59 Aligned_cols=236 Identities=24% Similarity=0.256 Sum_probs=182.9
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc---CCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV---RHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
||+|+||+||+|+.. +++.||||++.... ......+..|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999987542 12233445566676655 699999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 99999987654 4899999999999999999999 88999999999999999999999999999875433221 223
Q ss_pred ccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 844 MTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
..+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ ..... ..+.. .+ ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~i-~~~~~-----~~--~~~-- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRNI-AFGKV-----RF--PKN-- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHHH-HcCCC-----CC--CCc--
Confidence 34699999999988754 58999999999999999999999986532211 11110 00000 00 000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYMT 951 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 951 (977)
.....+.+++.+|++.+|.+||++.
T Consensus 220 ----~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 ----VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ----cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1233467899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.49 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=200.0
Q ss_pred CCCcCccccCcceEEEEEEEeCC--CCEEEEEEeeccc----------hhhHHHHHHHHHHHHh-cCCCCcceEeeeeec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSD--GTSFAIKVFNLQL----------DRAFRSFDSECEVLRN-VRHRNLIKIFSSCCN 750 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 750 (977)
+|++.+.||+|+||.||+|+... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 7889999875332 2334557788888875 699999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 751 NDFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
.+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+ ..+++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988753 33458999999999999999999993 368999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
|.+....... ......++..|+|||+..+..++.++||||||+++|||++|+.||...... ...........
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLATKIVEAVY 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHHHHhhccC
Confidence 9998765432 223346889999999999988999999999999999999999998643111 11111100000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
... ....+...+.+++.+||+.+|++||++.|+.++++
T Consensus 231 ~~~-------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPL-------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcC-------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 00112345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.22 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=194.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 754 (977)
.+|+..+.||+|+||.||+|... +++.||+|++.... .+....+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 68999999886432 2334568899999999999999999998865 3567
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
+++|||+++++|.+++..... +++.....++.|++.||+||| +.+|+||||+|+||+++.++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999999999999976543 789999999999999999999 7899999999999999999999999999997654
Q ss_pred CCCCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 835 EGDDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 835 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... .......++..|+|||++.+..++.++||||+||++||+++|+.||......+ ... ...... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~-~~~~~~----~~~ 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIF-KIATQP----TNP 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHH-HHhcCC----CCC
Confidence 32111 11122358889999999999899999999999999999999999987532211 111 000000 000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+ +......+.+++ +||..+|++||+++|++++
T Consensus 229 ~~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 QL---------PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CC---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00 011222344555 7888999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.27 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=186.4
Q ss_pred cccCcceEEEEEEEeCCC---CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 690 LLGRGSFGSVYKGTFSDG---TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 356677665443 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 766 LEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 766 L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
|.++++... ...++..+..++.||++||+||| +.+++||||||+||+++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997642 23567778899999999999999 789999999999999999999999999998643222111122
Q ss_pred eccccCCcccCccccCC-------CCcCcccchhhHhHHHHHHhcC-CCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 843 TMTIATIGYMAPEYGTE-------GIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
....++..|+|||+... ..++.++||||||+++|||+++ ..||...... ...............++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----EVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhhcccccCCCc
Confidence 23457889999998743 3467899999999999999974 6676543221 111111111111122222
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
+.. .....+.+++..|| .+|++||++++|++.|.
T Consensus 234 ~~~---------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LEL---------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCC---------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 12235678889999 57999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.62 Aligned_cols=248 Identities=28% Similarity=0.347 Sum_probs=200.6
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
+|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+++++.++||||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 78999999986543 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.... .+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997654 4789999999999999999999 7899999999999999999999999999988764332
Q ss_pred CcceeeccccCCcccCccccCCCC-cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGI-VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
......++..|+|||...... ++.++|+||+|+++|++++|+.||......+ ....+... .... .
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~~~~-----~-- 222 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---KELP-----P-- 222 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---ccCC-----C--
Confidence 122345889999999887766 8999999999999999999999987643111 01111100 0000 0
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+..+...+.+++.+||+.+|.+||++.+++++
T Consensus 223 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 -------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 001123457889999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.28 Aligned_cols=257 Identities=25% Similarity=0.319 Sum_probs=206.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999864 68899999987543 33567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
+++++|.+++.... ..+++.....++.|++.|++||| +.|++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997642 35899999999999999999999 89999999999999999999999999999987765432
Q ss_pred cc--eeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 839 SV--TQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 839 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. ......++..|+|||++... .++.++||||+|+++|||++|+.||......+ ...++..... +.+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDP---------PSL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCC---------CCc
Confidence 21 12234588999999998776 78999999999999999999999997543221 1112111100 000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ......+...+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ET----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CC----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00011334567899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.20 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=202.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|++.+.||+|+||.||+++.. +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999864 68999999987542 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999987643 35789999999999999999999 78999999999999999999999999999986644221
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......|++.|+|||+..++.++.++||||||+++|+|++|+.||..... .............
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~----------- 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSYP----------- 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCCC-----------
Confidence 11223588899999999999999999999999999999999999864221 1111111111000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.+|++||++.||+++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 ---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0011234467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=315.20 Aligned_cols=194 Identities=29% Similarity=0.399 Sum_probs=169.8
Q ss_pred CCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-C-----CCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-H-----RNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 756 (977)
+|++.+.||+|+||.|.+|.. ++++.||||+++.. ..-..+-..|+.+|..++ | -|+|+++++|...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 689999999999999999985 46999999999755 344556678999999996 4 489999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC--CceEEeeccccccc
Q 036011 757 VLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED--MVAHVSDFGLSKLF 833 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~ 833 (977)
|+|.++ .+|.++++.++. .++...+..++.||+.||.+|| +.+|||+||||+|||+... ..|||+|||.|++.
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999994 599999987654 5899999999999999999999 8999999999999999743 47999999999987
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
...-. ..+-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 54332 23466789999999999999999999999999999999887765
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.10 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=198.7
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 689999999875532 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+. +++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 6887777655555788889999999999999999 78999999999999999999999999999976433221
Q ss_pred cceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH-HHHhhCCCc----------
Q 036011 839 SVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK-WVKESLPHG---------- 906 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~---------- 906 (977)
......+++.|+|||+..+. .++.++||||+|+++|||++|+.||.........+.+ |.....+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233578899999988654 5788999999999999999999999764332111111 111000100
Q ss_pred --hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 907 --LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 907 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
..+......................+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000000011345678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=309.94 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=200.5
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeee---
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCC--- 749 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 749 (977)
+..+.++.++|++.+.||+|+||.||+|+.. +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567889999999999999999999864 68899999876432 2235678899999999 6999999999874
Q ss_pred --cCCeeEEEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 750 --NNDFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 750 --~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
..+..++||||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+++||||||+||++++++.+|+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999998753 2335788999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHH
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 899 (977)
+|||++........ ......|++.|+|||++. +..++.++||||+||++|||++|+.||........ ...+.
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~~ 242 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKIP 242 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhcc
Confidence 99999987643221 122345899999999875 34578999999999999999999999865322110 00000
Q ss_pred HhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. .......++ ..+...+.+++.+||+.+|++||++.|++++
T Consensus 243 ~----~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 R----NPPPTLHQP------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c----cCCCcccCC------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000000 0123357899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.15 Aligned_cols=266 Identities=22% Similarity=0.272 Sum_probs=203.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 68999999987654 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+ +++|.+++......+++..++.++.||++||+||| +.+++|+||||+||+++.++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999999776667899999999999999999999 78999999999999999999999999999987654322 1
Q ss_pred eeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc----hhh---hcc
Q 036011 841 TQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG----LME---VVD 912 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~ 912 (977)
......++.+|+|||++.+. .++.++||||+|+++|||++|.+||...... ..+ .+....+... +.+ ..+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQL-AIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHH-HHHHHHcCCCChHHHhhccCcch
Confidence 22234688999999987654 4689999999999999999998777543221 111 1111111000 000 000
Q ss_pred hh---hhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TN---LLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~---~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ....... .....+....+.+++.+|++.+|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000 00001234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=308.35 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=202.6
Q ss_pred CHHHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeec-
Q 036011 674 SYLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN- 750 (977)
Q Consensus 674 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 750 (977)
++.++....+.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45555667788999999999999999999974 68999999987653 3345688899999998 69999999999853
Q ss_pred -----CCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 751 -----NDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 751 -----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
.+..+++|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+|||++|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999987643 34788889999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHH
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 899 (977)
+|||++........ ......|++.|+|||.+. ...++.++||||+||++|||++|+.||.+....+....
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--- 237 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--- 237 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence 99999876543211 122345889999999875 35688899999999999999999999865322111000
Q ss_pred HhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
....... .....+++..+.+++.+||+.+|.+||++.|+++
T Consensus 238 -------~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -------IPRNPPP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------HhhCCCC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000 0011124456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=309.94 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=199.3
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334467999999999999864 6899999998766555667789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
++|.+++... .+++..+..++.||+.|++||| +.+|+||||||+||+++.++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9999988654 3789999999999999999999 78999999999999999999999999999876543221 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...++..|+|||...+..++.++||||+|+++|||++|+.||......+ .... .....+ .....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~~~~~--------~~~~~------ 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IRDNLP--------PRVKD------ 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhcCC--------Ccccc------
Confidence 3458899999999988899999999999999999999999986532111 0111 111010 10100
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+.+++.+|++.+|.+|||+.|++++
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01123356789999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.66 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=199.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch----------hhHHHHHHHHHHHHhcCCCCcceEeeeeecCC
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD----------RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND 752 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 752 (977)
+|...+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 689999998864311 12346788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999997764 4889999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCC--cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
..............++..|+|||...... ++.++||||+|+++||+++|..||...... ..+.. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFK-LGNKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHH-hhccccCCc
Confidence 54322222222345888999999887654 889999999999999999999998643211 11111 000000000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.. ....++...+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP---------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc---------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0111234567899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.81 Aligned_cols=251 Identities=23% Similarity=0.273 Sum_probs=204.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367889999999999999999854 6889999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++.... +++..+..++.|++.|++||| +.|++|||++|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 99999999987643 789999999999999999999 88999999999999999999999999999876654322
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......+++.|+|||...++.++.++||||||+++|++++|+.||......+.....+ . . ...
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~----~------------~~~ 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T----N------------GTP 233 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-c----C------------CCC
Confidence 1223358889999999988889999999999999999999999996532211100000 0 0 000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...........+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111234457889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=310.83 Aligned_cols=257 Identities=27% Similarity=0.349 Sum_probs=201.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|+..+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 589999999876532 24567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
||+.+++|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999987642 45899999999999999999999 7899999999999999999999999999987654321
Q ss_pred Ccc---------------------------eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCc
Q 036011 838 DSV---------------------------TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT 890 (977)
Q Consensus 838 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~ 890 (977)
... ......|+..|+|||+..+..++.++||||+|+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110 11123578899999999988999999999999999999999999865432
Q ss_pred ccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 891 GEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
... +.. +...... ..........+.+++.+|++.+|++||+....++.+...
T Consensus 238 ~~~-~~~------------~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DET-FSN------------ILKKEVT-----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHH-HHH------------HhcCCcc-----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 111 111 0110000 000011345689999999999999999944333333333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=311.27 Aligned_cols=267 Identities=25% Similarity=0.301 Sum_probs=201.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 589999999765432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|++++++.++..... .+++..+..++.|+++||+||| +.+++|||++|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 999999988776543 3899999999999999999999 78999999999999999999999999999987644322
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--cHHHHHHhhCCCchhhhcchh--
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--SLKKWVKESLPHGLMEVVDTN-- 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-- 914 (977)
......++..|+|||+..+ ..++.++||||||+++|||++|++||......+. ....+. ..+........+..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GNLIPRHQEIFQKNPL 233 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CCCchhhHHHhccchH
Confidence 2223457889999998765 4578899999999999999999998864322110 000000 01111111111100
Q ss_pred --------hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 --------LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 --------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.............+...+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000011235668899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.66 Aligned_cols=256 Identities=22% Similarity=0.258 Sum_probs=200.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+++.. .++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999975 58899999987653 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 4899999999999999999999 78999999999999999999999999999874211100
Q ss_pred -------------cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 839 -------------SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 839 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
........++..|+|||.+.+..++.++|+||||+++||+++|..||.+....+ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCC
Confidence 001112347889999999988899999999999999999999999986532211 111111100000
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
+ .. ...++..+.+++.+||+.+|++||++.++.+.++.
T Consensus 236 -------~--------~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 236 -------P--------EG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -------C--------Cc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 00 00134457899999999999999997666555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.50 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=205.6
Q ss_pred CCcCccccCcceEEEEEEEeCC-CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 685 FNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
|+++.-||.|+||.||+|..++ +-..|.|++...+....++|.-|++++..+.||+||++++.|..++..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 5566779999999999999764 445578999888888889999999999999999999999999889999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|-.+.++-.-+..+.+.++..+.+|++.||.||| +..|+|||+|+.|||++-+|.++++|||.+...... .....
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhhc
Confidence 9999998887778999999999999999999999 899999999999999999999999999998754321 12233
Q ss_pred ccccCCcccCcccc-----CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 844 MTIATIGYMAPEYG-----TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 844 ~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
..+|||.|||||+. ...+|+.++||||||+++.||..+.+|..+...... +.+..+...|. +
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-llKiaKSePPT---------L--- 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEPPT---------L--- 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-HHHHhhcCCCc---------c---
Confidence 46799999999974 467899999999999999999999999766433222 11111111111 1
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
-.+..-...+-+++.+|+..+|..||++++++++
T Consensus 256 ----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 ----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111234457889999999999999999999764
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=309.06 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=158.9
Q ss_pred ccccCcceEEEEEEEeC---CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 763 (977)
++||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 45789999886542 23457889999999999999999998853 5577899999864
Q ss_pred CCHHHHhhcC--------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee----CCCCceEEeeccccc
Q 036011 764 GSLEKWLYSD--------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLSK 831 (977)
Q Consensus 764 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~ 831 (977)
+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 124788999999999999999999 8899999999999999 566799999999998
Q ss_pred ccCCCCCc-ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 832 LFDEGDDS-VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 832 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76543221 12233468999999998876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.94 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=200.8
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh-----hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR-----AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
+|+..+.||+|+||.||+|... +++.||||.+...... ....+..|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 6899999998755322 334567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+ +|+|.+++......+++..+..++.||++||+||| +.||+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999876546899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC---CCchh---hh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL---PHGLM---EV 910 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~---~~ 910 (977)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+.+.....- ...+. ..
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhcccc
Confidence 21 222346788999998754 4678999999999999999999777754322 111111111000 00000 00
Q ss_pred cchhhh---ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLL---RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.... ...............+.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000000111234568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.93 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=200.8
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC-----
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND----- 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 752 (977)
..+++|++.+.||+|++|.||+|+.+ +++.+|+|++..... ..+.+.+|+++++++ +||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999975 678999999876543 346789999999999 6999999999997644
Q ss_pred -eeEEEEeccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 753 -FRALVLELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 753 -~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
..++||||+++++|.+++... +..+++..+..++.|+++||+||| +.+++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988653 246899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
++........ ......++..|+|||++.. ..++.++||||+|+++|+|++|+.||....... ...+.....
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~- 234 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNP- 234 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccC-
Confidence 9986543221 1223458899999998653 347889999999999999999999986532211 111111000
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. + ...........+.+++.+||+.||++|||+.|++++
T Consensus 235 ---~-----~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 ---P-----P-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---C-----C-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 001112244567899999999999999999999763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.57 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=198.2
Q ss_pred cCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 687 ECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999865 689999999876554555678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecc
Q 036011 766 LEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845 (977)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (977)
|.+++... .+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++........ .....
T Consensus 105 L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 105 LTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 99987653 3789999999999999999999 78999999999999999999999999999876543221 12234
Q ss_pred ccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHH
Q 036011 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925 (977)
Q Consensus 846 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (977)
.++..|+|||++.+..++.++||||+||++|||++|+.||......+ .. .......... ... .
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~-~~~~~~~~~~--------~~~-------~ 240 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AM-KRLRDSPPPK--------LKN-------A 240 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHhccCCCC--------ccc-------c
Confidence 58899999999998899999999999999999999999986432111 11 1111100000 000 0
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 926 MDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 926 ~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+.+++.+|++.+|++||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1123357889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.61 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=201.9
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC-
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN- 751 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 751 (977)
..++..++++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3455667889999999999999999999874 68999999986432 2345678899999999 799999999998653
Q ss_pred ----CeeEEEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 752 ----DFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 752 ----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
+..++||||+++|+|.++++. ....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEE
Confidence 357899999999999998863 2345899999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccCCC-----CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHH
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-----IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 899 (977)
+|||++........ ......++..|+|||++... .++.++||||+||++|||++|+.||...... ..+.++.
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP 246 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh
Confidence 99999987643221 11224588899999987543 3689999999999999999999998754221 1111111
Q ss_pred HhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+ .+.+ ..+....+.+++.+||+.+|++||++.|++++
T Consensus 247 ~~~~~----~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RNPPP----TLLH------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cCCCC----CCCc------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11000 0000 01123357899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=301.81 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=200.7
Q ss_pred CCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+|+..+.||+|++|.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 478999999987543 1235678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDE 835 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~ 835 (977)
||||+++++|.+++...+ .+++..+..++.|++.||+||| +.|++|+||+|+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 4889999999999999999999 78999999999999998776 699999999987654
Q ss_pred CCCc--ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 836 GDDS--VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 836 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.... .......++..|+|||+..+..++.++||||+|+++|++++|..||........ ...+ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~------- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALI-FKIASAT------- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHH-HHHhccC-------
Confidence 3211 111234588899999999888999999999999999999999999864322111 1111 1000000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
............+.+++.+|++.+|++||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000011123456788999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.73 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=200.8
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|+||.||+|... +++.+|||++.... ......+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~ 838 (977)
+++++|.+++.... ..+++..+.+++.++++|++||| +.+++||||+|+||+++++ +.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997653 35899999999999999999999 7899999999999999855 4689999999987654321
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||....... ....... .....+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~---~~~~~~-------- 221 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMS---GTFAPI-------- 221 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHh---cCCCCC--------
Confidence 122458889999999998889999999999999999999999986532211 1111110 000000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+...+.+++.+||+.+|++|||+.|++++
T Consensus 222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01134457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=303.26 Aligned_cols=256 Identities=23% Similarity=0.265 Sum_probs=200.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 758 (977)
++|+..+.||.|++|.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999975 689999999875433 3456789999999999999999999988653 4689999
Q ss_pred eccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
||+++++|.+++.. ....+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988653 2345788999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCc---ccccHHHHHHhhCCCchhhhcc
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT---GEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .......|........
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE------ 227 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh------
Confidence 221 123478899999999999999999999999999999999999976422 1111222222111000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+..... ........+.+++.+||+.+|++|||+.|++++
T Consensus 228 --~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 --LKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --hccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000000 001124467899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.27 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=202.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCeeEEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRALVL 758 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 758 (977)
+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 68999999986542 3445678899999999999999999998754 45678999
Q ss_pred eccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 759 ELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGH--STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 759 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
||+++++|.+++... ...+++..++.++.|++.||+|||..+ +.+++||||+|+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998753 346899999999999999999999654 688999999999999999999999999999877
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....+.... +.. +
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~----~~~----~ 228 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKE----GKF----R 228 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhc----CCC----C
Confidence 54332 12234588999999999998899999999999999999999999875431 111111111 000 0
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.........+.+++.+|++.+|++||++.+|+++
T Consensus 229 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=332.11 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=193.4
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeec------
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN------ 750 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 750 (977)
.+...+|+.++.||+||||.||+++.+ ||+.||||+++... +.....+.+|+..+++++|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 566778999999999999999999977 99999999998764 4455678899999999999999999832200
Q ss_pred --------------------------------------------------------------------------------
Q 036011 751 -------------------------------------------------------------------------------- 750 (977)
Q Consensus 751 -------------------------------------------------------------------------------- 750 (977)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHH
Q 036011 751 -------------------------N--------DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797 (977)
Q Consensus 751 -------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH 797 (977)
+ ...|+-||||+..++.++++.+...-.....++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1246789999998888888776543357889999999999999999
Q ss_pred hcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC----------------CCCCcceeeccccCCcccCccccCCC-
Q 036011 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD----------------EGDDSVTQTMTIATIGYMAPEYGTEG- 860 (977)
Q Consensus 798 ~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~- 860 (977)
+.|||||||||.||++|+++.|||+|||+|+... .+......+..+||.-|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 8999999999999999999999999999998721 11122244556899999999988765
Q ss_pred --CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHH
Q 036011 861 --IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALD 938 (977)
Q Consensus 861 --~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 938 (977)
.|+.|+|+||+|||++||+. ||.........+..-.+..+|.. ....++ ....-..++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~--------------~~~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP--------------EHPEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc--------------cchHHHHHHHH
Confidence 49999999999999999985 45432111111111111111111 111111 11123678999
Q ss_pred hhcCCCCCCCCHHHHHHH
Q 036011 939 CCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 939 cl~~~P~~RPs~~ev~~~ 956 (977)
+++.||.+|||+.|++..
T Consensus 854 Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HhcCCCccCCCHHHHhhc
Confidence 999999999999999753
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.37 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=196.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--Cee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 754 (977)
.+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999865 58999999876432 23356788999999999999999999988764 467
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++++|.+++.... .+++....+++.|++.||+||| +.+++||||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987654 3788899999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 835 EGDDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 835 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... .......++..|+|||+..+..++.++||||||+++|||++|+.||....... ... ....... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~-~~~~~~~----~~ 228 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----AIF-KIATQPT----NP 228 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----HHH-HHhcCCC----CC
Confidence 32111 11223458889999999988889999999999999999999999986532111 110 0000000 00
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+......+.+++.+|+. +|++||+++|++++
T Consensus 229 ---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 ---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011233456778888885 99999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.50 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=199.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999975 689999999875432 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++ +|.+++......+++.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9974 999998876656899999999999999999999 78999999999999999999999999999875432211
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CC-Cc-hhhhcch-h
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LP-HG-LMEVVDT-N 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~-~~~~~~~-~ 914 (977)
......++..|+|||+..+ ..++.++||||+|+++|||++|+.||................. .+ .. +..+... .
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346788999998765 4588999999999999999999999965432111111111000 00 00 0000000 0
Q ss_pred hh----ccccCchH-----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 915 LL----RQEHTSSA-----EMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 915 ~~----~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.. ........ ..+....+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 0011245689999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=305.98 Aligned_cols=246 Identities=26% Similarity=0.314 Sum_probs=197.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
+.|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999865 68999999986432 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||++ |++.+++......+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 9996 5787777655556899999999999999999999 7899999999999999999999999999987654321
Q ss_pred cceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 839 SVTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
...+++.|+|||++. .+.++.++||||||+++|||++|..||........ ..... ...
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~---~~~--------- 230 (307)
T cd06607 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA---QND--------- 230 (307)
T ss_pred -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHh---cCC---------
Confidence 235788999999874 45688999999999999999999999865321110 00000 000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+...+.+++.+||+.+|++||++.+++.+
T Consensus 231 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 ----SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000011234568899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.76 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=202.2
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 789999999876643 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++.... ..++..+..++.++++|++||| +.+|+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999997754 3789999999999999999999 8899999999999999999999999999998765433221
Q ss_pred e--eeccccCCcccCccccCCCC---cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 841 T--QTMTIATIGYMAPEYGTEGI---VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 841 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
. .....+++.|+|||++.+.. ++.++||||||+++||+++|+.||...... ............ +
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~--------~-- 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHK--------P-- 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCCC--------C--
Confidence 1 11245788999999988766 899999999999999999999999653211 111111110000 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
..+....+...+.+++.+||+.+|.+||++.|++.
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 -----PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111122445678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=303.57 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=207.1
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
..++.|+..+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+||+++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567888899999999999999976 689999999986544 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.+++......+++..+..++.|+++||+||| +.|++|+|++|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999886546899999999999999999999 79999999999999999999999999999876543221
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......++..|+|||+..+..++.++||||||+++|+|++|+.||....... ....+.. ...
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~----~~~----------- 233 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITT----KGI----------- 233 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----cCC-----------
Confidence 1122347889999999988889999999999999999999999986532211 1111110 000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+...+.+++.+|++.+|.+||++.+++++
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 -PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0011111234568899999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=280.11 Aligned_cols=250 Identities=24% Similarity=0.276 Sum_probs=198.6
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.+.+..+|.|.-|+||+++.+ .|...|||.+.+.. ....+++...++++..-+ +|+||+.+|+|..+..+++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344567999999999999975 58999999988764 344566777777776664 899999999999999999999998
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
. ..++.+++.-.+++++.-+-++...+..||.||-+ +++|+|||+||+|||+|+.|.+|+||||.+.++..+. .
T Consensus 174 s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A 247 (391)
T KOG0983|consen 174 S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A 247 (391)
T ss_pred H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence 4 46677777767779999999999999999999997 6689999999999999999999999999998776543 2
Q ss_pred eeccccCCcccCccccCCC---CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 842 QTMTIATIGYMAPEYGTEG---IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.+...|-+.|||||.+... .|+.++||||||++++|+.||+.||..-..+-..+.+... .+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln----------------~e 311 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN----------------EE 311 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh----------------cC
Confidence 3344588899999988644 6899999999999999999999999874332222222111 11
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+...+..+.....+.+++..|++.|+.+||...+++++
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11122222356678999999999999999999998765
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.20 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=197.7
Q ss_pred CccccCcceEEEEEEEeC-CCCEEE---EEEeecc-chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe--eEEEEec
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFA---IKVFNLQ-LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF--RALVLEL 760 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~va---vK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 760 (977)
..+||+|+|-+||+|.+. +|..|| ||.-+.. ..+..++|..|+++|+.|+||||++++.+|.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999874 466665 3322211 24456889999999999999999999999987654 6689999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+..|+|..|.++.+. .+......|++||++||.|||.. .++|+|||||-+||+|+ ..|.|||+|.|+|+....+.
T Consensus 125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999988775 88899999999999999999964 48999999999999998 56899999999999876432
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
....+|||.|||||+.. ..|++.+||||||+.++||+|+..||..-......+.+.....-|..+..+-|+
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP------ 271 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP------ 271 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH------
Confidence 22367999999999876 789999999999999999999999997644433333333333344445555443
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.++|.+|+.. .++|||+.|+++.
T Consensus 272 -----------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 -----------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 357899999998 9999999999763
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=296.74 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=205.6
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++||+|+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 689999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+++|.+++......+++..+..++.|+++|++||| +.+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999876556899999999999999999999 79999999999999999999999999999987765432 2
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
....++..|+|||...+..++.++||||+|+++|+|++|+.||......+. ... ... ......
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~---~~~~~~------------ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFK-IAT---NGPPGL------------ 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-HHh---cCCCCc------------
Confidence 234588899999999888899999999999999999999999865321110 000 000 000000
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011123457899999999999999999999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=302.05 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=200.6
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
-|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 68999999986543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence 999999998754 3789999999999999999999 89999999999999999999999999999876643221 1
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
.....++..|+|||...+..++.++||||+||++|+|++|..||...... .+......... . .+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~----~~------ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLIPKNNP-P----TL------ 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHHhcCCC-C----CC------
Confidence 22345888999999998888999999999999999999999998653211 11111000000 0 00
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...++..+.+++.+||+.+|.+||++.+++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01234457889999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.46 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=192.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHH-HHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEV-LRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++.+.||+|+||.||+|+.. +|+.||+|+++.... .....+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 699999999876532 223345556554 666789999999999999999999999
Q ss_pred ccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 760 LMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 760 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
|++ |+|.+++.. ....+++..++.++.|++.||+||| ++ +++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 688877754 2335899999999999999999999 65 899999999999999999999999999986643
Q ss_pred CCCcceeeccccCCcccCccccCC----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTE----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
.. ......++..|+|||++.+ ..++.++|+||+|+++|||++|+.||.........+........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 225 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-------- 225 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--------
Confidence 21 1222458889999998765 45688999999999999999999998643221111111111000
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
+.+ ....++..+.+++.+||..+|++||++.++++
T Consensus 226 -~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 -PQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00123456889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=303.07 Aligned_cols=243 Identities=26% Similarity=0.314 Sum_probs=198.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999975 68999999987543 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.+++.... .++...+..++.|+++||+||| +.|++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999997764 4899999999999999999999 799999999999999999999999999999876543
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....+++.|+|||...+..++.++||||+|+++|+|++|..||...... ....... .+ ....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-----~~-------~~~~- 217 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKIL-----EG-------KVRF- 217 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh-----cC-------CccC-
Confidence 22345889999999998888999999999999999999999998653311 0011100 00 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAA 954 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~ 954 (977)
+......+.+++.+||+.+|.+|| +++|++
T Consensus 218 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 218 ------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 001134578899999999999999 566664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=302.31 Aligned_cols=248 Identities=22% Similarity=0.279 Sum_probs=199.6
Q ss_pred CCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
|...+.||+|++|.||+|.. .+++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567899999999999986 47899999998765555556788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+........ ...
T Consensus 101 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 101 GALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 9999998773 4889999999999999999999 88999999999999999999999999998876543221 122
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...|++.|+|||...+..++.++||||+|+++|||++|+.||...... .......... .+...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~~~~~-----~~~~~------- 236 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRIRDNL-----PPKLK------- 236 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHhcC-----CCCCc-------
Confidence 345889999999998889999999999999999999999998653211 1111000000 00000
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+...+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 001123468899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.76 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=206.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|++|.||+|+.. +++.||||++..... .....+.+|++.+.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 599999999876644 4467799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999765 34899999999999999999999 7 99999999999999999999999999999876543322
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCc-ccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT-GEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
. ....++..|+|||...+..++.++||||||+++|+|++|+.||..... .......+.......
T Consensus 157 ~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 221 (264)
T cd06623 157 C--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP------------- 221 (264)
T ss_pred c--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC-------------
Confidence 1 233578899999999999999999999999999999999999876432 111111111100000
Q ss_pred ccCchHHHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMD-CLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... ++..+.+++.+|++.+|++||++.|++++
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00111 34568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.82 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=198.0
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|++|.||+|+.. +|+.||||++..+. ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 68999999987543 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+. ++|.+++... ...+++..+..++.|+++||+||| +.+++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6898888654 345899999999999999999999 78999999999999999999999999999886643221
Q ss_pred ceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CCCc-h----hhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LPHG-L----MEVVD 912 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~----~~~~~ 912 (977)
......+++.|+|||+..+. .++.++||||||+++|||+||+.||....... ...+..... .+.. . ..+..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 12223478899999987664 46889999999999999999999986532211 111111110 0000 0 00000
Q ss_pred --hhhhc--cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 --TNLLR--QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 --~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+.. ..............+.+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000 000000001123457789999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=304.39 Aligned_cols=267 Identities=23% Similarity=0.269 Sum_probs=201.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 58899999987543 2335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|++++.+..+.... ..+++..+..++.||+.|++||| +.+++|||++|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99987776665543 34899999999999999999999 789999999999999999999999999999877654321
Q ss_pred ceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH--HHHhhCCCchhhhcc--hh
Q 036011 840 VTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK--WVKESLPHGLMEVVD--TN 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~ 914 (977)
......++..|+|||+..+. .++.++||||+|+++|+|++|+.||......+. +.. ......+........ ..
T Consensus 157 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 -PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCcc
Confidence 22234578899999999888 889999999999999999999999875322111 100 000000100000000 00
Q ss_pred hhc----ccc-Cch----HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 915 LLR----QEH-TSS----AEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 915 ~~~----~~~-~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
... ... ... ....+...+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000 000 00113566899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=301.20 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=199.4
Q ss_pred CCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC---CCCcceEeeeeecCCeeEEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR---HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 758 (977)
.|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 478999999987553 344567889999999996 999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.+++... .+++.....++.|++.|++||| +.||+||||+|+||++++++.++++|||.+........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998664 4899999999999999999999 78999999999999999999999999999987754332
Q ss_pred cceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......|+..|+|||...+ ..++.++||||||+++|+|++|..||...... .+... .... ..+.+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-~~~~----~~~~~~~ 224 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-IPKS----KPPRLED 224 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-cccC----CCCCCCc
Confidence 2223468899999998765 45789999999999999999999999653221 11110 0000 0001100
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+.+++.+||+.+|++||++.|++++
T Consensus 225 --------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 --------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0133457899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.42 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=205.5
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.....|.+...||+|.|+.|..|++. ++..||+|.+++..- .....+.+|+++|+.+.|||||+++.+.+.....|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44577999999999999999999965 799999999987752 233558899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+.+|.+.+++..++. ..+..+..++.|+.+|++|+| +++|||||||++||+++.+..+||+|||++.++..+
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999998876 445888999999999999999 899999999999999999999999999999998743
Q ss_pred CCcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
. .....+|++.|.|||+..+..| ++++|+||+|+++|-|+.|..||++..-.+. -..++...+
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------r~rvl~gk~ 272 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------RPRVLRGKY 272 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------cchheeeee
Confidence 3 2344689999999999998876 5789999999999999999999987432211 001111111
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...... ..+.-+++++++-.+|.+|+++++++..
T Consensus 273 rIp~~m-------s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFYM-------SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccccee-------echhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1134578888888899999999999764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=282.98 Aligned_cols=202 Identities=27% Similarity=0.351 Sum_probs=171.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC---C--CCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeec-CCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS---D--GTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCN-NDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 753 (977)
...|+.+..||+|.||.||+|... + ...+|+|.|+.+.+ ......-+|+..++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356889999999999999999643 2 33789999976543 344567899999999999999999999877 778
Q ss_pred eEEEEeccCCCCHHHHhhcC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC----CceEEe
Q 036011 754 RALVLELMPNGSLEKWLYSD----NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED----MVAHVS 825 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~ 825 (977)
+++++||++. +|.++++-+ ...++...+..|+.||+.|++||| ++-|+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 888888643 236888999999999999999999 7889999999999999887 899999
Q ss_pred ecccccccCCCCC-cceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 826 DFGLSKLFDEGDD-SVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 826 Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
|||+++.+...-. ......++.|++|.|||.+.+. .||++.||||.|||+.||+|-.+-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999875433 2345567899999999988765 699999999999999999998877654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=302.65 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=199.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 756 (977)
.++|++.+.||+|+||.||+|+.+ +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888999999999999999976 689999999875432 2233567899999999999999999998877 88999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||++ ++|.+++......+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999997 5999998776656899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-------------
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES------------- 902 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------- 902 (977)
.. ......+++.|+|||...+. .++.++|+||+|+++|||++|..||......+ ...+.....
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhc
Confidence 21 12233578899999987654 46899999999999999999999987543211 111110000
Q ss_pred CCCc----hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 LPHG----LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.. ........+...... ......+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPA----LSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccc----cCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000000000000000 0024457899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.83 Aligned_cols=269 Identities=21% Similarity=0.251 Sum_probs=197.6
Q ss_pred CCCcCccccCcceEEEEEEEeC---CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRA 755 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 755 (977)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999974 47999999988643 33446678899999999999999999999888 7899
Q ss_pred EEEeccCCCCHHHHhhcC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC----CCceEEeec
Q 036011 756 LVLELMPNGSLEKWLYSD----NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE----DMVAHVSDF 827 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Df 827 (977)
+||||+++ ++.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666432 225789999999999999999999 889999999999999999 999999999
Q ss_pred ccccccCCCCC-cceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--------cHHH
Q 036011 828 GLSKLFDEGDD-SVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--------SLKK 897 (977)
Q Consensus 828 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~ 897 (977)
|++........ ........+++.|+|||+..+ ..++.++||||||+++|+|++|+.||........ .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 122233467899999998765 4588999999999999999999999976433220 1111
Q ss_pred HHHhhCC------------CchhhhcchhhhccccCchHHH------HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 898 WVKESLP------------HGLMEVVDTNLLRQEHTSSAEM------DCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 898 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....-. .......+.............. .....+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1100000 0000000000000000000000 233468899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=282.94 Aligned_cols=269 Identities=20% Similarity=0.312 Sum_probs=205.8
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEE-eCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCC
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNND 752 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 752 (977)
+.|+-+.|+ ++||+|+|+.|..+. ..+|..||||++.+.......+..+|++++.+.+ |+||++++++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455545443 579999999999987 5689999999999886666778899999999995 999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceEEeeccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAHVSDFGL 829 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgl 829 (977)
..|+|||-|.||+|..+++.+.. +++.++.++..+||.||.+|| .+||.|||+||+|||-.+.. -+||+||.+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999988765 899999999999999999999 89999999999999986543 589999998
Q ss_pred ccccCCCC-----CcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHH
Q 036011 830 SKLFDEGD-----DSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 830 a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 899 (977)
+.-+.... ....-...+|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+....+ ..|-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGWd 302 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGWD 302 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCcc
Confidence 86443211 112223357888999999643 3468999999999999999999999998865421 1222
Q ss_pred HhhCCCchhhhcchhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 900 KESLPHGLMEVVDTNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
+...=....+.+-..+.+.. .+...+........+++...+..+|..|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 21111111111111121111 122344556666777888888889999999998876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.98 Aligned_cols=248 Identities=27% Similarity=0.330 Sum_probs=201.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.+.|+.-++||+|+||.||-++.+ +|+.||.|.+.++. .........|-.++.+++.|.||.+-.+|+..+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456888899999999999999864 79999999886553 22233467899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 758 LELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
+..|.||+|.-++...+ ..+++..+.-++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999998888765 35899999999999999999999 899999999999999999999999999999988765
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.. ....+||.||||||++..+.|+...|.||+||++|||+.|+.||...-.. .+ .+-+|+..+
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk----------~eEvdrr~~ 403 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VK----------REEVDRRTL 403 (591)
T ss_pred Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hh----------HHHHHHHHh
Confidence 43 33457999999999999999999999999999999999999998642110 11 112233333
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMT 951 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 951 (977)
......+ ....++...+....++.||.+|....
T Consensus 404 ~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 EDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cchhhcc--cccCHHHHHHHHHHHccCHHHhccCC
Confidence 3222111 23445567788888999999998443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=296.96 Aligned_cols=247 Identities=26% Similarity=0.332 Sum_probs=201.2
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
+|++.+.||.|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 68999999997543 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+.+++|.+++... ..+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999776 35899999999999999999999 7899999999999999999999999999998765432
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......|+..|+|||+..+..++.++|+||+|+++|+|++|..||...... ...+........ .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~--------~---- 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETA--------D---- 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccc--------c----
Confidence 122345888999999998888999999999999999999999998754321 111111111100 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCH--HHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYM--TDAA 954 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~ev~ 954 (977)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 --VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00001123567899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=300.66 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=198.8
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999964 68999999986442 23445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+. |++.+++......+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 5888887665566899999999999999999999 789999999999999999999999999998754432
Q ss_pred eeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 841 TQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
....+++.|+|||++. .+.++.++|||||||++|||++|+.||...... .....+.....+.
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~------------ 243 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPT------------ 243 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCC------------
Confidence 1235888999999873 467899999999999999999999998653211 1111111111000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.........+.+++.+||+.+|.+||++.+++++.-...
T Consensus 244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 001123345789999999999999999999998764444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.40 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=205.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRALVL 758 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 758 (977)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 689999999876642 4567889999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.+++.... .+++..+..++.|+++|++||| +.+++|||++|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 5899999999999999999999 79999999999999999999999999999987765432
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC-Cchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP-HGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 917 (977)
........++..|+|||...+..++.++||||+|+++|+|++|..||...... . ........ ....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~-~~~~~~~~~~~~~--------- 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---M-AALYKIGSSGEPP--------- 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---H-HHHHhccccCCCc---------
Confidence 11123345888999999998888999999999999999999999998764311 1 10000000 0000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 224 -----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 -----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0011224568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=308.23 Aligned_cols=272 Identities=24% Similarity=0.278 Sum_probs=200.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Cee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 754 (977)
+++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999864 68999999986432 33456688899999999999999999987544 357
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++|+||+. +++.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 89999996 4888877654 3899999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCCcc-eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc----hh
Q 036011 835 EGDDSV-TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG----LM 908 (977)
Q Consensus 835 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 908 (977)
...... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.... ....+....+... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHH
Confidence 322211 1223468899999998654 56899999999999999999999999653211 1111111111110 11
Q ss_pred hhcchhhh-------ccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 909 EVVDTNLL-------RQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 909 ~~~~~~~~-------~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
.+.+.... ...... .........+.+++.+||+.+|++||++.|++++ ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 11111000 000000 0001224568899999999999999999999887 55444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.65 Aligned_cols=262 Identities=22% Similarity=0.249 Sum_probs=195.5
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcC-CCCcceEeeeeecC--CeeEEEEe
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVR-HRNLIKIFSSCCNN--DFRALVLE 759 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 759 (977)
|++.+.||+|+||.||+|+.. +++.||+|+++.... .......+|+.+++++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 689999999875432 22233457888999885 99999999999887 88999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|++ |++.+++......+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 997 5888888765556899999999999999999999 789999999999999999 99999999999876433221
Q ss_pred ceeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh---cchh-
Q 036011 840 VTQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV---VDTN- 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 914 (977)
....++..|+|||+.. ++.++.++||||+||++|||++|..||...... ....+..........++ ....
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2235788999999764 456789999999999999999999999653221 11222221111110000 0000
Q ss_pred -----hhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 -----LLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 -----~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... ............+.+++.+|++++|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 0000112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.98 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=198.7
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+++++.++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999865 79999999987553 223356888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 69999987654 35899999999999999999999 78999999999999999999999999999976543221
Q ss_pred eeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC-CCc-----hhhhcch
Q 036011 841 TQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-PHG-----LMEVVDT 913 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~ 913 (977)
......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||....... ...+...... +.. .....+.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 12223468899999987654 57899999999999999999999986542211 1111111100 000 0000000
Q ss_pred --hhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 --NLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 --~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...... ............+.+++.+|++.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0000011233567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.25 Aligned_cols=268 Identities=24% Similarity=0.282 Sum_probs=199.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh--hHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR--AFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 755 (977)
..++|++.+.||+|+||.||+|+.. +|+.||+|+++..... ....+.+|++++++++||||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3567999999999999999999975 6999999998754322 223466899999999999999999998765 5689
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+. ++|.+++......+++..+..++.|+++|++||| +.|++||||||+||+++.++.+||+|||.+.....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999996 4898888765566899999999999999999999 88999999999999999999999999999987654
Q ss_pred CCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc---hh-hh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG---LM-EV 910 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-~~ 910 (977)
... ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ .+.... ...... .. ..
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-QLLGTPNESIWPGF 236 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCChhhchhh
Confidence 321 1222346788999998765 568999999999999999999999997532211 111111 111000 00 00
Q ss_pred cc----hh--hhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VD----TN--LLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~----~~--~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .. +...... ..........+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 0000000 00001124557889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=293.27 Aligned_cols=249 Identities=21% Similarity=0.237 Sum_probs=195.2
Q ss_pred HHHHHhhcCCCcCccc--cCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 676 LDIQRATDGFNECNLL--GRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 676 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
.++....+.|++.+.+ |+|+||.||+++.+ +++.+|+|++....... . |+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4445556677887777 99999999999864 68899999987542211 1 22222222 699999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLS 830 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla 830 (977)
+..++||||+++|+|.+++.... .+++..+..++.|+++|++||| +.+++||||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999999997765 5899999999999999999999 78999999999999999988 9999999998
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
....... ...++..|+|||++.+..++.++||||+|+++|||++|+.||......+.....+.... ...
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---- 226 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK---- 226 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc----
Confidence 7654321 23488999999999999999999999999999999999999975443333333333221 000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-MTDAAV 955 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~ev~~ 955 (977)
. .........+.+++.+|++.+|.+||+ ++|+++
T Consensus 227 ----~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ----L-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----C-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 000123446789999999999999996 588764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.40 Aligned_cols=267 Identities=23% Similarity=0.267 Sum_probs=196.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCe-----
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDF----- 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 753 (977)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 689999999875532 23456888999999995 6999999999877655
Q ss_pred eEEEEeccCCCCHHHHhhcCC----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecc
Q 036011 754 RALVLELMPNGSLEKWLYSDN----YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFG 828 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg 828 (977)
.++||||+++ +|.+++.... ..+++..++.++.||++||+||| +.+|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 8888876532 34799999999999999999999 789999999999999998 8999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CCCc
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LPHG 906 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~ 906 (977)
++..+..... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||......+. +.+..... .+..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 9986543221 1122357889999998765 4679999999999999999999999875322111 11111100 0000
Q ss_pred --hhhhcchhh---hcc---ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 --LMEVVDTNL---LRQ---EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 --~~~~~~~~~---~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+........ ... .............+.+++.+|++++|.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 000 00000011245568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.82 Aligned_cols=271 Identities=21% Similarity=0.273 Sum_probs=196.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999965 689999998865432 22345678999999999999999999987654
Q ss_pred --eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 753 --FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 753 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
..++||||+. +++.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3489999996 5888888766556899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccc-cHHHHHHhhCCCc
Q 036011 831 KLFDEGDDS--VTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM-SLKKWVKESLPHG 906 (977)
Q Consensus 831 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 906 (977)
..+...... .......++..|+|||++.+. .++.++||||+|+++|||++|+.||........ ..........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 876433221 112234578899999987664 478899999999999999999999865332110 0000111111111
Q ss_pred hh-hhcchh----hhccccCchHH------HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 LM-EVVDTN----LLRQEHTSSAE------MDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ~~-~~~~~~----~~~~~~~~~~~------~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ...+.. ........... ......+.+++.+|++.+|++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 000000 00000000000 0012346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=295.72 Aligned_cols=242 Identities=24% Similarity=0.286 Sum_probs=186.5
Q ss_pred cccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHH---hcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 690 LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLR---NVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.||+|+||.||++... +++.||+|.+..... .....+.+|..+++ ..+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 689999998865431 11223344444443 3479999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999987654 4899999999999999999999 7899999999999999999999999999987654322 1
Q ss_pred eccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....|+..|+|||... +..++.++||||+||++|||++|..||........ .......... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~------~~~------- 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTV------NVE------- 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhcC------CcC-------
Confidence 2245899999999876 45689999999999999999999999975432211 1111100000 000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
.+......+.+++.+|++.+|++|| +++|++++
T Consensus 218 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 --LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112345678999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.10 Aligned_cols=285 Identities=22% Similarity=0.225 Sum_probs=208.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Ce
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 753 (977)
.++|.+.+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999864 68999999987532 23345677899999999999999999987643 35
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||+. ++|.+++...+ .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 68998887654 4899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh---hCCCchhh
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE---SLPHGLME 909 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 909 (977)
.... .......++..|+|||.+.. ..++.++||||+||++|+|++|+.||......+ ........ ..+.....
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhh
Confidence 4432 12223457889999998764 468999999999999999999999996532111 01100000 00000000
Q ss_pred hcchhhh-------cccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhhcCcccccccccc
Q 036011 910 VVDTNLL-------RQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKIIGVLVLSRAEIG 974 (977)
Q Consensus 910 ~~~~~~~-------~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~~~~~~~~~~~~~ 974 (977)
+.+.... .... ......++...+.+++.+|++.+|++|||++|++++ ++.+......+.++..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~ 311 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFS 311 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccc
Confidence 0000000 0000 001112345668899999999999999999999988 776665444555554443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=297.07 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=199.7
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+|+..+.||+|++|.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 689999999876543 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 762 PNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 762 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
++ +|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888886544 35899999999999999999999 78999999999999999999999999999976543221
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CC--Cchhhhcch-h
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LP--HGLMEVVDT-N 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~-~ 914 (977)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+....+ ......... .+ ..+..+.+. .
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence 1222357889999998765 457899999999999999999999987643221 111111100 00 001101000 0
Q ss_pred hhccccC------chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHT------SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+...... ..........+.+++.+|++.+|.+||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.82 Aligned_cols=271 Identities=24% Similarity=0.282 Sum_probs=201.1
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND---- 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 752 (977)
...++|++.+.||+|+||.||+|+.+ +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 689999999875432 23356778999999999999999999987654
Q ss_pred ------eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 753 ------FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 753 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
..++|+||+++ ++.+.+......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 777777765556899999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh---h
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE---S 902 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---~ 902 (977)
||.+........ .......++..|+|||...+ ..++.++||||+||++|||++|+.||..... ...+...... .
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 999987654332 11222346788999998764 4578999999999999999999999865321 1111111111 0
Q ss_pred CCCchhhhcc--------hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 LPHGLMEVVD--------TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.....+.. ................+..+.+++.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000100000 00000000001111234568999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.94 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=200.7
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 58999999987542 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 838 (977)
+++++|.+++..... .+++..+..++.|+++|++||| +.+++|+||+|+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999876443 5799999999999999999999 78999999999999999886 469999999987654322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......|++.|+|||+..+..++.++||||+|+++||+++|..||.... ..++............
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-------- 222 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI-------- 222 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC--------
Confidence 1222458889999999988889999999999999999999999986432 1222222111111100
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ......+.+++.+|++.+|++|||+.|++++
T Consensus 223 ~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 S------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred C------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 0123357899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.40 Aligned_cols=275 Identities=24% Similarity=0.287 Sum_probs=202.5
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC--Cee
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN--DFR 754 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 754 (977)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567889999999999999999975 68899999885432 23345677899999999 999999999988653 367
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||++ ++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988765 4889999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCc---ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh--hCCCc-h
Q 036011 835 EGDDS---VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPHG-L 907 (977)
Q Consensus 835 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~-~ 907 (977)
..... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+. ....... ..... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 43221 12223458899999998754 5678999999999999999999999865332211 1111000 00000 0
Q ss_pred h--------hhcchhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhhc
Q 036011 908 M--------EVVDTNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKII 963 (977)
Q Consensus 908 ~--------~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~~ 963 (977)
. ...+ ...... ........+...+.+++.+||+.+|++|||+.+++++ +.+....
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 238 ESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 0 0000 000000 0000011135568999999999999999999999876 4555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.04 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=196.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC-CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||.||+|+.++ ++.||||++.... ......+.+|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3668889999999999999999864 8999999987543 233455667777777775 999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+. +++.++.......+++..+..++.|++.|++|||+ ..+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9985 57887776655568999999999999999999993 25899999999999999999999999999976643221
Q ss_pred cceeeccccCCcccCccccCCCC----cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGI----VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.....++..|+|||++.+.. ++.++||||||+++|||++|+.||.........+..+.....+ .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------~ 238 (296)
T cd06618 171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP---------S 238 (296)
T ss_pred ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC---------C
Confidence 12234788999999987554 8899999999999999999999986532221111111111000 0
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. +....+...+.+++.+||+.+|.+||++.+++++
T Consensus 239 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 L-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000234467899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=301.65 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=193.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999865 68999999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHh---hc-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 761 MPNGSLEKWL---YS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 761 ~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
+.. ++.++. .. ....+++..+..++.++++||+|||+ +.+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 655433 22 22458999999999999999999994 358999999999999999999999999999765432
Q ss_pred CCcceeeccccCCcccCccccCCC---CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEG---IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.. .....|++.|+|||++.+. .++.++||||+||++|||++|+.||..... ............. +
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~-----~ 229 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGDP-----P 229 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCCC-----C
Confidence 21 1223588899999998766 689999999999999999999999864321 1111111111000 0
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.. .....+...+.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 0011245568899999999999999999999775
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.73 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=197.5
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
..+||+|+||.||+|..+ +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 7899999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 846 (977)
.+++... .+++.....++.|++.|++||| +.|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 9988654 3789999999999999999999 78999999999999999999999999999876543221 122345
Q ss_pred cCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 847 gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
+++.|+|||+..+..++.++||||+|+++|||++|..||...... ..........+..+. . ..
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~--------~-------~~ 240 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKLK--------N-------LH 240 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcccC--------C-------cc
Confidence 889999999998888999999999999999999999998642211 111111111111100 0 01
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+...+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 123356789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.37 Aligned_cols=266 Identities=24% Similarity=0.286 Sum_probs=200.5
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEEEEe
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRALVLE 759 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 759 (977)
|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999976 58999999998663 33445688999999999999999999999888 88999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++ +|.+++......+++..+..++.|+++|++||| +.+++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899988776556899999999999999999999 78999999999999999999999999999987754332
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--C-CCchhhhcc---
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--L-PHGLMEVVD--- 912 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~--- 912 (977)
.......++..|+|||...+ ..++.++||||||+++|||++|+.||...... .......... . ...+....+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence 12233457888999997654 46889999999999999999999998754321 1111111100 0 000000000
Q ss_pred -hhhhccccC----chHHHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 -TNLLRQEHT----SSAEMD-CLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 -~~~~~~~~~----~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......... ...... +...+.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 000011 25678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=292.95 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=191.0
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||.|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999987543 23446789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 846 (977)
.+++.+.. .+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997654 3889999999999999999999 8999999999999999999999999999998765432 122245
Q ss_pred cCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 847 gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
+++.|+|||...+..++.++|+||+|+++|+|++|..||....... .+......... ... ..+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~------~~~-------~~~~ 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGN------GKL-------EFPN 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccC------CCC-------CCCc
Confidence 8889999999988889999999999999999999999997643211 11111111000 000 0001
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC
Q 036011 927 DCLLSVLHLALDCCMESPDQRIY 949 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs 949 (977)
.....+.+++.+||+.+|++||+
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcC
Confidence 11446789999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=278.84 Aligned_cols=242 Identities=26% Similarity=0.291 Sum_probs=196.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
..++|+.+++||+|.||.|-.++-+ .|+.||+|+++++. ......-..|-++++..+||.+..+-..|+..+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3567889999999999999999855 79999999998775 3334445679999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+.||.|.-++...+ .+++....-+-..|..||.||| +++||+||+|.+|.|+|.||++||+|||+++.--.
T Consensus 246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 999999999998886644 4888888889999999999999 89999999999999999999999999999985322
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
........||||.|+|||++....|+.++|.|.+||++|||++|+.||....... + +.-++-..+.
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--L-----------FeLIl~ed~k 386 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--L-----------FELILMEDLK 386 (516)
T ss_pred -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--H-----------HHHHHhhhcc
Confidence 2334556799999999999999999999999999999999999999996532111 0 1111111222
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCC
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 948 (977)
.....+ ++...++...+..||.+|.
T Consensus 387 FPr~ls-------~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPRTLS-------PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCccCC-------HHHHHHHHHHhhcChHhhc
Confidence 222222 2345677777888999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=325.78 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=207.2
Q ss_pred CCcCccccCcceEEEEEEEeC----C----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 685 FNECNLLGRGSFGSVYKGTFS----D----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
..+.+.+|+|.||.|++|... . ...||||..+... ....+.+..|+++|+.+ +||||+.++|+|..++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 345568999999999999743 1 4578999987554 34567899999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC
Q 036011 755 ALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED 819 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 819 (977)
++|+||+..|+|.++++..+ ..++..+.+.++.|||.|++||+ +.++||||+.++|||++++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCC
Confidence 99999999999999998776 34889999999999999999999 8889999999999999999
Q ss_pred CceEEeecccccccCCCCCccee-eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHH
Q 036011 820 MVAHVSDFGLSKLFDEGDDSVTQ-TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKK 897 (977)
Q Consensus 820 ~~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 897 (977)
..+||+|||+|+.....+..... +...-+..|||||.+....|+.|+|||||||++||++| |..||.+....+ .+.+
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-~l~~ 533 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-ELLE 533 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-HHHH
Confidence 99999999999976655443322 11113566999999999999999999999999999999 778886632111 1111
Q ss_pred HHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
+.+ +......+..|..+++++++.||+.+|++||+++++++.++..
T Consensus 534 ~l~-----------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 FLK-----------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHh-----------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 211 1112222334567789999999999999999999999999884
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.57 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=189.4
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||+|+||+||+|... +|+.||+|++.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 68999999987543 22344567899999999999999999999999999999999999999
Q ss_pred HHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeecc
Q 036011 767 EKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845 (977)
Q Consensus 767 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (977)
.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.+||+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99987654 25899999999999999999999 7899999999999999999999999999988654321 12234
Q ss_pred ccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHH
Q 036011 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925 (977)
Q Consensus 846 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (977)
.++..|+|||+..+..++.++||||+|+++|+|++|+.||...... .............. . ...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~-------~~~ 218 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMA--------V-------EYP 218 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcccccc--------c-------cCC
Confidence 5788999999998888999999999999999999999998653221 11111111000000 0 000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 036011 926 MDCLLSVLHLALDCCMESPDQRIYMTD 952 (977)
Q Consensus 926 ~~~~~~l~~l~~~cl~~~P~~RPs~~e 952 (977)
......+.+++.+||+.+|++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 112445789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=295.87 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=202.7
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
|++.+.||+|++|.||+|+.. +++.+|+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 689999999875532 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++ ++.+++......+++..+..++.|+++||+||| +.+|+|+||+|+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 888888776556899999999999999999999 7899999999999999999999999999998775433 12
Q ss_pred eeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc----hhhhcc----
Q 036011 842 QTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG----LMEVVD---- 912 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---- 912 (977)
.....++..|+|||...+. .++.++||||+|+++|+|++|+.||......+ .+... ....... +....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKI-FRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHHcCCCchHhcccchhhhhh
Confidence 2234578889999998776 78999999999999999999999986543211 11111 1111100 000000
Q ss_pred --hhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 --TNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 --~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....... .......++..++.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 0011123456778999999999999999999999753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=292.72 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=204.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 689999999876543 4566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
+++++|.+++... ...+++..+..++.++++|++||| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999875 256899999999999999999999 7899999999999999999999999999998765433
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||..... .+............ +
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~-- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPP-----I-- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCC-----C--
Confidence 122334688899999999888899999999999999999999999865321 11111111110000 0
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+..+...+.+++.+||..+|++||++.|++++
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00233457899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=300.49 Aligned_cols=263 Identities=22% Similarity=0.216 Sum_probs=194.7
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeecc--chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 6999999998765 24456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc-----
Q 036011 766 LEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS----- 839 (977)
Q Consensus 766 L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----- 839 (977)
|.+++... ...+++.....++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+.........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999764 335889999999999999999999 789999999999999999999999999998755422111
Q ss_pred ceeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc-----------
Q 036011 840 VTQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG----------- 906 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 906 (977)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||............ .....+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcC
Confidence 11122347788999999866 35889999999999999999999999764332221111 11111000
Q ss_pred -hhh----hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 -LME----VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 -~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... ..+... ...............+.+++.+||+.+|++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNN-RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccch-hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 0011111122345568899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=301.54 Aligned_cols=265 Identities=19% Similarity=0.293 Sum_probs=194.5
Q ss_pred ccccCc--ceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRG--SFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
..||+| +||+||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999974 79999999987543 33457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc--
Q 036011 764 GSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV-- 840 (977)
Q Consensus 764 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 840 (977)
+++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987643 34889999999999999999999 7899999999999999999999999998654332211110
Q ss_pred ---eeeccccCCcccCccccCCC--CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--------CCCch
Q 036011 841 ---TQTMTIATIGYMAPEYGTEG--IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--------LPHGL 907 (977)
Q Consensus 841 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 907 (977)
......++..|+|||++.+. .++.++||||+||++|||++|+.||................. .+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00112345679999998764 478999999999999999999999976433221111100000 00000
Q ss_pred hhhc----------ch---------hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVV----------DT---------NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~----------~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... .. .........+....+...+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 00 0000011112233456778999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.77 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=202.3
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|++.+.||+|+||.||+++.. +++.+|+|++.... .....++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999864 68899999987543 33456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
+++++|.+++... ...+++..++.++.|+++|++||| +.|++||||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998662 235899999999999999999999 8999999999999999999999999999998765431
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.....+++.|+|||...+..++.++|+||+|+++|||++|+.||......+ ....... ....
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~---~~~~--------- 219 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYKVQR---GKYP--------- 219 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc---CCCC---------
Confidence 122458889999999999999999999999999999999999986532211 1111110 0000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.........+.+++.+|++.+|++||++.|++++
T Consensus 220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 -----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=305.70 Aligned_cols=271 Identities=26% Similarity=0.336 Sum_probs=201.6
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------CeeE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------DFRA 755 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 755 (977)
.|...+.||+|+||.||+|+.+ .|+.||||.++... .+..+..-+|++++++++|||||+++++-++. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556788999999999999954 79999999998654 45567788999999999999999999986543 3567
Q ss_pred EEEeccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC--CCC--ceEEeeccc
Q 036011 756 LVLELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD--EDM--VAHVSDFGL 829 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfgl 829 (977)
+|||||.+|+|...+.+... .+++.+.+.+..+++.||.||| ++|||||||||.||++- ++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999987533 6999999999999999999999 89999999999999983 333 579999999
Q ss_pred ccccCCCCCcceeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc-HHHHHHh-hCCCc
Q 036011 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS-LKKWVKE-SLPHG 906 (977)
Q Consensus 830 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~~ 906 (977)
|+-...+. .....+||..|.+||... .+.|+..+|.|||||++||+.||..||......... -..|... .-+.+
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99876543 344567999999999998 589999999999999999999999999765443211 1122211 11222
Q ss_pred hhhhcchhhhc----c---ccCchHHHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHHHch
Q 036011 907 LMEVVDTNLLR----Q---EHTSSAEMDCLLSVLHLALDCCMESPDQRI--YMTDAAVKLKKI 960 (977)
Q Consensus 907 ~~~~~~~~~~~----~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~ev~~~L~~~ 960 (977)
..-...+...+ . +.......-....+-.++..++..+|.+|- .+.+.-..+..|
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111111110 0 011111222334466677778888888888 655555555444
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.05 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=196.3
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 499999999875533 4456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC------cc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD------SV 840 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------~~ 840 (977)
.+++.+.+ .+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998755 5899999999999999999999 78999999999999999999999999999886543321 11
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......++..|+|||......++.++||||+|+++|++++|..||...... .......... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~~---- 219 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGK--------IE---- 219 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC--------cC----
Confidence 223345788999999998888999999999999999999999998653221 1111100000 00
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
.+........+.+++.+||+.+|++||++.++.+.++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 -WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000012456789999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=305.74 Aligned_cols=264 Identities=22% Similarity=0.243 Sum_probs=197.8
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------ 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 751 (977)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3477999999999999999999864 78999999986432 33445677899999999999999999988643
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
...++||||+. ++|.+.+... ++...+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35689999996 5888877543 788999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CCCchh-
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LPHGLM- 908 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~- 908 (977)
....... .....++..|+|||++.+..++.++||||+||++|+|++|+.||...... .......... .+..+.
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 7643221 22235788999999999999999999999999999999999998653211 1111110000 000000
Q ss_pred ----------------------hhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 ----------------------EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+...... ...............+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVL-FPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccc-cCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000011234557899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=276.05 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=199.5
Q ss_pred hcCCCcC-ccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeec----CCee
Q 036011 682 TDGFNEC-NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN----NDFR 754 (977)
Q Consensus 682 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 754 (977)
+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++... ....+|++.--.. .|||||.++++|+. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4555554 67999999999999865 7999999997522 4456788876666 69999999999864 3466
Q ss_pred EEEEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeecccc
Q 036011 755 ALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLS 830 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla 830 (977)
.+|||.|+||.|.+.++.++. .+++.++..|+.||+.|+.||| +.+|+||||||+|+|.+ .+..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 789999999999999987654 6899999999999999999999 89999999999999996 4567999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
+.-... ......+-||.|.|||++...+|+..+|+||+||++|-|+.|.+||....... + ..+
T Consensus 212 K~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--i--------spg---- 274 (400)
T KOG0604|consen 212 KETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--I--------SPG---- 274 (400)
T ss_pred cccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--C--------Chh----
Confidence 875432 23344679999999999999999999999999999999999999997643211 1 111
Q ss_pred cchhhhcc-c-cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQ-E-HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~-~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...++... + .+.+++....+...++++..+..+|++|.|+.|++.+
T Consensus 275 Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 275 MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111111 1 2345566677778899999999999999999999765
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=296.87 Aligned_cols=259 Identities=17% Similarity=0.185 Sum_probs=186.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccchhhH-----------HHHHHHHHHHHhcCCCCcceEee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQLDRAF-----------RSFDSECEVLRNVRHRNLIKIFS 746 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~ 746 (977)
.++|.+.++||+|+||+||+|+..+ +..+|+|+......... .....+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999998653 45677776443321110 11223444556678999999999
Q ss_pred eeecCC----eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 747 SCCNND----FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 747 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence 765443 4467888874 46666665432 3578888999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCc-----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH
Q 036011 823 HVSDFGLSKLFDEGDDS-----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 897 (977)
+|+|||+|+.+...... .......||+.|+|||+..+..++.++||||+||++|||++|+.||........ ...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHH
Confidence 99999999876432211 111224699999999999999999999999999999999999999976532221 111
Q ss_pred HHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
.....+. ..+...... ...++..+.+++..|++.+|++||++.++++.+
T Consensus 245 ~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFI---KRLHEGKIK--------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHH---HHhhhhhhc--------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110000 000001000 012245688999999999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=251.48 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=203.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.|...++||+|.||+||+|+.. .++.||+|+.+.+.+ .......+|+-+++.++|+|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566788999999999999954 689999999886643 3445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
|+. +|..+..+-.+.++.+....++.|+.+||.+.| ++.+.|||+||.|.+++.+|+.|++|||+++-++-.- .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence 954 899998887777999999999999999999999 8899999999999999999999999999999776432 2
Q ss_pred eeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCC-CCcCCcccccHHHHHHh------hCCCchhhhcc
Q 036011 841 TQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKP-TDDMFTGEMSLKKWVKE------SLPHGLMEVVD 912 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 912 (977)
..+..+.|.+|.+|+++.+. .|+...|+||.||++.|+.....| |.+. .-+.++.+..+- ..+..+..+-|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 44556799999999998875 589999999999999999985555 5443 223333333221 11122333333
Q ss_pred hhhhccccCchHHHHHHHHH----HHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSV----LHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l----~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
-.....+.....+.+.++++ .+++++.+.-+|..|.++++++++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 33222222233333333332 345556666699999999988764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=304.28 Aligned_cols=269 Identities=23% Similarity=0.285 Sum_probs=200.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec----CCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN----NDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 754 (977)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999865 69999999987543 2345667889999999999999999998753 3467
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+. |+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 89999995 689999876544 899999999999999999999 7899999999999999999999999999997664
Q ss_pred CCCCc--ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh--hCCCch-h
Q 036011 835 EGDDS--VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPHGL-M 908 (977)
Q Consensus 835 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~-~ 908 (977)
..... .......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+..... .+...... ..+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLN 237 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhh
Confidence 33221 11123468899999998765 568999999999999999999999997643211 11111100 000000 0
Q ss_pred hhcchh-------hhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDTN-------LLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~~-------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...... ........ .........+.+++.+|++.+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 00000000 0011235668999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=293.42 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=197.7
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhc---CCCCcceEeeeeecCCe-----
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNV---RHRNLIKIFSSCCNNDF----- 753 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 753 (977)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 489999999875432 2234566788877766 59999999999987776
Q ss_pred eEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
.+++|||++ ++|.+++.... ..+++..+..++.|+++||+||| +.+++|+|++|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 48988887643 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC-chhhhc
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH-GLMEVV 911 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 911 (977)
+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+.++....... ......
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence 643321 1223478899999999999999999999999999999999999875332 22222222211110 000000
Q ss_pred c-----hhhhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 D-----TNLLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~-----~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ......... .....+....+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 000000000 11112345667899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=286.78 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=202.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+|++.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 688999999876643 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++++|.+++.... .+++..+..++.|++.|++||| +.||+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99999999987663 4899999999999999999999 889999999999999999999999999999877644321
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ...|... ..... .+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~~~~--~~~~~-----~~----- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALFRIV--QDDHP-----PL----- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHh--ccCCC-----CC-----
Confidence 22345888999999988888999999999999999999999998653211 1111100 00000 00
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.......+.+++.+|++.+|++||++.|++.
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0112345789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=297.31 Aligned_cols=266 Identities=23% Similarity=0.260 Sum_probs=196.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++.+.||+|++|+||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56889999999999999999975 689999999865432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccccccCCCC
Q 036011 760 LMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~ 837 (977)
|++ +++.+++..... ..++..+..++.||+.||+||| +.+++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 578877755433 3678888999999999999999 789999999999999985 5679999999997654321
Q ss_pred CcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh-------
Q 036011 838 DSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME------- 909 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 909 (977)
. ......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||......+. ..+.. .........
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIF-RILGTPNEETWPGVTS 233 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHhCCCChhhcccccc
Confidence 1 1122357889999998765 4678999999999999999999999975322111 11100 000000000
Q ss_pred hcchhhhcc--ccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDTNLLRQ--EHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~~~~~~--~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.+...... ... ..........+.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 000 00011223457899999999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=318.30 Aligned_cols=271 Identities=18% Similarity=0.201 Sum_probs=189.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCC--CCEEEEEE--------------eec---cchhhHHHHHHHHHHHHhcCCCCc
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSD--GTSFAIKV--------------FNL---QLDRAFRSFDSECEVLRNVRHRNL 741 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ni 741 (977)
..++|++++.||+|+||+||++..+. +..+++|. +.+ ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987532 22222221 111 112234568899999999999999
Q ss_pred ceEeeeeecCCeeEEEEeccCCCCHHHHhhcCC----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDN----YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 742 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
+++++++.+.+..++|+|++. +++.+++.... ..........++.|++.||+||| +.+|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999985 57777765432 12345667789999999999999 88999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCC-CCcCCcc-cccH
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP-TDDMFTG-EMSL 895 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-~~~~~~~-~~~~ 895 (977)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..+ +...... ...+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999877543221 12234699999999999999999999999999999999998754 4322111 1112
Q ss_pred HHHHH------hhCCCc---hhhhcchh-hhccccCch---HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 896 KKWVK------ESLPHG---LMEVVDTN-LLRQEHTSS---AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 896 ~~~~~------~~~~~~---~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+... ..++.. +.+.++.. +........ ........+.+++.+|++.||.+|||+.|++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22111 111111 01111000 000000000 001123346778999999999999999999864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=329.48 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=199.3
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
+-+|.....||.|.||.||.|.. ++|+-.|+|-+.... ....+...+|+.++..++|||+|+++|+-...+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44677788999999999999985 579999999876543 344566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|||++|+|.+.++..+. .++.....+..|++.|++||| ++|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1314 EyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999876543 667777788999999999999 89999999999999999999999999999998865421
Q ss_pred c--ceeeccccCCcccCccccCCCC---cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH-hhCCCchhhhcc
Q 036011 839 S--VTQTMTIATIGYMAPEYGTEGI---VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK-ESLPHGLMEVVD 912 (977)
Q Consensus 839 ~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 912 (977)
. ..-....||+.|||||++.+.. ...+.||||+|||+.||+||+.||...... ..+..-+. .+.|+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~gh~Pq------- 1461 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAAGHKPQ------- 1461 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhccCCCC-------
Confidence 1 1122347999999999987643 556899999999999999999999764221 11111110 00110
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. +......=.+++..|++.||++|.++.|++++
T Consensus 1462 ---------~--P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 ---------I--PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---------C--chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0 11133344688999999999999998877665
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=321.96 Aligned_cols=205 Identities=25% Similarity=0.388 Sum_probs=182.8
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeecc---chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQ---LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
+.-..++|+++++||+|+||.|..++++ .++.||.|++.+- ......-|.+|-.+|..-..+-|+.++.+|++..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3445678999999999999999999975 6899999998763 23344568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+|||||+||+|...+.... .+++..+.-++..|.-||+.+| +.|+|||||||+|||+|..|++||+|||.+..+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999998887 6999999999999999999999 899999999999999999999999999999888
Q ss_pred CCCCCcceeeccccCCcccCccccC----C-CCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGT----E-GIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
...+ .......+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..
T Consensus 226 ~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 226 DADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 7543 45566678999999999864 3 6799999999999999999999999965
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=297.90 Aligned_cols=246 Identities=26% Similarity=0.320 Sum_probs=196.0
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeecc---chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQ---LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.|...+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+++++.++|||++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999965 6889999988643 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+. |++.+++......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+|++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 6888877665556899999999999999999999 789999999999999999999999999998765432
Q ss_pred ceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 840 VTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
....+++.|+|||.+. .+.++.++||||+||++|||++|+.||......+ ....+.....+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~------------ 232 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP------------ 232 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCC------------
Confidence 1234788999999864 4568899999999999999999999986532111 11111110000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
......+...+.+++.+||+.+|++||++.+++++-
T Consensus 233 -----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 000112344578999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=289.72 Aligned_cols=243 Identities=22% Similarity=0.255 Sum_probs=187.9
Q ss_pred ccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHH-HhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVL-RNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||.||+|+.. +|+.||||+++.... .....+..|..++ ...+||||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 689999999875431 2223344454444 455899999999999999999999999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
++|.+++.... .+++..+..++.|+++||.||| +.+++||||+|+||+++.++.+||+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997654 4889999999999999999999 78999999999999999999999999999875432 12
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
...+++.|+|||...+..++.++||||+|+++|||++|..||......+ ......... .... ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~------------~~~~---~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRR------------INWP---EE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcc------------cCCC---Cc
Confidence 2347889999999988889999999999999999999999996532211 111110000 0000 00
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
....+...+.+++.+||+.+|++||++.++.+.+
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0112345688999999999999999876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=301.96 Aligned_cols=268 Identities=22% Similarity=0.281 Sum_probs=196.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999964 68999999987542 223456789999999999999999999986542
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++|+||+. +++.++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4589999996 47776652 24789999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CCC-chhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LPH-GLME 909 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~ 909 (977)
..... ....++..|+|||++.+ ..++.++||||+||++|||++|+.||....... .+....... .+. .+.+
T Consensus 167 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 53221 22357889999998866 468999999999999999999999997532211 111100000 000 0000
Q ss_pred hcch----hhh------ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhh
Q 036011 910 VVDT----NLL------RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKI 962 (977)
Q Consensus 910 ~~~~----~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~ 962 (977)
.... ... ...............+.+++.+||+.+|++||+++|++++ +++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 000 0000000001123457899999999999999999999866 666664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=287.76 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=196.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--Cee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 754 (977)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999864 68999999875431 23456788999999999999999999998764 457
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++|+||+++++|.+++..... +++....+++.|++.|++||| +.+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999876543 789999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCC-cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 835 EGDD-SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 835 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.... ........++..|+|||+..+..++.++|||||||++|++++|+.||.+....+. ..+. ...... +
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~~~----~ 228 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKI----ATQPTK----P 228 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHH----HcCCCC----C
Confidence 3211 1111234588999999999988899999999999999999999999875322111 1110 000000 0
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+......+.+++.+|++ +|.+||++.+++.+
T Consensus 229 ---------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 ---------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0011233457899999999 57999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=295.25 Aligned_cols=244 Identities=27% Similarity=0.313 Sum_probs=194.0
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
|...+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999864 68999999987542 23445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+. |++.+++......+++..+..++.|++.|++||| +.|++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 5888888766666899999999999999999999 78999999999999999999999999999864322
Q ss_pred eeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 841 TQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||....... ....... ... +..
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~---~~~-----~~~-- 240 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ---NDS-----PTL-- 240 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHh---cCC-----CCC--
Confidence 12245888999999874 4668899999999999999999999986542211 1111110 000 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+.+++.+||+.+|.+||++.+++++
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001123357889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=299.85 Aligned_cols=268 Identities=24% Similarity=0.290 Sum_probs=199.6
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec-CC
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-ND 752 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 752 (977)
++...+++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 33456789999999999999999999865 79999999886432 2334667889999999999999999998865 55
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+ +++|.+++.... +++.....++.|+++||+||| +.+|+||||+|+||++++++.+||+|||.+..
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 788999998 568998886543 788888999999999999999 88999999999999999999999999999875
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh--hCCCch-h
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPHGL-M 908 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~-~ 908 (977)
..... ....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .....+... ..+..+ .
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 43221 12347888999998765 57899999999999999999999998654221 111111100 000000 0
Q ss_pred hhcch-------hhhcc-ccC-chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDT-------NLLRQ-EHT-SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~-------~~~~~-~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+. ..... ... ......+...+.+++.+|++.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000 000 00001234568899999999999999999999776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=288.57 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=186.0
Q ss_pred cccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHH---HHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 690 LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECE---VLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.||+|+||.||+|+.. +++.||+|.+..... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 689999999875421 11122333433 4444579999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999887654 4899999999999999999999 7899999999999999999999999999987654321 1
Q ss_pred eccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....|+..|+|||+..++ .++.++||||+|+++|||++|+.||................. ....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~------ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAVEL------ 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------cCCCC------
Confidence 223589999999998754 689999999999999999999999976422211110000000 00000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
+......+.+++.+|+..+|.+|| ++.|++++
T Consensus 219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 011234578899999999999999 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=300.36 Aligned_cols=271 Identities=25% Similarity=0.295 Sum_probs=205.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-----eeE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-----FRA 755 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 755 (977)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999975 58999999987654 334567899999999999999999999987765 789
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||++ ++|.+++.... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 58999887655 5899999999999999999999 88999999999999999999999999999987654
Q ss_pred CCCc-ceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC----ch--
Q 036011 836 GDDS-VTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH----GL-- 907 (977)
Q Consensus 836 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~-- 907 (977)
.... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+. ... ....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNL-IVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHhcCCCChhHhhh
Confidence 3210 112234578899999998887 899999999999999999999999976432111 111 1110000 00
Q ss_pred ------hhhcchhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhh
Q 036011 908 ------MEVVDTNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKI 962 (977)
Q Consensus 908 ------~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~ 962 (977)
...+.. ...... ...........+.+++.+||+.+|.+||++.+++++ +++++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000 000000 000011234567899999999999999999999986 566553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=280.25 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=213.6
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeee
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 749 (977)
++.....+++...++.+|.||+||+|.+.+ .+.|-||..+... +-....+..|...+..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 444455668888899999999999997643 3456666654332 345667889999999999999999999886
Q ss_pred c-CCeeEEEEeccCCCCHHHHhh-----cC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc
Q 036011 750 N-NDFRALVLELMPNGSLEKWLY-----SD--NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821 (977)
Q Consensus 750 ~-~~~~~lv~e~~~~gsL~~~l~-----~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 821 (977)
+ .+..+.++.++.-|+|..++. .. ...++..+...++.|++.|++||| +++|||.||.++|.++|+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence 5 456788899999999999998 22 225677888899999999999999 899999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHH
Q 036011 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (977)
+||+|-.+++...+++...-......+..||+||.+....|+.++|||||||++|||+| |+.|+.+..+.|+ ..+.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~ylk 512 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYLK 512 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHHh
Confidence 99999999999999888777666778899999999999999999999999999999999 8899876544332 11111
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
+......+.+|+++++.++.-||...|++||++++++.-|.+.
T Consensus 513 -----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 513 -----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1112223346788999999999999999999999999887653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.58 Aligned_cols=256 Identities=25% Similarity=0.292 Sum_probs=199.7
Q ss_pred CCCcCccccCcceEEEEEEEe----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 684 GFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
+|++.+.||+|++|.||+++. .+++.||||+++... ....+.+.+|++++.++ +||+|+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 257899999987542 22345688999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++|+|.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987644 4889999999999999999999 7899999999999999999999999999988765
Q ss_pred CCCCcceeeccccCCcccCccccCCCC--cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
..... ......|+..|+|||...+.. ++.++||||+|+++|||++|..||..... ......+.......
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~------- 227 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS------- 227 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc-------
Confidence 43221 122245889999999987655 78899999999999999999999854211 11111111111100
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.. .....+...+.+++.+||+.+|++|||+.++.+.++..
T Consensus 228 -----~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -----KP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 00011234578899999999999999999887776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=299.72 Aligned_cols=273 Identities=22% Similarity=0.270 Sum_probs=201.5
Q ss_pred CCCHHHHHHhhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeee
Q 036011 672 RTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSC 748 (977)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 748 (977)
+....++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 334456677889999999999999999999985 478999999987543 22345678899999999999999999987
Q ss_pred ecC------CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 749 CNN------DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 749 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
... ...+++++++ +++|.+++.... +++..+..++.|+++|++||| +.+|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence 543 3467888887 789998886543 899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||++...... .....++..|+|||...+ ..++.++||||+||++|||++|+.||...... ..+......
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRL 233 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence 99999998764321 122357889999998765 56889999999999999999999998653221 111111110
Q ss_pred h--CCCchhhhcchh--------hhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 902 S--LPHGLMEVVDTN--------LLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 902 ~--~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. .+......+... +....... .........+.+++.+|++.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000000000 00000000 0000123457899999999999999999999765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=290.93 Aligned_cols=252 Identities=24% Similarity=0.293 Sum_probs=196.0
Q ss_pred CCCcCccccCcceEEEEEEEe----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 684 GFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
.|++.+.||+|+||.||.|+. .+|+.||+|++.... ....+.+.+|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368999999987542 12345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++++|.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999997654 4788999999999999999999 7999999999999999999999999999998764
Q ss_pred CCCCcceeeccccCCcccCccccCCC--CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEG--IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.... .......|+..|+|||...+. .++.++||||+|+++|+|++|..||..... ......+........
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE------ 228 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC------
Confidence 3221 112234588999999988753 478899999999999999999999864211 111222221111100
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
+.. ...+...+.+++.+|++.+|++|| ++.++..+
T Consensus 229 ~~~---------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 PPY---------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCC---------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 000 011334578999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.26 Aligned_cols=262 Identities=23% Similarity=0.260 Sum_probs=195.9
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
|.+.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 588999999875532 22234557999999999 999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+|+|.+++.... ..+++..+..++.|++.+|+||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789998887654 45899999999999999999999 78999999999999999999999999999986643222
Q ss_pred eeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccH-----------HHHHHhhCCCchh
Q 036011 841 TQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSL-----------KKWVKESLPHGLM 908 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~ 908 (977)
.....++..|+|||+.. ...++.++|+||||+++|||++|+.||......+... ..|...... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 230 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL---A 230 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh---h
Confidence 12245788999999874 4568999999999999999999999986542211100 001110000 0
Q ss_pred hhcchhhhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDTNLLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+..+...... ..........+.+++.+||+.+|++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 00000113568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=297.28 Aligned_cols=270 Identities=21% Similarity=0.257 Sum_probs=196.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 689999999865432 22345778999999999999999999875433
Q ss_pred --eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 753 --FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 753 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
..++||||+.+ ++...+......+++..+..++.|+++||+||| +.||+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46899999965 777777665556999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcc---------eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH
Q 036011 831 KLFDEGDDSV---------TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 831 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 900 (977)
.......... ......+++.|+|||...+ ..++.++||||+||++|||++|+.||.+..... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 8664332211 1122356888999998765 458999999999999999999999986533221 1111110
Q ss_pred h-h-CCC-c------hhhhcchhhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 901 E-S-LPH-G------LMEVVDTNLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 901 ~-~-~~~-~------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. . ... . .....+.......... .........+.+++.+|++.+|++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 0 000 0 0000000000000000 0001123567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=290.95 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=201.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 757 (977)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999965 79999999987532 233467889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++...+ .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998765 4899999999999999999999 7899999999999999999999999999998765432
Q ss_pred Cc------------------ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHH
Q 036011 838 DS------------------VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWV 899 (977)
Q Consensus 838 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 899 (977)
.. .......++..|+|||+.....++.++||||+|++++++++|..||...... ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~-~ 234 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQK-I 234 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH-H
Confidence 11 1122335788999999988888999999999999999999999998754210 00111 0
Q ss_pred HhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHH
Q 036011 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM----TDAAV 955 (977)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~ev~~ 955 (977)
. ..... .+......+.+++.+||+.+|++||++ .++++
T Consensus 235 ~-----------~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 L-----------KLEYS-------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-----------hcCCC-------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00000 001123457899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=300.65 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=195.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecC---------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--------- 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 751 (977)
..+|.+.+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999864 6899999998766555667788999999999999999999876543
Q ss_pred -----CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEe
Q 036011 752 -----DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVS 825 (977)
Q Consensus 752 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~ 825 (977)
...++||||++ ++|.+++... .+++..+..++.||++||+||| +.||+||||||+||+++ +++.+|++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898888654 3889999999999999999999 78999999999999998 45678999
Q ss_pred ecccccccCCCCCcc-eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 826 DFGLSKLFDEGDDSV-TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 826 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
|||.+.......... ......++..|+|||++.. ..++.++||||+||++|||++|+.||......+. ....... .
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES-V 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-c
Confidence 999998654321111 1122357889999997654 5688999999999999999999999965432111 1111110 0
Q ss_pred CCc-------hhhhcchhhh---ccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PHG-------LMEVVDTNLL---RQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~-------~~~~~~~~~~---~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.. .......... ...... .........+.+++.+|++.+|.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0000000000 000000 0001233457899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.34 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=196.0
Q ss_pred cCCCc-CccccCcceEEEEEEEeC-CCCEEEEEEeeccchhh--------------HHHHHHHHHHHHhcCCCCcceEee
Q 036011 683 DGFNE-CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRA--------------FRSFDSECEVLRNVRHRNLIKIFS 746 (977)
Q Consensus 683 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 746 (977)
++|.. .+.||+|+||+||+|+.. +++.||||++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999865 68999999986543211 124778999999999999999999
Q ss_pred eeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 747 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
++...+..++||||++ |+|.+++.... .+++.....++.|++.||+||| +.|++||||+|+||+++.++.+|++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 69999887544 4899999999999999999999 79999999999999999999999999
Q ss_pred cccccccCCCC------------CcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 827 FGLSKLFDEGD------------DSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 827 fgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
||.+....... .........++..|+|||++.+. .++.++||||+||++|||++|+.||......+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99998665111 01111223467889999988764 47899999999999999999999987543221
Q ss_pred cHHHHHHhhCCCc----hhhhcchhhh----c-cc-cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 894 SLKKWVKESLPHG----LMEVVDTNLL----R-QE-HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 894 ~~~~~~~~~~~~~----~~~~~~~~~~----~-~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.... ...... +....+.... . .. ........+...+.+++.+|++.+|++||++.|++.+
T Consensus 242 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHH-HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111 111000 0000000000 0 00 0000011234567899999999999999999999864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.77 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=196.6
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND---- 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 752 (977)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999854 79999999986432 233456889999999999999999999886543
Q ss_pred --eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 753 --FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 753 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
..++||||+ +++|.+++... .+++..+..++.|+++|++||| +.||+||||||+||+++.++.+|++|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 77999888653 4899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--CCch
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--PHGL 907 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~ 907 (977)
....... ....+++.|+|||++.+ ..++.++|+||+|+++|++++|..||....... .......... +..+
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 8654321 22347889999998776 458899999999999999999999997532211 1111111000 0000
Q ss_pred hhhcch----hhhc----c--ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 908 MEVVDT----NLLR----Q--EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 908 ~~~~~~----~~~~----~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
...+.. .... . .........+...+.+++.+|++.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000 0 0000001123445789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=288.90 Aligned_cols=264 Identities=25% Similarity=0.293 Sum_probs=200.2
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+..|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999975 59999999988653 333466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+ ++|.+++......+++..+..++.|++.||+||| +.+|+||||+|+||++++++.+||+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 5999999876455899999999999999999999 78999999999999999999999999999987654322 1
Q ss_pred eeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC----Cchhhhc-----
Q 036011 842 QTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP----HGLMEVV----- 911 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~----- 911 (977)
.....++..|+|||++.+. .++.++||||+|+++||+++|+.||......+ .+.+ ...... ..+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFK-IFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHH-HHHHhCCCcHHHHHhhcccccc
Confidence 2223467789999988766 88999999999999999999999986533211 1111 100000 0000000
Q ss_pred chhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 DTNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+........ ...........+.+++.+|++.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 000011124568999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.82 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=198.1
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe---
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF--- 753 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 753 (977)
...++|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 68899999986532 2334567789999999999999999998766554
Q ss_pred ---eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 754 ---RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 754 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
.++|+||+ +++|.+++... .+++..+..++.|+++|++||| +.||+||||+|+||++++++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 67999998764 3899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CC---
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LP--- 904 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~--- 904 (977)
...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||......+ .+....... .+
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHH
Confidence 866432 122357889999998765 367899999999999999999999996532211 111111100 00
Q ss_pred ------CchhhhcchhhhccccCc-hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 905 ------HGLMEVVDTNLLRQEHTS-SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 905 ------~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.................. .........+.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000000 0011234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=317.02 Aligned_cols=146 Identities=28% Similarity=0.461 Sum_probs=132.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.++||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999975 68999999987542 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
|||+.+++|.+++...+ .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997654 3789999999999999999999 7899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=271.06 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=190.1
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+..||.|+||+|++-.++ .|+..|||+++.... ...+++..|.+...+- .+||||+++|++..++..++.||.|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 346999999999999875 699999999987653 5556778888765554 79999999999999999999999994 5
Q ss_pred CHHHHhh---c-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 765 SLEKWLY---S-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 765 sL~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
|++.+-+ . ....+++.-.-.|..-...||.||-+ ...|+|||+||+|||+|..|.+|+||||.+..+.. +.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence 7764422 1 22358888888999999999999986 56799999999999999999999999999987653 22
Q ss_pred eeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 841 TQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
..+..+|-..|||||.+.. ..|+.+|||||+|+++||+.||..|+.....--.++...+....|. +.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~----------l~- 291 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI----------LL- 291 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe----------ec-
Confidence 3344567788999998764 3489999999999999999999999865222111122212111111 11
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
...........|..++.-|+..|-..||...++.+
T Consensus 292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11122345667899999999999999999988754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=286.31 Aligned_cols=195 Identities=27% Similarity=0.430 Sum_probs=170.5
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
.++||+|.||+||-|+++ +|+.||||++.+.. .+....+.+|+.++..++||.||.+-..|+..+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999864 79999999998654 334467899999999999999999999999999999999999664
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC---CceEEeecccccccCCCCCcce
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED---MVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
=|.-++.+..+.+++....-++.||+.||.||| -++|||+|+||+|||+.+. -.+||||||+|++++... .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence 555555666667889888899999999999999 7899999999999999743 479999999999987543 3
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
....+|||.|+|||++..+.|...-|+||.|||+|.-++|..||.+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 34467999999999999999999999999999999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=291.75 Aligned_cols=267 Identities=24% Similarity=0.262 Sum_probs=191.9
Q ss_pred CCCcCccccCcceEEEEEEEeC-C--CCEEEEEEeeccc--hhhHHHHHHHHHHHHhc-CCCCcceEeeeeec----CCe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-D--GTSFAIKVFNLQL--DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN----NDF 753 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 753 (977)
+|++.+.||+|+||.||+++.. + +..||+|++.... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 4 7899999986432 22345678899999999 59999999987543 245
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++++||+. ++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899985 68999886544 4899999999999999999999 789999999999999999999999999999866
Q ss_pred CCCCCc--ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CCCc-h
Q 036011 834 DEGDDS--VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LPHG-L 907 (977)
Q Consensus 834 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~-~ 907 (977)
...... .......|+..|+|||+..+ ..++.++||||+|+++|++++|..||......+ ......... .+.. .
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 532211 11223468999999998765 568999999999999999999999986532111 111100000 0000 0
Q ss_pred hhhcchh-------hhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDTN-------LLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~-------~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+.++. ....... ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000 00000123457899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=282.86 Aligned_cols=248 Identities=22% Similarity=0.237 Sum_probs=192.9
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
+|.+.+.||+|+||.||+++.. .+..+++|+.+... ......+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999865 34556666554321 22334567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|||+++++|.+++.. ....+++..+..++.|+++|++||| +.|++|+|++|+||+++. +.+|++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2345899999999999999999999 789999999999999975 569999999998764
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.... ......+++.|+|||...+..++.++|+||+|+++|+|++|..||..... ........... .+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~-----~~- 223 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEGP-----TP- 223 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcCC-----CC-
Confidence 3322 12223578899999998888899999999999999999999999864211 11111110000 00
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.+|++||++.|++++
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 --------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0012334567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=276.54 Aligned_cols=236 Identities=28% Similarity=0.315 Sum_probs=192.3
Q ss_pred ccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 691 LGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 691 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
||+|+||.||++... +++.||+|++..... ...+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 589999999876532 2456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 846 (977)
.+++.... .+++.....++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 99997764 3899999999999999999999 79999999999999999999999999999987654321 223345
Q ss_pred cCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 847 gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
++..|+|||...+..++.++|+||+|+++|++++|..||..... ....... ... ... .+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~---~~~--------~~~-------~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI---LKD--------PLR-------FPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---hcC--------CCC-------CCC
Confidence 88899999999888899999999999999999999999865322 1111111 100 000 000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHH
Q 036011 927 DCLLSVLHLALDCCMESPDQRIYMTD 952 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs~~e 952 (977)
..+..+.+++.+||..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11345789999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=278.68 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=194.2
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchh-------hHHHHHHHHHHHHhcCCCCcceEeeeee-cCC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR-------AFRSFDSECEVLRNVRHRNLIKIFSSCC-NND 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~ 752 (977)
.++|-.+.+||+|+|+.||+|.+ ...+.||||+-...... -.+..-+|.++-+.+.||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45688889999999999999984 46889999987654321 1233568999999999999999999985 556
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeeccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGL 829 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgl 829 (977)
..|-|+|||+|.+|+-|++.++. +++.++..|+.||..||.||.+. +.+|+|=|+||.|||+- ..|.+||.|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 78899999999999999987764 89999999999999999999864 48999999999999984 568999999999
Q ss_pred ccccCCCCCc-----ceeeccccCCcccCccccC----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH
Q 036011 830 SKLFDEGDDS-----VTQTMTIATIGYMAPEYGT----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 830 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 900 (977)
++++...... .-.+...||.||++||.+. ..+++.|+||||.|||+|+++.|++||.........+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe--- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE--- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh---
Confidence 9998754332 2234567999999999754 235788999999999999999999999865332221111
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 953 (977)
..+ .....-.+..++. .......+|++|+++--++|....++
T Consensus 697 NTI----lkAtEVqFP~KPv-------VsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 697 NTI----LKATEVQFPPKPV-------VSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hch----hcceeccCCCCCc-------cCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 000 0000011111111 22335678999998888878776665
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.39 Aligned_cols=241 Identities=24% Similarity=0.259 Sum_probs=193.8
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++.|+....+|.|+|+.|-.+... +++..+||++.+.. ..-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3566777788999999999988854 68999999997652 2345577666665 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee-CCCCceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL-DEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|++.|+-+.+.+..... ....+..|+.+|+.|+.||| ++||||||+||+|||+ ++.++++|+|||.++...+.
T Consensus 396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999998887776553 22778889999999999999 8999999999999999 58999999999999977654
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
....+-|..|.|||++....|++++|+||+|+++|+|++|+.||.....+...... +.. +.+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~-----i~~-------~~~-- 531 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR-----IQM-------PKF-- 531 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh-----hcC-------Ccc--
Confidence 22245778899999999999999999999999999999999999765444111111 000 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.........+++.+|++.||.+||+|.++..+
T Consensus 532 -------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 -------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 02234456789999999999999999999654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.35 Aligned_cols=222 Identities=20% Similarity=0.154 Sum_probs=177.4
Q ss_pred cceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhc
Q 036011 694 GSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS 772 (977)
Q Consensus 694 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 772 (977)
|.+|.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 68999999987542 234455566666799999999999999999999999999999999876
Q ss_pred CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCccc
Q 036011 773 DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852 (977)
Q Consensus 773 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 852 (977)
.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 54 3899999999999999999999 7899999999999999999999999999887654321 1233567899
Q ss_pred CccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHH
Q 036011 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSV 932 (977)
Q Consensus 853 aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 932 (977)
|||...+..++.++||||+|+++|||++|..|+........ . ... ..+ +..+...+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~-~~~---~~~---------~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------T-HTT---LNI---------PEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------c-ccc---cCC---------cccCCHHH
Confidence 99999888899999999999999999999988653211100 0 000 000 01123457
Q ss_pred HHHHHHhhcCCCCCCCCHHHH
Q 036011 933 LHLALDCCMESPDQRIYMTDA 953 (977)
Q Consensus 933 ~~l~~~cl~~~P~~RPs~~ev 953 (977)
.+++.+|++.||++||++.+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHccCCHHHhcCCCcc
Confidence 889999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=272.62 Aligned_cols=240 Identities=25% Similarity=0.306 Sum_probs=192.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 757 (977)
.+|..+.+||+|+||.|-.|..+ +.+.||||+++++. +++.+--..|-+++..- +-|.++++..+|+.-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999865 57889999998775 23333344566777766 578999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+.||+|--++++.+. +.+..+.-+|..||-||-+|| ++||++||+|.+|||+|.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-- 502 (683)
T ss_pred EEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc--
Confidence 999999999888877665 778888899999999999999 89999999999999999999999999999974322
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
...+....+|||.|+|||++..++|+..+|.|||||++|||+.|++||++....+ +-+ .+.+.....
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~-----------aI~ehnvsy 569 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQ-----------AIMEHNVSY 569 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHH-----------HHHHccCcC
Confidence 2234556789999999999999999999999999999999999999998743221 111 111111111
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCC
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 948 (977)
+.....+.+.+....+...|.+|.
T Consensus 570 -------PKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 570 -------PKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------cccccHHHHHHHHHHhhcCCcccc
Confidence 112334456777788888998886
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=260.59 Aligned_cols=202 Identities=23% Similarity=0.403 Sum_probs=169.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--------C
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--------N 751 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 751 (977)
..|+...++|+|.||.||+|+.+ .|+.||+|+.-.+. ........+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999965 68889998654322 2223456789999999999999999998853 3
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
...|+|+++|+. +|.-++......++..++.+++.++..||.|+| ...|+|||+||.|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 357899999976 888888877667999999999999999999999 7889999999999999999999999999997
Q ss_pred ccCCCCC--cceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 832 LFDEGDD--SVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 832 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
.+...+. ....+..+.|.+|.+||.+.+ ..|+++.|||..|||+.||+||.+-+.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 6654332 223556778999999998766 47999999999999999999999887664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=289.07 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=205.4
Q ss_pred HhhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeec-----CC
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN-----ND 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~ 752 (977)
.-++.|++.+.||.|.+|.||+++. ++|+.+|||+.....+. .++.+.|.++++.. .|||++.++|++.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3457799999999999999999985 47899999998766543 36788899999988 69999999998853 67
Q ss_pred eeEEEEeccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
..++|||||.+||..|+++.- +..+.|..+..|.+.++.|+.+|| ...++|||||-.|||++.++.||++|||.+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 899999999999999999864 346899999999999999999999 7889999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
..+.... .....+|||.|||||++.- ..|+..+|+||+|++..||--|.+|+.++.+... .+
T Consensus 172 QldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--------LF--- 238 (953)
T KOG0587|consen 172 QLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LF--- 238 (953)
T ss_pred eeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------hc---
Confidence 8765332 2334579999999998753 3478899999999999999999999987644211 00
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+ ....+.....+..-..++.++|..|+..|.++||++.+++++
T Consensus 239 --~I----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 --LI----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --cC----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 00 001111122233446678999999999999999999888654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.35 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=199.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-C-C----CcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-H-R----NLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~~~ 754 (977)
+.+|.+...+|+|.||.|-.+... .+..||||+++. ...-.+...-|++++.++. + | -+|.+.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999999754 478999999863 3444566778999999993 2 2 377888899999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---------------
Q 036011 755 ALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE--------------- 818 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--------------- 818 (977)
++|+|.+ |-|+.+++..+.. +++...+..++.|+++++++|| +.+++|-|+||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 5699999987654 7899999999999999999999 899999999999999821
Q ss_pred -----CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 819 -----DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 819 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
+..||++|||.|++-.... +..+.|..|.|||++.+-.++.++||||+|||++|+.||...|+.....|.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3468999999998754322 445688999999999999999999999999999999999998876543321
Q ss_pred c-HHHHHHhhCCCchhhhc------chh---------------hhccccC----chHHHHHHHHHHHHHHHhhcCCCCCC
Q 036011 894 S-LKKWVKESLPHGLMEVV------DTN---------------LLRQEHT----SSAEMDCLLSVLHLALDCCMESPDQR 947 (977)
Q Consensus 894 ~-~~~~~~~~~~~~~~~~~------~~~---------------~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~R 947 (977)
. ..+-+-..+|..+..-. ... ......+ ..........+++++++|+.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 0 11101111111110000 000 0000000 00011234458999999999999999
Q ss_pred CCHHHHHHH
Q 036011 948 IYMTDAAVK 956 (977)
Q Consensus 948 Ps~~ev~~~ 956 (977)
+|+.|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=277.37 Aligned_cols=220 Identities=25% Similarity=0.383 Sum_probs=183.2
Q ss_pred CCCHHHHHHhh---cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceE
Q 036011 672 RTSYLDIQRAT---DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKI 744 (977)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l 744 (977)
...|..++++. .-|..++.||-|+||.|.+++. ++...||.|.+++.. .......+.|-++|.....+-||++
T Consensus 615 ESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL 694 (1034)
T KOG0608|consen 615 ESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL 694 (1034)
T ss_pred hhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE
Confidence 34456666664 3488889999999999999974 457789999987664 3445567889999999999999999
Q ss_pred eeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 745 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
|..|.+++.+|+||||++||++-.++-+.+- +++.-+.-++..+.+|+++.| +.|+|||||||+|||||.+|++||
T Consensus 695 yySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 695 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EEEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceee
Confidence 9999999999999999999999998877654 777778888999999999999 899999999999999999999999
Q ss_pred eecccccccC---------CCCCcc-------------------------------eeeccccCCcccCccccCCCCcCc
Q 036011 825 SDFGLSKLFD---------EGDDSV-------------------------------TQTMTIATIGYMAPEYGTEGIVSS 864 (977)
Q Consensus 825 ~Dfgla~~~~---------~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 864 (977)
.|||+++-+. .++... .....+||+.|+|||++....|+.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 9999996332 111000 001136999999999999999999
Q ss_pred ccchhhHhHHHHHHhcCCCCCCcCCcccccH
Q 036011 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSL 895 (977)
Q Consensus 865 ~~DvwslG~il~elltg~~p~~~~~~~~~~~ 895 (977)
.+|.||.|||+|||+.|+.||.+...++..+
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCccee
Confidence 9999999999999999999998877665443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=267.23 Aligned_cols=238 Identities=31% Similarity=0.381 Sum_probs=193.7
Q ss_pred ceEEEEEEEeC-CCCEEEEEEeeccchhh-HHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhc
Q 036011 695 SFGSVYKGTFS-DGTSFAIKVFNLQLDRA-FRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS 772 (977)
Q Consensus 695 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 772 (977)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999998665444 67899999999999999999999999999999999999999999999876
Q ss_pred CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCccc
Q 036011 773 DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852 (977)
Q Consensus 773 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 852 (977)
... +++..++.++.+++++++||| +.+++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 554 889999999999999999999 7899999999999999999999999999998775432 222345888999
Q ss_pred CccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHH
Q 036011 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSV 932 (977)
Q Consensus 853 aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 932 (977)
|||...+..++.++||||+|++++++++|..||...... ....++....... .......+...+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPP---------------FPPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCC---------------CccccccCCHHH
Confidence 999998888999999999999999999999998653111 1111111110000 000000034568
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHH
Q 036011 933 LHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 933 ~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=278.56 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=196.5
Q ss_pred CCCcCccccCcceEEEEEEEeCCCC-EEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSDGT-SFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++..+..||-|+||+|-.++.+... .+|+|++++.. .+..+....|-++|...+.|.||++|-.|.+...+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455667999999999999875433 48998887653 3445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
-|-||.+...++.++. ++.....-++..+.+|++||| +++||+||+||+|.++|.+|-+||.|||+|+.+..+..
T Consensus 501 aClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K- 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK- 575 (732)
T ss_pred hhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence 9999999999988775 888888899999999999999 89999999999999999999999999999999876543
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
....+|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+..+.. .+ ..+..++..+.-+
T Consensus 576 --TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tY-----n~ILkGid~i~~P------ 641 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TY-----NLILKGIDKIEFP------ 641 (732)
T ss_pred --eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HH-----HHHHhhhhhhhcc------
Confidence 344789999999999999999999999999999999999999998643221 11 1111121111111
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIY 949 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 949 (977)
........+++++.+..+|.+|..
T Consensus 642 ------r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 ------RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------cccchhHHHHHHHHHhcCcHhhhc
Confidence 122334567888889999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=257.24 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=200.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 756 (977)
-++|..+++||+|+|+.|..++++ +.+.||+|+++++. +++.+..+.|-.+..+. +||.+|-+..+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999865 68899999998664 44556677888888887 69999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|.||++||+|--+++++++ ++++.+.-+...|+-||.||| ++||++||+|.+|||+|..|++|+.|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999888876655 899999999999999999999 899999999999999999999999999999854322
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC--CcccccHHHHHHhhCCCchhhhcchh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM--FTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
. -..+..+|||.|.|||++.+..|...+|.|++||+++||+.|+.||+-. ...++...++....+.+. .
T Consensus 405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-------q 475 (593)
T KOG0695|consen 405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-------Q 475 (593)
T ss_pred C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-------c
Confidence 2 2345678999999999999999999999999999999999999999753 233444444433222111 1
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 948 (977)
+.. +.....+.-.++..-+..||.+|.
T Consensus 476 iri-------prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRI-------PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccc-------cceeehhhHHHHHHhhcCCcHHhc
Confidence 111 112233445677788889999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=241.02 Aligned_cols=211 Identities=27% Similarity=0.344 Sum_probs=170.0
Q ss_pred CCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEec
Q 036011 684 GFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
...-+..||+|++|.|-+.++ .+|+..|||+++... .+..++...|+.+..+. .+|.+|.+||........++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 344456799999999988886 479999999987654 34456677788876655 799999999999888999999999
Q ss_pred cCCCCHHHHhh---cCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLY---SDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|+ .||..+-. ..+..+++...-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||.+.++..+-
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 95 48775533 345568999999999999999999997 6689999999999999999999999999998775432
Q ss_pred CcceeeccccCCcccCccccC----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH
Q 036011 838 DSVTQTMTIATIGYMAPEYGT----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 900 (977)
..+...|-..|||||.+. .+.|+.|+||||+|+++.||.+++.||+.....-.++.+.+.
T Consensus 204 ---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 204 ---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 222234667899999765 346999999999999999999999999875554444444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=292.74 Aligned_cols=260 Identities=22% Similarity=0.220 Sum_probs=170.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-C----CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeee------ee
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-D----GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS------CC 749 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 749 (977)
..++|++.+.||+|+||.||+|++. + +..||||++...... +.+..| .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999975 4 789999987543211 111111 1222222333322221 24
Q ss_pred cCCeeEEEEeccCCCCHHHHhhcCCcc-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 036011 750 NNDFRALVLELMPNGSLEKWLYSDNYF-------------------LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810 (977)
Q Consensus 750 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 810 (977)
.....++||||+++++|.+++...... .....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 566789999999999999998754321 112345679999999999999 7899999999
Q ss_pred CCceeeCC-CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCC----------------------CcCcccc
Q 036011 811 PSNILLDE-DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG----------------------IVSSKCD 867 (977)
Q Consensus 811 ~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 867 (977)
|+|||++. ++.+||+|||+|+.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999866433222 22335689999999954321 2345679
Q ss_pred hhhHhHHHHHHhcCCCCCCcCC--------cccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHh
Q 036011 868 VYSYGVLLTETFTRKKPTDDMF--------TGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDC 939 (977)
Q Consensus 868 vwslG~il~elltg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 939 (977)
|||+||++|||+++..|++... ........|.....+.. .+...... ...........+++.+|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA-----SPDLRRGF---EVLDLDGGAGWELLKSM 433 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc-----chhhhhhh---hhccccchHHHHHHHHH
Confidence 9999999999999776654310 00111222222111100 00000000 00000112345899999
Q ss_pred hcCCCCCCCCHHHHHHH
Q 036011 940 CMESPDQRIYMTDAAVK 956 (977)
Q Consensus 940 l~~~P~~RPs~~ev~~~ 956 (977)
++.||++|||+.|++++
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=282.62 Aligned_cols=258 Identities=19% Similarity=0.200 Sum_probs=180.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEe-----------------CCCCEEEEEEeeccchhhHHH--------------HHHH
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTF-----------------SDGTSFAIKVFNLQLDRAFRS--------------FDSE 729 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 729 (977)
..++|++.++||+|+||+||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235789999987554332233 3347
Q ss_pred HHHHHhcCCCCc-----ceEeeeeec--------CCeeEEEEeccCCCCHHHHhhcCCc---------------------
Q 036011 730 CEVLRNVRHRNL-----IKIFSSCCN--------NDFRALVLELMPNGSLEKWLYSDNY--------------------- 775 (977)
Q Consensus 730 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 775 (977)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 677777643 3567999999999999999874211
Q ss_pred --cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccC
Q 036011 776 --FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853 (977)
Q Consensus 776 --~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 853 (977)
..++..+..++.|++++|+||| +.+|+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 2457788899999999999999 789999999999999999999999999999765433211 1112235789999
Q ss_pred ccccCCCC--------------------c--CcccchhhHhHHHHHHhcCCC-CCCcCCccc-------ccHHHHHHhhC
Q 036011 854 PEYGTEGI--------------------V--SSKCDVYSYGVLLTETFTRKK-PTDDMFTGE-------MSLKKWVKESL 903 (977)
Q Consensus 854 PE~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-p~~~~~~~~-------~~~~~~~~~~~ 903 (977)
||.+.... | ..+.||||+||++|||++|.. ||....... .....|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 99865322 1 134799999999999999875 664321111 111222111
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESP---DQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~ev~~~ 956 (977)
... .. ..+..........+++.+++..+| .+|+|++|++++
T Consensus 457 ~~~-------~~-----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQ-------KY-----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccc-------CC-----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 00 000111223456788899998765 689999999865
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=242.07 Aligned_cols=263 Identities=20% Similarity=0.319 Sum_probs=202.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCC--eeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNND--FRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l 756 (977)
..++|++.+++|+|.++.||.|.. .+.++++||+++.- ..+.+.+|+.++..++ ||||+.+++...++. ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999984 57899999998743 3467899999999997 999999999987754 5569
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccccccCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~ 835 (977)
|+||+.+.+....-.. ++..++...+.+++.||.|+| +.||+|||+||.|+++|. .-..+++|+|+|.++.+
T Consensus 113 iFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999887765432 677889999999999999999 999999999999999995 45799999999999987
Q ss_pred CCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh------------
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES------------ 902 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------ 902 (977)
+.. ....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||........++.+.++-.
T Consensus 186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 653 444567788999998765 4688999999999999999999999976555555555544311
Q ss_pred ---CCCchhhhcchhhhcccc---CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 ---LPHGLMEVVDTNLLRQEH---TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+...+..++......... ......-..++.++++.+.+..|..+|||++|++++
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111222222221111110 000000122557889999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=287.37 Aligned_cols=244 Identities=29% Similarity=0.429 Sum_probs=189.6
Q ss_pred CCcCccccCcceEE-EEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccC
Q 036011 685 FNECNLLGRGSFGS-VYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 685 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
|...+++|.|+.|+ ||+|.+ +|+.||||++-.. ..+...+|+..++.- .|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 33446789999985 799998 6899999987533 345567899999988 69999999999999999999999995
Q ss_pred CCCHHHHhhcCCc--c-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-----CCceEEeecccccccC
Q 036011 763 NGSLEKWLYSDNY--F-LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFD 834 (977)
Q Consensus 763 ~gsL~~~l~~~~~--~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~ 834 (977)
.+|.++++.... . ......+.+..|++.||++|| +.+|||||+||.||||+. ..+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 599999987411 1 111455788999999999999 899999999999999975 2579999999999987
Q ss_pred CCCCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcC-CCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 835 EGDDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.+.... ......||.||+|||++....-+.++||||+||++|+.++| .+||.+.-..+..+.. +...++.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccceee
Confidence 665433 23456799999999999998888899999999999999996 8999875333221111 1110000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
+ ....++ ...++|.+|+.++|..||++.+|+.
T Consensus 735 --L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 --L-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --e-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 001111 4678999999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=242.11 Aligned_cols=263 Identities=24% Similarity=0.309 Sum_probs=192.4
Q ss_pred CcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----CeeEEE
Q 036011 686 NECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DFRALV 757 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 757 (977)
+-.+.||-|+||.||.+++. +|+.||.|++..-.. ...+++-+|+.++..++|.|++..++...-. .+.|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999864 899999998864332 2346688999999999999999988876543 256788
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
+|.|. .+|..++-+... ++...+.-+.+||++||+||| +.+|.||||||.|.|++++...||||||+++.....
T Consensus 136 TELmQ-SDLHKIIVSPQ~-Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d- 209 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQA-LTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR- 209 (449)
T ss_pred HHHHH-hhhhheeccCCC-CCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh-
Confidence 88884 588887766554 788889999999999999999 899999999999999999999999999999976543
Q ss_pred CcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc----------
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG---------- 906 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 906 (977)
....++..+.|..|.|||++.+. .|+.+.||||.|||+.|++.++..|....+-+ ..+.+.+.+...
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhh
Confidence 34456667899999999998875 69999999999999999999988886532211 111111111100
Q ss_pred --hhhhcchhhh-----ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 907 --LMEVVDTNLL-----RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 907 --~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
...++..... .-+..... .+.--.-+.+..+++.+||++|.+..+.++..
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~-~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASP-DDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCC-cccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111110 00111110 01111246677888999999999999887765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=259.36 Aligned_cols=197 Identities=23% Similarity=0.355 Sum_probs=170.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---h-----hhHHHHHHHHHHHHhcC---CCCcceEeeeee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---D-----RAFRSFDSECEVLRNVR---HRNLIKIFSSCC 749 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 749 (977)
-.+|+.++.+|+|+||.|+.|.++ +...|+||.+.++. + +..-..-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999986 46778999887653 1 11223567999999997 999999999999
Q ss_pred cCCeeEEEEecc-CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 750 NNDFRALVLELM-PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 750 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
+++..|++||-. ++.+|.+++..+.. +++.++..|++||+-|+++|| +.||||||||-+||.++++|.+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 999999999986 45689999977654 999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCcC-cccchhhHhHHHHHHhcCCCCCC
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS-SKCDVYSYGVLLTETFTRKKPTD 886 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~ 886 (977)
.|.+...+. ....+||.+|.|||++.+.+|- ..-|||++|+++|.++....||.
T Consensus 716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765433 3345799999999999998874 56899999999999999998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=238.39 Aligned_cols=210 Identities=32% Similarity=0.486 Sum_probs=184.1
Q ss_pred ccCcceEEEEEEEeCC-CCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHH
Q 036011 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEK 768 (977)
Q Consensus 691 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 768 (977)
||+|++|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998866432 35679999999999999999999999999999999999999999999
Q ss_pred HhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccccccCCCCCcceeecccc
Q 036011 769 WLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847 (977)
Q Consensus 769 ~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 847 (977)
++......+++..+..++.++++++++|| +.+++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99876445899999999999999999999 789999999999999999 89999999999987654321 1222447
Q ss_pred CCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHH
Q 036011 848 TIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926 (977)
Q Consensus 848 t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (977)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999998877 888999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 927 ~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246789999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=266.09 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=202.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|+..+++|.|.+|.||||+.. .++..|||+++..-.......++|+-+++..+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 367999999999999999999965 7999999999988777888899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
|.+|+|++.-+..+ .+++.++..+.+...+|++||| +.|-+|||||-.||++++.|.+|++|||.+..+...-.
T Consensus 94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-- 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-- 167 (829)
T ss_pred cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence 99999998655443 5889999999999999999999 89999999999999999999999999999987764321
Q ss_pred eeeccccCCcccCcccc---CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 841 TQTMTIATIGYMAPEYG---TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......||+.|||||+. ..+.|..++|||+.|++..|+---++|..+..+..... -+... .+++--++
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~--LmTkS-------~~qpp~lk 238 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF--LMTKS-------GFQPPTLK 238 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH--Hhhcc-------CCCCCccc
Confidence 22335799999999974 45679999999999999999988888865532221100 00000 01111111
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
+. ..-...+-++++.|+..+|++||++..+++
T Consensus 239 Dk------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DK------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CC------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 111234678999999999999999876643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=241.21 Aligned_cols=131 Identities=25% Similarity=0.358 Sum_probs=109.9
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-----C---CCcceEeeeeec--
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-----H---RNLIKIFSSCCN-- 750 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~-- 750 (977)
.++|.+.++||-|.|++||+|.+ ...+.||+|+.+.. ..-.+....||+++++++ | ..||+++++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36789999999999999999985 46789999998644 333455678999999984 2 479999999864
Q ss_pred --CCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 751 --NDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 751 --~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
..++++|+|+. |.+|..++.... +.++...+.+|++||+.||.|||. +.||+|-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 45889999999 668888776543 368999999999999999999998 6699999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=229.58 Aligned_cols=243 Identities=20% Similarity=0.270 Sum_probs=185.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEee-eeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFS-SCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~ 758 (977)
.+.|.+.+.+|+|.||.+-.++++ ..+.+|+|.++.... ..++|.+|...--.+ .|.||+.-|+ .|+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356889999999999999999976 678999999886643 346788888776666 5899998887 577788888999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC--CCCceEEeecccccccCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD--EDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~ 836 (977)
||++.|+|.+-+...+ +.+....+++.|++.|+.||| +.++||||||.+||||- +..++|+||||.++..+..
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999887655 788889999999999999999 89999999999999983 4458999999999865432
Q ss_pred CCcceeeccccCCcccCccccCCC-----CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEG-----IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
-. ...-+..|.|||..... ...+.+|||.||+++|.++||+.||+.....+..+..|....-....
T Consensus 177 V~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---- 247 (378)
T KOG1345|consen 177 VK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---- 247 (378)
T ss_pred eh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc----
Confidence 21 12245568999965422 35678999999999999999999998766666666666543322211
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCC
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 947 (977)
+..... .-...+.+.+.++-+.++|++|
T Consensus 248 --~~P~~F------~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 248 --ALPKKF------NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred --cCchhh------cccCHHHHHHHHHhcCCccccc
Confidence 110000 1123345666777778888888
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=237.79 Aligned_cols=199 Identities=30% Similarity=0.411 Sum_probs=174.3
Q ss_pred CCcCccccCcceEEEEEEEeCC-CCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 685 FNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567889999999999999764 899999999876554 66789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+++|.+++......+++.....++.+++.++++|| +.+++|+|++|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999999875543789999999999999999999 789999999999999999999999999999887654211 11
Q ss_pred eccccCCcccCcccc-CCCCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 843 TMTIATIGYMAPEYG-TEGIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 223577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=246.49 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=205.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC------CCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR------HRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~ 753 (977)
.-.+|.+....|+|-|++|..|... .|..||||+|... +...+.=.+|+++|++|. .-|+++++-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4467999999999999999999865 5889999999865 444455678999999995 3589999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeecccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLS 830 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla 830 (977)
+|+|+|-. .-+|.++++..+. .+....+..++.|+.-||..|- ..||+|.||||.||||++. ...||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999988 4589999987654 4677889999999999999999 8999999999999999965 57899999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHH--------------
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK-------------- 896 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-------------- 896 (977)
.+....+. +....+..|.|||++.+-+|+...|+||.||++||+.||+.-|.+....++.-.
T Consensus 585 ~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 585 SFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred cccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 87764432 233456679999999999999999999999999999999998877443322100
Q ss_pred --HHHHhhCCCc--h----------------hhhcc------hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 897 --KWVKESLPHG--L----------------MEVVD------TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 897 --~~~~~~~~~~--~----------------~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
++...++-.. + ...+. ..+...+......+.....+.+++.+|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0011111000 0 00011 11222222334445677789999999999999999999
Q ss_pred HHHHHH
Q 036011 951 TDAAVK 956 (977)
Q Consensus 951 ~ev~~~ 956 (977)
.+++++
T Consensus 741 nqAL~H 746 (752)
T KOG0670|consen 741 NQALKH 746 (752)
T ss_pred HHHhcC
Confidence 998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=233.37 Aligned_cols=257 Identities=23% Similarity=0.263 Sum_probs=192.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec------CCe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN------NDF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 753 (977)
.+|.-++.+|.|+- .|..|.+. .+++||+|...... ...+++..+|...+..+.|+||++++.++.- ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778899988 66666543 68999999865442 3446778899999999999999999999853 336
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+|||+|+ ++|.+.+.. .++-.....+..|+++|+.||| +.||+||||||+||++..++..||.|||+|+.-
T Consensus 96 ~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence 789999995 589888772 2677889999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC----C----
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP----H---- 905 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~---- 905 (977)
+.. ...+..+.|..|.|||++.+-.|.+.+||||.||++.||++|+.-|. ++..+.+|.+-.-. .
T Consensus 169 ~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 169 DTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred Ccc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHHH
Confidence 433 33455678899999999988889999999999999999999998875 45555566432110 0
Q ss_pred --------------------chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 --------------------GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.+.+....-... .+...--.....+++.+|+-.+|++|.++++++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~--~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV--LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCccccccc--ccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 01111110000000 00000112235678889999999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=236.24 Aligned_cols=270 Identities=26% Similarity=0.332 Sum_probs=200.1
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
+....+.|..+++||+|.|++||+|... ..+.||+|.+...+.. .++..|++++..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445567889999999999999999853 4688999998765433 5688999999999 5999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEeeccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSK 831 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~ 831 (977)
.+.+|+||+++..-.++... ++...+..+++.+..||+++| +.|||||||||+|++.+ ..+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999998888765 678899999999999999999 89999999999999998 56788999999998
Q ss_pred ccCCCC---------------------------------Cc---------ceeeccccCCcccCccccCCC-CcCcccch
Q 036011 832 LFDEGD---------------------------------DS---------VTQTMTIATIGYMAPEYGTEG-IVSSKCDV 868 (977)
Q Consensus 832 ~~~~~~---------------------------------~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 868 (977)
...... .. .......||+||.|||++... .-+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 221100 00 000113699999999987754 56889999
Q ss_pred hhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh----------hCCCc--hhh---------------hcc-hhhhcccc
Q 036011 869 YSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE----------SLPHG--LME---------------VVD-TNLLRQEH 920 (977)
Q Consensus 869 wslG~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~--~~~---------------~~~-~~~~~~~~ 920 (977)
||.|||++.+++++.||.....+-..+.+.+.- ..+.. +.+ -++ ..+.....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999997644443333332110 00000 000 000 00111000
Q ss_pred ---CchHHHHH-HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 ---TSSAEMDC-LLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ---~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......++ +..+++++.+|+..+|.+|.|++|++++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11111222 2368899999999999999999999764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-27 Score=245.62 Aligned_cols=394 Identities=23% Similarity=0.226 Sum_probs=227.4
Q ss_pred cceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccC-CcccccccCCCccccCCCCceEE
Q 036011 172 LVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFG-NQLSGHLDLPPKVSYSLPNLRVF 250 (977)
Q Consensus 172 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~l~~L~~L 250 (977)
-..++|..|+|+...|.+|+.+++|+.||||+|+|+.+.|.+|.++.+|..|-+-+ |+|+ ++|.++|.+|..|+.|
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~---~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT---DLPKGAFGGLSSLQRL 145 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh---hhhhhHhhhHHHHHHH
Confidence 34556666666644445566666666666666666666666666665555554444 6665 5666666666666666
Q ss_pred EecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCch-----hhhhcccccCCC
Q 036011 251 SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAE-----WSFLSSLTNCRN 325 (977)
Q Consensus 251 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~~l~~l~~ 325 (977)
.+.-|++..+..+.|..+++|..|.+-.|.+..+.-..|..+..++.+.+..|.+.....-.+ ......++..+-
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 666666666666666666666667777776664444466666677777666666433211000 000011222222
Q ss_pred CceEEecCCCCCCCCCcccccccccccccccccCcccccCCc-cccccccccEEEeecCccCCCCChhhhccCCCCEEEe
Q 036011 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH-EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 404 (977)
..-..+.++.+..+-+.-+.....++..-....|...++.|. .|..+++|+.|+|++|+|+++-+.+|.++..+++|.|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 222233333333333322222222333333444444444443 3677777778888888877777777777777788888
Q ss_pred ecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCC-----CCCcccc-----------Cc
Q 036011 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS-----SIPSSFW-----------SL 468 (977)
Q Consensus 405 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~-----------~l 468 (977)
..|+|..+-...|.++..|+.|+|++|+|+...|.+|..+.+|..|+|-.|.+.- ++.+|+. +-
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p 385 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSP 385 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCC
Confidence 7777776666667777777777777777777777777777777777777765530 1111110 11
Q ss_pred ccCceEEccCCCCCC---CCccccc---------cccccCe-eeCcCCcCCCCcchhhhcccccceeccCCccccccccc
Q 036011 469 EYLLAVNLSSNSLSG---SLPSNIQ---------NLQVLIN-LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ 535 (977)
Q Consensus 469 ~~L~~L~L~~N~l~~---~~p~~~~---------~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 535 (977)
..++.+.++++.+.. ..|+..+ .++-+.+ ..-|++.++ .+|..+. ..-.+|++.+|.++ .+|.
T Consensus 386 ~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~ 461 (498)
T KOG4237|consen 386 GFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPD 461 (498)
T ss_pred chhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCH
Confidence 234444444443321 1121111 1122222 223333343 4444322 34567888888888 5676
Q ss_pred cccCccccCeeeccCCccCCCCCcccccccccCccccCCC
Q 036011 536 TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575 (977)
Q Consensus 536 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 575 (977)
+ .+.+| .+|||+|+++..--..|.++++|.+|-||+|
T Consensus 462 ~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 462 E--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred H--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 6 66777 8899999888655667888888888888876
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-27 Score=243.40 Aligned_cols=276 Identities=24% Similarity=0.229 Sum_probs=172.7
Q ss_pred EEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcC-ccCCCCCCccccccccCcEEecc
Q 036011 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDY-NEFSGSFPSWIGVLSKLQILSLR 130 (977)
Q Consensus 52 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~ 130 (977)
.+.|+|..|+|+..-|.+|+.+.+||.||||+|+|+.+-|++|.+|.+|..|-+.+ |+|+...-+.|+.|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 45566666666622223466666666666666666666666666666655555555 55663223356666666666666
Q ss_pred CcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccc------------ccccCCccccCCCCCce
Q 036011 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNN------------LQGEIPSEIGNLQNLEI 198 (977)
Q Consensus 131 ~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~------------i~~~~p~~l~~l~~L~~ 198 (977)
-|++.-...+.|..|++|..|.+..|.+...--..|..+.+++.+.+..|. +....|..+++..-..-
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 666665555556666666666666666652222256666666666666555 22223333444444444
Q ss_pred EEeeccCCCCCCchhhccc-ccee-EEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEee
Q 036011 199 LVLGMNNLSGPIQPSIFNI-STIT-LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDL 276 (977)
Q Consensus 199 L~l~~N~l~~~~~~~l~~l-~~L~-~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 276 (977)
..+.++++..+.+..|... ..+. .+....+... ..|...|..|++|++|+|++|+|+.+-+.+|..+..+++|.|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~---~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS---ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC---cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 4444444443333333322 1111 1122222222 346667788899999999999999888888888889999999
Q ss_pred cccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCC
Q 036011 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337 (977)
Q Consensus 277 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 337 (977)
..|+|..+....|.++..|+.|+|.+|+|+.+.|.+ |..+..|.+|.|-.|++.
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~a-------F~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGA-------FQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEeccc-------ccccceeeeeehccCccc
Confidence 999988777788888899999999999998888776 777888888888888765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=264.69 Aligned_cols=363 Identities=20% Similarity=0.227 Sum_probs=205.8
Q ss_pred CCcEEEEEcCCCCCCc--cCCccccCcccccEeeccCCc------ccccCCCCcCCCC-CCCEEeCcCccCCCCCCcccc
Q 036011 49 HQRVRALNLSNMGLRG--TIPPHLGNFSFLMSLDISKNN------FHAYLPNELGQLR-RLRFISLDYNEFSGSFPSWIG 119 (977)
Q Consensus 49 ~~~v~~L~l~~~~l~~--~~~~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~ 119 (977)
+.+|..+.|.-..+.. .-+.++..+.+|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..+
T Consensus 531 ~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f- 608 (1153)
T PLN03210 531 TKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF- 608 (1153)
T ss_pred cceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-
Confidence 3455555444333321 123446677778888776543 2334566666654 5777777777776 677766
Q ss_pred ccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceE
Q 036011 120 VLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEIL 199 (977)
Q Consensus 120 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L 199 (977)
...+|++|+|++|++. .+|.++..+++|+.|+|++|.....+|. ++.+++|++|+|++|.....+|..++++++|+.|
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L 686 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686 (1153)
T ss_pred CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEE
Confidence 4577777777777776 5666666777777777776654445553 6666677777777665555666666777777777
Q ss_pred EeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccc
Q 036011 200 VLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFN 279 (977)
Q Consensus 200 ~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 279 (977)
++++|.....+|..+ .+++|+.|++++|.....+|.. ..+|++|+|++|
T Consensus 687 ~L~~c~~L~~Lp~~i----------------------------~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n 735 (1153)
T PLN03210 687 DMSRCENLEILPTGI----------------------------NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDET 735 (1153)
T ss_pred eCCCCCCcCccCCcC----------------------------CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCC
Confidence 776654333333322 3455555555555433344432 245677777777
Q ss_pred ccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccC
Q 036011 280 SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359 (977)
Q Consensus 280 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n 359 (977)
.+.. +|..+ .+++|+.|.+.++....+... +.. ++
T Consensus 736 ~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~------------------------~~~-l~------------------ 770 (1153)
T PLN03210 736 AIEE-FPSNL-RLENLDELILCEMKSEKLWER------------------------VQP-LT------------------ 770 (1153)
T ss_pred cccc-ccccc-cccccccccccccchhhcccc------------------------ccc-cc------------------
Confidence 7764 34433 466777777765443221100 000 00
Q ss_pred cccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchh
Q 036011 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQ 439 (977)
Q Consensus 360 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 439 (977)
+..+...++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.
T Consensus 771 ------~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 771 ------PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred ------hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 0011122345555555554444555555555556666665554333445443 456666666666544333443
Q ss_pred hhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccC-CCCCCCCccccccccccCeeeCcCC
Q 036011 440 CLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS-NSLSGSLPSNIQNLQVLINLDLSRN 503 (977)
Q Consensus 440 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (977)
. .++|++|+|++|.|+ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|++++|
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 2 245667777777776 4666667777777777766 3454 35666667777777777766
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=212.13 Aligned_cols=168 Identities=20% Similarity=0.160 Sum_probs=129.8
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (977)
|+|.++++..+..+++..++.++.|++.||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 7899999876667999999999999999999999 455 999999999999999 99998764322
Q ss_pred ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCch
Q 036011 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923 (977)
Q Consensus 844 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (977)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.........+..+........ .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------------PRDRS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------------ccccc
Confidence 24889999999999999999999999999999999999998654332222222222111110 00001
Q ss_pred HHHHHHH--HHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 924 AEMDCLL--SVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 924 ~~~~~~~--~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
....... .+.+++.+||+.+|.+||++.|+++++..+.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1112222 5899999999999999999999999987665
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=267.79 Aligned_cols=197 Identities=19% Similarity=0.259 Sum_probs=139.9
Q ss_pred hcCC-CCcceEeeee-------ecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 036011 735 NVRH-RNLIKIFSSC-------CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806 (977)
Q Consensus 735 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 806 (977)
.++| +||++++++| ...+..+.++||+ +++|.+++......+++.++..++.||++||+||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 3455 6888888877 2234566788987 66999999876666899999999999999999999 899999
Q ss_pred CCCCCCceeeCCC-------------------CceEEeecccccccCCCCC--------------cceeeccccCCcccC
Q 036011 807 CDLKPSNILLDED-------------------MVAHVSDFGLSKLFDEGDD--------------SVTQTMTIATIGYMA 853 (977)
Q Consensus 807 ~dlk~~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~a 853 (977)
|||||+|||++.. +.+|++|||+++....... ........||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4556666666653211000 000112358899999
Q ss_pred ccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHH
Q 036011 854 PEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVL 933 (977)
Q Consensus 854 PE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 933 (977)
||++.+..|+.++|||||||++|||++|..|+.... .....+.....+ +.. ........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~--------~~~----------~~~~~~~~ 242 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLP--------PQI----------LLNWPKEA 242 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcC--------hhh----------hhcCHHHH
Confidence 999999999999999999999999999888764311 011111111000 000 01122346
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHH
Q 036011 934 HLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 934 ~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.++.+||+++|.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78889999999999999999764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=260.50 Aligned_cols=307 Identities=24% Similarity=0.285 Sum_probs=170.0
Q ss_pred CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCC
Q 036011 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325 (977)
Q Consensus 246 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 325 (977)
+|+.|.+.++.+. .+|..+ ...+|++|+|++|++.. .+..+..+++|+.|+|++|......| .+..+++
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip--------~ls~l~~ 658 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIP--------DLSMATN 658 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCC--------ccccCCc
Confidence 3555555555554 344444 23455555555555542 23444555555555555443211111 1344555
Q ss_pred CceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEee
Q 036011 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 405 (977)
|+.|++++|.....+|..+..+. +|+.|++.+|...+.+|..+ ++++|+.|++++|...+.+|.. .++|++|+++
T Consensus 659 Le~L~L~~c~~L~~lp~si~~L~-~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~ 733 (1153)
T PLN03210 659 LETLKLSDCSSLVELPSSIQYLN-KLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLD 733 (1153)
T ss_pred ccEEEecCCCCccccchhhhccC-CCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecC
Confidence 55555555544444444444332 45555555554444455444 5666666666666444344432 3456666666
Q ss_pred cccccCccccccccccccceeeecCCcc-------CCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccC
Q 036011 406 GNNLEGSIPYDLCHLERLNGIRLNGNKL-------SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478 (977)
Q Consensus 406 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 478 (977)
+|.++ .+|..+ .+++|+.|++.++.. ....+..+...++|+.|+|++|...+.+|..++++++|+.|++++
T Consensus 734 ~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~ 811 (1153)
T PLN03210 734 ETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIEN 811 (1153)
T ss_pred CCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCC
Confidence 66665 444433 455666666655321 111122222345677777777766666777777777777777776
Q ss_pred CCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCC-ccCCCC
Q 036011 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNN-NLSGEI 557 (977)
Q Consensus 479 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~ 557 (977)
|..-+.+|..+ ++++|+.|+|++|..-..+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+
T Consensus 812 C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l 885 (1153)
T PLN03210 812 CINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RV 885 (1153)
T ss_pred CCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-cc
Confidence 64333556554 5677777777776443344432 356777777777776 56777777777777777773 444 56
Q ss_pred CcccccccccCccccCCCc
Q 036011 558 PKSLEALLFLKQLNVSHNK 576 (977)
Q Consensus 558 p~~~~~l~~L~~L~l~~N~ 576 (977)
|..+..++.|+.+++++|.
T Consensus 886 ~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 886 SLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CcccccccCCCeeecCCCc
Confidence 6666777777777777764
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=245.42 Aligned_cols=162 Identities=28% Similarity=0.371 Sum_probs=89.4
Q ss_pred CCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEc
Q 036011 397 EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNL 476 (977)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 476 (977)
++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|... .+|+.|++
T Consensus 302 ~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~L 369 (788)
T PRK15387 302 PGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWA 369 (788)
T ss_pred cccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccceehh
Confidence 345555555555552 2221 1234455555555552 3321 1246666666666663 33322 34555666
Q ss_pred cCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCC
Q 036011 477 SSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE 556 (977)
Q Consensus 477 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 556 (977)
++|+|+. +|... .+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .
T Consensus 370 s~N~L~~-LP~l~---~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 370 YNNRLTS-LPALP---SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-R 436 (788)
T ss_pred hcccccc-Ccccc---cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-c
Confidence 6666663 44322 35666666666666 34432 2456666777777663 45432 35666777777776 5
Q ss_pred CCcccccccccCccccCCCcccccCCC
Q 036011 557 IPKSLEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 557 ~p~~~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHH
Confidence 676677777777777777777766553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=242.27 Aligned_cols=167 Identities=27% Similarity=0.366 Sum_probs=110.4
Q ss_pred ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeec
Q 036011 373 RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452 (977)
Q Consensus 373 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 452 (977)
++|+.|+|++|++++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++
T Consensus 302 ~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~L 369 (788)
T PRK15387 302 PGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWA 369 (788)
T ss_pred cccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehh
Confidence 345555555555553 2321 1245556666666652 3421 1356677777777763 4432 235677777
Q ss_pred CCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccccc
Q 036011 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532 (977)
Q Consensus 453 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 532 (977)
++|+|++ +|.. ..+|+.|++++|+|++ +|... ++|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .
T Consensus 370 s~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 370 YNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-R 436 (788)
T ss_pred hcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-c
Confidence 7777773 5543 2467888888888874 55433 56888899999888 46653 346788899999998 6
Q ss_pred ccccccCccccCeeeccCCccCCCCCcccccc
Q 036011 533 IPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL 564 (977)
Q Consensus 533 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 564 (977)
+|..+.++++|+.|+|++|+|++..|..+..+
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 88888899999999999999998877766443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=221.71 Aligned_cols=177 Identities=23% Similarity=0.215 Sum_probs=135.4
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC--CCCEEEEEEeecc-----chhhHHHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS--DGTSFAIKVFNLQ-----LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
....++|.+.+.||+|+||+||+|++. +++.||||++... .......+.+|++++++++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 5788899986533 122355689999999999999998533322
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCceeeCCCCceEEeecccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL-KPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla 830 (977)
+..++||||++|++|... ... . ...++.++++||+||| +.||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999732 111 1 1467899999999999 899999999 999999999999999999999
Q ss_pred cccCCCCCcce------eeccccCCcccCccccCCCC------cCcccchh
Q 036011 831 KLFDEGDDSVT------QTMTIATIGYMAPEYGTEGI------VSSKCDVY 869 (977)
Q Consensus 831 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 869 (977)
+.+........ .....+++.|+|||++.... .+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 97765432111 12346888999999876543 22346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=203.93 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=187.5
Q ss_pred CCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.....+|.+...|..|+|+++ |..+++|++.... .+..++|.+|.-.++-+.||||++++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344567899999999999995 5667778765442 3445679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEe--ecccccccCCCCCc
Q 036011 763 NGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVS--DFGLSKLFDEGDDS 839 (977)
Q Consensus 763 ~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~--Dfgla~~~~~~~~~ 839 (977)
.|+|...++.... ..+..++.+++.++|+|++|||... +-|.---+.++.|++|++.+++|+ |--++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 9999999998655 5788899999999999999999532 223344589999999999988775 221111
Q ss_pred ceeeccccCCcccCccccCCCCcC---cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVS---SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
......-.|.||+||.+..++-+ .++|+|||++++||+.|+..||.+..+.+-....-. +++. ..
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----eglr------v~ 409 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----EGLR------VH 409 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----cccc------cc
Confidence 11112346789999998877644 479999999999999999999988655442221110 1110 00
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+ .....+.+++.-|+..||.+||.++.++-.|++++
T Consensus 410 ipp-------gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPP-------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCC-------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111 12334678888899999999999999999999875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=234.75 Aligned_cols=208 Identities=13% Similarity=0.218 Sum_probs=111.3
Q ss_pred hHHHHHHHHHHHHhccCCCCC--ccCCCCCCCCCCcccc----------------eEecCCCCcEEEEEcCCCCCCccC-
Q 036011 6 LTTDQFALLAFKAHVTDPQSV--LANNWSISQPICKWVG----------------ISCGARHQRVRALNLSNMGLRGTI- 66 (977)
Q Consensus 6 ~~~~~~~l~~~~~~~~~~~~~--~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~L~l~~~~l~~~~- 66 (977)
..+|.+.++.+.+.+..|+.. ..+.|+.++|.|--.. |.|. ...|+.+..-+......-
T Consensus 61 ~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~~~~~ 138 (754)
T PRK15370 61 SPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQASSAS 138 (754)
T ss_pred CHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCcccccccccccccccCC
Confidence 467889999999999877743 1134998889885433 4553 234565554442221111
Q ss_pred -CccccCcccccEeeccCCcccccCC---CCc-----CCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCC
Q 036011 67 -PPHLGNFSFLMSLDISKNNFHAYLP---NEL-----GQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGP 137 (977)
Q Consensus 67 -~~~l~~l~~L~~L~L~~n~l~~~~p---~~~-----~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 137 (977)
+.+..+....- =+-..+.-.+.-+ ..+ +-..+...|+|++++++ .+|..+. ++|+.|+|++|+++ .
T Consensus 139 ~~~~~~~~~~~w-~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-s 213 (754)
T PRK15370 139 GSKDAVNYELIW-SEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-S 213 (754)
T ss_pred CCCChhhHHHHH-HHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-c
Confidence 01110000000 0000000000000 000 11234566777777776 5666553 46777777777777 4
Q ss_pred CCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccc
Q 036011 138 IPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNI 217 (977)
Q Consensus 138 ~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l 217 (977)
+|..+. ++|++|++++|.++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|..+.
T Consensus 214 LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-- 282 (754)
T PRK15370 214 LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-- 282 (754)
T ss_pred CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--
Confidence 555443 46777777777776 4565443 36777778887777 5666554 46777777777776 3443332
Q ss_pred cceeEEEccCCccc
Q 036011 218 STITLINLFGNQLS 231 (977)
Q Consensus 218 ~~L~~L~L~~N~l~ 231 (977)
.+|+.|+|++|+|+
T Consensus 283 ~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 283 EELRYLSVYDNSIR 296 (754)
T ss_pred CCCcEEECCCCccc
Confidence 24555555555444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-22 Score=233.61 Aligned_cols=225 Identities=24% Similarity=0.438 Sum_probs=140.4
Q ss_pred CcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEec
Q 036011 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129 (977)
Q Consensus 50 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 129 (977)
...+.|++++++++ .+|..+. +.|+.|+|++|+|+. +|..+. .+|++|+|++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 34678999999988 6787664 578999999999987 666554 58899999999888 6777653 47888999
Q ss_pred cCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCC
Q 036011 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP 209 (977)
Q Consensus 130 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~ 209 (977)
++|.++ .+|..+. ++|+.|++++|.|. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-
Confidence 998888 6676654 46777788777777 4666553 46777777777777 4554443 356777777777763
Q ss_pred CchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccc
Q 036011 210 IQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTF 289 (977)
Q Consensus 210 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 289 (977)
+|..+. ++|+.|++++|.++ .+|..+ .++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+.+ |..+
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt---~LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~L-P~~l 386 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALT---SLPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNL-PENL 386 (754)
T ss_pred CCcccc--ccceeccccCCccc---cCChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCC-CHhH
Confidence 333222 35555555555554 233222 134555555555554 3444332 3455555555555532 2222
Q ss_pred ccccccccccccccccCC
Q 036011 290 GNLRFLSVLNLANNYLTT 307 (977)
Q Consensus 290 ~~l~~L~~L~L~~N~l~~ 307 (977)
. ..|+.|++++|+++.
T Consensus 387 ~--~sL~~LdLs~N~L~~ 402 (754)
T PRK15370 387 P--AALQIMQASRNNLVR 402 (754)
T ss_pred H--HHHHHHhhccCCccc
Confidence 1 234455555554443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=206.90 Aligned_cols=260 Identities=19% Similarity=0.181 Sum_probs=193.8
Q ss_pred CCCcCccccCcceEEEEEEEeCCC--CEEEEEEeeccchhhHHHHHHHHHHHHhcCC----CCcceEeeee-ecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSDG--TSFAIKVFNLQLDRAFRSFDSECEVLRNVRH----RNLIKIFSSC-CNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 756 (977)
+|.+.+.||+|+||.||.|..... ..+|+|+-..........+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997543 5789998765533332368889999999873 6899999988 57788999
Q ss_pred EEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-----CceEEeecccc
Q 036011 757 VLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-----MVAHVSDFGLS 830 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgla 830 (977)
||+.+ |.+|.++..... ..++..+..+|+.|+..+|+++| +.|++||||||.|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 789999886554 57999999999999999999999 8999999999999999854 46999999999
Q ss_pred c--ccCCCCCc----c-e-eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 831 K--LFDEGDDS----V-T-QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 831 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
+ .+...... . . .....||..|+++.+..+...+.+.|+||++.++.|+..|..||........ ..+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 9 33222111 0 1 1234599999999999999999999999999999999999999865432211 11110000
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....... .....+..+.++...+-..+...+|....+...+++...
T Consensus 254 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 254 RKLLTDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhhcccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 0000000 000112334555555556799999999999888866654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-22 Score=230.04 Aligned_cols=253 Identities=22% Similarity=0.239 Sum_probs=191.7
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEee-----ccchhhH-HHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFN-----LQLDRAF-RSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.+++|.|++|.|+.+... ..+.++.|.+. ....... ..+..|+-+-..++|||++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999988777643 44445555432 1112221 2266788888889999999888877776666666999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc-
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS- 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 839 (977)
|++ +|..++.... .+...++..++.|+..|++|+| +.||.|||+|++|++++..|.+||+|||.+..+.-+...
T Consensus 403 ~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred ccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999 9999987763 3788999999999999999999 899999999999999999999999999999887655443
Q ss_pred -ceeeccccCCcccCccccCCCCcCc-ccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 840 -VTQTMTIATIGYMAPEYGTEGIVSS-KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 840 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......+|+-.|+|||++.+..|++ ..||||.|+++..|.+|+.||.-....+..+. ..... .....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~~--------~~~~~ 546 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNYS--------DQRNI 546 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhccc--------ccccc
Confidence 4455668999999999999999986 49999999999999999999865444333220 00111 11111
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+........+.....++.++++.+|.+|.|+++|++.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 222333445566677889999999999999999999653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-19 Score=201.54 Aligned_cols=258 Identities=29% Similarity=0.387 Sum_probs=198.6
Q ss_pred CCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchh---hHHHHHHHHHHHHhcCCC-CcceEeeeeecCCeeEEEEec
Q 036011 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR---AFRSFDSECEVLRNVRHR-NLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 760 (977)
|...+.+|.|+||.||++... ..+|+|.+...... ....+.+|+..++.+.|+ +|+++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999976 88999998766432 367799999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhcCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 837 (977)
+.++++.+++.... ..+.......++.|++.+++|+| +.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777654 25889999999999999999999 78899999999999999988 79999999998665433
Q ss_pred Ccc----eeeccccCCcccCccccCC---CCcCcccchhhHhHHHHHHhcCCCCCCcCCcc--cccHHHHHHhhCCCchh
Q 036011 838 DSV----TQTMTIATIGYMAPEYGTE---GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG--EMSLKKWVKESLPHGLM 908 (977)
Q Consensus 838 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 908 (977)
... ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... .................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2345679999999999887 67889999999999999999999996554321 11122211111111000
Q ss_pred hhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....... . ......+.+++..|+..+|..|.++.+....
T Consensus 237 ~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSN----P-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccc----c-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 0 1123456788999999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=178.05 Aligned_cols=203 Identities=22% Similarity=0.272 Sum_probs=169.9
Q ss_pred hcCCCcCccccCcceEEEEEEE-eCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC-CCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH-RNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 759 (977)
.+.|..+++||.|+||.+|.|. ..+|+.||||+-.... ....+..|.++.+.+++ ..|..+..+..+.+...+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4679999999999999999998 4689999999854332 23567789999999975 788888888889999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeecccccccCCC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 836 (977)
.. |.+|.+...--...++..+++-.+.|+..-++|+| .++++||||||+|+|.. ....+.++|||+|+.+...
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 98 78999988766666899999999999999999999 78899999999999986 4457899999999987643
Q ss_pred CCc-----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCc
Q 036011 837 DDS-----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFT 890 (977)
Q Consensus 837 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~ 890 (977)
... .......||.+|.+-....+..-+.+.|+=|+|.++.+.-.|..||.+...
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 322 122234699999988777777778899999999999999999999988643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=190.35 Aligned_cols=171 Identities=13% Similarity=0.104 Sum_probs=133.8
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhH---------HHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAF---------RSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
..++|..++++|.|+||.||.+.. ++..+|||+++....... +.+.+|++.+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999766 577899999975542222 2268999999999999999999886543
Q ss_pred --------CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceE
Q 036011 752 --------DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 752 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
...++||||++|.+|.++.. .+. ....++++++..+| +.|++|||++|+||++++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988732 222 34669999999999 89999999999999999988 99
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHh
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 879 (977)
++|||.......... . ..+.....|..++|+|+||+++....
T Consensus 175 liDfg~~~~~~e~~a-~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKA-K-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhh-H-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999998865432110 0 11333445677999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=184.29 Aligned_cols=141 Identities=19% Similarity=0.175 Sum_probs=109.4
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchh--h-------H-----------------HHHHHHHHHHHhcCCCCc
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR--A-------F-----------------RSFDSECEVLRNVRHRNL 741 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni 741 (977)
.+.||+|+||.||+|...+|+.||||+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998754211 0 0 122359999999988877
Q ss_pred ceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc
Q 036011 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821 (977)
Q Consensus 742 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 821 (977)
.....+.. ...++||||++++++....... ..++......++.|++.+|+|+|+ +.||+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCc
Confidence 44333222 2237999999988776543222 348899999999999999999942 78999999999999998 478
Q ss_pred eEEeecccccccC
Q 036011 822 AHVSDFGLSKLFD 834 (977)
Q Consensus 822 ~kl~Dfgla~~~~ 834 (977)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-19 Score=178.80 Aligned_cols=200 Identities=19% Similarity=0.290 Sum_probs=171.3
Q ss_pred CCCcCccccCcceEEEEEEE-eCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEecc
Q 036011 684 GFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.|.+.++||+|.||+.+.|+ .-++++||||.=+..++ ...+..|.+..+.+ ..++|..++.+..+..+-.+|+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 48888999999999999998 45799999998654433 35678899999988 5799999999988888999999998
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-----CCceEEeecccccccCCC
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~ 836 (977)
|-+|.|+..--++.++..++..||.|+..-++|+| ++..|.|||||+|+||.. ...+.++|||+|+.+...
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 77999988766667999999999999999999999 788999999999999964 346999999999988765
Q ss_pred CCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCC
Q 036011 837 DDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMF 889 (977)
Q Consensus 837 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~ 889 (977)
.... ......||.+||+=....+..-+.+.|.=|+|=++++.+-|..||.+.-
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 4321 2223469999999988888899999999999999999999999998753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-22 Score=179.84 Aligned_cols=182 Identities=30% Similarity=0.491 Sum_probs=141.4
Q ss_pred ccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceE
Q 036011 395 RLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAV 474 (977)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 474 (977)
.+.+++.|.||+|+++ .+|+.+..+.+|++|++++|+|. .+|..+..++.|+.|+++-|++. +.|..|++++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4556667777777777 66777777788888888888877 67777888888888888888887 788888888888888
Q ss_pred EccCCCCCC-CCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCcc
Q 036011 475 NLSSNSLSG-SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553 (977)
Q Consensus 475 ~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 553 (977)
||++|++.. .+|..|-.++.|+.|+|+.|.+. .+|..++.+++|+.|.+..|.+- .+|.+++.++.|++|++.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 888888763 57888888888888888888887 77888888888888888888887 6788888888888888888888
Q ss_pred CCCCCccccccc---ccCccccCCCcccccCC
Q 036011 554 SGEIPKSLEALL---FLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 554 ~~~~p~~~~~l~---~L~~L~l~~N~l~~~~p 582 (977)
+ .+|..++++. +-+.+.+.+|+|...|.
T Consensus 186 ~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 186 T-VLPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred e-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 7 7777766543 23556667777765554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-20 Score=211.66 Aligned_cols=250 Identities=23% Similarity=0.255 Sum_probs=182.3
Q ss_pred CCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch-hhHHHHH---HHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD-RAFRSFD---SECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
+|...+.+|++.|=.|.+|++++|. |+||++-+..+ -..+.|. +|++ ...++|||++++.-+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999998887 99999976652 2233444 3444 556689999999888888888899999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc--CCC-
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF--DEG- 836 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~--~~~- 836 (977)
|+.+ +|.|.+..+. .+...+...|+.|+..|+.-+| ..||+|||||.+|||+++=..+.|+||-.-+.. ..+
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9965 8999886654 4777888889999999999999 899999999999999999999999999665432 211
Q ss_pred --CCcceeeccccCCcccCccccCC----------CC-cCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhh
Q 036011 837 --DDSVTQTMTIATIGYMAPEYGTE----------GI-VSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 837 --~~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 902 (977)
+..........-..|+|||.+.. .. .+++=||||+||+++|+++ |++||.-. ++-.|....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 11122222234456999996543 12 5778999999999999998 56666421 122222111
Q ss_pred --CCCc-hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 903 --LPHG-LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 903 --~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.++. +.++.|. .+.+++..|++.||++|.++++.++.-.++..
T Consensus 252 ~~~~e~~Le~Ied~-----------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDV-----------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred ccCHHHHHHhCcCc-----------------cHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 0111 1111111 35678999999999999999999999777654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=177.18 Aligned_cols=140 Identities=20% Similarity=0.198 Sum_probs=111.5
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchh--------------------------hHHHHHHHHHHHHhcCCCCc
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR--------------------------AFRSFDSECEVLRNVRHRNL 741 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 741 (977)
...||+|+||.||+|+..+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998764210 01224678999999999987
Q ss_pred ceEeeeeecCCeeEEEEeccCCCCHHHH-hhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCC
Q 036011 742 IKIFSSCCNNDFRALVLELMPNGSLEKW-LYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDED 819 (977)
Q Consensus 742 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~ 819 (977)
.....+... ..++||||++++++... +.. ..++.....+++.|++.++.++| + .||+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 554444333 24799999998865433 433 23678899999999999999999 6 8999999999999999 8
Q ss_pred CceEEeecccccccCC
Q 036011 820 MVAHVSDFGLSKLFDE 835 (977)
Q Consensus 820 ~~~kl~Dfgla~~~~~ 835 (977)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 9999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.4e-21 Score=174.43 Aligned_cols=168 Identities=32% Similarity=0.480 Sum_probs=156.5
Q ss_pred ccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCcccccccccc
Q 036011 416 DLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL 495 (977)
Q Consensus 416 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 495 (977)
.+.++..++.|.|++|+++ .+|..+..+.+|+.|++++|+|+ ..|..++++++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3556788999999999999 77888999999999999999999 78999999999999999999998 899999999999
Q ss_pred CeeeCcCCcCCC-CcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCC
Q 036011 496 INLDLSRNQLSG-DIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSH 574 (977)
Q Consensus 496 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 574 (977)
+.|||++|++.. .+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+.+|.+. .+|..++.++.|++|.+.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 999999999964 67999999999999999999999 89999999999999999999998 8999999999999999999
Q ss_pred CcccccCCCCCCCC
Q 036011 575 NKLEGEIPANGPFK 588 (977)
Q Consensus 575 N~l~~~~p~~~~~~ 588 (977)
|+++-.+|+.+++.
T Consensus 183 nrl~vlppel~~l~ 196 (264)
T KOG0617|consen 183 NRLTVLPPELANLD 196 (264)
T ss_pred ceeeecChhhhhhh
Confidence 99998888765544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=171.21 Aligned_cols=186 Identities=18% Similarity=0.101 Sum_probs=139.7
Q ss_pred CcCccccCcceEEEEEEEeCCCCEEEEEEeeccchh----hHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEec
Q 036011 686 NECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR----AFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.+...|++|+||+||.+.. .+.+++.+.+...... ....+.+|++++++++ |++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 6788888877644321 1225789999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL-KPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+.|.+|.+.... ....++.|++++++++| +.||+|||| ||.||+++.++.++|+|||+|....+....
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999999754321 12357889999999999 899999999 799999999999999999999865543210
Q ss_pred ----ce-------eeccccCCcccCccccCC-CCcC-cccchhhHhHHHHHHhcCCCCCCc
Q 036011 840 ----VT-------QTMTIATIGYMAPEYGTE-GIVS-SKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 840 ----~~-------~~~~~gt~~y~aPE~~~~-~~~~-~~~DvwslG~il~elltg~~p~~~ 887 (977)
.. ......++.|++|+...- ...+ ...+.++-|.-+|.++||..|+-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 011236777888874321 1223 567899999999999999988643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.7e-19 Score=194.28 Aligned_cols=218 Identities=27% Similarity=0.348 Sum_probs=166.9
Q ss_pred HHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 036011 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPS 812 (977)
Q Consensus 733 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 812 (977)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....++++|+.||+|+|+ +...+|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 357889999999999999999999999999999999999877789999999999999999999994 444499999999
Q ss_pred ceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCC-------cCcccchhhHhHHHHHHhcCCCCC
Q 036011 813 NILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI-------VSSKCDVYSYGVLLTETFTRKKPT 885 (977)
Q Consensus 813 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltg~~p~ 885 (977)
|.++|....+|++|||+.................-..-|.|||.+.... .+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999998775311111222222445699999877632 466799999999999999999999
Q ss_pred CcCCccccc--HHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 886 DDMFTGEMS--LKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 886 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
+.....+.. +..+++. +....+.+.+... .+....+..++.+||..+|.+||+++.|...++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~~----~~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK----GGSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHh----cCCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 875443332 2222222 1111122222111 02334688999999999999999999999988877653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-20 Score=205.47 Aligned_cols=210 Identities=27% Similarity=0.318 Sum_probs=125.2
Q ss_pred cccccccccEEEeecCccCCCCChhhhccCC---CCEEEeecccccC----ccccccccc-cccceeeecCCccCCC---
Q 036011 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQ---LQGLSLYGNNLEG----SIPYDLCHL-ERLNGIRLNGNKLSGP--- 436 (977)
Q Consensus 368 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~--- 436 (977)
.+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.
T Consensus 76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 155 (319)
T cd00116 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155 (319)
T ss_pred HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence 3344445555555555554444444444443 5666666655542 122233444 5666666666666532
Q ss_pred -chhhhcCCCCCCeeecCCCcCCCC----CCccccCcccCceEEccCCCCCCC----CccccccccccCeeeCcCCcCCC
Q 036011 437 -IPQCLASLISLRELNLGSNKFSSS----IPSSFWSLEYLLAVNLSSNSLSGS----LPSNIQNLQVLINLDLSRNQLSG 507 (977)
Q Consensus 437 -~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 507 (977)
++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++
T Consensus 156 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 233455556677777777766632 222334445677777777766532 23345566778888888888875
Q ss_pred Ccchhhhc-----ccccceeccCCccccc----cccccccCccccCeeeccCCccCCC----CCcccccc-cccCccccC
Q 036011 508 DIPITIGS-----LKDLVTLSLASNQFEG----PIPQTFGSLTGLESLDLSNNNLSGE----IPKSLEAL-LFLKQLNVS 573 (977)
Q Consensus 508 ~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~l~ 573 (977)
.....+.. .+.|+.|++++|.++. .+...+..+++|+.+|+++|+++.. +...+... +.|+++++.
T Consensus 236 ~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (319)
T cd00116 236 AGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK 315 (319)
T ss_pred HHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence 33333332 3688888888888862 2345566668899999999998854 44445555 788889988
Q ss_pred CCcc
Q 036011 574 HNKL 577 (977)
Q Consensus 574 ~N~l 577 (977)
+|++
T Consensus 316 ~~~~ 319 (319)
T cd00116 316 DDSF 319 (319)
T ss_pred CCCC
Confidence 8875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=178.27 Aligned_cols=197 Identities=24% Similarity=0.279 Sum_probs=137.6
Q ss_pred CCCCcceEeeeeec---------------------------CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHH
Q 036011 737 RHRNLIKIFSSCCN---------------------------NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGV 789 (977)
Q Consensus 737 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i 789 (977)
+|||||+++++|.+ ....|+||..++. +|.+++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999987632 2356899998865 9999998766 4666777799999
Q ss_pred HHHHHHHHhcCCCCeEeCCCCCCceeeC--CCC--ceEEeecccccccCCCC---Ccc-eeeccccCCcccCccccCCCC
Q 036011 790 ALALEYLHHGHSTPVVHCDLKPSNILLD--EDM--VAHVSDFGLSKLFDEGD---DSV-TQTMTIATIGYMAPEYGTEGI 861 (977)
Q Consensus 790 ~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfgla~~~~~~~---~~~-~~~~~~gt~~y~aPE~~~~~~ 861 (977)
++|+.||| ++||.|||+|++|||+. +|+ ...|+|||.+---.... ... ..-..-|.-..||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 89999999999999983 443 57899999875322100 001 111123666789999865322
Q ss_pred ------cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHH
Q 036011 862 ------VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHL 935 (977)
Q Consensus 862 ------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 935 (977)
--.|+|.|+.|.+.||+++...||........+...|....+| ..+..++..+.++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP------------------alp~~vpp~~rql 489 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP------------------ALPSRVPPVARQL 489 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC------------------CCcccCChHHHHH
Confidence 1258999999999999999999997632222222222111111 1122345567889
Q ss_pred HHHhhcCCCCCCCCHHHHHHHH
Q 036011 936 ALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 936 ~~~cl~~~P~~RPs~~ev~~~L 957 (977)
+...++.||.+|++..-....+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999876555444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=202.81 Aligned_cols=199 Identities=22% Similarity=0.243 Sum_probs=162.8
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC---CCCcceEeeeeecCCee
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR---HRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~ 754 (977)
.+...+.|.+.+.+|+|+||.||+|...+|+.||+|+=+..... +|.--.+++.+|+ -+-|..+..++...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34456778899999999999999999888999999986544332 2222234444444 34555566666677788
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-------CCCceEEeec
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-------EDMVAHVSDF 827 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-------~~~~~kl~Df 827 (977)
++|+||.+.|+|.+++... +.++|.-.+.++.|++..++.|| ..+||||||||+|.|+. +...++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 8999999999999999844 45999999999999999999999 88999999999999994 3457999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCC
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK 883 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 883 (977)
|.+..+..-.........++|-.+-.+|+..+.+++..+|.|.++.+++-|+.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99987765444455566789999999999999999999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-18 Score=176.95 Aligned_cols=230 Identities=20% Similarity=0.286 Sum_probs=148.4
Q ss_pred CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCC----------CCcceEeeeee-
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRH----------RNLIKIFSSCC- 749 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~- 749 (977)
+...+.||.|+++.||.+++. +|+.+|||++.... ...++.+++|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344578999999999999976 59999999986554 3456677777766655432 12222222221
Q ss_pred --------cC---C-----eeEEEEeccCCCCHHHHhhc---CC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeC
Q 036011 750 --------NN---D-----FRALVLELMPNGSLEKWLYS---DN---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807 (977)
Q Consensus 750 --------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 807 (977)
.. . ..+++|+-+ .++|.+++.. .. .......+..+..|+.+.+++|| ..|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 11 1 125678877 5688877542 11 12445566778899999999999 8999999
Q ss_pred CCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCC--------CCcCcccchhhHhHHHHHHh
Q 036011 808 DLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE--------GIVSSKCDVYSYGVLLTETF 879 (977)
Q Consensus 808 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell 879 (977)
||+|+|++++.+|.++|+||+.....+.. ......+..|.+||.... -.++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999887755421 111335678999996533 35789999999999999999
Q ss_pred cCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCC
Q 036011 880 TRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947 (977)
Q Consensus 880 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 947 (977)
+|..||+......... | .+ ..+ .+.++.+..++..+++++|.+|
T Consensus 245 C~~lPf~~~~~~~~~~--~---------------~f----~~C---~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE--W---------------DF----SRC---RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG--G---------------GG----TTS---S---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc--c---------------cc----hhc---CCcCHHHHHHHHHHccCCcccC
Confidence 9999997643221100 0 11 111 1456778899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=167.87 Aligned_cols=136 Identities=17% Similarity=0.250 Sum_probs=106.6
Q ss_pred CcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-----CCCCcceEeeeeecCC---eeE-E
Q 036011 686 NECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-----RHRNLIKIFSSCCNND---FRA-L 756 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 756 (977)
...+.||+|+||.||. +++....+||++........+.+.+|+++++.+ .||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 443333479998765444557799999999999 5799999999998863 333 7
Q ss_pred EEec--cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCceeeCC----CCceEEeeccc
Q 036011 757 VLEL--MPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL-EYLHHGHSTPVVHCDLKPSNILLDE----DMVAHVSDFGL 829 (977)
Q Consensus 757 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfgl 829 (977)
|+|| +.+|+|.+++.... +++. ..++.+++.++ +||| +++|+||||||+||+++. ++.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 55799999997643 4544 35677888777 9999 899999999999999973 34899999544
Q ss_pred c
Q 036011 830 S 830 (977)
Q Consensus 830 a 830 (977)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-19 Score=198.30 Aligned_cols=267 Identities=24% Similarity=0.261 Sum_probs=155.7
Q ss_pred ccccccccceEeecccccccc----cccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCC
Q 036011 264 SITNASKLTGLDLSFNSFSGL----IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI 339 (977)
Q Consensus 264 ~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 339 (977)
.+..+.+|+.|++++|.++.. ++..+...++|+.|+++++.+... +.........+..+++|+.|++++|.+.+.
T Consensus 18 ~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~-~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~ 96 (319)
T cd00116 18 LLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI-PRGLQSLLQGLTKGCGLQELDLSDNALGPD 96 (319)
T ss_pred HHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc-chHHHHHHHHHHhcCceeEEEccCCCCChh
Confidence 344445556666666555321 233344455566666666655431 111122333455666777777777766543
Q ss_pred CCcccccccccccccccccCcccccCCccccccccccEEEeecCccCC----CCChhhhcc-CCCCEEEeecccccCc--
Q 036011 340 LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG----TIPSTVGRL-EQLQGLSLYGNNLEGS-- 412 (977)
Q Consensus 340 ~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~-- 412 (977)
.+..+..+. .. ++|++|++++|.+++ .+...+..+ ++|++|++++|.+++.
T Consensus 97 ~~~~~~~l~---------------------~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 154 (319)
T cd00116 97 GCGVLESLL---------------------RS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASC 154 (319)
T ss_pred HHHHHHHHh---------------------cc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHH
Confidence 333222111 11 336666666666552 222344455 6677777777776632
Q ss_pred --cccccccccccceeeecCCccCCC----chhhhcCCCCCCeeecCCCcCCCCC----CccccCcccCceEEccCCCCC
Q 036011 413 --IPYDLCHLERLNGIRLNGNKLSGP----IPQCLASLISLRELNLGSNKFSSSI----PSSFWSLEYLLAVNLSSNSLS 482 (977)
Q Consensus 413 --~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 482 (977)
++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+.+.. +..+..+++|+.|++++|.++
T Consensus 155 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 155 EALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 233455566777777777777632 3344555667777777777776432 234556677888888888777
Q ss_pred CCCcccccc-----ccccCeeeCcCCcCCC----CcchhhhcccccceeccCCcccccc----ccccccCc-cccCeeec
Q 036011 483 GSLPSNIQN-----LQVLINLDLSRNQLSG----DIPITIGSLKDLVTLSLASNQFEGP----IPQTFGSL-TGLESLDL 548 (977)
Q Consensus 483 ~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L 548 (977)
+.....+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++.. ....+... +.|++||+
T Consensus 235 ~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~ 314 (319)
T cd00116 235 DAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWV 314 (319)
T ss_pred hHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhccc
Confidence 532222222 3688888888888862 3345566678888999999988854 34444444 68889998
Q ss_pred cCCcc
Q 036011 549 SNNNL 553 (977)
Q Consensus 549 s~N~l 553 (977)
.+|.+
T Consensus 315 ~~~~~ 319 (319)
T cd00116 315 KDDSF 319 (319)
T ss_pred CCCCC
Confidence 88864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-19 Score=194.99 Aligned_cols=186 Identities=29% Similarity=0.327 Sum_probs=157.0
Q ss_pred cccCcceEEEEEEEe----CCCCEEEEEEeeccch--hhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEeccC
Q 036011 690 LLGRGSFGSVYKGTF----SDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.+|+|+||.|+.++- +.|..+|.|+..+... +.......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997642 3578899998876542 12224556888888886 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|.+...+..... ++......+...++-+++++| +.+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 9999988876654 667777777888889999999 89999999999999999999999999999987654332
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
.+||..|||||+.. ....++|.||||++++||+||..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27999999999988 567789999999999999999999865
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.3e-17 Score=166.33 Aligned_cols=134 Identities=22% Similarity=0.307 Sum_probs=114.3
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccch--------hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD--------RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+.||+|++|.||+|.. .|..|++|+...... .....+.+|++++..++|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 678899998654321 1224578899999999999998877777777888999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
++|++|.+++.... . .+..++.+++.+++++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986533 2 88899999999999999 89999999999999999 78999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=166.96 Aligned_cols=143 Identities=19% Similarity=0.128 Sum_probs=112.1
Q ss_pred cCCCcCccccCcceEEEEEEE--eCCCCEEEEEEeeccchh------------------------hHHHHHHHHHHHHhc
Q 036011 683 DGFNECNLLGRGSFGSVYKGT--FSDGTSFAIKVFNLQLDR------------------------AFRSFDSECEVLRNV 736 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 736 (977)
..|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788999999999999998 468999999998754210 112357899999999
Q ss_pred CCC--CcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCc
Q 036011 737 RHR--NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP-VVHCDLKPSN 813 (977)
Q Consensus 737 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~N 813 (977)
.+. .+.+++++ ...++||||++++++..+..... ..+......++.|++.++++|| +.| |+|||+||+|
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence 753 33444443 23479999999988876543322 3556667899999999999999 888 9999999999
Q ss_pred eeeCCCCceEEeecccccccC
Q 036011 814 ILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 814 Ill~~~~~~kl~Dfgla~~~~ 834 (977)
|+++ ++.++++|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-16 Score=159.65 Aligned_cols=144 Identities=19% Similarity=0.162 Sum_probs=113.1
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchh----------------------hHHHHHHHHHHHH
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR----------------------AFRSFDSECEVLR 734 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~ 734 (977)
++.+....|.+.+.||+|+||.||+|...+|+.||||+++..... ....+..|...+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458888999999999999999888999999987653210 1123677899999
Q ss_pred hcCCCC--cceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 036011 735 NVRHRN--LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPS 812 (977)
Q Consensus 735 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 812 (977)
.+.|++ +...++ ....++||||+++++|.+.... .....++.+++.++.++| +.||+||||+|+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence 998874 444443 2345899999999999775431 345678899999999999 799999999999
Q ss_pred ceeeCCCCceEEeecccccccC
Q 036011 813 NILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 813 NIll~~~~~~kl~Dfgla~~~~ 834 (977)
||++++++.++|+|||.+....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.7e-16 Score=186.89 Aligned_cols=136 Identities=33% Similarity=0.628 Sum_probs=115.1
Q ss_pred ChHHHHHHHHHHHHhccCCCCCccCCCCCCCCCC----cccceEecCC--C--CcEEEEEcCCCCCCccCCccccCcccc
Q 036011 5 NLTTDQFALLAFKAHVTDPQSVLANNWSISQPIC----KWVGISCGAR--H--QRVRALNLSNMGLRGTIPPHLGNFSFL 76 (977)
Q Consensus 5 ~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~L~l~~~~l~~~~~~~l~~l~~L 76 (977)
..++|.+||+++|+++.++.. .+|. +.+|| .|.||+|... . ..|+.|+|+++++.|.+|+.++.+++|
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~---~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR---FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc---CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 356799999999999976642 3796 34453 7999999532 2 258999999999999999999999999
Q ss_pred cEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccC
Q 036011 77 MSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFN 144 (977)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 144 (977)
+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..++.+++|++|+|++|+++|.+|..+..
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 99999999999889989999999999999999999999999999999999999999998888877654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-17 Score=176.56 Aligned_cols=122 Identities=32% Similarity=0.514 Sum_probs=107.3
Q ss_pred eeEEEEeccCCCCHHHHhhcCC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
..|+.|++|...+|.+|+..+. ...++.....++.|++.|++| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 5679999999999999996443 357888999999999999999 68999999999999999999999999999
Q ss_pred cccCCCC----CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc
Q 036011 831 KLFDEGD----DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880 (977)
Q Consensus 831 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 880 (977)
....... .....+..+||.+||+||.+.+..|+.|+||||+|++++|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8776543 2334455679999999999999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-17 Score=186.03 Aligned_cols=214 Identities=24% Similarity=0.268 Sum_probs=145.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+|+.++.|..|++|.||.++++ ..+.+|.|+-+ +. -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 468999999999999999999876 47788885422 21 01110 22233344443
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc-
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS- 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 839 (977)
|+-...++..+. ++... +.+++|+| +.||||||+||+|.+|+.-|++|+.|||+++........
T Consensus 136 ---gDc~tllk~~g~-lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCCC-Ccchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 444455544332 33222 77899999 899999999999999999999999999999864321111
Q ss_pred ------------ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 840 ------------VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 840 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
......+||+.|+|||++..+.|...+|+|++|+|+||.+-|+.||++..+.+ .+...+...+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i---- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDI---- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhc----
Confidence 11123589999999999999999999999999999999999999998753322 2222222111
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 953 (977)
..... ......+..+++.+.++.+|..|--....
T Consensus 276 --------~wpE~----dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 276 --------EWPEE----DEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred --------ccccc----CcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 00000 01123345677888888899999754433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.7e-16 Score=157.05 Aligned_cols=130 Identities=24% Similarity=0.314 Sum_probs=107.3
Q ss_pred cccCcceEEEEEEEeCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 690 LLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 690 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.||+|+||.||+|.+ +|..|++|+..... .....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 57889999865321 112356788999999999887665555555666778999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
+|++|.+++..... .++.+++++|+++| +.|++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 78999999999999 89999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=179.38 Aligned_cols=139 Identities=21% Similarity=0.233 Sum_probs=112.9
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 752 (977)
....|...+.||+|+||+||+|.+... .+++|+..... ....+.+.+|+++++.++|++++....++.+..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556788999999999999987544 34444322111 112356889999999999999998888777777
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+++++|.+++. ....++.+++++++||| +.+++|||+||+||++ +++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999999875 35678999999999999 8999999999999999 678999999999875
Q ss_pred c
Q 036011 833 F 833 (977)
Q Consensus 833 ~ 833 (977)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=141.14 Aligned_cols=136 Identities=21% Similarity=0.257 Sum_probs=116.2
Q ss_pred cCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC--CCcceEeeeeecCCeeEEEEeccCCC
Q 036011 687 ECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH--RNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
+.+.+|+|.++.||+++..+ ..+++|+...... ...+.+|+..++.++| +.+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899999865433 4678899999999976 58999999888888899999999988
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.+..+ +......++.+++++++++|..+..+++|||++|.||++++.+.++++|||.+...
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77654 45677788999999999999665578999999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=145.63 Aligned_cols=136 Identities=21% Similarity=0.229 Sum_probs=98.5
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchh--hHHH----------------------HHHHHHHHHhcCCCC--c
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR--AFRS----------------------FDSECEVLRNVRHRN--L 741 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i 741 (977)
.+.||+|+||+||+|...+|+.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998754211 1111 135666666664432 4
Q ss_pred ceEeeeeecCCeeEEEEeccCCCCHHH-HhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCC
Q 036011 742 IKIFSSCCNNDFRALVLELMPNGSLEK-WLYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDED 819 (977)
Q Consensus 742 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~ 819 (977)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++| . .+|+|||+||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 444443 23589999999854321 111111 11 567889999999999999 6 8999999999999999 9
Q ss_pred CceEEeecccccccC
Q 036011 820 MVAHVSDFGLSKLFD 834 (977)
Q Consensus 820 ~~~kl~Dfgla~~~~ 834 (977)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-15 Score=177.73 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=195.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC--CCEEEEEEeeccc--hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD--GTSFAIKVFNLQL--DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 756 (977)
...|...+.||+|+|+.|-.+.... ...+|+|.+.... ....+....|..+-+.+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457778889999999998887533 4456666554432 233344556777777776 9999999999999999999
Q ss_pred EEeccCCCCHHHHh-hcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccC
Q 036011 757 VLELMPNGSLEKWL-YSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFD 834 (977)
Q Consensus 757 v~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~ 834 (977)
+++|..++++.+-+ +......+......+..|+..++.|+|. ..+++|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999888 5444246777888899999999999995 57899999999999999999 99999999999887
Q ss_pred C-CCCcceeecccc-CCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 835 E-GDDSVTQTMTIA-TIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 835 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|........
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence 6 444445555678 9999999998874 5567899999999999999999999876655555555544321100
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAA 954 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~ 954 (977)
. ..+........++..+++..+|..|.+.+++.
T Consensus 252 ---~-------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 ---Q-------LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---c-------CccccCChhhhhcccccccCCchhcccccccc
Confidence 0 00011122346777788888999999888773
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=144.54 Aligned_cols=135 Identities=18% Similarity=0.202 Sum_probs=104.8
Q ss_pred cccc-CcceEEEEEEEeCCCCEEEEEEeeccc------h-------hhHHHHHHHHHHHHhcCCCCc--ceEeeeeecC-
Q 036011 689 NLLG-RGSFGSVYKGTFSDGTSFAIKVFNLQL------D-------RAFRSFDSECEVLRNVRHRNL--IKIFSSCCNN- 751 (977)
Q Consensus 689 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~------~-------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~- 751 (977)
..|| .|+.|+||.+... +..+|||++.... . .....+.+|++++.+++|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 8889999998874 7889999885421 1 122457889999999998875 6677664332
Q ss_pred C---eeEEEEeccCC-CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 752 D---FRALVLELMPN-GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 752 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
. ..++||||++| .+|.+++.... ++.. .+.++++++.+|| +.||+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 69998886532 4433 3678999999999 899999999999999999999999999
Q ss_pred cccccc
Q 036011 828 GLSKLF 833 (977)
Q Consensus 828 gla~~~ 833 (977)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-15 Score=165.64 Aligned_cols=175 Identities=31% Similarity=0.501 Sum_probs=105.8
Q ss_pred cCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEE
Q 036011 396 LEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVN 475 (977)
Q Consensus 396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 475 (977)
+..-...||+.|++. .+|..++.+..|+.+.|+.|.+. .+|.++.++..|++|||+.|+++ ..|..++.++ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 333445556666665 55666666666666666666665 55666666666666666666666 4555555443 56666
Q ss_pred ccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCC
Q 036011 476 LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 476 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.+++.| .|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 6666665 45666666666666666666665 55666666666666666666666 345555533 3666666666666
Q ss_pred CCCcccccccccCccccCCCcccc
Q 036011 556 EIPKSLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 556 ~~p~~~~~l~~L~~L~l~~N~l~~ 579 (977)
.+|-.|.+|..|++|-|.+|+|..
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCC
Confidence 566666666666666666666654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.3e-14 Score=166.27 Aligned_cols=118 Identities=38% Similarity=0.587 Sum_probs=95.4
Q ss_pred ccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccC
Q 036011 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVS 573 (977)
Q Consensus 494 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 573 (977)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46788888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCcccccCCCCCC--CCcCCCCCcccCccccCCCccCCCCCC
Q 036011 574 HNKLEGEIPANGP--FKYFAPQSFSWNYALCGPTTLQVPPCR 613 (977)
Q Consensus 574 ~N~l~~~~p~~~~--~~~~~~~~~~~n~~lcg~~~~~~~~~~ 613 (977)
+|+++|.+|..-. +.......+.+|+.+||.|. ++.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 8888888886321 12233456789999999763 45675
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.7e-15 Score=161.34 Aligned_cols=196 Identities=31% Similarity=0.498 Sum_probs=165.1
Q ss_pred ccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCee
Q 036011 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLREL 450 (977)
Q Consensus 371 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 450 (977)
.+..-...+|+.|++. .+|..+..+-.|+.+.|..|.|. .+|..++++..|+.|+|+.|+++ ..|..+..++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3455566788888888 78888888888888999999888 88888999999999999999998 7787787776 8999
Q ss_pred ecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc
Q 036011 451 NLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530 (977)
Q Consensus 451 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 530 (977)
-+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|..++.| .|..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 99999999 78888888889999999999998 68888999999999999999998 778888855 5889999999999
Q ss_pred ccccccccCccccCeeeccCCccCCCCCcccc---cccccCccccCCCc
Q 036011 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLE---ALLFLKQLNVSHNK 576 (977)
Q Consensus 531 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~N~ 576 (977)
.+|-.|.+|+.|++|-|.+|.|+ ..|..+. ...-.++|+..-++
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 78999999999999999999998 6676653 33445677776664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.7e-13 Score=150.90 Aligned_cols=141 Identities=21% Similarity=0.247 Sum_probs=101.3
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchhhH----------------------------------------HHHHH
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAF----------------------------------------RSFDS 728 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 728 (977)
+.||.|++|.||+|+.++|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421100 02455
Q ss_pred HHHHHHhcC----CCCcceEeeee-ecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHH-HHHHHHhcCCC
Q 036011 729 ECEVLRNVR----HRNLIKIFSSC-CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVAL-ALEYLHHGHST 802 (977)
Q Consensus 729 e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~LH~~~~~ 802 (977)
|++.+.+++ |..-+.+-.++ ......++||||++|++|.++........ .+.+++..++. .+..+| ..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---RD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---hC
Confidence 666666652 32223333333 23445789999999999988765322112 23456666666 466777 79
Q ss_pred CeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 803 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
|++|+|++|.||++++++.++++|||++..+.+
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.5e-13 Score=153.78 Aligned_cols=198 Identities=36% Similarity=0.551 Sum_probs=149.5
Q ss_pred EEEeecCccCCCCChhhhccCCCCEEEeecccccCcccccccccc-ccceeeecCCccCCCchhhhcCCCCCCeeecCCC
Q 036011 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE-RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSN 455 (977)
Q Consensus 377 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 455 (977)
.+.+..|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666666664 34445555677888888888887 5666666664 7888888888887 56667778888888888888
Q ss_pred cCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccc
Q 036011 456 KFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ 535 (977)
Q Consensus 456 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 535 (977)
++. .+|...+..++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+..+..+.++..|.+++|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 888 55655557788888888888888 56666566667888888888654 56777888888888888888887 4477
Q ss_pred cccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCC
Q 036011 536 TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 536 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
.++.+++|+.|++++|+++ .++. +..+.+++.|++++|.++..+|.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 7888888888888888888 4444 78888888888888888877664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=149.44 Aligned_cols=197 Identities=35% Similarity=0.448 Sum_probs=114.8
Q ss_pred CEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcC-cccceeccccccccccCccccCccccceeeeec
Q 036011 101 RFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLS-RLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY 179 (977)
Q Consensus 101 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~ 179 (977)
..|+++.|.+. .-+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 35667777664 23334455566777777777777 5555555553 6667777777666 5555666777777777777
Q ss_pred ccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeee
Q 036011 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG 259 (977)
Q Consensus 180 n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 259 (977)
|+++ .+|...+.+++|+.|++++|++. .+|........|++|.+++|.+.. . ......+.++..|.+.+|++.
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~---~-~~~~~~~~~l~~l~l~~n~~~- 245 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE---L-LSSLSNLKNLSGLELSNNKLE- 245 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCccee---c-chhhhhcccccccccCCceee-
Confidence 7776 56655556677777777777776 344433344445555555553210 1 122334555555556666665
Q ss_pred cCCcccccccccceEeecccccccccccccccccccccccccccccCCCC
Q 036011 260 TIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDS 309 (977)
Q Consensus 260 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 309 (977)
.++..+..++++++|++++|+++.+.+ ++.+.+|+.|++++|.+....
T Consensus 246 ~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 246 DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccc
Confidence 334555555666666666666664422 555566666666666555543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.2e-13 Score=134.24 Aligned_cols=208 Identities=24% Similarity=0.233 Sum_probs=144.1
Q ss_pred CccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCC-ccCCCchhhhcCC
Q 036011 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGN-KLSGPIPQCLASL 444 (977)
Q Consensus 366 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l 444 (977)
|-.+..+++|..+.++.+.-. .+-+-...-+.|+++...+..++. .| .+-....+....-+.- -..|..-..+..-
T Consensus 207 ~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTW 283 (490)
T KOG1259|consen 207 SFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTW 283 (490)
T ss_pred ccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchH
Confidence 334455566666666665433 222222233567777776665542 11 1111222211111111 1122222223333
Q ss_pred CCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceecc
Q 036011 445 ISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSL 524 (977)
Q Consensus 445 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 524 (977)
..|+++|||+|.|+ .+.++..-+++++.|++|+|.|... +.+..+.+|+.||||+|.++ .+..+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 56899999999999 6788888899999999999999833 45899999999999999998 67777778999999999
Q ss_pred CCccccccccccccCccccCeeeccCCccCCC-CCcccccccccCccccCCCcccccCC
Q 036011 525 ASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE-IPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 525 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
++|.|... ..++++-+|..||+++|+|... -...++++|-|+.+.|.+|++.+.+-
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999843 5678889999999999999742 23578999999999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.1e-12 Score=140.66 Aligned_cols=249 Identities=22% Similarity=0.237 Sum_probs=181.6
Q ss_pred cCCCcCccccC--cceEEEEEEEe--C-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGR--GSFGSVYKGTF--S-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
..|.+.+.+|. |.+|.||.+.. . ++..+|+|+-+.... .....=.+|+..-+.+ .|++.++.+..+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566778999 99999999986 3 688999998443322 2222334566666666 499999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeeccc
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVAL----ALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGL 829 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgl 829 (977)
++-+|++. .++.++.+.....++....+.+..+..+ |++++| +.+++|-|+||.||+..++ ..++++|||+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 99999995 7999998887777888888889988888 999999 8999999999999999999 8999999999
Q ss_pred ccccCCCCCcceee---ccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 830 SKLFDEGDDSVTQT---MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 830 a~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
...+..+....... ...|...|++||... +.++.++|+|++|.+..+..++..++...-. ..|..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~------ 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQ------ 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----CCccc------
Confidence 99887655322211 124677899999754 5688999999999999999998766432100 01110
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
++....... .......++...+..+++.+|..|++.+++..
T Consensus 338 ----~r~~~ip~e----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ----LRQGYIPLE----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----cccccCchh----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 001010000 00011122334788899999999999887754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.9e-12 Score=129.36 Aligned_cols=203 Identities=18% Similarity=0.254 Sum_probs=139.0
Q ss_pred HHHHhcCCCCcceEeeeeecCC-----eeEEEEeccCCCCHHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036011 731 EVLRNVRHRNLIKIFSSCCNND-----FRALVLELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHST 802 (977)
Q Consensus 731 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 802 (977)
.-+-++-|-|||+++.|+.+.. ...+++|||..|++.+++++.. ..+......+|..||..||.|||. +.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3444557999999999986543 4678999999999999998643 257778888999999999999994 468
Q ss_pred CeEeCCCCCCceeeCCCCceEEeecccccccCCCC---CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHh
Q 036011 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD---DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879 (977)
Q Consensus 803 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 879 (977)
.|+|+++.-+-|++..+|-+|++----.. ..... .........+-++|.|||.......+.++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999999875221111 11110 111112234678999999988888888999999999999998
Q ss_pred cCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 036011 880 TRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957 (977)
Q Consensus 880 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L 957 (977)
-+..--.... ... .+.+.... .+....... =...+.+|++..|..||+|.+++.+.
T Consensus 277 ilEiq~tnse-S~~----~~ee~ia~--------~i~~len~l---------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSE-SKV----EVEENIAN--------VIIGLENGL---------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCc-cee----ehhhhhhh--------heeeccCcc---------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 8764311100 000 00000000 000000000 13467899999999999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=130.75 Aligned_cols=166 Identities=17% Similarity=0.176 Sum_probs=129.3
Q ss_pred eCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHH
Q 036011 704 FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL 783 (977)
Q Consensus 704 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 783 (977)
..++.+|.|.+++.......+...+-++.++.++||+|+++++.++.++..|+|+|-+. .|..+++..+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34788899988876655444567788899999999999999999999999999999984 6777776633 56677
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcC
Q 036011 784 NIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863 (977)
Q Consensus 784 ~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 863 (977)
..+.||+.||.+||+ ..+++|++|.-..|+|++.|+.||++|.++........ ......--..|..|+......
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 789999999999996 67899999999999999999999999998865432221 011111223466776543332
Q ss_pred cccchhhHhHHHHHHhcC
Q 036011 864 SKCDVYSYGVLLTETFTR 881 (977)
Q Consensus 864 ~~~DvwslG~il~elltg 881 (977)
-..|.|.||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.8e-11 Score=120.55 Aligned_cols=131 Identities=18% Similarity=0.217 Sum_probs=96.8
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcc-eEeeeeecCCeeEEEEeccCCCCH
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI-KIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
++.++.|.++.||+++.. ++.|++|+...... ....+.+|+++++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 457899999999999874 78899999764432 233568899999998655544 444443 2345799999999887
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH--STPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
.+. . .....++.+++++++.||... ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 112345788999999999422 22369999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-11 Score=139.72 Aligned_cols=145 Identities=16% Similarity=0.177 Sum_probs=95.1
Q ss_pred CCCcCccccCcceEEEEEEEeCC-CCEEEEEEeeccchhh----------------------------------HH----
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRA----------------------------------FR---- 724 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~---- 724 (977)
.|+. +.||+|++|.||+|+.++ |+.||||+.+...... .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 789999999999999887 9999999987542110 01
Q ss_pred --HHHHHHHHHHhcC----CCCcceEeeeeec-CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHH-HHHH
Q 036011 725 --SFDSECEVLRNVR----HRNLIKIFSSCCN-NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA-LEYL 796 (977)
Q Consensus 725 --~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~L 796 (977)
+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-.....+.. .++...++. +..+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Qi 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQV 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHHH
Confidence 1344555555442 3444444443332 445679999999999987532111112211 222222221 2223
Q ss_pred HhcCCCCeEeCCCCCCceeeCCCC----ceEEeecccccccCC
Q 036011 797 HHGHSTPVVHCDLKPSNILLDEDM----VAHVSDFGLSKLFDE 835 (977)
Q Consensus 797 H~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~~~ 835 (977)
. ..|++|+|++|.||+++.++ .+++.|||++..+.+
T Consensus 277 f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 68999999999999999888 999999999987754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.8e-12 Score=133.72 Aligned_cols=206 Identities=27% Similarity=0.301 Sum_probs=143.1
Q ss_pred cccccccEEEeecCccCCCCC--hhhhccCCCCEEEeecccccCccc--cccccccccceeeecCCccCCCchhh-hcCC
Q 036011 370 GNLRSLIVLSLFINALNGTIP--STVGRLEQLQGLSLYGNNLEGSIP--YDLCHLERLNGIRLNGNKLSGPIPQC-LASL 444 (977)
Q Consensus 370 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l 444 (977)
.++.+|++..|.+..+. ..+ .....+++++.|||+.|-+....+ .....+++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46778888888888776 333 467788889999999988875433 33456888888888888886333222 1245
Q ss_pred CCCCeeecCCCcCCCC-CCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcc--hhhhcccccce
Q 036011 445 ISLRELNLGSNKFSSS-IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIP--ITIGSLKDLVT 521 (977)
Q Consensus 445 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~ 521 (977)
++|+.|.|++|.++.. +......+++|+.|+|..|....+-......++.|++|||++|++- ..+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 6788888988888732 1223446788888889888643344455666788899999998886 344 45778888888
Q ss_pred eccCCcccccc-cccc-----ccCccccCeeeccCCccCCCCC--cccccccccCccccCCCccc
Q 036011 522 LSLASNQFEGP-IPQT-----FGSLTGLESLDLSNNNLSGEIP--KSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 522 L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~ 578 (977)
|+++.+.++.. .|+. ....++|++|++++|++. ..+ ..+..+++|+.|.+..|.++
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhccccccc
Confidence 88888888753 2333 345678888888888885 222 34555667777777777765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.6e-10 Score=111.64 Aligned_cols=136 Identities=21% Similarity=0.187 Sum_probs=98.8
Q ss_pred ccccCcceEEEEEEEeCC-------CCEEEEEEeeccc------------h----------hhHHH----HHHHHHHHHh
Q 036011 689 NLLGRGSFGSVYKGTFSD-------GTSFAIKVFNLQL------------D----------RAFRS----FDSECEVLRN 735 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~~ 735 (977)
..||.|.-+.||.|...+ +..+|||+++... + ..... .++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998543 4799999875321 0 00112 2389999999
Q ss_pred cCC--CCcceEeeeeecCCeeEEEEeccCCCCHH-HHhhcCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeCCCCC
Q 036011 736 VRH--RNLIKIFSSCCNNDFRALVLELMPNGSLE-KWLYSDNYFLDLLERLNIMIGVALALEYL-HHGHSTPVVHCDLKP 811 (977)
Q Consensus 736 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~ 811 (977)
+.. -++.+++++ ...++||||+.++.+. ..++.. .++......+..+++.++..+ | +.|+||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 853 455566654 4567999999765442 222221 245556677889999999999 6 78999999999
Q ss_pred CceeeCCCCceEEeecccccccC
Q 036011 812 SNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 812 ~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
.||+++ ++.++++|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3e-12 Score=135.17 Aligned_cols=142 Identities=23% Similarity=0.247 Sum_probs=93.4
Q ss_pred Cccccceeeeecccccc-cCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCC-ccccCCC
Q 036011 168 NLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPP-KVSYSLP 245 (977)
Q Consensus 168 ~l~~L~~L~L~~n~i~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~~~~l~ 245 (977)
.+++|+.|.|+.|.++. .+...+..+++|+.|+|..|..-........-++.|+.|||++|++-. ++. -....++
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~---~~~~~~~~~l~ 271 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID---FDQGYKVGTLP 271 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc---ccccccccccc
Confidence 45678888888888873 223345667888888888885333333344456778888888887752 221 1234578
Q ss_pred CceEEEecCceeeecC-Ccc-----cccccccceEeeccccccccc-ccccccccccccccccccccCCCCCCc
Q 036011 246 NLRVFSLGKNKLTGTI-PNS-----ITNASKLTGLDLSFNSFSGLI-PHTFGNLRFLSVLNLANNYLTTDSPTA 312 (977)
Q Consensus 246 ~L~~L~L~~N~l~~~~-p~~-----l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~ 312 (977)
.|+.|+++.+.+..+- |+. ...+++|++|+++.|+|.... -..+..+++|+.|.+..|.++.....+
T Consensus 272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~~~a 345 (505)
T KOG3207|consen 272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKETDTA 345 (505)
T ss_pred chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccccccce
Confidence 8888888888887432 222 355678888888888885321 134555678888888888887765544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-11 Score=124.14 Aligned_cols=141 Identities=24% Similarity=0.340 Sum_probs=95.9
Q ss_pred cccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCc
Q 036011 160 GNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK 239 (977)
Q Consensus 160 ~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 239 (977)
|..-..+...+.|++|+|++|.|+ .+..+..-++.++.|++|.|.|... ..+..+.+|+.||||+|.++... .
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~----G 346 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECV----G 346 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhh----h
Confidence 333444455566777777777777 6666777777777777777777632 23666677777777777766332 2
Q ss_pred cccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccc-ccccccccccccccccccccCCCC
Q 036011 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI-PHTFGNLRFLSVLNLANNYLTTDS 309 (977)
Q Consensus 240 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~ 309 (977)
.-.++.|.++|.|+.|.|.. -+.+..+-+|..||+++|+|.... -..+++++-|+.|.|.+|.+..++
T Consensus 347 wh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 347 WHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 22356778888888888773 245777788888888888886432 355777888888888888877654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.1e-12 Score=130.84 Aligned_cols=192 Identities=19% Similarity=0.231 Sum_probs=96.4
Q ss_pred cccccCCCCceEEecCCCCCCCCCccccccc---ccccccccccCcccccC-------------CccccccccccEEEee
Q 036011 318 SSLTNCRNLTTLAVASNPLRGILPPVIGNFS---ASLQNFYAYDCKLTGNI-------------PHEIGNLRSLIVLSLF 381 (977)
Q Consensus 318 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~---~~L~~L~l~~n~l~~~~-------------p~~~~~l~~L~~L~L~ 381 (977)
+.+..+++|+.|+||+|-+....+..+..+- ..|++|++.||.+...- ......-+.|+++..+
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~ 165 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICG 165 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEee
Confidence 3455556666666666666544444433222 24555555555554211 1122334556666666
Q ss_pred cCccCCCC----ChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcC
Q 036011 382 INALNGTI----PSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKF 457 (977)
Q Consensus 382 ~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 457 (977)
+|++.... ...|...+.|+.+.++.|.|...-. ..+...+..+++|++|||..|-|
T Consensus 166 rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~--------------------~al~eal~~~~~LevLdl~DNtf 225 (382)
T KOG1909|consen 166 RNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGV--------------------TALAEALEHCPHLEVLDLRDNTF 225 (382)
T ss_pred ccccccccHHHHHHHHHhccccceEEEecccccCchh--------------------HHHHHHHHhCCcceeeecccchh
Confidence 66654221 2234445556666666665541100 01223444555555555555554
Q ss_pred CCC----CCccccCcccCceEEccCCCCCCCCcccc-----ccccccCeeeCcCCcCCC----Ccchhhhcccccceecc
Q 036011 458 SSS----IPSSFWSLEYLLAVNLSSNSLSGSLPSNI-----QNLQVLINLDLSRNQLSG----DIPITIGSLKDLVTLSL 524 (977)
Q Consensus 458 ~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L 524 (977)
+.. +...++.++.|+.|+++++.++..-..+| ...++|+.|.|.+|.++. .+...+...+.|..|+|
T Consensus 226 t~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnL 305 (382)
T KOG1909|consen 226 TLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNL 305 (382)
T ss_pred hhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcC
Confidence 421 12234445555555555555543222211 124567777777777763 22334556777888888
Q ss_pred CCccc
Q 036011 525 ASNQF 529 (977)
Q Consensus 525 s~N~l 529 (977)
++|++
T Consensus 306 ngN~l 310 (382)
T KOG1909|consen 306 NGNRL 310 (382)
T ss_pred Ccccc
Confidence 88887
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.1e-12 Score=143.62 Aligned_cols=199 Identities=29% Similarity=0.307 Sum_probs=96.6
Q ss_pred cccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCch-hhhcCCCCCC
Q 036011 370 GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLR 448 (977)
Q Consensus 370 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~ 448 (977)
..+++|++|++++|.|+... .+..++.|+.|++++|.|+ ....+..+..|+.+++++|++...-+ . ...+.+|+
T Consensus 115 ~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~--~~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~ 189 (414)
T KOG0531|consen 115 SSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS--DISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLE 189 (414)
T ss_pred hhhhcchheecccccccccc--chhhccchhhheeccCcch--hccCCccchhhhcccCCcchhhhhhhhh-hhhccchH
Confidence 34555555555555554222 2334444666666666665 22234445666666666666653322 1 34555666
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCcccccccc--ccCeeeCcCCcCCCCcchhhhcccccceeccCC
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ--VLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 526 (977)
.+++++|.+.. ...+..+..+..+++..|.++... .+..+. .|+.+++++|++. ..+..+..+.++..|++++
T Consensus 190 ~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~ 264 (414)
T KOG0531|consen 190 ELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSS 264 (414)
T ss_pred HHhccCCchhc--ccchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhh
Confidence 66666666552 222333444444455555555221 111122 2556666666665 3334455555555566666
Q ss_pred ccccccccccccCccccCeeeccCCccCCC---CCcc-cccccccCccccCCCccccc
Q 036011 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSGE---IPKS-LEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 527 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~l~~N~l~~~ 580 (977)
|++... ..+.....+..+.++.|++... .... ....+.++.+.+.+|+....
T Consensus 265 n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 265 NRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred cccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccc
Confidence 555532 2234444555555555555421 1111 33444555555555555443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.3e-12 Score=142.13 Aligned_cols=251 Identities=28% Similarity=0.353 Sum_probs=180.6
Q ss_pred cCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccc
Q 036011 71 GNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEK 150 (977)
Q Consensus 71 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 150 (977)
..+..++.+++..|.+.. +-..+..+++|++|+|.+|+|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 356777778888888876 4455888889999999999888 5555577888999999999998854 45667777888
Q ss_pred eeccccccccccCccccCccccceeeeecccccccCCcc-ccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCc
Q 036011 151 WDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE-IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQ 229 (977)
Q Consensus 151 L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~-l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 229 (977)
|++++|.|. -...+..++.|+.+++++|++.. +... +..+.+|+.++++.|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~--~~~~~~~l~~L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLIS--DISGLESLKSLKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcch--hccCCccchhhhcccCCcchhhh-hhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 999999886 23445668889999999999984 3332 57788899999999988733 344555566666888888
Q ss_pred ccccccCCCccccCCC--CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCC
Q 036011 230 LSGHLDLPPKVSYSLP--NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307 (977)
Q Consensus 230 l~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 307 (977)
++....++ .+. .|+.+++++|++. ..+..+..+..+..|++++|++... ..+...+.+..+.+..|.+..
T Consensus 220 i~~~~~l~-----~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 220 ISKLEGLN-----ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred ceeccCcc-----cchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcc
Confidence 87443222 223 3888999999988 4446677888889999999988765 346667778888888888764
Q ss_pred CCCCchhhhhcccccCCCCceEEecCCCCCCCCC
Q 036011 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341 (977)
Q Consensus 308 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 341 (977)
..... -.......+.++.+.+..|++....+
T Consensus 292 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 292 SEAIS---QEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhhhh---ccccccccccccccccccCccccccc
Confidence 32111 00114566778888888887776544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.4e-11 Score=115.86 Aligned_cols=125 Identities=30% Similarity=0.393 Sum_probs=45.5
Q ss_pred cCCCCCCeeecCCCcCCCCCCcccc-CcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhh-hccccc
Q 036011 442 ASLISLRELNLGSNKFSSSIPSSFW-SLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI-GSLKDL 519 (977)
Q Consensus 442 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L 519 (977)
.+..++++|+|++|+|+. +. .+. .+.+|+.|+|++|.|+.. +.+..++.|++|++++|+|+ .++..+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred cccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 344467778888888773 32 344 467788888888888743 35777888888888888887 454444 467888
Q ss_pred ceeccCCccccccc-cccccCccccCeeeccCCccCCCCCc----ccccccccCcccc
Q 036011 520 VTLSLASNQFEGPI-PQTFGSLTGLESLDLSNNNLSGEIPK----SLEALLFLKQLNV 572 (977)
Q Consensus 520 ~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~l 572 (977)
+.|+|++|+|...- -..+..+++|+.|+|.+|.++.. +. -+..+|+|+.||-
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 88888888887431 13456678888888888888733 32 2456777777764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.7e-10 Score=105.38 Aligned_cols=131 Identities=23% Similarity=0.279 Sum_probs=102.6
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+++|+-+.+|.+.+. |.++++|.-..+. .-...+..+|++++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 4457777533221 11234567899999999876766666666777888899999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
++|..|.+.+... ...++..+-.-+.-|| ..||||||+.++||.+..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888664 2456777778888899 89999999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=103.51 Aligned_cols=142 Identities=20% Similarity=0.250 Sum_probs=107.9
Q ss_pred cCccccCcceEEEEEEEeCCCCEEEEEEe-eccc-------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 687 ECNLLGRGSFGSVYKGTFSDGTSFAIKVF-NLQL-------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
....+-+|+-++|+++.+ .|+.+.||.- .+.- .-...+..+|++.+.+++--.|....-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 5777777743 2221 112456788999999997666666666667777778999
Q ss_pred eccCC-CCHHHHhhcCCcc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceEEeecccccc
Q 036011 759 ELMPN-GSLEKWLYSDNYF-LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAHVSDFGLSKL 832 (977)
Q Consensus 759 e~~~~-gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~ 832 (977)
||++| -++.+++...-.. ........++..|-+.+.-|| ..+|+|||+..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4778887754332 223333688999999999999 88999999999999997554 468999999864
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.1e-12 Score=131.67 Aligned_cols=136 Identities=26% Similarity=0.312 Sum_probs=102.3
Q ss_pred CCCCCCeeecCCCcCCCCCC----ccccCcccCceEEccCCCCCC----CCccccccccccCeeeCcCCcCCC----Ccc
Q 036011 443 SLISLRELNLGSNKFSSSIP----SSFWSLEYLLAVNLSSNSLSG----SLPSNIQNLQVLINLDLSRNQLSG----DIP 510 (977)
Q Consensus 443 ~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p 510 (977)
.-+.|+++..++|++..... ..|...+.|+.+.+++|.|.. .+...|..+++|+.|||..|-++. .+.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 34578888888888874322 345666788888888888762 234568889999999999998874 234
Q ss_pred hhhhcccccceeccCCccccccccccc-----cCccccCeeeccCCccCC----CCCcccccccccCccccCCCccc
Q 036011 511 ITIGSLKDLVTLSLASNQFEGPIPQTF-----GSLTGLESLDLSNNNLSG----EIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 511 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
..+..++.|+.|++++|.++..-..+| ...++|+.|+|.+|.|+. .+...+...+.|..|+|++|.+.
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 567788999999999999985543333 236899999999999984 23445667899999999999984
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.4e-11 Score=143.74 Aligned_cols=128 Identities=25% Similarity=0.257 Sum_probs=86.4
Q ss_pred cEEEEEcCCCCCCccCCccccCcccccEeeccCCc--ccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEe
Q 036011 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNN--FHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILS 128 (977)
Q Consensus 51 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 128 (977)
.++...+-++.+. .++.+.. .+.|++|-+..|. +....++.|..++.|++|||++|.=-+.+|.+++.|-+|+||+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 3555555566554 3333332 2367777777775 4443444567788888888887765557888888888888888
Q ss_pred ccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccc
Q 036011 129 LRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNN 181 (977)
Q Consensus 129 L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 181 (977)
|+++.++ .+|.++.+|+.|.+|++.++.-...+|..+..+++|++|.+..-.
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 8888777 777777777777777777776655556666667777777776554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=114.09 Aligned_cols=142 Identities=23% Similarity=0.222 Sum_probs=111.2
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCC--CcceEeeeeecC---CeeEEEEeccC
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHR--NLIKIFSSCCNN---DFRALVLELMP 762 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 762 (977)
+.++.|.++.||+++..+|+.+++|+...... .....+.+|+++++.+++. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999764432 1345789999999999753 456777776654 25689999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG------------------------------------------- 799 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 799 (977)
|.++.+.+.. ..++......++.++++++++||+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988775532 2367778888899999999999842
Q ss_pred ----------CCCCeEeCCCCCCceeeCC--CCceEEeecccccc
Q 036011 800 ----------HSTPVVHCDLKPSNILLDE--DMVAHVSDFGLSKL 832 (977)
Q Consensus 800 ----------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~ 832 (977)
....++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.2e-11 Score=115.96 Aligned_cols=39 Identities=36% Similarity=0.516 Sum_probs=5.8
Q ss_pred CCCCCCCEEeCcCccCCCCCCcccc-ccccCcEEeccCcCCC
Q 036011 95 GQLRRLRFISLDYNEFSGSFPSWIG-VLSKLQILSLRNNSFT 135 (977)
Q Consensus 95 ~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~ 135 (977)
.+..++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.++
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~ 55 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT 55 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc
Confidence 34445566666666555 332 233 3455555555555555
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-10 Score=129.40 Aligned_cols=249 Identities=20% Similarity=0.156 Sum_probs=173.6
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC--CCCEEEEEEeeccchhhHHH--HHHHHHHHHhc-CCCCcceEeeeeecCCe
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS--DGTSFAIKVFNLQLDRAFRS--FDSECEVLRNV-RHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 753 (977)
.....+|..+..||.|.|+.|++...+ ++..|++|...........+ -..|+.+...+ .|.++++++..|...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567889999999999999988643 67889999765543322222 23455555555 59999999888888888
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeecccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKL 832 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~ 832 (977)
.|+--||+++++......- ...++...++++..|++.++.++| +..++|+|+||+||++..+ +..+++|||.+..
T Consensus 341 ~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 8899999999988766522 223778889999999999999999 8999999999999999876 8899999999874
Q ss_pred cCCCCCcceeeccccCCccc--CccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 833 FDEGDDSVTQTMTIATIGYM--APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
+.-. .......-++. +|+......+..+.|++|||..+.|.+++.+--.. .. .| ..+
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~------~~---------~~i 475 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GV------QS---------LTI 475 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-cc------cc---------eee
Confidence 2211 11111223344 55566677889999999999999999998653211 00 01 000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHc
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~ 959 (977)
.... .+........+..+...+...++..||.+.+...+.+-
T Consensus 476 ~~~~-------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGD-------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eccc-------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0000 00001112345667777888899999998887665443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-09 Score=133.11 Aligned_cols=131 Identities=24% Similarity=0.323 Sum_probs=102.5
Q ss_pred CcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCcc--CCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCccc
Q 036011 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE--FSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLE 149 (977)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 149 (977)
+....+...+-+|.+.. ++.... .+.|++|-+..|. +....+..|..++.|++|||++|.--+.+|.++++|-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~~-~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIEH-IAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchhh-ccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 44778888888888866 443333 3379999999996 5533344578899999999999887778898898888888
Q ss_pred ceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccC
Q 036011 150 KWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNN 205 (977)
Q Consensus 150 ~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~ 205 (977)
+|++++..|. .+|..+++|+.|.+|++..+.-...+|..+..|++|++|.+-.-.
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 8888888888 888888888888888888887665666677778888888877554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-10 Score=132.58 Aligned_cols=206 Identities=25% Similarity=0.279 Sum_probs=150.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeecc---chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQ---LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
..+++.+.+-+.+|.++.++.++-. .|...+.|+.... .....+....+-.+.-..+||.+++...-+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4567788888999999999988643 3544555543322 12222333334344444456777776666556677889
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|++|..+++|..-++..+. .+..........+.++.+||| +..+.|+|++|.|++...++..++.|||......-.
T Consensus 882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 9999999999998887653 555556666777889999999 677999999999999999999999999844322110
Q ss_pred ---------------------C--------CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCc
Q 036011 837 ---------------------D--------DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDD 887 (977)
Q Consensus 837 ---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~ 887 (977)
. .........+|+.|.+||...+......+|.|+.|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00112224689999999999999999999999999999999999999976
Q ss_pred CCc
Q 036011 888 MFT 890 (977)
Q Consensus 888 ~~~ 890 (977)
...
T Consensus 1038 ~tp 1040 (1205)
T KOG0606|consen 1038 ETP 1040 (1205)
T ss_pred cch
Confidence 533
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.4e-08 Score=101.65 Aligned_cols=260 Identities=13% Similarity=0.051 Sum_probs=161.1
Q ss_pred cCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeee-------ecCCeeEEEE
Q 036011 687 ECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSC-------CNNDFRALVL 758 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~-------~~~~~~~lv~ 758 (977)
..+.||+|+.+.+|-.-- -...+.|++...-..... +-+..|... .||-+-.=+.+= .......++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 356799999999996532 223466777654322211 122333333 566443311110 1122356788
Q ss_pred eccCCCC-HHHHhhc-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 759 ELMPNGS-LEKWLYS-----DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 759 e~~~~gs-L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
+.+++-. ...+... .-...+|...+++++.+|.+.+.|| ..|.+-||+.++|+|+.+++.+.++|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 8876642 2222221 1114789999999999999999999 78999999999999999999999998654433
Q ss_pred cCCCCCcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcC-CCCCCcCCccc---ccHH-HHHHhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGE---MSLK-KWVKES 902 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~---~~~~-~~~~~~ 902 (977)
.. ........+|...|.+||.-. +..-+..+|-|.+|+++++++.| ++||.+..... ..++ +.....
T Consensus 167 ~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred cc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 223344567999999999643 44456789999999999999887 99998753321 1111 111111
Q ss_pred CCCchhhhcchhhhcc-ccCchHHHHHHHHHHHHHHHhhcC--CCCCCCCHHHHHHHHHchh
Q 036011 903 LPHGLMEVVDTNLLRQ-EHTSSAEMDCLLSVLHLALDCCME--SPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~--~P~~RPs~~ev~~~L~~~~ 961 (977)
+ ...-+...-.. ..........+..+.-+..+|+.. .+.-|||++..+..|..++
T Consensus 244 f----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 244 F----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred e----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 1 11111111111 111222334555666777888865 3568999999888886654
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-09 Score=76.93 Aligned_cols=40 Identities=35% Similarity=0.755 Sum_probs=29.1
Q ss_pred HHHHHHHHHHHHhccCCCCCccCCCCCC--CCCCcccceEec
Q 036011 7 TTDQFALLAFKAHVTDPQSVLANNWSIS--QPICKWVGISCG 46 (977)
Q Consensus 7 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 46 (977)
++|++||++||+++.+++.....+|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 6899999999999995443344699986 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.1e-08 Score=97.48 Aligned_cols=126 Identities=22% Similarity=0.259 Sum_probs=83.4
Q ss_pred EEEEEEeCCCCEEEEEEeeccch--------------------------hhHHHHHHHHHHHHhcCCC--CcceEeeeee
Q 036011 698 SVYKGTFSDGTSFAIKVFNLQLD--------------------------RAFRSFDSECEVLRNVRHR--NLIKIFSSCC 749 (977)
Q Consensus 698 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 749 (977)
.||.|...+|..+|||+.+.... .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998754310 0123467899999999765 455666542
Q ss_pred cCCeeEEEEeccC--CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 750 NNDFRALVLELMP--NGSLEKWLYSDNYFLDLLERLNIMIGVALALEY-LHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 750 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
...+||||++ |..+..+.... ++......++.++...+.. +| ..||+|||+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3469999998 65555443322 1133455677777775555 46 8899999999999999988 999999
Q ss_pred cccccccC
Q 036011 827 FGLSKLFD 834 (977)
Q Consensus 827 fgla~~~~ 834 (977)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.3e-08 Score=102.29 Aligned_cols=140 Identities=14% Similarity=0.060 Sum_probs=100.3
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchh-----------hHHHHHHHHHHHHhcCCCCcc--eEeeeeec-----
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR-----------AFRSFDSECEVLRNVRHRNLI--KIFSSCCN----- 750 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv--~l~~~~~~----- 750 (977)
+.+-+.....|++... +|+.|.||+....... ....+.+|.+.+.++...+|. +++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 6789999987433211 111477899999888543333 33444432
Q ss_pred CCeeEEEEeccCCC-CHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-------CCc
Q 036011 751 NDFRALVLELMPNG-SLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-------DMV 821 (977)
Q Consensus 751 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-------~~~ 821 (977)
....++|||++++. +|.+++... ....+......++.+++..+.-|| ..||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999886 899987532 223556677899999999999999 899999999999999975 568
Q ss_pred eEEeecccccc
Q 036011 822 AHVSDFGLSKL 832 (977)
Q Consensus 822 ~kl~Dfgla~~ 832 (977)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=5e-09 Score=83.88 Aligned_cols=59 Identities=42% Similarity=0.562 Sum_probs=28.9
Q ss_pred ccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCc
Q 036011 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNN 552 (977)
Q Consensus 494 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 552 (977)
+|++|++++|+++...+..|..+++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555543333344455555555555555554444455555555555555554
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.8e-10 Score=126.98 Aligned_cols=126 Identities=30% Similarity=0.307 Sum_probs=75.8
Q ss_pred CCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcch-hhhcccccceeccC
Q 036011 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPI-TIGSLKDLVTLSLA 525 (977)
Q Consensus 447 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 525 (977)
|...+.+.|++. ....++.-++.|+.|+|++|+++.. +.+..++.|++|||++|.++ .+|. ....+ .|+.|+|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 555666666666 4555566666666666666666632 25666666777777777766 4443 22223 36677777
Q ss_pred CccccccccccccCccccCeeeccCCccCCCCC-cccccccccCccccCCCcccc
Q 036011 526 SNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIP-KSLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 526 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 579 (977)
+|.++.. ..+.+|.+|+.|||++|-|.+.-- .-+..|..|+.|+|.||++.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 7776632 345666777777777776664211 123456667777777777654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.9e-07 Score=100.46 Aligned_cols=166 Identities=20% Similarity=0.227 Sum_probs=126.6
Q ss_pred eEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeee----cCCeeEEEEeccCC-CCHHHH
Q 036011 696 FGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC----NNDFRALVLELMPN-GSLEKW 769 (977)
Q Consensus 696 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 769 (977)
-.+.|++..+ ||..|++|+++............-+++++++.|+|||++.+++. .+...++||+|+++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999854 89999999996554433333455688999999999999999886 34567899999876 466554
Q ss_pred hhc--------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 770 LYS--------------DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 770 l~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
--. .+...++...|.++.|+..||.++| +.|..-+-+.+++|+++++.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 321 1123678899999999999999999 89999999999999999999999998887766544
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCC
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK 883 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 883 (977)
... |-+.+ -.+-|.=.+|.+++.|.||..
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 320 11111 125688889999999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.2e-08 Score=97.30 Aligned_cols=135 Identities=22% Similarity=0.189 Sum_probs=98.4
Q ss_pred CCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch----------------------hhHHHHHHHHHHHHhcCCC--C
Q 036011 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD----------------------RAFRSFDSECEVLRNVRHR--N 740 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--n 740 (977)
+.+...||.|.-+.||.|..+.|.++|||.-+.... -.....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345578999999999999999999999996432210 1123467899999999654 5
Q ss_pred cceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC
Q 036011 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM 820 (977)
Q Consensus 741 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 820 (977)
|.+.+++ +...+||||++|-.|...- ++......++..|.+-+.-.- ..||||||+.+-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 6666654 4457999999997775432 123334445555555555555 58899999999999999999
Q ss_pred ceEEeecccccc
Q 036011 821 VAHVSDFGLSKL 832 (977)
Q Consensus 821 ~~kl~Dfgla~~ 832 (977)
.+.++||-.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999966553
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-08 Score=81.67 Aligned_cols=61 Identities=44% Similarity=0.644 Sum_probs=41.1
Q ss_pred CCceEEEecCceeeecCCcccccccccceEeeccccccccccccccccccccccccccccc
Q 036011 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305 (977)
Q Consensus 245 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 305 (977)
++|++|++++|+++...+..|..+++|++|++++|+++.+.|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655555666677777777777777766666677777777777766654
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2e-09 Score=96.06 Aligned_cols=134 Identities=23% Similarity=0.331 Sum_probs=90.0
Q ss_pred CCeeecCCCcCCCCCCcccc---CcccCceEEccCCCCCCCCccccc-cccccCeeeCcCCcCCCCcchhhhccccccee
Q 036011 447 LRELNLGSNKFSSSIPSSFW---SLEYLLAVNLSSNSLSGSLPSNIQ-NLQVLINLDLSRNQLSGDIPITIGSLKDLVTL 522 (977)
Q Consensus 447 L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 522 (977)
+..++|+++++- -++.... ....|+..+|++|.+.. .|..|. ..+.+++|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 344455555444 2333222 23345555666666663 344443 3347788888888888 778888888888888
Q ss_pred ccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCCC
Q 036011 523 SLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANG 585 (977)
Q Consensus 523 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 585 (977)
+++.|.|. ..|..+..|.+|-.||..+|.+. .+|-.+-.-+.....++.+++|.+..|...
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 88888888 67788888888888888888887 666655444455666778888888877643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-09 Score=122.33 Aligned_cols=182 Identities=27% Similarity=0.313 Sum_probs=117.2
Q ss_pred CccccccccCcEEeccCcCCCCCCCCcccCcC-cccceecccc--ccccccCccccCc------cccceeeeeccccccc
Q 036011 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLS-RLEKWDSMFN--IIDGNIPSRIGNL------SSLVNVNLAYNNLQGE 185 (977)
Q Consensus 115 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~n--~i~~~~p~~~~~l------~~L~~L~L~~n~i~~~ 185 (977)
|-.|..+.+|++|.|.++.+.. ..++..+. +|++|...+. .+...+....+.. -.|...+.++|.+. .
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~ 178 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L 178 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence 4445555566666666666552 23333332 3444433221 1111112222222 24778888899988 6
Q ss_pred CCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCccc
Q 036011 186 IPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI 265 (977)
Q Consensus 186 ~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 265 (977)
...++.-++.|+.|+|++|+++.. ..+..+..|+.|||+.|.++ .+|.....++. |..|.+++|.++.. ..+
T Consensus 179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~---~vp~l~~~gc~-L~~L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR---HVPQLSMVGCK-LQLLNLRNNALTTL--RGI 250 (1096)
T ss_pred HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc---cccccchhhhh-heeeeecccHHHhh--hhH
Confidence 777888888999999999998854 37778888888888888887 33433333333 88888888888832 457
Q ss_pred ccccccceEeeccccccccc-ccccccccccccccccccccCC
Q 036011 266 TNASKLTGLDLSFNSFSGLI-PHTFGNLRFLSVLNLANNYLTT 307 (977)
Q Consensus 266 ~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 307 (977)
.++.+|+.|||++|-|.+.- -..+..|..|++|+|.+|.+-.
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 78888899999999886431 1235667888888888888754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.1e-07 Score=106.34 Aligned_cols=141 Identities=18% Similarity=0.193 Sum_probs=96.7
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchhh------------------------------HH----------HHHH
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRA------------------------------FR----------SFDS 728 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 728 (977)
+.|+.++-|.||+|++++|+.||||+.+...... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999976542110 01 2445
Q ss_pred HHHHHHhcC-----CCCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 036011 729 ECEVLRNVR-----HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA-LEYLHHGHST 802 (977)
Q Consensus 729 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~LH~~~~~ 802 (977)
|+.-+.+++ .|.+.-.-=|++......++|||++|..+.+...-.....+.. .++..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHHHHHHHH---hc
Confidence 666665553 3443322223344566789999999999988743322334532 333333333 22233 47
Q ss_pred CeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 803 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
|+.|+|..|.||+++.+|.+.+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999987654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-08 Score=91.58 Aligned_cols=129 Identities=22% Similarity=0.212 Sum_probs=58.1
Q ss_pred CCEEEeecccccCcccccc---ccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEE
Q 036011 399 LQGLSLYGNNLEGSIPYDL---CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVN 475 (977)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 475 (977)
+..++|+.+++- .+++.. .....|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|..+..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 344455555543 233322 22233444455555554222222223334555555555555 3444455555555555
Q ss_pred ccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccc
Q 036011 476 LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531 (977)
Q Consensus 476 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 531 (977)
++.|.+. ..|..+..|.+|..||..+|.+. .+|..+-.-...-...+.++.+.+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 5555554 34444544555555555555554 344333222223333334444443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.2e-08 Score=109.71 Aligned_cols=151 Identities=17% Similarity=0.157 Sum_probs=101.6
Q ss_pred HHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce--eec-----cccCCcccCccccC
Q 036011 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT--QTM-----TIATIGYMAPEYGT 858 (977)
Q Consensus 786 ~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--~~~-----~~gt~~y~aPE~~~ 858 (977)
+.+++.|+.|+|. +.++||++|.|++|.++..+..|++.|+++........... ++. ......|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4445599999997 78999999999999999999999999999876554221111 111 12345799999999
Q ss_pred CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHH
Q 036011 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALD 938 (977)
Q Consensus 859 ~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 938 (977)
+...+.++|+||+|+.+|.+..|..+........... . ......+ ... .....+.+.++.+-+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~--~~~~~~~------~~~------~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-S--FSRNLLN------AGA------FGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh-h--hhhcccc------ccc------ccccccCcHHHHHHHHH
Confidence 9889999999999999999996655533222111100 0 0000000 000 00112345567778888
Q ss_pred hhcCCCCCCCCHHHH
Q 036011 939 CCMESPDQRIYMTDA 953 (977)
Q Consensus 939 cl~~~P~~RPs~~ev 953 (977)
.+..++..||++.++
T Consensus 248 ~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLL 262 (700)
T ss_pred HhcCCcccCcchhhh
Confidence 899999999977666
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=89.02 Aligned_cols=106 Identities=24% Similarity=0.253 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHhcCCCC--cceEeeeeecC----CeeEEEEeccCCC-CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHH
Q 036011 724 RSFDSECEVLRNVRHRN--LIKIFSSCCNN----DFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796 (977)
Q Consensus 724 ~~~~~e~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L 796 (977)
....+|.+.+..+.... +.+.+++.+.. ...++|||++++. +|.+++..... .+......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45778888888875333 34455555442 2457999999874 89999876433 56677889999999999999
Q ss_pred HhcCCCCeEeCCCCCCceeeCCCC---ceEEeeccccccc
Q 036011 797 HHGHSTPVVHCDLKPSNILLDEDM---VAHVSDFGLSKLF 833 (977)
Q Consensus 797 H~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 833 (977)
| ..||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 89999999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 977 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-40 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-37 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-40 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-37 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 4eco_A | 636 | Crystal Structure Of A Hypothetical Protein (Bacegg | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 2e-04 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 3e-04 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 3e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 5e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 6e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4ECO|A Chain A, Crystal Structure Of A Hypothetical Protein (Bacegg_03329) From Bacteroides Eggerthii Dsm 20697 At 2.70 A Resolution Length = 636 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = e-170
Identities = 180/580 (31%), Positives = 265/580 (45%), Gaps = 23/580 (3%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
L++S+ IP LG+ S L LDIS N + L+ +++ N+F G
Sbjct: 203 EFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRIGNLSS 171
P L LQ LSL N FTG IP+ L L D N G +P G+ S
Sbjct: 262 PIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 172 LVNVNLAYNNLQGEIPSE-IGNLQNLEILVLGMNNLSGPIQPSIFNIST-ITLINLFGNQ 229
L ++ L+ NN GE+P + + ++ L++L L N SG + S+ N+S + ++L N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 230 LSGHLDLPPKV-SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
SG + P + L+ L N TG IP +++N S+L L LSFN SG IP +
Sbjct: 380 FSGPI--LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFS 348
G+L L L L N L L + L TL + N L G +P + N +
Sbjct: 438 LGSLSKLRDLKLWLNMLE-------GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 349 ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN 408
+L + +LTG IP IG L +L +L L N+ +G IP+ +G L L L N
Sbjct: 491 -NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 409 LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSN--KFSSSIPSSFW 466
G+IP + + N ++G + + +E + N +F
Sbjct: 550 FNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605
Query: 467 SLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526
L N++S G N ++ LD+S N LSG IP IGS+ L L+L
Sbjct: 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665
Query: 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGP 586
N G IP G L GL LDLS+N L G IP+++ AL L ++++S+N L G IP G
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
Query: 587 FKYFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKASRN 626
F+ F P F N LCG + P A+ +++ +
Sbjct: 726 FETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHHH 765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 480 bits (1239), Expect = e-157
Identities = 164/592 (27%), Positives = 268/592 (45%), Gaps = 39/592 (6%)
Query: 6 LTTDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLR-- 63
L + L++FK + D ++L + WS ++ C + G++C R +V +++LS+ L
Sbjct: 10 LYREIHQLISFKDVLPDK-NLLPD-WSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVG 65
Query: 64 -GTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPS--WIGV 120
+ L + + L SL +S ++ + + L + L N SG + +G
Sbjct: 66 FSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGS 124
Query: 121 LSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRI---GNLSSLVNVN 176
S L+ L++ +N+ P S L+ LE D N I G L ++
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184
Query: 177 LAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDL 236
++ N + G++ + NLE L + NN S I P + + S + +++ GN+LSG
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDF-- 239
Query: 237 PPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT-FGNLRFL 295
+ + L++ ++ N+ G IP L L L+ N F+G IP G L
Sbjct: 240 -SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 296 SVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPP-VIGNFSASLQNF 354
+ L+L+ N+ P +C L +LA++SN G LP + L+
Sbjct: 297 TGLDLSGNHFYGAVP-------PFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVL 348
Query: 355 YAYDCKLTGNIPHEIGNLR-SLIVLSLFINALNGTIPSTVGR--LEQLQGLSLYGNNLEG 411
+ +G +P + NL SL+ L L N +G I + + LQ L L N G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 412 SIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471
IP L + L + L+ N LSG IP L SL LR+L L N IP ++ L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
Query: 472 LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531
+ L N L+G +PS + N L + LS N+L+G+IP IG L++L L L++N F G
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 532 PIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583
IP G L LDL+ N +G IP + +F + ++ N + G+
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAA----MFKQSGKIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-38
Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 10/197 (5%)
Query: 394 GRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLG 453
++ + S N ++ L L L + L+ + ++G + SL L+L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 454 SNKFSSSIPS--SFWSLEYLLAVNLSSNSLSGSLP-SNIQNLQVLINLDLSRNQLSGDIP 510
N S + + S S L +N+SSN+L S L L LDLS N +SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 511 ITI---GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFL 567
+ +L L+++ N+ G + LE LD+S+NN S IP L L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 568 KQLNVSHNKLEGEIPAN 584
+ L++S NKL G+
Sbjct: 226 QHLDISGNKLSGDFSRA 242
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-21
Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 25/145 (17%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
N+++ G P N +M LD+S N Y+P E+G + L ++L +N+ S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSS 171
GS P +G L L IL L +N G IP ++ L+
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAM------------------------SALTM 705
Query: 172 LVNVNLAYNNLQGEIPSEIGNLQNL 196
L ++L+ NNL G IP +G +
Sbjct: 706 LTEIDLSNNNLSGPIPE-MGQFETF 729
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-12
Identities = 29/92 (31%), Positives = 48/92 (52%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+ L++S L G IP +G+ +L L++ N+ +P+E+G LR L + L N+
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFTGPIPNS 141
G P + L+ L + L NN+ +GPIP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 318 bits (816), Expect = 2e-96
Identities = 109/558 (19%), Positives = 199/558 (35%), Gaps = 43/558 (7%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
+ S++ L +P L + + L+++ N + +L + + +N S
Sbjct: 9 ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
P L L++L+L++N + + + L + M N I + +L+
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSG--PIQPSIFNISTITLINLFGNQLSG 232
++L++N L L+NL+ L+L N + + IF S++ + L NQ+
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSIT---NASKLTGLDLSFNSFSGLIPHTF 289
P +++ L L +L ++ + + + L LS + S TF
Sbjct: 186 ---FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 290 GNLRF--LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGN- 346
L++ L++L+L+ N L S L + N ++ + +
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGN-------DSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 347 -------FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQL 399
S L L+ L L++ N + G + L L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 400 QGLSLYGNNLEGSIPYDL----CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSN 455
+ LSL + + L+ + L NK+S + L L L+LG N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 456 KFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG--DIPIT 512
+ + + LE + + LS N ++ + L L L R L P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 513 IGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS--------GEIPKSLEAL 564
L++L L L++N L LE LDL +NNL+ G L+ L
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 565 LFLKQLNVSHNKLEGEIP 582
L LN+ N +
Sbjct: 536 SHLHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-85
Identities = 108/578 (18%), Positives = 183/578 (31%), Gaps = 65/578 (11%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELG--QLRRLRFISLDYNEF 110
L+LS+ GL T L L +S N A EL L+ + L N+
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF---NLSRLEKWDSMFNIIDGNIPSRIG 167
P + +L L L N + L + + + + +
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 168 NL--SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINL 225
L ++L ++L+YNNL L LE L NN+ S+ + + +NL
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
+ + L L S L L++ N G+
Sbjct: 304 KRSFTKQSISL------------------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
+ F L L L+L+N++ + + T E SL + L L + N
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNE--TFVSLAH-SPLHILNLTKN----------- 391
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSL 404
K++ L L VL L +N + + LE + + L
Sbjct: 392 --------------KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437
Query: 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSG--PIPQCLASLISLRELNLGSNKFSSSIP 462
N + L + L L P L +L L+L +N ++
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497
Query: 463 SSFWSLEYLLAVNLSSNSLS--------GSLPSNIQNLQVLINLDLSRNQLSGDIPITIG 514
LE L ++L N+L+ G ++ L L L+L N
Sbjct: 498 DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557
Query: 515 SLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL-FLKQLNVS 573
L +L + L N F + L+SL+L N ++ K L +L++
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617
Query: 574 HNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPP 611
N + + F + ++ + L PP
Sbjct: 618 FNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-68
Identities = 96/546 (17%), Positives = 174/546 (31%), Gaps = 95/546 (17%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNF---SFLMSLDISKNNFHAYLPNELGQLR--RLRFIS 104
R+ L L+N+ L ++ L + + +L +S + L+ L +
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPS 164
L YN + L +L+ L N+ +SL L + + +
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS-------- 306
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLIN 224
+++ +L L+ LE L + N++ G + + ++
Sbjct: 307 -------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
Query: 225 LFGNQLSGHLDLPPKVSYSLPN--LRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFS 282
L + S L + SL + L + +L KNK++ ++ + L LDL N
Sbjct: 360 LSNSFTSL-RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 283 GLIP-HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
+ + L + + L+ N + +S +L L + L+ +
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTR-------NSFALVPSLQRLMLRRVALKNV-- 469
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQG 401
+ P LR+L +L L N + + LE+L+
Sbjct: 470 ---------------------DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508
Query: 402 LSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI 461
L L NNL RL + G L L L LNL SN F
Sbjct: 509 LDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552
Query: 462 PSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVT 521
F ++L L +DL N L+ + L +
Sbjct: 553 VEVF------------------------KDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 522 LSLASNQFEGPIPQTFG-SLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580
L+L N + FG + L LD+ N + ++ + + + +L
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
Query: 581 IPANGP 586
N P
Sbjct: 649 YLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-61
Identities = 87/386 (22%), Positives = 155/386 (40%), Gaps = 30/386 (7%)
Query: 219 TITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSF 278
+ + + +L+ +P + N+ V +L N+L + T S+LT LD+ F
Sbjct: 5 SHEVADCSHLKLT---QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 279 NSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338
N+ S L P L L VLNL +N L+ S + C NLT L + SN ++
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSD-------KTFAFCTNLTELHLMSNSIQK 111
Query: 339 ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLE- 397
I +L L+ L +L L L N + +
Sbjct: 112 IKNNPFVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 398 -QLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA---SLISLRELNLG 453
L+ L L N ++ P + RL G+ LN +L + + L + S+R L+L
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 454 SNKFSSSIPSSFWSLEY--LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPI 511
+++ S++ ++F L++ L ++LS N+L+ + L L L N +
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 512 TIGSLKDLVTLSLASN---------QFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLE 562
++ L ++ L+L + +F L LE L++ +N++ G
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
Query: 563 ALLFLKQLNVSHNKLEGEIPANGPFK 588
L+ LK L++S++ N F
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFV 376
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-48
Identities = 78/470 (16%), Positives = 148/470 (31%), Gaps = 93/470 (19%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYL---------PNELGQLRRLR 101
++ L ++ L + L++ ++ + L+ L
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 102 FISLDYNEFSGSFPSWIGVLSKLQILSLRNN--SFTGPIPNSLFNLSRLEKWDSMFNIID 159
++++ N+ G + L L+ LSL N+ S + +L+
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA------------- 379
Query: 160 GNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NIS 218
S L +NL N + L +LE+L LG+N + + + +
Sbjct: 380 ---------HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 219 TITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG--TIPNSITNASKLTGLDL 276
I I L N+ L +P+L+ L + L + P+ LT LDL
Sbjct: 431 NIFEIYLSYNKYLQ---LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
S N+ + + L L +L+L +N L A
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA------------------------ 523
Query: 337 RGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRL 396
G + + L L +L+L N + L
Sbjct: 524 ------------------------NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 397 EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA-SLISLRELNLGSN 455
+L+ + L NNL + L + L N ++ + + +L EL++ N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 456 KFSSSIPSSFWSLEYLLAVNLSSNSLSG----SLPSNIQNLQVLINLDLS 501
F + S W + ++ + + LS + P + + D S
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG-FPVRLFDTS 668
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = 1e-95
Identities = 107/551 (19%), Positives = 187/551 (33%), Gaps = 38/551 (6%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ L+LS LR +F L LD+S+ L L + L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFN-IIDGNIPSRIGNLS 170
LS LQ L + + +L L++ + N I +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNLEI----LVLGMNNLSGPIQPSIFNISTITLINLF 226
+L +++L+ N +Q +++ L + + L L +N ++ IQP F + + L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSL------GKNKLTGTIPNSITNASKLTGLDLSFNS 280
N S ++ L L V L + L +++ LT +
Sbjct: 209 NNFDSLNV--MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 281 ---FSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+ I F L +S +L + + + + L + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER---------VKDFSYNFGWQHLELVNCKFG 317
Query: 338 GILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALN--GTIPSTVGR 395
+ + G +L SL L L N L+ G +
Sbjct: 318 QFPTLKLKSLK------RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 396 LEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQ-CLASLISLRELNLGS 454
L+ L L N + + + LE+L + + L SL +L L++
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 455 NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI 513
+ F L L + ++ NS + +I L+ L LDLS+ QL P
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL-FLKQLNV 572
SL L L+++ N F + L L+ LD S N++ + L+ L LN+
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
Query: 573 SHNKLEGEIPA 583
+ N
Sbjct: 551 TQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-45
Identities = 80/460 (17%), Positives = 141/460 (30%), Gaps = 63/460 (13%)
Query: 48 RHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDY 107
+ R+ L L N + + L L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVM-----------------------KTCIQGLAGLEVHRLVL 234
Query: 108 NEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIG 167
EF + ++ G ++ + + +I
Sbjct: 235 GEFRNEG----------NLEKFDKSALEGLCNLTIEEFR-----LAYLDYYLDDIIDLFN 279
Query: 168 NLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFG 227
L+++ + +L ++ + L L + ++ +T + G
Sbjct: 280 CLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
Query: 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLT--GTIPNSITNASKLTGLDLSFNSFSGLI 285
LP+L L +N L+ G S + L LDLSFN +
Sbjct: 338 GNAFS--------EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
F L L L+ ++ L S S + RNL L ++ R +
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSE------FSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 346 NFSASLQNFYAYDCKLTGNIPHEI-GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404
S SL+ N +I LR+L L L L P+ L LQ L++
Sbjct: 443 GLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI-SLRELNLGSNKFSSSIPS 463
NN + L L + + N + Q L SL LNL N F+ +
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
Query: 464 S--FWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLS 501
++ + + + + PS+ Q + VL +L+++
Sbjct: 562 QSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL-SLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-36
Identities = 55/244 (22%), Positives = 90/244 (36%), Gaps = 10/244 (4%)
Query: 343 VIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGL 402
+ N S +N L + + L VL L + L L L
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
Query: 403 SLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS-SI 461
L GN ++ L L + L+ + L +L+ELN+ N S +
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 462 PSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ----VLINLDLSRNQLSGDIPITIGSLK 517
P F +L L ++LSSN + ++++ L + ++LDLS N ++ P ++
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201
Query: 518 DLVTLSLASNQFEGPIPQT-FGSLTGLESLDLSNNNLSGEI---PKSLEALLFLKQLNVS 573
L L+L +N + +T L GLE L E AL L L +
Sbjct: 202 -LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 574 HNKL 577
+L
Sbjct: 261 EFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 42/191 (21%), Positives = 72/191 (37%), Gaps = 6/191 (3%)
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS 458
+ L L N L Y L + L+ ++ SL L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQL-SGDIPITIGSLK 517
S +F L L + +L+ I +L+ L L+++ N + S +P +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGLE----SLDLSNNNLSGEIPKSLEALLFLKQLNVS 573
+L L L+SN+ + L + SLDLS N ++ P + + L +L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLR 208
Query: 574 HNKLEGEIPAN 584
+N +
Sbjct: 209 NNFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-27
Identities = 35/147 (23%), Positives = 58/147 (39%), Gaps = 3/147 (2%)
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
IP L S + L+L N SF+S L ++LS + Q+L L
Sbjct: 22 IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL-SG 555
L L+ N + L L L G L L+ L++++N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 556 EIPKSLEALLFLKQLNVSHNKLEGEIP 582
++P+ L L+ L++S NK++
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYC 166
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = 2e-94
Identities = 89/586 (15%), Positives = 178/586 (30%), Gaps = 106/586 (18%)
Query: 25 SVLANNWSISQPICKWV---GISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDI 81
+ NW+ ++ + W G+S + RV L+L G G +P +G + L L +
Sbjct: 54 TQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112
Query: 82 SKNNF----HAYLPNELGQLRRLRFISLDYNEFSGSFPSWIG--VLSKLQILSLRNNSFT 135
+ + P + + +F + S L + ++
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 136 GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQN 195
I S + NN+ + + L
Sbjct: 173 KSIKKS------------------------SRITLKDTQIGQLSNNI-TFVSKAVMRLTK 207
Query: 196 LEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKN 255
L +G + + +
Sbjct: 208 LRQFYMGNSPFVAENICEAWENE--------------------------------NSEYA 235
Query: 256 KLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT-DSPTAEW 314
+ T N LT +++ +P L + ++N+A N + + +W
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 315 SFLSSLTNCRNLTTLAVASNPLRGI-LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR 373
L+ + + + N L+ + + L +L G +P G+
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEI 353
Query: 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG-SIPYDLCHLERLNGIRLNGNK 432
L L+L N + + G EQ++ LS N L+ +D + ++ I + N+
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE 413
Query: 433 LSG-------PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG-- 483
+ P+ I++ +NL +N+ S F + L ++NL N L+
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 484 -----SLPSNIQNLQVLINLDLSRNQLSGDIP-ITIGSLKDLVTLSLASNQFEGPIPQTF 537
N +N +L ++DL N+L+ +L LV + L+ N F P
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
Query: 538 GSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583
+ + L+ + N + N+ E P
Sbjct: 533 LNSSTLKGFGIRNQ------------------RDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 5e-92
Identities = 78/541 (14%), Positives = 167/541 (30%), Gaps = 71/541 (13%)
Query: 55 LNLSNMGLRGTIPPHLG--NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
M + T + +FS L+ I+ + + + I N +
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT- 196
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
+ L+KL+ + N+ F + E + + NL L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDL 251
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQ--------PSIFNISTITLIN 224
+V + ++P+ + L ++++ + N Q I +I
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 225 LFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGL 284
+ N L + + + L + N+L G +P + + KL L+L++N + +
Sbjct: 312 IGYNNLK-TFPVETSLQ-KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368
Query: 285 IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344
+ G + L+ A+N L + + ++ + + N + +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAK------SVSVMSAIDFSYNEIGSVDGKNF 422
Query: 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404
+ ++ ++L N ++ L ++L
Sbjct: 423 DP------------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS- 463
GN L IP + + + L ++L NK +
Sbjct: 465 MGNMLTE-IPKNSL----------------KDENENFKNTYLLTSIDLRFNKLTKLSDDF 507
Query: 464 SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI------NLDLSRNQLSGDIPITIGSLK 517
+L YL+ ++LS NS S P+ N L D N+ + P I
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L L + SN + + + LD+ +N + + + ++K
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 578 E 578
+
Sbjct: 624 Q 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 3e-69
Identities = 62/468 (13%), Positives = 137/468 (29%), Gaps = 58/468 (12%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
R + N K + L+ L + +
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLT 263
Query: 113 SFPSWIGVLSKLQILSLRNNSFT--------GPIPNSLFNLSRLEKWDSMFN-IIDGNIP 163
P+++ L ++Q++++ N +++ +N + +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 164 SRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNIST-ITL 222
+ + + L + YN L+G++P G+ L L L N ++ I + + +
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVEN 381
Query: 223 INLFGNQLSGHLDLPPKVS-YSLPNLRVFSLGKNKLTG-------TIPNSITNASKLTGL 274
++ N+L +P S+ + N++ + + ++ +
Sbjct: 382 LSFAHNKLKY---IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 275 DLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASN 334
+LS N S F LS +NL N LT + + N LT++ + N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 335 PLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVG 394
L + L + P + N +L +
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ----------- 546
Query: 395 RLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGS 454
GN P + L +++ N + + + + ++ L++
Sbjct: 547 -------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKD 596
Query: 455 NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSR 502
N S S L + Q+++ LD+ R
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYD--------KTQDIRGCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 22/120 (18%), Positives = 38/120 (31%), Gaps = 4/120 (3%)
Query: 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
L + + N + S N + + +++ S + LSL
Sbjct: 35 LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSG----EIPKSLEALLFLKQLNVSHNKLEGEIPANGP 586
G +P G LT LE L L ++ PK + A + +Q + P
Sbjct: 95 GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-84
Identities = 97/356 (27%), Positives = 140/356 (39%), Gaps = 61/356 (17%)
Query: 261 IPNSITNASKL----TGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSF 316
I + N + L D ++ G++ T ++ L+L+ L +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP-----KPYPI 68
Query: 317 LSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLI 376
SSL N L L + L G IP I L L
Sbjct: 69 PSSLANLPYLNFLYIGGIN------------------------NLVGPIPPAIAKLTQLH 104
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436
L + ++G IP + +++ L L N L G++P + L L GI +GN++SG
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
IP S L + +S N L+G +P NL L
Sbjct: 165 IPDSYGSFSKL--------------------FTSM---TISRNRLTGKIPPTFANLN-LA 200
Query: 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE 556
+DLSRN L GD + GS K+ + LA N + + G L LDL NN + G
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGT 259
Query: 557 IPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPC 612
+P+ L L FL LNVS N L GEIP G + F +++ N LCG +P C
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 4e-76
Identities = 91/345 (26%), Positives = 143/345 (41%), Gaps = 49/345 (14%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPIC--KWVGISCGARHQ--RVRALNLSNMGLR 63
D+ ALL K + +P + L++ W + C W+G+ C Q RV L+LS + L
Sbjct: 6 QDKQALLQIKKDLGNP-TTLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 64 GT--IPPHLGNFSFLMSLDISK-NNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGV 120
IP L N +L L I NN +P + +L +L ++ + + SG+ P ++
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
+ L L N+ +G +P S I +L +LV + N
Sbjct: 124 IKTLVTLDFSYNALSGTLPPS------------------------ISSLPNLVGITFDGN 159
Query: 181 NLQGEIPSEIGNLQNL-EILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK 239
+ G IP G+ L + + N L+G I P+ N++ + ++L N L G D
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG--DASVL 216
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
S N + L KN L + + + L GLDL N G +P L+FL LN
Sbjct: 217 FG-SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNP-LRGI-LPP 342
++ N L + P N + A A+N L G LP
Sbjct: 275 VSFNNLCGEIPQ--------GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-84
Identities = 109/300 (36%), Positives = 152/300 (50%), Gaps = 22/300 (7%)
Query: 665 LPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAF- 723
+ L +R S ++Q A+D F+ N+LGRG FG VYKG +DGT A+K +L
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERT 67
Query: 724 ----RSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLY---SDNYF 776
F +E E++ HRNL+++ C R LV M NGS+ L
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 777 LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836
LD +R I +G A L YLH ++H D+K +NILLDE+ A V DFGL+KL D
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE---M 893
D VT T TIG++APEY + G S K DV+ YGV+L E T ++ D +
Sbjct: 188 DTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 894 SLKKWVKESLPHG-LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTD 952
L WVK L L +VD +L Q + E+ ++ +AL C SP +R M++
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEV---EQLIQVALLCTQSSPMERPKMSE 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-83
Identities = 96/293 (32%), Positives = 145/293 (49%), Gaps = 13/293 (4%)
Query: 671 RRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSEC 730
R +D++ AT+ F+ L+G G FG VYKG DG A+K + + F++E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 731 EVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLY---SDNYFLDLLERLNIMI 787
E L RH +L+ + C + L+ + M NG+L++ LY + +RL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847
G A L YLH ++H D+K NILLDE+ V ++DFG+SK E D + T+
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMF-TGEMSLKKWVKESLPHG 906
T+GY+ PEY +G ++ K DVYS+GV+L E + ++L +W ES +G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 907 -LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958
L ++VD NL + L A+ C S + R M D KL+
Sbjct: 264 QLEQIVDPNL-----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 2e-80
Identities = 109/545 (20%), Positives = 189/545 (34%), Gaps = 34/545 (6%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
+ N N+GL IP L + L+ S N +L L F+ L +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
+L L L N +L L+ + I + N +L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF----NISTITLINLFGN 228
++ L N++ + + L++L N + + + ++L NL GN
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSL-NLNGN 189
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS--KLTGLDLSFNSFSGLIP 286
++G + P + + G + I + N++ L + P
Sbjct: 190 DIAG---IEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 287 HTFGNLRFLSV--LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344
F L +SV +NL +Y S ++ L L + + L + P +
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISS-------NTFHCFSGLQELDLTATHLSEL-PSGL 297
Query: 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPS-TVGRLEQLQGLS 403
S +L+ K N SL LS+ N + + + LE L+ L
Sbjct: 298 VGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 404 LYGNNLEGS--IPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI 461
L +++E S L +L L + L+ N+ + L L+L +
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 462 P-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKD-- 518
S F +L L +NLS + L S L L +L+L N SL+
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 519 -LVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L L L+ F SL + +DLS+N L+ ++L L + LN++ N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 578 EGEIP 582
+P
Sbjct: 536 SIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 2e-70
Identities = 103/537 (19%), Positives = 179/537 (33%), Gaps = 49/537 (9%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
L L+ L L L L + + L + L + L N S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKW--DSMFNIIDGNIPSRIGNLS 170
KL++L +NN+ + +L + + N I I + +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSA 202
Query: 171 SLVNVNLAYNNLQGEIPSEIGN--LQNLEILVLGMNNLSGPIQPSIFNISTITL--INLF 226
++N I + N +Q+L + + + +++ INL
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
+ + + L+ L L+ +P+ + S L L LS N F L
Sbjct: 263 KHYFFN---ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGN 346
+ N L+ L++ N + T L N NL L ++ + +
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGT------GCLENLENLRELDLSHDDIETS------- 365
Query: 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYG 406
++ NL L L+L N QL+ L L
Sbjct: 366 ----------------DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 407 NNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI---P 462
L+ +L L + L+ + L Q L +L+ LNL N F
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 463 SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTL 522
+S +L L + LS LS +L+++ ++DLS N+L+ + LK + L
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-L 528
Query: 523 SLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579
+LASN +P L+ +++L N L + FL+ + KLE
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLED 581
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-60
Identities = 75/425 (17%), Positives = 140/425 (32%), Gaps = 30/425 (7%)
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL 234
N L EIP + + E L N L + + +T ++L Q+
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-- 71
Query: 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF 294
+ S L L N L +++ L L S + N +
Sbjct: 72 -IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
L L L +N++++ L L +N + + + + N
Sbjct: 131 LESLYLGSNHISSIKL-------PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ-QATNL 182
Query: 355 YAYDCKLTGN----IPHEIGNLRSLIVLSLFINALNGTIPSTVG--RLEQLQGLSLYGNN 408
L GN I + L+ I + ++ L + +
Sbjct: 183 S---LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 409 LEGSIPYDLCHLERLNG--IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFW 466
E P L ++ I L + L+EL+L + S +PS
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLV 298
Query: 467 SLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDI-PITIGSLKDLVTLSLA 525
L L + LS+N + N L +L + N ++ + +L++L L L+
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 526 SNQFE--GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583
+ E +L+ L+SL+LS N ++ + L+ L+++ +L+ A
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDA 417
Query: 584 NGPFK 588
PF+
Sbjct: 418 QSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-49
Identities = 62/344 (18%), Positives = 121/344 (35%), Gaps = 21/344 (6%)
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
+ ++ L IP ++ + L+ SFN + TF L L+ L+L +
Sbjct: 15 KTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH 367
+ L TL + +NPL + + +L++ + ++
Sbjct: 72 IHEDT-------FQSQHRLDTLVLTANPLIFMAETALSGPK-ALKHLFFIQTGISSIDFI 123
Query: 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGI- 426
+ N ++L L L N ++ E+L+ L N + D+ L++ +
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183
Query: 427 -RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIP-----SSFWSLEYLLAVNLSSNS 480
LNGN ++G I + LN G + I S+ SL ++
Sbjct: 184 LNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242
Query: 481 LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSL 540
+S ++ + + + +++L ++ T L L L + +P L
Sbjct: 243 ISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGL 300
Query: 541 TGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
+ L+ L LS N S L L++ N E+
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-40
Identities = 61/290 (21%), Positives = 106/290 (36%), Gaps = 13/290 (4%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
++ L+L+ L +P L S L L +S N F L +S+ N
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 111 SGS-FPSWIGVLSKLQILSLRNNSFT--GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIG 167
+ L L+ L L ++ L NLS L+ + +N
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 168 NLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF 226
L ++LA+ L+ + S NL L++L L + L + + + +NL
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
GN +L L + L L+ ++ T+ + +DLS N +
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
+L+ + LNLA+N+++ P S L T+ + NPL
Sbjct: 518 EALSHLKGI-YLNLASNHISIILP-------SLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-39
Identities = 82/371 (22%), Positives = 140/371 (37%), Gaps = 24/371 (6%)
Query: 46 GARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISL 105
G V ++NL FS L LD++ + LP+ L L L+ + L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 106 DYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIID--GNI 162
N+F L LS++ N+ + NL L + D + I+
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 163 PSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTIT 221
++ NLS L ++NL+YN LE+L L L S F N+ +
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTI---PNSITNASKLTGLDLSF 278
++NL + L ++ LP L+ +L N NS+ +L L LSF
Sbjct: 429 VLNLSHSLLDI---SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 279 NSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338
S + H F +L+ ++ ++L++N LT+ S +L++ + + L +ASN +
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI-------EALSHLKGI-YLNLASNHISI 537
Query: 339 ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQ 398
ILP ++ S + L ++ L T +
Sbjct: 538 ILPSLLPILS-QQRTINLRQNPLDCTC--SNIYFLEWYKENM--QKLEDTEDTLCENPPL 592
Query: 399 LQGLSLYGNNL 409
L+G+ L L
Sbjct: 593 LRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 42/201 (20%), Positives = 70/201 (34%), Gaps = 7/201 (3%)
Query: 402 LSLYGNNLEGSIPYDL-CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS 460
+ L IP L E L + N L + LI+L L+L +
Sbjct: 17 YNCENLGLN-EIPGTLPNSTECLE---FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 461 IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV 520
+F S L + L++N L + + + L +L + +S I + + K L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 521 TLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL--LFLKQLNVSHNKLE 578
+L L SN L+ LD NN + + + +L LN++ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 579 GEIPANGPFKYFAPQSFSWNY 599
G P F +F
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQ 213
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 277 bits (709), Expect = 1e-79
Identities = 96/653 (14%), Positives = 201/653 (30%), Gaps = 96/653 (14%)
Query: 8 TDQFALLAFKAHVTDP----------QSVLANNWSISQPICKWVGISCGARHQRVRALNL 57
D AL A + ++ + NW+ ++ + W
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD---------- 318
Query: 58 SNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSW 117
L N + L ++ +P+ +GQL L+ +S + + S +
Sbjct: 319 ------------LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 118 IGVLSKLQILSLRNNSFTGPIPN-SLFNLSRLEKWDSMFNIIDGN---IPSRIGNLSSLV 173
+ R + L RL D + + I+ N P + + SL
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426
Query: 174 NVNL-AYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSG 232
+ + N I I L L+I+ + + + + + N
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN---- 482
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGL-------- 284
S +L +L L +P+ + + +L L+++ N
Sbjct: 483 ---EELSWS-NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 285 -IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPV 343
+ + + + N L +A SL L L N +R +
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEEFPASA------SLQKMVKLGLLDCVHNKVRHL--EA 590
Query: 344 IGNFSASLQNFYAYDCKLTGNIPHEIG-NLRSLIVLSLFINALNGTIPSTV--GRLEQLQ 400
G L + ++ IP + + L N L IP+ + +
Sbjct: 591 FGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG 647
Query: 401 GLSLYGNNLEG-----SIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSN 455
+ N + S D + + L+ N++ + A+ + + L +N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 456 KFSS-------SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ--NLQVLINLDLSRNQLS 506
+S ++ + L ++L N L+ SL + + L L N+D+S N S
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS 766
Query: 507 GDIPITIGSLKDLVTLSL------ASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS 560
P + L + N+ P + L L + +N++ ++ +
Sbjct: 767 S-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEK 824
Query: 561 LEALLFLKQLNVSHNKL-EGEIPANGPFKYFAPQSFSWNY--ALCGPTTLQVP 610
L L L+++ N ++ + P+ ++ + G L +
Sbjct: 825 L--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-71
Identities = 71/522 (13%), Positives = 172/522 (32%), Gaps = 52/522 (9%)
Query: 96 QLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMF 155
+L + + + E + + + + + L +N + N+ + ++
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKEL 308
Query: 156 NIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF 215
++ + N + ++LA +G +P IG L L++L G ++ + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 216 NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLD 275
T + +++ + L + L ++ + + K + +
Sbjct: 369 EELTPDMSEERKHRIR--MHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRIS 424
Query: 276 LSFNSFSGL------IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
L L I L L ++ AN+ T +
Sbjct: 425 LKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFT------------YDNIAVDWEDA 472
Query: 330 AVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG-- 387
N L + Y+C +P + +L L L++ N
Sbjct: 473 NSDYAKQYENEELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 388 -------TIPSTVGRLEQLQGLSLYGNNLEG-SIPYDLCHLERLNGIRLNGNKLSGPIPQ 439
+ ++Q + NNLE L + +L + NK+ +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLE 589
Query: 440 CLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS--NIQNLQVLIN 497
+ + L +L L N+ + + + S N L +P+ N +++ V+ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648
Query: 498 LDLSRNQLSGDIP-----ITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNN 552
+D S N++ + + + T++L+ N+ + + F + + + ++ LSNN
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 553 LS-------GEIPKSLEALLFLKQLNVSHNKLEGEIPANGPF 587
++ + + L +++ NKL + +
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA 749
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-47
Identities = 69/416 (16%), Positives = 127/416 (30%), Gaps = 59/416 (14%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG-- 112
N N L +++ LP+ L L L+ +++ N
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 113 -------SFPSWIGVLSKLQILSLRNNSFTG-PIPNSLFNLSRLEKWDSMFNIIDGNIPS 164
K+QI + N+ P SL + +L D + N + ++ +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV-RHLEA 590
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEIG-NLQNLEILVLGMNNLSG-PIQPSIFNISTITL 222
G L ++ L YN ++ EIP + +E L N L P + ++ +
Sbjct: 591 -FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGS 648
Query: 223 INLFGNQLSGHLD--LPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280
++ N++ Y N +L N++ S ++ + LS N
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 281 FSGL-------IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVAS 333
+ + + N L+ ++L N LT+ S T L+ + V+
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDF------RATTLPYLSNMDVSY 762
Query: 334 NPLRGILPPVIGNFSA-----SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL--- 385
N P N S A ++ P I SLI L + N +
Sbjct: 763 NCFSSF-PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKV 821
Query: 386 -------------------NGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
+ + S +E L + + D +ER
Sbjct: 822 DEKLTPQLYILDIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQDIRGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-31
Identities = 59/437 (13%), Positives = 128/437 (29%), Gaps = 51/437 (11%)
Query: 167 GNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF 226
+ L + + Y E + + + + + + + + T +
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQS 227
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
G + S ++ F++ NKLT K + + + I
Sbjct: 228 GIKRS-------ELETQSVRGESFTVIDNKLT-----------KDANVPIQLKETAEYIK 269
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR--GILPPVI 344
L+ N W + S N + + L G P V
Sbjct: 270 DYKALKAIWEALDGKN-----------WRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404
+ + + G +P IG L L VLS ++ +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 405 YGNNLEGSIPYD----LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLG-SNKFSS 459
+ + L + ++ N+ P S ISL++ +G +
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 460 SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519
I + L L + +++ + + + + + + ++ +LKDL
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDL 493
Query: 520 VTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG---------EIPKSLEALLFLKQL 570
+ L + +P L L+SL+++ N + + ++
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 571 NVSHNKLEGEIPANGPF 587
+ +N LE E PA+
Sbjct: 554 YMGYNNLE-EFPASASL 569
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 6e-77
Identities = 111/543 (20%), Positives = 188/543 (34%), Gaps = 36/543 (6%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ ++LS L+ NFS L LD+S+ L L + L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEK-WDSMFNIIDGNIPSRIGNLS 170
P L+ L+ L + L L+K + I +P+ NL+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNL----EILVLGMNNLSGPIQPSIFNISTITLINLF 226
+LV+V+L+YN +Q +++ L+ L + +N + IQ F + + L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLR 212
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGL--------DLSF 278
GN S ++ +L L V L + I S + GL L++
Sbjct: 213 GNFNSS--NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 279 NSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338
+ F L +S ++LA + L + +L++ L+
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKY---------LEDVPKHFKWQSLSIIRCQLKQ 321
Query: 339 ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLE- 397
L++ K + I + L SL L L NAL+ + + L
Sbjct: 322 F----PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 398 -QLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLRELNLGSN 455
L+ L L N + + LE L + + L SL L L++
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 456 KFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIG 514
F L L + ++ NS + SN+ N L LDLS+ QL
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 515 SLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSH 574
+L L L+++ N + L L +LD S N + L N+++
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 575 NKL 577
N +
Sbjct: 555 NSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-65
Identities = 107/540 (19%), Positives = 169/540 (31%), Gaps = 53/540 (9%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
+ L +P + S ++D+S N L+++ L E
Sbjct: 16 YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
L L L L N P S L+SL N
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSF------------------------SGLTSLEN 108
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGH 233
+ L IG L L+ L + N + P+ F N++ + ++L N +
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT- 167
Query: 234 LDLPPKVSYSLPNLRVF----SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP-HT 288
+ L + N + I + KL L L N S I
Sbjct: 168 --ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTC 224
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEW--SFLSSLTNCRNLTTLAVASNPLRGILPPVIGN 346
NL L V L + + S + L + +
Sbjct: 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE-FRLTYTNDFSDDIVKFHC 283
Query: 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYG 406
+ ++ + ++ LS+ L L L+ L+L
Sbjct: 284 LA-NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTM 337
Query: 407 NNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASL--ISLRELNLGSNKFSSSIPSS 464
N SI + L L+ + L+ N LS + L SLR L+L N + ++
Sbjct: 338 NKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN 394
Query: 465 FWSLEYLLAVNLSSNSLSGSLP-SNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523
F LE L ++ ++L S +L+ L+ LD+S D L L TL
Sbjct: 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454
Query: 524 LASNQFEGPIPQ-TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582
+A N F+ F + T L LDLS L + L L+ LN+SHN L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-31
Identities = 54/359 (15%), Positives = 119/359 (33%), Gaps = 27/359 (7%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
+ L+ + + ++ ++ + ++ + + + +S+ +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIID--GNIPSRIGN 168
L L+ L+L N + I L L D N + G
Sbjct: 320 KQFPTLD---LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 169 LSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFG 227
+SL +++L++N + + L+ L+ L + L + S F ++ + +++
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433
Query: 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIP-NSITNASKLTGLDLSFNSFSGLIP 286
+ L +L + N N N + LT LDLS +
Sbjct: 434 TNTKI---DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGN 346
F L L +LN+++N L S +L+TL + N + ++ +
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDS-------SHYNQLYSLSTLDCSFNRIETS-KGILQH 542
Query: 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405
F SL F + + I L+ + F+ + +T ++ +
Sbjct: 543 FPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCAT---PVEMNTSLVL 597
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-29
Identities = 40/191 (20%), Positives = 66/191 (34%), Gaps = 6/191 (3%)
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS 458
+ + L N L+ Y + L + L+ ++ + L L L L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG-DIPITIGSLK 517
S P SF L L + L+ I L L L+++ N + +P +L
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGL----ESLDLSNNNLSGEIPKSLEALLFLKQLNVS 573
+LV + L+ N + L SLD+S N + I + L +L +
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212
Query: 574 HNKLEGEIPAN 584
N I
Sbjct: 213 GNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-24
Identities = 35/170 (20%), Positives = 67/170 (39%), Gaps = 5/170 (2%)
Query: 411 GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEY 470
GS+ + + + + KLS +P + S S + ++L N SF +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
L ++LS + L L NL L+ N + P + L L L +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSG-EIPKSLEALLFLKQLNVSHNKLEG 579
G L L+ L++++N + ++P L L +++S+N ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 19/86 (22%), Positives = 27/86 (31%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+ L+LS L L L++S NN + QL L + +N
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFT 135
S L +L NNS
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-74
Identities = 83/301 (27%), Positives = 139/301 (46%), Gaps = 26/301 (8%)
Query: 674 SYLDIQRATDGFNE------CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRA----F 723
S+ +++ T+ F+E N +G G FG VYKG + T+ A+K +D
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 724 RSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF--LDLLE 781
+ FD E +V+ +H NL+++ + D LV MPNGSL L + L
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 782 RLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841
R I G A + +LH +H D+K +NILLDE A +SDFGL++ ++ +V
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE 901
+ + T YMAPE G ++ K D+YS+GV+L E T D+ L +E
Sbjct: 192 TSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEE 249
Query: 902 SL--PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKK 959
+ + +D + + A+ + ++ +A C E ++R + L++
Sbjct: 250 IEDEEKTIEDYIDKKM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 960 I 960
+
Sbjct: 304 M 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-61
Identities = 65/308 (21%), Positives = 116/308 (37%), Gaps = 27/308 (8%)
Query: 674 SYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEV- 732
++ + + RG FG V+K A+K+F +Q +S+ +E EV
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---DKQSWQNEYEVY 70
Query: 733 -LRNVRHRNLIKIFSSCCNNDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLNIMI 787
L ++H N+++ + L+ GSL +L + E +I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAE 128
Query: 788 GVALALEYLH------HGHSTP-VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840
+A L YLH P + H D+K N+LL ++ A ++DFGL+ F+ G +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 841 TQTMTIATIGYMAPEYGTEGI-----VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSL 895
+ T YMAPE I + D+Y+ G++L E +R D M
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 896 KKWVKESLP--HGLMEVVDTNLLRQEHTSS-AEMDCLLSVLHLALDCCMESPDQRIYMTD 952
+ P + EVV R + + + +C + R+
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 953 AAVKLKKI 960
++ ++
Sbjct: 309 VGERITQM 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+G GSFG+VYKG + A+K+ N+ + ++F +E VLR RH N++ F
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL-FMGY 88
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
A+V + SL L++ ++ + ++I A ++YLH + ++H D
Sbjct: 89 STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE---YGTEGIVSSK 865
LK +NI L ED + DFGL+ S +I +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 866 CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925
DVY++G++L E T + P ++ + ++E+V L + S
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI-------------NNRDQIIEMVGRGSLSPD-LSKVR 251
Query: 926 MDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+C + L +C + D+R +++++
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-57
Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 53/292 (18%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRA-------FRSFDSECEVLRNVRHRNLI 742
+G+G FG V+KG D + AIK L F+ F E ++ N+ H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
K +N +V+E +P G L L + + +L +M+ +AL +EY+ + +
Sbjct: 87 K-LYGLMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 803 PVVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPE 855
P+VH DL+ NI L + A V+DFGLS+ +++ + +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLLGNFQWMAPE 196
Query: 856 --YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE-----SLPHGLM 908
E + K D YS+ ++L T + P D+ G++ ++E ++P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE--- 253
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
DC + ++ C P +R + + +L ++
Sbjct: 254 ------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-56
Identities = 101/535 (18%), Positives = 185/535 (34%), Gaps = 43/535 (8%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ L+LS LR +F L LD+S+ L L + L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNII-DGNIPSRIGNLS 170
LS LQ L + + +L L++ + N+I +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNLEI----LVLGMNNLSGPIQPSIFNISTITLINLF 226
+L +++L+ N +Q +++ L + + L L +N ++ IQP F + + L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
N S L++ L L V L + + +
Sbjct: 209 NNFDS--LNVMKTCIQGLAGLEVHRLVLGEF------------------RNEGNLEKFDK 248
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGN 346
L L++ YL + N+++ ++ S + + +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLD----DIIDLFNCLTNVSSFSLVSVTIERVKD---FS 301
Query: 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYG 406
++ Q+ +CK ++ +L+ L S S V L L+ L L
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG----NAFSEVD-LPSLEFLDLSR 356
Query: 407 NNLE--GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSS 464
N L G L + L+ N + + L L L+ + S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
Query: 465 -FWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDI-PITIGSLKDLVTL 522
F SL L+ +++S + L L L ++ N + P L++L L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 523 SLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L+ Q E P F SL+ L+ L++++N L + L L+++ + N
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-50
Identities = 104/539 (19%), Positives = 166/539 (30%), Gaps = 73/539 (13%)
Query: 56 NLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFP 115
+ IP +L +LD+S N L+ + L E
Sbjct: 13 QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 116 SWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNV 175
LS L L L N + F+ LSSL +
Sbjct: 70 GAYQSLSHLSTLILTGNPIQS-LALGAFS-----------------------GLSSLQKL 105
Query: 176 NLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLD 235
NL IG+L+ L+ L + N + P F+
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS------------------- 146
Query: 236 LPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTG----LDLSFNSFSGLIPHTFGN 291
+L NL L NK+ + ++ LDLS N + + P F
Sbjct: 147 -------NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSAS- 350
+R L L L NN+ + + L+ L R + L +
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 351 -LQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
+ AY +I L ++ SL + + Q L L
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-NFGWQHLELVNCKF 316
Query: 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNK--FSSSIPSSFWS 467
L L+RL NK L SL L+L N F S +
Sbjct: 317 GQFPTLKLKSLKRLT---FTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 468 LEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLAS 526
L ++LS N + ++ SN L+ L +LD + L ++ SL++L+ L ++
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPK-SLEALLFLKQLNVSHNKLEGEIPAN 584
F L+ LE L ++ N+ L L L++S +LE ++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-44
Identities = 89/474 (18%), Positives = 151/474 (31%), Gaps = 33/474 (6%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF-S 111
L L+ ++ S L L + N + +G L+ L+ +++ +N S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLE----KWDSMFNIIDGNIPSRIG 167
P + L+ L+ L L +N L L ++ D N ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 168 NLSSLVNVNLAYNNLQGEIPSE-IGNLQNLEILVL------GMNNLSGPIQPSIFNISTI 220
L + L N + I L LE+ L NL + ++ + +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280
T+ L +LD + L N+ FSL + S L+L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCK 315
Query: 281 FSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI- 339
F L+ L L +N S + +L L ++ N L
Sbjct: 316 FGQF---PTLKLKSLKRLTFTSNKGGN---------AFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 340 LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQ 398
+ SL+ + + L L L + L +V L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQ-CLASLISLRELNLGSNKF 457
L L + + + L L +++ GN L +L L+L +
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 458 SSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIP 510
P++F SL L +N++SN L S+P I L L + L N P
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-42
Identities = 85/431 (19%), Positives = 144/431 (33%), Gaps = 41/431 (9%)
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL 234
N +IP + + + L L N L S F+ + +++L ++
Sbjct: 12 YQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ--- 65
Query: 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF 294
+ SL +L L N + + + S L L + + L G+L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
L LN+A+N + + +N NL L ++SN ++ I +
Sbjct: 126 LKELNVAHNLIQSFKLP------EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 355 YAYDCKLTGN----IPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYG--- 406
+ D L+ N I L L+L N + + T L L+ L
Sbjct: 180 LSLD--LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 407 ---NNLEGSIPYDLCHLERLNGIRLNGNKLSG---PIPQCLASLISLRELNLGSNKFSSS 460
NLE L L L L I L ++ +L S
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 461 IPSSF-WSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519
S+ + ++L VN L+ L L + N+ L L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSL 349
Query: 520 VTLSLASNQ--FEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L L+ N F+G Q+ T L+ LDLS N + + + L L+ L+ H+ L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408
Query: 578 EGEIPANGPFK 588
+ ++ F
Sbjct: 409 K-QMSEFSVFL 418
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 55/269 (20%), Positives = 105/269 (39%), Gaps = 15/269 (5%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
V + +L ++ + + NF L++ F + +L L+RL N+
Sbjct: 282 TNVSSFSLVSVTIE-RVKDFSYNFG-WQHLELVNCKFGQFPTLKLKSLKRLT---FTSNK 336
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFT--GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIG 167
+ S + L L+ L L N + G S F + L+ D FN + + S
Sbjct: 337 GG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 393
Query: 168 NLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINL 225
L L +++ ++NL+ + +L+NL L + + IF +S++ ++ +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKM 452
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
GN + P + L NL L + +L P + + S L L+++ N +
Sbjct: 453 AGNSFQENF--LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEW 314
F L L + L N P ++
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-56
Identities = 71/277 (25%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
+GRG+FG V K + AIK + +R ++F E L V H N++K C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK-LYGACL 71
Query: 751 NDFRALVLELMPNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
N LV+E GSL L+ + ++ + + + YLH ++H D
Sbjct: 72 NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 809 LKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPEYGTEGIVSSK 865
LKP N+LL V + DFG + + MT + +MAPE S K
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACD-------IQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 866 CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925
CDV+S+G++L E TR+KP D++ +M V R
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFR------------IMWAVHNG-TRPPLIK--- 227
Query: 926 MDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962
+ + L C + P QR M + + +
Sbjct: 228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-56
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 26/287 (9%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+G GSFG+V++ + G+ A+K+ Q F E +++ +RH N++ +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDN--YFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
++V E + GSL + L+ LD RL++ VA + YLH+ + P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
+LK N+L+D+ V DFGLS+L + ++ T +MAPE + + K
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 867 DVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926
DVYS+GV+L E T ++P ++ P ++ V R E
Sbjct: 221 DVYSFGVILWELATLQQPWGNL--------------NPAQVVAAVGFKCKRLEIPR---- 262
Query: 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVLVLSRAEI 973
+ V + C P +R L+ + V +R+++
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 71/283 (25%), Positives = 109/283 (38%), Gaps = 39/283 (13%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLD----RAFRSFDSECEVLRNVRHRNLIKIFS 746
+G G FG VY+ + G A+K D + + E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
C LV+E G L + L + +N + +A + YLH P++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 807 CDLKPSNILLDEDMVAH--------VSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPEYG 857
DLK SNIL+ + + ++DFGL++ + T M+ A +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVI 186
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917
+ S DV+SYGVLL E T + P + + V N L
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------------AYGVAMNKLA 232
Query: 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
S C L DC P R T+ +L I
Sbjct: 233 LPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-54
Identities = 102/494 (20%), Positives = 188/494 (38%), Gaps = 47/494 (9%)
Query: 70 LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129
+ M + K N + L ++ + D + L+ L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE 189
NN T P L NL++L N I P + NL++L + L N + P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 190 IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249
+ NL NL L L N +S ++ ++++ ++ GNQ++ L +L L
Sbjct: 130 LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDLKPL-----ANLTTLER 181
Query: 250 FSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDS 309
+ NK++ + + + L L + N S + P G L L L+L N L
Sbjct: 182 LDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-- 235
Query: 310 PTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI 369
+ +L + NLT L +A+N + + P + + L +++ P +
Sbjct: 236 -------IGTLASLTNLTDLDLANNQISNLAP--LSGLT-KLTELKLGANQISNISP--L 283
Query: 370 GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLN 429
L +L L L N L P + L+ L L+LY NN+ P + L +L +
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 430 GNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI 489
NK+S LA+L ++ L+ G N+ S P +L + + L+ + + + +
Sbjct: 340 NNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYK 395
Query: 490 QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLS 549
N+ + + L P TI + N + + + ++
Sbjct: 396 ANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKG 452
Query: 550 NNNLSGEIPKSLEA 563
SG + + L+A
Sbjct: 453 TTTFSGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-53
Identities = 94/461 (20%), Positives = 179/461 (38%), Gaps = 46/461 (9%)
Query: 118 IGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNL 177
L++ L + T + +L ++ + I + L++L +N
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 178 AYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLP 237
+ N L P + NL L +++ N ++ + N++ +T + LF NQ++ L
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDIDPLK 131
Query: 238 PKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSV 297
+L NL L N ++ ++++ + L L N + L P NL L
Sbjct: 132 -----NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLER 181
Query: 298 LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAY 357
L++++N ++ +S L NL +L +N + I P +G + +L
Sbjct: 182 LDISSNKVSD---------ISVLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLN 229
Query: 358 DCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDL 417
+L + +L +L L L N ++ P + L +L L L N + P L
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 283
Query: 418 CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLS 477
L L + LN N+L P +++L +L L L N S P SL L +
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTF 537
+N +S S++ NL + L NQ+S P+ +L + L L +
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYK 395
Query: 538 GSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
+++ ++ L P ++ + +++ N
Sbjct: 396 ANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-50
Identities = 112/484 (23%), Positives = 187/484 (38%), Gaps = 69/484 (14%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
V L +G+ + + L ++ S N P L L +L I ++ N+ +
Sbjct: 48 VTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSS 171
P + L+ L L+L NN T P L NL+ L + + N I S + L+S
Sbjct: 104 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTS 157
Query: 172 LVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
L ++ N + P + NL LE L + N +S + ++ + + NQ+S
Sbjct: 158 LQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQIS 212
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291
L L NL SL N+L ++ + + LT LDL+ N S L P
Sbjct: 213 DITPLG-----ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSG 263
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASL 351
L L+ L L N ++ +S L LT L + N L I P
Sbjct: 264 LTKLTELKLGANQISN---------ISPLAGLTALTNLELNENQLEDISP---------- 304
Query: 352 QNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG 411
I NL++L L+L+ N ++ P V L +LQ L Y N +
Sbjct: 305 -----------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345
Query: 412 SIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471
L +L +N + N++S P LA+L + +L L ++++ + ++
Sbjct: 346 VSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 472 LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531
V + +L P+ I + D++ N S + VT+ + F G
Sbjct: 402 NTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSG 458
Query: 532 PIPQ 535
+ Q
Sbjct: 459 TVTQ 462
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-49
Identities = 111/412 (26%), Positives = 177/412 (42%), Gaps = 43/412 (10%)
Query: 171 SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230
L + + + +I + L VLG N++ + S ++ +T + +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI 58
Query: 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290
V Y L NL + N+LT P + N +KL + ++ N + + P
Sbjct: 59 KS----IDGVEY-LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LA 109
Query: 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSAS 350
NL L+ L L NN +T + L N NL L ++SN + I + + S
Sbjct: 110 NLTNLTGLTLFNNQITD---------IDPLKNLTNLNRLELSSNTISDI--SALSGLT-S 157
Query: 351 LQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLE 410
LQ + ++T P + NL +L L + N + + S + +L L+ L N +
Sbjct: 158 LQQLS-FGNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQIS 212
Query: 411 GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEY 470
P L L L+ + LNGN+L LASL +L +L+L +N+ S+ P L
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTK 266
Query: 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
L + L +N +S S + L L NL+L+ NQL PI +LK+L L+L N
Sbjct: 267 LTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNIS 322
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582
P SLT L+ L NN +S SL L + L+ HN++ P
Sbjct: 323 DISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 43/211 (20%), Positives = 81/211 (38%), Gaps = 16/211 (7%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
L L + P L + L +L++++N + + L+ L +++L +N S
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS 325
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
P + L+KLQ L NN + +SL NL+ + + N I P + NL+ +
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL 234
+ L + N+ + L P +I + + T ++ N S
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPA--TISDGGSYTEPDITWNLPSY-- 435
Query: 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI 265
+VSY+ G +GT+ +
Sbjct: 436 --TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-54
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 37/280 (13%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
L G ++KG + G +KV ++ R R F+ EC LR H N++
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP-VLGA 75
Query: 749 CNN---DFRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C + L+ MP GSL L+ N+ +D + + + +A + +LH +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE---YGTEGI 861
L ++++DEDM A +S + F + ++APE E
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDT 187
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921
D++S+ VLL E TR+ P D+ E+ M+V LR
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIG-------------MKVALEG-LRPTIP 233
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
V L C E P +R L+K++
Sbjct: 234 P----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-54
Identities = 62/284 (21%), Positives = 106/284 (37%), Gaps = 33/284 (11%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
LG+G FG K T G +K + R+F E +V+R + H N++K
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 750 NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
+ + E + G+L + S + +R++ +A + YL HS ++H DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDL 134
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ------------TMTIATIGYMAPEYG 857
N L+ E+ V+DFGL++L + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917
K DV+S+G++L E R D M V+ L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF-------------LD 241
Query: 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
+ +C S + + CC P++R L+ ++
Sbjct: 242 RY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 56/287 (19%), Positives = 109/287 (37%), Gaps = 38/287 (13%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFS 746
L+G+G FG VY G + AI++ +++ D ++F E R RH N++
Sbjct: 39 ELIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
+C + A++ L +L + LD+ + I + + YL H+ ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT-MTIA--TIGYMAPE-------- 855
DLK N+ D V ++DFGL + + + I + ++APE
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 856 -YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
+ S DV++ G + E R+ P ++ + T
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------------PAEAIIWQMGTG 258
Query: 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
+ + +++ + + L C ++R T L+K+
Sbjct: 259 MKP----NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-51
Identities = 75/321 (23%), Positives = 121/321 (37%), Gaps = 40/321 (12%)
Query: 673 TSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEV 732
+ + D L+GRG +G+VYKG+ D A+KVF+ ++F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58
Query: 733 --LRNVRHRNLIKIFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDNYFLDLLERLNI 785
+ + H N+ + LV+E PNGSL K+L D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 786 MIGVALALEYLH-----HGHSTP-VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839
V L YLH H P + H DL N+L+ D +SDFGLS
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 840 VTQTMTIA------TIGYMAPEYGTEGI-------VSSKCDVYSYGVLLTETFTRKK--- 883
A TI YMAPE + + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 884 PTDDMFTGEMSLKKWVKESLPHGLM-EVVDTNLLR---QEHTSSAEMDCLLSVLHLALDC 939
P + + +M+ + V M +V R E + + S+ DC
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLKETIEDC 295
Query: 940 CMESPDQRIYMTDAAVKLKKI 960
+ + R+ A ++ ++
Sbjct: 296 WDQDAEARLTAQXAEERMAEL 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 74/318 (23%), Positives = 117/318 (36%), Gaps = 35/318 (11%)
Query: 665 LPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFR 724
LPL R T IQ +G+G +G V+ G + G A+KVF
Sbjct: 27 LPLLVQR-TIAKQIQ-------MVKQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEA 74
Query: 725 SFDSECEV--LRNVRHRNLIKIFSSCCNNDFR----ALVLELMPNGSLEKWLYSDNYFLD 778
S+ E E+ +RH N++ ++ L+ + NGSL +L + LD
Sbjct: 75 SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLD 132
Query: 779 LLERLNIMIGVALALEYLH-----HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833
L + L +LH + H DLK NIL+ ++ ++D GL+ F
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 834 DEGDDSVTQTMTIA--TIGYMAPE--YGTEGIVSS----KCDVYSYGVLLTETFTRKKPT 885
+ V T YM PE + D+YS+G++L E R
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 886 DDMFTGEMSLKKWVKESLPHGLM-EVVDTNLLRQEHTSSAEMD-CLLSVLHLALDCCMES 943
+ ++ V + M E+V LR + D CL + L +C +
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 944 PDQRIYMTDAAVKLKKIK 961
P R+ L K+
Sbjct: 313 PASRLTALRVKKTLAKMS 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-51
Identities = 103/513 (20%), Positives = 182/513 (35%), Gaps = 86/513 (16%)
Query: 66 IPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQ 125
I P + +FL +N +P E ++ ++E+ + P G ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 126 ILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGE 185
+ LR+ LE + + ++P +L SL + N+L E
Sbjct: 62 VSRLRDCLDR--------QAHELELNNLGLS----SLPELPPHLESL---VASCNSLT-E 105
Query: 186 IPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLP 245
+P +L++L + + LS + + + NQL LP +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE---KLPE--LQNSS 153
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
L++ + N L +P+ + L + N L NL FL+ + NN L
Sbjct: 154 FLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSL 207
Query: 306 TT--DSPTA---------EWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
D P + L L N LTT+ +N L+ LP + + L+
Sbjct: 208 KKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEAL 262
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPS-------------TVGRLEQLQG 401
D LT ++P +L L V + L+ P+ L+
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE 321
Query: 402 LSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI 461
L++ N L +P LERL + N L+ +P +L++L++ N
Sbjct: 322 LNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VP---ELPQNLKQLHVEYNPL-REF 372
Query: 462 PSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVT 521
P S+E +L NS +P QNL+ L + N L + P S++D
Sbjct: 373 PDIPESVE-----DLRMNSHLAEVPELPQNLKQ---LHVETNPLR-EFPDIPESVED--- 420
Query: 522 LSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS 554
L + S + P + LE +++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-47
Identities = 110/477 (23%), Positives = 180/477 (37%), Gaps = 85/477 (17%)
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLS---- 170
P + + LQ +++ T +P N+ ++ + ++ + N P G
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 171 ---------SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
+ L L +P +L++L V N+L+ + ++ ++
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLL 117
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
+ N LS DLPP L + N+L +P + N+S L +D+ NS
Sbjct: 118 VDNNNLKALS---DLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL 165
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
L P +L + NN L L L N LT + +N L+ LP
Sbjct: 166 KKL-PDLPPSLE---FIAAGNNQLEE---------LPELQNLPFLTAIYADNNSLKK-LP 211
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQG 401
+ + L++ A + L E+ NL L + N L T+P L+
Sbjct: 212 DLPLS----LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEA 261
Query: 402 LSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI 461
L++ N L +P L L+ + LS P +L LN SN+ S +
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-L 312
Query: 462 PSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVT 521
SLE L N+S+N L LP+ L+ L S N L+ ++P +LK
Sbjct: 313 CDLPPSLEEL---NVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLK---Q 361
Query: 522 LSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
L + N P S+ DL N+ E+P+ + L KQL+V N L
Sbjct: 362 LHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNL---KQLHVETNPLR 409
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 9e-50
Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 27/293 (9%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEV--LRNVRHRNLIKIFS 746
+G+G +G V++G++ G + A+K+F+ R +S+ E E+ +RH N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 747 SCCNNDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH----- 797
S + + L+ GSL +L LD + L I++ +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAPE 855
+ H DLK NIL+ ++ ++D GL+ + + + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 856 ------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM- 908
+ D++++G++L E R + + V M
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVL-HLALDCCMESPDQRIYMTDAAVKLKKI 960
+VV + R + D L+ L L +C ++P R+ L KI
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-49
Identities = 108/550 (19%), Positives = 191/550 (34%), Gaps = 47/550 (8%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
+ + +IP L + + SLD+S N +L L+ + L + +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFN-IIDGNIPSRIGNLSSL 172
L L+ L L +N + + +S F LS L+ + M N + S NL++L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 173 VNVNLAYNNLQGEIPSE-IGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQL 230
+ + EI L +L L + +L Q +I I + L ++
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSES 184
Query: 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGL-----------DLSFN 279
+ L + L ++R L L + + + + D SFN
Sbjct: 185 A---FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 280 SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLS-SLTNCRNLTTLAVASNPLRG 338
L+ + L + + N L +P+ + L + L
Sbjct: 242 ELLKLLRYIL-ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 339 ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG-NLRSLIVLSLFINALNGTIPST---VG 394
L V ++ + K+ +P +L+SL L L N + G
Sbjct: 301 DLSTVYSLLE-KVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 395 RLEQLQGLSLYGNNLE--GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452
LQ L L N+L L L+ L + ++ N P+P +R LNL
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPIT 512
S +LE L ++S+N+L S + LQ L +SRN+L +P
Sbjct: 418 SSTGIRVVKTCIPQTLEVL---DVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLP-D 468
Query: 513 IGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNV 572
L+ + ++ NQ + F LT L+ + L N S + +L +
Sbjct: 469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC----SCPRIDYLSRWLN 524
Query: 573 SHNKLEGEIP 582
+++ E
Sbjct: 525 KNSQKEQGSA 534
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 71/423 (16%), Positives = 144/423 (34%), Gaps = 29/423 (6%)
Query: 53 RALNLSNMGLRGTIPPH-LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ L + N+ I + L L+I + Y L +R + ++L +E +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSS 171
+ +LS ++ L LR+ + + L + L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 172 LVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
L+ L + ++ + + + + TI +++ L
Sbjct: 246 LLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT--- 288
V L ++ ++ +K+ + + L LDLS N
Sbjct: 300 Y---DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFS 348
G L L L+ N+L + T L +NLT+L ++ N +P
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTG-----EILLTLKNLTSLDISRNTFH-PMPDSCQW-P 409
Query: 349 ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN 408
++ + + I ++L VL + N L+ + L +LQ L + N
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNK 462
Query: 409 LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL 468
L+ ++P D L ++++ N+L L SL+++ L +N + S P +
Sbjct: 463 LK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 520
Query: 469 EYL 471
+L
Sbjct: 521 RWL 523
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 62/367 (16%), Positives = 117/367 (31%), Gaps = 31/367 (8%)
Query: 241 SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300
S S V T +IP+ +T + + LDLSFN + + L VL L
Sbjct: 1 SLSCDASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 301 ANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCK 360
++ + T A + +L L ++ N L + G S SL+
Sbjct: 58 KSSRINTIEGDA-------FYSLGSLEHLDLSDNHLSSLSSSWFGPLS-SLKYLNLMGNP 109
Query: 361 LTG-NIPHEIGNLRSLIVLSL-FINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC 418
+ NL +L L + + + L L L + +L L
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169
Query: 419 HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478
+ ++ + L+ ++ + + L S+R L L + S E + +
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 479 NSLSG----------SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKD--------LV 520
S L I L + D + N L P + + +
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 521 TLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580
L + + + L ++ + + N+ + + L L+ L++S N + E
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 581 IPANGPF 587
N
Sbjct: 350 YLKNSAC 356
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 2e-49
Identities = 119/563 (21%), Positives = 187/563 (33%), Gaps = 52/563 (9%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNE-LGQLRRLRFISLDYNEF 110
L LS +R L L++ + E L LR + L ++
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPI--PNSLFNLSRLEKWDSMFN-IIDGNIPSRIG 167
P L L L L + + NL L + D N I + G
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 168 NLSSLVNVNLAYNNLQGEIPSEIGNLQ--NLEILVLGMNNLSGPIQPSIFNIS------T 219
L+SL +++ + N + E+ LQ L L N+L +
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205
Query: 220 ITLINLFGNQLSGHL---------DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITN--A 268
+ ++++ GN + + ++ G + + N+
Sbjct: 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265
Query: 269 SKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTT 328
S + LDLS L F L+ L VLNLA N + + A NL
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA-------FYGLDNLQV 318
Query: 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGT 388
L ++ N L + + + L L L L NAL
Sbjct: 319 LNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL--- 374
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSG-PIPQCLASLISL 447
+T+ + + + L GN L +L N I L+ N+L I L + L
Sbjct: 375 --TTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHL 428
Query: 448 RELNLGSNKFSS-SIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-----QNLQVLINLDLS 501
+ L L N+FSS S + L + L N L + + + + L L L L+
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488
Query: 502 RNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSL 561
N L+ P L L LSL SN+ LE LD+S N L P
Sbjct: 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNP--- 543
Query: 562 EALLFLKQLNVSHNKLEGEIPAN 584
+ + L L+++HNK E +
Sbjct: 544 DVFVSLSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-48
Identities = 92/545 (16%), Positives = 180/545 (33%), Gaps = 40/545 (7%)
Query: 44 SCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFI 103
SC + L +P L L +S N + L +L+ +
Sbjct: 1 SCSFDGRIA---FYRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 104 SLDYNEFSGSF-PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNI 162
L + L L+IL L ++ P++ L L + F + +
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 163 --PSRIGNLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNIST 219
NL +L ++L+ N ++ + G L +L+ + N + + + +
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFN 279
TL S + + + R L ++G N + N
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSN 226
Query: 280 SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI 339
+ S + + + + + + L ++ L ++ + +
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQ----NTFAGLAR-SSVRHLDLSHGFVFSL 281
Query: 340 LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQL 399
V L+ K+ L +L VL+L N L S L ++
Sbjct: 282 NSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340
Query: 400 QGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS 459
+ L N++ LE+L + L N L+ + + S+ ++ L NK +
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT 395
Query: 460 SIPSSFWSLEYLLAVNLSSNSLSG-SLPSNIQNLQVLINLDLSRNQLSG-DIPITIGSLK 517
+P + + +LS N L + + + L L L++N+ S T
Sbjct: 396 -LPKINLTANLI---HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451
Query: 518 DLVTLSLASNQFEGPI-----PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNV 572
L L L N + F L+ L+ L L++N L+ P L L+ L++
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 573 SHNKL 577
+ N+L
Sbjct: 512 NSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-45
Identities = 105/511 (20%), Positives = 178/511 (34%), Gaps = 58/511 (11%)
Query: 97 LRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFN 156
L + L +N S L +LQ+L L + I F
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR------------ 70
Query: 157 IIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLS-GPIQPSIF 215
NL +L ++L + + P L +L L L LS ++ F
Sbjct: 71 -----------NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 216 -NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITN--ASKLT 272
N+ +T ++L NQ+ L L P L +L+ N++ + + L+
Sbjct: 120 RNLKALTRLDLSKNQIR-SLYLHPSFG-KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177
Query: 273 GLDLSFNSFSGLIPHTFGNL------RFLSVLNLANNYLTTDSPTAEWSFLS-----SLT 321
L+ NS + +G L +L+++ N T D + +S SL
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237
Query: 322 NCRNLTTLAVASNPLRGILPPVIGN-FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSL 380
++ + ++ +S+++ + L+ L VL+L
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNL 297
Query: 381 FINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQC 440
N +N L+ LQ L+L N L + L ++ I L N ++ Q
Sbjct: 298 AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 441 LASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDL 500
L L+ L+L N ++ + + + LS N L +LP ++ L
Sbjct: 358 FKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLI---HL 408
Query: 501 SRNQLSG-DIPITIGSLKDLVTLSLASNQFEG-PIPQTFGSLTGLESLDLSNNNLSGEIP 558
S N+L DI + + L L L N+F QT LE L L N L
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468
Query: 559 KSLEALLF-----LKQLNVSHNKLEGEIPAN 584
L +F L+ L ++HN L +P
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLN-SLPPG 498
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-35
Identities = 94/473 (19%), Positives = 163/473 (34%), Gaps = 49/473 (10%)
Query: 50 QRVRALNLSNMGLRGTIPPH--LGNFSFLMSLDISKNNFHA-YLPNELGQLRRLRFISLD 106
+ L L GL + N L LD+SKN + YL G+L L+ I
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 107 YNEFSGSFPSWIGVLS--KLQILSLRNNSFTGPIPNSLF------------------NLS 146
N+ + L L SL NS + N
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216
Query: 147 RLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQ--NLEILVLGMN 204
++ + N I + + ++ ++N++ + L ++ L L
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276
Query: 205 NLSGPIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPN 263
+ + +F + + ++NL N+++ + + Y L NL+V +L N L +
Sbjct: 277 FVFS-LNSRVFETLKDLKVLNLAYNKIN---KIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 264 SITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTA-------EWSF 316
+ K+ +DL N + + TF L L L+L +N LTT +
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNK 392
Query: 317 LSSL-TNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLRS 374
L +L + ++ N L + LQ + + + S
Sbjct: 393 LVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 375 LIVLSLFINALNGTIPSTVGR-----LEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLN 429
L L L N L + + L LQ L L N L P HL L G+ LN
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512
Query: 430 GNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
N+L+ L + +L L++ N+ + P F SL ++++ N
Sbjct: 513 SNRLTVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-25
Identities = 95/522 (18%), Positives = 160/522 (30%), Gaps = 96/522 (18%)
Query: 27 LANNWSISQPICKWVGISCGARHQRVRALNLSNM------------GLRGTIPPHLGNFS 74
LA N S+ W R+ + L++S + + L
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 75 FLMSLDISKNNFHAYLPNELGQLRR--LRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132
+M +N N L R +R + L + L L++L+L N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-G 191
I + F L +L +NL+YN L E+ S
Sbjct: 301 KINK-IADEAFY-----------------------GLDNLQVLNLSYNLLG-ELYSSNFY 335
Query: 192 NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFS 251
L + + L N+++ + + L L+
Sbjct: 336 GLPKVAYIDLQKNHIA---------------------------IIQDQTFKFLEKLQTLD 368
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311
L N LT +I + + LS N L ++++L+ N L
Sbjct: 369 LRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDI- 418
Query: 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-- 369
L L +L L + N + + SL+ + + L E+
Sbjct: 419 -----LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473
Query: 370 ---GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGI 426
L L VL L N LN P L L+GLSL N L + ++ L +
Sbjct: 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEIL 531
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSF---WSLEYLLAVNLSSNSLSG 483
++ N+L P P +SL L++ NKF S W + + +
Sbjct: 532 DISRNQLLAPNPD---VFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYC 588
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLA 525
P + + L +L + SL + T++L
Sbjct: 589 VYPDSFSGVS-LFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 7e-13
Identities = 25/116 (21%), Positives = 45/116 (38%), Gaps = 5/116 (4%)
Query: 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533
+L+ +P + + L LS N + + L+ L L L S I
Sbjct: 9 AFYRFCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 534 -PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFK 588
+ F +L L LDL ++ + P + + L L +L + L + +G F+
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-48
Identities = 87/411 (21%), Positives = 170/411 (41%), Gaps = 67/411 (16%)
Query: 169 LSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGN 228
++L + N + +L VL +++ + + + +IT + + G
Sbjct: 2 AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGE 54
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
+++ + + Y L NL +L N++T P ++N KLT L + N + +
Sbjct: 55 KVA---SIQG-IEY-LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA-- 105
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFS 348
NL L L L + ++ +S L N + +L + +N L P
Sbjct: 106 LQNLTNLRELYLNEDNISD---------ISPLANLTKMYSLNLGANHNLSDLSP------ 150
Query: 349 ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN 408
+ N+ L L++ + + P + L L LSL N
Sbjct: 151 --------------------LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188
Query: 409 LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIP-SSFWS 467
+E P L L L+ N+++ P +A++ L L +G+NK + P ++
Sbjct: 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQ 244
Query: 468 LEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASN 527
L +L + +N +S + +++L L L++ NQ+S DI + + +L L +L L +N
Sbjct: 245 LTWL---EIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNN 297
Query: 528 QFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
Q + G LT L +L LS N+++ P L +L + + ++ ++
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-46
Identities = 81/340 (23%), Positives = 141/340 (41%), Gaps = 31/340 (9%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
L L K +T + +T L ++ + + L L LNL
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLNG 75
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N +T +S L+N LT L + +N + I + N + +L+ Y + ++
Sbjct: 76 NQITD---------ISPLSNLVKLTNLYIGTNKITDI--SALQNLT-NLRELYLNEDNIS 123
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
P + NL + L+L N + S + + L L++ + ++ P + +L
Sbjct: 124 DISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L + LN N++ P LASL SL N+ + P ++ L ++ + +N ++
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234
Query: 483 GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTG 542
S + NL L L++ NQ+S DI + L L L++ SNQ +L+
Sbjct: 235 DL--SPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISDISV--LNNLSQ 288
Query: 543 LESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582
L SL L+NN L E + + L L L +S N + P
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-41
Identities = 73/404 (18%), Positives = 143/404 (35%), Gaps = 62/404 (15%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
L + P + + + + K + + +L + + + + +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
I L+ L+ L+L N T P + NL L N
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISP--------------------------LSNLVKLTN 92
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL 234
+ + N + S + NL NL L L +N+S + N++ + +NL N
Sbjct: 93 LYIGTNKI--TDISALQNLTNLRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLSD- 147
Query: 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF 294
++ L ++ ++K+ P I N + L L L++N + P +L
Sbjct: 148 ---LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTS 200
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
L N +T ++ + N L +L + +N + + P + N S L
Sbjct: 201 LHYFTAYVNQITD---------ITPVANMTRLNSLKIGNNKITDLSP--LANLS-QLTWL 248
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP 414
+++ + + +L L +L++ N + + S + L QL L L N L
Sbjct: 249 EIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDM 304
Query: 415 YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS 458
+ L L + L+ N ++ P LASL + + +
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 1e-15
Identities = 38/179 (21%), Positives = 73/179 (40%), Gaps = 12/179 (6%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
+L+L+ + P L + + L N + + RL + + N+ +
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD 235
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
P + LS+L L + N + N++ +L++L+ + N I S + NLS L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
++ L N L E IG L NL L L N+++ + ++S + + +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVIK 346
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-48
Identities = 68/318 (21%), Positives = 121/318 (38%), Gaps = 35/318 (11%)
Query: 665 LPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFR 724
LPL R T I +G+G FG V++G + G A+K+F+ R R
Sbjct: 32 LPLLVQR-TIARTIVLQ-------ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREER 79
Query: 725 SFDSECEV--LRNVRHRNLIKIFSSCCNNDFRA----LVLELMPNGSLEKWLYSDNYFLD 778
S+ E E+ +RH N++ ++ ++ LV + +GSL +L + Y +
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVT 137
Query: 779 LLERLNIMIGVALALEYLH-----HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833
+ + + + A L +LH + H DLK NIL+ ++ ++D GL+
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 834 DEGDDSVTQTMTIA--TIGYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRKKPT 885
D D++ T YMAPE + D+Y+ G++ E R
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 886 DDMFTGEMSLKKWVKESLPHGLM-EVVDTNLLRQEHTSSAEMD-CLLSVLHLALDCCMES 943
++ V M +VV LR + + L + + +C +
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 944 PDQRIYMTDAAVKLKKIK 961
R+ L ++
Sbjct: 318 GAARLTALRIKKTLSQLS 335
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 62/347 (17%), Positives = 111/347 (31%), Gaps = 38/347 (10%)
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
+ + ++ + D + + N +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 304 YLTTDSPTAEWSFLSSLTNCR--NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKL 361
L + L + L + S PL P S LQ+ L
Sbjct: 67 ALK--------ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGL 116
Query: 362 TGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421
+P + L L+L N L +P+++ L +L+ LS+ +P L +
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
L++L+ L L S +P+S +L+ L ++ + ++ L
Sbjct: 175 ---------------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPL 218
Query: 482 SGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS-NQFEGPIPQTFGSL 540
S +L I +L L LDL + P G L L L + +P L
Sbjct: 219 S-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRL 276
Query: 541 TGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPF 587
T LE LDL +P + L + V + L+ ++ + P
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 61/338 (18%), Positives = 108/338 (31%), Gaps = 32/338 (9%)
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
S + L + ++ P + L R D + R N ++
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGR 66
Query: 181 NLQGEIPSEIGNLQ--NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPP 238
L+ + + L L L F +S + + + L +LP
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM---ELPD 121
Query: 239 KVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF---- 294
+ L +L +N L +P SI + ++L L + +P +
Sbjct: 122 TMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 295 -----LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSA 349
L L L + S +S+ N +NL +L + ++PL L P I +
Sbjct: 180 QGLVNLQSLRLEWTGIR--------SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP- 229
Query: 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
L+ C N P G L L L + T+P + RL QL+ L L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISL 447
+P + L I + + + + +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 47/278 (16%), Positives = 86/278 (30%), Gaps = 24/278 (8%)
Query: 319 SLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVL 378
+ L + V+ Q Y D + N + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQ----WQRHYNADRNRW-HSAWRQANSNNPQIE 61
Query: 379 SLFINALNGTIPSTVGRL--EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436
+ AL + L L L P L L + ++ L
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQV-- 494
+P + L L L N + +P+S SL L +++ + LP + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 495 -------LINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLD 547
L +L L + +P +I +L++L +L + ++ + L LE LD
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235
Query: 548 LSNNNLSGEIPKSLEALLFLKQLNVSH-NKLEGEIPAN 584
L P LK+L + + L +P +
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 56/263 (21%), Positives = 99/263 (37%), Gaps = 27/263 (10%)
Query: 47 ARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLD 106
A AL L ++ L P S L + I LP+ + Q L ++L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLA 135
Query: 107 YNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI 166
N + P+ I L++L+ LS+R +P L +
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD---------------ASGEH 179
Query: 167 GNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF 226
L +L ++ L + ++ +P+ I NLQNL+ L + + LS + P+I ++ + ++L
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR 237
Query: 227 G-NQLSGHLDLPPKVSYSLPNLRVFSL-GKNKLTGTIPNSITNASKLTGLDLSFNSFSGL 284
G L PP L+ L + L T+P I ++L LDL
Sbjct: 238 GCTALRN---YPPIFGG-RAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 285 IPHTFGNLRFLSVLNLANNYLTT 307
+P L ++ + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 54/356 (15%), Positives = 94/356 (26%), Gaps = 82/356 (23%)
Query: 67 PPHLGNFSFLMSLDISKNNFHAYLPNELGQLRR--LRFISLDYNEFSGSFPSWIGVLSKL 124
N + + A + L + + L FP LS L
Sbjct: 49 AWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 125 QILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG 184
Q +++ +P + + L + LA N L+
Sbjct: 107 QHMTIDAAGLM-------------------------ELPDTMQQFAGLETLTLARNPLR- 140
Query: 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSL 244
+P+ I +L L L + + + + L
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDA------------------SGEHQGL 182
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
NL+ L + ++P SI N L L + + S L +L L L+
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELD----- 235
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
L C L PP+ G + L+ DC
Sbjct: 236 ---------------LRGCTALRN-----------YPPIFGGRA-PLKRLILKDCSNLLT 268
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHL 420
+P +I L L L L +PS + +L + + + +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 41/201 (20%), Positives = 74/201 (36%), Gaps = 17/201 (8%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQ---------LRRLRFISL 105
L L+ LR +P + + + L L I LP L L L+ + L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 106 DYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWD-SMFNIIDGNIPS 164
++ S P+ I L L+ L +RN+ + + ++ +L +LE+ D + P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN-YPP 247
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLIN 224
G + L + L + +P +I L LE L L + I + +I
Sbjct: 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307
Query: 225 LFGNQLSGHLDLPPKVSYSLP 245
+ + + P + P
Sbjct: 308 VPPHLQAQLDQHRP---VARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 22/119 (18%), Positives = 40/119 (33%), Gaps = 3/119 (2%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISL-DYNEFSGS 113
L + N L + P + + L LD+ P G L+ + L D + +
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-T 268
Query: 114 FPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
P I L++L+ L LR +P+ + L ++ R +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-42
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 27/275 (9%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+GRG+FG V+ G +D T A+K L F E +L+ H N++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V+EL+ G +L ++ L + L ++ A +EYL S +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N L+ E V +SDFG+S+ +G + + + + + APE G SS+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 869 YSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAEM 926
+S+G+LL ETF+ P ++ + +E + G +
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRLP--------------CPE 338
Query: 927 DCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
C +V L C P QR + +L+ I+
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 64/421 (15%), Positives = 124/421 (29%), Gaps = 31/421 (7%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
I N + + ++L+ + S + N++ L L N LS + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
L+NL N L LDL SL LR L N + + + L + N+
Sbjct: 62 LLNLSSNVLYETLDL-----ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
S + + + LANN +T + L + N + +
Sbjct: 112 SRVSCSRGQGKKN---IYLANNKITMLRDLD-------EGCRSRVQYLDLKLNEIDTVNF 161
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQG 401
+ S +L++ + ++ ++ L L L N L + +
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 402 LSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLS-GPIPQCLASLISLRELNLGSNKFSSS 460
+SL N L I L + L L GN G + + ++ + + K +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 461 IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGD----IPITIGSL 516
++ L + + L L + + G + +
Sbjct: 278 QNEEECTVPTLG--HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 517 KDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNK 576
+ Q+ I Q +L+ L ++ A L
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 577 L 577
Sbjct: 396 Q 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-41
Identities = 69/495 (13%), Positives = 132/495 (26%), Gaps = 82/495 (16%)
Query: 90 LPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLE 149
+ R + + + + S ++ L L N +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD-------- 53
Query: 150 KWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP 209
+ + L +NL+ N L ++ +L L L L N +
Sbjct: 54 ----------------LAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-- 93
Query: 210 IQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS 269
+ +I ++ N +S + + L NK+T S
Sbjct: 94 ---ELLVGPSIETLHAANNNIS---RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRS 144
Query: 270 KLTGLDLSFNSFSGL-IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTT 328
++ LDL N + + L LNL N++ + L T
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD---------VKGQVVFAKLKT 195
Query: 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGT 388
L ++SN L + E + + +SL N L
Sbjct: 196 LDLSSNKLA--------------------------FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 389 IPSTVGRLEQLQGLSLYGNNLE-GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISL 447
I + + L+ L GN G++ +R+ + + Q
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVP 286
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ----NLQVLINLDLSRN 503
+ G+ L L + S GS ++ N +D +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 504 QLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEA 563
Q I + +TL + + + L+ E+ + E
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEE 405
Query: 564 LLFLKQLNVSHNKLE 578
L+ L + E
Sbjct: 406 QSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-39
Identities = 67/492 (13%), Positives = 151/492 (30%), Gaps = 35/492 (7%)
Query: 71 GNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLR 130
N + ++ ++ L + ++ + L N S + + +KL++L+L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI 190
+N + L +LS L D ++ N + S+ ++ A NN+ +
Sbjct: 67 SNVLYETLD--LESLSTLRTLD-----LNNNYVQELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 191 GNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVF 250
Q + + L N ++ S + ++L N++ ++ +++ S L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN-FAELAASSDTLEHL 174
Query: 251 SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSP 310
+L N + + + +KL LDLS N + + F + ++ ++L NN L
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEK 231
Query: 311 TAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG 370
+L +NL + N +F + Q + + +
Sbjct: 232 --------ALRFSQNLEHFDLRGNGFHCGTLR---DFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 371 -NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGS----IPYDLCHLERLNG 425
+ RL L+ + +GS + + + R
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
I + I Q + L + + + L + L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IEL 399
Query: 486 PSNIQNLQVLINLDLSRNQLS-GDIPITIGSLKDLVTLSLASNQFEGPIPQTFG--SLTG 542
+ L L + + + + ++ + L G
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNG 459
Query: 543 LESLDLSNNNLS 554
L L++ N +
Sbjct: 460 EADLALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-37
Identities = 56/356 (15%), Positives = 118/356 (33%), Gaps = 24/356 (6%)
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
+ + ++ + + L + + +A + LDLS N S + L +LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359
L++N L L + L TL + +N ++ +L S++ +A +
Sbjct: 65 LSSNVLYE---------TLDLESLSTLRTLDLNNNYVQELLVG------PSIETLHAANN 109
Query: 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG-SIPYDLC 418
++ + + + L N + G ++Q L L N ++ +
Sbjct: 110 NIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 419 HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478
+ L + L N + + L+ L+L SNK + + F S + ++L +
Sbjct: 167 SSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRN 223
Query: 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFG 538
N L + ++ Q L + DL N + K+ ++A + Q
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCG-TLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 539 SLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQS 594
T + L+ LK+ + +G +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 14/221 (6%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
I N + + ++L + S ++ L L GN L DL +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+ L+ N L + L SL +LR L+L +N + ++ ++N++S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG-PIPQTFGSLTGL 543
S Q + N+ L+ N+++ + G + L L N+ + + S L
Sbjct: 115 SCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
E L+L N + ++ + LK L++S NKL +
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 60/486 (12%), Positives = 117/486 (24%), Gaps = 83/486 (17%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
LNLS+ L L + S L +LD++ N EL + + N S
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
+ + L NN T G S +
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLD------------------------EGCRSRV 146
Query: 173 VNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
++L N + + LE L L N + ++ +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV---------------- 189
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291
L+ L NKL + +A+ +T + L N I
Sbjct: 190 ------------FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASL 351
+ L +L N + +S + VA ++ L
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--------VAKQTVKK-LTGQNEEECTVP 286
Query: 352 QNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG----TIPSTVGRLEQLQGLSLYGN 407
+ L +L + + G + + + +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 408 NLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWS 467
I + + L + + L + ++
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
Query: 468 LEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL---VTLSL 524
L + + + + D+ +++ + + LK L L+L
Sbjct: 407 SPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLNGEADLAL 465
Query: 525 ASNQFE 530
AS
Sbjct: 466 ASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 47/386 (12%), Positives = 100/386 (25%), Gaps = 38/386 (9%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+ L+ +N + + ++ ++ N + G R++++ L NE
Sbjct: 99 PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 110 FSG-SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGN 168
+F L+ L+L+ N + + ++L+ D N + + +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS 212
Query: 169 LSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF------------N 216
+ + ++L N L I + QNLE L N F
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 217 ISTITLINLFGNQLSGHL--------DLPPKVSYSLPNLRVFSLGKNKLTG----TIPNS 264
+ +T N + DLP + L L+ G +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 265 ITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324
N ++ +D + +I + L L + +
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
Query: 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINA 384
+ P + + + N ++ L
Sbjct: 392 QAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEEN 451
Query: 385 LNGTIPSTVGRLEQLQGLSLYGNNLE 410
+L L+L N
Sbjct: 452 ARLK------KLNGEADLALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 6e-16
Identities = 29/125 (23%), Positives = 53/125 (42%), Gaps = 8/125 (6%)
Query: 460 SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519
+I + ++ +SL +L S Q+ + LDLS N LS + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 520 VTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579
L+L+SN + SL+ L +LDL+NN + L ++ L+ ++N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 580 EIPAN 584
+ +
Sbjct: 113 RVSCS 117
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-41
Identities = 83/417 (19%), Positives = 148/417 (35%), Gaps = 57/417 (13%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
I S + +V++ E L N +I+ + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-------------- 58
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
LP + S + + +L ++ + A + L + FN+
Sbjct: 59 -------------KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
L PH F N+ L+VL L N L++ N LTTL++++N L I
Sbjct: 106 RYLPPHVFQNVPLLTVLVLERNDLSSLPRGI-------FHNTPKLTTLSMSNNNLERIED 158
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQG 401
+ SLQN +LT ++ + + SL ++ N L ST+ ++
Sbjct: 159 DTFQATT-SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEE 209
Query: 402 LSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS 460
L N++ + + L L L N L+ L + L E++L N+
Sbjct: 210 LDASHNSIN-VVRGPVNVELTILK---LQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKI 263
Query: 461 IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV 520
+ F ++ L + +S+N L +L Q + L LDLS N L + L
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 321
Query: 521 TLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L L N + + L++L LS+N+ ++L + + V
Sbjct: 322 NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 66/343 (19%), Positives = 122/343 (35%), Gaps = 50/343 (14%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+L N ++ + + + + + ++ L+L+ + + F + L +
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N + P N LT L + N L
Sbjct: 103 NAIRYLPPHV-------FQNVPLLTVLVLERNDLS------------------------- 130
Query: 363 GNIPHEI-GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421
++P I N L LS+ N L T LQ L L N L + L +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IP 186
Query: 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
L ++ N LS LA I++ EL+ N + L L L N+L
Sbjct: 187 SLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNL 238
Query: 482 SGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLT 541
+ + + N L+ +DLS N+L + ++ L L +++N+ + +
Sbjct: 239 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 295
Query: 542 GLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
L+ LDLS+N+L + ++ L+ L + HN + + +
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 336
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-35
Identities = 76/422 (18%), Positives = 146/422 (34%), Gaps = 83/422 (19%)
Query: 90 LPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLE 149
+ + L + +D F L+ +I++ +N++ +P +L
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALL------ 65
Query: 150 KWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSG 208
+ + +NL ++ EI + ++ L +G N +
Sbjct: 66 -----------------DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY 107
Query: 209 PIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITN 267
+ P +F N+ +T++ L N LS LP + ++ P L S+ N L ++
Sbjct: 108 -LPPHVFQNVPLLTVLVLERNDLS---SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163
Query: 268 ASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLT 327
+ L L LS N + + +L N++ N L+ +L +
Sbjct: 164 TTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLS------------TLAIPIAVE 208
Query: 328 TLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG 387
L + N + + PV L +L L N L
Sbjct: 209 ELDASHNSINVVRGPV----------------------------NVELTILKLQHNNL-- 238
Query: 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQCLASLIS 446
T + + L + L N LE I Y ++RL + ++ N+L + + +
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT 296
Query: 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLS 506
L+ L+L N + + + L + L NS+ +L + L NL LS N
Sbjct: 297 LKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD 352
Query: 507 GD 508
+
Sbjct: 353 CN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 66/414 (15%), Positives = 133/414 (32%), Gaps = 61/414 (14%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
+++ + + + L R++ ++L+ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
+Q L + N+ +P +F N+ L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRY-LPPHVFQ-----------------------NVPLLTV 121
Query: 175 VNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSG 232
+ L N+L +P I N L L + NNL I+ F +++ + L N+L+
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT- 178
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292
+ + +P+L ++ N L+ ++ + LD S NS + + L
Sbjct: 179 --HVDLSL---IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL 228
Query: 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQ 352
L L +N LT + L N L + ++ N L I+ L+
Sbjct: 229 TI---LKLQHNNLTD---------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLE 275
Query: 353 NFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGS 412
Y + +L + + +L VL L N L + + ++L+ L L N++ +
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 413 IPYDLCHLERLNGIRLNGNKLSGPIPQCLASLIS-LRELNLGSNKFSSSIPSSF 465
+ L + L+ N L +L + + I
Sbjct: 333 LKLST--HHTLKNLTLSHNDWDCN---SLRALFRNVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 65/370 (17%), Positives = 128/370 (34%), Gaps = 37/370 (10%)
Query: 53 RALNLSNMGLRGTIPPH-LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ + N +R +P L +F + L+++ ++ + + +N
Sbjct: 48 KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRI-GNL 169
P + L +L L N + +P +F N +L N ++ I
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 170 SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQ 229
+SL N+ L+ N L + + + +L + N LS ++ + ++ N
Sbjct: 165 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216
Query: 230 LSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTF 289
++ + V L + L N LT + N L +DLS+N ++ H F
Sbjct: 217 IN---VVRGPV---NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 290 GNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSA 349
++ L L ++NN L + L L ++ N L + F
Sbjct: 269 VKMQRLERLYISNNRLVALNLY--------GQPIPTLKVLDLSHNHLLHV-ERNQPQFD- 318
Query: 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
L+N Y + + + +L L+L N + S + ++ +
Sbjct: 319 RLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQ 373
Query: 410 EGSIPYDLCH 419
I Y L H
Sbjct: 374 HCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-29
Identities = 55/303 (18%), Positives = 108/303 (35%), Gaps = 20/303 (6%)
Query: 278 FNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+N + + + ++ + F N + ++ +R
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDV--YFGFEDITLNNQKIVTFKNSTMR 58
Query: 338 GILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLRSLIVLSLFINALNGTIPSTVGRL 396
+ ++ +F ++ D ++ I ++ L + NA+ P +
Sbjct: 59 KLPAALLDSFR-QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 116
Query: 397 EQLQGLSLYGNNLEGSIPYDL-CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSN 455
L L L N+L S+P + + +L + ++ N L + SL+ L L SN
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 456 KFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGS 515
+ + S SL + N+S N LS + + LD S N ++ +
Sbjct: 176 RLTHVDLSLIPSLFHA---NVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPV 224
Query: 516 LKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
+L L L N + GL +DLS N L + + L++L +S+N
Sbjct: 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
Query: 576 KLE 578
+L
Sbjct: 283 RLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 42/221 (19%), Positives = 81/221 (36%), Gaps = 11/221 (4%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
I + + + + + L + ++ + + L ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+ LN ++ A ++++L +G N P F ++ L + L N LS S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 485 LPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
LP I N L L +S N L T + L L L+SN+ + + L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSL 188
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
++S N LS +L + +++L+ SHN + +
Sbjct: 189 FHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 16/266 (6%)
Query: 691 LGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG+G+FGSV + + G A+K + R F+ E E+L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 746 SSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
C + R L++E +P GSL +L +D ++ L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGIV 862
+H DL NIL++ + + DFGL+K+ + + + + I + APE TE
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQEHT 921
S DV+S+GV+L E FT + + M + + G M V LL+
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQGQMIVFHLIELLKNNGR 250
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQR 947
C + + +C + +QR
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQR 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 16/266 (6%)
Query: 691 LGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG+G+FGSV + + G A+K + R F+ E E+L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 746 SSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
C + R L++E +P GSL +L +D ++ L + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGIV 862
+H DL NIL++ + + DFGL+K+ + + + + I + APE TE
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQEHT 921
S DV+S+GV+L E FT + + M + + G M V LL+
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQGQMIVFHLIELLKNNGR 281
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQR 947
C + + +C + +QR
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQR 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 22/269 (8%)
Query: 691 LGRGSFGSVYKGTF-----SDGTSFAIKVFNLQ---LDRAFRSFDSECEVLRNVRHRNLI 742
LG G FG V + + G A+K L+ E E+LRN+ H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 743 KIFSSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
K C + L++E +P+GSL+++L + ++L ++L + + ++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTE 859
VH DL N+L++ + + DFGL+K + + + + + + APE +
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD-TNLLRQ 918
DV+S+GV L E T + + HG M V N L++
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG-----PTHGQMTVTRLVNTLKE 258
Query: 919 EHTSSAEMDCLLSVLHLALDCCMESPDQR 947
+C V L C P R
Sbjct: 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 77/370 (20%), Positives = 137/370 (37%), Gaps = 29/370 (7%)
Query: 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSL 244
I S + + + M ++ ++ + + LP + S
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR---KLPAALLDSF 74
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
+ + +L ++ + A + L + FN+ L PH F N+ L+VL L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
L++ N LTTL++++N L I + SLQN +LT +
Sbjct: 135 LSSLPRGI-------FHNTPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLT-H 185
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+ + + SL ++ N L ST+ ++ L N++ L L
Sbjct: 186 VD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILK 238
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
L N L+ L + L E++L N+ + F ++ L + +S+N L +
Sbjct: 239 ---LQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLE 544
L Q + L LDLS N L + L L L N + + L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 348
Query: 545 SLDLSNNNLS 554
+L LS+N+
Sbjct: 349 NLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 80/503 (15%), Positives = 169/503 (33%), Gaps = 65/503 (12%)
Query: 90 LPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLE 149
+ + L + +D F L+ +I++ +N++ +P +L
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALL------ 71
Query: 150 KWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSG 208
+ + +NL ++ EI + ++ L +G N +
Sbjct: 72 -----------------DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY 113
Query: 209 PIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITN 267
+ P +F N+ +T++ L N LS LP + ++ P L S+ N L ++
Sbjct: 114 -LPPHVFQNVPLLTVLVLERNDLS---SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 268 ASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLT 327
+ L L LS N + + +L N++ N L+ +L +
Sbjct: 170 TTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLS------------TLAIPIAVE 214
Query: 328 TLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG 387
L + N + + + L LT + + N L+ + L N L
Sbjct: 215 ELDASHNSINVVRG----PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEK 268
Query: 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISL 447
+ ++++L+ L + N L ++ + L + L+ N L + + L
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRL 326
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS----LPSNIQNLQVLINLDLSRN 503
L L N + S+ +L+ L LS N + L N+ V +
Sbjct: 327 ENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383
Query: 504 QLSGDIPITIG----SLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPK 559
+ + D + +A + + G + ++++ + +
Sbjct: 384 DYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQ 443
Query: 560 SLEALLFLKQLNVSHNKLEGEIP 582
L +QL N+L E+
Sbjct: 444 GGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 81/522 (15%), Positives = 164/522 (31%), Gaps = 66/522 (12%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
+++ + + + L R++ ++L+ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
+Q L + N+ +P +F N+ L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRY-LPPHVFQ-----------------------NVPLLTV 127
Query: 175 VNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSG 232
+ L N+L +P I N L L + NNL I+ F +++ + L N+L+
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT- 184
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292
+ + +P+L ++ N L+ ++ + LD S NS + + L
Sbjct: 185 --HVDLSL---IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL 234
Query: 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQ 352
L L +N LT + L N L + ++ N L I+ L+
Sbjct: 235 TI---LKLQHNNLTD---------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLE 281
Query: 353 NFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGS 412
Y + +L + + +L VL L N L + + ++L+ L L N++ +
Sbjct: 282 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338
Query: 413 IPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLL 472
+ L + L+ N C + R + + + + LE+ L
Sbjct: 339 LKLS--THHTLKNLTLSHNDW-----DCNSLRALFRNVARPAVDDADQHCKIDYQLEHGL 391
Query: 473 AVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
S L I V+ + ++ + S I + Q P
Sbjct: 392 CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQS----LSHYITQQGGVP 447
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSH 574
+ + L L+ E + + L L ++
Sbjct: 448 LQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTN 489
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 86/560 (15%), Positives = 178/560 (31%), Gaps = 64/560 (11%)
Query: 50 QRVRALNLSNMGLRGTIPPH-LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYN 108
+ + N +R +P L +F + L+++ ++ + + +N
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 109 EFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRI- 166
P + L +L L N + +P +F N +L N ++ I
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167
Query: 167 GNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF 226
+SL N+ L+ N L + + + +L + N LS ++ + ++
Sbjct: 168 QATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
N ++ + V L + L N LT + N L +DLS+N ++
Sbjct: 220 HNSIN---VVRGPV---NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMY 271
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGN 346
H F ++ L L ++NN L + L L ++ N L +
Sbjct: 272 HPFVKMQRLERLYISNNRLVALNLY--------GQPIPTLKVLDLSHNHLLHV-ERNQPQ 322
Query: 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYG 406
F L+N Y + + + +L L+L N + S + ++
Sbjct: 323 FD-RLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDD 376
Query: 407 NNLEGSIPYD----LCHLERLNGIR------LNGNKLSGPIPQCLASLISLRELNLGSNK 456
+ I Y LC E + + + + + +N +
Sbjct: 377 ADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 457 FSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS----------NIQNLQVLINLDLSRNQLS 506
L+ + N L + +Q L I+ +L R +L
Sbjct: 437 SHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLP 496
Query: 507 -GDIPITIGSLKDLVTLSLASNQFEGPIPQT-----FGSLTGLESLDLSNNNLSGEI-PK 559
+ + +L + T F+ Q E L+ N L ++ K
Sbjct: 497 KDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNK 556
Query: 560 SLEALLFLKQLNVSHNKLEG 579
+ ++ ++ K++
Sbjct: 557 RAKQAELRQETSLKRQKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 68/327 (20%), Positives = 125/327 (38%), Gaps = 27/327 (8%)
Query: 260 TIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSS 319
I +++ + + + L ++ N+ + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA-------AL 70
Query: 320 LTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLRSLIVL 378
L + R + L + + I ++Q Y + +P + N+ L VL
Sbjct: 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 128
Query: 379 SLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPI 437
L N L+ +L LS+ NNLE I D L ++L+ N+L+ +
Sbjct: 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-V 186
Query: 438 PQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLIN 497
L+ + SL N+ N S++ ++E L + S NS++ + + L
Sbjct: 187 D--LSLIPSLFHANVSYNLL-STLAIPI-AVEEL---DASHNSIN-VVRGPV--NVELTI 236
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557
L L N L+ D + + LV + L+ N+ E + F + LE L +SNN L +
Sbjct: 237 LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 558 PKSLEALLFLKQLNVSHNKLEGEIPAN 584
+ + LK L++SHN L + N
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERN 319
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 18/131 (13%), Positives = 37/131 (28%), Gaps = 1/131 (0%)
Query: 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI 513
I S+ V++ + L + + + +
Sbjct: 12 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 71
Query: 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVS 573
S + + L+L Q E F ++ L + N + P + + L L +
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 574 HNKLEGEIPAN 584
N L +P
Sbjct: 132 RNDLS-SLPRG 141
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 12/109 (11%), Positives = 36/109 (33%), Gaps = 1/109 (0%)
Query: 476 LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ 535
+ SN+Q V ++ + +L + ++ ++
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 536 TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
S +E L+L++ + + +++L + N + +P +
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPH 117
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 56/335 (16%), Positives = 110/335 (32%), Gaps = 50/335 (14%)
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
+ + ++ + + L + + +A + LDLS N S + L +LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359
L++N L L + L TL + +N ++
Sbjct: 65 LSSNVLYE---------TLDLESLSTLRTLDLNNNYVQ---------------------- 93
Query: 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCH 419
E+ S+ L N ++ + + G+ + + L N + D
Sbjct: 94 --------ELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGC 142
Query: 420 LERLNGIRLNGNKLSG-PIPQCLASLISLRELNLGSNKFSSSIPSSFW-SLEYLLAVNLS 477
R+ + L N++ + AS +L LNL N + L+ L +LS
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTL---DLS 199
Query: 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE-GPIPQT 536
SN L+ + Q+ + + L N+L I + ++L L N F G +
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 537 FGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLN 571
F ++++ + + L
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 54/315 (17%), Positives = 102/315 (32%), Gaps = 25/315 (7%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
I N + + ++L+ + S + N++ L L N LS + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
L+NL N L LDL SL LR L N + + + L + N+
Sbjct: 62 LLNLSSNVLYETLDLE-----SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
S + + + LANN +T + L + N + +
Sbjct: 112 SRVSCSRGQGKKN---IYLANNKITMLRDLD-------EGCRSRVQYLDLKLNEIDTVNF 161
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQG 401
+ S +L++ + ++ ++ L L L N L + +
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 402 LSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLS-GPIPQCLASLISLRELNLGSNKFSSS 460
+SL N L I L + L L GN G + + ++ + + K +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 461 IPSSFWSLEYLLAVN 475
++ L
Sbjct: 278 QNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 49/274 (17%), Positives = 92/274 (33%), Gaps = 18/274 (6%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
R + +++ L+ + + + LD+S N +L +L ++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNL 169
+ + LS L+ L L NN L +E + N I +
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSR--G 119
Query: 170 SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSG-PIQPSIFNISTITLINLFGN 228
N+ LA N + + G ++ L L +N + + T+ +NL N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
+ D+ +V L+ L NKL + +A+ +T + L N I
Sbjct: 180 FIY---DVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKA 232
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTN 322
+ L +L N + +S +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 51/336 (15%), Positives = 102/336 (30%), Gaps = 51/336 (15%)
Query: 90 LPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLE 149
+ R + + + + S ++ L L N + I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADL------ 54
Query: 150 KWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP 209
+ L +NL+ N L ++ +L L L L N +
Sbjct: 55 -----------------APFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-- 93
Query: 210 IQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS 269
+ +I ++ N +S + + L NK+T S
Sbjct: 94 ---ELLVGPSIETLHAANNNIS---RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRS 144
Query: 270 KLTGLDLSFNSFSGL-IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTT 328
++ LDL N + + L LNL N++ + L T
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD---------VKGQVVFAKLKT 195
Query: 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALN-G 387
L ++SN L + P + + + + KL I + ++L L N + G
Sbjct: 196 LDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERL 423
T+ + +++Q ++ + C + L
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 14/221 (6%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
I N + + ++L + S ++ L L GN L DL +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+ L+ N L + L SL +LR L+L +N + ++ ++N++S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG-PIPQTFGSLTGL 543
S Q + N+ L+ N+++ + G + L L N+ + + S L
Sbjct: 115 SCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
E L+L N + ++ + LK L++S NKL +
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 49/312 (15%), Positives = 112/312 (35%), Gaps = 26/312 (8%)
Query: 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRN 131
N + ++ ++ L + ++ + L N S + + +KL++L+L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG 191
N + L +LS L D ++ N + S+ ++ A NN+ +
Sbjct: 68 NVLYETLD--LESLSTLRTLD-----LNNNYVQELLVGPSIETLHAANNNIS-RVSCSR- 118
Query: 192 NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFS 251
Q + + L N ++ S + ++L N++ ++ +++ S L +
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN-FAELAASSDTLEHLN 175
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311
L N + + + +KL LDLS N + + F + ++ ++L NN L
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEK- 231
Query: 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGN 371
+L +NL + N +F + Q + + +
Sbjct: 232 -------ALRFSQNLEHFDLRGNGFHCGTLR---DFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 372 LRSLIVLSLFIN 383
++ L +
Sbjct: 282 ECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 46/230 (20%), Positives = 86/230 (37%), Gaps = 14/230 (6%)
Query: 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
+ D L + + ++ L L N L+ + + +L+ L+L N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLE 469
DL L L + LN N + L S+ L+ +N S S +
Sbjct: 71 Y-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKK 123
Query: 470 YLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG-DIPITIGSLKDLVTLSLASNQ 528
+ L++N ++ + + LDL N++ + S L L+L N
Sbjct: 124 NI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 529 FEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
Q L++LDLS+N L+ + ++ + +++ +NKL
Sbjct: 181 IYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 29/125 (23%), Positives = 53/125 (42%), Gaps = 8/125 (6%)
Query: 460 SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519
+I + ++ +SL +L S Q+ + LDLS N LS + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 520 VTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579
L+L+SN + SL+ L +LDL+NN + L ++ L+ ++N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 580 EIPAN 584
+ +
Sbjct: 113 RVSCS 117
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-38
Identities = 72/263 (27%), Positives = 126/263 (47%), Gaps = 29/263 (11%)
Query: 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG+G FG V+ GT++ T AIK + +F E +V++ +RH L+++++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 748 CCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
+ + +V E M GSL +L +L L + +++ +A + Y+ + VH
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
DL+ +NIL+ E++V V+DFGL++L ++ + + Q I + APE G + K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKS 362
Query: 867 DVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSA 924
DV+S+G+LLTE T+ + P M E V + + G M
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMP--------------C 402
Query: 925 EMDCLLSVLHLALDCCMESPDQR 947
+C S+ L C + P++R
Sbjct: 403 PPECPESLHDLMCQCWRKEPEER 425
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-37
Identities = 70/342 (20%), Positives = 134/342 (39%), Gaps = 55/342 (16%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
V ++G++ LT T+P+ + +T L + N+ + L P LR L ++ N L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTSL-PALPPELR---TLEVSGNQL 93
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
T+ L+ + L + L + + +LT ++
Sbjct: 94 TSLPV--------LPPGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQLT-SL 136
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
P L+ L V + +L +L L Y N L S+P L+ L+
Sbjct: 137 PVLPPGLQELSVSDNQLASLPALPS-------ELCKLWAYNNQLT-SLPMLPSGLQELS- 187
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
++ N+L+ +P L +L +N+ +S +P+ L+ L +S N L+ SL
Sbjct: 188 --VSDNQLAS-LP---TLPSELYKLWAYNNRLTS-LPALPSGLKEL---IVSGNRLT-SL 236
Query: 486 PSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES 545
P L+ L +S N+L+ +P+ L +LS+ NQ +P++ L+ +
Sbjct: 237 PVLPSELK---ELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLTR-LPESLIHLSSETT 288
Query: 546 LDLSNNNLS---GEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
++L N LS + + + + + + P
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 3e-36
Identities = 80/417 (19%), Positives = 143/417 (34%), Gaps = 86/417 (20%)
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
+ +L++ + T +P+ L + N + ++P+ L +L ++ N
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 181 NLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKV 240
L +P L L I + +L S + + +FGNQL+ LP
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT---SLPV-- 138
Query: 241 SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300
P L+ S+ N+L ++P + L L N + L P L+ L++
Sbjct: 139 --LPPGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLTSL-PMLPSGLQ---ELSV 188
Query: 301 ANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCK 360
++N L + LP + L +AY+ +
Sbjct: 189 SDNQLAS--------------------------------LPTLPSE----LYKLWAYNNR 212
Query: 361 LTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHL 420
LT ++P L+ LIV + +L P +L+ L + GN L S+P L
Sbjct: 213 LT-SLPALPSGLKELIVSGNRLTSL----PVLPS---ELKELMVSGNRLT-SLPMLPSGL 263
Query: 421 ERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS---SIPSSFWSLEYLLAVNLS 477
L+ + N+L+ +P+ L L S +NL N S S +
Sbjct: 264 LSLS---VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
Query: 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPIT----IGSLKDLVTLSLASNQFE 530
+ S P + L + L + P G + SL ++
Sbjct: 320 FDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-34
Identities = 85/437 (19%), Positives = 152/437 (34%), Gaps = 65/437 (14%)
Query: 180 NNLQGEIPSEIGN--LQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLP 237
+ + + ++ +L +G + L+ + + IT + + N L+ LP
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT---SLP 77
Query: 238 PKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSV 297
P LR + N+LT ++P +L+ L L
Sbjct: 78 A----LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCK 125
Query: 298 LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAY 357
L + N LT S L L+V+ N L LP + L +AY
Sbjct: 126 LWIFGNQLT--------SLPVLPPG---LQELSVSDNQLAS-LPALPSE----LCKLWAY 169
Query: 358 DCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDL 417
+ +LT ++P L+ L S+ N L ++P+ +L L Y N L S+P
Sbjct: 170 NNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPS---ELYKLWAYNNRLT-SLPALP 220
Query: 418 CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLS 477
L+ L ++GN+L+ +P L+EL + N+ +S +P L L ++
Sbjct: 221 SGLKELI---VSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPMLPSGLLSL---SVY 269
Query: 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS---LASNQFEGPIP 534
N L+ LP ++ +L ++L N LS + + S + + P
Sbjct: 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAP 328
Query: 535 QTFGSLTGLESLDLSNNNLSG----EIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYF 590
+ +L + L + ++ ++L E F
Sbjct: 329 RETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS-ETENFIKDAGF 387
Query: 591 APQSFSWNYALCGPTTL 607
Q SW L L
Sbjct: 388 KAQISSWLAQLAEDEAL 404
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 70/416 (16%), Positives = 116/416 (27%), Gaps = 108/416 (25%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+ L + + L ++P L +L++S N + LP L L S
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTH 115
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNL 169
+ S L L + N T +P L L D+ ++P+ L
Sbjct: 116 LP-------ALPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDNQLA----SLPALPSEL 163
Query: 170 SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQ 229
L N L +P LQ L ++ NQ
Sbjct: 164 CKL---WAYNNQLT-SLPMLPSGLQEL---------------------------SVSDNQ 192
Query: 230 LSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTF 289
L+ LP L N+LT ++P + L L +S N + L P
Sbjct: 193 LA---SLPT----LPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTSL-PVLP 240
Query: 290 GNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSA 349
L+ L ++ N LT+ LP +
Sbjct: 241 SELK---ELMVSGNRLTS--------------------------------LPMLPSG--- 262
Query: 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
L + Y +LT +P + +L S ++L N L+ R ++ Y +
Sbjct: 263 -LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPI 317
Query: 410 EGSIPYDLCHLERLNG--IRLNGNKLSGPIPQCLASLISLREL--NLGSNKFSSSI 461
R + L A ++ FS +
Sbjct: 318 I-RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFL 372
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-24
Identities = 55/327 (16%), Positives = 101/327 (30%), Gaps = 51/327 (15%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
R L +S L ++P L + LP L +L + N+ +
Sbjct: 84 RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT- 134
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
S P LQ LS+ +N +P L +L +++ ++P L L
Sbjct: 135 SLPVLPP---GLQELSVSDNQLAS-LPALPSELCKLWAYNNQLT----SLPMLPSGLQEL 186
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN---------------- 216
+++ N L +P+ L L NN +
Sbjct: 187 ---SVSDNQLA-SLPTLPSELYKLWAY----NNRLTSLPALPSGLKELIVSGNRLTSLPV 238
Query: 217 -ISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLD 275
S + + + GN+L+ LP L S+ +N+LT +P S+ + S T ++
Sbjct: 239 LPSELKELMVSGNRLT---SLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 276 LSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNP 335
L N S + + +A + + A P
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
Query: 336 LRGILPPVIGNFSASLQNFYAYDCKLT 362
+ G + F + +L+
Sbjct: 351 APADRWHMFGQ-EDNADAFSLFLDRLS 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-37
Identities = 72/263 (27%), Positives = 126/263 (47%), Gaps = 29/263 (11%)
Query: 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG+G FG V+ GT++ T AIK + +F E +V++ +RH L+++++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 748 CCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
+ + +V E M GSL +L +L L + +++ +A + Y+ + VH
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
DL+ +NIL+ E++V V+DFGL++L ++ + + Q I + APE G + K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKS 445
Query: 867 DVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSA 924
DV+S+G+LLTE T+ + P M E V + + G M
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMP--------------C 485
Query: 925 EMDCLLSVLHLALDCCMESPDQR 947
+C S+ L C + P++R
Sbjct: 486 PPECPESLHDLMCQCWRKEPEER 508
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
+G G FG V+ G + + AIK + + F E EV+ + H L++++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810
LV E M +G L +L + L + + V + YL V+H DL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 131
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYS 870
N L+ E+ V VSDFG+++ + + + + + +PE + SSK DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-VKWASPEVFSFSRYSSKSDVWS 190
Query: 871 YGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAEMDC 928
+GVL+ E F+ K P ++ E V E + G +
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLY--------------KPRLA 230
Query: 929 LLSVLHLALDCCMESPDQR 947
V + C E P+ R
Sbjct: 231 STHVYQIMNHCWRERPEDR 249
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-37
Identities = 84/382 (21%), Positives = 131/382 (34%), Gaps = 66/382 (17%)
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGH 233
V +P I +L LG N + + F + + + L N +S
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVS-- 69
Query: 234 LDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLR 293
+ P +L NLR L N+L T S LT LD+S N L+ + F +L
Sbjct: 70 -AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 294 FLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQN 353
L L + +N L S A + +L L + L I S
Sbjct: 129 NLKSLEVGDNDLVYISHRA-------FSGLNSLEQLTLEKCNLTSIPT---EALS----- 173
Query: 354 FYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSI 413
+L LIVL L +N + RL +L+ L + ++
Sbjct: 174 -----------------HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216
Query: 414 PYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLA 473
+ + L + + L+ + L+ LR LNL N S+ S L L
Sbjct: 217 TPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQE 276
Query: 474 VNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
+ L L+ + + L L L++S NQL+ TL
Sbjct: 277 IQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT--------------TLE--------- 312
Query: 533 IPQTFGSLTGLESLDLSNNNLS 554
F S+ LE+L L +N L+
Sbjct: 313 -ESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 73/334 (21%), Positives = 123/334 (36%), Gaps = 34/334 (10%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
R+ LGKN++ + + L L+L+ N S + P F NL L L L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
L T NLT L ++ N + +L F
Sbjct: 92 LKLIPLGV-------FTGLSNLTKLDISENKIVILLD---YMFQ---------------- 125
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+L +L L + N L L L+ L+L NL L HL L
Sbjct: 126 ------DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLI 179
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+RL ++ L L+ L + + ++ + L +++++ +L+ +
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-A 238
Query: 485 LPSN-IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
+P +++L L L+LS N +S + L L + L Q P F L L
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L++S N L+ ++ L+ L + N L
Sbjct: 299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-34
Identities = 74/324 (22%), Positives = 121/324 (37%), Gaps = 19/324 (5%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTI 220
+P I + ++L N ++ E + +LE L L N +S ++P F N+ +
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNL 82
Query: 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280
+ L N+L +P V L NL + +NK+ + + L L++ N
Sbjct: 83 RTLGLRSNRLK---LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139
Query: 281 FSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGIL 340
+ F L L L L LT+ A L++ L L + + I
Sbjct: 140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA-------LSHLHGLIVLRLRHLNINAIR 192
Query: 341 PPVIGNFS--ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQ 398
+F L+ + +L LS+ L V L
Sbjct: 193 D---YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS 458
L+ L+L N + L L RL I+L G +L+ P L LR LN+ N+ +
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLS 482
+ S F S+ L + L SN L+
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 83/422 (19%), Positives = 142/422 (33%), Gaps = 62/422 (14%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS- 111
RA+ +P + + LD+ KN +E L + L+ N S
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 112 ---GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRI- 166
G+F + L L+ L LR+N IP +F LS L K D N I + +
Sbjct: 71 VEPGAFNN----LFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKI-VILLDYMF 124
Query: 167 GNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLIN 224
+L +L ++ + N+L I L +LE L L NL+ I ++ + ++
Sbjct: 125 QDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLR 182
Query: 225 LFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGL 284
L ++ + L L+V + T+ + LT L ++ + + +
Sbjct: 183 LRHLNIN---AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239
Query: 285 IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344
+L +L LNL+ N ++T + L L + + L + P
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSM-------LHELLRLQEIQLVGGQLAVVEP--- 289
Query: 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404
F L L VL++ N L S + L+ L L
Sbjct: 290 YAFR----------------------GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327
Query: 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSS 464
N L C L + R + P C A+ ++ P+
Sbjct: 328 DSNPLACD-----CRLLWVFR-RRWRLNFNRQQPTC-ATPEFVQGKEFKDFPDVLL-PNY 379
Query: 465 FW 466
F
Sbjct: 380 FT 381
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 67/341 (19%), Positives = 109/341 (31%), Gaps = 62/341 (18%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
R + + +P I ++ LDL N L F + L L L N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
++ P A N NL TL + SN L+ I G F+
Sbjct: 68 VSAVEPGA-------FNNLFNLRTLGLRSNRLKLIPL---GVFT---------------- 101
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD-LCHLERL 423
L +L L + N + + L L+ L + N+L I + L L
Sbjct: 102 ------GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154
Query: 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
+ L L+ + L+ L L L L ++ SF L L + +S
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
++ N L +L ++ L+ +P L L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVP-----------------------YLAVRHLVYL 250
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
L+LS N +S L LL L+++ + +L +
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPY 290
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 69/318 (21%), Positives = 116/318 (36%), Gaps = 48/318 (15%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
R L+L ++ +F L L++++N A P L LR + L N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 111 S----GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSR 165
G F LS L L + N + + +F +L L+ + N + I R
Sbjct: 93 KLIPLGVFTG----LSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDL-VYISHR 146
Query: 166 I-GNLSSLVNVNLAYNNLQGEIPSEI-------------------------GNLQNLEIL 199
L+SL + L NL IP+E L L++L
Sbjct: 147 AFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVL 205
Query: 200 VLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG 259
+ + P+ +T +++ L+ +P L LR +L N ++
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT---AVPYLAVRHLVYLRFLNLSYNPIST 262
Query: 260 TIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSS 319
+ + +L + L + + P+ F L +L VLN++ N LTT +
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV------- 315
Query: 320 LTNCRNLTTLAVASNPLR 337
+ NL TL + SNPL
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 32/135 (23%), Positives = 55/135 (40%), Gaps = 2/135 (1%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
R++ L +S+ T+ P+ L SL I+ N A + L LRF++L YN
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GN 168
S S + L +LQ + L P + L+ L + N + + + +
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 169 LSSLVNVNLAYNNLQ 183
+ +L + L N L
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 65/268 (24%), Positives = 99/268 (36%), Gaps = 35/268 (13%)
Query: 691 LGRGSFGSVYKGTF----SDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIK 743
LG GSFG V +G + S A+K L A F E + ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
++ + +V EL P GSL L L + VA + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT---IGYMAPEYGTEG 860
+H DL N+LL + + DFGL + + DD M + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFAWCAPESLKTR 199
Query: 861 IVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919
S D + +GV L E FT ++P + ++ + +D R
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKEGERLP 245
Query: 920 HTSSAEMDCLLSVLHLALDCCMESPDQR 947
DC + ++ + C P+ R
Sbjct: 246 ----RPEDCPQDIYNVMVQCWAHKPEDR 269
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-37
Identities = 61/263 (23%), Positives = 116/263 (44%), Gaps = 29/263 (11%)
Query: 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG G FG V+ T++ T A+K + +F +E V++ ++H L+K+ +
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 748 CCNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
++ E M GSL +L S + L + ++ +A + ++ + +H
Sbjct: 252 VTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
DL+ +NIL+ +V ++DFGL+++ ++ + + + I + APE G + K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKS 366
Query: 867 DVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSA 924
DV+S+G+LL E T + P M E V +L G M
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMP--------------R 406
Query: 925 EMDCLLSVLHLALDCCMESPDQR 947
+C + ++ + C P++R
Sbjct: 407 PENCPEELYNIMMRCWKNRPEER 429
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 65/265 (24%), Positives = 102/265 (38%), Gaps = 32/265 (12%)
Query: 691 LGRGSFGSVYKGTFSDG-----TSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG+VYKG + AIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C L+ +LMP G L ++ + LN + +A + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH DL N+L+ ++DFGL+KL + I +MA E I +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTS 922
+ DV+SYGV + E T KP D + E + L G +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLP------------- 239
Query: 923 SAEMDCLLSVLHLALDCCMESPDQR 947
C + V + C M D R
Sbjct: 240 -QPPICTIDVYMIMRKCWMIDADSR 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 27/259 (10%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V G + A+K+ + + F E + + + H L+K + C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810
+V E + NG L +L S L+ + L + V + +L +H DL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLA 131
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYS 870
N L+D D+ VSDFG+++ + + + + APE SSK DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-VKWSAPEVFHYFKYSSKSDVWA 190
Query: 871 YGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAEMDC 928
+G+L+ E F+ K P D E V + G +
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHRLY--------------RPHLA 230
Query: 929 LLSVLHLALDCCMESPDQR 947
++ + C E P++R
Sbjct: 231 SDTIYQIMYSCWHELPEKR 249
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 70/267 (26%), Positives = 111/267 (41%), Gaps = 19/267 (7%)
Query: 691 LGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG+G+FGSV + + G A+K R F E ++L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 746 SSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
++ LV+E +P+G L +L LD L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGIV 862
VH DL NIL++ + ++DFGL+KL D V + + I + APE ++ I
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 863 SSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLP-HGLMEVVDTNLLRQEH 920
S + DV+S+GV+L E FT K + + + L +++ LL +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLE--LLEEGQ 261
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQR 947
A C V L C SP R
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDR 288
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 68/268 (25%), Positives = 110/268 (41%), Gaps = 31/268 (11%)
Query: 689 NLLGRGSFGSVYKGTFSDG----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743
++GRG FG VY GT D A+K N F +E ++++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 744 IFSSCCNNDFRAL-VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ C ++ L VL M +G L ++ ++ + + + + + VA ++YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--IGYMAPEYGTEG 860
VH DL N +LDE V+DFGL++ + + T A + +MA E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD-TNLLRQE 919
++K DV+S+GVLL E TR G P+ + D T L Q
Sbjct: 208 KFTTKSDVWSFGVLLWELMTR---------GAP----------PYPDVNTFDITVYLLQG 248
Query: 920 HTSSAEMDCLLSVLHLALDCCMESPDQR 947
C + + L C + R
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMR 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-36
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIK 743
F ++LG G+ G++ D A+K + F D E ++LR H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
F + + F+ + +EL +L++++ ++ LE + ++ L +L HS
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLN 138
Query: 804 VVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPEY- 856
+VH DLKP NIL+ + A +SDFGL K G S ++ + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 857 --GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+ + D++S G + +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 65/264 (24%), Positives = 105/264 (39%), Gaps = 31/264 (11%)
Query: 691 LGRGSFGSVYKGTFSDG---TSFAIKVF-NLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
LG G+FGSV +G + AIKV E +++ + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
C LV+E+ G L K+L + + ++ V++ ++YL + VH
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 133
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGIVSSK 865
DL N+LL A +SDFGLSK D ++ + + APE SS+
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 866 CDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG-LMEVVDTNLLRQEHTSS 923
DV+SYGV + E + +KP M E V + G ME
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRME-------------- 233
Query: 924 AEMDCLLSVLHLALDCCMESPDQR 947
+C + L DC + + R
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDR 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-36
Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 31/265 (11%)
Query: 691 LGRGSFGSVYKGTF----SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIF 745
+G G FG V G S AIK + ++ R F E ++ H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+ +V E M NGSL+ +L + +++ + ++ G+A ++YL V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
H DL NIL++ ++V VSDFGL + L D+ + + T I + +PE +S
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG-LMEVVDTNLLRQEHTS 922
DV+SYG++L E + ++P +M + V +++ G +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLP------------- 270
Query: 923 SAEMDCLLSVLHLALDCCMESPDQR 947
MDC ++ L LDC + + R
Sbjct: 271 -PPMDCPAALYQLMLDCWQKDRNNR 294
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 72/269 (26%), Positives = 110/269 (40%), Gaps = 24/269 (8%)
Query: 691 LGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLI 742
LG G FG V + G A+K L+ D + + E ++LR + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 743 KIFSSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
K C + + LV+E +P GSL +L + + L + L + + YLH H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTE 859
+H DL N+LLD D + + DFGL+K EG + + + + + APE E
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT-NLLRQ 918
DV+S+GV L E T + T + L + G M V+ LL +
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGIAQGQMTVLRLTELLER 266
Query: 919 EHTSSAEMDCLLSVLHLALDCCMESPDQR 947
C V HL +C R
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFR 295
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 63/259 (24%), Positives = 104/259 (40%), Gaps = 27/259 (10%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V G + AIK+ + + F E +V+ N+ H L++++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810
++ E M NG L +L + + L + V A+EYL +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 147
Query: 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYS 870
N L+++ V VSDFGLS+ + + + + + + PE SSK D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 206
Query: 871 YGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAEMDC 928
+GVL+ E ++ K P + E E + GL +
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLY--------------RPHLA 246
Query: 929 LLSVLHLALDCCMESPDQR 947
V + C E D+R
Sbjct: 247 SEKVYTIMYSCWHEKADER 265
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 678 IQRATDGFNECNLLGRGSFGSVYKGTFSDG----TSFAIKVFN-LQLDRAFRSFDSECEV 732
I + ++G+G FG VY G + D AIK + + + +F E +
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 733 LRNVRHRNLIKIFSSCCNNDFRAL-VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVAL 791
+R + H N++ + + +L M +G L +++ S + + ++ + VA
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--I 849
+EYL VH DL N +LDE V+DFGL++ + + Q A +
Sbjct: 136 GMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR 881
+ A E ++K DV+S+GVLL E TR
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-36
Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 31/268 (11%)
Query: 689 NLLGRGSFGSVYKGTFSDG----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743
++GRG FG VY GT D A+K N F +E ++++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 744 IFSSCCNNDF-RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ C ++ +VL M +G L ++ ++ + + + + + VA +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT--IGYMAPEYGTEG 860
VH DL N +LDE V+DFGL++ + + T A + +MA E
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD-TNLLRQE 919
++K DV+S+GVLL E TR G P+ + D T L Q
Sbjct: 272 KFTTKSDVWSFGVLLWELMTR---------GAP----------PYPDVNTFDITVYLLQG 312
Query: 920 HTSSAEMDCLLSVLHLALDCCMESPDQR 947
C + + L C + R
Sbjct: 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 691 LGRGSFGSVYKGTF----SDGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKIF 745
+G G G V G AIK +R R F SE ++ H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+V E M NGSL+ +L + + +++ + ++ GV + YL V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
H DL N+L+D ++V VSDFGLS+ L D+ D + T T I + APE SS
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDM 888
DV+S+GV++ E ++P +M
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 32/264 (12%)
Query: 691 LGRGSFGSVYKGTFSDG----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIF 745
+G G FG V++G + + AIK D F E +R H +++K+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
N +++EL G L +L Y LDL + ++ AL YL V
Sbjct: 83 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H D+ N+L+ + + DFGLS+ ++ + I +MAPE +S
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSA 197
Query: 866 CDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG-LMEVVDTNLLRQEHTSS 923
DV+ +GV + E KP + + V + +G +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLP-------------- 237
Query: 924 AEMDCLLSVLHLALDCCMESPDQR 947
+C ++ L C P +R
Sbjct: 238 MPPNCPPTLYSLMTKCWAYDPSRR 261
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 61/265 (23%), Positives = 104/265 (39%), Gaps = 32/265 (12%)
Query: 691 LGRGSFGSVYKGTFSDG-----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKI 744
LG G FG+V+KG + IKV + ++F++ + ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C LV + +P GSL + L LN + +A + YL +
Sbjct: 81 LG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---M 136
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH +L N+LL V+DFG++ L D + + I +MA E G +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTS 922
+ DV+SYGV + E T +P + E V + L G +
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKGERLA------------- 237
Query: 923 SAEMDCLLSVLHLALDCCMESPDQR 947
C + V + + C M + R
Sbjct: 238 -QPQICTIDVYMVMVKCWMIDENIR 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 67/266 (25%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-----AIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKI 744
+G G FG VYKG + AIK ++ F E ++ H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
++ E M NG+L+K+L + +L+ + ++ G+A ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSK-LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVS 863
VH DL NIL++ ++V VSDFGLS+ L D+ + + T + I + APE + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 864 SKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHG-LMEVVDTNLLRQEHT 921
S DV+S+G+++ E T ++P ++ E V +++ G +
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLP------------ 270
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQR 947
MDC ++ L + C + +R
Sbjct: 271 --TPMDCPSAIYQLMMQCWQQERARR 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 64/260 (24%), Positives = 122/260 (46%), Gaps = 29/260 (11%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
LG G FG V+ G ++ T A+K Q + +F +E +++ ++H+ L+++++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 751 NDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDL 809
+ ++ E M NGSL +L + L + + L++ +A + ++ + +H DL
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 810 KPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVY 869
+ +NIL+ + + ++DFGL++L ++ + + + I + APE G + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 870 SYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAEMD 927
S+G+LLTE T + P M E V ++L G M +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMV--------------RPDN 234
Query: 928 CLLSVLHLALDCCMESPDQR 947
C + L C E P+ R
Sbjct: 235 CPEELYQLMRLCWKERPEDR 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-35
Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 29/264 (10%)
Query: 688 CNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+ LG G +G VY+G + + A+K + F E V++ ++H NL+++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
C ++ E M G+L +L N + + L + ++ A+EYL + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H +L N L+ E+ + V+DFGLS+L GD I + APE S K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 866 CDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSS 923
DV+++GVLL E T P + + V E L ME
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRME-------------- 439
Query: 924 AEMDCLLSVLHLALDCCMESPDQR 947
C V L C +P R
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDR 463
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 33/265 (12%)
Query: 691 LGRGSFGSVYKGTF---SDGTSFAIKVF--NLQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG G+FG+V KG + + A+K+ +E V++ + + ++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
C + LV+E+ G L K+L N + + ++ V++ ++YL + V
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 139
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGIVSS 864
H DL N+LL A +SDFGLSK ++ QT + + APE SS
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTS 922
K DV+S+GVL+ E F+ +KP M E V L G M
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMG------------- 240
Query: 923 SAEMDCLLSVLHLALDCCMESPDQR 947
C + L C + R
Sbjct: 241 -CPAGCPREMYDLMNLCWTYDVENR 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-35
Identities = 74/261 (28%), Positives = 113/261 (43%), Gaps = 35/261 (13%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
+G+G FG V G + G A+K ++ D ++F +E V+ +RH NL+++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 751 NDFRA-LVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+V E M GSL +L S L L + V A+EYL + VH D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 809 LKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDV 868
L N+L+ ED VA VSDFGL+K + S TQ + + APE E S+K DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 869 YSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAEM 926
+S+G+LL E ++ + P + + V + G M+ A
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMD--------------APD 409
Query: 927 DCLLSVLHLALDCCMESPDQR 947
C +V + +C R
Sbjct: 410 GCPPAVYDVMKNCWHLDAATR 430
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 64/264 (24%), Positives = 103/264 (39%), Gaps = 30/264 (11%)
Query: 691 LGRGSFGSVYKGTFSDG-----TSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG+VYKG + AIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
C L+ +LMP G L ++ + LN + +A + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH DL N+L+ ++DFGL+KL + I +MA E I +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 865 KCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923
+ DV+SYGV + E T KP D + E+ +L +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGI-----------------PASEISS--ILEKGERLP 239
Query: 924 AEMDCLLSVLHLALDCCMESPDQR 947
C + V + + C M D R
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSR 263
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 11/204 (5%)
Query: 691 LGRGSFGSVYKGTF----SDGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG G FG VY+G + + + A+K F SE +++N+ H +++K+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+++EL P G L +L + L +L + + + A+ YL + V
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H D+ NIL+ + DFGLS+ ++ D + I +M+PE ++
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRFTTA 194
Query: 866 CDVYSYGVLLTETFTR-KKPTDDM 888
DV+ + V + E + K+P +
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWL 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 45/230 (19%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH 738
R F E +LG+G+FG V K D +AIK + + SE +L ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 739 RNLIKIFSSCCNNDFRA-------------LVLELMPNGSLEKWLYSDNYFLDLLERLNI 785
+ +++ +++ + +E NG+L ++S+N E +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 786 MIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
+ AL Y+H G ++H DLKP NI +DE + DFGL+K D +
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 845 TIAT---------IG---YMAPE-------YGTEGIVSSKCDVYSYGVLL 875
IG Y+A E Y K D+YS G++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIF 221
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 64/264 (24%), Positives = 105/264 (39%), Gaps = 31/264 (11%)
Query: 691 LGRGSFGSVYKGTFSDG---TSFAIKVF-NLQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
LG G+FGSV +G + AIKV E +++ + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
C LV+E+ G L K+L + + ++ V++ ++YL + VH
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQTMTIATIGYMAPEYGTEGIVSSK 865
+L N+LL A +SDFGLSK D ++ + + APE SS+
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 866 CDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSS 923
DV+SYGV + E + +KP M E V + G ME
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRME-------------- 559
Query: 924 AEMDCLLSVLHLALDCCMESPDQR 947
+C + L DC + + R
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDR 583
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 23/232 (9%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNL--IKI 744
+G G V++ +AIK NL+ ++ S+ +E L ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTP 803
+ + + +V+E N L WL D ER + + A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-------- 855
+VH DLKP+N L+ + M+ + DFG++ SV + + T+ YM PE
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 856 ---YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
++ +S K DV+S G +L K P + L + +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 691 LGRGSFGSVYKGTFSDG----TSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKI 744
LG G FGSV +G A+K L R F SE +++ H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 745 FSSCCNNDFRA-----LVLELMPNGSLEKWL-----YSDNYFLDLLERLNIMIGVALALE 794
C + ++L M G L +L + + L L M+ +AL +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YL + + +H DL N +L +DM V+DFGLSK GD + + ++A
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTR 881
E + + +SK DV+++GV + E TR
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 23/232 (9%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNL--IKI 744
+G G V++ +AIK NL+ ++ S+ +E L ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTP 803
+ + + +V+E N L WL D ER + + A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-------- 855
+VH DLKP+N L+ + M+ + DFG++ SV + + T+ YM PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 856 ---YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
++ +S K DV+S G +L K P + L + +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 74/263 (28%), Positives = 112/263 (42%), Gaps = 35/263 (13%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+G+G FG V G + G A+K ++ D ++F +E V+ +RH NL+++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 749 CNNDFRA-LVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
+V E M GSL +L S L L + V A+EYL VH
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
DL N+L+ ED VA VSDFGL+K + S TQ + + APE E S+K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 867 DVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSA 924
DV+S+G+LL E ++ + P + + V + G M+ A
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMD--------------A 235
Query: 925 EMDCLLSVLHLALDCCMESPDQR 947
C +V + +C R
Sbjct: 236 PDGCPPAVYEVMKNCWHLDAAMR 258
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 68/262 (25%), Positives = 105/262 (40%), Gaps = 31/262 (11%)
Query: 691 LGRGSFGSVYKGTFSDG-TSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKIFSSC 748
LG G +G VY+G + + A+K L+ D F E V++ ++H NL+++ C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
++ E M G+L +L N + + L + ++ A+EYL +H
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 808 DLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCD 867
DL N L+ E+ + V+DFGLS+L + I + APE S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSD 194
Query: 868 VYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGL-MEVVDTNLLRQEHTSSAE 925
V+++GVLL E T P + + V E L ME
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRME--------------RP 234
Query: 926 MDCLLSVLHLALDCCMESPDQR 947
C V L C +P R
Sbjct: 235 EGCPEKVYELMRACWQWNPSDR 256
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-34
Identities = 97/515 (18%), Positives = 186/515 (36%), Gaps = 55/515 (10%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
++ S GL +P L L+IS+N +++ L +LR + + +N
Sbjct: 5 VDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLV 173
S +L+ L L +N + NL L D FN D I GN+S L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFDALPICKEFGNMSQLK 118
Query: 174 NVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQP-SIFNISTITLI--------- 223
+ L+ +L+ I +L ++L++ P + + +T +L
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 224 -NLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFS 282
+ + +L + S + L N + L ++ ++NSF
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 283 GLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPP 342
+ + +V + + + F S T+ + L+ V S+
Sbjct: 239 RI----LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF------ 288
Query: 343 VIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGL 402
Y Y+ ++ + + ++ ++ L
Sbjct: 289 -------GFPQSYIYE------------IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329
Query: 403 SLYGNNLEGSIPYDLCHLERLNGIRLNGNKLS--GPIPQCLASLISLRELNLGSNKFSSS 460
N L ++ + HL L + L N+L I + + SL++L++ N S
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389
Query: 461 IPS-SFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKD 518
+ LL++N+SSN L+ ++ + ++VL DL N++ IP + L+
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVL---DLHSNKIK-SIPKQVVKLEA 445
Query: 519 LVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
L L++ASNQ + F LT L+ + L N
Sbjct: 446 LQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 63/388 (16%), Positives = 126/388 (32%), Gaps = 36/388 (9%)
Query: 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLS 277
T++N+ N +S +L SL LR+ + N++ + +L LDLS
Sbjct: 21 QKTTILNISQNYIS---ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 278 FNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
N + H NL+ L +L+ N E +++ L L +++ L
Sbjct: 78 HNKLVKISCHPTVNLKHL---DLSFNAFDALPICKE---FGNMSQ---LKFLGLSTTHLE 128
Query: 338 GILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLE 397
I + + S + + L+ SL I + +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 398 QLQGLSLYGNNLEGSIPYDLCHLER----------------LNGIRLNGNKLSGPIPQCL 441
+L +N++ + + C LN I N +
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW 245
Query: 442 ASLI---SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINL 498
+ + S+ + L S SL+ L + S+ + +
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
Query: 499 DLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS--GE 556
+ + + + + + L ++N + + G LT LE+L L N L +
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365
Query: 557 IPKSLEALLFLKQLNVSHNKLEGEIPAN 584
I + + L+QL++S N + +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 8e-15
Identities = 44/274 (16%), Positives = 93/274 (33%), Gaps = 21/274 (7%)
Query: 43 ISCGARHQRVRALNLSNMGLRGTIPPHLGNF---SFLMSLDISKNNFHAYLPNELG---- 95
++ + ++ L L+N+ + + + IS L
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 96 -QLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSM 154
L+ L + + F + S + I + + +S D
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 155 FNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG---NLQNLEILVLGMNNLSGPIQ 211
N++ + G+L+ L + L N L+ E+ +++L+ L + N++S +
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 212 PSIF-NISTITLINLFGNQLSGHLDLPPKVSYSLP-NLRVFSLGKNKLTGTIPNSITNAS 269
++ +N+ N L + LP ++V L NK+ +IP +
Sbjct: 392 KGDCSWTKSLLSLNMSSNIL------TDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 270 KLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
L L+++ N + F L L + L N
Sbjct: 445 ALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 9/117 (7%)
Query: 472 LAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
V+ S N L +P ++ Q +L ++S+N +S I SL L L ++ N+ +
Sbjct: 3 FLVDRSKNGLI-HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPF 587
F LE LDLS+N L LK L++S N + +P F
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFD-ALPICKEF 111
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKV------FNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG+G FGSV + +KV ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 745 FSSCCNNDFRA------LVLELMPNGSLEKWL-----YSDNYFLDLLERLNIMIGVALAL 793
+ + ++L M +G L +L + + L L + M+ +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
EYL + +H DL N +L EDM V+DFGLS+ GD + + ++A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFTR 881
E + + + DV+++GV + E TR
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 28/228 (12%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR 737
+R F E L+G G FG V+K DG ++ IK ++A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 738 HRNLIKIFSSCCNNDFRA----------------LVLELMPNGSLEKWLYSDN-YFLDLL 780
H N++ D+ + +E G+LE+W+ LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 781 ERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840
L + + ++Y+H S +++ DLKPSNI L + + DFGL
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+ T+ YM+PE + + D+Y+ G++L E +
Sbjct: 180 R---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQ-LDRAFRSFDSECEVLR-NV 736
Q + +LG GS G+V G A+K + D A E ++L +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESD 66
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL------NIMIGVA 790
H N+I+ + S + F + LEL N +L+ + S N + L+ +++ +A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 791 LALEYLH-HGHSTPVVHCDLKPSNILLD-------------EDMVAHVSDFGLSKLFDEG 836
+ +LH ++H DLKP NIL+ E++ +SDFGL K D G
Sbjct: 126 SGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 837 DDSVTQTMTIA--TIGYMAPE-------YGTEGIVSSKCDVYSYGVLL 875
S + T G+ APE T+ ++ D++S G +
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 690 LLGRGSFGSVYKGTFSD---GTSFAIKVFNLQL--DRAFRS-FDSECEVLRNVRHRNLIK 743
L+GRG G VY+ D A+K+ + L D FR+ E ++ +++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
I + + + L+ L L L + I+ + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAG--- 154
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT-MTIATIGYMAPEYGTEGIV 862
H D+KP NIL+ D A++ DFG++ D+ +TQ T+ T+ YMAPE +E
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
+ + D+Y+ +L E T P + G+
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 80/400 (20%), Positives = 151/400 (37%), Gaps = 26/400 (6%)
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NIST 219
+P+ + + +L+ N++ + LQ+L+ L + I+ + F +S+
Sbjct: 27 ELPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTI--PNSITNASKLTGLDLS 277
+ ++ L NQ L L NL V +L + L G + N + L L L
Sbjct: 81 LIILKLDYNQFL---QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 278 FNSFSGLIPHT-FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
N+ + P + F N+R VL+L N + + +F L+++ +
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 337 RGILPPVIGNFS--ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVG 394
+ GN S+ ++ + + + I + + + S+
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-- 255
Query: 395 RLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGS 454
+G + L+ +K+ + + L +L L
Sbjct: 256 -FGHTNFKDPDNFTFKGLEASGVKTC------DLSKSKIFALLKSVFSHFTDLEQLTLAQ 308
Query: 455 NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI 513
N+ + ++FW L +LL +NLS N L S+ S + +NL L LDLS N + +
Sbjct: 309 NEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367
Query: 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
L +L L+L +NQ + F LT L+ + L N
Sbjct: 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 69/392 (17%), Positives = 137/392 (34%), Gaps = 46/392 (11%)
Query: 195 NLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLG 253
++ + L +N+++ + + F + + + + L + L +L + L
Sbjct: 31 HVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPG--LVIRNNTFRGLSSLIILKLD 87
Query: 254 KNKLTGTIPNSI-TNASKLTGLDLSFNSF-SGLIPH-TFGNLRFLSVLNLANNYLTTDSP 310
N+ + + L L L+ + ++ F L L +L L +N + P
Sbjct: 88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 311 TAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG 370
+ F ++ L + N ++ I + NF T
Sbjct: 147 AS---FFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGK---------HFTLL------ 185
Query: 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430
L S+ + + L + + L L GN + S+
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT------ 239
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEY--LLAVNLSSNSLSGSLPSN 488
I + S + G F +F LE + +LS + + +L +
Sbjct: 240 -----KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKS 293
Query: 489 I-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESL 546
+ + L L L++N+++ I L L+ L+L+ N + F +L LE L
Sbjct: 294 VFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVL 352
Query: 547 DLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
DLS N++ +S L LK+L + N+L+
Sbjct: 353 DLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-31
Identities = 81/438 (18%), Positives = 142/438 (32%), Gaps = 70/438 (15%)
Query: 100 LRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIID 159
+ ++ L N + + L LQ L + + I N+ F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFR--------------- 76
Query: 160 GNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNL-SGPIQPSIFNI 217
LSSL+ + L YN ++ + L NLE+L L NL + + F
Sbjct: 77 --------GLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK- 126
Query: 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDL 276
L +L + L N + P S N + LDL
Sbjct: 127 -------------------------PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161
Query: 277 SFNSFSGLIPHTFGNL--RFLSVLNLANNYLTTDSPTA-EWSFLSSLTNCRNLTTLAVAS 333
+FN + N + ++L L++ L + W + ++TTL ++
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221
Query: 334 NPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV 393
N + + F ++ L+ N + + G S
Sbjct: 222 NGFKESMA---KRFFDAIAGTKIQSLILS-NSYNMGSSFGHTNFKDPDNFTFKGLEAS-- 275
Query: 394 GRLEQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452
++ L + + ++ + H L + L N+++ L L +LNL
Sbjct: 276 ----GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330
Query: 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPI 511
N S F +L+ L ++LS N + +L L L L L NQL
Sbjct: 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDG 389
Query: 512 TIGSLKDLVTLSLASNQF 529
L L + L +N +
Sbjct: 390 IFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 77/404 (19%), Positives = 124/404 (30%), Gaps = 80/404 (19%)
Query: 53 RALNLSNMGLRGTIPPHL-GNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ L + I + S L+ L + N F L L ++L
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116
Query: 112 ------GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPS 164
F L+ L++L LR+N+ P S F N+ R D FN + +I
Sbjct: 117 GAVLSGNFFKP----LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICE 171
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLIN 224
L + + L ++ + + L + F ++IT ++
Sbjct: 172 ED--LLNFQGKHFTLL-----------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218
Query: 225 LFGNQLSGHLDLPPKVSYSLPNLR-----VFSLGKNKLTGTIPNSITN----------AS 269
L GN + K + + S N + + + AS
Sbjct: 219 LSGNGFK---ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS 275
Query: 270 KLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
+ DLS + L+ F + L L LA N + A +L L
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA-------FWGLTHLLKL 328
Query: 330 AVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI 389
++ N L I F NL L VL L N + +
Sbjct: 329 NLSQNFLGSIDS---RMFE----------------------NLDKLEVLDLSYNHI-RAL 362
Query: 390 PSTV-GRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGN 431
L L+ L+L N L+ S+P L L I L+ N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-17
Identities = 54/297 (18%), Positives = 100/297 (33%), Gaps = 36/297 (12%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSL---DISKNNFHAYLPNELGQL--RRLRFISLDYNE 109
L L + ++ I P F + D++ N + +L + + L
Sbjct: 134 LVLRDNNIK-KIQPA-SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191
Query: 110 FSGSFPSWIGV--------LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGN 161
W+G + + L L N F + F+ K S+ N
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTI 220
+ S G+ + N + L+ ++ L + + + S+F + + +
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEA---------SGVKTCDLSKSKIFA-LLKSVFSHFTDL 301
Query: 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280
+ L N+++ + + L +L +L +N L N KL LDLS+N
Sbjct: 302 EQLTLAQNEIN---KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 281 FSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
L +F L L L L N L + LT +L + + +NP
Sbjct: 359 IRALGDQSFLGLPNLKELALDTNQLKSVPDGI----FDRLT---SLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 9/118 (7%)
Query: 474 VNLSSNSLSG--SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531
+ L LP+++ + DLS N ++ + L+DL L +
Sbjct: 15 AICINRGLHQVPELPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68
Query: 532 PIPQ-TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFK 588
I TF L+ L L L N + L L+ L ++ L+G + + FK
Sbjct: 69 VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 29/224 (12%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVR 737
R F LGRG FG V++ D ++AIK L + A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 738 HRNLIKIFSSCCNNDFRA------------LVLELMPNGSLEKWLYSDNYFLDLLER--L 783
H +++ F++ + + ++L +L+ W+ + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 784 NIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843
+I + +A A+E+LH ++H DLKPSNI D V V DFGL D+ ++ T
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 844 MTIATIG----------YMAPEYGTEGIVSSKCDVYSYGVLLTE 877
+ YM+PE S K D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 23/232 (9%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNL--IKI 744
+G G V++ +AIK NL+ ++ S+ +E L ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTP 803
+ + + +V+E N L WL D ER + + A+ +H HG
Sbjct: 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-------- 855
+VH DLKP+N L+ + M+ + DFG++ SV + + + YM PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 856 ---YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
++ +S K DV+S G +L K P + L + +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G GS+G K SDG K + + + SE +LR ++H N+++ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 747 SCCNNDFRAL--VLELMPNGSLEKWL---YSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ L V+E G L + + +LD L +M + LAL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 802 TP--VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE---- 855
V+H DLKP+N+ LD + DFGL+++ + D S +T + T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTF-VGTPYYMSPEQMNR 190
Query: 856 --YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
Y + K D++S G LL E P FT
Sbjct: 191 MSY------NEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-33
Identities = 57/263 (21%), Positives = 98/263 (37%), Gaps = 30/263 (11%)
Query: 691 LGRGSFGSVYKGTFSDG----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIF 745
+G G FG V++G + + AIK D F E +R H +++K+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+ +++EL G L +L + LDL + ++ AL YL S V
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H D+ N+L+ + + DFGLS+ ++ + I +MAPE +S
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESINFRRFTSA 572
Query: 866 CDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924
DV+ +GV + E KP + +V+ +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGV-KNN----------------DVI--GRIENGERLPM 613
Query: 925 EMDCLLSVLHLALDCCMESPDQR 947
+C ++ L C P +R
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRR 636
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 15/234 (6%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNL--QLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
+GRGSF +VYKG A + F E E+L+ ++H N+++ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 747 SCCNNDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
S + LV ELM +G+L+ +L + R + + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLH-TRTP 150
Query: 803 PVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
P++H DLK NI + + D GL+ L S + + I T +MAPE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEK- 205
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915
DVY++G+ + E T + P + ++ P +V +
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G GSFG DG + IK N+ + E VL N++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLHHGHSTPV 804
S N +V++ G L K + + L E L+ + + LAL+++H +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRK---I 146
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE------YGT 858
+H D+K NI L +D + DFG++++ + + + + I T Y++PE Y
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARAC-IGTPYYLSPEICENKPYNN 204
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP 884
K D+++ G +L E T K
Sbjct: 205 ------KSDIWALGCVLYELCTLKHA 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 691 LGRGSFGSVYKGTFSDG------TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743
LG+GSFG VY+G T AIK N R F +E V++ ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL---------YSDNYFLDLLERLNIMIGVALALE 794
+ +++ELM G L+ +L L + + + +A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YL+ + VH DL N ++ ED + DFG+++ E D + + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTR 881
E +G+ ++ DV+S+GV+L E T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN-LQLDRAFRSFDSECEVLRNVRHRNLIKIFS- 746
+LG+G+ +V++G G FAIKVFN + R E EVL+ + H+N++K+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 747 -SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGHST 802
+ L++E P GSL L + L E L ++ V + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 803 PVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--- 855
+VH ++KP NI+ D V ++DFG ++ ++ + V+ T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYE 188
Query: 856 -----YGTEGIVSSKCDVYSYGVLL 875
+ + D++S GV
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 47/218 (21%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 691 LGRGSFGSVYKGTF--------SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI 742
LG+G+F ++KG T +KV + SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ C D LV E + GSL+ +L + +++L +L + +A A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 803 PVVHCDLKPSNILLD--------EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
++H ++ NILL +SD G+S D + I ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPP 186
Query: 855 E---YGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDM 888
E ++ D +S+G L E + KP +
Sbjct: 187 ECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 683 DGFNECNLLGRGSFGSVYKGT-FSDGTSFAIK---VFNLQLDRAFRSFDSECEVLRNVRH 738
F +GRG F VY+ DG A+K +F+L +A E ++L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL-ER--LNIMIGVALALEY 795
N+IK ++S ++ +VLEL G L + + L+ ER + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
+H V+H D+KP+N+ + V + D GL + F + ++ + T YM+PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL-VGTPYYMSPE 206
Query: 856 YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
E + K D++S G LL E + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 58/240 (24%)
Query: 672 RTSYLDIQRATDGFNE----CNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSF 726
R + L +T GF E +LGRG V + +A+K+ ++ +F +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 727 D---------SECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMPNGSL-----EKWLY 771
+ E ++LR V H N+I++ + N F LV +LM G L EK
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 772 SDNYFLDLLER--LNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828
S E+ IM + + LH +VH DLKP NILLD+DM ++DFG
Sbjct: 122 S--------EKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFG 169
Query: 829 LSKLFDEGDDSVTQTMTIA-TIGYMAPE------------YGTEGIVSSKCDVYSYGVLL 875
S D G+ + + T Y+APE YG E D++S GV++
Sbjct: 170 FSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 68/315 (21%), Positives = 123/315 (39%), Gaps = 38/315 (12%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN-LQLDRAFRSFDSECEVLRNVRHRNLIKIFS- 746
+LG+G+ +V++G G FAIKVFN + R E EVL+ + H+N++K+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 747 -SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGHST 802
+ L++E P GSL L + L E L ++ V + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 803 PVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--- 855
+VH ++KP NI+ D V ++DFG ++ ++ + V+ T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYE 188
Query: 856 -----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE---MSLKKWVKESLPHGL 907
+ + D++S GV T P + K + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 908 MEVVDTNLLRQEHTSSAEMDCLLS-----VLHLALDCCMES-PDQRIYMTDAAVKLKKI- 960
V + + + C LS +L L +E+ ++ + I
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
Query: 961 --KIIGVLVLSRAEI 973
+I V L +
Sbjct: 309 HRMVIHVFSLQQMTA 323
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/227 (23%), Positives = 87/227 (38%), Gaps = 23/227 (10%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LG G F V DG +A+K + E ++ R H N++++ + C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 749 CNNDFRA----LVLELMPNGSLEKWLY---SDNYFLDLLERLNIMIGVALALEYLHHGHS 801
L+L G+L + FL + L +++G+ LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-------TIGYMAP 854
H DLKP+NILL ++ + D G + Q +T+ TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 855 E----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
E I + DV+S G +L + P D +F S+
Sbjct: 213 ELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 691 LGRGSFGSVYKGTFSDG------TSFAIKVFN-LQLDRAFRSFDSECEVLRNVRHRNLIK 743
LG G+FG VY+G S A+K + ++ F E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL------YSDNYFLDLLERLNIMIGVALALEYLH 797
+ R +++ELM G L+ +L S L +L+ L++ +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 798 HGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
H +H D+ N LL VA + DFG+++ + + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFT 880
E EGI +SK D +S+GVLL E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 690 LLGRGSFGSVYKGTFSD---GTSFAIKVFNLQL--DRAFRS-FDSECEVLRNVRHRNLIK 743
LG G +VY D AIK + F+ E + H+N++
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+ +D LV+E + +L +++ + L + +N + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT-MTIATIGYMAPEYGTEGIV 862
+VH D+KP NIL+D + + DFG++K + S+TQT + T+ Y +PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
D+YS G++L E + P F GE
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+LG+G++G VY G AIK + R + E + ++++H+N+++ S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLHHGHSTPVVH 806
N F + +E +P GSL L S L E+ + L+YL H +VH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVH 145
Query: 807 CDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--YGTEGIVS 863
D+K N+L++ V +SDFG SK G + T+T T T+ YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEIIDKGPRGYG 203
Query: 864 SKCDVYSYGVLLTETFTRKKP 884
D++S G + E T K P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 691 LGRGSFGSVYKGTFSDG------TSFAIKVFN-LQLDRAFRSFDSECEVLRNVRHRNLIK 743
LG G+FG VY+G S A+K + ++ F E ++ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL------YSDNYFLDLLERLNIMIGVALALEYLH 797
+ R ++LELM G L+ +L S L +L+ L++ +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 798 HGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
H +H D+ N LL VA + DFG+++ + + +M P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFT 880
E EGI +SK D +S+GVLL E F+
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 67/385 (17%), Positives = 125/385 (32%), Gaps = 50/385 (12%)
Query: 194 QNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLG 253
N V + S ++T+T ++ + ++ D+ + L L
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT---DMTG-IEK-LTGLTKLICT 72
Query: 254 KNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAE 313
N +T T+ ++ + LT L N + L L L+ LN N LT
Sbjct: 73 SNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLD---- 122
Query: 314 WSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR 373
++ LT L A N L I + + + L + K + +
Sbjct: 123 ------VSQNPLLTYLNCARNTLTEI---DVSHNT-QLTELDCHLNKKITKLD--VTPQT 170
Query: 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433
L L N + + V + + L L+ NN+ + DL +L + + NKL
Sbjct: 171 QLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKL 224
Query: 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ 493
+ I + L L + N + S+ L L + L + + +
Sbjct: 225 TE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL---HCIQTDLL-EID--LTHNT 275
Query: 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
LI + + + L L + + L L L+N L
Sbjct: 276 QLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
Query: 554 SGEIPKSLEALLFLKQLNVSHNKLE 578
+ E+ + LK L+ + ++
Sbjct: 331 T-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 71/459 (15%), Positives = 142/459 (30%), Gaps = 57/459 (12%)
Query: 140 NSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEIL 199
N F + + L++L +++ +++ + I L L L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKL 69
Query: 200 VLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG 259
+ NN++ + + +T + N+L+ +LD+ L L + NKLT
Sbjct: 70 ICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLDV-----TPLTKLTYLNCDTNKLT- 119
Query: 260 TIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSS 319
++ LT L+ + N+ + + + L+ L+ N T
Sbjct: 120 --KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT---------KLD 165
Query: 320 LTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLS 379
+T LTTL + N + + + L +T + + L L
Sbjct: 166 VTPQTQLTTLDCSFNKITEL---DVSQNK-LLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218
Query: 380 LFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQ 439
N L I V L QL N L D+ L +L + L I
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLE-ID- 270
Query: 440 CLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLD 499
L L + + L ++ + ++ L + L+ L
Sbjct: 271 -LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324
Query: 500 LSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPK 559
L+ +L+ ++ + L +LS + + + G + L + + +
Sbjct: 325 LNNTELT-ELDV--SHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKE 379
Query: 560 SLEALLF-----LKQLNVSHNKLEGEIPANGPFKYFAPQ 593
+L L+ N + E G +
Sbjct: 380 TLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNT 418
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 74/462 (16%), Positives = 148/462 (32%), Gaps = 57/462 (12%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
+ + ++ T + L SLD ++ + +L L + N +
Sbjct: 21 ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT- 77
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
+ + + L L+ +N T L L+ L + +D + L
Sbjct: 78 TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKLD------VSQNPLL 129
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSG 232
+N A N L EI + + L L +N + + +T ++ N+++
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK--LDVTPQTQLTTLDCSFNKIT- 183
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292
LD+ L + N +T + + +LT LD S N + + L
Sbjct: 184 ELDVS-----QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQ 352
L+ + + N LT ++ LTTL L I + N L
Sbjct: 233 TQLTYFDCSVNPLTE----------LDVSTLSKLTTLHCIQTDLLEI--DLTHN--TQLI 278
Query: 353 NFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGS 412
F A C+ + ++ + L +L + + + + +L L L L
Sbjct: 279 YFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-E 332
Query: 413 IPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLL 472
+ D+ H +L + + + + +L + + + + +
Sbjct: 333 L--DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
Query: 473 AVNLSSNSLSG----SLPSNIQNLQVLINLDLSRNQLSGDIP 510
AV+ G P + N ++ LS D P
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATN-TITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 38/285 (13%), Positives = 82/285 (28%), Gaps = 29/285 (10%)
Query: 70 LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129
+ L L+ NN L L Q +L F+ N+ + + L++L
Sbjct: 187 VSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240
Query: 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE 189
N T ++L L+ L + ID + + + L+ E+ +
Sbjct: 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEID------LTHNTQLIYFQAEGCRKIKEL--D 292
Query: 190 IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249
+ + L +L ++ + + + + L +L+ +L L+
Sbjct: 293 VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT---ELDVS---HNTKLKS 343
Query: 250 FSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDS 309
S + S+ L + + T N + ++ + L
Sbjct: 344 LSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSL--TIAVSPDLLDQFG 399
Query: 310 PTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
+ T + L P V F++
Sbjct: 400 NPMNIEPGDGGVY--DQATNTITWENLSTDNPAVTYTFTSENGAI 442
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG V+ D A+K A + F E E+L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFLDLLERLNIMIGV 789
+ C + D +V E M +G L K+L L L + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
A + YL H VH DL N L+ +++ + DFG+S+ D T+ I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+M PE +++ DV+S+GV+L E FT
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 52/214 (24%), Positives = 78/214 (36%), Gaps = 22/214 (10%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV 736
F + LG GS+G V+K DG +A+K + +E V
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 737 -RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
+H +++ + L EL SL++ + L + + LAL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
LH +VH D+KP+NI L + DFGL Q YMAPE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ---EGDPRYMAPE 226
Query: 856 -----YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
YGT DV+S G+ + E +
Sbjct: 227 LLQGSYGT------AADVFSLGLTILEVACNMEL 254
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 691 LGRGSFGSVYKGTFSDG------TSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G+FG V+ + A+K + A + F E E+L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWL--------------YSDNYFLDLLERLNIMIGVA 790
F C +V E M +G L ++L L L + L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
+ YL H VH DL N L+ + +V + DFG+S+ D T+ I
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+M PE +++ DV+S+GV+L E FT
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 72/343 (20%), Positives = 122/343 (35%), Gaps = 56/343 (16%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
+LRV L +P + LDL N + + F NL+ L L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
+ SP A L L ++ N L+ + +
Sbjct: 89 SKISPGA-------FAPLVKLERLYLSKNQLKELPEKM---------------------- 119
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNL-EGSIPYD-LCHLER 422
++L L + N + + +V L Q+ + L N L I +++
Sbjct: 120 ------PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L+ IR+ ++ IPQ SL EL+L NK + +S L L + LS NS+S
Sbjct: 173 LSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229
Query: 483 GSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG------PIPQ 535
++ + N L L L+ N+L +P + K + + L +N P
Sbjct: 230 -AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 536 TFGSLTGLESLDLSNNNLS-GEIPKSL-EALLFLKQLNVSHNK 576
+ L +N + EI S + + + + K
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 70/364 (19%), Positives = 120/364 (32%), Gaps = 77/364 (21%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS- 111
R + S++GL +P L LD+ N + L+ L + L N+ S
Sbjct: 34 RVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 112 ---GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGN 168
G+F L KL+ L L N +P +
Sbjct: 91 ISPGAFAP----LVKLERLYLSKNQLKE-LPEKMP------------------------- 120
Query: 169 LSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNL-SGPIQPSIF-NISTITLINL 225
+L + + N + ++ + L + ++ LG N L S I+ F + ++ I +
Sbjct: 121 -KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
++ +P + P+L L NK+T S+ + L L LSFNS S +
Sbjct: 179 ADTNIT---TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
+ N L L+L NN L L + + + + + +N + I
Sbjct: 233 NGSLANTPHLRELHLNNNKLVKVPGG--------LADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI--PSTVGRLEQLQGLS 403
P S +SLF N + PST + +
Sbjct: 285 P-------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325
Query: 404 LYGN 407
L
Sbjct: 326 LGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 55/289 (19%), Positives = 106/289 (36%), Gaps = 39/289 (13%)
Query: 52 VRALNLSNMGLRGTIPPH-LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
L+L N + I N L +L + N P L +L + L N+
Sbjct: 54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLS 170
P + LQ L + N T + S+FN L+
Sbjct: 113 K-ELPE--KMPKTLQELRVHENEITK-VRKSVFN-----------------------GLN 145
Query: 171 SLVNVNLAYNNLQ-GEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGN 228
++ V L N L+ I + ++ L + + N++ I + ++T ++L GN
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGN 202
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
+++ + L NL L N ++ S+ N L L L+ N +P
Sbjct: 203 KIT---KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+ +++ V+ L NN ++ + T + + +++ SNP++
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSND-FCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 46/221 (20%), Positives = 98/221 (44%), Gaps = 10/221 (4%)
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
+ NL++L L L N ++ P L +L+ L L N L+ +P + + L
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQE 125
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI--PSSFWSLEYLLAVNLSSNSLSG 483
+R++ N+++ L + + LG+N SS +F ++ L + ++ +++
Sbjct: 126 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
++P + L L L N+++ ++ L +L L L+ N + + L
Sbjct: 185 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 242
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
L L+NN L ++P L +++ + + +N + I +N
Sbjct: 243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 54/237 (22%), Positives = 98/237 (41%), Gaps = 12/237 (5%)
Query: 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
L+ D L +P ++ +L L N + L+ L L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLE 469
P L +L + L+ N+L +P+ + +L+EL + N+ + S F L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 470 YLLAVNLSSNSL-SGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASN 527
++ V L +N L S + + Q ++ L + ++ ++ I G L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGN 202
Query: 528 QFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
+ + L L L LS N++S SL L++L++++NKL ++P
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 39/239 (16%), Positives = 86/239 (35%), Gaps = 42/239 (17%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
++ L LS L+ +P + L L + +N + L ++ + L N
Sbjct: 101 KLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 157
Query: 111 SGSF--PSWIGVLSKLQILSLRNNSFTGPIPNSLF-----------NLSRLEKWDSMFN- 156
S + KL + + + + T IP L +++++ +
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLDGNKITKVD--AASLKG 214
Query: 157 -------IIDGNIPSRIG-----NLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMN 204
+ N S + N L ++L N L ++P + + + ++++ L N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 205 NLSGPIQPSIF-------NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK 256
N+S I + F ++ + ++LF N + + ++ P + LG K
Sbjct: 274 NISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 25/89 (28%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557
+ S L +P + D L L +N+ F +L L +L L NN +S
Sbjct: 36 VQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 558 PKSLEALLFLKQLNVSHNKLEGEIPANGP 586
P + L+ L++L +S N+L+ E+P P
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELPEKMP 120
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 44/206 (21%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN--LQLDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG+GSFG V K +A+KV N ++ + E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 748 CCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HG 799
++ +V EL G L ++ +S E I+ V + Y+H H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS--------EHDAARIIKQVFSGITYMHKHN 141
Query: 800 HSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAP 854
+VH DLKP NILL ++D + DFGLS F + M T Y+AP
Sbjct: 142 ----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAP 192
Query: 855 E-----YGTEGIVSSKCDVYSYGVLL 875
E Y + CDV+S GV+L
Sbjct: 193 EVLRGTYDEK------CDVWSAGVIL 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 691 LGRGSFGSVYKGTFSDG------TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743
LG FG VYKG + AIK + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFLDLLERLNIMIG 788
+ + +++ +G L ++L + L+ + ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+A +EYL H VVH DL N+L+ + + +SD GL + D ++
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
I +MAPE G S D++SYGV+L E F+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 42/205 (20%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+LG G+F V+ G FA+K S ++E VL+ ++H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 749 CNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLERL--NIMIGVALALEYLH-HGH 800
+ LV++L+ G L E+ +Y+ E+ ++ V A++YLH +G
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYT--------EKDASLVIQQVLSAVKYLHENG- 126
Query: 801 STPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPE- 855
+VH DLKP N+L +E+ ++DFGLSK+ G T T GY+APE
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEV 178
Query: 856 -----YGTEGIVSSKCDVYSYGVLL 875
Y D +S GV+
Sbjct: 179 LAQKPYSKA------VDCWSIGVIT 197
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-30
Identities = 101/468 (21%), Positives = 170/468 (36%), Gaps = 40/468 (8%)
Query: 119 GVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSSLVNVNL 177
+ + + LSL NS + + LS L N I ++ + L +++
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 178 AYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLDL 236
++N LQ I + +L L L N+ F N++ +T + L + LDL
Sbjct: 108 SHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDL 163
Query: 237 PPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLS 296
P L + + L + G S+ T L L F+ S ++ L
Sbjct: 164 LPVAHLHLSCILL-DLVSYHIKGGETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 297 VLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL--RGILPPVIGNFSASLQNF 354
L L+N L ++ +FLS LT L + + + + + ++
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP 414
Y+ +T I E + SL I + S
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMI-------------------EHVKNQVFLFSKE 322
Query: 415 YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAV 474
+N L+ + C S S LN N F+ S+ +L+ L +
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 475 NLSSNSLSGSLPS---NIQNLQVLINLDLSRNQL-SGDIPITIGSLKDLVTLSLASNQFE 530
L N L + +N+ L LD+S N L S T + ++ L+L+SN
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 531 GPIPQTFGSLTG-LESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
G + F L ++ LDL NN + IPK + L L++LNV+ N+L
Sbjct: 442 GSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 80/455 (17%), Positives = 145/455 (31%), Gaps = 57/455 (12%)
Query: 170 SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGN 228
V+ + NL +P ++ + L L N++S ++ +S + ++ L N
Sbjct: 31 ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHN 86
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPH- 287
++ L V +L + N+L I + L LDLSFN F L
Sbjct: 87 RIR---SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCK 140
Query: 288 TFGNLRFLSVLNLANNYLTTDSPTA-------------------EWSFLSSLTNCRNLTT 328
FGNL L+ L L+ S +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200
Query: 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI--GNLRSLIVLSLFINALN 386
L N L + + N LQ R +L++ + +
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 387 GTIPSTVGRLE-----QLQGLSLYGNNLEGSIP-----YDLCHLERLNGIRLNGNKLSGP 436
T +V + ++ L++Y + I Y L+ L +
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 437 IPQCLASLISLRELNLGSNK---FSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ 493
+ + L + P S S +L N + N + S+ L+
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLK 377
Query: 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF----EGPIPQTFGSLTGLESLDLS 549
L L L RN L + K++ +L +T + L+LS
Sbjct: 378 RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 550 NNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
+N L+G + + L +K L++ +N++ IP +
Sbjct: 437 SNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKD 468
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 8e-22
Identities = 86/493 (17%), Positives = 157/493 (31%), Gaps = 80/493 (16%)
Query: 78 SLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS----GSFPSWIGVLSKLQILSLRNNS 133
+L +S+N+ ++ L LR + L +N F L+ L + +N
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF----NQDLEYLDVSHNR 111
Query: 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP--SEIG 191
NI ++SL +++L++N+ +P E G
Sbjct: 112 LQ-------------------------NISC--CPMASLRHLDLSFNDFD-VLPVCKEFG 143
Query: 192 NLQNLEILVLGMNNL-SGPIQPSIFNISTITLINLFGNQLSG--------------HLDL 236
NL L L L + P + L++L + G HL
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 237 PPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLS 296
P +S+ + + I + N +L L+ T ++
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 297 --------------VLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPP 342
V L LT F S T ++L V +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKE 322
Query: 343 VIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGL 402
+ + A + + S L+ N ++ L++LQ L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 403 SLYGNNLEGSIPYDLCHLERLNGIRLNGNKL----SGPIPQCLASLISLRELNLGSNKFS 458
L N L+ + + ++ + L S + A S+ LNL SN +
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 459 SSIPSSF-WSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPI-TIGSL 516
S+ ++ L +L +N + S+P ++ +LQ L L+++ NQL +P L
Sbjct: 442 GSVFRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRL 496
Query: 517 KDLVTLSLASNQF 529
L + L N +
Sbjct: 497 TSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 81/440 (18%), Positives = 152/440 (34%), Gaps = 52/440 (11%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAY-LPNELGQLRRLRFISLDYNEF-SG 112
L++S+ L+ I + L LD+S N+F + E G L +L F+ L +F
Sbjct: 105 LDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLS-- 170
+ +L L + G SL + ++ + +
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 171 --SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQP-----SIFNISTITLI 223
L N+ L N Q + + +L + + ++ + F + +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 224 NLFGNQLSGHLDL--PPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
N++ ++ +D +L +L + + + + +++ LS +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
+ + + LN N T S+L L TL + N L+
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG----CSTLKR---LQTLILQRNGLK-NFF 393
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALN-GTIPSTVGRLEQLQ 400
V N+ SL L + +N+LN T E +
Sbjct: 394 KVALMTK----------------------NMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431
Query: 401 GLSLYGNNLEGSIPYDL-CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS 459
L+L N L GS+ L ++ L+ L+ N++ IP+ + L +L+ELN+ SN+ S
Sbjct: 432 VLNLSSNMLTGSVFRCLPPKVKVLD---LHNNRIMS-IPKDVTHLQALQELNVASNQLKS 487
Query: 460 SIPSSFWSLEYLLAVNLSSN 479
F L L + L N
Sbjct: 488 VPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 50/287 (17%), Positives = 96/287 (33%), Gaps = 19/287 (6%)
Query: 29 NNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNF---SFLMSLDISKNN 85
+ +S R + + L ++ L F + L+I
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 86 F-----HAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPN 140
L+ L + F S + V +++ I L +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 141 SLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ--GEIPSEIGNLQNLEI 198
+ S + N+ ++ L L + L N L+ ++ N+ +LE
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407
Query: 199 LVLGMNNL-SGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLP-NLRVFSLGKNK 256
L + +N+L S + +I ++NL N L V LP ++V L N+
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNM------LTGSVFRCLPPKVKVLDLHNNR 461
Query: 257 LTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
+ +IP +T+ L L+++ N + F L L + L +N
Sbjct: 462 IM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 10/229 (4%)
Query: 377 VLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLS 434
LSL N+++ + L +L+ L L N + S+ + + + L + ++ N+L
Sbjct: 56 ALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ 113
Query: 435 GPIPQCLASLISLRELNLGSNKFSS-SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ 493
I + SLR L+L N F + F +L L + LS+ + +L
Sbjct: 114 N-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 494 -VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNN 552
I LDL + G ++ L L + Q S+ L L LSN
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 553 LSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYAL 601
L+ E + L L + + + F W +
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 690 LLGRGSFGSVYKGTFSD---GTSFAIKVFNLQL--DRAFRS-FDSECEVLRNVRHRNLIK 743
+LG G V+ D A+KV L D +F F E + + H ++
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 744 IFSSCCNNDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
++ + +V+E + +L + + + ++ AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT-MTIATIGYMAPEYGT 858
++H D+KP+NI++ V DFG+++ + +SVTQT I T Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
V ++ DVYS G +L E T + P FTG+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 43/206 (20%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG+G+F V + + G FA K+ N + R F+ + E + R ++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 748 CCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HG 799
F LV +L+ G L + YS E + + + ++ Y H +G
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQILESIAYCHSNG 125
Query: 800 HSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPE 855
+VH +LKP N+LL + ++DFGL+ ++ + A T GY++PE
Sbjct: 126 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPE 177
Query: 856 ------YGTEGIVSSKCDVYSYGVLL 875
Y D+++ GV+L
Sbjct: 178 VLKKDPYSKP------VDIWACGVIL 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 38/202 (18%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
+GRGS+G V A K F E E+++++ H N+I+++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 750 NNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGHS 801
+N LV+EL G L K ++ E IM V A+ Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFR--------ESDAARIMKDVLSAVAYCHKLN-- 126
Query: 802 TPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE--- 855
V H DLKP N L D + DFGL+ F G + T Y++P+
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLE 181
Query: 856 --YGTEGIVSSKCDVYSYGVLL 875
YG E CD +S GV++
Sbjct: 182 GLYGPE------CDEWSAGVMM 197
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 31/226 (13%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIF--- 745
LG G FG V + G AIK +L + + E ++++ + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 746 ---SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLHHGH 800
ND L +E G L K+L L E ++ ++ AL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 801 STPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-- 855
++H DLKP NI+L + ++ + D G +K D + + T+ Y+APE
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEF-VGTLQYLAPELL 195
Query: 856 ----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
Y D +S+G L E T +P + K
Sbjct: 196 EQKKYT------VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 53/216 (24%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNL--------QLDRAFRSFDSECEVLRNVR-HRN 740
+GRG V + + G FA+K+ + QL+ + E +LR V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALAL 793
+I + S ++ F LV +LM G L EK S E+ +IM + A+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS--------EKETRSIMRSLLEAV 213
Query: 794 EYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGY 851
+LH + +VH DLKP NILLD++M +SDFG S + G+ + + T GY
Sbjct: 214 SFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGY 265
Query: 852 MAPE------------YGTEGIVSSKCDVYSYGVLL 875
+APE YG E D+++ GV+L
Sbjct: 266 LAPEILKCSMDETHPGYGKE------VDLWACGVIL 295
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 67/317 (21%), Positives = 110/317 (34%), Gaps = 50/317 (15%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
P+ + L N ++ + L L L N S + F LR L L ++ N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
L P +L L + N +R + G FS
Sbjct: 114 LVEIPPNL---P-------SSLVELRIHDNRIRKVPK---GVFS---------------- 144
Query: 365 IPHEIGNLRSLIVLSLFINAL-NGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERL 423
LR++ + + N L N +L L + L IP DL E L
Sbjct: 145 ------GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETL 195
Query: 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
N + L+ NK+ + L L L LG N+ S L L ++L +N LS
Sbjct: 196 NELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITI-------GSLKDLVTLSLASNQFEGPI--P 534
+P+ + +L++L + L N ++ + + +SL +N P
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 535 QTFGSLTGLESLDLSNN 551
TF +T ++ N
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 58/296 (19%), Positives = 109/296 (36%), Gaps = 35/296 (11%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS- 111
R + S++GL+ +P + LD+ N+ ++ L+ L + L N+ S
Sbjct: 36 RVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 112 ---GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGN----IP 163
+F L KLQ L + N IP +L +L L I N +P
Sbjct: 93 IHEKAFSP----LRKLQKLYISKNHLVE-IPPNLPSSLVELR--------IHDNRIRKVP 139
Query: 164 SRI-GNLSSLVNVNLAYNNLQ-GEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
+ L ++ + + N L+ + L L + L+G I + T+
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLP--ETLN 196
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
++L N++ + + L LG N++ S++ L L L N
Sbjct: 197 ELHLDHNKIQ---AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
S +P +L+ L V+ L N +T + + +++ +NP+
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVND-FCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 74/367 (20%), Positives = 118/367 (32%), Gaps = 82/367 (22%)
Query: 236 LPPKVSYSLP-----NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290
LPP S P +LRV L +P I+ T LDL N S L F
Sbjct: 19 LPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFK 75
Query: 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSAS 350
L+ L L L NN ++ A + R L L ++ N L I P +
Sbjct: 76 GLQHLYALVLVNNKISKIHEKA-------FSPLRKLQKLYISKNHLVEIPPNL------- 121
Query: 351 LQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL- 409
SL+ L + N + L + + + GN L
Sbjct: 122 ---------------------PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLE 469
+LN +R++ KL+G IP+ L +L EL+L NK +
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQAIELEDLLRYS 217
Query: 470 YLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528
L + L N + + + L L L L N+LS
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR--------------------- 255
Query: 529 FEGPIPQTFGSLTGLESLDLSNNNLSGEIP-------KSLEALLFLKQLNVSHNKLEGEI 581
+P L L+ + L NN++ ++ + +++ +N +
Sbjct: 256 ----VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 582 PANGPFK 588
F+
Sbjct: 311 VQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 65/343 (18%), Positives = 114/343 (33%), Gaps = 77/343 (22%)
Query: 124 LQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ 183
+L L+NN + + F L L + L N +
Sbjct: 56 TTLLDLQNNDISE-LRKDDFK-----------------------GLQHLYALVLVNNKIS 91
Query: 184 GEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSY 242
+I + L+ L+ L + N+L I P++ S++ + + N++ +P V
Sbjct: 92 -KIHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIR---KVPKGVFS 144
Query: 243 SLPNLRVFSLGKNKLTGT-IPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLA 301
L N+ +G N L + + KL L +S +G+ L L+L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLN---ELHLD 201
Query: 302 NNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKL 361
+N + L L L + N +R I G+ S
Sbjct: 202 HNKIQAIEL-------EDLLRYSKLYRLGLGHNQIRMIEN---GSLS------------- 238
Query: 362 TGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421
L +L L L N L+ +P+ + L+ LQ + L+ NN+ D C +
Sbjct: 239 ---------FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG 288
Query: 422 ------RLNGIRLNGNKLS-GPIPQCL-ASLISLRELNLGSNK 456
NGI L N + + + + G+ K
Sbjct: 289 FGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 48/238 (20%), Positives = 84/238 (35%), Gaps = 41/238 (17%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE- 109
+++ L +S L IPP+L S L+ L I N LR + I + N
Sbjct: 103 KLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159
Query: 110 ---------FSG--------------SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLS 146
F G P + L L L +N L S
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLTGIPK--DLPETLNELHLDHNKIQAIELEDLLRYS 217
Query: 147 RLEKWDSMFNIIDGNIPSRI-GNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNN 205
+L + N I I + L +L ++L N L +P+ + +L+ L+++ L NN
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275
Query: 206 LSGPIQPSIF-------NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK 256
++ + + F + I+LF N + + ++ P + + G K
Sbjct: 276 ITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-29
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 30/213 (14%)
Query: 690 LLGRGSFGSVYKG--TFSDGTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKIF- 745
+ G G +Y +G +K D ++ +E + L V H ++++IF
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 746 ----SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGH 800
+ + +V+E + SL++ L + E + ++ + AL YLH G
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIG- 202
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT-MTIATIGYMAPEYGTE 859
+V+ DLKP NI+L E+ + + D G + T G+ APE
Sbjct: 203 ---LVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVRT 251
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
G + D+Y+ G L G
Sbjct: 252 G-PTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 59/203 (29%), Positives = 82/203 (40%), Gaps = 35/203 (17%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN-LQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LG G+FG V+ S G IK N + ++E EVL+++ H N+IKIF
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 749 CNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+ +V+E G L E +M + AL Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144
Query: 801 STPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-- 855
VVH DLKP NIL + DFGL++LF + T T YMAPE
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVF 198
Query: 856 ---YGTEGIVSSKCDVYSYGVLL 875
+ CD++S GV++
Sbjct: 199 KRDVTFK------CDIWSAGVVM 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 42/247 (17%), Positives = 77/247 (31%), Gaps = 24/247 (9%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQLDRAFRSFDSE 729
+ Q + +LLG G+F VY+ T D F +KV F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 730 CEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL----EKWLYSDNYFLDLLERLNI 785
E L+ +K +S+ + LV EL G+L + + + ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH-----------VSDFGLSKLFD 834
+ + +E + H ++H D+KP N +L + + D G S
Sbjct: 178 AMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS 894
T T G+ E + + + D + + GE
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 895 LKKWVKE 901
+ +
Sbjct: 295 PEGLFRR 301
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 76/285 (26%), Positives = 116/285 (40%), Gaps = 56/285 (19%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSF---AIKVFNLQL-----DRAFRSFDSECEVLRNV-RHR 739
+++G G+FG V K AIK ++ R F E EVL + H
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIK----RMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFLDLLERLN 784
N+I + +C + + L +E P+G+L +L S L + L+
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
VA ++YL +H DL NIL+ E+ VA ++DFGLS+ + V +TM
Sbjct: 147 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 200
Query: 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESL 903
+ +MA E + ++ DV+SYGVLL E + P M E + E L
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL 254
Query: 904 PHG-LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR 947
P G +E ++C V L C E P +R
Sbjct: 255 PQGYRLE--------------KPLNCDDEVYDLMRQCWREKPYER 285
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 28/215 (13%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFNLQ-LDRAFRSFDSECEVLRNV-RHRNLI 742
LG G+FG V + T + A+K+ + SE +VL + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWL-----------------YSDNYFLDLLERLNI 785
+ +C ++ E G L +L D LDL + L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
VA + +L S +H DL NILL + + DFGL++ + V +
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + DV+SYG+ L E F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 33/220 (15%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFN-LQLDRAFRSFDSECEVLRNVRHRNLIK 743
+G G+FG V++ + T A+K+ F E ++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL-----------------------YSDNYFLDLL 780
+ C L+ E M G L ++L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 781 ERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840
E+L I VA + YL VH DL N L+ E+MV ++DFGLS+ D
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
I +M PE +++ DV++YGV+L E F+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 47/223 (21%)
Query: 678 IQRATDGFNE----CNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSEC 730
+ A+ F++ LG+G+F V + + G FA K+ N + R F+ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 731 EVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--L 783
+ R ++H N++++ S F LV +L+ G L + YS E
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS--------EADAS 131
Query: 784 NIMIGVALALEYLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDS 839
+ + + ++ Y H +G +VH +LKP N+LL + ++DFGL+ ++ +
Sbjct: 132 HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185
Query: 840 VTQTMTIA-TIGYMAPE------YGTEGIVSSKCDVYSYGVLL 875
A T GY++PE Y D+++ GV+L
Sbjct: 186 --AWHGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 691 LGRGSFGSVYKGTFSDG------TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIK 743
LG G FG V K T T+ A+K+ R SE VL+ V H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWL-----------------------YSDNYFLDLL 780
++ +C + L++E GSL +L + D L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 781 ERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840
+ ++ ++ ++YL +VH DL NIL+ E +SDFGLS+ E D V
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
++ + +MA E + I +++ DV+S+GVLL E T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 691 LGRGSFGSVYKGTFSD--------GTSFAIKVFN-LQLDRAFRSFDSECEVLRNV-RHRN 740
LG G+FG V + A+K+ ++ SE E+++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFLDLLERLNI 785
+I + +C + +++E G+L ++L + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
+A +EYL +H DL N+L+ E+ V ++DFGL++ + D T
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 689 NLLGRGSFGSVYKGT------FSDGTSFAIKVFNLQ-LDRAFRSFDSECEVLRNV-RHRN 740
LG G+FG V + T A+K+ + SE +++ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL-------------YSDNYFLDLLERLNIMI 787
++ + +C + ++ E G L +L N + L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847
VA + +L + +H D+ N+LL VA + DFGL++ + + +
Sbjct: 172 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+SYG+LL E F+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 43/201 (21%), Positives = 77/201 (38%), Gaps = 14/201 (6%)
Query: 689 NLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
+GRGSFG V++ G A+K L++ R E + ++ ++ +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
+ + +EL+ GSL + + + + LEYLH + ++H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLH---TRRILHG 174
Query: 808 DLKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMTIATIG---YMAPEYGTEGIVS 863
D+K N+LL D A + DFG + + G +MAPE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 864 SKCDVYSYGVLLTETFTRKKP 884
+K D++S ++ P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 44/205 (21%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSC 748
LG GSF K +FA+K+ + R + E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 749 CNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+ LV+EL+ G L +K +S E IM + A+ ++H G
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFS--------ETEASYIMRKLVSAVSHMHDVG- 126
Query: 801 STPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPE- 855
VVH DLKP N+L ++++ + DFG ++L + + T T+ Y APE
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTPCFTLHYAAPEL 180
Query: 856 -----YGTEGIVSSKCDVYSYGVLL 875
Y CD++S GV+L
Sbjct: 181 LNQNGYDES------CDLWSLGVIL 199
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 40/204 (19%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG+GSFG V K +A+KV N ++ + E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 748 CCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HG 799
++ +V EL G L ++ +S E I+ V + Y+H H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS--------EHDAARIIKQVFSGITYMHKHN 141
Query: 800 HSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE- 855
+VH DLKP NILL ++D + DFGLS F + + I T Y+APE
Sbjct: 142 ----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEV 194
Query: 856 ----YGTEGIVSSKCDVYSYGVLL 875
Y KCDV+S GV+L
Sbjct: 195 LRGTYDE------KCDVWSAGVIL 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 47/227 (20%), Positives = 86/227 (37%), Gaps = 43/227 (18%)
Query: 676 LDIQRATDGFNE----CNLLGRGSFGSVYKGTF-SDGTSFAIKV-----FNLQLDRAFRS 725
LD+ F + C ++G+G F V + G FA+K+ F +
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 726 FDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLL 780
E + ++H +++++ + ++ +V E M L ++ Y
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS---- 128
Query: 781 ERL--NIMIGVALALEYLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFD 834
E + + M + AL Y H + ++H D+KP +LL + + FG++
Sbjct: 129 EAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 835 EGDDSVTQTMTIATIGYMAPE------YGTEGIVSSKCDVYSYGVLL 875
E + T +MAPE YG DV+ GV+L
Sbjct: 185 ESGLVAGG--RVGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 55/216 (25%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFN--------LQLDRAFRSFDSECEVLRNVRHRNL 741
LG G+ G V AIK+ + + + ++E E+L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 742 IKIFSSCCNNDFRALVLELMPNGSL-----EKWLYSD----NYFLDLLERLNIMIGVALA 792
IKI + D+ +VLELM G L + YF +L A
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----------A 126
Query: 793 LEYLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
++YLH +G ++H DLKP N+LL +ED + ++DFG SK+ E S+ +T+ T
Sbjct: 127 VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL-CGT 179
Query: 849 IGYMAPE---------YGTEGIVSSKCDVYSYGVLL 875
Y+APE Y D +S GV+L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRA------VDCWSLGVIL 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIFS 746
LG+GSFG V G A+KV + ++ S E ++L+ + H N++K++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLH-HGHSTP 803
+ + LV E+ G L + S F E I+ V + Y+H +
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFS---EVDAARIIRQVLSGITYMHKNK---- 146
Query: 804 VVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
+VH DLKP N+LL +D + DFGLS F+ I T Y+APE G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAPEV-LHG 202
Query: 861 IVSSKCDVYSYGVLL 875
KCDV+S GV+L
Sbjct: 203 TYDEKCDVWSTGVIL 217
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLI 742
LGRG+FG V + + + A+K+ R+ SE ++L ++ H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 743 KIFSSCCNNDF-RALVLELMPNGSLEKWL---------------YSDNYFLDLLERLNIM 786
+ +C +++E G+L +L FL L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
VA +E+L +H DL NILL E V + DFGL++ + D V +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 56/194 (28%), Positives = 84/194 (43%), Gaps = 20/194 (10%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSS 747
LG G++G V AIK+ + E VL+ + H N++K++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGHSTPV 804
+ LV+E G L + F E I+ V + YLH H +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN---EVDAAVIIKQVLSGVTYLHKHN----I 157
Query: 805 VHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
VH DLKP N+LL ++D + + DFGLS +F+ + + T Y+APE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---LGTAYYIAPEV-LRKK 213
Query: 862 VSSKCDVYSYGVLL 875
KCDV+S GV+L
Sbjct: 214 YDEKCDVWSIGVIL 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFN---LQLDRAFRSFDS--------------ECEVL 733
L +G F + D +A+K + L+ R F ++ E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWL-------YSDNYFLDLLERLNIM 786
++++ + N D ++ E M N S+ K+ + F+ + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
V + Y+H+ + + H D+KPSNIL+D++ +SDFG S+ D + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-SR 211
Query: 847 ATIGYMAPE--YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
T +M PE +K D++S G+ L F P F+ ++SL +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 52/215 (24%), Positives = 81/215 (37%), Gaps = 47/215 (21%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSS 747
+LG G+ V +A+K+ Q E E+L + HRN++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 748 CCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HG 799
D LV E M GS+ ++ ++ E ++ VA AL++LH G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFN--------ELEASVVVQDVASALDFLHNKG 131
Query: 800 HSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGD---DSVTQTMTIA--TIGY 851
+ H DLKP NIL ++ + DF L T + + Y
Sbjct: 132 ----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 852 MAPE-----------YGTEGIVSSKCDVYSYGVLL 875
MAPE Y CD++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKR------CDLWSLGVIL 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 42/209 (20%)
Query: 688 CNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKI 744
LG+G+F V + G +A + N + R + + E + R ++H N++++
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 745 FSSCCNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH 797
S L+ +L+ G L + YS E + + + A+ + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--------EADASHCIQQILEAVLHCH 127
Query: 798 -HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYM 852
G VVH +LKP N+LL + ++DFGL+ + + A T GY+
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYL 180
Query: 853 APE------YGTEGIVSSKCDVYSYGVLL 875
+PE YG D+++ GV+L
Sbjct: 181 SPEVLRKDPYGKP------VDLWACGVIL 203
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 691 LGRGSFGSVYKGT--------FSDGTSFAIKVFN-LQLDRAFRSFDSECEVLRNV-RHRN 740
LG G FG V + + A+K+ ++ SE E+++ + +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFLDLLERLNI 785
+I + +C + +++E G+L ++L + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
+A +EYL +H DL N+L+ E+ V ++DFGL++ + D T
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 30/296 (10%), Positives = 63/296 (21%), Gaps = 56/296 (18%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
L G V+ FA+KVF + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 746 SSC----------------------CNNDFRA----LVLELM-----PNGSLEKWLYSDN 774
+D+ L++ S ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 775 YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834
+L + + L +VH P N+ + D + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 835 EGDDSVTQTMTIATIGYMAPEY--GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
+ + Y E+ + + + + G+ + + P F
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLV 296
Query: 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948
K + + L+ L D +R+
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIGRF-LNFD-----RRRRL 345
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 22/198 (11%)
Query: 689 NLLGRGSFGSVYKGT-FSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG+G FG+VY A+KV L+ E E+ ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ + L+LE P G++ + L + F + + +A AL Y H V
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR---V 130
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
+H D+KP N+LL ++DFG S S + T+ Y+ PE ++
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTDLC-GTLDYLPPE-----MIEG 181
Query: 865 K-----CDVYSYGVLLTE 877
+ D++S GVL E
Sbjct: 182 RMHDEKVDLWSLGVLCYE 199
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 29/203 (14%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN--------LQLDRAFRSFDSECEVLRNVRHRNL 741
LG G+ G V AI++ + + + ++E E+L+ + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALEYLH-H 798
IKI + D+ +VLELM G L + + E + LA++YLH +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 258
Query: 799 GHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
G ++H DLKP N+LL +ED + ++DFG SK+ E S+ +T+ T Y+APE
Sbjct: 259 G----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL-CGTPTYLAPE 311
Query: 856 ---YGTEGIVSSKCDVYSYGVLL 875
+ D +S GV+L
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 59/237 (24%), Positives = 90/237 (37%), Gaps = 56/237 (23%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFD-----SECEVLRNVRHRNLIKI 744
+G+GS+G V AIK+ N R D +E +++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 745 FSSCCNNDFRALVLELMPNGSL-------------------------------------E 767
+ + + LV+EL G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 768 KWLYSDNYFLDLLERL--NIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHV 824
+ ++ E+L NIM + AL YLH G + H D+KP N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209
Query: 825 --SDFGLSKLFDEGDDSVTQTMTIA--TIGYMAPE--YGTEGIVSSKCDVYSYGVLL 875
DFGLSK F + ++ MT T ++APE T KCD +S GVLL
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 41/224 (18%)
Query: 691 LGRGSFGSVYKGT------FSDGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNV-RH 738
LG G+FG V T A+K L + SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWL----------------------YSDNYF 776
N++ + +C + L+ E G L +L D
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 777 LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836
L + L VA +E+L VH DL N+L+ V + DFGL++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ V + + +MAPE EGI + K DV+SYG+LL E F+
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 45/206 (21%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LGRG+ VY+ +A+KV +D+ +E VL + H N+IK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 749 CNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+LVLEL+ G L EK YS ER + + + A+ YLH +G
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYS--------ERDAADAVKQILEAVAYLHENG- 168
Query: 801 STPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAPE 855
+VH DLKP N+L D ++DFGLSK+ + M T GY APE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-----VLMKTVCGTPGYCAPE 220
Query: 856 ------YGTEGIVSSKCDVYSYGVLL 875
YG E D++S G++
Sbjct: 221 ILRGCAYGPE------VDMWSVGIIT 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 18/264 (6%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
+ L+ +P I S L+L N+ + TF +L L VL L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
+ A +L TL + N L I S L+ + + + +
Sbjct: 111 IRQIEVGA-------FNGLASLNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-S 161
Query: 365 IPHEI-GNLRSLIVLSLF-INALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
IP + SL+ L L + L L L+ L+L N++ +P +L L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVG 219
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L + ++GN P L SL++L + +++ S ++F L L+ +NL+ N+LS
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
Query: 483 GSLPSNI-QNLQVLINLDLSRNQL 505
SLP ++ L+ L+ L L N
Sbjct: 280 -SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 8/222 (3%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD-LCHLERL 423
+P I + L+L N + T L L+ L L N++ I L L
Sbjct: 69 VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
N + L N L+ L LREL L +N S +F + L+ ++L
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 484 SLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTG 542
+ + L L L+L + D+P + L L L ++ N F P +F L+
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 543 LESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
L+ L + N+ +S + + L L +LN++HN L +P +
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 64/291 (21%), Positives = 96/291 (32%), Gaps = 50/291 (17%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS- 111
+ + GL +P + S L++ +NN + L L + L N
Sbjct: 57 SKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113
Query: 112 ---GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGN 168
G+F L+ L L L +N T IP+ F
Sbjct: 114 IEVGAFNG----LASLNTLELFDNWLTV-IPSGAFE-----------------------Y 145
Query: 169 LSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLF 226
LS L + L N ++ IPS + +L L LG I F + + +NL
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
+ +L P L L + N P S S L L + + S +
Sbjct: 205 MCNIKDMPNLTP-----LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+ F L L LNLA+N L++ T R L L + NP
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDL-------FTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 5/232 (2%)
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405
++ + + + +L L VL L N++ L L L L+
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131
Query: 406 GNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS- 463
N L IP +L +L + L N + + SL L+LG K I
Sbjct: 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 464 SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523
+F L L +NL ++ +P+ + L L L++S N P + L L L
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 524 LASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
+ ++Q F L L L+L++NNLS L +L +L++ HN
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 20/251 (7%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTI 220
+P I S+ +NL NN+Q +L +LE+L LG N++ I+ F ++++
Sbjct: 69 VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASL 125
Query: 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLS-F 278
+ LF N L+ +P L LR L N + +IP+ L LDL
Sbjct: 126 NTLELFDNWLT---VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL 181
Query: 279 NSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338
+ F L L LNL + + +LT L L ++ N
Sbjct: 182 KKLEYISEGAFEGLFNLKYLNLGMCNIKD---------MPNLTPLVGLEELEMSGNHFPE 232
Query: 339 ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQ 398
I P S SL+ + + +++ + L SL+ L+L N L+ L
Sbjct: 233 IRPGSFHGLS-SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291
Query: 399 LQGLSLYGNNL 409
L L L+ N
Sbjct: 292 LVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 58/254 (22%), Positives = 93/254 (36%), Gaps = 28/254 (11%)
Query: 119 GVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSSLVNVNL 177
G+ S + L+L N+ ++ +L LE N I I L+SL + L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLEL 130
Query: 178 AYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF---GNQLSGH 233
N L IPS L L L L N + I FN +L+ L +L
Sbjct: 131 FDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFN-RVPSLMRLDLGELKKLE-- 185
Query: 234 LDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLR 293
+ L NL+ +LG + +P ++T L L++S N F + P +F L
Sbjct: 186 -YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242
Query: 294 FLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQN 353
L L + N+ ++ A +L L +A N L + + L
Sbjct: 243 SLKKLWVMNSQVSLIERNA-------FDGLASLVELNLAHNNLSSLPHDLFTPLR-YLVE 294
Query: 354 FYAY------DCKL 361
+ + DC +
Sbjct: 295 LHLHHNPWNCDCDI 308
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 48/196 (24%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LLG+GSF VY+ G AIK+ + + + +E ++ ++H ++++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+ ++++ LVLE+ NG + ++L + E + M + + YLH ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE------YGTE 859
H DL SN+LL +M ++DFGL+ + T+ T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLC-GTPNYISPEIATRSAHG-- 190
Query: 860 GIVSSKCDVYSYGVLL 875
+ DV+S G +
Sbjct: 191 ----LESDVWSLGCMF 202
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 691 LGRGSFGSVYKGT--------FSDGTSFAIKVFN-LQLDRAFRSFDSECEVLRNV-RHRN 740
LG G+FG V + T A+K+ ++ SE E+++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFLDLLERLNI 785
+I + +C + +++E G+L ++L ++ L + ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
VA +EYL +H DL N+L+ ED V ++DFGL++ D T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + I + + DV+S+GVLL E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 45/261 (17%), Positives = 86/261 (32%), Gaps = 55/261 (21%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVR-------- 737
+LG+ + + T G SF + V A + E LR +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 738 --HRNLIKIFSSCCNNDFRALV--------------LELMP--NGSLEKWL------YSD 773
H I F + + ++ L P +L+ + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 774 NYFLDLLERLNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832
+ L RL + + V L LH +G +VH L+P +I+LD+ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 833 FDEGDDSVTQ-TMTIATIGYMAPE-----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTD 886
+G +V+ A A +++ D ++ G+ + + P
Sbjct: 261 --DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-- 316
Query: 887 DMFTGE--MSLKKWVKESLPH 905
T + + +W+ S +
Sbjct: 317 --NTDDAALGGSEWIFRSCKN 335
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 689 NLLGRGSFGSVYKGTF-SDGTSFAIKV-------------FNLQLDRAFRSFDSECEVLR 734
LG G++G V + + AIKV N +++ +E +L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALA 792
++ H N+IK+F + + LV E G L + + + + F E NIM +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQILSG 158
Query: 793 LEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
+ YLH + +VH D+KP NILL + + + DFGLS F + + + T
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTA 212
Query: 850 GYMAPE-----YGTEGIVSSKCDVYSYGVLL 875
Y+APE Y KCDV+S GV++
Sbjct: 213 YYIAPEVLKKKYNE------KCDVWSCGVIM 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 10/190 (5%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG+G F ++ + FA K+ L E + R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+NDF +VLEL SL + + R + + L +YLH V+
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 137
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H DLK N+ L+ED+ + DFGL+ E D + + T Y+APE ++ S +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLC-GTPNYIAPEVLSKKGHSFE 195
Query: 866 CDVYSYGVLL 875
DV+S G ++
Sbjct: 196 VDVWSIGCIM 205
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 53/231 (22%), Positives = 94/231 (40%), Gaps = 15/231 (6%)
Query: 653 KKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNE----CNLLGRGSFGSVYKGTF-SDG 707
K KI D W++ ++ + LG G+FG V++ + G
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 708 TSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLE 767
F K N + +E ++ + H LI + + + L+LE + G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 768 KWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILL--DEDMVAHV 824
+ +++Y + E +N M L+++H H +VH D+KP NI+ + +
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKI 192
Query: 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLL 875
DFGL+ + + +T AT + APE V D+++ GVL
Sbjct: 193 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 46/206 (22%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVL-RNVRHRNLIKIFSSC 748
+G GS+ + + FA+K+ + E E+L R +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 749 CNNDFRALVLELMPNGSL-----EKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+ + +V ELM G L + +S ER ++ + +EYLH G
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFS--------EREASAVLFTITKTVEYLHAQG- 136
Query: 801 STPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPE 855
VVH DLKPSNIL + DFG +K + MT T ++APE
Sbjct: 137 ---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTANFVAPE 190
Query: 856 ------YGTEGIVSSKCDVYSYGVLL 875
Y CD++S GVLL
Sbjct: 191 VLERQGYDAA------CDIWSLGVLL 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 28/200 (14%)
Query: 690 LLGRGSFGSVY----KGTFSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLI 742
LG+G FG+VY K A+KV L+ + E E+ ++RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
++++ + L+LE P G L K L F + M +A AL Y H
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERK-- 134
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
V+H D+KP N+L+ ++DFG S +TM T+ Y+ PE ++
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMC-GTLDYLPPE-----MI 184
Query: 863 SSK-----CDVYSYGVLLTE 877
K D++ GVL E
Sbjct: 185 EGKTHDEKVDLWCAGVLCYE 204
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 10/190 (5%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
LG+G F ++ + FA K+ L E + R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVV 805
+NDF +VLEL SL + + R + + L +YLH V+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163
Query: 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSK 865
H DLK N+ L+ED+ + DFGL+ E D + + T Y+APE ++ S +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLC-GTPNYIAPEVLSKKGHSFE 221
Query: 866 CDVYSYGVLL 875
DV+S G ++
Sbjct: 222 VDVWSIGCIM 231
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 36/263 (13%), Positives = 82/263 (31%), Gaps = 58/263 (22%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRS----------------------- 725
+LG+ + + T G SF + V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 726 -----FDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM-PNGSLEKWL------YSD 773
F +++++ + + +I++ + + +L+ + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 774 NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833
+ L RL + + V L LHH +VH L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 834 DEGDDSVTQTMTIATIGYMAPEY-----------GTEGIVSSKCDVYSYGVLLTETFTRK 882
S + G+ PE +++ D ++ G+++ +
Sbjct: 257 GARVVSSV------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 883 KPTDDMFTGEMSLKKWVKESLPH 905
P + +W+ S +
Sbjct: 311 LPITK--DAALGGSEWIFRSCKN 331
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 9/264 (3%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSF-DSECEVLRNVRHRN 740
D F + + LG G+ G V+K + G A K+ +L++ A R+ E +VL
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++ + + ++ ++ +E M GSL++ + + + I V L YL H
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
++H D+KPSNIL++ + DFG+S + DS+ + + T YM+PE
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSF-VGTRSYMSPERLQGT 205
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920
S + D++S G+ L E + P E+ L + R +
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 921 TSSAEMDCLLSVLHLALDCCMESP 944
+ +++ L E P
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 60/307 (19%), Positives = 107/307 (34%), Gaps = 37/307 (12%)
Query: 285 IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344
I N LS N N ++ + S+ N +L +
Sbjct: 3 IMLPINNNFSLS-QNSFYNTISGTYA----DYFSAWDKWEKQALPGENRNEAVSLLKECL 57
Query: 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404
N L+ ++P + + VL + NAL ++P L+ L
Sbjct: 58 IN---QFSELQLNRLNLS-SLPDNLPP--QITVLEITQNAL-ISLPELPA---SLEYLDA 107
Query: 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSS 464
N L ++P L+ L+ ++ N+L+ +P+ A L +N +N+ + +P
Sbjct: 108 CDNRLS-TLPELPASLKHLD---VDNNQLTM-LPELPALL---EYINADNNQLTM-LPEL 158
Query: 465 FWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL----V 520
SLE L ++ +N L+ LP ++L+ L D+S N L +P +
Sbjct: 159 PTSLEVL---SVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEI 210
Query: 521 TLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580
N+ IP+ SL ++ L +N LS I +SL +
Sbjct: 211 FFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS 269
Query: 581 IPANGPF 587
Sbjct: 270 DGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 1e-21
Identities = 70/458 (15%), Positives = 141/458 (30%), Gaps = 84/458 (18%)
Query: 77 MSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTG 136
MS+ + NN L Q IS Y ++ ++ W K + N
Sbjct: 1 MSIMLPINNNF-----SLSQNSFYNTISGTYADYFSAWDKW----EKQALPGENRNEAVS 51
Query: 137 PIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNL 196
+ L +++ + + ++P + + + + N L +P +L+ L
Sbjct: 52 LLKECL--INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYL 105
Query: 197 EILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK 256
+ N+LS LP +L+ + N+
Sbjct: 106 ---------------------------DACDNRLS---TLPE----LPASLKHLDVDNNQ 131
Query: 257 LTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT--DSPTAEW 314
LT +P L ++ N + L P +L VL++ NN LT + P
Sbjct: 132 LT-MLPELPAL---LEYINADNNQLTML-PELPTSLE---VLSVRNNQLTFLPELPE--- 180
Query: 315 SFLSSLTNCRNLTTLAVASNPLRGILPPVIG---NFSASLQNFYAYDCKLTGNIPHEIGN 371
+L L V++N L LP V + + F + ++T +IP I +
Sbjct: 181 ----------SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228
Query: 372 LRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGN 431
L + L N L+ I ++ + +G + S+ +
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPD--YHGPRIYFSMSDGQQNTLHRPLADAVTA 286
Query: 432 KLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQN 491
++ + E +N FS+ + ++ + + ++
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQ-----VAAWLEK 341
Query: 492 LQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF 529
L L ++ D + L +L
Sbjct: 342 LSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 1e-15
Identities = 42/208 (20%), Positives = 74/208 (35%), Gaps = 22/208 (10%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
L+ + L T+P + L LD+ N LP L + + D N+ +
Sbjct: 103 EYLDACDNRLS-TLPELPAS---LKHLDVDNNQL-TMLPELPALLEYI---NADNNQLT- 153
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
P L++LS+RNN T +P +L L D N+++ ++P+
Sbjct: 154 MLPELPT---SLEVLSVRNNQLTF-LPELPESLEAL---DVSTNLLE-SLPAVPVRNHHS 205
Query: 173 ----VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGN 228
+ N + IP I +L ++L N LS I+ S+ + +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNK 256
S + L + +NK
Sbjct: 265 YFSMSDGQQNTLHRPLADAVTAWFPENK 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
++ +LG G FG V+K + G A K+ + + +E V+ + H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
++ + + + LV+E + G L + ++Y L L+ + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--- 207
Query: 803 PVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAPEYG 857
++H DLKP NIL D + + DFGL++ + + + + T ++APE
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPR-----EKLKVNFGTPEFLAPEVV 260
Query: 858 TEGIVSSKCDVYSYGVLL 875
VS D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 51/234 (21%), Positives = 91/234 (38%), Gaps = 15/234 (6%)
Query: 650 SCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNE----CNLLGRGSFGSVYKGTF- 704
+ D W++ ++ D + LG G+FG V++ T
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 705 SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNG 764
+ G +FA K + + E + + +RH L+ + + +++ ++ E M G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAH 823
L + + ++ + E + M V L ++H + VH DLKP NI+
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNE 295
Query: 824 V--SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLL 875
+ DFGL+ D +T T + APE V D++S GVL
Sbjct: 296 LKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 49/223 (21%), Positives = 81/223 (36%), Gaps = 27/223 (12%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSS 747
+L G F VY+ G +A+K + R+ E ++ + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 748 CC-------NNDFRALVLELMPNGSLEKWL--YSDNYFLDLLERLNIMIGVALALEYLHH 798
L+L + G L ++L L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA----------T 848
P++H DLK N+LL + DFG + D A T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 849 IGYMAPE----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDD 887
Y PE Y I K D+++ G +L R+ P +D
Sbjct: 214 PMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFED 255
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 76/327 (23%), Positives = 119/327 (36%), Gaps = 40/327 (12%)
Query: 203 MNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIP 262
M L P P++ +S ++++ + +G P V + L +P
Sbjct: 1 MGILPSPGMPALLLVSLLSVLLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNLR-EVP 59
Query: 263 NSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTN 322
+ I ++ L+L N + ++F +LR L +L L+ N++ T A
Sbjct: 60 DGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA-------FNG 110
Query: 323 CRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFI 382
NL TL + N L I G F L L L L
Sbjct: 111 LANLNTLELFDNRLTTIPN---GAFV----------------------YLSKLKELWLRN 145
Query: 383 NALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQC 440
N + +IPS R+ L+ L L I L L + L L IP
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN- 202
Query: 441 LASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDL 500
L LI L EL+L N S+ P SF L +L + + + + + NLQ L+ ++L
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 501 SRNQLSGDIPITIGSLKDLVTLSLASN 527
+ N L+ L L + L N
Sbjct: 263 AHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 66/293 (22%), Positives = 99/293 (33%), Gaps = 50/293 (17%)
Query: 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
+ + LR +P + + L++ +N N LR L + L N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 111 S----GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI 166
G+F L+ L L L +N T IPN F
Sbjct: 101 RTIEIGAFNG----LANLNTLELFDNRLTT-IPNGAFV---------------------- 133
Query: 167 GNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLIN 224
LS L + L N ++ IPS + +L L LG I F +S + +N
Sbjct: 134 -YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 225 LFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGL 284
L L +L P L L L N L+ P S L L + + +
Sbjct: 192 LAMCNLREIPNLTP-----LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246
Query: 285 IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+ F NL+ L +NLA+N LT + L +L + + NP
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDL----FTPLH---HLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 8/222 (3%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD-LCHLERL 423
+P I + +L+L N + ++ L L+ L L N++ +I L L
Sbjct: 58 VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114
Query: 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
N + L N+L+ L L+EL L +N S +F + L ++L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 484 SLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTG 542
+ + L L L+L+ L +IP + L L L L+ N P +F L
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 543 LESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
L+ L + + + + + L L ++N++HN L +P +
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 5/232 (2%)
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405
S + + ++ ++ + +LR L +L L N + L L L L+
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 406 GNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS- 463
N L +IP +L +L + L N + + SLR L+LG K S I
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 464 SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523
+F L L +NL+ +L +P+ + L L LDLS N LS P + L L L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 524 LASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
+ +Q + F +L L ++L++NNL+ L L+++++ HN
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 60/240 (25%), Positives = 92/240 (38%), Gaps = 15/240 (6%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
N R+ +L +N++ NS + L L LS N + F L L+ L L +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFS--ASLQNFYAYDCKLT 362
LTT A L L + +NP+ I F+ SL+ + K
Sbjct: 124 LTTIPNGA-------FVYLSKLKELWLRNNPIESIPS---YAFNRIPSLRRLDLGELKRL 173
Query: 363 GNIPHEI-GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421
I L +L L+L + L IP + L +L L L GN+L P L
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
L + + +++ +L SL E+NL N + F L +L ++L N
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 26/253 (10%)
Query: 119 GVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSSLVNVNL 177
G+ + ++L+L N NS +L LE N I I L++L + L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLEL 119
Query: 178 AYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFG-NQLSGHL 234
N L IP+ L L+ L L N + I F I ++ ++L +LS
Sbjct: 120 FDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLS--- 174
Query: 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF 294
+ L NLR +L L IP ++T KL LDLS N S + P +F L
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
L L + + + A N ++L + +A N L + + L+
Sbjct: 233 LQKLWMIQSQIQVIERNA-------FDNLQSLVEINLAHNNLTLLPHDLFTPLH-HLERI 284
Query: 355 YAY------DCKL 361
+ + +C +
Sbjct: 285 HLHHNPWNCNCDI 297
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 44/196 (22%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQ-LDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LGRG FG V++ S ++ K ++ D+ E +L RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--LVKKEISILNIARHRNILHLHESF 70
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHSTPVVHC 807
+ + ++ E + + + + + + L+ E ++ + V AL++LH H + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN----IGHF 126
Query: 808 DLKPSNILL--DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE------YGTE 859
D++P NI+ + +FG ++ GD + Y APE T
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 860 GIVSSKCDVYSYGVLL 875
D++S G L+
Sbjct: 184 ------TDMWSLGTLV 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 53/200 (26%), Positives = 78/200 (39%), Gaps = 26/200 (13%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFD------SECEVLRNVRHRNLIK 743
LG G F V K S G +A K + RA R E +LR V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLHHGHS 801
+ N L+LEL+ G L +L E + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEATSFIKQILDGVNYLHTKK- 135
Query: 802 TPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAPE 855
+ H DLKP NI+L + DFGL+ ++G T ++APE
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-----VEFKNIFGTPEFVAPE 188
Query: 856 YGTEGIVSSKCDVYSYGVLL 875
+ + D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 53/201 (26%), Positives = 78/201 (38%), Gaps = 28/201 (13%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFD------SECEVLRNVRHRNLIK 743
LG G F V K S G +A K + RA R E +LR V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+ N L+LEL+ G L +L E + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEATSFIKQILDGVNYLHTKK- 135
Query: 801 STPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAP 854
+ H DLKP NI+L + DFGL+ ++G T ++AP
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-----VEFKNIFGTPEFVAP 187
Query: 855 EYGTEGIVSSKCDVYSYGVLL 875
E + + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/207 (25%), Positives = 77/207 (37%), Gaps = 40/207 (19%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN---LQLDRAFRSFDS---ECEVLRNVRHRNLIK 743
LG G F V K G +A K L R S + E +LR +RH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+ N L+LEL+ G L +L E + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT---EDEATQFLKQILDGVHYLHSKR- 128
Query: 801 STPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAP 854
+ H DLKP NI+L + + DFG++ + G T ++AP
Sbjct: 129 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-----NEFKNIFGTPEFVAP 180
Query: 855 E------YGTEGIVSSKCDVYSYGVLL 875
E G E D++S GV+
Sbjct: 181 EIVNYEPLGLE------ADMWSIGVIT 201
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRA-FRSFDSECEV-LRNVRHRNLIKIFSS 747
+GRG++GSV K G A+K +D + + +V +R+ +++ + +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN------IMIGVALALEYLHHGHS 801
+ +ELM + S +K+ + L + + I + AL +L
Sbjct: 90 LFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE----YG 857
++H D+KPSNILLD + DFG+S + DS+ +T YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 858 TEGIVSSKCDVYSYGVLLTE 877
+ + DV+S G+ L E
Sbjct: 202 SRQGYDVRSDVWSLGITLYE 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 28/201 (13%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN-LQLDRAFRSFD-----SECEVLRNVRHRNLIK 743
LG G F V K S G +A K + + R E +L+ ++H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLH-HGH 800
+ N L+LEL+ G L +L E + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT---EEEATEFLKQILNGVYYLHSLQ- 134
Query: 801 STPVVHCDLKPSNILL----DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--TIGYMAP 854
+ H DLKP NI+L + DFGL+ D G T ++AP
Sbjct: 135 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-----NEFKNIFGTPEFVAP 186
Query: 855 EYGTEGIVSSKCDVYSYGVLL 875
E + + D++S GV+
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 54/219 (24%), Positives = 82/219 (37%), Gaps = 9/219 (4%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLE--GSIPYDLCHLER 422
+P I S L L N L +L QL LSL N L G
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSS-FWSLEYLLAVNLSSNSL 481
L + L+ N + + L L L+ + S F SL L+ +++S
Sbjct: 80 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 482 SGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGS 539
+ I L L L ++ N + I L++L L L+ Q E P F S
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 540 LTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
L+ L+ L++S+NN + L L+ L+ S N +
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/291 (18%), Positives = 105/291 (36%), Gaps = 49/291 (16%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS--- 111
+ ++ GL ++P + S L++ N + +L +L +SL N S
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 112 ---GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-G 167
S + L+ L L N + ++ L +LE D + + +
Sbjct: 69 CCSQSDFG----TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 168 NLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF 226
+L +L+ +++++ + + + I L +LE+L + N+ P IF
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT---------- 172
Query: 227 GNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286
L NL L + +L P + + S L L++S N+F L
Sbjct: 173 ----------------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216
Query: 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+ L L VL+ + N++ T L +L L + N
Sbjct: 217 FPYKCLNSLQVLDYSLNHIMTSKKQE----LQHFP--SSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 59/289 (20%), Positives = 96/289 (33%), Gaps = 41/289 (14%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
+ LT ++P I S T L+L N L F L L+ L+L++N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
+ ++ S +L L ++ N + +
Sbjct: 65 SFKGCCSQ-----SDFGTTSLKYLDLSFNGVI--------------------------TM 93
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
L L L + L +V L L L + + + L L
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 153
Query: 425 GIRLNGNK-LSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
+++ GN +P L +L L+L + P++F SL L +N+S N+
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF- 212
Query: 484 SLPSNI-QNLQVLINLDLSRNQLSGDIPITI--GSLKDLVTLSLASNQF 529
SL + + L L LD S N + L L+L N F
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 53/285 (18%), Positives = 86/285 (30%), Gaps = 39/285 (13%)
Query: 274 LDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVAS 333
+ + + + + L L +N L + LT L+++S
Sbjct: 12 IRCNSKGLTSVPTGIPSSAT---RLELESNKLQSLPHGV-------FDKLTQLTKLSLSS 61
Query: 334 NPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV 393
N L SL L L N + T+ S
Sbjct: 62 NGLSFKGCC-----------------------SQSDFGTTSLKYLDLSFNGVI-TMSSNF 97
Query: 394 GRLEQLQGLSLYGNNLEGSIPYDL-CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452
LEQL+ L +NL+ + + L L + ++ L SL L +
Sbjct: 98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157
Query: 453 GSNKFSSSIPS-SFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIP 510
N F + F L L ++LS L L +L L L++S N
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDT 216
Query: 511 ITIGSLKDLVTLSLASNQFEGPIPQTFGSL-TGLESLDLSNNNLS 554
L L L + N Q + L L+L+ N+ +
Sbjct: 217 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 51/257 (19%), Positives = 92/257 (35%), Gaps = 33/257 (12%)
Query: 52 VRALNLSNMGLRGTIPPH-LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110
L L + L+ ++P + L L +S N L F
Sbjct: 30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNG--------------LSFKGCCSQSD 74
Query: 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNL 169
G + L+ L L N + ++ L +LE D + + + +L
Sbjct: 75 FG--------TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 170 SSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFG 227
+L+ +++++ + + + I L +LE+L + N+ P IF + +T ++L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPH 287
QL L P SL +L+V ++ N + L LD S N
Sbjct: 185 CQLE---QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 288 TFGNL-RFLSVLNLANN 303
+ L+ LNL N
Sbjct: 242 ELQHFPSSLAFLNLTQN 258
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 56/213 (26%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVL-RNVRHRNLIKIFSS 747
+LG G G V + G A+K+ +A + E + + +++ I
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 748 CCNNDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVALAL 793
N +++E M G L F + ER + IM + A+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 794 EYLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-T 848
++LH H + H D+KP N+L ++D V ++DFG +K + T T
Sbjct: 142 QFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYT 192
Query: 849 IGYMAPE------YGTEGIVSSKCDVYSYGVLL 875
Y+APE Y CD++S GV++
Sbjct: 193 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 50/213 (23%), Positives = 73/213 (34%), Gaps = 54/213 (25%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNVRHR-NLIKI 744
LGRG F V + S G +A K Q RA E VL + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA--EILHEIAVLELAKSCPRVINL 94
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL----------NIMIGVALALE 794
N L+LE G + F L L ++ + +
Sbjct: 95 HEVYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 795 YLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA--T 848
YLH + +VH DLKP NILL + DFG+S+ + T
Sbjct: 146 YLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-----CELREIMGT 196
Query: 849 IGYMAPE------YGTEGIVSSKCDVYSYGVLL 875
Y+APE T D+++ G++
Sbjct: 197 PEYLAPEILNYDPITTA------TDMWNIGIIA 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRA-FRSFDSECEV-LRNVRHR 739
D LGRG++G V K G A+K ++ + + ++ +R V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN------IMIGVALAL 793
+ + + + +ELM + SL+K Y +D + + I + + AL
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKAL 122
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
E+LH S V+H D+KPSN+L++ + DFG+S D V + + YMA
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMA 177
Query: 854 PE----YGTEGIVSSKCDVYSYGVLLTE 877
PE + S K D++S G+ + E
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN------------LQLDRAFRSFDS-------- 728
+G+GS+G V +D T +A+KV + R R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 729 ------ECEVLRNVRHRNLIKIFS--SCCNNDFRALVLELMPNGSL----EKWLYSDN-- 774
E +L+ + H N++K+ N D +V EL+ G + S++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 775 --YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832
YF DL+ +EYLH+ ++H D+KPSN+L+ ED ++DFG+S
Sbjct: 140 RFYFQDLI----------KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 833 FDEGDDSVTQTMTIATIGYMAPE--YGTEGIVS-SKCDVYSYGVLL 875
F +G D++ T+ T +MAPE T I S DV++ GV L
Sbjct: 187 F-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 48/212 (22%), Positives = 81/212 (38%), Gaps = 55/212 (25%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSC 748
LG G G V + FA+K+ +A R E E+ + ++++I
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 749 CNNDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVALALE 794
N +V+E + G L F + +R + IM + A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 795 YLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TI 849
YLH + H D+KP N+L + + ++DFG +K + T T
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTP 227
Query: 850 GYMAPE------YGTEGIVSSKCDVYSYGVLL 875
Y+APE Y CD++S GV++
Sbjct: 228 YYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNV 736
F +LG GSF +V T +AIK+ ++ ++ E +V+ +
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVT-RERDVMSRL 87
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
H +K++ + +++ L NG L K++ F + R + ALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYL 146
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLF-DEGDDSVTQTMTIATIGYMA 853
H ++H DLKP NILL+EDM H+ +DFG +K+ E + + + T Y++
Sbjct: 147 H---GKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSF-VGTAQYVS 200
Query: 854 PEYGTEGIVSSK-----CDVYSYGVLLTE 877
PE +++ K D+++ G ++ +
Sbjct: 201 PE-----LLTEKSACKSSDLWALGCIIYQ 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 36/232 (15%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV 736
R T F+E +G G FGSV+K DG +AIK L ++ E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 737 -RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL---ERLNIMIGVALA 792
+H ++++ FS+ +D + E GSL + + + E ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVS-------------------DFGLSKLF 833
L Y+H +VH D+KPSNI + + + + D G
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKP 884
Q ++A E E K D+++ + + +
Sbjct: 185 SS-----PQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 45/189 (23%), Positives = 69/189 (36%), Gaps = 6/189 (3%)
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS 458
Q + L+GN + L + L+ N L+ L L +L+L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 459 SSIPSS-FWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI-GS 515
S+ + F L L ++L L L + + L L L L N L +P
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 516 LKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
L +L L L N+ + F L L+ L L N ++ P + L L L + N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 576 KLEGEIPAN 584
L +P
Sbjct: 212 NLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 50/228 (21%), Positives = 78/228 (34%), Gaps = 17/228 (7%)
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSS 171
+ P G+ + Q + L N + S L N++ I + L+
Sbjct: 25 AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 172 LVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQ 229
L ++L+ N + L L L L L + P +F ++ + + L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNA 140
Query: 230 LSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTF 289
L LP L NL L N+++ + L L L N + + PH F
Sbjct: 141 LQ---ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 290 GNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+L L L L N L+ A L R L L + NP
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEA-------LAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 51/229 (22%), Positives = 81/229 (35%), Gaps = 14/229 (6%)
Query: 255 NKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEW 314
L +P I + + L N S + +F R L++L L +N L A
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-- 75
Query: 315 SFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLR 373
T L L ++ N + P + L + C L + + L
Sbjct: 76 -----FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129
Query: 374 SLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNK 432
+L L L NAL +P L L L L+GN + L L+ + L+ N+
Sbjct: 130 ALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 433 LSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
++ P L L L L +N S+ + L L + L+ N
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 3/210 (1%)
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405
A+ Q + + +++ R+L +L L N L + L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 406 GNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSS 464
N S+ L RL+ + L+ L P L +L+ L L N + +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 465 FWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523
F L L + L N +S S+P + L L L L +N+++ P L L+TL
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 524 LASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
L +N + L L+ L L++N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 26/115 (22%), Positives = 44/115 (38%), Gaps = 7/115 (6%)
Query: 472 LAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
+ + L ++P I Q + L N++S + + ++L L L SN
Sbjct: 14 VTTSCPQQGLQ-AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKS-LEALLFLKQLNVSHNKLEGEIPAN 584
F L LE LDLS+N + + L L L++ L+ E+
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 19/220 (8%)
Query: 671 RRTSYLDI-----QRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRA-F 723
++T YL I Q + +G G+ G V+K F G A+K ++
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67
Query: 724 RSFDSECEVL-RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLER 782
+ + +V+ ++ +++ F + N + +ELM EK +
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERIL 126
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842
+ + + AL YL H V+H D+KPSNILLDE + DFG+S D +
Sbjct: 127 GKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAK 181
Query: 843 TMTIATIGYMAPE-----YGTEGIVSSKCDVYSYGVLLTE 877
+ YMAPE T+ + DV+S G+ L E
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 52/265 (19%), Positives = 89/265 (33%), Gaps = 25/265 (9%)
Query: 636 ISTGIMVAIVIVFISCRKKIANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGS 695
AI + + R+ K+++E LA + A
Sbjct: 28 KVDDCNYAIKRIRLPNRELAREKVMREVKA-LAKLEHPGIVRYFNAWLETPPEKWQEEMD 86
Query: 696 FGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755
+ + S + + + +N + +
Sbjct: 87 EIWLKDESTDWPLSS---------PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLY 137
Query: 756 LVLELMPNGSLEKWLYSDNYFLDLLER--LNIMIGVALALEYLHHGHSTPVVHCDLKPSN 813
+ ++L +L+ W+ D L+I I +A A+E+LH ++H DLKPSN
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSN 194
Query: 814 ILLDEDMVAHVSDFGLSKLFDEGDD----------SVTQTMTIATIGYMAPEYGTEGIVS 863
I D V V DFGL D+ ++ T T + T YM+PE S
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254
Query: 864 SKCDVYSYGVLLTETFTRKKPTDDM 888
K D++S G++L E +
Sbjct: 255 HKVDIFSLGLILFELLYSFSTQMER 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 2/76 (2%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVR 737
R F +GRG FG V++ D ++AIK L + A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 738 HRNLIKIFSSCCNNDF 753
H +++ F++
Sbjct: 63 HPGIVRYFNAWLETPP 78
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-23
Identities = 49/277 (17%), Positives = 79/277 (28%), Gaps = 22/277 (7%)
Query: 320 LTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPH---EIGNLRSLI 376
R+L L + + S SL+ ++ I + + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDL------CHLERLNGIRLNG 430
L+L + GT P + L N+ + L + +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSI-------PSSFWSLEYLLAVNLSSNSLSG 483
+ + +L L+L N P F +L+ L N + SG
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGS-LKDLVTLSLASNQFEGPIPQTFGSLTG 542
+ L LDLS N L L +L+L+ +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AK 275
Query: 543 LESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579
L LDLS N L P E L + L++ N
Sbjct: 276 LSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 54/276 (19%), Positives = 81/276 (29%), Gaps = 27/276 (9%)
Query: 271 LTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLA 330
L +D + +L L L + + + + L L
Sbjct: 49 LKRVDTEADLGQ--FTDIIKSLS-LKRLTVRAARIPSRILFG----ALRVLGISGLQELT 101
Query: 331 VASNPLRGILPPVIGNFS-ASLQNFYAYDCKLTG--NIPHEIGNL--RSLIVLSLFINAL 385
+ + + G PP + + L + E+ L VLS+
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 386 NGTIPSTVGRLEQLQGLSLYGNNLEGSI-------PYDLCHLERLNGIRLNGNKLSGPIP 438
V L L L N G P L+ L SG
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 439 QCLASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLI 496
A+ + L+ L+L N + S L ++NLS L +P + L VL
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVL- 279
Query: 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
DLS N+L P L + LSL N F
Sbjct: 280 --DLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 45/277 (16%), Positives = 84/277 (30%), Gaps = 23/277 (8%)
Query: 73 FSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132
L +D + + L+RL + + +S LQ L+L N
Sbjct: 46 EYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENL 105
Query: 133 SFTGPIPNSLFNLSRLEKWD-SMFNIIDGNIPSRIGNLSSLVN-----VNLAYNNLQGEI 186
TG P L + + ++ N+ + + L + +++A +
Sbjct: 106 EVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFS 165
Query: 187 PSEIGNLQNLEILVLGMNNLSGPI----QPSIFNISTITLINLFGNQLSGHLDLPPKVSY 242
++ L L L N G T+ ++ L + + ++
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 243 SLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLA 301
+ L+ L N L S+L L+LSF + L VL+L+
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLS 282
Query: 302 NNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338
N L S + L++ NP
Sbjct: 283 YNRLDR---------NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 55/345 (15%), Positives = 102/345 (29%), Gaps = 64/345 (18%)
Query: 149 EKWDSMFNIIDGNIPSRIGNLSSL----VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMN 204
W S FN + G SL V+ + Q + +L+ L + +
Sbjct: 22 PDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIP 81
Query: 205 NLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG--TIP 262
+ + IS + + L +++G PP + + P+L + +L
Sbjct: 82 SRILFGALRVLGISGLQELTLENLEVTGTA-PPPLLEATGPDLNILNLRNVSWATRDAWL 140
Query: 263 NSITNASK--LTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSL 320
+ K L L ++ LS L+L++N +
Sbjct: 141 AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKF 200
Query: 321 TNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSL 380
L+ L + +
Sbjct: 201 P-------------------------------------------------TLQVLALRNA 211
Query: 381 FINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLSGPIPQ 439
+ +G + QLQGL L N+L + C +LN + L+ L +P+
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPK 270
Query: 440 CLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
L + L L+L N+ + S L + ++L N S
Sbjct: 271 GLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 38/235 (16%), Positives = 71/235 (30%), Gaps = 28/235 (11%)
Query: 362 TGNIPHEI-GNLRSLIVLSLFINA-LNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCH 419
G E+ G RSL L ++ + + + + L+ L++ + I +
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 420 LE--------RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSF-WSLEY 470
+ L + + G + L L N+ + + W
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
L ++++ ++ L LDLS N G+ +
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL-----------------IS 193
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANG 585
P F +L L + SG A + L+ L++SHN L A
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 35/191 (18%), Positives = 63/191 (32%), Gaps = 35/191 (18%)
Query: 49 HQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNF-------HAYLPNELGQLRRLR 101
++ L+++ + F L +LD+S N A P + L+ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 102 FISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGN 161
+ SG + +LQ L L +NS +
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD----------------- 250
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
S L ++NL++ L+ ++P + L +L L N L PS + +
Sbjct: 251 ------WPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVG 299
Query: 222 LINLFGNQLSG 232
++L GN
Sbjct: 300 NLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 19/116 (16%), Positives = 32/116 (27%), Gaps = 23/116 (19%)
Query: 45 CGARHQRVRALNLSNMGLR---GTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQ-LRRL 100
C + ++ L L N G+ G L LD+S N+ +L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 101 RFISLDYNEFSGSFPSW-------------------IGVLSKLQILSLRNNSFTGP 137
++L + L ++ LSL+ N F
Sbjct: 256 NSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVR 737
F +G+GSFG V T +A+K N Q R+ E ++++ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALEYL 796
H L+ ++ S + + +V++L+ G L L + +F + E + + I + +AL+YL
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMALDYL 131
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPE 855
+ ++H D+KP NILLDE H++DF ++ + TQ T+A T YMAPE
Sbjct: 132 QNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPE 184
Query: 856 YGTEGIVSSKC--------DVYSYGVLLTETFTRKKP 884
+ SS+ D +S GV E ++P
Sbjct: 185 -----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
+ +G+G+ G+VY + G AI+ NLQ +E V+R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLE--RLN------IMIGVALALEY 795
S D +V+E + GSL D++ ++ + ALE+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IATIG 850
LH S V+H D+K NILL D ++DFG +T + + T
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-------QITPEQSKRSTMVGTPY 181
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTE 877
+MAPE T K D++S G++ E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 48/207 (23%), Positives = 95/207 (45%), Gaps = 34/207 (16%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
+ +G GS G V G A+K+ +L+ + +E ++R+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLE--RLN------IMIGVALALEY 795
++ S + +++E + G+L D++ RLN + V AL Y
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IATIG 850
LH + V+H D+K +ILL D +SDFG +++ + + T
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA-------QISKDVPKRKSLVGTPY 206
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTE 877
+MAPE + + +++ D++S G+++ E
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 53/298 (17%), Positives = 101/298 (33%), Gaps = 36/298 (12%)
Query: 56 NLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS---- 111
S+ L +IP L + SLD+S N ++L + L+ + L N +
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRI-GNL 169
SF S L L+ L L N + + +S F LS L + + N + + +L
Sbjct: 94 DSFSS----LGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 170 SSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFG 227
+ L + + + +I + L LE L + ++L +P +I ++ + L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHM 207
Query: 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI--------TNASKLTGLDLSFN 279
Q L ++ L L + + + ++
Sbjct: 208 KQHI---LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264
Query: 280 SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
S + + L L + N L + LT +L + + +NP
Sbjct: 265 SLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGI----FDRLT---SLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 56/302 (18%), Positives = 94/302 (31%), Gaps = 38/302 (12%)
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSS 171
S PS G+ ++ L L NN T + L L+ N I+ I +L S
Sbjct: 45 SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 172 LVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFN--ISTITLINLFGN 228
L +++L+YN L + S L +L L L N + S+F+ L +
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
+ + K L L + + L P S+ + ++ L L L+
Sbjct: 161 TFT---KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217
Query: 289 FGNLRFLSVLNLANNYLTTDSPTA-EWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNF 347
+ L L + L T + +SL + + L
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF---------- 267
Query: 348 SASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGN 407
+ + + L+ L N L RL LQ + L+ N
Sbjct: 268 ----------------QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
Query: 408 NL 409
Sbjct: 312 PW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 60/296 (20%), Positives = 101/296 (34%), Gaps = 49/296 (16%)
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
+ L+L+NN +T S + L C NL L + SN + I +FS
Sbjct: 54 VKSLDLSNNRITYISNSD-------LQRCVNLQALVLTSNGINTIEE---DSFS------ 97
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSI 413
+L SL L L N L + S+ L L L+L GN +
Sbjct: 98 ----------------SLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLG 140
Query: 414 PYDL-CHLERLNGIRLNGNKLSGPIP-QCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471
L HL +L +R+ I + A L L EL + ++ S P S S++ +
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200
Query: 472 LAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGS--------LKDLVTL 522
+ L L + L+L L + + +
Sbjct: 201 SHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 523 SLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS-LEALLFLKQLNVSHNKL 577
+ + + ++GL L+ S N L +P + L L+++ + N
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 36/136 (26%), Positives = 66/136 (48%), Gaps = 6/136 (4%)
Query: 446 SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQ 504
+++ L+L +N+ + S L A+ L+SN ++ ++ + +L L +LDLS N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 505 LSGDIPITI-GSLKDLVTLSLASNQFEG-PIPQTFGSLTGLESLDLSNNNLSGEIP-KSL 561
LS ++ + L L L+L N ++ F LT L+ L + N + +I K
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 562 EALLFLKQLNVSHNKL 577
L FL++L + + L
Sbjct: 171 AGLTFLEELEIDASDL 186
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 18/79 (22%), Positives = 36/79 (45%), Gaps = 3/79 (3%)
Query: 499 DLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIP 558
S L+ IP + + +L L++N+ L++L L++N ++
Sbjct: 37 KGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 559 KSLEALLFLKQLNVSHNKL 577
S +L L+ L++S+N L
Sbjct: 94 DSFSSLGSLEHLDLSYNYL 112
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 44/221 (19%), Positives = 85/221 (38%), Gaps = 18/221 (8%)
Query: 682 TDGFNECNLLGRG--SFGSVYKGTF-SDGTSFAIKVFNL--QLDRAFRSFDSECEVLRNV 736
+ ++G+G +V + G ++ NL + E V +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--NIMIGVALALE 794
H N++ ++ ++ +V M GS + L ++ + E I+ GV AL+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALD 142
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVT-QTMTIATIG-- 850
Y+HH VH +K S+IL+ D ++S + + G ++
Sbjct: 143 YIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 851 -YMAPEYGTEGIV--SSKCDVYSYGVLLTETFTRKKPTDDM 888
+++PE + + +K D+YS G+ E P DM
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 43/226 (19%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
+ LG G+FG VYK G A KV + + + E E+L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVALAL 793
+ + ++ +++E P G++ ++ L+ + + AL
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAV----------DAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMT-----IA 847
+LH ++H DLK N+L+ + ++DFG+S K +T+ I
Sbjct: 131 NFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN--------LKTLQKRDSFIG 179
Query: 848 TIGYMAPE-----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
T +MAPE + K D++S G+ L E + P ++
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 59/205 (28%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVLRN 735
F + +LG+G FG V + T G +A K L+ R + ++L
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQILEK 240
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALE 794
V R ++ + + D LVL LM G L+ +Y R + LE
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGYM 852
LH +V+ DLKP NILLD+ H+ SD GL+ EG + + T+GYM
Sbjct: 301 DLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ--TIKGR-VGTVGYM 352
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTE 877
APE + D ++ G LL E
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYE 377
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 45/233 (19%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQ-----LDRAFRSFDSECEVLRNVRHRNLIK 743
LG G++G V + A+K+ +++ + + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSD---------NYFLDLLERLNIMIGVALALE 794
+ + + L LE G L + D +F L+ +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVV 119
Query: 795 YLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
YLH G + H D+KP N+LLDE +SDFGL+ +F + T+ Y+A
Sbjct: 120 YLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 854 PEYGTEGIVS------SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900
PE ++ DV+S G++LT + P D W +
Sbjct: 176 PE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-22
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 36/229 (15%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC--------EV 732
F+ ++GRG FG VY T G +A+K L R +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKC--LDKKRIKMKQGETLALNERIMLSL 245
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
+ ++ + + D + +L+LM G L L F + + + L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--ADMRFYAAEIIL 303
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATI 849
LE++H + VV+ DLKP+NILLDE HV SD GL+ + + T
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLAC---DFSKKKPHAS-VGTH 354
Query: 850 GYMAPEYGTEGIVSSKC-DVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
GYMAPE +G+ D +S G +L + P F + K
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK 399
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 7e-22
Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 35/230 (15%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
D F + +LGRG FG V+ K T G +A K L R + + ++L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--LNKKRLKKRKGYQGAMVEKKIL 239
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLL--ERLNIMIG-VA 790
V R ++ + + LV+ +M G + +Y+ + R +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIAT 848
LE+LH +++ DLKP N+LLD+D +V SD GL+ G T+ T
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTK-TKGY-AGT 352
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT---------RKKPTDDMF 889
G+MAPE D ++ GV L E K ++
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
F+ LG GS+GSVYK G AIK ++ D + E +++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVALAL 793
+ S N +V+E GS+ D++ N I+ L
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSV----------SDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-----IAT 848
EYLH +H D+K NILL+ + A ++DFG++ +T TM I T
Sbjct: 139 EYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG-------QLTDTMAKRNTVIGT 188
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTE 877
+MAPE E + D++S G+ E
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 30/186 (16%), Positives = 71/186 (38%), Gaps = 10/186 (5%)
Query: 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430
++ + L + T T ++ L ++L N+ + + + + +N
Sbjct: 21 TFKAYLNGLL---GQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ 490
+ P ++ L +L L + +S + L L +++S ++ S+ + I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 491 NLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSN 550
L + ++DLS N DI + +L +L +L++ + L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 551 NNLSGE 556
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 27/137 (19%), Positives = 55/137 (40%), Gaps = 7/137 (5%)
Query: 442 ASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDL 500
A + SL + L + + +++ L +++ + + I L L L +
Sbjct: 41 AQMNSLTYITLANINVTDLTGIEYAHNIKDL---TINNIHATNY--NPISGLSNLERLRI 95
Query: 501 SRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS 560
++ D + L L L ++ + + I +L + S+DLS N +I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 561 LEALLFLKQLNVSHNKL 577
L+ L LK LN+ + +
Sbjct: 155 LKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 32/196 (16%), Positives = 72/196 (36%), Gaps = 21/196 (10%)
Query: 168 NLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFG 227
+ +N L ++ +++ +L + + + + +L+G I I + +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPH 287
+ + P L NL + +T +++ + LT LD+S ++ I
Sbjct: 76 IHAT---NYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 288 TFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNF 347
L ++ ++L+ N TD + L L +L + + + I +F
Sbjct: 131 KINTLPKVNSIDLSYNGAITD--------IMPLKTLPELKSLNIQFDGVHDYRG--IEDF 180
Query: 348 SASLQNFYAYDCKLTG 363
L YA+ + G
Sbjct: 181 P-KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 30/174 (17%), Positives = 62/174 (35%), Gaps = 17/174 (9%)
Query: 166 IGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINL 225
++SL + LA N+ ++ + I N++ L + + + P I +S + + +
Sbjct: 40 EAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNP-ISGLSNLERLRI 95
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
G ++ L +L + + + +I I K+ +DLS+N I
Sbjct: 96 MGKDVT---SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI 339
L L LN+ + + + + L L S + G
Sbjct: 153 MP-LKTLPELKSLNIQFDGVHD---------YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 31/213 (14%), Positives = 75/213 (35%), Gaps = 37/213 (17%)
Query: 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRN 131
F ++ + +++ ++ L + +++ + +G I ++ L++ N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG 191
T P + LS LE+ M + + + L+SL ++++++ I ++I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 192 NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFS 251
L + + L N I +I + +LP L+ +
Sbjct: 134 TLPKVNSIDLSYNGA-------ITDIMPLK---------------------TLPELKSLN 165
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGL 284
+ + + I + KL L + G
Sbjct: 166 IQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 25/159 (15%), Positives = 59/159 (37%), Gaps = 7/159 (4%)
Query: 349 ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN 408
SL + +T ++ I ++ L++ T + + L L+ L + G +
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKD 99
Query: 409 LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL 468
+ +L L L + ++ + I + +L + ++L N + I +L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 469 EYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG 507
L ++N+ + + I++ L L + G
Sbjct: 159 PELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 20/118 (16%), Positives = 48/118 (40%), Gaps = 7/118 (5%)
Query: 467 SLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526
+ + L L +S + + + +L + L+ ++ D+ I ++ L++ +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVT-DLT-GIEYAHNIKDLTINN 75
Query: 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
P L+ LE L + +++ + +L L L L++SH+ + I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 24/131 (18%), Positives = 45/131 (34%), Gaps = 5/131 (3%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114
L ++N+ P + S L L I + + L L L + + ++ S
Sbjct: 71 LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174
+ I L K+ + L N I L L L+ + F+ + I + L
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 175 VNLAYNNLQGE 185
+ + G+
Sbjct: 186 LYAFSQTIGGK 196
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNL-QLDRAFRSFDSECEVLRNVRHRNLI 742
F + +G+GSFG V+KG AIK+ +L + + E VL +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLE--RLN------IMIGVALALE 794
K + S + +++E + GS LDLLE L+ I+ + L+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLD 133
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVTQTMTIATIGYMA 853
YLH S +H D+K +N+LL E ++DFG++ +L D T + T +MA
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTF-VGTPFWMA 187
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
PE + SK D++S G+ E + P ++
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 36/205 (17%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFN------------LQLDRAFRSFDSECEVLRNVR 737
LG G+FG V+ +K +L + E +L V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN------IMIGVAL 791
H N+IK+ N F LV+E +G L+ L++ F+D RL+ I +
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVS 141
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
A+ YL ++H D+K NI++ ED + DFG + + G T TI Y
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEY 195
Query: 852 MAPE-YGTEGIVSSKCDVYSYGVLL 875
APE + +++S GV L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 45/233 (19%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQ-----LDRAFRSFDSECEVLRNVRHRNLIK 743
LG G++G V + A+K+ +++ + + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSD---------NYFLDLLERLNIMIGVALALE 794
+ + + L LE G L + D +F L+ +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVV 119
Query: 795 YLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
YLH G + H D+KP N+LLDE +SDFGL+ +F + T+ Y+A
Sbjct: 120 YLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 854 PEYGTEGIVS------SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900
PE ++ DV+S G++LT + P D W +
Sbjct: 176 PE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 34/206 (16%)
Query: 690 LLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDS----ECEVLRNVRHRNLIKI 744
LLG GS+G V + S+ A+K+ + R + ++ E ++LR +RH+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 745 FS--SCCNNDFRALVLELMPNGSLE-------KWLYSD---NYFLDLLERLNIMIGVALA 792
+V+E G E K YF L++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------G 121
Query: 793 LEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
LEYLH G +VH D+KP N+LL +S G+++ T + + +
Sbjct: 122 LEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 852 MAPE--YGTEGIVSSKCDVYSYGVLL 875
PE G + K D++S GV L
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 22/220 (10%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVF---NLQLDRAFRSFDSECEVLRN 735
+ F LLG+G+FG V K T G +A+K+ + +E VL+N
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALE 794
RH L + S +D V+E G L L + F + +R + AL+
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSALD 262
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
YLH + VV+ DLK N++LD+D ++DFGL K D + +T T Y+AP
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTF-CGTPEYLAP 318
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
E + D + GV++ E + P + +F
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 58/240 (24%), Positives = 93/240 (38%), Gaps = 69/240 (28%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN----LQL-DRAFRSFDSECEVLRN 735
F ++GRG+FG V K FA+K+ N L+ + A F E +VL N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVN 130
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG------- 788
+ + + + +++ LV++ G L L LL + +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFY 180
Query: 789 ---VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQT 843
+ +A++ +H VH D+KP NIL+D + H+ +DFG E +
Sbjct: 181 LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV 235
Query: 844 MTIATIGYMAPE-----------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
+ T Y++PE YG E CD +S GV + E M GE
Sbjct: 236 A-VGTPDYISPEILQAMEGGKGRYGPE------CDWWSLGVCMYE----------MLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-21
Identities = 54/230 (23%), Positives = 100/230 (43%), Gaps = 52/230 (22%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN----LQLDRAFRSFDSECEVLRNV 736
+ ++GRG+FG V K T +A+K+ + ++ + F E +++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVA------ 790
++++F + ++ + +V+E MP G L ++L+ ++ A
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAE 176
Query: 791 --LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTI 846
LAL+ +H S +H D+KP N+LLD+ H+ +DFG ++ T +
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTA-V 230
Query: 847 ATIGYMAPE----YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
T Y++PE G +G +CD +S GV L E M G+
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE----------MLVGD 270
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRN 735
D F ++GRG+F V K T G +A+K+ N + F E +VL N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALE 794
R + ++ + + ++ LV+E G L L + E + + +A++
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-EMARFYLAEIVMAID 176
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+H VH D+KP NILLD H+ +DFG + + T Y+
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVA-VGTPDYL 230
Query: 853 APE-------------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
+PE YG E CD ++ GV E MF G+
Sbjct: 231 SPEILQAVGGGPGTGSYGPE------CDWWALGVFAYE----------MFYGQ 267
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 62/251 (24%), Positives = 95/251 (37%), Gaps = 53/251 (21%)
Query: 670 WRRTSYLDIQRATD---GFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRS 725
R +D+ D F L+G G++G VYKG G AIKV ++ D
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEE 66
Query: 726 FDSECEVLRNV-RHRNLIKIFSS------CCNNDFRALVLELMPNGSLEKWLYSDNYFLD 778
E +L+ HRN+ + + +D LV+E GS+ D
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TD 116
Query: 779 LLERLN-----------IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827
L++ I + L +LH V+H D+K N+LL E+ + DF
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173
Query: 828 GLSKLFDEGDDSVTQTMT-----IATIGYMAPE-----YGTEGIVSSKCDVYSYGVLLTE 877
G+S + +T+ I T +MAPE + K D++S G+ E
Sbjct: 174 GVSA-------QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 878 TFTRKKPTDDM 888
P DM
Sbjct: 227 MAEGAPPLCDM 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 48/221 (21%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIK-------------VFNLQLD--RAFRSFDSECEVLRN 735
+ GS+G+V G S+G AIK + + R R E +L +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85
Query: 736 VRHRNLIK---IFSSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVA 790
H N++ IF LV ELM L + ++ + M +
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IAT 848
L L LH VVH DL P NILL ++ + DF L++ + T +
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTH 196
Query: 849 IGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE + T+ + D++S G ++ E F RK
Sbjct: 197 RWYRAPELVMQFKGF-TKLV-----DMWSAGCVMAEMFNRK 231
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 67/344 (19%), Positives = 127/344 (36%), Gaps = 56/344 (16%)
Query: 192 NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFS 251
L N + G +N++ + + ++ IT ++ FG ++ + V Y L NL
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT---TIEG-VQY-LNNLIGLE 69
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311
L N++T + + N +K+T L+LS N + L+ + L+L + +T
Sbjct: 70 LKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD---- 121
Query: 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGN 371
++ L NL L + N + I P +
Sbjct: 122 -----VTPLAGLSNLQVLYLDLNQITNISP---------------------------LAG 149
Query: 372 LRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGN 431
L +L LS+ + + + + L +L L N + I L L L + L N
Sbjct: 150 LTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNN 205
Query: 432 KLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQN 491
++S P LA+ +L + L + ++ +L V S + P+ I +
Sbjct: 206 QISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISD 261
Query: 492 LQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ 535
+ +L+ N S ++ + VT + F G + Q
Sbjct: 262 NGTYASPNLTWNLTSFINNVSY-TFNQSVTFKNTTVPFSGTVTQ 304
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 67/324 (20%), Positives = 117/324 (36%), Gaps = 57/324 (17%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+L N + GK+ +T T+ + +T L + + L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKD 72
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N +T L+ L N +T L ++ NPL+ +
Sbjct: 73 NQITD---------LAPLKNLTKITELELSGNPLKNVSA--------------------- 102
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
I L+S+ L L + P + L LQ L L N + +I L L
Sbjct: 103 ------IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTN 152
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L + + ++S P LA+L L L NK S S SL L+ V+L +N +S
Sbjct: 153 LQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS 208
Query: 483 GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTG 542
S + N L + L+ ++ + +LV ++ PI S
Sbjct: 209 DV--SPLANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATIS--- 260
Query: 543 LESLDLSNNNLSGEIPKSLEALLF 566
++ ++ NL+ + + + +
Sbjct: 261 -DNGTYASPNLTWNLTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 52/256 (20%), Positives = 108/256 (42%), Gaps = 21/256 (8%)
Query: 317 LSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLI 376
+ N +A + + + + + A+ +T I + L +LI
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLD-GITTLSAFGTGVT-TIE-GVQYLNNLI 66
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436
L L N + T + + L ++ L L GN L+ ++ + L+ + + L +++
Sbjct: 67 GLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV 122
Query: 437 IPQCLASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL 495
P LA L +L+ L L N+ ++ P + +L+YL ++ + +S + + NL L
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISPLAGLTNLQYL---SIGNAQVSDL--TPLANLSKL 175
Query: 496 INLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG 555
L N++S DI + SL +L+ + L +NQ P + + L + L+N ++
Sbjct: 176 TTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231
Query: 556 EIPKSLEALLFLKQLN 571
+ L+ +
Sbjct: 232 QPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/266 (19%), Positives = 102/266 (38%), Gaps = 31/266 (11%)
Query: 121 LSKLQILSLRNNSFTGPIP-NSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY 179
L+ ++ ++ T + L ++ L + + I+G + L++L+ + L
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72
Query: 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK 239
N + + + NL + L L N L +I + +I ++L Q++ L
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
L NL+V L N++T P + + L L + S L P NL L+ L
Sbjct: 127 ---GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359
+N ++ +S L + NL + + +N + + P + N S +L +
Sbjct: 180 ADDNKISD---------ISPLASLPNLIEVHLKNNQISDVSP--LANTS-NLFIVTLTNQ 227
Query: 360 KLTGNIPHEIGNLRSLIVLSLFINAL 385
+T NL V+ A
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 55/272 (20%), Positives = 98/272 (36%), Gaps = 24/272 (8%)
Query: 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111
+ + T+ + + +L + L L + L N+ +
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76
Query: 112 GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSS 171
P + L+K+ L L N + L ++ D I P + LS+
Sbjct: 77 DLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 172 LVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
L + L N + I S + L NL+ L +G +S + P + N+S +T + N++S
Sbjct: 131 LQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKIS 186
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291
D+ P S LPNL L N+++ P + N S L + L+ + + N
Sbjct: 187 ---DISPLAS--LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNC 323
L V N+ A S + +
Sbjct: 240 ---LVVPNVVKGPSGAPIAPATISDNGTYASP 268
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 34/209 (16%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDS---ECEVLRNVRHRNLIKIFS 746
+G G+ V AIK NL ++ S D E + + H N++ ++
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 747 SCCNNDFRALVLELMPNGSLE---KWLYSDNYFLD-LLERLNIMI---GVALALEYLHHG 799
S D LV++L+ GS+ K + + +L+ I V LEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-KLFDEGDDSVT---QTMTIATIGYMAPE 855
+H D+K NILL ED ++DFG+S L GD + +T + T +MAPE
Sbjct: 141 G---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWMAPE 196
Query: 856 -------YGTEGIVSSKCDVYSYGVLLTE 877
Y K D++S+G+ E
Sbjct: 197 VMEQVRGYD------FKADIWSFGITAIE 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 685 FNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVLRN 735
F LG GSFG V+ + G +A+KV L+ + R E +L
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSI 62
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
V H +I+++ + + ++++ + G L L F + + + V LALEY
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEY 121
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
LH +++ DLKP NILLD++ H+ +DFG +K VT T+ T Y+A
Sbjct: 122 LHSKD---IIYRDLKPENILLDKN--GHIKITDFGFAKY----VPDVTYTL-CGTPDYIA 171
Query: 854 PEYGTEGIVSSK-----CDVYSYGVLLTE 877
PE +VS+K D +S+G+L+ E
Sbjct: 172 PE-----VVSTKPYNKSIDWWSFGILIYE 195
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 43/230 (18%)
Query: 683 DGFNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
+ F+ LLG+G+FG V K T G +A+K+ L+ + + VL
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVL 59
Query: 734 RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALA 792
+N RH L + + +D V+E G L L + F ER + A
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGAEIVSA 117
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIG 850
LEYLH S VV+ D+K N++LD+D H+ +DFGL K D + +T T
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKE-GISDGATMKTF-CGTPE 170
Query: 851 YMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
Y+APE YG D + GV++ E + P + +F
Sbjct: 171 YLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 41/231 (17%)
Query: 683 DGFNECNLLGRGSFGSVY---KGTFSD-GTSFAIKVFNLQLDRAFRSFD------SECEV 732
+ F +LG+G +G V+ K T ++ G FA+KV L+ R+ +E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNI 74
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
L V+H ++ + + L+LE + G L L + F+ + + +++
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM--EDTACFYLAEISM 132
Query: 792 ALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIAT 848
AL +LH G +++ DLKP NI+L+ HV +DFGL K D +VT T T
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKE-SIHDGTVTHTF-CGT 184
Query: 849 IGYMAPEYGTEGIVSSK-----CDVYSYGVLLTETFTRKKP-----TDDMF 889
I YMAPE I+ D +S G L+ + T P
Sbjct: 185 IEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 43/231 (18%)
Query: 683 DGFNECNLLGRGSFGSVY---KGTFSD-GTSFAIKVFN----LQLDRAFRSFDSECE--V 732
F +LG+GSFG V+ K + SD +A+KV DR ++ E +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV----RTKMERDI 79
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
L V H ++K+ + L+L+ + G L L + F E + + +AL
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVKFYLAELAL 137
Query: 792 ALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIAT 848
AL++LH G +++ DLKP NILLDE+ H+ +DFGLSK + + T
Sbjct: 138 ALDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKE-SIDHEKKAYSF-CGT 189
Query: 849 IGYMAPEYGTEGIVSSK-----CDVYSYGVLLTETFTRKKP-----TDDMF 889
+ YMAPE +V+ + D +S+GVL+ E T P +
Sbjct: 190 VEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 685 FNECNLLGRGSFGSVY---KGTFSD-GTSFAIKVFN----LQLDRAFRSFDSECEVLRNV 736
F +LG G++G V+ K + D G +A+KV +Q + +E +VL ++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 737 RHRN-LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALALE 794
R L+ + + L+L+ + G L L F + + I +G + LALE
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALE 173
Query: 795 YLH-HGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGY 851
+LH G +++ D+K NILLD + HV +DFGLSK F + TI Y
Sbjct: 174 HLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDF-CGTIEY 226
Query: 852 MAPE---YGTEGIVSSKCDVYSYGVLLTE 877
MAP+ G G + D +S GVL+ E
Sbjct: 227 MAPDIVRGGDSGHDKA-VDWWSLGVLMYE 254
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 92.6 bits (229), Expect = 3e-19
Identities = 88/611 (14%), Positives = 179/611 (29%), Gaps = 190/611 (31%)
Query: 390 PSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE 449
V RL+ L L L + ++G SG +A +
Sbjct: 128 KYNVSRLQPYLKLRQA-----------LLELRPAKNVLIDGVLGSGK--TWVALDV-CLS 173
Query: 450 LNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDL-SRNQLSGD 508
+ K I FW +NL + + ++ +Q L I+ + SR+ S +
Sbjct: 174 YKVQC-KMDFKI---FW-------LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 509 IPITIGSLKDLVTLSLASNQFE-----------GPIPQTFG----------------SLT 541
I + I S++ + L S +E F L+
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 542 GLESLDLSNNNLSG--EIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNY 599
+ +S ++ S + L LK L+ L E+ P +
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKS--LLLKYLDCRPQDLPREVLTTNPRR----------L 330
Query: 600 ALCGPTTLQVPPCRAN--KTEGSKKASR---NFLKYVLPPLISTGIMVAIVIVFISCRKK 654
++ +++ + K K + + L VL P + + + F
Sbjct: 331 SIIA-ESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKMFDRLSV-F---PPS 384
Query: 655 IANKIVKEDLLPLAAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKV 714
I LL L W D+ + ++ +L+ + I +
Sbjct: 385 A--HI-PTILLSL-IWFDVIKSDVMVVVNKLHKYSLVEK------------QPKESTISI 428
Query: 715 FNLQLDRAFRSFDSECEVLRNVRHRNLI---KIFSSCCNNDFRALVLELMPNGSLEKWLY 771
++ L+ + E + HR+++ I + ++D +P Y
Sbjct: 429 PSIYLE-----LKVKLENEYAL-HRSIVDHYNIPKTFDSDDL-------IPP-------Y 468
Query: 772 SDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV-SDFGL- 829
D YF Y H GH H LK + V DF
Sbjct: 469 LDQYF------------------YSHIGH-----H--LKNIEHPERMTLFRMVFLDFRFL 503
Query: 830 -SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
K+ + + I+++ + Y P +
Sbjct: 504 EQKIRHDS----------------TAWNASGSILNTLQQLKFYK----PYICDNDPKYER 543
Query: 889 FTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948
++ ++ + ++ NL+ ++T +L +AL + D+ I
Sbjct: 544 LVN--AILDFLPK---------IEENLICSKYT---------DLLRIAL----MAEDEAI 579
Query: 949 YMTDAAVKLKK 959
+ +A ++++
Sbjct: 580 F-EEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 9e-10
Identities = 86/576 (14%), Positives = 174/576 (30%), Gaps = 149/576 (25%)
Query: 67 PPHLGNFSFLMSLDISKNNF------HAY-LPNELGQLRRLRFISLDYNE-----FSGSF 114
+ NF D+ K+ H + + RL + L E F
Sbjct: 27 DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 115 P----SWIGVLSKLQI------------LSLRNNSFTGPIPNSLFNLSRLEKWDSMFNII 158
++ +S ++ + R+ + + +N+SRL+ + + +
Sbjct: 87 LRINYKFL--MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 159 DGNIPSR---------IGNLSSLVNVNLAYNNLQGEIPSEI-----GNLQNLEILVLGMN 204
P++ G + + +Q ++ +I N + E ++ +
Sbjct: 145 LELRPAKNVLIDGVLGSGK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 205 NLSGPIQPS----IFNISTITL-INLFGNQLSGHLDLPPKVSYSL--------PN-LRVF 250
L I P+ + S I L I+ +L L P + L F
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-CLLVLLNVQNAKAWNAF 262
Query: 251 SLG-KNKLTGTIPNSITNA-SKLTGLDLSFNSFS-GLIPHTFGNLRFLSVLNLANNYLTT 307
+L K LT T +T+ S T +S + S L P +L L L+
Sbjct: 263 NLSCKILLT-TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-LLKYLDCR----PQ 316
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLR-GILPPVIGNFSASLQNFYAYDC-KLTGNI 365
D P E + +NP R I+ I + A+ N+ +C KLT I
Sbjct: 317 DLP-RE----------------VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 366 PHEIGNLRSLIV------LSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD-LC 418
+ L LS+F + + IP+ + LSL ++ S +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAH--IPTIL--------LSLIWFDVIKSDVMVVVN 409
Query: 419 HLERLNGIRLNGNKLSGPIPQCL--------------ASLISLRELNLGSNKFSSSIPS- 463
L + + + + + IP S++ + + P
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL 469
Query: 464 ---SFWSLEY---------------LLAVNLS-------SNSLSGSLPSNIQNLQVLINL 498
+ + + ++ ++ +S + + +I N L L
Sbjct: 470 DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT--LQQL 527
Query: 499 DLSRNQLSGDIPITIGSLKDLVT--LSLASNQFEGP 532
+ + + P + ++ + N
Sbjct: 528 KFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFN----LQLDRAFRSFDSECEVLR 734
D F+ LG GSFG V K + G +A+K+ + ++L + + +E +L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTL-NEKRILQ 96
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALAL 793
V L+K+ S +N +V+E + G + L F + + L
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--PHARFYAAQIVLTF 154
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
EYLH +++ DLKP N+L+D+ V+DFG +K T T+ T +A
Sbjct: 155 EYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTL-CGTPEALA 206
Query: 854 PEYGTEGIVSSK-----CDVYSYGVLLTE 877
PE I+ SK D ++ GVL+ E
Sbjct: 207 PE-----IILSKGYNKAVDWWALGVLIYE 230
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 54/183 (29%), Positives = 78/183 (42%), Gaps = 12/183 (6%)
Query: 399 LQGLSLYGNNLEGSIPYDL-CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKF 457
++ NL ++P DL L+ L+ N L L L +LNL +
Sbjct: 12 HLEVNCDKRNL-TALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 458 SSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI-GSL 516
+ +L L ++LS N L SLP Q L L LD+S N+L+ +P+ L
Sbjct: 68 TK--LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 517 KDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSL-EALLFLKQLNVSHN 575
+L L L N+ + P LE L L+NNNL+ E+P L L L L + N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 576 KLE 578
L
Sbjct: 183 SLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 14/190 (7%)
Query: 364 NIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERL 423
++P + +L L N L +T+ +L L+L L + D L L
Sbjct: 28 DLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVL 79
Query: 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
+ L+ N+L +P +L +L L++ N+ +S + L L + L N L
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 484 SLPSNI-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLT 541
+LP + L L L+ N L+ ++P + L++L TL L N IP+ F
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 542 GLESLDLSNN 551
L L N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 10/204 (4%)
Query: 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINA 384
+ + L + PP + + + L + L L+L
Sbjct: 11 SHLEVNCDKRNLTAL-PP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 385 LNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASL 444
L T G L L L L N L+ S+P L L + ++ N+L+ L L
Sbjct: 67 L--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 445 ISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRN 503
L+EL L N+ + P L ++L++N+L+ LP+ + L+ L L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 504 QLSGDIPITIGSLKDLVTLSLASN 527
L IP L L N
Sbjct: 183 SLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 56/212 (26%), Positives = 82/212 (38%), Gaps = 36/212 (16%)
Query: 168 NLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLF 226
++S + VN NL +P ++ ++ IL L N L + + +T +NL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYT-FSLATLMPYTRLTQLNLD 63
Query: 227 GNQLS-----------GHLDLP-------PKVSYSLPNLRVFSLGKNKLTGTIPNSI-TN 267
+L+ G LDL P + +LP L V + N+LT ++P
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
Query: 268 ASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLT 327
+L L L N L P L L+LANN LT L+ L NL
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL----LNGLE---NLD 175
Query: 328 TLAVASNPLRGILPPVIGNF-SASLQNFYAYD 358
TL + N L I P G F S L + +
Sbjct: 176 TLLLQENSLYTI-PK--GFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 44/206 (21%), Positives = 71/206 (34%), Gaps = 35/206 (16%)
Query: 100 LRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIID 159
+ L N + + ++L L+L L++L+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-----------LTKLQVDG------- 74
Query: 160 GNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NIS 218
L L ++L++N LQ +P L L +L + N L+ + +
Sbjct: 75 --------TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLG 124
Query: 219 TITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLS 277
+ + L GN+L LPP + P L SL N LT +P + L L L
Sbjct: 125 ELQELYLKGNELK---TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 278 FNSFSGLIPHTFGNLRFLSVLNLANN 303
NS + FG+ L L N
Sbjct: 181 ENSLYTIPKGFFGSHL-LPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 11/133 (8%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
L+LS+ L+ ++P L LD+S N + L L L+ + L NE
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 113 SFPSWIGV---LSKLQILSLRNNSFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRIGN 168
+ P G+ KL+ LSL NN+ T +P L L L+ N + IP
Sbjct: 138 TLPP--GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 169 LSSLVNVNLAYNN 181
L L + N
Sbjct: 194 SHLLPFAFL-HGN 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 60/221 (27%), Positives = 87/221 (39%), Gaps = 37/221 (16%)
Query: 685 FNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDS---ECEVLRNVRHRN 740
F++ +G GSFG+VY + AIK + ++ + E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLN----------IMIGVA 790
I+ LV+E GS DLLE + G
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSA----------SDLLEVHKKPLQEVEIAAVTHGAL 164
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
L YLH S ++H D+K NILL E + + DFG + + + + T
Sbjct: 165 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSF-VGTPY 215
Query: 851 YMAPE---YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
+MAPE EG K DV+S G+ E RK P +M
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 36/202 (17%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRHRNLIKIF 745
+G G+FG A+K + R E R++RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 746 SSCCNNDFRALVLELMPNGSLEKWLYSD---------NYFLDLLERLNIMIGVALALEYL 796
A+++E G L + + + +F LL + Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVSYC 132
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAH--VSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
H + H DLK N LLD + DFG SK S ++ T+ T Y+AP
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKS-TVGTPAYIAP 186
Query: 855 E-YGTEGIVSSKCDVYSYGVLL 875
E + DV+S GV L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTL 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH 738
++ + C ++G GSFG V++ + AIK R E +++R V+H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 739 RNLIK----IFSSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNI---MIGV 789
N++ +S+ D LVLE +P ++ + + L I M +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+L Y+H S + H D+KP N+LLD V + DFG +K+ G+ +V+ I +
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY---ICS 204
Query: 849 IGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y ++ D++S G ++ E +
Sbjct: 205 RYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 43/213 (20%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+G G+ G V + + AIK F Q RA+R E +++ V H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 744 IF----SSCCNNDFRA--LVLELMPNGSLEKWLYSD------NYFLDLLERLNIMIGVAL 791
+ +F+ +V+ELM +L + + + +Y L +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--------- 138
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATI 849
+++LH S ++H DLKPSNI++ D + DFGL++ MT + T
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-----MTPYVVTR 190
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE D++S G ++ E
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGTFSD-GTSFAIK-VFNLQLDRAFRSFDSECEVLRNV 736
++ D F + G+G+FG+V G G S AIK V R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNREL-QIMQDLAVL 76
Query: 737 RHRNLIK---IFSSCCNNDFR----ALVLELMPNGSLEKWLYSDNYFLDLLERLNI---M 786
H N+++ F + D R +V+E +P+ +L + + + I +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
+ ++ LH S V H D+KP N+L++ D + DFG +K + +V
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---Y 191
Query: 846 IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
I + Y APE Y T D++S G + E +
Sbjct: 192 ICSRYYRAPELIFGNQHYTT------AVDIWSVGCIFAEMMLGE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK---VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK- 743
+G G++G V + AIK F Q R R E ++L RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 744 --IFSSCCNNDFRA--LVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVALA 792
I + + +V +LM L K L + + YFL + R
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR---------G 140
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIG 850
L+Y+H S V+H DLKPSN+LL+ + DFGL+++ D D T +T +AT
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP-DHDHTGFLTEYVATRW 196
Query: 851 YMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y T+ I D++S G +L E + +
Sbjct: 197 YRAPEIMLNSKGY-TKSI-----DIWSVGCILAEMLSNR 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 63/310 (20%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR------AFRSFDSECEV 732
Q + + + +G G++G VYK S G A+K L + A R E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA 792
L+ + H N++ + + LV E M L+K L + L + + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+ + H ++H DLKP N+L++ D ++DFGL++ F G + T + T+ Y
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYR 186
Query: 853 APE-------YGTEGIVSSKCDVYSYGVLLTETFTRK--------------------KPT 885
AP+ Y T D++S G + E T K P
Sbjct: 187 APDVLMGSKKYSTS------VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 886 DDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE--HTSSAEMDCLLSVLHLALDCCMES 943
+ L W + + + +D LLS + L D
Sbjct: 241 PREWPQVQELPLWKQRTFQV-----FEKKPWSSIIPGFCQEGID-LLSNM-LCFD----- 288
Query: 944 PDQRIYMTDA 953
P++RI DA
Sbjct: 289 PNKRISARDA 298
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 19/193 (9%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFN------LQLDRAFRSFDSECEVLRNVRHRNLIK 743
+G+G+F V G AIK+ + L + FR E +++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
+F L++E G + +L + + E + + A++Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 804 VVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-YGTEGIV 862
+VH DLK N+LLD DM ++DFG S F G Y APE + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYD 191
Query: 863 SSKCDVYSYGVLL 875
+ DV+S GV+L
Sbjct: 192 GPEVDVWSLGVIL 204
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 56/225 (24%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK---VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK- 743
LG G++G V T G AIK F+ L R R E ++L++ +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 744 --IFSSCCNNDFRA--LVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVALA 792
I +F ++ ELM L + + + YF+ R A
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR---------A 124
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT------MT- 845
++ LH + V+H DLKPSN+L++ + V DFGL+++ DE ++ M
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 846 -IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+AT Y APE Y + + DV+S G +L E F R+
Sbjct: 182 FVATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFLRR 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 685 FNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
+ + ++G GSFG VY+ D G AIK R E +++R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 744 ----IFSSCCNNDFRAL--VLELMPNGSLEKWLYSDNYFLDLLERLNI---MIGVALALE 794
+SS D L VL+ +P ++ + + L + + M + +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
Y+H S + H D+KP N+LLD D V + DFG +K G+ +V+ I + Y A
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 854 PE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
PE Y + DV+S G +L E +
Sbjct: 225 PELIFGATDYTS------SIDVWSAGCVLAELLLGQ 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 38/204 (18%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQ-------LDRAFRSFDSECEVLRNVRHRNL 741
LG G+FG V G G A+K+ N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSD---------NYFLDLLERLNIMIGVALA 792
IK++ +V+E + G L ++ F +L A
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----------A 123
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
++Y H VVH DLKP N+LLD M A ++DFGLS + +G+ T + + Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYA 177
Query: 853 APE-YGTEGIVSSKCDVYSYGVLL 875
APE + D++S GV+L
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVIL 201
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 4e-18
Identities = 68/342 (19%), Positives = 107/342 (31%), Gaps = 26/342 (7%)
Query: 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL 385
+ S P++ I P F A +T + L S+ + + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAF-AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 386 NGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI 445
+ L + L L GN L I L +L+ L + L+ NK+ L L
Sbjct: 56 --KSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSS--LKDLK 109
Query: 446 SLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504
L+ L+L N S LE L L +N ++ + + L L L L NQ
Sbjct: 110 KLKSLSLEHNGISDINGLVHLPQLESL---YLGNNKITD--ITVLSRLTKLDTLSLEDNQ 164
Query: 505 LSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL 564
+S DI + L L L L+ N + L L+ L+L + + L
Sbjct: 165 IS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 565 LFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPCRANKTEGSKKAS 624
+ + + L + Y P N P + KA
Sbjct: 221 VVPNTVKNTDGSLVTPEIISDDGDYEKP-----NVKWHLPEFTNEVSFIFYQPVTIGKAK 275
Query: 625 RNFLKYVLPPLISTGIMVAIVIVFISCRKKIANKIVKEDLLP 666
F V PL + V + K A + P
Sbjct: 276 ARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPP 317
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 2e-15
Identities = 50/300 (16%), Positives = 104/300 (34%), Gaps = 22/300 (7%)
Query: 70 LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129
F+ + ++ K + + +L + I + ++ I L + L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 72
Query: 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE 189
N T I L NL L N I ++ S + +L L +++L +N + +I
Sbjct: 73 NGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING- 126
Query: 190 IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249
+ +L LE L LG N ++ + ++ + ++L NQ+S D+ P L L+
Sbjct: 127 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS---DIVPLAG--LTKLQN 179
Query: 250 FSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDS 309
L KN ++ + + L L+L + NL + + + L T
Sbjct: 180 LYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 237
Query: 310 PTAEWSFLSSLTNCRNLTTLAVASN---PLRGILPPVIGNFSASLQNFYAYDCKLTGNIP 366
++ +L + + F + ++ ++
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 685 FNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL-R 734
F +LG+GSFG V +K T FAIK L+ D D EC VL
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSL 73
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALAL 793
H L +F + + V+E + G L + S + F L R + L L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIILGL 131
Query: 794 EYLH-HGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIG 850
++LH G +V+ DLK NILLD+D H+ +DFG+ K + D+ T T T
Sbjct: 132 QFLHSKG----IVYRDLKLDNILLDKD--GHIKIADFGMCKE-NMLGDAKTNTFCG-TPD 183
Query: 851 YMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
Y+APE + D +S+GVLL E + P +++F
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 7e-18
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 44/231 (19%)
Query: 683 DGFNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
FN +LG+GSFG V KGT +A+K+ L+ D + D EC VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 395
Query: 734 -RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
+ L ++ S D V+E + G L + F +A+
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAI 453
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATI 849
L +L S +++ DLK N++LD + H+ +DFG+ K + D T+T T
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKE-NIWDGVTTKTF-CGTP 506
Query: 850 GYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
Y+APE YG D +++GVLL E + P D++F
Sbjct: 507 DYIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 67/230 (29%), Positives = 98/230 (42%), Gaps = 42/230 (18%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
F+ ++G+GSFG V K +A+KV LQ + + + VL
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVL 92
Query: 734 -RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
+NV+H L+ + S D VL+ + G L L + FL R +A
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL--EPRARFYAAEIAS 150
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATI 849
AL YLH S +V+ DLKP NILLD H+ +DFGL K + +S T T T
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKE-NIEHNSTTSTF-CGTP 203
Query: 850 GYMAPEYGTEGIVSSK-----CDVYSYGVLLTETFTRKKP-----TDDMF 889
Y+APE ++ + D + G +L E P T +M+
Sbjct: 204 EYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 27/293 (9%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+ +L K +T + + + + + + + L ++ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N LT + L N +NL L + N ++ + + + L++ ++
Sbjct: 78 NKLTD---------IKPLANLKNLGWLFLDENKVKDLSS--LKDLK-KLKSLSLEHNGIS 125
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
+I + +L L L L N + T + + RL +L LSL N + I L L +
Sbjct: 126 -DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTK 179
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L + L+ N +S + LA L +L L L S + + + +L V + SL
Sbjct: 180 LQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 483 GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ 535
P I + ++ + L VT+ A +F G + Q
Sbjct: 238 T--PEIISDDGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARFHGRVTQ 287
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 53/265 (20%), Positives = 98/265 (36%), Gaps = 17/265 (6%)
Query: 317 LSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLI 376
+ S + + + + S+ A + + ++ I L ++
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SVQ-GIQYLPNVT 71
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436
L L N L P + L+ L L L N ++ + L L++L + L N +S
Sbjct: 72 KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDI 127
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
L L L L LG+NK + + L L ++L N +S + + L L
Sbjct: 128 NG--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQ 181
Query: 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE 556
NL LS+N +S D+ + LK+L L L S + +L ++ ++ +L
Sbjct: 182 NLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
Query: 557 IPKSLEALLFLKQLNVSHNKLEGEI 581
S + + + E+
Sbjct: 240 EIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 57/304 (18%), Positives = 102/304 (33%), Gaps = 54/304 (17%)
Query: 260 TIPNSIT------NASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAE 313
T+P I ++ +L S + + L + + N+ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS------ 60
Query: 314 WSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR 373
+ + N+T L + N L I P + NL+
Sbjct: 61 ---VQGIQYLPNVTKLFLNGNKLTDIKP---------------------------LANLK 90
Query: 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433
+L L L N + S++ L++L+ LSL N + I L HL +L + L NK+
Sbjct: 91 NLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI 146
Query: 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ 493
+ L+ L L L+L N+ S L L + LS N +S L + L+
Sbjct: 147 TDITV--LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHIS-DL-RALAGLK 200
Query: 494 VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
L L+L + +L T+ P + ++
Sbjct: 201 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEF 260
Query: 554 SGEI 557
+ E+
Sbjct: 261 TNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 40/268 (14%), Positives = 85/268 (31%), Gaps = 57/268 (21%)
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
++ +L+ S T + L+S+ + +
Sbjct: 23 FAETIKDNLKKKSVTDAVT--------------------------QNELNSIDQIIANNS 56
Query: 181 NLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNIST---ITLINLFGNQLSGHLDLP 237
+++ + I L N+ L L N L+ I ++ + + L N++ DL
Sbjct: 57 DIK-SV-QGIQYLPNVTKLFLNGNKLT-----DIKPLANLKNLGWLFLDENKVK---DLS 106
Query: 238 PKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSV 297
L L+ SL N ++ I + + +L L L N + + L L
Sbjct: 107 S--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDT 160
Query: 298 LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAY 357
L+L +N ++ + L L L ++ N + + + +L +
Sbjct: 161 LSLEDNQISD---------IVPLAGLTKLQNLYLSKNHISDLRA--LAGLK-NLDVLELF 208
Query: 358 DCKLTGNIPHEIGNLRSLIVLSLFINAL 385
+ + NL + +L
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 48/260 (18%), Positives = 96/260 (36%), Gaps = 19/260 (7%)
Query: 70 LGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129
F+ + ++ K + + +L + I + ++ I L + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75
Query: 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE 189
N T I L NL L N + ++ S + +L L +++L +N + +I
Sbjct: 76 NGNKLTD-IKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING- 129
Query: 190 IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249
+ +L LE L LG N ++ + ++ + ++L NQ+S D+ P L L+
Sbjct: 130 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS---DIVPLA--GLTKLQN 182
Query: 250 FSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDS 309
L KN ++ ++ L L+L + NL + + + L T
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 240
Query: 310 PTAEWSFLSSLTNCRNLTTL 329
++ +L
Sbjct: 241 IISDDGDYEKPNVKWHLPEF 260
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 49/231 (21%), Positives = 82/231 (35%), Gaps = 18/231 (7%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
L L+ L I P L N L L + +N L L++L+ +SL++N S
Sbjct: 71 TKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD 126
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
+ L +L+ L L NN T L L++L+ N I +I + L+ L
Sbjct: 127 ING--LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL 180
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSG 232
N+ L+ N++ ++ + L+NL++L L N+ + L
Sbjct: 181 QNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSG 283
+ Y PN++ I K F G
Sbjct: 239 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA------RFHG 283
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 14/196 (7%)
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448
+P + + L L N L Y L + L+ ++ SL L
Sbjct: 26 LPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQL-S 506
L L N S +F L L + +L+ SL + +L+ L L+++ N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138
Query: 507 GDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLE----SLDLSNNNLSGEIPKSLE 562
+P +L +L L L+SN+ + L + SLDLS N ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 563 ALLFLKQLNVSHNKLE 578
+ LK+L + N+L+
Sbjct: 198 KEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 374 SLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGN 431
S L L N L + S +LQ L L ++ +I L L+ + L GN
Sbjct: 29 STKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 432 KLSGPIPQCLASLISLRELNLGSNKFSSSIPS-SFWSLEYLLAVNLSSNSLSGSLPSN-- 488
+ + L SL++L +S+ + L+ L +N++ N + S
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144
Query: 489 IQNLQVLINLDLSRNQLSGDIPITI----GSLKDL-VTLSLASNQFEGPIPQTFGSLTGL 543
NL L +LDLS N++ I T + L ++L L+ N P F + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-L 202
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
+ L L N L + L L+++ + N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 51/240 (21%), Positives = 84/240 (35%), Gaps = 38/240 (15%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
+ + L N L S + +L LDLS + + +L LS L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
+ + + A + +L L L + IG+ +L+ + N
Sbjct: 88 IQSLALGA-------FSGLSSLQKLVAVETNLASLENFPIGHLK-TLKELN-----VAHN 134
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD----LCHL 420
++S + F N L L+ L L N ++ SI L +
Sbjct: 135 ------LIQSFKLPEYFSN------------LTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175
Query: 421 ERLNG-IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSN 479
LN + L+ N ++ I I L+EL L +N+ S F L L + L +N
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 48/233 (20%), Positives = 79/233 (33%), Gaps = 24/233 (10%)
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSS 171
P + + L L N S F+ L+ D I I +LS
Sbjct: 21 KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 172 LVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFNI-STITLINLFGNQ 229
L + L N +Q + L +L+ LV NL+ ++ T+ +N+ N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNL 135
Query: 230 LSGHLDLP-PKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTG----LDLSFNSFSGL 284
+ P+ +L NL L NK+ + ++ LDLS N + +
Sbjct: 136 IQ---SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 285 IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
P F +R L L L N L + +L + + +NP
Sbjct: 193 QPGAFKEIR-LKELALDTNQLKSVPDGI-------FDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 19/227 (8%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTI 220
IP + S N++L++N L+ + L++L L + I+ + ++S +
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHL 78
Query: 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280
+ + L GN + L L +L+ + L I + L L+++ N
Sbjct: 79 STLILTGNPIQ---SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 281 FSGLI-PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLT-TLAVASNPLRG 338
P F NL L L+L++N + + T L L L +L ++ NP+
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD----LRVLHQMPLLNLSLDLSLNPMNF 191
Query: 339 ILPPVIGNFSA-SLQNFYAYDCKLTGNIPHEI-GNLRSLIVLSLFIN 383
I P G F L+ +L ++P I L SL + L N
Sbjct: 192 IQP---GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 45/236 (19%), Positives = 75/236 (31%), Gaps = 43/236 (18%)
Query: 78 SLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS----GSFPSWIGVLSKLQILSLRNNS 133
+LD+S N L+ + L E G++ S LS L L L N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS----LSHLSTLILTGNP 87
Query: 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GN 192
+ F+ LSSL + NL + + G+
Sbjct: 88 IQS-LALGAFS-----------------------GLSSLQKLVAVETNLA-SLENFPIGH 122
Query: 193 LQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVF- 250
L+ L+ L + N + P F N++ + ++L N++ + L + +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ---SIYCTDLRVLHQMPLLN 179
Query: 251 ---SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
L N + I +L L L N + F L L + L N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 28/159 (17%), Positives = 56/159 (35%), Gaps = 32/159 (20%)
Query: 76 LMSLDISKNNFHAYLPNELGQLRRLRFISLDYN-----EFSGSFPSWIGVLSKLQILSLR 130
L L + N + +G L+ L+ +++ +N + F + L+ L+ L L
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN----LTNLEHLDLS 157
Query: 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI 190
+N L L ++ ++++L+ N + I
Sbjct: 158 SNKIQSIYCTDLRVLHQMP--------------------LLNLSLDLSLNPMN-FIQPGA 196
Query: 191 GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGN 228
L+ L L N L + IF ++++ I L N
Sbjct: 197 FKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 683 DGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDR------AFRSFDSECEVLRN 735
+ + +G G++G+V+K A+K L D A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
++H+N++++ ++ LV E L+K+ S N LD + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
H + V+H DLKP N+L++ + +++FGL++ F G + + T+ Y P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPD 171
Query: 856 -------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892
Y T D++S G + E +P +F G
Sbjct: 172 VLFGAKLYSTS------IDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 52/206 (25%), Positives = 77/206 (37%), Gaps = 36/206 (17%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN-LQLDRAFRSFDS-----ECEVLRNVRHR--N 740
LLG G FGSVY G SD AIK ++ + E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 741 LIKIFSSCCNNDFRALVLEL-MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-H 798
+I++ D L+LE P L ++ ++ L + V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 799 GHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEG--DDSVTQTMTIATIGYMAPE 855
G V+H D+K NIL+D + + DFG L + D T Y PE
Sbjct: 169 G----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPE 218
Query: 856 YGTEGIVSSKC------DVYSYGVLL 875
+ V+S G+LL
Sbjct: 219 -----WIRYHRYHGRSAAVWSLGILL 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 58/220 (26%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+G G++GSV G AIK F ++ RA+R E +L++++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 744 IF----SSCCNNDFRA--LVLELMPNGSLEKWLYSD------NYFLDLLERLNIMIGVAL 791
+ + +F LV+ M L+K + Y + + +
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--------- 137
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATI 849
L+Y+H S VVH DLKP N+ ++ED + DFGL++ D MT + T
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-------EMTGYVVTR 187
Query: 850 GYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y + + D++S G ++ E T K
Sbjct: 188 WYRAPEVILSWMHY-NQTV-----DIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 60/228 (26%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK--VFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIF 745
LG G G V+ +D AIK V A R E +++R + H N++K+F
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 746 ------------SSCCNNDFRA--LVLELMPNGSLEKWLYSDN-------YFLDLLERLN 784
+ + +V E M L L F+ L R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR-- 131
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQT 843
L+Y+H S V+H DLKP+N+ ++ ED+V + DFGL+++ D
Sbjct: 132 -------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH-KGH 180
Query: 844 MT--IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
++ + T Y +P Y T+ I D+++ G + E T K
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGK 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 44/207 (21%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQ-------LDRAFRSFDSECEVLRNVRHRNL 741
LG G+FG V G G A+K+ N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSD---------NYFLDLLERLNIMIGVALA 792
IK++ +V+E + G L ++ + F +L
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----------G 128
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG-- 850
++Y H VVH DLKP N+LLD M A ++DFGLS + +G+ T + G
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSP 179
Query: 851 -YMAPE-YGTEGIVSSKCDVYSYGVLL 875
Y APE + D++S GV+L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNV 736
+ ++ +G G++G VYK + G +FA+K L+ + R E +L+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
+H N++K++ LV E + L+K L L+ + + ++ + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE- 855
H V+H DLKP N+L++ + ++DFGL++ F G T I T+ Y AP+
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDV 171
Query: 856 ------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y T D++S G + E
Sbjct: 172 LMGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 66/231 (28%), Positives = 92/231 (39%), Gaps = 44/231 (19%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
D F +LG+GSFG V K T G +A+KV L+ D + D EC +L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRIL 77
Query: 734 RNV-RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
H L ++F D V+E + G L + F R +
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIIS 135
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATI 849
AL +LH +++ DLK N+LLD + H +DFG+ K + T T T
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKE-GICNGVTTATF-CGTP 188
Query: 850 GYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
Y+APE YG D ++ GVLL E P DD+F
Sbjct: 189 DYIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 40/216 (18%), Positives = 69/216 (31%), Gaps = 84/216 (38%)
Query: 691 LGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEV---LRNVRHRNLIKIF- 745
LG G G V + FA+K+ + EV R + ++++I
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 746 ---SSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERL--------------NIMIG 788
+ +V+E + G +L R+ IM
Sbjct: 79 VYENLYAGRKCLLIVMECLDGG-------------ELFSRIQDRGDQAFTEREASEIMKS 125
Query: 789 VALALEYLH-HGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
+ A++YLH + H D+KP N+L + + ++DFG
Sbjct: 126 IGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166
Query: 845 TIATIGYMAPE-----YGTEGIVSSKCDVYSYGVLL 875
A E Y CD++S GV++
Sbjct: 167 --------AKETTGEKYDKS------CDMWSLGVIM 188
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/202 (25%), Positives = 78/202 (38%), Gaps = 26/202 (12%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFN------LQLDRAFRSFDSECEVLRNVR----H 738
LLG+G FG+V+ G +D AIKV + E +L V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 739 RNLIKIFSSCCNNDFRALVLEL-MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
+I++ + LVLE +P L ++ ++ L V A+++ H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 798 HGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEG--DDSVTQTMTIATIGYMAP 854
VVH D+K NIL+D A + DFG L + D T Y P
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD------GTRVYSPP 207
Query: 855 EY-GTEGIVSSKCDVYSYGVLL 875
E+ + V+S G+LL
Sbjct: 208 EWISRHQYHALPATVWSLGILL 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 32/223 (14%)
Query: 685 FNECNLLGRGSFGSV----YKGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL-R 734
FN +LG+GSFG V KGT +A+K+ L+ D + D EC VL
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VALAL 793
+ L ++ S D V+E + G L + F +A+ L
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGL 134
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGY 851
+L S +++ DLK N++LD + H+ +DFG+ K + D T+T T Y
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKE-NIWDGVTTKTF-CGTPDY 187
Query: 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMF 889
+APE D +++GVLL E + P D++F
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 61/302 (20%), Positives = 103/302 (34%), Gaps = 69/302 (22%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIK 743
+G GS+G V+K D G AIK F D A R E +L+ ++H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
+ LV E + ++ L + +I A+ + H H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPE----- 855
+H D+KP NIL+ + V + DFG ++L + +AT Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLL----TGPSDYYDDEVATRWYRSPELLVGD 177
Query: 856 --YGTEGIVSSKCDVYSYGVLLTETFTRK--------------------KPTDDMFTGEM 893
YG + DV++ G + E +
Sbjct: 178 TQYGP-PV-----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 894 SLKKWVKESLPHGLMEVVDTNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMT 951
+ + + +P + D L + + S + LL L +D P +R+
Sbjct: 232 TNQYFSGVKIP----DPEDMEPLELKFPNISYPALG-LLKGC-LHMD-----PTERLTCE 280
Query: 952 DA 953
Sbjct: 281 QL 282
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 68/310 (21%), Positives = 112/310 (36%), Gaps = 63/310 (20%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDR------AFRSFDSECEV 732
++ + + L+G GS+G V K D G AIK F D A R E ++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA 792
L+ +RH NL+ + C LV E + + ++ L LD + +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+ + H + ++H D+KP NIL+ + V + DFG ++ +AT Y
Sbjct: 137 IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYR 191
Query: 853 APE-------YGTEGIVSSKCDVYSYGVLLTETFTRK--------------------KPT 885
APE YG + DV++ G L+TE F +
Sbjct: 192 APELLVGDVKYGK-AV-----DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245
Query: 886 DDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE--HTSSAEMDCLLSVLHLALDCCMES 943
+ LP E+ + L + S +D L L +D
Sbjct: 246 PRHQELFNKNPVFAGVRLP----EIKEREPLERRYPKLSEVVID-LAKKC-LHID----- 294
Query: 944 PDQRIYMTDA 953
PD+R + +
Sbjct: 295 PDKRPFCAEL 304
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 59/221 (26%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+G G++GSV + G A+K F + R +R E +L++++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 744 IF----SSCCNNDFRA--LVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVA 790
+ + +F LV LM L + + + + R
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-------- 143
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IAT 848
L+Y+H S ++H DLKPSN+ ++ED + DFGL++ MT +AT
Sbjct: 144 -GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVAT 192
Query: 849 IGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y + + D++S G ++ E T +
Sbjct: 193 RWYRAPEIMLNWMHY-NQTV-----DIWSVGCIMAELLTGR 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 6e-17
Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 3/154 (1%)
Query: 727 DSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIM 786
D + +++ R S + L E FL L +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 787 IGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTI 846
VA +E+L S +H DL NILL E V + DFGL++ + D V +
Sbjct: 200 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 847 ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT 880
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 56/177 (31%), Positives = 76/177 (42%), Gaps = 4/177 (2%)
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCH-LERLNGIRLNGNKLSG 435
L L N L+ RL +L+ L L N L+ ++P + L+ L + + NKL
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA 99
Query: 436 PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQV 494
L++L EL L N+ S P F SL L ++L N L SLP + L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158
Query: 495 LINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNN 551
L L L NQL L +L TL L +NQ + F SL L+ L L N
Sbjct: 159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 55/190 (28%), Positives = 77/190 (40%), Gaps = 12/190 (6%)
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448
IP+ + L L N L L +L + LN NKL L +L
Sbjct: 35 IPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 449 ELNLGSNKFSSSIPSS-FWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLS 506
L + NK + +P F L L + L N L SLP + +L L L L N+L
Sbjct: 89 TLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 507 GDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL 565
+P + L L L L +NQ + F LT L++L L NN L + ++L
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205
Query: 566 FLKQLNVSHN 575
LK L + N
Sbjct: 206 KLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 20/213 (9%)
Query: 174 NVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSG 232
+V+ + L IPS I + + L L N LS + F ++ + L+ L N+L
Sbjct: 20 SVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQ- 74
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSFNSFSGLIPHTFGN 291
LP + L NL + NKL +P + L L L N L P F +
Sbjct: 75 --TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS 131
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASL 351
L L+ L+L N L + F LT +L L + +N L+ + P + L
Sbjct: 132 LTKLTYLSLGYNELQSLPKGV---F-DKLT---SLKELRLYNNQLKRV-PEGAFDKLTEL 183
Query: 352 QNFYAYDCKLTGNIPHEI-GNLRSLIVLSLFIN 383
+ + +L +P +L L +L L N
Sbjct: 184 KTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 9/183 (4%)
Query: 124 LQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRI-GNLSSLVNVNLAYNNL 182
+ L L++N + + L++L N + +P+ I L +L + + N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 183 QGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLDLPPKV 240
Q +P + L NL L L N L + P +F +++ +T ++L N+L LP V
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ---SLPKGV 152
Query: 241 SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300
L +L+ L N+L + ++L L L N + F +L L +L L
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 301 ANN 303
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 76 LMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGV---LSKLQILSLRNN 132
L L ++ N +L+ L + + N+ + P GV L L L L N
Sbjct: 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPI--GVFDQLVNLAELRLDRN 119
Query: 133 SFTGPIPNSLF-NLSRLEKWDSMFNIIDGNIPSRI-GNLSSLVNVNLAYNNLQGEIPSEI 190
+P +F +L++L +N + ++P + L+SL + L N L+ +P
Sbjct: 120 QLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA 176
Query: 191 -GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGN 228
L L+ L L N L + F ++ + ++ L N
Sbjct: 177 FDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQEN 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 25/202 (12%), Positives = 50/202 (24%), Gaps = 45/202 (22%)
Query: 690 LLGRGSFGSVYKGTFSD---GTSFAIKVFNLQL--DRAFRS-FDSECEVLRNVRHRNLIK 743
G ++ D A+ + Q S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 744 IFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH-HGHST 802
+ +V E + GSL++ + + + M +A A + H G
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--- 149
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
V PS + + D ++ M
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD-------A 179
Query: 863 SSKCDVYSYGVLLTETFTRKKP 884
+ + D+ G L + P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP 201
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 9e-17
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+G G+ G V + + AIK F Q RA+R E +++ V H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 744 IF----SSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
+ +F+ LV+ELM +L + + + LD ++ + +++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH 181
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPE 855
++H DLKPSNI++ D + DFGL++ + MT + T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPE 233
Query: 856 YGTEGIVSSKC----DVYSYGVLLTETFTRK 882
I+ D++S G ++ E K
Sbjct: 234 V----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 59/221 (26%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+G G++G+V G AIK F +L RA+R E +L+++RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 744 IF----SSCCNNDFRA--LVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVA 790
+ +DF LV+ M L K + + + + + +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IAT 848
L Y+H + ++H DLKP N+ ++ED + DFGL++ D MT + T
Sbjct: 140 -GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------EMTGYVVT 188
Query: 849 IGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y APE Y T+ + D++S G ++ E T K
Sbjct: 189 RWYRAPEVILNWMRY-TQTV-----DIWSVGCIMAEMITGK 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNL-QLDRAFRSFDS----E 729
LD++ + + + LG G F +VYK + AIK L A + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 730 CEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGV 789
++L+ + H N+I + + + +LV + M LE + ++ L M+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IA 847
LEYLH ++H DLKP+N+LLDE+ V ++DFGL+K F S + T +
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF----GSPNRAYTHQVV 174
Query: 848 TIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
T Y APE YG G+ D+++ G +L E R
Sbjct: 175 TRWYRAPELLFGARMYGV-GV-----DMWAVGCILAELLLRV 210
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 39/204 (19%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQ-------LDRAFRSFDSECEVLRNVRHRNL 741
LG GSFG V T + A+K + Q R R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 742 IKIFSSCCNNDFRALVLE---------LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA 792
IK++ +V+E ++ + + +F ++ A
Sbjct: 72 IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDE-GRRFFQQIIC----------A 120
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+EY H +VH DLKP N+LLD+++ ++DFGLS + +G+ T + + Y
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPNYA 174
Query: 853 APE-YGTEGIVSSKCDVYSYGVLL 875
APE + + DV+S G++L
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVL 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 39/214 (18%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
F+ ++GRGS+ V K T +A+KV ++ + D + V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVF 63
Query: 734 -RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
+ H L+ + S V+E + G L + E ++L
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISL 121
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATI 849
AL YLH +++ DLK N+LLD + H+ +D+G+ K T T T
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKE-GLRPGDTTSTF-CGTP 174
Query: 850 GYMAPE------YGTEGIVSSKCDVYSYGVLLTE 877
Y+APE YG D ++ GVL+ E
Sbjct: 175 NYIAPEILRGEDYGFS------VDWWALGVLMFE 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 47/228 (20%)
Query: 683 DGFNECNLLGRGSFGSVY----KGTFSDGTSFAIKVFNLQLDRAFRSFDSEC-----EVL 733
F+ ++GRGS+ V K T +A++V ++ + D + V
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVF 106
Query: 734 -RNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIG-VAL 791
+ H L+ + S V+E + G L + E ++L
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISL 164
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATI 849
AL YLH +++ DLK N+LLD + H+ +D+G+ K T T T
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKE-GLRPGDTTSTF-CGTP 217
Query: 850 GYMAPEYGTEGIVSSK-----CDVYSYGVLLTETFTRKKPTDDMFTGE 892
Y+APE I+ + D ++ GVL+ E M G
Sbjct: 218 NYIAPE-----ILRGEDYGFSVDWWALGVLMFE----------MMAGR 250
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 43/215 (20%), Positives = 81/215 (37%), Gaps = 14/215 (6%)
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
+ L L + + S + ++LQ L +I + L+ L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLG--SNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
+ S L ++ +R L +KF + ++L+ L+
Sbjct: 401 EKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT- 454
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
+ +++ L ++ +LDLS N+L +P + +L+ L L + N E + +L L
Sbjct: 455 -VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRL 510
Query: 544 ESLDLSNNNLSG-EIPKSLEALLFLKQLNVSHNKL 577
+ L L NN L + L + L LN+ N L
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 3e-14
Identities = 45/213 (21%), Positives = 77/213 (36%), Gaps = 18/213 (8%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLS---LYGNNLEGSIPYDLCHLE 421
+ E+ + + L L TI + L+ L Y + L+ P +L+
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423
Query: 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
L L N + + R L+L + L + ++LS N L
Sbjct: 424 DLRSKFLLENSVLKMEYADV------RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRL 475
Query: 482 SGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG-PIPQTFGSL 540
+LP + L+ L L S N L ++ + +L L L L +N+ + Q S
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 541 TGLESLDLSNNNLS---GEIPKSLEALLFLKQL 570
L L+L N+L G + E L + +
Sbjct: 533 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 47/211 (22%), Positives = 73/211 (34%), Gaps = 27/211 (12%)
Query: 380 LFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC----HLERLNGIRLNGNKLSG 435
L +LN +P R+ S L P C E+L L+ K +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362
Query: 436 PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL 495
+ L S L+EL P + W L ++ + + + L +Q L
Sbjct: 363 VLQSELESCKELQELE----------PENKWCLLTIILLMRALDPLL-YEKETLQYFSTL 411
Query: 496 INLD--------LSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLD 547
+D R++ + + D+ L LA L + LD
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLD 469
Query: 548 LSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
LS+N L +P +L AL L+ L S N LE
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 45/307 (14%), Positives = 89/307 (28%), Gaps = 46/307 (14%)
Query: 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRN 131
+ + + + L R+ + L +E S
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNI--------PSRIGNLSSLVNVNLAYNNLQ 183
+ + + L + W + + + L L+
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 184 GEIPSEIGNLQNLE-----------ILVLGMNNLSGPIQP--SIFNISTITLIN-----L 225
+ SE+ + + L+ ++L M L + ++ ST+ ++
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI 285
+ S L + ++RV L LT + + + +T LDLS N +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-L 478
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTA----------------EWSFLSSLTNCRNLTTL 329
P LR L VL ++N L A + + + L +C L L
Sbjct: 479 PPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538
Query: 330 AVASNPL 336
+ N L
Sbjct: 539 NLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 6e-10
Identities = 29/152 (19%), Positives = 61/152 (40%), Gaps = 6/152 (3%)
Query: 99 RLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNII 158
R ++ ++F + +++L L + T + + L L + D N +
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRL 475
Query: 159 DGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSG-PIQPSIFNI 217
+P + L L + + N L+ + + NL L+ L+L N L + +
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249
+ L+NL GN L + +++ LP++
Sbjct: 533 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+G GS+G V + + AIK VF +D R R E +L + H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 744 ---IFSSCCNNDFRA--LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
I F +VLE+ + +K + Y +L + ++ + + ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
S ++H DLKP+N L+++D V DFGL++ D ++ +Q M
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 859 E 859
Sbjct: 232 H 232
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 72/318 (22%), Positives = 125/318 (39%), Gaps = 66/318 (20%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDR------AFRSFDSECEV 732
+ + +G+G+FG V+K G A+K ++ ++ A R E ++
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69
Query: 733 LRNVRHRN---LIKIFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDNYFLDLLERLN 784
L+ ++H N LI+I + + R LV + + L L + L E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 785 IMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844
+M + L Y+H ++H D+K +N+L+ D V ++DFGL++ F +S
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 845 T--IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK------------- 882
T + T+ Y PE YG D++ G ++ E +TR
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 883 -------KPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHL 935
T +++ + + + K L G V + L+ +D L+ L L
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK-DRLKAYVRDPYALD-LIDKL-L 296
Query: 936 ALDCCMESPDQRIYMTDA 953
LD P QRI DA
Sbjct: 297 VLD-----PAQRIDSDDA 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 54/248 (21%), Positives = 91/248 (36%), Gaps = 63/248 (25%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK---IFS 746
LG GSFG V + + G FA+K R E ++++ + H N+IK F
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY----------- 795
+ + + + N K +N+ ++ + + + +EY
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 796 -----------------------LHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSK 831
+ HS + H D+KP N+L++ +D + DFG +K
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
Query: 832 LFDEGDDSVTQTMTIATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+ S I + Y APE Y T I D++S G + E KP
Sbjct: 191 KLIPSEPS---VAYICSRFYRAPELMLGATEY-TPSI-----DLWSIGCVFGELILG-KP 240
Query: 885 TDDMFTGE 892
+F+GE
Sbjct: 241 ---LFSGE 245
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 72/249 (28%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVRHRNLIK 743
+GRGS+G VY + + AIK +F +D R R E +L ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 744 ---IFSSCCNNDFRA--LVLELMPNGSLEKWLYSDN--------YFL-DLLERLNIMIGV 789
+ F +VLE+ + L+K + L +LL
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT------ 843
L ++H + ++H DLKP+N LL++D V DFGL++ + D+
Sbjct: 140 -LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 844 ------------MT--IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+T + T Y APE Y T+ I D++S G + E
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY-TKSI-----DIWSTGCIFAELLNML 249
Query: 883 KPTDDMFTG 891
+ + T
Sbjct: 250 QSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 66/235 (28%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIK----VFNLQLD--RAFRSFDSECEVLRNVR-HRNLI 742
LG+G++G V+K G A+K F D R FR E +L + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 743 KIFSSCCNNDFRA--LVLELMPNGSLEKWLYSDN-------YFLDLLERLNIMIGVALAL 793
+ + ++ R LV + M L + ++ Y + L + +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK---------VI 122
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-----------------KLFDEG 836
+YLH S ++H D+KPSNILL+ + V+DFGLS E
Sbjct: 123 KYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 837 DDSVTQTMT--IATIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
D +T +AT Y APE Y T+GI D++S G +L E K
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCGK 228
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 39/267 (14%), Positives = 80/267 (29%), Gaps = 33/267 (12%)
Query: 78 SLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS----GSFPSWIGVLSKLQILSLRNNS 133
++ +P++L R + + G+F L+ + + N
Sbjct: 13 VFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSG----FGDLEKIEISQND 65
Query: 134 FTGPIPNSLF-NLSRLEK-WDSMFNIIDGNIPSRI-GNLSSLVNVNLAYNNLQGEIPSEI 190
I +F NL +L + N + I NL +L + ++ ++ +P
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVH 123
Query: 191 -GNLQNLEILVLGMNNLSGPIQPSIFN--ISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247
+ +L + N I+ + F ++ L N + ++
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ---EIHNSAFNGTQLD 180
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307
+ N L + AS LD+S L + NL+ L + N
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---- 236
Query: 308 DSPTAEWSFLSSLTNCRNLTTLAVASN 334
L +L L ++
Sbjct: 237 -------KKLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 48/310 (15%), Positives = 86/310 (27%), Gaps = 67/310 (21%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
+ RVF ++K+T IP+ + L + F L + ++ N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVA-SNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
+N L + + +N L I P F
Sbjct: 67 LEVIEA------DVFSNLPKLHEIRIEKANNLLYINP---EAFQ---------------- 101
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYD-LCHLER 422
NL +L L + + +P Q L + N +I + L
Sbjct: 102 ------NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L L N S+F + +N+L
Sbjct: 155 E-----------------------SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
Query: 483 GSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLT 541
LP+++ + LD+SR ++ + +LK L S + + L
Sbjct: 192 -ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT----LEKLV 246
Query: 542 GLESLDLSNN 551
L L+
Sbjct: 247 ALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 38/193 (19%), Positives = 64/193 (33%), Gaps = 9/193 (4%)
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLRELNL-GSNK 456
L L L I ++ N + I ++L L E+ + +N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 457 FSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI-- 513
P +F +L L + +S+ + LP + + LD+ N I
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPK-SLEALLFLKQLNV 572
G + V L L N + F E NNNL E+P L++
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDI 209
Query: 573 SHNKLEGEIPANG 585
S ++ +P+ G
Sbjct: 210 SRTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 42/286 (14%), Positives = 87/286 (30%), Gaps = 66/286 (23%)
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
L L A + +L + ++ N + ++ FS
Sbjct: 32 AIELRFVLTKLRVIQKGA-------FSGFGDLEKIEISQNDVLEVIEA--DVFS------ 76
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP 414
NL L + + NNL I
Sbjct: 77 ----------------NLPKLHEIRI-----------------------EKANNLL-YIN 96
Query: 415 YDLC-HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS-SFWSLEYLL 472
+ +L L + ++ + + L++ N +I SF L +
Sbjct: 97 PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156
Query: 473 AV-NLSSNSLSGSLPSNIQNLQVLINLDLSR-NQLSGDIPITI-GSLKDLVTLSLASNQF 529
+ L+ N + + ++ N L L+LS N L ++P + V L ++ +
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214
Query: 530 EGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
+L L + N ++P +LE L+ L + ++++
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 31/163 (19%), Positives = 59/163 (36%), Gaps = 8/163 (4%)
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
+K++ IP L + EL K +F L + +S N + +
Sbjct: 14 FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 486 PSNI-QNLQVLINLDLSR-NQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
+++ NL L + + + N L P +L +L L +++ +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130
Query: 544 ESLDLSNNNLSGEIP-KSLEALLF-LKQLNVSHNKLEGEIPAN 584
LD+ +N I S L F L ++ N ++ EI +
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNS 172
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 47/213 (22%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD-----RAFRSFDSECEVLRNV 736
+ + + + LG G++ +VYKG A+K L+ + A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 737 RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYL 796
+H N++ + LV E + L+++L +++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE- 855
H V+H DLKP N+L++E ++DFGL++ + T + T+ Y P+
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAK--SIPTKTYDNEVVTLWYRPPDI 171
Query: 856 ------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y T+ D++ G + E T +
Sbjct: 172 LLGSTDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 15/209 (7%)
Query: 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRL 428
L + + +L ++ T + L +Q + +N++ S+ + L + L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 429 NGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSN 488
+ N++S P L L L EL++ N+ + L L L +N L +
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRD--TDS 123
Query: 489 IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDL 548
+ +L+ L L + N+L I + +G L L L L N+ L + +DL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 549 SNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
+ E K L + +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 52/293 (17%), Positives = 93/293 (31%), Gaps = 50/293 (17%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
L N +LGK +T + S + + ++ L L L+L++
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSH 72
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N ++ LS L + L L+V N L+ +
Sbjct: 73 NQISD---------LSPLKDLTKLEELSVNRNRLKNL----------------------- 100
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
L L L N L ++ L+ L+ LS+ N L+ SI L L +
Sbjct: 101 -----NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSK 151
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482
L + L+GN+++ L L + ++L K + L V
Sbjct: 152 LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
Query: 483 GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ 535
P I N ++ + +L + + + F+G + Q
Sbjct: 210 S--PYYISNGGSYVDGCVL-WELPVYTDEVSYKFSEYINVGETEAIFDGTVTQ 259
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 36/223 (16%), Positives = 69/223 (30%), Gaps = 32/223 (14%)
Query: 166 IGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT---L 222
L++ V NL ++ + L ++ +N+ S+ + T
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-----SLAGMQFFTNLKE 67
Query: 223 INLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFS 282
++L NQ+S DL P L L S+ +N+L + ++ L+ L L N
Sbjct: 68 LHLSHNQIS---DLSPL--KDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELR 119
Query: 283 GLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPP 342
+L+ L +L++ NN L + + L L L + N +
Sbjct: 120 DTDS--LIHLKNLEILSIRNNKLKS---------IVMLGFLSKLEVLDLHGNEITNTGG- 167
Query: 343 VIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL 385
+ + K L +
Sbjct: 168 -LTRLK-KVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 42/238 (17%), Positives = 79/238 (33%), Gaps = 50/238 (21%)
Query: 94 LGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDS 153
L +L + LS +Q + N++ SL +
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-----SLAGMQ------- 60
Query: 154 MFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPS 213
++L ++L++N + ++ S + +L LE L + N L +
Sbjct: 61 --------------FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-----N 99
Query: 214 IFNISTITL--INLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKL 271
+ I + L + L N+L L L NL + S+ NKL +I + SKL
Sbjct: 100 LNGIPSACLSRLFLDNNELRDTDSL-----IHLKNLEILSIRNNKLK-SIVM-LGFLSKL 152
Query: 272 TGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
LDL N + L+ ++ ++L + + L +
Sbjct: 153 EVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNE----PVKYQPELYITNTVKDP 204
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-15
Identities = 76/457 (16%), Positives = 146/457 (31%), Gaps = 96/457 (21%)
Query: 170 SSLVNVNLAYNNLQGEIPSEIG-NLQNLEILVLGMNNLS----GPIQPSIFNISTITLIN 224
+ ++++ L +E+ LQ +++ L L+ I ++ + +N
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 225 LFGNQL--SGHLDLPPKVSYSLPNLRVFSLGKNKLTGT----IPNSITNASKLTGLDLSF 278
L N+L G + + ++ SL LTG + +++ L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 279 NSFSG-----LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVAS 333
N L L L L L+ S S L + L V++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP---LASVLRAKPDFKELTVSN 179
Query: 334 NPLRG----ILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI 389
N + +L + + L+ C +T + L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS---------DNCRDLC---------- 220
Query: 390 PSTVGRLEQLQGLSLYGNNLEGS--------IPYDLCHLERLNGIRLNGNKLSGP----I 437
V L+ L+L N L + + L L + ++ +
Sbjct: 221 -GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW---IWECGITAKGCGDL 276
Query: 438 PQCLASLISLRELNLGSNKF--------SSSIPSSFWSLEYLLAVNLSSNSLSG----SL 485
+ L + SL+EL+L N+ ++ LE L + S S +
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL---WVKSCSFTAACCSHF 333
Query: 486 PSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES 545
S + + L+ L +S N+L + L + L
Sbjct: 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQ-------GLGQPG------------SVLRV 374
Query: 546 LDLSNNNLSGE----IPKSLEALLFLKQLNVSHNKLE 578
L L++ ++S + +L A L++L++S+N L
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-15
Identities = 87/516 (16%), Positives = 157/516 (30%), Gaps = 119/516 (23%)
Query: 100 LRFISLDYNEFS-GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNII 158
++ + + E S + + +L + Q++ L + T ++S
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSA---------- 51
Query: 159 DGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNL-----QNLEILVLGMNNLS----GP 209
+ +L +NL N L + ++ L L L+ G
Sbjct: 52 -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104
Query: 210 IQPSIFNISTITLINLFGNQL--SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITN 267
+ ++ + T+ ++L N L +G L + L L L+ + +
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164
Query: 268 A----SKLTGLDLSFNSFSG-----LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLS 318
L +S N + L + L L L + +T+D+ L
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN----CRDLC 220
Query: 319 S-LTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIV 377
+ + +L LA+ SN +G+ + L + H L
Sbjct: 221 GIVASKASLRELALGSNK--------LGDVGMAE---------LCPGLLHP---SSRLRT 260
Query: 378 LSLFINALN----GTIPSTVGRLEQLQGLSLYGNNLEGS--------IPYDLCHLERLNG 425
L ++ + G + + E L+ LSL GN L + C LE L
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW- 319
Query: 426 IRLNGNKLSG----PIPQCLASLISLRELNLGSNK--------FSSSIPSSFWSLEYLLA 473
+ + LA L EL + +N+ + L L
Sbjct: 320 --VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL-- 375
Query: 474 VNLSSNSLS----GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF 529
L+ +S SL + + L LDLS N L + + S+
Sbjct: 376 -WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-------SVRQPG- 426
Query: 530 EGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL 565
LE L L + S E+ L+AL
Sbjct: 427 -----------CLLEQLVLYDIYWSEEMEDRLQALE 451
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 69/445 (15%), Positives = 130/445 (29%), Gaps = 109/445 (24%)
Query: 49 HQRVRALNLSN--MGLRG--TIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFIS 104
+++ L+L N + G + L L L +S N L +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL----- 138
Query: 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPS 164
+L+ L L S + L ++
Sbjct: 139 --------------DPQCRLEKLQLEYCSLSAASCEPLASV------------------- 165
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEIG-----NLQNLEILVLGMNNLS----GPIQPSIF 215
+ + ++ N++ + + LE L L ++ + +
Sbjct: 166 -LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 216 NISTITLINLFGNQL--SGHLDLPPKVSYSLPNLRVFSLGKNKLT----GTIPNSITNAS 269
+ +++ + L N+L G +L P + + LR + + +T G + +
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 270 KLTGLDLSFNSFS-----GLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324
L L L+ N L L L + + T + F S L R
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH---FSSVLAQNR 341
Query: 325 NLTTLAVASNPLR--GILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFI 382
L L +++N L G+ L L VL L
Sbjct: 342 FLLELQISNNRLEDAGVR-----ELCQGLGQ-----------------PGSVLRVLWLAD 379
Query: 383 NALN----GTIPSTVGRLEQLQGLSLYGNNLEGS--------IPYDLCHLERLNGIRLNG 430
++ ++ +T+ L+ L L N L + + C LE+L L
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV---LYD 436
Query: 431 NKLSGPIPQCLASLI----SLRELN 451
S + L +L SLR ++
Sbjct: 437 IYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDR------AFRSFDSECEV 732
+ D + LG G++G VYK + AIK L+ + A R E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 733 LRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALA 792
L+ ++HRN+I++ S +N L+ E N L+K++ N + + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLING 144
Query: 793 LEYLHHGHSTPVVHCDLKPSNILLDEDMVAH-----VSDFGLSKLFDEGDDSVTQTMTIA 847
+ + H +H DLKP N+LL + + DFGL++ F G T I
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEII 199
Query: 848 TIGYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
T+ Y PE Y T D++S + E +
Sbjct: 200 TLWYRPPEILLGSRHYSTS------VDIWSIACIWAEMLMKT 235
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 12/164 (7%)
Query: 399 LQGLSLYGNNLEGSIP--YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNK 456
L L NNL + + L L+ + L+ N L+ + + +LR L+L SN
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 457 FSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIP----I 511
+ F L+ L + L +N + + N +++ L L LS+NQ+S P
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 512 TIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL--ESLDLSNNNL 553
L L+ L L+SN+ + L L L NN L
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 40/166 (24%), Positives = 60/166 (36%), Gaps = 12/166 (7%)
Query: 413 IPYDLCHLERLNGIRLNGNKLSGPIPQC-LASLISLRELNLGSNKFSSSIPSSFWSLEYL 471
+P L L+ N LS + L +L L L N + +F + L
Sbjct: 37 LPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90
Query: 472 LAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
++LSSN L +L + +LQ L L L N + + L L L+ NQ
Sbjct: 91 RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 531 GPIPQTFG---SLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVS 573
+ L L LDLS+N L L+ L + +
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 35/182 (19%), Positives = 71/182 (39%), Gaps = 15/182 (8%)
Query: 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF--NISTITLINLFGNQLSG 232
++ + L +P + + +L L NNLS ++ ++ + + L N L+
Sbjct: 23 LSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN- 77
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSFNSFSGLIPHTFGN 291
+ + +PNLR L N L T+ + ++ L L L N + + F +
Sbjct: 78 --FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASL 351
+ L L L+ N ++ + L L ++SN L+ + + A +
Sbjct: 135 MAQLQKLYLSQNQISRFPVEL----IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 352 QN 353
+N
Sbjct: 191 KN 192
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 39/139 (28%), Positives = 54/139 (38%), Gaps = 8/139 (5%)
Query: 446 SLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRN 503
L+L N S + L L ++ LS N L+ + S + L LDLS N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 504 QLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIP----K 559
L L+ L L L +N F + L+ L LS N +S P K
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 560 SLEALLFLKQLNVSHNKLE 578
L L L++S NKL+
Sbjct: 158 DGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 41/161 (25%), Positives = 61/161 (37%), Gaps = 10/161 (6%)
Query: 377 VLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGNKLS 434
+L L N L+ RL L L L N+L I + + L + L+ N L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 435 GPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP----SNIQ 490
+ L +L L L +N ++F + L + LS N +S P +
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160
Query: 491 NLQVLINLDLSRNQLSGDIPITIGSLKDLV--TLSLASNQF 529
L L+ LDLS N+L + L V L L +N
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 42/222 (18%), Positives = 77/222 (34%), Gaps = 25/222 (11%)
Query: 168 NLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINL 225
L++L ++ L++N+L I SE + NL L L N+L + +F ++ + ++ L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLL 119
Query: 226 FGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGL---DLSFNSFS 282
+ N + + + L+ L +N+++ I + +KL L DLS N
Sbjct: 120 YNNHIV---VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 283 GLIPHTFGNLRFLSV--LNLANNYLTTD---SPTAEWSFLSSLTNCRNLTTLAVASNP-- 335
L L L L NN L D L++ + +
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKK 236
Query: 336 LRGIL--------PPVIGNFSASLQNFYAYDCKLTGNIPHEI 369
L I + A L + C ++
Sbjct: 237 LHNIFSLDFFNCSEYKESAWEAHLGDTLTIRCDTKQQGMTKV 278
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 31/140 (22%), Positives = 50/140 (35%), Gaps = 19/140 (13%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMS---LDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+L LS+ L I F + + LD+S N+ H L+ L + L N
Sbjct: 67 HSLLLSHNHLN-FISS--EAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH 123
Query: 110 FS----GSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF----NLSRLEKWDSMFNIIDGN 161
+F +++LQ L L N + P L L +L D N +
Sbjct: 124 IVVVDRNAFED----MAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 162 IPSRIGNLSSLVNVNLAYNN 181
+ + L + V L +N
Sbjct: 179 PLTDLQKLPAWVKNGLYLHN 198
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 14/210 (6%)
Query: 372 LRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYDL-CHLERLNGIRLN 429
S L L L TIPS L + + + + + +L ++ I +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 430 GNK-LSGPIPQCLASLISLRELNLGSNKFSSSIP--SSFWSLEYLLAVNLSSNSLSGSLP 486
+ L+ P L L L+ L + + P + +S + + ++ N S+P
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 487 SNI-QNLQ-VLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ-TFGSL-TG 542
N Q L + L L N + + + L + L N++ I + FG + +G
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 543 LESLDLSNNNLSGEIP-KSLEALLFLKQLN 571
LD+S +++ +P K LE L L N
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 31/193 (16%), Positives = 66/193 (34%), Gaps = 12/193 (6%)
Query: 398 QLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKF 457
Q + + +++ IP + L L L ++L ++ + + +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPSTQTLK---LIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 458 SSSIPS-SFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIP--ITI 513
+ S SF++L + + + + + + + L +L L + L P +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126
Query: 514 GSLKDLVTLSLASNQFEGPIP-QTFGSLTG-LESLDLSNNNLSGEIPKSLEALLFLKQLN 571
S L + N + IP F L +L L NN + + L +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185
Query: 572 VSHNKLEGEIPAN 584
++ NK I +
Sbjct: 186 LNKNKYLTVIDKD 198
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 44/265 (16%), Positives = 87/265 (32%), Gaps = 50/265 (18%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLA-NNY 304
F + + IP+ + L L + H F NL +S + ++ +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPS---TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
L + N +T + + + + P
Sbjct: 68 LQQLESHS-------FYNLSKVTHIEIRNTRNLTYIDP--DALK---------------- 102
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIP--STVGRLEQLQGLSLYGNNLEGSIPYD----LC 418
L L L +F L P + V + L + N SIP + LC
Sbjct: 103 ------ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 419 HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS-SFWSLEYLLAV-NL 476
+ ++L N + + + L + L NK+ + I +F + ++ ++
Sbjct: 156 NE--TLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDV 212
Query: 477 SSNSLSGSLPSNI-QNLQVLINLDL 500
S S++ +LPS ++L+ LI +
Sbjct: 213 SQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 41/239 (17%), Positives = 81/239 (33%), Gaps = 38/239 (15%)
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFN-SFSGLIPHTFGNLRFLSVLNLAN 302
P+ + L + L ++ +N ++ + +S + + L H+F NL ++ + + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 303 N-YLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKL 361
LT P A L L L + + L+ +
Sbjct: 90 TRNLTYIDPDA-------LKELPLLKFLGIFNTGLK------------MFPDLTK----- 125
Query: 362 TGNIPHEIGNLRSLIVLSLFINALNGTIPSTV--GRLEQLQGLSLYGNNLEGSIPYDLCH 419
+ + +L + N +IP G + L LY N S+ +
Sbjct: 126 -------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN 177
Query: 420 LERLNGIRLNGNKLSGPIPQ-CLASLIS-LRELNLGSNKFSSSIPSSFWSLEYLLAVNL 476
+L+ + LN NK I + + S L++ ++ L+ L+A N
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 38/234 (16%), Positives = 69/234 (29%), Gaps = 43/234 (18%)
Query: 78 SLDISKNNFHAYLPNELGQLRRLRFISLDYNEF-----SGSFPSWIGVLSKLQILSLRNN 132
+L + + + + L + I + + S SF + LSK+ + +RN
Sbjct: 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYN----LSKVTHIEIRNT 90
Query: 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE--I 190
I L L + + L+ P +
Sbjct: 91 RNLTYIDPDALK-----------------------ELPLLKFLGIFNTGLK-MFPDLTKV 126
Query: 191 GNLQNLEILVLGMNNLSGPIQPSIFN--ISTITLINLFGNQLSGHLDLPPKVSYSLPNLR 248
+ IL + N I + F + + L+ N + + ++ L
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT---SVQGYA-FNGTKLD 182
Query: 249 VFSLGKNKLTGTIPNSI--TNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300
L KNK I S + LD+S S + L +L+ L N
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 46/228 (20%), Positives = 87/228 (38%), Gaps = 24/228 (10%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NIST 219
IPS + +L L +L+ IPS NL N+ + + ++ ++ F N+S
Sbjct: 26 IPSLPPSTQTL---KLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPN--SITNASKLTGLDLS 277
+T I + + ++ P LP L+ + L P+ + + L+++
Sbjct: 82 VTHIEIRNTRNLTYI--DPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEIT 138
Query: 278 FNSFSGLIP-HTFGNLRFLSV-LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNP 335
N + IP + F L ++ L L NN T+ A F + L + + N
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYA---FNGT-----KLDAVYLNKNK 190
Query: 336 -LRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLRSLIVLSLF 381
L I G + +T +P + +L+ LI + +
Sbjct: 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTW 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 52/223 (23%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNL-QLDRAFRSFDSECEVLRNVR-HRNLIKIF-- 745
LGRG + V++ +K+ + + R E ++L N+R N+I +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 746 --SSCCNNDFRALVLELMPNGSLEKWLY--SDN---YFL-DLLERLNIMIGVALALEYLH 797
ALV E + N ++ +D +++ ++L+ AL+Y H
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK----------ALDYCH 147
Query: 798 HGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAP 854
S ++H D+KP N+++D E + D+GL++ + G Q +A+ + P
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-----QEYNVRVASRYFKGP 199
Query: 855 EYGTEGIVSSKC-----DVYSYGVLLTETFTRKKPTDDMFTGE 892
E +V + D++S G +L RK+P F G
Sbjct: 200 EL----LVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 48/230 (20%)
Query: 680 RATDGFNECNLLGRGSFGSVYKG--TFSDGTSFAIKVFNLQLDR------AFRSFDSECE 731
RA + +G G++G V+K + G A+K +Q R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 732 V-----LRNVRHRNLIKIFSSCCNNDFRA-----LVLELMPNGSLEKWLYS-DNYFLDLL 780
V L H N++++F C + LV E + L +L +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 781 ERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840
++M + L++LH VVH DLKP NIL+ ++DFGL++++ S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY-----SF 172
Query: 841 TQTMT--IATIGYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
+T + T+ Y APE Y T D++S G + E F RK
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 681 ATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDR-----AFRSFDSECEVLR 734
++ F + LG G++ +VYKG + G A+K L + A R E +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF-----LDLLERLNIMIGV 789
++H N+++++ + LV E M N L+K++ S L+L +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
L + H ++H DLKP N+L+++ + DFGL++ F G T + + T+
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTL 172
Query: 850 GYMAPE-------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
Y AP+ Y T D++S G +L E T K
Sbjct: 173 WYRAPDVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 54/248 (21%), Positives = 92/248 (37%), Gaps = 55/248 (22%)
Query: 666 PLAAWRRTSYLDIQRATDGFNECNL-LGRGSFGSVYKGTFSD---GTSFAIKVFNLQ--L 719
L++ R R D F +GRG++G VYK D +A+K
Sbjct: 10 KLSSERE-------RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 720 DRAFRSFDSECEVLRNVRHRN---LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF 776
A R E +LR ++H N L K+F S + L+ + + L + +
Sbjct: 63 MSACR----EIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHII--KFHR 114
Query: 777 LDLLERLNIMIGVAL----------ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH--- 823
+ + + + + YLH V+H DLKP+NIL+ +
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171
Query: 824 -VSDFGLSKLFDEGDDSVTQ-TMTIATIGYMAPE-------YGTEGIVSSKCDVYSYGVL 874
++D G ++LF+ + + T Y APE Y D+++ G +
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA------IDIWAIGCI 225
Query: 875 LTETFTRK 882
E T +
Sbjct: 226 FAELLTSE 233
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 32/132 (24%), Positives = 61/132 (46%), Gaps = 4/132 (3%)
Query: 446 SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQ 504
++ E+ L N P +F + L ++LS+N +S L + Q L+ L +L L N+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 505 LSGDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEA 563
++ ++P ++ L L L L +N+ F L L L L +N L +
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 564 LLFLKQLNVSHN 575
L ++ ++++ N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
IRL N + P + LR ++L +N+ S P +F L L ++ L N ++ L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 486 PSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLE 544
P ++ + L L L L+ N+++ L +L LSL N+ + TF L ++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
Query: 545 SLDLSNN 551
++ L+ N
Sbjct: 156 TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 33/144 (22%), Positives = 62/144 (43%), Gaps = 11/144 (7%)
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN-IST 219
N+P I + L N ++ P + L + L N +S + P F + +
Sbjct: 29 NLPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS 81
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFN 279
+ + L+GN+++ +LP + L +L++ L NK+ ++ + L L L N
Sbjct: 82 LNSLVLYGNKIT---ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138
Query: 280 SFSGLIPHTFGNLRFLSVLNLANN 303
+ TF LR + ++LA N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 39/143 (27%), Positives = 61/143 (42%), Gaps = 8/143 (5%)
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448
+P T+ + L N ++ P ++L I L+ N++S P L SL
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSG 507
L L NK + S F L L + L++N ++ L + Q+L L L L N+L
Sbjct: 84 SLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 508 DIPITIGSLKDLVTLSLASNQFE 530
T L+ + T+ LA N F
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 31/130 (23%), Positives = 55/130 (42%), Gaps = 6/130 (4%)
Query: 377 VLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLS 434
+ L N + IP ++L+ + L N + + D L LN + L GNK++
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 435 GPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQ 493
L SL+ L L +NK + +F L L ++L N L ++ L+
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152
Query: 494 VLINLDLSRN 503
+ + L++N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 37/163 (22%), Positives = 57/163 (34%), Gaps = 32/163 (19%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
+ L +N + P + + KL +DLS N S L P F LR L+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
+T + L +L L + +N + + F
Sbjct: 92 ITELPKSL----FEGLF---SLQLLLLNANKINCLRV---DAFQ---------------- 125
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGN 407
+L +L +LSL+ N L T L +Q + L N
Sbjct: 126 ------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 33/154 (21%), Positives = 51/154 (33%), Gaps = 32/154 (20%)
Query: 79 LDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGV---LSKLQILSLRNNSFT 135
+ + +N P ++LR I L N+ S L L L L N T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGLRSLNSLVLYGNKIT 93
Query: 136 GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GNLQ 194
+P SLF L SL + L N + + + +L
Sbjct: 94 E-LPKSLFE-----------------------GLFSLQLLLLNANKIN-CLRVDAFQDLH 128
Query: 195 NLEILVLGMNNLSGPIQPSIFNISTITLINLFGN 228
NL +L L N L + + + I ++L N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 50/232 (21%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDR---------AFRSFDSE 729
AT + +G G++G+VYK G A+K + R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60
Query: 730 CEV-----LRNVRHRNLIKIFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDN-YFLD 778
EV L H N++++ C + LV E + L +L L
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 779 LLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838
++M L++LH +VH DLKP NIL+ ++DFGL++++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----- 170
Query: 839 SVTQTMT--IATIGYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRK 882
S +T + T+ Y APE Y T D++S G + E F RK
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 3e-13
Identities = 40/251 (15%), Positives = 71/251 (28%), Gaps = 66/251 (26%)
Query: 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKV--------FNLQLDRAFRSFDSECEV 732
T+ C +G G FG V++ +D T AIK+ N + F E +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 733 LRNV---------RHRNLIKIFSSCC------------------------------NNDF 753
+ + R I + S C +D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 754 RALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPS 812
+VLE G LE+ L +I+ + +L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 813 NILLDEDMVAHVSDFGLSKLFD---------EGDDSVTQTMTIATIGYMAPEYGTE---G 860
N+LL + + + K D ++++ + + + G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 861 IVSSKCDVYSY 871
+ D+Y
Sbjct: 252 DGDYQFDIYRL 262
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 42/130 (32%), Positives = 57/130 (43%), Gaps = 6/130 (4%)
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L L+ L L LNL N+ + F L L + L++N L+ SLP
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 487 SNI-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQ-TFGSLTGL 543
+ +L L L L NQL +P + L L L L +NQ + IP F LT L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNL 157
Query: 544 ESLDLSNNNL 553
++L LS N L
Sbjct: 158 QTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 6/133 (4%)
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLS 506
+L+L S ++ ++F L L +NL N L +L + + +L L L L+ NQL+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 507 GDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSL-EAL 564
+P+ + L L L L NQ + F LT L+ L L+ N L IP + L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 565 LFLKQLNVSHNKL 577
L+ L++S N+L
Sbjct: 155 TNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 48/165 (29%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448
IP+ +L+ L L L +L + L+ N+L L L
Sbjct: 33 IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSG 507
L L +N+ +S F L L + L N L SLPS + L L L L+ NQL
Sbjct: 87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ- 144
Query: 508 DIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNN 551
IP L +L TLSL++NQ + F L L+++ L N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 42/177 (23%), Positives = 66/177 (37%), Gaps = 20/177 (11%)
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN-IST 219
IP+ L +L L + L L L L N L + +F+ ++
Sbjct: 32 GIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSF 278
+ + L NQL+ LP V L L LG N+L ++P+ + +KL L L+
Sbjct: 85 LGTLGLANNQLA---SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 279 NSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNP 335
N + F L L L+L+ N L + A L T+ + N
Sbjct: 141 NQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA-------FDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 53/163 (32%), Positives = 69/163 (42%), Gaps = 14/163 (8%)
Query: 272 TGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAV 331
LDL + L TF L L+ LNL N L T S LT L TL +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV----FDDLT---ELGTLGL 90
Query: 332 ASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLRSLIVLSLFINALNGTIP 390
A+N L LP + + L Y +L +P + L L L L N L +IP
Sbjct: 91 ANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIP 147
Query: 391 STV-GRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGN 431
+ +L LQ LSL N L+ S+P+ L +L I L GN
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 34/110 (30%), Positives = 47/110 (42%), Gaps = 15/110 (13%)
Query: 474 VNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
V+ SL S+PS I + + LDL L+ T L L L+L NQ +
Sbjct: 19 VDCQGKSLD-SVPSGIPADTE---KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL 74
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLF-----LKQLNVSHNKL 577
F LT L +L L+NN L SL +F L +L + N+L
Sbjct: 75 SAGVFDDLTELGTLGLANNQL-----ASLPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 44/164 (26%), Positives = 62/164 (37%), Gaps = 10/164 (6%)
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSL 404
A + L L L L+L N L T+ + V L +L L L
Sbjct: 32 GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGL 90
Query: 405 YGN---NLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI 461
N +L + L L++L L GN+L L L+EL L +N+ SI
Sbjct: 91 ANNQLASLPLGVFDHLTQLDKLY---LGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSI 146
Query: 462 PSS-FWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504
P+ F L L ++LS+N L L L + L NQ
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 43/201 (21%), Positives = 63/201 (31%), Gaps = 55/201 (27%)
Query: 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPS 164
L + + L+KL L+L N + +F+
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFD-------------------- 80
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEI-GNLQNLEILVLGMNNLSGPIQPSIFNISTITLI 223
+L+ L + LA N L +P + +L L+ L
Sbjct: 81 ---DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKL------------------------ 112
Query: 224 NLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSFNSFS 282
L GNQL LP V L L+ L N+L +IP + L L LS N
Sbjct: 113 YLGGNQLKS---LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168
Query: 283 GLIPHTFGNLRFLSVLNLANN 303
+ F L L + L N
Sbjct: 169 SVPHGAFDRLGKLQTITLFGN 189
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 24/185 (12%)
Query: 402 LSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLS--GPIPQCLASLISLRELNLGSNKFSS 459
+L ++ ++ + L ++ I N + + I L ++R L LG NK
Sbjct: 24 ANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGGNKLHD 77
Query: 460 SIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI-GSLK 517
S+ L L + L+ N L SLP+ + L L L L NQL +P + L
Sbjct: 78 --ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLF-----LKQLNV 572
+L L+LA NQ + F LT L LDLS N L +SL +F LK L +
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-----QSLPEGVFDKLTQLKDLRL 188
Query: 573 SHNKL 577
N+L
Sbjct: 189 YQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 69/270 (25%), Positives = 99/270 (36%), Gaps = 68/270 (25%)
Query: 174 NVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGH 233
+ ++ Q P + L +++ + +++I I + +
Sbjct: 2 TITVSTPIKQI-FPDDAFA--ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV 56
Query: 234 LDLPPKVSYSLPNLRVFSLGKNKLTGTIP--NSITNASKLTGLDLSFNSFSGLIPHTFGN 291
+ LPN+R +LG NKL I +TN LT L L+ N L F
Sbjct: 57 QGIQ-----YLPNVRYLALGGNKLH-DISALKELTN---LTYLILTGNQLQSLPNGVFDK 107
Query: 292 LRFLSVLNLANNYLTT------DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
L L L L N L + D T NLT L +A N L+ LP G
Sbjct: 108 LTNLKELVLVENQLQSLPDGVFDKLT-------------NLTYLNLAHNQLQS-LPK--G 151
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSL 404
F KLT +L L L N L ++P V +L QL+ L L
Sbjct: 152 VFD-----------KLT-----------NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRL 188
Query: 405 YGNNLEGSIP---YDLCHLERLNGIRLNGN 431
Y N L+ S+P +D L L I L+ N
Sbjct: 189 YQNQLK-SVPDGVFD--RLTSLQYIWLHDN 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 33/129 (25%), Positives = 58/129 (44%), Gaps = 5/129 (3%)
Query: 426 IRLNGNKLSG-PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+RLN N+ + L LR++N +NK + +F + + L+SN L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 485 LPSNI-QNLQVLINLDLSRNQLSGDIPI-TIGSLKDLVTLSLASNQFEGPIPQTFGSLTG 542
+ + + L+ L L L N+++ + + L + LSL NQ P F +L
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 543 LESLDLSNN 551
L +L+L N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/133 (24%), Positives = 60/133 (45%), Gaps = 5/133 (3%)
Query: 446 SLRELNLGSNKFSSSIPS-SFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRN 503
EL L +N+F+ + F L L +N S+N ++ + + + + L+ N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN 91
Query: 504 QLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLE 562
+L ++ + L+ L TL L SN+ +F L+ + L L +N ++ P + +
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150
Query: 563 ALLFLKQLNVSHN 575
L L LN+ N
Sbjct: 151 TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 34/143 (23%), Positives = 55/143 (38%), Gaps = 9/143 (6%)
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCH-LERLNGIRLNGNKLSGPIPQCLASLISL 447
IP L L N + L +L I + NK++ +
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLS 506
E+ L SN+ + F LE L + L SN ++ + ++ L + L L NQ++
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 507 GDIPITIGSLKDLVTLSLASNQF 529
P +L L TL+L +N F
Sbjct: 143 TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 21/106 (19%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 475 NLSSNSLSGSLPSN--IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
L++N + L + + L L ++ S N+++ + + L SN+ E
Sbjct: 38 RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPK-SLEALLFLKQLNVSHNKL 577
+ F L L++L L +N ++ + S L ++ L++ N++
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 21/151 (13%)
Query: 261 IPNSITNASKLTGLDLSFNSFSGLIPH-TFGNLRFLSVLNLANNYLTTDSPTAEWSFLSS 319
IP L L+ N F+ L F L L +N +NN +T A
Sbjct: 30 IPQYTAE------LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA----FEG 79
Query: 320 LTNCRNLTTLAVASNPLRGILPPVIGNFS--ASLQNFYAYDCKLTGNIPHEI-GNLRSLI 376
+ + + + SN L + F SL+ ++T + ++ L S+
Sbjct: 80 ASG---VNEILLTSNRLEN-VQH--KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVR 132
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGN 407
+LSL+ N + P L L L+L N
Sbjct: 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 32/160 (20%)
Query: 125 QILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG 184
L L NN FT +F L L +N + N +
Sbjct: 35 AELRLNNNEFTVLEATGIFK-----------------------KLPQLRKINFSNNKIT- 70
Query: 185 EIPSEI-GNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSY 242
+I + ++L N L +Q +F + ++ + L N+++ +
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT---CVGNDSFI 126
Query: 243 SLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSFNSF 281
L ++R+ SL N++T T+ L+ L+L N F
Sbjct: 127 GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 24/123 (19%), Positives = 45/123 (36%), Gaps = 11/123 (8%)
Query: 218 STITLINLFGNQLSGHLDLPPKVSYS-LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDL 276
+ L N+ + L + LP LR + NK+T + AS + + L
Sbjct: 32 QYTAELRLNNNEFT---VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88
Query: 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
+ N + F L L L L +N +T + L+ ++ L++ N +
Sbjct: 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDS----FIGLS---SVRLLSLYDNQI 141
Query: 337 RGI 339
+
Sbjct: 142 TTV 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 28/159 (17%), Positives = 58/159 (36%), Gaps = 37/159 (23%)
Query: 79 LDISKNNFHAYLPN-ELGQLRRLRFISLDYNEFS----GSFPSWIGVLSKLQILSLRNNS 133
L ++ N F +L +LR I+ N+ + G+F S + + L +N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEG----ASGVNEILLTSNR 92
Query: 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI-GN 192
+ + +F L SL + L N + + ++
Sbjct: 93 LEN-VQHKMFK-----------------------GLESLKTLMLRSNRIT-CVGNDSFIG 127
Query: 193 LQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQL 230
L ++ +L L N ++ + P F + +++ +NL N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 35/161 (21%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI-KIFSSC 748
+G G+FG + G AIK+ + E + + + I +++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 749 CNNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLN--------IMIGVAL--ALEYLH 797
+ A+VLEL+ G SLE DL + + +MI + L +EY+H
Sbjct: 75 PCGKYNAMVLELL--GPSLE----------DLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 798 HGHSTPVVHCDLKPSNILL-----DEDMVAHVSDFGLSKLF 833
S +++ D+KP N L+ V H+ DF L+K +
Sbjct: 123 ---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 35/170 (20%)
Query: 691 LGRGSFGSVYKGT---------FSDGTSFAIKV--FNLQLDRAFRSFDSECEV------- 732
R + G +Y+ F++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 733 -LRNVRHRNLIKIFSSCCN-NDFRALVLELMPNG-SLEK-WLYSDNYFLDLLERLNIMIG 788
L + + + + +R LVL + G SL+ S + L R + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSE--RSVLQVA 165
Query: 789 VAL--ALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLF 833
L ALE+LH VH ++ NI + D+ V ++ +G + +
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRY 211
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 30/206 (14%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHR------NLI 742
++G+GSFG V K A+K+ R R E +L ++R + N+I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 743 KIFSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYF---LDLLERLNIMIGVALALEYL 796
+ + FR + EL+ + +L + + + + L L+ + + L+ L
Sbjct: 163 HMLENF---TFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDAL 216
Query: 797 HHGHSTPVVHCDLKPSNILLDEDMVAH--VSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
H ++HCDLKP NILL + + V DFG S + + Q+ Y AP
Sbjct: 217 HKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAP 268
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFT 880
E D++S G +L E T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 47/243 (19%), Positives = 93/243 (38%), Gaps = 53/243 (21%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LG G F +V+ + T A+K+ + + E ++L+ V + K S
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 749 CNN--------DFRA-------LVLELMPNGSLEKWLYSDNYF---LDLLERLNIMIGVA 790
N+ + + +V E++ +L + + L +++ I +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH------VSDFGLSKLFDEGDDSVTQTM 844
L L+Y+H ++H D+KP N+L++ ++D G + +DE T
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTN 194
Query: 845 TIATIGYMAPE------YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKW 898
+I T Y +PE +G D++S L+ E T +F + +
Sbjct: 195 SIQTREYRSPEVLLGAPWGC------GADIWSTACLIFELITGDF----LFEPD-EGHSY 243
Query: 899 VKE 901
K+
Sbjct: 244 TKD 246
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI-KIFSSC 748
+G GSFG +Y GT + G AIK+ ++ E ++ + ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 749 CNNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
D+ +V+EL+ G SLE + L L + + +EY+H S +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 808 DLKPSNILL---DEDMVAHVSDFGLSKLF 833
D+KP N L+ + + ++ DFGL+K +
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 37/162 (22%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI-KIFSSC 748
+G GSFG +++GT + AIK + D E + + I ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 749 CNNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLN--------IMIGVAL--ALEYLH 797
LV++L+ G SLE DLL+ M + ++ +H
Sbjct: 76 QEGLHNVLVIDLL--GPSLE----------DLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 798 HGHSTPVVHCDLKPSNILL------DEDMVAHVSDFGLSKLF 833
+V+ D+KP N L+ + +M+ +V DFG+ K +
Sbjct: 124 ---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFY 161
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 34/169 (20%), Positives = 68/169 (40%), Gaps = 34/169 (20%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNL------QLDRAFRSF---DSECEVLRNVRHR 739
+G G FG +Y + A V + L + + + + + + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 740 NLIKI---------FSSCCNNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMIGV 789
L + + +R +V+E + G L+K + F + + +G+
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFK---KSTVLQLGI 158
Query: 790 AL--ALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLF 833
+ LEY+H VH D+K +N+LL + D V +++D+GLS +
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSYRY 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 32/171 (18%), Positives = 65/171 (38%), Gaps = 35/171 (20%)
Query: 690 LLGRGSFGSVYKGTFSDGTS------FAIKVF---NLQLDRAFRSF-----DSECEVLRN 735
+G+G FG +Y + S +KV N L + + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 736 VRHRNLIKI-------FSSCCNNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMI 787
R + + +R ++++ G L+K ++ + + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSR--KTVLQL 157
Query: 788 GVAL--ALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLF 833
+ + LEY+H VH D+K SN+LL + D V ++ D+GL+ +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRY 204
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 2/101 (1%)
Query: 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIP-ITIGSLKDLVTLSLASNQFEGPIPQT 536
+ + ++ + L L + Q + + L +L L++ + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 537 FGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
F L L+LS N L + L L++L +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 23/107 (21%), Positives = 38/107 (35%), Gaps = 10/107 (9%)
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPN-SITNASKLTGLDLSFNSFSGLIPHTFG 290
G LD + NL + + + + +L L + + + P F
Sbjct: 19 GALDSLHHLPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH 77
Query: 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
LS LNL+ N L + W + L +L L ++ NPL
Sbjct: 78 FTPRLSRLNLSFNALE----SLSWKTVQGL----SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 21/101 (20%), Positives = 29/101 (28%), Gaps = 2/101 (1%)
Query: 382 INALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP-YDLCHLERLNGIRLNGNKLSGPIPQC 440
+ E L L + + DL L L + + + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 441 LASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
L LNL N S + L L + LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 24/95 (25%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 412 SIPYDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLRELNLGSNKFSSSIPSSFWSLEY 470
+ L E L + + + + + L L LR L + + P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQL 505
L +NLS N+L SL L L LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 15/98 (15%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLDLPPKVSYS 243
+ + +NL L + ++ + + + + + L + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR---FVAPDAFHF 78
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
P L +L N L ++ L L LS N
Sbjct: 79 TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 17/100 (17%), Positives = 32/100 (32%), Gaps = 7/100 (7%)
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSE-IGNLQNLEILVLGMNNLSGPIQPSIF-NIS 218
+ + +L + + + + L L L + + L + P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 219 TITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLT 258
++ +NL N L L K +L+ L N L
Sbjct: 81 RLSRLNLSFNALES---LSWKT-VQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 8/53 (15%), Positives = 15/53 (28%), Gaps = 2/53 (3%)
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPK-SLEALLFLKQLNVSHNKLEGEIPAN 584
L L + N + L L L+ L + + L + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/87 (19%), Positives = 28/87 (32%), Gaps = 9/87 (10%)
Query: 65 TIPPHLGNFSFLMSLDISKNNFHAYLPNE-LGQLRRLRFISLDYNEFS----GSFPSWIG 119
HL L L I +L L L LR +++ + +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHF--- 78
Query: 120 VLSKLQILSLRNNSFTGPIPNSLFNLS 146
+L L+L N+ ++ LS
Sbjct: 79 -TPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L+ N+++ P SLI+L+EL LGSN+ + F SL L ++L +N L+ LP
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 487 SNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLES 545
S + L L L + N+L+ +P I L L L+L NQ + F L+ L
Sbjct: 105 SAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163
Query: 546 LDLSNN 551
L N
Sbjct: 164 AYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 35/108 (32%), Positives = 49/108 (45%), Gaps = 5/108 (4%)
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLS 506
+ L L N+ + P F SL L + L SN L +LP + +L L LDL NQL+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 507 GDIPITI-GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
+P + L L L + N+ +P+ LT L L L N L
Sbjct: 102 V-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 9/120 (7%)
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI-GSLK 517
+ IP++ L L N ++ P +L L L L NQL +P+ + SL
Sbjct: 36 AGIPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLT 88
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
L L L +NQ F L L+ L + N L+ E+P+ +E L L L + N+L
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 12/144 (8%)
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN-IST 219
IP+ L L N + P +L NL+ L LG N L + +F+ ++
Sbjct: 37 GIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQ 89
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFN 279
+T+++L NQL+ LP V L +L+ + NKLT +P I + LT L L N
Sbjct: 90 LTVLDLGTNQLTV---LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 280 SFSGLIPHTFGNLRFLSVLNLANN 303
+ F L L+ L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 41/138 (29%), Positives = 51/138 (36%), Gaps = 13/138 (9%)
Query: 272 TGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAV 331
L L N + L P F +L L L L +N L SLT LT L +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPV----GVFDSLT---QLTVLDL 95
Query: 332 ASNPLRGILPPVIGNFS--ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI 389
+N L LP F L+ + KLT +P I L L L+L N L
Sbjct: 96 GTNQLTV-LPS--AVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP 151
Query: 390 PSTVGRLEQLQGLSLYGN 407
RL L L+GN
Sbjct: 152 HGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 38/152 (25%), Positives = 56/152 (36%), Gaps = 25/152 (16%)
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436
+L L N + P L L+ L L N L ++P G+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP---------VGV---------- 83
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
SL L L+LG+N+ + + F L +L + + N L+ LP I+ L L
Sbjct: 84 ----FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT 138
Query: 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528
+L L +NQL L L L N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 46/152 (30%), Positives = 61/152 (40%), Gaps = 23/152 (15%)
Query: 216 NISTITLI-NLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGT---IPNSITNASKL 271
I T I L NQ++ L P V SL NL+ LG N+L + +S+T L
Sbjct: 37 GIPTNAQILYLHDNQITK---LEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ---L 90
Query: 272 TGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAV 331
T LDL N + L F L L L + N LT + +LT LA+
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT--------ELPRGIERLTHLTHLAL 142
Query: 332 ASNPLRGILPPVIGNFSASLQNFYAY----DC 359
N L+ I S SL + Y + DC
Sbjct: 143 DQNQLKSIPHGAFDRLS-SLTHAYLFGNPWDC 173
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 35/133 (26%), Positives = 54/133 (40%), Gaps = 17/133 (12%)
Query: 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTG-P--IPNSLFNLSRLEKWDSMFNIIDGN 161
L N+ + P L L+ L L +N P + +SL L+ L+ + N
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD--------LGTN 98
Query: 162 ----IPSRI-GNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN 216
+PS + L L + + N L E+P I L +L L L N L +
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 217 ISTITLINLFGNQ 229
+S++T LFGN
Sbjct: 158 LSSLTHAYLFGNP 170
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI-KIFSSC 748
+G GSFG +Y GT AIK+ + E ++ R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 749 CNNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
D+ LV++L+ G SLE + L L L + + +E++H S +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 808 DLKPSNILLDEDMVAH---VSDFGLSKLF 833
D+KP N L+ A+ + DFGL+K +
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 39/165 (23%)
Query: 172 LVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231
V ++ ++ ++ + + L+ + L L NN+ I ++S
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLS------------- 67
Query: 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291
+ NLR+ SLG+N + I N A L L +S+N + L
Sbjct: 68 -----------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG--IEK 113
Query: 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
L L VL ++NN +T W + L L L +A NPL
Sbjct: 114 LVNLRVLYMSNNKIT------NWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 35/162 (21%), Positives = 56/162 (34%), Gaps = 39/162 (24%)
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS 487
+ + L++L + + L L +N I S
Sbjct: 32 GMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-------------------------S 64
Query: 488 NIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ---FEGPIPQTFGSLTGLE 544
++ ++ L L L RN + I L L ++ NQ G L L
Sbjct: 65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLR 118
Query: 545 SLDLSNNNLS--GEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584
L +SNN ++ GEI L AL L+ L ++ N L + N
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 42/201 (20%), Positives = 77/201 (38%), Gaps = 50/201 (24%)
Query: 382 INALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGN---KLSGPIP 438
+ + ++E L +E + L L+ + L+ N K+S
Sbjct: 14 FEERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--- 65
Query: 439 QCLASLISLRELNLGSNKFS--SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
L+ + +LR L+LG N ++ + +LE L +S N ++ SL S I+ L L
Sbjct: 66 --LSGMENLRILSLGRNLIKKIENLDAVADTLEEL---WISYNQIA-SL-SGIEKLVNLR 118
Query: 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE 556
L +S N+ I + ++ L+ +L LE L L+ N L +
Sbjct: 119 VLYMSNNK--------ITNWGEIDKLA---------------ALDKLEDLLLAGNPLYND 155
Query: 557 IPKS-------LEALLFLKQL 570
++ +E + L L
Sbjct: 156 YKENNATSEYRIEVVKRLPNL 176
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 28/207 (13%)
Query: 689 NLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHR------NL 741
+L+G+GSFG V K + AIK+ + E +L + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 742 IKIFSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYF---LDLLERLNIMIGVALALEY 795
+ + FR LV E++ + +L L + N+ L+L + + AL +
Sbjct: 119 VHLKRHF---MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLF 172
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAH--VSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
L + ++HCDLKP NILL + + DFG S + I + Y +
Sbjct: 173 LATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRS 226
Query: 854 PEYGTEGIVSSKCDVYSYGVLLTETFT 880
PE D++S G +L E T
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 50/225 (22%)
Query: 690 LLGRGSFGSVYKG--TFSDGTSFAIKVF-NLQLDRAFRSFDSECEVLRNVRHR------N 740
LG G+FG V + + A+K+ N+ + + E VL+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFL 83
Query: 741 LIKIFSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYF---LDLLERLNIMIGVALALE 794
+ + +F + EL+ + ++L +N+ L + + + AL
Sbjct: 84 CVLMSDWF---NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQLCHALR 137
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-----------KLFDEG---DDSV 840
+LH + H DLKP NIL + + S ++ D G D
Sbjct: 138 FLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 841 TQTMTIATIGYMAPEYGTEGIV-----SSKCDVYSYGVLLTETFT 880
T +AT Y PE ++ + CDV+S G +L E +
Sbjct: 195 HHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 38/223 (17%), Positives = 69/223 (30%), Gaps = 44/223 (19%)
Query: 399 LQGLSLYGNNL--EG--SIPYDLCHLERLNGIRLNGNKLSGP----IPQCLASLISLREL 450
++G SL + + E S+ L + + I L+GN + + + +AS L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 451 NLGSNKFS----------SSIPSSFWSLEYLLAVNLSSNSLSG----SLPSNIQNLQVLI 496
+ + L V LS N+ L + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 497 NLDLSRNQLS-------------GDIPITIGSLKDLVTLSLASNQFEGP----IPQTFGS 539
+L L N L + + L ++ N+ E +TF S
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 540 LTGLESLDLSNNNLSGE-----IPKSLEALLFLKQLNVSHNKL 577
L ++ + N + E + + L LK L++ N
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 50/316 (15%), Positives = 97/316 (30%), Gaps = 69/316 (21%)
Query: 251 SLGKNKLTG----TIPNSITNASKLTGLDLSFNSFSG----LIPHTFGNLRFLSVLNLAN 302
SL + +T ++ + + + LS N+ + + + L + ++
Sbjct: 10 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 69
Query: 303 NY---LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNF---SASLQNFYA 356
+ + + P A L +L C L T+ ++ N + +F L++ Y
Sbjct: 70 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129
Query: 357 YDCKLT-------------GNIPHEIGNLRSLIVLSLFINALNG----TIPSTVGRLEQL 399
++ L + + N L + N L T L
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189
Query: 400 QGLSLYGNNL--EGSIP------YDLCHLERLNGIRLNGNKLSGP----IPQCLASLISL 447
+ + N + EG L+ L+ L N + + L S +L
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD---LQDNTFTHLGSSALAIALKSWPNL 246
Query: 448 RELNLGSNKFSSS---------IPSSFWSLEYLLAVNLSSN--------SLSGSLPSNIQ 490
REL L S+ L+ L L N +L + +
Sbjct: 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTL---RLQYNEIELDAVRTLKTVIDEKMP 303
Query: 491 NLQVLINLDLSRNQLS 506
+L L+L+ N+ S
Sbjct: 304 DLL---FLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 26/144 (18%), Positives = 52/144 (36%), Gaps = 26/144 (18%)
Query: 446 SLRELNLGSNKFSS----SIPSSFWSLEYLLAVNLSSNSLSG----SLPSNIQNLQVLIN 497
S+ +L + ++ S+ + + + + LS N++ L NI + + L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557
+ S G +KD + +L + Q L ++ LS+N
Sbjct: 65 AEFSDIF--------TGRVKDEIPEALRL------LLQALLKCPKLHTVRLSDNAFGPTA 110
Query: 558 PKSLEALL----FLKQLNVSHNKL 577
+ L L L+ L + +N L
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGL 134
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 5e-08
Identities = 28/189 (14%), Positives = 57/189 (30%), Gaps = 27/189 (14%)
Query: 386 NGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS-- 443
+ + + L L + G N +L+ L + L + + +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSD 217
Query: 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503
L +L +L L L + P+ L L +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFS--------KDRFPN-------LKWLGIVDA 262
Query: 504 QLSGDIPITIGS---LKDLVTLSLASNQF--EG--PIPQTFGSLTGLESLDLSNNNLSGE 556
+ + L L T+ +++ EG + + L+ +++ N LS E
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 557 IPKSLEALL 565
+ K L+ L
Sbjct: 323 MKKELQKSL 331
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 6e-08
Identities = 30/162 (18%), Positives = 63/162 (38%), Gaps = 17/162 (10%)
Query: 435 GPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL--LAVNLSSNSLSGSLPSNIQNL 492
+ L ++ L L + S +L+ L ++ L + + L S++ NL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 493 QVLINLDLSRNQLSGDIPITI-------GSLKDLVTLSLASNQFEGPIPQTFGS---LTG 542
+ L L + D + + +L L + + + + + F L
Sbjct: 222 EKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 543 LESLDLSNNNLSGE----IPKSLEALLFLKQLNVSHNKLEGE 580
LE++D+S L+ E + ++ + LK +N+ +N L E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 3e-05
Identities = 33/232 (14%), Positives = 63/232 (27%), Gaps = 45/232 (19%)
Query: 84 NNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLF 143
++ + + + +F SWI + L
Sbjct: 125 SDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQ---------------VDLSPVLD 169
Query: 144 NLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG--NLQNLEILVL 201
+ L NL SL + L + +I +L NLE L
Sbjct: 170 AMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSDLPNLEKL-- 224
Query: 202 GMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTI 261
L ++ F+ LF PNL+ + + +
Sbjct: 225 ---VLYVGVEDYGFDGDMNVFRPLFSKD-------------RFPNLKWLGIVDAEEQNVV 268
Query: 262 PNSITNA---SKLTGLDLSFNSFSG----LIPHTFGNLRFLSVLNLANNYLT 306
+ +L +D+S + L+ ++ L +N+ NYL+
Sbjct: 269 VEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 36/108 (33%), Positives = 47/108 (43%), Gaps = 4/108 (3%)
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLS 506
L+L +N S F L L + L N L SLP+ + L L L+LS NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 507 GDIPITIGSLKDLVTLSLASNQFEGPIPQ-TFGSLTGLESLDLSNNNL 553
L L L+L +NQ + +P F LT L+ L L N L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 44/128 (34%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L N L L SL +L LG NK S F L L +NLS+N L SLP
Sbjct: 34 DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLP 92
Query: 487 SNI-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQ-TFGSLTGL 543
+ + L L L L+ NQL +P + L L L L NQ + +P F LT L
Sbjct: 93 NGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSL 150
Query: 544 ESLDLSNN 551
+ + L +N
Sbjct: 151 QYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 32/109 (29%), Positives = 44/109 (40%), Gaps = 13/109 (11%)
Query: 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533
V S + S+P+ I LDL N L L L L L N+ +
Sbjct: 12 VECYSQGRT-SVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68
Query: 534 PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLF-----LKQLNVSHNKL 577
F LT L L+LS N L +SL +F LK+L ++ N+L
Sbjct: 69 NGVFNKLTSLTYLNLSTNQL-----QSLPNGVFDKLTQLKELALNTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 15/146 (10%)
Query: 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN-IST 219
IP++ L +L N+L+ L +L L LG N L + +FN +++
Sbjct: 25 GIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTS 77
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSI-TNASKLTGLDLSF 278
+T +NL NQL LP V L L+ +L N+L ++P+ + ++L L L
Sbjct: 78 LTYLNLSTNQLQ---SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 279 NSFSGLIPH-TFGNLRFLSVLNLANN 303
N +P F L L + L +N
Sbjct: 134 NQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 44/155 (28%), Positives = 60/155 (38%), Gaps = 28/155 (18%)
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436
L L N+L L L L L GN L+ S+P NG+
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLP---------NGV---------- 71
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVL 495
L SL LNL +N+ S F L L + L++N L SLP + L L
Sbjct: 72 ----FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQL 126
Query: 496 INLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQF 529
+L L +NQL +P + L L + L N +
Sbjct: 127 KDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPW 160
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 54/229 (23%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVF-NLQLDRAFRSFDSECEVLRNVRHR-----NLI 742
+G G+FG V + +A+KV N++ + RS E ++L+ +++ N++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 743 KIFSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYF---LDLLERLNIMIGVALALEYL 796
K + L+ E + SL + + +NY ++ ++ I + AL YL
Sbjct: 100 KYHGKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL--YCIEILKALNYL 153
Query: 797 HHGHSTPVVHCDLKPSNILL-DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI--G--- 850
+ H DLKP NILL D + + T++ I I G
Sbjct: 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 851 --------------YMAPEYGTEGIV-----SSKCDVYSYGVLLTETFT 880
Y APE ++ D++S+G +L E +T
Sbjct: 211 FKSDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 46/228 (20%), Positives = 86/228 (37%), Gaps = 56/228 (24%)
Query: 690 LLGRGSFGSVYKG--TFSDGTSFAIKVFNLQLDRAFRSF----DSECEVLRNVRHR---- 739
LG G+FG V + + G A+K+ + + SE +VL ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 740 --NLIKIFSSCCNNDFRA---LVLELMPNGSLEKWLYSDNYF---LDLLERLNIMIGVAL 791
+++ + +V EL+ S ++ + + LD + + + +
Sbjct: 76 TFRCVQMLEWF---EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQICK 129
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS-----------KLFDEG---D 837
++ +LH + H DLKP NIL + + + K+ D G
Sbjct: 130 SVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 838 DSVTQTMTIATIGYMAPEYGTEGIV-----SSKCDVYSYGVLLTETFT 880
D + ++T Y APE ++ S CDV+S G +L E +
Sbjct: 187 DDEHHSTLVSTRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
L S LT +I N + +KL L+LS N SG + L+ LNL+
Sbjct: 40 EFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
N + + S + L NL +L + + +
Sbjct: 98 NKI------KDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 446 SLRELNLGSNKFSS----SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLS 501
++EL L +++ + + F LE+L + + L+ S+ +N+ L L L+LS
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFL---STINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 502 RNQLSGDIPITIGSLKDLVTLSLASNQFEGP-IPQTFGSLTGLESLDLSNN 551
N++SG + + +L L+L+ N+ + + L L+SLDL N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 26/134 (19%), Positives = 46/134 (34%), Gaps = 10/134 (7%)
Query: 121 LSKLQILSLRNNSFT-GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNV---N 176
S ++ L L N+ G + LE ++ + + I NL L +
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLE 70
Query: 177 LAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIF-NISTITLINLFGNQLSGHLD 235
L+ N + G + NL L L N + + + ++LF +++ D
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 236 LPPKVSYSLPNLRV 249
V LP L
Sbjct: 131 YRENVFKLLPQLTY 144
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 5/110 (4%)
Query: 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430
+++ L++ + N G + E+L+ LS L SI +L L +L + L+
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSD 73
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSS-SIPSSFWSLEYLLAVNLSSN 479
N++SG + +L LNL NK S LE L +++L +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 13/101 (12%)
Query: 481 LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF---EGPIPQTF 537
L PS+++ L LD SR+ G + ++L LS +
Sbjct: 11 LRNRTPSDVKELV----LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSIAN-----L 60
Query: 538 GSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
L L+ L+LS+N +SG + E L LN+S NK++
Sbjct: 61 PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 27/142 (19%), Positives = 50/142 (35%), Gaps = 34/142 (23%)
Query: 267 NASKLTGLDLSFNSFS-GLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325
S + L L + + G + L L+ N LT+ +++L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---------IANLPKLNK 65
Query: 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL 385
L L ++ N + G L + +L + L+GN +I +L ++ L
Sbjct: 66 LKKLELSDNRVSGGLEVLAEKCP-NLTHLN-----LSGN---KIKDLSTIEPLK------ 110
Query: 386 NGTIPSTVGRLEQLQGLSLYGN 407
+LE L+ L L+
Sbjct: 111 ---------KLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 4/129 (3%)
Query: 446 SLRELNLGSNKFS-SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504
++REL L + K + I L ++L + L S+ SN+ L L L+LS N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENR 82
Query: 505 LSGDIPITIGSLKDLVTLSLASNQFEGP-IPQTFGSLTGLESLDLSNNNLSGEIPKSLEA 563
+ G + + L +L L+L+ N+ + + L L+SLDL N ++
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESV 142
Query: 564 LLFLKQLNV 572
L QL
Sbjct: 143 FKLLPQLTY 151
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 25/94 (26%), Positives = 37/94 (39%), Gaps = 8/94 (8%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
NL SL L ++ N + KL L+LS N G + L L+ LNL+
Sbjct: 47 EFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
N L + S L L L +L + + +
Sbjct: 105 NKLK------DISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 28/135 (20%), Positives = 48/135 (35%), Gaps = 12/135 (8%)
Query: 121 LSKLQILSLRNNSFT-GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNV---N 176
+ ++ L L N G I LE + + + NL L +
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLE 77
Query: 177 LAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP--IQPSIFNISTITLINLFGNQLSGHL 234
L+ N + G + L NL L L N L ++P + + + ++LF +++
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLN 136
Query: 235 DLPPKVSYSLPNLRV 249
D V LP L
Sbjct: 137 DYRESVFKLLPQLTY 151
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 27/103 (26%), Positives = 40/103 (38%), Gaps = 13/103 (12%)
Query: 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ---FEGPIPQ 535
L P+ ++ L LD ++ G I +L LSL +
Sbjct: 16 LELRNRTPAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSN---- 66
Query: 536 TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
L L+ L+LS N + G + E L L LN+S NKL+
Sbjct: 67 -LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 27/136 (19%)
Query: 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430
+R L++ + N +G I L+ LSL L S+ +L L +L + L+
Sbjct: 25 AVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSE 80
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ 490
N++ G + L +L LNL NK +LE L +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPL------------------K 117
Query: 491 NLQVLINLDLSRNQLS 506
L+ L +LDL +++
Sbjct: 118 KLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 27/142 (19%), Positives = 49/142 (34%), Gaps = 34/142 (23%)
Query: 267 NASKLTGLDLSFNSFS-GLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325
+ + L L + G I L L+L N L + +S+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---------VSNLPKLPK 72
Query: 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL 385
L L ++ N + G L + +L + L+GN ++ ++ +L L
Sbjct: 73 LKKLELSENRIFGGLDMLAEKLP-NLTHLN-----LSGN---KLKDISTLEPLK------ 117
Query: 386 NGTIPSTVGRLEQLQGLSLYGN 407
+LE L+ L L+
Sbjct: 118 ---------KLECLKSLDLFNC 130
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 26/132 (19%), Positives = 51/132 (38%), Gaps = 16/132 (12%)
Query: 450 LNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQV----LINLDLSRNQL 505
+ L + + + + + ++L + I+NL +D S N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEI 54
Query: 506 SGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS--GEIPKSLEA 563
+ L+ L TL + +N+ +L L L L+NN+L G++ L +
Sbjct: 55 R-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLAS 111
Query: 564 LLFLKQLNVSHN 575
L L L + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+L N++ + +L L ++ N + L L+ L L N
Sbjct: 40 TLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
N L E L L + ++LT L + NP+
Sbjct: 98 NSL------VELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 25/134 (18%), Positives = 49/134 (36%), Gaps = 12/134 (8%)
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNV---NL 177
+ + L LR I N L + + D N I ++ L + +
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLKTLLV 71
Query: 178 AYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP--IQPSIFNISTITLINLFGNQLSGHLD 235
N + L +L L+L N+L + P + ++ ++T + + N ++
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVTNKKH 130
Query: 236 LPPKVSYSLPNLRV 249
V Y +P +RV
Sbjct: 131 YRLYVIYKVPQVRV 144
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 21/105 (20%), Positives = 43/105 (40%), Gaps = 5/105 (4%)
Query: 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533
V L++ + + + N LDL ++ I +L + + N+ +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 534 PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
F L L++L ++NN + +AL L +L +++N L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 28/144 (19%), Positives = 43/144 (29%), Gaps = 34/144 (23%)
Query: 264 SITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNC 323
TNA + LDL +I + L ++ ++N + L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK---------LDGFPLL 63
Query: 324 RNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFIN 383
R L TL V +N + I + L LT N + L L L+
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALP-DLTELI-----LTNN---SLVELGDLDPLA---- 110
Query: 384 ALNGTIPSTVGRLEQLQGLSLYGN 407
L+ L L + N
Sbjct: 111 -----------SLKSLTYLCILRN 123
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKD 518
IP L L N + +P + N + L +DLS N++S + ++
Sbjct: 27 KGIPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79
Query: 519 LVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS 554
L+TL L+ N+ P+TF L L L L N++S
Sbjct: 80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLS 277
+T + L GNQ + L PK + +L + L N+++ S +N ++L L LS
Sbjct: 31 RDVTELYLDGNQFT----LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86
Query: 278 FNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
+N + P TF L+ L +L+L N ++ E +F + L+ LA+ +NPL
Sbjct: 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISV---VPEGAF----NDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L+GN+ + +P+ L++ L ++L +N+ S+ SF ++ LL + LS N L +P
Sbjct: 37 YLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIP 94
Query: 487 SNI-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQF 529
L+ L L L N +S +P L L L++ +N
Sbjct: 95 PRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 32/118 (27%), Positives = 52/118 (44%), Gaps = 9/118 (7%)
Query: 389 IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448
IP V L L GN +P +L + + L I L+ N++S Q +++ L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQL 505
L L N+ P +F L+ L ++L N +S +P +L L +L + N L
Sbjct: 82 TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 50/310 (16%), Positives = 95/310 (30%), Gaps = 77/310 (24%)
Query: 320 LTNCRNLTTLAVASNPL--RGI--LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSL 375
+ +T+L ++ N L L N AS+ + L ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF---------KNS 68
Query: 376 IVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLE--------GSIPYDLCHLERLNGIR 427
L + A+ + L+L GN L ++ + L+
Sbjct: 69 DELVQILAAIPAN----------VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLD--- 115
Query: 428 LNGNKLSGPIPQCLASLI-----SLRELNLGSNK--------FSSSIPSSFWSLEYLLAV 474
L N S S+ LNL N + + ++ L
Sbjct: 116 LGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL--- 172
Query: 475 NLSSNS--------LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSL-----KDLVT 521
NL N+ L+ L S ++ LDLS N L + + +V+
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTS---LDLSANLLGLKSYAELAYIFSSIPNHVVS 229
Query: 522 LSLASNQFEGP----IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL-------FLKQL 570
L+L N GP + SL L+++ L + + + +AL + +
Sbjct: 230 LNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILV 289
Query: 571 NVSHNKLEGE 580
+ + ++
Sbjct: 290 DKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 57/345 (16%), Positives = 107/345 (31%), Gaps = 76/345 (22%)
Query: 269 SKLTGLDLSFNSFS-----GLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNC 323
+T LDLS N+ LI ++ LNL+ N L + L++
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA--IP 79
Query: 324 RNLTTLAVASNPLRGI----LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLS 379
N+T+L ++ N L L + ++ + +S
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS---------KSSSEFK 130
Query: 380 LFINALNGTIPSTVGRLEQLQGLSLYGNNL--EG------SIPYDLCHLERLNGIRLNGN 431
+ L + + L+L GN+L + + ++ LN L GN
Sbjct: 131 QAFSNLPAS----------ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGN 177
Query: 432 KLSGPIPQCLASLI-----SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L+ LA + S+ L+L +N S L+
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLK----------------SYAELAYIFS 221
Query: 487 SNIQNLQVLINLDLSRNQLSGDIPITIGSLKD----LVTLSLASNQFEGP-------IPQ 535
S ++ +L+L N L G + LKD L T+ L + + +
Sbjct: 222 SIPNHVV---SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278
Query: 536 TFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580
F ++ + +D + + + L+ L +
Sbjct: 279 AFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 60/357 (16%), Positives = 108/357 (30%), Gaps = 72/357 (20%)
Query: 245 PNLRVFSLGKNKLTGTIPNSI-----TNASKLTGLDLSFNSFS-----GLIPHTFGNLRF 294
+ L N L + + +T L+LS NS L+
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG----ILPPVIGNFSAS 350
++ LNL+ N+L+ S L++ +T L + N N AS
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAA--IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 351 LQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL- 409
+ + L +S L + A+ + L+L GNNL
Sbjct: 140 ITSLNLRGNDLGI---------KSSDELIQILAAIPAN----------VNSLNLRGNNLA 180
Query: 410 -EG------SIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI-----SLRELNLGSNKF 457
+ + + L+ L+ N L LA + + LNL N
Sbjct: 181 SKNCAELAKFLASIPASVTSLD---LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 458 SSS----IPSSFWSLEYLLAVNLSSNSLSG-------SLPSNIQNLQVLINLDLSRNQLS 506
+ SL++L V L + + +L + N+Q +I +D + ++
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
Query: 507 GDIPITIG-SLKD----LVTLSLASN-----QFEGPIPQTFGSLTGLESLDLSNNNL 553
I I +++ SL + Q + L + L
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 37/187 (19%), Positives = 59/187 (31%), Gaps = 40/187 (21%)
Query: 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS--------IPSSFWSLEYLLA 473
G+ + + + + L+L N S ++ S+ L
Sbjct: 2 NYKLTLHPGSNP---VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSL-- 56
Query: 474 VNLSSNS--------LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSL-----KDLV 520
NLS NS L L + N+ +L+LS N LS + +
Sbjct: 57 -NLSGNSLGFKNSDELVQILAAIPANVT---SLNLSGNFLSYKSSDELVKTLAAIPFTIT 112
Query: 521 TLSLASNQFEGPIPQTFGSL-----TGLESLDLSNNNLSGEIPKSL-EALLF----LKQL 570
L L N F F + SL+L N+L + L + L + L
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172
Query: 571 NVSHNKL 577
N+ N L
Sbjct: 173 NLRGNNL 179
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 474 VNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEG 531
V+ + L +P +I + L L+ N+L + G L LV L L NQ G
Sbjct: 13 VDCTGRGLK-EIPRDIPLHTT---ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 532 PIPQTFGSLTGLESLDLSNNNLSGEIPKSL-EALLFLKQLNVSHNKL 577
P F + ++ L L N + EI + L LK LN+ N++
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 11/120 (9%)
Query: 218 STITLINLFGNQLSGHLDLPPK-VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDL 276
T + L N+L + + LP+L L +N+LTG PN+ AS + L L
Sbjct: 29 LHTTELLLNDNELG---RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85
Query: 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
N + F L L LNL +N ++ P + F + +LT+L +ASNP
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS---F----EHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 475 NLSSNSLSGSLPSN--IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
L+ N L + S+ L L+ L+L RNQL+G P + L L N+ +
Sbjct: 35 LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93
Query: 533 IPQTFGSLTGLESLDLSNNNLS 554
+ F L L++L+L +N +S
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 426 IRLNGNKLSG-PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+ LN N+L L L +L L N+ + P++F ++ + L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 485 LPSNI-QNLQVLINLDLSRNQLSGDIPITIG---SLKDLVTLSLASNQF 529
+ + + L L L+L NQ+S + G L L +L+LASN F
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISC---VMPGSFEHLNSLTSLNLASNPF 138
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 51/249 (20%), Positives = 81/249 (32%), Gaps = 64/249 (25%)
Query: 691 LGRGSFGSVYKGTFSDGTSF-AIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC 749
LG G F +V+ G F A+KV + D E +L++VR+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 750 ------------NNDFRALVLELMPNG-SLEKWLYSDNYFLDLLERL-NIMIGVALALEY 795
N +V E++ G L KW+ NY L + I+ V L+Y
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 796 LHHGHSTPVVHCDLKPSNILLD-EDMVAH------------------------------- 823
LH ++H D+KP NILL +
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 824 ---------VSDFGLSKLFDEGD---DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSY 871
++ K+ D G+ T I T Y + E ++ D++S
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWST 279
Query: 872 GVLLTETFT 880
+ E T
Sbjct: 280 ACMAFELAT 288
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 216 NISTITLI-NLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNA-SKLTG 273
I + L N+L LP V L L SL +N++ ++P+ + + +KLT
Sbjct: 25 GIPSSATRLELESNKLQ---SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTI 80
Query: 274 LDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTN 322
L L N L F L L L L N L + P + L+SL
Sbjct: 81 LYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQK 128
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 30/103 (29%), Positives = 38/103 (36%), Gaps = 2/103 (1%)
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L NKL L L +L+L N+ S F L L + L N L SLP
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLP 92
Query: 487 SNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528
+ + L L L L NQL L L + L +N
Sbjct: 93 NGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 34/97 (35%), Positives = 42/97 (43%), Gaps = 10/97 (10%)
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLK 517
+ IPSS LE L SN L SLP + L L L LS+NQ+ L
Sbjct: 24 TGIPSSATRLE------LESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT 76
Query: 518 DLVTLSLASNQFEGPIPQ-TFGSLTGLESLDLSNNNL 553
L L L N+ + +P F LT L+ L L N L
Sbjct: 77 KLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQL 112
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 47/305 (15%), Positives = 94/305 (30%), Gaps = 35/305 (11%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISK------NNFHAYLPNELGQLRRLRFISLD 106
++L L+ + L L L + ++ L L + LR +S
Sbjct: 214 KSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGF 273
Query: 107 YNEFSGSFPSWIGVLSKLQILSLRNNSFTGP-IPNSLFNLSRLEKWDSMFNIIDGNIPSR 165
++ P+ V S+L L+L + + L +L++ + I D +
Sbjct: 274 WDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVL 333
Query: 166 IGNLSSLVNVNLAYNNLQGEIPSE----------IGNLQNLEILVLGMNNLSGP-IQPSI 214
L + + + P+ LE ++ ++ +
Sbjct: 334 ASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIA 393
Query: 215 FNISTITLINLFGNQLSGHLDLPPKVS--------YSLPNLRVFSLGKNKLTGTIPNSI- 265
N +T L + L + +LR SL LT + I
Sbjct: 394 RNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIG 452
Query: 266 TNASKLTGLDLSFNSFSGL-IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324
T A K+ L ++F S L + H L L + + + L++ +
Sbjct: 453 TYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK------ALLANASKLE 506
Query: 325 NLTTL 329
+ +L
Sbjct: 507 TMRSL 511
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 36/299 (12%), Positives = 85/299 (28%), Gaps = 26/299 (8%)
Query: 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQ 352
+ + + + A S + + + ++ + P +F+
Sbjct: 36 SWYEIERWCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPH-------FADFNLVPD 87
Query: 353 NFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL--E 410
+ Y + L + + + + + + + + L L
Sbjct: 88 GWGGYVYPWIEAMSSSYTWLEEIRLKRMVVT--DDCLELIAKSFKNFKVLVLSSCEGFST 145
Query: 411 GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI----SLRELNLGSNKFS---SSIPS 463
+ L + L + + L+ SL LN+ S++
Sbjct: 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER 205
Query: 464 SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGD------IPITIGSLK 517
L ++ L+ L + +Q L L + + + K
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE-IPKSLEALLFLKQLNVSHN 575
+L LS + +P + + L +L+LS + + K L L++L V
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 66/511 (12%), Positives = 151/511 (29%), Gaps = 92/511 (18%)
Query: 94 LGQLRRLRFISLDYNEFSGSFPSWIGVLSK----LQILSLRNNSFT----GPIPNSLF-N 144
L R +L + G W+ +S L+ + R + + + +
Sbjct: 80 LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADD 139
Query: 145 LSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ-------GEIPSEIGNLQNLE 197
L L K D + S + + + + + ++ E+ +L+ L
Sbjct: 140 LETL-KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198
Query: 198 ILVLGMNNLSGPIQPSIFNIST-ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK 256
+ +S +I + + + ++ + + +L SL ++
Sbjct: 199 FYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAA-NLEEFCGGSLNEDI 257
Query: 257 LTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSF 316
++ KL L LS+ + + P F + L+L L T+
Sbjct: 258 GMPEKYMNLVFPRKLCRLGLSYMGPNEM-PILFPFAAQIRKLDLLYALLETED------H 310
Query: 317 LSSLTNCRNLTTLAVASN-PLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSL 375
+ + C NL L + RG+ V+ + L+ + E G +
Sbjct: 311 CTLIQKCPNLEVLETRNVIGDRGLE--VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368
Query: 376 IVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSG 435
+++L L+ +++Y +++ +
Sbjct: 369 GLIALAQGCQE------------LEYMAVYVSDITNE------------SLE-------- 396
Query: 436 PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL 495
I L +L R + L + ++ L + S + + L
Sbjct: 397 SIGTYLKNLCDFRLVLLDREE------------------RITDLPLDNGVRSLLIGCKKL 438
Query: 496 INLDLSRN--QLSGDIPITIGSL-KDLVTLSLASNQF--EGPIPQTFGSLTGLESLDLSN 550
L+ IG ++ + L EG + + L+ L++
Sbjct: 439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG-LMEFSRGCPNLQKLEMRG 497
Query: 551 NNLSGEIPKSLEALLF----LKQLNVSHNKL 577
S +++ A + L+ L V +
Sbjct: 498 CCFS---ERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 42/205 (20%), Positives = 67/205 (32%), Gaps = 32/205 (15%)
Query: 399 LQGLSLYGNN-LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLREL----NLG 453
L GL N + + + +L+ L + KL Q L L L
Sbjct: 3 LVGLLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQ 62
Query: 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS--------LPSNIQNLQVLINLDLSRNQL 505
+ +FS+ + L L +NL+ ++ L S L + +L+ QL
Sbjct: 63 NQRFSAEV------LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEV---NLASCQL 113
Query: 506 SGDIPITIGS-LKDLVTLSLASNQFEGPIPQTFGSL-----TGLESLDLSNNNLSGEIPK 559
T+ L L N + L + +L LSNN L+
Sbjct: 114 DPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVA 173
Query: 560 SL-EALL---FLKQLNVSHNKLEGE 580
L E L + L++ H L E
Sbjct: 174 VLMEGLAGNTSVTHLSLLHTGLGDE 198
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 36/193 (18%), Positives = 56/193 (29%), Gaps = 35/193 (18%)
Query: 418 CHLERLNGIRLNGNKLSGPIPQCLAS-LISLRELNLGSNKF--------SSSIPSSFWSL 468
L+ +N L +L + L + R+L L N + +
Sbjct: 101 HALDEVN---LASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQI 157
Query: 469 EYLLAVNLSSNS--------LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGS-LKD- 518
L LS+N L L N + +L L L + + + L
Sbjct: 158 TTL---RLSNNPLTAAGVAVLMEGLAGN----TSVTHLSLLHTGLGDEGLELLAAQLDRN 210
Query: 519 --LVTLSLASNQFEGP----IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNV 572
L L++A N + + LE L L N LS E + L L +
Sbjct: 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGA 270
Query: 573 SHNKLEGEIPANG 585
E A
Sbjct: 271 RVVVSLTEGTAVS 283
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 14/214 (6%)
Query: 373 RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL-EGSIPYDLCHLERLNGIRLNGN 431
+ +I + ++ + ++Q + L + + ++ L +L + L G
Sbjct: 70 QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 128
Query: 432 KLSGPIPQCLASLISLRELNLG-----SNKFSSSIPSSFWSLEYL-LA--VNLSSNSLSG 483
+LS PI LA +L LNL S ++ SS L+ L L+ + + +
Sbjct: 129 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIG-SLKDLVTLSLAS-NQFEGPIPQTFGSLT 541
++ + + L NL R L T+ +LV L L+ + Q F L
Sbjct: 189 AVAHVSETITQL-NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247
Query: 542 GLESLDLSN-NNLSGEIPKSLEALLFLKQLNVSH 574
L+ L LS ++ E L + LK L V
Sbjct: 248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 977 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.57 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.06 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.23 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.83 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.15 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.65 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-83 Score=791.88 Aligned_cols=607 Identities=31% Similarity=0.496 Sum_probs=451.4
Q ss_pred cccChHHHHHHHHHHHHhccCCCCCccCCCCCCCCCCcccceEecCCCCcEEEEEcCCCCCCcc---CCcc---------
Q 036011 2 IVQNLTTDQFALLAFKAHVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGT---IPPH--------- 69 (977)
Q Consensus 2 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~---~~~~--------- 69 (977)
.+++.++|++||++||+++.||. .+ ++|+.++|||+|.||+|+ +++|+.|+|+++++.|. +|++
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~-~l-~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKN-LL-PDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTT-SS-TTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred cccCCHHHHHHHHHHHhhCCCcc-cc-cCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 45778999999999999999887 55 699888999999999998 68999999999999987 6654
Q ss_pred --------------ccCcccccEeeccCCcccccCCC--CcCCCCCCCEEeCcCccCCCCCCccc-cccccCcEEeccCc
Q 036011 70 --------------LGNFSFLMSLDISKNNFHAYLPN--ELGQLRRLRFISLDYNEFSGSFPSWI-GVLSKLQILSLRNN 132 (977)
Q Consensus 70 --------------l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~n 132 (977)
++.+++|++|||++|.+++.+|. .++++++|++|+|++|.+++.+|..+ +.+++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 44555555555555555555555 55555555555555555555555443 45555555555555
Q ss_pred CCCCCCCCc---ccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCC
Q 036011 133 SFTGPIPNS---LFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP 209 (977)
Q Consensus 133 ~l~~~~p~~---l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~ 209 (977)
.+++..|.. +.++++|++|++++|.+.+.+|. +.+++|++|+|++|++++.+|. ++++++|++|++++|++++.
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 555444433 44444455555555544443332 5666677777777777766665 77777777777777777777
Q ss_pred CchhhccccceeEEEccCCcccccc--------------------cCCCccccCCCCceEEEecCceeeecCCccccccc
Q 036011 210 IQPSIFNISTITLINLFGNQLSGHL--------------------DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS 269 (977)
Q Consensus 210 ~~~~l~~l~~L~~L~L~~N~l~~~~--------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 269 (977)
++..+..+++|+.|+|++|++.+.. .+|..++..+++|++|+|++|++++.+|..+..++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~ 318 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence 7777777777777777777665421 23333333346666777777776666666667777
Q ss_pred ccceEeecccccccccccc-cccccccccccccccccCCCCCCchhhhh------------------ccccc--CCCCce
Q 036011 270 KLTGLDLSFNSFSGLIPHT-FGNLRFLSVLNLANNYLTTDSPTAEWSFL------------------SSLTN--CRNLTT 328 (977)
Q Consensus 270 ~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~------------------~~l~~--l~~L~~ 328 (977)
+|++|+|++|++++.+|.. |..+++|++|++++|.+++..|....... ..+.. +++|++
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 7777777777776555544 66677777777777776644333221111 01111 455666
Q ss_pred EEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeeccc
Q 036011 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN 408 (977)
Q Consensus 329 L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 408 (977)
|++++|.+.+.+|..+..+. +|+.|++.+|++++.+|..++.+++|++|++++|.+.+.+|..+..+++|++|+|++|+
T Consensus 399 L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 477 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477 (768)
T ss_dssp EECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence 66666666666666665543 57778888888888888888888888888888888888888888888888888888888
Q ss_pred ccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccc
Q 036011 409 LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSN 488 (977)
Q Consensus 409 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 488 (977)
+++.+|..+..+++|++|++++|++++.+|.+++.+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..
T Consensus 478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888887766654
Q ss_pred c----------------------------------------------------------------------ccccccCee
Q 036011 489 I----------------------------------------------------------------------QNLQVLINL 498 (977)
Q Consensus 489 ~----------------------------------------------------------------------~~l~~L~~L 498 (977)
+ ..+++|++|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 3 335678999
Q ss_pred eCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCccc
Q 036011 499 DLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 499 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
||++|+++|.+|..++.+++|+.|+|++|+++|.+|..|+++++|++|||++|+++|.+|..+..+++|++||+++|+++
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcCCCCCcccCccccCCCccCCCCCCCCCCCC
Q 036011 579 GEIPANGPFKYFAPQSFSWNYALCGPTTLQVPPCRANKTEG 619 (977)
Q Consensus 579 ~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~~~~~~ 619 (977)
|.||..++|.+|+..+|.||+++||+| +++|....++.
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~~~~~~ 755 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADG 755 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEESTT---SCCCCSCC---
T ss_pred ccCCCchhhccCCHHHhcCCchhcCCC---CcCCCCCccCC
Confidence 999999999999999999999999998 34887664443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=625.39 Aligned_cols=520 Identities=33% Similarity=0.467 Sum_probs=417.0
Q ss_pred CCcEEEEEcCCCCCCccCCc--cccCcccccEeeccCCcccccCCCCc-CCCCCCCEEeCcCccCCCCCCcc--------
Q 036011 49 HQRVRALNLSNMGLRGTIPP--HLGNFSFLMSLDISKNNFHAYLPNEL-GQLRRLRFISLDYNEFSGSFPSW-------- 117 (977)
Q Consensus 49 ~~~v~~L~l~~~~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~-------- 117 (977)
..++++|||++|.+.|.+|. .++++++|++|||++|.+++..|..+ .++++|++|+|++|++++..|..
T Consensus 99 l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~ 178 (768)
T 3rgz_A 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178 (768)
T ss_dssp CTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCT
T ss_pred CCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCC
Confidence 35688999999999999998 89999999999999999988777765 66666777666666666544432
Q ss_pred -----------------ccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecc
Q 036011 118 -----------------IGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180 (977)
Q Consensus 118 -----------------~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n 180 (977)
++.+++|++|+|++|.+++.+|. +.++++|++|++++|.+++.+|..|+++++|++|+|++|
T Consensus 179 ~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n 257 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257 (768)
T ss_dssp TCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSS
T ss_pred CCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCC
Confidence 14566777777777777776666 777777777777777777777777777777777766666
Q ss_pred ccccc----------------------CCccccCC-CCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCC
Q 036011 181 NLQGE----------------------IPSEIGNL-QNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLP 237 (977)
Q Consensus 181 ~i~~~----------------------~p~~l~~l-~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 237 (977)
++++. +|..+.++ ++|++|++++|++++.+|..+..+++|+.|+|++|++.+ .+|
T Consensus 258 ~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~--~ip 335 (768)
T 3rgz_A 258 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG--ELP 335 (768)
T ss_dssp CCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEE--ECC
T ss_pred cccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccC--cCC
Confidence 66554 44444443 556666666666555555556666666666666666553 234
Q ss_pred CccccCCCCceEEEecCceeeecCCccccccc-ccceEeeccccccccccccccc--ccccccccccccccCCCCCCchh
Q 036011 238 PKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS-KLTGLDLSFNSFSGLIPHTFGN--LRFLSVLNLANNYLTTDSPTAEW 314 (977)
Q Consensus 238 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~~~~~~ 314 (977)
...+..+++|++|+|++|++++.+|..+..++ +|++|++++|++++.+|..+.. +++|++|++++|.+++..|.
T Consensus 336 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~--- 412 (768)
T 3rgz_A 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP--- 412 (768)
T ss_dssp HHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG---
T ss_pred HHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH---
Confidence 44455566666666666666666666666665 6666666666666655555555 56677777777766654443
Q ss_pred hhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhh
Q 036011 315 SFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVG 394 (977)
Q Consensus 315 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 394 (977)
.+..+++|++|++++|.+.+..|..++.+. +|+.|++.+|++++.+|..+..+++|++|++++|.+++.+|..++
T Consensus 413 ----~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 487 (768)
T 3rgz_A 413 ----TLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487 (768)
T ss_dssp ----GGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred ----HHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHh
Confidence 488999999999999999999999888775 799999999999999999999999999999999999999999999
Q ss_pred ccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccc---------
Q 036011 395 RLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSF--------- 465 (977)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~--------- 465 (977)
.+++|++|+|++|++++.+|.++..+++|++|++++|++++.+|..+..+++|++|++++|+++|.+|..+
T Consensus 488 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~ 567 (768)
T 3rgz_A 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 567 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCC
T ss_pred cCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999988777644
Q ss_pred -------------------------------------------------------------cCcccCceEEccCCCCCCC
Q 036011 466 -------------------------------------------------------------WSLEYLLAVNLSSNSLSGS 484 (977)
Q Consensus 466 -------------------------------------------------------------~~l~~L~~L~L~~N~l~~~ 484 (977)
..+++|+.|+|++|+++|.
T Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ 647 (768)
T 3rgz_A 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647 (768)
T ss_dssp STTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSC
T ss_pred hccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccccc
Confidence 3357899999999999999
Q ss_pred CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccc
Q 036011 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL 564 (977)
Q Consensus 485 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 564 (977)
+|..|+++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|||++|+++|.+|.. ..+
T Consensus 648 ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~ 726 (768)
T 3rgz_A 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQF 726 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSG
T ss_pred CCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999975 456
Q ss_pred cccCccccCCCc-cccc
Q 036011 565 LFLKQLNVSHNK-LEGE 580 (977)
Q Consensus 565 ~~L~~L~l~~N~-l~~~ 580 (977)
..+....+.+|+ +.|.
T Consensus 727 ~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 727 ETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGSCGGGGCSCTEEEST
T ss_pred ccCCHHHhcCCchhcCC
Confidence 667778888997 5553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=574.18 Aligned_cols=553 Identities=23% Similarity=0.226 Sum_probs=444.7
Q ss_pred CCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEe
Q 036011 49 HQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILS 128 (977)
Q Consensus 49 ~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 128 (977)
..++++|+|+++++++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+.+++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 35799999999999976667899999999999999999998899999999999999999999954445799999999999
Q ss_pred ccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCcccc--CCCCCceEEeeccCC
Q 036011 129 LRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG--NLQNLEILVLGMNNL 206 (977)
Q Consensus 129 L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~--~l~~L~~L~l~~N~l 206 (977)
|++|.+++..|..|.++++|++|++++|.+.+..|..++++++|++|++++|++++..+..++ .+++|+.|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999988888999999999999999999999999999999999999999999977666654 568999999999999
Q ss_pred CCCCchhhccccc---------------------------eeEEEccCCcccccccCCCccccCCC--CceEEEecCcee
Q 036011 207 SGPIQPSIFNIST---------------------------ITLINLFGNQLSGHLDLPPKVSYSLP--NLRVFSLGKNKL 257 (977)
Q Consensus 207 ~~~~~~~l~~l~~---------------------------L~~L~L~~N~l~~~~~~~~~~~~~l~--~L~~L~L~~N~l 257 (977)
++..+..+..+.+ |+.|++++|.+++ +++..+..++ +|++|+|++|++
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~---~~~~~~~~l~~~~L~~L~Ls~n~l 260 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST---TSNTTFLGLKWTNLTMLDLSYNNL 260 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCE---ECTTTTGGGGGSCCCEEECTTSCC
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccc---cChhHhhccCcCCCCEEECCCCCc
Confidence 9888887776654 4555666666653 3344444443 488888888888
Q ss_pred eecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhh--hhcccccCCCCceEEecCCC
Q 036011 258 TGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWS--FLSSLTNCRNLTTLAVASNP 335 (977)
Q Consensus 258 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--~~~~l~~l~~L~~L~L~~N~ 335 (977)
++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|......+..... -...+..+++|++|++++|.
T Consensus 261 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~ 340 (680)
T 1ziw_A 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND 340 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCC
T ss_pred CccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCc
Confidence 8777777888888888888888888877778888888888888876544211100000 00136788899999999999
Q ss_pred CCCCCCcccccccccccccccccCccccc--CCcccccc--ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccC
Q 036011 336 LRGILPPVIGNFSASLQNFYAYDCKLTGN--IPHEIGNL--RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG 411 (977)
Q Consensus 336 l~~~~p~~~~~~~~~L~~L~l~~n~l~~~--~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 411 (977)
+.+..+..+..+. +|++|++++|.+... .+..|..+ ++|+.|++++|++++..|.+|..+++|++|+|++|.+++
T Consensus 341 l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 419 (680)
T 1ziw_A 341 IPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419 (680)
T ss_dssp BCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEE
T ss_pred cCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcc
Confidence 9987777776654 688888888875432 22334333 578888999999988888889999999999999999887
Q ss_pred ccc-cccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCC--CCCCccccCcccCceEEccCCCCCCCCccc
Q 036011 412 SIP-YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS--SSIPSSFWSLEYLLAVNLSSNSLSGSLPSN 488 (977)
Q Consensus 412 ~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 488 (977)
.+| ..+.++++|+.|++++|++.+..+..|..+++|+.|++++|.+. +..|..|.++++|+.|++++|++++..+..
T Consensus 420 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~ 499 (680)
T 1ziw_A 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499 (680)
T ss_dssp ECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred ccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhh
Confidence 665 67888999999999999988888888888999999999999886 567888889999999999999999877788
Q ss_pred cccccccCeeeCcCCcCCCCcc--------hhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcc
Q 036011 489 IQNLQVLINLDLSRNQLSGDIP--------ITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS 560 (977)
Q Consensus 489 ~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 560 (977)
|.++++|++|+|++|++++..+ ..|..+++|+.|+|++|+++...+..|.++++|+.|||++|+|++..+..
T Consensus 500 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~ 579 (680)
T 1ziw_A 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579 (680)
T ss_dssp TTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred hccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhH
Confidence 8899999999999998875322 23788889999999999998655567889999999999999998666666
Q ss_pred cccccccCccccCCCcccccCCCCC--CCCcCCCCCcccCccccCCC
Q 036011 561 LEALLFLKQLNVSHNKLEGEIPANG--PFKYFAPQSFSWNYALCGPT 605 (977)
Q Consensus 561 ~~~l~~L~~L~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~lcg~~ 605 (977)
|..+++|+.|++++|++++.+|... .+.......+++|+..|...
T Consensus 580 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred hCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 7888999999999999988766421 24455556678898888644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=564.98 Aligned_cols=531 Identities=21% Similarity=0.222 Sum_probs=460.0
Q ss_pred EEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcC
Q 036011 54 ALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNS 133 (977)
Q Consensus 54 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 133 (977)
.+|+++++++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|.+++..|..++.+++|++|+|++|.
T Consensus 8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 4788888887 7888775 789999999999999777889999999999999999998889999999999999999999
Q ss_pred CCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchh
Q 036011 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPS 213 (977)
Q Consensus 134 l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 213 (977)
+++..+..|.++++|++|++++|.+.+..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++..+..
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred cCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence 99766668999999999999999999888899999999999999999999888999999999999999999999887776
Q ss_pred hc--cccceeEEEccCCcccccccCCCccccCC---------------------------CCceEEEecCceeeecCCcc
Q 036011 214 IF--NISTITLINLFGNQLSGHLDLPPKVSYSL---------------------------PNLRVFSLGKNKLTGTIPNS 264 (977)
Q Consensus 214 l~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~l---------------------------~~L~~L~L~~N~l~~~~p~~ 264 (977)
+. .+++|+.|++++|++++ +++..+..+ ++|+.|++++|++++..|..
T Consensus 165 ~~~~~~~~L~~L~L~~n~l~~---~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~ 241 (680)
T 1ziw_A 165 LDIFANSSLKKLELSSNQIKE---FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241 (680)
T ss_dssp HGGGTTCEESEEECTTCCCCC---BCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred hhccccccccEEECCCCcccc---cChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence 64 45899999999999984 444444332 56888999999999888999
Q ss_pred cccccc--cceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCC---
Q 036011 265 ITNASK--LTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI--- 339 (977)
Q Consensus 265 l~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~--- 339 (977)
+..+.. |++|+|++|++++..|..|..+++|++|++++|.+++..+.. +..+++|+.|++++|...+.
T Consensus 242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~L~~L~L~~~~~~~~~~~ 314 (680)
T 1ziw_A 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS-------LHGLFNVRYLNLKRSFTKQSISL 314 (680)
T ss_dssp TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTT-------TTTCTTCCEEECTTCBCCC----
T ss_pred hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhh-------hcCCCCccEEeccchhhhccccc
Confidence 988866 999999999999998899999999999999999999877654 88899999999998866542
Q ss_pred --CCc----ccccccccccccccccCcccccCCccccccccccEEEeecCccCC--CCChhhhcc--CCCCEEEeecccc
Q 036011 340 --LPP----VIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG--TIPSTVGRL--EQLQGLSLYGNNL 409 (977)
Q Consensus 340 --~p~----~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l--~~L~~L~L~~N~l 409 (977)
+|. .+. ...+|++|++.+|++++..+..|..+++|++|++++|.+.. ..+..|..+ ++|+.|++++|++
T Consensus 315 ~~lp~i~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l 393 (680)
T 1ziw_A 315 ASLPKIDDFSFQ-WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393 (680)
T ss_dssp --CCEECTTTTT-TCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCC
T ss_pred ccccccChhhcc-cCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCC
Confidence 222 222 23579999999999999999999999999999999998543 223344443 5899999999999
Q ss_pred cCccccccccccccceeeecCCccCCCch-hhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCC--CCCc
Q 036011 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS--GSLP 486 (977)
Q Consensus 410 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p 486 (977)
++..|..+..+++|+.|++++|++++.+| ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|
T Consensus 394 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p 473 (680)
T 1ziw_A 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSS
T ss_pred CeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCC
Confidence 99889999999999999999999987665 78999999999999999999999999999999999999999987 5789
Q ss_pred cccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccccccc--------ccccCccccCeeeccCCccCCCCC
Q 036011 487 SNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIP--------QTFGSLTGLESLDLSNNNLSGEIP 558 (977)
Q Consensus 487 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p 558 (977)
..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+ ..|.++++|+.|+|++|+++...+
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 553 (680)
T 1ziw_A 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553 (680)
T ss_dssp CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCH
Confidence 999999999999999999998778889999999999999999996532 237899999999999999995444
Q ss_pred cccccccccCccccCCCcccccCCCC-CCCCcCCCCCcccC
Q 036011 559 KSLEALLFLKQLNVSHNKLEGEIPAN-GPFKYFAPQSFSWN 598 (977)
Q Consensus 559 ~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n 598 (977)
..|..+++|+.|++++|++++..|.. ..+.......+++|
T Consensus 554 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred HHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 57899999999999999999655542 23344444445666
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-59 Score=561.89 Aligned_cols=512 Identities=21% Similarity=0.203 Sum_probs=380.3
Q ss_pred EEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCC
Q 036011 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSF 134 (977)
Q Consensus 55 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 134 (977)
++.++.+++ .+|..+.. .+++|||++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|+|++|++
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 334444444 44444432 455555555555555555555555555555555555544455555555555555555555
Q ss_pred CCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhh
Q 036011 135 TGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSI 214 (977)
Q Consensus 135 ~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l 214 (977)
++..|..|.++++|++|++++|.+++..|..++++++|++|++++|++++..+..+.++++|++|++++|++++..+..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 55555555555555555555555554445555555555555555555554222333335555555555555555555555
Q ss_pred cccccee--EEEccCCcccccccCCCccccCCCCceEEEecCce---------------------ee-----ecCCcccc
Q 036011 215 FNISTIT--LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK---------------------LT-----GTIPNSIT 266 (977)
Q Consensus 215 ~~l~~L~--~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~---------------------l~-----~~~p~~l~ 266 (977)
..+++|+ .|++++|.+++ +++..+ ...+|+.|++++|. +. ...+..+.
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~---~~~~~~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~ 249 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAG---IEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCE---ECTTTT-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred hhhcccceeEEecCCCccCc---cChhHh-hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence 5555555 55555555552 223332 22455555555443 11 11122233
Q ss_pred ccc--ccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccc
Q 036011 267 NAS--KLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344 (977)
Q Consensus 267 ~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 344 (977)
.+. +|++|++++|+++++.+..|..+++|++|++++|.++.++.. +..+++|++|++++|.+.+..|..+
T Consensus 250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~--------l~~l~~L~~L~l~~n~l~~~~~~~~ 321 (606)
T 3t6q_A 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSG--------LVGLSTLKKLVLSANKFENLCQISA 321 (606)
T ss_dssp GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSS--------CCSCTTCCEEECTTCCCSBGGGGCG
T ss_pred hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChh--------hcccccCCEEECccCCcCcCchhhh
Confidence 332 788999999999988888899999999999999999876543 7888999999999999998777777
Q ss_pred ccccccccccccccCcccccCCcc-ccccccccEEEeecCccCCCC--ChhhhccCCCCEEEeecccccCcccccccccc
Q 036011 345 GNFSASLQNFYAYDCKLTGNIPHE-IGNLRSLIVLSLFINALNGTI--PSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421 (977)
Q Consensus 345 ~~~~~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 421 (977)
..+. +|+.|++.+|.+.+.+|.. +..+++|++|++++|.+++.. +..++.+++|++|++++|.+++..|..+..++
T Consensus 322 ~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 400 (606)
T 3t6q_A 322 SNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400 (606)
T ss_dssp GGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT
T ss_pred hccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc
Confidence 6664 7999999999998777655 899999999999999999766 78899999999999999999988899999999
Q ss_pred ccceeeecCCccCCCchh-hhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCC---CCccccccccccCe
Q 036011 422 RLNGIRLNGNKLSGPIPQ-CLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG---SLPSNIQNLQVLIN 497 (977)
Q Consensus 422 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~ 497 (977)
+|+.|++++|++++..|. .+..+++|++|++++|.+.+..|..|..+++|+.|++++|++++ ..+..+..+++|++
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~ 480 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCE
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccE
Confidence 999999999999877664 48999999999999999999999999999999999999999986 23467999999999
Q ss_pred eeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcc
Q 036011 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577 (977)
Q Consensus 498 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 577 (977)
|+|++|++++..|..|+.+++|+.|+|++|++++.+|..+.++++| .|+|++|++++..|..+..+++|+.|++++|++
T Consensus 481 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 559 (606)
T 3t6q_A 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559 (606)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCE
T ss_pred EECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCc
Confidence 9999999998889999999999999999999999999999999999 999999999988898999999999999999999
Q ss_pred cccCCC
Q 036011 578 EGEIPA 583 (977)
Q Consensus 578 ~~~~p~ 583 (977)
++.++.
T Consensus 560 ~c~c~~ 565 (606)
T 3t6q_A 560 DCTCSN 565 (606)
T ss_dssp ECSGGG
T ss_pred cccCCc
Confidence 998763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=565.83 Aligned_cols=490 Identities=18% Similarity=0.258 Sum_probs=303.7
Q ss_pred ChHHHHHHHHHHHHhccCCCCCccC-------CCCCCCCCCcc---cceEecCCCCcEEEEEcCCCCCCccCCccccCcc
Q 036011 5 NLTTDQFALLAFKAHVTDPQSVLAN-------NWSISQPICKW---VGISCGARHQRVRALNLSNMGLRGTIPPHLGNFS 74 (977)
Q Consensus 5 ~~~~~~~~l~~~~~~~~~~~~~~~~-------~w~~~~~~c~w---~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~ 74 (977)
....|+.||.+|+.++.++.|.... +|+.++|||.| .||+|+.. ++|+.|+|+++++.|.+|+++++++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence 4457999999999999877665433 79999999999 99999865 8999999999999999999999999
Q ss_pred cccEeeccCCccc------c------cCCCCcCCCCCCCEEeCcCccCCCCCCccccc-cccCcEEecc-----------
Q 036011 75 FLMSLDISKNNFH------A------YLPNELGQLRRLRFISLDYNEFSGSFPSWIGV-LSKLQILSLR----------- 130 (977)
Q Consensus 75 ~L~~L~L~~n~l~------~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~----------- 130 (977)
+|++|||++|.+. + .+|... +..|+ +++++|.+.+.+|..++. +..+..+++.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 9999999999873 2 233333 56677 888899888888887763 2333333333
Q ss_pred ---------CcCCCCCCCCcccCcCcccceeccccccccc-----------------cCcccc--Cccccceeeeecccc
Q 036011 131 ---------NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGN-----------------IPSRIG--NLSSLVNVNLAYNNL 182 (977)
Q Consensus 131 ---------~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~-----------------~p~~~~--~l~~L~~L~L~~n~i 182 (977)
+|++++ +|..++++++|++|+|++|.+++. +|+.++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 466666 666666677777777777766664 666666 677777777777776
Q ss_pred cccCCccccCCCCCceEEeeccC-CCC-CCchhhccc------cceeEEEccCCcccccccCCC-ccccCCCCceEEEec
Q 036011 183 QGEIPSEIGNLQNLEILVLGMNN-LSG-PIQPSIFNI------STITLINLFGNQLSGHLDLPP-KVSYSLPNLRVFSLG 253 (977)
Q Consensus 183 ~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~l~~~~~~~~-~~~~~l~~L~~L~L~ 253 (977)
.+.+|..|+++++|++|++++|+ +++ .+|..+..+ ++|+.|+|++|+++ .+|. ..+..+++|++|+++
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~---~ip~~~~l~~l~~L~~L~L~ 338 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK---TFPVETSLQKMKKLGMLECL 338 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS---SCCCHHHHTTCTTCCEEECC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC---ccCchhhhccCCCCCEEeCc
Confidence 66667667777777777777776 666 566666655 66666666666665 3443 244556666666666
Q ss_pred CceeeecCCcccccccccceEeecccccccccccccccccc-cccccccccccCCCCCCchhhhhccccc--CCCCceEE
Q 036011 254 KNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF-LSVLNLANNYLTTDSPTAEWSFLSSLTN--CRNLTTLA 330 (977)
Q Consensus 254 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~~l~~--l~~L~~L~ 330 (977)
+|+++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|.++.++.. +.. +++|++|+
T Consensus 339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~--------~~~~~l~~L~~L~ 408 (636)
T 4eco_A 339 YNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNI--------FDAKSVSVMSAID 408 (636)
T ss_dssp SCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSC--------CCTTCSSCEEEEE
T ss_pred CCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchh--------hhhcccCccCEEE
Confidence 666666666 6666666666666666666 44555666666 66666666666543321 222 22455555
Q ss_pred ecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeeccccc
Q 036011 331 VASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLE 410 (977)
Q Consensus 331 L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 410 (977)
+++|.+.+..|..+.... .....+++|++|+|++|.+++..+..+..+++|++|+|++|+++
T Consensus 409 Ls~N~l~~~~p~~l~~~~------------------~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 409 FSYNEIGSVDGKNFDPLD------------------PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp CCSSCTTTTTTCSSCTTC------------------SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred CcCCcCCCcchhhhcccc------------------cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 555555444333221100 00015567777777777777444444555777777777777776
Q ss_pred Ccccccccc-c-------cccceeeecCCccCCCchhhhc--CCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCC
Q 036011 411 GSIPYDLCH-L-------ERLNGIRLNGNKLSGPIPQCLA--SLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNS 480 (977)
Q Consensus 411 ~~~p~~~~~-l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 480 (977)
.+|..+.. . ++|+.|+|++|+++ .+|..+. .+++|++|+|++|+|++ +|..+..+++|+.|+|++|+
T Consensus 471 -~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~ 547 (636)
T 4eco_A 471 -EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547 (636)
T ss_dssp -BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB
T ss_pred -CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc
Confidence 44433222 1 14455555555544 3444443 44444444444444443 44444444444444444433
Q ss_pred CCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccC
Q 036011 481 LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 481 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 554 (977)
++++|++.+.+|..++.+++|+.|+|++|++ +.+|..+. ++|+.|||++|++.
T Consensus 548 ------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 548 ------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp ------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred ------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 2344555555555555555555555555555 24454443 45555555555544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=548.61 Aligned_cols=511 Identities=21% Similarity=0.193 Sum_probs=357.7
Q ss_pred cEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEecc
Q 036011 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLR 130 (977)
Q Consensus 51 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 130 (977)
++++|+|+++++++..+..++++++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+.+++|++|+|+
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECT
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEcc
Confidence 34445555555544333444455555555555555544444444455555555555555444444445555555555555
Q ss_pred CcCCCCCCCCcccCcCcccceecccccccc-ccCccccCccccceeeeecccccccCCccccCCCCCc----eEEeeccC
Q 036011 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLE----ILVLGMNN 205 (977)
Q Consensus 131 ~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~----~L~l~~N~ 205 (977)
+|.+++..|..++++++|++|++++|.+.+ .+|..|+++++|++|++++|++++..|..|+.+++|+ .|++++|+
T Consensus 113 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~ 192 (606)
T 3vq2_A 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192 (606)
T ss_dssp TSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCC
T ss_pred CCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCC
Confidence 555444444444455555555555554443 3344455555555555555555444444444444333 44555554
Q ss_pred CCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeee---------cCCcccccccccceEee
Q 036011 206 LSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG---------TIPNSITNASKLTGLDL 276 (977)
Q Consensus 206 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~---------~~p~~l~~l~~L~~L~L 276 (977)
+++..+..+ ...+|+.|++++|.+.+. ..+..+..+++|+.+++..+.+.+ ..+..+..+ +++.+++
T Consensus 193 l~~~~~~~~-~~~~L~~L~L~~n~~~~~--~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~~l~l 268 (606)
T 3vq2_A 193 IDFIQDQAF-QGIKLHELTLRGNFNSSN--IMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TIDEFRL 268 (606)
T ss_dssp CCEECTTTT-TTCEEEEEEEESCCSCHH--HHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS-EEEEEEE
T ss_pred cceeCcccc-cCceeeeeeccCCccchh--HHHHHhccccccccccccccccccCCcccccChHHhhhhhhc-cHhheec
Confidence 443222222 222445555554444321 112223344444444443332221 001111111 3444555
Q ss_pred -cccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccc
Q 036011 277 -SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFY 355 (977)
Q Consensus 277 -s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~ 355 (977)
..|.+++.+|. +..+++|+.|++++|.+..++ .+..+++|++|++++|.+ +.+|.. ..++|+.|+
T Consensus 269 ~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~---------~l~~~~~L~~L~l~~n~l-~~lp~~---~l~~L~~L~ 334 (606)
T 3vq2_A 269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE---------DVPKHFKWQSLSIIRCQL-KQFPTL---DLPFLKSLT 334 (606)
T ss_dssp CCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC---------CCCTTCCCSEEEEESCCC-SSCCCC---CCSSCCEEE
T ss_pred cccccccccccc-cccCCCCCEEEecCccchhhh---------hccccccCCEEEcccccC-cccccC---CCCccceee
Confidence 77778877777 899999999999999998765 278889999999999999 667743 446899999
Q ss_pred cccCcccccCCccccccccccEEEeecCccCCC--CChhhhccCCCCEEEeecccccCccccccccccccceeeecCCcc
Q 036011 356 AYDCKLTGNIPHEIGNLRSLIVLSLFINALNGT--IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433 (977)
Q Consensus 356 l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 433 (977)
+.+|+..+.+ .+..+++|++|++++|.+++. .|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++
T Consensus 335 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l 411 (606)
T 3vq2_A 335 LTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTL 411 (606)
T ss_dssp EESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEE
T ss_pred ccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCcc
Confidence 9999766544 677999999999999999866 4899999999999999999998 4678899999999999999999
Q ss_pred CCCch-hhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCC-CCccccccccccCeeeCcCCcCCCCcch
Q 036011 434 SGPIP-QCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG-SLPSNIQNLQVLINLDLSRNQLSGDIPI 511 (977)
Q Consensus 434 ~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 511 (977)
.+..| ..+..+++|++|++++|++.+..|..|..+++|+.|++++|++++ .+|..|..+++|++|+|++|++++..|.
T Consensus 412 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 491 (606)
T 3vq2_A 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491 (606)
T ss_dssp ESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred CCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh
Confidence 98877 689999999999999999999999999999999999999999997 4788999999999999999999988889
Q ss_pred hhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCccccccc-ccCccccCCCcccccCCC
Q 036011 512 TIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL-FLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 512 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~ 583 (977)
.|+.+++|+.|+|++|++++.+|..|+++++|+.|||++|+|+ .+|..+..++ +|++|++++|++.+..+-
T Consensus 492 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred hhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999999999999999999989999999999999999999999 7888899987 599999999999998774
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=554.97 Aligned_cols=498 Identities=20% Similarity=0.246 Sum_probs=367.3
Q ss_pred cChHHHHHHHHHHHHhccCCCCCccCCCCCCC-----CC--Ccc------------cceEecCCCCcEEEEEcCCCCCCc
Q 036011 4 QNLTTDQFALLAFKAHVTDPQSVLANNWSISQ-----PI--CKW------------VGISCGARHQRVRALNLSNMGLRG 64 (977)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~L~l~~~~l~~ 64 (977)
.+..+|++||++||+++.+| +|+.+. +| |.| .||+|+. .++|+.|+|+++++.|
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEE
T ss_pred ccchHHHHHHHHHHHHcCCC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCC
Confidence 45568999999999999877 454332 55 999 9999987 6899999999999999
Q ss_pred cCCccccCcccccEeec-cCCcccccCCCCcC------------------------------------------------
Q 036011 65 TIPPHLGNFSFLMSLDI-SKNNFHAYLPNELG------------------------------------------------ 95 (977)
Q Consensus 65 ~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~------------------------------------------------ 95 (977)
.+|+++++|++|++||| ++|.+.|..|-...
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 88988875332211
Q ss_pred ---CCCCCCEEeCcC--ccCCCCCCccccccccCcEEeccCcCCCC-CCCCcccCcCcccceeccccccccccCcccc--
Q 036011 96 ---QLRRLRFISLDY--NEFSGSFPSWIGVLSKLQILSLRNNSFTG-PIPNSLFNLSRLEKWDSMFNIIDGNIPSRIG-- 167 (977)
Q Consensus 96 ---~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~-- 167 (977)
....++.+.+.. |++++ +|..|+++++|++|+|++|.+++ .+|..+. .++.|...+.+|+.++
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~--------~~s~n~~~g~iP~~l~f~ 488 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE--------DANSDYAKQYENEELSWS 488 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS--------CTTSHHHHHHTTSCCCGG
T ss_pred ccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccc--------ccccccccccCChhhhhc
Confidence 111222223322 55554 55555555555555555555554 1111111 1111333346888877
Q ss_pred CccccceeeeecccccccCCccccCCCCCceEEeeccC-CCC-CCchhhcccc-------ceeEEEccCCcccccccCCC
Q 036011 168 NLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNN-LSG-PIQPSIFNIS-------TITLINLFGNQLSGHLDLPP 238 (977)
Q Consensus 168 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~l~~~~~~~~ 238 (977)
++++|++|+|++|++.+.+|..|+++++|+.|+|++|+ +++ .+|..+..+. +|+.|+|++|+++ .+|.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~---~ip~ 565 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE---EFPA 565 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC---BCCC
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC---ccCC
Confidence 88888888888888888888888888888888888887 887 7787777766 8888888888887 4555
Q ss_pred -ccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccc-cccccccccccCCCCCCchhhh
Q 036011 239 -KVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRF-LSVLNLANNYLTTDSPTAEWSF 316 (977)
Q Consensus 239 -~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~ 316 (977)
..+..+++|++|+|++|+++ .+| .+..+++|++|+|++|+++ .+|..+..+++ |+.|+|++|.++.++..
T Consensus 566 ~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~----- 637 (876)
T 4ecn_A 566 SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNI----- 637 (876)
T ss_dssp HHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSC-----
T ss_pred hhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchh-----
Confidence 35668889999999999998 778 8888999999999999998 67788889988 99999999998865432
Q ss_pred hcccccC--CCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCcccc--ccccccEEEeecCccCCCCChh
Q 036011 317 LSSLTNC--RNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIG--NLRSLIVLSLFINALNGTIPST 392 (977)
Q Consensus 317 ~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~ 392 (977)
+..+ ++|+.|++++|.+.+.+|... ..+. .+++|+.|+|++|.++ .+|..
T Consensus 638 ---~~~~~~~~L~~L~Ls~N~l~g~ip~l~----------------------~~l~~~~~~~L~~L~Ls~N~L~-~lp~~ 691 (876)
T 4ecn_A 638 ---FNAKSVYVMGSVDFSYNKIGSEGRNIS----------------------CSMDDYKGINASTVTLSYNEIQ-KFPTE 691 (876)
T ss_dssp ---CCTTCSSCEEEEECCSSCTTTTSSSCS----------------------SCTTTCCCCCEEEEECCSSCCC-SCCHH
T ss_pred ---hhccccCCCCEEECcCCcCCCccccch----------------------hhhccccCCCcCEEEccCCcCC-ccCHH
Confidence 4444 348888888888887655321 1122 3457888999999988 45544
Q ss_pred -hhccCCCCEEEeecccccCcccccccc--------ccccceeeecCCccCCCchhhhc--CCCCCCeeecCCCcCCCCC
Q 036011 393 -VGRLEQLQGLSLYGNNLEGSIPYDLCH--------LERLNGIRLNGNKLSGPIPQCLA--SLISLRELNLGSNKFSSSI 461 (977)
Q Consensus 393 -~~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~ 461 (977)
+..+++|+.|+|++|+|+ .+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +
T Consensus 692 ~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-l 768 (876)
T 4ecn_A 692 LFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-F 768 (876)
T ss_dssp HHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-C
T ss_pred HHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-c
Confidence 457889999999999888 55554433 237777777777777 5666665 77777777777777775 5
Q ss_pred CccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCcc
Q 036011 462 PSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLT 541 (977)
Q Consensus 462 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 541 (977)
|..+..+++|+.|+|++|+ ++++|++.+.+|..++.+++|+.|+|++|+| +.+|..+. +
T Consensus 769 p~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~ 827 (876)
T 4ecn_A 769 PTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--P 827 (876)
T ss_dssp CCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--S
T ss_pred chhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--C
Confidence 6667777777777777665 5566888888888888888888888888888 57777765 5
Q ss_pred ccCeeeccCCccCCCCCcccccccccCccccCCCccc
Q 036011 542 GLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 542 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
+|+.|||++|++....+..+.....+..+.|++|++.
T Consensus 828 ~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp SSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 8888888888887666667766667777777777664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-57 Score=543.83 Aligned_cols=516 Identities=21% Similarity=0.157 Sum_probs=454.8
Q ss_pred CCCCCCc--ccceEecCC---------CCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCC
Q 036011 33 ISQPICK--WVGISCGAR---------HQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLR 101 (977)
Q Consensus 33 ~~~~~c~--w~gv~c~~~---------~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 101 (977)
...+.|. +..+.|... ...++.|+|++|.+++..|..++++++|++|+|++|++++..|.+|.++++|+
T Consensus 5 ~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 84 (606)
T 3t6q_A 5 DQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84 (606)
T ss_dssp -CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCC
T ss_pred cCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccC
Confidence 3344443 455778532 34689999999999987788999999999999999999998999999999999
Q ss_pred EEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccc
Q 036011 102 FISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNN 181 (977)
Q Consensus 102 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 181 (977)
+|+|++|++++..|..|+.+++|++|+|++|.+++..|..+.++++|++|++++|.+.+..+..+..+++|++|++++|+
T Consensus 85 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp EEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred eeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 99999999998889999999999999999999998778899999999999999999997544445559999999999999
Q ss_pred ccccCCccccCCCCCc--eEEeeccCCCCCCchhhccccceeEEEccCCccc-----------------------ccccC
Q 036011 182 LQGEIPSEIGNLQNLE--ILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS-----------------------GHLDL 236 (977)
Q Consensus 182 i~~~~p~~l~~l~~L~--~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-----------------------~~~~~ 236 (977)
+++..|..|+.+++|+ .|++++|++++..+..+ ...+|+.|++++|... ....+
T Consensus 165 l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i 243 (606)
T 3t6q_A 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243 (606)
T ss_dssp CCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTT-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred ccccChhhhhhhcccceeEEecCCCccCccChhHh-hhccccccccCCchhHHHHhhhccccchhheechhhcccccccc
Confidence 9988888999999999 89999999997766554 4578999999987510 01123
Q ss_pred CCccccCCC--CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchh
Q 036011 237 PPKVSYSLP--NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEW 314 (977)
Q Consensus 237 ~~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 314 (977)
++..+..+. +|+.|++++|++++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|.++...+.
T Consensus 244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~--- 319 (606)
T 3t6q_A 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI--- 319 (606)
T ss_dssp CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGG---
T ss_pred ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchh---
Confidence 333343333 7999999999999888888999999999999999999 5678899999999999999999986554
Q ss_pred hhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccC--CccccccccccEEEeecCccCCCCChh
Q 036011 315 SFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI--PHEIGNLRSLIVLSLFINALNGTIPST 392 (977)
Q Consensus 315 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~ 392 (977)
.+..+++|++|++++|.+.+.+|........+|++|++.+|++++.. +..+..+++|++|++++|.+.+..|..
T Consensus 320 ----~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 395 (606)
T 3t6q_A 320 ----SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395 (606)
T ss_dssp ----CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT
T ss_pred ----hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH
Confidence 37889999999999999998777654344468999999999999876 888999999999999999999899999
Q ss_pred hhccCCCCEEEeecccccCccccc-cccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCC---CCccccCc
Q 036011 393 VGRLEQLQGLSLYGNNLEGSIPYD-LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS---IPSSFWSL 468 (977)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l 468 (977)
|..+++|++|++++|++++..+.. +..+++|+.|++++|++++..|..+..+++|++|++++|++.+. .+..+..+
T Consensus 396 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred hcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 999999999999999999876654 89999999999999999999999999999999999999999862 34679999
Q ss_pred ccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeec
Q 036011 469 EYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDL 548 (977)
Q Consensus 469 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 548 (977)
++|+.|++++|++++..|..|..+++|++|+|++|++++..|..+..+++| .|+|++|++++.+|..+..+++|+.|+|
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 999999999999999889999999999999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCccCCCCC
Q 036011 549 SNNNLSGEIP 558 (977)
Q Consensus 549 s~N~l~~~~p 558 (977)
++|++++..+
T Consensus 555 ~~N~~~c~c~ 564 (606)
T 3t6q_A 555 RQNPLDCTCS 564 (606)
T ss_dssp TTCCEECSGG
T ss_pred CCCCccccCC
Confidence 9999997654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=554.48 Aligned_cols=520 Identities=23% Similarity=0.200 Sum_probs=420.4
Q ss_pred CcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccC-CCCcCCCCCCCEEeCcCccCCCCCCc
Q 036011 38 CKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYL-PNELGQLRRLRFISLDYNEFSGSFPS 116 (977)
Q Consensus 38 c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~ 116 (977)
|.|.+|.+ ...+++.|||++|.+++..|.+++++++|++|||++|.+.+.+ |.+|.++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 45666666 4567888888888888777888888888888888888655444 77888888888888888888877788
Q ss_pred cccccccCcEEeccCcCCCCCCCCc--ccCcCcccceeccccccccccC-ccccCccccceeeeecccccccCCccccCC
Q 036011 117 WIGVLSKLQILSLRNNSFTGPIPNS--LFNLSRLEKWDSMFNIIDGNIP-SRIGNLSSLVNVNLAYNNLQGEIPSEIGNL 193 (977)
Q Consensus 117 ~~~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l 193 (977)
+|+.+++|++|+|++|.+++.+|.. +.++++|++|++++|.+.+..+ ..|+++++|++|+|++|.+++..+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 8888888888888888888766665 8888888888888888887654 578888888888888888888888888877
Q ss_pred --CCCceEEeeccCCCCCCchhhccccc------eeEEEccCCcccccccCCCcccc--CCCCceEEEecCcee------
Q 036011 194 --QNLEILVLGMNNLSGPIQPSIFNIST------ITLINLFGNQLSGHLDLPPKVSY--SLPNLRVFSLGKNKL------ 257 (977)
Q Consensus 194 --~~L~~L~l~~N~l~~~~~~~l~~l~~------L~~L~L~~N~l~~~~~~~~~~~~--~l~~L~~L~L~~N~l------ 257 (977)
++|+.|+++.|.+.+..+..+..+.+ |+.|++++|.+++. .+..... ...+++.|.++.+.+
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~--~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~ 249 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD--ITGNFSNAISKSQAFSLILAHHIMGAGFGF 249 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTT--TTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchh--HHHHHHhhcCcccccceecccccccccccc
Confidence 88888888888888877776666554 88888888877642 2222221 235677777763332
Q ss_pred ---eecCCcccccc--cccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEec
Q 036011 258 ---TGTIPNSITNA--SKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVA 332 (977)
Q Consensus 258 ---~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~ 332 (977)
....+..|..+ ++|++|+|++|.+.+..|..|..+++|+.|+|++|.++.+.+.. +..+++|++|+++
T Consensus 250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-------~~~l~~L~~L~Ls 322 (844)
T 3j0a_A 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA-------FYGLDNLQVLNLS 322 (844)
T ss_dssp SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTT-------TTTCSSCCEEEEE
T ss_pred cccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHH-------hcCCCCCCEEECC
Confidence 22223334433 67999999999998888888999999999999999998876654 7888999999999
Q ss_pred CCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCc
Q 036011 333 SNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGS 412 (977)
Q Consensus 333 ~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 412 (977)
+|.+.+..|..+..+. +|+.|++.+|++.+..+..|..+++|++|+|++|.+++. + .+++|+.|++++|+++ .
T Consensus 323 ~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~ 395 (844)
T 3j0a_A 323 YNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-T 395 (844)
T ss_dssp SCCCSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-C
T ss_pred CCCCCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-c
Confidence 9999888787777664 689999999999888888899999999999999999843 2 3889999999999998 4
Q ss_pred cccccccccccceeeecCCccCCCc-hhhhcCCCCCCeeecCCCcCCCCCCc-cccCcccCceEEccCCCCC-----CCC
Q 036011 413 IPYDLCHLERLNGIRLNGNKLSGPI-PQCLASLISLRELNLGSNKFSSSIPS-SFWSLEYLLAVNLSSNSLS-----GSL 485 (977)
Q Consensus 413 ~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~ 485 (977)
+|.. ..+++.|++++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..
T Consensus 396 l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~ 472 (844)
T 3j0a_A 396 LPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC 472 (844)
T ss_dssp CCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCC
T ss_pred cccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccc
Confidence 5543 567899999999998642 34467899999999999999965544 4667899999999999997 445
Q ss_pred ccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCccccccc
Q 036011 486 PSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL 565 (977)
Q Consensus 486 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 565 (977)
+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++..|..|.
T Consensus 473 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~--- 547 (844)
T 3j0a_A 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV--- 547 (844)
T ss_dssp SSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---
T ss_pred hhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---
Confidence 57789999999999999999988888899999999999999999987777766 8999999999999998887754
Q ss_pred ccCccccCCCcccccCCC
Q 036011 566 FLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 566 ~L~~L~l~~N~l~~~~p~ 583 (977)
+|+.|++++|++.+.++-
T Consensus 548 ~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 548 SLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCCEEEEEEECCCCSSSC
T ss_pred CcCEEEecCCCccccccc
Confidence 788999999999998763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=528.76 Aligned_cols=491 Identities=19% Similarity=0.158 Sum_probs=431.2
Q ss_pred CCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEe
Q 036011 49 HQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILS 128 (977)
Q Consensus 49 ~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 128 (977)
-.++++|+|++|.+++..|..++++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++.+++|++|+
T Consensus 55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 35799999999999977788899999999999999999998899999999999999999999977778999999999999
Q ss_pred ccCcCCCC-CCCCcccCcCcccceeccccccccccCccccCccccc----eeeeecccccccCCccccCCCCCceEEeec
Q 036011 129 LRNNSFTG-PIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLV----NVNLAYNNLQGEIPSEIGNLQNLEILVLGM 203 (977)
Q Consensus 129 L~~n~l~~-~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~----~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~ 203 (977)
|++|.+++ .+|..+.++++|++|++++|.+++..|..|+.+++|+ +|++++|.+++..+..+... +|+.|++++
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~ 213 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRG 213 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEES
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccC
Confidence 99999987 6799999999999999999999999899999888876 79999999996555555554 999999999
Q ss_pred cCCC-CCCchhhccccceeEEEccCCccccccc---CCCccccCCC--CceEEEe-cCceeeecCCcccccccccceEee
Q 036011 204 NNLS-GPIQPSIFNISTITLINLFGNQLSGHLD---LPPKVSYSLP--NLRVFSL-GKNKLTGTIPNSITNASKLTGLDL 276 (977)
Q Consensus 204 N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~l~--~L~~L~L-~~N~l~~~~p~~l~~l~~L~~L~L 276 (977)
|.+. +..+..+.+++.|+.+++..+.+.+... ++...+..+. +++.+++ ..|.+.+.+|. +..+++|++|++
T Consensus 214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l 292 (606)
T 3vq2_A 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSL 292 (606)
T ss_dssp CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEE
T ss_pred CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEe
Confidence 9997 4567778899999999987666543222 1222222222 4667777 78888888777 999999999999
Q ss_pred cccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccccccccccccccc
Q 036011 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYA 356 (977)
Q Consensus 277 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l 356 (977)
++|.+..+ | .+..+++|+.|++++|.+..++ . + .+++|++|++++|...+.. .+. ..++|+.|++
T Consensus 293 ~~~~~~~l-~-~l~~~~~L~~L~l~~n~l~~lp-~--------~-~l~~L~~L~l~~n~~~~~~--~~~-~l~~L~~L~l 357 (606)
T 3vq2_A 293 AGVSIKYL-E-DVPKHFKWQSLSIIRCQLKQFP-T--------L-DLPFLKSLTLTMNKGSISF--KKV-ALPSLSYLDL 357 (606)
T ss_dssp ESCCCCCC-C-CCCTTCCCSEEEEESCCCSSCC-C--------C-CCSSCCEEEEESCSSCEEC--CCC-CCTTCCEEEC
T ss_pred cCccchhh-h-hccccccCCEEEcccccCcccc-c--------C-CCCccceeeccCCcCccch--hhc-cCCCCCEEEC
Confidence 99999865 4 8999999999999999996654 1 5 8899999999999655433 233 3357999999
Q ss_pred ccCccccc--CCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccc-cccccccccceeeecCCcc
Q 036011 357 YDCKLTGN--IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP-YDLCHLERLNGIRLNGNKL 433 (977)
Q Consensus 357 ~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l 433 (977)
++|++++. +|..+..+++|++|++++|.++ .+|..+..+++|++|++++|++.+..| ..+..+++|+.|++++|++
T Consensus 358 s~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l 436 (606)
T 3vq2_A 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436 (606)
T ss_dssp CSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCC
T ss_pred cCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCC
Confidence 99999976 4889999999999999999998 477899999999999999999998877 6899999999999999999
Q ss_pred CCCchhhhcCCCCCCeeecCCCcCCC-CCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchh
Q 036011 434 SGPIPQCLASLISLRELNLGSNKFSS-SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPIT 512 (977)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 512 (977)
++..|..+..+++|++|++++|++.+ .+|..|..+++|+.|++++|++++..|..|.++++|++|+|++|++++.+|..
T Consensus 437 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 516 (606)
T 3vq2_A 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516 (606)
T ss_dssp EECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGG
T ss_pred CccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHH
Confidence 99999999999999999999999997 47999999999999999999999988999999999999999999999888999
Q ss_pred hhcccccceeccCCccccccccccccCcc-ccCeeeccCCccCCCCC
Q 036011 513 IGSLKDLVTLSLASNQFEGPIPQTFGSLT-GLESLDLSNNNLSGEIP 558 (977)
Q Consensus 513 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p 558 (977)
|+.+++|+.|+|++|+|+ .+|..+..++ +|+.|+|++|++.+..+
T Consensus 517 ~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 517 YNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred ccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999999999999999 6788899997 69999999999997554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=538.65 Aligned_cols=524 Identities=21% Similarity=0.216 Sum_probs=452.9
Q ss_pred EEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCC-CccccccccCcEEeccC
Q 036011 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF-PSWIGVLSKLQILSLRN 131 (977)
Q Consensus 53 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~ 131 (977)
...|.++++++ .+|. ..++|++|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 45677888998 7887 5689999999999999989999999999999999999777676 78999999999999999
Q ss_pred cCCCCCCCCcccCcCcccceeccccccccccCcc--ccCccccceeeeecccccccCC-ccccCCCCCceEEeeccCCCC
Q 036011 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSR--IGNLSSLVNVNLAYNNLQGEIP-SEIGNLQNLEILVLGMNNLSG 208 (977)
Q Consensus 132 n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~--~~~l~~L~~L~L~~n~i~~~~p-~~l~~l~~L~~L~l~~N~l~~ 208 (977)
|.+++..|..|.++++|++|+|++|.+.+.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 9999999999999999999999999999877766 9999999999999999997655 579999999999999999999
Q ss_pred CCchhhccc--cceeEEEccCCcccccccCCCccccCCC------CceEEEecCceeeecCCcccccc---cccceEeec
Q 036011 209 PIQPSIFNI--STITLINLFGNQLSGHLDLPPKVSYSLP------NLRVFSLGKNKLTGTIPNSITNA---SKLTGLDLS 277 (977)
Q Consensus 209 ~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~------~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~Ls 277 (977)
..+..+..+ ++|+.|+|++|.+.+.. + ..+..++ +|++|++++|++++..+..+... .+++.|+++
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~--~-~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~ 239 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRV--S-VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCC--C-CCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECC
T ss_pred eCHHHcccccCCccceEECCCCcccccc--c-cchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecc
Confidence 999999888 89999999999998532 2 2222233 49999999999998888777543 568888877
Q ss_pred ---------ccccccccccccccc--cccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccccc
Q 036011 278 ---------FNSFSGLIPHTFGNL--RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGN 346 (977)
Q Consensus 278 ---------~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 346 (977)
.|++....+..|.++ ++|+.|++++|.++.+.+.. +..+++|+.|++++|.+.+..|..+..
T Consensus 240 ~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~-------~~~l~~L~~L~L~~n~i~~~~~~~~~~ 312 (844)
T 3j0a_A 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV-------FETLKDLKVLNLAYNKINKIADEAFYG 312 (844)
T ss_dssp SSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCC-------SSSCCCCCEEEEESCCCCEECTTTTTT
T ss_pred cccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhh-------hhcCCCCCEEECCCCcCCCCChHHhcC
Confidence 344554555666665 78999999999999876654 889999999999999999988888776
Q ss_pred ccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCcccccccccccccee
Q 036011 347 FSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGI 426 (977)
Q Consensus 347 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 426 (977)
+. +|+.|++++|++++..|..|..+++|++|++++|.+.+..+..|..+++|++|+|++|.+++ + ..+++|+.|
T Consensus 313 l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i----~~~~~L~~L 386 (844)
T 3j0a_A 313 LD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-I----HFIPSIPDI 386 (844)
T ss_dssp CS-SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-C----SSCCSCSEE
T ss_pred CC-CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-c----cCCCCcchh
Confidence 64 79999999999999999999999999999999999998888899999999999999999984 2 338899999
Q ss_pred eecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCC-ccccCcccCceEEccCCCCCCCCcc-ccccccccCeeeCcCCc
Q 036011 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPS-NIQNLQVLINLDLSRNQ 504 (977)
Q Consensus 427 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~ 504 (977)
++++|+++ .+|.. ..+++.|++++|++++... ..+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.
T Consensus 387 ~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~ 462 (844)
T 3j0a_A 387 FLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462 (844)
T ss_dssp EEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCC
T ss_pred ccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCc
Confidence 99999998 45543 4679999999999996533 2356899999999999999965443 46678999999999999
Q ss_pred CC-----CCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccc
Q 036011 505 LS-----GDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 505 l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 579 (977)
++ +..+..|..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|+|++|++++
T Consensus 463 l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~ 540 (844)
T 3j0a_A 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLA 540 (844)
T ss_dssp CSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCC
T ss_pred cccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCC
Confidence 97 44556789999999999999999999999999999999999999999977777666 899999999999999
Q ss_pred cCCCCCCCCcCCCCCcccCccccCC
Q 036011 580 EIPANGPFKYFAPQSFSWNYALCGP 604 (977)
Q Consensus 580 ~~p~~~~~~~~~~~~~~~n~~lcg~ 604 (977)
.+|.. +..+....+++|+..|..
T Consensus 541 ~~~~~--~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 541 PNPDV--FVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CCSCC--CSSCCEEEEEEECCCCSS
T ss_pred CChhH--hCCcCEEEecCCCccccc
Confidence 99863 556666778899988843
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=504.12 Aligned_cols=498 Identities=19% Similarity=0.179 Sum_probs=402.7
Q ss_pred CCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCc
Q 036011 37 ICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPS 116 (977)
Q Consensus 37 ~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 116 (977)
.|.|.|+ |+ +++++++ .+|+.+. +.|++|+|++|++++..|.+|.++++|++|+|++|++++..|.
T Consensus 3 ~C~~~~~-c~----------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CD----------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EE----------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EE----------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 5999998 85 4556676 6787664 7889999999999887788899999999999999999877778
Q ss_pred cccccccCcEEeccCcCCCCCCCCcccCcCcccceecccccccc-ccCccccCccccceeeeecccccccCC-ccccCCC
Q 036011 117 WIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIP-SEIGNLQ 194 (977)
Q Consensus 117 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p-~~l~~l~ 194 (977)
.|+.+++|++|+|++|++++..|..|+++++|++|++++|.+++ ..|..++++++|++|++++|++.+.+| ..|++++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 88999999999999999987777778899999999999998886 467788889999999999988444554 5788899
Q ss_pred CCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecC--C-ccccccccc
Q 036011 195 NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTI--P-NSITNASKL 271 (977)
Q Consensus 195 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p-~~l~~l~~L 271 (977)
+|++|++++|++++..+..+..+++|+.|++++|.+. .++...+..+++|++|++++|++++.. | .....+++|
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L 225 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA---FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST---THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCC
T ss_pred ccCeeeccCCcccccChhhhhccccCceEecccCccc---ccchhhHhhcccccEEEccCCccccccccccchhhhhhcc
Confidence 9999999999998888888888899999999988876 344444556888999999999888532 2 223456788
Q ss_pred ceEeecccccccccc----cccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccc
Q 036011 272 TGLDLSFNSFSGLIP----HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNF 347 (977)
Q Consensus 272 ~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~ 347 (977)
++|++++|.+++..+ ..+..+++|+.+++++|.+.+...... .....+..+++|+.|++.++.+.....
T Consensus 226 ~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~-~~~~~~~~l~~L~~L~l~~~~i~~~~~------ 298 (549)
T 2z81_A 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP-SESDVVSELGKVETVTIRRLHIPQFYL------ 298 (549)
T ss_dssp CEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCC-CTTTCCCCCTTCCEEEEESCBCSCGGG------
T ss_pred cceeccccccchhHHHHHHHHhhhhccccccccccccccccccccc-cchhhhhhhcccccccccccccchhhh------
Confidence 999999998876544 334567888899999988876532110 012235677888888888887553110
Q ss_pred cccccccccccCcccccCCccccccccccEEEeecCccCCCCChhh-hccCCCCEEEeecccccCcccc---cccccccc
Q 036011 348 SASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV-GRLEQLQGLSLYGNNLEGSIPY---DLCHLERL 423 (977)
Q Consensus 348 ~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L 423 (977)
...++..+....+|+.|++++|.+. .+|..+ ..+++|++|+|++|++++.+|. .+..+++|
T Consensus 299 --------------~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L 363 (549)
T 2z81_A 299 --------------FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363 (549)
T ss_dssp --------------SCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTC
T ss_pred --------------cccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccC
Confidence 0122333455678999999999998 677665 6899999999999999987653 47889999
Q ss_pred ceeeecCCccCCCch--hhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCc
Q 036011 424 NGIRLNGNKLSGPIP--QCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLS 501 (977)
Q Consensus 424 ~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 501 (977)
+.|++++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++ +|..+. ++|++|+|+
T Consensus 364 ~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls 439 (549)
T 2z81_A 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVS 439 (549)
T ss_dssp CEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECC
T ss_pred cEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECC
Confidence 999999999986543 56899999999999999999 688889999999999999999984 444442 689999999
Q ss_pred CCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccC
Q 036011 502 RNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 502 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
+|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|+.|||++|++++.+|..+..+++|+.|++++|+++|.+
T Consensus 440 ~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 440 NNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp SSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred CCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 99999643 57899999999999999 6776 578999999999999999988889999999999999999999988
Q ss_pred CC
Q 036011 582 PA 583 (977)
Q Consensus 582 p~ 583 (977)
|.
T Consensus 514 ~~ 515 (549)
T 2z81_A 514 PR 515 (549)
T ss_dssp HH
T ss_pred cc
Confidence 84
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=495.72 Aligned_cols=507 Identities=21% Similarity=0.224 Sum_probs=325.0
Q ss_pred EEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCC
Q 036011 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSF 134 (977)
Q Consensus 55 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 134 (977)
++.++.+++ .+|..+. +.+++|||++|++++..+.+|.++++|++|+|++|++++..|..|+.+++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 333444444 3444332 3455555555555554444555555555555555555544444455555555555555555
Q ss_pred CCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccc-cCCccccCCCCCceEEeeccCCCCCCchh
Q 036011 135 TGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPS 213 (977)
Q Consensus 135 ~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 213 (977)
++..|..|.++++|++|++++|.+++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 54444555555555555555555554333345555555555555555553 23555555555555555555555444444
Q ss_pred hccccce----eEEEccCCcccccccCCCccccCCCCceEEEecCceeee-cCCcccccccccceEeeccccc------c
Q 036011 214 IFNISTI----TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG-TIPNSITNASKLTGLDLSFNSF------S 282 (977)
Q Consensus 214 l~~l~~L----~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l------~ 282 (977)
+..+.+| +.|++++|.+++ +++..+... +|+.|++++|.... .++..+..+.+++.+.+..+.+ .
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~~---~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~ 244 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMNF---IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCE---ECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCE
T ss_pred ccchhccchhhhhcccCCCCcee---cCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhh
Confidence 5555544 455555555542 233333322 45555555543221 1222233333333333322211 1
Q ss_pred cccccccccccc--ccccccccc-ccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccC
Q 036011 283 GLIPHTFGNLRF--LSVLNLANN-YLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359 (977)
Q Consensus 283 ~~~p~~~~~l~~--L~~L~L~~N-~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n 359 (977)
......+..+.+ ++.+++++| .+....+. .+..+++|++|++++|.+.+ +|..+... +|+.|++.+|
T Consensus 245 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-------~~~~l~~L~~L~l~~~~l~~-l~~~~~~~--~L~~L~l~~n 314 (570)
T 2z63_A 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIID-------LFNCLTNVSSFSLVSVTIER-VKDFSYNF--GWQHLELVNC 314 (570)
T ss_dssp ECCTTTTGGGGGSEEEEEEEEETTEEESCSTT-------TTGGGTTCSEEEEESCEECS-CCBCCSCC--CCSEEEEESC
T ss_pred hcchhhhccccccchhhhhhhcchhhhhhchh-------hhcCcCcccEEEecCccchh-hhhhhccC--CccEEeeccC
Confidence 111122222221 233333333 23222222 14444555555555555442 34444333 4555555555
Q ss_pred cccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCcc--ccccccccccceeeecCCccCCCc
Q 036011 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSI--PYDLCHLERLNGIRLNGNKLSGPI 437 (977)
Q Consensus 360 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~ 437 (977)
.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|.+++.. |..+..+++|+.|++++|++++..
T Consensus 315 ~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 389 (570)
T 2z63_A 315 KFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389 (570)
T ss_dssp BCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEE
T ss_pred ccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccc
Confidence 555 4444 4678899999999998866655 78899999999999998654 678889999999999999998554
Q ss_pred hhhhcCCCCCCeeecCCCcCCCCCC-ccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCC-CCcchhhhc
Q 036011 438 PQCLASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLS-GDIPITIGS 515 (977)
Q Consensus 438 p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~ 515 (977)
+. +..+++|++|++++|++.+..| ..|.++++|+.|++++|.+++..|..|.++++|++|+|++|+++ +.+|..+..
T Consensus 390 ~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~ 468 (570)
T 2z63_A 390 SN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468 (570)
T ss_dssp EE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred cc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence 44 8999999999999999997766 57889999999999999999889999999999999999999997 578999999
Q ss_pred ccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCC
Q 036011 516 LKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584 (977)
Q Consensus 516 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 584 (977)
+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|+++|.+|..
T Consensus 469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 999999999999999888999999999999999999999888888999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=444.15 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=206.5
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
+++.+.++||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56788899999999999999975 369999987442 3456789999999999999999999998865 568999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
|++|+|.++++.....+++..+..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+.........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999877667999999999999999999999 7899999999999999999999999999998776544333
Q ss_pred eeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 841 TQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.....+||+.|||||++. .++|+.++|||||||++|||+||+.||.+...... ....+...... +.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~~~~-------p~~-- 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRGYAS-------PDL-- 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTTCCC-------CCS--
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCC-------CCc--
Confidence 444567999999999985 34699999999999999999999999976433221 11111111110 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.....+++..+.+++.+||+.+|++||||+||+++|+.++.
T Consensus 260 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 260 ----SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ----TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ----ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01112345568899999999999999999999999999874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=484.07 Aligned_cols=492 Identities=21% Similarity=0.193 Sum_probs=411.6
Q ss_pred CCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEe
Q 036011 49 HQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILS 128 (977)
Q Consensus 49 ~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 128 (977)
...++.|+|++|++++..+.+++++++|++|||++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 34699999999999977778899999999999999999998889999999999999999999977778999999999999
Q ss_pred ccCcCCCCCCCCcccCcCcccceecccccccc-ccCccccCccccceeeeecccccccCCccccCCCCC----ceEEeec
Q 036011 129 LRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNL----EILVLGM 203 (977)
Q Consensus 129 L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L----~~L~l~~ 203 (977)
|++|++++..+..++++++|++|++++|.+.+ .+|..|+++++|++|++++|++++..+..++.+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997766689999999999999999987 579999999999999999999998888889999999 8999999
Q ss_pred cCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceee------ecCCccccccc--ccceEe
Q 036011 204 NNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLT------GTIPNSITNAS--KLTGLD 275 (977)
Q Consensus 204 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~------~~~p~~l~~l~--~L~~L~ 275 (977)
|.+++..+..+... +|+.|++++|..... .+ +..+..+++++.+.+..+.+. ......+..+. .++.++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~-~~-~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~ 263 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLN-VM-KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTT-HH-HHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEE
T ss_pred CCceecCHHHhccC-cceeEeccccccccc-ch-hhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhh
Confidence 99998777776665 899999999854321 11 223345666666555433222 12222233333 245666
Q ss_pred eccc-ccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccccccccccccc
Q 036011 276 LSFN-SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354 (977)
Q Consensus 276 Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L 354 (977)
+++| .+.+..|..|..+++|+.|++++|.++.++.. +..+ +|++|++++|.+.. +|.. ..++|+.|
T Consensus 264 l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~--------~~~~-~L~~L~l~~n~~~~-l~~~---~l~~L~~L 330 (570)
T 2z63_A 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--------SYNF-GWQHLELVNCKFGQ-FPTL---KLKSLKRL 330 (570)
T ss_dssp EEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBC--------CSCC-CCSEEEEESCBCSS-CCBC---BCSSCCEE
T ss_pred hhcchhhhhhchhhhcCcCcccEEEecCccchhhhhh--------hccC-CccEEeeccCcccc-cCcc---cccccCEE
Confidence 7766 66666777777777777777777777765432 4555 77777777777763 3331 23467777
Q ss_pred ccccCcccccCCccccccccccEEEeecCccCCCC--ChhhhccCCCCEEEeecccccCccccccccccccceeeecCCc
Q 036011 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI--PSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNK 432 (977)
Q Consensus 355 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 432 (977)
++.+|.+.+..+. ..+++|++|++++|.+++.. |..+..+++|++|++++|.+++..+ .+..+++|+.|++++|+
T Consensus 331 ~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~ 407 (570)
T 2z63_A 331 TFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSN 407 (570)
T ss_dssp EEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSE
T ss_pred eCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCc
Confidence 7777777766655 68899999999999998654 7889999999999999999995544 49999999999999999
Q ss_pred cCCCch-hhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCC-CCCccccccccccCeeeCcCCcCCCCcc
Q 036011 433 LSGPIP-QCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS-GSLPSNIQNLQVLINLDLSRNQLSGDIP 510 (977)
Q Consensus 433 l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 510 (977)
+.+..| ..+..+++|++|++++|++.+..|..|.++++|+.|++++|.++ +.+|..|..+++|++|+|++|++++..|
T Consensus 408 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 487 (570)
T 2z63_A 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487 (570)
T ss_dssp EESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred cccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCCh
Confidence 997766 57899999999999999999999999999999999999999998 5789999999999999999999998889
Q ss_pred hhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCc
Q 036011 511 ITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPK 559 (977)
Q Consensus 511 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 559 (977)
..|+.+++|+.|+|++|++++.+|..|.++++|+.|+|++|++++..|.
T Consensus 488 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999999999999998888999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=452.10 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=207.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|.+.+.||+|+||+||+|+++ +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478999999987766677889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 757 VLELMPNGSLEKWLYSDN--------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
|||||++|+|.++++... ..++|.++..|+.|||+||+||| +++||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999997642 25899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ ....+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999997765444444445679999999999999999999999999999999999 899997643221 1111111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
... . +.+..++..+.+++.+||+.||++||||+||+++|+++..
T Consensus 276 g~~----------~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 GRE----------L-------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TCC----------C-------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC----------C-------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 000 0 0111345568899999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=450.01 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=215.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 478899999987766777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEE
Q 036011 757 VLELMPNGSLEKWLYSDN------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 824 (977)
|||||++|+|.++++..+ ..++|..+..|+.|||+||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 35899999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhC
Q 036011 825 SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+ +...+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~~- 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQG- 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHHT-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC-
Confidence 99999987765443333344569999999999999999999999999999999999 899997653221 11111110
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.... .+..++..+.+++.+||+.||++||||+||.+.|+++..
T Consensus 247 ----------~~~~------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 ----------RVLQ------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ----------CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCC------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0000 111345568999999999999999999999999998875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=477.75 Aligned_cols=491 Identities=19% Similarity=0.189 Sum_probs=402.8
Q ss_pred CCCCCCCCCCcccceEecC--CCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCc
Q 036011 29 NNWSISQPICKWVGISCGA--RHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLD 106 (977)
Q Consensus 29 ~~w~~~~~~c~w~gv~c~~--~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 106 (977)
..|. +.+.|++.+++.-. ....+++|+|++|++++..|..++++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 4 C~~~-~~c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDAS-GVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTT-SEEECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCC-ceEECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 4573 34335676666533 23579999999999998888899999999999999999999888999999999999999
Q ss_pred CccCCCCCCccccccccCcEEeccCcCCCC-CCCCcccCcCcccceeccccccccccC-ccccCccccceeeeecccccc
Q 036011 107 YNEFSGSFPSWIGVLSKLQILSLRNNSFTG-PIPNSLFNLSRLEKWDSMFNIIDGNIP-SRIGNLSSLVNVNLAYNNLQG 184 (977)
Q Consensus 107 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~L~L~~n~i~~ 184 (977)
+|++++..|..|+.+++|++|+|++|.+++ ..|..+.++++|++|++++|.+.+.+| ..|+++++|++|++++|++++
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 999997777789999999999999999997 467889999999999999999555555 689999999999999999999
Q ss_pred cCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCc-
Q 036011 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPN- 263 (977)
Q Consensus 185 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~- 263 (977)
..|..++++++|+.|+++.|.+.......+..+++|+.|++++|++++....+......+++|+.|++++|++++..+.
T Consensus 163 ~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 242 (549)
T 2z81_A 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242 (549)
T ss_dssp ECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHH
T ss_pred cChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHH
Confidence 9999999999999999999998744333345689999999999999864322334455688999999999999865443
Q ss_pred ---ccccccccceEeeccccccccc------ccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCC
Q 036011 264 ---SITNASKLTGLDLSFNSFSGLI------PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASN 334 (977)
Q Consensus 264 ---~l~~l~~L~~L~Ls~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 334 (977)
.+..+++|+.|++++|.+.+.. ...+..+++|+.|.++++.+....... .....+...++|+.|++++|
T Consensus 243 l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~--~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY--DLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSC--CCCHHHHHSTTCCEEEEESS
T ss_pred HHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcc--cchhhhhhcccceEEEeccC
Confidence 3467789999999999997642 234567889999999999876532100 00111233566777777777
Q ss_pred CCCCCCCcccccccccccccccccCcccccCCccc-cccccccEEEeecCccCCCCCh---hhhccCCCCEEEeeccccc
Q 036011 335 PLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEI-GNLRSLIVLSLFINALNGTIPS---TVGRLEQLQGLSLYGNNLE 410 (977)
Q Consensus 335 ~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~ 410 (977)
.+. .+|..+ ..+++|++|++++|.+++.+|. .++.+++|++|+|++|+++
T Consensus 321 ~l~--------------------------~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 374 (549)
T 2z81_A 321 KVF--------------------------LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374 (549)
T ss_dssp CCC--------------------------CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCC
T ss_pred ccc--------------------------cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccc
Confidence 665 344444 4688899999999999876643 3788899999999999998
Q ss_pred Cccc--cccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccc
Q 036011 411 GSIP--YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSN 488 (977)
Q Consensus 411 ~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 488 (977)
+..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++ +|..+ .++|+.|++++|+|++..
T Consensus 375 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~--- 447 (549)
T 2z81_A 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS--- 447 (549)
T ss_dssp CHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC---
T ss_pred ccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc---
Confidence 6543 46888999999999999998 678888899999999999999984 44443 268999999999999743
Q ss_pred cccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCC
Q 036011 489 IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIP 558 (977)
Q Consensus 489 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 558 (977)
..+++|++|+|++|+|+ .+|. .+.+++|+.|+|++|++++.+|..|..+++|+.|+|++|++++..|
T Consensus 448 -~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 448 -LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp -CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred -ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 57889999999999999 6776 5789999999999999999999999999999999999999998766
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=447.15 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=211.3
Q ss_pred CCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++++.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999863 46889999997554 3345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc
Q 036011 757 VLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV 821 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 821 (977)
|||||++|+|.+++.... ..++|..+.+|+.|||+||+||| +++||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 999999999999996532 25899999999999999999999 789999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHH
Q 036011 822 AHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (977)
+||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.... .+...+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~ 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIR 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987765444334445679999999999999999999999999999999999 89999765322 1222211
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.. .. .+.+.+++..+.+++.+||+.||++||||+||+++|++..
T Consensus 262 ~~-----------~~------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 262 NR-----------QV------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TT-----------CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cC-----------CC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 10 00 0111235567899999999999999999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=471.88 Aligned_cols=462 Identities=19% Similarity=0.222 Sum_probs=344.8
Q ss_pred EEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCc
Q 036011 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132 (977)
Q Consensus 53 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 132 (977)
+.||+++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999998 6888776 89999999999999877788999999999999999999777889999999999999999
Q ss_pred CCCCCCCCcccCcCcccceecccccccc-ccCccccCccccceeeeecccccccCCccccCCCCC--ceEEeeccCC--C
Q 036011 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNL--EILVLGMNNL--S 207 (977)
Q Consensus 133 ~l~~~~p~~l~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L--~~L~l~~N~l--~ 207 (977)
+++ .+|.. .+++|++|++++|.+++ .+|..|+++++|++|++++|++++ ..+..+++| +.|++++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 998 56666 78899999999999987 578889999999999999999885 456777777 9999999988 7
Q ss_pred CCCchhhcccc-ceeEEEccCCcccccccCCCccccCCCCceEEEecCce-------eeecCCcccccccccceEeeccc
Q 036011 208 GPIQPSIFNIS-TITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK-------LTGTIPNSITNASKLTGLDLSFN 279 (977)
Q Consensus 208 ~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~Ls~N 279 (977)
+..|..+..+. +...+++++|++.+ .++...+..+++|+.|++++|+ +.+.+| .+..+++|++|++++|
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~--~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~ 230 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFH--FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNI 230 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCC--CCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchh--hhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccc
Confidence 77777776654 34455666666554 2344444555555555555554 443333 4455555555555555
Q ss_pred ccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccC
Q 036011 280 SFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359 (977)
Q Consensus 280 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n 359 (977)
.+++..+..+. . ...+++|++|++++|.+.+.+|..+...
T Consensus 231 ~l~~~~~~~~~---------------------------~-~~~~~~L~~L~l~~n~l~~~~p~~~~~~------------ 270 (520)
T 2z7x_B 231 ETTWNSFIRIL---------------------------Q-LVWHTTVWYFSISNVKLQGQLDFRDFDY------------ 270 (520)
T ss_dssp EEEHHHHHHHH---------------------------H-HHHTSSCSEEEEEEEEEESCCCCCCCCC------------
T ss_pred ccCHHHHHHHH---------------------------H-HhhhCcccEEEeecccccCccccchhhc------------
Confidence 54432111100 0 0112355556665555554444322111
Q ss_pred cccccCCccccccccccEEEeecCccCCCCC-hhhhcc---CCCCEEEeecccccCccccccccccccceeeecCCccCC
Q 036011 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIP-STVGRL---EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSG 435 (977)
Q Consensus 360 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 435 (977)
..+.+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++
T Consensus 271 --------~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~ 338 (520)
T 2z7x_B 271 --------SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTD 338 (520)
T ss_dssp --------CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCT
T ss_pred --------ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccCh
Confidence 016777888888888888 344 556555 67888888888876322 12678888888888888888
Q ss_pred CchhhhcCCCCCCeeecCCCcCCC--CCCccccCcccCceEEccCCCCCCCCcc-ccccccccCeeeCcCCcCCCCcchh
Q 036011 436 PIPQCLASLISLRELNLGSNKFSS--SIPSSFWSLEYLLAVNLSSNSLSGSLPS-NIQNLQVLINLDLSRNQLSGDIPIT 512 (977)
Q Consensus 436 ~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~ 512 (977)
.+|..+..+++|++|++++|++++ .+|..+..+++|+.|++++|++++.+|. .+..+++|++|++++|++++.+|..
T Consensus 339 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 418 (520)
T 2z7x_B 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418 (520)
T ss_dssp TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGS
T ss_pred hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhh
Confidence 788888888888888888888886 4557788888899999999988874554 4788889999999999998777766
Q ss_pred hhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcc-cccccccCccccCCCcccccCC
Q 036011 513 IGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS-LEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 513 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p 582 (977)
+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|++|++++|+++|.++
T Consensus 419 l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 419 LP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 54 78999999999998 67887789999999999999998 56665 8889999999999999988765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=485.69 Aligned_cols=484 Identities=19% Similarity=0.225 Sum_probs=320.8
Q ss_pred hHHHHHHHHHHHHhccCCCCCccCCCCCCCCC----CcccceE-ecCC--CCcEEEEEcCCCCCCccCCccccCcccccE
Q 036011 6 LTTDQFALLAFKAHVTDPQSVLANNWSISQPI----CKWVGIS-CGAR--HQRVRALNLSNMGLRGTIPPHLGNFSFLMS 78 (977)
Q Consensus 6 ~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~----c~w~gv~-c~~~--~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~ 78 (977)
..++.+.-.|+++-+..-.+ .+|....+. |.|..-+ |..= ...|++ +. -.+++.
T Consensus 25 ~~~~~~d~~aL~~~~~~~~~---~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~~-------------~~~V~~ 85 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALNG---KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---NS-------------NGRVTG 85 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTTG---GGCCCCC------CCCCCSSCGGGTTCCTTEEE---CT-------------TCCEEE
T ss_pred hhhHHHHHHHHHHHHHHcCC---CCcccCCcCCccCCCCCCCCCcccccCCCCeEE---cC-------------CCCEEE
Confidence 34555666777766644332 479754422 3785322 2111 022443 10 046889
Q ss_pred eeccCCcccccCCCCcCCCCCCCEEeCcCccC------CC------CCCccccccccCcEEeccCcCCCCCCCCcccCc-
Q 036011 79 LDISKNNFHAYLPNELGQLRRLRFISLDYNEF------SG------SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNL- 145 (977)
Q Consensus 79 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l- 145 (977)
|+|++|+++|.+|.+|++|++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|..+..+
T Consensus 86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~ 162 (636)
T 4eco_A 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLI 162 (636)
T ss_dssp EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHH
T ss_pred EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHH
Confidence 99999999999999999999999999999976 33 455544 67788 9999999998888777632
Q ss_pred Ccccceecc--------------------ccccccccCccccCccccceeeeeccccccc-----------------CCc
Q 036011 146 SRLEKWDSM--------------------FNIIDGNIPSRIGNLSSLVNVNLAYNNLQGE-----------------IPS 188 (977)
Q Consensus 146 ~~L~~L~l~--------------------~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~-----------------~p~ 188 (977)
..+..+++. .|.+++ +|..|+++++|++|+|++|++++. +|.
T Consensus 163 ~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~ 241 (636)
T 4eco_A 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE 241 (636)
T ss_dssp HHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch
Confidence 223333332 467776 777777777777777777777764 777
Q ss_pred ccc--CCCCCceEEeeccCCCCCCchhhccccceeEEEccCCc-ccc-cccCCCccccC------CCCceEEEecCceee
Q 036011 189 EIG--NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQ-LSG-HLDLPPKVSYS------LPNLRVFSLGKNKLT 258 (977)
Q Consensus 189 ~l~--~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~~~~------l~~L~~L~L~~N~l~ 258 (977)
.++ ++++|++|+|++|++.+.+|..+.++++|+.|+|++|+ +++ . +|.. +.. +++|++|+|++|+++
T Consensus 242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~--lp~~-~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ--LKDD-WQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHH--HHHH-HHHHHHSGGGGTCCEEECCSSCCS
T ss_pred hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcccc--chHH-HHhhhccccCCCCCEEECCCCcCC
Confidence 777 77777777777777777777667666666666666665 543 1 1211 112 255666666666665
Q ss_pred ecCCc--ccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCC
Q 036011 259 GTIPN--SITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336 (977)
Q Consensus 259 ~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 336 (977)
.+|. .+..+++|++|+|++|++++.+| .|..+++|++|++++|+++.+
T Consensus 319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~l---------------------------- 368 (636)
T 4eco_A 319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI---------------------------- 368 (636)
T ss_dssp -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEEC----------------------------
T ss_pred -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccc----------------------------
Confidence 5555 55566666666666666655555 555555555555555555432
Q ss_pred CCCCCcccccccccccccccccCcccccCCcccccccc-ccEEEeecCccCCCCChhhhccC--CCCEEEeecccccCcc
Q 036011 337 RGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRS-LIVLSLFINALNGTIPSTVGRLE--QLQGLSLYGNNLEGSI 413 (977)
Q Consensus 337 ~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~ 413 (977)
|..+..+++ |++|++++|.++ .+|..+..++ +|++|++++|.+++.+
T Consensus 369 -----------------------------p~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~ 418 (636)
T 4eco_A 369 -----------------------------PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418 (636)
T ss_dssp -----------------------------CTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT
T ss_pred -----------------------------cHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc
Confidence 333444444 555555555555 4444444433 5666666666666666
Q ss_pred ccccc-------cccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCc-------ccCceEEccCC
Q 036011 414 PYDLC-------HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL-------EYLLAVNLSSN 479 (977)
Q Consensus 414 p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~L~~N 479 (977)
|..+. .+++|+.|++++|+++...+..+..+++|++|+|++|+++...+..+... ++|+.|+|++|
T Consensus 419 p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N 498 (636)
T 4eco_A 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498 (636)
T ss_dssp TCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSS
T ss_pred hhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCC
Confidence 66555 56667777777777764444445567777777777777773333333322 27777888888
Q ss_pred CCCCCCccccc--cccccCeeeCcCCcCCCCcchhhhcccccceecc------CCccccccccccccCccccCeeeccCC
Q 036011 480 SLSGSLPSNIQ--NLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSL------ASNQFEGPIPQTFGSLTGLESLDLSNN 551 (977)
Q Consensus 480 ~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N 551 (977)
+|+ .+|..+. .+++|++|+|++|++++ +|..++.+++|+.|+| ++|++.+.+|..++++++|+.|+|++|
T Consensus 499 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 576 (636)
T 4eco_A 499 KLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576 (636)
T ss_dssp CCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSS
T ss_pred cCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCC
Confidence 777 5666665 77788888888888875 7777777888888877 678899999999999999999999999
Q ss_pred ccCCCCCcccccccccCccccCCCccccc
Q 036011 552 NLSGEIPKSLEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 552 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 580 (977)
+| +.+|..+. ++|+.|++++|++...
T Consensus 577 ~l-~~ip~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 577 DI-RKVNEKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp CC-CBCCSCCC--TTCCEEECCSCTTCEE
T ss_pred cC-CccCHhHh--CcCCEEECcCCCCccc
Confidence 99 58898876 8999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=436.09 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=210.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999975 69999999998776666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+||+|.+++.... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 154 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 9999999997644 899999999999999999999 78999999999999999999999999999998754322 2
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ....+....+.. +
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~--------~------ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPR--------L------ 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSSCCC--------C------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCC--------C------
Confidence 334679999999999999999999999999999999999999997642211 111111111111 0
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.||++|||++|++++
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111234457899999999999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=469.02 Aligned_cols=504 Identities=21% Similarity=0.189 Sum_probs=339.2
Q ss_pred EcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCC
Q 036011 56 NLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFT 135 (977)
Q Consensus 56 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 135 (977)
+.++.+++ .+|+.+- +.+++|||++|+|+++.|.+|.++++|++|+|++|+|++..|++|++|++|++|+|++|+++
T Consensus 37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 44555555 4554431 34555666666655544555555666666666666555444445555556666666666555
Q ss_pred CCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccc-cCCccccCCCCCceEEeeccCCCCCCchhh
Q 036011 136 GPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSI 214 (977)
Q Consensus 136 ~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l 214 (977)
+..+..|.++++|++|++++|.|++..+..|+++++|++|+|++|++++ .+|..++++++|++|++++|++++..+..+
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 4444455555566666666665555444455555566666666655543 234555555556666666665555555554
Q ss_pred cccccee----EEEccCCcccccccCCCccccCCCCceEEEecCceee-------------------------------e
Q 036011 215 FNISTIT----LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLT-------------------------------G 259 (977)
Q Consensus 215 ~~l~~L~----~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------------~ 259 (977)
..+.+++ .++++.|.+.. +++..+ ....++.+++++|... .
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~---i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~ 269 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNF---IQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 269 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCE---ECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred cchhhhhhhhhhhhcccCcccc---cCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccc
Confidence 4443322 45555555542 222222 2223444444444332 1
Q ss_pred cCCcccccccccceEeeccccccc---ccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCC
Q 036011 260 TIPNSITNASKLTGLDLSFNSFSG---LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336 (977)
Q Consensus 260 ~~p~~l~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 336 (977)
.....+.....+...++..+.... ..+..+..+.+++.+.+.+|.+..+. .+.....|+.|++.+|.+
T Consensus 270 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~---------~~~~~~~L~~L~l~~~~~ 340 (635)
T 4g8a_A 270 FDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK---------DFSYNFGWQHLELVNCKF 340 (635)
T ss_dssp CCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG---------GGGSCCCCSEEEEESCEE
T ss_pred ccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc---------ccccchhhhhhhcccccc
Confidence 122233334444444444433221 12334555666777777777665533 255667788888888887
Q ss_pred CCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCC--CCChhhhccCCCCEEEeecccccCccc
Q 036011 337 RGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG--TIPSTVGRLEQLQGLSLYGNNLEGSIP 414 (977)
Q Consensus 337 ~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p 414 (977)
.+..+..+ ..++.+.+.+|..... .....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+
T Consensus 341 ~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~ 413 (635)
T 4g8a_A 341 GQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMS 413 (635)
T ss_dssp SSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EEC
T ss_pred cCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-ccc
Confidence 76544332 3566777777776543 334578899999999998853 45677888899999999999887 466
Q ss_pred cccccccccceeeecCCccCCCch-hhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCC-CCCCccccccc
Q 036011 415 YDLCHLERLNGIRLNGNKLSGPIP-QCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSL-SGSLPSNIQNL 492 (977)
Q Consensus 415 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l 492 (977)
..+..+++|+.++++.|+.....+ ..+..+++++.+++++|++.+..+..+..++.|+.|++++|++ .+..|..|..+
T Consensus 414 ~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l 493 (635)
T 4g8a_A 414 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 493 (635)
T ss_dssp SCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred ccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhc
Confidence 678889999999999888765444 5678889999999999999988899999999999999999974 44578889999
Q ss_pred cccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccc-cccCccc
Q 036011 493 QVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL-LFLKQLN 571 (977)
Q Consensus 493 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ 571 (977)
++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..|..|.++++|++|||++|+|++..|..|..+ ++|++|+
T Consensus 494 ~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~ 573 (635)
T 4g8a_A 494 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 573 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEE
T ss_pred cccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEE
Confidence 999999999999998888899999999999999999998888899999999999999999998889999888 6899999
Q ss_pred cCCCcccccCC
Q 036011 572 VSHNKLEGEIP 582 (977)
Q Consensus 572 l~~N~l~~~~p 582 (977)
|++|+|++...
T Consensus 574 L~~Np~~C~C~ 584 (635)
T 4g8a_A 574 LTQNDFACTCE 584 (635)
T ss_dssp CTTCCBCCSGG
T ss_pred eeCCCCcccCC
Confidence 99999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=433.40 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=203.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999965 69999999997653 345677999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+||+|.+++...+ ..+++..+..|+.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999997654 35789999999999999999999 7999999999999999999999999999998764321
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+.......++.
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~------------ 244 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPP------------ 244 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCC------------
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCC------------
Confidence 12234579999999999999999999999999999999999999997642221 111211111110
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ...++..+.+++.+||+.||++|||++|++++
T Consensus 245 ~------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 V------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01123457899999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=426.61 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=209.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999965 79999999998653 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||++||+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998654 4999999999999999999999 79999999999999999999999999999998765444
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ .........+. ..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~------------~p 254 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEYD------------FP 254 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC------------CC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCC------------CC
Confidence 334455689999999999999999999999999999999999999997632211 11111111110 00
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
. .+...+.+++.+|++.||++|||++|+..
T Consensus 255 ~-------~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 255 E-------KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp T-------TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred c-------ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0 12335688999999999999999998743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=431.18 Aligned_cols=252 Identities=22% Similarity=0.270 Sum_probs=205.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.|++.++||+|+||+||+|++. +|+.||||+++.+. ...+|++++++++|||||++++++.+++..|+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45778889999999999999975 69999999997542 2357999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 840 (977)
+||+|.++++..+ .+++..+..++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+.+.......
T Consensus 133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999999998654 4999999999999999999999 89999999999999999988 69999999999876433221
Q ss_pred ---eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 841 ---TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 841 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. .........+ ..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~--~~--------- 276 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPP--IR--------- 276 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCG--GG---------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCC--ch---------
Confidence 22335799999999999999999999999999999999999999976543332 2221111100 00
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
..+.+++..+.+++.+||+.||++|||+.|+++++.+.
T Consensus 277 -----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 -----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 00112345678999999999999999999999988554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=431.56 Aligned_cols=268 Identities=21% Similarity=0.310 Sum_probs=204.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----eeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND----FRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 758 (977)
++|.+.+.||+|+||+||+|++ +|+.||||++...... ...++.|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577788999999999999998 5899999999754322 233456777778899999999999997654 578999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG-----HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
|||++|+|.++++... ++|..+.+++.|+++||+|||+. ++.+||||||||+|||++.++.+||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999998754 89999999999999999999943 2449999999999999999999999999999887
Q ss_pred CCCCCcc--eeeccccCCcccCccccCCC------CcCcccchhhHhHHHHHHhcCCCCCCcCCcccc----------cH
Q 036011 834 DEGDDSV--TQTMTIATIGYMAPEYGTEG------IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM----------SL 895 (977)
Q Consensus 834 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----------~~ 895 (977)
....... .....+||++|||||++.+. .|+.++|||||||++|||+||+.||......+. ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 6543322 22335799999999998754 478899999999999999999887754322221 11
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
........... .++.+ .......+++..+.+++.+||+.||++||||.||++.|+++..
T Consensus 239 ~~~~~~~~~~~----~rp~~----p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCEQK----LRPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSC----CCCCC----CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccc----CCCCC----CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12111111111 11111 1111223466778999999999999999999999999998874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=415.43 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=195.9
Q ss_pred CcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec----CCeeEEEE
Q 036011 686 NECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN----NDFRALVL 758 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 758 (977)
...+.||+|+||+||+|++. +++.||||++.... ....+.|.+|++++++++|||||+++++|.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 68999999997543 3445779999999999999999999999865 34678999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeC-CCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 835 (977)
|||++|+|.+++.... .+++..+..++.||+.||+||| +++ ||||||||+|||++ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998654 4899999999999999999999 666 99999999999998 479999999999986433
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
. .....+||+.|||||++.+ .|+.++||||+||++|||+||+.||.+...... +...+..... +
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i~~~~~--------~-- 248 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVK--------P-- 248 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCC--------C--
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHHHcCCC--------C--
Confidence 2 2234579999999999865 699999999999999999999999975322211 1111111000 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+..++..+.+++.+||+.||++|||++|++++
T Consensus 249 ------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011123357889999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=437.15 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=210.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 69999999998776666677999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+||+|.++++... +++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 303 (423)
T 4fie_A 231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 303 (423)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence 9999999997654 899999999999999999999 78999999999999999999999999999998754332 2
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ....+....+.. +..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~--------~~~---- 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPR--------LKN---- 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCC--------CSC----
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCC--------Ccc----
Confidence 334679999999999999999999999999999999999999997642211 111111111110 000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+...+.+++.+||+.||++|||+.|++++
T Consensus 370 ---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123457889999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=431.34 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=214.5
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCC-CCcceEeeeeecC
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRH-RNLIKIFSSCCNN 751 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~ 751 (977)
...++|++.+.||+|+||+||+|++.. ++.||||++.... ....+.|.+|++++++++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345789999999999999999998642 4689999997654 3445779999999999965 9999999998764
Q ss_pred -CeeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcee
Q 036011 752 -DFRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNIL 815 (977)
Q Consensus 752 -~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 815 (977)
+..++|||||++|+|.++++... ..+++..+..++.|||+||+||| +++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence 56899999999999999997532 24899999999999999999999 789999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCccccc
Q 036011 816 LDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMS 894 (977)
Q Consensus 816 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 894 (977)
+++++.+||+|||+|+.+............+||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999998766554444555679999999999999999999999999999999998 8999977543322
Q ss_pred HHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 895 LKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+...+...... . .+..++..+.+++.+||+.||++|||++|++++|+++-.
T Consensus 297 ~~~~i~~g~~~-----------~------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 FCRRLKEGTRM-----------R------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHTCCC-----------C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC-----------C------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 22211111100 0 011234568899999999999999999999999988753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=408.55 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=191.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 79999999997553 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+ +|+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 689999997765 4999999999999999999999 7999999999999999999999999999998765432
Q ss_pred cceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.....+||+.|||||++.+..| +.++||||+||++|||+||+.||.+....+ ..........+ .
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~~------------~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVYT------------L 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC------------C
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC------------C
Confidence 2234579999999999998876 579999999999999999999997632211 11111111000 0
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ..+...+.+++.+|++.||++|||++|++++
T Consensus 232 p-------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 P-------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C-------CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 0123456889999999999999999999764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=467.40 Aligned_cols=442 Identities=19% Similarity=0.212 Sum_probs=292.2
Q ss_pred ccccEeeccCCcccccCCCCcCCCCCCCEEeC-cCccCCCCCCcccccc----c-----cCcE------Eec-cCcC---
Q 036011 74 SFLMSLDISKNNFHAYLPNELGQLRRLRFISL-DYNEFSGSFPSWIGVL----S-----KLQI------LSL-RNNS--- 133 (977)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-~~n~l~~~~p~~~~~l----~-----~L~~------L~L-~~n~--- 133 (977)
.+++.|+|++|++.|.+|.+|++|++|++|+| ++|.++|..|-..... + .++. ++. ....
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 56899999999999999999999999999999 8998887644321111 0 0000 000 0000
Q ss_pred --------CCCCCCCcccCcCcccceeccc--cccccccCccccCccccceeeeecccccc-----------------cC
Q 036011 134 --------FTGPIPNSLFNLSRLEKWDSMF--NIIDGNIPSRIGNLSSLVNVNLAYNNLQG-----------------EI 186 (977)
Q Consensus 134 --------l~~~~p~~l~~l~~L~~L~l~~--n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-----------------~~ 186 (977)
.....+........++.+.+.. |.+++ +|..|+++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0001122223444566666655 89998 89999999999999999999998 38
Q ss_pred Ccccc--CCCCCceEEeeccCCCCCCchhhccccceeEEEccCCc-ccc-cccCCCc------cccCCCCceEEEecCce
Q 036011 187 PSEIG--NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQ-LSG-HLDLPPK------VSYSLPNLRVFSLGKNK 256 (977)
Q Consensus 187 p~~l~--~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~------~~~~l~~L~~L~L~~N~ 256 (977)
|..++ ++++|++|+|++|++.+.+|..+.++++|+.|+|++|+ +++ . +|.. .+..+++|++|+|++|+
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~--iP~~i~~L~~~~~~l~~L~~L~Ls~N~ 559 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ--LKADWTRLADDEDTGPKIQIFYMGYNN 559 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHH--HHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCccccc--chHHHHhhhhcccccCCccEEEeeCCc
Confidence 99988 99999999999999999999999999999999998887 764 1 2221 22345577777777777
Q ss_pred eeecCCc--ccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCC-CceEEecC
Q 036011 257 LTGTIPN--SITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN-LTTLAVAS 333 (977)
Q Consensus 257 l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~-L~~L~L~~ 333 (977)
++ .+|. .+.++++|++|+|++|+++ .+| .|+.+++|+.|+|++|+++.++.. +..+++ |+.|++++
T Consensus 560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~~--------l~~l~~~L~~L~Ls~ 628 (876)
T 4ecn_A 560 LE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPED--------FCAFTDQVEGLGFSH 628 (876)
T ss_dssp CC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCTT--------SCEECTTCCEEECCS
T ss_pred CC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchHH--------HhhccccCCEEECcC
Confidence 77 6676 6777777777777777777 445 677777777777777776643321 445555 55555555
Q ss_pred CCCCCCCCcccccccccccccccccCcccccCCcccccc--ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccC
Q 036011 334 NPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNL--RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG 411 (977)
Q Consensus 334 N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 411 (977)
|.+. .+| ..+..+ ++|+.|+|++|.+.+.+|...
T Consensus 629 N~L~-~lp-------------------------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~------------------ 664 (876)
T 4ecn_A 629 NKLK-YIP-------------------------NIFNAKSVYVMGSVDFSYNKIGSEGRNIS------------------ 664 (876)
T ss_dssp SCCC-SCC-------------------------SCCCTTCSSCEEEEECCSSCTTTTSSSCS------------------
T ss_pred CCCC-cCc-------------------------hhhhccccCCCCEEECcCCcCCCccccch------------------
Confidence 5554 222 222222 225555555555544333211
Q ss_pred ccccccc--cccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccC--------cccCceEEccCCCC
Q 036011 412 SIPYDLC--HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWS--------LEYLLAVNLSSNSL 481 (977)
Q Consensus 412 ~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~L~~N~l 481 (977)
..+. .+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+ .+|..+.. +++|+.|+|++|+|
T Consensus 665 ---~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L 740 (876)
T 4ecn_A 665 ---CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740 (876)
T ss_dssp ---SCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCC
T ss_pred ---hhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCC
Confidence 0111 2235555555555555322223335555666666666555 33332221 22666666666666
Q ss_pred CCCCccccc--cccccCeeeCcCCcCCCCcchhhhcccccceeccC------CccccccccccccCccccCeeeccCCcc
Q 036011 482 SGSLPSNIQ--NLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLA------SNQFEGPIPQTFGSLTGLESLDLSNNNL 553 (977)
Q Consensus 482 ~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls------~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 553 (977)
+ .+|..+. .+++|+.|+|++|++++ +|..++.+++|+.|+|+ +|++.+.+|..|.++++|+.|+|++|+|
T Consensus 741 ~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 741 T-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp C-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred c-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 6 4555554 66666666666666664 56666666666666665 4889999999999999999999999999
Q ss_pred CCCCCcccccccccCccccCCCcccccCC
Q 036011 554 SGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 554 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
+.+|..+. ++|+.|||++|++...-+
T Consensus 819 -~~Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 819 -RKVDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp -CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred -CccCHhhc--CCCCEEECCCCCCCccCh
Confidence 68998876 699999999999875443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=447.12 Aligned_cols=468 Identities=17% Similarity=0.187 Sum_probs=343.2
Q ss_pred EEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCc
Q 036011 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132 (977)
Q Consensus 53 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 132 (977)
+.+|+++++++ .+|..+. ++|++|+|++|++++..|.+|.++++|++|+|++|++++..|+.|+.+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 78999999999 5998764 89999999999999988889999999999999999999878999999999999999999
Q ss_pred CCCCCCCCcccCcCcccceecccccccc-ccCccccCccccceeeeecccccccCCccccCCCCC--ceEEeeccCC--C
Q 036011 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNL--EILVLGMNNL--S 207 (977)
Q Consensus 133 ~l~~~~p~~l~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L--~~L~l~~N~l--~ 207 (977)
+++ .+|.. .+++|++|++++|.+++ .+|..|+++++|++|+|++|++++. .+..+++| +.|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 999 67766 89999999999999986 4578999999999999999999853 45555555 9999999999 7
Q ss_pred CCCchhhcccc-ceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccc
Q 036011 208 GPIQPSIFNIS-TITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIP 286 (977)
Q Consensus 208 ~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 286 (977)
+..+..+..+. ....+++++|.+.+ .++...+..+++|+.|++++|+.... .+.+. .
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~--~~~~~~~~~l~~L~~L~l~~n~~~~~-------------------~l~~~-~ 242 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFS--VQVNMSVNALGHLQLSNIKLNDENCQ-------------------RLMTF-L 242 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCC--CCCEEEESSEEEEEEEEEECCSTTHH-------------------HHHHH-H
T ss_pred ccCcccccccCcceEEEEecCccchh--hhhhhcccccceEEEecccccccccc-------------------hHHHH-H
Confidence 77777777654 12244666666553 23333344455555555555431000 01111 1
Q ss_pred cccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCC
Q 036011 287 HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIP 366 (977)
Q Consensus 287 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p 366 (977)
..|..+++|+.|+++++.++..... .... ....++|++|++++|.+.+.+|..+...
T Consensus 243 ~~l~~l~~L~~L~L~~~~l~~~~~~---~~~~-~~~~~~L~~L~l~~n~l~~~ip~~~~~~------------------- 299 (562)
T 3a79_B 243 SELTRGPTLLNVTLQHIETTWKCSV---KLFQ-FFWPRPVEYLNIYNLTITERIDREEFTY------------------- 299 (562)
T ss_dssp HHHHSCSSCEEEEEEEEEECHHHHH---HHHH-HHTTSSEEEEEEEEEEECSCCCCCCCCC-------------------
T ss_pred HHHhccCcceEEEecCCcCcHHHHH---HHHH-hhhcccccEEEEeccEeeccccchhhhc-------------------
Confidence 2234444444444444443321100 0000 1112355666666665554444332111
Q ss_pred ccccccccccEEEeecCccCCCCC-hhhhcc---CCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhc
Q 036011 367 HEIGNLRSLIVLSLFINALNGTIP-STVGRL---EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA 442 (977)
Q Consensus 367 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 442 (977)
....++.|+.+++..|.+ .+| ..+..+ .+|++|++++|.+.... ....+++|++|++++|++++.+|..+.
T Consensus 300 -~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~ 374 (562)
T 3a79_B 300 -SETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCS 374 (562)
T ss_dssp -CSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred -ccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhc
Confidence 015666777777777777 344 333333 67889999998886322 126788899999999999888888889
Q ss_pred CCCCCCeeecCCCcCCCCC--CccccCcccCceEEccCCCCCCCCc-cccccccccCeeeCcCCcCCCCcchhhhccccc
Q 036011 443 SLISLRELNLGSNKFSSSI--PSSFWSLEYLLAVNLSSNSLSGSLP-SNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519 (977)
Q Consensus 443 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 519 (977)
.+++|++|+|++|++++.. |..|.++++|+.|++++|++++.+| ..+..+++|++|+|++|++++.+|..+. ++|
T Consensus 375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 9999999999999998633 4678889999999999999987444 4588889999999999999877666554 689
Q ss_pred ceeccCCccccccccccccCccccCeeeccCCccCCCCCcc-cccccccCccccCCCcccccCCC
Q 036011 520 VTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS-LEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 520 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++++|+++|.+|-
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 99999999998 67777779999999999999999 56665 88999999999999999988763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=414.33 Aligned_cols=242 Identities=27% Similarity=0.312 Sum_probs=193.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|++.+.||+|+||+||+|+.. .++.||||++++.. ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47899999997553 2234468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||++||+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999998754 4899999999999999999999 799999999999999999999999999999875433
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ ..........+
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~------------ 244 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAKLG------------ 244 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC------------
T ss_pred Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCCC------------
Confidence 22 2234579999999999999999999999999999999999999997643221 11111111100
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
. + ..++..+.+++.+||+.||++|||+
T Consensus 245 ~-p------~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 M-P------QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C-C------TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C-C------CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 0 1123457889999999999999985
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=446.80 Aligned_cols=462 Identities=20% Similarity=0.243 Sum_probs=348.9
Q ss_pred cEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceecccc
Q 036011 77 MSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFN 156 (977)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n 156 (977)
++||+++|+++. +|..+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|++|++++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 578999999986 777766 88999999999998777788889999999999999998777888888888888888888
Q ss_pred ccccccCccccCccccceeeeecccccc-cCCccccCCCCCceEEeeccCCCCCCchhhccccce--eEEEccCCccccc
Q 036011 157 IIDGNIPSRIGNLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTI--TLINLFGNQLSGH 233 (977)
Q Consensus 157 ~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L--~~L~L~~N~l~~~ 233 (977)
.|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..+..+++| +.|++++|.+.+
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~- 152 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG- 152 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT-
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc-
Confidence 887 56665 78888888888888876 467788888888888888888764 234444444 555555554411
Q ss_pred ccCCCccccCCCCceEEEecCceeeecCCccccccc-ccceEeeccccccccc-ccccccccccccccccccccCCCCCC
Q 036011 234 LDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNAS-KLTGLDLSFNSFSGLI-PHTFGNLRFLSVLNLANNYLTTDSPT 311 (977)
Q Consensus 234 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~ 311 (977)
.+..|..+..+. +...+++++|++.+.+ +..+..+++|+.|++++|.......
T Consensus 153 ------------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~- 207 (520)
T 2z7x_B 153 ------------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS- 207 (520)
T ss_dssp ------------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH-
T ss_pred ------------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccc-
Confidence 334444444433 2334566666655433 2345666777777777765110000
Q ss_pred chhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCCh
Q 036011 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPS 391 (977)
Q Consensus 312 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 391 (977)
.....++.+..+++|+.|++++|.+.+..+. +.. ..+ ..++|++|++++|.+++.+|.
T Consensus 208 ~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~--------------------~~~-~~~-~~~~L~~L~l~~n~l~~~~p~ 265 (520)
T 2z7x_B 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFI--------------------RIL-QLV-WHTTVWYFSISNVKLQGQLDF 265 (520)
T ss_dssp HHHHHHHGGGGCTTCCEEEEEEEEEEHHHHH--------------------HHH-HHH-HTSSCSEEEEEEEEEESCCCC
T ss_pred eeecchhhhccccchhhccccccccCHHHHH--------------------HHH-HHh-hhCcccEEEeecccccCcccc
Confidence 0011223466777777777777765532111 111 111 245899999999999989999
Q ss_pred hh-----hccCCCCEEEeecccccCccc-cccccc---cccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCC
Q 036011 392 TV-----GRLEQLQGLSLYGNNLEGSIP-YDLCHL---ERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIP 462 (977)
Q Consensus 392 ~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 462 (977)
.+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|++.... .+..+++|++|++++|++++..|
T Consensus 266 ~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~ 341 (520)
T 2z7x_B 266 RDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVF 341 (520)
T ss_dssp CCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTT
T ss_pred chhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhh
Confidence 88 9999999999999999 455 555555 78999999999987432 13688999999999999999899
Q ss_pred ccccCcccCceEEccCCCCCC--CCccccccccccCeeeCcCCcCCCCcchh-hhcccccceeccCCccccccccccccC
Q 036011 463 SSFWSLEYLLAVNLSSNSLSG--SLPSNIQNLQVLINLDLSRNQLSGDIPIT-IGSLKDLVTLSLASNQFEGPIPQTFGS 539 (977)
Q Consensus 463 ~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 539 (977)
..+..+++|+.|++++|++++ .+|..+..+++|++|+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+.
T Consensus 342 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~- 420 (520)
T 2z7x_B 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420 (520)
T ss_dssp TTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred hhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence 999999999999999999996 45678999999999999999999757764 88899999999999999988887765
Q ss_pred ccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCC--CCCCcCCCCCcccCccccC
Q 036011 540 LTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN--GPFKYFAPQSFSWNYALCG 603 (977)
Q Consensus 540 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~~lcg 603 (977)
++|+.|||++|+|+ .+|..+..+++|++|++++|++++ +|.. ..+.......+++|+..|.
T Consensus 421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 79999999999999 889988899999999999999994 6653 2344444556688877774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=407.68 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=190.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCC--------
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-------- 752 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 752 (977)
++|++++.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 799999999976543 34567899999999999999999999987544
Q ss_pred ----eeEEEEeccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 753 ----FRALVLELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 753 ----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
..|+|||||++|+|.+++..... ..++..++.++.||++||+||| ++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999987543 3567778999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCcc----------eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHH
Q 036011 827 FGLSKLFDEGDDSV----------TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896 (977)
Q Consensus 827 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 896 (977)
||+|+.+....... ..+..+||+.|||||++.+..|+.++||||+||++|||++ ||..... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HHH
Confidence 99999875432211 1233579999999999999999999999999999999996 7643211 011
Q ss_pred HHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .. +.. ....+...+......+++.+||+.||++|||+.|++++
T Consensus 236 ~~-~~--------~~~------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TL-TD--------VRN------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-HH--------HHT------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH-HH--------Hhc------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 00 000 00011222334456789999999999999999999873
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=444.23 Aligned_cols=490 Identities=21% Similarity=0.188 Sum_probs=407.6
Q ss_pred CcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEec
Q 036011 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSL 129 (977)
Q Consensus 50 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 129 (977)
..+++|||++|.|++..|.+|+++++|++|||++|+|+++.|.+|.+|++|++|+|++|++++..+..|+.+++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 46899999999999655678999999999999999999988889999999999999999999666678999999999999
Q ss_pred cCcCCCCCCCCcccCcCcccceecccccccc-ccCccccCccccceeeeecccccccCCccccCCCCCc----eEEeecc
Q 036011 130 RNNSFTGPIPNSLFNLSRLEKWDSMFNIIDG-NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLE----ILVLGMN 204 (977)
Q Consensus 130 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~----~L~l~~N 204 (977)
++|++++..+..|+++++|++|++++|.+++ .+|..++.+++|++|+|++|+|++..+..|..+.+++ .++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999998777889999999999999999976 5689999999999999999999988888887766554 6888999
Q ss_pred CCCCCCchhhccccceeEEEccCCccccc----------------------------ccCCCccccCCCCceEEEecCce
Q 036011 205 NLSGPIQPSIFNISTITLINLFGNQLSGH----------------------------LDLPPKVSYSLPNLRVFSLGKNK 256 (977)
Q Consensus 205 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~----------------------------~~~~~~~~~~l~~L~~L~L~~N~ 256 (977)
.++... ...+....+..+++.+|..... .......+..+..+..+.+..+.
T Consensus 212 ~l~~i~-~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 212 PMNFIQ-PGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCEEC-TTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred cccccC-cccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 988544 3444455677777777743310 00111222233444555544433
Q ss_pred ee---ecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecC
Q 036011 257 LT---GTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVAS 333 (977)
Q Consensus 257 l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 333 (977)
.. ...+..+....+++.+++.+|.+.... .+.....|+.|++.+|.+..+.. ..++.|+.+++..
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~----------~~l~~L~~l~l~~ 358 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT----------LKLKSLKRLTFTS 358 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC----------CBCTTCCEEEEES
T ss_pred hcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc----------ccchhhhhccccc
Confidence 22 234556777888999999999988653 46667889999999999887653 3467889999999
Q ss_pred CCCCCCCCcccccccccccccccccCccc--ccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccC
Q 036011 334 NPLRGILPPVIGNFSASLQNFYAYDCKLT--GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG 411 (977)
Q Consensus 334 N~l~~~~p~~~~~~~~~L~~L~l~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 411 (977)
|.+....+. .. .++++.+++.+|.+. +..+..+..+.+|+.|++..|.+. ..+..+..+++|+.++++.|+...
T Consensus 359 n~~~~~~~~--~~-l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~ 434 (635)
T 4g8a_A 359 NKGGNAFSE--VD-LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 434 (635)
T ss_dssp CCSCCBCCC--CB-CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEES
T ss_pred ccCCCCccc--cc-ccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccc
Confidence 987754332 12 347889999999886 456777888999999999999987 466778899999999999988776
Q ss_pred ccc-cccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcC-CCCCCccccCcccCceEEccCCCCCCCCcccc
Q 036011 412 SIP-YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKF-SSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI 489 (977)
Q Consensus 412 ~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 489 (977)
..+ ..+..+.+++.+++++|++.+..+..+..+++|+.|+|++|++ .+..|..|..+++|+.|+|++|+|++..|..|
T Consensus 435 ~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 514 (635)
T 4g8a_A 435 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 514 (635)
T ss_dssp TTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence 554 5678899999999999999999999999999999999999985 45678999999999999999999999899999
Q ss_pred ccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCc-cccCeeeccCCccCCC
Q 036011 490 QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSL-TGLESLDLSNNNLSGE 556 (977)
Q Consensus 490 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~ 556 (977)
.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+ ++|+.|+|++|++++.
T Consensus 515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred cCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999999999998888999999999999999999999999999998 6899999999999864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=423.60 Aligned_cols=462 Identities=22% Similarity=0.242 Sum_probs=349.6
Q ss_pred cccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceecc
Q 036011 75 FLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSM 154 (977)
Q Consensus 75 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 154 (977)
..+++|+++|++++ +|..+. ++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..|.++++|++|+++
T Consensus 32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 34889999999988 776664 789999999999987667888999999999999999988778888888888888888
Q ss_pred ccccccccCccccCccccceeeeecccccc-cCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCccccc
Q 036011 155 FNIIDGNIPSRIGNLSSLVNVNLAYNNLQG-EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGH 233 (977)
Q Consensus 155 ~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 233 (977)
+|.|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++. .+..+++|
T Consensus 109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L------------- 169 (562)
T 3a79_B 109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHL------------- 169 (562)
T ss_dssp TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTS-------------
T ss_pred CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhc-------------
Confidence 88887 56665 77888888888888875 3457788888888888888877642 22222222
Q ss_pred ccCCCccccCCCCceEEEecCcee--eecCCccccccc-ccceEeecccccccccc-cccccccccccccccccccCCCC
Q 036011 234 LDLPPKVSYSLPNLRVFSLGKNKL--TGTIPNSITNAS-KLTGLDLSFNSFSGLIP-HTFGNLRFLSVLNLANNYLTTDS 309 (977)
Q Consensus 234 ~~~~~~~~~~l~~L~~L~L~~N~l--~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 309 (977)
+|++|++++|++ ++..|..+..+. +...+++++|.+.+.++ ..+..+++|+.|++++|....
T Consensus 170 ------------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~-- 235 (562)
T 3a79_B 170 ------------HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC-- 235 (562)
T ss_dssp ------------CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTH--
T ss_pred ------------eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccccccccc--
Confidence 236666666666 555666665543 12256777887765443 346678888888888885210
Q ss_pred CCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCC
Q 036011 310 PTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTI 389 (977)
Q Consensus 310 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 389 (977)
......++.+..+++|+.|++.++.+.+. .+.+ ++..+ ..++|++|++++|.+++.+
T Consensus 236 -~~l~~~~~~l~~l~~L~~L~L~~~~l~~~--------------------~~~~-~~~~~-~~~~L~~L~l~~n~l~~~i 292 (562)
T 3a79_B 236 -QRLMTFLSELTRGPTLLNVTLQHIETTWK--------------------CSVK-LFQFF-WPRPVEYLNIYNLTITERI 292 (562)
T ss_dssp -HHHHHHHHHHHSCSSCEEEEEEEEEECHH--------------------HHHH-HHHHH-TTSSEEEEEEEEEEECSCC
T ss_pred -chHHHHHHHHhccCcceEEEecCCcCcHH--------------------HHHH-HHHhh-hcccccEEEEeccEeeccc
Confidence 01112334577888899998888766531 1221 11112 2358999999999999888
Q ss_pred Chhh-----hccCCCCEEEeecccccCccc-ccccc---ccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCC
Q 036011 390 PSTV-----GRLEQLQGLSLYGNNLEGSIP-YDLCH---LERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS 460 (977)
Q Consensus 390 p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 460 (977)
|..+ ..++.|+.++++.|.+ .+| ..+.. ..+|+.|++++|++.... ....+++|++|++++|++++.
T Consensus 293 p~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~ 368 (562)
T 3a79_B 293 DREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDS 368 (562)
T ss_dssp CCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTT
T ss_pred cchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccc
Confidence 8887 7777777777887777 344 33333 367999999999986332 126889999999999999999
Q ss_pred CCccccCcccCceEEccCCCCCCC--CccccccccccCeeeCcCCcCCCCcch-hhhcccccceeccCCccccccccccc
Q 036011 461 IPSSFWSLEYLLAVNLSSNSLSGS--LPSNIQNLQVLINLDLSRNQLSGDIPI-TIGSLKDLVTLSLASNQFEGPIPQTF 537 (977)
Q Consensus 461 ~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~ 537 (977)
.|..+.++++|+.|++++|++++. +|..|.++++|++|+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+
T Consensus 369 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 448 (562)
T 3a79_B 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448 (562)
T ss_dssp TTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred hhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh
Confidence 999999999999999999999964 356799999999999999999975665 58899999999999999998877766
Q ss_pred cCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCC--CCCCcCCCCCcccCccccC
Q 036011 538 GSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN--GPFKYFAPQSFSWNYALCG 603 (977)
Q Consensus 538 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~~lcg 603 (977)
. ++|+.|+|++|+|+ .+|..+..+++|++|++++|++++ +|.. ..+.......+++|+..|.
T Consensus 449 ~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp C--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred c--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCC
Confidence 5 79999999999999 788888899999999999999995 6553 3444555566788887774
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=390.39 Aligned_cols=295 Identities=30% Similarity=0.475 Sum_probs=275.8
Q ss_pred ccChHHHHHHHHHHHHhccCCCCCccCCCCCCCCCCc--ccceEecCCC--CcEEEEEcCCCCCCc--cCCccccCcccc
Q 036011 3 VQNLTTDQFALLAFKAHVTDPQSVLANNWSISQPICK--WVGISCGARH--QRVRALNLSNMGLRG--TIPPHLGNFSFL 76 (977)
Q Consensus 3 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~L~l~~~~l~~--~~~~~l~~l~~L 76 (977)
+.|.++|++||++||+++.+|. .+ ++|..++|||. |.||+|+..+ ++|+.|+|++++++| .+|+.++++++|
T Consensus 1 ~~c~~~~~~aL~~~k~~~~~~~-~l-~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLGNPT-TL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTTCCG-GG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCCHHHHHHHHHHHHhcCCcc-cc-cCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 3588999999999999998876 44 68988889998 9999998765 899999999999999 899999999999
Q ss_pred cEeeccC-CcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccc
Q 036011 77 MSLDISK-NNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMF 155 (977)
Q Consensus 77 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~ 155 (977)
++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..++.+++|++|+|++|.+++.+|..+.++++|++|++++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999995 999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCccccCcc-ccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccc
Q 036011 156 NIIDGNIPSRIGNLS-SLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL 234 (977)
Q Consensus 156 n~i~~~~p~~~~~l~-~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 234 (977)
|.+++.+|..++.++ +|++|++++|++++.+|..++.++ |++|++++|++++..+..+..+++|+.|+|++|++++.
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~- 236 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD- 236 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB-
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee-
Confidence 999999999999998 999999999999999999999997 99999999999999999999999999999999999853
Q ss_pred cCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccccccccccccccccccc
Q 036011 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305 (977)
Q Consensus 235 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 305 (977)
++. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|+.
T Consensus 237 --~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~ 303 (313)
T 1ogq_A 237 --LGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303 (313)
T ss_dssp --GGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSE
T ss_pred --cCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCC
Confidence 223 567899999999999999999999999999999999999999888876 8899999999999983
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=397.55 Aligned_cols=202 Identities=23% Similarity=0.287 Sum_probs=172.5
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCe
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 753 (977)
....+.|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++++.+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999853 46889999986543 235678999999998 69999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeecccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKL 832 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~ 832 (977)
.++||||+++|+|.+++.. +++.++..++.|++.||+||| ++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999999843 889999999999999999999 8999999999999999876 7999999999986
Q ss_pred cCCCCCc--------------------------ceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCC
Q 036011 833 FDEGDDS--------------------------VTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPT 885 (977)
Q Consensus 833 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~ 885 (977)
....... ...+..+||++|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 112234799999999998775 5899999999999999999999999
Q ss_pred CcCC
Q 036011 886 DDMF 889 (977)
Q Consensus 886 ~~~~ 889 (977)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=401.52 Aligned_cols=268 Identities=23% Similarity=0.260 Sum_probs=202.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec------CCe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN------NDF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 753 (977)
++|++++.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 79999999997543 3345678899999999999999999998753 367
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+|||||+ |+|.+++...+ .+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 68999997655 4999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCC--cceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--CCchh
Q 036011 834 DEGDD--SVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--PHGLM 908 (977)
Q Consensus 834 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 908 (977)
..... .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+....+ .+........ +....
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHh
Confidence 54321 1223446899999999998775 57999999999999999999999997643221 1222221111 00000
Q ss_pred hhcc----h----hhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVD----T----NLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~----~----~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... . .+....... .........+.+++.+|++.||++|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 000000000 0001123457899999999999999999999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=404.31 Aligned_cols=403 Identities=26% Similarity=0.307 Sum_probs=193.8
Q ss_pred CcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccce
Q 036011 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKW 151 (977)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 151 (977)
..++|++|++++|++ +.+|++|+++++|++|+|++|+++|.+|.+++.+++|+++++++|.. .+|++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 345566666666666 44565666666666666666666655666666665555555554432 234455
Q ss_pred eccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCccc
Q 036011 152 DSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231 (977)
Q Consensus 152 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 231 (977)
++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++.
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l---------------------- 126 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL---------------------- 126 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC----------------------
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc----------------------
Confidence 555555442 2221 2345555555555553 4432 24555555555555431
Q ss_pred ccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCC
Q 036011 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311 (977)
Q Consensus 232 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 311 (977)
+.. .++|++|++++|++++ +| .+.++++|++|++++|++++ +|..+ .+|++|++++|++++++
T Consensus 127 -----~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-- 189 (454)
T 1jl5_A 127 -----SDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-- 189 (454)
T ss_dssp -----CSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC--
T ss_pred -----cCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc--
Confidence 110 1345555555555553 44 35555555555555555554 23222 35555555555555432
Q ss_pred chhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCCh
Q 036011 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPS 391 (977)
Q Consensus 312 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 391 (977)
.+..+++|++|++++|.+.+ +|.. ..+|+.|++++|+++ .+| .++.+++|++|++++|++++ +|.
T Consensus 190 -------~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~ 254 (454)
T 1jl5_A 190 -------ELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD 254 (454)
T ss_dssp -------CCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS
T ss_pred -------cccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccc
Confidence 14455555555555555553 2211 124555555555555 445 36677777777777777774 443
Q ss_pred hhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCc-cc
Q 036011 392 TVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL-EY 470 (977)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~ 470 (977)
. +++|++|++++|++++ +|.. .++|+.|++++|++++ +|.. .++|++|++++|++++ ++ .+ ++
T Consensus 255 ~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~ 318 (454)
T 1jl5_A 255 L---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLPPS 318 (454)
T ss_dssp C---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCCTT
T ss_pred c---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCcCc
Confidence 2 3677777777777774 4433 3677777777777774 2211 1467777777777774 22 22 46
Q ss_pred CceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccc--cccccccCccccCeeec
Q 036011 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG--PIPQTFGSLTGLESLDL 548 (977)
Q Consensus 471 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L 548 (977)
|+.|++++|++++ +|.. +++|++|++++|+++ .+|. .+++|+.|+|++|++++ .+|.+++.+
T Consensus 319 L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L-------- 382 (454)
T 1jl5_A 319 LEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL-------- 382 (454)
T ss_dssp CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------
T ss_pred CCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------
Confidence 7777777777775 4443 466777777777777 4555 46777777777777776 556655443
Q ss_pred cCCccCCCCCcccccccccCccccCCCcccc--cCCC
Q 036011 549 SNNNLSGEIPKSLEALLFLKQLNVSHNKLEG--EIPA 583 (977)
Q Consensus 549 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~ 583 (977)
+.|++.|.+|.. +++|+.|++++|+++| .+|.
T Consensus 383 ~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 383 RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp ECCC---------------------------------
T ss_pred hhcccccccccc---cCcCCEEECCCCcCCccccchh
Confidence 234555555542 3567777777777776 5553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=402.90 Aligned_cols=394 Identities=21% Similarity=0.249 Sum_probs=246.1
Q ss_pred cEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceecccc
Q 036011 77 MSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFN 156 (977)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n 156 (977)
+.++.++++++. +|. + .++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.++
T Consensus 13 ~~~~c~~~~l~~-lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~----------------- 71 (455)
T 3v47_A 13 YNAICINRGLHQ-VPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR----------------- 71 (455)
T ss_dssp TEEECCSSCCSS-CCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC-----------------
T ss_pred cccCcCCCCccc-CCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC-----------------
Confidence 345666666655 444 2 2566666666666665556666666666666666666553321
Q ss_pred ccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccC
Q 036011 157 IIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDL 236 (977)
Q Consensus 157 ~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 236 (977)
|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++..+..
T Consensus 72 ------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------------- 122 (455)
T 3v47_A 72 ------NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG----------------------- 122 (455)
T ss_dssp ------TTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS-----------------------
T ss_pred ------cccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCc-----------------------
Confidence 233444555555555555555444555555555555555555554322211
Q ss_pred CCccccCCCCceEEEecCceeeecCCcc-cccccccceEeecccccccccccccccc--cccccccccccccCCCCCCch
Q 036011 237 PPKVSYSLPNLRVFSLGKNKLTGTIPNS-ITNASKLTGLDLSFNSFSGLIPHTFGNL--RFLSVLNLANNYLTTDSPTAE 313 (977)
Q Consensus 237 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~ 313 (977)
..+..+++|++|+|++|++++..|.. +..+++|++|+|++|++++..+..+..+ .+|+.|++++|.+..+++...
T Consensus 123 --~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~ 200 (455)
T 3v47_A 123 --NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200 (455)
T ss_dssp --STTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCT
T ss_pred --ccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhc
Confidence 11223344444444444444444443 5556666666666666666555555554 455666666665554433210
Q ss_pred hhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhh
Q 036011 314 WSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTV 393 (977)
Q Consensus 314 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 393 (977)
. ......+..+++|++|++++|.+++..|..+
T Consensus 201 -------------------------------~-----------------~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 232 (455)
T 3v47_A 201 -------------------------------G-----------------WEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232 (455)
T ss_dssp -------------------------------T-----------------HHHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred -------------------------------c-----------------ccccccccccceeeeEecCCCcccccchhhh
Confidence 0 0000112233455555555555555555554
Q ss_pred hcc---CCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcC--CCCCCeeecCCCcCCCCCCccccCc
Q 036011 394 GRL---EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS--LISLRELNLGSNKFSSSIPSSFWSL 468 (977)
Q Consensus 394 ~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l 468 (977)
... ++|+.|++++|.+.+.. +..+.+.+..+..+.. .++|++|++++|++.+..|..|..+
T Consensus 233 ~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 298 (455)
T 3v47_A 233 FDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF 298 (455)
T ss_dssp HHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTC
T ss_pred hccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccC
Confidence 443 56666666666654321 1122222222222332 3578888888888888888888888
Q ss_pred ccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeec
Q 036011 469 EYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDL 548 (977)
Q Consensus 469 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 548 (977)
++|+.|++++|++++..|..|.++++|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..|..+++|++|+|
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 88888888888888777888888889999999999998777888888999999999999998888888999999999999
Q ss_pred cCCccCCCCCcccccccccCccccCCCcccccCCCC
Q 036011 549 SNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPAN 584 (977)
Q Consensus 549 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 584 (977)
++|+|++..+..+..+++|++|++++|+++|.+|..
T Consensus 379 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 999998766667788999999999999999988853
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=402.22 Aligned_cols=384 Identities=21% Similarity=0.205 Sum_probs=240.6
Q ss_pred EEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCC-CccccccccCcEEeccCcC
Q 036011 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF-PSWIGVLSKLQILSLRNNS 133 (977)
Q Consensus 55 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~ 133 (977)
++.++++++ .+|. + .++|++|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+.+++|++|+|++|.
T Consensus 15 ~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~ 90 (455)
T 3v47_A 15 AICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90 (455)
T ss_dssp EECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT
T ss_pred cCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCc
Confidence 344555666 6776 3 378999999999999988999999999999999999998666 5679999999999999999
Q ss_pred CCCCCCCcccCcCcccceeccccccccccCcc--ccCccccceeeeecccccccCCcc-ccCCCCCceEEeeccCCCCCC
Q 036011 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSR--IGNLSSLVNVNLAYNNLQGEIPSE-IGNLQNLEILVLGMNNLSGPI 210 (977)
Q Consensus 134 l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~--~~~l~~L~~L~L~~n~i~~~~p~~-l~~l~~L~~L~l~~N~l~~~~ 210 (977)
+++..|..|.++++|++|++++|.+++.+|.. |+++++|++|+|++|++++..|.. +.++++|++|++++|++++..
T Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 170 (455)
T 3v47_A 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170 (455)
T ss_dssp TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCC
T ss_pred cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccC
Confidence 99888999999999999999999998866655 999999999999999999877776 899999999999999999888
Q ss_pred chhhccc--cceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccc
Q 036011 211 QPSIFNI--STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288 (977)
Q Consensus 211 ~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 288 (977)
+..+..+ .+|+.|++++|.+.+. ++..+. ......+..+++|++|++++|++++..|..
T Consensus 171 ~~~l~~l~~~~L~~L~l~~n~l~~~---~~~~~~----------------~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~ 231 (455)
T 3v47_A 171 EEDLLNFQGKHFTLLRLSSITLQDM---NEYWLG----------------WEKCGNPFKNTSITTLDLSGNGFKESMAKR 231 (455)
T ss_dssp TTTSGGGTTCEEEEEECTTCBCTTC---STTCTT----------------HHHHCCTTTTCEEEEEECTTSCCCHHHHHH
T ss_pred hhhhhccccccccccccccCccccc---chhhcc----------------ccccccccccceeeeEecCCCcccccchhh
Confidence 7777765 5677777777766532 211110 000111234455666666666666555554
Q ss_pred cccc---cccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccC
Q 036011 289 FGNL---RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365 (977)
Q Consensus 289 ~~~l---~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~ 365 (977)
+..+ ++|+.|++++|.+..... ..+.+. ...
T Consensus 232 ~~~~~~~~~L~~L~l~~~~~~~~~~---------------------~~~~~~-------------------------~~~ 265 (455)
T 3v47_A 232 FFDAIAGTKIQSLILSNSYNMGSSF---------------------GHTNFK-------------------------DPD 265 (455)
T ss_dssp HHHHTTTCCEEEEECTTCTTTSCCT---------------------TCCSSC-------------------------CCC
T ss_pred hhccccccceeeEeecccccccccc---------------------chhhhc-------------------------cCc
Confidence 4433 455555555554332110 001111 011
Q ss_pred Ccccc--ccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcC
Q 036011 366 PHEIG--NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS 443 (977)
Q Consensus 366 p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 443 (977)
+..+. ..++|++|++++|.+.+..|..++.+++|++|+|++|++++..|..|..+++|+.|++++|++++..|..|..
T Consensus 266 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (455)
T 3v47_A 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345 (455)
T ss_dssp TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTT
T ss_pred ccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcC
Confidence 11111 1234555555555555555555555555555555555555444444545555555555555554444444444
Q ss_pred CCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCC
Q 036011 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG 507 (977)
Q Consensus 444 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 507 (977)
+++|++|+|++|++++..|..|..+++|+.|++++|+|++..+..|..+++|++|+|++|++++
T Consensus 346 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 4555555555555444444444444444444444444443333333444444444444444443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=404.76 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=198.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHH---HHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSF---DSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.++||+|+||+||+|+.. +|+.||||++.+.. ......+ ..++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999975 69999999997643 1112223 3446677788999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|+||||++||+|.+++...+ .+++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999998754 4899999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc-cHHHHHHhhCCCchhhhcc
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM-SLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 912 (977)
... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+...... .+.......
T Consensus 344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------- 409 (689)
T 3v5w_A 344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 409 (689)
T ss_dssp SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----------
T ss_pred CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----------
Confidence 432 233579999999999864 5799999999999999999999999976432221 111111100
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAV 955 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~ 955 (977)
..... ..+...+.+++.+|++.||.+|++ ++||.+
T Consensus 410 -~~~~p-------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 -AVELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCCC-------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCCC-------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00000 112345688999999999999998 677754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=410.85 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=211.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 7999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC--CceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED--MVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~ 838 (977)
|+||+|.+++......+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999776666999999999999999999999 7899999999999999854 899999999999876533
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ .+..........
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~~~------------- 375 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNM------------- 375 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCCC-------------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCCCC-------------
Confidence 2334579999999999999999999999999999999999999997643221 111111111100
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+||+.||.+|||+.|++++
T Consensus 376 --~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111223456889999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=381.96 Aligned_cols=280 Identities=34% Similarity=0.559 Sum_probs=232.6
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
+.++...+++|+..+.||+|+||+||+|+.++|+.||||++........+.+.+|+++++.++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33455678899999999999999999999888999999998876666678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 755 ALVLELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
++||||+++|+|.+++.... ..+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999997643 25899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcc-cccHHHHHHhhCCCc-hhh
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG-EMSLKKWVKESLPHG-LME 909 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~ 909 (977)
...............||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ......|........ +..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 765433333334456899999999998889999999999999999999999999765433 234455544332222 333
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+++.... ....+++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 268 ~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 268 IVDPNLAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSCTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcChhhcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 33333221 1123567789999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=379.52 Aligned_cols=291 Identities=36% Similarity=0.523 Sum_probs=239.5
Q ss_pred hhccCCCHHHHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEee
Q 036011 668 AAWRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFS 746 (977)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~ 746 (977)
.....+++.++....++|++.+.||+|+||+||+|+..+|+.||||++..... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567888999999999999999999999999999988899999999876542 22346899999999999999999999
Q ss_pred eeecCCeeEEEEeccCCCCHHHHhhcCCc---cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceE
Q 036011 747 SCCNNDFRALVLELMPNGSLEKWLYSDNY---FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 747 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
++.+.+..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+..||+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999986543 489999999999999999999954444999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC---CcccccHHHHHH
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM---FTGEMSLKKWVK 900 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~---~~~~~~~~~~~~ 900 (977)
|+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||+.. .........|..
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999877543322 233456999999999998889999999999999999999999999632 233455667766
Q ss_pred hhCCCc-hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcC
Q 036011 901 ESLPHG-LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIG 964 (977)
Q Consensus 901 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (977)
...... .....+...... ...+....+.+++.+||+.+|.+|||++|++++|++.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTS-----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHhhchhhhhhcChhhccc-----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 655443 334444333221 12355678999999999999999999999999998766433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=391.85 Aligned_cols=406 Identities=25% Similarity=0.291 Sum_probs=195.3
Q ss_pred CcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCC-------------CEEeCcCccCCCCCCc
Q 036011 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRL-------------RFISLDYNEFSGSFPS 116 (977)
Q Consensus 50 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~p~ 116 (977)
.++++|+++++++ |.+|++++++++|++|++++|.+++.+|.+++++++| ++|++++|+++ .+|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCC
Confidence 5689999999999 7999999999999999999999999999999999987 55555555555 2333
Q ss_pred cccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCC
Q 036011 117 WIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNL 196 (977)
Q Consensus 117 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L 196 (977)
. .++|++|++++|.+++ +|.. +++|++|++++|.+++ +|.. .++|++|++++|++++ +| .|+++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 1 2445555555555553 3432 2445555555554442 1211 1344555555555542 34 34445555
Q ss_pred ceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEee
Q 036011 197 EILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDL 276 (977)
Q Consensus 197 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 276 (977)
++|++++|++++ +|.. ..+|++|++++|++++ +| .+..+++|++|++
T Consensus 156 ~~L~l~~N~l~~---------------------------lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 156 KIIDVDNNSLKK---------------------------LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp CEEECCSSCCSC---------------------------CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CEEECCCCcCcc---------------------------cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 555555544442 2211 1355566666666553 34 3555666666666
Q ss_pred cccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccccccccccccccc
Q 036011 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYA 356 (977)
Q Consensus 277 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l 356 (977)
++|+++++ |... ++|++|++++|.++.++. +..+++|++|++++|.+++. |.
T Consensus 203 ~~N~l~~l-~~~~---~~L~~L~l~~n~l~~lp~---------~~~l~~L~~L~l~~N~l~~l-~~-------------- 254 (454)
T 1jl5_A 203 DNNSLKKL-PDLP---LSLESIVAGNNILEELPE---------LQNLPFLTTIYADNNLLKTL-PD-------------- 254 (454)
T ss_dssp CSSCCSSC-CCCC---TTCCEEECCSSCCSSCCC---------CTTCTTCCEEECCSSCCSSC-CS--------------
T ss_pred CCCcCCcC-CCCc---CcccEEECcCCcCCcccc---------cCCCCCCCEEECCCCcCCcc-cc--------------
Confidence 66666542 2221 356666666666554331 44556666666666655531 11
Q ss_pred ccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCC
Q 036011 357 YDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP 436 (977)
Q Consensus 357 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 436 (977)
.+++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|+.|++++|++++
T Consensus 255 --------------~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~- 311 (454)
T 1jl5_A 255 --------------LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS- 311 (454)
T ss_dssp --------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-
T ss_pred --------------cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-
Confidence 11345555555555553 3332 2566677777776664 2211 1567777777777763
Q ss_pred chhhhcCC-CCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCC--Ccchhh
Q 036011 437 IPQCLASL-ISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG--DIPITI 513 (977)
Q Consensus 437 ~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~ 513 (977)
++ .+ ++|++|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|++|++++|++++ .+|..+
T Consensus 312 i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l 379 (454)
T 1jl5_A 312 LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESV 379 (454)
T ss_dssp EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHH
Confidence 22 22 478888888888885 4543 4778888888888884 555 46788899999999887 566655
Q ss_pred hcccccceeccCCccccccccccccCccccCeeeccCCccCC--CCCcccccccccCccccCCCcccccCCC
Q 036011 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG--EIPKSLEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 514 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
+.+ +.|.+.+.+|.. +++|+.|||++|++++ .+|.+ ++.|.+.+|.+.+.+|.
T Consensus 380 ~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 380 EDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp CEE--------ECCC---------------------------------------------------------
T ss_pred Hhh--------hhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence 433 346677777763 5789999999999987 66654 56677888998887764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=375.67 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=211.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----eeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND----FRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 757 (977)
.++|++.+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367899999999999999999875 7999999997553 33455677999999999999999999998744 36899
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEeCCCCCCceeeCCCCceEEeec
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST----------PVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
|||+++|+|.++++... +++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999998754 899999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc---------
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--------- 893 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------- 893 (977)
|+++.+.............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99988765443333344579999999999876 4577889999999999999999999976433211
Q ss_pred --cHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 894 --SLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 894 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....+.......... ...........+...+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKR--------PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SCCHHHHHHHHTTSCCC--------CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCC--------CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111111111100 0001111122355678999999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=369.78 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=215.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|.+.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999975 6999999998766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999986667999999999999999999999 7899999999999999999999999999998765432211
Q ss_pred e------------eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc----cHHHHHHhhCC
Q 036011 841 T------------QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM----SLKKWVKESLP 904 (977)
Q Consensus 841 ~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----~~~~~~~~~~~ 904 (977)
. .....||+.|+|||++.+..++.++||||+|+++|||++|..|+........ ..........+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 0 1134699999999999999999999999999999999999999876433221 11111111100
Q ss_pred CchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
..++..+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 246 ---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 246 ---------------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11233578899999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.52 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=209.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999996 47999999999877666667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++|+|.+++.... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 99999999998754 899999999999999999999 78999999999999999999999999999987754332
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........+. .
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~---------~----- 236 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE---------L----- 236 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC---------C-----
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC---------C-----
Confidence 23345699999999999999999999999999999999999999975422211 11111111100 0
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+..+...+.+++.+||+.||++|||++|++++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0011234457899999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.77 Aligned_cols=268 Identities=26% Similarity=0.363 Sum_probs=204.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
..++|++.+.||+|+||+||+|+. .|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346788999999999999999987 68899999987553 344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 759 ELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
||+++|+|.+++..... .+++..++.++.|++.||+||| +.| |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999987543 4899999999999999999999 788 9999999999999999999999999998654
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ....+......
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~--------- 257 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCKR--------- 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSCCC---------
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCC---------
Confidence 322 12233569999999999999999999999999999999999999997643221 11111100000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCcccccccc
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVLVLSRAE 972 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~~~ 972 (977)
. ..+..+...+.+++.+||+.+|++|||++|+++.|+.+.....++-.|++
T Consensus 258 ~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~~ 308 (309)
T 3p86_A 258 L-------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308 (309)
T ss_dssp C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----------
T ss_pred C-------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCccc
Confidence 0 00012234578999999999999999999999999998876666655554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=378.41 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=213.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
.++|++.+.||+|+||+||+|+.. ++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 35679999997653 34457799999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 752 DFRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
+..++||||+++|+|.+++.... ..+++..+..++.||++||+||| +.||+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999998653 24789999999999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999987765433333334457889999999999999999999999999999999 999987643221 1
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.......... ..+..+...+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 315 ~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 315 FKLLKEGHRM-----------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHHHTTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC-----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111000 0011234468899999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=360.11 Aligned_cols=282 Identities=29% Similarity=0.453 Sum_probs=229.2
Q ss_pred hccCCCHHHHHHhhcCCCcC------ccccCcceEEEEEEEeCCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhcCC
Q 036011 669 AWRRTSYLDIQRATDGFNEC------NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRH 738 (977)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h 738 (977)
....+++.++..+++.|... +.||+|+||+||+|+. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678899999999998877 8999999999999987 68899999986532 3345779999999999999
Q ss_pred CCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSD--NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 739 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
|||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999999999999999999999999998743 235899999999999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 896 (977)
+.++.+||+|||++................||+.|+|||++.+ .++.++||||+|+++|+|++|..||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 9999999999999987765443333344569999999998765 58999999999999999999999997654332 222
Q ss_pred HHHHhh--CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 897 KWVKES--LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 897 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+.... ....+.+.++..+. .....++..+.+++.+||+.+|.+|||+.+++++|++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhcccccc------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222211 11223333333221 1123456778999999999999999999999999998863
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=377.67 Aligned_cols=363 Identities=18% Similarity=0.216 Sum_probs=204.1
Q ss_pred CCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCc
Q 036011 62 LRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNS 141 (977)
Q Consensus 62 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 141 (977)
..+..+.+++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++ +| ++.+++|++|+|++|.+++. |
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--
Confidence 344455667788888888888888887 45 67888888888888888874 44 77788888888888888753 3
Q ss_pred ccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhcccccee
Q 036011 142 LFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221 (977)
Q Consensus 142 l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~ 221 (977)
++++++|++|++++|.+++ +| ++.+++|++|++++|++++ ++ ++++++|++|++++|+..+.+ .+..+
T Consensus 102 ~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l---- 169 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQ---- 169 (457)
T ss_dssp CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTC----
T ss_pred cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccC----
Confidence 6777777777777777765 33 6777777777777777775 32 667777777777777544333 23344
Q ss_pred EEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccccccccccccccc
Q 036011 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLA 301 (977)
Q Consensus 222 ~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 301 (977)
++|++|++++|++++ +| +..+++|++|++++|++++. .++.+++|+.|+++
T Consensus 170 -----------------------~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls 220 (457)
T 3bz5_A 170 -----------------------TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCS 220 (457)
T ss_dssp -----------------------TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECC
T ss_pred -----------------------CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECc
Confidence 445555555555553 23 44555555555555555543 25555566666666
Q ss_pred ccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEee
Q 036011 302 NNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLF 381 (977)
Q Consensus 302 ~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 381 (977)
+|++++++ +..+++|+.|++++|++++.. ++.+++|+.|+++
T Consensus 221 ~N~l~~ip----------~~~l~~L~~L~l~~N~l~~~~----------------------------~~~l~~L~~L~l~ 262 (457)
T 3bz5_A 221 SNKLTEID----------VTPLTQLTYFDCSVNPLTELD----------------------------VSTLSKLTTLHCI 262 (457)
T ss_dssp SSCCSCCC----------CTTCTTCSEEECCSSCCSCCC----------------------------CTTCTTCCEEECT
T ss_pred CCcccccC----------ccccCCCCEEEeeCCcCCCcC----------------------------HHHCCCCCEEecc
Confidence 66655532 334455555555555544321 1233444444444
Q ss_pred cCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCC
Q 036011 382 INALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSI 461 (977)
Q Consensus 382 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 461 (977)
+| +|+.|++++|.+.+.+| +..+++|+.|++++|++.+.+|. ...+|+.|++++|
T Consensus 263 ~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~------ 317 (457)
T 3bz5_A 263 QT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN------ 317 (457)
T ss_dssp TC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC------
T ss_pred CC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc------
Confidence 33 23444555555544444 34455555555555555544442 2233444444433
Q ss_pred CccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCcc
Q 036011 462 PSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLT 541 (977)
Q Consensus 462 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 541 (977)
++|+.|++++|+|++. + +.++++|+.|++++|++++ ++.|..|++++|.+.|. +++.
T Consensus 318 -------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~ 374 (457)
T 3bz5_A 318 -------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTI 374 (457)
T ss_dssp -------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEE
T ss_pred -------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceee
Confidence 3455555555555542 1 4445555555555555543 12344444444444432 2333
Q ss_pred ccCeeeccCCccCCCCCc
Q 036011 542 GLESLDLSNNNLSGEIPK 559 (977)
Q Consensus 542 ~L~~L~Ls~N~l~~~~p~ 559 (977)
.|+.++|++|+++|.+|.
T Consensus 375 ~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 375 TMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp ECCCBCCBTTBEEEECCT
T ss_pred ecCccccccCcEEEEcCh
Confidence 344444444444444443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=382.57 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=212.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999986 78999999987553 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999876666999999999999999999999 789999999999999999999999999999865432211
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......+++.|+|||++.++.++.++|||||||++|||++ |..||......+ ....+......
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGGRL------------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTCCC-------------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC-------------
Confidence 11112235778999999998899999999999999999998 999987643221 11111111000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+.+..++..+.+++.+||+.+|++|||++++++.|++++.
T Consensus 335 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 ----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0011234567899999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=369.73 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=211.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.+.||+|+||+||+|++. .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888999999999999999974 34569999997653 3445779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999877667999999999999999999999 789999999999999999999999999999887543
Q ss_pred CCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 837 DDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 837 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
... .......+|+.|+|||++.+..++.++||||+|+++|||++ |..||......+ ....+......
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~--------- 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYRL--------- 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCCC---------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCCC---------
Confidence 322 22233456788999999998999999999999999999999 999996643221 11111111000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
+....++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 274 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 --------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 00112345688999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=365.84 Aligned_cols=274 Identities=24% Similarity=0.396 Sum_probs=210.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 754 (977)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999984 2689999999987766667889999999999999999999999855 3568
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999887767999999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchh-hhcc
Q 036011 835 EGDDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM-EVVD 912 (977)
Q Consensus 835 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 912 (977)
..... .......++..|+|||++.+..++.++||||+|+++|||++|..|+...... ...+.......... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence 43322 1222345777899999999999999999999999999999999998643111 11111110000000 0000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+ ......+.+..++..+.+++.+||+.+|++|||++|+++.|+++..
T Consensus 243 ~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 243 ELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000 0000111122345678999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=362.14 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=213.3
Q ss_pred CCCHHHHHHhhcC----------CCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC
Q 036011 672 RTSYLDIQRATDG----------FNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN 740 (977)
Q Consensus 672 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n 740 (977)
.+++.+++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666666653 666789999999999999976 79999999998766666678999999999999999
Q ss_pred cceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC
Q 036011 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM 820 (977)
Q Consensus 741 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 820 (977)
|+++++++...+..++||||+++|+|.+++... .+++..+..++.|+++||+||| +.||+||||||+||+++.++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 999999999999999999999999999998754 3899999999999999999999 78999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH
Q 036011 821 VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK 900 (977)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 900 (977)
.+||+|||++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .......
T Consensus 179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~~ 254 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLR 254 (321)
T ss_dssp CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh
Confidence 999999999987654322 223456999999999999999999999999999999999999999753221 1111111
Q ss_pred hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 901 ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+.. +. ....+...+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~--------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 255 DSPPPK--------LK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HSSCCC--------CT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCC--------cC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 00 011123457899999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=359.70 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=213.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||+||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357888999999999999999988899999999975532 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence 999999999877777999999999999999999999 7899999999999999999999999999998764322 112
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ............ .+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~~-----------~~- 229 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRLY-----------KP- 229 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCCC-----------CC-
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCccCC-----------CC-
Confidence 223347788999999998999999999999999999999 999987532221 111111110000 00
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcC
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIG 964 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (977)
..+...+.+++.+||+.+|++||+++|++++|+++...|
T Consensus 230 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 230 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 012345789999999999999999999999999988543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=357.05 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=213.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||+||+|+.+++..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467889999999999999999998888999999975532 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++......+++..++.++.|+++||+||| +.||+||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 999999999877667999999999999999999999 78999999999999999999999999999987654332 22
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+. .... ..... ...+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~-~~~~~-----------~~~~- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKV-SQGHR-----------LYRP- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHH-HTTCC-----------CCCC-
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHH-HcCCC-----------CCCC-
Confidence 233446778999999998899999999999999999999 9999875432211 1111 00000 0000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..++..+.+++.+||+.+|++|||+.|++++|++++.
T Consensus 228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 -----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0123357899999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=362.98 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=206.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
..++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999997 579999999997653 34456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+. +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999976543 899999999999999999999 7899999999999999999999999999998765433
Q ss_pred CcceeeccccCCcccCccccCCCCcC-cccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVS-SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.....+||++|+|||++.+..++ .++||||+||++|||++|+.||.+....+. ..........
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~------------ 232 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-RERVLRGKYR------------ 232 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC------------
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC------------
Confidence 23345799999999999888765 899999999999999999999976432111 1111110000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ..+...+.+++.+|++.||.+|||+.|++++
T Consensus 233 ~p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 IP-------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC-------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC-------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0123456889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=363.38 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=207.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 799999999875432 334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++..... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.+......
T Consensus 86 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999976543 899999999999999999999 789999999999999999999999999999876543333
Q ss_pred ceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|........
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 229 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN------------ 229 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC------------
Confidence 33344579999999999887765 78999999999999999999999765444333444332211110
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
....+...+.+++.+|++.||++|||+.|++++
T Consensus 230 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011223456889999999999999999999765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=373.34 Aligned_cols=259 Identities=27% Similarity=0.451 Sum_probs=200.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.+.||+|+||+||+|+.. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 57789999997653 3445679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.++++.....+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999887767999999999999999999999 789999999999999999999999999999877543
Q ss_pred CCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 837 DDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 837 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+.. .
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~------------~ 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDE------------G 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHT------------T
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc------------C
Confidence 221 11222346788999999999999999999999999999998 999987543211 1111110 0
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.... ...+++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 267 ~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 YRLP-----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp EECC-----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 0000 011234568899999999999999999999999988764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.00 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=207.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHh--cCCCCcceEeeeeec----CCeeE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN--VRHRNLIKIFSSCCN----NDFRA 755 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~ 755 (977)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+.+|.+++.. ++||||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999998 68999999987542 3445566666666 799999999998654 34578
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG-----HSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
+||||+++|+|.++++.. .+++..+..++.|++.||+|||.. ++.+|+||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999999999654 489999999999999999999932 2678999999999999999999999999999
Q ss_pred cccCCCCCcce--eeccccCCcccCccccCCC------CcCcccchhhHhHHHHHHhcC----------CCCCCcCCccc
Q 036011 831 KLFDEGDDSVT--QTMTIATIGYMAPEYGTEG------IVSSKCDVYSYGVLLTETFTR----------KKPTDDMFTGE 892 (977)
Q Consensus 831 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~~~~~~~~ 892 (977)
+.......... .....||+.|+|||++.+. .++.++||||+||++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 87654433211 2234699999999998876 566899999999999999999 88887655444
Q ss_pred ccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
................. .+ ........++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~----~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRP----NI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCC----CC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCC----CC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 44443333222111100 00 00111224567789999999999999999999999999876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.84 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=209.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 68899999987543 3446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC--CCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE--DMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 838 (977)
+++|+|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++. ++.+||+|||++..+....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999877667999999999999999999999 789999999999999997 7899999999998876433
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......||+.|+|||++.+..++.++||||+||++|||++|..||......+ ............
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~------------- 222 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTF------------- 222 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCC-------------
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCCC-------------
Confidence 2334569999999999999999999999999999999999999997642211 111111111110
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......++..+.+++.+|++.||.+|||+.|++++
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001111234567899999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.42 Aligned_cols=268 Identities=23% Similarity=0.304 Sum_probs=206.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467999999999999999999998899999999875532 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++ +|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9974 888888877667999999999999999999999 78999999999999999999999999999987654322
Q ss_pred ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh---CCCchhhhcchhh
Q 036011 840 VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES---LPHGLMEVVDTNL 915 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 915 (977)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+....... .+..+....+...
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccch
Confidence 2333568999999998876 568999999999999999999999997654332 222222211 1111111111000
Q ss_pred h--------ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 L--------RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~--------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ...........+...+.+++.+|++.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000000011233467899999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=365.45 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=203.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCE----EEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTS----FAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|++.+.||+|+||+||+|++. +++. ||+|++.... ....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56889999999999999999864 4444 5788775433 344577999999999999999999999998755 779
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|+||+.+|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999887777999999999999999999999 789999999999999999999999999999987655
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ............
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~--------- 239 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLP--------- 239 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCC---------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCCCCC---------
Confidence 44444444567889999999999999999999999999999999 999997643322 222221111000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....+...+.+++.+||+.+|.+||++.|++++|+++..
T Consensus 240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001123457899999999999999999999999988753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=368.43 Aligned_cols=268 Identities=26% Similarity=0.376 Sum_probs=216.0
Q ss_pred CHHHHHHhhcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEe
Q 036011 674 SYLDIQRATDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIF 745 (977)
Q Consensus 674 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~ 745 (977)
...+.....++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444455678899999999999999999973 246899999997653 34456799999999999 799999999
Q ss_pred eeeecCC-eeEEEEeccCCCCHHHHhhcCCc-------------------------------------------------
Q 036011 746 SSCCNND-FRALVLELMPNGSLEKWLYSDNY------------------------------------------------- 775 (977)
Q Consensus 746 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------- 775 (977)
+++.+.+ ..++||||+++|+|.++++....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9988755 48999999999999999976532
Q ss_pred ----------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 776 ----------------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 776 ----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
.+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 2889999999999999999999 789999999999999999999999999999877654444
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......||+.|+|||++.+..++.++||||+||++|||++ |+.||......+. .............
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~----------- 317 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRA----------- 317 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCCC-----------
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCCC-----------
Confidence 44445678999999999999999999999999999999998 9999976433322 1111111111000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+..+...+.+++.+||+.+|++|||+.|++++|+++..
T Consensus 318 ------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 318 ------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 01123457899999999999999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=366.10 Aligned_cols=346 Identities=25% Similarity=0.354 Sum_probs=177.5
Q ss_pred CcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccce
Q 036011 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKW 151 (977)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 151 (977)
.+++|++|++++|.++. +| .+..+++|++|+|++|.+++ +|. ++.+++|++|+|++|.+++..| +.++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 45667777777777665 44 36667777777777777763 333 6677777777777777764433 5666666666
Q ss_pred eccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCccc
Q 036011 152 DSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231 (977)
Q Consensus 152 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 231 (977)
++++|.+++..+ ++++++|++|++++|++++ ++ .++++++|+.|+++ |.+.+.. .
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~------------------ 172 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--P------------------ 172 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--G------------------
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--h------------------
Confidence 666666554322 5666666666666666663 33 36666666666664 3333211 1
Q ss_pred ccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCC
Q 036011 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311 (977)
Q Consensus 232 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 311 (977)
+..+++|++|++++|++++. ..+..+++|++|++++|++++..| ++.+++|+.|++++|.++.++
T Consensus 173 ---------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-- 237 (466)
T 1o6v_A 173 ---------LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-- 237 (466)
T ss_dssp ---------GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--
T ss_pred ---------hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch--
Confidence 22344455555555554421 234555556666666665554433 444455555555555444321
Q ss_pred chhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCCh
Q 036011 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPS 391 (977)
Q Consensus 312 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 391 (977)
.+..+ ++|+.|++++|.+++..+
T Consensus 238 -------~l~~l-------------------------------------------------~~L~~L~l~~n~l~~~~~- 260 (466)
T 1o6v_A 238 -------TLASL-------------------------------------------------TNLTDLDLANNQISNLAP- 260 (466)
T ss_dssp -------GGGGC-------------------------------------------------TTCSEEECCSSCCCCCGG-
T ss_pred -------hhhcC-------------------------------------------------CCCCEEECCCCccccchh-
Confidence 12233 333344444443332222
Q ss_pred hhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccC
Q 036011 392 TVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471 (977)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 471 (977)
+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|
T Consensus 261 -~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 333 (466)
T 1o6v_A 261 -LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333 (466)
T ss_dssp -GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTC
T ss_pred -hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccC
Confidence 4444455555555555543222 4444445555555555443322 4445555555555555554333 4444455
Q ss_pred ceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccc
Q 036011 472 LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531 (977)
Q Consensus 472 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 531 (977)
+.|++++|++++. ..+..+++|++|++++|++++..| +..+++|+.|++++|++++
T Consensus 334 ~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 334 QRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 5555555544432 234445555555555555554433 4455555555555555543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.75 Aligned_cols=249 Identities=24% Similarity=0.276 Sum_probs=205.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||+||+|+.. +|+.||+|++++.. ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999975 69999999997653 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999987654 4899999999999999999999 7899999999999999999999999999998643322
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ ....
T Consensus 160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~------------~~~~ 224 (337)
T 1o6l_A 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME------------EIRF 224 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC------------CCCC
T ss_pred C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-HHHHHHcC------------CCCC
Confidence 1 2334579999999999999999999999999999999999999997532211 11111110 0000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
. ..+...+.+++.+|++.||++|| +++|++++
T Consensus 225 p-------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 P-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 01234578999999999999999 89998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=370.42 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=214.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
.++|.+.+.||+|+||+||+|+.. .++.||||++.... ......+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467889999999999999999852 34679999997654 34457789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 752 DFRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999998654 34899999999999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987765443333444567889999999999999999999999999999999 99998754221 11
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
.+.+....... . ...+...+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 303 ~~~~~~~~~~~-----------~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 303 FKLLKEGHRMD-----------K------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHTTCCCC-----------C------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-----------C------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111000 0 012344578999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=356.05 Aligned_cols=261 Identities=21% Similarity=0.363 Sum_probs=207.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 68999999986442 34457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999997654 4899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+... +......+. ...
T Consensus 166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~-~~~-------- 234 (294)
T 4eqm_A 166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-KHIQDSVPN-VTT-------- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-HHHSSCCCC-HHH--------
T ss_pred c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhhccCCC-cch--------
Confidence 2 12233569999999999999999999999999999999999999997643221111 111110010 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHchhh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI-YMTDAAVKLKKIKI 962 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~ev~~~L~~~~~ 962 (977)
....+++..+.+++.+|++.||.+|| +++++.+.|+++..
T Consensus 235 -----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 -----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00012345678999999999999999 99999999988764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=361.34 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=207.0
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
..+.|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999975 6999999999765422 24678999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC----ceEEeeccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM----VAHVSDFGL 829 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgl 829 (977)
.++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999997654 4899999999999999999999 78999999999999998777 799999999
Q ss_pred ccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 830 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
+........ ....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ .........+.
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~----- 236 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAVSYD----- 236 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC-----
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC-----
Confidence 987754322 233569999999999999999999999999999999999999997642211 11111111000
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+ ..........+.+++.+|++.||.+|||+.|++++
T Consensus 237 -~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 -FD---------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -CC---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CC---------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 01111234457899999999999999999999753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=367.78 Aligned_cols=367 Identities=21% Similarity=0.210 Sum_probs=272.3
Q ss_pred CCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceecccccccccc
Q 036011 83 KNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNI 162 (977)
Q Consensus 83 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~ 162 (977)
.....+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++. | ++.+++|++|++++|.+++.
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~- 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL- 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-
Confidence 334444445567777777777777777774 45 577777777777777777753 2 55666666666666666542
Q ss_pred CccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCcccc
Q 036011 163 PSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSY 242 (977)
Q Consensus 163 p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 242 (977)
| ++++++|++|++++|++++ +| ++++++|++|++++|++++. + +.
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---------------------------~---l~ 145 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---------------------------D---VS 145 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---------------------------C---CT
T ss_pred e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---------------------------c---cc
Confidence 2 5555666666666666553 33 55555555555555555431 1 33
Q ss_pred CCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhccccc
Q 036011 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTN 322 (977)
Q Consensus 243 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~ 322 (977)
.+++|++|++++|+..+.+ .+..+++|++|++++|+++++ | +..+++|+.|++++|.++.++ +..
T Consensus 146 ~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~----------l~~ 210 (457)
T 3bz5_A 146 HNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLD----------LNQ 210 (457)
T ss_dssp TCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCC----------CTT
T ss_pred cCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeec----------ccc
Confidence 5667777777777544444 477889999999999999875 4 888899999999999988752 667
Q ss_pred CCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEE
Q 036011 323 CRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGL 402 (977)
Q Consensus 323 l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 402 (977)
+++|+.|++++|++++ +| +..+++|+.|++++|++++.. ++.+++|+.|
T Consensus 211 l~~L~~L~Ls~N~l~~--------------------------ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L 259 (457)
T 3bz5_A 211 NIQLTFLDCSSNKLTE--------------------------ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTL 259 (457)
T ss_dssp CTTCSEEECCSSCCSC--------------------------CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEE
T ss_pred CCCCCEEECcCCcccc--------------------------cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEE
Confidence 7888888888887764 22 557788999999999998654 4567888999
Q ss_pred EeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCC
Q 036011 403 SLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLS 482 (977)
Q Consensus 403 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 482 (977)
++++|+ |+.|++++|++.+.+| ++.+++|+.|++++|.+.+.+|. ...+|+.|++++|
T Consensus 260 ~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~--- 317 (457)
T 3bz5_A 260 HCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN--- 317 (457)
T ss_dssp ECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC---
T ss_pred eccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc---
Confidence 887764 5678899999888887 57889999999999998877764 3455666665554
Q ss_pred CCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccc
Q 036011 483 GSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLE 562 (977)
Q Consensus 483 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 562 (977)
++|++|++++|++++ ++ ++.+++|+.|++++|+|++ ++.|+.|++++|+++|. .
T Consensus 318 ----------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~ 371 (457)
T 3bz5_A 318 ----------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----G 371 (457)
T ss_dssp ----------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----E
T ss_pred ----------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----c
Confidence 689999999999997 43 8999999999999999996 35688889999999976 4
Q ss_pred cccccCccccCCCcccccCCCC
Q 036011 563 ALLFLKQLNVSHNKLEGEIPAN 584 (977)
Q Consensus 563 ~l~~L~~L~l~~N~l~~~~p~~ 584 (977)
.+..|..+++++|+++|.||..
T Consensus 372 ~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 372 QTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp EEEECCCBCCBTTBEEEECCTT
T ss_pred eeeecCccccccCcEEEEcChh
Confidence 6678899999999999999963
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=372.52 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=209.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
++|++.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888999999999999999853 46789999987543 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceEEee
Q 036011 756 LVLELMPNGSLEKWLYSDN------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAHVSD 826 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~D 826 (977)
+||||+++|+|.+++.... ..+++..++.++.||++||+||| +.||+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997643 35899999999999999999999 78999999999999999555 599999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCC
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+......
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i~~~~~~ 305 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGGRM 305 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC
Confidence 999986643333333334568999999999998999999999999999999998 999987642211 11111111000
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. ....++..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 306 -----------~------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 306 -----------D------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp -----------C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------C------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 0 011233457899999999999999999999999988775
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=355.90 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=208.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||+||+|++.++..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 467888999999999999999998888999999975532 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc-cc
Confidence 999999999876666999999999999999999999 78999999999999999999999999999987643221 11
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+....... .+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~~-----------~~- 243 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRLY-----------RP- 243 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCCC-----------CC-
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhcccCCC-----------CC-
Confidence 222346788999999998899999999999999999998 999997643221 111111100000 00
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+...+.+++.+||+.+|++|||++|++++|+++.
T Consensus 244 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 011345789999999999999999999999998876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.55 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=198.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+.. ..||||++.... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 469999987553 34557799999999999999999999965 4566889999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999999877777999999999999999999999 789999999999999999999999999999876543333
Q ss_pred ceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 840 VTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.......||+.|+|||++. +..++.++||||+|+++|||++|+.||......+..................
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 250 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV------ 250 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc------
Confidence 3334456999999999886 6678999999999999999999999997643332211111111111111100
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
...++..+.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 251 --------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 --------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0123456889999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=366.61 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=212.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999874 34889999997653 3445779999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 036011 754 RALVLELMPNGSLEKWLYSDN-----------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 810 (977)
.++||||+++|+|.+++.... ..+++..++.++.||++||+||| +.+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 999999999999999997642 45899999999999999999999 7899999999
Q ss_pred CCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCC
Q 036011 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMF 889 (977)
Q Consensus 811 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~ 889 (977)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654332223334568899999999988899999999999999999999 999997643
Q ss_pred cccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 890 TGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+ ....+... ..... +..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 282 ~~~--~~~~~~~~-----------~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HEE--VIYYVRDG-----------NILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHH--HHHHHHTT-----------CCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hHH--HHHHHhCC-----------CcCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 211 11111110 00000 01234467899999999999999999999999998873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.85 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=212.9
Q ss_pred hcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788999999999999999985 245889999997553 34457789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 036011 755 ALVLELMPNGSLEKWLYSDN-----------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKP 811 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~ 811 (977)
++||||+++|+|.+++.... ..+++..++.++.||++||+||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 99999999999999998643 23789999999999999999999 78999999999
Q ss_pred CceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCc
Q 036011 812 SNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFT 890 (977)
Q Consensus 812 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~ 890 (977)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765443333334457889999999998899999999999999999999 9999976433
Q ss_pred ccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 891 GEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+ ............ ....++..+.+++.+||+.||++||++.|++++|+++.
T Consensus 259 ~~--~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ER--LFNLLKTGHRME-----------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GG--HHHHHHTTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--HHHHhhcCCcCC-----------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22 222211111000 00123446789999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=353.58 Aligned_cols=279 Identities=21% Similarity=0.263 Sum_probs=214.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC--eeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND--FRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 757 (977)
.++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357899999999999999999976 59999999997543 334567889999999999999999999987755 77999
Q ss_pred EeccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee----CCCCceEEeeccccc
Q 036011 758 LELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLSK 831 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~ 831 (977)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999986543 3899999999999999999999 7899999999999999 888899999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccC--------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccH---HHHHH
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGT--------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSL---KKWVK 900 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---~~~~~ 900 (977)
....... .....||+.|+|||++. +..++.++||||+||++|||++|+.||.......... .....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7755432 22346999999999875 5789999999999999999999999997543332222 22222
Q ss_pred hhCCCchhhhc---chhhhc---cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCcc
Q 036011 901 ESLPHGLMEVV---DTNLLR---QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVL 966 (977)
Q Consensus 901 ~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~ 966 (977)
...+..+..+. ...+.. .+............+.+++.+|++.||++|||++|++++.......|..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~ 313 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC----
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCc
Confidence 22211111110 000000 0011122245667788999999999999999999999999877765543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=349.15 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=205.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh-------hHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR-------AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367899999999999999999974 7999999998654321 1267899999999999999999999987665
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeCCCCc-----eEEee
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLDEDMV-----AHVSD 826 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl~D 826 (977)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999999877777999999999999999999999 788 999999999999988776 99999
Q ss_pred cccccccCCCCCcceeeccccCCcccCcccc--CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYG--TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (977)
||+++.... ......||+.|+|||++ ....++.++||||+|+++|||++|+.||...................
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999985433 22335699999999998 45668999999999999999999999997654433322222211110
Q ss_pred CchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.. .....++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 248 ~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RP----------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CC----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CC----------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00 00012344678999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=372.04 Aligned_cols=263 Identities=21% Similarity=0.256 Sum_probs=210.0
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeec
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 750 (977)
+.++....++|++.++||+|+||+||+|+.+ +++.||||++.+.. ......+.+|+.+++.++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455566789999999999999999999976 58899999997543 2223448899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
.+..++||||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999876566999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
+....... ......+||++|+|||++. .+.++.++||||+||++|||++|+.||......+ ..........
T Consensus 223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-- 298 (437)
T 4aw2_A 223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKE-- 298 (437)
T ss_dssp EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH--
T ss_pred hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhccc--
Confidence 87654332 2233457999999999986 5679999999999999999999999997643221 1111111000
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQ--RIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~ev~~~ 956 (977)
.+..... ...+...+.+++.+|++.+|++ ||+++|++++
T Consensus 299 --------~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 --------RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000000 0012335688999999888888 9999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=355.39 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=205.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
+.|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56889999999999999999975 6899999998765321 3567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC----ceEEeeccccc
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM----VAHVSDFGLSK 831 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~ 831 (977)
+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999997654 4899999999999999999999 78999999999999999887 89999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
....... .....||+.|+|||++.+..++.++||||+||++|||++|..||......+ ............
T Consensus 167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~------ 236 (326)
T 2y0a_A 167 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNYEF------ 236 (326)
T ss_dssp ECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCCCC------
T ss_pred ECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCCCc------
Confidence 7754322 233469999999999999999999999999999999999999997542211 111111110000
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+||+.||++|||+.|++++
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 ---------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000111234457899999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.27 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=195.7
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCC-C---CEEEEEEeecc--chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSD-G---TSFAIKVFNLQ--LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
..++|++.+.||+|+||+||+|+... + ..||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999998753 3 27999998765 244567899999999999999999999999877655
Q ss_pred ------EEEEeccCCCCHHHHhhcCC-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceE
Q 036011 755 ------ALVLELMPNGSLEKWLYSDN-----YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 755 ------~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
++||||+++|+|.+++.... ..+++..+..++.|+++||+||| +.||+||||||+||++++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 89999999999999986432 14899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhh
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 902 (977)
|+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||......+ ........
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~ 255 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLIGG 255 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHhcC
Confidence 999999987755443333334457889999999999999999999999999999999 899987643322 11111110
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCc
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGV 965 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~ 965 (977)
.. ... ...++..+.+++.+||+.||++|||+.|+++.|+++....+
T Consensus 256 ~~-----------~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 256 NR-----------LKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp CC-----------CCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CC-----------CCC------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 00 000 01223457899999999999999999999999998875443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=362.99 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=205.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCE----EEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTS----FAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|++.+.||+|+||+||+|++. +++. ||+|++.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57889999999999999999864 4544 7788775433 233456788999999999999999999986 456889
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++.+...
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999887667999999999999999999999 789999999999999999999999999999987655
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ .............
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~-------- 238 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLAQ-------- 238 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCBCCC--------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCCC--------
Confidence 44444455568889999999998999999999999999999999 999997643322 1121111100000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+ ..+...+.+++.+||+.+|.+||++.|++++|+++..
T Consensus 239 ---~------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 ---P------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---C------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---C------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0112246789999999999999999999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.98 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=199.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||+||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56888999999999999999984 789999998643 345678999999999999999999999874 4789999999
Q ss_pred CCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc-eEEeecccccccCCCCCc
Q 036011 763 NGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV-AHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 763 ~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~ 839 (977)
+|+|.+++..... .+++..++.++.|+++||+|||+.+..||+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986553 4789999999999999999999555489999999999999998886 799999999765432
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..................... .
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~---- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP--------L---- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC--------C----
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC--------c----
Confidence 12235999999999999999999999999999999999999999764332211111111100000 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...++..+.+++.+||+.+|++|||++|+++.|+++..
T Consensus 226 -----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 -----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 01123457899999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=368.29 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=206.4
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+..++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34577999999999999999999864 78999999987653 3445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeeccccccc
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLF 833 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~ 833 (977)
||||+++|+|.+++..... +++..+..++.||+.||+||| +.||+||||||+||+++ .++.+||+|||++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999987654 899999999999999999999 78999999999999998 5678999999999876
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... ......||++|+|||++.+..++.++||||+||++|+|++|..||.+....+ .............
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~------- 233 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFP------- 233 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCC-------
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCCCC-------
Confidence 54322 2233569999999999999999999999999999999999999996532211 1111111111000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+....+...+.+++.+|++.||++|||+.|++++
T Consensus 234 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 --------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00111233457899999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=362.62 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=209.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 6899999999876555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC--CCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE--DMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 838 (977)
+++|+|.+++......+++..+..++.||+.||+||| +.||+||||||+||+++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999877667999999999999999999999 789999999999999974 57899999999988754322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....||+.|+|||++.+..++.++||||+||++|||++|..||.+.... ..+.......... +.
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~------~~----- 271 (387)
T 1kob_A 207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEF------DE----- 271 (387)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCC------CS-----
T ss_pred ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC------Cc-----
Confidence 23346999999999999999999999999999999999999999764221 1111111111000 00
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.||++|||+.|++++
T Consensus 272 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001223457899999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=358.69 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=211.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 753 (977)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46789999999999999999986 246689999997543 33456789999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCc----------------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 036011 754 RALVLELMPNGSLEKWLYSDNY----------------------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKP 811 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~ 811 (977)
.++||||+++|+|.+++..... .+++..++.++.||+.||+||| +.||+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence 9999999999999999986542 3789999999999999999999 78999999999
Q ss_pred CceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCc
Q 036011 812 SNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFT 890 (977)
Q Consensus 812 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~ 890 (977)
+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987765444333444568889999999988899999999999999999998 9999976533
Q ss_pred ccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 891 GEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.. ............. . +..++..+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus 281 ~~-~~~~~~~~~~~~~-----------~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 DA-NFYKLIQNGFKMD-----------Q------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp SH-HHHHHHHTTCCCC-----------C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HH-HHHHHHhcCCCCC-----------C------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 22 1222222111100 0 01123457899999999999999999999999998774
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=349.47 Aligned_cols=268 Identities=20% Similarity=0.249 Sum_probs=205.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 68999999997553 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++ ++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9975 666666665556999999999999999999999 78999999999999999999999999999987653322
Q ss_pred ceeeccccCCcccCccccCCCC-cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC---Cchhhhcch-h
Q 036011 840 VTQTMTIATIGYMAPEYGTEGI-VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP---HGLMEVVDT-N 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~ 914 (977)
......||+.|+|||++.+.. ++.++||||+||++|||++|..||.........+......... ..+...... .
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 223456899999999987765 8999999999999999999998865433333333332221111 001000000 0
Q ss_pred hhc------cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLR------QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... ..........+...+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000011234457899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=359.87 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=203.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-----hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-----RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+.|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999865 699999999875431 135678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc---eEEeecccc
Q 036011 757 VLELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV---AHVSDFGLS 830 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla 830 (977)
||||+++|+|.+++... ...+++..+..++.||++||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887643 234899999999999999999999 789999999999999986654 999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
........ .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... +..............
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~~---- 252 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMN---- 252 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCCC----
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCCC----
Confidence 87754322 2234569999999999999999999999999999999999999997631 111111111111000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+...+.+++.+||+.||++|||+.|++++
T Consensus 253 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 253 -----------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -----------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111234567899999999999999999999763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=373.14 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=207.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-eeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND-FRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|++. |+.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888999999999999999985 7899999997543 4567999999999999999999999987655 78999999
Q ss_pred cCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|+|.+++...+. .+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999986543 4699999999999999999999 7899999999999999999999999999998643221
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+.....
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~-------------- 404 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK-------------- 404 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCC--------------
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence 12357889999999999999999999999999999998 999997653322 1111111000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...+..++..+.+++.+||+.+|++|||+.++++.|++++.
T Consensus 405 ---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 ---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 00011245568899999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=362.59 Aligned_cols=268 Identities=15% Similarity=0.171 Sum_probs=208.5
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCC------CCEEEEEEeeccchhh-----------HHHHHHHHHHHHhcCCCCcce
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQLDRA-----------FRSFDSECEVLRNVRHRNLIK 743 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 743 (977)
..++|++.+.||+|+||+||+|++.. ++.||||++....... ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 4789999987653211 122445666778889999999
Q ss_pred EeeeeecC----CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC--
Q 036011 744 IFSSCCNN----DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-- 817 (977)
Q Consensus 744 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-- 817 (977)
+++++... ...++||||+ +++|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998764 4579999999 99999999887667999999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE 892 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 892 (977)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998765432111 1123459999999999999999999999999999999999999998643322
Q ss_pred ccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 893 MSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
....+........+.++.++.+.. ..++..+.+++..||+.+|++||++.++++.|+++.
T Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 269 -KYVRDSKIRYRENIASLMDKCFPA--------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp -HHHHHHHHHHHHCHHHHHHHHSCT--------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHHhhhhHHHHHHHhccc--------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 222222222222233333322211 122456889999999999999999999999997764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=360.88 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=199.7
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 755 (977)
..++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999975 68999999998653 33456678999999988 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999997654 3899999999999999999999 78999999999999999999999999999986433
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ ..
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~------------~~ 241 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILND------------EV 241 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC------------CC
T ss_pred CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcC------------CC
Confidence 22 22334579999999999999899999999999999999999999997643221 11111111 00
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM------TDAAV 955 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~ev~~ 955 (977)
.... .....+.+++.+|++.+|++||++ .|+++
T Consensus 242 ~~p~-------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 VYPT-------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCT-------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCC-------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0000 123346889999999999999998 66654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=351.96 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=206.3
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc--CCCCcceEeeeeecC----C
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV--RHRNLIKIFSSCCNN----D 752 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~ 752 (977)
....++|++.+.||+|+||+||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999985 8999999986442 23344555555554 899999999999877 6
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeEeCCCCCCceeeCCCCceEE
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST--------PVVHCDLKPSNILLDEDMVAHV 824 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivH~dlk~~NIll~~~~~~kl 824 (977)
..++||||+++|+|.++++... +++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 8899999999999999997654 899999999999999999999 55 9999999999999999999999
Q ss_pred eecccccccCCCCCcc--eeeccccCCcccCccccCCCCcCcc------cchhhHhHHHHHHhcC----------CCCCC
Q 036011 825 SDFGLSKLFDEGDDSV--TQTMTIATIGYMAPEYGTEGIVSSK------CDVYSYGVLLTETFTR----------KKPTD 886 (977)
Q Consensus 825 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~p~~ 886 (977)
+|||+++.+....... ......||+.|+|||++.+..++.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998765433221 1123469999999999887766655 9999999999999999 66665
Q ss_pred cCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 887 DMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...........+........... .........+++..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRP--------SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCC--------CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCc--------cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 54443333333322221111110 011111123567789999999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.95 Aligned_cols=261 Identities=15% Similarity=0.126 Sum_probs=212.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+++++.+ +|++++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 479999999986543 335688999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc-----eEEeecccccccC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV-----AHVSDFGLSKLFD 834 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~ 834 (977)
|+ +++|.+++...+..+++..+..++.||++||+||| +.||+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999877667999999999999999999999 899999999999999987776 9999999998776
Q ss_pred CCCCc-----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--cHHHHHHhhCCCch
Q 036011 835 EGDDS-----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--SLKKWVKESLPHGL 907 (977)
Q Consensus 835 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 907 (977)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 54321 122345699999999999999999999999999999999999999976432211 11111110000000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. .....++..+.+++.+||+.+|++||+++++++.|+++..
T Consensus 243 ~--------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 243 R--------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp H--------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred H--------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0 0011234568899999999999999999999999988764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=359.48 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=205.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 68999999997553 344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC---CceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED---MVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~ 835 (977)
||+++|+|.+++.... .+++..+..++.||++||+||| +.||+||||||+||+++.+ +.+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999987654 4899999999999999999999 7899999999999999865 4599999999987754
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... .....||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ ............
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~---------- 249 (362)
T 2bdw_A 184 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDY---------- 249 (362)
T ss_dssp CCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC----------
T ss_pred Ccc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC----------
Confidence 322 233569999999999999999999999999999999999999997532211 111111111100
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+||+.||++||++.|++++
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111234457899999999999999999999765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=356.76 Aligned_cols=260 Identities=17% Similarity=0.164 Sum_probs=210.3
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 4789999999875432 35688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc-----eEEeecccccccC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV-----AHVSDFGLSKLFD 834 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~ 834 (977)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999876667999999999999999999999 789999999999999998887 9999999999765
Q ss_pred CCCCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--cHHHHHHhhCCCch
Q 036011 835 EGDDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--SLKKWVKESLPHGL 907 (977)
Q Consensus 835 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 907 (977)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+.....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 433211 12345799999999999999999999999999999999999999986532211 01111110000000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. .....++ .+.+++.+||+.+|.+||+++++.+.|+++..
T Consensus 242 ~--------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 242 E--------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp H--------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred H--------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0 0000123 68899999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.35 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=198.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.+.||+|+||+||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999998642 4579999987543 344567899999999999999999999984 466889
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999877667999999999999999999999 789999999999999999999999999999877543
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||......+ ....+.......
T Consensus 170 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~~~--------- 237 (281)
T 1mp8_A 170 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERLP--------- 237 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCC---------
T ss_pred ccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCCCC---------
Confidence 221 2223457789999999988899999999999999999997 999997643322 111111110000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
....++..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 238 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 238 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00123456789999999999999999999999998875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=353.11 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=214.2
Q ss_pred hcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccch-hhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQLD-RAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 753 (977)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36788999999999999999984 2578999999975543 3457799999999999 99999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCc-----------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 754 RALVLELMPNGSLEKWLYSDNY-----------------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
.++||||+++|+|.+++..... .+++..++.++.|+++||+||| +.||+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 9999999999999999986542 3899999999999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |+.||........ .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence 9999999999999988765544333344557889999999988999999999999999999999 9999876433221 2
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
........... . ...++..+.+++.+||+.||.+|||+.|++++|+++..
T Consensus 258 ~~~~~~~~~~~------------~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMIKEGFRML------------S-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHTCCCC------------C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCCC------------C-----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 22221111100 0 01123457899999999999999999999999988763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.15 Aligned_cols=246 Identities=25% Similarity=0.310 Sum_probs=204.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999975 69999999997653 23456688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999998755 3899999999999999999999 899999999999999999999999999999876432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ........ ....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~------------~~~~ 222 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNA------------ELRF 222 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHC------------CCCC
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC------------CCCC
Confidence 223469999999999999999999999999999999999999997532211 11111111 0000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
.. .....+.+++.+|++.||++|| ++.|++++
T Consensus 223 p~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 PP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC-------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 00 1233578999999999999999 88888753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=361.53 Aligned_cols=344 Identities=28% Similarity=0.413 Sum_probs=173.1
Q ss_pred CCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceee
Q 036011 97 LRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVN 176 (977)
Q Consensus 97 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~ 176 (977)
+++|+.|++++|.+. .+|. +..+++|++|+|++|.+++..| ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--------------------------~~~l~~L~~L~ 96 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--------------------------LKNLTKLVDIL 96 (466)
T ss_dssp HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--------------------------GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--------------------------hhccccCCEEE
Confidence 455555555555555 3443 4555555555555555553221 44444445555
Q ss_pred eecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCce
Q 036011 177 LAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK 256 (977)
Q Consensus 177 L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~ 256 (977)
+++|++++..+ ++++++|++|++++|++++.. + +..+++|++|++++|+
T Consensus 97 l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~---------------------------~--~~~l~~L~~L~l~~n~ 145 (466)
T 1o6v_A 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDID---------------------------P--LKNLTNLNRLELSSNT 145 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG---------------------------G--GTTCTTCSEEEEEEEE
T ss_pred CCCCccccChh--hcCCCCCCEEECCCCCCCCCh---------------------------H--HcCCCCCCEEECCCCc
Confidence 55555443222 445555555555555444221 1 2233444444444444
Q ss_pred eeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCC
Q 036011 257 LTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336 (977)
Q Consensus 257 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 336 (977)
+++ ++ .+..+++|++|+++ |.+.+..+ +..+++|+.|++++|.++.++ .+..+++|++|++++|.+
T Consensus 146 l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~---------~l~~l~~L~~L~l~~n~l 211 (466)
T 1o6v_A 146 ISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDIS---------VLAKLTNLESLIATNNQI 211 (466)
T ss_dssp ECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCCG---------GGGGCTTCSEEECCSSCC
T ss_pred cCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCCh---------hhccCCCCCEEEecCCcc
Confidence 442 12 24445555555554 33332221 555555555555555554321 144455555555555554
Q ss_pred CCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccc
Q 036011 337 RGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYD 416 (977)
Q Consensus 337 ~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 416 (977)
.+..| ++.+++|+.|++++|.+++. ..+..+++|++|++++|.+++..+
T Consensus 212 ~~~~~---------------------------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-- 260 (466)
T 1o6v_A 212 SDITP---------------------------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-- 260 (466)
T ss_dssp CCCGG---------------------------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred ccccc---------------------------ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--
Confidence 43211 33455566666666665532 345666666666666666664433
Q ss_pred cccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccC
Q 036011 417 LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496 (977)
Q Consensus 417 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 496 (977)
+..+++|+.|++++|++++..+ +..+++|++|++++|++.+..+ +..+++|+.|++++|++++..| +..+++|+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 334 (466)
T 1o6v_A 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334 (466)
T ss_dssp GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCC
T ss_pred hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCC
Confidence 5556666666666666654333 5555666666666666654332 4555555555555555554433 44555555
Q ss_pred eeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccC
Q 036011 497 NLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 497 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 554 (977)
+|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 335 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 335 RLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp EEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred EeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 555555555532 245555555555555555554444 455555555555555555
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=359.15 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=211.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467899999999999999999863 47789999997653 34467789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCc---------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNY---------------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
+..++||||+++|+|.+++..... .+++..++.++.||++||+||| +.||+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 999999999999999999986542 3889999999999999999999 7899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||......+ .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--H
Confidence 9999999999999987765443333334457889999999988899999999999999999999 999987542211 1
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
........... . ...+...+.+++.+||+.+|.+||++.|+++.|+++..
T Consensus 269 ~~~~~~~~~~~-----------~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 269 FKLLKEGHRMD-----------K------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHTCCCC-----------C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----------C------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111111000 0 01233457899999999999999999999999998865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.32 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=196.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--------------------------hhHHHHHHHHHHHH
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--------------------------RAFRSFDSECEVLR 734 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 734 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999864 689999999875431 12356889999999
Q ss_pred hcCCCCcceEeeeeec--CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 036011 735 NVRHRNLIKIFSSCCN--NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPS 812 (977)
Q Consensus 735 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 812 (977)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 56889999999999998876443 4899999999999999999999 789999999999
Q ss_pred ceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCC---cCcccchhhHhHHHHHHhcCCCCCCcCC
Q 036011 813 NILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI---VSSKCDVYSYGVLLTETFTRKKPTDDMF 889 (977)
Q Consensus 813 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~ 889 (977)
||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987754322 233456999999999987765 4789999999999999999999997532
Q ss_pred cccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 890 TGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. ............ . + ....+...+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~--~~~~~~~~~~~~---------~---~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IM--CLHSKIKSQALE---------F---P----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HH--HHHHHHHHCCCC---------C---C----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HH--HHHHHHhcccCC---------C---C----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11 111111110000 0 0 001123457899999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=349.88 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=203.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999988899999999875532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+++ +|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 975 999999876667999999999999999999999 78999999999999999999999999999987653221
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC-C--Cchhhh-----c
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-P--HGLMEV-----V 911 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~-----~ 911 (977)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+.......- + ..+... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence 2233468999999999876 468999999999999999999999997643222 1222111110 0 001000 0
Q ss_pred chhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 DTNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
++....... .......+...+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111000000 000001234457899999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=358.26 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=197.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCC--CCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRH--RNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 757 (977)
.+.|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45699999999999999999998889999999987543 3445778999999999976 9999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
||+ .+|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+|||++ ++.+||+|||+++......
T Consensus 88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 994 5889999998754 4899999999999999999999 78999999999999997 6789999999998876544
Q ss_pred CcceeeccccCCcccCccccCC-----------CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTE-----------GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------- 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------- 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh-------
Confidence 3333345579999999998754 6789999999999999999999999975432211111111
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
++........ .....+.+++.+||+.||.+|||+.|++++
T Consensus 235 -----~~~~~~~~~~-----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 -----DPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----CTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----cCCcccCCcc-----cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111000000 012347899999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.25 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=212.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999988889999999976533 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence 999999999887667899999999999999999999 7899999999999999999999999999998764321 111
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+...... ..+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~~-----------~~~- 227 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL-----------YKP- 227 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCC-----------CCC-
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCcC-----------CCC-
Confidence 223357788999999988899999999999999999999 899987532211 11111111000 000
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+...+.+++.+||+.+|++||+++|++++|+++..
T Consensus 228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0123457899999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=356.66 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=202.6
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||+||+|+. .+++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999996 478999999997543 22345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+ +|+|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 789988887654 3899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. ....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+....+. ...+.....
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~~- 225 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCVY- 225 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSCC-
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCCC-
Confidence 2 233469999999999988876 7899999999999999999999976422211 000000000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+ ..+...+.+++.+|++.||.+|||++|++++
T Consensus 226 ~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMP------DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCC------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCc------ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 1123457899999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=377.28 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=209.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 46688889999999999999999888999999997543 34678999999999999999999999986 56789999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.++++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-H
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-e
Confidence 9999999997543 25889999999999999999999 78999999999999999999999999999987643211 1
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......+|+.|+|||++..+.++.++|||||||++|||+| |+.||.+....+ ....+.....
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~--------------- 403 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYR--------------- 403 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTCC---------------
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence 1122346788999999998899999999999999999999 999997643221 1111111100
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+.+..++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 404 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00011245568899999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.72 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=194.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch----hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD----RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||+||+|++. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367889999999999999999974 89999999875432 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEeCCCCCCceeeCC--------CCceEEee
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP---VVHCDLKPSNILLDE--------DMVAHVSD 826 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~dlk~~NIll~~--------~~~~kl~D 826 (977)
|||+++++|.+++... .+++..+..++.|+++||+||| +.+ |+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998654 4899999999999999999999 566 999999999999986 77899999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
||++........ ....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ............
T Consensus 160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 234 (271)
T 3dtc_A 160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLALP 234 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHHHHTSCCCCC
T ss_pred CCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHhhhcCCCCCC
Confidence 999987654322 234589999999999988999999999999999999999999976432211 001000000000
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
....++..+.+++.+||+.+|++|||+.|++++|+++
T Consensus 235 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 -----------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0012234578999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=361.78 Aligned_cols=249 Identities=20% Similarity=0.277 Sum_probs=198.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.++||+|+||+||+|+.+ +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999975 58899999998653 23345578899999887 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999997654 4899999999999999999999 789999999999999999999999999999864322
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc---HHHHHHhhCCCchhhhcch
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS---LKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 913 (977)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ...+.... +...
T Consensus 207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~-------i~~~ 277 (396)
T 4dc2_A 207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILEK 277 (396)
T ss_dssp T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH-------HHHC
T ss_pred C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH-------Hhcc
Confidence 2 2233457999999999999999999999999999999999999999653221110 00111000 0000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
..... ..+...+.+++.+||+.||.+||++
T Consensus 278 ~~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 QIRIP-------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCC-------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccCCC-------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00000 1123457899999999999999996
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.28 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=206.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC-C-------CEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD-G-------TSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
.++|.+.+.||+|+||+||+|+... + ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578899999999999999998652 3 5799999987766677889999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc--------eEEe
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV--------AHVS 825 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~ 825 (977)
.++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999887767999999999999999999999 789999999999999998887 9999
Q ss_pred ecccccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC
Q 036011 826 DFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904 (977)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (977)
|||++...... ....+|+.|+|||++.+ ..++.++||||+|+++|||++|..|+.......... ........
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~ 236 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQ 236 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCC
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCC
Confidence 99998755321 22358899999999887 779999999999999999999665543322211111 11110000
Q ss_pred CchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCcccccc
Q 036011 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVLVLSR 970 (977)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~~ 970 (977)
.. .. ....+.+++.+||+.||++|||+.|++++|+++...+..+.+.
T Consensus 237 --~~----------~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 237 --LP----------AP-------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp --CC----------CC-------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred --CC----------CC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 00 00 1123678999999999999999999999999998766555443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.15 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=200.0
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467899999999999999999976 79999999997544 335577999999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEeccCCCCHHHHhhcCCc--cCCH
Q 036011 753 ---------------------------------------------------FRALVLELMPNGSLEKWLYSDNY--FLDL 779 (977)
Q Consensus 753 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~--~~~~ 779 (977)
..++||||+++|+|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37899999999999999987543 4567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc----------ceeeccccCC
Q 036011 780 LERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS----------VTQTMTIATI 849 (977)
Q Consensus 780 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~ 849 (977)
..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 788999999999999999 789999999999999999999999999999887654221 1223346999
Q ss_pred cccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHH
Q 036011 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCL 929 (977)
Q Consensus 850 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (977)
.|+|||++.+..++.++||||+||++|||++|..|+... ........ ............
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~~~~~-----------------~~~~~~~~~~~~ 299 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRIITDVR-----------------NLKFPLLFTQKY 299 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHHHHHH-----------------TTCCCHHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHHHHhh-----------------ccCCCcccccCC
Confidence 999999999999999999999999999999987764221 00000000 001111223345
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 930 LSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 930 ~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+.+++.+||+.||++|||+.|++++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 567899999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=359.39 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=199.9
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999864 6999999999876656677899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee--CCCCceEEeecccccccCCCCCcceeec
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL--DEDMVAHVSDFGLSKLFDEGDDSVTQTM 844 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (977)
.+++......+++..+..++.||++||+||| +.+|+||||||+||++ +.++.+||+|||+++.+..... ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 9999877667999999999999999999999 7899999999999999 6778999999999998754332 223
Q ss_pred cccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchH
Q 036011 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924 (977)
Q Consensus 845 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (977)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+........ ...
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~---------------~~~ 311 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLE---------------DEE 311 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSC---------------SGG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC---------------hhh
Confidence 46999999999999999999999999999999999999999764321 11222221111000 000
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 925 EMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
...+...+.+++.+|++.||.+|||+.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1123446789999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.88 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=202.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999965 68999999997553 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+.+|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.+....
T Consensus 95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 9999999999998654 4899999999999999999999 7899999999999999999999999999998775432
Q ss_pred cceeeccccCCcccCccccCC---CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc-cHHHHHHhhCCCchhhhcchh
Q 036011 839 SVTQTMTIATIGYMAPEYGTE---GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM-SLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ............
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 238 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--------- 238 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC---------
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC---------
Confidence 2334579999999999864 4589999999999999999999999975322211 111111110000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-MTDAAV 955 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~ev~~ 955 (977)
.+ ..+...+.+++.+||+.+|.+||+ ++++.+
T Consensus 239 ---~p------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 ---YP------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CC------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CC------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 112345789999999999999998 666543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=362.04 Aligned_cols=277 Identities=20% Similarity=0.267 Sum_probs=208.8
Q ss_pred hhcCCCcCccccCc--ceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 681 ATDGFNECNLLGRG--SFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
..++|++.+.||+| +||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999976 79999999997654 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 756 LVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
+||||+++|+|.+++... ...+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999765 235899999999999999999999 7899999999999999999999999999987553
Q ss_pred CCCCc-----ceeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc-
Q 036011 835 EGDDS-----VTQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG- 906 (977)
Q Consensus 835 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 906 (977)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+.....+ ....+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCccc
Confidence 22111 11122368999999999887 679999999999999999999999997644332211111 1000000
Q ss_pred ----------------------hhhhcchhh----hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HH
Q 036011 907 ----------------------LMEVVDTNL----LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LK 958 (977)
Q Consensus 907 ----------------------~~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~ 958 (977)
..+...... .......+....+...+.+++.+||+.||++|||++|++++ ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 000000000 00000011122345568999999999999999999999876 44
Q ss_pred chh
Q 036011 959 KIK 961 (977)
Q Consensus 959 ~~~ 961 (977)
+++
T Consensus 339 ~~~ 341 (389)
T 3gni_B 339 QIK 341 (389)
T ss_dssp GC-
T ss_pred HHh
Confidence 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=357.38 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=201.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCE----EEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTS----FAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
.++|++.+.||+|+||+||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999964 4554 5677664332 345677999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+|+||+.+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999887777999999999999999999999 78999999999999999999999999999988765
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
...........+|+.|+|||++.+..++.++||||+||++|||++ |..||......+ ............
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~~-------- 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLP-------- 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCC--------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCC--------
Confidence 443333344457889999999999999999999999999999999 999997643322 222221111000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....+...+.+++.+||+.+|.+||++.|+++.|+++..
T Consensus 240 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 240 ---------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001123457899999999999999999999999998874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=357.58 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=191.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567999999999999999999976 58899999987543 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeecccccccCCC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~ 836 (977)
|+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999997654 4899999999999999999999 789999999999999975 889999999999876532
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+............. .
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----~----- 271 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----I----- 271 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----C-----
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----C-----
Confidence 2 22335699999999999999999999999999999999999999976433322222221111100 0
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+....+...+.+++.+|++.||++|||+.|++++
T Consensus 272 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 -----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011233457899999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=377.45 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=211.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||.||+|++. .+..||||++.... ...+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 356888899999999999999976 48899999997553 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 99999999998643 45899999999999999999999 7899999999999999999999999999998765432 1
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+..... .
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~------------~- 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR------------M- 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCC------------C-
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC------------C-
Confidence 12223346788999999998999999999999999999999 999987643221 1221111110 0
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 439 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 001123456889999999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.58 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=209.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 78999999987553 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++++|.+++.... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||.+..+......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999987654 4899999999999999999999 789999999999999999999999999999876543322
Q ss_pred ceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||............|........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN------------ 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST------------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC------------
Confidence 22334568999999999987765 78999999999999999999999765444333444332111000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........+.+++.+|++.+|++|||++|++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001123457889999999999999999999763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.10 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=197.7
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcC--CCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVR--HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 758 (977)
+.|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999998889999999987543 345577999999999996 599999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
| +.+++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56889999998765 4889999999999999999999 89999999999999996 58999999999988765433
Q ss_pred cceeeccccCCcccCccccCC-----------CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 839 SVTQTMTIATIGYMAPEYGTE-----------GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~--------- 280 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI--------- 280 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH---------
Confidence 333344579999999998764 468999999999999999999999997543221111111
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.......... ....+.+++.+||+.||.+|||+.|++++
T Consensus 281 ---~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 ---IDPNHEIEFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HCTTSCCCCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---hCccccCCCCcc-----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111000000 12357899999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.56 Aligned_cols=260 Identities=20% Similarity=0.340 Sum_probs=197.4
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe----
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF---- 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 753 (977)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 478999999997653 2345678999999999999999999999876543
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 389999999999999997654 4899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 834 DEGDDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 834 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+. ...........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~------- 238 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPIP------- 238 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCCC-------
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCCCCC-------
Confidence 543322 222335689999999999999999999999999999999999999976432211 11111110000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH-HHHHchh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAA-VKLKKIK 961 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~-~~L~~~~ 961 (977)
+ ......++..+.+++.+||+.||++||++.+++ +.+.++.
T Consensus 239 ~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 P--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H--------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c--------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0 000112345678999999999999999666554 5555544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.86 Aligned_cols=269 Identities=23% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCCCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--Cee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 754 (977)
+.|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999983 368999999987553 33457789999999999999999999999876 668
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999766666999999999999999999999 7899999999999999999999999999998876
Q ss_pred CCCCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC--c-hhhh
Q 036011 835 EGDDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH--G-LMEV 910 (977)
Q Consensus 835 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~-~~~~ 910 (977)
..... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+.... ..+.....+. . ....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHHH
Confidence 54332 12233468888999999999999999999999999999999999864321 1111100000 0 0000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
....+... ........++..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 252 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEG-KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcc-CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000000 000111123456889999999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.82 Aligned_cols=273 Identities=26% Similarity=0.339 Sum_probs=212.7
Q ss_pred cCCCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeee--cCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC--NNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 755 (977)
++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788999999999999999984 368899999998776666778999999999999999999999886 456788
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999876556999999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 836 GDDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 836 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
..... ......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ...+...........+...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~- 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCERDVPALSRLLEL- 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC----CCHHHHHHHH-
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccccccccHHHHHHH-
Confidence 43321 2233458888999999999999999999999999999999999986422110 0000000000001111100
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+. ..........++..+.+++.+||+.||++|||++|++++|+++..
T Consensus 257 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hh-cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 000011112345568899999999999999999999999988754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.01 Aligned_cols=258 Identities=26% Similarity=0.466 Sum_probs=203.1
Q ss_pred cCCCcCccccCcceEEEEEEEeCC-----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD-----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
++|+..+.||+|+||+||+|+... +..||||++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999998642 2469999987653 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999877667999999999999999999999 789999999999999999999999999999876543
Q ss_pred CCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 837 DDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 837 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+.....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~~---------- 268 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFR---------- 268 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC----------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCCc----------
Confidence 221 12222346788999999999999999999999999999999 999996543211 1111111000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. +....++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 269 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 L-------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp C-------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0011234467899999999999999999999999988764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=365.56 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=207.7
Q ss_pred HHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 676 LDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 676 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
.++....++|++.+.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556788999999999999999999975 68999999997542 22234588999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
+..++||||+++|+|.+++.... +++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999997654 899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCC----cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGI----VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
...... .......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||......+ ..........
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~---- 290 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKN---- 290 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH----
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHhccc----
Confidence 765432 22233467999999999987655 8899999999999999999999997532211 1111111000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQ--RIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~ev~~~ 956 (977)
.+... ....+...+.+++.+|++.+|.+ ||++.|++++
T Consensus 291 ------~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 ------SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ------HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ------cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000 00012345788999999999988 9999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=352.92 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=199.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357899999999999999999975 68999999998653 33456688999999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999997654 4899999999999999999999 789999999999999999999999999999864322
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc---HHHHHHhhCCCchhhhcch
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS---LKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 913 (977)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ....... .+...
T Consensus 164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------~i~~~ 234 (345)
T 3a8x_A 164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILEK 234 (345)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-------HHHHC
T ss_pred CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-------HHHcC
Confidence 21 233457999999999999999999999999999999999999999653221110 0011100 00000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM 950 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 950 (977)
..... ......+.+++.+||+.||.+||++
T Consensus 235 ~~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 QIRIP-------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCCC-------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCC-------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 00000 1123457899999999999999996
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.69 Aligned_cols=267 Identities=26% Similarity=0.377 Sum_probs=215.4
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEee
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFS 746 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~ 746 (977)
..+.....++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567899999999999999999974 256899999997654 33456789999999999 7999999999
Q ss_pred eeecCC-eeEEEEeccCCCCHHHHhhcCCc---------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 036011 747 SCCNND-FRALVLELMPNGSLEKWLYSDNY---------------FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810 (977)
Q Consensus 747 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 810 (977)
++...+ ..++||||+++|+|.+++..... .+++..+..++.|+++||+||| +.||+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCc
Confidence 987654 58999999999999999987543 2789999999999999999999 7899999999
Q ss_pred CCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCC
Q 036011 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMF 889 (977)
Q Consensus 811 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~ 889 (977)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987765444344444568899999999999999999999999999999998 999997643
Q ss_pred cccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 890 TGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+. ............. . ..+...+.+++.+||+.+|.+|||+.|++++|+++..
T Consensus 256 ~~~~-~~~~~~~~~~~~~-----------~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 256 IDEE-FCRRLKEGTRMRA-----------P------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CSHH-HHHHHHHTCCCCC-----------C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHH-HHHHhccCccCCC-----------C------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3222 1111111111000 0 0123457899999999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=355.87 Aligned_cols=250 Identities=27% Similarity=0.345 Sum_probs=202.8
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCe
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 753 (977)
....++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999975 68999999997653 23456678899999887 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999997644 3899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+....+
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~--------- 235 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNP--------- 235 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC---------
T ss_pred ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHhCCC---------
Confidence 33221 2334579999999999999999999999999999999999999997542211 1111111000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMT-DAA 954 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-ev~ 954 (977)
.+ . ..+...+.+++.+|++.+|++||++. |+.
T Consensus 236 ~~--p-------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 FY--P-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC--C-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC--C-------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 0 01234578899999999999999997 554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.78 Aligned_cols=261 Identities=22% Similarity=0.263 Sum_probs=207.4
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeee----cCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC----NNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l 756 (977)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35789999999999999999997 579999999987766666788999999999999999999999986 3447789
Q ss_pred EEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 757 VLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
||||+++|+|.+++.. ....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999876 3446899999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCCcc-------eeeccccCCcccCccccCCCC---cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 834 DEGDDSV-------TQTMTIATIGYMAPEYGTEGI---VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 834 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
....... ......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||..................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 4211110 011235799999999987554 789999999999999999999998643222222222111100
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. .. ....+...+.+++.+||+.||.+|||+.|++++|+++++
T Consensus 265 ~------------~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 265 S------------IP-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -------------CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred C------------CC-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 00 001123457899999999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=372.72 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=204.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||+||+|+++++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35688889999999999999999888889999997543 234679999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 999999999753 235899999999999999999999 78999999999999999999999999999987654322 1
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......+++.|+|||++.++.++.++||||||+++|||++ |+.||.+....+ ....+.....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~--------------- 399 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR--------------- 399 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC---------------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence 2223347889999999998899999999999999999999 999987643221 1111111000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+.+..++..+.+++.+||+.+|++|||++++++.|+++..
T Consensus 400 --~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 00011244568899999999999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.01 Aligned_cols=246 Identities=23% Similarity=0.237 Sum_probs=204.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999975 69999999997653 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999998654 3899999999999999999999 789999999999999999999999999999876532
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........... ..
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~------------~~ 257 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV------------RF 257 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC------------CC
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCC------------CC
Confidence 12346999999999999999999999999999999999999999753221 11111111100 00
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
. ..+...+.+++.+||+.||.+||+ ++|++++
T Consensus 258 p-------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 P-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C-------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0 012345789999999999999998 7877653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=356.47 Aligned_cols=274 Identities=24% Similarity=0.334 Sum_probs=198.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec-----CCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~l 756 (977)
.++|++.+.||+|+||+||+|+. +++.||||++....... .....|+..+..++||||+++++++.. ....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 46799999999999999999987 68999999997543221 122344444556899999999985532 335689
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEeCCCCCCceeeCCCCceEEeec
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST---------PVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
||||+++|+|.+++.... .++..+..++.||++||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999997765 589999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCC------cceeeccccCCcccCccccCC-------CCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc
Q 036011 828 GLSKLFDEGDD------SVTQTMTIATIGYMAPEYGTE-------GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS 894 (977)
Q Consensus 828 gla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 894 (977)
|+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987654321 112223469999999999887 46778999999999999999998776442221110
Q ss_pred HHHHHHhhCCCc----hhhhcchhhhcc--ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 895 LKKWVKESLPHG----LMEVVDTNLLRQ--EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 895 ~~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...+........ ............ +........+...+.+++.+||+.||++|||++|+++.|+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 000000000000 000000000000 01111122356678999999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.06 Aligned_cols=245 Identities=21% Similarity=0.225 Sum_probs=194.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56899999999999999999976 79999999986543 23334455566666555 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+ +++|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 67999998876667999999999999999999999 7899999999999999999999999999998765432
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......||++|+|||++.+ .++.++|||||||++|||++|..|+... ....... .. ...+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~-----~~---~~~~----- 271 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLR-----QG---YLPP----- 271 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHT-----TT---CCCH-----
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHh-----cc---CCCc-----
Confidence 2233469999999998876 7999999999999999999997776431 1111110 00 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+|++.||++|||++|++++
T Consensus 272 ----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 ----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111234568899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=363.59 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=208.4
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeec
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 750 (977)
+.+.....++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|.+++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444556788999999999999999999975 79999999997542 2334558899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
.+..++||||+++|+|.+++...+..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999876556999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccC-------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGT-------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
+....... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||......+ .........
T Consensus 210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~- 286 (412)
T 2vd5_A 210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYK- 286 (412)
T ss_dssp EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHH-
T ss_pred eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc-
Confidence 87754322 2223457999999999886 4679999999999999999999999997643221 111111100
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR---IYMTDAAVK 956 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~ev~~~ 956 (977)
..+... .....++..+.+++.+|++ +|++| |+++|++++
T Consensus 287 ---------~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 ---------EHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---------HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---------cCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000 0011234457899999999 99998 588888654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.59 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=205.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC--CeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN--DFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 757 (977)
.++|.+.+.||+|+||+||+|+++ ++.||||++.... ....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357889999999999999999984 8999999987653 34456799999999999999999999999877 788999
Q ss_pred EeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.++++|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999987654 5899999999999999999999 778 9999999999999999999999999876533
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCc---ccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSS---KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
. ....||+.|+|||++.+..++. ++||||+|+++|||++|+.||......+. .............
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~---- 232 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRPTI---- 232 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCCCCC----
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCCCCC----
Confidence 2 1235899999999988765544 89999999999999999999976432221 1111111000000
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
+..++..+.+++.+||+.||++|||++|+++.|++++
T Consensus 233 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 -------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0122345789999999999999999999999999886
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=368.18 Aligned_cols=329 Identities=22% Similarity=0.218 Sum_probs=239.3
Q ss_pred CCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCC
Q 036011 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324 (977)
Q Consensus 245 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 324 (977)
+++++|+|++|++++..+..|.++++|++|+|++|.++++.|..|.++++|++|+|++|.++.+++.. +..++
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~ 104 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGV-------FTGLS 104 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTS-------STTCT
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCccc-------ccCCC
Confidence 46777777777777766777777777888888888777777777777777888888777777766543 56677
Q ss_pred CCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEe
Q 036011 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404 (977)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 404 (977)
+|++|++++|.+.+. .|..|..+++|++|++++|.+.+..+..|.++++|++|+|
T Consensus 105 ~L~~L~Ls~n~i~~~-------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 159 (477)
T 2id5_A 105 NLTKLDISENKIVIL-------------------------LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159 (477)
T ss_dssp TCCEEECTTSCCCEE-------------------------CTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEE
T ss_pred CCCEEECCCCccccC-------------------------ChhHccccccCCEEECCCCccceeChhhccCCCCCCEEEC
Confidence 777777777766543 3344566677777777777777666677777777777777
Q ss_pred ecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCC
Q 036011 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484 (977)
Q Consensus 405 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 484 (977)
++|++++..+..+..+++|+.|++++|++.+..+..|..+++|++|++++|.+.+.+|.......+|+.|++++|++++.
T Consensus 160 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 239 (477)
T 2id5_A 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239 (477)
T ss_dssp ESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSC
T ss_pred CCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccccc
Confidence 77777766666677777777777777777766666777777777777777777666666666666788888888888765
Q ss_pred CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccc
Q 036011 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEAL 564 (977)
Q Consensus 485 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 564 (977)
.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+
T Consensus 240 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 319 (477)
T 2id5_A 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319 (477)
T ss_dssp CHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCG
T ss_pred CHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCC
Confidence 55677778888888888888876666677888888888888888887778888888888888888888886666677788
Q ss_pred cccCccccCCCcccccCCCCCCCCcCCCCCcccCccccCCC
Q 036011 565 LFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT 605 (977)
Q Consensus 565 ~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 605 (977)
++|++|++++|+|.+..+-.+.+.......+.++...|+.|
T Consensus 320 ~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 320 GNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp GGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred cccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 88888888888887766532222222334456666677654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.05 Aligned_cols=274 Identities=22% Similarity=0.364 Sum_probs=216.9
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHh--cCCCCcceEeeeeecCC
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRN--VRHRNLIKIFSSCCNND 752 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~ 752 (977)
........++|++.+.||+|+||+||+|+. +|+.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445567899999999999999999998 5899999998644 23567788888887 78999999999998776
Q ss_pred ----eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCceeeCCCCceE
Q 036011 753 ----FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG-----HSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 753 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
..++||||+++|+|.+++.... +++..++.++.|++.||+|||.. ++.+|+||||||+||+++.++.+|
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred CccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 7899999999999999997654 89999999999999999999932 257899999999999999999999
Q ss_pred EeecccccccCCCCCcc--eeeccccCCcccCccccCCC------CcCcccchhhHhHHHHHHhcC----------CCCC
Q 036011 824 VSDFGLSKLFDEGDDSV--TQTMTIATIGYMAPEYGTEG------IVSSKCDVYSYGVLLTETFTR----------KKPT 885 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~ 885 (977)
|+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999998776543221 12334699999999998765 345789999999999999999 7788
Q ss_pred CcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 886 DDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
............+.......... +.+ .......++...+.+++.+||+.+|++|||+.|++++|+++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLR----PNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCC----CCC----CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhC----CCC----cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 76555444444444332222111 111 0111123466778999999999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=354.23 Aligned_cols=274 Identities=24% Similarity=0.392 Sum_probs=212.1
Q ss_pred hcCCCcCccccCcceEEEEEEEe-----CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC--ee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-----SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND--FR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 754 (977)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 368999999998766666788999999999999999999999986644 78
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++++|.+++......+++..++.++.|+++||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999887667999999999999999999999 7899999999999999999999999999998876
Q ss_pred CCCCcce-eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch-hhhcc
Q 036011 835 EGDDSVT-QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL-MEVVD 912 (977)
Q Consensus 835 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 912 (977)
....... .....++..|+|||++.+..++.++||||+|+++|||+||..|+..... .............. ...+.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHHH
Confidence 5432211 2223577789999999888899999999999999999999998753210 00110000000000 00000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+. .....+....++..+.+++.+||+.+|++|||+.|+++.|++++.
T Consensus 274 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhh-cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000 000001112245568899999999999999999999999998873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.18 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=208.9
Q ss_pred cCCCcCc-cccCcceEEEEEEEeC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECN-LLGRGSFGSVYKGTFS---DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|.+.+ .||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 8999999999999853 57889999997653 34567799999999999999999999999 45668999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999876667999999999999999999999 7899999999999999999999999999998775433
Q ss_pred Ccc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 838 DSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 838 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+......
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~~~~---------- 232 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRM---------- 232 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCC----------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcCCcC----------
Confidence 221 1223346889999999988899999999999999999998 999997643221 11211111000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. .+..++..+.+++.+||+.+|++||++.|++++|+++..
T Consensus 233 -~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 233 -E------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -C------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 001234568899999999999999999999999988754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=357.04 Aligned_cols=253 Identities=22% Similarity=0.245 Sum_probs=194.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999976 79999999997543 2336688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc--eEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV--AHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~~~~~~ 838 (977)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 99999999987644 3899999999999999999999 789999999999999987765 9999999997543222
Q ss_pred cceeeccccCCcccCccccCCCCcCcc-cchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSK-CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......||+.|+|||++.+..++.+ +||||+||++|||++|+.||........ ............ ...
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~--------~~~ 241 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK--------YSI 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC--------CCC
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC--------CCC
Confidence 2233469999999999988877655 8999999999999999999976433222 222211111100 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+....+...+.+++.+||+.+|++|||+.|++++
T Consensus 242 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 -----PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000123457899999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.21 Aligned_cols=268 Identities=22% Similarity=0.323 Sum_probs=191.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999965 689999999876542 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 760 LMPNGSLEKWLYSDN-----YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|++ |+|.+++.... ..+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886532 34899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CCCc-hhhh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LPHG-LMEV 910 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~ 910 (977)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+....... .... +...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence 3322 2233468999999999876 468999999999999999999999997643322 122221110 0010 0000
Q ss_pred c-----chhhhccccC-c------hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 V-----DTNLLRQEHT-S------SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~-----~~~~~~~~~~-~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. .+.+...... . .........+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000000 0 0000123468899999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.07 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=211.7
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999864 37889999987543 33456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 752 DFRALVLELMPNGSLEKWLYSDN---------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999987532 24689999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||......+ ....+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~ 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVME 255 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHHT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHHHHHc
Confidence 9999999987654332222233457889999999998899999999999999999999 888886542211 1111111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. ...... ..++..+.+++.+||+.+|++|||+.|++++|+++..
T Consensus 256 ---~--------~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 ---G--------GLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---T--------CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---C--------CcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 000000 1234457899999999999999999999999988754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.02 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=201.6
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeecc---chhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQ---LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35689999999999999999996 47999999998753 234557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|||+++|+|.+++.. ....+++..++.++.|+++||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 3345899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||................. ....
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~----- 257 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPP----- 257 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---CSCC-----
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---cCCC-----
Confidence 4321 12234689999999999999999999999999999999999999975432221121111110 0000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhcCcc
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKIIGVL 966 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~ 966 (977)
. . ...+...+.+++.+||+.||++|||+.++++.|+++++....
T Consensus 258 ~---~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 L---P-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp C---C-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred C---c-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0 0 011234578999999999999999999999999999875443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.54 Aligned_cols=250 Identities=22% Similarity=0.260 Sum_probs=203.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 755 (977)
..++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999976 48899999998653 23456688899999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999997654 3899999999999999999999 78999999999999999999999999999986432
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ ..
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~------------~~ 238 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEH------------NV 238 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC------------CC
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhC------------CC
Confidence 22 12334579999999999999999999999999999999999999997532211 11111111 00
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
... ......+.+++.+|++.+|++||+ +.|++++
T Consensus 239 ~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCC-------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000 012345789999999999999995 4666543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.04 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=206.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457899999999999999999975 5789999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~ 837 (977)
+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999887654 3899999999999999999999 7899999999999999 788999999999998775433
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......||+.|+|||++.+. ++.++||||+|+++|||++|+.||......+ ............
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~------------ 226 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFTF------------ 226 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCC------------
T ss_pred ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC------------
Confidence 22334699999999998764 8999999999999999999999997643221 111111111100
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+|++.||++|||+.|++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 ---PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111234567899999999999999999999763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.73 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=206.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|.+.+.||+|+||+||+|++.. +..||||++.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678899999999999999998642 3469999987653 3456779999999999999999999999865 45689
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++++|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999876666899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ............
T Consensus 167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~~--------- 234 (281)
T 3cc6_A 167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRLP--------- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCCC---------
T ss_pred cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCCC---------
Confidence 22 12233457889999999988899999999999999999998 999997543322 112111110000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. +..++..+.+++.+||+.+|++||++.|++++|+++..
T Consensus 235 --~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 --K------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0 01123457899999999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.04 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=198.7
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC-
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND- 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 752 (977)
...++|.+.+.||+|+||+||+|+.. .++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567889999999999999999864 34589999987553 344577899999999999999999999997755
Q ss_pred ----eeEEEEeccCCCCHHHHhhc-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceE
Q 036011 753 ----FRALVLELMPNGSLEKWLYS-----DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823 (977)
Q Consensus 753 ----~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 823 (977)
..++||||+++|+|.+++.. ....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 34899999999999999853 2345899999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhh
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 902 (977)
|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ........
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~ 265 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDYLLHG 265 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHHcC
Confidence 999999987755433333334457889999999999999999999999999999999 888887643221 11111111
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.... ....++..+.+++.+||+.+|++|||+.+++++|+++..
T Consensus 266 ~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 266 HRLK-----------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp CCCC-----------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000 001234468899999999999999999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=360.21 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=197.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC--C--CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeec-CCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS--D--GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-NDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 756 (977)
..|.+.+.||+|+||+||+|+.. + +..||||++.... ....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34667789999999999999863 2 2468999986543 3456789999999999999999999998754 567899
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999887767899999999999999999999 789999999999999999999999999999876443
Q ss_pred CCc--ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 837 DDS--VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 837 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+ ..........
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~~--------- 314 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRR--------- 314 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTCC---------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCCC---------
Confidence 221 12223457889999999999999999999999999999999 677776543222 2221111100
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
... +..++..+.+++.+||+.+|++|||++|+++.|+++..
T Consensus 315 --~~~------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 --LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp --CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 01234468899999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=355.97 Aligned_cols=255 Identities=27% Similarity=0.302 Sum_probs=196.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHH-HHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEV-LRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.+.||+|+||.||+|+.+ +++.||||++.+.. ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367899999999999999999975 68899999997653 2233456667766 567899999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999997654 4889999999999999999999 789999999999999999999999999999864332
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. ......+||+.|+|||++.+..++.++||||+||++|||++|..||......+ ........ ...
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~------------~~~ 257 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNK------------PLQ 257 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHS------------CCC
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhc------------ccC
Confidence 2 12334579999999999999999999999999999999999999997542211 11111111 010
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
... .+...+.+++.+|++.||.+||++.+..+.+.+-..
T Consensus 258 ~~~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 258 LKP-------NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp CCS-------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred CCC-------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 001 123357889999999999999998655555444333
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.58 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=199.9
Q ss_pred hcCCCcC-ccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNEC-NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.+.|++. +.||+|+||+||+|+.. +++.||||++........+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568774 78999999999999964 7999999999876555567889999999985 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc---eEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV---AHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~ 835 (977)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999997654 4899999999999999999999 789999999999999998776 99999999986643
Q ss_pred CCC-----cceeeccccCCcccCccccCC-----CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 836 GDD-----SVTQTMTIATIGYMAPEYGTE-----GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 836 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+... .......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~ 243 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW---DRGEACP 243 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc---cccccch
Confidence 211 111223459999999998865 568999999999999999999999997654322110 0000000
Q ss_pred chhhhcchhhhccc-c-CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQE-H-TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.... . .......+...+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000000000 0 001111234568899999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=350.78 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=212.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSD------GTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
..++|.+.+.||+|+||+||+|+... +..||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35778999999999999999998642 3489999987653 34456789999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCC-------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC
Q 036011 753 FRALVLELMPNGSLEKWLYSDN-------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED 819 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 819 (977)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence 9999999999999999987532 24789999999999999999999 7899999999999999999
Q ss_pred CceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHH
Q 036011 820 MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKW 898 (977)
Q Consensus 820 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 898 (977)
+.+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||+| |..||.+..... .....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHH
Confidence 9999999999987755443333334557889999999988899999999999999999999 899987643322 12222
Q ss_pred HHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 899 VKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
......... + ..++..+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus 280 ~~~~~~~~~-----------~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 280 VKDGYQMAQ-----------P------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHTCCCCC-----------C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCC-----------C------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 222111100 0 0123457899999999999999999999999988763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.05 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=213.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
..++|++.+.||+|+||+||+|++. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567889999999999999999976 4889999998754 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 999999999998643 35899999999999999999999 78999999999999999999999999999987764332
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||....... ............
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~~----------- 232 (288)
T 3kfa_A 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRME----------- 232 (288)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCCCC-----------
T ss_pred -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccCCCC-----------
Confidence 22333457889999999998899999999999999999999 999987643221 222111111100
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....++..+.+++.+|++.+|.+|||+.|+++.|+++..
T Consensus 233 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 233 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 001223467899999999999999999999999987664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=361.54 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=205.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999975 799999999976532 2356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999997654 4899999999999999999999 8999999999999999999999999999998775432
Q ss_pred CcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+..... ....+.. ....
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~i~~-----------~~~~ 234 (476)
T 2y94_A 171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFKKICD-----------GIFY 234 (476)
T ss_dssp C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHHHHHT-----------TCCC
T ss_pred c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHHHHhc-----------CCcC
Confidence 2 233569999999999988765 789999999999999999999997643211 1111110 0000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. +. .+...+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~-p~------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 T-PQ------YLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C-CT------TCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-Cc------cCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 00 123357889999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=353.14 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=203.9
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHhcCCCCcceEeeeeec
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 750 (977)
++....++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556788999999999999999999974 68899999987552 3445779999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHhhcC---------------------------------------CccCCHHHHHHHHHHHHH
Q 036011 751 NDFRALVLELMPNGSLEKWLYSD---------------------------------------NYFLDLLERLNIMIGVAL 791 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~ 791 (977)
.+..++||||+++|+|.+++... ...+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 112357788899999999
Q ss_pred HHHHHHhcCCCCeEeCCCCCCceeeCCCC--ceEEeecccccccCCCCCc--ceeeccccCCcccCccccCC--CCcCcc
Q 036011 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDM--VAHVSDFGLSKLFDEGDDS--VTQTMTIATIGYMAPEYGTE--GIVSSK 865 (977)
Q Consensus 792 ~L~~LH~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~ 865 (977)
||+||| +.+|+||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 78999999999999998776 8999999999876432221 12334569999999999865 678999
Q ss_pred cchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCC
Q 036011 866 CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPD 945 (977)
Q Consensus 866 ~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 945 (977)
+||||+||++|||++|+.||......+. ........... ..+....+...+.+++.+||+.+|.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKLCF---------------ENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCT---------------TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhccccc---------------CCcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999976433221 11111111100 0011112344578999999999999
Q ss_pred CCCCHHHHHHH
Q 036011 946 QRIYMTDAAVK 956 (977)
Q Consensus 946 ~RPs~~ev~~~ 956 (977)
+||++.|++++
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.50 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=205.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 68999999987653 344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc---eEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV---AHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~ 835 (977)
||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999998887654 4899999999999999999999 789999999999999986655 99999999987654
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||......+ .............
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~--------- 227 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYP--------- 227 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCC---------
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccCC---------
Confidence 322 233569999999999999999999999999999999999999996532211 1111111111000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+...+.+++.+|++.+|++|||+.|++++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 ------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00011223457899999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.06 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=193.9
Q ss_pred hcCCCcCccccCcceEEEEEEEe----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 478999999987642 2334567899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999997654 4889999999999999999999 789999999999999999999999999999864
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... .....+||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ .........
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~----------- 237 (327)
T 3a62_A 172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCK----------- 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTC-----------
T ss_pred ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC-----------
Confidence 33221 2234569999999999999999999999999999999999999997642211 111111110
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
.... ..+...+.+++.+||+.+|++|| ++.|++++
T Consensus 238 -~~~p-------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -LNLP-------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -CCCC-------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CCCC-------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0000 01234578999999999999999 67777653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=359.04 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=194.4
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCC--e
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNND--F 753 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 753 (977)
...++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999864 79999999986442 344567889999999997 999999999997544 6
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||++ |+|.+++... .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||+++.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 6999999764 4899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCC-------------------CcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 834 DEGD-------------------DSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 834 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
.... .....+..+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~- 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN- 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 4311 1112233579999999999876 679999999999999999999999997643221
Q ss_pred cHHHHHHhh-CCCc--hhhh-------cchhhhcc--------ccCchH----------HHHHHHHHHHHHHHhhcCCCC
Q 036011 894 SLKKWVKES-LPHG--LMEV-------VDTNLLRQ--------EHTSSA----------EMDCLLSVLHLALDCCMESPD 945 (977)
Q Consensus 894 ~~~~~~~~~-~~~~--~~~~-------~~~~~~~~--------~~~~~~----------~~~~~~~l~~l~~~cl~~~P~ 945 (977)
.+....... .+.. +..+ ....+... ....+. ...+...+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 122211110 0100 0000 00000000 000000 002244678999999999999
Q ss_pred CCCCHHHHHHH
Q 036011 946 QRIYMTDAAVK 956 (977)
Q Consensus 946 ~RPs~~ev~~~ 956 (977)
+|||++|++++
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999887
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.87 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=204.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeee-ecCCeeE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSC-CNNDFRA 755 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~ 755 (977)
...|++.+.||+|+||+||+|+..+ +..||+|++.... ....+.+.+|++++++++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998642 2368999987543 34457789999999999999999999986 4566789
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999877667899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCc--ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcC-CCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 836 GDDS--VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTR-KKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 836 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
.... .......+|+.|+|||.+.+..++.++||||+|+++|||++| .+||......+ ...........
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~------- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRRL------- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHTTCCC-------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhcCCCC-------
Confidence 3211 122334578899999999999999999999999999999995 55554432221 11111111000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..+ ..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 252 ----~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 ----LQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 1123457899999999999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.33 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=208.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||+||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46788899999999999999998888899999987543 235678999999999999999999999864 5688999999
Q ss_pred CCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++++|.+++..... .+++..+..++.|+++||+||| +.||+||||||+||++++++.+||+|||++........ .
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence 99999999976432 5899999999999999999999 78999999999999999999999999999987754321 1
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......+++.|+|||++.++.++.++||||+|+++|||++ |+.||......+ ........... ..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~~-----------~~- 231 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGYRM-----------VR- 231 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCC-----------CC-
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhcccCC-----------CC-
Confidence 2223347788999999988899999999999999999999 899987542211 11111111000 00
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...++..+.+++.+|++.+|++|||+.++++.|+++..
T Consensus 232 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 232 -----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 01233467899999999999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=338.76 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=185.8
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46789999999999999999996 4799999999975432 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999887667999999999999999999999 7899999999999999999999999999998765332
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+. . ..+.......
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~------------~~~~~~~~~~ 231 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L------------NKVVLADYEM 231 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCCCC
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H------------HHHhhcccCC
Confidence 2 12234689999999999999999999999999999999999999975432211 0 0000000000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ..+...+.+++.+||+.||++|||++|++++
T Consensus 232 ~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 P-------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c-------cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 0123457899999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=354.29 Aligned_cols=264 Identities=17% Similarity=0.190 Sum_probs=202.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccchh-----------hHHHHHHHHHHHHhcCCCCcceEee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQLDR-----------AFRSFDSECEVLRNVRHRNLIKIFS 746 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 746 (977)
.++|.+.+.||+|+||+||+|+.. .+..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5789999998765321 1234668889999999999999999
Q ss_pred eeec----CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC--
Q 036011 747 SCCN----NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-- 820 (977)
Q Consensus 747 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-- 820 (977)
++.+ ....++||||+ +++|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence 9987 67889999999 999999998765 5899999999999999999999 78999999999999999877
Q ss_pred ceEEeecccccccCCCCCc-----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccH
Q 036011 821 VAHVSDFGLSKLFDEGDDS-----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSL 895 (977)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 895 (977)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876532211 11133469999999999999999999999999999999999999996533322222
Q ss_pred HHHHHh---hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKE---SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...... ..+........ ...++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAP------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSC------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhhcccccHHHHhhcc------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 221111 11111100000 00234468899999999999999999999999988764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=348.63 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=181.5
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
.+.||+|+||+||+|+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 6899999998754 3456788999999997 9999999999999999999999999999
Q ss_pred HHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceEEeecccccccCCCCCccee
Q 036011 766 LEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++....... ..
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~ 166 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL 166 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence 999998765 4899999999999999999999 78999999999999998665 899999999987654322 22
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc--ccHHHHHHhhCCCchhhhcchhhhcccc
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE--MSLKKWVKESLPHGLMEVVDTNLLRQEH 920 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (977)
...+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......... ..+ .. ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~-------~~---~~ 235 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKG-------DF---SF 235 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTT-------CC---CC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcC-------CC---CC
Confidence 34568999999999999999999999999999999999999997643211 1111111110 000 00 01
Q ss_pred CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 112223345668899999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=347.62 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=208.0
Q ss_pred CCcCccccCcceEEEEEEEeC-----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCeeEE
Q 036011 685 FNECNLLGRGSFGSVYKGTFS-----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRAL 756 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 756 (977)
|++.+.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988653 58899999998654 3446779999999999999999999999987 467889
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++.... +++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999997765 899999999999999999999 789999999999999999999999999999987654
Q ss_pred CCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc------hhh
Q 036011 837 DDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG------LME 909 (977)
Q Consensus 837 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~ 909 (977)
.... ......+|+.|+|||++.+..++.++||||+|+++|||++|+.||........ .+ ...... ..+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~---~~--~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL---EL--IGIAQGQMTVLRLTE 262 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HH--HCSCCHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh---hh--hcccccchhHHHHHH
Confidence 3321 22334588889999999998999999999999999999999999864321100 00 000000 011
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+.... .......++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 263 ~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 263 LLERGE-----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccc-----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111110 011112344568999999999999999999999999998864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=348.43 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=203.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--------hhHHHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--------RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567999999999999999999864 789999999876531 1344678899999999999999999999999
Q ss_pred CeeEEEEeccCCC-CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 752 DFRALVLELMPNG-SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 752 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
+..++||||+.+| +|.+++..... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 99999977654 899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
+....... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 87765432 223469999999999988876 88999999999999999999999652110
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........ . .+...+.+++.+||+.||++|||+.|++++
T Consensus 237 -~~~~~~~~-~------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIHPP-Y------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCCCS-S------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccCCC-c------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001000 0 123457899999999999999999999886
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=378.61 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=202.3
Q ss_pred CCcCc-cccCcceEEEEEEEeC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 685 FNECN-LLGRGSFGSVYKGTFS---DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 685 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
+.+.+ .||+|+||+||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999864 46679999997653 3456789999999999999999999999976 56899999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 99999999999877667999999999999999999999 789999999999999999999999999999877543322
Q ss_pred c-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 840 V-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 840 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. ......+++.|+|||++.++.++.++|||||||++|||++ |+.||......+ ....+.....
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~------------- 557 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR------------- 557 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCC-------------
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence 1 1222346789999999998999999999999999999998 999997653322 1121111100
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
...+..++..+.+++.+||+.+|++||++.++++.|+.+-
T Consensus 558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0001124556899999999999999999999999998864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=344.40 Aligned_cols=267 Identities=21% Similarity=0.260 Sum_probs=200.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 599999999865432 33566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.+++.... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999999887554 4899999999999999999999 78999999999999999999999999999987653322
Q ss_pred cceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC---chhhhcch-
Q 036011 839 SVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH---GLMEVVDT- 913 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 913 (977)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+. ... +...... ........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYL-IRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-HHHHHCSCCHHHHHHHHTC
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHhcccccccccccccc
Confidence 2233468999999998875 6789999999999999999999999976433221 111 1111000 00000000
Q ss_pred ------hhhccccC---chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 ------NLLRQEHT---SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 ------~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........ ......+...+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 00001234557899999999999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=346.02 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=205.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999975 6899999998765321 356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC----ceEEeecccc
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM----VAHVSDFGLS 830 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla 830 (977)
++||||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999997654 4899999999999999999999 78999999999999999888 7999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ...........
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~------ 236 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITSVSYD------ 236 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC------
T ss_pred eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccc------
Confidence 87754322 233469999999999999999999999999999999999999997542211 11111110000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.++ .........+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 FDE---------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCH---------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cCh---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0011223457899999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.17 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=201.5
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+.++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567999999999999999999865 57899999987543 2234668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999987654 3899999999999999999999 899999999999999999999999999998655432
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+ .......... ..
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~--------- 226 (279)
T 3fdn_A 163 R----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEF--TF--------- 226 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC--CC---------
T ss_pred c----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHhCCC--CC---------
Confidence 2 223468999999999999999999999999999999999999997532211 1111100000 00
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+ ..+...+.+++.+||+.+|++|||+.|++++
T Consensus 227 --~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 --P------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --C------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --C------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0123357889999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.59 Aligned_cols=262 Identities=19% Similarity=0.228 Sum_probs=209.2
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeee-ecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC-CNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+++++.++|++++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999996 5799999999875432 35688999999999988877666655 66778899999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccCCC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~ 836 (977)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 89999999866667999999999999999999999 7899999999999999 48899999999999877654
Q ss_pred CCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc--ccHHHHHHhhCCCchhh
Q 036011 837 DDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE--MSLKKWVKESLPHGLME 909 (977)
Q Consensus 837 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 909 (977)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 3211 1234569999999999999999999999999999999999999997643221 1111211111110000
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
.....++..+.+++.+||+.+|++|||++++++.|+++...
T Consensus 241 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 241 -------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00012345688999999999999999999999999887643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.41 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=205.4
Q ss_pred hcCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999984 257799999987443 34556789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEe
Q 036011 755 ALVLELMPNGSLEKWLYSDN------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVS 825 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 825 (977)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998654 34889999999999999999999 789999999999999994 4469999
Q ss_pred ecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCC
Q 036011 826 DFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLP 904 (977)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (977)
|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |..||...... ....++.....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR 263 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcCCC
Confidence 9999986654433333344568899999999988899999999999999999998 99998653221 11111111100
Q ss_pred CchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.. . ...++..+.+++.+||+.+|.+||++.|++++++.+..
T Consensus 264 ~~-----------~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 264 MD-----------P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CC-----------C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----------C------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00 0 01223457899999999999999999999999988764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=357.29 Aligned_cols=275 Identities=21% Similarity=0.268 Sum_probs=213.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC--eeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND--FRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 757 (977)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357899999999999999999976 59999999997543 334567889999999999999999999998755 67999
Q ss_pred EeccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee----CCCCceEEeeccccc
Q 036011 758 LELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHVSDFGLSK 831 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~ 831 (977)
|||+++|+|.+++..... .+++..++.++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976443 3899999999999999999999 7899999999999999 788889999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCC--------CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHH---HHHH
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTE--------GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK---KWVK 900 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---~~~~ 900 (977)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 765432 2223469999999998764 5788999999999999999999999975433222221 2222
Q ss_pred hhCCCchhhh---cchhhhc---cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 901 ESLPHGLMEV---VDTNLLR---QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 901 ~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...+..+..+ ....+.. .+........+...+.+++.+||+.||++||+++|+++.++++-.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111111111 0000000 001112224566778899999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.29 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=205.7
Q ss_pred CCCcCccccCcceEEEEEEEeC-C---CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee-EEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-D---GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR-ALV 757 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 757 (977)
.|...++||+|+||+||+|++. + +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999853 2 2379999987543 34567789999999999999999999999776655 899
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+.+|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999886667899999999999999999999 7899999999999999999999999999998664322
Q ss_pred C--cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 838 D--SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 838 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
. ........+|+.|+|||...+..++.++||||+|+++|||++|..|+...... ...............
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~-------- 249 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLPQ-------- 249 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCCCC--------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCCCC--------
Confidence 1 11223345788999999999999999999999999999999966665432222 222222221111000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...++..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 250 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 250 ---------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01123457899999999999999999999999998864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.76 Aligned_cols=263 Identities=19% Similarity=0.235 Sum_probs=205.7
Q ss_pred HhhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeee-ecCCeeEEE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC-CNNDFRALV 757 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 757 (977)
...++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++.++|++++..++++ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999996 578999999876443 235688999999999988877776655 667788999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 834 (977)
|||+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 99999999876666999999999999999999999 7899999999999999 788999999999998876
Q ss_pred CCCCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc--ccHHHHHHhhCCCch
Q 036011 835 EGDDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE--MSLKKWVKESLPHGL 907 (977)
Q Consensus 835 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~ 907 (977)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 543211 2224569999999999999999999999999999999999999997643321 111111111110000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. .....++..+.+++.+||+.+|++|||++++++.|+++..
T Consensus 240 ~--------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 E--------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H--------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred h--------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 0001224568899999999999999999999999988764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=343.91 Aligned_cols=268 Identities=25% Similarity=0.323 Sum_probs=200.9
Q ss_pred hhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccch-----hhHHHHHHHHHHHHhcC---CCCcceEeeeeecC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD-----RAFRSFDSECEVLRNVR---HRNLIKIFSSCCNN 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 751 (977)
..++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 4789999999875431 12345667777777664 99999999999775
Q ss_pred C-----eeEEEEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEe
Q 036011 752 D-----FRALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVS 825 (977)
Q Consensus 752 ~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 825 (977)
. ..++||||+. |+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5789999997 599999987543 4899999999999999999999 7899999999999999999999999
Q ss_pred ecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-C-
Q 036011 826 DFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-L- 903 (977)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~- 903 (977)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ......... .
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 999998765332 2234569999999999999999999999999999999999999997643222 222222111 0
Q ss_pred CC-chhhhc---chhhhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PH-GLMEVV---DTNLLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~-~~~~~~---~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+. .+.... ...+...... .....++...+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 010000 0000000000 00011234567899999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.42 Aligned_cols=250 Identities=28% Similarity=0.332 Sum_probs=197.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56889999999999999999964 68999999987654 23457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccC
Q 036011 761 MPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 761 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 834 (977)
+++|+|.+++... ...+++..+..++.|+++||+||| +.||+||||||+||++ +.++.+||+|||++..+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 245899999999999999999999 7899999999999999 456889999999998765
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
... ......||+.|+|||++. +.++.++||||+|+++|||++|+.||......+. ........+.
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~--------- 243 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPN--------- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCC---------
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCcc---------
Confidence 432 223356999999999876 5689999999999999999999999976432211 1111110000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... ......+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 244 YAVEC------RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCC--------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccc------CcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0123457899999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=348.79 Aligned_cols=246 Identities=26% Similarity=0.327 Sum_probs=200.5
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
+.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4488889999999999999996 478999999987542 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+. |++.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6888888765566999999999999999999999 789999999999999999999999999999876432
Q ss_pred cceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 839 SVTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ ..........+. .
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~---------~ 273 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA---------L 273 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------C
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC---------C
Confidence 2246999999999873 5779999999999999999999999986542211 111111110000 0
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ...+...+.+++.+||+.+|++|||+.+++++
T Consensus 274 ~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00123457889999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.86 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=205.3
Q ss_pred hcCCCcCc-cccCcceEEEEEEEe---CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 682 TDGFNECN-LLGRGSFGSVYKGTF---SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 682 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
.++|.+.+ .||+|+||+||+|.+ ..++.||||++.... ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999964 247889999987553 23357799999999999999999999999 566788
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999999999999998754 3899999999999999999999 78999999999999999999999999999987755
Q ss_pred CCCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 836 GDDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 836 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.......
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~------- 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMG------- 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCC-------
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCC-------
Confidence 43322 1222346788999999988889999999999999999999 99999764321 1111111110000
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+..++..+.+++.+||+.||++||++.|+++.|+++-.
T Consensus 241 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 241 ----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 001234568899999999999999999999999988764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.04 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=199.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-CeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-DFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+. .|+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788999999999999999987 48899999987543 456789999999999999999999987554 578999999
Q ss_pred cCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|+|.+++..... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999976543 3789999999999999999999 7899999999999999999999999999998654322
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+..... ..
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~~------------~~ 234 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK------------MD 234 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTCC------------CC
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCC------------CC
Confidence 12347889999999988899999999999999999998 999987643221 1111111000 00
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....++..+.+++.+||+.+|++||++.|+++.|++++.
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 235 -----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 001234467899999999999999999999999999885
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=352.45 Aligned_cols=252 Identities=17% Similarity=0.134 Sum_probs=204.8
Q ss_pred hhcCCCcCccccCcceEEEEEEE------eCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC---CCCcceEeeeeecC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGT------FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR---HRNLIKIFSSCCNN 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 751 (977)
..++|.+.+.||+|+||+||+|+ ..+++.||||++.... ..++.+|+++++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35679999999999999999994 3468999999987543 346777888888886 99999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhc----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---------
Q 036011 752 DFRALVLELMPNGSLEKWLYS----DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE--------- 818 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--------- 818 (977)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.||+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975 3345999999999999999999999 899999999999999998
Q ss_pred --CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHH
Q 036011 819 --DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896 (977)
Q Consensus 819 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 896 (977)
++.+||+|||+|+.+............+||++|+|||++.+..++.++|||||||++|||+||+.||.....+...
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 8999999999998765443444455567999999999999999999999999999999999999998543222110
Q ss_pred HHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHHHchhh
Q 036011 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQR-IYMTDAAVKLKKIKI 962 (977)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~ev~~~L~~~~~ 962 (977)
....+. ... ....+.+++..|++.+|.+| |+++++.+.|++.-.
T Consensus 295 --------------~~~~~~-~~~-------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 --------------PEGLFR-RLP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --------------ECSCCT-TCS-------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------echhcc-ccC-------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 000000 000 12345678899999999998 578888888877653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=357.40 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=195.1
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcCCCCcceEeeeeec
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 750 (977)
...++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999865 68999999987542 1223358899999999999999999999854
Q ss_pred CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceEEeec
Q 036011 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAHVSDF 827 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Df 827 (977)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 55789999999999999887654 4899999999999999999999 78999999999999997544 5999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (977)
|+++...... .....+||+.|+|||++. ...++.++||||+||++|||++|+.||....... ...........
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKY 362 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCC
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCC
Confidence 9998765422 223456999999999975 3678899999999999999999999997643322 22222211111
Q ss_pred CchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .......+...+.+++.+|++.||++|||++|++++
T Consensus 363 ~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 NF--------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC--------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC--------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 001111234567899999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=343.56 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=200.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 68999999987553 23346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999997654 4899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. .......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... ..........+..
T Consensus 189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~----------- 254 (309)
T 2h34_A 189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPRP----------- 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCCG-----------
T ss_pred c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCCc-----------
Confidence 2 1223346899999999999999999999999999999999999999753221 1111111111100
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHchhh
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRI-YMTDAAVKLKKIKI 962 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~ev~~~L~~~~~ 962 (977)
......++..+.+++.+||+.+|++|| ++.++++.|++.-.
T Consensus 255 ----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 ----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp ----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 000112234578899999999999999 99999999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=349.60 Aligned_cols=207 Identities=25% Similarity=0.329 Sum_probs=180.1
Q ss_pred CCCHHHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-----CCCcceEe
Q 036011 672 RTSYLDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-----HRNLIKIF 745 (977)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~ 745 (977)
.+++.+.....++|.+.++||+|+||+||+|+.. +++.||||++... ....+.+..|+++++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3344444455788999999999999999999974 7899999998743 334566788999999996 99999999
Q ss_pred eeeecCCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC------
Q 036011 746 SSCCNNDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE------ 818 (977)
Q Consensus 746 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~------ 818 (977)
+++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 899999998654 35899999999999999999999 789999999999999975
Q ss_pred -------------------CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHh
Q 036011 819 -------------------DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETF 879 (977)
Q Consensus 819 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 879 (977)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998754322 2346899999999999999999999999999999999
Q ss_pred cCCCCCCcC
Q 036011 880 TRKKPTDDM 888 (977)
Q Consensus 880 tg~~p~~~~ 888 (977)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.28 Aligned_cols=267 Identities=20% Similarity=0.261 Sum_probs=199.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh-hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR-AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|.+.+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 7899999998755422 223456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++ |+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence 97 5999999887777999999999999999999999 78999999999999999999999999999986543222
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh---CCCchhhhcchhhh
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES---LPHGLMEVVDTNLL 916 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 916 (977)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ......... ....+.........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhh
Confidence 2233468999999998876 578999999999999999999999997643222 122211111 01111111110000
Q ss_pred c----c----ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 R----Q----EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~----~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. . .........+...+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0 00000111234567899999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=349.22 Aligned_cols=272 Identities=24% Similarity=0.312 Sum_probs=201.1
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-----hhHHHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-----RAFRSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
+....++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445678999999999999999999975 689999999875432 1234688999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
+..++||||+++ +|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999976 899998877667899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CC--Cch
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LP--HGL 907 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~--~~~ 907 (977)
.+..... ......||+.|+|||++.+. .++.++||||+||++|||++|..||......+ .+....... .+ ..+
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhh
Confidence 7654322 22335689999999998654 58999999999999999999999987643222 222222211 11 001
Q ss_pred hhhcc--hhhhccc-cCc---hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVD--TNLLRQE-HTS---SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~--~~~~~~~-~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... ....... ... .....+...+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0000000 000 0001234568999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=358.49 Aligned_cols=262 Identities=22% Similarity=0.232 Sum_probs=197.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------C
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------D 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 752 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999865 68999999997652 34456788999999999999999999998654 4
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+++ ++.+.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999976 46666643 3889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC-CC------
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-PH------ 905 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~------ 905 (977)
..... .....+||++|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+.......- +.
T Consensus 214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTT
T ss_pred cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence 65432 2334579999999999999999999999999999999999999997643211 1111111100 00
Q ss_pred ---c---------------hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 ---G---------------LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ---~---------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. +.......+. .............+.+++.+|++.||++|||++|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLF--PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCccccc--ccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000000 01111222335678999999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=362.37 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=206.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 79999999997643 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 758 LELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|||++||+|.+++...+. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999976543 4899999999999999999999 789999999999999999999999999999877543
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--cHHHHHHhhCCCchhhhcchh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--SLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 914 (977)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+...+.. .+..+.
T Consensus 340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p------ 409 (576)
T 2acx_A 340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYS------ 409 (576)
T ss_dssp C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCC------
T ss_pred c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCC------
Confidence 3 22335799999999999999999999999999999999999999976432211 11111111 010000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
..+...+.+++.+|++.||.+|| +++|++++
T Consensus 410 -----------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 -----------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11234578999999999999999 78888754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=354.91 Aligned_cols=263 Identities=13% Similarity=0.130 Sum_probs=206.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC---------CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcce---------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD---------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK--------- 743 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 743 (977)
.++|++.+.||+|+||+||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999763 789999998754 46889999999999999988
Q ss_pred ------Eeeeeec-CCeeEEEEeccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCcee
Q 036011 744 ------IFSSCCN-NDFRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNIL 815 (977)
Q Consensus 744 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 815 (977)
+++++.. .+..++||||+ +++|.+++... ...+++..+..++.||+.||+||| +.||+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 5666665 67889999999 99999999875 346999999999999999999999 789999999999999
Q ss_pred eCCCC--ceEEeecccccccCCCCCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 816 LDEDM--VAHVSDFGLSKLFDEGDDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 816 l~~~~--~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 99999999998765432211 113346999999999999999999999999999999999999999765
Q ss_pred CcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 889 FTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
............... .......+... ....++..+.+++.+||+.||++||+++++++.|+++..
T Consensus 272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 272 LPNTEDIMKQKQKFV-DKPGPFVGPCG--------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TTCHHHHHHHHHHHH-HSCCCEECTTS--------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhcc-CChhhhhhhcc--------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 433222222221110 00000000000 000123457899999999999999999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=363.88 Aligned_cols=248 Identities=25% Similarity=0.267 Sum_probs=194.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 69999999997642 23345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
|||+++|+|.+++.... .+++..+..++.||+.||+||| + .||+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999987654 4899999999999999999999 6 89999999999999999999999999999864332
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. ......+||++|+|||++.+..++.++||||+||++|||++|+.||......+ .......... .
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~------------~ 367 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILMEEI------------R 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------C
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCC------------C
Confidence 2 22334579999999999999999999999999999999999999997542211 1111111000 0
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAV 955 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~ 955 (977)
.. ..+...+.+++.+||+.||.+|| +++|+++
T Consensus 368 ~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FP-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC-------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00 01234578999999999999999 9999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.11 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=191.9
Q ss_pred cCCCcC-ccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHh-cCCCCcceEeeeeec----CCeeE
Q 036011 683 DGFNEC-NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRN-VRHRNLIKIFSSCCN----NDFRA 755 (977)
Q Consensus 683 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~ 755 (977)
++|.+. +.||+|+||+||+|+.. +|+.||||++... ..+.+|++++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 566665 68999999999999975 6899999998633 356788888754 589999999998865 56789
Q ss_pred EEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeeccccc
Q 036011 756 LVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDFGLSK 831 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~ 831 (977)
+||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998754 35899999999999999999999 789999999999999997 7899999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--cHHHHHH-hhCCCchh
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--SLKKWVK-ESLPHGLM 908 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~-~~~~~~~~ 908 (977)
...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....+. ..+..
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~--- 286 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF--- 286 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC---
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC---
Confidence 764322 22345689999999999999999999999999999999999999976433221 1111111 11000
Q ss_pred hhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+||+.||++|||+.|++++
T Consensus 287 ------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 ------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000111234457899999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=362.03 Aligned_cols=195 Identities=25% Similarity=0.390 Sum_probs=155.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec-----CCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-----NDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 753 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999865 78999999986543 3445678999999999999999999999843 357
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+||||+ +|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 579999987654 4899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCc-------------------------ceeeccccCCcccCcccc-CCCCcCcccchhhHhHHHHHHhcC
Q 036011 834 DEGDDS-------------------------VTQTMTIATIGYMAPEYG-TEGIVSSKCDVYSYGVLLTETFTR 881 (977)
Q Consensus 834 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg 881 (977)
...... ......+||++|+|||++ .+..|+.++||||+||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 532211 122345789999999975 566799999999999999999993
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.92 Aligned_cols=255 Identities=30% Similarity=0.466 Sum_probs=203.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEE--EEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSF--AIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||.||+|+.. ++..+ |||++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999865 56644 999887532 34456789999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 758 LELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
|||+++|+|.+++.... ..+++..++.++.|+++||+||| +.||+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997654 35899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||+++...... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK 253 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHH
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----HHHH
Confidence 999999997543211 1223357889999999988899999999999999999998 999997643211 1111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
...+ .... ....+...+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus 254 -~~~~--------~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 254 -LPQG--------YRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -GGGT--------CCCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhcC--------CCCC-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1110 0000 001233457899999999999999999999999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=335.19 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=197.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec----CCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN----NDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 755 (977)
..|.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999864 68899999987543 3456778999999999999999999998865 45688
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeC-CCCceEEeecccccc
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLD-EDMVAHVSDFGLSKL 832 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~ 832 (977)
+||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999997644 3899999999999999999999 777 99999999999998 889999999999976
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
..... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||............ .......
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~---- 248 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----VTSGVKP---- 248 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----HTTTCCC----
T ss_pred ccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH----HhccCCc----
Confidence 54322 223469999999998764 5899999999999999999999999764322211111 1110000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..........+.+++.+||+.+|.+|||+.|++++
T Consensus 249 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00001122357899999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=343.38 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=199.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC--CCC--EEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS--DGT--SFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999853 333 68999987542 345677899999999999999999999998765 7
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999876666999999999999999999999 7899999999999999999999999999998875
Q ss_pred CCCCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 835 EGDDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 835 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
...... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ...... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~---~~~~----- 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKID---KEGE----- 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---TSCC-----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHHH---ccCC-----
Confidence 543322 2223457889999999988889999999999999999999 999997642211 111110 0000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.. .....++..+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 243 -~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 -RL-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -CC-------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00 0011234568899999999999999999999999998885
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=346.80 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 758 (977)
..++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999975 689999999975532 345788888888 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC----CceEEeecccccccC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED----MVAHVSDFGLSKLFD 834 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~~ 834 (977)
||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||++..+ +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999997654 4899999999999999999999 7899999999999998533 359999999998765
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|..||...... ........... ..
T Consensus 172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~--------~~ 239 (342)
T 2qr7_A 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGS--------GK 239 (342)
T ss_dssp CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHH--------CC
T ss_pred CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHcc--------CC
Confidence 4322 223356899999999998888999999999999999999999999753221 11111111000 00
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... ...+..+...+.+++.+|++.||++||++.|++++
T Consensus 240 ~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 FSLS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 00011233457899999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=354.11 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=205.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357899999999999999999975 68999999997653 3445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
|+++|+|.+++.... .+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999997654 3899999999999999999999 54 8999999999999999999999999999765322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH---------------------
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK--------------------- 897 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------------------- 897 (977)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 122346999999999999999999999999999999999999999764322110000
Q ss_pred ---HHHh-hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 898 ---WVKE-SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 898 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+... ..+....+..+........ ......+...+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 0000011111111111110 00011234468899999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=373.49 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=208.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
.++|++.+.||+|+||+||+|+++++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688889999999999999999888889999997543 234679999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence 999999999753 235899999999999999999999 7899999999999999999999999999998764321 11
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......+++.|+|||++.++.++.++|||||||++|||++ |+.||.+....+ ....+..... .
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~----------~---- 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR----------M---- 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCC----------C----
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC----------C----
Confidence 1122346788999999998899999999999999999999 899987643221 1111111000 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.....++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 484 ---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0011234568899999999999999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=341.53 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=204.6
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec---------
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--------- 750 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 750 (977)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567899999999999999999976 79999999987543 357789999999999999999998854
Q ss_pred -------CCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 751 -------NDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 751 -------~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 345789999999999999997642 45899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
||+|||++........ .....|++.|+|||++.+..++.++||||+|+++|||++|..|+... ..+....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTDL 231 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHHh
Confidence 9999999987754322 22345999999999999999999999999999999999999886421 0111100
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
.. ..+ . ..+...+.+++.+||+.||.+|||+.|+++++..++..
T Consensus 232 ~~--------~~~-~--------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 RD--------GII-S--------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HT--------TCC-C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hc--------ccc-c--------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00 000 0 01223467899999999999999999999999988853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.23 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=202.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|.+.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467889999999999999999975 7999999999866544556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~ 837 (977)
+++++|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999987654 4899999999999999999999 7899999999999999 78899999999999765432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ............
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~------------ 226 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYEF------------ 226 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCCC------------
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCC------------
Confidence 1223469999999999999999999999999999999999999997542211 111111110000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......++..+.+++.+|++.||++|||+.|++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000011234457899999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.48 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=205.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD------RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999976 699999999876531 13567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC----ceEEeeccccc
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM----VAHVSDFGLSK 831 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~ 831 (977)
+||||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999997644 4899999999999999999999 78999999999999999877 89999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
....... .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+ ....+.......
T Consensus 161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~------ 230 (283)
T 3bhy_A 161 KIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVNYDF------ 230 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCC------
T ss_pred eccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhcccCC------
Confidence 7654322 223458999999999999999999999999999999999999997642211 111111100000
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhh
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKI 962 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~ 962 (977)
.......++..+.+++.+||+.+|++||++.|++++ +++++.
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 231 ---------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 000111234457899999999999999999999873 455553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=355.69 Aligned_cols=300 Identities=25% Similarity=0.218 Sum_probs=151.9
Q ss_pred ccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccC
Q 036011 148 LEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFG 227 (977)
Q Consensus 148 L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~ 227 (977)
|+.|+|++|.|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus 34 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-------------------- 93 (477)
T 2id5_A 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-------------------- 93 (477)
T ss_dssp CSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC--------------------
T ss_pred CcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC--------------------
Confidence 333333333333333444444455555555555555444445555555555555555444
Q ss_pred CcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCC
Q 036011 228 NQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307 (977)
Q Consensus 228 N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 307 (977)
.+++..+..+++|++|+|++|++++..+..|..+++|++|+|++|+++++.+..|..+++|+.|++++|.++.
T Consensus 94 -------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 166 (477)
T 2id5_A 94 -------LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166 (477)
T ss_dssp -------SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS
T ss_pred -------ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc
Confidence 2334444455566666666666665556666666777777777777766666666666666666666665554
Q ss_pred CCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCC
Q 036011 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNG 387 (977)
Q Consensus 308 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 387 (977)
+++.. +..++ +|+.|++++|.+.+
T Consensus 167 ~~~~~-------l~~l~-------------------------------------------------~L~~L~l~~n~i~~ 190 (477)
T 2id5_A 167 IPTEA-------LSHLH-------------------------------------------------GLIVLRLRHLNINA 190 (477)
T ss_dssp CCHHH-------HTTCT-------------------------------------------------TCCEEEEESCCCCE
T ss_pred cChhH-------hcccC-------------------------------------------------CCcEEeCCCCcCcE
Confidence 33211 23333 33333333333333
Q ss_pred CCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccC
Q 036011 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWS 467 (977)
Q Consensus 388 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 467 (977)
..+..|..+++|++|++++|.+.+.+|.......+|+.|++++|++++..+..+..+++|++|+|++|++++..+..|..
T Consensus 191 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (477)
T 2id5_A 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE 270 (477)
T ss_dssp ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTT
T ss_pred eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccc
Confidence 33344444455555555555444444444444445555555555555433344555555555555555555444444555
Q ss_pred cccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc
Q 036011 468 LEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530 (977)
Q Consensus 468 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 530 (977)
+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 555555555555554444444444444555555555444333334444444444444444444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=346.98 Aligned_cols=268 Identities=23% Similarity=0.293 Sum_probs=201.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467889999999999999999975 58999999986543 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.++..... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999988876544 4899999999999999999999 78999999999999999999999999999987654322
Q ss_pred cceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--CCc---------
Q 036011 839 SVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--PHG--------- 906 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~--------- 906 (977)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ........- ...
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcc
Confidence 22334699999999998775 789999999999999999999999976433221 111111000 000
Q ss_pred -hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 -LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+..............+...+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000011110000001111245568999999999999999999999764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.20 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=190.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeee--------cC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCC--------NN 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~ 751 (977)
..+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 356889999999999999999964 78999999987766666778999999999996 999999999984 33
Q ss_pred CeeEEEEeccCCCCHHHHhhc--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeCCCCceEEeec
Q 036011 752 DFRALVLELMPNGSLEKWLYS--DNYFLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
...++||||+. |+|.+++.. ....+++..++.++.||+.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45789999995 799998865 3345899999999999999999999 778 999999999999999999999999
Q ss_pred ccccccCCCCCcc----------eeeccccCCcccCcccc---CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc
Q 036011 828 GLSKLFDEGDDSV----------TQTMTIATIGYMAPEYG---TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS 894 (977)
Q Consensus 828 gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 894 (977)
|+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998775432211 11134589999999998 56788999999999999999999999996532111
Q ss_pred HHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 895 LKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
........ ... ..+...+.+++.+||+.+|++|||+.|++++|+.+...
T Consensus 261 ---~~~~~~~~------------~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 ---IVNGKYSI------------PPH-----DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------CCC------------CTT-----CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---hhcCcccC------------Ccc-----cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11110000 000 00112367899999999999999999999999988753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=345.69 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=206.0
Q ss_pred HHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhc-CCCCcceEeee
Q 036011 678 IQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNV-RHRNLIKIFSS 747 (977)
Q Consensus 678 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 747 (977)
.....++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445677999999999999999999975 79999999987543 12245688999999999 79999999999
Q ss_pred eecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 748 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
+......++||||+++++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999999997643 4899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccC------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGT------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 901 (977)
|++..+..... .....||+.|+|||++. ...++.++||||+||++|||++|+.||....... ........
T Consensus 245 G~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 320 (365)
T 2y7j_A 245 GFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-MLRMIMEG 320 (365)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT
T ss_pred CcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC
Confidence 99987764332 23356999999999875 3468899999999999999999999996532111 11111111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... ..+....+...+.+++.+|++.||++|||+.|++++
T Consensus 321 ~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 321 QYQF---------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCCC---------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCC---------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 001111234457899999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.58 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=201.4
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
..+.|++.+.||+|+||+||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999976 589999999987666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 99999999998875556999999999999999999999 789999999999999999999999999997643211 1
Q ss_pred ceeeccccCCcccCcccc-----CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 840 VTQTMTIATIGYMAPEYG-----TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.......||+.|+|||++ .+..++.++||||+|+++|||++|..||....... ..........+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 241 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPT--------- 241 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcc---------
Confidence 112234589999999987 46778999999999999999999999997643211 111111111110
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+...+.+++.+||+.+|++|||+.|++++
T Consensus 242 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 -------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00011223457899999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=349.26 Aligned_cols=265 Identities=20% Similarity=0.296 Sum_probs=206.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhh-----------------HHHHHHHHHHHHhcCCCCcceE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRA-----------------FRSFDSECEVLRNVRHRNLIKI 744 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 744 (977)
.++|++.+.||+|+||.||+|+. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999987553221 1789999999999999999999
Q ss_pred eeeeecCCeeEEEEeccCCCCHHHH------hhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCceee
Q 036011 745 FSSCCNNDFRALVLELMPNGSLEKW------LYSD-NYFLDLLERLNIMIGVALALEYLHHGHS-TPVVHCDLKPSNILL 816 (977)
Q Consensus 745 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~NIll 816 (977)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||+||| + .||+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999998 5542 346899999999999999999999 6 899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCC-CcCc-ccchhhHhHHHHHHhcCCCCCCcCCccccc
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSS-KCDVYSYGVLLTETFTRKKPTDDMFTGEMS 894 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~ 894 (977)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||.........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999876443 23345699999999999887 6766 999999999999999999999764332221
Q ss_pred HHHHHHhhC--CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 895 LKKWVKESL--PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 895 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......... +........+ .. ..........+...+.+++.+||+.||.+|||+.|++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYP-LT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTT-TC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhcc-cc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111 0000000000 00 000000112234568899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=347.05 Aligned_cols=268 Identities=23% Similarity=0.285 Sum_probs=195.9
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4567999999999999999999864 789999999975542 2345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee-----CCCCceEEeecccccc
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL-----DEDMVAHVSDFGLSKL 832 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll-----~~~~~~kl~Dfgla~~ 832 (977)
|||++ |+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 112 ~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99997 599999987654 899999999999999999999 7899999999999999 4556699999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CCCc--hh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LPHG--LM 908 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~ 908 (977)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+....... .+.. +.
T Consensus 187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTST
T ss_pred cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhhh
Confidence 653322 22334689999999998774 58999999999999999999999997643222 122222111 1110 00
Q ss_pred hhcc-----hhh---hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVD-----TNL---LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~-----~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... ... ............+...+.+++.+|++.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 000 00000000011134567899999999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.03 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=205.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999975 58899999987653 34456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999887644 4899999999999999999999 7899999999999999999999999999998765332
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ......... ...
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~------------~~~ 234 (294)
T 2rku_A 170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNE------------YSI 234 (294)
T ss_dssp C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC------------CCC
T ss_pred c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcc------------CCC
Confidence 2 2233568999999999999999999999999999999999999997643221 111111100 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ..+...+.+++.+||+.||++|||++|++++
T Consensus 235 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 P-------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c-------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0123357889999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=333.60 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=203.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367899999999999999999975 67899999987543 22346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999997654 4899999999999999999999 8999999999999999999999999999997654322
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
.....|++.|+|||++.+..++.++||||+|+++|||++|+.||......+ ....... .....
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~------------~~~~~ 231 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVN------------VDLKF 231 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT------------TCCCC
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhc------------cccCC
Confidence 223468999999999999999999999999999999999999997532211 1111100 00000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ......+.+++.+|++.+|.+||++.|++++
T Consensus 232 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 P-------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred C-------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0 0123457899999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.92 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=198.4
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
+|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455568999999999999964 689999999987666666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccccccCCCCCc
Q 036011 763 NGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 763 ~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|.+++..... ..++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999987533 4678899999999999999999 789999999999999987 89999999999987654221
Q ss_pred ceeeccccCCcccCccccCCCC--cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
......|++.|+|||++.+.. ++.++||||+|+++|||++|+.||................... +.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~-- 247 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------PEI-- 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--------CCC--
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--------ccc--
Confidence 123346899999999987643 8899999999999999999999996532221111110000000 000
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+..+...+.+++.+||+.||++||++.|++++
T Consensus 248 -------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 -------PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -------cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01123457899999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.76 Aligned_cols=250 Identities=24% Similarity=0.286 Sum_probs=188.1
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999997 478999999987653 223334555666688889999999999999999999999
Q ss_pred eccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 759 ELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 759 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
||++ |+|.+++.. ....+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777654 3446999999999999999999999 66 99999999999999999999999999998765
Q ss_pred CCCCcceeeccccCCcccCcccc----CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYG----TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
.... .....||+.|+|||++ .+..++.++||||+|+++|||++|+.||..................+...
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 235 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP--- 235 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC---
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc---
Confidence 4322 2234699999999995 56678999999999999999999999997543332222222221111100
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
...+...+.+++.+|++.+|++|||+.|+++
T Consensus 236 --------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 --------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0112345789999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=373.46 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=198.5
Q ss_pred ccccCcceEEEEEEEeC---CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976532 345789999999999999999999999965 457899999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc-cee
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-VTQ 842 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~ 842 (977)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 4899999999999999999999 789999999999999999999999999999877544322 222
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+......
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~---------------- 591 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERM---------------- 591 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCC----------------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC----------------
Confidence 33457889999999999999999999999999999998 999997643221 11111111000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+..++..+.+++.+||+.||++||++.++++.|+++-
T Consensus 592 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 001123456889999999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=358.76 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=204.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++.+.. ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999975 69999999997653 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|||++||+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987643 35899999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......... ...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~--------~~~ 409 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL--------EQA 409 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH--------HCC
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh--------hcc
Confidence 4332 1233479999999999999999999999999999999999999997643211 1111111110 000
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM-----TDAAV 955 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~ev~~ 955 (977)
.... ..+...+.+++.+|++.||++||++ .|+++
T Consensus 410 ~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 VTYP-------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCC-------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCCC-------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0000 1123457889999999999999975 56653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=355.27 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=168.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Ce
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 753 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 68899999997543 34456789999999999999999999998765 57
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||++ |+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999986 59999997654 4899999999999999999999 789999999999999999999999999999977
Q ss_pred CCCCCc--------------------ceeeccccCCcccCcccc-CCCCcCcccchhhHhHHHHHHhcCCCCCC
Q 036011 834 DEGDDS--------------------VTQTMTIATIGYMAPEYG-TEGIVSSKCDVYSYGVLLTETFTRKKPTD 886 (977)
Q Consensus 834 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~ 886 (977)
...... ......+||++|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543221 122446799999999985 56679999999999999999998665554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=359.89 Aligned_cols=251 Identities=27% Similarity=0.348 Sum_probs=203.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999975 79999999987543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~ 835 (977)
||+.+|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++ .++.+||+|||+++.+..
T Consensus 101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999887654 4899999999999999999999 78999999999999995 556899999999987654
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+ .+...........
T Consensus 177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~--------- 242 (486)
T 3mwu_A 177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD--------- 242 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSC---------
T ss_pred CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC---------
Confidence 32 2234569999999999876 59999999999999999999999997642211 1111111111110
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+....+...+.+++.+||+.+|.+|||+.|++++
T Consensus 243 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112234457899999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=352.25 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=209.3
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC-CCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH-RNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.++||+|+||.||+|+. .+++.||||++..... ...+.+|+++++.++| ++|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 4799999998765432 3468899999999986 566666667778889999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccCCC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~ 836 (977)
|+ +++|.+++......+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 99999999876667999999999999999999999 7899999999999999 68899999999999887654
Q ss_pred CCcc-----eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc--cHHHHHHhhCCCchhh
Q 036011 837 DDSV-----TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM--SLKKWVKESLPHGLME 909 (977)
Q Consensus 837 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 909 (977)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+..........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~- 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE- 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-
Confidence 3221 12245699999999999999999999999999999999999999987533221 111111111111000
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.....++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 239 -------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 -------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0011234568999999999999999999999999988754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.89 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=206.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.+.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999864 68999999997654 3446789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 99999999999754 4899999999999999999999 78999999999999999999999999999987654321
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ .........+.. +
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~--------~---- 239 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPPT--------L---- 239 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCC--------C----
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCCC--------C----
Confidence 2233468999999999999999999999999999999999999987542211 111111111000 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+...+.+++.+||+.+|++|||+.|++++
T Consensus 240 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 -----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00123457899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=336.92 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=201.2
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4577999999999999999999975 59999999987543 34678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999999755556899999999999999999999 78999999999999999999999999999987654321
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ........+.. .
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~--------~---- 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTNPPPT--------F---- 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCCCC--------C----
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCcc--------c----
Confidence 22334689999999999999999999999999999999999999975422111 00011110000 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+...+.+++.+||+.||.+|||+.+++++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011123457899999999999999999999763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.59 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=204.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeee--cCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCC--NNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 756 (977)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999975 78999999997543 344567899999999999999999999874 4678899
Q ss_pred EEeccCCCCHHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCceeeCCCCceEEeecc
Q 036011 757 VLELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHSTP-----VVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997532 34899999999999999999999 566 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchh
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM 908 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (977)
+++....... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~~~-- 235 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKFRR-- 235 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC--
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhccccc--
Confidence 9987654321 122346899999999999989999999999999999999999999764321 1111111110000
Q ss_pred hhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
+ ...++..+.+++.+||+.+|++||++.|+++++....
T Consensus 236 ------~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 236 ------I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ------C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ------C---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 0 0112345789999999999999999999998765544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.13 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=205.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999975 58899999987653 34456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.... .+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999987644 4899999999999999999999 7899999999999999999999999999998765332
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ........... .
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~------------~ 260 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEYS------------I 260 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC------------C
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCCC------------C
Confidence 2 2233569999999999999999999999999999999999999997543211 11111111000 0
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ..+...+.+++.+||+.||++|||+.|++++
T Consensus 261 ~-------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 P-------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0122346889999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=342.22 Aligned_cols=262 Identities=19% Similarity=0.297 Sum_probs=202.2
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeec--CCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCN--NDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 757 (977)
.++|++.+.||+|+||+||+|+. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36789999999999999999986 478999999987432 367889999999997 9999999999987 6678999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEG 836 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 836 (977)
|||+++++|.+++.. +++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999854 789999999999999999999 78999999999999999776 8999999999877543
Q ss_pred CCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc---------
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG--------- 906 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 906 (977)
.. .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+.......-...
T Consensus 185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 32 233468999999999877 67999999999999999999999999654333222222211110000
Q ss_pred ------hhhhcchhhh---ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 ------LMEVVDTNLL---RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ------~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+....... ...........+...+.+++.+|++.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 0000011111234568999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=357.83 Aligned_cols=240 Identities=17% Similarity=0.177 Sum_probs=189.0
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeecc---chhhHHHHHHHH---HHHHhcCCCCcceEe-------ee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQ---LDRAFRSFDSEC---EVLRNVRHRNLIKIF-------SS 747 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 747 (977)
.++|.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 46999999999743 234567789999 555556899999998 55
Q ss_pred eecCC-----------------eeEEEEeccCCCCHHHHhhcCCc------cCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036011 748 CCNND-----------------FRALVLELMPNGSLEKWLYSDNY------FLDLLERLNIMIGVALALEYLHHGHSTPV 804 (977)
Q Consensus 748 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 804 (977)
+.+.+ ..++||||+ +|+|.+++..... .+++..++.++.||+.||+||| +.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55443 278999999 6899999986432 2335888899999999999999 7899
Q ss_pred EeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCC-----------CcCcccchhhHhH
Q 036011 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-----------IVSSKCDVYSYGV 873 (977)
Q Consensus 805 vH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 873 (977)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334457 999999999887 8999999999999
Q ss_pred HHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 036011 874 LLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953 (977)
Q Consensus 874 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 953 (977)
++|||++|+.||......+. ...+.. ... .++..+.+++.+||+.||++|||+.|+
T Consensus 302 il~elltg~~Pf~~~~~~~~-------------~~~~~~-----~~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-------------SEWIFR-----SCK------NIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHSSCCC------CC-------------SGGGGS-----SCC------CCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHCCCCCcccccccc-------------hhhhhh-----hcc------CCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999965322110 111100 001 123457899999999999999999999
Q ss_pred HH
Q 036011 954 AV 955 (977)
Q Consensus 954 ~~ 955 (977)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 86
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=346.29 Aligned_cols=274 Identities=22% Similarity=0.248 Sum_probs=202.5
Q ss_pred HHHHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch-----------hhHHHHHHHHHHHHhcCCCCcce
Q 036011 675 YLDIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD-----------RAFRSFDSECEVLRNVRHRNLIK 743 (977)
Q Consensus 675 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~ 743 (977)
..++....++|.+.+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4567788899999999999999999999988899999999865322 12367899999999999999999
Q ss_pred Eeeeeec-----CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC
Q 036011 744 IFSSCCN-----NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE 818 (977)
Q Consensus 744 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 818 (977)
+++++.. ....++||||++ |+|.+++......+++..+..++.||+.||+||| +.||+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 9999843 336799999997 6898888877667999999999999999999999 789999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH
Q 036011 819 DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897 (977)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 897 (977)
++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ ....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~ 245 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNK 245 (362)
T ss_dssp TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred CCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 9999999999998654322 2233468999999998876 679999999999999999999999997643221 1111
Q ss_pred HHHhhCCCch-----------hhhcchhhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 898 WVKESLPHGL-----------MEVVDTNLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 898 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....-.... .+............. .....+...+.+++.+|++.||++|||+.|++++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111100000 000000000000000 0011224457899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=359.60 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=199.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356889999999999999999975 68999999987653 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~ 835 (977)
||+++|+|.+++.... .+++..+..++.||++||+||| +.||+||||||+||+++. ++.+||+|||++..+..
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999887654 3899999999999999999999 789999999999999976 45599999999987754
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. .....+||+.|+|||++. +.++.++||||+||++|+|++|..||......+ ............
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~---------- 256 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVEKGKYTF---------- 256 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC----------
T ss_pred Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC----------
Confidence 32 223356999999999886 569999999999999999999999997643221 111111111110
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+....++..+.+++.+||+.+|.+|||+.|++++
T Consensus 257 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 -----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 001111234457899999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.58 Aligned_cols=254 Identities=12% Similarity=0.078 Sum_probs=183.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc--CCCCcceEe-------eee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV--RHRNLIKIF-------SSC 748 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~ 748 (977)
...|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999965 78999999998754 23455677885555544 699988755 444
Q ss_pred ecC-----------------CeeEEEEeccCCCCHHHHhhcCCccCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 036011 749 CNN-----------------DFRALVLELMPNGSLEKWLYSDNYFLDLLER------LNIMIGVALALEYLHHGHSTPVV 805 (977)
Q Consensus 749 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~~iv 805 (977)
... ...++||||++ |+|.+++...+..+++..+ ..++.||++||+||| +.||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 332 33799999998 8999999875544566666 788899999999999 78999
Q ss_pred eCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCC
Q 036011 806 HCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKK 883 (977)
Q Consensus 806 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~ 883 (977)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987642 1213457799999999987 789999999999999999999999
Q ss_pred CCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 884 PTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 884 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
||......... .|... ........... .+....++..+.+++.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~--~~~~~----~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKG--SWKRP----SLRVPGTDSLA-----FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTT--CCCBC----CTTSCCCCSCC-----CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCccccc--chhhh----hhhhccccccc-----hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99775332110 00000 00000000000 0111123456889999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.23 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=195.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467899999999999999999974 79999999986542 334567889999999999999999999987653
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+ +++|.+++... .+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 88999999874 3899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh--CCCchhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES--LPHGLME 909 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 909 (977)
.... ....++|++|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+....... .+.....
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 6432 223468999999998876 689999999999999999999999997643211 111111110 0000000
Q ss_pred hcc--------hhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVD--------TNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~--------~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+. ..+.... ............+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0000000 0000001224457899999999999999999999885
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=330.12 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=196.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999976 79999999987543 23356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999997654 3899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. .....|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||......+ ..+.......
T Consensus 166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~------------ 228 (276)
T 2h6d_A 166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRGGVF------------ 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC------------
T ss_pred c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhcCcc------------
Confidence 1 223468999999999988765 689999999999999999999997532211 1111111000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+ ..+...+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 YIP------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCc------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0123357889999999999999999999885
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=357.89 Aligned_cols=252 Identities=25% Similarity=0.309 Sum_probs=201.8
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch-------------hhHHHHHHHHHHHHhcCCCCcceEee
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-------------RAFRSFDSECEVLRNVRHRNLIKIFS 746 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 746 (977)
..++|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 689999999875431 23467889999999999999999999
Q ss_pred eeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC---ceE
Q 036011 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM---VAH 823 (977)
Q Consensus 747 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k 823 (977)
++.+....++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999887654 4899999999999999999999 78999999999999999776 699
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
|+|||++..+.... ......||+.|+|||++. +.++.++||||+||++|+|++|..||.+....+ ..........
T Consensus 190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~ 264 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-IIKKVEKGKY 264 (504)
T ss_dssp ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC
T ss_pred EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC
Confidence 99999998775432 223356999999999987 469999999999999999999999997643221 1111111111
Q ss_pred CCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .......++..+.+++.+|++.||.+|||+.|++++
T Consensus 265 ~~---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YF---------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 011112234567899999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.21 Aligned_cols=264 Identities=24% Similarity=0.320 Sum_probs=187.5
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
...++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44678999999999999999999864 68999999987543 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhc-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 758 LELMPNGSLEKWLYS-------DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
|||+++++|.+++.. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999874 2345899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCc---ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc
Q 036011 831 KLFDEGDDS---VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG 906 (977)
Q Consensus 831 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (977)
......... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||........ .........+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 247 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQNDPPSL 247 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHTSSCCCT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhccCCCcc
Confidence 876543211 11223469999999998865 5689999999999999999999999976433221 111111111100
Q ss_pred hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.....+.... ..+...+.+++.+||+.||.+||++.|++++
T Consensus 248 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEML---------KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCC---------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhh---------hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000011000 0123457899999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.19 Aligned_cols=270 Identities=22% Similarity=0.294 Sum_probs=203.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeec--------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCN-------- 750 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 750 (977)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999997 4799999999865532 234567899999999999999999999876
Q ss_pred CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
.+..++||||+++ +|.+.+......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999975 888887776666999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH--hhCCC
Q 036011 831 KLFDEGDDS--VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK--ESLPH 905 (977)
Q Consensus 831 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~ 905 (977)
+.+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....... ...+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence 876533221 22334568999999998876 568999999999999999999999997643221 1111111 11111
Q ss_pred c-hhhhcchhhh------ccccCchH----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 G-LMEVVDTNLL------RQEHTSSA----EMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~-~~~~~~~~~~------~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. +......... ........ .......+.+++.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1 1111000000 00000000 00113457899999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=339.56 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=198.0
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN 751 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 751 (977)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999975 68999999986542 12234588999999999999999999998766
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc---eEEeecc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV---AHVSDFG 828 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg 828 (977)
+ .++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 799999999999999987654 4899999999999999999999 789999999999999987664 9999999
Q ss_pred cccccCCCCCcceeeccccCCcccCcccc---CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYG---TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
++....... ......||+.|+|||++ ....++.++||||+||++|||++|..||....... .+..........
T Consensus 163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCC
T ss_pred cceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCccc
Confidence 998764321 12234699999999986 35678999999999999999999999997643322 222222111100
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.. ......+...+.+++.+||+.||++||++.|+++
T Consensus 239 ~~--------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC--------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 0011123456789999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=342.10 Aligned_cols=258 Identities=18% Similarity=0.229 Sum_probs=203.8
Q ss_pred HHHHhhcCCCcC-ccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 677 DIQRATDGFNEC-NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 677 ~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
......+.|.+. +.||+|+||+||+|+.. +++.||||++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556677777 88999999999999975 699999999876542 3356789999999999 569999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeec
Q 036011 752 DFRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDF 827 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Df 827 (977)
+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999998654 346899999999999999999999 789999999999999997 789999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
|+++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......+. ...........
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~-- 252 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVDY-- 252 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCC--
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhccccc--
Confidence 99987754322 2334699999999999999999999999999999999999999976432211 11111100000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+||+.||++|||++|++++
T Consensus 253 -------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 -------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000011233457899999999999999999999765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=336.65 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=197.0
Q ss_pred hhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcC--CCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVR--HRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l 756 (977)
..++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++ ||||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 456799999999999999999998889999999987543 345677899999999997 5999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||| +.+++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||++++ +.+||+|||++......
T Consensus 106 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 999 56889999998765 4899999999999999999999 789999999999999964 89999999999877554
Q ss_pred CCcceeeccccCCcccCccccCC-----------CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTE-----------GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
..........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..............
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~------ 253 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 253 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH------
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH------
Confidence 33333334569999999999865 5788999999999999999999999975432221111111
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+......... .....+.+++.+||+.||++||++.|++++
T Consensus 254 ------~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 ------DPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ------CTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------hcccccCCcc-----cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1110000000 012357889999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=334.75 Aligned_cols=245 Identities=21% Similarity=0.281 Sum_probs=198.6
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 756 (977)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999975 79999999987643 33456788999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC--------------
Q 036011 757 VLELMPNGSLEKWLYSDN---YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-------------- 819 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-------------- 819 (977)
||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997642 35899999999999999999999 7899999999999999844
Q ss_pred -----CceEEeecccccccCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 820 -----MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 820 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||+|+++|||++|.+|+... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence 479999999998765432 23489999999998766 6778999999999999999998876432 1
Q ss_pred cHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 894 SLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..........+. .+ ..+...+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~------------~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 QWHEIRQGRLPR------------IP------QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHHTTCCCC------------CS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHcCCCCC------------CC------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111111111100 00 0123457899999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.14 Aligned_cols=255 Identities=24% Similarity=0.285 Sum_probs=202.3
Q ss_pred hcCCCcCccccCcceEEEEEEEe----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL----DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNND 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 752 (977)
.++|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 368999999987542 23345678899999999 6999999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999997654 4899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+......
T Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~------ 280 (355)
T 1vzo_A 209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILK------ 280 (355)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHH------
T ss_pred cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhc------
Confidence 643222 12233569999999999885 457899999999999999999999997533221 11221111100
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVKL 957 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~L 957 (977)
..... +..+...+.+++.+||+.||.+|| +++|++++.
T Consensus 281 ------~~~~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 ------SEPPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------cCCCC---CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00000 011234578899999999999999 999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=361.15 Aligned_cols=251 Identities=28% Similarity=0.368 Sum_probs=205.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356889999999999999999975 79999999987543 33457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee---CCCCceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---DEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 834 (977)
|||+.+|+|.+++..... +++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+++.+.
T Consensus 105 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999876554 899999999999999999999 7899999999999999 567899999999998775
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.... ....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ .............
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~-------- 247 (484)
T 3nyv_A 181 ASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKGKYTFE-------- 247 (484)
T ss_dssp CCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCC--------
T ss_pred cccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCC--------
Confidence 4332 233569999999999866 69999999999999999999999997642211 1111111111100
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+....+...+.+++.+|++.+|.+|||+.|++++
T Consensus 248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11112234567899999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.53 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=204.4
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---------hhhHHHHHHHHHHHHhcC-CCCcceEeeee
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---------DRAFRSFDSECEVLRNVR-HRNLIKIFSSC 748 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 748 (977)
...++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 68999999987542 233466889999999996 99999999999
Q ss_pred ecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 749 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999997653 4899999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccC------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGT------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
++........ .....|++.|+|||++. ...++.++||||+|+++|||++|+.||......+ .........
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGN 245 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCC
Confidence 9987654332 23346899999999874 5578999999999999999999999996532211 111111111
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
... ..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQF---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccc---------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 100 00111123456889999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=346.47 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=195.9
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec-------
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN------- 750 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 750 (977)
....++|++.+.||+|+||+||+|+. .+|+.||||++..+. ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 479999999986542 223479999999999999999999843
Q ss_pred -------------------------------CCeeEEEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHH
Q 036011 751 -------------------------------NDFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYL 796 (977)
Q Consensus 751 -------------------------------~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~L 796 (977)
....++||||++ |+|.+.+.. ....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999998 587777653 344689999999999999999999
Q ss_pred HhcCCCCeEeCCCCCCceeeC-CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHH
Q 036011 797 HHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVL 874 (977)
Q Consensus 797 H~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~i 874 (977)
| +.||+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||+
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9 89999999999999998 689999999999987754332 2234689999999988765 59999999999999
Q ss_pred HHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh--cch--------hhhccccCchHHHHHHHHHHHHHHHhhcCCC
Q 036011 875 LTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV--VDT--------NLLRQEHTSSAEMDCLLSVLHLALDCCMESP 944 (977)
Q Consensus 875 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P 944 (977)
+|||++|+.||.+.... ..+...+...-......+ .++ ..............++..+.+++.+||+.+|
T Consensus 232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999764322 222222211110000000 000 0000000000001134457899999999999
Q ss_pred CCCCCHHHHHHH
Q 036011 945 DQRIYMTDAAVK 956 (977)
Q Consensus 945 ~~RPs~~ev~~~ 956 (977)
++|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.86 Aligned_cols=261 Identities=20% Similarity=0.207 Sum_probs=194.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999865 68999999987542 344567889999999999999999999987654
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+++ +|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 77999999974 78888753 3889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc------
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG------ 906 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 906 (977)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+..... .....
T Consensus 177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~-~~~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE-QLGTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC--CCCCCHHHHT
T ss_pred ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCCHHHHH
Confidence 64322 2233569999999999999999999999999999999999999997642211 1111110 00000
Q ss_pred --------------------hhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 --------------------LMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+........ .+............+.+++.+|++.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVL--FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhccccc--CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 011112223446678999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=366.32 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=203.7
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 755 (977)
..++|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999975 68899999998652 33456678899999988 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999998754 3899999999999999999999 78999999999999999999999999999986433
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ ...... ....
T Consensus 495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~------------~~~~ 559 (674)
T 3pfq_A 495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIM------------EHNV 559 (674)
T ss_dssp TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH------------SSCC
T ss_pred CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHH------------hCCC
Confidence 222 2334579999999999999999999999999999999999999997642211 111111 1111
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYM-----TDAAV 955 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~ev~~ 955 (977)
... ......+.+++.+|++.||++||++ +|+++
T Consensus 560 ~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCC-------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCC-------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 000 1123457899999999999999997 55543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.36 Aligned_cols=252 Identities=22% Similarity=0.251 Sum_probs=199.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc----hhhHHHHHHHHHHHHhcCCCCcceEeeeee--cCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRHRNLIKIFSSCC--NNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 753 (977)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999974 68999999997653 234567899999999999999999999984 4567
Q ss_pred eEEEEeccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 754 RALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
.++||||++++ +.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 77766653 346899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCC--cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGI--VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
..............||+.|+|||+..+.. ++.++||||+|+++|||++|+.||......+ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~i~~~~-------- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-LFENIGKGS-------- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCC--------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHHHhcCC--------
Confidence 76443333444456999999999987643 4789999999999999999999997532111 011100000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .. .++...+.+++.+||+.||.+|||+.|++++
T Consensus 230 ----~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ----YA-IP------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CC-CC------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CC-CC------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00 0123457899999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.78 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=172.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc------CCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV------RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 754 (977)
..+|++.+.||+|+||+||+|+.. +++.||||++... ......+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999865 5899999999754 33446677888888877 477999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc--eEEeeccccc
Q 036011 755 ALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV--AHVSDFGLSK 831 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~ 831 (977)
++||||+. ++|.+++.... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999887654 35899999999999999999999 789999999999999999887 9999999997
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
...... ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 251 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 654322 2346899999999999999999999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=334.20 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec---------
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--------- 750 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 750 (977)
..++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999964 7999999999654 3445778999999999999999999998865
Q ss_pred ----CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 751 ----NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 751 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
.+..++||||+++|+|.+++......+++..++.++.|+++||+||| +.||+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 35678999999999999999877667889999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCC------------cceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 827 FGLSKLFDEGDD------------SVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 827 fgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
||++........ ........||+.|+|||++.+. .++.++||||+|+++|||++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999987653211 1122334689999999998764 78999999999999999998 5432111111
Q ss_pred cHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 894 SLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........ ...+. +. .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 237 -~~~~~~~~-~~~~~----~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 -ILKKLRSV-SIEFP----PD---------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHST-TCCCC----TT---------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHhcccc-ccccC----cc---------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111100 00000 00 001223457899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=348.24 Aligned_cols=265 Identities=20% Similarity=0.242 Sum_probs=200.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC--------CCCcceEeeeee---
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR--------HRNLIKIFSSCC--- 749 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 749 (977)
.++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999864 6899999999754 344567889999999985 788999999987
Q ss_pred -cCCeeEEEEeccCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeCCCC------
Q 036011 750 -NNDFRALVLELMPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLDEDM------ 820 (977)
Q Consensus 750 -~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~~~~------ 820 (977)
+....++||||+ ++++.+++... ...+++..+..++.||++||+||| ++ ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 556789999999 55666555443 346899999999999999999999 66 999999999999999775
Q ss_pred -------------------------------------------ceEEeecccccccCCCCCcceeeccccCCcccCcccc
Q 036011 821 -------------------------------------------VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG 857 (977)
Q Consensus 821 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 857 (977)
.+||+|||+++..... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876532 2234689999999999
Q ss_pred CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc-----HHHHHHh--hCCCch-------hhhcchh--hh--ccc
Q 036011 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS-----LKKWVKE--SLPHGL-------MEVVDTN--LL--RQE 919 (977)
Q Consensus 858 ~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-----~~~~~~~--~~~~~~-------~~~~~~~--~~--~~~ 919 (977)
.+..++.++||||+||++|||++|+.||......+.. +...... ..+... ....... .. ...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999764433211 1111100 000000 0000000 00 000
Q ss_pred ----------cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 ----------HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
............+.+++.+||+.||++|||++|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0001123456678999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.18 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=200.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+..+ .||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4778999999999999999998753 49999987543 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC-
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD- 838 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 838 (977)
|+++++|.+++...+..+++..+..++.|+++||+||| +.||+||||||+||+++ ++.+||+|||+++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999887667999999999999999999999 78999999999999998 68999999999876542211
Q ss_pred --cceeeccccCCcccCccccCC---------CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 839 --SVTQTMTIATIGYMAPEYGTE---------GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 839 --~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
........|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .........
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~--- 260 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQMGTGMK--- 260 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHHHHTTCC---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhccCCC---
Confidence 112223458999999998764 4578999999999999999999999975432211 111111000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
+.... ..++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 261 -----~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 261 -----PNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -----CCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -----CCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 01123478999999999999999999999999998853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=339.36 Aligned_cols=256 Identities=25% Similarity=0.324 Sum_probs=198.2
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeec----
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN---- 750 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 750 (977)
++....++|++.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445788999999999999999999974 78999999987543 3346788999999999 79999999999976
Q ss_pred --CCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 751 --NDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 751 --~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 467899999999999999998653 46899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
|++........ ......||+.|+|||++. +..++.++||||+||++|||++|+.||.+...... ........
T Consensus 174 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNP 250 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC
T ss_pred cCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcCc
Confidence 99987653221 122346899999999986 56789999999999999999999999965432111 11111100
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+ ... ...+...+.+++.+||+.||.+||++.|++++
T Consensus 251 ~~---------~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 AP---------RLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CC---------CCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc---------cCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 00123457899999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=343.04 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=184.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------C
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------D 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 752 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467999999999999999999864 68999999986542 34456788999999999999999999998654 5
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+ +++|.+++... .+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 78999998763 4899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC-CC-c-hh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-PH-G-LM 908 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~-~~ 908 (977)
.... .....||++|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+.......- +. . +.
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 5432 233469999999999876 68999999999999999999999999764321 11222111110 00 0 00
Q ss_pred hhcc-------hhhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVD-------TNLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~-------~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.. ..+....... .........+.+++.+|++.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0000000000 0001123457899999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=368.16 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=205.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.++|++.+.||+|+||+||+|++. .+..||||++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 467888999999999999999864 25679999987543 344577999999999999999999999985 456899
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+++|+|.+++......+++..+..++.|+++||+||| +.||+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999877667999999999999999999999 789999999999999999999999999999877543
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....+.......
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~~~~--------- 612 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERLP--------- 612 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTCCCC---------
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCCCC---------
Confidence 22 22233457889999999988899999999999999999997 999987643221 111111110000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 613 --------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01123456789999999999999999999999998875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.30 Aligned_cols=269 Identities=23% Similarity=0.261 Sum_probs=203.0
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Ce
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 753 (977)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999865 68899999987543 34457789999999999999999999998654 46
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||++ |+|.+++.... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 899999997 59999987654 899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCcc-eeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc---hh
Q 036011 834 DEGDDSV-TQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG---LM 908 (977)
Q Consensus 834 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 908 (977)
....... ......||+.|+|||++. +..++.++||||+||++|||++|+.||......+ .+.......-... +.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 5432211 123347999999999765 4558999999999999999999999997643322 1222111100000 00
Q ss_pred hhcch-------hhhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 909 EVVDT-------NLLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 909 ~~~~~-------~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+. ........ ......+...+.+++.+|++.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000 00001224467899999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=339.65 Aligned_cols=274 Identities=20% Similarity=0.224 Sum_probs=192.1
Q ss_pred HHHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe-
Q 036011 676 LDIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF- 753 (977)
Q Consensus 676 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 753 (977)
.+.....++|++.+.||+|+||+||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345667789999999999999999999975 68999999986542 333456788888999999999999999865333
Q ss_pred ------eEEEEeccCCCCHHHHhh---cCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceE
Q 036011 754 ------RALVLELMPNGSLEKWLY---SDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAH 823 (977)
Q Consensus 754 ------~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~k 823 (977)
.++||||+++ +|.+.+. .....+++..+..++.|++.||+||| .|+.||+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 5544433 23345899999999999999999999 34689999999999999996 89999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
|+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..+....
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~ 248 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL 248 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence 999999987754332 2234689999999988654 4899999999999999999999999764322 2222222211
Q ss_pred CCC--chhhhcchh-----hhccccC------chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 LPH--GLMEVVDTN-----LLRQEHT------SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ~~~--~~~~~~~~~-----~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
-.. ......++. ....... ......+...+.+++.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 100 000000000 0000000 00001134568999999999999999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=338.80 Aligned_cols=348 Identities=16% Similarity=0.116 Sum_probs=212.8
Q ss_pred CCCCCCCCCCc-ccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcC
Q 036011 29 NNWSISQPICK-WVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDY 107 (977)
Q Consensus 29 ~~w~~~~~~c~-w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 107 (977)
++|..+.+||. |.+..|.....++ +...... .....-..++++++|++++|.++...+..|..+++|++|+|++
T Consensus 4 ~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~~~~--~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~ 78 (390)
T 3o6n_A 4 KPRQPEYKCIDSNLQYDCVFYDVHI---DMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78 (390)
T ss_dssp ---CCEECBCC------EEEESCEE---CSSCCCC--EESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTT
T ss_pred CCCCCccceehhhhhhccceeeeee---ecccccc--cccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCC
Confidence 57988877774 5555554322111 2222222 2222233578899999999999885555578899999999999
Q ss_pred ccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCC
Q 036011 108 NEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIP 187 (977)
Q Consensus 108 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p 187 (977)
|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|++++|.++...+..|+++++|++|++++|++++..|
T Consensus 79 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 158 (390)
T 3o6n_A 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 158 (390)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh
Confidence 99996667789999999999999999998888888999999999999999885444556888899999999999987777
Q ss_pred ccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCccccc
Q 036011 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITN 267 (977)
Q Consensus 188 ~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 267 (977)
..|+++++|++|++++|++++. .+..+++|+.|++++|.+++.. ..++|++|++++|+++.. |...
T Consensus 159 ~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~~--------~~~~L~~L~l~~n~l~~~-~~~~-- 224 (390)
T 3o6n_A 159 DTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTLA--------IPIAVEELDASHNSINVV-RGPV-- 224 (390)
T ss_dssp TTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEEE--------CCSSCSEEECCSSCCCEE-ECCC--
T ss_pred hhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccccC--------CCCcceEEECCCCeeeec-cccc--
Confidence 7888889999999998888754 2445566666666666655321 123455555555555532 2211
Q ss_pred ccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccc
Q 036011 268 ASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNF 347 (977)
Q Consensus 268 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~ 347 (977)
.++|++|++++|++++. ..+..+++|+.|++++|.++++.
T Consensus 225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~-------------------------------------- 264 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM-------------------------------------- 264 (390)
T ss_dssp CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEE--------------------------------------
T ss_pred cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcC--------------------------------------
Confidence 24455555555555432 23444444444444444444332
Q ss_pred cccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceee
Q 036011 348 SASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427 (977)
Q Consensus 348 ~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 427 (977)
|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 265 ------------------~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 265 ------------------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324 (390)
T ss_dssp ------------------SGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred ------------------hhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence 2233344444444444444442 3333444555555555555554 3344445555555555
Q ss_pred ecCCccCCCchhhhcCCCCCCeeecCCCcCC
Q 036011 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFS 458 (977)
Q Consensus 428 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 458 (977)
+++|+++.. + +..+++|+.|++++|.+.
T Consensus 325 L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 325 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp CCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred CCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 555555432 2 444555566666666555
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.07 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=196.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeee-----------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC----------- 749 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 749 (977)
.++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999976 58999999998776666788999999999999999999999873
Q ss_pred ---cCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEe
Q 036011 750 ---NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVS 825 (977)
Q Consensus 750 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~ 825 (977)
+....++||||++ |+|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 6999999754 4899999999999999999999 78999999999999997 56799999
Q ss_pred ecccccccCCCCC-cceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC
Q 036011 826 DFGLSKLFDEGDD-SVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903 (977)
Q Consensus 826 Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (977)
|||+++....... ........+|..|+|||++.+ ..++.++||||+|+++|||++|+.||......+ ....... ..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~-~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILE-SI 241 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-HS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hc
Confidence 9999987653221 112233457999999998755 679999999999999999999999997643221 1111111 11
Q ss_pred CCc----hhhh-------cchhhhccccC-chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 904 PHG----LMEV-------VDTNLLRQEHT-SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 904 ~~~----~~~~-------~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.. ..+. ........... ......+...+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 110 0000 00000000000 00011235568899999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=342.61 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=196.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------eeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------FRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 756 (977)
.+|++.+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 56899999999999999999987777799998764322 2347999999999999999999985433 3789
Q ss_pred EEeccCCCCHHHHhh--cCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEeeccccccc
Q 036011 757 VLELMPNGSLEKWLY--SDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLF 833 (977)
Q Consensus 757 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~ 833 (977)
||||++++.+..... .....+++..+..++.||++||+||| +.||+||||||+||+++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754443322 22345899999999999999999999 78999999999999999 7999999999999877
Q ss_pred CCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc--hhhh
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG--LMEV 910 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 910 (977)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+....+..-... ....
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 54332 2234689999999988764 5999999999999999999999999764322 22222222110000 0000
Q ss_pred cchhhhccc----cCch----HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhh
Q 036011 911 VDTNLLRQE----HTSS----AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKI 962 (977)
Q Consensus 911 ~~~~~~~~~----~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~ 962 (977)
.++...... .... ........+.+++.+||+.||.+|||+.|++++ +++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011000000 0000 001134468899999999999999999999876 455443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=334.14 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=203.2
Q ss_pred hcCCCcCccccCcceEEEEEEEe-C-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCC------CcceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-S-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHR------NLIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~ 753 (977)
.++|++.+.||+|+||+||+|.. . +++.||||++... ....+.+.+|+++++.++|+ +|+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46799999999999999999986 3 6889999998754 34456788999999988765 49999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC--------------
Q 036011 754 RALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-------------- 818 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-------------- 818 (977)
.++||||+ +++|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 8899999987653 5889999999999999999999 789999999999999987
Q ss_pred -----CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 819 -----DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 819 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|..||......+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE- 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred cccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 6689999999998754322 23468999999999999999999999999999999999999997643221
Q ss_pred cHHHHHHh--hCCCchhhhcc-h----------------------hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC
Q 036011 894 SLKKWVKE--SLPHGLMEVVD-T----------------------NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948 (977)
Q Consensus 894 ~~~~~~~~--~~~~~~~~~~~-~----------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 948 (977)
........ ..+..+..... . ..............+...+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 11111111 11110000000 0 00000000001123456789999999999999999
Q ss_pred CHHHHHHH
Q 036011 949 YMTDAAVK 956 (977)
Q Consensus 949 s~~ev~~~ 956 (977)
|+.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.87 Aligned_cols=252 Identities=27% Similarity=0.337 Sum_probs=202.9
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999975 78999999987553 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC---CceEEeecccccccC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED---MVAHVSDFGLSKLFD 834 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~ 834 (977)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.+ +.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999887644 4899999999999999999999 7899999999999999754 479999999998765
Q ss_pred CCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchh
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (977)
.... .....+++.|+|||++.+ .++.++||||+|+++|+|++|+.||......+ .............
T Consensus 176 ~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-------- 242 (287)
T 2wei_A 176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD-------- 242 (287)
T ss_dssp CCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCC--------
T ss_pred CCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCC--------
Confidence 4322 223358899999998876 48999999999999999999999997642211 1111111111100
Q ss_pred hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+....++..+.+++.+|++.+|++|||+.|++++
T Consensus 243 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 01111234467899999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.95 Aligned_cols=268 Identities=22% Similarity=0.258 Sum_probs=183.3
Q ss_pred cCCCc-CccccCcceEEEEEEEeC---CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeee--cCCeeEE
Q 036011 683 DGFNE-CNLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCC--NNDFRAL 756 (977)
Q Consensus 683 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 756 (977)
+.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999965 57899999987542 2356889999999999999999999995 4678899
Q ss_pred EEeccCCCCHHHHhhcCC--------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee----CCCCceEE
Q 036011 757 VLELMPNGSLEKWLYSDN--------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL----DEDMVAHV 824 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl 824 (977)
||||+. |+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 58887775321 24899999999999999999999 7899999999999999 67889999
Q ss_pred eecccccccCCCCC-cceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcc--------ccc
Q 036011 825 SDFGLSKLFDEGDD-SVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTG--------EMS 894 (977)
Q Consensus 825 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~--------~~~ 894 (977)
+|||+++.+..... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987754321 122334579999999999887 45999999999999999999999999654321 011
Q ss_pred HHHHHHhh-CCC--chhhhc---c-----hhhhccc-cCchHHH-------HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 895 LKKWVKES-LPH--GLMEVV---D-----TNLLRQE-HTSSAEM-------DCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 895 ~~~~~~~~-~~~--~~~~~~---~-----~~~~~~~-~~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
+....... .+. .+..+. . ..+.... ....... .....+.+++.+||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111110 000 011000 0 0000000 0000000 01345789999999999999999999987
Q ss_pred H
Q 036011 956 K 956 (977)
Q Consensus 956 ~ 956 (977)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=337.07 Aligned_cols=201 Identities=24% Similarity=0.301 Sum_probs=173.0
Q ss_pred HhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CC-----CcceEeeeeecCC
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HR-----NLIKIFSSCCNND 752 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 752 (977)
...++|++.+.||+|+||+||+|+.. +++.||||++... ......+..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999865 6889999999754 334566788999998885 55 4999999999999
Q ss_pred eeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC--CCCceEEeeccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD--EDMVAHVSDFGL 829 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgl 829 (977)
..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||. |+.||+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 59999998754 358999999999999999999993 347899999999999995 578899999999
Q ss_pred ccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcC
Q 036011 830 SKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDM 888 (977)
Q Consensus 830 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~ 888 (977)
++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 22346899999999999999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=338.49 Aligned_cols=262 Identities=22% Similarity=0.272 Sum_probs=197.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee----
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR---- 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 754 (977)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467889999999999999999865 68999999997643 33456788999999999999999999999876654
Q ss_pred --EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 755 --ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 755 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
++||||+. ++|.+++.. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 688887743 3899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CC-Cchhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LP-HGLME 909 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~ 909 (977)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+....... .+ .....
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHH
Confidence 5432 233468999999999877 789999999999999999999999997643221 111111111 00 00000
Q ss_pred hcch--------hhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDT--------NLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~--------~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... .+....... .....+...+.+++.+|++.||++|||++|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000000000 0001234568899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.90 Aligned_cols=268 Identities=25% Similarity=0.285 Sum_probs=200.5
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Cee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 754 (977)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 68999999986443 33456788999999999999999999987654 678
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
++||||+. |+|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 6999998764 3899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCcc--------eeeccccCCcccCccccC-CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh-hCC
Q 036011 835 EGDDSV--------TQTMTIATIGYMAPEYGT-EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE-SLP 904 (977)
Q Consensus 835 ~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~ 904 (977)
...... ......||+.|+|||++. +..++.++||||+||++|||++|+.||.+....+. +...... ..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCC
Confidence 432111 112246899999999865 47799999999999999999999999976432211 1111110 000
Q ss_pred C--c-hhhhcchh-------hhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 905 H--G-LMEVVDTN-------LLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 905 ~--~-~~~~~~~~-------~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. . ........ +...... ......+...+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0 00000000 0000000 00011234567899999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=333.02 Aligned_cols=269 Identities=26% Similarity=0.330 Sum_probs=202.5
Q ss_pred HhhcCCCcCccccCcceEEEEEEEe--CCCCEEEEEEeeccch--hhHHHHHHHHHHHHhc---CCCCcceEeeeee---
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTF--SDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNV---RHRNLIKIFSSCC--- 749 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--- 749 (977)
++.++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999997 3688999999875532 2234567788877776 8999999999987
Q ss_pred --cCCeeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 750 --NNDFRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 750 --~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 4567889999997 69999987654 34899999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC-CC
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL-PH 905 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~ 905 (977)
||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ .+.......- +.
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence 99998764321 2233468999999999999999999999999999999999999997643221 1222211110 00
Q ss_pred --chhhhc---chhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 --GLMEVV---DTNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 --~~~~~~---~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.... ...+.... .......++...+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00000000 0000011234567899999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=344.65 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=193.2
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecC----C--eeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN----D--FRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~ 755 (977)
.+|++.+.||+|+||+||+|++. +|+.||||++.... ....+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 69999999986542 2345799999999999999999988432 2 356
Q ss_pred EEEeccCCCCHHHHhhc---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-CceEEeeccccc
Q 036011 756 LVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSK 831 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~ 831 (977)
+||||+++ ++.+.+.. ....+++..+..++.||++||+||| +.||+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 66655542 3446899999999999999999999 8999999999999999965 578999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc---h
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG---L 907 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 907 (977)
.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+.++++..-... +
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 7654332 2234689999999998764 7999999999999999999999999764322 22222222110000 0
Q ss_pred hhhcchhhhc---cccCchH-----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDTNLLR---QEHTSSA-----EMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~~~~---~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... ++.... ....... .......+.+++.+||+.||++||++.|++++
T Consensus 282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 000000 0000000 01123567899999999999999999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=352.11 Aligned_cols=347 Identities=16% Similarity=0.130 Sum_probs=209.6
Q ss_pred CCCCCCCCCCc----ccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEe
Q 036011 29 NNWSISQPICK----WVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFIS 104 (977)
Q Consensus 29 ~~w~~~~~~c~----w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 104 (977)
++|.++.+||. |.++.|+. .++....... .+..--.+++++.|++++|.++...+..|.++++|++|+
T Consensus 10 ~~~~~~~~C~~~~~~~~c~~~~~------~i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~ 81 (597)
T 3oja_B 10 KPRQPEYKCIDSNLQYDCVFYDV------HIDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81 (597)
T ss_dssp -CCCSEECCCCC--CCSEEECSC------EECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEE
T ss_pred cCCCCCCcCcccCcCceeEecCc------eecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEE
Confidence 58988888874 66555542 1222222221 111122467888888888888885555677888888888
Q ss_pred CcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccc
Q 036011 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG 184 (977)
Q Consensus 105 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~ 184 (977)
|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|++|.+++
T Consensus 82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~ 161 (597)
T 3oja_B 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161 (597)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC
Confidence 88888887667788888888888888888887777777777777777777777775444555677777777777777776
Q ss_pred cCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcc
Q 036011 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNS 264 (977)
Q Consensus 185 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 264 (977)
..|..|+++++|+.|++++|++++.. + ..+++|+.|++++|.+++.
T Consensus 162 ~~~~~~~~l~~L~~L~L~~N~l~~~~---~---------------------------~~l~~L~~L~l~~n~l~~l---- 207 (597)
T 3oja_B 162 IEDDTFQATTSLQNLQLSSNRLTHVD---L---------------------------SLIPSLFHANVSYNLLSTL---- 207 (597)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSBCC---G---------------------------GGCTTCSEEECCSSCCSEE----
T ss_pred CChhhhhcCCcCcEEECcCCCCCCcC---h---------------------------hhhhhhhhhhcccCccccc----
Confidence 66666666777777766666665321 1 1234444555554444421
Q ss_pred cccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccc
Q 036011 265 ITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344 (977)
Q Consensus 265 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 344 (977)
....+|++|++++|.++...+.. . ++|+.|++
T Consensus 208 -~~~~~L~~L~ls~n~l~~~~~~~---~-------------------------------~~L~~L~L------------- 239 (597)
T 3oja_B 208 -AIPIAVEELDASHNSINVVRGPV---N-------------------------------VELTILKL------------- 239 (597)
T ss_dssp -ECCTTCSEEECCSSCCCEEECSC---C-------------------------------SCCCEEEC-------------
T ss_pred -cCCchhheeeccCCccccccccc---C-------------------------------CCCCEEEC-------------
Confidence 12234455555555544321110 0 12233333
Q ss_pred ccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccc
Q 036011 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424 (977)
Q Consensus 345 ~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 424 (977)
++|.+++ +..++.+++|++|+|++|.+++..|..|..+++|+
T Consensus 240 ------------------------------------~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 281 (597)
T 3oja_B 240 ------------------------------------QHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281 (597)
T ss_dssp ------------------------------------CSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred ------------------------------------CCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCC
Confidence 3333322 13344445555555555555555555555555555
Q ss_pred eeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCc
Q 036011 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504 (977)
Q Consensus 425 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 504 (977)
.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.|++. | +..+++|+.|+|++|.
T Consensus 282 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~ 356 (597)
T 3oja_B 282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHND 356 (597)
T ss_dssp EEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSC
T ss_pred EEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCC
Confidence 55555555553 3444555666777777777766 4556666677777777777777643 2 5667788899999998
Q ss_pred CCCC
Q 036011 505 LSGD 508 (977)
Q Consensus 505 l~~~ 508 (977)
+++.
T Consensus 357 ~~~~ 360 (597)
T 3oja_B 357 WDCN 360 (597)
T ss_dssp EEHH
T ss_pred CCCh
Confidence 8743
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=334.92 Aligned_cols=317 Identities=22% Similarity=0.244 Sum_probs=194.2
Q ss_pred CCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhh
Q 036011 237 PPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSF 316 (977)
Q Consensus 237 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 316 (977)
|+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|++++|.++.+++..
T Consensus 61 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~---- 136 (390)
T 3o6n_A 61 PAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI---- 136 (390)
T ss_dssp CTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT----
T ss_pred ChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHH----
Confidence 3333334444444444444444444444555555555555555555444444555555555555555555444322
Q ss_pred hcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhcc
Q 036011 317 LSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRL 396 (977)
Q Consensus 317 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 396 (977)
+..+++|++|++++|.+.+ ..|..+..+++|++|++++|.+++. .+..+
T Consensus 137 ---~~~l~~L~~L~L~~n~l~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l 185 (390)
T 3o6n_A 137 ---FHNTPKLTTLSMSNNNLER-------------------------IEDDTFQATTSLQNLQLSSNRLTHV---DLSLI 185 (390)
T ss_dssp ---TTTCTTCCEEECCSSCCCB-------------------------CCTTTTSSCTTCCEEECCSSCCSBC---CGGGC
T ss_pred ---hcCCCCCcEEECCCCccCc-------------------------cChhhccCCCCCCEEECCCCcCCcc---ccccc
Confidence 3444455555555544432 2233455556666666666666543 24556
Q ss_pred CCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEc
Q 036011 397 EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNL 476 (977)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 476 (977)
++|+.|++++|.+++ +....+|+.|++++|++... |.. ..++|+.|++++|++++. ..+..+++|+.|++
T Consensus 186 ~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 255 (390)
T 3o6n_A 186 PSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDL 255 (390)
T ss_dssp TTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred cccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEEC
Confidence 667777777776653 22334677777777777633 332 235777777777777753 46777777888888
Q ss_pred cCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCC
Q 036011 477 SSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE 556 (977)
Q Consensus 477 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 556 (977)
++|.+++..|..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++.
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~- 332 (390)
T 3o6n_A 256 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT- 332 (390)
T ss_dssp CSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-
T ss_pred CCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-
Confidence 888877777777777888888888888887 45666677788888888888887 456667778888888888888874
Q ss_pred CCcccccccccCccccCCCcccccCCCCCCCCcCCCCCcccCccccCC
Q 036011 557 IPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGP 604 (977)
Q Consensus 557 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~ 604 (977)
+| +..+++|+.|++++|++++.... ..+..+....+.++...|+.
T Consensus 333 ~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 333 LK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred eC--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence 33 66777888888888888775432 22344444556666666754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=330.44 Aligned_cols=252 Identities=25% Similarity=0.289 Sum_probs=182.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888999999999999999975 799999999976532 22334555666788889999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
||+ ++.+..+.......+++..+..++.|+++||+||| +. ||+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 55666666554456899999999999999999999 54 99999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccC-----CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 838 DSVTQTMTIATIGYMAPEYGT-----EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
......|++.|+|||++. ...++.++||||+|+++|||++|+.||..................+.
T Consensus 180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 249 (318)
T 2dyl_A 180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL------- 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-------
T ss_pred ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-------
Confidence 122346999999999984 56788999999999999999999999975332221111111111000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+ +....+...+.+++.+||+.||.+||+++|++++
T Consensus 250 --~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 --L-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --C-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 0001123457899999999999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=342.74 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=187.5
Q ss_pred CCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEeccC
Q 036011 684 GFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
.|...+.||+|+||+||.+...+|+.||||++..+. .+.+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345568899999999987766689999999987542 34578899999986 89999999999999999999999995
Q ss_pred CCCHHHHhhcCCcc------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCC-------------CceE
Q 036011 763 NGSLEKWLYSDNYF------LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDED-------------MVAH 823 (977)
Q Consensus 763 ~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-------------~~~k 823 (977)
|+|.+++...... .++..++.++.||+.||+||| +.+|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999865431 123345789999999999999 7899999999999999754 4899
Q ss_pred EeecccccccCCCCCcc--eeeccccCCcccCccccCC-------CCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccc
Q 036011 824 VSDFGLSKLFDEGDDSV--TQTMTIATIGYMAPEYGTE-------GIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEM 893 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~ 893 (977)
|+|||+++......... ......||++|+|||++.+ ..++.++||||+||++|||++ |+.||.+....+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999999876543221 1234579999999999865 678999999999999999999 999997543222
Q ss_pred cHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 894 SLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
..+........ .........+...+.+++.+||+.||.+|||+.|+++
T Consensus 248 --~~i~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFSLD------------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCCCC------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCCcc------------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 12221111100 0001112245667899999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.09 Aligned_cols=262 Identities=22% Similarity=0.271 Sum_probs=196.7
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe-----
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF----- 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 753 (977)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367899999999999999999975 69999999987543 3345678899999999999999999999987654
Q ss_pred -eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 754 -RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 754 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
.++||||+. |+|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 688887743 3899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-CC-Cchhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES-LP-HGLME 909 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~ 909 (977)
.... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+....... .+ ..+..
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 5432 223468999999998876 678999999999999999999999997643211 111111110 00 00000
Q ss_pred hcch--------hhhcc--ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDT--------NLLRQ--EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~--------~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... .+... .........+...+.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000 00000011234568899999999999999999999865
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.66 Aligned_cols=254 Identities=35% Similarity=0.543 Sum_probs=238.5
Q ss_pred cccccccccCcccc--cCCccccccccccEEEeec-CccCCCCChhhhccCCCCEEEeecccccCcccccccccccccee
Q 036011 350 SLQNFYAYDCKLTG--NIPHEIGNLRSLIVLSLFI-NALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGI 426 (977)
Q Consensus 350 ~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 426 (977)
.++.|++.+|.+++ .+|..+..+++|++|++++ |.+.+.+|..|+.+++|++|+|++|.+++.+|..+..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 46666666666766 7788899999999999995 99999999999999999999999999999999999999999999
Q ss_pred eecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcc-cCceEEccCCCCCCCCccccccccccCeeeCcCCcC
Q 036011 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLE-YLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQL 505 (977)
Q Consensus 427 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 505 (977)
++++|++++.+|..+..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++..|..|..+. |++|+|++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 9999999999999999999999999999999999999999998 999999999999999999999997 99999999999
Q ss_pred CCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCCC
Q 036011 506 SGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANG 585 (977)
Q Consensus 506 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 585 (977)
++.+|..|+.+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|++++|+++|.+|..+
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 999999999999999999999999977766 8899999999999999999999999999999999999999999999988
Q ss_pred CCCcCCCCCcccCccccCCC
Q 036011 586 PFKYFAPQSFSWNYALCGPT 605 (977)
Q Consensus 586 ~~~~~~~~~~~~n~~lcg~~ 605 (977)
.+..+....+.+|+++||.|
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTT
T ss_pred cccccChHHhcCCCCccCCC
Confidence 88888888999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=332.93 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=177.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHH-HHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECE-VLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367889999999999999999975 78999999997653 233345555655 777789999999999999999999999
Q ss_pred eccCCCCHHHHhhc----CCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 759 ELMPNGSLEKWLYS----DNYFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 759 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
||+++ +|.+++.. ....+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88877753 2345899999999999999999999 66 9999999999999999999999999999876
Q ss_pred CCCCCcceeeccccCCcccCcccc----CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYG----TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~--- 246 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGD--- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSC---
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCC---
Confidence 5432 12233699999999998 46678999999999999999999999997532111 0000000000
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+.+... ....+...+.+++.+||+.||++|||+.|++++
T Consensus 247 --~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 247 --PPQLSNS-----EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --CCCCCCC-----SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CCCCCCc-----ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000000 001124467899999999999999999999763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=331.02 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=199.6
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CC-CEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC------cceEeeeeecCCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DG-TSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN------LIKIFSSCCNNDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 753 (977)
.++|++.+.||+|+||+||+|+.. ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467999999999999999999864 34 68999999754 344567888999999997665 8999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee----------------
Q 036011 754 RALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL---------------- 816 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---------------- 816 (977)
.++||||+ ++++.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 567766666543 46899999999999999999999 8899999999999999
Q ss_pred ---CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccc
Q 036011 817 ---DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893 (977)
Q Consensus 817 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 893 (977)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 567899999999998754322 23469999999999999999999999999999999999999997643221
Q ss_pred cHHHHHH--hhCCCchhh-hcchh----------------------hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC
Q 036011 894 SLKKWVK--ESLPHGLME-VVDTN----------------------LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI 948 (977)
Q Consensus 894 ~~~~~~~--~~~~~~~~~-~~~~~----------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 948 (977)
....... ...+..+.. ..... .................+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 1111111 111111000 00000 0000000000112345688999999999999999
Q ss_pred CHHHHHHH
Q 036011 949 YMTDAAVK 956 (977)
Q Consensus 949 s~~ev~~~ 956 (977)
|+.|++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=353.24 Aligned_cols=319 Identities=23% Similarity=0.240 Sum_probs=223.4
Q ss_pred CCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhh
Q 036011 236 LPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWS 315 (977)
Q Consensus 236 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 315 (977)
+|+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++++|..|+++++|++|+|++|.++.+++..
T Consensus 66 lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~--- 142 (597)
T 3oja_B 66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI--- 142 (597)
T ss_dssp ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT---
T ss_pred cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHH---
Confidence 34444444555555555555555555555555566666666666665555555556666666666666655554432
Q ss_pred hhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhc
Q 036011 316 FLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGR 395 (977)
Q Consensus 316 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 395 (977)
+..+++|++|++++|.+.+ ..|..|+.+++|++|++++|.+++.. ++.
T Consensus 143 ----~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~ 190 (597)
T 3oja_B 143 ----FHNTPKLTTLSMSNNNLER-------------------------IEDDTFQATTSLQNLQLSSNRLTHVD---LSL 190 (597)
T ss_dssp ----TTTCTTCCEEECCSSCCCB-------------------------CCTTTTTTCTTCCEEECTTSCCSBCC---GGG
T ss_pred ----hccCCCCCEEEeeCCcCCC-------------------------CChhhhhcCCcCcEEECcCCCCCCcC---hhh
Confidence 4455555555555555443 33344566667777777777776432 455
Q ss_pred cCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEE
Q 036011 396 LEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVN 475 (977)
Q Consensus 396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 475 (977)
+++|+.|++++|.+++ +....+|+.|++++|.++.. +..+ .++|+.|+|++|.+++ +..+..+++|+.|+
T Consensus 191 l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~ 260 (597)
T 3oja_B 191 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260 (597)
T ss_dssp CTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEE
T ss_pred hhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEE
Confidence 6777777887777763 23345778888888887733 3322 2578888888888885 46788888899999
Q ss_pred ccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCC
Q 036011 476 LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 476 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++
T Consensus 261 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~ 338 (597)
T 3oja_B 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 338 (597)
T ss_dssp CCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred CCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC
Confidence 99999888888888889999999999999984 6777788899999999999998 577788889999999999999985
Q ss_pred CCCcccccccccCccccCCCcccccCCCCCCCCcCCCCCcccCccccCCC
Q 036011 556 EIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALCGPT 605 (977)
Q Consensus 556 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 605 (977)
. | +..+++|+.|++++|+|+|..+. ..+..+....+.++...|+.+
T Consensus 339 ~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 339 L-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp C-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred c-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 4 3 66788999999999999887543 245566666778888899864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.26 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=173.0
Q ss_pred hcCCCcCc-cccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec----CCeeE
Q 036011 682 TDGFNECN-LLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN----NDFRA 755 (977)
Q Consensus 682 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 755 (977)
.++|.+.+ .||+|+||+||+|+.. +|+.||||++.... ....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788855 6999999999999976 69999999986532 122233344566799999999999876 44578
Q ss_pred EEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeeccccc
Q 036011 756 LVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDFGLSK 831 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~ 831 (977)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998764 36899999999999999999999 789999999999999986 4559999999998
Q ss_pred ccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......... .. .......
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~~~~~~~----- 248 (336)
T 3fhr_A 180 ETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GM-KRRIRLG----- 248 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hH-HHhhhcc-----
Confidence 664322 223468999999999999999999999999999999999999996543221100 00 0000000
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... ........+...+.+++.+|++.||.+|||+.|++++
T Consensus 249 --~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 --QYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----C---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --ccc---cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000011234467899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=327.53 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=191.3
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHhc----CCCCcceEe
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD------RAFRSFDSECEVLRNV----RHRNLIKIF 745 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~ 745 (977)
+.....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455688999999999999999999864 789999999975532 1234466799999998 899999999
Q ss_pred eeeecCCeeEEEEec-cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceE
Q 036011 746 SSCCNNDFRALVLEL-MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAH 823 (977)
Q Consensus 746 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~k 823 (977)
+++.+.+..++|||| +.+++|.+++.... .+++..++.++.||++||+||| +.+|+||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999999 78999999997654 4899999999999999999999 78999999999999999 899999
Q ss_pred EeecccccccCCCCCcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh
Q 036011 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902 (977)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (977)
|+|||++....... .....|++.|+|||++.+..+ +.++||||+|+++|||++|+.||.... .....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~- 248 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEA- 248 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHT-
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhh-
Confidence 99999998775432 223458999999998877666 458999999999999999999986421 11110
Q ss_pred CCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... ..+...+.+++.+||+.+|++|||+.|++++
T Consensus 249 -----------~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 -----------ELHFP-------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----------CCCCC-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------ccCCc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0123457889999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=337.32 Aligned_cols=265 Identities=19% Similarity=0.258 Sum_probs=198.6
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-----------CCCcceEeeeee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-----------HRNLIKIFSSCC 749 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 749 (977)
.++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999996 47899999998754 334467889999999886 899999999987
Q ss_pred cCC----eeEEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCceeeC------
Q 036011 750 NND----FRALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHST-PVVHCDLKPSNILLD------ 817 (977)
Q Consensus 750 ~~~----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~NIll~------ 817 (977)
..+ ..++||||+ +++|.+++.... ..+++..+..++.||+.||+||| ++ ||+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 644 788999999 899999998643 35899999999999999999999 66 999999999999994
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc-----
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE----- 892 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~----- 892 (977)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876532 223468999999999999999999999999999999999999997543211
Q ss_pred ccHHHHHHhh--CCCchh-------hhcch-hhhcc-------------ccCchHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 036011 893 MSLKKWVKES--LPHGLM-------EVVDT-NLLRQ-------------EHTSSAEMDCLLSVLHLALDCCMESPDQRIY 949 (977)
Q Consensus 893 ~~~~~~~~~~--~~~~~~-------~~~~~-~~~~~-------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 949 (977)
..+....... .+..+. ..+.. ..... .........+...+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111100 000000 00000 00000 0000112346677899999999999999999
Q ss_pred HHHHHHH
Q 036011 950 MTDAAVK 956 (977)
Q Consensus 950 ~~ev~~~ 956 (977)
++|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.25 Aligned_cols=243 Identities=23% Similarity=0.250 Sum_probs=199.2
Q ss_pred HhhcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccchh------hHHHHHHHHHHHHhcC--CCCcceEeeeeec
Q 036011 680 RATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDR------AFRSFDSECEVLRNVR--HRNLIKIFSSCCN 750 (977)
Q Consensus 680 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 750 (977)
...++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999986 47899999998765321 2345778999999996 5999999999999
Q ss_pred CCeeEEEEeccCC-CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC-CCCceEEeecc
Q 036011 751 NDFRALVLELMPN-GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFG 828 (977)
Q Consensus 751 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg 828 (977)
.+..++||||+.+ ++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999976 89999997644 4899999999999999999999 78999999999999999 78999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCch
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGL 907 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (977)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......
T Consensus 196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~---- 260 (320)
T 3a99_A 196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV---- 260 (320)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC----
T ss_pred ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc----
Confidence 998775432 223459999999999877665 688999999999999999999986421 1111000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.... .+...+.+++.+||+.||++|||++|++++
T Consensus 261 --------~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 --------FFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------CCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------cccc-------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 123457899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.55 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=188.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34688889999999999765555679999999986542 23467899999999 799999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-----CCceEEeecccccccCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~ 835 (977)
+. |+|.+++........+..+..++.||++||+||| +.+|+||||||+||+++. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 96 6999999877655666677899999999999999 789999999999999953 33688999999987754
Q ss_pred CCCc-ceeeccccCCcccCccccC---CCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 836 GDDS-VTQTMTIATIGYMAPEYGT---EGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 836 ~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
.... ......+||++|+|||++. ...++.++||||+||++|||++ |..||....... .... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~~~~---~~~~~~~~ 249 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---ANIL---LGACSLDC 249 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---HHHH---TTCCCCTT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---HHHH---hccCCccc
Confidence 3221 2233457999999999987 4667889999999999999999 888885432211 1110 00000000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
. .........+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 L-----------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp S-----------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-----------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 001123345678999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=349.43 Aligned_cols=270 Identities=22% Similarity=0.268 Sum_probs=201.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeec------CCe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN------NDF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 753 (977)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999874 68999999987543 4446779999999999999999999998765 667
Q ss_pred eEEEEeccCCCCHHHHhhcCCc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCc---eEEeecc
Q 036011 754 RALVLELMPNGSLEKWLYSDNY--FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMV---AHVSDFG 828 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg 828 (977)
.++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999986542 5889999999999999999999 789999999999999997664 9999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc--
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG-- 906 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 906 (977)
++........ .....||+.|+|||++.+..++.++||||+|+++|||++|..||..... ...|........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC-----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccch
Confidence 9987754332 2335699999999999999999999999999999999999999965321 122211111100
Q ss_pred ---hhhhcchhhhcc---ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHH-----HHHHHHchh
Q 036011 907 ---LMEVVDTNLLRQ---EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTD-----AAVKLKKIK 961 (977)
Q Consensus 907 ---~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e-----v~~~L~~~~ 961 (977)
..+......... +............+.+++.+|++.||++|||+.| ..+.++.+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000000000000 0011111234567899999999999999999987 344454444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=322.72 Aligned_cols=282 Identities=22% Similarity=0.286 Sum_probs=217.1
Q ss_pred cChHHHHHHHHHHHHhcc-CCCCCccCCC----CCCCCCCcccceEec--------CCCCcEEEEEcCCCCCCccCCccc
Q 036011 4 QNLTTDQFALLAFKAHVT-DPQSVLANNW----SISQPICKWVGISCG--------ARHQRVRALNLSNMGLRGTIPPHL 70 (977)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~-~~~~~~~~~w----~~~~~~c~w~gv~c~--------~~~~~v~~L~l~~~~l~~~~~~~l 70 (977)
.++.+|+.||++||.++. ++..+. .+| ..+.++|.|.|++|. ....+|+.|+|++++++ .+|+.+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHH-HHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred ccCchHHHHHHHHHHhccCCchhhh-hhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 356789999999999995 665555 589 557889999999995 34568999999999998 899999
Q ss_pred cCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccc
Q 036011 71 GNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEK 150 (977)
Q Consensus 71 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 150 (977)
+++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..+...
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~----- 173 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----- 173 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-----
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-----
Confidence 99999999999999999 58999999999999999999999 889999999999999999999998998877641
Q ss_pred eeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcc
Q 036011 151 WDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230 (977)
Q Consensus 151 L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 230 (977)
.++..|+++++|++|+|++|+++ .+|..++++++|++|+|++|++++ ++..+..+++|+.|+|++|.+
T Consensus 174 ----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~ 241 (328)
T 4fcg_A 174 ----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241 (328)
T ss_dssp ----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT
T ss_pred ----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc
Confidence 12233445556666666666665 555556666666666666666653 344455566666666666555
Q ss_pred cccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCC
Q 036011 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDS 309 (977)
Q Consensus 231 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 309 (977)
.+. .+..+..+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..++.+++|+.+++..|.+....
T Consensus 242 ~~~---~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l~ 317 (328)
T 4fcg_A 242 LRN---YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317 (328)
T ss_dssp CCB---CCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC--
T ss_pred hhh---hHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHHh
Confidence 532 2344556778888888888777788888888888999999998888888888888888888888888766543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.58 Aligned_cols=230 Identities=13% Similarity=0.074 Sum_probs=184.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++.+++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999975 58999999997653 234577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++++|.++++.. ....++.+++.|++.||+||| +.||+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999643 356678899999999999999 7899999999999999999999997443
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
|++| ++.++||||+||++|||+||+.||.+....+. +.. ........
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------------~~~-~~~~~~~~ 221 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------------LAP-AERDTAGQ 221 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-------------SEE-CCBCTTSC
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-------------hHH-HHHHhccC
Confidence 4433 68899999999999999999999976433210 000 00000000
Q ss_pred cc-CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 919 EH-TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 919 ~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.. ......+++..+.+++.+||+.||++| |+.|+++.|+++..
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 001111244568899999999999999 99999999998774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=312.31 Aligned_cols=174 Identities=28% Similarity=0.404 Sum_probs=88.8
Q ss_pred hhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCc
Q 036011 393 VGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLL 472 (977)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 472 (977)
+..+++|++|++++|.+++..+ +..+++|+.|++++|++.+..+ +..+++|++|++++|++++..+ +..+++|+
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~ 246 (347)
T 4fmz_A 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT 246 (347)
T ss_dssp GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCC
Confidence 3344444444444444442221 4444444444444444443322 4444555555555555553222 44555555
Q ss_pred eEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCc
Q 036011 473 AVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNN 552 (977)
Q Consensus 473 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 552 (977)
.|++++|.+++. +.+..+++|++|++++|++++ + ..+..+++|+.|+|++|++++..|..++.+++|+.|+|++|+
T Consensus 247 ~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 247 WLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp EEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred EEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 555555555532 345555556666666665553 2 235556666666666666665555556666666666666666
Q ss_pred cCCCCCcccccccccCccccCCCccc
Q 036011 553 LSGEIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 553 l~~~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
+++..| +..+++|++|++++|+++
T Consensus 323 l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 323 ITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCCCGG--GGGCTTCSEESSSCC---
T ss_pred cccccC--hhhhhccceeehhhhccc
Confidence 664433 556666666666666653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.30 Aligned_cols=308 Identities=29% Similarity=0.418 Sum_probs=256.8
Q ss_pred hhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccc
Q 036011 213 SIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292 (977)
Q Consensus 213 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 292 (977)
.+..+++|+.|++++|.+.. ++. +..+++|++|++++|++++. +. +..+++|++|++++|.++.. ..|..+
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~---~~~--~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l 109 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS---IQG--IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNL 109 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC---CTT--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred cchhcccccEEEEeCCcccc---chh--hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCC
Confidence 45678899999999999873 432 56789999999999999854 44 88999999999999999865 368999
Q ss_pred cccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCcccccc
Q 036011 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNL 372 (977)
Q Consensus 293 ~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l 372 (977)
++|++|++++|.++.+++ +..+++|++|++++|.....++. +..+ .+|++|++.+|.+.+..+ +..+
T Consensus 110 ~~L~~L~l~~n~i~~~~~---------~~~l~~L~~L~l~~n~~~~~~~~-~~~l-~~L~~L~l~~~~~~~~~~--~~~l 176 (347)
T 4fmz_A 110 TNLRELYLNEDNISDISP---------LANLTKMYSLNLGANHNLSDLSP-LSNM-TGLNYLTVTESKVKDVTP--IANL 176 (347)
T ss_dssp TTCSEEECTTSCCCCCGG---------GTTCTTCCEEECTTCTTCCCCGG-GTTC-TTCCEEECCSSCCCCCGG--GGGC
T ss_pred CcCCEEECcCCcccCchh---------hccCCceeEEECCCCCCcccccc-hhhC-CCCcEEEecCCCcCCchh--hccC
Confidence 999999999999887542 67889999999999976655544 3333 479999999999886544 8889
Q ss_pred ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeec
Q 036011 373 RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452 (977)
Q Consensus 373 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 452 (977)
++|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEEC
Confidence 999999999999985443 8889999999999999986554 8889999999999999986544 888999999999
Q ss_pred CCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccccc
Q 036011 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532 (977)
Q Consensus 453 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 532 (977)
++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++..|..++.+++|+.|+|++|++++.
T Consensus 251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 99999864 5688899999999999999864 4688899999999999999988888899999999999999999977
Q ss_pred ccccccCccccCeeeccCCccC
Q 036011 533 IPQTFGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 533 ~p~~~~~l~~L~~L~Ls~N~l~ 554 (977)
.| +..+++|+.||+++|+|+
T Consensus 327 ~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 327 RP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GG--GGGCTTCSEESSSCC---
T ss_pred cC--hhhhhccceeehhhhccc
Confidence 66 888999999999999886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=348.63 Aligned_cols=239 Identities=22% Similarity=0.293 Sum_probs=192.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC--CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe-----
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS--DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF----- 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 753 (977)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 68999999986543 3445678899999999999999999999987655
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+||||+++++|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988755 4899999999999999999999 7899999999999999985 9999999999876
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
... ....||++|+|||++.++. +.++|||||||++|||++|..||........ +
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~--------- 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P--------- 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C---------
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c---------
Confidence 542 2346999999999887654 8999999999999999999988764221110 0
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHHHHch
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-MTDAAVKLKKI 960 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~ev~~~L~~~ 960 (977)
...........+.+++.+||+.||.+||+ ++++.+.+.++
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00111223456789999999999999995 56666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.52 Aligned_cols=231 Identities=21% Similarity=0.290 Sum_probs=179.7
Q ss_pred hcCCCcC-ccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHH-HhcCCCCcceEeeeeec----CCee
Q 036011 682 TDGFNEC-NLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVL-RNVRHRNLIKIFSSCCN----NDFR 754 (977)
Q Consensus 682 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 754 (977)
.++|.+. +.||+|+||.||+|+.. +++.||||++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999974 7899999998643 4567888888 55689999999999876 6678
Q ss_pred EEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeecccc
Q 036011 755 ALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDFGLS 830 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla 830 (977)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998754 36899999999999999999999 789999999999999998 789999999998
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
.... +..++.++||||+||++|||++|+.||........ ....... +
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~~~~~~~---~ 214 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKTR---I 214 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCS---S
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------hHHHHHH---H
Confidence 6432 24578899999999999999999999965322110 0000000 0
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... .........+...+.+++.+||+.||.+|||+.|++++
T Consensus 215 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 00111112345568899999999999999999999874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=304.66 Aligned_cols=288 Identities=27% Similarity=0.339 Sum_probs=206.2
Q ss_pred CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCC
Q 036011 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325 (977)
Q Consensus 246 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 325 (977)
+++.+++++|.++ .+|..+. ++|++|+|++|+++++.|..|.++++|++|++++|.++.+.+.. +..+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~ 103 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA-------FSPLRK 103 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG-------STTCTT
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhH-------hhCcCC
Confidence 4555555555555 4444442 35556666666655555555555666666666666555543322 555566
Q ss_pred CceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEee
Q 036011 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 405 (977)
|++|++++|.+... |..+. ++|++|++++|.+++..+..|..+++|++|+++
T Consensus 104 L~~L~L~~n~l~~l--------------------------~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 104 LQKLYISKNHLVEI--------------------------PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CCEEECCSSCCCSC--------------------------CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred CCEEECCCCcCCcc--------------------------Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence 66666666655421 11121 567777777777776666677778888888888
Q ss_pred ccccc--CccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCC
Q 036011 406 GNNLE--GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483 (977)
Q Consensus 406 ~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 483 (977)
+|.++ +..+..+..+ +|+.|++++|++++ +|..+. ++|++|++++|++++..+..|..+++|+.|++++|++++
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 88875 3566677777 88888888888884 555443 688899999999988888888889999999999999988
Q ss_pred CCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCc------cccCeeeccCCccC--C
Q 036011 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSL------TGLESLDLSNNNLS--G 555 (977)
Q Consensus 484 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~ 555 (977)
..+..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|... .+|+.|++++|++. +
T Consensus 232 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~ 310 (332)
T 2ft3_A 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310 (332)
T ss_dssp CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGG
T ss_pred CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccc
Confidence 77778888999999999999998 788888999999999999999997777777653 67899999999987 5
Q ss_pred CCCcccccccccCccccCCCc
Q 036011 556 EIPKSLEALLFLKQLNVSHNK 576 (977)
Q Consensus 556 ~~p~~~~~l~~L~~L~l~~N~ 576 (977)
..|..|..++.|+.+++++|+
T Consensus 311 ~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 311 VQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SCGGGGTTBCCSTTEEC----
T ss_pred cCcccccccchhhhhhccccc
Confidence 678888999999999999885
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=326.11 Aligned_cols=240 Identities=18% Similarity=0.158 Sum_probs=180.5
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccch---hhHHHHHHHHHHHHhcCC-CCcceEe-----------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVRH-RNLIKIF----------- 745 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l~----------- 745 (977)
...|...++||+|+||+||+|++ .+|+.||||++..... ...+.+.+|+.+++.++| ++.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999995 4799999999874432 335779999999999987 3221111
Q ss_pred ----------eeeec-----CCeeEEEEeccCCCCHHHHhh------cCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036011 746 ----------SSCCN-----NDFRALVLELMPNGSLEKWLY------SDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804 (977)
Q Consensus 746 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 804 (977)
.++.. ....+++|+++ +++|.+++. .....+++..+..++.||++||+||| +.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 11111 12356777766 689999884 22445788899999999999999999 7899
Q ss_pred EeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCcccc----------CCCCcCcccchhhHhHH
Q 036011 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG----------TEGIVSSKCDVYSYGVL 874 (977)
Q Consensus 805 vH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~i 874 (977)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865432 333467 999999998 66679999999999999
Q ss_pred HHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 036011 875 LTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAA 954 (977)
Q Consensus 875 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~ 954 (977)
+|||++|+.||......+. ...+ +.... .++..+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~-------------~~~~----~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG-------------SEWI----FRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC-------------SGGG----GSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh-------------HHHH----Hhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999976432111 0011 11011 1234578999999999999999987775
Q ss_pred H
Q 036011 955 V 955 (977)
Q Consensus 955 ~ 955 (977)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=301.02 Aligned_cols=289 Identities=25% Similarity=0.308 Sum_probs=189.8
Q ss_pred CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCC
Q 036011 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325 (977)
Q Consensus 246 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 325 (977)
+++.++++++.++ .+|..+. ++|++|+|++|+++++.+..|.++++|++|++++|.++.+.+.. +..+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~ 101 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-------FAPLVK 101 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT-------TTTCTT
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH-------hcCCCC
Confidence 4455555555555 3444332 35556666666665555555566666666666666655554332 555566
Q ss_pred CceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEee
Q 036011 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 405 (977)
|++|++++|.++. +| ..+. ++|++|++++|.+++..+..|.++++|++|+++
T Consensus 102 L~~L~Ls~n~l~~-l~-------------------------~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 102 LERLYLSKNQLKE-LP-------------------------EKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CCEEECCSSCCSB-CC-------------------------SSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCEEECCCCcCCc-cC-------------------------hhhc--ccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 6666666665542 11 1111 456666666666665555666667777777777
Q ss_pred cccccC--ccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCC
Q 036011 406 GNNLEG--SIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483 (977)
Q Consensus 406 ~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 483 (977)
+|.++. ..+..+..+++|+.|++++|+++. +|..+. ++|++|++++|++++..|..|..+++|+.|++++|++++
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 776642 455666677777777777777763 444433 677888888888877777777778888888888888877
Q ss_pred CCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCc------cccCeeeccCCccCC--
Q 036011 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSL------TGLESLDLSNNNLSG-- 555 (977)
Q Consensus 484 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~-- 555 (977)
..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|... ..|+.|+|++|++..
T Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~ 309 (330)
T 1xku_A 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309 (330)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred eChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccc
Confidence 66667788888888888888887 677778888888888888888887666666543 678888888888863
Q ss_pred CCCcccccccccCccccCCCc
Q 036011 556 EIPKSLEALLFLKQLNVSHNK 576 (977)
Q Consensus 556 ~~p~~~~~l~~L~~L~l~~N~ 576 (977)
..|..|..+..++.++|++|+
T Consensus 310 i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 310 IQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCGGGGTTCCCGGGEEC----
T ss_pred cCccccccccceeEEEecccC
Confidence 556778888888888888885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=317.19 Aligned_cols=243 Identities=19% Similarity=0.236 Sum_probs=184.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcC---------CCCcceE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVR---------HRNLIKI 744 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l 744 (977)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999998 68999999998653 223467889999999886 6666665
Q ss_pred eee-----------------eec-------------CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHH
Q 036011 745 FSS-----------------CCN-------------NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALE 794 (977)
Q Consensus 745 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~ 794 (977)
.++ +.+ .+..++||||+++|++.+.+.. ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 554 333 6789999999999977666644 34899999999999999999
Q ss_pred HHHhcCCCCeEeCCCCCCceeeCCCC--------------------ceEEeecccccccCCCCCcceeeccccCCcccCc
Q 036011 795 YLHHGHSTPVVHCDLKPSNILLDEDM--------------------VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854 (977)
Q Consensus 795 ~LH~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 854 (977)
|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 9993 36899999999999999887 9999999999876532 23699999999
Q ss_pred cccCCCCcCcccchhhHhHH-HHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHH
Q 036011 855 EYGTEGIVSSKCDVYSYGVL-LTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVL 933 (977)
Q Consensus 855 E~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 933 (977)
|++.+.. +.++||||+|++ .+++++|..||... .|..... ..+.................+...+.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT----DKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH----HHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH----HhhhhhhccCcccchhhhhhcCHHHH
Confidence 9998776 899999998777 77889999987431 1211100 00000000011112233456778899
Q ss_pred HHHHHhhcCCCCCCCCHHHHH
Q 036011 934 HLALDCCMESPDQRIYMTDAA 954 (977)
Q Consensus 934 ~l~~~cl~~~P~~RPs~~ev~ 954 (977)
+++.+|++.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 998887
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=296.86 Aligned_cols=290 Identities=24% Similarity=0.295 Sum_probs=143.7
Q ss_pred cccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceecc
Q 036011 75 FLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSM 154 (977)
Q Consensus 75 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 154 (977)
+++.++++++.++. +|..+. ++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCccc-cCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 45566666655554 444442 455555555555554444455555555555555555554444444444444444444
Q ss_pred ccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccc
Q 036011 155 FNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL 234 (977)
Q Consensus 155 ~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 234 (977)
+|.++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|+++. .
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------~- 162 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN------------------------S- 162 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG------------------------G-
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc------------------------C-
Confidence 44444 3333322 344444444444443323334444444444444444321 0
Q ss_pred cCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchh
Q 036011 235 DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEW 314 (977)
Q Consensus 235 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 314 (977)
.+.+..+..+ +|++|++++|++++ +|..+. ++|++|++++|++++..+..|..+++|+.|++++|+++.+++
T Consensus 163 ~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~---- 234 (332)
T 2ft3_A 163 GFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN---- 234 (332)
T ss_dssp GSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT----
T ss_pred CCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCCh----
Confidence 1112222222 44444444444442 333332 345555555555554444445555555555555544444332
Q ss_pred hhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhh
Q 036011 315 SFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVG 394 (977)
Q Consensus 315 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 394 (977)
..+..+++|++|++++|+++ .+|..+.
T Consensus 235 ----------------------------------------------------~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 261 (332)
T 2ft3_A 235 ----------------------------------------------------GSLSFLPTLRELHLDNNKLS-RVPAGLP 261 (332)
T ss_dssp ----------------------------------------------------TGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred ----------------------------------------------------hHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence 22344455555555555555 4555566
Q ss_pred ccCCCCEEEeecccccCcccccccc------ccccceeeecCCccC--CCchhhhcCCCCCCeeecCCCc
Q 036011 395 RLEQLQGLSLYGNNLEGSIPYDLCH------LERLNGIRLNGNKLS--GPIPQCLASLISLRELNLGSNK 456 (977)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~ 456 (977)
.+++|++|++++|+|++..+..|.. ...|+.|++++|.+. +..|..|..+++|+.|++++|+
T Consensus 262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 6666666666666666554444443 255777777777776 5666777777788888887774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-31 Score=294.78 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=172.1
Q ss_pred EEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccC
Q 036011 52 VRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRN 131 (977)
Q Consensus 52 v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 131 (977)
++.+++++++++ .+|..+. +.|++|+|++|++++..+..|.++++|++|+|++|++++..|..++.+++|++|+|++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 345777777877 6777654 6889999999999987777899999999999999999977788899999999999999
Q ss_pred cCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccc--cCCccccCCCCCceEEeeccCCCCC
Q 036011 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG--EIPSEIGNLQNLEILVLGMNNLSGP 209 (977)
Q Consensus 132 n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~l~~N~l~~~ 209 (977)
|.++ .+|..+. ++|++|++++|.+.+..+..|+++++|++|++++|.++. ..+..+.++++|++|++++|+++.
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~- 185 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT- 185 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-
Confidence 9988 5565554 566777777776665555566666666666666666642 445556666666666666666552
Q ss_pred CchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccc
Q 036011 210 IQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTF 289 (977)
Q Consensus 210 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 289 (977)
+|...+ ++|++|++++|++++..|..+..+++|++|+|++|++++..+..|
T Consensus 186 --------------------------l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 236 (330)
T 1xku_A 186 --------------------------IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236 (330)
T ss_dssp --------------------------CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred --------------------------CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhc
Confidence 232222 566677777777766666667777777777777777776666667
Q ss_pred ccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCc
Q 036011 290 GNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPP 342 (977)
Q Consensus 290 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 342 (977)
..+++|+.|++++|+++.++.. +..+++|++|++++|++++..+.
T Consensus 237 ~~l~~L~~L~L~~N~l~~lp~~--------l~~l~~L~~L~l~~N~i~~~~~~ 281 (330)
T 1xku_A 237 ANTPHLRELHLNNNKLVKVPGG--------LADHKYIQVVYLHNNNISAIGSN 281 (330)
T ss_dssp GGSTTCCEEECCSSCCSSCCTT--------TTTCSSCCEEECCSSCCCCCCTT
T ss_pred cCCCCCCEEECCCCcCccCChh--------hccCCCcCEEECCCCcCCccChh
Confidence 7777777777777776654432 55566666666666666654433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-35 Score=342.50 Aligned_cols=383 Identities=21% Similarity=0.164 Sum_probs=240.1
Q ss_pred cccceeccccccccccCcc-ccCccccceeeeecccccc----cCCccccCCCCCceEEeeccCCCCCCchhhcccccee
Q 036011 147 RLEKWDSMFNIIDGNIPSR-IGNLSSLVNVNLAYNNLQG----EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221 (977)
Q Consensus 147 ~L~~L~l~~n~i~~~~p~~-~~~l~~L~~L~L~~n~i~~----~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~ 221 (977)
+|++|++++|.++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|++....+..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~------ 77 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL------ 77 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH------
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHH------
Confidence 4555555555554332222 4445555555555555542 1233444445555555555554432222222
Q ss_pred EEEccCCcccccccCCCccccCCC----CceEEEecCceeee----cCCcccccccccceEeeccccccccccccccc--
Q 036011 222 LINLFGNQLSGHLDLPPKVSYSLP----NLRVFSLGKNKLTG----TIPNSITNASKLTGLDLSFNSFSGLIPHTFGN-- 291 (977)
Q Consensus 222 ~L~L~~N~l~~~~~~~~~~~~~l~----~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-- 291 (977)
..++ +|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+..
T Consensus 78 --------------------~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 137 (461)
T 1z7x_W 78 --------------------QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 137 (461)
T ss_dssp --------------------HTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred --------------------HHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHH
Confidence 1222 57777777777663 44666777777888888888776544443332
Q ss_pred ---ccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCcc
Q 036011 292 ---LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHE 368 (977)
Q Consensus 292 ---l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~ 368 (977)
.++|++|++++|.++..... .+...+..+++|++|++++|.+.+..+..+. ..
T Consensus 138 ~~~~~~L~~L~L~~n~l~~~~~~---~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~---------------------~~ 193 (461)
T 1z7x_W 138 LDPQCRLEKLQLEYCSLSAASCE---PLASVLRAKPDFKELTVSNNDINEAGVRVLC---------------------QG 193 (461)
T ss_dssp TSTTCCCCEEECTTSCCBGGGHH---HHHHHHHHCTTCCEEECCSSBCHHHHHHHHH---------------------HH
T ss_pred hcCCCcceEEECCCCCCCHHHHH---HHHHHHhhCCCCCEEECcCCCcchHHHHHHH---------------------HH
Confidence 45677777877777653321 1233456677888888888776532221111 11
Q ss_pred c-cccccccEEEeecCccCCC----CChhhhccCCCCEEEeecccccCcc-----ccccccccccceeeecCCccCCC--
Q 036011 369 I-GNLRSLIVLSLFINALNGT----IPSTVGRLEQLQGLSLYGNNLEGSI-----PYDLCHLERLNGIRLNGNKLSGP-- 436 (977)
Q Consensus 369 ~-~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~-- 436 (977)
+ ...++|++|++++|.+++. ++..+..+++|++|++++|.+++.. +..+..+++|+.|++++|++++.
T Consensus 194 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~ 273 (461)
T 1z7x_W 194 LKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC 273 (461)
T ss_dssp HHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH
T ss_pred HhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHH
Confidence 1 1245777888888877753 4667777888888888888877532 22233578888888888888753
Q ss_pred --chhhhcCCCCCCeeecCCCcCCCCCCccccCc-----ccCceEEccCCCCCCC----CccccccccccCeeeCcCCcC
Q 036011 437 --IPQCLASLISLRELNLGSNKFSSSIPSSFWSL-----EYLLAVNLSSNSLSGS----LPSNIQNLQVLINLDLSRNQL 505 (977)
Q Consensus 437 --~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 505 (977)
++..+..+++|++|++++|.+.+..+..+... ++|+.|++++|.+++. ++..+..+++|++|+|++|++
T Consensus 274 ~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 353 (461)
T 1z7x_W 274 GDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353 (461)
T ss_dssp HHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBC
T ss_pred HHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcc
Confidence 56777778888888888888875444444332 5888888888888754 456667778888888888888
Q ss_pred CCCcchhhhc-----ccccceeccCCccccc----cccccccCccccCeeeccCCccCCCCCcccc-----cccccCccc
Q 036011 506 SGDIPITIGS-----LKDLVTLSLASNQFEG----PIPQTFGSLTGLESLDLSNNNLSGEIPKSLE-----ALLFLKQLN 571 (977)
Q Consensus 506 ~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~ 571 (977)
++..+..+.. .++|+.|+|++|++++ .+|..+..+++|++|||++|++++.-...+. ....|+.|+
T Consensus 354 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~ 433 (461)
T 1z7x_W 354 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 433 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEE
T ss_pred ccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhhee
Confidence 7655555554 5688888888888886 6788888888888888888888753222221 123466666
Q ss_pred cCCCcccc
Q 036011 572 VSHNKLEG 579 (977)
Q Consensus 572 l~~N~l~~ 579 (977)
+.+|.+..
T Consensus 434 ~~~~~~~~ 441 (461)
T 1z7x_W 434 LYDIYWSE 441 (461)
T ss_dssp CTTCCCCH
T ss_pred ecccccCH
Confidence 66665543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-35 Score=345.61 Aligned_cols=398 Identities=21% Similarity=0.187 Sum_probs=198.9
Q ss_pred ccccEeeccCCcccccCCCC-cCCCCCCCEEeCcCccCCC----CCCccccccccCcEEeccCcCCCCCCCCcccCcCcc
Q 036011 74 SFLMSLDISKNNFHAYLPNE-LGQLRRLRFISLDYNEFSG----SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRL 148 (977)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 148 (977)
+.|++|||++|+++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l------ 76 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV------ 76 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHH------
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHH------
Confidence 34566666666655422222 4455555555555555552 234444445555555555555442211111
Q ss_pred cceeccccccccccCccccCcc----ccceeeeecccccc----cCCccccCCCCCceEEeeccCCCCCCchhhccccce
Q 036011 149 EKWDSMFNIIDGNIPSRIGNLS----SLVNVNLAYNNLQG----EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTI 220 (977)
Q Consensus 149 ~~L~l~~n~i~~~~p~~~~~l~----~L~~L~L~~n~i~~----~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L 220 (977)
+..++ +|++|+|++|+++. .++..+..+++|++|++++|++++..+..+..
T Consensus 77 -----------------~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~---- 135 (461)
T 1z7x_W 77 -----------------LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE---- 135 (461)
T ss_dssp -----------------HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH----
T ss_pred -----------------HHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH----
Confidence 11222 46666666666653 34556666666666666666655332222221
Q ss_pred eEEEccCCcccccccCCCccccCCCCceEEEecCceeeec----CCcccccccccceEeeccccccccccccccc-----
Q 036011 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGT----IPNSITNASKLTGLDLSFNSFSGLIPHTFGN----- 291 (977)
Q Consensus 221 ~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~----- 291 (977)
......++|++|+|++|++++. ++..+..+++|++|+|++|.++...+..+..
T Consensus 136 ------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 197 (461)
T 1z7x_W 136 ------------------GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDS 197 (461)
T ss_dssp ------------------HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHS
T ss_pred ------------------HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcC
Confidence 1111234566666666666542 2444556677777777777776554444432
Q ss_pred ccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccc
Q 036011 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGN 371 (977)
Q Consensus 292 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~ 371 (977)
.++|++|++++|.++..... .+...+..+++|++|++++|.+.+.....+ .+..+..
T Consensus 198 ~~~L~~L~L~~n~l~~~~~~---~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l--------------------~~~~~~~ 254 (461)
T 1z7x_W 198 PCQLEALKLESCGVTSDNCR---DLCGIVASKASLRELALGSNKLGDVGMAEL--------------------CPGLLHP 254 (461)
T ss_dssp CCCCCEEECTTSCCBTTHHH---HHHHHHHHCTTCCEEECCSSBCHHHHHHHH--------------------HHHHTST
T ss_pred CCCceEEEccCCCCcHHHHH---HHHHHHHhCCCccEEeccCCcCChHHHHHH--------------------HHHHhcC
Confidence 34666777777666543211 122234555666666666665442100000 0111123
Q ss_pred cccccEEEeecCccCCC----CChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhc-CCCC
Q 036011 372 LRSLIVLSLFINALNGT----IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA-SLIS 446 (977)
Q Consensus 372 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~ 446 (977)
+++|++|++++|.++.. ++..+..+++|++|+|++|.+++..+..+... +. ..++
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~--------------------l~~~~~~ 314 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET--------------------LLEPGCQ 314 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH--------------------HTSTTCC
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH--------------------hccCCcc
Confidence 45566666666655532 34445555555555555555543333222221 10 1134
Q ss_pred CCeeecCCCcCCCC----CCccccCcccCceEEccCCCCCCCCcccccc-----ccccCeeeCcCCcCCC----Ccchhh
Q 036011 447 LRELNLGSNKFSSS----IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQN-----LQVLINLDLSRNQLSG----DIPITI 513 (977)
Q Consensus 447 L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~ 513 (977)
|++|++++|.+++. ++..+..+++|+.|++++|.+++..+..+.. .++|++|+|++|++++ .+|..+
T Consensus 315 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l 394 (461)
T 1z7x_W 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred ceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHH
Confidence 55555555554433 2333444455555555555554333333322 4567777777777764 566667
Q ss_pred hcccccceeccCCcccccccccccc-----CccccCeeeccCCccCCCCCc
Q 036011 514 GSLKDLVTLSLASNQFEGPIPQTFG-----SLTGLESLDLSNNNLSGEIPK 559 (977)
Q Consensus 514 ~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~ 559 (977)
..+++|++|+|++|++++.....+. ...+|+.|++.+|.+....+.
T Consensus 395 ~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~ 445 (461)
T 1z7x_W 395 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 445 (461)
T ss_dssp HHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred HhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHH
Confidence 7777777777777777643222211 123566666666666543333
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=297.81 Aligned_cols=288 Identities=18% Similarity=0.153 Sum_probs=222.1
Q ss_pred CCCCCCCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCcc
Q 036011 30 NWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109 (977)
Q Consensus 30 ~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 109 (977)
.|....++|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 22 ~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 46566788999987 64 4566777 6777654 478888898888888666688888889999998888
Q ss_pred CCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccC-ccccCccccceeeeecc-cccccCC
Q 036011 110 FSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIP-SRIGNLSSLVNVNLAYN-NLQGEIP 187 (977)
Q Consensus 110 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~L~L~~n-~i~~~~p 187 (977)
+++..|..|+.+++|++|+|++|++++..+..+.++++|++|++++|.+++..+ ..++++++|++|++++| .++...+
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 887677788888888999998888886544558888888888888888884333 47888888999999888 4665566
Q ss_pred ccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccc-
Q 036011 188 SEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSIT- 266 (977)
Q Consensus 188 ~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~- 266 (977)
..|+++++|++|++++|++++..+..+..+++|+.|++++|+++ .++...+..+++|++|++++|++++..+..+.
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~---~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 244 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI---LLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST---THHHHHHHHTTTEEEEEEESCBCTTCCCC----
T ss_pred HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc---cchhhhhhhcccccEEECCCCcccccccccccc
Confidence 78888888899999988888887888888888888888888886 44555555678899999999988865444332
Q ss_pred --cccccceEeeccccccc----ccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCC
Q 036011 267 --NASKLTGLDLSFNSFSG----LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGIL 340 (977)
Q Consensus 267 --~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 340 (977)
....++.++|++|.+++ .+|..+..+++|+.|++++|+++.++... +..+++|++|++++|++.+..
T Consensus 245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~-------~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGI-------FDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTT-------TTTCTTCCEEECCSSCBCCCH
T ss_pred ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHH-------HhcCCCCCEEEeeCCCccCcC
Confidence 35567778888877765 35677888999999999999998776543 578899999999999888654
Q ss_pred C
Q 036011 341 P 341 (977)
Q Consensus 341 p 341 (977)
|
T Consensus 318 ~ 318 (353)
T 2z80_A 318 P 318 (353)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=336.89 Aligned_cols=456 Identities=15% Similarity=0.111 Sum_probs=228.7
Q ss_pred CCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcc---cccCCCCcC------------CCCC
Q 036011 35 QPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNF---HAYLPNELG------------QLRR 99 (977)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~ 99 (977)
.-|++|.++.+... ..+.+.++ +....+..+..+++|++|+|+++.. .+.+|..++ .+++
T Consensus 39 ~vck~W~~~~~~~~----~~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 113 (592)
T 3ogk_B 39 LVCRRWFKIDSETR----EHVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQ 113 (592)
T ss_dssp TSCHHHHHHHHHHC----CEEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHhHHHHHhhhccc----cEEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCC
Confidence 33558999864321 22333332 3323344566788899999987543 133454444 5667
Q ss_pred CCEEeCcCccCCCCCCcccccc--ccCcEEeccCcC-CCC-CCCCcccCcCcccceeccccccccc----cCccccCccc
Q 036011 100 LRFISLDYNEFSGSFPSWIGVL--SKLQILSLRNNS-FTG-PIPNSLFNLSRLEKWDSMFNIIDGN----IPSRIGNLSS 171 (977)
Q Consensus 100 L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~l~~n~i~~~----~p~~~~~l~~ 171 (977)
|++|+|++|.+++..+..++.. .+|++|+|++|. ++. .++....++++|++|+|++|.+.+. ++..+..+++
T Consensus 114 L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 114 LKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred CCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 7777777776665555555553 337777777665 110 0111112445555555555554433 2223334445
Q ss_pred cceeeeecccccc----cCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCc
Q 036011 172 LVNVNLAYNNLQG----EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNL 247 (977)
Q Consensus 172 L~~L~L~~n~i~~----~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L 247 (977)
|++|++++|.+++ .++..+.++++|+.|++++|.+.+ ++..+. .+++|
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~---------------------------~~~~L 245 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK---------------------------AAANL 245 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH---------------------------HCTTC
T ss_pred ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh---------------------------hhhHH
Confidence 5555555555441 222223344445555555444442 333344 44555
Q ss_pred eEEEecCceee---ecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCC
Q 036011 248 RVFSLGKNKLT---GTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324 (977)
Q Consensus 248 ~~L~L~~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 324 (977)
++|+++..... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.++... ....+..++
T Consensus 246 ~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~------~~~~~~~~~ 318 (592)
T 3ogk_B 246 EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETED------HCTLIQKCP 318 (592)
T ss_dssp CEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHH------HHHHHTTCT
T ss_pred HhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHH------HHHHHHhCc
Confidence 55555532221 123345666777788877775443 34566666777777777777643211 111245556
Q ss_pred CCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEee-----------cCccCCCC-Chh
Q 036011 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLF-----------INALNGTI-PST 392 (977)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~-p~~ 392 (977)
+|++|+++ +.+.. +.++..+..+++|++|+++ .|.+++.. +..
T Consensus 319 ~L~~L~L~-~~~~~------------------------~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l 373 (592)
T 3ogk_B 319 NLEVLETR-NVIGD------------------------RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373 (592)
T ss_dssp TCCEEEEE-GGGHH------------------------HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred CCCEEecc-CccCH------------------------HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence 66666665 22210 0111222344556666665 23443221 112
Q ss_pred hhccCCCCEEEeecccccCcccccccc-ccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCC-----CCcccc
Q 036011 393 VGRLEQLQGLSLYGNNLEGSIPYDLCH-LERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS-----IPSSFW 466 (977)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~ 466 (977)
+..+++|++|+++.|++++..+..+.. +++|+.|+++.+. ..|++++. ++..+.
T Consensus 374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~--------------------~~n~l~~~p~~~~~~~~~~ 433 (592)
T 3ogk_B 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD--------------------REERITDLPLDNGVRSLLI 433 (592)
T ss_dssp HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECS--------------------CCSCCSSCCCHHHHHHHHH
T ss_pred HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecC--------------------CCccccCchHHHHHHHHHH
Confidence 333555555555555555443333333 4444444443000 13444432 112234
Q ss_pred CcccCceEEccCC--CCCCCCccccc-cccccCeeeCcCCcCCC-CcchhhhcccccceeccCCcccccc-ccccccCcc
Q 036011 467 SLEYLLAVNLSSN--SLSGSLPSNIQ-NLQVLINLDLSRNQLSG-DIPITIGSLKDLVTLSLASNQFEGP-IPQTFGSLT 541 (977)
Q Consensus 467 ~l~~L~~L~L~~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~ 541 (977)
++++|+.|++++| .+++..+..+. .+++|++|+|++|++++ .++..+..+++|+.|+|++|.+++. ++..+..++
T Consensus 434 ~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~ 513 (592)
T 3ogk_B 434 GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLP 513 (592)
T ss_dssp HCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCS
T ss_pred hCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcC
Confidence 4555555555432 23332222232 25667777777777664 2344456677777777777776644 333345677
Q ss_pred ccCeeeccCCccCCCCCccc-ccccccCccccCCC
Q 036011 542 GLESLDLSNNNLSGEIPKSL-EALLFLKQLNVSHN 575 (977)
Q Consensus 542 ~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N 575 (977)
+|+.|+|++|++++.-...+ ..++.+....+..+
T Consensus 514 ~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 514 SLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp SCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred ccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 77777777777765433333 34565555555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=283.62 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=169.0
Q ss_pred CCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCC--C
Q 036011 35 QPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS--G 112 (977)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~--~ 112 (977)
.+.|.|.+|.|.. ++++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++ +
T Consensus 4 ~C~C~~~~l~c~~------------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 4 RCSCSGTEIRCNS------------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp TCEEETTEEECCS------------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CCeeCCCEEEcCC------------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence 3447888777753 3454 5666543 67888888888888755556788888888888888887 2
Q ss_pred CCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccC-ccccCccccceeeeecccccccCCcccc
Q 036011 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIP-SRIGNLSSLVNVNLAYNNLQGEIPSEIG 191 (977)
Q Consensus 113 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~L~L~~n~i~~~~p~~l~ 191 (977)
..|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|++++..+..+.
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 147 (306)
T 2z66_A 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147 (306)
T ss_dssp EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTT
T ss_pred CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcc
Confidence 33666777888888888888887 456667777777777777777775544 5677777777777777777766666777
Q ss_pred CCCCCceEEeeccCCCC-CCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccc
Q 036011 192 NLQNLEILVLGMNNLSG-PIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASK 270 (977)
Q Consensus 192 ~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 270 (977)
++++|++|++++|++++ ..|..+..+++|+.|+|++|+++ .+++..+..+++|++|+|++|++++..+..+..+++
T Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 224 (306)
T 2z66_A 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE---QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224 (306)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC---EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTT
T ss_pred cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcC---CcCHHHhcCCCCCCEEECCCCccCccChhhccCccc
Confidence 77777777777777765 34555555556666666666555 233444455555666666666655444445555556
Q ss_pred cceEeeccccccccccccccccc-ccccccccccccCCC
Q 036011 271 LTGLDLSFNSFSGLIPHTFGNLR-FLSVLNLANNYLTTD 308 (977)
Q Consensus 271 L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ 308 (977)
|++|+|++|++++..|..+..++ +|+.|+|++|.++..
T Consensus 225 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 225 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 66666666666555555555553 555555555555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=279.45 Aligned_cols=211 Identities=24% Similarity=0.255 Sum_probs=120.7
Q ss_pred ccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccc-cccccccccceeeecCCccCCCchhhhcCCCCCCe
Q 036011 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP-YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE 449 (977)
Q Consensus 371 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 449 (977)
.+++|++|++++|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++.+..+..+..+++|++
T Consensus 76 ~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 154 (306)
T 2z66_A 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 154 (306)
T ss_dssp SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE
Confidence 3444455555555444 344445555556666666665554333 34555556666666666655555555666666666
Q ss_pred eecCCCcCCC-CCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 450 LNLGSNKFSS-SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 450 L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
|++++|++.+ ..|..|..+++|+.|++++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+
T Consensus 155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 234 (306)
T 2z66_A 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234 (306)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence 6666666654 355566666666666666666665555666666666666666666665555556666666666666666
Q ss_pred ccccccccccCcc-ccCeeeccCCccCCCCC--cccccccccCccccCCCcccccCC
Q 036011 529 FEGPIPQTFGSLT-GLESLDLSNNNLSGEIP--KSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 529 l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
+++..|..+..++ +|+.|+|++|++++..+ .....+...+.+.+..+.+.+..|
T Consensus 235 l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp CCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred CcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 6666666666663 66666666666664321 112333444455555555555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=294.55 Aligned_cols=290 Identities=26% Similarity=0.320 Sum_probs=194.1
Q ss_pred CCCCCCCCCCcccceEe------cCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCE
Q 036011 29 NNWSISQPICKWVGISC------GARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRF 102 (977)
Q Consensus 29 ~~w~~~~~~c~w~gv~c------~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 102 (977)
+.|..+.+||.|.|..| .+....++.|++++++++ .+|..+. ++|++|+|++|+|+. +|. .+++|++
T Consensus 13 ~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~ 85 (622)
T 3g06_A 13 SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRT 85 (622)
T ss_dssp HHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCE
T ss_pred HHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCE
Confidence 46877788999977432 222335788999999998 8888776 789999999999886 565 5788889
Q ss_pred EeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccc
Q 036011 103 ISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNL 182 (977)
Q Consensus 103 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i 182 (977)
|+|++|+++ .+|. .+++|++|+|++|.+++ +|. .+++|++|++++|.|++ +|.. +++|++|+|++|++
T Consensus 86 L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l 153 (622)
T 3g06_A 86 LEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQL 153 (622)
T ss_dssp EEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred EEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcC
Confidence 999998888 6776 67888888888888884 444 45566666666666663 4442 35566666666666
Q ss_pred cccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCC
Q 036011 183 QGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIP 262 (977)
Q Consensus 183 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 262 (977)
++ +|. .+++|+.|++++|++++ +| ..+++|+.|+|++|++++ +|
T Consensus 154 ~~-l~~---~~~~L~~L~L~~N~l~~---------------------------l~----~~~~~L~~L~Ls~N~l~~-l~ 197 (622)
T 3g06_A 154 AS-LPA---LPSELCKLWAYNNQLTS---------------------------LP----MLPSGLQELSVSDNQLAS-LP 197 (622)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCSC---------------------------CC----CCCTTCCEEECCSSCCSC-CC
T ss_pred CC-cCC---ccCCCCEEECCCCCCCC---------------------------Cc----ccCCCCcEEECCCCCCCC-CC
Confidence 63 332 23455556666665553 22 123556666666666653 33
Q ss_pred cccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCc
Q 036011 263 NSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPP 342 (977)
Q Consensus 263 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 342 (977)
.. +++|+.|++++|.++.+ |. .+++|+.|+|++|.|+.++ ..+++|+.|++++|.+++
T Consensus 198 ~~---~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~lp-----------~~l~~L~~L~Ls~N~L~~---- 255 (622)
T 3g06_A 198 TL---PSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTSLP-----------VLPSELKELMVSGNRLTS---- 255 (622)
T ss_dssp CC---CTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSCCC-----------CCCTTCCEEECCSSCCSC----
T ss_pred Cc---cchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCcCC-----------CCCCcCcEEECCCCCCCc----
Confidence 32 24566666666666643 32 2356666666666666543 123566666666666552
Q ss_pred ccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCcccccccccc
Q 036011 343 VIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLE 421 (977)
Q Consensus 343 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 421 (977)
+|. .+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|.+++..|..+..++
T Consensus 256 ----------------------lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 256 ----------------------LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ----------------------CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ----------------------CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 222 3467888888888888 6788888999999999999999888887776655
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=282.73 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=164.2
Q ss_pred EEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCc
Q 036011 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132 (977)
Q Consensus 53 ~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 132 (977)
..++.++.+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34667777887 6887664 68899999999999888888999999999999999998777788899999999999999
Q ss_pred CCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeec-ccccccCCccccCCCCCceEEeeccCCCCCCc
Q 036011 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY-NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQ 211 (977)
Q Consensus 133 ~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~-n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 211 (977)
++++..+..|.++++|++|+|++|.|+...+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|++++. |
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c
Confidence 99876667788888888888888888866666788888888888887 444433334577788888888888877743 2
Q ss_pred hhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccccc
Q 036011 212 PSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGN 291 (977)
Q Consensus 212 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 291 (977)
.+..+++|+.|+|++|+++ .+++..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|+++.+..|..
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFP---EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCS---EECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred -cccccccccEEECcCCcCc---ccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 3444444555555555444 223334444444444444444444444444444444444444444444444444444
Q ss_pred ccccccccccccccC
Q 036011 292 LRFLSVLNLANNYLT 306 (977)
Q Consensus 292 l~~L~~L~L~~N~l~ 306 (977)
+++|+.|+|++|.+.
T Consensus 289 l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 289 LRYLVELHLHHNPWN 303 (452)
T ss_dssp CTTCCEEECCSSCEE
T ss_pred ccCCCEEEccCCCcC
Confidence 444444444444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-31 Score=317.30 Aligned_cols=307 Identities=13% Similarity=0.055 Sum_probs=220.1
Q ss_pred CCCCceEEEecCceee----ecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhc
Q 036011 243 SLPNLRVFSLGKNKLT----GTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLS 318 (977)
Q Consensus 243 ~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 318 (977)
.+++|++|++++|+++ +.++..+.++++|++|+|++|.+.+ +|..+..+++|+.|+++++....... ....
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~----~~~~ 264 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMP----EKYM 264 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCT----TSSS
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchH----HHHH
Confidence 4566677777777665 2334445667788888888888776 45677778888888887533221111 1123
Q ss_pred ccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCC-hhhhccC
Q 036011 319 SLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIP-STVGRLE 397 (977)
Q Consensus 319 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~ 397 (977)
.+..+++|+.|+++++... .+|..+..+++|++|++++|.+++... ..+..++
T Consensus 265 ~l~~~~~L~~L~l~~~~~~--------------------------~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~ 318 (592)
T 3ogk_B 265 NLVFPRKLCRLGLSYMGPN--------------------------EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP 318 (592)
T ss_dssp CCCCCTTCCEEEETTCCTT--------------------------TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCT
T ss_pred HhhccccccccCccccchh--------------------------HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCc
Confidence 4667778888887764322 344556677888888888888764433 3467888
Q ss_pred CCCEEEeecccccCccccccccccccceeeec-----------CCccCCC-chhhhcCCCCCCeeecCCCcCCCCCCccc
Q 036011 398 QLQGLSLYGNNLEGSIPYDLCHLERLNGIRLN-----------GNKLSGP-IPQCLASLISLRELNLGSNKFSSSIPSSF 465 (977)
Q Consensus 398 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 465 (977)
+|++|+++++-..+.++..+..+++|+.|+++ .|.+++. ++.....+++|++|+++.|++++..+..+
T Consensus 319 ~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l 398 (592)
T 3ogk_B 319 NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI 398 (592)
T ss_dssp TCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHH
T ss_pred CCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHH
Confidence 99999998333333344445678889999998 3666643 23335568899999999999987766666
Q ss_pred cC-cccCceEEcc----CCCCCCC-----CccccccccccCeeeCcCC--cCCCCcchhhhc-ccccceeccCCccccc-
Q 036011 466 WS-LEYLLAVNLS----SNSLSGS-----LPSNIQNLQVLINLDLSRN--QLSGDIPITIGS-LKDLVTLSLASNQFEG- 531 (977)
Q Consensus 466 ~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~- 531 (977)
.. +++|+.|+++ .|.+++. ++..+.++++|++|+|++| .+++..+..++. +++|+.|+|++|++++
T Consensus 399 ~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 478 (592)
T 3ogk_B 399 GTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE 478 (592)
T ss_dssp HHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHH
T ss_pred HhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHH
Confidence 65 8899999996 7788864 3444778999999999854 477666666655 8999999999999986
Q ss_pred cccccccCccccCeeeccCCccCCC-CCcccccccccCccccCCCccccc
Q 036011 532 PIPQTFGSLTGLESLDLSNNNLSGE-IPKSLEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 532 ~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~ 580 (977)
.++..+..+++|+.|+|++|++++. ++..+..+++|++|++++|+++..
T Consensus 479 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 479 GLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 3556668899999999999998754 444557899999999999998764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=286.29 Aligned_cols=250 Identities=20% Similarity=0.196 Sum_probs=122.5
Q ss_pred CcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCC-CCCCcccc-------ccccCcEEeccCcCCCCCCCCcc-
Q 036011 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS-GSFPSWIG-------VLSKLQILSLRNNSFTGPIPNSL- 142 (977)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L~~L~L~~n~l~~~~p~~l- 142 (977)
..++|++|++++|.+ .+|..+... |++|+|++|+++ +.+|..+. .+++|++|+|++|++++.+|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 334444444444444 234433332 444445544442 23444333 34455555555555554444443
Q ss_pred -cCcCcccceeccccccccccCccccCc-----cccceeeeecccccccCCccccCCCCCceEEeeccCCCCC--Cchhh
Q 036011 143 -FNLSRLEKWDSMFNIIDGNIPSRIGNL-----SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP--IQPSI 214 (977)
Q Consensus 143 -~~l~~L~~L~l~~n~i~~~~p~~~~~l-----~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~--~~~~l 214 (977)
..+++|++|++++|.+++. |..++.+ ++|++|+|++|++++..|..|+++++|++|++++|++.+. .+..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 4445555555555555443 4444444 4555555555555544445555555555555555554432 12222
Q ss_pred --ccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCC-cccccccccceEeeccccccccccccccc
Q 036011 215 --FNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIP-NSITNASKLTGLDLSFNSFSGLIPHTFGN 291 (977)
Q Consensus 215 --~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 291 (977)
..+++|+.|+|++|++++...++...+..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+.
T Consensus 196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~- 273 (312)
T 1wwl_A 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP- 273 (312)
T ss_dssp CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence 445555555555555543222233333445555666666665554443 33444555666666666665 3344443
Q ss_pred ccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCC
Q 036011 292 LRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338 (977)
Q Consensus 292 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 338 (977)
++|++|+|++|+|++++. +..+++|++|++++|++++
T Consensus 274 -~~L~~L~Ls~N~l~~~p~---------~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRNPS---------PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -SEEEEEECCSSCCCSCCC---------TTTSCEEEEEECTTCTTTC
T ss_pred -CCceEEECCCCCCCCChh---------HhhCCCCCEEeccCCCCCC
Confidence 556666666666655421 4455666666666666553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=275.34 Aligned_cols=208 Identities=19% Similarity=0.156 Sum_probs=122.4
Q ss_pred CCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccce
Q 036011 95 GQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVN 174 (977)
Q Consensus 95 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~ 174 (977)
..+......++++|.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|++++|.+++..|..|+++++|++
T Consensus 28 ~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp CEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 34455555677777776 6666544 36667777776666544445555555555555555555555555555555555
Q ss_pred eeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCC-ccccCCCCceEEEec
Q 036011 175 VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPP-KVSYSLPNLRVFSLG 253 (977)
Q Consensus 175 L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~~~~l~~L~~L~L~ 253 (977)
|+|++|++++..+..|+++++|++|++++|+++ .++. ..+..+++|++|+++
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---------------------------~l~~~~~~~~l~~L~~L~l~ 157 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK---------------------------TLGETSLFSHLTKLQILRVG 157 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS---------------------------SSCSSCSCTTCTTCCEEEEE
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCc---------------------------ccCchhhhccCCCCcEEECC
Confidence 555555555322233555555555555555554 2333 344556666666666
Q ss_pred Cc-eeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEec
Q 036011 254 KN-KLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVA 332 (977)
Q Consensus 254 ~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~ 332 (977)
+| .++...+..+..+++|++|++++|++++..|..|..+++|++|++++|.++.++.. .+..+++|+.|+++
T Consensus 158 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~-------~~~~~~~L~~L~L~ 230 (353)
T 2z80_A 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI-------FVDVTSSVECLELR 230 (353)
T ss_dssp ESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHH-------HHHHTTTEEEEEEE
T ss_pred CCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhh-------hhhhcccccEEECC
Confidence 66 35555556666777777777777777766666777777777777777766543321 13345666666666
Q ss_pred CCCCCCC
Q 036011 333 SNPLRGI 339 (977)
Q Consensus 333 ~N~l~~~ 339 (977)
+|.+.+.
T Consensus 231 ~n~l~~~ 237 (353)
T 2z80_A 231 DTDLDTF 237 (353)
T ss_dssp SCBCTTC
T ss_pred CCccccc
Confidence 6666543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=269.13 Aligned_cols=226 Identities=25% Similarity=0.309 Sum_probs=189.3
Q ss_pred CCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEE
Q 036011 323 CRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGL 402 (977)
Q Consensus 323 l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 402 (977)
.++++.|++++|.+. .+|..+..+++|++|+|++|.++ .+|..++.+++|++|
T Consensus 80 ~~~l~~L~L~~n~l~--------------------------~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L 132 (328)
T 4fcg_A 80 QPGRVALELRSVPLP--------------------------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETL 132 (328)
T ss_dssp STTCCEEEEESSCCS--------------------------SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEE
T ss_pred ccceeEEEccCCCch--------------------------hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEE
Confidence 356677777777665 34556667778888888888887 777778888888888
Q ss_pred EeecccccCccccccccccccceeeecCCccCCCchhhhcC---------CCCCCeeecCCCcCCCCCCccccCcccCce
Q 036011 403 SLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS---------LISLRELNLGSNKFSSSIPSSFWSLEYLLA 473 (977)
Q Consensus 403 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 473 (977)
+|++|.++ .+|..+..+++|++|++++|++.+.+|..+.. +++|++|+|++|+++ .+|..+..+++|+.
T Consensus 133 ~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~ 210 (328)
T 4fcg_A 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210 (328)
T ss_dssp EEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE
T ss_pred ECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE
Confidence 88888887 66777888888888888887777777776654 889999999999998 78888999999999
Q ss_pred EEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCcc
Q 036011 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553 (977)
Q Consensus 474 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 553 (977)
|+|++|++++ +|..+..+++|++|+|++|++.+.+|..++.+++|+.|+|++|.+.+.+|..++++++|+.|+|++|++
T Consensus 211 L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp EEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred EEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 9999999985 666789999999999999999889999999999999999999999989999999999999999999999
Q ss_pred CCCCCcccccccccCccccCCCccc
Q 036011 554 SGEIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 554 ~~~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
.+.+|..+.++++|+.+++..|.+.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999877654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=266.75 Aligned_cols=236 Identities=22% Similarity=0.232 Sum_probs=180.7
Q ss_pred ceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCcccccc
Q 036011 42 GISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVL 121 (977)
Q Consensus 42 gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 121 (977)
+.+|.... .+.+++++++++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..++.+
T Consensus 5 ~C~C~~~~--~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 79 (285)
T 1ozn_A 5 ACVCYNEP--KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79 (285)
T ss_dssp TCEEECSS--SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CceECCCC--CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCc
Confidence 34564332 367888999998 677654 5789999999999999777889999999999999999997778899999
Q ss_pred ccCcEEeccCcC-CCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEE
Q 036011 122 SKLQILSLRNNS-FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILV 200 (977)
Q Consensus 122 ~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~ 200 (977)
++|++|+|++|. +++..|..+.++++|++|++++|.+.+..|..|+++++|++|++++|++++..+..|+++++|++|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 999999999997 7766677788888888888877777776677777777777777777777755555577777777777
Q ss_pred eeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccc
Q 036011 201 LGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNS 280 (977)
Q Consensus 201 l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 280 (977)
+++|++++ +++..+..+++|++|++++|++++..|..+..+++|++|+|++|+
T Consensus 160 l~~n~l~~---------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 160 LHGNRISS---------------------------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp CCSSCCCE---------------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCcccc---------------------------cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence 77776663 334444556677777777777776667777777888888888888
Q ss_pred cccccccccccccccccccccccccCCCC
Q 036011 281 FSGLIPHTFGNLRFLSVLNLANNYLTTDS 309 (977)
Q Consensus 281 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 309 (977)
+++..+..|..+++|+.|++++|++....
T Consensus 213 l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 213 LSALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCcCCHHHcccCcccCEEeccCCCccCCC
Confidence 87776666777788888888888776544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=263.19 Aligned_cols=254 Identities=25% Similarity=0.219 Sum_probs=123.0
Q ss_pred eEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCc
Q 036011 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLT 327 (977)
Q Consensus 248 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~ 327 (977)
++++.+++.++ .+|..+ .++|++|+|++|+++++.+..|..+++|++|++++|.++.+.+.
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~---------------- 74 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA---------------- 74 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT----------------
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHh----------------
Confidence 44555555555 344433 24566666666666655555555555555555555555443222
Q ss_pred eEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCc-cCCCCChhhhccCCCCEEEeec
Q 036011 328 TLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINA-LNGTIPSTVGRLEQLQGLSLYG 406 (977)
Q Consensus 328 ~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~ 406 (977)
.|..+++|++|++++|. +....|..|..+++|++|++++
T Consensus 75 ----------------------------------------~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~ 114 (285)
T 1ozn_A 75 ----------------------------------------AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114 (285)
T ss_dssp ----------------------------------------TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred ----------------------------------------hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCC
Confidence 22233333333333333 3333344444444555555555
Q ss_pred ccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCc
Q 036011 407 NNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486 (977)
Q Consensus 407 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 486 (977)
|.+++..|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++..|
T Consensus 115 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 194 (285)
T 1ozn_A 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (285)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCH
Confidence 55544444444444555555555555544444445555555555555555554444445555555555555555554445
Q ss_pred cccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCccc
Q 036011 487 SNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSL 561 (977)
Q Consensus 487 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 561 (977)
..|..+++|+.|++++|++++..+..+..+++|+.|+|++|++....+. ..-+..++.+..+.|.+.+..|..+
T Consensus 195 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred hHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHh
Confidence 5555555555555555555544444455555555555555555432211 1112234444455555555555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=276.96 Aligned_cols=224 Identities=20% Similarity=0.200 Sum_probs=182.6
Q ss_pred ccccccccCcc-cccCCcccc-------ccccccEEEeecCccCCCCChhh--hccCCCCEEEeecccccCccccccccc
Q 036011 351 LQNFYAYDCKL-TGNIPHEIG-------NLRSLIVLSLFINALNGTIPSTV--GRLEQLQGLSLYGNNLEGSIPYDLCHL 420 (977)
Q Consensus 351 L~~L~l~~n~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l 420 (977)
++.|++.+|++ ...+|..+. .+++|++|+|++|.+++.+|..+ +.+++|++|+|++|++++. |..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 44455555555 234555554 68899999999999998888876 8899999999999999876 7777777
Q ss_pred -----cccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCC--CCccc--cCcccCceEEccCCCCCCC---Cccc
Q 036011 421 -----ERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS--IPSSF--WSLEYLLAVNLSSNSLSGS---LPSN 488 (977)
Q Consensus 421 -----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~~---~p~~ 488 (977)
++|++|++++|++++..|..|..+++|++|+|++|++.+. .|..+ ..+++|+.|+|++|+|++. ....
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 223 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence 8999999999999988888999999999999999998764 23334 7889999999999999832 1234
Q ss_pred cccccccCeeeCcCCcCCCCcc-hhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCccccccccc
Q 036011 489 IQNLQVLINLDLSRNQLSGDIP-ITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFL 567 (977)
Q Consensus 489 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 567 (977)
+..+++|++|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|
T Consensus 224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L 298 (312)
T 1wwl_A 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQV 298 (312)
T ss_dssp HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEE
T ss_pred HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCC
Confidence 5677899999999999997765 45667899999999999999 6788776 8999999999999965 66 8999999
Q ss_pred CccccCCCccccc
Q 036011 568 KQLNVSHNKLEGE 580 (977)
Q Consensus 568 ~~L~l~~N~l~~~ 580 (977)
++|++++|++++.
T Consensus 299 ~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 299 GNLSLKGNPFLDS 311 (312)
T ss_dssp EEEECTTCTTTCC
T ss_pred CEEeccCCCCCCC
Confidence 9999999999863
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=274.84 Aligned_cols=253 Identities=22% Similarity=0.246 Sum_probs=178.2
Q ss_pred eEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccc
Q 036011 43 ISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLS 122 (977)
Q Consensus 43 v~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 122 (977)
..|... ...++.++.+++ .+|..+. +.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..++
T Consensus 39 C~C~~~---~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~ 112 (440)
T 3zyj_A 39 CSCSNQ---FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA 112 (440)
T ss_dssp SEECTT---SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCS
T ss_pred CEeCCC---CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCc
Confidence 456432 345778888888 7888765 7899999999999998889999999999999999999977778999999
Q ss_pred cCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecc-cccccCCccccCCCCCceEEe
Q 036011 123 KLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN-NLQGEIPSEIGNLQNLEILVL 201 (977)
Q Consensus 123 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n-~i~~~~p~~l~~l~~L~~L~l 201 (977)
+|++|+|++|++++..+..|.++++|++|++++|.|....+..|.++++|++|+|++| .+....+..|.++++|++|+|
T Consensus 113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L 192 (440)
T 3zyj_A 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192 (440)
T ss_dssp SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEEC
T ss_pred cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecC
Confidence 9999999999999777778889999999999999988777778888888999998884 444333446888888888888
Q ss_pred eccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccc
Q 036011 202 GMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281 (977)
Q Consensus 202 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 281 (977)
++|+++.. | .+..+++|+.|+|++|+++ .+++..+..+++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 193 ~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 267 (440)
T 3zyj_A 193 AMCNLREI-P-NLTPLIKLDELDLSGNHLS---AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267 (440)
T ss_dssp TTSCCSSC-C-CCTTCSSCCEEECTTSCCC---EECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCC
T ss_pred CCCcCccc-c-ccCCCcccCEEECCCCccC---ccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCC
Confidence 88888732 2 3444555555555555544 23334444445555555555555444444444444555555555555
Q ss_pred ccccccccccccccccccccccccC
Q 036011 282 SGLIPHTFGNLRFLSVLNLANNYLT 306 (977)
Q Consensus 282 ~~~~p~~~~~l~~L~~L~L~~N~l~ 306 (977)
+.+.+..|..+++|+.|+|++|.+.
T Consensus 268 ~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 268 TLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CccChhHhccccCCCEEEcCCCCcc
Confidence 4444444444444444444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=278.12 Aligned_cols=232 Identities=23% Similarity=0.245 Sum_probs=204.1
Q ss_pred ccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeee
Q 036011 349 ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRL 428 (977)
Q Consensus 349 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 428 (977)
..++.|++.+|++++..|..|..+++|++|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 34556666666666667778889999999999999999888899999999999999999999777777999999999999
Q ss_pred cCCccCCCchhhhcCCCCCCeeecCC-CcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCC
Q 036011 429 NGNKLSGPIPQCLASLISLRELNLGS-NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG 507 (977)
Q Consensus 429 ~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 507 (977)
++|+++...+..|..+++|++|++++ |.+....+..|.++++|+.|+|++|++++. | .+..+++|++|+|++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 99999977777899999999999998 556655556799999999999999999854 4 58889999999999999998
Q ss_pred CcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCC
Q 036011 508 DIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 508 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 889999999999999999999998889999999999999999999997777788999999999999999987654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=276.80 Aligned_cols=231 Identities=24% Similarity=0.278 Sum_probs=203.4
Q ss_pred cccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeec
Q 036011 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLN 429 (977)
Q Consensus 350 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 429 (977)
.++.|++.+|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence 45555566666666667788899999999999999998888999999999999999999997777789999999999999
Q ss_pred CCccCCCchhhhcCCCCCCeeecCC-CcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCC
Q 036011 430 GNKLSGPIPQCLASLISLRELNLGS-NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGD 508 (977)
Q Consensus 430 ~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 508 (977)
+|+++...+..|..+++|++|+|++ |.+....+..|.++++|+.|+|++|+++. +| .+..+++|++|+|++|++++.
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEE
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCcc
Confidence 9999977777899999999999999 45555555689999999999999999984 45 488899999999999999988
Q ss_pred cchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCC
Q 036011 509 IPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 509 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
.|..|..+++|+.|+|++|++++..|..|.++++|+.|||++|+|++..+..|..+++|+.|+|++|+|.+...
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 88999999999999999999999889999999999999999999998777888999999999999999987653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-29 Score=274.02 Aligned_cols=180 Identities=20% Similarity=0.157 Sum_probs=113.4
Q ss_pred CCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCcccc-CcccCceEE
Q 036011 397 EQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFW-SLEYLLAVN 475 (977)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ 475 (977)
++|++|++++|++++..+.. +++|+.|++++|++++..+..+..+++|++|+|++|++++..+..+. .+++|+.|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 34444444444444332222 34455555555555544444555555555555555555544444442 455566666
Q ss_pred ccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccC-
Q 036011 476 LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS- 554 (977)
Q Consensus 476 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~- 554 (977)
|++|.|++. + ....+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++
T Consensus 176 L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 666665533 2 2223677788888888887 45555778888888888888888 46777888888888888888887
Q ss_pred CCCCcccccccccCccccC-CCcccccCCC
Q 036011 555 GEIPKSLEALLFLKQLNVS-HNKLEGEIPA 583 (977)
Q Consensus 555 ~~~p~~~~~l~~L~~L~l~-~N~l~~~~p~ 583 (977)
+.+|..+..++.|+.++++ .+.++|..|.
T Consensus 252 ~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cCHHHHHhccccceEEECCCchhccCCchh
Confidence 6677778888888888888 4467776664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=271.76 Aligned_cols=268 Identities=21% Similarity=0.188 Sum_probs=201.2
Q ss_pred CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCC
Q 036011 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325 (977)
Q Consensus 246 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 325 (977)
+++.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++.++ +..+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---------~~~l~~ 81 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---------LESLST 81 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---------ETTCTT
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---------hhhcCC
Confidence 46666777777765544555566678888888888887777777888888888888887765331 566777
Q ss_pred CceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEee
Q 036011 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 405 (977)
|++|++++|.+++ +...++|++|++++|.+++..+.. +++|++|+++
T Consensus 82 L~~L~Ls~n~l~~------------------------------l~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~ 128 (317)
T 3o53_A 82 LRTLDLNNNYVQE------------------------------LLVGPSIETLHAANNNISRVSCSR---GQGKKNIYLA 128 (317)
T ss_dssp CCEEECCSSEEEE------------------------------EEECTTCCEEECCSSCCSEEEECC---CSSCEEEECC
T ss_pred CCEEECcCCcccc------------------------------ccCCCCcCEEECCCCccCCcCccc---cCCCCEEECC
Confidence 7777777776542 123368888888888888655443 5778888888
Q ss_pred cccccCccccccccccccceeeecCCccCCCchhhhc-CCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCC
Q 036011 406 GNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA-SLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484 (977)
Q Consensus 406 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 484 (977)
+|++++..+..+..+++|+.|++++|++++..+..+. .+++|++|+|++|++++. + ....+++|+.|+|++|+|++
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~- 205 (317)
T 3o53_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF- 205 (317)
T ss_dssp SSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-
T ss_pred CCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-
Confidence 8888877777888888888888888888877676664 678888888888888855 2 23347888888888888885
Q ss_pred CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc-ccccccccCccccCeeeccC-CccCCCCCc
Q 036011 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE-GPIPQTFGSLTGLESLDLSN-NNLSGEIPK 559 (977)
Q Consensus 485 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~ 559 (977)
+|..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++ +.++|..|.
T Consensus 206 l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 4555888888888888888888 57778888888888888888888 67788888888888888884 456655443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=273.69 Aligned_cols=269 Identities=26% Similarity=0.327 Sum_probs=142.8
Q ss_pred cceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccccccccccc
Q 036011 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSV 297 (977)
Q Consensus 218 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 297 (977)
.+++.|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+.+ |. .+++|++
T Consensus 40 ~~l~~L~ls~n~L~---~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~ 105 (622)
T 3g06_A 40 NGNAVLNVGESGLT---TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PV---LPPGLLE 105 (622)
T ss_dssp HCCCEEECCSSCCS---CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCC-CC---CCTTCCE
T ss_pred CCCcEEEecCCCcC---ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcC-CC---CCCCCCE
Confidence 34666666666666 4444333 56666666666666 3444 345566666666666543 32 4455666
Q ss_pred ccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccE
Q 036011 298 LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIV 377 (977)
Q Consensus 298 L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 377 (977)
|++++|.++.++. .+++|+.|++++|.+++ +|.. +++|++
T Consensus 106 L~Ls~N~l~~l~~-----------~l~~L~~L~L~~N~l~~--------------------------lp~~---l~~L~~ 145 (622)
T 3g06_A 106 LSIFSNPLTHLPA-----------LPSGLCKLWIFGNQLTS--------------------------LPVL---PPGLQE 145 (622)
T ss_dssp EEECSCCCCCCCC-----------CCTTCCEEECCSSCCSC--------------------------CCCC---CTTCCE
T ss_pred EECcCCcCCCCCC-----------CCCCcCEEECCCCCCCc--------------------------CCCC---CCCCCE
Confidence 6666665555432 23445555555554442 2221 255666
Q ss_pred EEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcC
Q 036011 378 LSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKF 457 (977)
Q Consensus 378 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 457 (977)
|++++|.+++ +|. .+++|+.|++++|.|++ +| ..+++|+.|++++|++++ +|. .+++|+.|++++|++
T Consensus 146 L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l 213 (622)
T 3g06_A 146 LSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRL 213 (622)
T ss_dssp EECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCcc
Confidence 6666666663 332 23456666666666663 33 334556666666666653 332 134566666666666
Q ss_pred CCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccc
Q 036011 458 SSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTF 537 (977)
Q Consensus 458 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 537 (977)
+. +|.. +++|+.|++++|+|++ +| ..+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|
T Consensus 214 ~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l 280 (622)
T 3g06_A 214 TS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESL 280 (622)
T ss_dssp SS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGG
T ss_pred cc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHH
Confidence 52 3322 2455556666665553 33 23345555555555555 3443 3455555555555555 445555
Q ss_pred cCccccCeeeccCCccCCCCCccccccc
Q 036011 538 GSLTGLESLDLSNNNLSGEIPKSLEALL 565 (977)
Q Consensus 538 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 565 (977)
.++++|+.|+|++|++++.+|..+..++
T Consensus 281 ~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 281 IHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp GGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred hhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 5555555555555555555555444443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=248.94 Aligned_cols=217 Identities=21% Similarity=0.282 Sum_probs=165.0
Q ss_pred CCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCC
Q 036011 35 QPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114 (977)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 114 (977)
.++|.|.|+.|.... .++.+++++++++ .+|..+. +.|++|+|++|++++..+..|.++++|++|+|++|++++..
T Consensus 2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 579999999997643 4678999999999 6888764 68999999999999977778999999999999999999544
Q ss_pred CccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCC
Q 036011 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQ 194 (977)
Q Consensus 115 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~ 194 (977)
+..++.+++|++|+|++|++++..+..|.++++|++|++++|.+++..+..|+.+++|++|+|++|++++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 55678899999999999999977667778888888888888888877777778888888888888888865555677888
Q ss_pred CCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceE
Q 036011 195 NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGL 274 (977)
Q Consensus 195 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 274 (977)
+|+.|++++|++++..+..|..++ +|++|+|++|++++..+..+..+++|++|
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~---------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 210 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLT---------------------------ELKTLKLDNNQLKRVPEGAFDSLEKLKML 210 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCT---------------------------TCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ccceeEecCCcCcEeChhHhccCC---------------------------CcCEEECCCCcCCcCCHHHhccccCCCEE
Confidence 888888888877755444444444 45555555555553333445555556666
Q ss_pred eecccccc
Q 036011 275 DLSFNSFS 282 (977)
Q Consensus 275 ~Ls~N~l~ 282 (977)
+|++|.+.
T Consensus 211 ~l~~N~~~ 218 (270)
T 2o6q_A 211 QLQENPWD 218 (270)
T ss_dssp ECCSSCBC
T ss_pred EecCCCee
Confidence 66666554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-28 Score=283.70 Aligned_cols=184 Identities=18% Similarity=0.105 Sum_probs=131.5
Q ss_pred ccCcceEEEEEEE-eCCCCEEEEEEeeccc----------hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEEE
Q 036011 691 LGRGSFGSVYKGT-FSDGTSFAIKVFNLQL----------DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 691 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 758 (977)
.+.|++|.+..++ ..-|+.||||++.+.. +...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666654 2358999999997542 23456799999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||++|++|.+++...+. ++.. +|+.||+.||+|+| ++|||||||||+|||++++|.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999987654 5543 58999999999999 89999999999999999999999999999987654322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCC
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 884 (977)
.....+||++|||||++.+. +..++|+||+|++++++.++..|
T Consensus 395 --~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 --WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred --cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 23345799999999998764 67789999999998888766443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-30 Score=310.44 Aligned_cols=463 Identities=15% Similarity=0.132 Sum_probs=219.6
Q ss_pred CCCcccceEecCCCCcEEEEEcCCCCCCccCC-ccccCcccccEeeccCCcccc---cCCCC------------cCCCCC
Q 036011 36 PICKWVGISCGARHQRVRALNLSNMGLRGTIP-PHLGNFSFLMSLDISKNNFHA---YLPNE------------LGQLRR 99 (977)
Q Consensus 36 ~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~-~~l~~l~~L~~L~L~~n~l~~---~~p~~------------~~~l~~ 99 (977)
-|++|.++.. .....++++++... .| ..+..+++|++|+|+++.... ..|.. ...+++
T Consensus 33 vck~W~~~~~----~~~~~l~~~~~~~~--~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~ 106 (594)
T 2p1m_B 33 VCKSWYEIER----WCRRKVFIGNCYAV--SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106 (594)
T ss_dssp SCHHHHHHHH----HHCCEEEESSTTSS--CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHHHHHHhhh----hhceEEeecccccc--CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCC
Confidence 3558998832 12345666654332 33 346678889999999875321 12222 234567
Q ss_pred CCEEeCcCccCCCCCCcccc-ccccCcEEeccCc-CCCCC-CCCcccCcCcccceeccccccccccCcccc----Ccccc
Q 036011 100 LRFISLDYNEFSGSFPSWIG-VLSKLQILSLRNN-SFTGP-IPNSLFNLSRLEKWDSMFNIIDGNIPSRIG----NLSSL 172 (977)
Q Consensus 100 L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~----~l~~L 172 (977)
|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|++++|.+++..+..+. .+++|
T Consensus 107 L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L 186 (594)
T 2p1m_B 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186 (594)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCC
T ss_pred CCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcC
Confidence 77777777776655555554 5677777777776 34321 222233566666666666665544333332 34456
Q ss_pred ceeeeeccc--cccc-CCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceE
Q 036011 173 VNVNLAYNN--LQGE-IPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRV 249 (977)
Q Consensus 173 ~~L~L~~n~--i~~~-~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~ 249 (977)
++|++++|. ++.. ++..+.++++|+.|++++|...+.++..+..+++|+.|+++.+..
T Consensus 187 ~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~------------------- 247 (594)
T 2p1m_B 187 VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA------------------- 247 (594)
T ss_dssp CEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCC-------------------
T ss_pred cEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccC-------------------
Confidence 666666554 1100 111123345666666665522112444444555555555433311
Q ss_pred EEecCceeeecCCcccccccccceE-eecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCce
Q 036011 250 FSLGKNKLTGTIPNSITNASKLTGL-DLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTT 328 (977)
Q Consensus 250 L~L~~N~l~~~~p~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~ 328 (977)
+++.|.+.+ ++..+.++++|+.| .+.+.... .++..+..+++|++|++++|.++... ....+..+++|++
T Consensus 248 -~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~~~------l~~~~~~~~~L~~ 318 (594)
T 2p1m_B 248 -EVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSYATVQSYD------LVKLLCQCPKLQR 318 (594)
T ss_dssp -CCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTTCCCCHHH------HHHHHTTCTTCCE
T ss_pred -ccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccCCCCCHHH------HHHHHhcCCCcCE
Confidence 022333332 23345566666666 33333222 23334445566666666666643211 1112345556666
Q ss_pred EEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeec---------CccCCCCChhhh-ccCC
Q 036011 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFI---------NALNGTIPSTVG-RLEQ 398 (977)
Q Consensus 329 L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~---------N~l~~~~p~~~~-~l~~ 398 (977)
|++++| +... .++.....+++|++|++.+ +.+++.....+. .+++
T Consensus 319 L~l~~~-~~~~------------------------~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~ 373 (594)
T 2p1m_B 319 LWVLDY-IEDA------------------------GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPK 373 (594)
T ss_dssp EEEEGG-GHHH------------------------HHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTT
T ss_pred EeCcCc-cCHH------------------------HHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchh
Confidence 666554 2100 0011112244455555422 222222112222 2455
Q ss_pred CCEEEeecccccCccccccc-cccccceeeec--C----CccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccC
Q 036011 399 LQGLSLYGNNLEGSIPYDLC-HLERLNGIRLN--G----NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL 471 (977)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 471 (977)
|++|.++.|++++..+..+. .+++|+.|+++ + |.++....+. .++..+..+++|
T Consensus 374 L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~-------------------~~~~l~~~~~~L 434 (594)
T 2p1m_B 374 LESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI-------------------GFGAIVEHCKDL 434 (594)
T ss_dssp CCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH-------------------HHHHHHHHCTTC
T ss_pred HHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh-------------------HHHHHHhhCCCc
Confidence 55555555554433333332 24444444444 2 2222110000 000112334445
Q ss_pred ceEEccCCCCCCCCcccccc-ccccCeeeCcCCcCCCCcchhh-hcccccceeccCCccccccccc-cccCccccCeeec
Q 036011 472 LAVNLSSNSLSGSLPSNIQN-LQVLINLDLSRNQLSGDIPITI-GSLKDLVTLSLASNQFEGPIPQ-TFGSLTGLESLDL 548 (977)
Q Consensus 472 ~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 548 (977)
+.|++++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|+|
T Consensus 435 ~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l 513 (594)
T 2p1m_B 435 RRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513 (594)
T ss_dssp CEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEE
T ss_pred cEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEee
Confidence 5555543 333222233332 5566666666666654433333 4566777777777776543333 3344677777777
Q ss_pred cCCccCCCCCccc-ccccccCccccCCCcc
Q 036011 549 SNNNLSGEIPKSL-EALLFLKQLNVSHNKL 577 (977)
Q Consensus 549 s~N~l~~~~p~~~-~~l~~L~~L~l~~N~l 577 (977)
++|+++......+ ..++.|+...+..+.-
T Consensus 514 ~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 514 SSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp ESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred eCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 7777643222233 3456665555555543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-29 Score=300.82 Aligned_cols=209 Identities=14% Similarity=0.088 Sum_probs=140.1
Q ss_pred ccccccccEEEeecCccCCCCC-hhhhccCCCCEEEeecccccCc-cccccccccccceeee---------cCCccCCCc
Q 036011 369 IGNLRSLIVLSLFINALNGTIP-STVGRLEQLQGLSLYGNNLEGS-IPYDLCHLERLNGIRL---------NGNKLSGPI 437 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L---------~~N~l~~~~ 437 (977)
+..+++|+.|++++|.+++... ..+..+++|++|++++| +... ++.....+++|+.|++ +.|.+++..
T Consensus 285 ~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~ 363 (594)
T 2p1m_B 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363 (594)
T ss_dssp HHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred HHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence 3455666666666666543222 22446667777777666 3322 2222234666777766 334554333
Q ss_pred hhhhc-CCCCCCeeecCCCcCCCCCCcccc-CcccCceEEcc--C----CCCCCC-----CccccccccccCeeeCcCCc
Q 036011 438 PQCLA-SLISLRELNLGSNKFSSSIPSSFW-SLEYLLAVNLS--S----NSLSGS-----LPSNIQNLQVLINLDLSRNQ 504 (977)
Q Consensus 438 p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~ 504 (977)
...+. .+++|+.|.++.|++++..+..+. .+++|+.|+++ + |.+++. ++..+..+++|+.|+|++ .
T Consensus 364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~ 442 (594)
T 2p1m_B 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-L 442 (594)
T ss_dssp HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-S
T ss_pred HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-c
Confidence 33333 477788888877877765555554 47788888888 4 556532 122367789999999988 7
Q ss_pred CCCCcchhhhc-ccccceeccCCccccccccccc-cCccccCeeeccCCccCCCCCc-ccccccccCccccCCCcccc
Q 036011 505 LSGDIPITIGS-LKDLVTLSLASNQFEGPIPQTF-GSLTGLESLDLSNNNLSGEIPK-SLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 505 l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~ 579 (977)
+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|++|++++|+++.
T Consensus 443 l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 443 LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred ccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 77666666666 8999999999999987666555 6789999999999999654443 44568999999999999853
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=244.02 Aligned_cols=217 Identities=23% Similarity=0.232 Sum_probs=189.7
Q ss_pred cCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcC
Q 036011 364 NIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS 443 (977)
Q Consensus 364 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 443 (977)
.+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 3454443 57899999999999777778999999999999999999777778999999999999999999888888999
Q ss_pred CCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCC-CccccccccccCeeeCcCCcCCCCcchhhhcccccc--
Q 036011 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS-LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV-- 520 (977)
Q Consensus 444 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-- 520 (977)
+++|++|++++|++.+..+..+..+++|+.|++++|++++. +|..|..+++|++|+|++|++++..+..+..+++|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 99999999999999988777899999999999999999874 589999999999999999999977777888888888
Q ss_pred --eeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCC
Q 036011 521 --TLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 521 --~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
.|++++|++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|++++|++++..|.
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 899999999976555554 45899999999999977666789999999999999999998875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=270.50 Aligned_cols=192 Identities=20% Similarity=0.139 Sum_probs=129.0
Q ss_pred cccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCe
Q 036011 370 GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE 449 (977)
Q Consensus 370 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 449 (977)
..+++|++|+|++|.+++.. ..++|++|++++|.|++..+. .+++|+.|+|++|++++..|..+..+++|+.
T Consensus 77 ~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 148 (487)
T 3oja_A 77 ESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148 (487)
T ss_dssp TTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEE
T ss_pred ccCCCCCEEEecCCcCCCCC-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCE
Confidence 34444555555555444222 125666666666666654443 2356666666666666666666666667777
Q ss_pred eecCCCcCCCCCCcccc-CcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 450 LNLGSNKFSSSIPSSFW-SLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 450 L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
|+|++|.+++..|..+. .+++|+.|+|++|.|++. | .+..+++|++|+|++|+|++ +|..+..+++|+.|+|++|.
T Consensus 149 L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225 (487)
T ss_dssp EECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSC
T ss_pred EECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCc
Confidence 77777777666666665 566777777777777644 2 23347778888888888875 44557888888888888888
Q ss_pred ccccccccccCccccCeeeccCCccC-CCCCcccccccccCccccC
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLS-GEIPKSLEALLFLKQLNVS 573 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~ 573 (977)
|++ +|..+..+++|+.|+|++|++. +.+|..+..++.|+.++++
T Consensus 226 l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred Ccc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 884 6777888888888888888887 5667777888888888876
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-27 Score=271.22 Aligned_cols=171 Identities=21% Similarity=0.153 Sum_probs=131.4
Q ss_pred ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhc-CCCCCCeee
Q 036011 373 RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA-SLISLRELN 451 (977)
Q Consensus 373 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ 451 (977)
++|++|++++|.+++..+. .+++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..|..+. .+++|+.|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 4555555555555544433 246677777777777777777777788888888888888777777765 678888888
Q ss_pred cCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc-
Q 036011 452 LGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE- 530 (977)
Q Consensus 452 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~- 530 (977)
|++|.|++..+ +..+++|+.|+|++|.|++ +|..|..+++|+.|+|++|.|+ .+|..++.+++|+.|++++|.+.
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCH
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcC
Confidence 88888886532 3357888888888888886 4445888899999999999998 47888888999999999999998
Q ss_pred ccccccccCccccCeeeccC
Q 036011 531 GPIPQTFGSLTGLESLDLSN 550 (977)
Q Consensus 531 ~~~p~~~~~l~~L~~L~Ls~ 550 (977)
+.+|..+..++.|+.|+++.
T Consensus 252 ~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 252 GTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp HHHHHHHTTCHHHHHHHHHH
T ss_pred cchHHHHHhCCCCcEEeccc
Confidence 67888888999999888863
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=236.77 Aligned_cols=227 Identities=22% Similarity=0.215 Sum_probs=168.2
Q ss_pred EEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCC
Q 036011 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSF 134 (977)
Q Consensus 55 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 134 (977)
.+..+.++. .+|..+. +.|++|+|++|++++..+..|.++++|++|+|++|++++..+..++.+++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344555665 6777653 5799999999999997777899999999999999999966677899999999999999999
Q ss_pred CCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccccccc-CCccccCCCCCceEEeeccCCCCCCchh
Q 036011 135 TGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGE-IPSEIGNLQNLEILVLGMNNLSGPIQPS 213 (977)
Q Consensus 135 ~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 213 (977)
++..+..|.++++|++|++++|.+.+..+..++++++|++|++++|++++. +|..++++++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 988888899999999999999999877777788899999999999998863 5888888999999999999888766666
Q ss_pred hccccceeEEEccCCcccccccCCCccccCCCCce-EEEecCceeeecCCcccccccccceEeecccccccccccccccc
Q 036011 214 IFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLR-VFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292 (977)
Q Consensus 214 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 292 (977)
+..+.+|+ .|. .|++++|++++..+..+. ..+|++|+|++|++++..+..|..+
T Consensus 169 ~~~l~~L~------------------------~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l 223 (276)
T 2z62_A 169 LRVLHQMP------------------------LLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRL 223 (276)
T ss_dssp GHHHHTCT------------------------TCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTC
T ss_pred hhhhhhcc------------------------ccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhccc
Confidence 66655554 111 344444444433232222 2356666666666655555555566
Q ss_pred cccccccccccccCCCC
Q 036011 293 RFLSVLNLANNYLTTDS 309 (977)
Q Consensus 293 ~~L~~L~L~~N~l~~~~ 309 (977)
++|+.|++++|+++...
T Consensus 224 ~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 224 TSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CSCCEEECCSSCBCCCT
T ss_pred ccccEEEccCCcccccC
Confidence 66666666666665543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=234.31 Aligned_cols=206 Identities=26% Similarity=0.261 Sum_probs=172.4
Q ss_pred cccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecC
Q 036011 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLG 453 (977)
Q Consensus 374 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 453 (977)
+.+.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|+++...+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4667888888887 4565443 578888888888887666788888888888888888886666677888899999999
Q ss_pred CCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccc
Q 036011 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533 (977)
Q Consensus 454 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 533 (977)
+|++++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 99988777778888899999999999998877888888999999999999998666666888999999999999999877
Q ss_pred cccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCC
Q 036011 534 PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 534 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++.+..+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7788899999999999999987666678889999999999999987665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=235.55 Aligned_cols=206 Identities=23% Similarity=0.208 Sum_probs=177.8
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (977)
+..+++++++++++|.++ .+|..+. ++++.|+|++|.+++..+..|..+++|+.|+|++|++++..+ . ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence 567788899999999888 5565553 688999999999988888889999999999999999985433 2 7888999
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
+|+|++|+|+ .+|..+..+++|+.|++++|+|++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999998 678888899999999999999998777889999999999999999997777778899999999999999
Q ss_pred ccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccC
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.+..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 99777777888999999999999998 78888888889999999999997754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=235.25 Aligned_cols=220 Identities=25% Similarity=0.217 Sum_probs=192.9
Q ss_pred ccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecC
Q 036011 351 LQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430 (977)
Q Consensus 351 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 430 (977)
+..+.+.++.+... .....+++|+.|++++|.++. + ..+..+++|++|++++|.+++. ..+..+++|++|++++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 33444555554433 235678999999999999873 3 4588999999999999999853 4788999999999999
Q ss_pred CccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcc
Q 036011 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIP 510 (977)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 510 (977)
|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 99998888889999999999999999998888889999999999999999998888888999999999999999998777
Q ss_pred hhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCC
Q 036011 511 ITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 511 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
..++.+++|+.|+|++|++++..|..|..+++|+.|+|++|++.+. ++.|+.|+++.|.++|.+|.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 7889999999999999999998888899999999999999999865 44689999999999999996
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=235.42 Aligned_cols=189 Identities=26% Similarity=0.229 Sum_probs=150.8
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (977)
+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++..+..+..+++|++|++++|++++..+..|..+++|+
T Consensus 59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 45566777777777777642 3677778888888888888876666777888888888888888877777788888888
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
+|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|++++..|..++.+++|+.|+|++|.
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 88888888887777778888888888888888887777778888888888888888887777778888899999999998
Q ss_pred ccccccccccCccccCeeeccCCccCCCCCcccccccc
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLF 566 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 566 (977)
+.+. +++|+.|+++.|+++|.+|.++..++.
T Consensus 217 ~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 217 WDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp BCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred cccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 8754 456888999999999999988776644
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=227.48 Aligned_cols=190 Identities=22% Similarity=0.298 Sum_probs=151.7
Q ss_pred CCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCC
Q 036011 35 QPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114 (977)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 114 (977)
++||.|.|++|... .+.+++++++++ .+|..+. +.|+.|+|++|++++..|..|.++++|++|+|++|++++..
T Consensus 2 ~~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 2 KTCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp --CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred ccCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 46899999999532 356899999998 7888775 68999999999999988888999999999999999999877
Q ss_pred CccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCC
Q 036011 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQ 194 (977)
Q Consensus 115 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~ 194 (977)
|..+..+++|++|+|++|++++..+..|..+++|++|++++|.|++..+..|+++++|++|+|++|+|++..+..|++++
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 88899999999999999999977777788888888888888888866666678888888888888888865556788888
Q ss_pred CCceEEeeccCCCCCCchhhccccceeEEEccCCcc
Q 036011 195 NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230 (977)
Q Consensus 195 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 230 (977)
+|++|+|++|++++..+..+..+++|+.|+|++|.+
T Consensus 156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 191 (251)
T 3m19_A 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191 (251)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCce
Confidence 888888888888755444454444444444444444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=258.68 Aligned_cols=186 Identities=17% Similarity=0.169 Sum_probs=147.2
Q ss_pred CcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--------hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 686 NECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--------DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
...+.||+|+||+||+|+. .++.+|+|+..... ....+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 57889999864332 11245589999999999999999766666677788999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++++|.+++.. +..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999875 5689999999999999 789999999999999999 99999999999875432
Q ss_pred Ccc-----eeeccccCCcccCccccCC--CCcCcccchhhHhHHHHHHhcCCCCCC
Q 036011 838 DSV-----TQTMTIATIGYMAPEYGTE--GIVSSKCDVYSYGVLLTETFTRKKPTD 886 (977)
Q Consensus 838 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~ 886 (977)
... ......||+.|||||++.. ..|+.++|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 111 1124579999999999887 668889999999999999888877763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=226.12 Aligned_cols=206 Identities=22% Similarity=0.212 Sum_probs=172.3
Q ss_pred ccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCC
Q 036011 319 SLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQ 398 (977)
Q Consensus 319 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 398 (977)
.+..+++++++++++|.++.. |..+. ++++.|+|++|.+++..+..|..+++
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~i--------------------------p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~ 56 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTAL--------------------------PPDLP--KDTTILHLSENLLYTFSLATLMPYTR 56 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSC--------------------------CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTT
T ss_pred cccccCCccEEECCCCCCCcC--------------------------CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCC
Confidence 367778888888888887732 32222 57788888888888777888888888
Q ss_pred CCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccC
Q 036011 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478 (977)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 478 (977)
|++|+|++|.|++..+ . ..+++|+.|++++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 57 L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 57 LTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp CCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred CCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 9999999988885433 2 78889999999999998 6777888899999999999999988788899999999999999
Q ss_pred CCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCC
Q 036011 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE 556 (977)
Q Consensus 479 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 556 (977)
|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++...
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 9999877788889999999999999999665666788999999999999999 6788888889999999999998753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.6e-24 Score=221.96 Aligned_cols=203 Identities=20% Similarity=0.170 Sum_probs=139.6
Q ss_pred cCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCcc-CCCCCCccccccccCcEEeccC-cCCCCCCCCcc
Q 036011 65 TIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE-FSGSFPSWIGVLSKLQILSLRN-NSFTGPIPNSL 142 (977)
Q Consensus 65 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l 142 (977)
.+|. +. ..|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|+.+++|++|+|++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 5666 43 378999999999998777789999999999999997 7744555788889999999988 88886666677
Q ss_pred cCcCcccceeccccccccccCccccCccccc---eeeeecc-cccccCCccccCCCCCc-eEEeeccCCCCCCchhhccc
Q 036011 143 FNLSRLEKWDSMFNIIDGNIPSRIGNLSSLV---NVNLAYN-NLQGEIPSEIGNLQNLE-ILVLGMNNLSGPIQPSIFNI 217 (977)
Q Consensus 143 ~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~---~L~L~~n-~i~~~~p~~l~~l~~L~-~L~l~~N~l~~~~~~~l~~l 217 (977)
.++++|++|++++|.+++ +|. |+.+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++ .
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~-------- 170 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-S-------- 170 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-E--------
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-c--------
Confidence 777777777777777764 555 66666666 7777777 66654455566666776 6766666665 2
Q ss_pred cceeEEEccCCcccccccCCCccccCCCCceEEEecCce-eeecCCcccccc-cccceEeeccccccccccccccccccc
Q 036011 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK-LTGTIPNSITNA-SKLTGLDLSFNSFSGLIPHTFGNLRFL 295 (977)
Q Consensus 218 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L 295 (977)
+|+..+.. ++|++|+|++|+ ++...+..|..+ ++|++|++++|+++.+.+. .+++|
T Consensus 171 ------------------i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L 228 (239)
T 2xwt_C 171 ------------------VQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHL 228 (239)
T ss_dssp ------------------ECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTC
T ss_pred ------------------cCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccC
Confidence 33333333 556666666663 654445556666 6677777777777654333 45566
Q ss_pred cccccccc
Q 036011 296 SVLNLANN 303 (977)
Q Consensus 296 ~~L~L~~N 303 (977)
+.|+++++
T Consensus 229 ~~L~l~~~ 236 (239)
T 2xwt_C 229 KELIARNT 236 (239)
T ss_dssp SEEECTTC
T ss_pred ceeeccCc
Confidence 66666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-25 Score=252.88 Aligned_cols=205 Identities=20% Similarity=0.203 Sum_probs=140.6
Q ss_pred ccccccccEEEeecCccCC----CCChhhhccCCCCEEEeecccccCccccccc----cc---------cccceeeecCC
Q 036011 369 IGNLRSLIVLSLFINALNG----TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC----HL---------ERLNGIRLNGN 431 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N 431 (977)
+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|+.|++++|
T Consensus 90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n 169 (386)
T 2ca6_A 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169 (386)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCC
Confidence 4566777777777777775 3667777888888888888887644333333 33 78888888888
Q ss_pred ccC-CCch---hhhcCCCCCCeeecCCCcCCC-----CCCccccCcccCceEEccCCCCC----CCCccccccccccCee
Q 036011 432 KLS-GPIP---QCLASLISLRELNLGSNKFSS-----SIPSSFWSLEYLLAVNLSSNSLS----GSLPSNIQNLQVLINL 498 (977)
Q Consensus 432 ~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L 498 (977)
+++ +.++ ..+..+++|++|+|++|+++. ..|..+..+++|+.|+|++|.++ +.+|..+..+++|++|
T Consensus 170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 876 3444 466677788888888888772 33446777778888888888775 4566777777888888
Q ss_pred eCcCCcCCCC----cchhhhc--ccccceeccCCccccc----cccccc-cCccccCeeeccCCccCCCCC--ccc-ccc
Q 036011 499 DLSRNQLSGD----IPITIGS--LKDLVTLSLASNQFEG----PIPQTF-GSLTGLESLDLSNNNLSGEIP--KSL-EAL 564 (977)
Q Consensus 499 ~Ls~N~l~~~----~p~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p--~~~-~~l 564 (977)
+|++|++++. +|..+.. +++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..+ ..+ ..+
T Consensus 250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l 329 (386)
T 2ca6_A 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 329 (386)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHH
T ss_pred ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHh
Confidence 8888887754 4555533 7778888888888876 366666 557788888888888876653 333 234
Q ss_pred cccCccccC
Q 036011 565 LFLKQLNVS 573 (977)
Q Consensus 565 ~~L~~L~l~ 573 (977)
+.++.+++.
T Consensus 330 ~~~~~~~l~ 338 (386)
T 2ca6_A 330 STRGRGELD 338 (386)
T ss_dssp HHHTCCEEC
T ss_pred hhcCcchhh
Confidence 555544443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-24 Score=232.67 Aligned_cols=203 Identities=18% Similarity=0.159 Sum_probs=162.7
Q ss_pred ccccccEEEeecCccCCCCChhh--hccCCCCEEEeecccccCccc----cccccccccceeeecCCccCCCchhhhcCC
Q 036011 371 NLRSLIVLSLFINALNGTIPSTV--GRLEQLQGLSLYGNNLEGSIP----YDLCHLERLNGIRLNGNKLSGPIPQCLASL 444 (977)
Q Consensus 371 ~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 444 (977)
.+++|++|++++|.+.+..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|++++|++++..|..|..+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 34668888888888888888877 888888888888888886544 345578888899999998888888888888
Q ss_pred CCCCeeecCCCcCCCC---C-CccccCcccCceEEccCCCCCCCCcc----ccccccccCeeeCcCCcCCCCcchhhhcc
Q 036011 445 ISLRELNLGSNKFSSS---I-PSSFWSLEYLLAVNLSSNSLSGSLPS----NIQNLQVLINLDLSRNQLSGDIPITIGSL 516 (977)
Q Consensus 445 ~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 516 (977)
++|++|+|++|++.+. . +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 8999999999987642 1 2334678889999999998873 333 35777899999999999987778777776
Q ss_pred ---cccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccc
Q 036011 517 ---KDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 517 ---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 579 (977)
++|+.|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|+.|++++|+++.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 5677664 7999999999999853 43 6788999999999999864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-25 Score=249.78 Aligned_cols=264 Identities=15% Similarity=0.135 Sum_probs=164.6
Q ss_pred EEcCCCCCCccCCccccCcccccEeeccCCcccccCC----CCcCCCC-CCCEEeCcCccCCCCCCcccccc-----ccC
Q 036011 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLP----NELGQLR-RLRFISLDYNEFSGSFPSWIGVL-----SKL 124 (977)
Q Consensus 55 L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~L 124 (977)
++|+.++++|.+|..+...+.|++|||++|.+++..+ +.|..++ +|++|+|++|.+++..+..++.+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5678888888777777777778888888888887555 6677777 78888888888887667777665 788
Q ss_pred cEEeccCcCCCCCCCCcccCc-----CcccceeccccccccccCccccC-----ccccceeeeecccccccCC----ccc
Q 036011 125 QILSLRNNSFTGPIPNSLFNL-----SRLEKWDSMFNIIDGNIPSRIGN-----LSSLVNVNLAYNNLQGEIP----SEI 190 (977)
Q Consensus 125 ~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~l~~n~i~~~~p~~~~~-----l~~L~~L~L~~n~i~~~~p----~~l 190 (977)
++|+|++|.+++..+..+... ++|++|++++|.|++..+..++. .++|++|+|++|+++...+ ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 888888888876666544433 67777777777776555544332 2467777777777664332 223
Q ss_pred cCCC-CCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCC-CCceEEEecCceeeec----CCcc
Q 036011 191 GNLQ-NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSL-PNLRVFSLGKNKLTGT----IPNS 264 (977)
Q Consensus 191 ~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~~ 264 (977)
..++ +|++|+|++|++++..+..+... +..+ ++|++|+|++|+++.. ++..
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~-----------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~ 219 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKF-----------------------LASIPASVTSLDLSANLLGLKSYAELAYI 219 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHH-----------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHH-----------------------HHhCCCCCCEEECCCCCCChhHHHHHHHH
Confidence 3443 66666666666665554433322 1112 2445555555554421 3333
Q ss_pred ccc-ccccceEeecccccccccc----cccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCC
Q 036011 265 ITN-ASKLTGLDLSFNSFSGLIP----HTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI 339 (977)
Q Consensus 265 l~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 339 (977)
+.. .++|++|+|++|++++..+ ..+..+++|++|+|++|.+..+.+.....+...+..+++|+.|++++|++...
T Consensus 220 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 433 2366666666666655433 23455566777777777665555443333444566777777777777777654
Q ss_pred CC
Q 036011 340 LP 341 (977)
Q Consensus 340 ~p 341 (977)
.+
T Consensus 300 ~~ 301 (362)
T 3goz_A 300 HS 301 (362)
T ss_dssp GC
T ss_pred ch
Confidence 33
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-25 Score=245.69 Aligned_cols=269 Identities=19% Similarity=0.225 Sum_probs=183.5
Q ss_pred CCCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCc--ccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCC
Q 036011 34 SQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNF--SFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111 (977)
Q Consensus 34 ~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 111 (977)
+.-|.+|.++.|+. ..++.||++++.+. |..++.+ +.++.|++++|.+.+..+. +..+++|++|+|++|.++
T Consensus 33 ~~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 33 SGVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp TSSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC
T ss_pred HHHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC
Confidence 34466899999863 35788999998886 5667777 8899999999999986554 667899999999999988
Q ss_pred CC-CCccccccccCcEEeccCcCCCCCCCCcccCcCcccceecccc-ccccc-cCccccCccccceeeeecc-ccccc-C
Q 036011 112 GS-FPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFN-IIDGN-IPSRIGNLSSLVNVNLAYN-NLQGE-I 186 (977)
Q Consensus 112 ~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n-~i~~~-~p~~~~~l~~L~~L~L~~n-~i~~~-~ 186 (977)
+. +|..++.+++|++|+|++|.+++..|..+..+++|++|++++| .+++. ++..+.++++|++|++++| .+++. +
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~ 186 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHH
Confidence 65 8888888999999999999888766777777777777777777 56542 5555666777777777777 66643 4
Q ss_pred CccccCCC-CCceEEeecc--CCC-CCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCce-eeecC
Q 036011 187 PSEIGNLQ-NLEILVLGMN--NLS-GPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNK-LTGTI 261 (977)
Q Consensus 187 p~~l~~l~-~L~~L~l~~N--~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~ 261 (977)
+..+..++ +|++|++++| .++ +.++..+. .+++|++|++++|. +++..
T Consensus 187 ~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~---------------------------~~~~L~~L~l~~~~~l~~~~ 239 (336)
T 2ast_B 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR---------------------------RCPNLVHLDLSDSVMLKNDC 239 (336)
T ss_dssp HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH---------------------------HCTTCSEEECTTCTTCCGGG
T ss_pred HHHHHhcccCCCEEEeCCCcccCCHHHHHHHHh---------------------------hCCCCCEEeCCCCCcCCHHH
Confidence 55566666 6777777666 333 22233333 34556666666665 44455
Q ss_pred CcccccccccceEeecccc-cccccccccccccccccccccccccCCCCCCchhhhhcccccC-CCCceEEecCCCCCCC
Q 036011 262 PNSITNASKLTGLDLSFNS-FSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNC-RNLTTLAVASNPLRGI 339 (977)
Q Consensus 262 p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~ 339 (977)
+..+..+++|++|++++|. +.......+..+++|+.|++++| ++. .. +..+ .++..|++++|.+++.
T Consensus 240 ~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~-------~~~l~~~l~~L~l~~n~l~~~ 308 (336)
T 2ast_B 240 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GT-------LQLLKEALPHLQINCSHFTTI 308 (336)
T ss_dssp GGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TC-------HHHHHHHSTTSEESCCCSCCT
T ss_pred HHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HH-------HHHHHhhCcceEEecccCccc
Confidence 5566667777777777774 32222235666777777777777 322 11 2222 2355666778888877
Q ss_pred CCccccc
Q 036011 340 LPPVIGN 346 (977)
Q Consensus 340 ~p~~~~~ 346 (977)
.|+.++.
T Consensus 309 ~~~~~~~ 315 (336)
T 2ast_B 309 ARPTIGN 315 (336)
T ss_dssp TCSSCSS
T ss_pred cCCcccc
Confidence 7776654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=216.97 Aligned_cols=180 Identities=24% Similarity=0.252 Sum_probs=90.4
Q ss_pred ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeec
Q 036011 373 RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452 (977)
Q Consensus 373 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 452 (977)
.+.++++++++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 34555666666665 3444333 35555555555555554545555555555555555555544444555555555555
Q ss_pred CCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccccc
Q 036011 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532 (977)
Q Consensus 453 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 532 (977)
++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|+.+++|+.|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 55555544444445555555555555555544444444444555555555554433333444444444444444444444
Q ss_pred ccccccCccccCeeeccCCccCC
Q 036011 533 IPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 533 ~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
.+..|..+++|+.|+|++|++++
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCT
T ss_pred CHHHHhCCCCCCEEEeeCCceeC
Confidence 44444444444444444444443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=242.96 Aligned_cols=258 Identities=19% Similarity=0.186 Sum_probs=128.5
Q ss_pred EeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCC-CCceEEecCCCCCCCCCccccccccccc
Q 036011 274 LDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR-NLTTLAVASNPLRGILPPVIGNFSASLQ 352 (977)
Q Consensus 274 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~~~~~L~ 352 (977)
+++++|.+++.+|..+...++|++|+|++|.++...+.. +...+..++ +|++|++++|.+.+..+..+..
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~---l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~------ 73 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVE---LIQAFANTPASVTSLNLSGNSLGFKNSDELVQ------ 73 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHH---HHHHHHTCCTTCCEEECCSSCGGGSCHHHHHH------
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHH---HHHHHHhCCCceeEEECcCCCCCHHHHHHHHH------
Confidence 455555555555554444444555555555555443211 112244444 5555555555554332222111
Q ss_pred ccccccCcccccCCcccccc-ccccEEEeecCccCCCCChhhhcc-----CCCCEEEeecccccCcccccccc-----cc
Q 036011 353 NFYAYDCKLTGNIPHEIGNL-RSLIVLSLFINALNGTIPSTVGRL-----EQLQGLSLYGNNLEGSIPYDLCH-----LE 421 (977)
Q Consensus 353 ~L~l~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~ 421 (977)
.+... ++|++|+|++|.+++..+..+... ++|++|+|++|++++..+..+.. .+
T Consensus 74 ---------------~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 138 (362)
T 3goz_A 74 ---------------ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138 (362)
T ss_dssp ---------------HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCT
T ss_pred ---------------HHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCC
Confidence 11122 677777777777776666544443 67777777777776555444332 24
Q ss_pred ccceeeecCCccCCCc----hhhhcCCC-CCCeeecCCCcCCCCCCccccC----c-ccCceEEccCCCCCCC----Ccc
Q 036011 422 RLNGIRLNGNKLSGPI----PQCLASLI-SLRELNLGSNKFSSSIPSSFWS----L-EYLLAVNLSSNSLSGS----LPS 487 (977)
Q Consensus 422 ~L~~L~L~~N~l~~~~----p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~L~~N~l~~~----~p~ 487 (977)
+|++|+|++|++++.. +..+..++ +|++|+|++|++++..+..+.. . ++|+.|+|++|.|++. ++.
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 6666666666666422 33334444 6666666666666544443332 2 3555555555555532 223
Q ss_pred cccc-ccccCeeeCcCCcCCCCcch----hhhcccccceeccCCcccccc-------ccccccCccccCeeeccCCccCC
Q 036011 488 NIQN-LQVLINLDLSRNQLSGDIPI----TIGSLKDLVTLSLASNQFEGP-------IPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 488 ~~~~-l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
.+.. .++|++|+|++|++++..+. .+..+++|+.|+|++|.+.+. ++..+..+++|+.|||++|++.+
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 3333 23555555555555533221 223344555555555553221 22234444445555555555443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=217.62 Aligned_cols=203 Identities=17% Similarity=0.195 Sum_probs=148.9
Q ss_pred CCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcC-CCCCCCCcccCcCcccceeccc-cccccccCcccc
Q 036011 90 LPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNS-FTGPIPNSLFNLSRLEKWDSMF-NIIDGNIPSRIG 167 (977)
Q Consensus 90 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~l~~-n~i~~~~p~~~~ 167 (977)
+|. +. .+|++|+|++|++++..+..|+.+++|++|+|++|+ +++..+..|.++++|++|++++ |.+++..+..|+
T Consensus 26 ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~ 102 (239)
T 2xwt_C 26 IPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK 102 (239)
T ss_dssp CCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEE
T ss_pred cCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhC
Confidence 555 33 378888888888885555578888888888888886 7755555666666666666666 666655555666
Q ss_pred CccccceeeeecccccccCCccccCCCCCc---eEEeecc-CCCCCCchhhccccceeEEEccCCcccccccCCCccccC
Q 036011 168 NLSSLVNVNLAYNNLQGEIPSEIGNLQNLE---ILVLGMN-NLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYS 243 (977)
Q Consensus 168 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~---~L~l~~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 243 (977)
++++|++|++++|++++ +|. +..+++|+ +|++++| +++ .+++..+..
T Consensus 103 ~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~---------------------------~i~~~~~~~ 153 (239)
T 2xwt_C 103 ELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT---------------------------SIPVNAFQG 153 (239)
T ss_dssp CCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC---------------------------EECTTTTTT
T ss_pred CCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchh---------------------------hcCcccccc
Confidence 66666666666666663 444 55555555 5555555 444 455666778
Q ss_pred CCCce-EEEecCceeeecCCcccccccccceEeecccc-cccccccccccc-cccccccccccccCCCCCCchhhhhccc
Q 036011 244 LPNLR-VFSLGKNKLTGTIPNSITNASKLTGLDLSFNS-FSGLIPHTFGNL-RFLSVLNLANNYLTTDSPTAEWSFLSSL 320 (977)
Q Consensus 244 l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~~l 320 (977)
+++|+ +|++++|+++ .+|......++|++|+|++|+ ++.+.+..|..+ ++|+.|++++|+++.+++.
T Consensus 154 l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--------- 223 (239)
T 2xwt_C 154 LCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--------- 223 (239)
T ss_dssp TBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---------
T ss_pred hhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---------
Confidence 89999 9999999999 455544344899999999995 998888899999 9999999999999987643
Q ss_pred ccCCCCceEEecCCC
Q 036011 321 TNCRNLTTLAVASNP 335 (977)
Q Consensus 321 ~~l~~L~~L~L~~N~ 335 (977)
.+++|+.|+++++.
T Consensus 224 -~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 224 -GLEHLKELIARNTW 237 (239)
T ss_dssp -TCTTCSEEECTTC-
T ss_pred -HhccCceeeccCcc
Confidence 46889999998874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-25 Score=250.24 Aligned_cols=214 Identities=22% Similarity=0.280 Sum_probs=173.7
Q ss_pred ccccccccEEEeecC---ccCCCCChh-------hhccCCCCEEEeecccccC----ccccccccccccceeeecCCccC
Q 036011 369 IGNLRSLIVLSLFIN---ALNGTIPST-------VGRLEQLQGLSLYGNNLEG----SIPYDLCHLERLNGIRLNGNKLS 434 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N---~l~~~~p~~-------~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~ 434 (977)
+..+++|++|+|++| ++++.+|.. +..+++|++|+|++|.+++ .+|..+..+++|+.|+|++|.++
T Consensus 56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 135 (386)
T 2ca6_A 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135 (386)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence 344555555555553 233334443 4789999999999999997 47888999999999999999997
Q ss_pred CCchhhhc----CC---------CCCCeeecCCCcCC-CCCC---ccccCcccCceEEccCCCCC--C---CCccccccc
Q 036011 435 GPIPQCLA----SL---------ISLRELNLGSNKFS-SSIP---SSFWSLEYLLAVNLSSNSLS--G---SLPSNIQNL 492 (977)
Q Consensus 435 ~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l 492 (977)
...+..+. .+ ++|++|+|++|+++ +.++ ..+..+++|+.|+|++|+|+ | ..|..+..+
T Consensus 136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~ 215 (386)
T 2ca6_A 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence 54444444 34 89999999999998 3444 46778899999999999998 2 344488899
Q ss_pred cccCeeeCcCCcCC----CCcchhhhcccccceeccCCcccccc----ccccc--cCccccCeeeccCCccCC----CCC
Q 036011 493 QVLINLDLSRNQLS----GDIPITIGSLKDLVTLSLASNQFEGP----IPQTF--GSLTGLESLDLSNNNLSG----EIP 558 (977)
Q Consensus 493 ~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p 558 (977)
++|++|+|++|+++ +.+|..+..+++|+.|+|++|++++. +|..+ +.+++|+.|+|++|++++ .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 99999999999996 57888999999999999999999976 56777 449999999999999997 488
Q ss_pred ccc-ccccccCccccCCCcccccCC
Q 036011 559 KSL-EALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 559 ~~~-~~l~~L~~L~l~~N~l~~~~p 582 (977)
..+ .++++|++|++++|++++..|
T Consensus 296 ~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHhcCCCceEEEccCCcCCcchh
Confidence 888 668999999999999987553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-23 Score=228.21 Aligned_cols=225 Identities=19% Similarity=0.184 Sum_probs=177.1
Q ss_pred cccEeeccCCcccccC-CC--CcCCCCCCCEEeCcCccCCCCCCccc--cccccCcEEeccCcCCCCCCC----CcccCc
Q 036011 75 FLMSLDISKNNFHAYL-PN--ELGQLRRLRFISLDYNEFSGSFPSWI--GVLSKLQILSLRNNSFTGPIP----NSLFNL 145 (977)
Q Consensus 75 ~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p----~~l~~l 145 (977)
.++.|.+.++.++... .. .+..+++|++|+|++|++++..|..+ +.+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 4677888887765311 10 12245679999999999998888888 889999999999999987665 345678
Q ss_pred CcccceeccccccccccCccccCccccceeeeeccccccc--C--CccccCCCCCceEEeeccCCCCCCch----hhccc
Q 036011 146 SRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGE--I--PSEIGNLQNLEILVLGMNNLSGPIQP----SIFNI 217 (977)
Q Consensus 146 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~--~--p~~l~~l~~L~~L~l~~N~l~~~~~~----~l~~l 217 (977)
++|++|++++|.+.+..|..|+.+++|++|+|++|++.+. + +..++.+++|++|+|++|+++.. +. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhcC
Confidence 8999999999999888888999999999999999998652 2 23457889999999999999732 22 24677
Q ss_pred cceeEEEccCCcccccccCCCcccc--CCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccccccccc
Q 036011 218 STITLINLFGNQLSGHLDLPPKVSY--SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFL 295 (977)
Q Consensus 218 ~~L~~L~L~~N~l~~~~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 295 (977)
++|+.|+|++|++++. .|+.... .+++|++|+|++|+++ .+|..+. ++|++|+|++|+|+++ |. +..+++|
T Consensus 224 ~~L~~L~Ls~N~l~~~--~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L 296 (310)
T 4glp_A 224 VQPHSLDLSHNSLRAT--VNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV 296 (310)
T ss_dssp CCCSSEECTTSCCCCC--CCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred CCCCEEECCCCCCCcc--chhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence 9999999999999853 1332221 2379999999999999 6788775 7999999999999976 33 7889999
Q ss_pred ccccccccccCC
Q 036011 296 SVLNLANNYLTT 307 (977)
Q Consensus 296 ~~L~L~~N~l~~ 307 (977)
+.|+|++|+++.
T Consensus 297 ~~L~L~~N~l~~ 308 (310)
T 4glp_A 297 DNLTLDGNPFLV 308 (310)
T ss_dssp SCEECSSTTTSC
T ss_pred cEEECcCCCCCC
Confidence 999999999875
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=221.81 Aligned_cols=173 Identities=25% Similarity=0.384 Sum_probs=116.6
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (977)
+..+++|++|++++|.+++..+ +..+++|++|+|++|++++. + .+..+++|+.|++++|++++. +. +..+++|+
T Consensus 59 ~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~ 132 (308)
T 1h6u_A 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQ 132 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCC
T ss_pred hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCC
Confidence 4455566666666666654333 66666777777777776642 2 566677777777777777643 32 67777777
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
+|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|+
T Consensus 133 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred EEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence 77777777775433 6677777777777777775333 7777777777777777774332 6777778888888887
Q ss_pred ccccccccccCccccCeeeccCCccCC
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
+++.. .+..+++|+.|+|++|++++
T Consensus 207 l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 207 ISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred cCccc--cccCCCCCCEEEccCCeeec
Confidence 77544 27777788888888888774
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=220.49 Aligned_cols=196 Identities=26% Similarity=0.363 Sum_probs=174.0
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (977)
+..+++|+.|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|+.|++++|++++. + .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 5578999999999999984 45 68999999999999999996554 99999999999999999864 3 699999999
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
+|++++|++++. + .+..+++|+.|++++|++++..+ +..+++|++|+|++|++++. +. +..+++|+.|+|++|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCc
Confidence 999999999964 3 38999999999999999996544 89999999999999999954 44 9999999999999999
Q ss_pred ccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCccccc
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 580 (977)
+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|++++|++++.
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred cCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 997544 899999999999999999654 389999999999999999873
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-23 Score=240.62 Aligned_cols=215 Identities=22% Similarity=0.287 Sum_probs=157.8
Q ss_pred CCCCCCCCC-----cccce-EecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEE
Q 036011 30 NWSISQPIC-----KWVGI-SCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFI 103 (977)
Q Consensus 30 ~w~~~~~~c-----~w~gv-~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 103 (977)
+|..+.++| .|.|+ .|.. .+++.|+|+++++++ +|+.+. ++|++|+|++|+|+. +| ..+++|++|
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L 105 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYL 105 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEE
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEE
Confidence 576666777 79999 7864 368999999999985 888774 789999999999985 67 557899999
Q ss_pred eCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccccc
Q 036011 104 SLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ 183 (977)
Q Consensus 104 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~ 183 (977)
+|++|+|++ +|. +.. +|++|+|++|.+++ +|. .+++|++|++++|.|++ +|. .+++|++|+|++|+|+
T Consensus 106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT 173 (571)
T ss_dssp ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence 999999985 777 665 89999999999986 565 56778888888887775 555 4567777777777777
Q ss_pred ccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCc
Q 036011 184 GEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPN 263 (977)
Q Consensus 184 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 263 (977)
+ +|. |+ ++|+.|+|++|+|+ .+|. +.. +| ....+.|+.|+|++|+|+ .+|.
T Consensus 174 ~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L--------------------~~~~~~L~~L~Ls~N~l~-~lp~ 224 (571)
T 3cvr_A 174 F-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN--------------------HHSEETEIFFRCRENRIT-HIPE 224 (571)
T ss_dssp C-CCC-CC--TTCCEEECCSSCCS-SCCC-CC------------------------------CCEEEECCSSCCC-CCCG
T ss_pred C-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh--------------------hcccccceEEecCCCcce-ecCH
Confidence 4 665 55 67777777777776 3332 221 11 111233478888888887 5777
Q ss_pred ccccccccceEeecccccccccccccccccc
Q 036011 264 SITNASKLTGLDLSFNSFSGLIPHTFGNLRF 294 (977)
Q Consensus 264 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 294 (977)
.+..+++|++|+|++|++++.+|..|..+..
T Consensus 225 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp GGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 7777888888888888888877777766543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-23 Score=229.82 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=193.9
Q ss_pred CceEEecCCCCCCCCCcccccc-cccccccccccCcccccCCccccccccccEEEeecCccCCC-CChhhhccCCCCEEE
Q 036011 326 LTTLAVASNPLRGILPPVIGNF-SASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGT-IPSTVGRLEQLQGLS 403 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~-~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 403 (977)
++.+++++|.+. +..+..+ ...++.+.+.+|.+.+..+. +..+++|++|++++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 455555555443 2222222 13455566666666555444 45788999999999998865 788889999999999
Q ss_pred eecccccCccccccccccccceeeecCC-ccCCC-chhhhcCCCCCCeeecCCC-cCCCC-CCccccCcc-cCceEEccC
Q 036011 404 LYGNNLEGSIPYDLCHLERLNGIRLNGN-KLSGP-IPQCLASLISLRELNLGSN-KFSSS-IPSSFWSLE-YLLAVNLSS 478 (977)
Q Consensus 404 L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~ 478 (977)
|++|.+++..+..+..+++|++|++++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|+.|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 9999998888888999999999999999 67753 6777888999999999999 88854 567788889 999999999
Q ss_pred C--CCC-CCCccccccccccCeeeCcCCc-CCCCcchhhhcccccceeccCCcc-ccccccccccCccccCeeeccCCcc
Q 036011 479 N--SLS-GSLPSNIQNLQVLINLDLSRNQ-LSGDIPITIGSLKDLVTLSLASNQ-FEGPIPQTFGSLTGLESLDLSNNNL 553 (977)
Q Consensus 479 N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l 553 (977)
| .++ +.+|..+..+++|++|++++|. +++..+..++.+++|+.|+|++|. +.......++++++|+.|+|++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 9 455 4567778889999999999999 777788899999999999999995 33222236888999999999999 4
Q ss_pred CCCCCcccccc-cccCccccCCCcccccCCC
Q 036011 554 SGEIPKSLEAL-LFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 554 ~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~ 583 (977)
+ ...+..+ ..+..|++++|++++..|.
T Consensus 284 ~---~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 284 P---DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp C---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred C---HHHHHHHHhhCcceEEecccCccccCC
Confidence 4 2345555 3488899999999998875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=222.89 Aligned_cols=237 Identities=16% Similarity=0.089 Sum_probs=147.3
Q ss_pred EcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCc-cccccccCcE-EeccCcC
Q 036011 56 NLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPS-WIGVLSKLQI-LSLRNNS 133 (977)
Q Consensus 56 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~-L~L~~n~ 133 (977)
+.++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|. .|.++++|++ +.+++|+
T Consensus 15 ~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~ 91 (350)
T 4ay9_X 15 LCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91 (350)
T ss_dssp EEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETT
T ss_pred EecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCc
Confidence 33556677 788766 46789999999999886666788899999999999988766654 5777877664 5666777
Q ss_pred CCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeec-ccccccCCccccCCC-CCceEEeeccCCCCCCc
Q 036011 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY-NNLQGEIPSEIGNLQ-NLEILVLGMNNLSGPIQ 211 (977)
Q Consensus 134 l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~-n~i~~~~p~~l~~l~-~L~~L~l~~N~l~~~~~ 211 (977)
+++..|..|.++++|++|++++|.|....+..+....++..|++.+ +++....+..|..+. .++.|++++|+|+
T Consensus 92 l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~---- 167 (350)
T 4ay9_X 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ---- 167 (350)
T ss_dssp CCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC----
T ss_pred ccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc----
Confidence 8766666666676666666666666655555555555566666644 445533334454443 3555666666555
Q ss_pred hhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecC-ceeeecCCcccccccccceEeecccccccccccccc
Q 036011 212 PSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGK-NKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290 (977)
Q Consensus 212 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 290 (977)
.+++.++ ...+|++|++++ |.++.+.+..|..+++|++|||++|+|+.+.+..|.
T Consensus 168 -----------------------~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~ 223 (350)
T 4ay9_X 168 -----------------------EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223 (350)
T ss_dssp -----------------------EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred -----------------------CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence 2333333 234455555543 444433334556666677777777777666555566
Q ss_pred cccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCC
Q 036011 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASN 334 (977)
Q Consensus 291 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 334 (977)
++++|+.+++. .+..++ .+..+++|+.+++.++
T Consensus 224 ~L~~L~~l~~~--~l~~lP---------~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 224 NLKKLRARSTY--NLKKLP---------TLEKLVALMEASLTYP 256 (350)
T ss_dssp TCCEEECTTCT--TCCCCC---------CTTTCCSCCEEECSCH
T ss_pred cchHhhhccCC--CcCcCC---------CchhCcChhhCcCCCC
Confidence 66666655542 233333 2556677777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-22 Score=219.54 Aligned_cols=240 Identities=18% Similarity=0.165 Sum_probs=151.3
Q ss_pred cEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCC-ccccccccCcEEeccCcCCCCCCCC-cccCcCcccceecc
Q 036011 77 MSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFP-SWIGVLSKLQILSLRNNSFTGPIPN-SLFNLSRLEKWDSM 154 (977)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~l~ 154 (977)
++++.++++++. +|..+ .+++++|+|++|+|+ .+| .+|+++++|++|+|++|++.+.+|. .|.++++|++
T Consensus 12 ~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~---- 83 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE---- 83 (350)
T ss_dssp TEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE----
T ss_pred CEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh----
Confidence 456777777776 56555 356777777777777 444 4567777777777777776554443 3444444433
Q ss_pred ccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccC-Cccccc
Q 036011 155 FNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFG-NQLSGH 233 (977)
Q Consensus 155 ~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~ 233 (977)
.+.+++|+++...|..|.++++|++|++++|+++...+..+....++..|++.+ |++.
T Consensus 84 -------------------~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-- 142 (350)
T 4ay9_X 84 -------------------IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-- 142 (350)
T ss_dssp -------------------EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC--
T ss_pred -------------------hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc--
Confidence 233344555544444555555555555555555544444444444555555533 3343
Q ss_pred ccCCCccccCC-CCceEEEecCceeeecCCcccccccccceEeecc-cccccccccccccccccccccccccccCCCCCC
Q 036011 234 LDLPPKVSYSL-PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSF-NSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311 (977)
Q Consensus 234 ~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 311 (977)
.++...+..+ ..+++|+|++|+|+. +|.......+|++|++++ |.++.+.++.|..+++|++|+|++|+|+.+++.
T Consensus 143 -~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~ 220 (350)
T 4ay9_X 143 -TIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220 (350)
T ss_dssp -EECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS
T ss_pred -cccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh
Confidence 3455555555 468999999999995 555555678899999975 778877778899999999999999999998864
Q ss_pred chhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccC
Q 036011 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359 (977)
Q Consensus 312 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n 359 (977)
. +.+|+.|.+.++.--..+|. +..+ .+|+.+++.++
T Consensus 221 ~----------~~~L~~L~~l~~~~l~~lP~-l~~l-~~L~~l~l~~~ 256 (350)
T 4ay9_X 221 G----------LENLKKLRARSTYNLKKLPT-LEKL-VALMEASLTYP 256 (350)
T ss_dssp S----------CTTCCEEECTTCTTCCCCCC-TTTC-CSCCEEECSCH
T ss_pred h----------hccchHhhhccCCCcCcCCC-chhC-cChhhCcCCCC
Confidence 3 44566666555544445553 3333 35777776553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.9e-22 Score=202.91 Aligned_cols=157 Identities=18% Similarity=0.210 Sum_probs=99.8
Q ss_pred CCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCC
Q 036011 35 QPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114 (977)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 114 (977)
.+.|+|.+|.|.. ++++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..
T Consensus 4 ~C~C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (208)
T 2o6s_A 4 RCSCSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68 (208)
T ss_dssp TCEEETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCEECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC
Confidence 4458899988864 3344 455544 457888899888888866667888888888888888888555
Q ss_pred CccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCC
Q 036011 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQ 194 (977)
Q Consensus 115 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~ 194 (977)
+..++.+++|++|+|++|++++..+..|.++++|++|++++|.|++..+..|+++++|++|+|++|++++..+..+..++
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 148 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCC
Confidence 55677888888888888888755544455555555555555555544444444555555555555555433333344444
Q ss_pred CCceEEeeccCC
Q 036011 195 NLEILVLGMNNL 206 (977)
Q Consensus 195 ~L~~L~l~~N~l 206 (977)
+|+.|++++|.+
T Consensus 149 ~L~~L~l~~N~~ 160 (208)
T 2o6s_A 149 SLQYIWLHDNPW 160 (208)
T ss_dssp TCCEEECCSCCB
T ss_pred CccEEEecCCCe
Confidence 444444444433
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-22 Score=214.36 Aligned_cols=151 Identities=17% Similarity=0.123 Sum_probs=120.9
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch------------------hhHHHHHHHHHHHHhcCC
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD------------------RAFRSFDSECEVLRNVRH 738 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h 738 (977)
.+......|.+.+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556777899999999999999997799999999864321 13456889999999999
Q ss_pred CCcceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC
Q 036011 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE 818 (977)
Q Consensus 739 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 818 (977)
| +++.+++.. +..++||||++||+|.+ +.. .....++.|+++||+||| +.||+||||||+|||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence 4 566665543 55699999999999998 422 224479999999999999 79999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeccccCCcccCccccC
Q 036011 819 DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858 (977)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 858 (977)
++.+||+|||+|+. +..|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999863 33478898764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.8e-21 Score=196.00 Aligned_cols=155 Identities=28% Similarity=0.254 Sum_probs=79.9
Q ss_pred ccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCc
Q 036011 422 RLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLS 501 (977)
Q Consensus 422 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 501 (977)
+|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 34444444444443333344444555555555555554444444455555555555555554444445555555555555
Q ss_pred CCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccC
Q 036011 502 RNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 502 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
+|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.+. ++.|+.|+++.|.++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence 5555544444455555555555555555544444455555566666666655432 234555666666666666
Q ss_pred CC
Q 036011 582 PA 583 (977)
Q Consensus 582 p~ 583 (977)
|+
T Consensus 182 p~ 183 (208)
T 2o6s_A 182 RN 183 (208)
T ss_dssp BC
T ss_pred ec
Confidence 54
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.5e-21 Score=223.12 Aligned_cols=182 Identities=25% Similarity=0.331 Sum_probs=115.5
Q ss_pred cccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecC
Q 036011 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLG 453 (977)
Q Consensus 374 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 453 (977)
+|+.|+|++|.+++ +|..+ +++|++|+|++|+|+ .+| ..+++|+.|++++|+|++ +|. +.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 66667777776664 44444 256777777777766 445 345667777777777765 454 444 67777777
Q ss_pred CCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccc
Q 036011 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533 (977)
Q Consensus 454 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 533 (977)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 777765 444 45667777777777764 444 45667777777777764 555 44 66777777777776 45
Q ss_pred cccccCcccc-------CeeeccCCccCCCCCcccccccccCccccCCCcccccCCC
Q 036011 534 PQTFGSLTGL-------ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583 (977)
Q Consensus 534 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 583 (977)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 55 443 55 77777777776 5666666677777777777777766653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.6e-22 Score=240.04 Aligned_cols=233 Identities=20% Similarity=0.171 Sum_probs=136.3
Q ss_pred hHHHHHHHHHHHHhccCCCCCccCCCC-CCCCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccE-----e
Q 036011 6 LTTDQFALLAFKAHVTDPQSVLANNWS-ISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMS-----L 79 (977)
Q Consensus 6 ~~~~~~~l~~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~-----L 79 (977)
.+.++++|+++..+...+.+...+.|. ..+..+.|.++++.. .+++.|+|.++++.. ++..+.....|.. +
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccCc
Confidence 456789999999888644433335674 445677999988865 579999999999984 5555433333333 2
Q ss_pred eccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccc
Q 036011 80 DISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIID 159 (977)
Q Consensus 80 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~ 159 (977)
+++.|.+. ..|+.+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 33334444 36888999999999999999999 89988889999999999999999 88999999999999999999999
Q ss_pred cccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccc-eeEEEccCCcccccccCCC
Q 036011 160 GNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNIST-ITLINLFGNQLSGHLDLPP 238 (977)
Q Consensus 160 ~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~ 238 (977)
.+|..|+++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++. +|
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~--~p- 358 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP--LP- 358 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC--CC-
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc--Cc-
Confidence 88999999999999999999998 78988999999999999999999988888776532 23467777777642 22
Q ss_pred ccccCCCCceEEEecCc
Q 036011 239 KVSYSLPNLRVFSLGKN 255 (977)
Q Consensus 239 ~~~~~l~~L~~L~L~~N 255 (977)
..|+.|+++.|
T Consensus 359 ------~~l~~l~l~~n 369 (727)
T 4b8c_D 359 ------HERRFIEINTD 369 (727)
T ss_dssp ------CC---------
T ss_pred ------cccceeEeecc
Confidence 34556666665
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.2e-20 Score=192.32 Aligned_cols=164 Identities=20% Similarity=0.198 Sum_probs=137.4
Q ss_pred CCCCCCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccC
Q 036011 31 WSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEF 110 (977)
Q Consensus 31 w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 110 (977)
|..+++.|+|.+|.|.. +++. .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 12 ~~~~~~~Cs~~~v~c~~------------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l 76 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRS------------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL 76 (229)
T ss_dssp CCCTTCEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCCCEEeCCEeEccC------------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence 44578899999999964 3344 6776554 8899999999999998899999999999999999999
Q ss_pred CCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccc
Q 036011 111 SGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI 190 (977)
Q Consensus 111 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l 190 (977)
++..+..|+.+++|++|+|++|++++..+..|..+++|++|++++|.|+ .+|..+..+++|++|+|++|+|++..+..|
T Consensus 77 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~ 155 (229)
T 3e6j_A 77 GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155 (229)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTT
T ss_pred CCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHH
Confidence 8555567899999999999999999777777888889999999998888 778888888888888888888886666678
Q ss_pred cCCCCCceEEeeccCCCCCC
Q 036011 191 GNLQNLEILVLGMNNLSGPI 210 (977)
Q Consensus 191 ~~l~~L~~L~l~~N~l~~~~ 210 (977)
..+++|+.|++++|.+....
T Consensus 156 ~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 156 DRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TTCTTCCEEECTTSCBCTTB
T ss_pred hCCCCCCEEEeeCCCccCCc
Confidence 88888888888888887543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.5e-21 Score=197.08 Aligned_cols=155 Identities=23% Similarity=0.281 Sum_probs=108.3
Q ss_pred eeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCC-ccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCC
Q 036011 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503 (977)
Q Consensus 425 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (977)
.+++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5555555555 3444332 245667777777665533 34666777777777777777666667777777777777777
Q ss_pred cCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCC
Q 036011 504 QLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 504 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|+|++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 7776666667777777777777777777777777777777778887777777777777777778888888888777665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=196.63 Aligned_cols=173 Identities=25% Similarity=0.348 Sum_probs=117.0
Q ss_pred ccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCC
Q 036011 369 IGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLR 448 (977)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (977)
+..+++|+.|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|+.|++++|++++ +| .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 34677777777777777643 3 36777777777777777775444 7777777777777777764 33 367777777
Q ss_pred eeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc
Q 036011 449 ELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ 528 (977)
Q Consensus 449 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 528 (977)
+|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|+|++|++++..| +..+++|+.|+|++|+
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 777777777753 3566677777777777777653 456667777777777777764433 6667777777777777
Q ss_pred ccccccccccCccccCeeeccCCccCC
Q 036011 529 FEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 529 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
+++ +| .+..+++|+.|+|++|+++.
T Consensus 190 i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 190 ISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 764 33 36667777777777777664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=207.00 Aligned_cols=176 Identities=26% Similarity=0.214 Sum_probs=93.9
Q ss_pred cEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccc-cccccceeeecCCccCCCchhhhcCCCCCCeeecCC
Q 036011 376 IVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGS 454 (977)
Q Consensus 376 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 454 (977)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46677777776 3554433 3466666666666655555555 566666666666666655555566666666666666
Q ss_pred CcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhh---hcccccceeccCCccccc
Q 036011 455 NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI---GSLKDLVTLSLASNQFEG 531 (977)
Q Consensus 455 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 531 (977)
|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66665555555555555555555555555445555555555555555555553222222 334444444444444443
Q ss_pred cccccccCccc--cCeeeccCCccC
Q 036011 532 PIPQTFGSLTG--LESLDLSNNNLS 554 (977)
Q Consensus 532 ~~p~~~~~l~~--L~~L~Ls~N~l~ 554 (977)
..+..|..++. |+.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 33334444433 244444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=215.07 Aligned_cols=202 Identities=22% Similarity=0.285 Sum_probs=146.0
Q ss_pred cccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCC
Q 036011 352 QNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGN 431 (977)
Q Consensus 352 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 431 (977)
..+.+..+.+....+ +..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|+|++..| +..+++|+.|+|++|
T Consensus 24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred HHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence 334444444443332 4567788888888888873 33 57888888888888888886554 778888888888888
Q ss_pred ccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcch
Q 036011 432 KLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPI 511 (977)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 511 (977)
++++ +| .+..+++|+.|+|++|+|.+. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++..|
T Consensus 98 ~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 98 KIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp CCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 8874 33 677888888888888888853 4577788888888888888754 567788888888888888886555
Q ss_pred hhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCc
Q 036011 512 TIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQ 569 (977)
Q Consensus 512 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 569 (977)
+..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.....+..+..+..
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~ 225 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECCCCCCCSSCEEECC
T ss_pred -hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCCcccccccEEeccc
Confidence 78888888888888888853 3 5788888888888888887544333444443333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.7e-20 Score=188.99 Aligned_cols=135 Identities=23% Similarity=0.292 Sum_probs=76.5
Q ss_pred CCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccC
Q 036011 446 SLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLA 525 (977)
Q Consensus 446 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 525 (977)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 45555555555554444455555555555555555555445555555555555555555553333345555566666666
Q ss_pred CccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCccccc
Q 036011 526 SNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 526 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 580 (977)
+|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|++++|+|.+.
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 6666655555566666666666666666655555555666666666666666553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=195.08 Aligned_cols=191 Identities=27% Similarity=0.346 Sum_probs=163.5
Q ss_pred cccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecC
Q 036011 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLG 453 (977)
Q Consensus 374 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 453 (977)
++..+.+..+.+++. ..+..+++|++|++++|.++.. + .+..+++|+.|++++|++++..+ +..+++|++|+++
T Consensus 25 ~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCcccc--cchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence 344444555555533 3356789999999999999844 4 58899999999999999997655 9999999999999
Q ss_pred CCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccc
Q 036011 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533 (977)
Q Consensus 454 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 533 (977)
+|++++ ++ .+..+++|+.|++++|++++. ..+..+++|++|++++|++++. ..++.+++|+.|+|++|++++..
T Consensus 99 ~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 999996 33 499999999999999999964 5789999999999999999954 67999999999999999999765
Q ss_pred cccccCccccCeeeccCCccCCCCCcccccccccCccccCCCccccc
Q 036011 534 PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 534 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 580 (977)
| +..+++|+.|+|++|++++ +| .+..+++|+.|++++|+++..
T Consensus 173 ~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp G--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred h--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 5 9999999999999999995 55 489999999999999999863
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-19 Score=183.79 Aligned_cols=151 Identities=22% Similarity=0.230 Sum_probs=121.9
Q ss_pred EEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcC
Q 036011 54 ALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNS 133 (977)
Q Consensus 54 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 133 (977)
.+++++++++ .+|..+. +.|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|+.+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3566677777 6887765 789999999999999778899999999999999999997778999999999999999999
Q ss_pred CCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCC
Q 036011 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLS 207 (977)
Q Consensus 134 l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~ 207 (977)
+++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 99655556677778888888777777777777777777777777777777665666777777777777777665
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-19 Score=184.15 Aligned_cols=153 Identities=21% Similarity=0.201 Sum_probs=126.9
Q ss_pred EEEcCCCCCCccCCccccCcccccEeeccCCcccccCC-CCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCc
Q 036011 54 ALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLP-NELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132 (977)
Q Consensus 54 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 132 (977)
.+++++++++ .+|..+. ..+++|+|++|++++..| ..|..+++|++|+|++|++++..+..|+.+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5888888888 6887764 456899999999998655 45889999999999999999766778999999999999999
Q ss_pred CCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCC
Q 036011 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGP 209 (977)
Q Consensus 133 ~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~ 209 (977)
.+++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+...
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99977777788888888888888888877788888888888888888888877777888888888888888877654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=186.26 Aligned_cols=153 Identities=26% Similarity=0.306 Sum_probs=77.3
Q ss_pred CCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccC
Q 036011 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478 (977)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 478 (977)
-+.++.++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345566666555 3443332 4555555555555555555555555555555555555544444445555555555555
Q ss_pred CCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCC
Q 036011 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 479 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 5555444444455555555555555554 444444445555555555555544433444444445555555544443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-21 Score=231.06 Aligned_cols=207 Identities=19% Similarity=0.158 Sum_probs=134.9
Q ss_pred CCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcC-------------CCCCCCCcccCcCccccee-cccccccc
Q 036011 95 GQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNS-------------FTGPIPNSLFNLSRLEKWD-SMFNIIDG 160 (977)
Q Consensus 95 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-------------l~~~~p~~l~~l~~L~~L~-l~~n~i~~ 160 (977)
..+++|+.|+|++|+++ .+|..++.|++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 55777778888888877 778888888888888876664 4556666677777777776 555543
Q ss_pred ccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCcc
Q 036011 161 NIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKV 240 (977)
Q Consensus 161 ~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 240 (977)
.+|+.+.+++|.|+.. |. ..|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+ .+|. .
T Consensus 423 ---------~~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~---~lp~-~ 481 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR---ALPP-A 481 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC---CCCG-G
T ss_pred ---------chhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc---ccch-h
Confidence 2444555555555532 21 136666666666664 343 666666666666666666 3443 4
Q ss_pred ccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccc-ccccccccccccccccccccCCCCCCchhhhhcc
Q 036011 241 SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLI-PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSS 319 (977)
Q Consensus 241 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 319 (977)
+..+++|++|+|++|+|++ +| .+..+++|++|+|++|+|++.. |..|+.+++|+.|+|++|++++.++.. ...
T Consensus 482 ~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~----~~l 555 (567)
T 1dce_A 482 LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ----ERL 555 (567)
T ss_dssp GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT----THH
T ss_pred hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH----HHH
Confidence 4567777777777777774 45 6777777777777777777665 777777777777777777777765532 111
Q ss_pred cccCCCCceEEe
Q 036011 320 LTNCRNLTTLAV 331 (977)
Q Consensus 320 l~~l~~L~~L~L 331 (977)
+..+++|+.|++
T Consensus 556 ~~~lp~L~~L~l 567 (567)
T 1dce_A 556 AEMLPSVSSILT 567 (567)
T ss_dssp HHHCTTCSEEEC
T ss_pred HHHCcccCccCC
Confidence 344677777754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.1e-19 Score=197.83 Aligned_cols=175 Identities=21% Similarity=0.161 Sum_probs=144.1
Q ss_pred EEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcC-CCCCCCEEeCcCccCCCCCCccccccccCcEEeccCc
Q 036011 54 ALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELG-QLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN 132 (977)
Q Consensus 54 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 132 (977)
.+++++++++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|+.+++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 5888999998 6888764 4689999999999998788887 9999999999999999777788999999999999999
Q ss_pred CCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccc---cCCCCCceEEeeccCCCCC
Q 036011 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEI---GNLQNLEILVLGMNNLSGP 209 (977)
Q Consensus 133 ~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l---~~l~~L~~L~l~~N~l~~~ 209 (977)
++++..+..|.++++|++|+|++|.|.+..|..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|+..
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9997777788999999999999999998888899999999999999999985433444 5688899999999988866
Q ss_pred Cchhhccccc--eeEEEccCCccc
Q 036011 210 IQPSIFNIST--ITLINLFGNQLS 231 (977)
Q Consensus 210 ~~~~l~~l~~--L~~L~L~~N~l~ 231 (977)
.+..+..+.. ++.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 6566666654 255666666554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=210.36 Aligned_cols=160 Identities=29% Similarity=0.349 Sum_probs=95.2
Q ss_pred cccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCe
Q 036011 370 GNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE 449 (977)
Q Consensus 370 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 449 (977)
..+++|+.|+|++|.+.+..| +..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|++++. ..+..+++|+.
T Consensus 62 ~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~ 135 (605)
T 1m9s_A 62 QYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLES 135 (605)
T ss_dssp GGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSE
T ss_pred ccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCE
Confidence 344444444444444443332 5555555666666665553 22 455666666666666666542 23666666777
Q ss_pred eecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccc
Q 036011 450 LNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF 529 (977)
Q Consensus 450 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 529 (977)
|+|++|+|++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++
T Consensus 136 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 136 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp EECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEE
T ss_pred EECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcC
Confidence 77777766644 456666777777777777765544 6677777777777777764 33 467777777777777777
Q ss_pred cccccccccCcc
Q 036011 530 EGPIPQTFGSLT 541 (977)
Q Consensus 530 ~~~~p~~~~~l~ 541 (977)
.+.....+..+.
T Consensus 210 ~~~p~~~~~~l~ 221 (605)
T 1m9s_A 210 LNKPINHQSNLV 221 (605)
T ss_dssp ECCCCCCCSSCE
T ss_pred cCCcccccccEE
Confidence 654333333333
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.8e-21 Score=226.54 Aligned_cols=187 Identities=21% Similarity=0.201 Sum_probs=118.0
Q ss_pred cCCccccccccccEEEeecCc-------------cCCCCChhhhccCCCCEEE-eecccccCccccccccccccceeeec
Q 036011 364 NIPHEIGNLRSLIVLSLFINA-------------LNGTIPSTVGRLEQLQGLS-LYGNNLEGSIPYDLCHLERLNGIRLN 429 (977)
Q Consensus 364 ~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~p~~~~~l~~L~~L~L~ 429 (977)
.+|..++.+++|+.|++++|. +.+..|..++.+++|+.|+ ++.|.+. .|..+.++
T Consensus 363 ~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-----------~L~~l~l~ 431 (567)
T 1dce_A 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-----------DLRSKFLL 431 (567)
T ss_dssp HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-----------HHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-----------hhhhhhhh
Confidence 344445555555555544332 3334455555555555555 4444332 34444455
Q ss_pred CCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCc
Q 036011 430 GNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDI 509 (977)
Q Consensus 430 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 509 (977)
+|.++.. |. ..|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +
T Consensus 432 ~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-l 501 (567)
T 1dce_A 432 ENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-V 501 (567)
T ss_dssp HHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-C
T ss_pred ccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-C
Confidence 5555422 21 147777888887775 455 777777777777777777 567777777777777777777774 5
Q ss_pred chhhhcccccceeccCCccccccc-cccccCccccCeeeccCCccCCCCCcc---cccccccCcccc
Q 036011 510 PITIGSLKDLVTLSLASNQFEGPI-PQTFGSLTGLESLDLSNNNLSGEIPKS---LEALLFLKQLNV 572 (977)
Q Consensus 510 p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~l 572 (977)
| .++.+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|+|++..|.. +..+++|+.||+
T Consensus 502 p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 6 6777777777777777777665 777777777777777777777554422 234677777653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-19 Score=188.75 Aligned_cols=171 Identities=22% Similarity=0.316 Sum_probs=123.8
Q ss_pred ccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCee
Q 036011 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLREL 450 (977)
Q Consensus 371 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 450 (977)
.+.++..+++++|.+++ ++ .+..+++|++|++++|+++ .++ .+..+++|+.|++++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 45666677777777773 33 5777888888888888887 344 67778888888888888875544 7788888888
Q ss_pred ecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc
Q 036011 451 NLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530 (977)
Q Consensus 451 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 530 (977)
+|++|++++. |... . ++|+.|++++|++++. ..+..+++|+.|+|++|++++ ++ .++.+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~l-~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCc
Confidence 8888888753 3322 2 7788888888887753 357777788888888888874 33 5777778888888888877
Q ss_pred ccccccccCccccCeeeccCCccCCC
Q 036011 531 GPIPQTFGSLTGLESLDLSNNNLSGE 556 (977)
Q Consensus 531 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ 556 (977)
+. ..+..+++|+.|+|++|++++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 55 5677777788888888877744
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-19 Score=216.02 Aligned_cols=191 Identities=21% Similarity=0.213 Sum_probs=114.3
Q ss_pred eecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCC
Q 036011 380 LFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS 459 (977)
Q Consensus 380 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 459 (977)
+..|.+. ..+..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 55677777788888888888887 66666678888888888888888 77788888888888888888888
Q ss_pred CCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccc-cceeccCCcccccccccccc
Q 036011 460 SIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKD-LVTLSLASNQFEGPIPQTFG 538 (977)
Q Consensus 460 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~ 538 (977)
.+|..|+++++|+.|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence 67888888888888888888887 56777888888888888888888888887766543 234788888888877764
Q ss_pred CccccCeeeccCC--------ccCCCCCcccccccccCccccCCCcccccC
Q 036011 539 SLTGLESLDLSNN--------NLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 539 ~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
|+.|++++| .|.+..+..+..+..+....+++|-+.+..
T Consensus 361 ----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~ 407 (727)
T 4b8c_D 361 ----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHY 407 (727)
T ss_dssp ---------------------------------------------CCCGGG
T ss_pred ----cceeEeecccccccccCCccccccchhhcccccceeeeecccccccc
Confidence 455667766 344444444556666666777777665433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.8e-19 Score=185.96 Aligned_cols=170 Identities=19% Similarity=0.256 Sum_probs=112.4
Q ss_pred CcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccce
Q 036011 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKW 151 (977)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 151 (977)
++.+++.+++++|.++.. + .+..+++|++|++++|+++ .+| .++.+++|++|+|++|++++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 456677777777777763 3 5677777777777777777 555 57777777777777777775433 6777777777
Q ss_pred eccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCccc
Q 036011 152 DSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLS 231 (977)
Q Consensus 152 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 231 (977)
++++|.+++ +|... . ++|++|+|++|++++ ++ .++++++|+.|++++|++++. +.+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCc
Confidence 777777764 33322 2 677777777777774 33 577777777777777777753 25666666666666666665
Q ss_pred ccccCCCccccCCCCceEEEecCceeee
Q 036011 232 GHLDLPPKVSYSLPNLRVFSLGKNKLTG 259 (977)
Q Consensus 232 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 259 (977)
+. ..+..+++|+.|++++|++++
T Consensus 164 ~~-----~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 164 NT-----GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp BC-----TTSTTCCCCCEEEEEEEEEEC
T ss_pred ch-----HHhccCCCCCEEeCCCCcccC
Confidence 32 233455666666666666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.3e-18 Score=174.70 Aligned_cols=154 Identities=18% Similarity=0.262 Sum_probs=80.3
Q ss_pred hhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCc
Q 036011 393 VGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLL 472 (977)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 472 (977)
.+.+++|++|++++|.++ .+| .+..+++|+.|++++|.++. +..+..+++|++|++++|++++..+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~---------- 105 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKI---------- 105 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGS----------
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccC----------
Confidence 355666666666666666 333 45555555555555554431 2244455555555555555554444
Q ss_pred eEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcc-ccccccccccCccccCeeeccCC
Q 036011 473 AVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQ-FEGPIPQTFGSLTGLESLDLSNN 551 (977)
Q Consensus 473 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N 551 (977)
..|..+++|++|+|++|++++..|..++.+++|+.|+|++|+ ++ .+| .+..+++|+.|+|++|
T Consensus 106 --------------~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 106 --------------PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFD 169 (197)
T ss_dssp --------------CCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTB
T ss_pred --------------hhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCC
Confidence 444445555555555555554445555555555555555555 33 233 3555555555555555
Q ss_pred ccCCCCCcccccccccCccccCCCccc
Q 036011 552 NLSGEIPKSLEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 552 ~l~~~~p~~~~~l~~L~~L~l~~N~l~ 578 (977)
++++ ++ .+..+++|+.|++++|++.
T Consensus 170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 170 GVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 5553 22 4555555666666665553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=174.31 Aligned_cols=155 Identities=17% Similarity=0.227 Sum_probs=120.4
Q ss_pred cccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCC
Q 036011 368 EIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISL 447 (977)
Q Consensus 368 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 447 (977)
....+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 4578899999999999999 566 7999999999999999876 34578999999999999999998788899999999
Q ss_pred CeeecCCCcCCCCCCccccCcccCceEEccCCC-CCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCC
Q 036011 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNS-LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526 (977)
Q Consensus 448 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 526 (977)
++|++++|++++..|..+..+++|+.|++++|. ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 999999999997777777777777777777776 55 333 46666666666666666663 33 455555566666665
Q ss_pred cccc
Q 036011 527 NQFE 530 (977)
Q Consensus 527 N~l~ 530 (977)
|++.
T Consensus 191 N~i~ 194 (197)
T 4ezg_A 191 QTIG 194 (197)
T ss_dssp C---
T ss_pred cccC
Confidence 5554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-18 Score=175.94 Aligned_cols=131 Identities=26% Similarity=0.355 Sum_probs=79.3
Q ss_pred ceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCc-cccCcccCceEEccCCCCCCCCccccccccccCeeeCcC
Q 036011 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS-SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSR 502 (977)
Q Consensus 424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 502 (977)
+.+++++|+++ .+|..+.. +|++|++++|+|++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56667777765 45544432 666666666666654443 356666666666666666655566666666666666666
Q ss_pred CcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCC
Q 036011 503 NQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557 (977)
Q Consensus 503 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 557 (977)
|+|++..|..|..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|++++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 6666555555666666666666666666555666666666666666666665543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=189.28 Aligned_cols=102 Identities=11% Similarity=0.016 Sum_probs=55.9
Q ss_pred ccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCc-eEEccCCCCCCCCccccccccccCee
Q 036011 420 LERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLL-AVNLSSNSLSGSLPSNIQNLQVLINL 498 (977)
Q Consensus 420 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L 498 (977)
+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++.+|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 445555555555555444445555555555555555 4444555555555555 555555 4444445556666666666
Q ss_pred eCcCCcCCCCcchhhhcccccceec
Q 036011 499 DLSRNQLSGDIPITIGSLKDLVTLS 523 (977)
Q Consensus 499 ~Ls~N~l~~~~p~~~~~l~~L~~L~ 523 (977)
++++|+++...+..|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 6666666544444566666665554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-18 Score=182.63 Aligned_cols=137 Identities=18% Similarity=0.252 Sum_probs=107.1
Q ss_pred CCcCccccCcceEEEEEEEe-CCCCE--EEEEEeeccchh------------------------hHHHHHHHHHHHHhcC
Q 036011 685 FNECNLLGRGSFGSVYKGTF-SDGTS--FAIKVFNLQLDR------------------------AFRSFDSECEVLRNVR 737 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 737 (977)
|.+.+.||+|+||.||+|+. .+|+. ||||+++..... ....+.+|++.+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999997 68889 999997543211 1135789999999998
Q ss_pred CCCc--ceEeeeeecCCeeEEEEeccCC-C----CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 036011 738 HRNL--IKIFSSCCNNDFRALVLELMPN-G----SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810 (977)
Q Consensus 738 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 810 (977)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||+|||. +.||+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8764 333332 356899999942 3 67766533 2345677899999999999994 4789999999
Q ss_pred CCceeeCCCCceEEeeccccccc
Q 036011 811 PSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 811 ~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
|.|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=167.97 Aligned_cols=132 Identities=25% Similarity=0.318 Sum_probs=74.2
Q ss_pred CeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCcc-ccccccccCeeeCcCCcCCCCcchhhhcccccceeccCC
Q 036011 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS-NIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526 (977)
Q Consensus 448 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 526 (977)
+.+++++|+++ .+|..+.. +|+.|++++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555554 34443322 555566666665544332 255555666666666666555555555556666666666
Q ss_pred ccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCC
Q 036011 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 527 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|++++|+|+|..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 66655555555555666666666666655555555555566666666666655544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-17 Score=182.27 Aligned_cols=102 Identities=16% Similarity=0.125 Sum_probs=72.7
Q ss_pred CCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccC-eeeCcCCcCCCCcchhhhccccccee
Q 036011 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI-NLDLSRNQLSGDIPITIGSLKDLVTL 522 (977)
Q Consensus 444 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 522 (977)
+++|+.|+|++|+++.+.+..|.++++|+.|++.+| ++.+.+.+|.++.+|+ .|++.+ .++...+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 567777777777777666667777777777777776 6656666777777777 777776 5654445677777777777
Q ss_pred ccCCccccccccccccCccccCeee
Q 036011 523 SLASNQFEGPIPQTFGSLTGLESLD 547 (977)
Q Consensus 523 ~Ls~N~l~~~~p~~~~~l~~L~~L~ 547 (977)
++++|+++...+.+|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 7777777766666777777777765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.5e-17 Score=163.08 Aligned_cols=111 Identities=26% Similarity=0.353 Sum_probs=61.9
Q ss_pred cCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeecc
Q 036011 470 YLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLS 549 (977)
Q Consensus 470 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 549 (977)
+|+.|++++|+|+ .+|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4455555555554 344555555555555555555554444455555555555555555555555556666666666666
Q ss_pred CCccCCCCCcccccccccCccccCCCcccccC
Q 036011 550 NNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 550 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
+|+|++..+..|..+++|+.|++++|+|.+..
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 66665444444555666666666666665543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=155.63 Aligned_cols=133 Identities=25% Similarity=0.263 Sum_probs=95.8
Q ss_pred CCCCeeecCCCcCC-CCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceec
Q 036011 445 ISLRELNLGSNKFS-SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523 (977)
Q Consensus 445 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 523 (977)
++|++|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 55666677777777777777777754 6677777777777777777766777777777777777
Q ss_pred cCCccccccc-cccccCccccCeeeccCCccCCCCC---cccccccccCccccCCCcccc
Q 036011 524 LASNQFEGPI-PQTFGSLTGLESLDLSNNNLSGEIP---KSLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 524 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~ 579 (977)
|++|++++.. +..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 7777777532 2667777888888888888775444 367777888888888877653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=156.60 Aligned_cols=135 Identities=26% Similarity=0.243 Sum_probs=76.2
Q ss_pred ccceeeecCCccC-CCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeC
Q 036011 422 RLNGIRLNGNKLS-GPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDL 500 (977)
Q Consensus 422 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 500 (977)
+|+.|++++|+++ +.+|..+..+++|++|++++|++++. ..+..+++|+.|++++|++++.+|..+..+++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 3444444444443 33444444445555555555555533 44555555555555555555545555555666666666
Q ss_pred cCCcCCCCc-chhhhcccccceeccCCcccccccc---ccccCccccCeeeccCCccCCCCCc
Q 036011 501 SRNQLSGDI-PITIGSLKDLVTLSLASNQFEGPIP---QTFGSLTGLESLDLSNNNLSGEIPK 559 (977)
Q Consensus 501 s~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~ 559 (977)
++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 666666321 1556666677777777777765443 36667777777777777765 4443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.4e-16 Score=151.94 Aligned_cols=128 Identities=23% Similarity=0.274 Sum_probs=87.1
Q ss_pred CCCCeeecCCCcCC-CCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceec
Q 036011 445 ISLRELNLGSNKFS-SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLS 523 (977)
Q Consensus 445 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 523 (977)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..++.+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 55566666666666666666666644 5566677777777777777755666666777777777
Q ss_pred cCCcccccc-ccccccCccccCeeeccCCccCCCCC---cccccccccCccccCC
Q 036011 524 LASNQFEGP-IPQTFGSLTGLESLDLSNNNLSGEIP---KSLEALLFLKQLNVSH 574 (977)
Q Consensus 524 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~ 574 (977)
+++|++++. .|..++.+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777753 34667777777777777777775544 4677777777777753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=152.28 Aligned_cols=133 Identities=22% Similarity=0.266 Sum_probs=81.8
Q ss_pred CCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCC
Q 036011 36 PICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFP 115 (977)
Q Consensus 36 ~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 115 (977)
+.|+|.++.|. +++++ .+|..+ .+.|++|+|++|++++..+..|..+++|++|+|++|++++..+
T Consensus 5 C~C~~~~l~~~------------~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 5 CSCSGTEIRCN------------SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp CEEETTEEECC------------SSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEeCCCEEEec------------CCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 34677766664 34555 456544 3678888888888887666677888888888888888875555
Q ss_pred ccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccccc
Q 036011 116 SWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ 183 (977)
Q Consensus 116 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~ 183 (977)
..++.+++|++|+|++|++++..+..+.++++|++|++++|.+++..+..+..+++|++|+|++|.+.
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 56677788888888888777554444444444444444444444333333333444444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.1e-16 Score=153.91 Aligned_cols=129 Identities=28% Similarity=0.292 Sum_probs=62.6
Q ss_pred ceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCC
Q 036011 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503 (977)
Q Consensus 424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (977)
+.+++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45556666655 2333222 35555555555555444444555555555555555555444444445555555555555
Q ss_pred cCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCC
Q 036011 504 QLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 504 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5543333334444444444444444443333334444444444444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-16 Score=149.67 Aligned_cols=128 Identities=21% Similarity=0.222 Sum_probs=92.6
Q ss_pred cccceeeecCCccC-CCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeee
Q 036011 421 ERLNGIRLNGNKLS-GPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLD 499 (977)
Q Consensus 421 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 499 (977)
++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|+.|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666666666665 55666666677777777777777754 5667777777777777777766777777778888888
Q ss_pred CcCCcCCCC-cchhhhcccccceeccCCcccccccc---ccccCccccCeeeccC
Q 036011 500 LSRNQLSGD-IPITIGSLKDLVTLSLASNQFEGPIP---QTFGSLTGLESLDLSN 550 (977)
Q Consensus 500 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 550 (977)
+++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888742 23677888888888888888886555 4677888888888764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-15 Score=152.24 Aligned_cols=108 Identities=23% Similarity=0.275 Sum_probs=55.5
Q ss_pred CCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeee
Q 036011 99 RLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLA 178 (977)
Q Consensus 99 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~ 178 (977)
+|++|+|++|+++ .+|..|+.+++|++|+|++|.+++..+..|.++++|++|+|++|.|++..|..|+++++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 3444444444444 344444444444444444444444434444444444444444444444444455556666666666
Q ss_pred cccccccCCccccCCCCCceEEeeccCCC
Q 036011 179 YNNLQGEIPSEIGNLQNLEILVLGMNNLS 207 (977)
Q Consensus 179 ~n~i~~~~p~~l~~l~~L~~L~l~~N~l~ 207 (977)
+|+|+...+..|..+++|+.|+|++|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66666444445666666666666666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-16 Score=173.65 Aligned_cols=140 Identities=14% Similarity=0.129 Sum_probs=102.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccch--------------hhH--------HHHHHHHHHHHhcCCCC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD--------------RAF--------RSFDSECEVLRNVRHRN 740 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~e~~~l~~l~h~n 740 (977)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ... ....+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998753210 000 11245677777775554
Q ss_pred cceEeeeeecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC
Q 036011 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM 820 (977)
Q Consensus 741 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 820 (977)
+....-+... ..++||||++|++|.++... .....++.|++.+|.||| +.|||||||||.|||+++++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence 4322212111 23699999999998765422 234568899999999999 78999999999999998776
Q ss_pred ----------ceEEeecccccccC
Q 036011 821 ----------VAHVSDFGLSKLFD 834 (977)
Q Consensus 821 ----------~~kl~Dfgla~~~~ 834 (977)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999886543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-17 Score=166.64 Aligned_cols=135 Identities=24% Similarity=0.287 Sum_probs=105.9
Q ss_pred hhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhccc
Q 036011 438 PQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLK 517 (977)
Q Consensus 438 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 517 (977)
|..+..+++|++|+|++|++++ +| .+..+++|+.|++++|+++ .+|..+..+++|++|+|++|++++ +| .++.++
T Consensus 41 ~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~ 115 (198)
T 1ds9_A 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV 115 (198)
T ss_dssp HHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHH
T ss_pred hHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCC
Confidence 3477888888888888888885 55 7788888888888888888 567777778888888888888884 55 688888
Q ss_pred ccceeccCCcccccccc-ccccCccccCeeeccCCccCCCCCcc----------cccccccCccccCCCcccc
Q 036011 518 DLVTLSLASNQFEGPIP-QTFGSLTGLESLDLSNNNLSGEIPKS----------LEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 518 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~l~~N~l~~ 579 (977)
+|+.|+|++|++++..+ ..+..+++|+.|++++|++++.+|.. +..+++|+.|| +|+++.
T Consensus 116 ~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 88888888888885432 46888888888888888887665543 77888888886 676653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1e-14 Score=164.20 Aligned_cols=88 Identities=10% Similarity=0.152 Sum_probs=40.2
Q ss_pred ccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCccccccc
Q 036011 486 PSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALL 565 (977)
Q Consensus 486 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 565 (977)
+.+|.++.+|+.++|. |.++......|.++.+|+.++|..| ++.+.+.+|.++ +|+.|++++|.+....+..|..++
T Consensus 293 ~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~ 369 (401)
T 4fdw_A 293 PYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFP 369 (401)
T ss_dssp TTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSC
T ss_pred HHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCC
Confidence 3444444555555554 2243233334555555555555333 443344455555 555555555554433334444442
Q ss_pred -ccCccccCCCc
Q 036011 566 -FLKQLNVSHNK 576 (977)
Q Consensus 566 -~L~~L~l~~N~ 576 (977)
.++.|++..|.
T Consensus 370 ~~l~~l~vp~~~ 381 (401)
T 4fdw_A 370 DDITVIRVPAES 381 (401)
T ss_dssp TTCCEEEECGGG
T ss_pred CCccEEEeCHHH
Confidence 34445444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.4e-14 Score=161.12 Aligned_cols=249 Identities=14% Similarity=0.115 Sum_probs=163.3
Q ss_pred cccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCccccee
Q 036011 73 FSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWD 152 (977)
Q Consensus 73 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 152 (977)
+..++.+.+.+ .++.+-..+|.++ +|+.+.|..| ++..-..+|.++ +|+.+.|.. .++...+..|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35566666653 4555555667764 6888887766 553334456663 577787775 56655566777777788888
Q ss_pred ccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccc
Q 036011 153 SMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSG 232 (977)
Q Consensus 153 l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 232 (977)
+..|.++......|. ..+|+.+.|..+ ++.....+|.++++|+.+++..| ++.....+|.+ .+|+.+.+.+ .++
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~-~i~- 260 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPN-GVT- 260 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEET-TCC-
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCC-Ccc-
Confidence 777777755555555 477777777744 66455567777788888887764 45444445555 6777777743 343
Q ss_pred cccCCCccccCCCCceEEEecCceee-----ecCCcccccccccceEeecccccccccccccccccccccccccccccCC
Q 036011 233 HLDLPPKVSYSLPNLRVFSLGKNKLT-----GTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTT 307 (977)
Q Consensus 233 ~~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 307 (977)
.++..+|..+++|+.+.+.+|.+. .+.+..|..+.+|+.++|. +.++.+...+|.++.+|+.+.+..| ++.
T Consensus 261 --~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~ 336 (401)
T 4fdw_A 261 --NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQ 336 (401)
T ss_dssp --EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCE
T ss_pred --EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccE
Confidence 466777777777777777777664 3556677777777777777 4466677777777777777777544 555
Q ss_pred CCCCchhhhhcccccCCCCceEEecCCCCCCCCCccc
Q 036011 308 DSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344 (977)
Q Consensus 308 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 344 (977)
+...+ |.++ +|+.+++.+|.+....+..+
T Consensus 337 I~~~a-------F~~~-~L~~l~l~~n~~~~l~~~~F 365 (401)
T 4fdw_A 337 INFSA-------FNNT-GIKEVKVEGTTPPQVFEKVW 365 (401)
T ss_dssp ECTTS-------SSSS-CCCEEEECCSSCCBCCCSSC
T ss_pred EcHHh-------CCCC-CCCEEEEcCCCCcccccccc
Confidence 55543 6677 77777777776654433333
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.57 E-value=4e-14 Score=160.12 Aligned_cols=67 Identities=9% Similarity=-0.045 Sum_probs=32.1
Q ss_pred CCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEee
Q 036011 134 FTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLG 202 (977)
Q Consensus 134 l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~ 202 (977)
++......|.++++|+.+.+..+ ++......|.++++|+.+++.++ ++.....+|.++++|+.+.+.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 33333445555566666655432 44333445555555555555433 332333445555555554443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.8e-14 Score=159.50 Aligned_cols=330 Identities=13% Similarity=0.037 Sum_probs=154.0
Q ss_pred CccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCC
Q 036011 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQ 194 (977)
Q Consensus 115 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~ 194 (977)
..+|.++++|+.+.|..+ ++......|.++++|+.+++..+ ++......|.++.+|+.+.+..+ +......+|.++.
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 345677777777777643 55455566777777777777654 44344556777777777665543 3323344555543
Q ss_pred CCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceE
Q 036011 195 NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGL 274 (977)
Q Consensus 195 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 274 (977)
.++...... .. .+...+|..+.+|+.+.+..+..+ +....|.++.+|+.+
T Consensus 141 ~~~~~~~~~--~~---------------------------~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i 190 (394)
T 4fs7_A 141 FKEITIPEG--VT---------------------------VIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSI 190 (394)
T ss_dssp CSEEECCTT--CC---------------------------EECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBC
T ss_pred ccccccCcc--cc---------------------------ccchhhhcccCCCcEEecCCccce-eccccccCCCCceEE
Confidence 322221111 11 112233333444444444333222 333344444455555
Q ss_pred eecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccccccccccccc
Q 036011 275 DLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354 (977)
Q Consensus 275 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L 354 (977)
++..| ++.+...+|.+...|+.+.+..+...- .. ......+
T Consensus 191 ~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i-~~--------~~~~~~~----------------------------- 231 (394)
T 4fs7_A 191 KLPRN-LKIIRDYCFAECILLENMEFPNSLYYL-GD--------FALSKTG----------------------------- 231 (394)
T ss_dssp CCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEE-CT--------TTTTTCC-----------------------------
T ss_pred EcCCC-ceEeCchhhccccccceeecCCCceEe-eh--------hhcccCC-----------------------------
Confidence 54443 333334444444444444443332110 00 0111122
Q ss_pred ccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccC
Q 036011 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLS 434 (977)
Q Consensus 355 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 434 (977)
|+.+.+..+ ++.....+|..+..|+.+.+..+... .....|..+..++.+....+.+
T Consensus 232 --------------------l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i- 288 (394)
T 4fs7_A 232 --------------------VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV- 288 (394)
T ss_dssp --------------------CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE-
T ss_pred --------------------CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee-
Confidence 233333211 11122333444444444444444332 3334444445555444444332
Q ss_pred CCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhh
Q 036011 435 GPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIG 514 (977)
Q Consensus 435 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 514 (977)
...+|..+.+|+.+.+.++ ++.+...+|.++++|+.+++.++ ++.+...+|.++.+|+.+++..| ++..-..+|.
T Consensus 289 --~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 289 --PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp --CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred --ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 1234445555555555443 34344455555555555555433 44344455666666666666554 4433344566
Q ss_pred cccccceeccCCccccccccccccCccccCee
Q 036011 515 SLKDLVTLSLASNQFEGPIPQTFGSLTGLESL 546 (977)
Q Consensus 515 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 546 (977)
++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 364 ~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 364 GCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 6666666666543 22 234556666666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=3.8e-15 Score=147.96 Aligned_cols=131 Identities=21% Similarity=0.210 Sum_probs=75.6
Q ss_pred cCCCCCCeeecCCCcCCCCCCccccCcc-cCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccc
Q 036011 442 ASLISLRELNLGSNKFSSSIPSSFWSLE-YLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV 520 (977)
Q Consensus 442 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 520 (977)
..+.+|++|++++|+++. +|. +..+. +|+.|++++|.|++. ..|..+++|++|+|++|++++..+..++.+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 344455555555555552 232 23332 555555555555542 4555666666666666666643333446666666
Q ss_pred eeccCCccccccccc--cccCccccCeeeccCCccCCCCCcc----cccccccCccccCCCccc
Q 036011 521 TLSLASNQFEGPIPQ--TFGSLTGLESLDLSNNNLSGEIPKS----LEALLFLKQLNVSHNKLE 578 (977)
Q Consensus 521 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 578 (977)
.|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|.. +..+++|+.||+++|...
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666666665 3444 5666667777777777766 44543 666777777777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-16 Score=161.99 Aligned_cols=155 Identities=24% Similarity=0.257 Sum_probs=108.0
Q ss_pred hccCCCCEEEeecccccCcccc------ccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccC
Q 036011 394 GRLEQLQGLSLYGNNLEGSIPY------DLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWS 467 (977)
Q Consensus 394 ~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 467 (977)
.....++.++++.+.+++.+|. .+..+++|++|++++|++++ +| .+..+++|++|++++|+++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3344444445555555444443 56666666666666666664 44 6666777777777777777 45666667
Q ss_pred cccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcc-hhhhcccccceeccCCcccccccccc----------
Q 036011 468 LEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIP-ITIGSLKDLVTLSLASNQFEGPIPQT---------- 536 (977)
Q Consensus 468 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~---------- 536 (977)
+++|+.|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|++++|++++.+|..
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 7788888888888875 44 57888888888888888874222 36888888999999999888766653
Q ss_pred ccCccccCeeeccCCccCC
Q 036011 537 FGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 537 ~~~l~~L~~L~Ls~N~l~~ 555 (977)
+..+++|+.|| +|.++.
T Consensus 170 ~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHCSSCSEEC--CGGGTT
T ss_pred HHhCCCcEEEC--CcccCH
Confidence 78889999887 777763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=5.4e-15 Score=146.83 Aligned_cols=133 Identities=21% Similarity=0.213 Sum_probs=87.7
Q ss_pred cccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccC
Q 036011 417 LCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496 (977)
Q Consensus 417 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 496 (977)
+..+.+|+.|++++|+++. +|......++|++|++++|+|++. ..|..+++|+.|++++|+|++..+..|..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 4445556666666666653 333222223677777777777654 4566677777777777777754444457777777
Q ss_pred eeeCcCCcCCCCcch--hhhcccccceeccCCcccccccccc----ccCccccCeeeccCCccC
Q 036011 497 NLDLSRNQLSGDIPI--TIGSLKDLVTLSLASNQFEGPIPQT----FGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 497 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 554 (977)
+|+|++|+++ .+|. .+..+++|+.|++++|+++ .+|.. ++.+++|+.||+++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777775 5555 6777777888888888877 34553 777788888888888765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-14 Score=138.75 Aligned_cols=106 Identities=25% Similarity=0.266 Sum_probs=59.5
Q ss_pred CCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCC
Q 036011 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526 (977)
Q Consensus 447 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 526 (977)
.+.+++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566666666663 444332 5556666666666655555555556666666666665544444455555555555555
Q ss_pred ccccccccccccCccccCeeeccCCccCC
Q 036011 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 527 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
|+|++..+..|..+++|+.|+|++|++++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 55555444455555555555555555553
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=136.39 Aligned_cols=104 Identities=21% Similarity=0.244 Sum_probs=64.0
Q ss_pred CeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCc
Q 036011 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASN 527 (977)
Q Consensus 448 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 527 (977)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56677777776 4554443 56666666666666655666666666666666666666444444566666666666666
Q ss_pred cccccccccccCccccCeeeccCCccC
Q 036011 528 QFEGPIPQTFGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 528 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 554 (977)
+|++..+..|..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666544444666666666666666665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=133.97 Aligned_cols=109 Identities=26% Similarity=0.276 Sum_probs=73.1
Q ss_pred CceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccC
Q 036011 471 LLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSN 550 (977)
Q Consensus 471 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 550 (977)
.+.+++++|.++. +|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566777777763 454442 5667777777777766666677777777777777777766666666777777777777
Q ss_pred CccCCCCCcccccccccCccccCCCcccccCC
Q 036011 551 NNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 551 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 77775555556677777777777777766654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-13 Score=133.66 Aligned_cols=108 Identities=27% Similarity=0.293 Sum_probs=60.7
Q ss_pred ceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCC
Q 036011 472 LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNN 551 (977)
Q Consensus 472 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 551 (977)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45556666655 3444443 55566666666666555555666666666666666666544444555666666666666
Q ss_pred ccCCCCCcccccccccCccccCCCcccccCC
Q 036011 552 NLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 552 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
+|++..+..|..+++|++|+|++|+|.+..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 6654433345556666666666666655443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-11 Score=139.23 Aligned_cols=308 Identities=10% Similarity=0.129 Sum_probs=127.1
Q ss_pred CccccCCCCCceEEeeccC---CCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCc
Q 036011 187 PSEIGNLQNLEILVLGMNN---LSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPN 263 (977)
Q Consensus 187 p~~l~~l~~L~~L~l~~N~---l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 263 (977)
..+|.++++|+.+.++.|. ++.....+|.++.+|+.+.+..+ ++ .++..+|..+.+|+.+.+..+.-. +...
T Consensus 80 ~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~---~I~~~aF~~c~~L~~i~lp~~~~~-I~~~ 154 (394)
T 4gt6_A 80 SNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT---EIDSEAFHHCEELDTVTIPEGVTS-VADG 154 (394)
T ss_dssp TTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS---EECTTTTTTCTTCCEEECCTTCCE-ECTT
T ss_pred HHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc---eehhhhhhhhcccccccccceeee-eccc
Confidence 3445555555555554442 33233344444555554444433 11 344555555566666666543322 4445
Q ss_pred ccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcc
Q 036011 264 SITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPV 343 (977)
Q Consensus 264 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 343 (977)
.|..+.+|+.+.+..+ ++.+...+|.. ..|+.+.+..+-. .+... .+..+.+++......+...... ..
T Consensus 155 ~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~-------af~~c~~l~~~~~~~~~~~~~~-~~ 223 (394)
T 4gt6_A 155 MFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGTN-------AFSECFALSTITSDSESYPAID-NV 223 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECTT-------TTTTCTTCCEEEECCSSSCBSS-SC
T ss_pred ceecccccccccccce-eeEeccccccc-cceeEEEECCccc-ccccc-------hhhhccccceeccccccccccc-ce
Confidence 5566666666666543 33344444543 3455555543321 11111 2555566666555544332110 00
Q ss_pred cccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCcccccccccccc
Q 036011 344 IGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERL 423 (977)
Q Consensus 344 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 423 (977)
+.. .+.........+.....+..+.+. +.++.....+|.++.+|+.+.+.++..+ +..
T Consensus 224 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~--------- 281 (394)
T 4gt6_A 224 LYE-----------KSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGT--------- 281 (394)
T ss_dssp EEE-----------ECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECT---------
T ss_pred eec-----------ccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecC---------
Confidence 000 000000000001111122222221 1122223344555555555555433322 233
Q ss_pred ceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCC
Q 036011 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503 (977)
Q Consensus 424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (977)
.+|.++++|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+
T Consensus 282 ---------------~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 282 ---------------GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp ---------------TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred ---------------cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 344444444444443 2233333444555555555555432 33333445555555555555433
Q ss_pred cCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCcc
Q 036011 504 QLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553 (977)
Q Consensus 504 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 553 (977)
++..-..+|.++.+|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 345 -v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 345 -VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp -CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred -cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 432334455566666666665554331 3455555666666655543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-14 Score=159.18 Aligned_cols=87 Identities=22% Similarity=0.266 Sum_probs=43.0
Q ss_pred ccCceEEccCCCCCC----CCccccccccccCeeeCcCCcCCCC----cchhhhcccccceeccCCcccccc----cccc
Q 036011 469 EYLLAVNLSSNSLSG----SLPSNIQNLQVLINLDLSRNQLSGD----IPITIGSLKDLVTLSLASNQFEGP----IPQT 536 (977)
Q Consensus 469 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 536 (977)
++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.. ++..+...++|+.|+|++|.|++. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 344444444444432 1223334455555566666655431 133444555666666666666532 2233
Q ss_pred ccCccccCeeeccCCccCC
Q 036011 537 FGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 537 ~~~l~~L~~L~Ls~N~l~~ 555 (977)
+...++|++|||++|+|+.
T Consensus 235 L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHCSSCCEEECTTSSCCH
T ss_pred HHhCCCCCEEeccCCCCCH
Confidence 3344566666666666653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-11 Score=137.09 Aligned_cols=335 Identities=11% Similarity=0.088 Sum_probs=177.6
Q ss_pred CCccccCCC-CCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcc
Q 036011 186 IPSEIGNLQ-NLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNS 264 (977)
Q Consensus 186 ~p~~l~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 264 (977)
...+|.++. .|+.+.+..+ ++.+...+|.++.+|+.+.+..|.-.....+...+|..+.+|+.+.+..+ ++.+-...
T Consensus 55 g~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~a 132 (394)
T 4gt6_A 55 GDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEA 132 (394)
T ss_dssp CTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTT
T ss_pred CHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhh
Confidence 345676664 5777777644 55455556666666666666665422222445555555555555554433 22233444
Q ss_pred cccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCccc
Q 036011 265 ITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVI 344 (977)
Q Consensus 265 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 344 (977)
|..+.+|+.+.+..+ +..+....|.....|+.+.+.++ ++.+...+ |. ..+|+.+.+..+..
T Consensus 133 F~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~a-------F~-~~~l~~i~ip~~~~-------- 194 (394)
T 4gt6_A 133 FHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERA-------FT-GTALTQIHIPAKVT-------- 194 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTT-------TT-TCCCSEEEECTTCC--------
T ss_pred hhhhcccccccccce-eeeecccceecccccccccccce-eeEecccc-------cc-ccceeEEEECCccc--------
Confidence 555555555555432 22233444444555555544332 22222211 11 12233333322110
Q ss_pred ccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccc
Q 036011 345 GNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424 (977)
Q Consensus 345 ~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 424 (977)
..-...|..+.++.......+... .....+.. .+.........+.....+.
T Consensus 195 ------------------~i~~~af~~c~~l~~~~~~~~~~~-~~~~~~~~----------~~~~~~~~~~~~~~~~~~~ 245 (394)
T 4gt6_A 195 ------------------RIGTNAFSECFALSTITSDSESYP-AIDNVLYE----------KSANGDYALIRYPSQREDP 245 (394)
T ss_dssp ------------------EECTTTTTTCTTCCEEEECCSSSC-BSSSCEEE----------ECTTSCEEEEECCTTCCCS
T ss_pred ------------------ccccchhhhccccceecccccccc-cccceeec----------ccccccccccccccccccc
Confidence 011222333444444433333222 11111000 0000000001112223344
Q ss_pred eeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCc
Q 036011 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504 (977)
Q Consensus 425 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 504 (977)
.+.+.. .+..+-..+|.++..|+.+.+.++... +....|.++.+|+.+.+. +.++.+...+|.++.+|+.++|..+
T Consensus 246 ~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~- 321 (394)
T 4gt6_A 246 AFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG- 321 (394)
T ss_dssp EEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-
T ss_pred eEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-
Confidence 444432 233344567888889999998776554 677788899999999986 4566566778999999999999765
Q ss_pred CCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcc
Q 036011 505 LSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577 (977)
Q Consensus 505 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 577 (977)
++..-..+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|... -..+.....|+.+.+..|.+
T Consensus 322 v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 322 ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence 55344568888999999999655 66566778999999999999888654 14566677788887766644
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=6.7e-14 Score=155.97 Aligned_cols=168 Identities=17% Similarity=0.147 Sum_probs=121.3
Q ss_pred cccccEEEeecCccCCCCChhhhcc-----CCCCEEEeecccccCccccccc-cccccceeeecCCccCCCchhhh----
Q 036011 372 LRSLIVLSLFINALNGTIPSTVGRL-----EQLQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLSGPIPQCL---- 441 (977)
Q Consensus 372 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~---- 441 (977)
++.|+.|+|++|.++......+... ++|++|+|++|.++......+. .+++|+.|+|++|+++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4567788888888875544454443 6888888888888754343333 46788888999998875444444
Q ss_pred -cCCCCCCeeecCCCcCCCC----CCccccCcccCceEEccCCCCCCC----CccccccccccCeeeCcCCcCCCC----
Q 036011 442 -ASLISLRELNLGSNKFSSS----IPSSFWSLEYLLAVNLSSNSLSGS----LPSNIQNLQVLINLDLSRNQLSGD---- 508 (977)
Q Consensus 442 -~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---- 508 (977)
...++|++|+|++|.|+.. ++..+...++|++|+|++|.|+.. ++..+...++|++|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 2467899999999988742 334446778899999999998742 355677788999999999999853
Q ss_pred cchhhhcccccceeccCCccccccccccccC
Q 036011 509 IPITIGSLKDLVTLSLASNQFEGPIPQTFGS 539 (977)
Q Consensus 509 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 539 (977)
++..+...++|++|+|++|.|++.....+..
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 3445566789999999999998665555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=5.2e-12 Score=140.19 Aligned_cols=107 Identities=19% Similarity=0.170 Sum_probs=91.1
Q ss_pred CcccceEecCCCCcEEEEEcCCC-CCCccCCccccCcccccEeeccC-CcccccCCCCcCCCCCCCEEeCcCccCCCCCC
Q 036011 38 CKWVGISCGARHQRVRALNLSNM-GLRGTIPPHLGNFSFLMSLDISK-NNFHAYLPNELGQLRRLRFISLDYNEFSGSFP 115 (977)
Q Consensus 38 c~w~gv~c~~~~~~v~~L~l~~~-~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 115 (977)
|.|.+|.| +++ +|+ .+|+ ++.+++|++|+|++ |+|++..|..|.+|++|++|+|++|+|++..|
T Consensus 8 C~~~~v~~------------~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 8 HGSSGLRC------------TRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp SSSSCEEC------------CSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred ccCCEEEc------------CCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 77766555 445 677 5898 99999999999996 99999777899999999999999999998888
Q ss_pred ccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccc
Q 036011 116 SWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIID 159 (977)
Q Consensus 116 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~ 159 (977)
..|+.|++|++|+|++|+|++..+..+..++ |+.|+|.+|.+.
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 8999999999999999999966555555555 888888888876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=5.6e-12 Score=139.95 Aligned_cols=103 Identities=23% Similarity=0.210 Sum_probs=53.1
Q ss_pred eecCCC-cCCCCCCccccCcccCceEEccC-CCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCc
Q 036011 450 LNLGSN-KFSSSIPSSFWSLEYLLAVNLSS-NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASN 527 (977)
Q Consensus 450 L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 527 (977)
++++++ +++ .+|. +..+++|+.|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|+.+++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344444 444 2333 44444555555543 5555444445555555555555555555544555555555555555555
Q ss_pred cccccccccccCccccCeeeccCCccCC
Q 036011 528 QFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 528 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
+|++..+..|..++ |+.|+|++|++..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 55544444444444 6666666666553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.9e-11 Score=129.86 Aligned_cols=146 Identities=14% Similarity=0.101 Sum_probs=116.0
Q ss_pred HHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEE
Q 036011 679 QRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 679 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 757 (977)
....++|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888888999999999999864 6899999987543233456899999999984 67788999999888899999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH------------------------------------- 800 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 800 (977)
|||++|.++.+.... ......++.+++++++.||...
T Consensus 89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999876321 1233478899999999999611
Q ss_pred -------------------CCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 801 -------------------STPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 801 -------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
...++|||++|.||+++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667799998765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=2e-10 Score=121.78 Aligned_cols=138 Identities=17% Similarity=0.104 Sum_probs=102.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC--cceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN--LIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 760 (977)
.+|.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+++.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333456669999998777888999997643 2356889999999986444 45688888877788999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH---------------------------------------- 800 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 800 (977)
++|.++. ... .+ ...++.++++.++.||...
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 11 2367788888888888532
Q ss_pred ---------------CCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 801 ---------------STPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 801 ---------------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..+++|||++|.||++++++.+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.9e-09 Score=118.50 Aligned_cols=302 Identities=11% Similarity=0.058 Sum_probs=137.8
Q ss_pred cccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCC
Q 036011 165 RIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSL 244 (977)
Q Consensus 165 ~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l 244 (977)
++....+|+.+.+.. .++.....+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++ .+...+|..
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~---~I~~~aF~~- 112 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK---KFGDYVFQG- 112 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC---EECTTTTTT-
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee---Eeccceecc-
Confidence 455556788877764 455444567888888888888654 554444555554 4555555433 22 233444433
Q ss_pred CCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCC
Q 036011 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCR 324 (977)
Q Consensus 245 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 324 (977)
.+|+.+.+..+-.. .-...|.+ .+|+.+.+..+ ++.+....|. .+.
T Consensus 113 ~~L~~i~lp~~~~~-i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~-------------------------------~~~ 158 (379)
T 4h09_A 113 TDLDDFEFPGATTE-IGNYIFYN-SSVKRIVIPKS-VTTIKDGIGY-------------------------------KAE 158 (379)
T ss_dssp CCCSEEECCTTCCE-ECTTTTTT-CCCCEEEECTT-CCEECSCTTT-------------------------------TCT
T ss_pred CCcccccCCCcccc-cccccccc-ceeeeeeccce-eeccccchhc-------------------------------ccc
Confidence 25555555543222 22223332 23444433322 2223333333 444
Q ss_pred CCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEe
Q 036011 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404 (977)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 404 (977)
+++.+.+..+.......... . .+ . .......+.....+..+.+....- ......+....+|+.+.+
T Consensus 159 ~l~~~~~~~~~~~~~~~~~~-~----------~~-~-~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~ 224 (379)
T 4h09_A 159 NLEKIEVSSNNKNYVAENYV-L----------YN-K-NKTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITI 224 (379)
T ss_dssp TCCEEEECTTCSSEEEETTE-E----------EE-T-TSSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEEC
T ss_pred cccccccccccceeecccce-e----------cc-c-ccceecccccccccccccccccee-EEeecccccccccceeee
Confidence 44444444332211000000 0 00 0 001111222333333333332221 133444555556666655
Q ss_pred ecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCC
Q 036011 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484 (977)
Q Consensus 405 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 484 (977)
..+ +..+....+..+..|+.+.+..+ ++.+-..+|.++.+|+.+.+..+ +..+....|.++++|+.+.+.++.++.+
T Consensus 225 ~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I 301 (379)
T 4h09_A 225 TSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETL 301 (379)
T ss_dssp CTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred ccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccccccccee
Confidence 443 22233445555555666555544 33333445555555665555433 3334444555555555555555555544
Q ss_pred CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCC
Q 036011 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526 (977)
Q Consensus 485 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 526 (977)
...+|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+..
T Consensus 302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 4455555555555555433 3322233455555555555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.05 E-value=5e-09 Score=117.59 Aligned_cols=316 Identities=10% Similarity=0.045 Sum_probs=201.6
Q ss_pred cccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccce
Q 036011 141 SLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTI 220 (977)
Q Consensus 141 ~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L 220 (977)
++....+|+.+.+..+ ++......|.++.+|+.+.|..+ ++.....+|.++ +|+.+.+..+ ++.....+|.. .+|
T Consensus 41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL 115 (379)
T ss_dssp TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence 4556677888887643 55456678999999999999755 664556688887 7888888754 55344444544 589
Q ss_pred eEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccc
Q 036011 221 TLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300 (977)
Q Consensus 221 ~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 300 (977)
+.+.+.++.. .+...+|... +|+.+.+..+ ++..-...+..+.+++.+.+..+.........+ ........
T Consensus 116 ~~i~lp~~~~----~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~-- 186 (379)
T 4h09_A 116 DDFEFPGATT----EIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-LYNKNKTI-- 186 (379)
T ss_dssp SEEECCTTCC----EECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-EEETTSSE--
T ss_pred ccccCCCccc----cccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccce-ecccccce--
Confidence 9999987643 3445556543 6777776654 343566778888999998887765543221111 00000000
Q ss_pred cccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEe
Q 036011 301 ANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSL 380 (977)
Q Consensus 301 ~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 380 (977)
...+..+..+..+.+.... .......+....+|+.+.+
T Consensus 187 ----------------~~~~~~~~~~~~~~~~~~~--------------------------~~i~~~~f~~~~~l~~i~~ 224 (379)
T 4h09_A 187 ----------------LESYPAAKTGTEFTIPSTV--------------------------KTVTAYGFSYGKNLKKITI 224 (379)
T ss_dssp ----------------EEECCTTCCCSEEECCTTC--------------------------CEECTTTTTTCSSCSEEEC
T ss_pred ----------------eccccccccccccccccce--------------------------eEEeecccccccccceeee
Confidence 0012223333333322211 1122234455566666666
Q ss_pred ecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCC
Q 036011 381 FINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSS 460 (977)
Q Consensus 381 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 460 (977)
..+ +......+|.++..|+.+.+..+ ++.+-...|.++.+|+.+.+..+ +..+...+|.++++|+.+.+.++.++.+
T Consensus 225 ~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I 301 (379)
T 4h09_A 225 TSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETL 301 (379)
T ss_dssp CTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred ccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccccccccee
Confidence 544 33355667777888888888765 55455667777888888888654 5435556788888888888888888877
Q ss_pred CCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhccc
Q 036011 461 IPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLK 517 (977)
Q Consensus 461 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 517 (977)
...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++..-..+|.++.
T Consensus 302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 7788888888888888754 66556678888888988888665 5533345666654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.94 E-value=5.2e-10 Score=123.29 Aligned_cols=184 Identities=15% Similarity=0.167 Sum_probs=102.9
Q ss_pred cccccccccEEEeecCccC---------CCCChhhhccCCCCEEEeeccc-ccCccccccccccccceeeecCCccCCCc
Q 036011 368 EIGNLRSLIVLSLFINALN---------GTIPSTVGRLEQLQGLSLYGNN-LEGSIPYDLCHLERLNGIRLNGNKLSGPI 437 (977)
Q Consensus 368 ~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 437 (977)
++..+++|+.|.+..+... +.+...+..+++|+.|+|++|. +. ++. + .+++|+.|+|..|.+....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHH
Confidence 4556778888877655331 1244556777888888887773 22 222 2 3677777777777765433
Q ss_pred hhhhc--CCCCCCeeecCC--CcCCCCCCccccCcccCceEEccCCCCCCCCcccc--ccccccCeeeCcCCcCCCCcch
Q 036011 438 PQCLA--SLISLRELNLGS--NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNI--QNLQVLINLDLSRNQLSGDIPI 511 (977)
Q Consensus 438 p~~~~--~l~~L~~L~L~~--N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~ 511 (977)
...+. .+++|+.|+|+. |...+.. .+. .| ...+ ..+++|+.|+|++|.+.+..+.
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~~---~l--------------~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDG--DMN---VF--------------RPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCS--CGG---GT--------------GGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred HHHHHHccCCCCcEEEEeccccccccch--hHH---HH--------------HHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 33343 567777777642 2211110 000 00 0011 1345677777777766543333
Q ss_pred hhh---cccccceeccCCcccccc----ccccccCccccCeeeccCCccCCCCCccccc-ccccCccccCCCc
Q 036011 512 TIG---SLKDLVTLSLASNQFEGP----IPQTFGSLTGLESLDLSNNNLSGEIPKSLEA-LLFLKQLNVSHNK 576 (977)
Q Consensus 512 ~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~ 576 (977)
.+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 333 466777777777777653 3334455677888888888776332222322 2 2557777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.94 E-value=3.4e-10 Score=124.78 Aligned_cols=190 Identities=20% Similarity=0.224 Sum_probs=116.4
Q ss_pred ccccEEEeecCccCC-C-------CChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCC
Q 036011 373 RSLIVLSLFINALNG-T-------IPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASL 444 (977)
Q Consensus 373 ~~L~~L~L~~N~l~~-~-------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 444 (977)
..++.|.+......+ . +..+...+++|+.|.+..+..... .++... .+.+...+..+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~--------------~is~~~-~~~L~~ll~~~ 171 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ--------------EISWIE-QVDLSPVLDAM 171 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC--------------CGGGCB-CCBCHHHHHTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc--------------cccccc-ccCHHHHHhcC
Confidence 455667776555432 1 123455677888887765433210 000000 11344556667
Q ss_pred CCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccc--cccccCeeeCcC--CcCCCC-----cchhh--
Q 036011 445 ISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ--NLQVLINLDLSR--NQLSGD-----IPITI-- 513 (977)
Q Consensus 445 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~-- 513 (977)
++|+.|+|++|.-. .++. + .+++|+.|++..+.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 77777777776311 1222 3 267788888887776533223333 577888888753 221111 11122
Q ss_pred hcccccceeccCCcccccccccccc---CccccCeeeccCCccCCC----CCcccccccccCccccCCCccccc
Q 036011 514 GSLKDLVTLSLASNQFEGPIPQTFG---SLTGLESLDLSNNNLSGE----IPKSLEALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 514 ~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 580 (977)
..+++|+.|+|++|.+.+..+..+. .+++|++|||+.|.|++. ++..+..+++|+.|+|++|.++..
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 3578999999999999865444443 588999999999999863 455557789999999999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.4e-09 Score=117.02 Aligned_cols=143 Identities=16% Similarity=0.196 Sum_probs=107.6
Q ss_pred cCccccCcceEEEEEEEeCCCCEEEEEEee--ccc-hhhHHHHHHHHHHHHhcC--CCCcceEeeeeecC---CeeEEEE
Q 036011 687 ECNLLGRGSFGSVYKGTFSDGTSFAIKVFN--LQL-DRAFRSFDSECEVLRNVR--HRNLIKIFSSCCNN---DFRALVL 758 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 758 (977)
..+.++.|.++.||+.+.. +..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999875 4688899876 322 123457889999999997 45578888888766 4588999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH-------------------------------------- 800 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 800 (977)
||++|..+.+.. -..++...+..++.+++++|+.||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998875421 112678888899999999999999621
Q ss_pred -----------------CCCeEeCCCCCCceeeCCCCc--eEEeeccccccc
Q 036011 801 -----------------STPVVHCDLKPSNILLDEDMV--AHVSDFGLSKLF 833 (977)
Q Consensus 801 -----------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~ 833 (977)
...++|||+++.||+++.++. +.|+||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999998753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.83 E-value=3e-11 Score=126.07 Aligned_cols=145 Identities=14% Similarity=0.104 Sum_probs=72.3
Q ss_pred CCCcccceEecCCCCcEEEEEcCC---CCCCccCCc-cccCcccccEeeccCCcccccCC-CCcCCCCCCCE--EeCcCc
Q 036011 36 PICKWVGISCGARHQRVRALNLSN---MGLRGTIPP-HLGNFSFLMSLDISKNNFHAYLP-NELGQLRRLRF--ISLDYN 108 (977)
Q Consensus 36 ~~c~w~gv~c~~~~~~v~~L~l~~---~~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~--L~L~~n 108 (977)
..|.|.|+.|+....+|..+-..+ ..+.+.+++ .+..++. .|....|.-++.++ +.|...+.|.. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 357899999998777777665544 233444432 2333332 22223333332222 12444445554 566666
Q ss_pred cCCCCCCcc----ccccccCcEEeccCcCCCC--CCCCcccCcCcccceeccccccccccCccccCcc--ccceeeeecc
Q 036011 109 EFSGSFPSW----IGVLSKLQILSLRNNSFTG--PIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLS--SLVNVNLAYN 180 (977)
Q Consensus 109 ~l~~~~p~~----~~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~--~L~~L~L~~n 180 (977)
... .++.. ..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|.|++. ..+..+. +|++|+|++|
T Consensus 154 ~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~N 230 (267)
T 3rw6_A 154 RRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGN 230 (267)
T ss_dssp SHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTS
T ss_pred HHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCC
Confidence 433 33322 2456677777777777775 2233344444555555555544432 1222222 4455555555
Q ss_pred ccccc
Q 036011 181 NLQGE 185 (977)
Q Consensus 181 ~i~~~ 185 (977)
.+.+.
T Consensus 231 pl~~~ 235 (267)
T 3rw6_A 231 SLCDT 235 (267)
T ss_dssp TTGGG
T ss_pred cCccc
Confidence 55443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=3.5e-09 Score=114.86 Aligned_cols=187 Identities=15% Similarity=0.156 Sum_probs=123.2
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCC--cceEeeeeecCC---eeEEEEecc
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRN--LIKIFSSCCNND---FRALVLELM 761 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 761 (977)
++.++.|.+..||+.. +.+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999873 56889986533 34567889999999884 333 334444443332 347899999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH----------------------------------------- 800 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 800 (977)
+|.++.+.... .++..++..++.++++.++.||...
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888653321 2677788888999999999998511
Q ss_pred --------------CCCeEeCCCCCCceeeCC--CCceEEeecccccccCCCCCcceeec------------cccCCccc
Q 036011 801 --------------STPVVHCDLKPSNILLDE--DMVAHVSDFGLSKLFDEGDDSVTQTM------------TIATIGYM 852 (977)
Q Consensus 801 --------------~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt~~y~ 852 (977)
...++|+|++|.||++++ ...+.++||+.+....+......... .....++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 135799999999999998 55688999999876433211000000 00000111
Q ss_pred C-ccccCCCCcCcccchhhHhHHHHHHhcCCCCC
Q 036011 853 A-PEYGTEGIVSSKCDVYSYGVLLTETFTRKKPT 885 (977)
Q Consensus 853 a-PE~~~~~~~~~~~DvwslG~il~elltg~~p~ 885 (977)
. |+... ......+.|++|.++|.+.+|..+|
T Consensus 256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 22111 1112368999999999999998775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=1.8e-08 Score=105.04 Aligned_cols=79 Identities=27% Similarity=0.386 Sum_probs=45.1
Q ss_pred cccccCeeeCcCCcCCC--CcchhhhcccccceeccCCccccccccccccCcc--ccCeeeccCCccCCCCCc-------
Q 036011 491 NLQVLINLDLSRNQLSG--DIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLT--GLESLDLSNNNLSGEIPK------- 559 (977)
Q Consensus 491 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------- 559 (977)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 44556666666666654 3344555666666666666666643 2333333 666677777766655542
Q ss_pred ccccccccCccc
Q 036011 560 SLEALLFLKQLN 571 (977)
Q Consensus 560 ~~~~l~~L~~L~ 571 (977)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 245566666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=3.2e-08 Score=98.33 Aligned_cols=43 Identities=12% Similarity=0.166 Sum_probs=18.7
Q ss_pred ccccccccceeeecCC-ccCCC----chhhhcCCCCCCeeecCCCcCC
Q 036011 416 DLCHLERLNGIRLNGN-KLSGP----IPQCLASLISLRELNLGSNKFS 458 (977)
Q Consensus 416 ~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 458 (977)
.+...++|+.|+|++| .+... +...+...++|++|+|++|+|.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 3444455555555555 44321 2223333444444444444443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=3.8e-08 Score=97.76 Aligned_cols=70 Identities=14% Similarity=0.191 Sum_probs=37.7
Q ss_pred chhhhcCCCCCCeeecCCC-cCCCC----CCccccCcccCceEEccCCCCCCC----CccccccccccCeeeCcCCcCC
Q 036011 437 IPQCLASLISLRELNLGSN-KFSSS----IPSSFWSLEYLLAVNLSSNSLSGS----LPSNIQNLQVLINLDLSRNQLS 506 (977)
Q Consensus 437 ~p~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 506 (977)
+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 4456667778888888888 77632 122333445566666666655421 1222333344555555555554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.7e-06 Score=90.79 Aligned_cols=136 Identities=13% Similarity=0.097 Sum_probs=96.6
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCC---CcceEeeeee-cCCeeEEEEeccCC
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHR---NLIKIFSSCC-NNDFRALVLELMPN 763 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 763 (977)
++.++.|....||+. |+.+++|+... ......+.+|+++++.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788988999988 56788998532 23456789999999999652 3556666664 45567899999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG-------------------------------------------- 799 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 799 (977)
.++.+.... .++......++.++++.|+.||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 888763211 134555566666666666666632
Q ss_pred -------------CCCCeEeCCCCCCceeeCC---CCc-eEEeecccccc
Q 036011 800 -------------HSTPVVHCDLKPSNILLDE---DMV-AHVSDFGLSKL 832 (977)
Q Consensus 800 -------------~~~~ivH~dlk~~NIll~~---~~~-~kl~Dfgla~~ 832 (977)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999997 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=4.7e-06 Score=88.30 Aligned_cols=135 Identities=19% Similarity=0.118 Sum_probs=99.2
Q ss_pred cccCcceE-EEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 690 LLGRGSFG-SVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 690 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
.+..|..+ .||+.... ++..+++|+-+.. ....+.+|.+.++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68988764 5678999986533 3456888999999884 33367788888889999999999999888
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH---------------------------------------------- 800 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------- 800 (977)
.+...... .....+..+++..|+.||...
T Consensus 108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77654321 233456677777777777310
Q ss_pred ---------CCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 801 ---------STPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 801 ---------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=3.1e-06 Score=93.75 Aligned_cols=80 Identities=11% Similarity=-0.026 Sum_probs=56.8
Q ss_pred Cccc-cCcceEEEEEEEeC-------CCCEEEEEEeeccch---hhHHHHHHHHHHHHhcC-C--CCcceEeeeeecC--
Q 036011 688 CNLL-GRGSFGSVYKGTFS-------DGTSFAIKVFNLQLD---RAFRSFDSECEVLRNVR-H--RNLIKIFSSCCNN-- 751 (977)
Q Consensus 688 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 751 (977)
.+.| +.|....+|+.... +++.+++|+...... .....+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999998764 267899998654320 01246788999999884 3 3466788877654
Q ss_pred -CeeEEEEeccCCCCHH
Q 036011 752 -DFRALVLELMPNGSLE 767 (977)
Q Consensus 752 -~~~~lv~e~~~~gsL~ 767 (977)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=6.9e-05 Score=82.24 Aligned_cols=138 Identities=12% Similarity=0.065 Sum_probs=80.2
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-----CCCcceEe-e--eeecCCeeEEEEec
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-----HRNLIKIF-S--SCCNNDFRALVLEL 760 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 760 (977)
+.++.|..+.||+....+| .+++|+..... ..+..|+++++.+. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 58999987531 23344555555553 24443311 1 12345677899999
Q ss_pred cCCCCHH-----H---------Hhhc--C----C-------ccCCHHHH-------------------------------
Q 036011 761 MPNGSLE-----K---------WLYS--D----N-------YFLDLLER------------------------------- 782 (977)
Q Consensus 761 ~~~gsL~-----~---------~l~~--~----~-------~~~~~~~~------------------------------- 782 (977)
++|.++. + .++. . . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 1111 0 0 00123211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 783 LNIMIGVALALEYLHH----------GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 783 ~~i~~~i~~~L~~LH~----------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
..+...+..++++|+. .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224445666652 135789999999999999888899999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=4.4e-05 Score=85.73 Aligned_cols=75 Identities=16% Similarity=0.206 Sum_probs=49.6
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccch-------hhHHHHHHHHHHHHhcCC--CC-cceEeeeeecCCeeEE
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD-------RAFRSFDSECEVLRNVRH--RN-LIKIFSSCCNNDFRAL 756 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 756 (977)
.+.+|.|.++.||+++.. +++.|+||....... ...+.+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 478899998653211 123456789999988742 33 3455544 3445689
Q ss_pred EEeccCCC
Q 036011 757 VLELMPNG 764 (977)
Q Consensus 757 v~e~~~~g 764 (977)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.78 E-value=5.7e-06 Score=79.79 Aligned_cols=35 Identities=14% Similarity=0.184 Sum_probs=23.5
Q ss_pred ccceeeeeccc-ccccCCccccCCCCCceEEeeccC
Q 036011 171 SLVNVNLAYNN-LQGEIPSEIGNLQNLEILVLGMNN 205 (977)
Q Consensus 171 ~L~~L~L~~n~-i~~~~p~~l~~l~~L~~L~l~~N~ 205 (977)
+|++|+|++|. |+...-..+.++++|+.|+|+++.
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 57777777764 665444556677777777777764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00016 Score=77.64 Aligned_cols=136 Identities=14% Similarity=0.115 Sum_probs=92.0
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC---CCCcceEeeeeecCCeeEEEEeccCCC
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR---HRNLIKIFSSCCNNDFRALVLELMPNG 764 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 764 (977)
.+.|+.|....+|+... +++.++||+.... ....+..|.+.++.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999986 4678999987643 2456889999999884 356788888888888899999999987
Q ss_pred CHH--------H---HhhcCCc---------------------cCCHHHHH---HHHHH----------------HH-HH
Q 036011 765 SLE--------K---WLYSDNY---------------------FLDLLERL---NIMIG----------------VA-LA 792 (977)
Q Consensus 765 sL~--------~---~l~~~~~---------------------~~~~~~~~---~i~~~----------------i~-~~ 792 (977)
.+. + .++.... .-+|.... ++..+ +. ..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 652 1 1222110 12454322 11111 11 11
Q ss_pred HHHHH-hcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 793 LEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 793 L~~LH-~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
.+.|. ......++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22332 12246799999999999999887 8889873
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.55 E-value=5.1e-05 Score=73.14 Aligned_cols=85 Identities=11% Similarity=0.049 Sum_probs=51.1
Q ss_pred cccccEEEeecCccCCCCChhhhccCCCCEEEeeccc-ccCccccccccc----cccceeeecCCc-cCCCchhhhcCCC
Q 036011 372 LRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN-LEGSIPYDLCHL----ERLNGIRLNGNK-LSGPIPQCLASLI 445 (977)
Q Consensus 372 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~ 445 (977)
-..|+.|+++++.|+..--..+.++++|++|+|++|. |++.--..+..+ ++|+.|+|++|. ++..--..+..++
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 3467777777777765555566677777777777774 554333344443 356666666653 5544344455566
Q ss_pred CCCeeecCCCc
Q 036011 446 SLRELNLGSNK 456 (977)
Q Consensus 446 ~L~~L~L~~N~ 456 (977)
+|+.|+|+++.
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 66666666553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00025 Score=75.66 Aligned_cols=78 Identities=15% Similarity=0.107 Sum_probs=56.9
Q ss_pred CCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCC---CcceEeeeeecCCeeEEEEecc
Q 036011 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHR---NLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 685 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~ 761 (977)
...++.+|.|..+.||+.+..+|+.|+||+.+.........|..|++.|+.+.-. -+.+++++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 4445778999999999999999999999987654433345688999999988421 234444432 247899999
Q ss_pred CCCCH
Q 036011 762 PNGSL 766 (977)
Q Consensus 762 ~~gsL 766 (977)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00035 Score=78.93 Aligned_cols=79 Identities=15% Similarity=0.089 Sum_probs=48.4
Q ss_pred CCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCC---CcCcccchhhHhHHHHH
Q 036011 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG---IVSSKCDVYSYGVLLTE 877 (977)
Q Consensus 801 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~e 877 (977)
...++|||+++.||+++.++ ++++||+.+..-.+...-...- ..-...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 67899999999999999876 9999999987643221100000 0011235666544311 12233555677777777
Q ss_pred HhcC
Q 036011 878 TFTR 881 (977)
Q Consensus 878 lltg 881 (977)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00099 Score=72.16 Aligned_cols=156 Identities=10% Similarity=0.102 Sum_probs=87.8
Q ss_pred CCHHHHHHhhcCCCc-----CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC--cceEe
Q 036011 673 TSYLDIQRATDGFNE-----CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN--LIKIF 745 (977)
Q Consensus 673 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~ 745 (977)
.+..++......|.. .+.++.|....+|+....+| .+++|+..... ..+.+..|+++++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555555544 34567788899999987655 68899886521 2234566777777764212 23333
Q ss_pred ee------eecCCeeEEEEeccCCCCHHH--------------HhhcC----Ccc----C---CHHHHHH----------
Q 036011 746 SS------CCNNDFRALVLELMPNGSLEK--------------WLYSD----NYF----L---DLLERLN---------- 784 (977)
Q Consensus 746 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~----~---~~~~~~~---------- 784 (977)
.. ....+..+++|+|++|..+.. .++.. ... . .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122456789999998865321 01110 000 1 1222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 785 --IMIGVALALEYLHHG----HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 785 --i~~~i~~~L~~LH~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
+...+.+.++++++. ...+++|+|+.+.||+++++..+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244555666532 23578999999999999987666899998765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.23 E-value=8.8e-05 Score=72.87 Aligned_cols=40 Identities=13% Similarity=0.238 Sum_probs=16.9
Q ss_pred cccccceeeecCC-ccCC----CchhhhcCCCCCCeeecCCCcCC
Q 036011 419 HLERLNGIRLNGN-KLSG----PIPQCLASLISLRELNLGSNKFS 458 (977)
Q Consensus 419 ~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~ 458 (977)
+-+.|+.|+|++| +|.. .+.+++...+.|+.|+|++|+|.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 3344555555543 4431 12233333444444444444444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0019 Score=70.22 Aligned_cols=140 Identities=14% Similarity=0.071 Sum_probs=75.5
Q ss_pred ccccCcceEE-EEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-C-CCcceEeeeeecCCeeEEEEeccCCCC
Q 036011 689 NLLGRGSFGS-VYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-H-RNLIKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 689 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
+.++.|.... +|+....+|+.+++|....... ..+..|+++++.+. + -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665554 6777664477888886543211 34556777777764 2 22455666543333 78999998767
Q ss_pred HHHHhhcCC-------------------------ccCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 036011 766 LEKWLYSDN-------------------------YFLDLLERL-------N-------------IMIGVALALEYLH--- 797 (977)
Q Consensus 766 L~~~l~~~~-------------------------~~~~~~~~~-------~-------------i~~~i~~~L~~LH--- 797 (977)
+.+++.... ..++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443211 001111100 0 0011112222221
Q ss_pred hcCCCCeEeCCCCCCceeeCCC----CceEEeeccccccc
Q 036011 798 HGHSTPVVHCDLKPSNILLDED----MVAHVSDFGLSKLF 833 (977)
Q Consensus 798 ~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~ 833 (977)
......++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224679999999999999875 68999999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=71.02 Aligned_cols=128 Identities=13% Similarity=0.125 Sum_probs=77.5
Q ss_pred CccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCc-ceEeeeeecCCeeEEEEecc-CCCC
Q 036011 688 CNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNL-IKIFSSCCNNDFRALVLELM-PNGS 765 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 765 (977)
++.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++++ .+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 56889987643221 2234568888887743223 4555543 33456899999 6655
Q ss_pred HHHH-hhcCCccCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 036011 766 LEKW-LYSDNYFLDLLERLNIMIGVALALEYLHH---------------------------------------------- 798 (977)
Q Consensus 766 L~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~LH~---------------------------------------------- 798 (977)
+... +.. +..++.++++.|+-||.
T Consensus 95 l~~~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 165 (301)
T 3dxq_A 95 MSPEKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA 165 (301)
T ss_dssp CCHHHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred CCHhhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence 4310 000 00122222222222221
Q ss_pred ----cCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 799 ----GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 799 ----~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.....++|+|+.+.||+ ..++.+.++||..+...
T Consensus 166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 12345799999999999 56677899999987653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00016 Score=71.06 Aligned_cols=68 Identities=18% Similarity=0.231 Sum_probs=45.7
Q ss_pred hhhccCCCCEEEeecc-cccC----ccccccccccccceeeecCCccCC----CchhhhcCCCCCCeeecCCCcCCC
Q 036011 392 TVGRLEQLQGLSLYGN-NLEG----SIPYDLCHLERLNGIRLNGNKLSG----PIPQCLASLISLRELNLGSNKFSS 459 (977)
Q Consensus 392 ~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 459 (977)
.+..-+.|++|+|++| +|.. .+...+...+.|+.|+|++|+|.. .+.+.+...+.|+.|+|++|.|..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3445677888888875 6653 244556667788888888888863 334445566677777777777763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00091 Score=73.69 Aligned_cols=140 Identities=11% Similarity=0.111 Sum_probs=83.4
Q ss_pred CccccCcceEEEEEEEeC--------CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEE
Q 036011 688 CNLLGRGSFGSVYKGTFS--------DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 758 (977)
.+.+..|-...+|+.... +++.|++|+.... ......+.+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899999864 3578999986432 223455678999998884 3334566666543 3999
Q ss_pred eccCCCCHHHH-----------------hhcCC----ccCC--HHHHHHHHHHHHH-------------------HHHHH
Q 036011 759 ELMPNGSLEKW-----------------LYSDN----YFLD--LLERLNIMIGVAL-------------------ALEYL 796 (977)
Q Consensus 759 e~~~~gsL~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~L~~L 796 (977)
||++|.++..- ++... .... +..+.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655310 11111 1112 3444444443322 23333
Q ss_pred H----h-cCCCCeEeCCCCCCceeeCCC----CceEEeecccccc
Q 036011 797 H----H-GHSTPVVHCDLKPSNILLDED----MVAHVSDFGLSKL 832 (977)
Q Consensus 797 H----~-~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~ 832 (977)
. . .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 123468999999999999876 7899999988763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0039 Score=67.62 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=82.0
Q ss_pred ccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC--cceEeee-----eecCCeeEEEEecc
Q 036011 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN--LIKIFSS-----CCNNDFRALVLELM 761 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 761 (977)
+.++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999887778789999986331 12345677888888774222 3344432 12245667899999
Q ss_pred CCCCHH-----HH---------hhc----C----CccCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 036011 762 PNGSLE-----KW---------LYS----D----NYFLDLLER----LNI---------------MIGVALALEYLHHG- 799 (977)
Q Consensus 762 ~~gsL~-----~~---------l~~----~----~~~~~~~~~----~~i---------------~~~i~~~L~~LH~~- 799 (977)
+|.++. .+ ++. . ....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 111 0 011222211 001 11122223333321
Q ss_pred ---CCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 800 ---HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 800 ---~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
....++|||+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245689999999999999 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0013 Score=74.19 Aligned_cols=73 Identities=12% Similarity=0.175 Sum_probs=49.8
Q ss_pred CccccCcceEEEEEEEeCC--------CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC-cceEeeeeecCCeeEEEE
Q 036011 688 CNLLGRGSFGSVYKGTFSD--------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN-LIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 758 (977)
++.|+.|....||++...+ ++.+++|+..... ..+.+..|..+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998653 5789999984321 1144557999988885333 3566665542 3899
Q ss_pred eccCCCCH
Q 036011 759 ELMPNGSL 766 (977)
Q Consensus 759 e~~~~gsL 766 (977)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0012 Score=60.63 Aligned_cols=57 Identities=23% Similarity=0.319 Sum_probs=31.9
Q ss_pred eeccCCcccc-ccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccc
Q 036011 521 TLSLASNQFE-GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579 (977)
Q Consensus 521 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 579 (977)
.++.+++.|+ ..+|..+. ++|+.|||++|+|+...+..|..+++|+.|+|++|+|..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 4555555554 12343221 246666666666664444555666666666666666654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0041 Score=70.35 Aligned_cols=74 Identities=15% Similarity=0.210 Sum_probs=48.7
Q ss_pred CccccCcceEEEEEEEeCC-CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCc-ceEeeeeecCCeeEEEEeccCCCC
Q 036011 688 CNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNL-IKIFSSCCNNDFRALVLELMPNGS 765 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 765 (977)
++.|+.|-...+|++...+ +..+++|+....... .-...+|..+++.+...++ .++++++. + ..||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4578888899999998764 578899987543221 1123689999998864444 46676663 2 36999998754
Q ss_pred H
Q 036011 766 L 766 (977)
Q Consensus 766 L 766 (977)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0051 Score=60.55 Aligned_cols=102 Identities=13% Similarity=0.029 Sum_probs=69.3
Q ss_pred CHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcceeec
Q 036011 765 SLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTM 844 (977)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (977)
+|.+++...+.++++.++|.++.|.+.+|.-.-. +..-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 8999999998899999999999999999887621 11111223457899999999988764 1110
Q ss_pred cccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCC
Q 036011 845 TIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884 (977)
Q Consensus 845 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 884 (977)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122366888753 3456788999999999999876555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0025 Score=70.40 Aligned_cols=73 Identities=14% Similarity=0.237 Sum_probs=45.2
Q ss_pred ccccCcceEEEEEEEeCC---------CCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCC-cceEeeeeecCCeeEEEE
Q 036011 689 NLLGRGSFGSVYKGTFSD---------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN-LIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 758 (977)
+.++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467788888999998653 278999987543221 223467888888885333 44666544 2 36899
Q ss_pred eccCCCCH
Q 036011 759 ELMPNGSL 766 (977)
Q Consensus 759 e~~~~gsL 766 (977)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.011 Score=64.33 Aligned_cols=68 Identities=13% Similarity=0.162 Sum_probs=44.3
Q ss_pred cCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC---CCCcceEeee------eecCCeeEEEEeccC
Q 036011 692 GRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR---HRNLIKIFSS------CCNNDFRALVLELMP 762 (977)
Q Consensus 692 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~ 762 (977)
|.|....||+....+| .+++|+...... ..|+..++.+. -|.+++++.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444679999987777 899998765431 34666666553 2334454432 233567789999999
Q ss_pred CCCH
Q 036011 763 NGSL 766 (977)
Q Consensus 763 ~gsL 766 (977)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.008 Score=54.98 Aligned_cols=56 Identities=25% Similarity=0.316 Sum_probs=32.8
Q ss_pred EEEcCCCCCC-ccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCC
Q 036011 54 ALNLSNMGLR-GTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFS 111 (977)
Q Consensus 54 ~L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 111 (977)
.++.++++|+ ..+|..+ -.+|++|+|++|+|+.+.+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777775 3455432 234666666666666654555556666666666666544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.012 Score=65.76 Aligned_cols=74 Identities=11% Similarity=0.174 Sum_probs=49.3
Q ss_pred CccccCcceEEEEEEEeCC--------CCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEE
Q 036011 688 CNLLGRGSFGSVYKGTFSD--------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 758 (977)
++.+..|-...+|+....+ ++.|++|+..... ...-...+|.++++.+. +.-..++++.+. -+.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999998753 6889999865432 22223467888888884 333445555332 26899
Q ss_pred eccCCCCH
Q 036011 759 ELMPNGSL 766 (977)
Q Consensus 759 e~~~~gsL 766 (977)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.65 E-value=0.11 Score=57.89 Aligned_cols=30 Identities=33% Similarity=0.396 Sum_probs=25.2
Q ss_pred CeEeCCCCCCceee------CCCCceEEeecccccc
Q 036011 803 PVVHCDLKPSNILL------DEDMVAHVSDFGLSKL 832 (977)
Q Consensus 803 ~ivH~dlk~~NIll------~~~~~~kl~Dfgla~~ 832 (977)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 977 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-30 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 7e-65
Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 25/278 (8%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G GSFG+VYKG + A+K+ N+ + ++F +E VLR RH N++
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
A+V + SL L+ ++++ ++I A ++YLH ++H
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY---GTEGIVS 863
DLK +NI L ED+ + DFGL+ + S +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 864 SKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSS 923
+ DVY++G++L E T + P ++ + + + L L +V
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------- 236
Query: 924 AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
+C ++ L +C + D+R ++ +
Sbjct: 237 ---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 2e-56
Identities = 70/304 (23%), Positives = 124/304 (40%), Gaps = 38/304 (12%)
Query: 674 SYLDIQRATDGFNEC---------NLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL- 719
++ D A F + ++G G FG V G AIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 720 DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDL 779
++ R F SE ++ H N+I + + ++ E M NGSL+ +L ++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 780 LERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839
++ + ++ G+A ++YL + VH DL NIL++ ++V VSDFGLS+ ++
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 840 VTQTMTI---ATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896
T T + I + APE +S DV+SYG+++ E + + T + +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
Query: 897 KWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956
+ Q++ MDC ++ L LDC + + R
Sbjct: 245 A------------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 957 LKKI 960
L K+
Sbjct: 287 LDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-56
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 9/271 (3%)
Query: 678 IQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRS-FDSECEVLRN 735
++ D F + + LG G+ G V+K + G A K+ +L++ A R+ E +VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
++ + + ++ ++ +E M GSL++ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
L H ++H D+KPSNIL++ + DFG+S + + T YM+PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173
Query: 856 YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915
S + D++S G+ L E + P E+ L +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQ 946
R + + +++ L E P +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 58/290 (20%), Positives = 117/290 (40%), Gaps = 23/290 (7%)
Query: 691 LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN 750
+G+G FG V++G + G A+K+F+ + +R++ ++E +RH N++ ++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 751 NDFRA----LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH-----GHS 801
++ LV + +GSL +L + Y + + + + + A L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPEYGTE 859
+ H DLK NIL+ ++ ++D GL+ D D++ + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 860 GI------VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE--SLPHGLMEVV 911
I + D+Y+ G++ E R ++ V S+ V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
+ L + L + + +C + R+ L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-55
Identities = 58/279 (20%), Positives = 123/279 (44%), Gaps = 25/279 (8%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI 742
+ LG G FG V+ G ++ T A+K + +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF-LDLLERLNIMIGVALALEYLHHGHS 801
++++ + ++ E M NGSL +L + + L + + L++ +A + ++ +
Sbjct: 72 RLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
+H DL+ +NIL+ + + ++DFGL++L ++ ++ + I + APE G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921
+ K DV+S+G+LLTE T + T ++ + ++R ++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------GYRMVRPDNC 235
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+ L C E P+ R L+
Sbjct: 236 PEE-------LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 8e-55
Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 27/277 (9%)
Query: 691 LGRGSFGSVYKGTF---SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRNLIKIFS 746
LG G+FGSV +G + AIKV ++A E +++ + + ++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 747 SCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVH 806
C + LV+E+ G L K+L + + ++ V++ ++YL VH
Sbjct: 77 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132
Query: 807 CDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPEYGTEGIVSSK 865
DL N+LL A +SDFGLSK D T + + APE SS+
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 866 CDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAE 925
DV+SYGV + E + + G + + Q
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------------IEQGKRMECP 234
Query: 926 MDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962
+C + L DC + + R +++
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-54
Identities = 63/276 (22%), Positives = 108/276 (39%), Gaps = 23/276 (8%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
+G G FG V+ G + + AIK F E EV+ + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ C LV E M +G L +L + L + + V + YL V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
+H DL N L+ E+ V VSDFG+++ + + + + + +PE + SS
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSS 181
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924
K DV+S+GVL+ E F+ K + + + + + L + S+
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFR----------LYKPRLAST- 229
Query: 925 EMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
V + C E P+ R + +L +I
Sbjct: 230 ------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-54
Identities = 65/283 (22%), Positives = 119/283 (42%), Gaps = 28/283 (9%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTS-----FAIKVFNLQLDRAFR-SFDSECEVLRNVRH 738
++G G FG VYKG + AIK R F E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
N+I++ ++ E M NG+L+K+L + +L+ + ++ G+A + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA---AGMKY 125
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV-TQTMTIATIGYMAPEYG 857
+ VH DL NIL++ ++V VSDFGLS++ ++ ++ T + I + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917
+ +S DV+S+G+++ E T + + H +M+ ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHEVMKAINDGFRL 232
Query: 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
MDC ++ L + C + +R D L K+
Sbjct: 233 PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-53
Identities = 61/276 (22%), Positives = 105/276 (38%), Gaps = 23/276 (8%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
LG G FG V G + AIK+ + F E +V+ N+ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ C ++ E M NG L +L + + L + V A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
+H DL N L+++ V VSDFGLS+ + D+ + + + + PE SS
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924
K D++++GVL+ E ++ K + FT + + + +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------------R 222
Query: 925 EMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
V + C E D+R + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 73/279 (26%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 685 FNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKI 744
+G+G FG V G + G A+K ++ D ++F +E V+ +RH NL+++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 745 FSSCCNNDFR-ALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHST 802
+V E M GSL +L S L L + V A+EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
VH DL N+L+ ED VA VSDFGL+K TQ + + APE E
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKF 177
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922
S+K DV+S+G+LL E ++ + + + + K
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------------ 219
Query: 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
A C +V + +C R +L+ IK
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-53
Identities = 68/279 (24%), Positives = 125/279 (44%), Gaps = 25/279 (8%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI 742
+ LG+G FG V+ GT++ T AIK + +F E +V++ +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHS 801
++++ +V E M GSL +L + +L L + +++ +A + Y+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGI 861
VH DL+ +NIL+ E++V V+DFGL++L ++ + + Q I + APE G
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGR 190
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921
+ K DV+S+G+LLTE T+ + L + + + +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------------------VERGYR 232
Query: 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+C S+ L C + P++R L+
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 8e-52
Identities = 64/317 (20%), Positives = 113/317 (35%), Gaps = 51/317 (16%)
Query: 674 SYLDIQRATDGFNECNLLGRGSFGSVYKGT------FSDGTSFAIKVFNLQLDRAFRS-F 726
L ++ + +G G+FG V++ + T A+K+ + ++ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 727 DSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF---------- 776
E ++ + N++K+ C L+ E M G L ++L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 777 -------------LDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAH 823
L E+L I VA + YL VH DL N L+ E+MV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 824 VSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK 883
++DFGLS+ D I +M PE +++ DV++YGV+L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 884 PTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMES 943
E + ++ + +C L + +L C +
Sbjct: 241 QPYYGMAHEEVIYYVRDGNIL------------------ACPENCPLELYNLMRLCWSKL 282
Query: 944 PDQRIYMTDAAVKLKKI 960
P R L+++
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 29/280 (10%)
Query: 687 ECNLLGRGSFGSVYKGTFSD---GTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNL 741
E LG G+FG+V KG + + A+K+ + + +E V++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+++ C + LV+E+ G L K+L + + + + ++ V++ ++YL +
Sbjct: 71 VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAPEYGTEG 860
VH DL N+LL A +SDFGLSK ++ + + APE
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920
SSK DV+S+GVL+ E F+ + + G EV +L +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK---PYRGMKG-------------SEVTA--MLEKGE 227
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
C + L C + R ++L+
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 32/284 (11%)
Query: 680 RATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNV 736
RA D + +G GS+G K SDG K + + + SE +LR +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 737 RHRNLIKIFSSCC--NNDFRALVLELMPNGSLEKWLYS---DNYFLDLLERLNIMIGVAL 791
+H N+++ + N +V+E G L + + +LD L +M + L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 792 ALEYLH--HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
AL+ H V+H DLKP+N+ LD + DFGL+++ + + T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TP 178
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909
YM+PE + K D++S G LL E P E+ +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------AGK 225
Query: 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
+ + R + S E++ +++ R + +
Sbjct: 226 IREGKFRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-51
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 29/280 (10%)
Query: 689 NLLGRGSFGSVYKGTFSDGTS----FAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIK 743
++GRG FG VY GT D A+K N D S F +E ++++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 744 IFSSCCNNDFRA-LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ C ++ +VL M +G L ++ ++ + + + + + VA + S
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASK 149
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGYMAPEYGTEG 860
VH DL N +LDE V+DFGL++ + + T + +MA E
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920
++K DV+S+GVLL E TR P +++ L Q
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY--------------LLQGR 251
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
C + + L C + R ++ ++ I
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 8e-51
Identities = 65/279 (23%), Positives = 98/279 (35%), Gaps = 35/279 (12%)
Query: 682 TDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNL---QLDRAFRSFDSECEVLRNVR 737
F++ +G GSFG+VY + AIK + Q + ++ E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
H N I+ LV+E + + L +E + G L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY- 856
S ++H D+K NILL E + + DFG + + + T +MAPE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183
Query: 857 --GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
EG K DV+S G+ E RK P +M L + P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESP---------- 232
Query: 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
L+ H S + C + P R
Sbjct: 233 ALQSGHWSEY-------FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-51
Identities = 63/297 (21%), Positives = 107/297 (36%), Gaps = 45/297 (15%)
Query: 689 NLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNV-RHRN 740
LG G+FG V + T + A+K+ R + SE +VL + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLY-----------------SDNYFLDLLERL 783
++ + +C ++ E G L +L D LDL + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 784 NIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQT 843
+ VA + +L + +H DL NILL + + DFGL++ + V +
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 844 MTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL 903
+ +MAPE + + + DV+SYG+ L E F+ + K +KE
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 904 PHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+L EH + + + C P +R ++K
Sbjct: 266 R----------MLSPEHAPAE-------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 64/288 (22%), Positives = 106/288 (36%), Gaps = 31/288 (10%)
Query: 675 YLDIQR---ATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSEC 730
Y + R D + LG G+FG VYK A KV + + + + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 731 EVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVA 790
++L + H N++K+ + + +++E G+++ + L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 791 LALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIG 850
AL YL H ++H DLK NIL D ++DFG+S + I T
Sbjct: 121 DALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPY 175
Query: 851 YMAPEY-----GTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905
+MAPE + K DV+S G+ L E + P ++ + L K K P
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPT 234
Query: 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
L Q S+ L C ++ D R +
Sbjct: 235 ----------LAQPSRWSSNFKDFLK------KCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-50
Identities = 67/292 (22%), Positives = 115/292 (39%), Gaps = 29/292 (9%)
Query: 676 LDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-----DRAFRSFDSE 729
L I + T+ F + +LG G+FG+VYKG + +G I V +L +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 730 CEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGV 789
V+ +V + ++ ++ C + + L+ +LMP G L ++ + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 790 ALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATI 849
A + YL +VH DL N+L+ ++DFGL+KL + I
Sbjct: 121 AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 850 GYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909
+MA E I + + DV+SYGV + E T D
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI------------ 225
Query: 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
L + C + V + + C M D R + ++ K+
Sbjct: 226 ------LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 5e-50
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 25/280 (8%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNL 741
+ LG G +G VY+G + + A+K F E V++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF-LDLLERLNIMIGVALALEYLHHGH 800
+++ C ++ E M G+L +L N + + L + ++ A+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
+H DL N L+ E+ + V+DFGLS+L GD I + APE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920
S K DV+++GVLL E T + L + + LL +++
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYE--------------LLEKDY 233
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
C V L C +P R + + +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-50
Identities = 57/274 (20%), Positives = 103/274 (37%), Gaps = 24/274 (8%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHRN 740
+ ++ LG G++G V + A+K+ +++ + E + + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++K + + + L LE G L + D + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY-GTE 859
+ H D+KP N+LLDE +SDFGL+ +F + T+ Y+APE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919
+ DV+S G++LT + P D W ++ + +D+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---- 236
Query: 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
L L +E+P RI + D
Sbjct: 237 -------------LALLHKILVENPSARITIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-50
Identities = 68/287 (23%), Positives = 99/287 (34%), Gaps = 29/287 (10%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF----SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRN 735
LG GSFG V +G + S A+K + A F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
+ HRNLI+++ + +V EL P GSL L L + VA + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYMAP 854
L S +H DL N+LL + + DFGL + + DD + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
E S D + +GV L E FT + G L K KE E
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238
Query: 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
DC + ++ + C P+ R L + +
Sbjct: 239 ------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-49
Identities = 61/293 (20%), Positives = 103/293 (35%), Gaps = 50/293 (17%)
Query: 690 LLGRGSFGSVYKGTFSD------GTSFAIKVFNLQLDRAFR-SFDSECEVLRNV-RHRNL 741
+LG G+FG V T A+K+ + D + R + SE +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYS----------------------DNYFLDL 779
+ + +C + L+ E G L +L S D L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 780 LERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839
+ L VA +E+L VH DL N+L+ V + DFGL++ +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWV 899
V + + +MAPE EGI + K DV+SYG+LL E F+ + + K +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 900 KESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTD 952
+ + + C +R +
Sbjct: 281 QNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 32/271 (11%)
Query: 691 LGRGSFGSVYKGTFSD-GTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSS 747
+GRGSF +VYKG ++ A + + F E E+L+ ++H N+++ + S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 748 CC----NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP 803
LV ELM +G+L+ +L + + + + L++LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 804 VVHCDLKPSNILL-DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV 862
++H DLK NI + + D GL+ L S + + I T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEM-YEEKY 189
Query: 863 SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922
DVY++G+ + E T + P + ++ P +V +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV------- 242
Query: 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
+ C ++ D+R + D
Sbjct: 243 ----------KEIIEGCIRQNKDERYSIKDL 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-48
Identities = 72/298 (24%), Positives = 116/298 (38%), Gaps = 44/298 (14%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDG---TSFAIKVFNLQLDR-AFRSFDSECEVLRNV-R 737
+ +++G G+FG V K AIK + R F E EVL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF---------------LDLLER 782
H N+I + +C + + L +E P+G+L +L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 783 LNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842
L+ VA ++YL +H DL NIL+ E+ VA ++DFGLS+ + V +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES 902
TM + +MA E + ++ DV+SYGVLL E + M+ + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYE-- 237
Query: 903 LPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
L Q + ++C V L C E P +R V L ++
Sbjct: 238 ------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 4e-48
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 25/273 (9%)
Query: 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRN 740
+ +G+G+ G+VY + G AI+ NLQ +E V+R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++ S D +V+E + GSL + D + + ALE+L H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFL---H 133
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
S V+H D+K NILL D ++DFG ++ + T +MAPE T
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK 191
Query: 861 IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEH 920
K D++S G++ E + P + +L P L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE----------LQNPE 240
Query: 921 TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
SA L+ C ++R +
Sbjct: 241 KLSAIFRDFLN------RCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 56/276 (20%), Positives = 98/276 (35%), Gaps = 28/276 (10%)
Query: 690 LLGRGSFGSVYKGTFSD----GTSFAIKVFNLQLDRAFRS-FDSECEVLRNVRHRNLIKI 744
+G G FG V++G + + AIK + R F E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 745 FSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPV 804
+ +++EL G L +L Y LDL + ++ AL + S
Sbjct: 74 IG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL---AYLESKRF 129
Query: 805 VHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSS 864
VH D+ N+L+ + + DFGLS+ ++ + I +MAPE +S
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTS 188
Query: 865 KCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSA 924
DV+ +GV + E + +
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------------PM 230
Query: 925 EMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+C ++ L C P +R T+ +L I
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 62/275 (22%), Positives = 102/275 (37%), Gaps = 32/275 (11%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFN---LQLDRAFRSFDSECEVLRNVRH 738
+ F LG+G FG+VY A+KV L+ E E+ ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
N+++++ + L+LE P G++ + L + F D + +A AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
S V+H D+KP N+LL ++DFG S +T T+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 177
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918
+ K D++S GVL E K P + + +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP-------------FEANTYQETYKRISRVEFTFP 224
Query: 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
+ + D L +P QR + +
Sbjct: 225 DFVTEGARD-------LISRLLKHNPSQRPMLREV 252
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 37/293 (12%)
Query: 685 FNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVR 737
LG+GSFG VY+G T AIK N R F +E V++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYF---------LDLLERLNIMIG 788
+++++ +++ELM G L+ +L S L + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 789 VALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIAT 848
+A + YL+ + VH DL N ++ ED + DFG+++ E D +
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 849 IGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM 908
+ +M+PE +G+ ++ DV+S+GV+L E T + + E L+ ++ L
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL---- 254
Query: 909 EVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961
+C + L C +P R + +K+
Sbjct: 255 --------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 5e-46
Identities = 51/279 (18%), Positives = 102/279 (36%), Gaps = 28/279 (10%)
Query: 679 QRATDGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQL---DRAFRSFDSECEVLR 734
++ + F +LG GSF +V + +AIK+ + + E +V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 735 NVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALE 794
+ H +K++ + +++ L NG L K++ F D + +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEI---VS 119
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
L + H ++H DLKP NILL+EDM ++DFG +K+ + T Y++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
E TE D+++ G ++ + P + + +++
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-------------FRAGNEYLIFQKIIKLE 226
Query: 915 LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
E D + + +R+ +
Sbjct: 227 YDFPEKFFPKARDLVEK-------LLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 1e-45
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 9/205 (4%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNL 741
D ++ LG G+FG V++ T + G +FA K + + E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+ + + +++ ++ E M G L + + ++ + E + M V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 802 TPVVHCDLKPSNILL--DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE 859
VH DLKP NI+ + DFGL+ D T T + APE
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 199
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKP 884
V D++S GVL + P
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 4e-44
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 46/303 (15%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF--------SDGTSFAIKVFNLQL-DRAFRSFDSECEVL 733
D LG G+FG V + T A+K+ ++ SE E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 734 RNV-RHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWL---------------YSDNYFL 777
+ + +H+N+I + +C + +++E G+L ++L ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 778 DLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837
+ ++ VA +EYL S +H DL N+L+ ED V ++DFGL++ D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897
T + +MAPE + I + + DV+S+GVLL E FT E K
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKL 957
L++ H +C + + DC P QR L
Sbjct: 250 ------------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 958 KKI 960
+I
Sbjct: 292 DRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 9e-44
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 9/209 (4%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNL 741
D ++ LG G+FG V++ + G F K N + +E ++ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
I + + + L+LE + G L + +++Y + E +N M L+++ H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HE 145
Query: 802 TPVVHCDLKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE 859
+VH D+KP NI+ + + V DFGL+ + + +T AT + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR 202
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDM 888
V D+++ GVL + P
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 68/302 (22%), Positives = 110/302 (36%), Gaps = 44/302 (14%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNL-QLDRAFRSFDSECEVLRN 735
D LGRG+FG V + + + A+K+ R+ SE ++L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 736 VRHRNLIKIFSSCC--NNDFRALVLELMPNGSLEKWLYSDNY---------------FLD 778
+ H + C +++E G+L +L S FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 779 LLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838
L + VA +E+L S +H DL NILL E V + DFGL++ + D
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKW 898
V + + +MAPE + + + + DV+S+GVLL E F+ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 899 VKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958
+KE M D + LDC P QR ++ L
Sbjct: 250 LKEGTR---MRAPD--------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 959 KI 960
+
Sbjct: 293 NL 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 6e-41
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 11/226 (4%)
Query: 670 WRRTSYLDIQRATDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQ-LDRAFRSFD 727
W++ DI+ D ++ ++LG G+F V AIK + L+ S +
Sbjct: 1 WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 728 SECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMI 787
+E VL ++H N++ + + L+++L+ G L + F + ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114
Query: 788 GVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA 847
V A++YLH LDED +SDFGLSK+ D G +
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171
Query: 848 TIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM 893
T GY+APE + S D +S GV+ P D ++
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 8e-41
Identities = 48/232 (20%), Positives = 98/232 (42%), Gaps = 13/232 (5%)
Query: 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVR 737
+D + +LG G V+ A+KV L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 738 HRNLIKIFSSCCNND----FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
H ++ ++ + +V+E + +L ++++ + + ++ AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIA-TIGYM 852
+ H ++H D+KP+NI++ V DFG+++ + +SVTQT + T Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
+PE V ++ DVYS G +L E T + P ++ + ++ +P
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 54/269 (20%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LGRG FG V++ S ++ K ++ E +L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+ + ++ E + + + + + + L+ E ++ + V AL++L HS + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFD 127
Query: 809 LKPSNILLDEDMVAHV--SDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKC 866
++P NI+ + + +FG ++ GD + Y APE +VS+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 867 DVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEM 926
D++S G L+ + P F E + ++++ N++ E+T E
Sbjct: 185 DMWSLGTLVYVLLSGINP----FLAETN-------------QQIIE-NIMNAEYTFDEEA 226
Query: 927 DCLLS--VLHLALDCCMESPDQRIYMTDA 953
+S + ++ R+ ++A
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (372), Expect = 4e-40
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNL---------QLDRAFRSFDSECEV 732
+ + +LGRG V + +A+K+ ++ ++ + E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 733 LRNVR-HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVAL 791
LR V H N+I++ + N F LV +LM G L +L ++ L E IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 792 ALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
+ LH + +VH DLKP NILLD+DM ++DFG S D G+ T Y
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSY 175
Query: 852 MAPEY------GTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+APE + D++S GV++ P
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 5e-40
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 16/241 (6%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSD-GTSFAIKVFNL------QLDRAFRSFDSECEVLRN 735
+ F+ ++GRG FG VY +D G +A+K + Q + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
++ + + D + +L+LM G L L S + + + L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
+H+ VV+ DLKP+NILLDE +SD GL+ F + ++ T GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPE 175
Query: 856 YGTEGI-VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
+G+ S D +S G +L + P T + + ++ L +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 915 L 915
L
Sbjct: 236 L 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (368), Expect = 4e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 13/218 (5%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRH 738
F LG GSFG V+ +G +A+KV ++ + + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
+I+++ + + ++++ + G L + V L L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCL---ALEY 119
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
HS +++ DLKP NILLD++ ++DFG +K + T Y+APE +
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVS 174
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK 896
+ D +S+G+L+ E P D T + K
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-39
Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 13/228 (5%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFN---LQLDRAFRSFDSECEVL-RNVR 737
+ F +LG+GSFG V+ F FAIK + +D E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 738 HRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLH 797
H L +F + + V+E + G L + S + F DL + L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG 857
+V+ DLK NILLD+D ++DFG+ K GD T Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEIL 175
Query: 858 TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905
+ D +S+GVLL E + P E L ++ P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPF 221
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 71/295 (24%), Positives = 112/295 (37%), Gaps = 25/295 (8%)
Query: 678 IQRATDGFNECNLLGRGSFGSVYKGTF--SDGTSFAIKVFNLQL--DRAFRSFDSECEVL 733
+ RA + +G G++G V+K + G A+K +Q + S E VL
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 734 R---NVRHRNLIKIFSSCCNNDFRA-----LVLELMPNGSLEKWLYSDNYFLDLLERLNI 785
R H N++++F C + LV E + + ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 786 MIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT 845
M + L++LH S VVH DLKP NIL+ ++DFGL++++ T
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSV 175
Query: 846 IATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905
+ T+ Y APE + ++ D++S G + E F RK + K LP
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 906 GLMEVVDTNLLRQEHTSSAEM-------DCLLSVLHLALDCCMESPDQRIYMTDA 953
D L RQ S + D L L C +P +RI A
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 4e-38
Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 18/283 (6%)
Query: 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRN 740
+ ++ +G G++G VYK + G +FA+K L+ + + E +L+ ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
++K++ LV E + + L+K L L+ + + ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-YGTE 859
V+H DLKP N+L++ + ++DFGL++ F T I T+ Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKP-----TDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
S+ D++S G + E D + + E+ +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 915 LLRQEHTSSAEMDCLLSVLHLALD----CCMESPDQRIYMTDA 953
+ L + +D P+QRI A
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 66/280 (23%), Positives = 106/280 (37%), Gaps = 21/280 (7%)
Query: 689 NLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-----DRAFRSFDSECEVLRNVRHRNLI 742
+ LG G F +VYK + AIK L D R+ E ++L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 743 KIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHST 802
+ + + +LV + M + ++ L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 803 PVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-YGTEGI 861
++H DLKP+N+LLDE+ V ++DFGL+K F + T + T Y APE +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARM 177
Query: 862 VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM------SLKKWVKESLPHGLMEVVDTNL 915
D+++ G +L E R + +L +E P
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 916 LRQEHTSSAEMDCLLS--VLHLALDCCMESPDQRIYMTDA 953
+ +L L + +P RI T A
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-37
Identities = 61/289 (21%), Positives = 102/289 (35%), Gaps = 20/289 (6%)
Query: 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFR-SFDSECEVLRNVRHR 739
+ + +G G++G V + AIK + + + E ++L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYS--DNYFLDLLERLNIMIGVALALEYLH 797
N+I I + + + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 798 HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT-IATIGYMAPEY 856
S V+H DLKPSN+LL+ + DFGL+++ D D +AT Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 857 GTEGIVSS-KCDVYSYGVLLTETFTRKKPTDDMFTGEM------SLKKWVKESLPHGLME 909
+ D++S G +L E + + + L +E L +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 910 VVDTNLLRQEHTSSAEMDCLLS-----VLHLALDCCMESPDQRIYMTDA 953
LL H + + L L L +P +RI + A
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 58/284 (20%), Positives = 104/284 (36%), Gaps = 18/284 (6%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHR 739
+ F + +G G++G VYK G A+K L + + E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 740 NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG 799
N++K+ + LV E + + S + L + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 800 HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-YGT 858
V+H DLKP N+L++ + ++DFGL++ F T T + T+ Y APE
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP-----TDDMFTGEMSLKKWVKESLPHGLMEVVDT 913
S+ D++S G + E TR+ D E + G+ + D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 914 NLLRQEHTSSAEMDCLLSVLHLALD----CCMESPDQRIYMTDA 953
+ + + P++RI A
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 21/228 (9%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRS------FDSECEVLRNVR--HRN 740
LLG G FGSVY G SD AIK + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 741 LIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
+I++ D L+LE ++ L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 801 STPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEY-GT 858
+ V+H D+K NIL+D + + DFG L + T T Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKP---TDDMFTGEMSLKKWVKESL 903
V+S G+LL + P +++ G++ ++ V
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 52/283 (18%), Positives = 111/283 (39%), Gaps = 20/283 (7%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNL 741
+ + +G G++G+V+K A+K L D S E +L+ ++H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 742 IKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHS 801
+++ ++ LV E + + + D + + + L + H +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 802 TPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE-YGTEG 860
V+H DLKP N+L++ + +++FGL++ F + + T+ Y P+
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK 177
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP------TDDMFTGEMSLKKWVKESLPHGLMEVVDTN 914
+ S+ D++S G + E +P DD L E + ++ D
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 915 LLRQEHTSSAEMDCLLSVLHLALD----CCMESPDQRIYMTDA 953
+++ ++ + + D +P QRI +A
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 34/282 (12%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRS------FDSECEVLRN 735
D ++ LG G F V K S G +A K + ++ R + E +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 736 VRHRNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
++H N+I + N L+LEL+ G L + ++ L E + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNG--- 125
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVA----HVSDFGLSKLFDEGDDSVTQTMTIATIGY 851
+++ HS + H DLKP NI+L + V + DFGL+ D G+ T +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEF 182
Query: 852 MAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911
+APE + + D++S GV+ + +G K+ + V
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYI----------LLSGASPFLGDTKQETLANVSAVN 232
Query: 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
+SA + ++ P +R+ + D+
Sbjct: 233 YEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 58/289 (20%), Positives = 107/289 (37%), Gaps = 30/289 (10%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK 743
+ + ++G GSFG VY+ G AIK + + R + E +++R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 744 IFSSCC------NNDFRALVLELMPNGSLEKWLY--SDNYFLDLLERLNIMIGVALALEY 795
+ + + LVL+ +P + L ++ M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 796 LHHGHSTPVVHCDLKPSNILLDED-MVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
+H + H D+KP N+LLD D V + DFG +K G+ +V+ I + Y AP
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191
Query: 855 -EYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK---------KWVKESLP 904
+S DV+S G +L E + + ++ + +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 905 HGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
E + T + L +P R+ +A
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-35
Identities = 55/274 (20%), Positives = 102/274 (37%), Gaps = 33/274 (12%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVL-RNVRHRNLIKIFSS 747
+LG G G V + FA+K+ + E E+ R + ++++I
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 748 C----CNNDFRALVLELMPNGSLEKWLYS-DNYFLDLLERLNIMIGVALALEYLHHGHST 802
+V+E + G L + + E IM + A++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 803 PVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTE 859
+ H D+KP N+L + + ++DFG +K + T T Y+APE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919
CD++S GV++ P +++ +K + G E + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEFPN----PEW 241
Query: 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDA 953
S E+ L+ + P QR+ +T+
Sbjct: 242 SEVSEEVKMLIR------NLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 5e-35
Identities = 46/283 (16%), Positives = 94/283 (33%), Gaps = 32/283 (11%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+G GSFG +Y GT + G AIK+ ++ E ++ + ++ I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 749 C-NNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHC 807
D+ +V+EL+ + + + F L L + + +EY+H + +H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FIHR 127
Query: 808 DLKPSNIL---LDEDMVAHVSDFGLSKLFDEGDDSVTQ-----TMTIATIGYMAPEYGTE 859
D+KP N L + + ++ DFGL+K + + T Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 860 GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE--MSLKKWVKESLPHGLMEVVDTNLLR 917
S + D+ S G +L P + ++ ++ + + +
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK----- 242
Query: 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
C D + + + +
Sbjct: 243 ---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (329), Expect = 3e-34
Identities = 40/284 (14%), Positives = 80/284 (28%), Gaps = 32/284 (11%)
Query: 690 LLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
+G GSFG +++GT + AIK + D E + + I
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 749 CNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCD 808
+++ + SLE L + + ++ +H +V+ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 809 LKPSNILLDEDMVAH-----VSDFGLSKLFDEGDDSVTQ-----TMTIATIGYMAPEYGT 858
+KP N L+ + V DFG+ K + + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918
S + D+ + G + G + + + + ++
Sbjct: 187 GREQSRRDDLEALGHVFMY----------FLRGSL----PWQGLKAATNKQKYERIGEKK 232
Query: 919 EHTSSAEM--DCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960
+ T E+ + D K+
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 5e-34
Identities = 61/270 (22%), Positives = 101/270 (37%), Gaps = 33/270 (12%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRH 738
D F+ LG GSFG V G +A+K+ + Q + +E +L+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
L+K+ S +N +V+E + G + L F + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
S +++ DLKP N+L+D+ V+DFG +K T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIIL 211
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918
+ D ++ GVL+ E P F + P + E + + +R
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQ----------PIQIYEKIVSGKVRF 257
Query: 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRI 948
S+++ LL + +R
Sbjct: 258 PSHFSSDLKDLLR------NLLQVDLTKRF 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-34
Identities = 60/295 (20%), Positives = 114/295 (38%), Gaps = 30/295 (10%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNL 741
+ + +G+G+FG V+K G A+K ++ + + E ++L+ ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 742 IKIFSSCCNNDFRA--------LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
+ + C LV + + F L E +M + L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQML---L 127
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMT--IATIGY 851
L++ H ++H D+K +N+L+ D V ++DFGL++ F +S T + T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 852 MAPE-YGTEGIVSSKCDVYSYGVLLTETFTRKKP-TDDMFTGEMSLKKWVKESLPHGLME 909
PE E D++ G ++ E +TR + +++L + S+ +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 910 VVDTNLLRQEHTSSAEMDCLLS-----------VLHLALDCCMESPDQRIYMTDA 953
VD L ++ + L L + P QRI DA
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 11/226 (4%)
Query: 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRH 738
+ F+ LLG+G+FG V + G +A+K+ ++ +E VL+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
L + + +D V+E G L L + F + AL +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSAL---EY 120
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGT 858
HS VV+ D+K N++LD+D ++DFGL K T T Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 178
Query: 859 EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP 904
+ D + GV++ E + P + + + + E +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIR 223
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 55/290 (18%), Positives = 108/290 (37%), Gaps = 32/290 (11%)
Query: 685 FNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNL 741
+ + +G G++G+V G AIK + + E +L+++RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 742 IKIFSSCCNNDFRA------LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEY 795
I + ++ LV+ M + + L ++ + L Y
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 796 LHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPE 855
+H H DLKP N+ ++ED + DFGL++ D T + T Y APE
Sbjct: 137 IHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPE 188
Query: 856 -YGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLK-KWVKESLPHGLMEVVDT 913
+ D++S G ++ E T K + + V + P ++ + +
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 914 NLLRQEHTSSAEMD------CLLSVLHLALD----CCMESPDQRIYMTDA 953
+ + E++ L + LA++ + +QR+ +A
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 121 bits (302), Expect = 2e-30
Identities = 77/310 (24%), Positives = 122/310 (39%), Gaps = 14/310 (4%)
Query: 8 TDQFALLAFKAHVTDPQSVLANNWSISQPIC--KWVGISC--GARHQRVRALNLSNMGLR 63
D+ ALL K + +P + L++ W + C W+G+ C + RV L+LS + L
Sbjct: 6 QDKQALLQIKKDLGNP-TTLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 64 G--TIPPHLGNFSFLMSLDISKN-NFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGV 120
IP L N +L L I N +P + +L +L ++ + + SG+ P ++
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
+ L L N+ +G +P S+ +L L N I G IP G+ S L
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 181 NLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKV 240
N NL ++ ++ + + L
Sbjct: 184 NRLTGKIPPTFANLNLAF----VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 241 SYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNL 300
NL L N++ GT+P +T L L++SFN+ G IP GNL+ V
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAY 298
Query: 301 ANNYLTTDSP 310
ANN SP
Sbjct: 299 ANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.5 bits (202), Expect = 1e-17
Identities = 51/281 (18%), Positives = 100/281 (35%), Gaps = 13/281 (4%)
Query: 258 TGTIPNSITNASKLTGLDLSFNSFSGL--IPHTFGNLRFLSVLNLANNYLTTDSPTAEWS 315
G + ++ T ++ LDLS + IP + NL +L+ L + +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 316 FLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSL 375
L+ L ++ P + +L L+G +P I +L +L
Sbjct: 99 KLTQLHYLYI-------THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 376 IVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSG 435
+ ++ N ++G IP + G +L N +
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRNMLE 210
Query: 436 PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL 495
L + + + + L ++L +N + G+LP + L+ L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 496 INLDLSRNQLSGDIPITIGSLKDLVTLSLASNQF--EGPIP 534
+L++S N L G+IP G+L+ + A+N+ P+P
Sbjct: 271 HSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.4 bits (194), Expect = 1e-16
Identities = 76/269 (28%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 370 GNLRSLIVLSLFINALNG--TIPSTVGRLEQLQGLSLYGN-NLEGSIPYDLCHLERLNGI 426
+ L L L IPS++ L L L + G NL G IP + L +L+ +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
+ +SG IP L+ + +L L+ N S ++P S SL L+ + N +SG++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 487 SNIQNLQVLI-NLDLSRNQLSGDIPITIGSLKDLVTLSLAS------------------- 526
+ + L ++ +SRN+L+G IP T +L +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 527 ---NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPA 583
G L LDL NN + G +P+ L L FL LNVS N L GEIP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 584 NGPFKYFAPQSFSWNYALCGPTTLQVPPC 612
G + F +++ N LCG +P C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.9 bits (190), Expect = 5e-16
Identities = 62/301 (20%), Positives = 105/301 (34%), Gaps = 26/301 (8%)
Query: 140 NSLFNLSRLEKWDSMFNIIDGNIP----SRIGNLSSLVNVNLAYNNLQG--EIPSEIGNL 193
L N + L W + + + N++L+ NL IPS + NL
Sbjct: 16 KDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANL 75
Query: 194 QNLEILVL-GMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSL 252
L L + G+NNL GPI P+I ++ + + + P + L
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN---VSGAIPDFLSQIKTLVTLDF 132
Query: 253 GKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVL------NLANNYLT 306
N L+GT+P SI++ L G+ N SG IP ++G+ L L
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 307 TDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAY--------- 357
T + S ++ S+ + + + L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR 252
Query: 358 DCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDL 417
+ ++ G +P + L+ L L++ N L G IP G L++ + N P
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPA 311
Query: 418 C 418
C
Sbjct: 312 C 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 2e-15
Identities = 72/289 (24%), Positives = 113/289 (39%), Gaps = 8/289 (2%)
Query: 299 NLANNYLTTDSPTAEWSFL--SSLTNCRNLTTLAVASNPLRGI--LPPVIGNFSASLQNF 354
L++ TTD W + + T + L ++ L +P + N +
Sbjct: 23 TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP 414
L G IP I L L L + ++G IP + +++ L L N L G++P
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 415 YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRE-LNLGSNKFSSSIPSSFWSLEYLLA 473
+ L L GI +GN++SG IP S L + + N+ + IP +F +L A
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--A 200
Query: 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPI 533
S ++ S + +G K+L L L +N+ G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 534 PQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582
PQ L L SL++S NNL GEIP L ++NK P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 683 DGFNECNLLGRGSFGSVYKG----TFSDGTSFAIKVFN----LQLDRAFRSFDSECEVLR 734
+ F +LG G++G V+ G +A+KV +Q + +E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 735 NVRHR-NLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
++R L+ + + L+L+ + G L L F + + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVGEIV 139
Query: 794 EYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMA 853
L H H +++ D+K NILLD + ++DFGLSK F + TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMA 198
Query: 854 PE--YGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
P+ G + D +S GVL+ E T P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (299), Expect = 6e-30
Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 683 DGFNECNLLGRGSFGSVYKGT-FSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRN 740
D + LGRG + V++ ++ +K+ + + E ++L N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPN 91
Query: 741 LIKIFSSCCNNDFR--ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
+I + + R ALV E + N ++ + L + M + AL+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147
Query: 799 GHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYG 857
++H D+KP N+++D E + D+GL++ + G + +A+ + PE
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 201
Query: 858 TE-GIVSSKCDVYSYGVLLTETFTRKKP 884
+ + D++S G +L RK+P
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 8e-28
Identities = 44/204 (21%), Positives = 76/204 (37%), Gaps = 19/204 (9%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFS 746
+G G+ G V + AIK + + E +++ V H+N+I + +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 747 SCCNNDFR------ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH 800
LV+ELM + D ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 801 STPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEG 860
++H DLKPSNI++ D + DFGL++ T + T Y APE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 193
Query: 861 IVSSKCDVYSYGVLLTETFTRKKP 884
D++S G ++ E K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 7e-27
Identities = 42/212 (19%), Positives = 81/212 (38%), Gaps = 20/212 (9%)
Query: 690 LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSC 748
LG G F +V+ + T A+K+ + + E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 749 CNNDFR---------------ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALAL 793
N+ + +V E++ L ++ + L+ I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 794 EYLHHGHSTPVVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYM 852
+Y+H ++H D+KP N+L++ D ++ ++ L + T +I T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 853 APEYGTEGIVSSKCDVYSYGVLLTETFTRKKP 884
+PE D++S L+ E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 53/292 (18%), Positives = 107/292 (36%), Gaps = 30/292 (10%)
Query: 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRH 738
+ + + +G G++GSV G A+K + + E +L++++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 739 RNLIKIFSSCCNN----DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALE 794
N+I + +F + L G+ + D ++ + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135
Query: 795 YLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAP 854
Y+H H DLKPSN+ ++ED + DFGL++ D+
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 188
Query: 855 EYGTEGIVSSKCDVYSYGVLLTETFTRKKP---TDDMFTGEMSLKKWVKESLPHGLMEVV 911
+ D++S G ++ E T + TD + ++ L+ + + L++ +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR--LVGTPGAELLKKI 246
Query: 912 DTNLLRQEHTSSAEM------DCLLSVLHLALD----CCMESPDQRIYMTDA 953
+ R S +M + + LA+D + D+RI A
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 109 bits (272), Expect = 4e-26
Identities = 81/389 (20%), Positives = 140/389 (35%), Gaps = 30/389 (7%)
Query: 192 NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFS 251
L VLG N++ + + ++ +T + + + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE-----YLNNLTQIN 72
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLS-----VLNLANNYLT 306
N+LT P + N +KL + ++ N + + P + +
Sbjct: 73 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 307 TDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIP 366
+ +++++ L+ L G + + +
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 367 HEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGI 426
+ L +L L N ++ P + L LSL GN L+ L L L +
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 427 RLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLP 486
L N++S P L+ L L EL LG+N+ S+ P L L + L+ N L
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--I 300
Query: 487 SNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESL 546
S I NL+ L L L N +S P+ SL L L A+N+ + +LT + L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSDV--SSLANLTNINWL 356
Query: 547 DLSNNNLSGEIPKSLEALLFLKQLNVSHN 575
+N +S P L L + QL ++
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 8e-22
Identities = 81/365 (22%), Positives = 131/365 (35%), Gaps = 41/365 (11%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+L LGK +T T+ S T+ ++T L + L L+ +N +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 303 NYLTTDSPTAEWSFLSSLTN-----CRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAY 357
N LT +P + L + + + + I +
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 358 DCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDL 417
+L+ N +I L L L T + L L+ L + N S L
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVL 193
Query: 418 CHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLS 477
L L + N++S P + + +L EL+L N+ + SL L ++L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPIT--------------------IGSLK 517
+N +S P + L L L L NQ+S P+ I +LK
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 518 DLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKL 577
+L L+L N P SLT L+ L +NN +S SL L + L+ HN++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 578 EGEIP 582
P
Sbjct: 364 SDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 8e-21
Identities = 73/393 (18%), Positives = 132/393 (33%), Gaps = 38/393 (9%)
Query: 72 NFSFLMSLDISKNNFHAYLP-NELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLR 130
+ M + K N + +L Q+ L+ L G + L+ L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 131 NNSFTGPIP-NSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSE 189
NN T P +L L + ++ I +L N + + + +
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 190 IGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL-------DLPPKVSY 242
+ + + + +T + N + V
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
L NL N+++ P I + L L L+ N T +L L+ L+LAN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N ++ L+ L+ LT L + +N + I P + +
Sbjct: 251 NQISN---------LAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQ 296
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
I NL++L L+L+ N ++ P V L +LQ L N + L +L
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSN 455
+N + N++S P LA+L + +L L
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.8 bits (229), Expect = 1e-20
Identities = 72/409 (17%), Positives = 133/409 (32%), Gaps = 48/409 (11%)
Query: 121 LSKLQILSLRNNSFTGPIPNS-LFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY 179
L++ L + T + + L ++ L+ IDG + L++L +N +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK 239
N L P + NL L +++ N ++ + T +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP------ 127
Query: 240 VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLN 299
K + +++ ++ + S + L L
Sbjct: 128 ---------------LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA 172
Query: 300 LANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDC 359
D + + S +S L NL +L +N + I P +L
Sbjct: 173 NLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGN 229
Query: 360 KLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCH 419
+L + +L +L L L N ++ P + L +L L L N + P
Sbjct: 230 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLT 285
Query: 420 LERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIP-SSFWSLEYLLAVNLSS 478
+ N +++L +L L L N S P SS L+ L ++
Sbjct: 286 ALTNLELNENQL----EDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL---FFAN 338
Query: 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASN 527
N +S S++ NL + L NQ+S P + +L + L L
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.3 bits (189), Expect = 2e-15
Identities = 73/371 (19%), Positives = 141/371 (38%), Gaps = 44/371 (11%)
Query: 50 QRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNE 109
+V L +G++ + + L ++ S N P L L +L I ++ N+
Sbjct: 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 110 FSGSFPSWIGVLSKLQILSLRNNSFTGPIP------------NSLFNLSRLEKWDSMFNI 157
+ P L + P+ N++ ++S L S+ +
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 158 IDGNIPSRIGNLSSLVNVNL-AYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFN 216
GN + + L++L + ++ + S + L NLE L+ N +S +
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT--PLGI 217
Query: 217 ISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDL 276
++ + ++L GNQL SL NL L N+++ P ++ +KLT L L
Sbjct: 218 LTNLDELSLNGNQLKD-----IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 277 SFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPL 336
N S + P L + + +S ++N +NLT L + N +
Sbjct: 271 GANQISNISP-----------LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 337 RGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRL 396
I P + + + LQ + + K++ + NL ++ LS N ++ P + L
Sbjct: 320 SDISP--VSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANL 372
Query: 397 EQLQGLSLYGN 407
++ L L
Sbjct: 373 TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 7e-13
Identities = 49/202 (24%), Positives = 76/202 (37%), Gaps = 14/202 (6%)
Query: 27 LANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNF 86
L N S+ + I+ + L+L+ L+ L + + L LD++ N
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 87 HAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLS 146
P L L +L + L N+ S P L+ L L L N P NL
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISPLAG--LTALTNLELNENQLEDISPI--SNLK 307
Query: 147 RLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNL 206
L FN I P + +L+ L + A N + S + NL N+ L G N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 207 SGPIQPSIFNISTITLINLFGN 228
S + N++ IT + L
Sbjct: 364 SDLT--PLANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.4 bits (228), Expect = 6e-21
Identities = 60/312 (19%), Positives = 105/312 (33%), Gaps = 45/312 (14%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
P+ + L NK+T N L L L N S + P F L L L L+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
L LP + L+ K+ +
Sbjct: 91 LKE--------------------------------LPEKMPKTLQELRVHENEITKVRKS 118
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+ + + N ++ L +G +++L + + N+ L L+
Sbjct: 119 VFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH 177
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
L+GNK++ L L +L +L L N S+ S + +L ++L++N L
Sbjct: 178 ---LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234
Query: 485 LPSNIQNLQVLINLDLSRNQLSG------DIPITIGSLKDLVTLSLASN--QFEGPIPQT 536
P + + + + + L N +S P +SL SN Q+ P T
Sbjct: 235 -PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293
Query: 537 FGSLTGLESLDL 548
F + ++ L
Sbjct: 294 FRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (225), Expect = 1e-20
Identities = 53/285 (18%), Positives = 106/285 (37%), Gaps = 12/285 (4%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
R + S++GL +P L LD+ N + L+ L + L N+ S
Sbjct: 13 RVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
P L KL+ L L N L L ++ + ++ + + N +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIV 128
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSG 232
V + G ++ L + + N++ I + ++T ++L GN+++
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITK 185
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292
L NL L N ++ S+ N L L L+ N +P +
Sbjct: 186 V---DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADH 241
Query: 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+++ V+ L NN ++ + T + + +++ SNP++
Sbjct: 242 KYIQVVYLHNNNISAIGSND-FCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (225), Expect = 1e-20
Identities = 46/261 (17%), Positives = 90/261 (34%), Gaps = 12/261 (4%)
Query: 324 RNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFIN 383
+ L + +N + I N +L + K++ P L L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 384 ALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS 443
L L++L+ + S+ L + + + N K SG
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG 148
Query: 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503
+ L + + ++ SL L +L N ++ ++++ L L L LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 504 QLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG------EI 557
+S ++ + L L L +N+ +P ++ + L NNN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 558 PKSLEALLFLKQLNVSHNKLE 578
P +++ N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 44/234 (18%), Positives = 89/234 (38%), Gaps = 5/234 (2%)
Query: 346 NFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405
+ + K+T + NL++L L L N ++ P L +L+ L L
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 406 GNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSF 465
N L+ L+ L K+ + L +I + EL K S +F
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAF 146
Query: 466 WSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLA 525
++ L + ++ +++ +L L L N+++ ++ L +L L L+
Sbjct: 147 QGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 526 SNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579
N + + L L L+NN L ++P L +++ + + +N +
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.9 bits (198), Expect = 4e-17
Identities = 57/300 (19%), Positives = 98/300 (32%), Gaps = 26/300 (8%)
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
P + +L L+NN T NL L + N I P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 173 VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSG 232
+ L+ N L+ LQ L + N ++ S+FN ++ G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVH----ENEITKVRKSVFNGLNQMIVVELGTNPLK 137
Query: 233 HLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNL 292
+ + L + +T TIP + LT L L N + + + L
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 194
Query: 293 RFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQ 352
L+ L L+ N ++ + N +L L + +N L + + + +Q
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLA-------NTPHLRELHLNNNKLVKVPGGLADHK--YIQ 245
Query: 353 NFYAYDCKLTG------NIPHEIGNLRSLIVLSLFINALNGT--IPSTVGRLEQLQGLSL 404
Y ++ ++ P S +SLF N + PST + + L
Sbjct: 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 7e-16
Identities = 44/204 (21%), Positives = 74/204 (36%), Gaps = 4/204 (1%)
Query: 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFS 458
L L N + D +L+ L+ + L NK+S P A L+ L L L N+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 459 SSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKD 518
+L+ L + S+ + + N +++ L + + SG +K
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 519 LVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLE 578
L + +A IPQ G L L L N ++ SL+ L L +L +S N +
Sbjct: 152 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 579 GEIPANGPFKYFAPQSFSWNYALC 602
+ + N L
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.5 bits (184), Expect = 3e-15
Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 6/234 (2%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+P ++ +L L N + L+ L L L N + P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484
+ L+ N+L + +L LR K S+ + + ++ + + SG
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN-GLNQMIVVELGTNPLKSSGI 141
Query: 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLE 544
Q ++ L + ++ ++ I G L L L N+ + L L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 545 SLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWN 598
L LS N++S SL L++L++++NKL KY N
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 1e-08
Identities = 29/109 (26%), Positives = 45/109 (41%), Gaps = 5/109 (4%)
Query: 474 VNLSSNSLSGSLPSNI-QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532
V S L +P ++ + +L DL N+++ +LK+L TL L +N+
Sbjct: 15 VQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581
P F L LE L LS N L K + L L+ K+ +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 6e-07
Identities = 25/146 (17%), Positives = 49/146 (33%), Gaps = 4/146 (2%)
Query: 454 SNKFSSSIPSSF-WSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPIT 512
S+ +P L +L +N ++ + +NL+ L L L N++S P
Sbjct: 18 SDLGLEKVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 513 IGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNV 572
L L L L+ NQ + + +L L + + + L ++ ++
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 573 SHNKLEGEIPANGPFKYFAPQSFSWN 598
E A K + +
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557
+ S L +P + D L L +N+ F +L L +L L NN +S
Sbjct: 15 VQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 558 PKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALC 602
P + L+ L++L +S N+L+ + +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (218), Expect = 8e-20
Identities = 65/261 (24%), Positives = 97/261 (37%), Gaps = 11/261 (4%)
Query: 295 LSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNF 354
+ L N ++ +S CRNLT L + SN L I + Q
Sbjct: 34 SQRIFLHGNRISHVPA-------ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86
Query: 355 YAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP 414
+ + +L P L L L L L P L LQ L L N L+
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146
Query: 415 YDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAV 474
L L + L+GN++S + L SL L L N+ + P +F L L+ +
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 475 NLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIP 534
L +N+LS + L+ L L L+ N D L +S++ +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP 265
Query: 535 QTFGSLTGLESLDLSNNNLSG 555
Q L G + L+ N+L G
Sbjct: 266 Q---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 9e-18
Identities = 54/257 (21%), Positives = 88/257 (34%), Gaps = 6/257 (2%)
Query: 324 RNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFIN 383
+ + N + + +L + + L L L L L N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 384 ALNGTI-PSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLA 442
A ++ P+T L +L L L L+ P L L + L N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 443 SLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSR 502
L +L L L N+ SS +F L L + L N ++ P ++L L+ L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 503 NQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLE 562
N LS + L+ L L L N + L+ S++ + +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 563 ALLFLKQLNVSHNKLEG 579
++ N L+G
Sbjct: 270 GRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (171), Expect = 1e-13
Identities = 50/295 (16%), Positives = 95/295 (32%), Gaps = 18/295 (6%)
Query: 45 CGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFIS 104
C ++ + GL+ +P + + + + N R L +
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPI-PNSLFNLSRLEKWDSMFNIIDGNIP 163
L N + + L+ L+ L L +N+ + P + L RL + P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 164 SRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLI 223
L++L + L N LQ +L NL L L N +S + + + ++ +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 224 NLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSG 283
L N+ + P L L L N L+ ++ L L L+ N +
Sbjct: 183 LLHQNR---VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 284 LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRG 338
+L +++ + P +A+N L+G
Sbjct: 240 DCRAR-PLWAWLQKFRGSSSEVPCSLP----------QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 2e-12
Identities = 56/246 (22%), Positives = 86/246 (34%), Gaps = 4/246 (1%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+P I + + L N ++ ++ L L L+ N L L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 425 GIRLNGNKLSGPI-PQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
+ L+ N + P L L L+L P F L L + L N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL 543
++L L +L L N++S L L L L N+ P F L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 544 ESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGPFKYFAPQSFSWNYALC- 602
+L L NNLS ++L L L+ L ++ N + A + + S + C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 603 GPTTLQ 608
P L
Sbjct: 264 LPQRLA 269
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 5e-19
Identities = 24/157 (15%), Positives = 48/157 (30%), Gaps = 18/157 (11%)
Query: 689 NLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL----------DRAFRSFDSECEVLRNVRH 738
L+G G +V+ +K + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 739 RNLIKIFSSCCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHH 798
R L K+ + ++ +E + Y + + ++ + + +H
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVL----MELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 799 GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835
+VH DL N+L+ E+ + + DF S E
Sbjct: 122 RG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGE 154
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.5 bits (142), Expect = 7e-10
Identities = 28/92 (30%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPS 487
N S I SL ELN+ +NK +P+ LE L S N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERL---IASFNHLA-EVPE 321
Query: 488 NIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519
QNL+ L + N L P S++DL
Sbjct: 322 LPQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 6e-09
Identities = 59/326 (18%), Positives = 102/326 (31%), Gaps = 22/326 (6%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
L L+ ++P + L L S NS + L P +L+ L V N L
Sbjct: 39 QAHELELNNLGLS-SLPELPPH---LESLVASCNSLTEL-PELPQSLKSLLVDNNNLKAL 93
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
+ P E+ +S+ + + + + + N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPD--LPPSLEFIAAGNNQ 151
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
E+ L++L L+ N L ++ E +L L +
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 426 IRLNGNKLSGPIPQCLASLISLRELN-----LGSNKFSSSIPSSFWSLEYLLAVNLSSNS 480
L P A + L S F + F L L N+
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 481 LSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSL 540
S + S L L++S N+L ++P L+ L + N +P+ +
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPELPQN- 325
Query: 541 TGLESLDLSNNNLSG--EIPKSLEAL 564
L+ L + N L +IP+S+E L
Sbjct: 326 --LKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 47/312 (15%), Positives = 93/312 (29%), Gaps = 17/312 (5%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTIT 221
+P +L SL + N+L E+P +L++L + + L P + ++
Sbjct: 53 LPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKAL--SDLPPLLEYLGVS 106
Query: 222 LINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSF 281
L + + +L+ L + +L F +
Sbjct: 107 NNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTA 166
Query: 282 SGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILP 341
++ L L + + + + P
Sbjct: 167 IYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSL 226
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLS--LFINALNGTIPSTVGRLEQL 399
+ L + LT E + ++NA + I S L
Sbjct: 227 EALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 286
Query: 400 QGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSS 459
+ L++ N L +P LERL + N L+ +P+ +L++L++ N
Sbjct: 287 EELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VPELPQ---NLKQLHVEYNPL-R 337
Query: 460 SIPSSFWSLEYL 471
P S+E L
Sbjct: 338 EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 23/94 (24%), Positives = 39/94 (41%), Gaps = 9/94 (9%)
Query: 105 LDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPS 164
N S S + L+ L++ NN +P L RL + FN + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHL-AEVPE 321
Query: 165 RIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEI 198
NL L ++ YN L+ E P ++++L +
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 8e-07
Identities = 48/327 (14%), Positives = 97/327 (29%), Gaps = 15/327 (4%)
Query: 170 SSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQ 229
+ L L +P +L++L N+L+ + ++ ++ + N
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 230 LSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTF 289
LS L + S L +N I + N+ K F +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 290 GNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSA 349
L L L ++ + L + P LP + ++
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 350 SLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNL 409
+ D + + N + + + L +L Y N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 410 EGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLE 469
I L + ++ NKL +P A L L N + +P +L+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHL-AEVPELPQNLK 327
Query: 470 YLLAVNLSSNSLSG--SLPSNIQNLQV 494
L ++ N L +P ++++L++
Sbjct: 328 QL---HVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 9/83 (10%)
Query: 500 LSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPK 559
N S +I L L++++N+ +P LE L S N+L+ E+P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLA-EVPE 321
Query: 560 SLEALLFLKQLNVSHNKLEGEIP 582
+ LKQL+V +N L E P
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 18/120 (15%), Positives = 31/120 (25%), Gaps = 9/120 (7%)
Query: 29 NNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHA 88
V + + + I L L++S N
Sbjct: 239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE 298
Query: 89 YLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRL 148
LP +L RL +N + P L+ L + N P+ ++ L
Sbjct: 299 -LPALPPRLERL---IASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 21/121 (17%), Positives = 34/121 (28%), Gaps = 36/121 (29%)
Query: 151 WDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPI 210
N I S SL +N++ N L E+P+ L+ L
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL-------------- 309
Query: 211 QPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASK 270
N L+ ++P NL+ + N L P+ +
Sbjct: 310 -------------IASFNHLA---EVPE----LPQNLKQLHVEYNPLR-EFPDIPESVED 348
Query: 271 L 271
L
Sbjct: 349 L 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 21/69 (30%), Positives = 30/69 (43%), Gaps = 7/69 (10%)
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
+ CL EL L + SS +P LE L S NSL+ LP Q+L+ L+
Sbjct: 32 LRDCLDR--QAHELELNNLGLSS-LPELPPHLESL---VASCNSLT-ELPELPQSLKSLL 84
Query: 497 NLDLSRNQL 505
+ + L
Sbjct: 85 VDNNNLKAL 93
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 50/294 (17%), Positives = 87/294 (29%), Gaps = 24/294 (8%)
Query: 78 SLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSW-IGVLSKLQILSLRNNSFTG 136
+LD++ N H P+ G+L I+ P ++Q + L N+
Sbjct: 4 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 137 -PIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQN 195
+ L S+L+ + I + + S+LV +NL+ + E +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 196 LEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKN 255
+ L ++ + + + LSG+ K S R +L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 256 ------KLTGTIPNSITNASKLTGLDLSF-NSFSGLIPHTFGNLRFLSVLNLANNYLTTD 308
L + L L LS G + L L + + D
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG--IVPD 238
Query: 309 SPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
L L + + I P IGN Q + C+LT
Sbjct: 239 GTLQLLK--------EALPHLQINCSHFTTIARPTIGN--KKNQEIWGIKCRLT 282
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 37/278 (13%), Positives = 83/278 (29%), Gaps = 22/278 (7%)
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPT 311
L L + + + + + + F R + ++L+N+ + +
Sbjct: 7 LTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST-- 62
Query: 312 AEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKL--TGNIPHEI 369
L+ C L L++ L + + S +L C + +
Sbjct: 63 ----LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFALQTLL 117
Query: 370 GNLRSLIVLSL------FINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERL 423
+ L L+L + + + QL N + + + L
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 424 NGIRLNGN-KLSGPIPQCLASLISLRELNL-GSNKFSSSIPSSFWSLEYLLAVNLSSNSL 481
+ L+ + L Q L L+ L+L + L + +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 482 SGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDL 519
G+L + L +L ++ + + TIG+ K+
Sbjct: 238 DGTLQLLKEALP---HLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 18/87 (20%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGE- 556
LDL+ L D+ + S ++ + + P+ + F S ++ +DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 557 IPKSLEALLFLKQLNVSHNKLEGEIPA 583
+ L L+ L++ +L I
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 5e-04
Identities = 44/254 (17%), Positives = 82/254 (32%), Gaps = 41/254 (16%)
Query: 366 PHEIGNL--RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG-SIPYDLCHLER 422
P G L + +I + ++ + ++Q + L + +E ++ L +
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGS--NKFSSSIPSSFWSLEYLLAVN----- 475
L + L G +LS PI LA +L LNL ++ + S L +N
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 476 -------------------------LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGD-I 509
N L + ++ L++LDLS + + +
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 510 PITIGSLKDLVTLSLAS-NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLK 568
L L LSL+ G + L++L + G + EA L
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LP 249
Query: 569 QLNVSHNKLEGEIP 582
L ++ +
Sbjct: 250 HLQINCSHFTTIAR 263
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 50/215 (23%), Positives = 70/215 (32%), Gaps = 15/215 (6%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+ + + K LT +P + T L LS N T L+ LNL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
LT L +L N + P++G +L +LT
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHN-----------QLQSLPLLGQTLPALTVLDVSFNRLT 113
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
+ L L L L N L P + +L+ LSL NNL L LE
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKF 457
L+ + L N L IP+ L L N +
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 50/218 (22%), Positives = 73/218 (33%), Gaps = 35/218 (16%)
Query: 36 PICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELG 95
PIC+ +S A H V N L +PP L L +S+N + + L
Sbjct: 2 PICE---VSKVASHLEV---NCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLM 52
Query: 96 QLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNN----------------------- 132
RL ++LD E + G L L L L +N
Sbjct: 53 PYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
Query: 133 SFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGN 192
T +L L L++ N + P + L ++LA NNL +
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 193 LQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230
L+NL+ L+L N I F + L GN
Sbjct: 171 LENLDTLLL-QENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 39/217 (17%), Positives = 68/217 (31%), Gaps = 12/217 (5%)
Query: 93 ELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWD 152
E+ ++ ++ D + + P + IL L N +L +RL + +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 153 -SMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQ 211
+ + + L +L + +L + N L+
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPL 117
Query: 212 PSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKL 271
++ + + + L GN+ LPP + P L SL N LT + L
Sbjct: 118 GALRGLGELQELYLKGNE---LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 272 TGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTD 308
L L NS IP F L L N +
Sbjct: 175 DTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 44/208 (21%), Positives = 69/208 (33%), Gaps = 27/208 (12%)
Query: 392 TVGRLEQLQGLSLYGNNLEGSIPYDL-CHLERLNGIRLNGNKLSGPIPQCLASLISLREL 450
V ++ ++ NL ++P DL L+ L+ N L L L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQL 60
Query: 451 NLGSNKFSSSIP---------------------SSFWSLEYLLAVNLSSNSLSGSLPSNI 489
NL + + +L L +++S N L+ +
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 490 QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLS 549
+ L L L L N+L P + L LSLA+N L L++L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 550 NNNLSGEIPKSLEALLFLKQLNVSHNKL 577
N+L IPK L + N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 8e-05
Identities = 38/185 (20%), Positives = 58/185 (31%), Gaps = 5/185 (2%)
Query: 324 RNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFIN 383
++ T L ++ N L + ++ L + G L L L L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYT-RLTQLNLDRAE--LTKLQVDGTLPVLGTLDLSHN 87
Query: 384 ALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLAS 443
L + N L L L L + L GN+L P L
Sbjct: 88 QLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503
L +L+L +N + LE L + L NSL ++P +L L N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 504 QLSGD 508
+
Sbjct: 206 PWLCN 210
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 3e-08
Identities = 34/242 (14%), Positives = 68/242 (28%), Gaps = 10/242 (4%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
+ RVF ++K+T IP+ + L + F L + ++ N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 306 TTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365
+S + + A+N L + K ++
Sbjct: 66 LEVIEADVFSN----LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121
Query: 366 PHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNG 425
+ L+ + IN S VG + L L N ++ +
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 426 IRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSL 485
+ N L L++ + S +L+ L A + + L
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 238
Query: 486 PS 487
P+
Sbjct: 239 PT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 29/228 (12%), Positives = 65/228 (28%), Gaps = 6/228 (2%)
Query: 78 SLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGP 137
++ +P++L R + + L+ + + N
Sbjct: 12 VFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 138 IPNSLFNLSRLEKWDSMFNII--DGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQN 195
I +F+ + P NL +L + ++ ++ +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 196 LEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKN 255
+L + N I+ + F + + L+ N+ + + + N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT-QLDELNLSDNN 187
Query: 256 KLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
L + AS LD+S L + NL+ L + N
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 33/221 (14%), Positives = 66/221 (29%), Gaps = 8/221 (3%)
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
PS + L + LEK + N + I + + +
Sbjct: 22 EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 173 VN--VNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQL 230
++ NNL P NL NL+ L++ + + L+++ N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFG 290
++ V S ++ ++ L KN + + N+ L F
Sbjct: 140 IHTIERNSFVGLSFESVILW-LNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH 198
Query: 291 NLRFLSVLNLANNYLTTDSPTAEWSFLSSLT--NCRNLTTL 329
+L+++ + + L L + NL L
Sbjct: 199 GASGPVILDISRTRIHSLPSYG-LENLKKLRARSTYNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 10/44 (22%), Positives = 16/44 (36%)
Query: 533 IPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNK 576
F +G LD+S + LE L L+ + + K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 12/105 (11%), Positives = 22/105 (20%)
Query: 29 NNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHA 88
+ + I S L L+ G++ NN
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 89 YLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNS 133
+ + + + L KL+ S N
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 24/219 (10%), Positives = 53/219 (24%), Gaps = 7/219 (3%)
Query: 245 PNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNY 304
N KL + + L +++S N +I +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 305 LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGN 364
E ++ + P + + + T
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL----LDIQDNINIHTIE 144
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+G ++L L N + + + NNLE
Sbjct: 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 204
Query: 425 GIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPS 463
+ ++ ++ L +L LR + + K +P+
Sbjct: 205 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 4e-08
Identities = 25/120 (20%), Positives = 37/120 (30%), Gaps = 26/120 (21%)
Query: 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG----SLPSNIQNLQVLINLDLSRNQLSGD 508
G + + L L L+ +S SL + + L LDLS N L
Sbjct: 356 GVRELCQGLGQPGSVLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 509 IPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLK 568
+ + S+ LE L L + S E+ L+AL K
Sbjct: 413 GILQLVE-------SVRQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 9e-08
Identities = 15/94 (15%), Positives = 28/94 (29%), Gaps = 8/94 (8%)
Query: 491 NLQVLINLDLSRNQLS-GDIPITIGSLKDLVTLSLASNQFEG----PIPQTFGSLTGLES 545
++Q +LD+ +LS + L+ + L I L
Sbjct: 3 DIQ---SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 546 LDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEG 579
L+L +N L + L + L+
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 5/70 (7%)
Query: 518 DLVTLSLASNQF-EGPIPQTFGSLTGLESLDLSNNNLSGE----IPKSLEALLFLKQLNV 572
D+ +L + + + + L + + L + L+ I +L L +LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 573 SHNKLEGEIP 582
N+L
Sbjct: 63 RSNELGDVGV 72
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/95 (15%), Positives = 33/95 (34%), Gaps = 10/95 (10%)
Query: 445 ISLRELNLGSNKFSSSIPSSFWS-LEYLLAVNLSSNSLSG----SLPSNIQNLQVLINLD 499
+ ++ L++ + S + + L+ V L L+ + S ++ L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 500 LSRNQLSGDIPITIGSL-----KDLVTLSLASNQF 529
L N+L + + LSL +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 4/77 (5%)
Query: 271 LTGLDLSFNSFSGL-IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
+ LD+ S L+ V+ L + LT S+L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD---ISSALRVNPALAEL 60
Query: 330 AVASNPLRGILPPVIGN 346
+ SN L + +
Sbjct: 61 NLRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 399 LQGLSLYGNNLEGSIPYDLC-HLERLNGIRLNGNKLSG----PIPQCLASLISLRELNLG 453
+Q L + L + +L L++ +RL+ L+ I L +L ELNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 454 SNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483
SN+ + + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 6/90 (6%)
Query: 220 ITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTG----TIPNSITNASKLTGLD 275
I +++ +LS ++ L +V L LT I +++ L L+
Sbjct: 4 IQSLDIQCEELSD--ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 276 LSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305
L N + H + L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 16/133 (12%), Positives = 38/133 (28%), Gaps = 9/133 (6%)
Query: 19 HVTDPQSVLANNWSISQPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMS 78
+ + + + + ++ L + G+R S L
Sbjct: 314 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 373
Query: 79 LDISKNNFH----AYLPNELGQLRRLRFISLDYNEFSGSFPSWIG-----VLSKLQILSL 129
L ++ + + L L LR + L N + + L+ L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 130 RNNSFTGPIPNSL 142
+ ++ + + L
Sbjct: 434 YDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 21/114 (18%), Positives = 35/114 (30%), Gaps = 30/114 (26%)
Query: 418 CHLERLNGIRLNGNKLSG----PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLA 473
L L L +S + L + SLREL+L +N +
Sbjct: 369 SVLRVLW---LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL---------- 415
Query: 474 VNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLK----DLVTLS 523
L S+ L+ L L S ++ + +L+ L +S
Sbjct: 416 ------QLVESVRQPGCLLEQ---LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/106 (16%), Positives = 33/106 (31%), Gaps = 9/106 (8%)
Query: 231 SGHLDLPPKVSYSLPNLRVFSLGKNKLTGT----IPNSITNASKLTGLDLSFNSFSGLIP 286
+G +L + LRV L ++ + + ++ L LDLS N
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 287 HTFG-----NLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLT 327
L L L + Y + + + + R ++
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 11/89 (12%), Positives = 25/89 (28%), Gaps = 7/89 (7%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNA-SKLTGLDLSFNSFSG----LIPHTFGNLRFLSVLNL 300
+++ + +L+ + + + L + I L+ LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 301 ANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
+N L L + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQT--PSCKIQKL 89
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 13/112 (11%), Positives = 33/112 (29%), Gaps = 26/112 (23%)
Query: 100 LRFISLDYNEFSGS-FPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNII 158
++ + + E S + + + +L + Q++ L + T + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50
Query: 159 DGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG-----NLQNLEILVLGMNN 205
+ +L +NL N L + ++ L L
Sbjct: 51 -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 11/102 (10%)
Query: 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGI----LP 341
L VL LA+ ++ S ++ ++L +L L +++N L L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSS---LAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 342 PVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR----SLIVLS 379
+ L+ YD + + + L SL V+S
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 31/231 (13%), Positives = 62/231 (26%), Gaps = 21/231 (9%)
Query: 72 NFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRN 131
+ + + K+N + L + +S + + L+ L L L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIG 191
N T P + I + + + S +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 192 NLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFS 251
L + ++ L+G +I +L L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGN-------------AQVSDLTPLANLSKLTTLK 179
Query: 252 LGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
NK++ P + + L + L N S + P N L ++ L N
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 45/235 (19%), Positives = 77/235 (32%), Gaps = 26/235 (11%)
Query: 243 SLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLAN 302
+L N + GK+ +T T+ + + +T L + + L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 303 NYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT 362
N +T + L +LT L + I L
Sbjct: 73 NQITD------LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 363 GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER 422
G + + I + L N + S L +L +
Sbjct: 127 GLSNLQ------------VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSK 174
Query: 423 LNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLS 477
L ++ + NK+S P LASL +L E++L +N+ S P + L V L+
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 43/218 (19%), Positives = 81/218 (37%), Gaps = 22/218 (10%)
Query: 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNG 430
L + I ++ + + T+ L+ + LS +G + +I + +L L G+ L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 431 NKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQ 490
N+++ P + I+ EL+ K S+I L ++ + SN+Q
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 491 NLQVLINLDLSRNQL--------------SGDIPITIGSLKDLVTLSLASNQFEGPIPQT 536
L + +N + + L + +L L TL N+ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 537 FGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSH 574
SL L + L NN +S P L L + +++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 36/221 (16%), Positives = 69/221 (31%), Gaps = 28/221 (12%)
Query: 121 LSKLQILSLRNNSFTGPIPNS-LFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY 179
L+ ++ ++ T + + L ++ L + + I+G + L++L+ + L
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72
Query: 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLF-----------GN 228
N + P + L I +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 229 QLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288
L L+ +S + L + + N SKLT L N S + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 289 FGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
+L L ++L NN ++ +S L N NL +
Sbjct: 191 LASLPNLIEVHLKNNQISD---------VSPLANTSNLFIV 222
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 28/125 (22%), Positives = 44/125 (35%), Gaps = 6/125 (4%)
Query: 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSG 507
R L+L + L + ++LS N L P+ + L+ L L S N L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 508 DIPITIGSLKDLVTLSLASNQFEG-PIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLF 566
+ L L L +N+ + Q S L L+L N+L E
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 567 LKQLN 571
L ++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 26/125 (20%), Positives = 50/125 (40%), Gaps = 6/125 (4%)
Query: 125 QILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG 184
++L L + T + L L + D N + P+ + L L + ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNAL 55
Query: 185 EIPSEIGNLQNLEILVLGMNNL-SGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYS 243
E + NL L+ L+L N L + + + L+NL GN L + +++
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 244 LPNLR 248
LP++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 32/151 (21%), Positives = 53/151 (35%), Gaps = 31/151 (20%)
Query: 53 RALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSG 112
R L+L++ L T+ HL + LD+S N A P L LR L + ++ +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNAL 55
Query: 113 SFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSL 172
+ L +LQ L L NN + + L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQ-----------------------QSAAIQPLVSCPRL 92
Query: 173 VNVNLAYNNL---QGEIPSEIGNLQNLEILV 200
V +NL N+L +G L ++ ++
Sbjct: 93 VLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 8e-05
Identities = 29/129 (22%), Positives = 45/129 (34%), Gaps = 16/129 (12%)
Query: 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIP--YDLCHLERLNGIRLNGNKLS 434
VL L L T+ + +L + L L N L P L LE L +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 435 GPIPQCLASLISLRELNLGSNKFSS-SIPSSFWSLEYLLAVNLSSNSLSG------SLPS 487
G L+EL L +N+ + S L+ +NL NSL L
Sbjct: 60 GVANLP-----RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 488 NIQNLQVLI 496
+ ++ ++
Sbjct: 115 MLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 22/106 (20%), Positives = 34/106 (32%), Gaps = 26/106 (24%)
Query: 498 LDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGL-------------- 543
L L+ L+ + + L + L L+ N+ P +L L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 544 --------ESLDLSNNNL-SGEIPKSLEALLFLKQLNVSHNKLEGE 580
+ L L NN L + L + L LN+ N L E
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 5e-04
Identities = 23/132 (17%), Positives = 42/132 (31%), Gaps = 10/132 (7%)
Query: 198 ILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKL 257
+L L +L+ + + +T ++L N+L +L L V N L
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALA----ALRCLEVLQASDNAL 55
Query: 258 TGTIPNSITNASKLTGLDLSFNSFSGL-IPHTFGNLRFLSVLNLANNYLTTDSPTAEWSF 316
+ + L L N + L +LNL N L + +
Sbjct: 56 ENVDGVANLPRLQE--LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQERL 112
Query: 317 LSSLTNCRNLTT 328
L + ++ T
Sbjct: 113 AEMLPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 25/115 (21%), Positives = 37/115 (32%), Gaps = 10/115 (8%)
Query: 365 IPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLN 424
+ + L + L L N L P+ + L L+ L N LE +
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQE- 69
Query: 425 GIRLNGNKL-SGPIPQCLASLISLRELNLGSNKFS------SSIPSSFWSLEYLL 472
+ L N+L Q L S L LNL N + S+ +L
Sbjct: 70 -LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 29/128 (22%), Positives = 40/128 (31%), Gaps = 32/128 (25%)
Query: 248 RVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSV---------- 297
RV L LT + + +T LDLS N L P LR L V
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 298 ------------LNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIG 345
L L NN L + + + L +C L L + N L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQ------QSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQE 110
Query: 346 NFSASLQN 353
+ L +
Sbjct: 111 RLAEMLPS 118
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 6e-07
Identities = 26/146 (17%), Positives = 56/146 (38%), Gaps = 5/146 (3%)
Query: 437 IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLI 496
+ ++ + L S + + +N S+ + +L +N+ L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 497 NLDLSRNQLSG--DIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS 554
+L+LS N+L D+ + +L L+L+ N+ + LE L L N+LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 555 GEIPKSLEALLFLKQLNVSHNKLEGE 580
+ +++ +L+G
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (111), Expect = 1e-06
Identities = 23/156 (14%), Positives = 47/156 (30%), Gaps = 9/156 (5%)
Query: 176 NLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLD 235
L ++ ++ + + L + L P + + ++N + +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA---- 55
Query: 236 LPPKVSYSLPNLRVFSLGKNKLTGT--IPNSITNASKLTGLDLSFNSFSGLIPHTFGNLR 293
+ ++P L +L N+L + + + A L L+LS N
Sbjct: 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115
Query: 294 FLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTL 329
L L L N L+ + L L
Sbjct: 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 38/347 (10%), Positives = 95/347 (27%), Gaps = 42/347 (12%)
Query: 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSG----LIPHTFGNLRFLSVLNLA 301
+L++ ++ ++ + + + LS N+ + + + L + +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 302 NNY---LTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYD 358
+ + + + P A L +L C L T+ ++ N + +F +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 359 CKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC 418
G P + + P + L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKN-APPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 419 HLERLNGIRLNGNKLSGPIPQCLA------SLISLRELNLGSNKFSSSIPSSFWSLEYLL 472
L + ++ + + N ++ SS++ + S L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 473 AVNLSSNSLSGSLPSNI------QNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526
+ L+ LS + + L L L N++ D T+ ++
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV---------- 296
Query: 527 NQFEGPIPQTFGSLTGLESLDLSNNNLS--GEIPKSLEALLFLKQLN 571
+ L L+L+ N S ++ + + +
Sbjct: 297 ---------IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 5e-06
Identities = 38/331 (11%), Positives = 92/331 (27%), Gaps = 39/331 (11%)
Query: 271 LTGLDLSFNSFSG----LIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNL 326
+ G L ++ + + + + L+ N + T++ ++S +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 327 TTLAVASNPLRGILPPVIGNFS------ASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSL 380
+ + ++ +P + L D + + S
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 381 FINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQC 440
+ N + G L N + P + N + K Q
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 441 LASLISLRELNL------GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQV 494
L +++ + + + L N ++ S +L +++
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 495 LINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLS 554
L L L+ LS + + GL++L L N +
Sbjct: 245 LRELGLNDCLLSARGAAAVVD------------------AFSKLENIGLQTLRLQYNEIE 286
Query: 555 GEIPKSLEALLF-----LKQLNVSHNKLEGE 580
+ ++L+ ++ L L ++ N+ E
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 40/307 (13%), Positives = 78/307 (25%), Gaps = 22/307 (7%)
Query: 162 IPSRIGNLSSLVNVNLAYNNLQGE----IPSEIGNLQNLEILVLGMNNLSGPIQPSIFNI 217
+ + + S+ + L+ N + E + I + ++LEI +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 218 STITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLS 277
+ L +L + + L K+ + G ++
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 278 FNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337
+ N L + N L S S + + P
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 338 GILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLE 397
+ G ++ + +L LN + S G
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 398 QLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI-----SLRELNL 452
+ S N L+ L L N++ + L ++I L L L
Sbjct: 263 VVDAFSKLEN----------IGLQTLR---LQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 453 GSNKFSS 459
N+FS
Sbjct: 310 NGNRFSE 316
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (103), Expect = 1e-05
Identities = 25/130 (19%), Positives = 46/130 (35%), Gaps = 4/130 (3%)
Query: 121 LSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYN 180
+ + L LR I N L + + D N I L L + + N
Sbjct: 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 181 NLQGEIPSEIGNLQNLEILVLGMNNLSG-PIQPSIFNISTITLINLFGNQLSGHLDLPPK 239
+ L +L L+L N+L + ++ ++T + + N ++
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 240 VSYSLPNLRV 249
V Y +P +RV
Sbjct: 134 VIYKVPQVRV 143
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 22/135 (16%), Positives = 34/135 (25%), Gaps = 7/135 (5%)
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
R L K+ I N + +D S N L LR L L + NN
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLVNNN 73
Query: 304 YLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTG 363
+ + + +L L + P L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSL----VELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 364 NIPHEIGNLRSLIVL 378
+ I + + VL
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 23/142 (16%), Positives = 46/142 (32%), Gaps = 13/142 (9%)
Query: 264 SITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNC 323
TNA + LDL I + L ++ ++N + L
Sbjct: 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR---------KLDGFPLL 62
Query: 324 RNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLF-- 381
R L TL V +N + I + + + + + +L+SL L +
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 382 -INALNGTIPSTVGRLEQLQGL 402
+ + ++ Q++ L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 28/130 (21%), Positives = 50/130 (38%), Gaps = 4/130 (3%)
Query: 444 LISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRN 503
+ REL+L K I + +L+ A++ S N + L+ L L ++ N
Sbjct: 17 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNN 73
Query: 504 QLSGDIPITIGSLKDLVTLSLASNQFEG-PIPQTFGSLTGLESLDLSNNNLSGEIPKSLE 562
++ +L DL L L +N SL L L + N ++ + L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 563 ALLFLKQLNV 572
+ + Q+ V
Sbjct: 134 VIYKVPQVRV 143
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 365 IPHEIG------NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLC 418
+P I I +L ++ + T L + + ++++ +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQ 65
Query: 419 HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478
+L + + LNGNKL+ + LA+L +L L L NK +LS
Sbjct: 66 YLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLK----SLSL 119
Query: 479 NSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFG 538
S + + +L L +L L N+++ ++ L L TLSL NQ +P
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LA 175
Query: 539 SLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVS 573
LT L++L LS N++S ++L L L L +
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 31/220 (14%), Positives = 64/220 (29%), Gaps = 28/220 (12%)
Query: 129 LRNNSFTGPIP-NSLF---NLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQG 184
L + + T P P +F + K + + + L+S+ + ++++
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 185 EIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPK----- 239
I L N+ L L N L+ + ++ + L K
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118
Query: 240 ----VSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPH--TFGNLR 293
+ L ++ G + + + I L
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLT 178
Query: 294 FLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVAS 333
L L L+ N+++ L +L +NL L + S
Sbjct: 179 KLQNLYLSKNHISD---------LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 43/225 (19%), Positives = 77/225 (34%), Gaps = 30/225 (13%)
Query: 260 TIPNSI------TNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAE 313
T+P I ++ +L S + + T L + + N+ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS------ 60
Query: 314 WSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLR 373
+ + N+T L + N L I P L N + +
Sbjct: 61 ---VQGIQYLPNVTKLFLNGNKLTDIKP---------LANLKNLGWLFLDENKVKDLSSL 108
Query: 374 SLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433
+ ++ + I G + Q SLY N + + L L +L+ + L N++
Sbjct: 109 KDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168
Query: 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSS 478
S +P LA L L+ L L N S + L+ L + L S
Sbjct: 169 SDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 40/198 (20%), Positives = 67/198 (33%), Gaps = 25/198 (12%)
Query: 120 VLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAY 179
++ +L+ S T + + L+ +++ + + I I L ++ + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 180 NNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHL----- 234
N L P + NL+NL L L N + + G L
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 235 ----------DLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGL 284
V L L SL N+++ +P + +KL L LS N S L
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 193
Query: 285 IPHTFGNLRFLSVLNLAN 302
L+ L VL L +
Sbjct: 194 RA--LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 12/85 (14%), Positives = 28/85 (32%), Gaps = 8/85 (9%)
Query: 475 NLSSNSLSGSLPSN----IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530
L S +++ P I +L + ++ +T L + + ++ +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 59
Query: 531 GPIPQTFGSLTGLESLDLSNNNLSG 555
L + L L+ N L+
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 7/167 (4%)
Query: 388 TIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLER-LNGIRLNGNKLSGPIPQCLASLIS 446
IP + L L N L L L + L N+L+G P
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLS 506
++EL LG NK F L L +NL N +S +P + ++L L +L+L+ N +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 507 GDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNL 553
+ + + L SL P + ++ DL ++
Sbjct: 140 CNCHLAWF-AEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 37/207 (17%), Positives = 71/207 (34%), Gaps = 23/207 (11%)
Query: 266 TNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325
T ++ L + + + + +L ++ L + + + + N
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS---------IDGVEYLNN 63
Query: 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINAL 385
LT + ++N L I P L+N L N + + +
Sbjct: 64 LTQINFSNNQLTDITP---------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 114
Query: 386 NGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLI 445
N I L ++ S L L L + + N+++ P LA+L
Sbjct: 115 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLT 172
Query: 446 SLRELNLGSNKFSS-SIPSSFWSLEYL 471
+L L++ SNK S S+ + +LE L
Sbjct: 173 TLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 35/187 (18%), Positives = 60/187 (32%), Gaps = 11/187 (5%)
Query: 244 LPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN 303
L LGK +T T+ S T+ ++T L + L L+ +N +NN
Sbjct: 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 304 YLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLT- 362
LT +P + L + N L + + N + + L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 363 -----GNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEG-SIPYD 416
I + L ++ T + L L+ L + N + S+
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 192
Query: 417 LCHLERL 423
L +LE L
Sbjct: 193 LTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 6e-04
Identities = 23/143 (16%), Positives = 40/143 (27%), Gaps = 2/143 (1%)
Query: 55 LNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNEL-GQLRRLRFISLDYNEFSGS 113
L + G HL L L I +L L LR +++ +
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 114 FPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLV 173
P +L L+L N+ ++ LS E S + +
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 174 NVNLAYNNLQGEIPSEIGNLQNL 196
+ LQ + ++ N
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNA 154
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 977 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.0 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.98 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=422.53 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=207.0
Q ss_pred hcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367999999999999999999874 469999987543 4456789999999999999999999998754 56789999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++...+..+++..+..++.|||+||+||| +++||||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877667999999999999999999999 789999999999999999999999999999887654444
Q ss_pred ceeeccccCCcccCccccCC---CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 840 VTQTMTIATIGYMAPEYGTE---GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+...... ....+...... +...
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~-------p~~~ 232 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLS-------PDLS 232 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSCC-------CCGG
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCC-------Ccch
Confidence 44445679999999999864 4589999999999999999999999976533222 11111111111 0000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
....+++..+.+++.+||+.+|++||||+|++++|+.++.
T Consensus 233 ------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 ------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111244568899999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=417.77 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=206.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999975 69999999997654 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++.... .+++..+..++.||++||+||| ++||+||||||+|||+++++.+||+|||+|+........
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999997654 4999999999999999999999 789999999999999999999999999999987654433
Q ss_pred ceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||............+.......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------------- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence 33445679999999999988776 6789999999999999999999976543333222222111110
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.....+...+.+++.+||+.||++|||++|+++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112345678999999999999999999865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=418.26 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=203.6
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999888999999997543 334679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.+++......+++..+..++.|||+||+||| +++|+||||||+||++++++.+||+|||+++........ ..
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence 99999999887777999999999999999999999 789999999999999999999999999999877543322 22
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccCc
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTS 922 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (977)
....||+.|+|||++.++.|+.++|||||||++|||+|+..|+....... .....+....... .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~~~-----------~---- 223 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLY-----------K---- 223 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HHHHHHHHTCCCC-----------C----
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HHHHHHHhcCCCC-----------C----
Confidence 33568999999999999999999999999999999999655543322211 1111111111100 0
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhhc
Q 036011 923 SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKII 963 (977)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (977)
+..++..+.+++.+||+.||++||||+|++++|++++.-
T Consensus 224 --p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 --PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 012234678999999999999999999999999998743
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=413.14 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=209.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 79999999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|.+++.... +++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 9999999887653 899999999999999999999 78999999999999999999999999999998754332 2
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....+||+.|+|||++.++.|+.++||||+||++|||++|+.||.+....+ .+........+. +
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~---------~------ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE---------L------ 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC---------C------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC---------C------
Confidence 334579999999999999999999999999999999999999997543221 111111111110 0
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+..+...+.+++.+||+.||++|||++|++++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011234457899999999999999999999763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=407.85 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=214.3
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998888999999986533 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCccee
Q 036011 763 NGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQ 842 (977)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (977)
+|+|.+++......+++..+.+++.|+++||+||| +.||+||||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence 99999998877777999999999999999999999 789999999999999999999999999999877654322 33
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....||+.|+|||++.++.++.|+|||||||++|||+| |+.||......+. ..-+..... ...+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~i~~~~~-----------~~~p-- 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIAQGLR-----------LYRP-- 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHHHTTCC-----------CCCC--
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HHHHHhCCC-----------CCCc--
Confidence 34569999999999999999999999999999999998 7999976543221 111111000 0001
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
..++..+.+++.+||+.+|++|||++|++++|.+|
T Consensus 224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12234678999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=415.35 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=208.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46889999999999999999975 68999999998776677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
++|+|.+++......+++..+..++.||++||+||| ++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 999999998766666999999999999999999999 7899999999999999999999999999997654321 12
Q ss_pred eeccccCCcccCcccc-----CCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 842 QTMTIATIGYMAPEYG-----TEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
.....||+.|+|||++ .+..|+.++||||+||++|||+||+.||.+....+ .+........+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~----------- 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPT----------- 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCC-----------
Confidence 2235699999999987 35668999999999999999999999997643322 122222111110
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
...+..++..+.+++.+||+.||++|||++|++++
T Consensus 235 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 -----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111234467899999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-48 Score=418.11 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=201.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CC---CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DG---TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.++||+|+||+||+|+++ ++ ..||||++.... ....+.|.+|++++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677889999999999999875 23 368999886543 44567799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++......+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999887777999999999999999999999 7899999999999999999999999999999876433
Q ss_pred Ccce---eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 838 DSVT---QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 838 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... .....+.....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~--------- 251 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYR--------- 251 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence 2211 122357899999999999999999999999999999998 89998764322 11221111100
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+.+.+++..+.+++.+||+.+|++||||+||++.|+++..
T Consensus 252 --------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 --------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 00111345568899999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=404.83 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=205.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 68999999987543 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++.... .+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999997654 3899999999999999999999 7899999999999999999999999999998765322
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+....... ....
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~------------~~~p 224 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVE------------FTFP 224 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC------------CCCC
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCC------------CCCC
Confidence 233569999999999999999999999999999999999999997542211 111111110 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..++..+.+++.+||+.||++|||++|++++
T Consensus 225 -------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 225 -------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0123457889999999999999999999763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=409.94 Aligned_cols=255 Identities=23% Similarity=0.394 Sum_probs=207.2
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5688899999999999999999888999999997543 335679999999999999999999998865 56789999999
Q ss_pred CCCHHHHhhcCCc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 763 NGSLEKWLYSDNY-FLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 763 ~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+|+|.+++..... .+++..+.+|+.||++||+||| +++|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc-cc
Confidence 9999998765433 5899999999999999999999 78999999999999999999999999999998764332 22
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
.....||+.|+|||++.++.++.++|||||||++|||+||..|+........ ....+......
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~~~~---------------- 229 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRM---------------- 229 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCC----------------
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCC----------------
Confidence 3345689999999999999999999999999999999997666544322211 11111110000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+..++..+.+++.+||+.+|++||||+||++.|+..-
T Consensus 230 -~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 001123456889999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=410.10 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=208.9
Q ss_pred cCCCcCcc-ccCcceEEEEEEEeC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNL-LGRGSFGSVYKGTFS---DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 44556664 999999999999864 35579999997554 3456789999999999999999999999875 457899
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+..+++..+..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998877667999999999999999999999 7899999999999999999999999999999876543
Q ss_pred Ccc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 838 DSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 838 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+ ....+......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~~~~~~---------- 231 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRM---------- 231 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCC----------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC----------
Confidence 322 2233468999999999999999999999999999999998 899997653321 11211110000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
+.+..++..+.+++.+||+.+|++||||.+|.+.|+.+.
T Consensus 232 -------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 001124456889999999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=407.31 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=204.3
Q ss_pred cCCCcCccccCcceEEEEEEEeCCC-----CEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDG-----TSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
+.|+..++||+|+||+||+|+++.. ..||||++.... +....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5678889999999999999987532 479999987554 3445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
||||+.+|++.+++......+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999998887777999999999999999999999 789999999999999999999999999999887543
Q ss_pred CCc-ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDS-VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
... .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... ...+.+.....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~----------- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFR----------- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCC-----------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccCC-----------
Confidence 322 22333468999999999999999999999999999999999777654432221 11121111100
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
. +.+.+++..+.+++.+||+.+|++||||+||++.|+++..
T Consensus 232 -~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -L-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -C-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -C-----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0 0111234568899999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-47 Score=407.99 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=212.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|++. +|+.||||+++.+. ...++|.+|++++++++|||||+++++|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457888999999999999999975 58899999987553 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 761 MPNGSLEKWLYSD-NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 761 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
+++|+|.+++... ...+++..+..++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence 9999999998754 446899999999999999999999 78999999999999999999999999999997754332
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
.......|++.|+|||++.++.|+.++|||||||++|||++|..||....... ...+.+...... .
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~~~------------~- 236 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRM------------E- 236 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCC------------C-
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcCCCC------------C-
Confidence 23334468999999999999999999999999999999999877764322211 111222111110 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
.+..++..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 237 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011234568899999999999999999999999988753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=407.86 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=193.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--CCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN--NDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 757 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++.... +...+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999975 69999999987653 3445678999999999999999999999865 4567899
Q ss_pred EeccCCCCHHHHhhcC---CccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 758 LELMPNGSLEKWLYSD---NYFLDLLERLNIMIGVALALEYLHHGH--STPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 345999999999999999999999532 24599999999999999999999999999998
Q ss_pred cCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
+..... .....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+ ..........+.
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~~~~~~------- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKFRR------- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCC-------
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCC-------
Confidence 754322 2234579999999999999999999999999999999999999997642211 111111111110
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.+ ..++..+.+++.+||+.||.+|||++|++++
T Consensus 234 -----~~------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 -----IP------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CC------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 1123457899999999999999999999763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=407.52 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=203.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 79999999997543 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999987655 3899999999999999999999 79999999999999999999999999999998765443
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ ........ .....
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~------------~~~~p 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKL------------EYDFP 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTT------------CCCCC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcC------------CCCCC
Confidence 334445679999999999999999999999999999999999999997532211 11111110 00000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+...+.+++.+||+.||++|||++|+.+.
T Consensus 231 -------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 231 -------EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0123457899999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=414.27 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=208.0
Q ss_pred cCCCcCccccCcceEEEEEEEeCC-C-----CEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD-G-----TSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
++|++.+.||+|+||+||+|++.. + ..||||++.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999998642 2 369999986543 34456789999999998 899999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC----------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 036011 755 ALVLELMPNGSLEKWLYSDN----------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPS 812 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 812 (977)
++||||+++|+|.++++... ..+++..++.++.||++||+||| +++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999997643 24789999999999999999999 789999999999
Q ss_pred ceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcc
Q 036011 813 NILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTG 891 (977)
Q Consensus 813 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 891 (977)
||+++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999988766554444445678999999999999999999999999999999998 89999764333
Q ss_pred cccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 036011 892 EMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLK 958 (977)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~ 958 (977)
+ .+.+.+...... +.+..++..+.+++.+||+.+|++|||++||+++|.
T Consensus 274 ~-~~~~~~~~~~~~-----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A-NFYKLIQNGFKM-----------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H-HHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHHHHhcCCCC-----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 222222221110 001123456889999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=395.61 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=195.7
Q ss_pred CcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec----CCeeEEEE
Q 036011 686 NECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN----NDFRALVL 758 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 758 (977)
+..+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999975 68899999987553 3445679999999999999999999999865 34678999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCceeeC-CCCceEEeecccccccCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTP--VVHCDLKPSNILLD-EDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 835 (977)
||+++|+|.+++.... .+++..+..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997654 4899999999999999999999 666 99999999999997 578999999999986543
Q ss_pred CCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 836 GDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 836 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
. .....+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+...... +.+.+......
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~~~~~---------- 231 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVKP---------- 231 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCCC----------
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHcCCCC----------
Confidence 2 2234579999999999875 599999999999999999999999975432221 11111110000
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+...+.+++.+||+.||++|||++|++++
T Consensus 232 ------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00011123357889999999999999999999763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=401.87 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=199.3
Q ss_pred ccccCcceEEEEEEEeC---CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccCC
Q 036011 689 NLLGRGSFGSVYKGTFS---DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMPN 763 (977)
Q Consensus 689 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 763 (977)
+.||+|+||+||+|.++ .++.||||+++... ....++|.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 35689999986543 3345679999999999999999999999965 456899999999
Q ss_pred CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce-e
Q 036011 764 GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT-Q 842 (977)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 842 (977)
|+|.++++.... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.+........ .
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999987654 899999999999999999999 78999999999999999999999999999998765433322 2
Q ss_pred eccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 843 TMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 843 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ....+.....
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~~----------------- 228 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER----------------- 228 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC-----------------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHHcCCC-----------------
Confidence 33568999999999999999999999999999999998 899997643221 1111111000
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.+.+..++..+.+++.+||+.||++|||+++|.+.|+..
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 000112345688999999999999999999999888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=415.02 Aligned_cols=272 Identities=22% Similarity=0.312 Sum_probs=209.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 78999999997654 3445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|+|.+++.+.+ .+++..+..++.|+++||+|||+ .+||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 999999999997654 38999999999999999999994 2489999999999999999999999999998764322
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH-------------------
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK------------------- 900 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~------------------- 900 (977)
....+||++|+|||++.+..|+.++||||+||++|||++|+.||......+........
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 22357999999999999999999999999999999999999999764322211100000
Q ss_pred ------hhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 901 ------ESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 901 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
........+..+......+... ........+.+++.+|++.||++|||++|++++ +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCC-CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccC-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000001111110000000000 000123457899999999999999999999885 44433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-46 Score=409.52 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=210.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999974 7999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC--CCCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD--EDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~ 838 (977)
+++|+|.+++......+++..+..++.||+.||+||| ++|||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999766666999999999999999999999 79999999999999996 468899999999998764332
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... ..+...........
T Consensus 182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~------------ 245 (350)
T d1koaa2 182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMD------------ 245 (350)
T ss_dssp ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSC------------
T ss_pred ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC------------
Confidence 23456999999999999999999999999999999999999999754221 11111111111000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......+...+.+++.+||+.||++|||++|++++
T Consensus 246 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 ---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111223457889999999999999999999885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-46 Score=404.13 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=191.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.+.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 68999999997654 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeecccccccCCC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 836 (977)
|++||+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++ +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999997654 4999999999999999999999 78999999999999995 5789999999999876543
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ............
T Consensus 164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~----------- 228 (307)
T d1a06a_ 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEYEF----------- 228 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCCCC-----------
T ss_pred C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCCC-----------
Confidence 2 2233569999999999999999999999999999999999999997643221 111111111000
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+...+++..+.+++.+||+.||++|||++|++++
T Consensus 229 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 ----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000111234457899999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-46 Score=408.24 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=210.7
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 761 (977)
+.|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 79999999998766556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC--CCCceEEeecccccccCCCCCc
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD--EDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
++|+|.+++......+++..+..|+.||+.||+||| +.||+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999988777667999999999999999999999 79999999999999998 678999999999998765432
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
.....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+ .+...........
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~------------- 248 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFD------------- 248 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCC-------------
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC-------------
Confidence 333569999999999999999999999999999999999999997643221 1111111111000
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......++..+.+++.+||+.||++|||++|++++
T Consensus 249 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 --EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011223457899999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=399.87 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=203.6
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEeccC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLELMP 762 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 762 (977)
++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5789999999999999999999888899999997553 335779999999999999999999999865 55789999999
Q ss_pred CCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcce
Q 036011 763 NGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSVT 841 (977)
Q Consensus 763 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (977)
+|+|..++.... ..+++..+..++.||++||+||| +.+|+||||||+|||+|.++.+||+|||+|+....... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-ee
Confidence 999998887543 35899999999999999999999 78999999999999999999999999999987754332 23
Q ss_pred eeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccccC
Q 036011 842 QTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQEHT 921 (977)
Q Consensus 842 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (977)
.....||+.|+|||++.++.++.++|||||||++|||++|..|+.........+ .++......
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~~~---------------- 233 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGYRM---------------- 233 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCC----------------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCC----------------
Confidence 334569999999999999999999999999999999999877765433322212 222111100
Q ss_pred chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 922 SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+....++..+.+++.+||+.+|++||++++|++.|+..-.
T Consensus 234 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 0011234568899999999999999999999999988664
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=406.33 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=205.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT----SFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 756 (977)
.+|+++++||+|+||+||+|++. +|+ +||||+++... ....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 444 58888876443 34567899999999999999999999999865 4678
Q ss_pred EEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCC
Q 036011 757 VLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEG 836 (977)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 836 (977)
++||+.+|+|.+++......+++..+..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999888778999999999999999999999 789999999999999999999999999999988665
Q ss_pred CCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhh
Q 036011 837 DDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNL 915 (977)
Q Consensus 837 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (977)
..........||+.|+|||++.++.|+.++|||||||++|||+| |..||.+....+ +...+......
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~~---------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERL---------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCCC----------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCC----------
Confidence 54444445568999999999999999999999999999999999 788887643322 22222111100
Q ss_pred hccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 916 LRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
+.+..++..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 233 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 001123456789999999999999999999999998775
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=403.49 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=200.5
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
.|+.++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4889999999999999999964 78999999987553 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+++|++..++.... .+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 999999987766544 4899999999999999999999 789999999999999999999999999999875432
Q ss_pred ceeeccccCCcccCccccCC---CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 840 VTQTMTIATIGYMAPEYGTE---GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
....||+.|||||++.+ +.|+.++||||+||++|||++|+.||.+....+. +........+. +.
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~~---------~~ 235 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPA---------LQ 235 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCC---------CS
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCC---------CC
Confidence 23469999999998753 4689999999999999999999999975432211 11111111000 00
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
...++..+.+++.+||+.||++|||++|+++
T Consensus 236 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0112345789999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-46 Score=404.73 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=211.1
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccch-hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCe
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQLD-RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDF 753 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 753 (977)
-.++|++.+.||+|+||+||+|+++ +++.||||+++.... ...++|.+|++++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3567999999999999999999863 357899999976543 345679999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 036011 754 RALVLELMPNGSLEKWLYSDN-----------------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLK 810 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 810 (977)
.++||||+++|+|.++++... ..+++..+..|+.|++.||+||| +++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence 999999999999999996532 14789999999999999999999 7999999999
Q ss_pred CCceeeCCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCC-CCCCcCC
Q 036011 811 PSNILLDEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK-KPTDDMF 889 (977)
Q Consensus 811 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~ 889 (977)
|+|||+|.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||.+..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998775544444444567899999999999999999999999999999999996 5665532
Q ss_pred cccccHHHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 890 TGEMSLKKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
..+ ....+... .... .+.+++..+.+++.+||+.+|++||||.||+++|++|.
T Consensus 248 ~~e--~~~~v~~~-----------~~~~------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEE--VIYYVRDG-----------NILA------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHH--HHHHHHTT-----------CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH--HHHHHHcC-----------CCCC------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 221 11111111 0000 01123456889999999999999999999999999885
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=393.29 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=199.0
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeec-CCeeEEEEecc
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-NDFRALVLELM 761 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 761 (977)
++|++.+.||+|+||+||+|++ .|+.||||+++.+ ...+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688889999999999999998 4789999999754 344779999999999999999999999855 46689999999
Q ss_pred CCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 762 PNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
++|+|.+++.... ..+++..+++|+.||+.||+||| +.+|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 9999999997643 35899999999999999999999 7899999999999999999999999999998654322
Q ss_pred eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 841 TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... ....++...... .+
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~~--------~~---- 221 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM--------DA---- 221 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCC--------CC----
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCC--------CC----
Confidence 23358899999999999999999999999999999998 67777654222 223322211100 00
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+..++..+.+++.+||+.||++||||.|++++|++++.
T Consensus 222 -----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11223467899999999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=395.08 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=206.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD------RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 799999999875431 2356799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC----ceEEeecccc
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM----VAHVSDFGLS 830 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla 830 (977)
++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999997654 4999999999999999999999 78999999999999998776 5999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+.........
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~------ 234 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNYE------ 234 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCCC------
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCC------
Confidence 88754332 233469999999999999999999999999999999999999997643221 11111110000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........++..+.+++.+||+.||++|||++|++++
T Consensus 235 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 ---------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001112234457899999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=398.27 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=203.9
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----eeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND----FRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 758 (977)
++|...+.||+|+||+||+|++ +|+.||||+++..... ....+.|+..+++++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4567788999999999999997 6899999998754322 223445666667889999999999997654 578999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHG-----HSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
||+++|+|.+++++.. ++|..+.+++.|+|.||+|+|+. +++|||||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999998764 89999999999999999999952 3579999999999999999999999999999987
Q ss_pred CCCCCcc--eeeccccCCcccCccccCCC------CcCcccchhhHhHHHHHHhcCCCCCCcCCcccc----------cH
Q 036011 834 DEGDDSV--TQTMTIATIGYMAPEYGTEG------IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEM----------SL 895 (977)
Q Consensus 834 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----------~~ 895 (977)
....... ......||++|+|||++.+. .++.|+|||||||++|||+||..||........ ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 6543322 23345799999999998754 367899999999999999999988754332211 11
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
......... ..............++...+.+++.+||+.||++|||+.||++.|+++..
T Consensus 239 ~~~~~~~~~--------~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 239 EEMRKVVCE--------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTT--------SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhc--------cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111 11111111112223456678999999999999999999999999998873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=394.41 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=198.9
Q ss_pred cCCCcCccccCcceEEEEEEEeCC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSD----GTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||+||+|++.. +..||||+++... +...+.|.+|++++++++|||||++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578899999999999999998642 4568899886543 344567999999999999999999999986 4678999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|++.+++......+++..+..++.||++||+||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998877777999999999999999999999 7999999999999999999999999999998765433
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhh
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLL 916 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (977)
. .......||+.|+|||++.++.++.++|||||||++|||+| |.+||.+....+ ....+......
T Consensus 163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~~~----------- 228 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERL----------- 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC-----------
T ss_pred c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC-----------
Confidence 2 22334568999999999999999999999999999999998 888887654332 22211111100
Q ss_pred ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 917 RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
+.+..++..+.+++.+||+.||++|||++||++.|+++.
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 001123456889999999999999999999999998875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=393.94 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=199.4
Q ss_pred cCCCcCccccCcceEEEEEEEeC--CC--CEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS--DG--TSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
++|++.+.||+|+||+||+|++. ++ ..||||++.... +...++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56889999999999999999863 22 378999987542 3445789999999999999999999999976 4668
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
+||||+++|++.+++......+++..+..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999988877667999999999999999999999 78999999999999999999999999999998765
Q ss_pred CCCcc-eeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 836 GDDSV-TQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 836 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ...++.. .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~---~~------- 231 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDK---EG------- 231 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT---SC-------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHh---CC-------
Confidence 43322 2233458889999999999999999999999999999998 899997643222 1122111 10
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
. ..+.+..++..+.+++.+||+.||++||||+||.+.|++.+
T Consensus 232 -~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 232 -E-----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -C-----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 0 00011123456789999999999999999999999988753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=394.69 Aligned_cols=249 Identities=24% Similarity=0.274 Sum_probs=207.1
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 757 (977)
.++|++++.||+|+||+||+|+.+ +|+.||||++++.. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999974 79999999998653 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++...+. +++..+..++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999887554 899999999999999999999 8999999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .........+. .
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~~~------------~ 224 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEEIR------------F 224 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC------------C
T ss_pred c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCCCC------------C
Confidence 2 2334579999999999999999999999999999999999999997643221 11111111100 0
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAVK 956 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~~ 956 (977)
. ..+...+.+++.+|++.||++||+ +.|++++
T Consensus 225 p-------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 P-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 0 112345678999999999999995 7888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-44 Score=391.77 Aligned_cols=245 Identities=25% Similarity=0.311 Sum_probs=205.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++++.||+|+||+||+|+.+ +|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 69999999997543 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||++||+|..++..... +++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 99999999999887664 788999999999999999999 8999999999999999999999999999998875432
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
...+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+ ......... ....
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~------------~~~p 221 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE------------LRFP 221 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCC------------CCCC
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCC------------CCCC
Confidence 23569999999999999999999999999999999999999997642211 111111110 0000
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~~ 956 (977)
..++..+.+++.+|++.||.+|| |++|++++
T Consensus 222 -------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 -------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01234578899999999999996 89998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-45 Score=389.04 Aligned_cols=260 Identities=19% Similarity=0.335 Sum_probs=203.1
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----e
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND----F 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 753 (977)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 479999999997553 334567999999999999999999999987644 3
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+||||++||+|.+++...+ .+++.++..++.||++||+||| +.||+||||||+||+++.++.++++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999887654 4899999999999999999999 799999999999999999999999999999766
Q ss_pred CCCCC-cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcc
Q 036011 834 DEGDD-SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVD 912 (977)
Q Consensus 834 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (977)
..... .......+||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+. ...........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~~~------- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPIP------- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCCC-------
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCCCC-------
Confidence 44322 2233445799999999999999999999999999999999999999976432211 11111111000
Q ss_pred hhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHchh
Q 036011 913 TNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRI-YMTDAAVKLKKIK 961 (977)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~ev~~~L~~~~ 961 (977)
+ .....+++..+.+++.+|++.||.+|| |++++.+.|.++.
T Consensus 234 ~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C--------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 000112344678999999999999999 8999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=390.93 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=199.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecC-Ce
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN-DF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 753 (977)
++|++.+.||+|+||+||+|++. +++.||||+++... ....+.+.+|+..+.++ +||||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 67999999999999999999853 34689999987543 34456678888888877 689999999987654 56
Q ss_pred eEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC
Q 036011 754 RALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE 818 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 818 (977)
.++||||+++|+|.++++... ..+++..+..++.||++||+||| +++|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 899999999999999997543 24889999999999999999999 789999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCC-CCCCcCCcccccHHH
Q 036011 819 DMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK-KPTDDMFTGEMSLKK 897 (977)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~ 897 (977)
++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||......+ .+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence 9999999999998776554444444567999999999999999999999999999999999975 5665433222 1222
Q ss_pred HHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+....... .+..++..+.+++.+||+.||++|||++|++++|+++-
T Consensus 249 ~~~~~~~~~-----------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 249 RLKEGTRMR-----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCC-----------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222111100 00113445789999999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=389.57 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=205.2
Q ss_pred CccccCcceEEEEEEEeCCC----CEEEEEEeecc-chhhHHHHHHHHHHHHhcCCCCcceEeeeeec-CCeeEEEEecc
Q 036011 688 CNLLGRGSFGSVYKGTFSDG----TSFAIKVFNLQ-LDRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-NDFRALVLELM 761 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 761 (977)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 36899998753 34556789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc--
Q 036011 762 PNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS-- 839 (977)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 839 (977)
++|+|.+++.......++..+.+++.|+++||.|+| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999888777889999999999999999999 789999999999999999999999999999977543322
Q ss_pred ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhccc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQE 919 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (977)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ....++..... .. .
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~----------~~-~- 255 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR----------LL-Q- 255 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC----------CC-C-
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC----------CC-C-
Confidence 12223468999999999999999999999999999999999888876533221 11222211100 00 0
Q ss_pred cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 920 HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+..++..+.+++.+||+.||++||+|.||+++|+++..
T Consensus 256 -----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01234568899999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=392.69 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=208.2
Q ss_pred hcCCCcCccccCcceEEEEEEEeCC--------CCEEEEEEeeccch-hhHHHHHHHHHHHHhc-CCCCcceEeeeeecC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFSD--------GTSFAIKVFNLQLD-RAFRSFDSECEVLRNV-RHRNLIKIFSSCCNN 751 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 751 (977)
.++|++.+.||+|+||.||+|+... +..||||+++.+.. ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678889999999999999998532 34799999976653 4457788999999888 799999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceee
Q 036011 752 DFRALVLELMPNGSLEKWLYSDN---------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILL 816 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 816 (977)
+..++||||+++|+|.+++.... ..+++..+.+++.||+.||+||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999997553 24899999999999999999999 8999999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhc-CCCCCCcCCcccccH
Q 036011 817 DEDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFT-RKKPTDDMFTGEMSL 895 (977)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 895 (977)
+.++.+||+|||+++...............+|+.|+|||++.++.|+.++|||||||++|||++ |..||.+.... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence 9999999999999998766554444455679999999999999999999999999999999998 67787654322 12
Q ss_pred HHHHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 896 KKWVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
..++....... . +..++..+.+++.+||+.||.+|||+.||++.|+++.+
T Consensus 247 ~~~i~~~~~~~-----------~------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEGHRMD-----------K------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTTCCCC-----------C------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-----------C------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22221111000 0 01133457899999999999999999999999998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=390.07 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=207.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
-++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999975 688999999986643 335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC--CCceEEeecccccccCCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE--DMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 838 (977)
++||+|.+++...+..+++.++..++.||++||+||| +.||+||||||+|||++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999999877666999999999999999999999 789999999999999985 4589999999998775433
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
......+|+.|+|||...+..|+.++||||+||++|||++|+.||......+ .+..........
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~~------------- 222 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTF------------- 222 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCC-------------
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC-------------
Confidence 2333569999999999999999999999999999999999999997643211 111111111100
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.......+...+.+++.+|++.||++|||++|++++
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111234457899999999999999999999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=389.05 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=212.7
Q ss_pred cCCCcCccccCcceEEEEEEEe------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCee
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF------SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 754 (977)
++|++.++||+|+||.||+|++ .+++.||||+++... ......|.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 6788899999999999999985 246789999997654 34456789999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC
Q 036011 755 ALVLELMPNGSLEKWLYSDN-----------------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD 817 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 817 (977)
++||||+++|+|.++++... ..+++..+..++.||++||+||| +++||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 99999999999999987543 25889999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH
Q 036011 818 EDMVAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK 897 (977)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 897 (977)
.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+..|+.........+.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999999887655555555668999999999999999999999999999999999955554333222222333
Q ss_pred HHHhhCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 898 WVKESLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+....... . +..++..+.+++.+||+.||++||||+|++++|+++-
T Consensus 260 ~i~~~~~~~------------~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 260 MIKEGFRML------------S-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHTCCCC------------C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCC------------C-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 332221110 0 0112345789999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-44 Score=380.61 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=204.9
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc---------hhhHHHHHHHHHHHHhcC-CCCcceEeeeeecC
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL---------DRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNN 751 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 751 (977)
++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999996 479999999987643 123456889999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 752 DFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
+..|+||||+++|+|.++++..+ .+++..+..++.||++||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999997655 4899999999999999999999 7899999999999999999999999999999
Q ss_pred ccCCCCCcceeeccccCCcccCccccC------CCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCC
Q 036011 832 LFDEGDDSVTQTMTIATIGYMAPEYGT------EGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 832 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
....... .....||+.|+|||++. ...++.++||||+||++|||++|+.||.+....+ ............
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~~ 234 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQF 234 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCCC
Confidence 8765332 23356999999999864 3457889999999999999999999997643211 111111111110
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..+....++..+.+++.+||+.+|++|||++|++++
T Consensus 235 ---------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 ---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011111234567899999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=392.92 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=198.9
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch---hhHHHHH---HHHHHHHhcCCCCcceEeeeeecCCee
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD---RAFRSFD---SECEVLRNVRHRNLIKIFSSCCNNDFR 754 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~ 754 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+... .....+. +|+++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999975 699999999875431 1122233 456777778899999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccC
Q 036011 755 ALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFD 834 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 834 (977)
|+||||+++|+|.+++.... .+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999997654 4889999999999999999999 8999999999999999999999999999999775
Q ss_pred CCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcch
Q 036011 835 EGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDT 913 (977)
Q Consensus 835 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (977)
... ....+||+.|+|||++.. ..|+.++||||+||++|||+||+.||......+. ...........
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~~------- 225 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMA------- 225 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSCC-------
T ss_pred CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccCC-------
Confidence 432 223469999999999864 5689999999999999999999999976433221 11111111110
Q ss_pred hhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 036011 914 NLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAV 955 (977)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~ 955 (977)
... +..++..+.+++.+||+.||++||| ++|+++
T Consensus 226 -~~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 -VEL-------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCC-------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCC-------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 000 0012345789999999999999999 678765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-44 Score=391.86 Aligned_cols=244 Identities=23% Similarity=0.242 Sum_probs=204.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 758 (977)
++|++++.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 79999999987543 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDD 838 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 838 (977)
||+.+|+|.+++...+ .+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.+....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 9999999999987655 4899999999999999999999 7899999999999999999999999999999875422
Q ss_pred cceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhcc
Q 036011 839 SVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLRQ 918 (977)
Q Consensus 839 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (977)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... ............ ..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~------------~p 258 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKVR------------FP 258 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC------------CC
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHHHhcCCCC------------CC
Confidence 2346999999999999999999999999999999999999999753221 111111111000 00
Q ss_pred ccCchHHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 036011 919 EHTSSAEMDCLLSVLHLALDCCMESPDQRI-----YMTDAAV 955 (977)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~ev~~ 955 (977)
..+...+.+++.+|++.||.+|+ |++|+++
T Consensus 259 -------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 -------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11234578999999999999994 8999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=389.93 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=202.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCC--EEEEEEeeccc-hhhHHHHHHHHHHHHhc-CCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGT--SFAIKVFNLQL-DRAFRSFDSECEVLRNV-RHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||+||+|+++ +|. .||||++.... ....+.|.+|+++++++ +|||||+++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999975 444 47788775433 34566799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcC---------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCce
Q 036011 758 LELMPNGSLEKWLYSD---------------NYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVA 822 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 822 (977)
|||+++|+|.++++.. ...+++..+..++.|||+||+|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999754 235899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCC-CCCcCCcccccHHHHHHh
Q 036011 823 HVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKK-PTDDMFTGEMSLKKWVKE 901 (977)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~ 901 (977)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.+....+ +...+..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHHHh
Confidence 999999998654322 2223458999999999999999999999999999999999765 565432111 1111111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+ .. .+.+..++..+.+++.+||+.||++||||+||+++|+++..
T Consensus 242 ----~--------~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 ----G--------YR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----T--------CC-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----c--------CC-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 00 00111234568899999999999999999999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=390.72 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=210.5
Q ss_pred cCCCcCccccCcceEEEEEEEeC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS------DGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 755 (977)
++|++.+.||+|+||+||+|++. +++.||||+++... ......|.+|++++++++||||+++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67888899999999999999863 35789999997543 344567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEee
Q 036011 756 LVLELMPNGSLEKWLYSDN---------YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSD 826 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 826 (977)
+||||+++|+|.+++.... ..+++..+.+++.|+|+||+||| +++|+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999986432 24689999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCC-CCCCcCCcccccHHHHHHhhCCC
Q 036011 827 FGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRK-KPTDDMFTGEMSLKKWVKESLPH 905 (977)
Q Consensus 827 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 905 (977)
||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||. .||.+.... ++...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-----~~~~~---- 247 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRF---- 247 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----HHHHH----
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-----HHHHH----
Confidence 99998776544444444456899999999999999999999999999999999985 566543221 11111
Q ss_pred chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchhh
Q 036011 906 GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIKI 962 (977)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (977)
+.+...... +..++..+.+++.+||+.+|++|||+.||+++|++...
T Consensus 248 ----i~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 ----VMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----HHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----HHhCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111100 11234568999999999999999999999999988754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=386.80 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=199.9
Q ss_pred hcCCCcCc-cccCcceEEEEEEEe-CCCCEEEEEEeeccchhhHHHHHHHHHHHHhc-CCCCcceEeeeeec----CCee
Q 036011 682 TDGFNECN-LLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLDRAFRSFDSECEVLRNV-RHRNLIKIFSSCCN----NDFR 754 (977)
Q Consensus 682 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 754 (977)
.++|.+.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788875 599999999999996 47999999998643 4567899987655 89999999999865 4568
Q ss_pred EEEEeccCCCCHHHHhhcCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC---CCceEEeecccc
Q 036011 755 ALVLELMPNGSLEKWLYSDN-YFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE---DMVAHVSDFGLS 830 (977)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla 830 (977)
|+|||||+||+|.+++...+ ..+++..+..++.||+.||+||| +.||+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 99999999999999998653 36899999999999999999999 799999999999999985 567999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEV 910 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (977)
+....... ....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+...... ...........
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~---- 232 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMG---- 232 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC----
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcC----
Confidence 87765332 2345699999999999999999999999999999999999999975432211 11111111100
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .........++..+.+++.+|++.||++|||+.|++++
T Consensus 233 ---~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 ---QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 01112233456678999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=386.44 Aligned_cols=247 Identities=28% Similarity=0.354 Sum_probs=202.0
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHH-hcCCCCcceEeeeeecCCeeEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL---DRAFRSFDSECEVLR-NVRHRNLIKIFSSCCNNDFRALV 757 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 757 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999975 69999999997643 233455667777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCC
Q 036011 758 LELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 837 (977)
|||+++|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999976554 899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhcchhhhc
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVVDTNLLR 917 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (977)
. ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ +..-+....+. +
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~~---------~-- 222 (320)
T d1xjda_ 158 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNPF---------Y-- 222 (320)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC---------C--
T ss_pred c--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCCC---------C--
Confidence 2 2334579999999999999999999999999999999999999997643221 11111110000 0
Q ss_pred cccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 036011 918 QEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMT-DAAV 955 (977)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-ev~~ 955 (977)
+..++..+.+++.+||+.||++||++. |+++
T Consensus 223 -------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 -------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 001234578999999999999999995 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=380.73 Aligned_cols=263 Identities=24% Similarity=0.273 Sum_probs=196.2
Q ss_pred cCccccCcceEEEEEEEeC-CCCEEEEEEeeccchh-----hHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 687 ECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDR-----AFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 687 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
.+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999975 6999999998755321 234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+.++++..+... ...+++..+..++.||++||+||| ++||+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 988877766543 445899999999999999999999 79999999999999999999999999999987654332
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC---Cchhhhc---ch
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP---HGLMEVV---DT 913 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~ 913 (977)
.....+||+.|+|||++.. ..|+.++||||+||++|||+||..||......+ .+......... ..+.... ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence 2233569999999998765 468999999999999999999999997643222 12222111100 0000000 00
Q ss_pred -hhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 914 -NLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 914 -~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
......... .........+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000 0001223467899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=381.13 Aligned_cols=273 Identities=22% Similarity=0.275 Sum_probs=204.8
Q ss_pred cCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccch--hhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQLD--RAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++++.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 4799999999975532 335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
|+.++.+..........+++..+..++.||+.||+||| +.|||||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99765454444444556999999999999999999999 78999999999999999999999999999987754332
Q ss_pred ceeeccccCCcccCccccCCCC-cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh-hCCCc-----hhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGI-VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE-SLPHG-----LMEVVD 912 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~ 912 (977)
......||+.|+|||+..... ++.++||||+||++|+|++|+.||.+....+. +...... ..+.. .....+
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhccccccccc
Confidence 233346999999999877655 57899999999999999999999976432221 2221111 11111 000000
Q ss_pred hhhhccccCc----hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 913 TNLLRQEHTS----SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 913 ~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
.......... .........+.+++.+|++.||++|||++|++++ ++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0000000000 0011223467899999999999999999999886 55443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.3e-42 Score=377.80 Aligned_cols=293 Identities=30% Similarity=0.468 Sum_probs=269.4
Q ss_pred ChHHHHHHHHHHHHhccCCCCCccCCCCCCCCCC--cccceEecCCC--CcEEEEEcCCCCCCc--cCCccccCcccccE
Q 036011 5 NLTTDQFALLAFKAHVTDPQSVLANNWSISQPIC--KWVGISCGARH--QRVRALNLSNMGLRG--TIPPHLGNFSFLMS 78 (977)
Q Consensus 5 ~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~--~~v~~L~l~~~~l~~--~~~~~l~~l~~L~~ 78 (977)
|+++|++||++||++++||.. + ++|..++||| .|+||+|+..+ .||+.|||+++++.| .+|+++++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~-l-~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTT-L-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGG-G-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCCc-C-CCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 899999999999999998763 4 6898899999 49999998754 489999999999988 58899999999999
Q ss_pred eeccC-CcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccc
Q 036011 79 LDISK-NNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNI 157 (977)
Q Consensus 79 L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~ 157 (977)
|||++ |+++|.+|.+|++|++|++|+|++|++.+..|..+..+.+|+++++++|.+.+.+|..+.++++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999999999999999999999999998899999999999999999999999999999999999999999999
Q ss_pred cccccCccccCcccc-ceeeeecccccccCCccccCCCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccC
Q 036011 158 IDGNIPSRIGNLSSL-VNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDL 236 (977)
Q Consensus 158 i~~~~p~~~~~l~~L-~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 236 (977)
+.+.+|+.++.+..+ +.+++++|++++..|..+..+..+ .++++.|.+.+.++..+..+.+++.+++++|.+.+.
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~--- 236 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD--- 236 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB---
T ss_pred cccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc---
Confidence 999999999999886 889999999999999999888655 799999999999999999999999999999999753
Q ss_pred CCccccCCCCceEEEecCceeeecCCcccccccccceEeeccccccccccccccccccccccccccccc
Q 036011 237 PPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYL 305 (977)
Q Consensus 237 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 305 (977)
++ .+..+++|++|+|++|+++|.+|..|.++++|++|||++|+|+|.+|. ++.+++|+.+++++|+.
T Consensus 237 ~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303 (313)
T ss_dssp GG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSE
T ss_pred cc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCcc
Confidence 22 355789999999999999999999999999999999999999988885 68899999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-42 Score=373.53 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=201.8
Q ss_pred cCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 760 (977)
++|++++.||+|+||+||+|++++|+.||||++.... +...+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999899999999997653 23356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCcc
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDSV 840 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 840 (977)
+.++.+..+.... ..+++..+..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 9876666665444 45999999999999999999999 78999999999999999999999999999987754322
Q ss_pred eeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC---Cch---hhhcc-
Q 036011 841 TQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP---HGL---MEVVD- 912 (977)
Q Consensus 841 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~- 912 (977)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. +......... ..+ .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhc
Confidence 2233468999999998865 4579999999999999999999999976433221 2221111110 000 00000
Q ss_pred -hhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 -TNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 -~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
........ ...........+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 000011123457899999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=371.91 Aligned_cols=241 Identities=23% Similarity=0.244 Sum_probs=196.3
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHhcC--CCCcceEeeeeecCC
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLD------RAFRSFDSECEVLRNVR--HRNLIKIFSSCCNND 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 752 (977)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999964 799999999875431 12244678999999996 899999999999999
Q ss_pred eeEEEEeccCC-CCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-CCceEEeecccc
Q 036011 753 FRALVLELMPN-GSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-DMVAHVSDFGLS 830 (977)
Q Consensus 753 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla 830 (977)
..++||||+.+ +++.+++.... .+++..+..++.||++||+||| +++|+||||||+|||++. ++.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999976 57788876544 4899999999999999999999 799999999999999985 479999999999
Q ss_pred cccCCCCCcceeeccccCCcccCccccCCCCc-CcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhh
Q 036011 831 KLFDEGDDSVTQTMTIATIGYMAPEYGTEGIV-SSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLME 909 (977)
Q Consensus 831 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (977)
+...... .+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ......
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~------- 220 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQ------- 220 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCC-------
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhcc-------
Confidence 8764322 233569999999999887665 677999999999999999999996521 111100
Q ss_pred hcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 910 VVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
..... .++..+.+++.+||+.||++|||++|++++
T Consensus 221 -----~~~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 -----VFFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----CCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----cCCCC-------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00011 123457889999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=376.83 Aligned_cols=269 Identities=24% Similarity=0.287 Sum_probs=201.3
Q ss_pred hhcCCCcCccccCcceEEEEEEEeC-C-CCEEEEEEeeccch--hhHHHHHHHHHHHHhc---CCCCcceEeeeeec---
Q 036011 681 ATDGFNECNLLGRGSFGSVYKGTFS-D-GTSFAIKVFNLQLD--RAFRSFDSECEVLRNV---RHRNLIKIFSSCCN--- 750 (977)
Q Consensus 681 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~--- 750 (977)
..++|++++.||+|+||+||+|++. + ++.||||+++.... .....+.+|+++++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4578999999999999999999963 4 66799999876532 2234567788877766 79999999999853
Q ss_pred --CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecc
Q 036011 751 --NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFG 828 (977)
Q Consensus 751 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 828 (977)
....+++|||++++.+..........+++..+..++.|++.||+||| +++||||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 34678999999988887666666667999999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc--
Q 036011 829 LSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG-- 906 (977)
Q Consensus 829 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 906 (977)
+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+...........
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred hhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchh
Confidence 998654322 233457999999999999999999999999999999999999999764322 22222221111000
Q ss_pred -hhh---hcchhhhcccc--CchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 907 -LME---VVDTNLLRQEH--TSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 907 -~~~---~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
+.. ........... ...........+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000000 000011223457789999999999999999999775
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=373.21 Aligned_cols=276 Identities=21% Similarity=0.226 Sum_probs=201.1
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC----eeE
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL-DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND----FRA 755 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 755 (977)
+.+|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 479999999997543 344567899999999999999999999986643 234
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCC
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDE 835 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 835 (977)
++++|+.+|+|.+++..+. +++..+..++.|+++||+||| ++|||||||||+|||++.++.+||+|||+|.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 5566677999999997654 899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCc-ceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchh--hhc
Q 036011 836 GDDS-VTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLM--EVV 911 (977)
Q Consensus 836 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 911 (977)
.... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...........+.... ...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3222 12234579999999999854 5678999999999999999999999976432221111100000110000 000
Q ss_pred c----h---hhhccccC--chHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchhh
Q 036011 912 D----T---NLLRQEHT--SSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIKI 962 (977)
Q Consensus 912 ~----~---~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~~ 962 (977)
. . ........ .........++.+++.+|++.||++|||++|++++ +++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 0 00000000 00001123457899999999999999999999986 554443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-40 Score=356.26 Aligned_cols=260 Identities=16% Similarity=0.139 Sum_probs=208.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC-CCcceEeeeeecCCeeEEEEe
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH-RNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 759 (977)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.++.++| +||+.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999965 68999999986543 23567889999999965 899999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCC-----CCceEEeecccccccC
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDE-----DMVAHVSDFGLSKLFD 834 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~ 834 (977)
|+ +++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 78999999887777999999999999999999999 899999999999999974 5789999999999875
Q ss_pred CCCCc-----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc--HHHHHHhhCCCch
Q 036011 835 EGDDS-----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS--LKKWVKESLPHGL 907 (977)
Q Consensus 835 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 907 (977)
..... ......+||+.|||||++.+..++.++||||+||++|||+||+.||......... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 1223357999999999999999999999999999999999999999764332211 1111110000000
Q ss_pred hhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHchh
Q 036011 908 MEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKIK 961 (977)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (977)
.+ ....+++.+.+++..|+..+|++||+++.+.+.|+++-
T Consensus 238 ~~--------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 RE--------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HH--------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HH--------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 01123456889999999999999999999988887653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-40 Score=360.31 Aligned_cols=258 Identities=19% Similarity=0.221 Sum_probs=200.6
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcce-EeeeeecCCeeEEEEec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIK-IFSSCCNNDFRALVLEL 760 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~ 760 (977)
++|++.+.||+|+||+||+|++. +|+.||||++..... .+++..|+++++.++|++++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 689999999875432 356889999999998766554 55566778889999999
Q ss_pred cCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeC---CCCceEEeecccccccCCCC
Q 036011 761 MPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLD---EDMVAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~ 837 (977)
+ ++++.+.+......+++..+..++.|++.||+||| ++||+||||||+|||++ .+..+|++|||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 56777777666667999999999999999999999 79999999999999986 45579999999999876443
Q ss_pred Cc-----ceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccccc--HHHHHHhhCCCchhhh
Q 036011 838 DS-----VTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMS--LKKWVKESLPHGLMEV 910 (977)
Q Consensus 838 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 910 (977)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...+..........
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh--
Confidence 22 1223457999999999999999999999999999999999999999765433221 11111110000000
Q ss_pred cchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHch
Q 036011 911 VDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVKLKKI 960 (977)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~L~~~ 960 (977)
.....++..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 239 ------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 ------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00112345688999999999999999999998888765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-41 Score=370.03 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=197.8
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCC------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNND------ 752 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 752 (977)
.++|++++.||+|+||+||+|+.. +|+.||||+++... +...+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467999999999999999999964 69999999997543 344567899999999999999999999997654
Q ss_pred eeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 753 FRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
..++||||+ +++|..+.+... +++..+..++.||+.||+||| ++||+||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 569999999 668888876543 899999999999999999999 79999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhC--CCchhh
Q 036011 833 FDEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESL--PHGLME 909 (977)
Q Consensus 833 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 909 (977)
.... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+........ +.....
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence 6542 233569999999998765 45789999999999999999999999764221 11212111110 000000
Q ss_pred hc--------chhhhccc--cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 910 VV--------DTNLLRQE--HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 910 ~~--------~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
.. ...+.... ............+.+++.+|++.||++|||++|++++ ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 00000000 0000001123456889999999999999999999986 65554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=363.57 Aligned_cols=270 Identities=21% Similarity=0.267 Sum_probs=196.4
Q ss_pred hcCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec--------
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN-------- 750 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 750 (977)
.++|++++.||+|+||+||+|++. +|+.||||++.... +...+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 79999999986553 3345678899999999999999999998855
Q ss_pred CCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccc
Q 036011 751 NDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLS 830 (977)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 830 (977)
.+..++||||+.++.+..+. .....++...+..++.|++.||+||| +.||+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 34678999999877666554 33445899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcc--eeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHH--hhCCC
Q 036011 831 KLFDEGDDSV--TQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVK--ESLPH 905 (977)
Q Consensus 831 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~ 905 (977)
+.+....... .....+||++|+|||++.+. .++.++||||+||++|||++|+.||.+....+ ....... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence 8765432221 22234699999999998755 68999999999999999999999997643211 1111111 11111
Q ss_pred c-hhhhcchh----hhccc--cCch----HHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 906 G-LMEVVDTN----LLRQE--HTSS----AEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 906 ~-~~~~~~~~----~~~~~--~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
. ........ +.... .... ........+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1 11100000 00000 0000 011123356789999999999999999999865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=357.26 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=205.9
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecCCeeEEEEe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNNDFRALVLE 759 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 759 (977)
++|++++.||+|+||+||+|++. +|+.||||+++... +.....+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 78999999987553 3446788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeecccccccCCCCCc
Q 036011 760 LMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLFDEGDDS 839 (977)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 839 (977)
++.++++..++...+ .+++..+..++.|+++||+||| +++|+||||||+|||++.++.+|++|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 999999888776554 4899999999999999999999 78999999999999999999999999999998764432
Q ss_pred ceeeccccCCcccCccccCCCC-cCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCC--Cc----hhhhcc
Q 036011 840 VTQTMTIATIGYMAPEYGTEGI-VSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLP--HG----LMEVVD 912 (977)
Q Consensus 840 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~ 912 (977)
......+++.|+|||++.+.. ++.++||||+||++|||++|+.||................... .. .....+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 222345788999999887665 6899999999999999999999975533322222222111110 00 000000
Q ss_pred hh----hhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 913 TN----LLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 913 ~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
.. .................+.+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000001111223457889999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=367.66 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=195.2
Q ss_pred CCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcceEeeeeecC------CeeEE
Q 036011 684 GFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN------DFRAL 756 (977)
Q Consensus 684 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 756 (977)
+|+..++||+|+||+||+|++. +|+.||||++..+.. ...+|++++++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 699999999875432 235799999999999999999998542 35789
Q ss_pred EEeccCCCCHHHHhh--cCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeeccccccc
Q 036011 757 VLELMPNGSLEKWLY--SDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLF 833 (977)
Q Consensus 757 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~ 833 (977)
||||++++.+..+.+ .....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998764444332 23446899999999999999999999 89999999999999999775 8999999999877
Q ss_pred CCCCCcceeeccccCCcccCccccCC-CCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHh-----------
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTE-GIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKE----------- 901 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~----------- 901 (977)
..... ....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence 54432 223469999999998765 578999999999999999999999997643221 12221111
Q ss_pred hCCCchhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 902 SLPHGLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
..+.. ....-+..................+.+++.+|++.||++|||+.|++++ +++++
T Consensus 250 ~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNY-TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccch-hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000 0000000000000000001123457899999999999999999999875 45544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=361.80 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=200.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC----CCCEEEEEEeeccc----hhhHHHHHHHHHHHHhcCC-CCcceEeeeeecCCe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS----DGTSFAIKVFNLQL----DRAFRSFDSECEVLRNVRH-RNLIKIFSSCCNNDF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 753 (977)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 58999999986542 2345678899999999966 899999999999999
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.++||||+.+|+|.+++...+. .++..+..++.||+.|++|+| +.+||||||||+||+++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999977654 678899999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCcceeeccccCCcccCccccCCC--CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCchhhhc
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEG--IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHGLMEVV 911 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (977)
...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+... .......
T Consensus 180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~-------- 249 (322)
T d1vzoa_ 180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRIL-------- 249 (322)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHH--------
T ss_pred cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcc--------
Confidence 543322 22335699999999988654 47889999999999999999999997654332211 1111100
Q ss_pred chhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 036011 912 DTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIY-----MTDAAV 955 (977)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~ev~~ 955 (977)
..... .+..+...+.+++.+||++||++||| ++|+++
T Consensus 250 ----~~~~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ----KSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----cCCCC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00000 00123446789999999999999994 788876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-40 Score=359.06 Aligned_cols=260 Identities=19% Similarity=0.302 Sum_probs=197.3
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeec--CCeeEEEE
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCN--NDFRALVL 758 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 758 (977)
++|+++++||+|+||+||+|+.. +|+.||||+++... .+++.+|++++++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 79999999987542 356889999999995 9999999999874 45688999
Q ss_pred eccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC-ceEEeecccccccCCCC
Q 036011 759 ELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM-VAHVSDFGLSKLFDEGD 837 (977)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 837 (977)
||+++++|.++.+ .+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999987643 3899999999999999999999 89999999999999998655 69999999999876543
Q ss_pred CcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHH------------HHHhh-C
Q 036011 838 DSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKK------------WVKES-L 903 (977)
Q Consensus 838 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~------------~~~~~-~ 903 (977)
. ....++|+.|+|||.+.+. .++.++||||+||++|||++|+.||............ |.... .
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 3345699999999997765 5799999999999999999999998654322111111 11110 0
Q ss_pred CC--chhhhcchhhh---ccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 036011 904 PH--GLMEVVDTNLL---RQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAV 955 (977)
Q Consensus 904 ~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~ 955 (977)
.. ........... ...........+...+.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 01111100000 000011111223445789999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=357.06 Aligned_cols=261 Identities=21% Similarity=0.212 Sum_probs=192.8
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeec------CCe
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCN------NDF 753 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 753 (977)
++|+++++||+|+||+||+|++. +|+.||||++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999975 69999999997553 3445678999999999999999999999854 467
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.|+||||+.++.+.. +. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 899999997655544 33 23899999999999999999999 789999999999999999999999999998876
Q ss_pred CCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhh-----------
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKES----------- 902 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------- 902 (977)
.... .....++|+.|+|||++.+..+++++||||+||++|||++|+.||.+..... .........
T Consensus 170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTS
T ss_pred cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHh
Confidence 5432 3344569999999999999999999999999999999999999996532111 111111000
Q ss_pred -----------CCC---chhhhcchhhhccccCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 036011 903 -----------LPH---GLMEVVDTNLLRQEHTSSAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK 956 (977)
Q Consensus 903 -----------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~ 956 (977)
... .......... ..............+.+++.+|++.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCcccccccccccccccc--ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0111111111 111223334566778999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=355.50 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=197.2
Q ss_pred hcCCCcCccccCcceEEEEEEEe-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHhcCCCCcceEeeeeecC-----Ce
Q 036011 682 TDGFNECNLLGRGSFGSVYKGTF-SDGTSFAIKVFNLQL--DRAFRSFDSECEVLRNVRHRNLIKIFSSCCNN-----DF 753 (977)
Q Consensus 682 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 753 (977)
.++|++++.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999996 479999999997553 33456788999999999999999999998643 34
Q ss_pred eEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeeccccccc
Q 036011 754 RALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSKLF 833 (977)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 833 (977)
.+++++|+.+|+|.+++..+. +++..+..++.||+.||+||| ++||+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~--l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccccc--ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 467778888999999996643 899999999999999999999 789999999999999999999999999999765
Q ss_pred CCCCCcceeeccccCCcccCccccCCC-CcCcccchhhHhHHHHHHhcCCCCCCcCCcccccHHHHHHhhCCCc--hhhh
Q 036011 834 DEGDDSVTQTMTIATIGYMAPEYGTEG-IVSSKCDVYSYGVLLTETFTRKKPTDDMFTGEMSLKKWVKESLPHG--LMEV 910 (977)
Q Consensus 834 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 910 (977)
... .....|++.|+|||+..+. .++.++||||+||++|+|++|+.||.+..... ............. ....
T Consensus 172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhh
Confidence 432 2234689999999986665 56899999999999999999999997542211 1111111111000 0000
Q ss_pred --------cchhhhccccCc--hHHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHchh
Q 036011 911 --------VDTNLLRQEHTS--SAEMDCLLSVLHLALDCCMESPDQRIYMTDAAVK--LKKIK 961 (977)
Q Consensus 911 --------~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (977)
............ .........+.+++.+|++.||.+|||++|++++ +.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000000 0001223457899999999999999999999874 44443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.7e-35 Score=324.29 Aligned_cols=266 Identities=18% Similarity=0.198 Sum_probs=189.1
Q ss_pred cCCCcCccccCcceEEEEEEEeC-CCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-----------CCCcceEeeeeec
Q 036011 683 DGFNECNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-----------HRNLIKIFSSCCN 750 (977)
Q Consensus 683 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 750 (977)
++|+++++||+|+||+||+|+.. +|+.||||+++.+. ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 79999999997653 23466788999888875 5789999988754
Q ss_pred --CCeeEEEEeccCCCCHH-H-HhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCC------
Q 036011 751 --NDFRALVLELMPNGSLE-K-WLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDM------ 820 (977)
Q Consensus 751 --~~~~~lv~e~~~~gsL~-~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~------ 820 (977)
....+++++++..+... . ........+++..+..++.||+.||+|||+ ..||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 45566677766554432 2 222334468999999999999999999994 48999999999999998655
Q ss_pred ceEEeecccccccCCCCCcceeeccccCCcccCccccCCCCcCcccchhhHhHHHHHHhcCCCCCCcCCccc-----ccH
Q 036011 821 VAHVSDFGLSKLFDEGDDSVTQTMTIATIGYMAPEYGTEGIVSSKCDVYSYGVLLTETFTRKKPTDDMFTGE-----MSL 895 (977)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----~~~ 895 (977)
.++++|||.+....... ...+||+.|+|||++....++.++||||+||+++||++|+.||....... ..+
T Consensus 170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 49999999998654322 33569999999999999999999999999999999999999996532210 111
Q ss_pred HHHHHhh--CCCch-------hhhcch-----hhhccc---------cCchHHHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 036011 896 KKWVKES--LPHGL-------MEVVDT-----NLLRQE---------HTSSAEMDCLLSVLHLALDCCMESPDQRIYMTD 952 (977)
Q Consensus 896 ~~~~~~~--~~~~~-------~~~~~~-----~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 952 (977)
...+... .+... ....+. .+.... ............+.+++.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1111100 00000 000000 000000 000112345667899999999999999999999
Q ss_pred HHHH
Q 036011 953 AAVK 956 (977)
Q Consensus 953 v~~~ 956 (977)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.1e-33 Score=303.98 Aligned_cols=258 Identities=35% Similarity=0.557 Sum_probs=236.4
Q ss_pred ccccccccCcccc--cCCccccccccccEEEeec-CccCCCCChhhhccCCCCEEEeecccccCccccccccccccceee
Q 036011 351 LQNFYAYDCKLTG--NIPHEIGNLRSLIVLSLFI-NALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIR 427 (977)
Q Consensus 351 L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 427 (977)
++.|++.+|.+++ .+|.+++++++|++|+|++ |.+.|.+|.+|+++++|++|+|++|++.+..+..+..+.+|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4444444444444 4788999999999999986 899999999999999999999999999999999999999999999
Q ss_pred ecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccC-ceEEccCCCCCCCCccccccccccCeeeCcCCcCC
Q 036011 428 LNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYL-LAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLS 506 (977)
Q Consensus 428 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 506 (977)
+++|++.+.+|..+..++.|+.+++++|++.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 99999999999999999999999999999999999999998876 889999999999999998887654 7999999999
Q ss_pred CCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCCCCCC
Q 036011 507 GDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIPANGP 586 (977)
Q Consensus 507 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 586 (977)
+.+|..++.+++|+.+++++|.+++.+| .++.+++|+.|||++|+++|.+|..|.++++|++|+|++|+++|.||+.+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 9999999999999999999999997665 689999999999999999999999999999999999999999999999888
Q ss_pred CCcCCCCCcccCccccCCCccCCCCCC
Q 036011 587 FKYFAPQSFSWNYALCGPTTLQVPPCR 613 (977)
Q Consensus 587 ~~~~~~~~~~~n~~lcg~~~~~~~~~~ 613 (977)
++.+....+.||+.+||.| +|+|+
T Consensus 290 L~~L~~l~l~~N~~l~g~p---lp~c~ 313 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSP---LPACT 313 (313)
T ss_dssp GGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred CCCCCHHHhCCCccccCCC---CCCCC
Confidence 8999999999999999987 57774
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.1e-28 Score=277.05 Aligned_cols=193 Identities=32% Similarity=0.424 Sum_probs=144.8
Q ss_pred ccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCC
Q 036011 367 HEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLIS 446 (977)
Q Consensus 367 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 446 (977)
..+..++++..+++++|.+++..| +...++|++|++++|.++. + +.+..+++|+.|++++|++++..+ +..+++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~ 264 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTK 264 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred cccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--cccccc
Confidence 345566777777777777775443 4556778888888888773 2 356777888888888888875443 677788
Q ss_pred CCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCC
Q 036011 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLAS 526 (977)
Q Consensus 447 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 526 (977)
|++|++++|++++.. .+..++.++.+.++.|.+++ ...+..+++++.|++++|++++.. .+..+++|+.|+|++
T Consensus 265 L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~ 338 (384)
T d2omza2 265 LTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN 338 (384)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred CCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCC
Confidence 888888888887543 36677888888888888875 235777888888888888888543 377888888888888
Q ss_pred ccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCC
Q 036011 527 NQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575 (977)
Q Consensus 527 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 575 (977)
|+|++ ++ .++++++|++|+|++|+|++..| +.++++|++|+|++|
T Consensus 339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88884 44 58888888888888888886544 788888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.7e-28 Score=275.46 Aligned_cols=166 Identities=30% Similarity=0.403 Sum_probs=122.3
Q ss_pred cccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeee
Q 036011 372 LRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELN 451 (977)
Q Consensus 372 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 451 (977)
.++|+.|++++|.++. +..+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..++.++.++
T Consensus 218 ~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~ 291 (384)
T d2omza2 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291 (384)
T ss_dssp CTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccc
Confidence 4455666666666653 2356667777777777777764433 6667777777777777774432 66777888888
Q ss_pred cCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccc
Q 036011 452 LGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEG 531 (977)
Q Consensus 452 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 531 (977)
+++|++.+ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .++.+++|++|+|++|+|++
T Consensus 292 ~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 292 LNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp CCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCB
T ss_pred cccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCC
Confidence 88888875 234777788888888888888643 37788888999999998883 44 58888899999999999987
Q ss_pred cccccccCccccCeeeccCC
Q 036011 532 PIPQTFGSLTGLESLDLSNN 551 (977)
Q Consensus 532 ~~p~~~~~l~~L~~L~Ls~N 551 (977)
.+| +.++++|+.|+|++|
T Consensus 366 l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 366 LTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CGG--GTTCTTCSEEECCCE
T ss_pred Chh--hccCCCCCEeeCCCC
Confidence 654 888899999999888
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=8.4e-26 Score=244.61 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=159.6
Q ss_pred CCCCcccceEecCCCCcEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCC
Q 036011 35 QPICKWVGISCGARHQRVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSF 114 (977)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 114 (977)
.+-|.|.+|.|. +.+++ .+|+.+. +.+++|+|++|+|+...+.+|.++++|++|++++|.+....
T Consensus 7 ~c~c~~~~~~C~------------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~ 71 (305)
T d1xkua_ 7 RCQCHLRVVQCS------------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71 (305)
T ss_dssp TCEEETTEEECT------------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC
T ss_pred CCEecCCEEEec------------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccc
Confidence 344566666664 45676 7888763 68999999999999866678999999999999999999666
Q ss_pred CccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccccc--ccCCccccC
Q 036011 115 PSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQ--GEIPSEIGN 192 (977)
Q Consensus 115 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~--~~~p~~l~~ 192 (977)
|..|..+++|++|++++|+++ .+|..+. ..|+.|++..|.+.+..+..+.....++.++...|... ...+..+..
T Consensus 72 ~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~ 148 (305)
T d1xkua_ 72 PGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148 (305)
T ss_dssp TTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred hhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccc
Confidence 888999999999999999998 4555432 46677777777777555555666666666666665433 233445666
Q ss_pred CCCCceEEeeccCCCCCCchhhccccceeEEEccCCcccccccCCCccccCCCCceEEEecCceeeecCCcccccccccc
Q 036011 193 LQNLEILVLGMNNLSGPIQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVFSLGKNKLTGTIPNSITNASKLT 272 (977)
Q Consensus 193 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 272 (977)
+++|+.+++++|++.. ++ ... .++|+.|++++|.+++..+..+..++.++
T Consensus 149 l~~L~~l~l~~n~l~~-l~--------------------------~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~ 198 (305)
T d1xkua_ 149 MKKLSYIRIADTNITT-IP--------------------------QGL---PPSLTELHLDGNKITKVDAASLKGLNNLA 198 (305)
T ss_dssp CTTCCEEECCSSCCCS-CC--------------------------SSC---CTTCSEEECTTSCCCEECTGGGTTCTTCC
T ss_pred ccccCccccccCCccc-cC--------------------------ccc---CCccCEEECCCCcCCCCChhHhhcccccc
Confidence 6666666666666652 22 211 24455555555555555555555555555
Q ss_pred eEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCC
Q 036011 273 GLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLR 337 (977)
Q Consensus 273 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 337 (977)
+|++++|.+++..+.+|.++++|++|+|++|+|+.++.. +..+++|++|+|++|+|+
T Consensus 199 ~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~--------l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG--------LADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp EEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTT--------TTTCSSCCEEECCSSCCC
T ss_pred ccccccccccccccccccccccceeeecccccccccccc--------cccccCCCEEECCCCccC
Confidence 555555555555555555555555555555555544321 444555555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=243.83 Aligned_cols=243 Identities=28% Similarity=0.338 Sum_probs=121.8
Q ss_pred CceEEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCC
Q 036011 246 NLRVFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRN 325 (977)
Q Consensus 246 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 325 (977)
.+++++-++++++ .+|..+. +++++|+|++|+|+.+.+..|.++++|++|++++|.+..+.+.+ +..+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~-------f~~l~~ 80 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-------FAPLVK 80 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT-------TTTCTT
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh-------hhCCCc
Confidence 3455566666666 4555553 45666666666666655556666666666666666666655433 555666
Q ss_pred CceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEee
Q 036011 326 LTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLY 405 (977)
Q Consensus 326 L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 405 (977)
|++|++++|+++.. | .. ....+..|.+.+|.+.+..+..+.....+..++..
T Consensus 81 L~~L~l~~n~l~~l-~-------------------------~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~ 132 (305)
T d1xkua_ 81 LERLYLSKNQLKEL-P-------------------------EK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132 (305)
T ss_dssp CCEEECCSSCCSBC-C-------------------------SS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred cCEecccCCccCcC-c-------------------------cc--hhhhhhhhhccccchhhhhhhhhhccccccccccc
Confidence 66666666655422 1 11 11234445555555554444445555555555555
Q ss_pred ccccc--CccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCC
Q 036011 406 GNNLE--GSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSG 483 (977)
Q Consensus 406 ~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 483 (977)
.|... ...+..+..+++|+.+++++|+++ .+|..+ +++|+.|++++|.+.+..+..|.+++.++.|++++|.+++
T Consensus 133 ~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~ 209 (305)
T d1xkua_ 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209 (305)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred cccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccc
Confidence 54332 122333444444555555555444 222221 2345555555555544444444444444444444444444
Q ss_pred CCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc
Q 036011 484 SLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530 (977)
Q Consensus 484 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 530 (977)
..+..|.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+
T Consensus 210 ~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 210 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 44444444444444444444444 33444444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-25 Score=238.89 Aligned_cols=269 Identities=24% Similarity=0.228 Sum_probs=153.8
Q ss_pred EEEecCceeeecCCcccccccccceEeecccccccccccccccccccccccccccccCCCCCCchhhhhcccccCCCCce
Q 036011 249 VFSLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTT 328 (977)
Q Consensus 249 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~ 328 (977)
.++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.+.. +..++.+..
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~-------~~~~~~~~~ 84 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-------FTGLALLEQ 84 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT-------TTTCTTCCE
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccc-------ccccccccc
Confidence 3455666666 5565554 45677777777777766666777777777777777766554432 233333333
Q ss_pred EEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeeccc
Q 036011 329 LAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNN 408 (977)
Q Consensus 329 L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 408 (977)
++... .|.++...+..|.++++|++|++++|.
T Consensus 85 l~~~~------------------------------------------------~~~~~~l~~~~~~~l~~L~~L~l~~n~ 116 (284)
T d1ozna_ 85 LDLSD------------------------------------------------NAQLRSVDPATFHGLGRLHTLHLDRCG 116 (284)
T ss_dssp EECCS------------------------------------------------CTTCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccc------------------------------------------------ccccccccchhhcccccCCEEecCCcc
Confidence 33221 223333344455555555555555555
Q ss_pred ccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccc
Q 036011 409 LEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSN 488 (977)
Q Consensus 409 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 488 (977)
+....+..+....+|+.+++++|+++++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..
T Consensus 117 ~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~ 196 (284)
T d1ozna_ 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhH
Confidence 55444445555555566666666665555555666666666666666666555666666666666666666666655666
Q ss_pred cccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccC
Q 036011 489 IQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLK 568 (977)
Q Consensus 489 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 568 (977)
|.++++|++||+++|++++..|..|+.+++|+.|+|++|++...-+ ...-...++.+....+++.+..|..+.. +.
T Consensus 197 f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~ 272 (284)
T d1ozna_ 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RD 272 (284)
T ss_dssp TTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CB
T ss_pred hhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---Cc
Confidence 6666666666666666665555666666666666666666654321 1111234555566666666655665543 33
Q ss_pred ccccCCCcccc
Q 036011 569 QLNVSHNKLEG 579 (977)
Q Consensus 569 ~L~l~~N~l~~ 579 (977)
..+++.+.|+|
T Consensus 273 l~~l~~~~l~g 283 (284)
T d1ozna_ 273 LKRLAANDLQG 283 (284)
T ss_dssp GGGSCGGGSCC
T ss_pred cccCCHHHCCC
Confidence 44455554443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.8e-25 Score=234.11 Aligned_cols=217 Identities=24% Similarity=0.211 Sum_probs=180.4
Q ss_pred cCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeee-cCCccCCCchhhhc
Q 036011 364 NIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRL-NGNKLSGPIPQCLA 442 (977)
Q Consensus 364 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L-~~N~l~~~~p~~~~ 442 (977)
.+|..+. +++++|+|++|+|++..+.+|.++++|++|++++|++....+..+..+..+..+.. ..|.++...+..|.
T Consensus 25 ~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 102 (284)
T d1ozna_ 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102 (284)
T ss_dssp SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 3444432 56788888888888666677888888888888888888777777778888888765 46667767778888
Q ss_pred CCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhccccccee
Q 036011 443 SLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTL 522 (977)
Q Consensus 443 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 522 (977)
++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|++++..+..|..+++|+.+
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence 88889999999998887777788888889999999999987777888888889999999999887777788888999999
Q ss_pred ccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccCC
Q 036011 523 SLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 523 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
++++|++++..|..|.++++|++||+++|++.+..|..|..+++|++|++++|+|.+..+
T Consensus 183 ~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999988888889999999999999999988778888888999999999999888765
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6e-24 Score=224.54 Aligned_cols=204 Identities=24% Similarity=0.218 Sum_probs=164.9
Q ss_pred ccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCee
Q 036011 371 NLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLREL 450 (977)
Q Consensus 371 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 450 (977)
....+.+++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|+.|+|++|+|+ .+| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 4455666777777777 4565553 46888888888888666677888888888888888887 344 35678888888
Q ss_pred ecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccc
Q 036011 451 NLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFE 530 (977)
Q Consensus 451 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 530 (977)
+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|+
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 88888888 45677888888888888888888777888888888999999999888666777788889999999999998
Q ss_pred ccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCCcccccC
Q 036011 531 GPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHNKLEGEI 581 (977)
Q Consensus 531 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 581 (977)
+..+..|..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|+|.+..
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 887888888999999999999988 78888888889999999999987653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.4e-22 Score=213.90 Aligned_cols=179 Identities=24% Similarity=0.201 Sum_probs=160.2
Q ss_pred ccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeec
Q 036011 373 RSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNL 452 (977)
Q Consensus 373 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 452 (977)
+++++|+|++|.|++..+.+|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+++ ..+..+..+++|++|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 57889999999998777788999999999999999998 444 3578899999999999998 45778889999999999
Q ss_pred CCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccccc
Q 036011 453 GSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGP 532 (977)
Q Consensus 453 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 532 (977)
++|++.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 999999888888999999999999999999888888899999999999999999877788999999999999999999 7
Q ss_pred ccccccCccccCeeeccCCccCC
Q 036011 533 IPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 533 ~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
+|..+..+++|+.|+|++|++..
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCC
T ss_pred cChhHCCCCCCCEEEecCCCCCC
Confidence 88888899999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.5e-22 Score=199.24 Aligned_cols=163 Identities=18% Similarity=0.184 Sum_probs=121.4
Q ss_pred CcCccccCcceEEEEEEEeCCCCEEEEEEeeccch------------------hhHHHHHHHHHHHHhcCCCCcceEeee
Q 036011 686 NECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLD------------------RAFRSFDSECEVLRNVRHRNLIKIFSS 747 (977)
Q Consensus 686 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 747 (977)
.+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35678999999999999988899999998753211 112335678899999999999988766
Q ss_pred eecCCeeEEEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCceeeCCCCceEEeec
Q 036011 748 CCNNDFRALVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGHSTPVVHCDLKPSNILLDEDMVAHVSDF 827 (977)
Q Consensus 748 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 827 (977)
.. .+++|||++++.+.+ ++......++.|++++++||| +.||+||||||+|||++++ .++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 32 379999998866543 344456789999999999999 7899999999999999965 5899999
Q ss_pred ccccccCCCCCcceeeccccCCcccCc------cccCCCCcCcccchhhHhHHH
Q 036011 828 GLSKLFDEGDDSVTQTMTIATIGYMAP------EYGTEGIVSSKCDVYSYGVLL 875 (977)
Q Consensus 828 gla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~il 875 (977)
|.|......... .|... |. ..+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999765432211 01111 11 135678899999975443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=1.3e-19 Score=199.65 Aligned_cols=96 Identities=22% Similarity=0.377 Sum_probs=60.3
Q ss_pred ccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceec
Q 036011 74 SFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDS 153 (977)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 153 (977)
.++++|||++|.++. +|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++. +
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----l-------- 96 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----L-------- 96 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----C--------
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----h--------
Confidence 357788888888876 6653 457777888888877 677654 46777777777766 2221 1
Q ss_pred cccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCC
Q 036011 154 MFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLS 207 (977)
Q Consensus 154 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~ 207 (977)
| +.|++|++++|.++ .+|. ++.+++|+.|++++|.+.
T Consensus 97 ---------p------~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 97 ---------P------PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp ---------C------TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred ---------c------cccccccccccccc-cccc-hhhhccceeecccccccc
Confidence 1 24666666666665 3442 455666666666666555
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=6.5e-20 Score=202.05 Aligned_cols=137 Identities=28% Similarity=0.344 Sum_probs=101.2
Q ss_pred cEEEEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCCccccccccCcEEecc
Q 036011 51 RVRALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFPSWIGVLSKLQILSLR 130 (977)
Q Consensus 51 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 130 (977)
.+++|||++++++ .+|+. .++|++|+|++|+|+. +|+.+ .+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4678999999998 68864 4689999999999996 68654 57899999999998 55542 1469999999
Q ss_pred CcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeecccccccCCccccCCCCCceEEeeccCCC
Q 036011 131 NNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQNLEILVLGMNNLS 207 (977)
Q Consensus 131 ~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~l~~N~l~ 207 (977)
+|.++ .+|. ++.+++|++|++++|.+.. .|.. ...+..+.+..+... .+..+..++.++.|+++.|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence 99998 4554 5778888888888887763 3322 344556666655554 3345667777777777777665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.2e-22 Score=230.66 Aligned_cols=313 Identities=22% Similarity=0.173 Sum_probs=152.4
Q ss_pred CCceEEEecCceeeec----CCcccccccccceEeeccccccccccccccc-----ccccccccccccccCCCCCCchhh
Q 036011 245 PNLRVFSLGKNKLTGT----IPNSITNASKLTGLDLSFNSFSGLIPHTFGN-----LRFLSVLNLANNYLTTDSPTAEWS 315 (977)
Q Consensus 245 ~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~~ 315 (977)
.+|++|+|++|+++.. ++..+..+++|++|+|++|.++......+.. ......+......+.. .....
T Consensus 84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~ 160 (460)
T d1z7xw1 84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA---ASCEP 160 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG---GGHHH
T ss_pred CCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccch---hhhcc
Confidence 4677777777777632 3445667778888888888876533222211 0111111222211111 11112
Q ss_pred hhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCC----CCh
Q 036011 316 FLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGT----IPS 391 (977)
Q Consensus 316 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 391 (977)
....+.....++.++++.+......-..+... + .........+++..+.+... ...
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~---l-----------------~~~~~~~~~l~~~~~~~~~~~~~~~~~ 220 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQG---L-----------------KDSPCQLEALKLESCGVTSDNCRDLCG 220 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHH---H-----------------HHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccc---c-----------------ccccccccccccccccccchhhhcccc
Confidence 23345566777777777765431100000000 0 00111223344444433211 112
Q ss_pred hhhccCCCCEEEeecccccC-----ccccccccccccceeeecCCccCCC----chhhhcCCCCCCeeecCCCcCCCCCC
Q 036011 392 TVGRLEQLQGLSLYGNNLEG-----SIPYDLCHLERLNGIRLNGNKLSGP----IPQCLASLISLRELNLGSNKFSSSIP 462 (977)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~ 462 (977)
.+...+.++.+++++|.+.. ..+........++.+++++|.+... ....+...+.++.+++++|.+.....
T Consensus 221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~ 300 (460)
T d1z7xw1 221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 300 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 23445556666666665432 1222333445666666666665422 12234455666666666666642211
Q ss_pred ccc-----cCcccCceEEccCCCCCCCCcc----ccccccccCeeeCcCCcCCCC----cchhhh-cccccceeccCCcc
Q 036011 463 SSF-----WSLEYLLAVNLSSNSLSGSLPS----NIQNLQVLINLDLSRNQLSGD----IPITIG-SLKDLVTLSLASNQ 528 (977)
Q Consensus 463 ~~~-----~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~ 528 (977)
..+ .....|+.+++++|.++..... .+....+|++|+|++|++++. ++..+. ..+.|++|+|++|+
T Consensus 301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~ 380 (460)
T d1z7xw1 301 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 380 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred chhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCC
Confidence 111 1234566666766666533222 223344677777777776532 222222 24557777777777
Q ss_pred cccc----ccccccCccccCeeeccCCccCCCCCccc----c-cccccCccccCCCccccc
Q 036011 529 FEGP----IPQTFGSLTGLESLDLSNNNLSGEIPKSL----E-ALLFLKQLNVSHNKLEGE 580 (977)
Q Consensus 529 l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~l~~N~l~~~ 580 (977)
|+.. ++..+..+++|++|||++|+|+......| . +...|+.|++++|.+..+
T Consensus 381 i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 381 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 7632 33445556777777777777764322222 1 223577777777776543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4.9e-22 Score=227.73 Aligned_cols=109 Identities=18% Similarity=0.262 Sum_probs=65.0
Q ss_pred CCCEEeCcCccCCCC-CCccccccccCcEEeccCcCCCC----CCCCcccCcCcccceeccccccccc----cCccccC-
Q 036011 99 RLRFISLDYNEFSGS-FPSWIGVLSKLQILSLRNNSFTG----PIPNSLFNLSRLEKWDSMFNIIDGN----IPSRIGN- 168 (977)
Q Consensus 99 ~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~n~i~~~----~p~~~~~- 168 (977)
+|++||+++|++++. +...+..+++|+.|+|++|.++. .++..+..+++|++|+|++|.|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 578888888888742 23445667888888888887763 2233345666677777776666421 1122211
Q ss_pred ccccceeeeeccccccc----CCccccCCCCCceEEeeccCCC
Q 036011 169 LSSLVNVNLAYNNLQGE----IPSEIGNLQNLEILVLGMNNLS 207 (977)
Q Consensus 169 l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~l~~N~l~ 207 (977)
..+|++|+|++|+++.. ++..+..+++|++|++++|.+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 23566666666666532 2344555666666666666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.2e-18 Score=178.86 Aligned_cols=167 Identities=26% Similarity=0.386 Sum_probs=72.4
Q ss_pred hhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCc
Q 036011 393 VGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLL 472 (977)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 472 (977)
+..+++|++|++++|++++..| +..+++|+.+++++|.++. ++ .+.++++|+.+++++|.+.+. ..+...+.++
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~ 132 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ 132 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred HhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccccccccccccc--chhccccchh
Confidence 3334444444444444432221 3344444444444444431 11 234444444444444444321 1233334444
Q ss_pred eEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCc
Q 036011 473 AVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNN 552 (977)
Q Consensus 473 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 552 (977)
.+.++.+.+... ..+...++|++|++++|++++.. .++++++|+.|+|++|++++. + .++++++|+.|+|++|+
T Consensus 133 ~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 133 VLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSC
T ss_pred hhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCc
Confidence 444444444321 22344445555555555554221 244555555555555555532 2 24555555555555555
Q ss_pred cCCCCCcccccccccCccccC
Q 036011 553 LSGEIPKSLEALLFLKQLNVS 573 (977)
Q Consensus 553 l~~~~p~~~~~l~~L~~L~l~ 573 (977)
|++ ++ .+.++++|+.|+++
T Consensus 207 lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 207 ISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCB-CG-GGTTCTTCCEEEEE
T ss_pred CCC-Cc-ccccCCCCCEEEee
Confidence 552 22 14555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.4e-18 Score=178.29 Aligned_cols=207 Identities=23% Similarity=0.344 Sum_probs=135.6
Q ss_pred CCceEEecCCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEe
Q 036011 325 NLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSL 404 (977)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 404 (977)
++..++++.+.+++..+ +.. ..+|++|.+.+|+++. + +.+..+++|++|++++|.+++..| +..+++|+++++
T Consensus 20 ~~~~~~l~~~~~~d~~~--~~~-l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTVT--QAD-LDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHTTCSSTTSEEC--HHH-HHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHhCCCCcCCcCC--HHH-cCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccc
Confidence 33445566666665332 111 2357777777777764 3 347777777777777777764433 777777777777
Q ss_pred ecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCC
Q 036011 405 YGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGS 484 (977)
Q Consensus 405 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 484 (977)
++|.++. ++ .+.++++|+.+++++|...+.. .+...+.++.+.++++.+... ..+...++|+.|++++|.+++.
T Consensus 93 ~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 93 SGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC
T ss_pred ccccccc-cc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccc
Confidence 7777763 22 4667777777777777766432 355666777777777777643 2356667777777777777643
Q ss_pred CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccC
Q 036011 485 LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSN 550 (977)
Q Consensus 485 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 550 (977)
..++++++|+.|+|++|++++ ++ .++.+++|++|+|++|++++.. .+.++++|+.|+|++
T Consensus 167 --~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 --TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp --GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred --hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 236777777777777777774 33 3677777777777777777543 267777777777763
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.1e-18 Score=178.97 Aligned_cols=218 Identities=17% Similarity=0.106 Sum_probs=135.7
Q ss_pred EEEcCCCCCCccCCccccCcccccEeeccCCcccccCCCCcCCCCCCCEEeCcCccCCCCCC-ccccccccCcEEeccC-
Q 036011 54 ALNLSNMGLRGTIPPHLGNFSFLMSLDISKNNFHAYLPNELGQLRRLRFISLDYNEFSGSFP-SWIGVLSKLQILSLRN- 131 (977)
Q Consensus 54 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~- 131 (977)
.++.++.+++ .+|+.+ .+++++|||++|+|+...+.+|.++++|++|+|++|.+...+| ..|..++++++|++..
T Consensus 12 ~i~c~~~~l~-~iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 3555666777 788765 3578899999999988666678888999999999888875543 4677888888888764
Q ss_pred cCCCCCCCCcccCcCcccceeccccccccccC-ccccCccccceeeeecccccccCCccccCCC-CCceEEeeccCCCCC
Q 036011 132 NSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIP-SRIGNLSSLVNVNLAYNNLQGEIPSEIGNLQ-NLEILVLGMNNLSGP 209 (977)
Q Consensus 132 n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~-~L~~L~l~~N~l~~~ 209 (977)
|.++...+..|.++++|++|++++|.+....+ ..+..+..+..+..+++++....+..|.+++ .++.|++++|+++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~- 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE- 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-
Confidence 56665555666666666666666666653222 1223334444444455555533334444433 45555555555542
Q ss_pred CchhhccccceeEEEccCCcccccccCCCccccCCCCceEE-EecCceeeecCCcccccccccceEeecccccccccccc
Q 036011 210 IQPSIFNISTITLINLFGNQLSGHLDLPPKVSYSLPNLRVF-SLGKNKLTGTIPNSITNASKLTGLDLSFNSFSGLIPHT 288 (977)
Q Consensus 210 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 288 (977)
++..++ ..++++++ ++++|+++...+..|.++++|++|+|++|+|+.+.+..
T Consensus 168 --------------------------i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 220 (242)
T d1xwdc1 168 --------------------------IHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220 (242)
T ss_dssp --------------------------ECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred --------------------------cccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence 233333 22333333 34556666433445677777777777777777666666
Q ss_pred cccccccccccccc
Q 036011 289 FGNLRFLSVLNLAN 302 (977)
Q Consensus 289 ~~~l~~L~~L~L~~ 302 (977)
|.++++|+.+++.+
T Consensus 221 ~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 221 LENLKKLRARSTYN 234 (242)
T ss_dssp CTTCCEEESSSEES
T ss_pred HcCCcccccCcCCC
Confidence 77777777777644
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.5e-18 Score=178.39 Aligned_cols=209 Identities=19% Similarity=0.182 Sum_probs=159.3
Q ss_pred cCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCcc-ccccccccccceeeec-CCccCCCchhhh
Q 036011 364 NIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSI-PYDLCHLERLNGIRLN-GNKLSGPIPQCL 441 (977)
Q Consensus 364 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~-~N~l~~~~p~~~ 441 (977)
.+|+.+. +++++|++++|.|+...+.+|.++++|++|++++|.+...+ +..|..+++++.+.+. .|++....+..|
T Consensus 22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~ 99 (242)
T d1xwdc1 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF 99 (242)
T ss_dssp SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSE
T ss_pred CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccc
Confidence 3444432 47888999999998666667889999999999999887654 4467888899988876 467776777888
Q ss_pred cCCCCCCeeecCCCcCCCCCCc-cccCcccCceEEccCCCCCCCCcccccccc-ccCeeeCcCCcCCCCcchhhhccccc
Q 036011 442 ASLISLRELNLGSNKFSSSIPS-SFWSLEYLLAVNLSSNSLSGSLPSNIQNLQ-VLINLDLSRNQLSGDIPITIGSLKDL 519 (977)
Q Consensus 442 ~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L 519 (977)
..+++|++|++++|++....+. .+..+..+..+...++.+....+..|.++. .++.|++++|+++ .++.......++
T Consensus 100 ~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l 178 (242)
T d1xwdc1 100 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQL 178 (242)
T ss_dssp ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCE
T ss_pred cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhh
Confidence 9999999999999998754333 344566777777788888866667777665 7888999999998 455544445555
Q ss_pred ce-eccCCccccccccccccCccccCeeeccCCccCCCCCcccccccccCccccCCC
Q 036011 520 VT-LSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQLNVSHN 575 (977)
Q Consensus 520 ~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 575 (977)
.. +++++|+++...+..|.++++|+.|||++|+|+...+..|.+++.|+.+++.+.
T Consensus 179 ~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235 (242)
T ss_dssp EEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred hccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence 44 467888998655667899999999999999999555567889999998888653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=8.8e-19 Score=174.39 Aligned_cols=128 Identities=26% Similarity=0.348 Sum_probs=64.7
Q ss_pred cEEEeecCccCCCCChhhhccCCCCEEEeecccccCcc-ccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCC
Q 036011 376 IVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSI-PYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGS 454 (977)
Q Consensus 376 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 454 (977)
++++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34556666665 4444332 35555555555554322 33444555555555555555544455555555555555555
Q ss_pred CcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCC
Q 036011 455 NKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLS 506 (977)
Q Consensus 455 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 506 (977)
|+|++..|.+|.++++|+.|+|++|+|+++.|+.|..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 5555444444555555555555555555444444444445555555544444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.7e-18 Score=172.29 Aligned_cols=177 Identities=21% Similarity=0.230 Sum_probs=141.6
Q ss_pred CCEEEeecccccCccccccccccccceeeecCCccCCC-chhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEcc
Q 036011 399 LQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGP-IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLS 477 (977)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 477 (977)
.+.++.++++++ .+|..+. +++++|+|++|+|++. .+..|..+++|++|+|++|++.+..+..|..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457888899988 6676654 6788999999999764 45677889999999999999998888889999999999999
Q ss_pred CCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCCCC
Q 036011 478 SNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEI 557 (977)
Q Consensus 478 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 557 (977)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+ ...-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 999998778889999999999999999987777788889999999999998875332 2222345777788888888777
Q ss_pred CcccccccccCccccCCCcccccCC
Q 036011 558 PKSLEALLFLKQLNVSHNKLEGEIP 582 (977)
Q Consensus 558 p~~~~~l~~L~~L~l~~N~l~~~~p 582 (977)
|..+ ..++.++|+.|.+.+..+
T Consensus 166 p~~l---~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCCCCC
T ss_pred Chhh---cCCEeeecCHhhCcCCCC
Confidence 7654 456778899998887554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=3.1e-18 Score=171.45 Aligned_cols=178 Identities=29% Similarity=0.388 Sum_probs=116.3
Q ss_pred EEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCc
Q 036011 377 VLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNK 456 (977)
Q Consensus 377 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 456 (977)
.+.++.+.+++.++ ...++++++|++++|.++. + ..+..+++|++|++++|++++..| +.++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 33444555543322 2455666677777776663 2 245666777777777777765433 6677777777777777
Q ss_pred CCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCcccccccccc
Q 036011 457 FSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQT 536 (977)
Q Consensus 457 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 536 (977)
+.. ++ .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++. + .
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~ 167 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-P 167 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred ccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-c
Confidence 663 22 366777777777777776642 34667777888888888776 333 477777888888888888754 2 3
Q ss_pred ccCccccCeeeccCCccCCCCCcccccccccCcc
Q 036011 537 FGSLTGLESLDLSNNNLSGEIPKSLEALLFLKQL 570 (977)
Q Consensus 537 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 570 (977)
++++++|+.|+|++|++++ ++ .+..+++|++|
T Consensus 168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 7778888888888888773 43 46677777654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=8.1e-18 Score=169.85 Aligned_cols=164 Identities=29% Similarity=0.358 Sum_probs=87.6
Q ss_pred cCCCCEEEeecccccCccccccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEE
Q 036011 396 LEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVN 475 (977)
Q Consensus 396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 475 (977)
+.+|++|++++|.++.. + .+..+++|+.|++++|++++.. .+..+++|++|++++|+|++ +| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 33444555555544421 1 2444555555555555554322 13455555555555555553 22 355555555555
Q ss_pred ccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccccccCccccCeeeccCCccCC
Q 036011 476 LSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSNNNLSG 555 (977)
Q Consensus 476 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 555 (977)
+++|.+.. ...+..+++|+.+++++|.+++ +..+..+++|+.+++++|++++. + .++++++|+.|+|++|+|+
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~- 191 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS- 191 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-
T ss_pred cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC-
Confidence 55555542 2345555666666666666653 22455566666666666666643 2 2566666666666666665
Q ss_pred CCCcccccccccCccccC
Q 036011 556 EIPKSLEALLFLKQLNVS 573 (977)
Q Consensus 556 ~~p~~~~~l~~L~~L~l~ 573 (977)
.+| .+..+++|++|+|+
T Consensus 192 ~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 192 DLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp BCG-GGTTCTTCSEEEEE
T ss_pred CCh-hhcCCCCCCEEEcc
Confidence 344 46666666666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=168.53 Aligned_cols=181 Identities=24% Similarity=0.307 Sum_probs=150.1
Q ss_pred cccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCcc
Q 036011 354 FYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433 (977)
Q Consensus 354 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 433 (977)
..+..+.+++.++. ..+.+|+.|++++|.++.. + .+..+++|++|+|++|+|++.. .+..+++|++|++++|++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34555555544443 3578899999999999853 3 4889999999999999999644 368899999999999999
Q ss_pred CCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhh
Q 036011 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI 513 (977)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 513 (977)
++ +| .+..+++|+.|++++|.+.. ...+..++.|+.+++++|.+++ +..+..+++|+++++++|++++ ++ .+
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l 174 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PL 174 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GG
T ss_pred cc-cc-cccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc-cc-cc
Confidence 84 45 58899999999999999874 3468889999999999999984 4467889999999999999985 44 38
Q ss_pred hcccccceeccCCccccccccccccCccccCeeeccC
Q 036011 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESLDLSN 550 (977)
Q Consensus 514 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 550 (977)
+.+++|+.|+|++|+|+. +| .+.++++|+.|+|++
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 899999999999999985 55 599999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=6e-17 Score=161.91 Aligned_cols=177 Identities=28% Similarity=0.385 Sum_probs=144.7
Q ss_pred cccccCcccccCCccccccccccEEEeecCccCCCCChhhhccCCCCEEEeecccccCccccccccccccceeeecCCcc
Q 036011 354 FYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPSTVGRLEQLQGLSLYGNNLEGSIPYDLCHLERLNGIRLNGNKL 433 (977)
Q Consensus 354 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 433 (977)
..+..+.+++.++ ...+.++++|++++|.++. + +.+..+++|++|++++|++++..| +.++++|+.|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 3455555554332 3467899999999999984 3 358889999999999999986543 88999999999999998
Q ss_pred CCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhh
Q 036011 434 SGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITI 513 (977)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 513 (977)
.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|++|++++|++++ ++ .+
T Consensus 97 ~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~-l~-~l 168 (199)
T d2omxa2 97 AD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTD-LK-PL 168 (199)
T ss_dssp CC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-GG
T ss_pred cc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccC-Cc-cc
Confidence 84 34 488999999999999998853 358889999999999999984 3 468889999999999999985 43 48
Q ss_pred hcccccceeccCCccccccccccccCccccCee
Q 036011 514 GSLKDLVTLSLASNQFEGPIPQTFGSLTGLESL 546 (977)
Q Consensus 514 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 546 (977)
+++++|+.|++++|++++ ++ .++++++|++|
T Consensus 169 ~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 899999999999999985 44 58889999876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.1e-14 Score=132.31 Aligned_cols=101 Identities=24% Similarity=0.298 Sum_probs=44.5
Q ss_pred EEeCcCccCCCCCCccccccccCcEEeccCcCCCCCCCCcccCcCcccceeccccccccccCccccCccccceeeeeccc
Q 036011 102 FISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGPIPNSLFNLSRLEKWDSMFNIIDGNIPSRIGNLSSLVNVNLAYNN 181 (977)
Q Consensus 102 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 181 (977)
+|+|++|+++ .++. ++.+++|++|++++|+++ .+|..++.+++|+.|++++|.|+ .+| .++++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 4455555554 3332 445555555555555554 23333333333333333333333 122 24455555555555555
Q ss_pred ccccC-CccccCCCCCceEEeeccCCC
Q 036011 182 LQGEI-PSEIGNLQNLEILVLGMNNLS 207 (977)
Q Consensus 182 i~~~~-p~~l~~l~~L~~L~l~~N~l~ 207 (977)
|+... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55221 123444555555555555443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.6e-14 Score=131.22 Aligned_cols=102 Identities=27% Similarity=0.366 Sum_probs=59.6
Q ss_pred CeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCc
Q 036011 448 RELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASN 527 (977)
Q Consensus 448 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 527 (977)
|.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|+.|..+++|+.|++++|+|+ .+| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 35566666665 233 2555666666666666665 34555666666666666666665 333 3566666666666666
Q ss_pred cccccc-cccccCccccCeeeccCCccC
Q 036011 528 QFEGPI-PQTFGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 528 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 554 (977)
+|++.. ...++.+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 666432 134566666666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=5.9e-15 Score=141.14 Aligned_cols=127 Identities=21% Similarity=0.199 Sum_probs=79.2
Q ss_pred hcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhcccccc
Q 036011 441 LASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLV 520 (977)
Q Consensus 441 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 520 (977)
+.++.+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 3445566666666666663 35555566666666666666663 2 3466667777777777777643334455677777
Q ss_pred eeccCCcccccccc-ccccCccccCeeeccCCccCCCCCc----ccccccccCccc
Q 036011 521 TLSLASNQFEGPIP-QTFGSLTGLESLDLSNNNLSGEIPK----SLEALLFLKQLN 571 (977)
Q Consensus 521 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 571 (977)
.|+|++|+|+.... ..+..+++|+.|++++|+++ ..|. .+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 77777777763211 35667777777777777776 3332 356677777766
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=9.9e-16 Score=162.06 Aligned_cols=124 Identities=17% Similarity=0.134 Sum_probs=63.9
Q ss_pred cEeeccCCcccccCCCCcCCC--CCCCEEeCcCccCCCCCCccccccccCcEEeccCcCCCCC-CCCcccCcCcccceec
Q 036011 77 MSLDISKNNFHAYLPNELGQL--RRLRFISLDYNEFSGSFPSWIGVLSKLQILSLRNNSFTGP-IPNSLFNLSRLEKWDS 153 (977)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l 153 (977)
+.|||+++.+.. +.++.+ ..+..+.++.+.+.. .........+|++|||++|.+++. ++..+..+++|++|++
T Consensus 3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCc---hHHHHHHhccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 367777766642 222221 234555565555442 222233445677777777666532 2233455566666666
Q ss_pred cccccccccCccccCccccceeeeecc-ccccc-CCccccCCCCCceEEeecc
Q 036011 154 MFNIIDGNIPSRIGNLSSLVNVNLAYN-NLQGE-IPSEIGNLQNLEILVLGMN 204 (977)
Q Consensus 154 ~~n~i~~~~p~~~~~l~~L~~L~L~~n-~i~~~-~p~~l~~l~~L~~L~l~~N 204 (977)
++|.+.+..+..++.+++|++|++++| .++.. +...+.++++|++|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 666665555555666666666666653 34321 1111234556666666553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=9.1e-16 Score=167.75 Aligned_cols=256 Identities=16% Similarity=0.132 Sum_probs=128.8
Q ss_pred ccccccccccccccccccccCCCCCCchhhhhcccccCCCCceEEecCCCCCCCCCcccccccccccccccccCcccccC
Q 036011 286 PHTFGNLRFLSVLNLANNYLTTDSPTAEWSFLSSLTNCRNLTTLAVASNPLRGILPPVIGNFSASLQNFYAYDCKLTGNI 365 (977)
Q Consensus 286 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~ 365 (977)
...+.....|+.|+|++|.+...... .+...+...++|+.++++++............ ...+
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~---~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~---------------~~~l 85 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAAR---WLSENIASKKDLEIAEFSDIFTGRVKDEIPEA---------------LRLL 85 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHH---HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH---------------HHHH
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHH---HHHHHHHhCCCCCEEECCCCcccccccccchH---------------HHHH
Confidence 34456677888888888887543211 23334667788888888877544211110000 0012
Q ss_pred CccccccccccEEEeecCccCCC----CChhhhccCCCCEEEeecccccCcccccc-------------ccccccceeee
Q 036011 366 PHEIGNLRSLIVLSLFINALNGT----IPSTVGRLEQLQGLSLYGNNLEGSIPYDL-------------CHLERLNGIRL 428 (977)
Q Consensus 366 p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-------------~~l~~L~~L~L 428 (977)
...+...++|+.|+|++|.++.. +...+...++|++|++++|.+.......+ ...+.|+.+.+
T Consensus 86 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l 165 (344)
T d2ca6a1 86 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 165 (344)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEEC
T ss_pred HHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeec
Confidence 23445566777777777777653 23344556777777777776642111111 12334445555
Q ss_pred cCCccCCC----chhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCc
Q 036011 429 NGNKLSGP----IPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQ 504 (977)
Q Consensus 429 ~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 504 (977)
++|+++.. +...+...+.|++|+|++|+|...... ..+...+..+++|+.|+|++|.
T Consensus 166 ~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~-------------------~~l~~~l~~~~~L~~L~Ls~N~ 226 (344)
T d2ca6a1 166 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE-------------------HLLLEGLAYCQELKVLDLQDNT 226 (344)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH-------------------HHHHTTGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccchhhhhhhhcccccccccccccccc-------------------cchhhhhcchhhhccccccccc
Confidence 55544321 122233344444444444444311000 0122334455556666666665
Q ss_pred CCCC----cchhhhcccccceeccCCccccccccccc----cC--ccccCeeeccCCccCCC----CCcccc-cccccCc
Q 036011 505 LSGD----IPITIGSLKDLVTLSLASNQFEGPIPQTF----GS--LTGLESLDLSNNNLSGE----IPKSLE-ALLFLKQ 569 (977)
Q Consensus 505 l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~ 569 (977)
++.. +...+..+++|++|+|++|.|++.....+ .. ...|++|||++|+|+.. +...+. +.++|+.
T Consensus 227 i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~ 306 (344)
T d2ca6a1 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306 (344)
T ss_dssp CHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred ccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCE
Confidence 5421 22344555666666666666654322222 21 24566677777766532 222332 4556677
Q ss_pred cccCCCccc
Q 036011 570 LNVSHNKLE 578 (977)
Q Consensus 570 L~l~~N~l~ 578 (977)
|++++|++.
T Consensus 307 L~l~~N~~~ 315 (344)
T d2ca6a1 307 LELNGNRFS 315 (344)
T ss_dssp EECTTSBSC
T ss_pred EECCCCcCC
Confidence 777777664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=8.8e-16 Score=167.88 Aligned_cols=254 Identities=18% Similarity=0.181 Sum_probs=161.3
Q ss_pred cCCcccccccccceEeeccccccccc----ccccccccccccccccccccCCCCCC---chhhhhcccccCCCCceEEec
Q 036011 260 TIPNSITNASKLTGLDLSFNSFSGLI----PHTFGNLRFLSVLNLANNYLTTDSPT---AEWSFLSSLTNCRNLTTLAVA 332 (977)
Q Consensus 260 ~~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~~~~l~~l~~L~~L~L~ 332 (977)
.+...+.+..+|++|+|++|.|.... ...+...++|+.|+++++........ ....+...+..+++|+.|+++
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 34566788899999999999986532 34566789999999998876544322 223345567788999999999
Q ss_pred CCCCCCCCCcccccccccccccccccCcccccCCccccccccccEEEeecCccCCCCChh-------------hhccCCC
Q 036011 333 SNPLRGILPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFINALNGTIPST-------------VGRLEQL 399 (977)
Q Consensus 333 ~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L 399 (977)
+|.+...... .+...+...++|+.|++++|.+....... ....+.|
T Consensus 102 ~n~i~~~~~~---------------------~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L 160 (344)
T d2ca6a1 102 DNAFGPTAQE---------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 160 (344)
T ss_dssp SCCCCTTTHH---------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cccccccccc---------------------chhhhhcccccchheecccccccccccccccccccccccccccccCccc
Confidence 9988743221 12234556789999999999875321111 2346789
Q ss_pred CEEEeecccccCc----cccccccccccceeeecCCccCCC-----chhhhcCCCCCCeeecCCCcCCCC----CCcccc
Q 036011 400 QGLSLYGNNLEGS----IPYDLCHLERLNGIRLNGNKLSGP-----IPQCLASLISLRELNLGSNKFSSS----IPSSFW 466 (977)
Q Consensus 400 ~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~ 466 (977)
+.+++++|.++.. +...+..++.|+.|++++|+++.. +...+..+++|+.|+|++|.++.. +...+.
T Consensus 161 ~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~ 240 (344)
T d2ca6a1 161 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240 (344)
T ss_dssp CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred ceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccc
Confidence 9999999998743 334456788999999999998742 334566777888888888877532 122334
Q ss_pred CcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhc--ccccceeccCCcccccc----cccccc-C
Q 036011 467 SLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGS--LKDLVTLSLASNQFEGP----IPQTFG-S 539 (977)
Q Consensus 467 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~ 539 (977)
..++|+.|+|++|.|++.....+ -..+.. ...|+.|++++|+|+.. +...+. +
T Consensus 241 ~~~~L~~L~Ls~n~i~~~g~~~l--------------------~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~ 300 (344)
T d2ca6a1 241 SWPNLRELGLNDCLLSARGAAAV--------------------VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300 (344)
T ss_dssp GCTTCCEEECTTCCCCHHHHHHH--------------------HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHH
T ss_pred ccccchhhhhhcCccCchhhHHH--------------------HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHcc
Confidence 44455555555555442111111 111111 23456666666665532 222232 3
Q ss_pred ccccCeeeccCCccC
Q 036011 540 LTGLESLDLSNNNLS 554 (977)
Q Consensus 540 l~~L~~L~Ls~N~l~ 554 (977)
+++|+.|+|++|++.
T Consensus 301 ~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 301 MPDLLFLELNGNRFS 315 (344)
T ss_dssp CTTCCEEECTTSBSC
T ss_pred CCCCCEEECCCCcCC
Confidence 556777777777775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.9e-14 Score=137.47 Aligned_cols=124 Identities=22% Similarity=0.215 Sum_probs=65.5
Q ss_pred cccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCee
Q 036011 419 HLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINL 498 (977)
Q Consensus 419 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 498 (977)
+..+|+.|+|++|+|+ .++..+..+++|+.|+|++|+|+.. + .|..+++|++|++++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3444444555555544 2233344455555555555555522 2 24555555555555555554333444555666666
Q ss_pred eCcCCcCCCCcc--hhhhcccccceeccCCcccccccc----ccccCccccCeee
Q 036011 499 DLSRNQLSGDIP--ITIGSLKDLVTLSLASNQFEGPIP----QTFGSLTGLESLD 547 (977)
Q Consensus 499 ~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~ 547 (977)
++++|+++ .++ ..+..+++|+.|++++|+++. .| ..+..+++|+.||
T Consensus 93 ~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred eecccccc-ccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 66666665 232 245566666666666666653 22 2355666677666
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2.2e-14 Score=151.49 Aligned_cols=214 Identities=17% Similarity=0.174 Sum_probs=120.4
Q ss_pred CCCCceEEEecCceeeec-CCcccccccccceEeeccccccccccccccccccccccccccc-ccCCCCCCchhhhhccc
Q 036011 243 SLPNLRVFSLGKNKLTGT-IPNSITNASKLTGLDLSFNSFSGLIPHTFGNLRFLSVLNLANN-YLTTDSPTAEWSFLSSL 320 (977)
Q Consensus 243 ~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~l 320 (977)
...+|++|+|+++.++.. ++..+..+++|++|+|++|.+++..+..+..+++|+.|+++++ .++... +...+
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~------l~~l~ 117 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA------LQTLL 117 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH------HHHHH
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccc------cchhh
Confidence 345677777777777633 3344567778888888888777666677777788888888774 343211 11123
Q ss_pred ccCCCCceEEecCCC-CCCC-CCcccccccccccccccccCcccccCCccccccccccEEEeecC--ccCCC-CChhhhc
Q 036011 321 TNCRNLTTLAVASNP-LRGI-LPPVIGNFSASLQNFYAYDCKLTGNIPHEIGNLRSLIVLSLFIN--ALNGT-IPSTVGR 395 (977)
Q Consensus 321 ~~l~~L~~L~L~~N~-l~~~-~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N--~l~~~-~p~~~~~ 395 (977)
..+++|++|+++++. ++.. +...+.. ..++|+.|+++++ .++.. +...+.+
T Consensus 118 ~~~~~L~~L~ls~c~~~~~~~~~~~~~~------------------------~~~~L~~L~l~~~~~~i~~~~l~~l~~~ 173 (284)
T d2astb2 118 SSCSRLDELNLSWCFDFTEKHVQVAVAH------------------------VSETITQLNLSGYRKNLQKSDLSTLVRR 173 (284)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHH------------------------SCTTCCEEECCSCGGGSCHHHHHHHHHH
T ss_pred HHHHhccccccccccccccccchhhhcc------------------------cccccchhhhcccccccccccccccccc
Confidence 567788888887753 2210 0011111 1245556665543 22211 2223345
Q ss_pred cCCCCEEEeecc-cccCccccccccccccceeeecCC-ccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCc-ccCc
Q 036011 396 LEQLQGLSLYGN-NLEGSIPYDLCHLERLNGIRLNGN-KLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSL-EYLL 472 (977)
Q Consensus 396 l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~ 472 (977)
+++|++|++++| .+++.....+.++++|++|++++| .+++.....++.+++|+.|+++++ ++ ...+..+ ..+.
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp 249 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALP 249 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHST
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCc
Confidence 667777777665 355555566666777777777763 555555556666777777777766 22 1122211 2233
Q ss_pred eEEccCCCCCCCCccccc
Q 036011 473 AVNLSSNSLSGSLPSNIQ 490 (977)
Q Consensus 473 ~L~L~~N~l~~~~p~~~~ 490 (977)
.|.+..+.++...+..++
T Consensus 250 ~L~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 250 HLQINCSHFTTIARPTIG 267 (284)
T ss_dssp TSEESCCCSCCTTCSSCS
T ss_pred cccccCccCCCCCCCccC
Confidence 444566666655444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=1.2e-14 Score=144.26 Aligned_cols=131 Identities=24% Similarity=0.308 Sum_probs=89.0
Q ss_pred CchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCCcchhhhc
Q 036011 436 PIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGDIPITIGS 515 (977)
Q Consensus 436 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 515 (977)
.++..+..+++|++|+|++|+|+. ++ .+.++++|+.|+|++|.|+ .+|..+..+++|++|++++|+++ .++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccc
Confidence 445667777777777777777774 33 4677777777777777776 34555555667788888888777 343 4777
Q ss_pred ccccceeccCCcccccccc-ccccCccccCeeeccCCccCCCCCcc----------cccccccCccc
Q 036011 516 LKDLVTLSLASNQFEGPIP-QTFGSLTGLESLDLSNNNLSGEIPKS----------LEALLFLKQLN 571 (977)
Q Consensus 516 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 571 (977)
+++|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+.. +..+|+|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 7788888888888774322 45777788888888888776433321 45677777765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=2.2e-14 Score=142.24 Aligned_cols=131 Identities=26% Similarity=0.312 Sum_probs=77.9
Q ss_pred ccccccccceeeecCCccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCcccccccccc
Q 036011 416 DLCHLERLNGIRLNGNKLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVL 495 (977)
Q Consensus 416 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 495 (977)
.+..+++|+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. + +.+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence 34444444444444444442 22 2455555666666666655 334444445566677777776663 2 346677777
Q ss_pred CeeeCcCCcCCCCcc--hhhhcccccceeccCCcccccccccc----------ccCccccCeeeccCCccC
Q 036011 496 INLDLSRNQLSGDIP--ITIGSLKDLVTLSLASNQFEGPIPQT----------FGSLTGLESLDLSNNNLS 554 (977)
Q Consensus 496 ~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~ 554 (977)
+.|++++|+++ .++ ..+..+++|+.|+|++|++....+.. +..+++|+.|| +..++
T Consensus 118 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 118 RVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred cccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 77777777776 333 35777788888888888776443332 55678888887 44554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=7.7e-13 Score=125.28 Aligned_cols=82 Identities=20% Similarity=0.183 Sum_probs=35.4
Q ss_pred ceeeecCCccCCCchhhhcCCCCCCeeecCCC-cCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcC
Q 036011 424 NGIRLNGNKLSGPIPQCLASLISLRELNLGSN-KFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSR 502 (977)
Q Consensus 424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 502 (977)
+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|.++++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 23444444444444444433 24433333444444444444444444433344444444444444444
Q ss_pred CcCC
Q 036011 503 NQLS 506 (977)
Q Consensus 503 N~l~ 506 (977)
|+|+
T Consensus 90 N~l~ 93 (156)
T d2ifga3 90 NALE 93 (156)
T ss_dssp SCCS
T ss_pred CCCc
Confidence 4444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=8e-12 Score=118.13 Aligned_cols=104 Identities=26% Similarity=0.212 Sum_probs=59.1
Q ss_pred EEEeecccccCccccccccccccceeeecCC-ccCCCchhhhcCCCCCCeeecCCCcCCCCCCccccCcccCceEEccCC
Q 036011 401 GLSLYGNNLEGSIPYDLCHLERLNGIRLNGN-KLSGPIPQCLASLISLRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSN 479 (977)
Q Consensus 401 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 479 (977)
.++.+++.+. ..|..+..+++|+.|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444444 33444555555555555443 255444455666666666666666666555666666666666666666
Q ss_pred CCCCCCccccccccccCeeeCcCCcCC
Q 036011 480 SLSGSLPSNIQNLQVLINLDLSRNQLS 506 (977)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 506 (977)
+|+...+..|..+ +|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCcccChhhhccc-cccccccCCCccc
Confidence 6664444444433 5677777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=2.3e-09 Score=101.65 Aligned_cols=124 Identities=23% Similarity=0.224 Sum_probs=74.9
Q ss_pred CCeeecCCCcCCCCCCccccCcccCceEEccCCCCCCCCccccccccccCeeeCcCCcCCCC--cchhhhcccccceecc
Q 036011 447 LRELNLGSNKFSSSIPSSFWSLEYLLAVNLSSNSLSGSLPSNIQNLQVLINLDLSRNQLSGD--IPITIGSLKDLVTLSL 524 (977)
Q Consensus 447 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L 524 (977)
.+.|++++++.. + .+..+..+..++..+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 445555554422 1 2333333444444444333 3344556677888888888888743 2345677888888888
Q ss_pred CCccccccccccccCccccCeeeccCCccCCCCCcc-------cccccccCccccCCCcc
Q 036011 525 ASNQFEGPIPQTFGSLTGLESLDLSNNNLSGEIPKS-------LEALLFLKQLNVSHNKL 577 (977)
Q Consensus 525 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------~~~l~~L~~L~l~~N~l 577 (977)
++|+|+...+-.+....+|+.|+|++|++++..... +..+|+|+.|| |+.+
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 888888544334444557888888888887554422 45678888775 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=9.1e-09 Score=97.37 Aligned_cols=80 Identities=28% Similarity=0.253 Sum_probs=42.6
Q ss_pred cccCceEEccCCCCCCC--CccccccccccCeeeCcCCcCCCCcchhhhcccccceeccCCccccccccc-------ccc
Q 036011 468 LEYLLAVNLSSNSLSGS--LPSNIQNLQVLINLDLSRNQLSGDIPITIGSLKDLVTLSLASNQFEGPIPQ-------TFG 538 (977)
Q Consensus 468 l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~ 538 (977)
+++|+.|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+..+....+|+.|++++|++...... .+.
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 33444444444444322 223455566666666666666633222333445667777777777644332 245
Q ss_pred CccccCeee
Q 036011 539 SLTGLESLD 547 (977)
Q Consensus 539 ~l~~L~~L~ 547 (977)
.+++|+.||
T Consensus 144 ~~P~L~~LD 152 (162)
T d1koha1 144 RFPKLLRLD 152 (162)
T ss_dssp TSTTCCEET
T ss_pred HCCCCCEEC
Confidence 667777776
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.45 E-value=4.6e-07 Score=93.15 Aligned_cols=149 Identities=14% Similarity=0.124 Sum_probs=105.7
Q ss_pred HHHHhhcCCCcCccccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeE
Q 036011 677 DIQRATDGFNECNLLGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRA 755 (977)
Q Consensus 677 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 755 (977)
++++..+.|+..+..+-++.+.||+... +++.++||+...........+.+|...++.++ +--+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4556666777666555455578999875 56678899887665555566888999988874 333567788888888999
Q ss_pred EEEeccCCCCHHHHhhcCCccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 036011 756 LVLELMPNGSLEKWLYSDNYFLDLLERLNIMIGVALALEYLHHGH----------------------------------- 800 (977)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 800 (977)
+||++++|.++.+..... .....++.++++.++.||...
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998886544221 123345566666666666311
Q ss_pred ---------------------CCCeEeCCCCCCceeeCCCCceEEeecccccc
Q 036011 801 ---------------------STPVVHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 801 ---------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877778999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=2.7e-05 Score=78.88 Aligned_cols=130 Identities=17% Similarity=0.124 Sum_probs=87.1
Q ss_pred cccCcce-EEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC--CCcceEeeeeecCCeeEEEEeccCCCCH
Q 036011 690 LLGRGSF-GSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH--RNLIKIFSSCCNNDFRALVLELMPNGSL 766 (977)
Q Consensus 690 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 766 (977)
.+..|.. +.||+...+++..+++|...... ...+..|++.++.+.. -.+.+++++..+.+..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 68999998888889999865432 3457788888887743 3356778888888888999999988665
Q ss_pred HHHhhcCCccCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 036011 767 EKWLYSDNYFLDLLERLNIMIGVALALEYLHH------------------------------------------------ 798 (977)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------------ 798 (977)
.+.. .. ....+.++++.|+.||.
T Consensus 94 ~~~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3310 01 01112233333333331
Q ss_pred -------cCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 799 -------GHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 799 -------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
.....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 112347999999999999987777899998765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=1.2e-05 Score=75.64 Aligned_cols=83 Identities=14% Similarity=0.121 Sum_probs=41.2
Q ss_pred cccCeeeCcCCcCCC----CcchhhhcccccceeccCCcccccc----ccccccCccccCeeeccCCccCCC-------C
Q 036011 493 QVLINLDLSRNQLSG----DIPITIGSLKDLVTLSLASNQFEGP----IPQTFGSLTGLESLDLSNNNLSGE-------I 557 (977)
Q Consensus 493 ~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-------~ 557 (977)
+.|++|+|++|.+.. .+...+...+.|+.|+|++|.++.. +-..+...++|++|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 444555555554432 2222333445556666666655532 222344456677777766655421 2
Q ss_pred CcccccccccCccccCCC
Q 036011 558 PKSLEALLFLKQLNVSHN 575 (977)
Q Consensus 558 p~~~~~l~~L~~L~l~~N 575 (977)
...+..-+.|+.|+++.+
T Consensus 124 ~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCCccEeeCcCC
Confidence 233444566666666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=2.4e-05 Score=73.52 Aligned_cols=11 Identities=9% Similarity=0.184 Sum_probs=6.1
Q ss_pred cCCCCEEEeec
Q 036011 396 LEQLQGLSLYG 406 (977)
Q Consensus 396 l~~L~~L~L~~ 406 (977)
.++|++|+|++
T Consensus 14 ~~~L~~L~L~~ 24 (167)
T d1pgva_ 14 DTDLKEVNINN 24 (167)
T ss_dssp CSSCCEEECTT
T ss_pred CCCCcEEEeCC
Confidence 35556666654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00021 Score=77.02 Aligned_cols=76 Identities=17% Similarity=0.211 Sum_probs=48.7
Q ss_pred CccccCcceEEEEEEEeC-CCCEEEEEEeeccc-------hhhHHHHHHHHHHHHhcC-C--CCcceEeeeeecCCeeEE
Q 036011 688 CNLLGRGSFGSVYKGTFS-DGTSFAIKVFNLQL-------DRAFRSFDSECEVLRNVR-H--RNLIKIFSSCCNNDFRAL 756 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 756 (977)
.+.||.|....||++... +++.|+||.-.... ....++...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999865 46789999643211 112334566888888763 3 334555554 4455679
Q ss_pred EEeccCCCC
Q 036011 757 VLELMPNGS 765 (977)
Q Consensus 757 v~e~~~~gs 765 (977)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.00 E-value=0.00087 Score=70.07 Aligned_cols=133 Identities=13% Similarity=0.123 Sum_probs=78.2
Q ss_pred EEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCCCCcc--eEe-----eeeecCCeeEEEEeccCCCCHH--
Q 036011 697 GSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRHRNLI--KIF-----SSCCNNDFRALVLELMPNGSLE-- 767 (977)
Q Consensus 697 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~gsL~-- 767 (977)
-.||+++.++|+.|++|+.+.. ....+++..|.+.+..+....+. ..+ ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4899999999999999998644 23346678898888887532221 111 1234456678899999764321
Q ss_pred ---HH------h---h----cC----CccCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCe
Q 036011 768 ---KW------L---Y----SD----NYFLDLL-------------------ERLNIMIGVALALEYLHH----GHSTPV 804 (977)
Q Consensus 768 ---~~------l---~----~~----~~~~~~~-------------------~~~~i~~~i~~~L~~LH~----~~~~~i 804 (977)
++ + + .. ....++. .+..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 0 0 00 0111111 111122223333333322 224578
Q ss_pred EeCCCCCCceeeCCCCceEEeecccccc
Q 036011 805 VHCDLKPSNILLDEDMVAHVSDFGLSKL 832 (977)
Q Consensus 805 vH~dlk~~NIll~~~~~~kl~Dfgla~~ 832 (977)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.98 E-value=7.4e-05 Score=70.00 Aligned_cols=44 Identities=11% Similarity=0.145 Sum_probs=22.3
Q ss_pred hhhcCCCCCCeeecCC-CcCCCCC----CccccCcccCceEEccCCCCC
Q 036011 439 QCLASLISLRELNLGS-NKFSSSI----PSSFWSLEYLLAVNLSSNSLS 482 (977)
Q Consensus 439 ~~~~~l~~L~~L~L~~-N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 482 (977)
....+.++|++|+|++ |.++... -..+...+.|+.|++++|.++
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 3344566777777776 3454211 112334455555555555544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.91 E-value=9.3e-05 Score=69.27 Aligned_cols=43 Identities=12% Similarity=0.204 Sum_probs=27.6
Q ss_pred cccccccceeeecC-CccCCC----chhhhcCCCCCCeeecCCCcCCC
Q 036011 417 LCHLERLNGIRLNG-NKLSGP----IPQCLASLISLRELNLGSNKFSS 459 (977)
Q Consensus 417 ~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 459 (977)
..+.++|+.|+|++ +.++.. +-.++...++|++|+|++|.++.
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~ 60 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSND 60 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccH
Confidence 34567777888876 445421 33445567778888888877763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.0052 Score=63.56 Aligned_cols=156 Identities=10% Similarity=0.033 Sum_probs=84.1
Q ss_pred CCHHHHHHhhcCCCcCcc-----ccCcceEEEEEEEeCCCCEEEEEEeeccchhhHHHHHHHHHHHHhcCC-----CCcc
Q 036011 673 TSYLDIQRATDGFNECNL-----LGRGSFGSVYKGTFSDGTSFAIKVFNLQLDRAFRSFDSECEVLRNVRH-----RNLI 742 (977)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv 742 (977)
.+..++.....+|.+.+. |..|---+.|+.+..+|+ +++|++.... ..+++..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 455677777778877543 446666788999886654 8999986432 22455667777777642 2222
Q ss_pred eEee---eeecCCeeEEEEeccCCCCHHHH--------------hhc----C----CccCCH------------------
Q 036011 743 KIFS---SCCNNDFRALVLELMPNGSLEKW--------------LYS----D----NYFLDL------------------ 779 (977)
Q Consensus 743 ~l~~---~~~~~~~~~lv~e~~~~gsL~~~--------------l~~----~----~~~~~~------------------ 779 (977)
...+ +.........++.+..+...... ++. . ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 2111 11223445566777665422110 000 0 000000
Q ss_pred HHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCCceeeCCCCceEEeeccccc
Q 036011 780 LERLNIMIGVALALEYLH-HGHSTPVVHCDLKPSNILLDEDMVAHVSDFGLSK 831 (977)
Q Consensus 780 ~~~~~i~~~i~~~L~~LH-~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 831 (977)
......+..+...+...+ .....|+||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111222222222222 2335789999999999999998888899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.23 E-value=0.0055 Score=65.65 Aligned_cols=73 Identities=11% Similarity=0.166 Sum_probs=49.9
Q ss_pred CccccCcceEEEEEEEeCC--------CCEEEEEEeeccchhhHHHHHHHHHHHHhcC-CCCcceEeeeeecCCeeEEEE
Q 036011 688 CNLLGRGSFGSVYKGTFSD--------GTSFAIKVFNLQLDRAFRSFDSECEVLRNVR-HRNLIKIFSSCCNNDFRALVL 758 (977)
Q Consensus 688 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 758 (977)
++.|+.|-.-.+|++...+ .+.|.+++.. .... .....+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568888889999998653 3567777765 2222 234567889998884 4444577777643 5899
Q ss_pred eccCCCCH
Q 036011 759 ELMPNGSL 766 (977)
Q Consensus 759 e~~~~gsL 766 (977)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|